PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ye, SY; Cihil, K; Stolz, DB; Pilewski, JM; Stanton, BA; Swiatecka-Urban, A				Ye, Siying; Cihil, Kristine; Stolz, Donna Beer; Pilewski, Joseph M.; Stanton, Bruce A.; Swiatecka-Urban, Agnieszka			c-Cbl Facilitates Endocytosis and Lysosomal Degradation of Cystic Fibrosis Transmembrane Conductance Regulator in Human Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CLATHRIN-COATED PITS; EGF RECEPTOR; MEDIATED ENDOCYTOSIS; NEGATIVE REGULATION; DOWN-REGULATION; RING FINGER; CFTR; MEMBRANE; UBIQUITIN	Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-activated Cl- channel expressed in the apical membrane of fluid-transporting epithelia. The apical membrane density of CFTR channels is determined, in part, by endocytosis and the postendocytic sorting of CFTR for lysosomal degradation or recycling to the plasma membrane. Although previous studies suggested that ubiquitination plays a role in the postendocytic sorting of CFTR, the specific ubiquitin ligases are unknown. c-Cbl is a multifunctional molecule with ubiquitin ligase activity and a protein adaptor function. c-Cbl co-immunoprecipitated with CFTR in primary differentiated human bronchial epithelial cells and in cultured human airway cells. Small interfering RNA-mediated silencing of c-Cbl increased CFTR expression in the plasma membrane by inhibiting CFTR endocytosis and increased CFTR-mediated Cl- currents. Silencing c-Cbl did not change the expression of the ubiquitinated fraction of plasma membrane CFTR. Moreover, the c-Cbl mutant with impaired ubiquitin ligase activity (FLAG-70Z-Cbl) did not affect the plasma membrane expression or the endocytosis of CFTR. In contrast, the c-Cbl mutant with the truncated C-terminal region (FLAG-Cbl-480), responsible for protein adaptor function, had a dominant interfering effect on the endocytosis and plasma membrane expression of CFTR. Moreover, CFTR and c-Cbl co-localized and co-immunoprecipitated in early endosomes, and silencing c-Cbl reduced the amount of ubiquitinated CFTR in early endosomes. In summary, our data demonstrate that in human airway epithelial cells, c-Cbl regulates CFTR by two mechanisms: first by acting as an adaptor protein and facilitating CFTR endocytosis by a ubiquitin-independent mechanism, and second by ubiquitinating CFTR in early endosomes and thereby facilitating the lysosomal degradation of CFTR.	[Cihil, Kristine; Swiatecka-Urban, Agnieszka] Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA; [Ye, Siying; Stanton, Bruce A.] Dartmouth Med Sch, Dept Physiol, Hanover, NH 03755 USA; [Stolz, Donna Beer; Pilewski, Joseph M.; Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15201 USA; [Pilewski, Joseph M.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Swiatecka-Urban, A (corresponding author), Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA.	asurban@pitt.edu	Ye, Siying/H-3156-2013; Swiatecka-Urban, Agnieszka/AAP-6041-2020; SWIATECKA-URBAN, AGNIESZKA/H-6494-2015; Pilewski, Joseph/AAF-5149-2021	Ye, Siying/0000-0002-0882-1642; SWIATECKA-URBAN, AGNIESZKA/0000-0002-6575-0334; 	National Institutes of Health [R01HL090767, R01-DK/HL-45881, R01-DK34533]; National Center for Research Resources [P20-RR018787]; Cystic Fibrosis Foundation;  [P30-DK072506]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090767, R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034533, R01DK045881, P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL090767 (to A. S.-U.), R01-DK/HL-45881 (to B. A. S.), R01-DK34533 (to B. A. S.), P20-RR018787 from the National Center for Research Resources (to B. A. S.), and P30-DK072506 (to J. M. P.). This work was also supported by Research Development Program grants from the Cystic Fibrosis Foundation (to J. M. P. and B. A. S.).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BLAKE TJ, 1991, ONCOGENE, V6, P653; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Chang CW, 1997, J NEUROCHEM, V69, P859; de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; de Melker AA, 2001, J CELL SCI, V114, P2167; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lin DH, 2005, P NATL ACAD SCI USA, V102, P4306, DOI 10.1073/pnas.0409767102; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Scaife RM, 2000, J CELL SCI, V113, P215; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; WATTS C, 1988, EMBO J, V7, P1937, DOI 10.1002/j.1460-2075.1988.tb03031.x	45	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27008	27018		10.1074/jbc.M110.139881	http://dx.doi.org/10.1074/jbc.M110.139881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20525683	hybrid, Green Published			2022-12-25	WOS:000281172700032
J	Chen, ZJ; Norris, JY; Finck, BN				Chen, Zhouji; Norris, Jin Y.; Finck, Brian N.			Peroxisome Proliferator-activated Receptor-gamma Coactivator-1 alpha (PGC-1 alpha) Stimulates VLDL Assembly through Activation of Cell Death-inducing DFFA-like Effector B (CideB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; FATTY-ACID OXIDATION; TRIGLYCERIDE TRANSFER PROTEIN; NUCLEAR FACTOR 4-ALPHA; APO-B; HEPATIC GLUCONEOGENESIS; HEPG2 CELLS; FAMILIAL HYPOBETALIPOPROTEINEMIA; APOLIPOPROTEIN-B; GENE-EXPRESSION	Abnormalities in very low density lipoprotein (VLDL) assembly and secretion impact intrahepatic lipid homeostasis, plasma lipoprotein profile, and energy metabolism of distal peripheral tissues. We have evaluated the role of the transcriptional coactivator, the peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), in VLDL assembly and secretion. PGC-1 alpha overexpression in HepG2 cells led to diminished rates of triglyceride (TG) synthesis but strongly stimulated VLDL-TG secretion, markedly increasing the efficiency of secretion of newly synthesized TG. PGC-1 alpha overexpression increased the rate of secretion of apoB100 and promoted secretion of larger, less dense VLDL particles. PGC-1 alpha overexpression in intact mouse liver also stimulated rates of VLDL TG secretion and attenuated hepatic TG accumulation resulting from high fat diet feeding. To determine the molecular mechanisms mediating the effect of PGC-1 alpha on VLDL assembly, we evaluated the expression of several candidate mediators known to be involved in VLDL assembly or hepatic lipid homeostasis. Cell death-inducing DFFA-like effector B (CideB) expression was greatly induced by PGC-1 alpha, and siRNA against CideB reversed the effects of PGC-1 alpha on the secretion of TG and VLDL-sized particles by HepG2 cells, indicating that CideB is a critical mediator of stimulatory effects of PGC-1 alpha on VLDL secretion. Collectively, these data suggest that PGC-1 alpha plays an important role in partitioning cytoplasmic TG toward the VLDL secretory compartments and promoting VLDL secretion via transcriptional induction of CideB.	[Chen, Zhouji; Norris, Jin Y.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA	Washington University (WUSTL)	Chen, ZJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, 660 S Euclid Ave,Box 8031, St Louis, MO 63110 USA.	zchen23@wustl.edu		Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R01 DK078187, R01 HL73939]; Digestive Diseases Research Core Center [P30 DK52574]; Nutrition Obesity Research Center at Washington University School of Medicine [P30 DK56341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK052574, R01DK078187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center; Nutrition Obesity Research Center at Washington University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078187 (to B. N. F.) and R01 HL73939 (to Z. C.). This work was also supported by the core services of the Digestive Diseases Research Core Center Grant P30 DK52574 and the Nutrition Obesity Research Center Grant P30 DK56341 at Washington University School of Medicine.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; ALEXANDER CA, 1976, J CELL BIOL, V69, P241, DOI 10.1083/jcb.69.2.241; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Blasiole DA, 2007, MOL BIOSYST, V3, P608, DOI 10.1039/b700706j; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1711; Chen ZJ, 2008, J LIPID RES, V49, P2013, DOI 10.1194/jlr.M800240-JLR200; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Chen ZJ, 2004, J LIPID RES, V45, P155, DOI 10.1194/jlr.M300275-JLR200; Chen ZJ, 2002, J BIOL CHEM, V277, P14135, DOI 10.1074/jbc.M200617200; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Da L, 2006, BIOCHEM J, V393, P779, DOI 10.1042/BJ20051027; DIXON JL, 1993, J LIPID RES, V34, P167; Duverger N, 1996, SCIENCE, V273, P966, DOI 10.1126/science.273.5277.966; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; GIBBONS GF, 1994, J LIPID RES, V35, P1801; Goldberg IJ, 2001, J CLIN ENDOCR METAB, V86, P965, DOI 10.1210/jc.86.3.965; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Hamilton R L, 1972, Adv Exp Med Biol, V26, P7; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kelder Bruce, 2007, Comp Hepatol, V6, P4, DOI 10.1186/1476-5926-6-4; Lelliott CJ, 2007, ARTERIOSCL THROM VAS, V27, P2707, DOI 10.1161/ATVBAHA.107.155739; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Li XH, 1997, J LIPID RES, V38, P1277; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin XB, 2005, AM J PHYSIOL-GASTR L, V289, pG146, DOI 10.1152/ajpgi.00309.2004; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Martinez-Jimenez CP, 2006, J BIOL CHEM, V281, P29840, DOI 10.1074/jbc.M604046200; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Neuzil J, 1998, J LIPID RES, V39, P354; Oberkofler H, 2004, BIOCHEM J, V381, P357, DOI 10.1042/BJ20040173; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Schonfeld G, 2003, J LIPID RES, V44, P878, DOI 10.1194/jlr.R300002-JLR200; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; SNIDERMAN AD, 1993, ARTERIOSCLER THROMB, V13, P629, DOI 10.1161/01.ATV.13.5.629; Swift LL, 2001, J LIPID RES, V42, P218; THRIFT RN, 1986, J LIPID RES, V27, P236; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wu XJ, 1996, J LIPID RES, V37, P1198; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; YANG LY, 1995, J LIPID RES, V36, P125; YAO ZM, 1993, ARTERIOSCLER THROMB, V13, P1476, DOI 10.1161/01.ATV.13.10.1476; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104	58	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25996	26004		10.1074/jbc.M110.141598	http://dx.doi.org/10.1074/jbc.M110.141598			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551328	hybrid, Green Published			2022-12-25	WOS:000280921000014
J	Gasser, A; Cheng, XY; Gilmore, ES; Tyrrell, L; Waxman, SG; Dib-Hajj, SD				Gasser, Andreas; Cheng, Xiaoyang; Gilmore, Elaine S.; Tyrrell, Lynda; Waxman, Stephen G.; Dib-Hajj, Sulayman D.			Two Nedd4-binding Motifs Underlie Modulation of Sodium Channel Na(v)1.6 by p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASES; CURRENT-DENSITY; AXONAL INJURY; C-TERMINUS; SCN8A; NEURONS; NEDD4; COLOCALIZATION; DETERMINANTS; ACTIVATION	Sodium channel Na(v)1.6 is essential for neuronal excitability in central and peripheral nervous systems. Loss-of-function mutations in Nav1.6 underlie motor disorders, with homozygous-null mutations causing juvenile lethality. Phosphorylation of Na(v)1.6 by the stress-induced p38 MAPK at a Pro-Gly-Ser(553)-Pro motif in its intracellular loop L1 reduces Na(v)1.6 current density in a dorsal root ganglion-derived cell line, without changing its gating properties. Phosphorylated Pro-Gly-Ser(553)-Pro motif is a putative binding site to Nedd4 ubiquitin ligases, and we hypothesized that Nedd4-like ubiquitin ligases may contribute to channel ubiquitination and internalization. We report here that p38 activation in hippocampal neurons from wild-type mice, but not from Scn8a(medtg) mice that lack Na(v)1.6, reduces tetrodotoxin-S sodium currents, suggesting isoform-specific modulation of Na(v)1.6 by p38 in these neurons. Pharmacological block of endocytosis completely abolishes p38-mediated Na(v)1.6 current reduction, supporting our hypothesis that channel internalization underlies current reduction. We also report that the ubiquitin ligase Nedd4-2 interacts with Na(v)1.6 via a Pro-Ser-Tyr(1945) motif in the C terminus of the channel and reduces Na(v)1.6 current density, and we show that this regulation requires both the Pro-Gly-Ser-Pro motif in L1 and the Pro-Ser-Tyr motif in the C terminus. Similarly, both motifs are necessary for p38-mediated reduction of Na(v)1.6 current, whereas abrogating binding of the ubiquitin ligase Nedd4-2 to the Pro-Ser-Tyr motif results in stress-mediated increase in Na(v)1.6 current density. Thus, phosphorylation of the Pro-Gly-Ser-Pro motif within L1 of Na(v)1.6 is necessary for stress-induced current modulation, with positive or negative regulation depending upon the availability of the C-terminal Pro-Ser-Tyr motif to bind Nedd4-2.	[Dib-Hajj, Sulayman D.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Gasser, Andreas; Cheng, Xiaoyang; Gilmore, Elaine S.; Tyrrell, Lynda; Waxman, Stephen G.; Dib-Hajj, Sulayman D.] Yale Univ, Ctr Neurosci & Regenerat Res, Sch Med, New Haven, CT 06510 USA; [Gasser, Andreas; Cheng, Xiaoyang; Gilmore, Elaine S.; Tyrrell, Lynda; Waxman, Stephen G.; Dib-Hajj, Sulayman D.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA; [Gilmore, Elaine S.] Yale Univ, Dept Dermatol, Sch Med, New Haven, CT 06511 USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Dib-Hajj, SD (corresponding author), Vet Affairs Connecticut Healthcare Syst, Ctr Neurosci & Regenerat Res 127A, Bldg 34,950 Campbell Ave, West Haven, CT 06516 USA.	sulayman.dib-hajj@yale.edu	Cheng, Xiaoyang/M-1257-2017; Cheng, Xiaoyang/N-9970-2019; Waxman, Stephen/Z-2507-2019; Cheng, Xiaoyang/A-1729-2012	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Waxman, Stephen/0000-0001-5718-7177; Cheng, Xiaoyang/0000-0003-1446-2815	National Multiple Sclerosis Society; Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007016] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by grants from the National Multiple Sclerosis Society and the Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs. The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Black JA, 2002, MOL BRAIN RES, V105, P19, DOI 10.1016/S0169-328X(02)00385-6; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Craner MJ, 2004, BRAIN, V127, P294, DOI 10.1093/brain/awh032; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Cummins TR, 2005, FEBS LETT, V579, P2166, DOI 10.1016/j.febslet.2005.03.009; Dargent B, 1996, NEUROSCIENCE, V73, P209, DOI 10.1016/0306-4522(95)00608-7; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Garcia KD, 1998, J NEUROSCI, V18, P5234, DOI 10.1523/JNEUROSCI.18-14-05234.1998; Garrido JJ, 2003, BIOL CELL, V95, P437, DOI 10.1016/S0248-4900(03)00091-1; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Hedstrom KL, 2006, J NEUROCHEM, V98, P1345, DOI 10.1111/j.1471-4159.2006.04001.x; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Herzog RI, 2003, J NEUROSCI, V23, P8261; Hudmon A, 2008, J NEUROSCI, V28, P3190, DOI 10.1523/JNEUROSCI.4403-07.2008; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Liu CJ, 2005, MOL CELL NEUROSCI, V28, P636, DOI 10.1016/j.mcn.2004.11.007; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Meisler MH, 2004, GENETICA, V122, P37, DOI 10.1007/s10709-004-1441-9; Meisler MH, 2001, NEUROSCIENTIST, V7, P136, DOI 10.1177/107385840100700208; Paillart C, 1996, J CELL BIOL, V134, P499, DOI 10.1083/jcb.134.2.499; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; Rush AM, 2006, EUR J NEUROSCI, V23, P2551, DOI 10.1111/j.1460-9568.2006.04789.x; Schaller KL, 2000, J COMP NEUROL, V420, P84; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wittmack EK, 2005, J NEUROSCI, V25, P6621, DOI 10.1523/JNEUROSCI.0541-05.2005; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084	48	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26149	26161		10.1074/jbc.M109.098681	http://dx.doi.org/10.1074/jbc.M109.098681			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20530479	Green Published, hybrid			2022-12-25	WOS:000280921000032
J	Wakabayashi, S; Nakamura, TY; Kobayashi, S; Hisamitsu, T				Wakabayashi, Shigeo; Nakamura, Tomoe Y.; Kobayashi, Soushi; Hisamitsu, Takashi			Novel Phorbol Ester-binding Motif Mediates Hormonal Activation of Na+/H+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INTRACELLULAR PH REGULATION; GROWTH-FACTOR; MOLECULAR PHYSIOLOGY; HOMOLOGOUS PROTEIN-1; ESSENTIAL COFACTOR; ISOFORM-1 NHE1; PHOSPHORYLATION; ALPHA; FIBROBLASTS	Protein kinase C (PKC) is considered crucial for hormonal Na+/H+ exchanger (NHE1) activation because phorbol esters (PEs) strongly activate NHE1. However, here we report that rather than PKC, direct binding of PEs/diacylglycerol to the NHE1 lipid-interacting domain (LID) and the subsequent tighter association of LID with the plasma membrane mainly underlies NHE1 activation. We show that (i) PEs directly interact with the LID of NHE1 in vitro, (ii) like PKC, green fluorescent protein (GFP)-labeled LID translocates to the plasma membrane in response to PEs and receptor agonists, (iii) LID mutations markedly inhibit these interactions and PE/receptor agonist-induced NHE1 activation, and (iv) PKC inhibitors ineffectively block NHE1 activation, except staurosporin, which itself inhibits NHE1 via LID. Thus, we propose a PKC-independent mechanism of NHE1 regulation via a PE-binding motif previously unrecognized.	[Wakabayashi, Shigeo; Nakamura, Tomoe Y.; Kobayashi, Soushi; Hisamitsu, Takashi] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Physiol, Osaka 5658565, Japan	National Cerebral & Cardiovascular Center - Japan	Wakabayashi, S (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Physiol, Fujishirodai 5-7-1, Osaka 5658565, Japan.	wak@ri.ncvc.go.jp			National Institute of Biomedical Innovation (NIBIO) [18077015, 19390080]; Ministry of Health, Labour, and Welfare of Japan [20C-3, 21A-13, nano-006]; Grants-in-Aid for Scientific Research [21590248] Funding Source: KAKEN	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas 18077015 and Grants-in-Aid for Scientific Research (B) 19390080, a grant for the Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation (NIBIO), research grants for Cardiovascular Diseases (20C-3 and 21A-13), and a grant (nano-006) for Research on Advanced Medical Technology from the Ministry of Health, Labour, and Welfare of Japan.	Aharonovitz O, 1996, J BIOL CHEM, V271, P16494, DOI 10.1074/jbc.271.28.16494; Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Attaphitaya S, 2001, AM J PHYSIOL-CELL PH, V281, pC1146, DOI 10.1152/ajpcell.2001.281.4.C1146; Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; BESTERMAN JM, 1984, J CELL BIOL, V99, P340, DOI 10.1083/jcb.99.1.340; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; GRINSTEIN S, 1985, J CELL BIOL, V101, P269, DOI 10.1083/jcb.101.1.269; Hisamitsu T, 2006, BIOCHEMISTRY-US, V45, P13346, DOI 10.1021/bi0608616; Ikeda T, 1997, J BIOCHEM-TOKYO, V121, P295; KANDASAMY RK, 1995, J BIOL CHEM, V270, P29209, DOI 10.1074/jbc.270.49.29209; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; LALLEMAIN G, 1984, J BIOL CHEM, V259, P5809; Liu FM, 2001, AM J PHYSIOL-RENAL, V280, pF415, DOI 10.1152/ajprenal.2001.280.3.F415; Maly K, 2002, FEBS LETT, V521, P205, DOI 10.1016/S0014-5793(02)02867-3; Mason D, 2007, J GEN PHYSIOL, V129, P267, DOI 10.1085/jgp.200609656; Matsushita M, 2007, AM J PHYSIOL-CELL PH, V293, pC246, DOI 10.1152/ajpcell.00464.2006; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; MOOLENAAR WH, 1984, NATURE, V312, P371, DOI 10.1038/312371a0; Nakamura TY, 2008, CIRC RES, V103, P891, DOI 10.1161/CIRCRESAHA.108.175141; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; PARIS S, 1984, J BIOL CHEM, V259, P989; Pedersen SF, 2004, J EXP ZOOL PART A, V301A, P569, DOI 10.1002/jez.a.47; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; SARDET C, 1991, J BIOL CHEM, V266, P19166; Slater SJ, 1998, J BIOL CHEM, V273, P23160, DOI 10.1074/jbc.273.36.23160; Slater SJ, 1996, J BIOL CHEM, V271, P4627; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Taylor CW, 2002, CELL, V111, P767, DOI 10.1016/S0092-8674(02)01197-2; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	54	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26652	26661		10.1074/jbc.M110.130120	http://dx.doi.org/10.1074/jbc.M110.130120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551318	Green Published, hybrid			2022-12-25	WOS:000280921000080
J	Adamczyk, P; Zenkert, C; Balasubramanian, PG; Yamada, S; Murakoshi, S; Sugahara, K; Hwang, JS; Gojobori, T; Holstein, TW; Ozbek, S				Adamczyk, Patrizia; Zenkert, Claudia; Balasubramanian, Prakash G.; Yamada, Shuhei; Murakoshi, Saori; Sugahara, Kazuyuki; Hwang, Jung Shan; Gojobori, Takashi; Holstein, Thomas W.; Ozbek, Suat			A Non-sulfated Chondroitin Stabilizes Membrane Tubulation in Cnidarian Organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; CENTRAL-NERVOUS-SYSTEM; CAENORHABDITIS-ELEGANS; CELL-DIVISION; HYDRA; PROTEOGLYCANS; NEMATOCYSTS; SULFATE; DIFFERENTIATION; IDENTIFICATION	Membrane tubulation is generally associated with rearrangements of the cytoskeleton and other cytoplasmic factors. Little is known about the contribution of extracellular matrix components to this process. Here, we demonstrate an essential role of proteoglycans in the tubulation of the cnidarian nematocyst vesicle. The morphogenesis of this extrusive organelle takes place inside a giant post-Golgi vesicle, which topologically represents extracellular space. This process includes the formation of a complex collagenous capsule structure that elongates into a long tubule, which invaginates after its completion. We show that a non-sulfated chondroitin appears as a scaffold in early morphogenesis of all nematocyst types in Hydra and Nematostella. It accompanies the tubulation of the vesicle membrane forming a provisional tubule structure, which after invagination matures by collagen incorporation. Inhibition of chondroitin synthesis by beta-xylosides arrests nematocyst morphogenesis at different stages of tubule outgrowth resulting in retention of tubule material and a depletion of mature capsules in the tentacles of hydra. Our data suggest a conserved role of proteoglycans in the stabilization of a membrane protrusion as an essential step in organelle morphogenesis.	[Yamada, Shuhei; Murakoshi, Saori; Sugahara, Kazuyuki] Hokkaido Univ, Fac Adv Life Sci, Lab Proteoglycan Signaling & Therapeut, Grad Sch Life Sci,Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Holstein, Thomas W.; Ozbek, Suat] Univ Heidelberg, Dept Mol Evolut & Genom, Inst Zool, D-69120 Heidelberg, Germany; [Hwang, Jung Shan; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Hwang, Jung Shan; Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 4118540, Japan	Hokkaido University; Ruprecht Karls University Heidelberg; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Sugahara, K (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lab Proteoglycan Signaling & Therapeut, Grad Sch Life Sci,Kita Ku, Nishi 11 Choume,Kita 21-Jo, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp; soezbek@zoo.uni-heidelberg.de	Hwang, Jung Shan/AAJ-3014-2020; Özbek, Suat/D-3701-2014	Hwang, Jung Shan/0000-0002-0908-2036; Holstein, Thomas/0000-0003-0480-4674; Ozbek, Suat/0000-0003-2569-3942	German Science Foundation (Deutsche Forschungsgemeinschaft); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [20390019]	German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the German Science Foundation (Deutsche Forschungsgemeinschaft) (to S. O. and T. W. H.) and in part by Grants-in-aid for Scientific Research (B) (20390019) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (to K. S.).	Adamczyk P, 2008, J MOL BIOL, V376, P1008, DOI 10.1016/j.jmb.2007.10.090; Bosch TCG, 2010, DEV GROWTH DIFFER, V52, P15, DOI 10.1111/j.1440-169X.2009.01143.x; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; CHAPMAN GB, 1959, J BIOPHYS BIOCHEM CY, V5, P69, DOI 10.1083/jcb.5.1.69; CHAPMAN GB, 1959, J BIOPHYS BIOCHEM CY, V5, P79, DOI 10.1083/jcb.5.1.79; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; DAVID CN, 1974, J CELL SCI, V16, P359; Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063; FAWCETT DW, 1959, J BIOPHYS BIOCHEM CY, V5, P453, DOI 10.1083/jcb.5.3.453; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; HOLSTEIN T, 1981, J ULTRA MOL STRUCT R, V75, P276, DOI 10.1016/S0022-5320(81)80085-8; HOLSTEIN TW, 1990, DEV BIOL, V142, P392, DOI 10.1016/0012-1606(90)90360-U; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Kaneiwa T, 2008, J BIOL CHEM, V283, P14971, DOI 10.1074/jbc.M709236200; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; KARAMANOS NK, 1988, BIOCHIM BIOPHYS ACTA, V966, P36, DOI 10.1016/0304-4165(88)90126-2; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; LOOMIS WF, 1953, SCIENCE, V117, P565, DOI 10.1126/science.117.3047.565; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Nakagawa H, 2007, GLYCOBIOLOGY, V17, P157, DOI 10.1093/glycob/cwl058; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Rich F., 1969, Revue Suisse de Zoologie, V76, P779; RODRIGUEZ ML, 1988, EUR J BIOCHEM, V177, P117, DOI 10.1111/j.1432-1033.1988.tb14351.x; Sakaguchi H, 2001, J BIOCHEM-TOKYO, V129, P107, DOI 10.1093/oxfordjournals.jbchem.a002820; SKAER RJ, 1973, J CELL SCI, V13, P371; SLAUTTERBACK DB, 1959, J BIOPHYS BIOCHEM CY, V5, P441, DOI 10.1083/jcb.5.3.441; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Technau U, 1996, DEV BIOL, V177, P599, DOI 10.1006/dbio.1996.0189; Watanabe H, 2009, SEMIN CELL DEV BIOL, V20, P1114, DOI 10.1016/j.semcdb.2009.09.008; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Yamada S, 1999, BIOCHEMISTRY-US, V38, P838, DOI 10.1021/bi981889n; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	38	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25613	25623		10.1074/jbc.M110.107904	http://dx.doi.org/10.1074/jbc.M110.107904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538610	Green Published, hybrid			2022-12-25	WOS:000280682400055
J	Costa, TRD; Edqvist, PJ; Broms, JE; Ahlund, MK; Forsberg, A; Francis, MS				Costa, Tiago R. D.; Edqvist, Petra J.; Broems, Jeanette E.; Ahlund, Monika K.; Forsberg, Ake; Francis, Matthew S.			YopD Self-assembly and Binding to LcrV Facilitate Type III Secretion Activity by Yersinia pseudotuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-CALCIUM-RESPONSE; TARGET-CELL CONTACT; V-ANTIGEN; TRANSLOCATORS YOPB; TIP COMPLEX; POSTTRANSCRIPTIONAL MECHANISM; PSEUDOMONAS-AERUGINOSA; AMPHIPATHIC DOMAIN; SHIGELLA-FLEXNERI; GENETIC-ANALYSIS	YopD-like translocator proteins encoded by several Gram-negative bacteria are important for type III secretion-dependent delivery of anti-host effectors into eukaryotic cells. This probably depends on their ability to form pores in the infected cell plasma membrane, through which effectors may gain access to the cell interior. In addition, Yersinia YopD is a negative regulator essential for the control of effector synthesis and secretion. As a prerequisite for this functional duality, YopD may need to establish molecular interactions with other key T3S components. A putative coiled-coil domain and an alpha-helical amphipathic domain, both situated in the YopD C terminus, may represent key protein-protein interaction domains. Therefore, residues within the YopD C terminus were systematically mutagenized. All 68 mutant bacteria were first screened in a variety of assays designed to identify individual residues essential for YopD function, possibly by providing the interaction interface for the docking of other T3S proteins. Mirroring the effect of a full-length yopD gene deletion, five mutant bacteria were defective for both yop regulatory control and effector delivery. Interestingly, all mutations clustered to hydrophobic amino acids of the amphipathic domain. Also situated within this domain, two additional mutants rendered YopD primarily defective in the control of Yop synthesis and secretion. Significantly, protein-protein interaction studies revealed that functionally compromised YopD variants were also defective in self-oligomerization and in the ability to engage another translocator protein, LcrV. Thus, the YopD amphipathic domain facilitates the formation of YopD/YopD and YopD/LcrV interactions, two critical events in the type III secretion process.	[Francis, Matthew S.] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Francis, Matthew S.] Umea Univ, Umea Ctr Microbial Res, SE-90187 Umea, Sweden; [Broems, Jeanette E.; Forsberg, Ake] Swedish Def Res Agcy, Div NBC Def, Dept Med Countermeasures, SE-90182 Umea, Sweden	Umea University; Umea University; Saab Group	Francis, MS (corresponding author), Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden.	matthew.francis@molbiol.umu.se	Costa, Tiago/K-8999-2019; Costa, Tiago/V-8203-2017	Costa, Tiago/0000-0003-2716-9669; Costa, Tiago/0000-0003-2716-9669; Francis, Matthew/0000-0001-6817-9535	Carl Tryggers Foundation for Scientific Research; Swedish Research Council; Foundation for Medical Research at Umea University; Swedish Medical Association; J.C. Kempe Memorial Fund	Carl Tryggers Foundation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Medical Research at Umea University; Swedish Medical Association; J.C. Kempe Memorial Fund	This work was performed within the framework of the Umea Centre for Microbial Research (UCMR) Linnaeus Program and supported by grants from the Carl Tryggers Foundation for Scientific Research, the Swedish Research Council, the Foundation for Medical Research at Umea University, the Swedish Medical Association, and the J.C. Kempe Memorial Fund.	Alli M, 2008, INT J MED MICROBIOL, V298, P183, DOI 10.1016/j.ijmm.2007.04.007; Anderson DM, 2002, J BACTERIOL, V184, P1287, DOI 10.1128/JB.184.5.1287-1295.2002; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; BERGMAN T, 1991, J BACTERIOL, V173, P1607, DOI 10.1128/jb.173.5.1607-1616.1991; Blocker A, 2000, CELL MICROBIOL, V2, P387, DOI 10.1046/j.1462-5822.2000.00068.x; BOLIN I, 1982, INFECT IMMUN, V37, P506; BOLIN I, 1984, INFECT IMMUN, V43, P72; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broms JE, 2005, J BACTERIOL, V187, P7738, DOI 10.1128/JB.187.22.7738-7752.2005; Broms JE, 2003, MICROBIOL-SGM, V149, P2615, DOI 10.1099/mic.0.26322-0; Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Brubaker RR, 2007, ADV EXP MED BIOL, V603, P116; Brubaker RR, 2005, INFECT IMMUN, V73, P4743, DOI 10.1128/IAI.73.8.4743-4752.2005; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Cambronne ED, 2002, J BACTERIOL, V184, P5880, DOI 10.1128/JB.184.21.5880-5893.2002; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Coombes BK, 2005, TRENDS MICROBIOL, V13, P92, DOI 10.1016/j.tim.2005.01.008; Deleage G, 2001, COMPUT BIOL MED, V31, P259, DOI 10.1016/S0010-4825(01)00008-7; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x; Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999; Fowler JM, 2009, MICROBIOL-SGM, V155, P2509, DOI 10.1099/mic.0.028852-0; Francis MS, 2000, MOL MICROBIOL, V38, P85, DOI 10.1046/j.1365-2958.2000.02112.x; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x; Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x; GEMSKI P, 1980, INFECT IMMUN, V27, P682, DOI 10.1128/IAI.27.2.682-685.1980; GEMSKI P, 1980, INFECT IMMUN, V28, P1044; GOGUEN JD, 1984, J BACTERIOL, V160, P842, DOI 10.1128/JB.160.3.842-848.1984; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hamada D, 2005, FEBS J, V272, P756, DOI 10.1111/j.1742-4658.2004.04513.x; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hartland EL, 1998, FEMS MICROBIOL LETT, V162, P207, DOI 10.1016/S0378-1097(98)00123-2; Higuchi R., 1989, PCR TECHNOLOGY, P61; Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x; Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x; Ivanov MI, 2008, INFECT IMMUN, V76, P5181, DOI 10.1128/IAI.00189-08; Kueltzo LA, 2003, J BIOL CHEM, V278, P2792, DOI 10.1074/jbc.M208383200; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MANT CT, 1993, AMPHIPATHIC HELIX, P39; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Olive AJ, 2007, INFECT IMMUN, V75, P2626, DOI 10.1128/IAI.01599-06; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Pallen MJ, 1997, MOL MICROBIOL, V25, P423, DOI 10.1046/j.1365-2958.1997.4901850.x; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Raab R, 2008, PROTEIN EXPRES PURIF, V58, P53, DOI 10.1016/j.pep.2007.11.001; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998; Schmid A, 2006, PROTEIN EXPRES PURIF, V49, P176, DOI 10.1016/j.pep.2006.04.012; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Shao F, 2008, CURR OPIN MICROBIOL, V11, P21, DOI 10.1016/j.mib.2008.01.005; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Swietnicki W, 2004, J BIOL CHEM, V279, P38693, DOI 10.1074/jbc.M405217200; Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793; Tengel T, 2002, EUR J BIOCHEM, V269, P3659, DOI 10.1046/j.1432-1033.2002.03051.x; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; ZAHORCHAK RJ, 1979, J BACTERIOL, V139, P792, DOI 10.1128/JB.139.3.792-799.1979	78	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25269	25284		10.1074/jbc.M110.144311	http://dx.doi.org/10.1074/jbc.M110.144311			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20525687	hybrid, Green Published			2022-12-25	WOS:000280682400020
J	Feng, H; Guo, L; Song, ZQ; Gao, HQ; Wang, D; Fu, WS; Han, JY; Li, ZY; Huang, B; Li, XA				Feng, Hong; Guo, Ling; Song, Zhiqing; Gao, Haiqing; Wang, Dan; Fu, Weisi; Han, Jingyan; Li, Zhenyu; Huang, Bin; Li, Xiang-An			Caveolin-1 Protects against Sepsis by Modulating Inflammatory Response, Alleviating Bacterial Burden, and Suppressing Thymocyte Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; MURINE MACROPHAGES; CARDIAC MYOCYTES; CECAL LIGATION; UNITED-STATES; LIVER-INJURY; CELL-DEATH; MICE; INNATE; SALMONELLA	Sepsis is a leading cause of death, which is characterized by uncontrolled inflammatory response. In this study, we report that caveolin-1, a major component of caveolae, is a critical survival factor of sepsis. We induced sepsis using a well established sepsis animal model, cecal ligation and puncture (CLP). CLP induced 67% fatality in caveolin-1 null mice, but only 27% fatality in wild type littermates (p = 0.015). Further studies revealed that mice deficient in caveolin-1 exhibited marked increase in tumor necrosis factor-alpha and interleukin-6 production 20 h following CLP treatment, indicating uncontrolled inflammatory responses in the absence of caveolin-1. Caveolin-1 null mice also had a significant increase in bacteria number recovered from liver and spleen, indicating elevated bacterial burdens. In addition, caveolin-1 null mice had a 2-fold increase in thymocyte apoptosis compared with wild type littermates, indicating caveolin-1 as a critical modulator of thymocyte apoptosis during sepsis. In conclusion, our findings demonstrate that caveolin-1 is a critical protective modulator of sepsis in mice. Caveolin-1 exerts its protective function likely through its roles in modulating inflammatory response, alleviating bacterial burdens, and suppressing thymocyte apoptosis.	[Feng, Hong; Guo, Ling; Song, Zhiqing; Wang, Dan; Fu, Weisi; Li, Xiang-An] Univ Kentucky, Sch Med, Dept Pediat, Lexington, KY 40536 USA; [Feng, Hong; Gao, Haiqing] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan 250012, Peoples R China; [Song, Zhiqing] Taian Cent Hosp, Dept Internal Med, Tai An 271000, Shandong, Peoples R China; [Han, Jingyan; Li, Zhenyu] Univ Kentucky, Sch Med, Dept Internal Med, Lexington, KY 40536 USA; [Huang, Bin] Univ Kentucky, Sch Med, Kentucky Canc Registry, Lexington, KY 40536 USA	University of Kentucky; Shandong University; University of Kentucky; University of Kentucky	Li, XA (corresponding author), Univ Kentucky, Sch Med, Dept Pediat, Biomed Biol Sci Res Bldg B365,741 S Limestone St, Lexington, KY 40536 USA.	xli2@email.uky.edu			National Institutes of Health [R01GM085231, 3R01GM085231-02S1]; American Heart Association [0530241N]; Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM085231 and 3R01GM085231-02S1. This work was also supported by the American Heart Association (0530241N) and the Children's Miracle Network (to X.-A.L.).	AYALA A, 1992, CIRC SHOCK, V36, P191; Ayala A, 2008, CURR PHARM DESIGN, V14, P1853, DOI 10.2174/138161208784980617; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; da Silva F, 2009, APOPTOSIS, V14, P509, DOI 10.1007/s10495-009-0320-3; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Gadjeva M, 2010, J IMMUNOL, V184, P296, DOI 10.4049/jimmunol.0900604; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Guo L, 2009, J BIOL CHEM, V284, P19826, DOI 10.1074/jbc.M109.020933; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Ko YG, 1999, J IMMUNOL, V162, P7217; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lalor D, 2004, CELL IMMUNOL, V230, P10, DOI 10.1016/j.cellimm.2004.08.003; Lei MG, 2005, INFECT IMMUN, V73, P8136, DOI 10.1128/IAI.73.12.8136-8143.2005; Li JW, 2005, CELL CYCLE, V4, P1599, DOI 10.4161/cc.4.11.2117; Li XA, 2005, TRENDS CARDIOVAS MED, V15, P92, DOI 10.1016/j.tcm.2005.04.001; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Razani B, 2001, J BIOL CHEM, V276, P38121; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Sessler Curtis N, 2004, Curr Opin Crit Care, V10, P354, DOI 10.1097/01.ccx.0000139363.76068.7b; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Sukumaran SK, 2002, J BIOL CHEM, V277, P50716, DOI 10.1074/jbc.M208830200; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Zhang M, 2009, AM J PHYSIOL-LUNG C, V297, pL945, DOI 10.1152/ajplung.00081.2009; Zhao J, 2009, TRENDS IMMUNOL, V30, P8, DOI 10.1016/j.it.2008.10.003; Zhao XX, 2009, BIOCHEM BIOPH RES CO, V378, P21, DOI 10.1016/j.bbrc.2008.10.123	41	46	51	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25154	25160		10.1074/jbc.M110.116897	http://dx.doi.org/10.1074/jbc.M110.116897			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534584	Green Published, hybrid			2022-12-25	WOS:000280682400007
J	May, JS; Bennett, NJ; Stevenson, PG				May, Janet S.; Bennett, Neil J.; Stevenson, Philip G.			An In Vitro System for Studying Murid Herpesvirus-4 Latency and Reactivation	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; PEPTIDE-LOADING COMPLEX; GAMMAHERPESVIRUS 68; GAMMA-HERPESVIRUS; LYTIC CYCLE; CELL LINES; GENE-EXPRESSION; KAPOSI-SARCOMA; INFECTION	The narrow species tropisms of Epstein-Barr Virus (EBV) and the Kaposi's Sarcoma-associated Herpesvirus (KSHV) have made Murid Herpesvirus-4 (MuHV-4) an important tool for understanding how gammaherpesviruses colonize their hosts. However, while MuHV-4 pathogenesis studies can assign a quantitative importance to individual genes, the complexity of in vivo infection can make the underlying mechanisms hard to discern. Furthermore, the lack of good in vitro MuHV-4 latency/reactivation systems with which to dissect mechanisms at the cellular level has made some parallels with EBV and KSHV hard to draw. Here we achieved control of the MuHV-4 lytic/latent switch in vitro by modifying the 59 untranslated region of its major lytic transactivator gene, ORF50. We terminated normal ORF50 transcripts by inserting a polyadenylation signal and transcribed ORF50 instead from a down-stream, doxycycline-inducible promoter. In this way we could establish fibroblast clones that maintained latent MuHV-4 episomes without detectable lytic replication. Productive virus reactivation was then induced with doxycycline. We used this system to show that the MuHV-4 K3 gene plays a significant role in protecting reactivating cells against CD8(+) T cell recognition.	[May, Janet S.; Bennett, Neil J.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	May, JS (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; 	Wellcome Trust; U.K. Medical Research Council; Medical Research Council [G9800943, G0701185] Funding Source: researchfish; MRC [G9800943, G0701185] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust and by the U.K. Medical Research Council. PGS is a Wellcome Trust Senior Clinical Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Ahn JW, 2002, J VIROL, V76, P6244, DOI 10.1128/JVI.76.12.6244-6256.2002; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Bennett NJ, 2005, PLOS BIOL, V3, P638, DOI 10.1371/journal.pbio.0030120; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bridgeman A, 2001, J EXP MED, V194, P301, DOI 10.1084/jem.194.3.301; Chen J, 2001, P NATL ACAD SCI USA, V98, P4119, DOI 10.1073/pnas.051004198; Coleman HM, 2003, J VIROL, V77, P13093, DOI 10.1128/JVI.77.24.13093-13105.2003; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Dutia BM, 1999, J GEN VIROL, V80, P2729, DOI 10.1099/0022-1317-80-10-2729; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; Faulkner GC, 1999, J VIROL, V73, P1555, DOI 10.1128/JVI.73.2.1555-1564.1999; Forrest JC, 2008, J VIROL, V82, P7688, DOI 10.1128/JVI.02689-07; GARDELLA T, 1984, J VIROL, V50, P248, DOI 10.1128/JVI.50.1.248-254.1984; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2009, J GEN VIROL, V90, P602, DOI 10.1099/vir.0.005785-0; Gray KS, 2010, J VIROL, V84, P4946, DOI 10.1128/JVI.00060-10; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Husain SM, 1999, P NATL ACAD SCI USA, V96, P7508, DOI 10.1073/pnas.96.13.7508; Jarousse N, 2008, J VIROL, V82, P12591, DOI 10.1128/JVI.01167-08; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Liu LZ, 1999, J IMMUNOL, V163, P868; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; May JS, 2004, J GEN VIROL, V85, P137, DOI 10.1099/vir.0.19599-0; Milho R, 2009, J GEN VIROL, V90, P21, DOI 10.1099/vir.0.006569-0; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Minarovits J, 2006, CURR TOP MICROBIOL, V310, P61; Pankiewicz R, 2005, J GENE MED, V7, P117, DOI 10.1002/jgm.644; Pantry SN, 2009, SEMIN CANCER BIOL, V19, P153, DOI 10.1016/j.semcancer.2009.02.010; Pavlova LV, 2003, J VIROL, V77, P5731, DOI 10.1128/JVI.77.10.5731-5739.2003; Persons DA, 1998, BLOOD CELL MOL DIS, V24, P167, DOI 10.1006/bcmd.1998.0184; Prince S, 2003, J VIROL, V77, P5000, DOI 10.1128/JVI.77.8.5000-5007.2003; Rice J, 2002, EUR J IMMUNOL, V32, P3481, DOI 10.1002/1521-4141(200212)32:12<3481::AID-IMMU3481>3.0.CO;2-J; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; Smit J, 2007, HORM RES, V68, P2; Stevenson PG, 2009, J GEN VIROL, V90, P2317, DOI 10.1099/vir.0.013300-0; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; Suarez AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000152; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; SUNILCHANDRA NP, 1993, VIROLOGY, V193, P825, DOI 10.1006/viro.1993.1191; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Usherwood EJ, 1996, J VIROL, V70, P6516, DOI 10.1128/JVI.70.9.6516-6518.1996; Usherwood EJ, 1996, J GEN VIROL, V77, P2819, DOI 10.1099/0022-1317-77-11-2819; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Weck KE, 1997, NAT MED, V3, P1346, DOI 10.1038/nm1297-1346; Wu TT, 2000, J VIROL, V74, P3659, DOI 10.1128/JVI.74.8.3659-3667.2000; Yang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004556; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	54	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11080	10.1371/journal.pone.0011080	http://dx.doi.org/10.1371/journal.pone.0011080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552028	Green Submitted, gold, Green Published			2022-12-25	WOS:000278662900020
J	Restall, IJ; Lorimer, IAJ				Restall, Ian J.; Lorimer, Ian A. J.			Induction of Premature Senescence by Hsp90 Inhibition in Small Cell Lung Cancer	PLOS ONE			English	Article							SHOCK-PROTEIN 90; MOLECULAR CHAPERONE; PHASE-I; GLIOBLASTOMA CELLS; RESPONSE PATHWAY; STRESS-RESPONSE; CYCLE ARREST; KINASE; TANESPIMYCIN; MACHINERY	Background: The molecular chaperone Hsp90 is a promising new target in cancer therapy and selective Hsp90 inhibitors are currently in clinical trials. Previously these inhibitors have been reported to induce either cell cycle arrest or cell death in cancer cells. Whether the cell cycle arrest is reversible or irreversible has not generally been assessed. Here we have examined in detail the cell cycle arrest and cell death responses of human small cell lung cancer cell lines to Hsp90 inhibition. Methodology/Principal Findings: In MTT assays, small cell lung cancer cells showed a biphasic response to the Hsp90 inhibitors geldanamycin and radicicol, with low concentrations causing proliferation arrest and high concentrations causing cell death. Assessment of Hsp90 intracellular activity using loss of client protein expression showed that geldanamycin concentrations that inhibited Hsp90 correlated closely with those causing proliferation arrest but not cell death. The proliferation arrest induced by low concentrations of geldanamycin was not reversed for a period of over thirty days following drug removal and showed features of senescence. Rare populations of variant small cell lung cancer cells could be isolated that had additional genetic alterations and no longer underwent irreversible proliferation arrest in response to Hsp90 inhibitors. Conclusions/Significance: We conclude that: (1) Hsp90 inhibition primarily induces premature senescence, rather than cell death, in small cell lung cancer cells; (2) small cell lung cancer cells can bypass this senescence through further genetic alterations; (3) Hsp90 inhibitor-induced cell death in small cell lung cancer cells is due to inhibition of a target other than cytosolic Hsp90. These results have implications with regard to how these inhibitors will behave in clinical trials and for the design of future inhibitors in this class.	[Restall, Ian J.; Lorimer, Ian A. J.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Restall, Ian J.; Lorimer, Ian A. J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Lorimer, Ian A. J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Restall, IJ (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	ilorimer@ohri.ca	Wang, Weili/D-1546-2011		Canadian Institutes of Health Research [62797]; Canadian Cancer Society [020121]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants to IL from the Canadian Institutes of Health Research (grant number62797)(http://www.cihr-irsc.gc.ca/e/193.html) and the Canadian Cancer Society (grant number 020121)(http://www.cancer.ca/canada-wide.aspx?sc_lang=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Baldwin RM, 2006, ONCOGENE, V25, P2909, DOI 10.1038/sj.onc.1209312; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang BD, 1999, CANCER RES, V59, P3761; COOK RM, 1993, CURR PROB CANCER, V17, P71; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Erlichman C, 2009, EXPERT OPIN INV DRUG, V18, P861, DOI 10.1517/13543780902953699; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Keppler BR, 2006, J BIOL CHEM, V281, P19840, DOI 10.1074/jbc.M511067200; Kim HR, 1999, IUBMB LIFE, V48, P425, DOI 10.1080/152165499306810; Lavictoire SJ, 2003, J BIOL CHEM, V278, P5292, DOI 10.1074/jbc.M209494200; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Munoz MJ, 1999, MOL GEN GENET, V261, P242, DOI 10.1007/s004380050963; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Oda T, 2007, BLOOD, V109, P5016, DOI 10.1182/blood-2006-08-038638; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Rodina A, 2007, NAT CHEM BIOL, V3, P498, DOI 10.1038/nchembio.2007.10; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Smith PJ, 1999, INT J RADIAT BIOL, V75, P1137, DOI 10.1080/095530099139610; Soengas MS, 2008, NATURE, V454, P586, DOI 10.1038/454586a; Srethapakdi M, 2000, CANCER RES, V60, P3940; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; 方岱宁, 1999, [力学与实践, Mechanics in Engineering], V21, P1	52	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11076	10.1371/journal.pone.0011076	http://dx.doi.org/10.1371/journal.pone.0011076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552022	gold, Green Published, Green Submitted			2022-12-25	WOS:000278662900016
J	Ali, SF; Ayub, S; Manzoor, NF; Azim, S; Afif, M; Akhtar, N; Jafery, WA; Tahir, I; Farid-ul-Hasnian, S; Uddin, N				Ali, Syed Faizan; Ayub, Samia; Manzoor, Nauman Fazal; Azim, Sidra; Afif, Muneeza; Akhtar, Nida; Jafery, Wassi Ali; Tahir, Imran; Farid-ul-Hasnian, Syed; Uddin, Najam			Knowledge and Awareness about Cervical Cancer and Its Prevention amongst Interns and Nursing Staff in Tertiary Care Hospitals in Karachi, Pakistan	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; COLLABORATIVE REANALYSIS; CHLAMYDIA-TRACHOMATIS; WOMENS KNOWLEDGE; HPV VACCINATION; INDIVIDUAL DATA; VIRUS HPV; CARCINOMA; ATTITUDES; VACCINES	Background and Objective: Cervical cancer is one of the leading causes of morbidity and mortality amongst the gynecological cancers worldwide, especially in developing countries. It is imperative for at least health professionals in developing countries like Pakistan to have a sound knowledge about the disease. This study was carried out to assess the knowledge and awareness about cervical cancer and its prevention amongst health professionals in tertiary care hospitals in Karachi, Pakistan. Methods and Design: A cross-sectional, interview based survey was conducted in June, 2009. Sample of 400 was divided between the three tertiary care centers. Convenience sampling was applied as no definitive data was available regarding the number of registered interns and nurses at each center. Results: Of all the interviews conducted, 1.8% did not know cervical cancer as a disease. Only 23.3% of the respondents were aware that cervical cancer is the most common cause of gynecological cancers and 26% knew it is second in rank in mortality. Seventy-eight percent were aware that infection is the most common cause of cervical cancer, of these 62% said that virus is the cause and 61% of the respondents knew that the virus is Human Papilloma Virus (HPV). Majority recognized that it is sexually transmitted but only a minority (41%) knew that it can be detected by PCR. Only 26% of the study population was aware of one or more risk factors. Thirty seven percent recognized Pap smear as a screening test. In total only 37 out of 400 respondents were aware of the HPV vaccine. Conclusion: This study serves to highlight that the majority of working health professionals are not adequately equipped with knowledge concerning cervical cancer. Continuing Medical Education program should be started at the hospital level along with conferences to spread knowledge about this disease.	[Ali, Syed Faizan; Farid-ul-Hasnian, Syed] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University	Ali, SF (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan.	fiq200best@hotmail.com						Anttila T, 2001, JAMA-J AM MED ASSOC, V285, P47, DOI 10.1001/jama.285.1.47; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Aziz Z, 2003, J Pak Med Assoc, V53, P350; Badar F, 2007, ASIAN PAC J CANCER P, V8, P24; Baykal C, 2008, EUR J GYNAECOL ONCOL, V29, P76; Bhurgri Y, 2007, ASIAN PAC J CANCER P, V8, P357; Bhurgri Yasmin, 2004, Asian Pac J Cancer Prev, V5, P77; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Castle PE, 2002, JNCI-J NATL CANCER I, V94, P1406, DOI 10.1093/jnci/94.18.1406; Das BC, 2008, VACCINE, V26, P2669, DOI 10.1016/j.vaccine.2008.03.056; Donders GGG, 2008, ARCH GYNECOL OBSTET, V277, P291, DOI 10.1007/s00404-007-0487-1; Ferlay J, 2001, CANC INCIDENCE MORTA; Giles M, 2006, AUST NZ J OBSTET GYN, V46, P311, DOI 10.1111/j.1479-828X.2006.00598.x; Goldsmith MR, 2007, J MED SCREEN, V14, P29, DOI 10.1258/096914107780154459; HANISCH R, 2007, INT J GYNECOL CANC; Imam SZ, 2008, ASIAN PAC J CANCER P, V9, P42; KWAN TT, 2008, SEX TRANSM INFECT; Laikangbam P, 2007, INT J GYNECOL CANCER, V17, P107, DOI 10.1111/j.1525-1438.2007.00827.x; Lee PWH, 2007, PREV MED, V45, P130, DOI 10.1016/j.ypmed.2007.07.013; Mosavel M, 2007, J HEALTH COMMUN, V12, P707, DOI 10.1080/10810730701671985; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; Nganwai P, 2008, ASIAN PAC J CANCER P, V9, P15; Pitts M, 2002, HEALTH EDUC RES, V17, P706, DOI 10.1093/her/17.6.706; Rajkumar T, 2006, INT J CANCER, V118, P1481; Rosenthal D, 2007, WOMEN HEALTH, V45, P59, DOI 10.1300/J013v45n02_04; Sankaranarayanan R, 2006, INT J GYNECOL OBSTET, V95, pS205, DOI 10.1016/S0020-7292(06)60035-0; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Shapley M, 2006, BRIT J GEN PRACT, V56, P453; Sherris J, 2005, INT J GYNECOL OBSTET, V89, pS46, DOI 10.1016/j.ijgo.2005.01.010; Stark A, 2008, CANCER DETECT PREV, V32, P15, DOI 10.1016/j.cdp.2008.02.002; TEBEU PM, 2007, INT J GYNECOL CANC; Tiro JA, 2007, CANCER EPIDEM BIOMAR, V16, P288, DOI 10.1158/1055-9965.EPI-06-0756; Vanslyke JG, 2008, QUAL HEALTH RES, V18, P584, DOI 10.1177/1049732308315734; Vrscaj MU, 2008, EUR J GYNAECOL ONCOL, V29, P148; Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639; Wheeler CM, 2007, NAT CLIN PRACT ONCOL, V4, P224, DOI 10.1038/ncponc0770	36	61	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11059	10.1371/journal.pone.0011059	http://dx.doi.org/10.1371/journal.pone.0011059			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608QA	20548787	Green Submitted, Green Published, gold			2022-12-25	WOS:000278599600017
J	Shumay, E; Fowler, JS; Volkow, ND				Shumay, Elena; Fowler, Joanna S.; Volkow, Nora D.			Genomic Features of the Human Dopamine Transporter Gene and Its Potential Epigenetic States: Implications for Phenotypic Diversity	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TANDEM REPEATS; SEGMENTAL DUPLICATIONS; PROMOTER ARCHITECTURE; TRANSCRIPTION FACTORS; SPLICING REGULATION; ALCOHOL DEPENDENCE; DNA METHYLATION; WIDE ANALYSIS; G-QUADRUPLEX	Human dopamine transporter gene (DAT1 or SLC6A3) has been associated with various brain-related diseases and behavioral traits and, as such, has been investigated intensely in experimental- and clinical-settings. However, the abundance of research data has not clarified the biological mechanism of DAT regulation; similarly, studies of DAT genotype-phenotype associations yielded inconsistent results. Hence, our understanding of the control of the DAT protein product is incomplete; having this knowledge is critical, since DAT plays the major role in the brain's dopaminergic circuitry. Accordingly, we reevaluated the genomic attributes of the SLC6A3 gene that might confer sensitivity to regulation, hypothesizing that its unique genomic characteristics might facilitate highly dynamic, region-specific DAT expression, so enabling multiple regulatory modes. Our comprehensive bioinformatic analyzes revealed very distinctive genomic characteristics of the SLC6A3, including high inter-individual variability of its sequence (897 SNPs, about 90 repeats and several CNVs spell out all abbreviations in abstract) and pronounced sensitivity to regulation by epigenetic mechanisms, as evident from the GC-bias composition (0.55) of the SLC6A3, and numerous intragenic CpG islands (27 CGIs). We propose that this unique combination of the genomic features and the regulatory attributes enables the differential expression of the DAT1 gene and fulfills seemingly contradictory demands to its regulation; that is, robustness of region-specific expression and functional dynamics.	[Shumay, Elena; Fowler, Joanna S.] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Volkow, Nora D.] Natl Inst Drug Abuse, NIH, Bethesda, MD USA	United States Department of Energy (DOE); Brookhaven National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Shumay, E (corresponding author), Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA.	eshumay@bnl.gov; fowler@bnl.gov; nvolkow@nida.nih.gov			Department of Energy, Office of Biological and Environmental Research; National Institute on Drug Abuse [KO1 DA025280-01A1, K05 DA20001]; NIH; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020001, K01DA025280] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was performed at Brookhaven National Laboratory with infrastructure support from the Department of Energy, Office of Biological and Environmental Research and funded by the National Institute on Drug Abuse, grants KO1 DA025280-01A1 (ES), K05 DA20001 (JSF) and NIH Intramural Research Program, NIDA (NDV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELGHANY M, 1989, P NATL ACAD SCI USA, V86, P1761, DOI 10.1073/pnas.86.6.1761; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Andken BB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-274; Aranda-Abreu GE, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-33; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bannon MJ, 1997, NEUROLOGY, V48, P969, DOI 10.1212/WNL.48.4.969; Barlati S, 2005, ACTA NEUROCHIR SUPPL, V93, P53; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Boeva V, 2006, BIOINFORMATICS, V22, P676, DOI 10.1093/bioinformatics/btk032; Brodskii L I, 1995, Biokhimiia, V60, P1221; Burt SA, 2008, AGGRESSIVE BEHAV, V34, P437, DOI 10.1002/ab.20251; Carlini DB, 2006, J MOL EVOL, V62, P89, DOI 10.1007/s00239-005-0055-x; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Chiang CWK, 2008, GENETICS, V180, P2277, DOI 10.1534/genetics.108.096537; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Chinta SJ, 2005, MOL BRAIN RES, V135, P81, DOI 10.1016/j.molbrainres.2004.12.014; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Cirulli F, 2009, NEUROSCI BIOBEHAV R, V33, P573, DOI 10.1016/j.neubiorev.2008.09.001; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; Conrad S, 2009, NATURE, V460, DOI 10.1038/nature08353; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Corral-Debrinski M, 2007, BBA-MOL CELL RES, V1773, P473, DOI 10.1016/j.bbamcr.2006.06.008; Crayton ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-16; Cruz-Muros I, 2009, NEUROBIOL AGING, V30, P973, DOI 10.1016/j.neurobiolaging.2007.09.009; Cusack BP, 2005, MOL BIOL EVOL, V22, P2198, DOI 10.1093/molbev/msi218; Dear PH, 2009, TRENDS BIOTECHNOL, V27, P448, DOI 10.1016/j.tibtech.2009.05.003; Denoeud F, 2003, GENOME RES, V13, P856, DOI 10.1101/gr.574403; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Drgon T, 2006, CELL MOL NEUROBIOL, V26, P875, DOI 10.1007/s10571-006-9014-3; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; DURET L, 2009, ANN REV GENOMICS HUM; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Finotti A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-110; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Frohna PA, 1997, SYNAPSE, V25, P293; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Greenwood TA, 2006, MOL PSYCHIATR, V11, P125, DOI 10.1038/sj.mp.4001764; Greenwood TA, 2002, MOL PSYCHIATR, V7, P165, DOI 10.1038/sj.mp.4000958; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Haddley K, 2008, NEUROCHEM RES, V33, P652, DOI 10.1007/s11064-007-9521-8; Hebert SS, 2007, SCIENCE, V317, P1179, DOI 10.1126/science.1148530; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hurst LD, 2009, NATURE, V457, P543, DOI 10.1038/457543a; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Jiang CZ, 2007, MOL BIOL EVOL, V24, P1991, DOI 10.1093/molbev/msm128; Kass SU, 1998, CIBA F SYMP, V214, P22; KASS SU, 1998, NOVART FDN SYMP, V214, P36; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kikin O, 2008, NUCLEIC ACIDS RES, V36, pD141, DOI 10.1093/nar/gkm982; Kim SR, 2007, DRUG METAB DISPOS, V35, P1865, DOI 10.1124/dmd.107.015339; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Krause J, 2006, WORLD J BIOL PSYCHIA, V7, P152, DOI 10.1080/15622970500518444; Kremerskothen J, 2006, J NEUROCHEM, V96, P1659, DOI 10.1111/j.1471-4159.2006.03679.x; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Kuyumcu-Martinez NM, 2006, PROG MOLEC, V44, P133; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lim MH, 2006, AM J MED GENET B, V141B, P309, DOI 10.1002/ajmg.b.30282; Lin JC, 2008, J AM CHEM SOC, V130, P14080, DOI 10.1021/ja8063638; Loria PM, 2003, CURR BIOL, V13, P1317, DOI 10.1016/S0960-9822(03)00532-3; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; McGowan PO, 2008, BRAIN RES, V1237, P12, DOI 10.1016/j.brainres.2008.07.074; Mehler-Wex C, 2006, NEUROTOX RES, V10, P167, DOI 10.1007/BF03033354; Michopoulos I, 2006, WORLD J BIOL PSYCHIA, V7, P265, DOI 10.1080/15622970600671036; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Myrick Hugh, 2003, Psychopharmacol Bull, V37 Suppl 2, P89; Nairn AC, 2001, NEURON, V32, P174, DOI 10.1016/S0896-6273(01)00469-X; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Nguyen DQ, 2008, GENOME RES, V18, P1711, DOI 10.1101/gr.077289.108; Ninio J, 2006, BIOCHIMIE, V88, P963, DOI 10.1016/j.biochi.2006.06.002; Nissim-Rafinia M, 2006, PROG MOLEC, V44, P233; O'Dushlaine CT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-175; O'Gara C, 2007, PHARMACOGENET GENOM, V17, P61, DOI 10.1097/01.fpc.0000236328.18928.4c; Okazaki N, 2005, DNA RES, V12, P181, DOI 10.1093/dnares/dsi001; Oki Masaya, 2007, Subcell Biochem, V41, P319; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ozsarac N, 2002, J NEUROCHEM, V82, P336, DOI 10.1046/j.1471-4159.2002.00964.x; Price RD, 2000, MOL PHARMACOL, V58, P859, DOI 10.1124/mol.58.4.859; PRISTUPA ZB, 1994, MOL PHARMACOL, V45, P125; Radwan A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-186; Rahman L, 2002, GENOMICS, V80, P245, DOI 10.1006/geno.2002.6826; Ralph-Williams RJ, 2003, BIOL PSYCHIAT, V53, P352, DOI 10.1016/S0006-3223(02)01489-0; Reid MS, 2005, ADDICTION, V100, P43, DOI 10.1111/j.1360-0443.2005.00990.x; Ringner M, 2005, PLOS COMPUT BIOL, V1, P585, DOI 10.1371/journal.pcbi.0010072; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Samochowiec J, 2006, NEUROSCI LETT, V410, P1, DOI 10.1016/j.neulet.2006.05.005; Santos-Reboucas CB, 2007, EUR J HUM GENET, V15, P10, DOI 10.1038/sj.ejhg.5201727; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Sawatzki HK, 2007, HUM MUTAT, V28, P99, DOI 10.1002/humu.20420; Schulz R, 2009, HUM MOL GENET, V18, P118, DOI 10.1093/hmg/ddn322; Semon M, 2006, MOL BIOL EVOL, V23, P1715, DOI 10.1093/molbev/msl034; Sethupathy P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003137; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Singh M, 2008, MOL CELL BIOCHEM, V312, P131, DOI 10.1007/s11010-008-9728-2; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stevens SE, 2009, AM J MED GENET B, V150B, P753, DOI 10.1002/ajmg.b.31010; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; THIERRYMIEG D, 2006, GENOME BIOL S1, V7, pS1211; Tzvetkov MV, 2007, GENE, V386, P52, DOI 10.1016/j.gene.2006.08.002; van der Zwaluw CS, 2009, PHARMACOGENOMICS, V10, P853, DOI 10.2217/PGS.09.24; VANDENBERGH DJ, 1992, MOL BRAIN RES, V15, P161, DOI 10.1016/0169-328X(92)90165-8; Vandenbergh DJ, 2000, MOL PSYCHIATR, V5, P283, DOI 10.1038/sj.mp.4000701; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Varriale A, 2006, GENE, V385, P111, DOI 10.1016/j.gene.2006.05.031; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Wang E, 2007, AGEING RES REV, V6, P1, DOI 10.1016/j.arr.2007.02.004; Wang GJ, 2004, BRAIN, V127, P2452, DOI 10.1093/brain/awh269; Wang J, 2005, J NEUROCHEM, V93, P474, DOI 10.1111/j.1471-4159.2005.03051.x; Wang J, 2007, EUR J NEUROSCI, V25, P1982, DOI 10.1111/j.1460-9568.2007.05460.x; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Wonodi I, 2009, AM J MED GENET B, V150B, P282, DOI 10.1002/ajmg.b.30811; Yang YK, 2008, PROG NEURO-PSYCHOPH, V32, P274, DOI 10.1016/j.pnpbp.2007.08.018; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zahniser NR, 2004, NEUROPHARMACOLOGY, V47, P80, DOI 10.1016/j.neuropharm.2004.07.010; Zelko IN, 2008, AM J RESP CELL MOL, V39, P243, DOI 10.1165/rcmb.2007-0378OC; ZHANG MQ, 2005, CURR PROTOC BIOINFOR, pCH2; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103; Zhou HL, 2007, MOL CELL BIOL, V27, P830, DOI 10.1128/MCB.01015-06; [No title captured]	148	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11067	10.1371/journal.pone.0011067	http://dx.doi.org/10.1371/journal.pone.0011067			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548783	gold, Green Published, Green Submitted			2022-12-25	WOS:000278599600023
J	Ferreira, ME; Berndt, KD; Nilsson, J; Wright, APH				Ferreira, Monica E.; Berndt, Kurt D.; Nilsson, Johan; Wright, Anthony P. H.			WD40 Domain Divergence Is Important for Functional Differences between the Fission Yeast Tup11 and Tup12 Co-Repressor Proteins	PLOS ONE			English	Article							COREPRESSOR COMPLEX; TERMINAL DOMAIN; TRANSCRIPTION; GENES; ASSOCIATION; TUP1-SSN6; GROUCHO; BINDING; TARGET; CYC8	We have previously demonstrated that subsets of Ssn6/Tup target genes have distinct requirements for the Schizosaccharomyces pombe homologs of the Tup1/Groucho/TLE co-repressor proteins, Tup11 and Tup12. The very high level of divergence in the histone interacting repression domains of the two proteins suggested that determinants distinguishing Tup11 and Tup12 might be located in this domain. Here we have combined phylogenetic and structural analysis as well as phenotypic characterization, under stress conditions that specifically require Tup12, to identify and characterize the domains involved in Tup12-specific action. The results indicate that divergence in the repression domain is not generally relevant for Tup12-specific function. Instead, we show that the more highly conserved C-terminal WD40 repeat domain of Tup12 is important for Tup12-specific function. Surface amino acid residues specific for the WD40 repeat domain of Tup12 proteins in different fission yeasts are clustered in blade 3 of the propeller-like structure that is characteristic of WD40 repeat domains. The Tup11 and Tup12 proteins in fission yeasts thus provide an excellent model system for studying the functional divergence of WD40 repeat domains.	[Ferreira, Monica E.; Berndt, Kurt D.; Nilsson, Johan; Wright, Anthony P. H.] Sodertorn Univ, Sch Life Sci, Huddinge, Sweden; [Wright, Anthony P. H.] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Ferreira, Monica E.; Berndt, Kurt D.; Wright, Anthony P. H.] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden	Sodertorn University; Karolinska Institutet; Karolinska Institutet	Ferreira, ME (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Div Canc & Dev Biol, Kansas City, KS 66103 USA.	anthony.wright@sh.se	Berndt, Kurt/J-8574-2015; Wright, Anthony/J-8187-2015	Berndt, Kurt/0000-0002-3049-967X; Wright, Anthony/0000-0003-1029-9969	Swedish Research Council; Swedish Cancer Society; Baltic Sea Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Baltic Sea Foundation	AW is supported by grants from the Swedish Research Council, the Swedish Cancer Society and the Baltic Sea Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P759, DOI 10.1093/nar/gkg134; Dang JJ, 2001, MOL CELL BIOL, V21, P5935, DOI 10.1128/MCB.21.17.5935-5945.2001; Davie JK, 2002, MOL CELL BIOL, V22, P693, DOI 10.1128/MCB.22.3.693-703.2002; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fagerstrom-Billai F, 2005, MOL CELL BIOL, V25, P716, DOI 10.1128/MCB.25.2.716-727.2005; Fagerstrom-Billai F, 2007, MOL CELL BIOL, V27, P1069, DOI 10.1128/MCB.01674-06; Green SR, 2005, MOL BIOL CELL, V16, P2605, DOI 10.1091/mbc.e05-02-0126; Jabet C, 2000, J BIOL CHEM, V275, P9011, DOI 10.1074/jbc.275.12.9011; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Mennella TA, 2003, EUKARYOT CELL, V2, P1288, DOI 10.1128/EC.2.6.1288-1303.2003; Mukai Y, 1999, MOL CELL BIOL, V19, P8461; Papamichos-Chronakis M, 2000, J BIOL CHEM, V275, P8397, DOI 10.1074/jbc.275.12.8397; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROFUMO F, 2002, P IEEE INT S IND EL, V1, P1; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; Varanasi US, 1996, MOL CELL BIOL, V16, P6707; Zhang Z, 2005, MOL CELL BIOL, V25, P7399, DOI 10.1128/MCB.25.17.7399-7411.2005; Zhang Z, 2004, J BIOL CHEM, V279, P39240, DOI 10.1074/jbc.M407159200	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11009	10.1371/journal.pone.0011009	http://dx.doi.org/10.1371/journal.pone.0011009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544037	Green Published, Green Submitted, gold			2022-12-25	WOS:000278494900021
J	Graveland, H; Wagenaar, JA; Heesterbeek, H; Mevius, D; van Duijkeren, E; Heederik, D				Graveland, Haitske; Wagenaar, Jaap A.; Heesterbeek, Hans; Mevius, Dik; van Duijkeren, Engeline; Heederik, Dick			Methicillin Resistant Staphylococcus aureus ST398 in Veal Calf Farming: Human MRSA Carriage Related with Animal Antimicrobial Usage and Farm Hygiene	PLOS ONE			English	Article							FOOD ANIMALS; HEALTH CONSEQUENCES; PET ANIMALS; TRANSMISSION; HOSPITALS; STRAINS; ORIGIN; AGENTS	Introduction: Recently a specific MRSA sequence type, ST398, emerged in food production animals and farmers. Risk factors for carrying MRSA ST398 in both animals and humans have not been fully evaluated. In this cross-sectional study, we investigated factors associated with MRSA colonization in veal calves and humans working and living on these farms. Methods: A sample of 102 veal calf farms were randomly selected and visited from March 2007-February 2008. Participating farmers were asked to fill in a questionnaire (n = 390) to identify potential risk factors. A nasal swab was taken from each participant. Furthermore, nasal swabs were taken from calves (n = 2151). Swabs were analysed for MRSA by selective enrichment and suspected colonies were confirmed as MRSA by using slide coagulase test and PCR for presence of the mecA-gene. Spa types were identified and a random selection of each spa type was tested with ST398 specific PCR. The Sequence Type of non ST398 strains was determined. Data were analyzed using logistic regression analysis. Results: Human MRSA carriage was strongly associated with intensity of animal contact and with the number of MRSA positive animals on the farm. Calves were more often carrier when treated with antibiotics, while farm hygiene was associated with a lower prevalence of MRSA. Conclusion: This is the first study showing direct associations between animal and human carriage of ST398. The direct associations between animal and human MRSA carriage and the association between MRSA and antimicrobial use in calves implicate prudent use of antibiotics in farm animals.	[Graveland, Haitske; Heederik, Dick] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Wagenaar, Jaap A.; Mevius, Dik; van Duijkeren, Engeline] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands; [Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Wagenaar, Jaap A.; Mevius, Dik] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Heederik, Dick] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Graveland, H (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	h.graveland@uu.nl		Heederik, Dick/0000-0002-4550-1437; Heesterbeek, Hans/0000-0001-8537-6418	Dutch Ministry of Agriculture, Nature and Food Quality; Product Boards for Livestock, Meat, and Eggs	Dutch Ministry of Agriculture, Nature and Food Quality; Product Boards for Livestock, Meat, and Eggs	This work was supported by the Dutch Ministry of Agriculture, Nature and Food Quality and the Product Boards for Livestock, Meat, and Eggs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AD, 2003, MICROB DRUG RESIST, V9, P373, DOI 10.1089/107662903322762815; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Dancer SJ, 2008, J ANTIMICROB CHEMOTH, V61, P246, DOI 10.1093/jac/dkm465; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Finch R., 2006, J ANTIMICROB CHEMOTH, V58, P3, DOI DOI 10.1093/JAC/DKL373; Fluit AC, 2001, J CLIN MICROBIOL, V39, P3727, DOI 10.1128/JCM.39.10.3727-3732.2001; Graveland H, 2009, VET MICROBIOL, V139, P121, DOI 10.1016/j.vetmic.2009.05.019; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Lee JH, 2003, APPL ENVIRON MICROB, V69, P6489, DOI 10.1128/AEM.69.11.6489-6494.2003; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; Nelson JM, 2007, CLIN INFECT DIS, V44, P977, DOI 10.1086/512369; Simoons-Smit AM, 2000, EUR J CLIN MICROBIOL, V19, P150, DOI 10.1007/s100960050450; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; SWARTZ MN, 2004, CLIN INFECT DIS, V3, P111; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; van den Broek IVF, 2008, EPIDEMIOL INFECT, V24, P1; van Duijkeren E, 2004, VET MICROBIOL, V103, P91, DOI 10.1016/j.vetmic.2004.07.014; van Duijkeren E, 2004, EMERG INFECT DIS, V10, P2235, DOI 10.3201/eid1012.040387; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; VandenbrouckeGrauls CMJE, 1996, INFECT CONT HOSP EP, V17, P512; Wassenberg M W M, 2008, Ned Tijdschr Geneeskd, V152, P2681; Willems RJL, 1999, ANTIMICROB AGENTS CH, V43, P483, DOI 10.1128/AAC.43.3.483	33	202	203	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10990	10.1371/journal.pone.0010990	http://dx.doi.org/10.1371/journal.pone.0010990			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544020	gold, Green Published, Green Submitted			2022-12-25	WOS:000278494900009
J	Liu, MY; Schmidt, EE; Halford, WP				Liu, Mingyu; Schmidt, Edward E.; Halford, William P.			ICP0 Dismantles Microtubule Networks in Herpes Simplex Virus-Infected Cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; EARLY REGULATORY PROTEIN; GENE-EXPRESSION; UBIQUITIN LIGASE; TYPE-1 INFECTION; NUCLEAR-LOCALIZATION; DELETION MUTANTS; VIRAL-DNA; COMPLEX; PML	Infected-cell protein 0 (ICP0) is a RING finger E3 ligase that regulates herpes simplex virus (HSV) mRNA synthesis, and strongly influences the balance between latency and replication of HSV. For 25 years, the nuclear functions of ICP0 have been the subject of intense scrutiny. To obtain new clues about ICP0's mechanism of action, we constructed HSV-1 viruses that expressed GFP-tagged ICP0. To our surprise, both GFP-tagged and wild-type ICP0 were predominantly observed in the cytoplasm of HSV-infected cells. Although ICP0 is exclusively nuclear during the immediate-early phase of HSV infection, further analysis revealed that ICP0 translocated to the cytoplasm during the early phase where it triggered a previously unrecognized process; ICP0 dismantled the microtubule network of the host cell. A RING finger mutant of ICP0 efficiently bundled microtubules, but failed to disperse microtubule bundles. Synthesis of ICP0 proved to be necessary and sufficient to disrupt microtubule networks in HSV-infected and transfected cells. Plant and animal viruses encode many proteins that reorganize microtubules. However, this is the first report of a viral E3 ligase that regulates microtubule stability. Intriguingly, several cellular E3 ligases orchestrate microtubule disassembly and reassembly during mitosis. Our results suggest that ICP0 serves a dual role in the HSV life cycle, acting first as a nuclear regulator of viral mRNA synthesis and acting later, in the cytoplasm, to dismantle the host cell's microtubule network in preparation for virion synthesis and/or egress.	[Liu, Mingyu; Halford, William P.] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA; [Schmidt, Edward E.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Southern Illinois University System; Southern Illinois University; Montana State University System; Montana State University Bozeman	Liu, MY (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu			Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health [R01 AI51414, R21 AI081072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072, R01AI051414] Funding Source: NIH RePORTER	Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine, as well as funds from the National Institutes of Health (R01 AI51414 and R21 AI081072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN M, 1984, J VIROL, V52, P108, DOI 10.1128/JVI.52.1.108-118.1984; Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; AVITABILE E, 1995, J VIROL, V69, P7472, DOI 10.1128/JVI.69.12.7472-7482.1995; Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Balliet JW, 2007, VIROLOGY, V361, P372, DOI 10.1016/j.virol.2006.11.022; Blanc S, 1996, P NATL ACAD SCI USA, V93, P15158, DOI 10.1073/pnas.93.26.15158; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Chen XP, 2000, J VIROL, V74, P10132, DOI 10.1128/JVI.74.21.10132-10141.2000; Choi E, 2008, FEBS LETT, V582, P1700, DOI 10.1016/j.febslet.2008.04.028; Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08; Cummings CM, 2009, J BIOL CHEM, V284, P11663, DOI 10.1074/jbc.M809374200; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Delboy MG, 2010, J VIROL, V84, P1637, DOI 10.1128/JVI.02041-09; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DESAI P, 1993, J VIROL, V67, P6125, DOI 10.1128/JVI.67.10.6125-6135.1993; Diefenbach RJ, 2002, J VIROL, V76, P3282, DOI 10.1128/JVI.76.7.3282-3291.2002; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Elliott G, 2005, J VIROL, V79, P9735, DOI 10.1128/JVI.79.15.9735-9745.2005; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; EVERETT R, 1995, J VIROL, V69, P7339, DOI 10.1128/JVI.69.11.7339-7344.1995; Everett RD, 2004, J VIROL, V78, P1763, DOI 10.1128/JVI.78.4.1763-1774.2004; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 1998, EMBO J, V17, P7161, DOI 10.1093/emboj/17.24.7161; EVERETT RD, 1989, J GEN VIROL, V70, P1185, DOI 10.1099/0022-1317-70-5-1185; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Everett RD, 1999, EMBO J, V18, P1526, DOI 10.1093/emboj/18.6.1526; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Everett RD, 2010, J VIROL, V84, P3476, DOI 10.1128/JVI.02544-09; Ferralli J, 2006, J VIROL, V80, P5807, DOI 10.1128/JVI.00254-06; GELMAN IH, 1986, J MOL BIOL, V191, P395, DOI 10.1016/0022-2836(86)90135-X; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2004, J VIROL, V78, P10086, DOI 10.1128/JVI.78.18.10086-10095.2004; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; HARMENBERG J, 1982, INTERVIROLOGY, V17, P215, DOI 10.1159/000149291; Hill JM, 1996, ANAL BIOCHEM, V235, P44, DOI 10.1006/abio.1996.0089; Hobbs WE, 1999, J VIROL, V73, P8245, DOI 10.1128/JVI.73.10.8245-8255.1999; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; JOACHIMS M, 1995, VIROLOGY, V211, P451, DOI 10.1006/viro.1995.1427; Kalamvoki M, 2010, J VIROL, V84, P4222, DOI 10.1128/JVI.02585-09; Kannan H, 2009, J VIROL, V83, P6375, DOI 10.1128/JVI.02571-08; KNIPE DM, 1986, MOL CELL BIOL, V6, P2371, DOI 10.1128/MCB.6.7.2371; Kotsakis A, 2001, J VIROL, V75, P8697, DOI 10.1128/JVI.75.18.8697-8711.2001; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Li H, 2008, VIROLOGY, V375, P13, DOI 10.1016/j.virol.2008.01.038; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; LILLEY CE, 2010, EMBO J; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008837; Livingston CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000619; Lomonte P, 1999, J VIROL, V73, P9456, DOI 10.1128/JVI.73.11.9456-9467.1999; Lopez P, 2001, J VIROL, V75, P3832, DOI 10.1128/JVI.75.8.3832-3840.2001; Lukashchuk V, 2010, J VIROL, V84, P4026, DOI 10.1128/JVI.02597-09; Man C, 2007, ONCOGENE, V26, P3069, DOI 10.1038/sj.onc.1210106; Maringer K, 2010, J VIROL, V84, P4682, DOI 10.1128/JVI.00126-10; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; Maul GG, 1996, VIROLOGY, V217, P67, DOI 10.1006/viro.1996.0094; Morishige N, 2006, J GEN VIROL, V87, P2817, DOI 10.1099/vir.0.82076-0; Moseley GW, 2009, J CELL SCI, V122, P3652, DOI 10.1242/jcs.045542; MULLEN MA, 1995, J VIROL, V69, P476, DOI 10.1128/JVI.69.1.476-491.1995; Nayak R, 2008, J VIROL, V82, P3803, DOI 10.1128/JVI.02532-07; NORRIS DM, 1986, CHEM PLANT PROTECTIO, V1, P97; Pierce AT, 2005, J GEN VIROL, V86, P2421, DOI 10.1099/vir.0.80979-0; Raben N, 2009, METHOD ENZYMOL, V453, P417, DOI 10.1016/S0076-6879(08)04021-4; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; REICH E, 1961, SCIENCE, V134, P556, DOI 10.1126/science.134.3478.556; Rodriguez JJ, 2004, VIRAL IMMUNOL, V17, P210, DOI 10.1089/0882824041310568; ROLLMECAK A, 2009, MICROTUBULE SEVERING; SACKS WR, 1987, J VIROL, V61, P829, DOI 10.1128/JVI.61.3.829-839.1987; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Sedlackova L, 2008, J VIROL, V82, P268, DOI 10.1128/JVI.01588-07; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Soboleski MR, 2005, FASEB J, V19, P440, DOI 10.1096/fj.04-3180fje; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; Steet R, 2006, MOL BIOL CELL, V17, P2312, DOI 10.1091/mbc.E05-08-0822; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; SZE P, 1992, VIRUS RES, V26, P141, DOI 10.1016/0168-1702(92)90153-Z; Tei S, 2009, J CELL SCI, V122, P3190, DOI 10.1242/jcs.049627; Terry-Allison T, 2007, J VIROL, V81, P12394, DOI 10.1128/JVI.01068-07; Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; WALKER GM, 1982, J GEN MICROBIOL, V128, P61; Watts NR, 2000, J CELL BIOL, V150, P349, DOI 10.1083/jcb.150.2.349; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAO F, 1994, J VIROL, V68, P8158, DOI 10.1128/JVI.68.12.8158-8168.1994; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000; Zhu ZM, 1996, J VIROL, V70, P5346, DOI 10.1128/JVI.70.8.5346-5356.1996	92	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10975	10.1371/journal.pone.0010975	http://dx.doi.org/10.1371/journal.pone.0010975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544015	Green Submitted, gold, Green Published			2022-12-25	WOS:000278494900004
J	Hilton, BJ; Wolkowicz, R				Hilton, Brett J.; Wolkowicz, Roland			An Assay to Monitor HIV-1 Protease Activity for the Identification of Novel Inhibitors in T-Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESONANCE ENERGY-TRANSFER; PARTICLE MATURATION; PEPSTATIN-A; PHARMACOKINETICS; PROTEINASE; PRECURSOR; CLEAVAGE; CULTURE; SYSTEM	The emergence of resistant HIV strains, together with the severe side-effects of existing drugs and lack of development of effective anti-HIV vaccines highlight the need for novel antivirals, as well as innovative methods to facilitate their discovery. Here, we have developed an assay in T-cells to monitor the proteolytic activity of the HIV-1 protease (PR). The assay is based on the inducible expression of HIV-1 PR fused within the Gal4 DNA-binding and transactivation domains. The fusion protein binds to the Gal4 responsive element and activates the downstream reporter, enhanced green fluorescent protein (eGFP) gene only in the presence of an effective PR Inhibitor (PI). Thus, in this assay, eGFP acts as a biosensor of PR activity, making it ideal for flow cytometry based screening. Furthermore, the assay was developed using retroviral technology in T-cells, thus providing an ideal environment for the screening of potential novel PIs in a cell-type that represents the natural milieu of HIV infection. Clones with the highest sensitivity, and robust, reliable and reproducible reporter activity, were selected. The assay is easily adaptable to other PR variants, a multiplex platform, as well as to high-throughput plate reader based assays and will greatly facilitate the search for novel peptide and chemical compound based PIs in T-cells.	[Hilton, Brett J.; Wolkowicz, Roland] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Hilton, BJ (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	roland@sciences.sdsu.edu			California State University	California State University	Funding is from the California State University Program for Education and Research in Biotechnology (CSUPERB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Baxter JD, 2006, J VIROL, V80, P10794, DOI 10.1128/JVI.00712-06; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; Cheng TJ, 2004, ANTIMICROB AGENTS CH, V48, P2437, DOI 10.1128/AAC.48.7.2437-2447.2004; Colvin R, 1995, Common Factor, P15; DASMAHAPATRA B, 1992, P NATL ACAD SCI USA, V89, P4159, DOI 10.1073/pnas.89.9.4159; ERICKSON J, 1990, SCIENCE, V249, P527, DOI 10.1126/science.2200122; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Fuse T, 2006, MICROBES INFECT, V8, P1783, DOI 10.1016/j.micinf.2006.02.016; Gong YF, 2000, ANTIMICROB AGENTS CH, V44, P2319, DOI 10.1128/AAC.44.9.2319-2326.2000; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hu K, 2005, J VIROL METHODS, V128, P93, DOI 10.1016/j.jviromet.2005.04.012; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; JOHNSTON SA, 1986, P NATL ACAD SCI USA, V83, P6553, DOI 10.1073/pnas.83.17.6553; KRAUSSLICH HG, 1989, P NATL ACAD SCI USA, V86, P807, DOI 10.1073/pnas.86.3.807; Lindsten K, 2001, ANTIMICROB AGENTS CH, V45, P2616, DOI 10.1128/AAC.45.9.2616-2622.2001; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; MATAYOSHI ED, 1990, SCIENCE, V247, P954, DOI 10.1126/science.2106161; Matsuda Zene, 2007, V375, P135; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Molla A, 1998, VIROLOGY, V250, P255, DOI 10.1006/viro.1998.9383; Mouland AJ, 2002, VIROLOGY, V292, P321, DOI 10.1006/viro.2001.1261; MURRAY MG, 1993, GENE, V134, P123, DOI 10.1016/0378-1119(93)90185-6; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nascimbeni M, 1999, ANTIMICROB AGENTS CH, V43, P2629, DOI 10.1128/AAC.43.11.2629; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; Sadler BM, 2002, ANN PHARMACOTHER, V36, P102; SEELMEIER S, 1988, P NATL ACAD SCI USA, V85, P6612, DOI 10.1073/pnas.85.18.6612; Speck RR, 2000, ANTIMICROB AGENTS CH, V44, P1397, DOI 10.1128/AAC.44.5.1397-1403.2000; Stoltzfus CM, 2009, ADV VIRUS RES, V74, P1, DOI 10.1016/S0065-3527(09)74001-1; TOTH MV, 1990, INT J PEPT PROT RES, V36, P544; Vogt VM, 1996, CURR TOP MICROBIOL, V214, P95; Vollenweider F, 1996, BIOCHEM J, V314, P521, DOI 10.1042/bj3140521; VONDERHELM K, 1989, FEBS LETT, V247, P349, DOI 10.1016/0014-5793(89)81368-7; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Wolkowicz Roland, 2004, Methods Mol Biol, V246, P391	36	13	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10940	10.1371/journal.pone.0010940	http://dx.doi.org/10.1371/journal.pone.0010940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532177	Green Submitted, gold, Green Published			2022-12-25	WOS:000278318700012
J	Meens, MJPMT; Compeer, MG; Hackeng, TM; van Zandvoort, MA; Janssen, BJA; De Mey, JGR				Meens, Merlijn J. P. M. T.; Compeer, Matthijs G.; Hackeng, Tilman M.; van Zandvoort, Marc A.; Janssen, Ben J. A.; De Mey, Jo G. R.			Stimuli of Sensory-Motor Nerves Terminate Arterial Contractile Effects of Endothelin-1 by CGRP and Dissociation of ET-1/ETA-Receptor Complexes	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; ETA-RECEPTOR; NITRIC-OXIDE; B-RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; CARDIOVASCULAR-DISEASE; LIGAND-BINDING; HIGHLY POTENT; ION-CHANNEL; ANTAGONIST	Background: Endothelin-1 (ET-1), a long-acting paracrine mediator, is implicated in cardiovascular diseases but clinical trials with ET-receptor antagonists were not successful in some areas. We tested whether the quasi-irreversible receptor-binding of ET-1 (i) limits reversing effects of the antagonists and (ii) can be selectively dissociated by an endogenous counterbalancing mechanism. Methodology/Principal findings: In isolated rat mesenteric resistance arteries, ETA-antagonists, endothelium-derived relaxing factors and synthetic vasodilators transiently reduced contractile effects of ET-1 but did not prevent persistent effects of the peptide. Stimuli of peri-vascular vasodilator sensory-motor nerves such as capsaicin not only reduced but also terminated long-lasting effects of ET-1. This was prevented by CGRP-receptor antagonists and was mimicked by exogenous calcitonin gene-related peptide (CGRP). Using 2-photon laser scanning microscopy in vital intact arteries, capsaicin and CGRP, but not ETA-antagonism, were observed to promote dissociation of pre-existing ET-1/ETA-receptor complexes. Conclusions: Irreversible binding and activation of ETA-receptors by ET-1 (i) occur at an antagonist-insensitive site of the receptor and (ii) are selectively terminated by endogenously released CGRP. Hence, natural stimuli of sensory-motor nerves that stimulate release of endogenous CGRP can be considered for therapy of diseases involving ET-1.	[Meens, Merlijn J. P. M. T.; Compeer, Matthijs G.; Janssen, Ben J. A.; De Mey, Jo G. R.] Maastricht Univ, CARIM, Dept Pharmacol & Toxicol, Maastricht, Netherlands; [Hackeng, Tilman M.] Maastricht Univ, CARIM, Dept Biochem, Maastricht, Netherlands; [van Zandvoort, Marc A.] Maastricht Univ, CARIM, Dept Biomed Technol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Meens, MJPMT (corresponding author), Maastricht Univ, CARIM, Dept Pharmacol & Toxicol, Maastricht, Netherlands.	j.demey@farmaco.unimaas.nl		De Mey, Jo G. R./0000-0001-6274-8071; Hackeng, Tilman/0000-0003-0142-0843	TIPharma (NL) [T2-108-1, T2-301]	TIPharma (NL)	Funding: This study was performed within the framework of TIPharma (NL) projects T2-108-1 (http://www.tipharma.com/projects/project-single/cardiovascular-diseases/metalloproteases-and-endothelial-dysfunction.html) and T2-301 (http://www.tipharma.com/projects/project-single/cardiovascular-diseases/reninangiotensin-system-blockade.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adner M, 2001, BRIT J PHARMACOL, V133, P927, DOI 10.1038/sj.bjp.0704135; Aiyar N, 2000, EUR J PHARMACOL, V403, P1, DOI 10.1016/S0014-2999(00)00419-2; Aumelas A, 1998, BIOCHEMISTRY-US, V37, P5220, DOI 10.1021/bi9723764; Bagnato A, 2008, CAN J PHYSIOL PHARM, V86, P473, DOI 10.1139/Y08-058; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Blandin V, 2000, MOL PHARMACOL, V58, P1461, DOI 10.1124/mol.58.6.1461; BOULANGER C, 1990, J CLIN INVEST, V85, P587, DOI 10.1172/JCI114477; Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003; Burnstock G, 2009, ANNU REV PHARMACOL, V49, P1, DOI 10.1146/annurev.pharmtox.052808.102215; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHIBA T, 1989, AM J PHYSIOL, V256, pE331, DOI 10.1152/ajpendo.1989.256.2.E331; CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228; Conner AC, 2007, BIOCHEM SOC T, V35, P729, DOI 10.1042/BST0350729; Davenport AP, 2002, PHARMACOL REV, V54, P219, DOI 10.1124/pr.54.2.219; De Mey JGR, 2008, J PHARMACOL EXP THER, V324, P930, DOI 10.1124/jpet.107.133660; DEMEY JGR, 2009, MOL CELLULAR PHARM, V5, P246; Deng PY, 2004, J HYPERTENS, V22, P1819, DOI 10.1097/00004872-200409000-00028; Doods H, 2000, BRIT J PHARMACOL, V129, P420, DOI 10.1038/sj.bjp.0703110; Hewage CM, 1999, J PEPT RES, V53, P223, DOI 10.1034/j.1399-3011.1999.00001.x; HilalDandan R, 1997, J PHARMACOL EXP THER, V281, P267; Hilgers RHP, 2009, BRIT J PHARMACOL, V156, P1239, DOI 10.1111/j.1476-5381.2009.00128.x; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; Hynynen Meri M, 2006, Recent Pat Cardiovasc Drug Discov, V1, P95; IHARA M, 1992, LIFE SCI, V50, P247, DOI 10.1016/0024-3205(92)90331-I; IHARA M, 1992, J CARDIOVASC PHARM, V20, pS11, DOI 10.1097/00005344-199204002-00005; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; KIMURA S, 1988, BIOCHEM BIOPH RES CO, V156, P1182, DOI 10.1016/S0006-291X(88)80757-5; Kirkby NS, 2008, BRIT J PHARMACOL, V153, P1105, DOI 10.1038/sj.bjp.0707516; Lattig J, 2009, J PEPT SCI, V15, P479, DOI 10.1002/psc.1146; MAGGI CA, 1989, EUR J PHARMACOL, V166, P121, DOI 10.1016/0014-2999(89)90693-6; Masaki T, 2004, TRENDS PHARMACOL SCI, V25, P219, DOI 10.1016/j.tips.2004.02.008; McMurray JJV, 2007, JAMA-J AM MED ASSOC, V298, P2009, DOI 10.1001/jama.298.17.2009; Meens MJPMT, 2009, J PHARMACOL EXP THER, V331, P87, DOI 10.1124/jpet.109.155143; Megens RTA, 2007, J VASC RES, V44, P87, DOI 10.1159/000098259; Molero MM, 2002, J HYPERTENS, V20, P1799, DOI 10.1097/00004872-200209000-00025; Morris GE, 2010, CARDIOVASC RES, V85, P424, DOI 10.1093/cvr/cvp310; MULVANY MJ, 1990, J HYPERTENS, V8, pS225; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Ohlstein EH, 1998, J PHARMACOL EXP THER, V286, P650; Oksche A, 2000, MOL PHARMACOL, V57, P1104; Peng XM, 2007, J MED CHEM, V50, P2254, DOI 10.1021/jm061327z; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plant TD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-35; RANDALL MD, 1989, BRIT J PHARMACOL, V98, P685, DOI 10.1111/j.1476-5381.1989.tb12644.x; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; SAEKI T, 1991, BIOCHEM BIOPH RES CO, V179, P286, DOI 10.1016/0006-291X(91)91367-L; SAKAMOTO A, 1993, J BIOL CHEM, V268, P8547; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Stassen FRM, 1998, J PHARMACOL EXP THER, V284, P399; Supowit SC, 1997, HYPERTENSION, V29, P945, DOI 10.1161/01.HYP.29.4.945; Szallasi A, 1999, PHARMACOL REV, V51, P159; TAKAI M, 1992, BIOCHEM BIOPH RES CO, V184, P953, DOI 10.1016/0006-291X(92)90683-C; Talbodec A, 2000, MOL PHARMACOL, V57, P797, DOI 10.1124/mol.57.4.797; TAM JP, 1994, PEPTIDES, V15, P703, DOI 10.1016/0196-9781(94)90099-X; Vanhoutte PM, 2000, J AUTONOM NERV SYST, V81, P271, DOI 10.1016/S0165-1838(00)00126-0; Wang JC, 2004, J NEUROSURG-SPINE, V1, P287, DOI 10.3171/spi.2004.1.3.0287; Xie CQ, 2009, HYPERTENSION, V54, P1298, DOI 10.1161/HYPERTENSIONAHA.109.132167; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zemanova L, 2004, BIOCHEMISTRY-US, V43, P9021, DOI 10.1021/bi035901+	60	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10917	10.1371/journal.pone.0010917	http://dx.doi.org/10.1371/journal.pone.0010917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532232	Green Published, Green Submitted, gold			2022-12-25	WOS:000278222400012
J	Elliott, KS; Zeggini, E; McCarthy, MI; Gudmundsson, J; Sulem, P; Stacey, SN; Thorlacius, S; Amundadottir, L; Gronberg, H; Xu, JF; Gaborieau, V; Eeles, RA; Neal, DE; Donovan, JL; Hamdy, FC; Muir, K; Hwang, SJ; Spitz, MR; Zanke, B; Carvajal-Carmona, L; Brown, KM; Hayward, NK; Macgregor, S; Tomlinson, IPM; Lemire, M; Amos, CI; Murabito, JM; Isaacs, WB; Easton, DF; Brennan, P; Barkardottir, RB; Gudbjartsson, DF; Rafnar, T; Hunter, DJ; Chanock, SJ; Stefansson, K; Ioannidis, JPA				Elliott, Katherine S.; Zeggini, Eleftheria; McCarthy, Mark I.; Gudmundsson, Julius; Sulem, Patrick; Stacey, Simon N.; Thorlacius, Steinunn; Amundadottir, Laufey; Groenberg, Henrik; Xu, Jianfeng; Gaborieau, Valerie; Eeles, Rosalind A.; Neal, David E.; Donovan, Jenny L.; Hamdy, Freddie C.; Muir, Kenneth; Hwang, Shih-Jen; Spitz, Margaret R.; Zanke, Brent; Carvajal-Carmona, Luis; Brown, Kevin M.; Hayward, Nicholas K.; Macgregor, Stuart; Tomlinson, Ian P. M.; Lemire, Mathieu; Amos, Christopher I.; Murabito, Joanne M.; Isaacs, William B.; Easton, Douglas F.; Brennan, Paul; Barkardottir, Rosa B.; Gudbjartsson, Daniel F.; Rafnar, Thorunn; Hunter, David J.; Chanock, Stephen J.; Stefansson, Kari; Ioannidis, John P. A.		Australian Melanoma Family Study I; PanScan Consortium	Evaluation of Association of HNF1B Variants with Diverse Cancers: Collaborative Analysis of Data from 19 Genome-Wide Association Studies	PLOS ONE			English	Article							PROSTATE-CANCER; DIABETES-MELLITUS; SUSCEPTIBILITY LOCUS; BREAST-CANCER; LUNG-CANCER; RISK LOCI; SEQUENCE VARIANTS; COMMON VARIANTS; GENE; METAANALYSIS	Background: Genome-wide association studies have found type 2 diabetes-associated variants in the HNF1B gene to exhibit reciprocal associations with prostate cancer risk. We aimed to identify whether these variants may have an effect on cancer risk in general versus a specific effect on prostate cancer only. Methodology/Principal Findings: In a collaborative analysis, we collected data from GWAS of cancer phenotypes for the frequently reported variants of HNF1B, rs4430796 and rs7501939, which are in linkage disequilibrium (r(2) = 0.76, HapMap CEU). Overall, the analysis included 16 datasets on rs4430796 with 19,640 cancer cases and 21,929 controls; and 21 datasets on rs7501939 with 26,923 cases and 49,085 controls. Malignancies other than prostate cancer included colorectal, breast, lung and pancreatic cancers, and melanoma. Meta-analysis showed large between-dataset heterogeneity that was driven by different effects in prostate cancer and other cancers. The per-T2D-risk-allele odds ratios (95% confidence intervals) for rs4430796 were 0.79 (0.76, 0.83)] per G allele for prostate cancer (p < 10(-15) for both); and 1.03 (0.99, 1.07) for all other cancers. Similarly for rs7501939 the per-T2D-risk-allele odds ratios (95% confidence intervals) were 0.80 (0.77, 0.83) per T allele for prostate cancer (p < 10(-15) for both); and 1.00 (0.97, 1.04) for all other cancers. No malignancy other than prostate cancer had a nominally statistically significant association. Conclusions/Significance: The examined HNF1B variants have a highly specific effect on prostate cancer risk with no apparent association with any of the other studied cancer types.	[Elliott, Katherine S.; Zeggini, Eleftheria; McCarthy, Mark I.; Carvajal-Carmona, Luis; Tomlinson, Ian P. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Zeggini, Eleftheria] Univ Cambridge, Wellcome Trust Sanger Inst, Cambridge, England; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Gudmundsson, Julius; Sulem, Patrick; Stacey, Simon N.; Thorlacius, Steinunn; Gudbjartsson, Daniel F.; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Amundadottir, Laufey; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Groenberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC USA; [Gaborieau, Valerie] IARC, Genet Epidemiol Grp, Lyon, France; [Eeles, Rosalind A.] Inst Canc Res, Oncogenet Team, Sutton, Surrey, England; [Neal, David E.] Univ Cambridge, Dept Oncol, Cambridge, England; [Donovan, Jenny L.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Muir, Kenneth] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Hwang, Shih-Jen] NHLBI, Framingham Study, Bethesda, MD 20892 USA; [Spitz, Margaret R.; Amos, Christopher I.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Zanke, Brent; Lemire, Mathieu] Ontario Inst Canc Res, MaRS Ctr, Toronto, ON, Canada; [Zanke, Brent] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Brown, Kevin M.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA; [Hayward, Nicholas K.; Macgregor, Stuart] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Murabito, Joanne M.] Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA; [Isaacs, William B.] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Easton, Douglas F.] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge, England; [Barkardottir, Rosa B.] Landspitali Univ Hosp Iceland, Dept Pathol, Reykjavik, Iceland; [Barkardottir, Rosa B.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modelling, Boston, MA 02111 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; Wellcome Trust Sanger Institute; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; World Health Organization; International Agency for Research on Cancer (IARC); University of London; Institute of Cancer Research - UK; University of Cambridge; University of Bristol; University of Oxford; University of Warwick; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Ottawa; Ottawa Hospital Research Institute; Translational Genomics Research Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Boston University; Johns Hopkins University; Johns Hopkins Medicine; Cancer Research UK; University of Cambridge; Landspitali National University Hospital; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University	Elliott, KS (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	jioannid@cc.uoi.gr	Albanes, Demetrius/B-9749-2015; Gallinger, Steven/E-4575-2013; Macgregor, Stuart/C-6442-2009; Wang, Zhaoming/R-5527-2018; Stolzenberg-Solomon, Rachael/Y-9280-2018; hayward, nick/AAV-8802-2020; Krogh, Vittorio/K-2628-2016; Hwang, Shih-Jen/HGU-5826-2022; hayward, nicholas k/C-1367-2015; Tobias, Geoffrey S/M-4135-2016; Aitken, Joanne F/C-5289-2009; Stefansson, Kari/AAE-7187-2019; Ioannidis, John P. A./G-9836-2011; Mann, Graham J/G-4758-2014; Amundadottir, Laufey T/L-7656-2016; Carvajal-Carmona, Luis G/B-3882-2010; McCarthy, Mark/M-3763-2015	Macgregor, Stuart/0000-0001-6731-8142; Wang, Zhaoming/0000-0001-7556-3869; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Krogh, Vittorio/0000-0003-0122-8624; hayward, nicholas k/0000-0003-4760-1033; Tobias, Geoffrey S/0000-0002-2878-8253; Mann, Graham J/0000-0003-1301-405X; Amundadottir, Laufey T/0000-0003-1859-8971; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Hamdy, Freddie/0000-0003-2627-2154; Kraft, Peter/0000-0002-4472-8103; Riboli, Elio/0000-0001-6795-6080; Eeles, Rosalind/0000-0002-3698-6241; Jacobs, Kevin/0000-0002-4657-6473; Jenab, Mazda/0000-0002-0573-1852; Murabito, Joanne/0000-0002-0192-7516; Canzian, Federico/0000-0002-4261-4583; McCarthy, Mark/0000-0002-4393-0510; Gudbjartsson, Daniel/0000-0002-5222-9857; Duell, Eric J/0000-0001-5256-0163; Zeggini, Eleftheria/0000-0003-4238-659X; Kefford, Richard/0000-0001-9251-9229; Aitken, Joanne Frances/0000-0001-6859-2186; Neal, David/0000-0002-6033-5086	National Institutes of Health [UL1 RR025752, R01-CA88363, RO1-CA83115]; Wellcome Trust [WT075491/Z/04, WT088885/Z/09/Z]; Australian National Health and Medical Research Council (NHMRC); Swedish Cancer Society (Cancerfonden),; Swedish Research Council; Predication and prevention of breast cancer and prostate cancer; Cancer Research [C5047/A8385, C5047/A7357]; Institute of Cancer Research; Everyman Campaign; Prostate Cancer Research Foundation; NIHR; Royal Marsden NHS Foundation Trust; National Cancer Research Institute (NCRI); Medical Research Council; Cancer Research UK; UK National Institute for Health Research Health Technology Assessment Programme [96/20/06, 96/20/99]; EU [018827]; NHMRC; Cancer Councils of Queensland; NSW; Victoria; National Heart Lung and Blood Institute of the National Institutes of Health; National Heart, Lung and Blood Institute's Framingham Heart Study [N01-HC-25195, N02-HL-6-4278]; Robert Dawson Evans Endowment; MRC [G0900871] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA083115, R01CA088363, R01CA097193, R01CA124908] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; Cancer Research UK [10118, 11022] Funding Source: researchfish; Medical Research Council [G0900871] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Swedish Cancer Society (Cancerfonden),(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Predication and prevention of breast cancer and prostate cancer; Cancer Research; Institute of Cancer Research; Everyman Campaign; Prostate Cancer Research Foundation; NIHR(National Institute for Health Research (NIHR)); Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); National Cancer Research Institute (NCRI); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); UK National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); EU(European Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Councils of Queensland(Cancer Council Queensland); NSW; Victoria; National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Dawson Evans Endowment; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	JPAI is supported by funding for the Tufts Clinical and Translational Science Institute and the Center for Genetic Epidemiology and Modeling is supported by grant UL1 RR025752 from the National Institutes of Health. KSE is supported by the Wellcome Trust (WT075491/Z/04). EZ is supported by the Wellcome Trust (WT088885/Z/09/Z). NH and SM were funded by the Australian National Health and Medical Research Council (NHMRC) and the National Institutes of Health (grant R01-CA88363). HG is supported by Swedish Cancer Society (Cancerfonden), Swedish Research Council, and Linneus grant "Predication and prevention of breast cancer and prostate cancer''. RE and KM are supported by Cancer Research UK Grant C5047/A8385; C5047/A7357, The Institute of Cancer Research and The Everyman Campaign and The Prostate Cancer Research Foundation. The authors acknowledge support from the NIHR to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. DEN, JLD and FCH would like to acknowledge the support of the National Cancer Research Institute (NCRI) formed by the Department of Health, the Medical Research Council and Cancer Research UK. The Prostate Testing for Cancer and Treatment (ProtecT) study is funded by the UK National Institute for Health Research Health Technology Assessment Programme (projects 96/20/06, 96/20/99). The NCRI provided funding through ProMPT (Prostate Mechanisms of Progression and Treatment) and this support is gratefully acknowledged. The Cambridge prostate biorepository also received funding from the NIHR Comprehensive Biomedical Research Centre Grant. This support is gratefully acknowledged. The views and opinions expressed therein are those of the authors and are not necessarily those of the funding bodies. deCODE acknowledges grant support from the 6th Framework Program of the EU: contract 018827 (Polygene). The Australian Melanoma Family Study (AMFS) was supported by grants from the NHMRC, Cancer Councils of Queensland, NSW and Victoria, and by National Institutes of Health grant RO1-CA83115 to the GenoMEL consortium. The Framingham Heart Study (FHS) The Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine were supported by the National Heart, Lung and Blood Institute's Framingham Heart Study Contract No. N01-HC-25195 and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278). Analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Brennan P, 2007, HUM MOL GENET, V16, P1794, DOI 10.1093/hmg/ddm127; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Calton BA, 2007, CANCER CAUSE CONTROL, V18, P493, DOI 10.1007/s10552-007-0126-y; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; Cust AE, 2009, AM J EPIDEMIOL, V170, P1541, DOI 10.1093/aje/kwp307; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edghill EL, 2006, J MED GENET, V43, P84, DOI 10.1136/jmg.2005.032854; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gong ZH, 2006, CANCER EPIDEM BIOMAR, V15, P1977, DOI 10.1158/1055-9965.EPI-06-0477; GUDMUNDSSON J, 2008, NAT GENET; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Levin AM, 2008, CANCER RES, V68, P6492, DOI 10.1158/0008-5472.CAN-08-0348; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; PETERSEN GM, NAT GENET; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Reber M, 2001, MECH DEVELOP, V100, P75, DOI 10.1016/S0925-4773(00)00493-7; Rebouissou S, 2005, HUM MOL GENET, V14, P603, DOI 10.1093/hmg/ddi057; Rousseau MC, 2006, INT J CANCER, V118, P2105, DOI 10.1002/ijc.21600; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; THOMAS G, 2008, NAT GENET; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Will JC, 1999, EPIDEMIOLOGY, V10, P313, DOI 10.1097/00001648-199905000-00021; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yamada H, 2009, JNCI-J NATL CANCER I, V101, P1330, DOI 10.1093/jnci/djp287; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	47	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10858	10.1371/journal.pone.0010858	http://dx.doi.org/10.1371/journal.pone.0010858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526366	Green Published, Green Submitted, gold			2022-12-25	WOS:000278222100002
J	Oliveira, MLS; Miyaji, EN; Ferreira, DM; Moreno, AT; Ferreira, PCD; Lima, FA; Santos, FL; Sakauchi, MA; Takata, CS; Higashi, HG; Raw, I; Kubrusly, FS; Ho, PL				Oliveira, Maria Leonor S.; Miyaji, Eliane N.; Ferreira, Daniela M.; Moreno, Adriana T.; Ferreira, Patricia C. D.; Lima, Fernanda A.; Santos, Fernanda L.; Sakauchi, Maria Aparecida; Takata, Celia S.; Higashi, Hisako G.; Raw, Isaias; Kubrusly, Flavia S.; Ho, Paulo L.			Combination of Pneumococcal Surface Protein A (PspA) with Whole Cell Pertussis Vaccine Increases Protection Against Pneumococcal Challenge in Mice	PLOS ONE			English	Article							ACELLULAR DTP VACCINE; STREPTOCOCCUS-PNEUMONIAE; INTRANASAL IMMUNIZATION; BORDETELLA-PERTUSSIS; COMPLEMENT DEPOSITION; IMMUNE-RESPONSES; WALL POLYSACCHARIDE; CYTOKINE PRODUCTION; ELICIT PROTECTION; CHILDREN YOUNGER	Streptococcus pneumoniae is the leading cause of respiratory acute infections around the world. In Latin America, approximately 20,000 children under 5 years of age die of pneumococcal diseases annually. Pneumococcal surface protein A (PspA) is among the best-characterized pneumococcal antigens that confer protection in animal models of pneumococcal infections and, as such, is a good alternative for the currently available conjugated vaccines. Efficient immune responses directed to PspA in animal models have already been described. Nevertheless, few low cost adjuvants for a subunit pneumococcal vaccine have been proposed to date. Here, we have tested the adjuvant properties of the whole cell Bordetella pertussis vaccine (wP) that is currently part of the DTP (diphtheria-tetanus-pertussis) vaccine administrated to children in several countries, as an adjuvant to PspA. Nasal immunization of BALB/c mice with a combination of PspA5 and wP or wP(low) - a new generation vaccine that contains low levels of B. pertussis LPS - conferred protection against a respiratory lethal challenge with S. pneumoniae. Both PspA5-wP and PspA5-wP(low) vaccines induced high levels of systemic and mucosal antibodies against PspA5, with similar profile, indicating no essential requirement for B. pertussis LPS in the adjuvant properties of wP. Accordingly, nasal immunization of C3H/HeJ mice with PspA5-wP conferred protection against the pneumococcal challenge, thus ruling out a role for TLR4 responses in the adjuvant activity and the protection mechanisms triggered by the vaccines. The high levels of anti-PspA5 antibodies correlated with increased cross-reactivity against PspAs from different clades and also reflected in cross-protection. In addition, passive immunization experiments indicated that antibodies played an important role in protection in this model. Finally, subcutaneous immunization with a combination of PspA5 with DTPlow protected mice against challenge with two different pneumococcal strains, opening the possibility for the development of a combined infant vaccine composed of DTP and PspA.	[Oliveira, Maria Leonor S.; Miyaji, Eliane N.; Ferreira, Daniela M.; Moreno, Adriana T.; Ferreira, Patricia C. D.; Lima, Fernanda A.; Raw, Isaias; Kubrusly, Flavia S.; Ho, Paulo L.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Santos, Fernanda L.; Sakauchi, Maria Aparecida; Takata, Celia S.; Higashi, Hisako G.] Inst Butantan, Div Bioind, Sao Paulo, Brazil	Instituto Butantan; Instituto Butantan	Oliveira, MLS (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	mloliveira@butantan.gov.br; hoplee@butantan.gov.br	S macarini, fernanda/V-8252-2017; Ferreira, Daniela M/AFF-4763-2022; SAKAUCHI, MARIA APARECIDA/D-8728-2015; Oliveira, Maria Leonor S/F-4988-2012; Miyaji, Eliane N/D-7642-2012; Ho, Paulo/P-8267-2015; Ferreira, Daniela M/AAE-9881-2022	Ferreira, Daniela M/0000-0002-0594-0902; Miyaji, Eliane N/0000-0003-1689-5366; Ho, Paulo/0000-0003-3652-241X; Oliveira, Maria Leonor/0000-0003-4849-3062; Kubrusly, Flavia/0000-0003-0646-583X	FAPESP; CNPq; Butantan Foundation; PAP-SES	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Butantan Foundation; PAP-SES	The authors gratefully acknowledge support from the folowing Brazilian agencies: FAPESP, CNPq, Butantan Foundation, and PAP-SES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Arulanandam BP, 2001, INFECT IMMUN, V69, P6718, DOI 10.1128/IAI.69.11.6718-6724.2001; Bamberger ES, 2008, EUR J PEDIATR, V167, P133, DOI 10.1007/s00431-007-0548-2; Banus S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-21; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Berstad AKH, 2000, VACCINE, V18, P2323, DOI 10.1016/S0264-410X(00)00024-4; Berstad AKH, 2000, VACCINE, V18, P1910, DOI 10.1016/S0264-410X(99)00442-9; BETTINGER JA, 2009, VACCINE; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Campos IB, 2008, MICROBES INFECT, V10, P481, DOI 10.1016/j.micinf.2008.01.007; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Dagan R, 2004, INFECT IMMUN, V72, P5383, DOI 10.1128/IAI.72.9.5383-5391.2004; Dagan R, 2009, VACCINE, V27, pC3, DOI 10.1016/j.vaccine.2009.06.002; Dagan R, 2009, VACCINE, V27, pC22, DOI 10.1016/j.vaccine.2009.06.004; Darrieux M, 2007, INFECT IMMUN, V75, P5930, DOI 10.1128/IAI.00940-07; Darrieux M, 2008, J MED MICROBIOL, V57, P273, DOI 10.1099/jmm.0.47661-0; de Quadros CA, 2009, VACCINE, V27, pC29, DOI 10.1016/j.vaccine.2009.06.006; ERREA A, 2010, MED MICROBIOL IMMUNO; Fedele G, 2007, MICROBES INFECT, V9, P855, DOI 10.1016/j.micinf.2007.03.002; Ferreira DM, 2009, CLIN VACCINE IMMUNOL, V16, P636, DOI 10.1128/CVI.00395-08; Ferreira DM, 2008, CLIN VACCINE IMMUNOL, V15, P499, DOI 10.1128/CVI.00400-07; Ferreira DM, 2009, MICROB PATHOGENESIS, V47, P157, DOI 10.1016/j.micpath.2009.05.005; Ferreira DM, 2006, J MED MICROBIOL, V55, P375, DOI 10.1099/jmm.0.46217-0; Franco CM, 2010, PEDIATR INFECT DIS J, V29, P77, DOI 10.1097/INF.0b013e3181af7e90; Fujimoto C, 2006, J IMMUNOL, V177, P6896, DOI 10.4049/jimmunol.177.10.6896; Hale C, 2004, VACCINE, V22, P3595, DOI 10.1016/j.vaccine.2004.03.039; Hanniffy SB, 2007, J INFECT DIS, V195, P185, DOI 10.1086/509807; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hollingshead SK, 2006, J MED MICROBIOL, V55, P215, DOI 10.1099/jmm.0.46268-0; HSU KK, 2009, PEDIAT INFECT DIS J; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106; Locht C, 2008, MICROBES INFECT, V10, P1051, DOI 10.1016/j.micinf.2008.07.008; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lu YJ, 2009, MICROB PATHOGENESIS, V47, P177, DOI 10.1016/j.micpath.2009.06.008; Lu YJ, 2009, INFECT IMMUN, V77, P2076, DOI 10.1128/IAI.01554-08; Mahon BP, 1996, INFECT IMMUN, V64, P5295, DOI 10.1128/IAI.64.12.5295-5301.1996; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; McGuirk P, 2000, INFECT IMMUN, V68, P1383, DOI 10.1128/IAI.68.3.1383-1390.2000; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Miyaji EN, 2003, FEMS IMMUNOL MED MIC, V37, P53, DOI 10.1016/S0928-8244(03)00108-1; MORENO AT, 2010, CLIN VACCINE IMMUNOL; Nicol M, 2002, PEDIATR INFECT DIS J, V21, P138, DOI 10.1097/00006454-200202000-00010; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Oliveira MLS, 2006, MICROBES INFECT, V8, P1016, DOI 10.1016/j.micinf.2005.10.020; Oma K, 2009, VACCINE, V27, P3181, DOI 10.1016/j.vaccine.2009.03.055; Orr B, 2007, VACCINE, V25, P64, DOI 10.1016/j.vaccine.2006.07.019; *PAHO, 2007, IMM NEWSL, P1; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pimenta FC, 2006, J CLIN MICROBIOL, V44, P2838, DOI 10.1128/JCM.00156-06; Prikazsky V, 2001, INT J CLIN PRACT, V55, P156; Quintilio W, 2009, VACCINE, V27, P4219, DOI 10.1016/j.vaccine.2009.04.047; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Reinert P, 2003, ARCH PEDIATRIE, V10, P1048, DOI 10.1016/j.arcped.2003.09.039; Ren B, 2004, INFECT IMMUN, V72, P114, DOI 10.1128/IAI.72.1.114-122.2004; Ren B, 2003, INFECT IMMUN, V71, P75, DOI 10.1128/IAI.71.1.75-85.2003; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Shouval DS, 2009, PEDIATR INFECT DIS J, V28, P277, DOI 10.1097/INF.0b013e31818e0e2e; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Tamizifar H, 1997, J MED MICROBIOL, V46, P61, DOI 10.1099/00222615-46-1-61; TAMIZIFAR H, 1995, VACCINE, V13, P1539, DOI 10.1016/0264-410X(95)00092-F; TECHASAENSIRI C, 2009, PEDIAT INFECT DIS J; Tonon S, 2006, EUR J IMMUNOL, V36, P1794, DOI 10.1002/eji.200535697; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Xin W, 2009, INFECT IMMUN, V77, P4518, DOI 10.1128/IAI.00486-09; Yano A, 2007, MICROBIOL IMMUNOL, V51, P685, DOI 10.1111/j.1348-0421.2007.tb03957.x; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zorzeto TQ, 2009, CLIN VACCINE IMMUNOL, V16, P544, DOI 10.1128/CVI.00339-08	69	37	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10863	10.1371/journal.pone.0010863	http://dx.doi.org/10.1371/journal.pone.0010863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523738	Green Published, gold, Green Submitted			2022-12-25	WOS:000278221900013
J	Meng, S; Luo, M; Sun, H; Yu, X; Shen, ML; Zhang, QC; Zhou, RD; Ju, XF; Tao, W; Liu, D; Deng, HK; Lu, ZG				Meng, Sha; Luo, Min; Sun, He; Yu, Xin; Shen, Meili; Zhang, Quancang; Zhou, Rudan; Ju, Xiaofang; Tao, Wei; Liu, Di; Deng, Hongkui; Lu, Zhigang			Identification and Characterization of Bmi-1-responding Element within the Human p16 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL SELF-RENEWAL; HEMATOPOIETIC STEM-CELLS; BMI-1 EXPRESSION; P-GLYCOPROTEIN; NEUROBLASTOMA-CELLS; TELOMERASE ACTIVITY; H2A UBIQUITYLATION; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; INK4A/ARF LOCUS	Bmi-1, the first functionally identified polycomb gene family member, plays critical roles in cell cycle regulation, cell immortalization, and cell senescence. Bmi-1 is involved in the development and progression of carcinomas and is a potent target for cancer therapy. One important pathway regulated by Bmi-1 is that involving two cyclin-dependent kinase inhibitors, p16(Ink4a) and p19(Arf), as Bmi-1 represses the INK4a locus on which they are encoded. A close correlation between the up-regulation of Bmi-1 and down-regulation of p16 has been demonstrated in various tumors; however, how Bmi-1 regulates p16 expression is not clear. In this study, we revealed that Bmi-1 regulates the expression of p16 by binding directly to the Bmi-1-responding element (BRE) within the p16 promoter. The BRE resided at bp -821 to -732 upstream of the p16 ATG codon. BRE alone was sufficient to allow Bmi-1-mediated regulation of the CMV promoter. Bmi-1 typically functions by forming a complex with Ring2; however, regulation of p16 was independent of Ring2. Chromatin immunoprecipitation sequencing of Bmi-1-precipitated chromatin DNA revealed that 1536 genes were targeted by Bmi-1, including genes involved in tissue-specific differentiation, cell cycle, and apoptosis. By analyzing the binding sequences of these genes, we found two highly conserved Bmi-1-binding motifs, which were required for Bmi-1-mediated p16 promoter regulation. Taken together, our results revealed the molecular mechanism of Bmi-1-mediated regulation of the p16 gene, thus providing further insights into the functions of Bmi-1 as well as a sensitive high-throughput platform with which to screen Bmi-1-targeted small molecules for cancer therapy.	[Liu, Di] Chinese Acad Sci, Inst Microbiol, Network Informat Ctr, Beijing 100101, Peoples R China; [Deng, Hongkui; Lu, Zhigang] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Sch Chem Biol & Biotechnol, Shenzhen 518055, Peoples R China; [Shen, Meili; Tao, Wei; Deng, Hongkui] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Yu, Xin] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Peking University; University Town of Shenzhen; Peking University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Liu, D (corresponding author), Chinese Acad Sci, Inst Microbiol, Network Informat Ctr, Beijing 100101, Peoples R China.	liud@im.ac.cn; hongkui_deng@pku.edu.cn; luzg@szpku.edu.cn	Liu, Di/G-6135-2014; Liu, Di/ABD-2729-2021	Liu, Di/0000-0003-3693-2726; Liu, Di/0000-0003-3693-2726; Lu, Zhigang/0000-0002-2880-7848	National Natural Science Foundation of China [30700411, 90919031, 30800640]; Shenzhen Bureau of Science Technology, and Information [SZKJ-2006018, SZKJ-2007012]; Ministry of Education [705001]; Ministry of Science and Technology [2010CB530303]; Shenzhen Key Laboratory Advancement Scheme [SZKJ-2006018, SZKJ-2007012]; Shenzhen Nanshan Shenzhen Bureau of Science Technology and Information	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Bureau of Science Technology, and Information; Ministry of Education; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shenzhen Key Laboratory Advancement Scheme; Shenzhen Nanshan Shenzhen Bureau of Science Technology and Information	This work was supported by National Natural Science Foundation of China Grant 30700411, Shenzhen Bureau of Science Technology, and Information Grants (SZKJ-2006018, SZKJ-2007012), Shenzhen Key Laboratory Advancement Scheme, and Shenzhen Nanshan Shenzhen Bureau of Science Technology and Information Grants (to Z. L.); Ministry of Education Grant 705001 and National Natural Science Foundation of China (90919031) (to H. D.); and the National Natural Science Foundation of China (30800640) and "Program 973" (2010CB530303) of the Ministry of Science and Technology (to D. L.).	Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Bartkova J, 1996, CANCER RES, V56, P5475; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Chumsri S, 2008, CURR OPIN MOL THER, V10, P323; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dimri GP, 2002, CANCER RES, V62, P4736; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; GOEBL MG, 1991, CELL, V66, P623, DOI 10.1016/0092-8674(91)90106-9; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Grinstein E, 2007, CELL SIGNAL, V19, P2428, DOI 10.1016/j.cellsig.2007.06.021; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Hara E, 1996, MOL CELL BIOL, V16, P859; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; JIN XM, 1995, CANCER RES, V55, P3250; Johnstone RW, 1999, BLOOD, V93, P1075, DOI 10.1182/blood.V93.3.1075.403k35_1075_1085; Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nilsson K, 2006, INT J CANCER, V118, P1120, DOI 10.1002/ijc.21466; Pallis M, 2000, BLOOD, V95, P2897, DOI 10.1182/blood.V95.9.2897.009k14_2897_2904; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang H, 2008, J CANCER RES CLIN, V134, P535, DOI 10.1007/s00432-007-0316-8; Wang Q, 2009, J CELL BIOCHEM, V106, P16, DOI 10.1002/jcb.21969; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zhang F., 2008, Experimental Oncology, V30, P70; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	52	46	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33219	33229		10.1074/jbc.M110.133686	http://dx.doi.org/10.1074/jbc.M110.133686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20551323	Green Published, hybrid			2022-12-25	WOS:000283048200059
J	Cardi, D; Pozza, A; Arnou, B; Marchal, E; Clausen, JD; Andersen, JP; Krishna, S; Moller, JV; le Maire, M; Jaxel, C				Cardi, Delphine; Pozza, Alexandre; Arnou, Bertrand; Marchal, Estelle; Clausen, Johannes D.; Andersen, Jens Peter; Krishna, Sanjeev; Moller, Jesper V.; le Maire, Marc; Jaxel, Christine			Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to Artemisinins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; FALCIPARUM MALARIA PARASITES; ANTIMALARIAL-DRUG-RESISTANCE; PLASMODIUM-FALCIPARUM; IN-VITRO; ADENOSINE-TRIPHOSPHATASE; TRANSMEMBRANE SEGMENTS; INORGANIC-PHOSPHATE; MEMBRANE-PROTEIN; S769N MUTATION	The antimalarial drugs artemisinins have been described as inhibiting Ca2+-ATPase activity of PfATP6 (Plasmodium falciparum ATP6) after expression in Xenopus oocytes. Mutation of an amino acid residue in mammalian SERCA1 (Glu(255)) to the equivalent one predicted in PfATP6 (Leu) was reported to induce sensitivity to artemisinin in the oocyte system. However, in the present experiments, we found that artemisinin did not inhibit mammalian SERCA1a E255L either when expressed in COS cells or after purification of the mutant expressed in Saccharomyces cerevisiae. Moreover, we found that PfATP6 after expression and purification from S. cerevisiae was insensitive to artemisinin and significantly less sensitive to thapsigargin and 2,5-di(tert-butyl)-1,4-benzo-hydroquinone than rabbit SERCA1 but retained higher sensitivity to cyclopiazonic acid, another type of SERCA1 inhibitor. Although mammalian SERCA and purified PfATP6 appear to have different pharmacological profiles, their insensitivity to artemisinins suggests that the mechanism of action of this class of drugs on the calcium metabolism in the intact cell is complex and cannot be ascribed to direct inhibition of PfATP6. Furthermore, the successful purification of PfATP6 affords the opportunity to develop new antimalarials by screening for inhibitors against PfATP6.	[Cardi, Delphine; Pozza, Alexandre; Marchal, Estelle; le Maire, Marc; Jaxel, Christine] Univ Paris Sud, Lab Rech Associe 17V, F-91191 Gif Sur Yvette, France; [Krishna, Sanjeev] St Georges Univ London, Div Cellular & Mol Med, Ctr Infect, London SW17 0RE, England; [Arnou, Bertrand; Clausen, Johannes D.; Andersen, Jens Peter; Moller, Jesper V.] Univ Aarhus, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Cardi, Delphine; Pozza, Alexandre; Marchal, Estelle; le Maire, Marc; Jaxel, Christine] Commissariat Energie Atom, Inst Biol & Technol Saclay, SB2SM, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay; St Georges University London; Aarhus University; Danmarks Grundforskningsfond; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	le Maire, M (corresponding author), CEA Saclay, CNRS, URA 2096, IBiTec S,SB2SM,LPM, F-91191 Gif Sur Yvette, France.	marc.lemaire@cea.fr; christine.jaxel@.cea.fr	Hua, QX/HGE-3640-2022	Marchal, Estelle/0000-0003-4121-311X; JAXEL, CHRISTINE/0000-0002-1387-4458; Krishna, Sanjeev/0000-0003-0066-0634; Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council; Danish Natural Science Research Council (Center for Structural Biology); Aarhus University Research Foundation; Novo-Nordic Foundation (Denmark); Commissariat a l'Energie Atomique (Saclay, France); CNRS; DIM Maladies Infectieuses, Parasitaires et Nosocomiales Emergentes/Ile de France (France); European Communities [018834]; Wellcome Trust [074395/Z/04/Z]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Natural Science Research Council (Center for Structural Biology)(Danish Natural Science Research Council); Aarhus University Research Foundation; Novo-Nordic Foundation (Denmark)(Novo Nordisk Foundation); Commissariat a l'Energie Atomique (Saclay, France)(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); DIM Maladies Infectieuses, Parasitaires et Nosocomiales Emergentes/Ile de France (France); European Communities(European Commission); Wellcome Trust(Wellcome Trust)	This work was supported by the Danish Medical Research Council, the Danish Natural Science Research Council (Center for Structural Biology, the Dansync program), the Aarhus University Research Foundation, the Novo-Nordic Foundation (Denmark), the Commissariat a l'Energie Atomique (Saclay, France), CNRS, and the DIM Maladies Infectieuses, Parasitaires et Nosocomiales Emergentes/Ile de France (France).; Supported by Commission of the European Communities ANTIMAL Grant 018834 and Wellcome Trust Grant 074395/Z/04/Z.	ASAWAMAHASAKDA W, 1994, ANTIMICROB AGENTS CH, V38, P1854, DOI 10.1128/AAC.38.8.1854; AVERY MA, 1993, J MED CHEM, V36, P4264, DOI 10.1021/jm00078a017; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Bhisutthibhan J, 1998, J BIOL CHEM, V273, P16192, DOI 10.1074/jbc.273.26.16192; Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019; CENTENO F, 1994, FEBS LETT, V354, P117, DOI 10.1016/0014-5793(94)01104-4; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Clausen JD, 2003, BIOCHEMISTRY-US, V42, P2585, DOI 10.1021/bi0271897; Cojean S, 2006, EMERG INFECT DIS, V12, P1798, DOI 10.3201/eid1211.060903; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Falson P, 1997, J BIOL CHEM, V272, P17258, DOI 10.1074/jbc.272.28.17258; Ferreira ID, 2008, TROP MED INT HEALTH, V13, P199, DOI 10.1111/j.1365-3156.2007.01991.x; Fidock DA, 2008, TRENDS PARASITOL, V24, P537, DOI 10.1016/j.pt.2008.09.005; Garah FBE, 2009, CHEMMEDCHEM, V4, P1469, DOI 10.1002/cmdc.200900200; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011; GU HM, 1984, T ROY SOC TROP MED H, V78, P265, DOI 10.1016/0035-9203(84)90296-7; Hartwig CL, 2009, BIOCHEM PHARMACOL, V77, P322, DOI 10.1016/j.bcp.2008.10.015; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Haynes RK, 2006, ANGEW CHEM INT EDIT, V45, P2082, DOI 10.1002/anie.200503071; Hedfalk K, 2008, PROTEIN EXPRES PURIF, V59, P69, DOI 10.1016/j.pep.2008.01.004; Hoppe HC, 2004, ANTIMICROB AGENTS CH, V48, P2370, DOI 10.1128/AAC.48.7.2370-2378.2004; Ittarat Wanida, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P744; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KIMURA M, 1993, J CELL SCI, V104, P1129; Kombila M, 1997, AM J TROP MED HYG, V57, P643, DOI 10.4269/ajtmh.1997.57.643; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; Krishna S, 2008, TRENDS PHARMACOL SCI, V29, P520, DOI 10.1016/j.tips.2008.07.004; KUMAR N, 1990, PARASITOL RES, V76, P214, DOI 10.1007/BF00930817; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; LUND S, 1989, J BIOL CHEM, V264, P4907; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Montigny C, 2004, J BIOL CHEM, V279, P43971, DOI 10.1074/jbc.M407142200; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Nagamune K, 2007, ANTIMICROB AGENTS CH, V51, P3816, DOI 10.1128/AAC.00582-07; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; O'Neill PM, 2005, EXPERT OPIN INV DRUG, V14, P1117, DOI 10.1517/13543784.14.9.1117; Olliaro PL, 2001, TRENDS PARASITOL, V17, P122, DOI 10.1016/S1471-4922(00)01838-9; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Riganti C, 2009, BRIT J PHARMACOL, V156, P1054, DOI 10.1111/j.1476-5381.2009.00117.x; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Soulie S, 1998, J BIOCHEM-TOKYO, V124, P417, DOI 10.1093/oxfordjournals.jbchem.a022128; Stockwin LH, 2009, INT J CANCER, V125, P1266, DOI 10.1002/ijc.24496; Tan W, 2006, ARCH BIOCHEM BIOPHYS, V452, P119, DOI 10.1016/j.abb.2006.06.017; TERKUILE F, 1993, EXP PARASITOL, V76, P85, DOI 10.1006/expr.1993.1010; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toovey S, 2008, BASIC CLIN PHARMACOL, V103, P209, DOI 10.1111/j.1742-7843.2008.00256.x; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Varotti FD, 2008, ANTIMICROB AGENTS CH, V52, P3868, DOI 10.1128/AAC.00510-08; Varotti FP, 2003, CELL CALCIUM, V33, P137, DOI 10.1016/S0143-4160(02)00224-5; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; VILSEN B, 1991, J BIOL CHEM, V266, P16157; Vyas N, 2002, ANTIMICROB AGENTS CH, V46, P105, DOI 10.1128/AAC.46.1.105-109.2002; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Witting PK, 2001, J BIOL CHEM, V276, P3991, DOI 10.1074/jbc.M005758200; Woodrow CJ, 2005, POSTGRAD MED J, V81, P71, DOI 10.1136/pgmj.2004.028399; Zhang GQ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-122; Zhang HB, 2002, J BIOL CHEM, V277, P49767, DOI 10.1074/jbc.M204005200	74	46	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26406	26416		10.1074/jbc.M109.090340	http://dx.doi.org/10.1074/jbc.M109.090340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20530490	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000280921000059
J	Osman, D; Waldron, KJ; Denton, H; Taylor, CM; Grant, AJ; Mastroeni, P; Robinson, NJ; Cavet, JS				Osman, Deenah; Waldron, Kevin J.; Denton, Harriet; Taylor, Clare M.; Grant, Andrew J.; Mastroeni, Pietro; Robinson, Nigel J.; Cavet, Jennifer S.			Copper Homeostasis in Salmonella Is Atypical and Copper-CueP Is a Major Periplasmic Metal Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH PHAGOCYTE OXIDASE; ANTIMICROBIAL ACTIONS; SUPEROXIDE-DISMUTASE; ATPASE REDUCE; ENTERICA; TYPHIMURIUM; INFECTION; PROTEIN; GENE; PROLIFERATION	Salmonella enterica sv. typhimurium (S. enterica sv. Typhimurium) has two metal-transporting P-1-type ATPases whose actions largely overlap with respect to growth in elevated copper. Mutants lacking both ATPases over-accumulate copper relative to wild-type or either single mutant. Such duplication of ATPases is unusual in bacterial copper tolerance. Both ATPases are under the control of MerR family metal-responsive transcriptional activators. Analyses of periplasmic copper complexes identified copper-CueP as one of the predominant metal pools. Expression of cueP was recently shown to be controlled by the same metal-responsive activator as one of the P1-type ATPase genes (copA), and copper-CueP is a further atypical feature of copper homeostasis in S. enterica sv. Typhimurium. Elevated copper is detected by a reporter construct driven by the promoter of copA in wild-type S. enterica sv. Typhimurium during infection of macrophages. Double mutants missing both ATPases also show reduced survival inside cultured macrophages. It is hypothesized that elevated copper within macrophages may have selected for specialized copper-resistance systems in pathogenic microorganism such as S. enterica sv. Typhimurium.	[Cavet, Jennifer S.] Univ Manchester, Manchester M13 9PT, Lancs, England; [Waldron, Kevin J.; Robinson, Nigel J.] Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Grant, Andrew J.; Mastroeni, Pietro] Univ Cambridge, Cambridge CB3 0ES, England	University of Manchester; Newcastle University - UK; University of Cambridge	Cavet, JS (corresponding author), Univ Manchester, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	Jennifer.s.cavet@manchester.ac.uk	Waldron, Kevin John/HHM-8983-2022; Robinson, Nigel J/J-6363-2012; Waldron, Kevin/J-2368-2016; Osman, Deenah/AAB-4516-2020	Waldron, Kevin John/0000-0002-5577-7357; Robinson, Nigel J/0000-0001-5586-1092; Waldron, Kevin/0000-0002-5577-7357; Osman, Deenah/0000-0002-0251-9231; Cavet, Jennifer/0000-0001-5913-7157; Mastroeni, Pietro/0000-0003-3838-4962	Biotechnology and Biological Science Research Council (BBSRC) Agri-food Committee [BB/G010765/1]; Biotechnology and Biological Sciences Research Council [BB/G010765/1] Funding Source: researchfish; Medical Research Council [G0801161] Funding Source: researchfish; BBSRC [BB/G010765/1] Funding Source: UKRI; MRC [G0801161] Funding Source: UKRI	Biotechnology and Biological Science Research Council (BBSRC) Agri-food Committee(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Biotechnology and Biological Science Research Council (BBSRC) Agri-food Committee (BB/G010765/1) and BBSRC studentship (to D.O.).	Aarestrup FM, 2004, VET MICROBIOL, V100, P83, DOI 10.1016/j.vetmic.2004.01.013; Achard MES, 2010, INFECT IMMUN, V78, P2312, DOI 10.1128/IAI.01208-09; Ammendola S, 2008, J BIOL CHEM, V283, P13688, DOI 10.1074/jbc.M710499200; Battistoni A, 2003, BIOCHEM SOC T, V31, P1326; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Checa SK, 2007, MOL MICROBIOL, V63, P1307, DOI 10.1111/j.1365-2958.2007.05590.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Field LS, 2002, J BIOENERG BIOMEMBR, V34, P373, DOI 10.1023/A:1021202119942; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Francis MS, 1997, MICROB PATHOGENESIS, V22, P67, DOI 10.1006/mpat.1996.0092; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Heithoff DM, 1997, P NATL ACAD SCI USA, V94, P934, DOI 10.1073/pnas.94.3.934; Huang ZXL, 2000, J NUTR, V130, P1536, DOI 10.1093/jn/130.6.1536; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Kim JS, 2002, FEMS MICROBIOL LETT, V210, P99, DOI 10.1111/j.1574-6968.2002.tb11166.x; Lim SY, 2002, MOL CELLS, V14, P177; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; NEWBERNE PM, 1968, BRIT J EXP PATHOL, V49, P448; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Percival SS, 1998, AM J CLIN NUTR, V67, p1064S, DOI 10.1093/ajcn/67.5.1064S; Pontel LB, 2009, MOL MICROBIOL, V73, P212, DOI 10.1111/j.1365-2958.2009.06763.x; Rankin S, 2002, INFECT IMMUN, V70, P3637, DOI 10.1128/IAI.70.7.3637-3648.2002; Sambrook J, 2001, MOL CLONING LAB MANU; Schwan WR, 2005, INT J MED MICROBIOL, V295, P237, DOI 10.1016/j.ijmm.2005.05.005; Segal AW, 1997, ANN NY ACAD SCI, V832, P215, DOI 10.1111/j.1749-6632.1997.tb46249.x; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Stoyanov JV, 2003, FEBS LETT, V546, P391, DOI 10.1016/S0014-5793(03)00640-9; Stoyanov JV, 2003, J BIOL CHEM, V278, P1407, DOI 10.1074/jbc.C200580200; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Taylor CM, 2009, MICROB PATHOGENESIS, V46, P114, DOI 10.1016/j.micpath.2008.11.001; Tottey S, 2005, ACCOUNTS CHEM RES, V38, P775, DOI 10.1021/ar0300118; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201	46	122	123	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25259	25268		10.1074/jbc.M110.145953	http://dx.doi.org/10.1074/jbc.M110.145953			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534583	Green Published, hybrid			2022-12-25	WOS:000280682400019
J	Wakabayashi, H; Griffiths, AE; Fay, PJ				Wakabayashi, Hironao; Griffiths, Amy E.; Fay, Philip J.			Factor VIII Lacking the C2 Domain Retains Cofactor Activity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; ACTIVATED PROTEIN-C; PORCINE FACTOR-VIII; CRYSTAL-STRUCTURE; MEMBRANE-BINDING; THROMBIN GENERATION; CHARGED RESIDUES; SITE; COMPLEX; INTERFACE	Factor (F) VIII consists of a heavy chain (A1A2B domains) and light chain (A3C1C2 domains). The activated form of FVIII, FVIIIa, functions as a cofactor for FIXa in catalyzing the membrane-dependent activation of FX. Whereas the FVIII C2 domain is believed to anchor FVIIIa to the phospholipid surface, recent x-ray crystal structures of FVIII suggest that the C1 domain may also contribute to this function. We constructed a FVIII variant lacking the C2 domain (designated Delta C2) to characterize the contributions of the C1 domain to function. Binding affinity of the Delta C2 variant to phospholipid vesicles as measured by energy transfer was reduced similar to 14-fold. However, the activity of Delta C2 as measured by FXa generation and one-stage clotting assays retained 76 and 36%, respectively, of the WT FVIII value. Modest reductions (similar to 4-fold) were observed in the functional affinity of Delta C2 FVIII for FIXa and rates of thrombin activation. On the other hand, deletion of C2 resulted in significant reductions in FVIIIa stability (similar to 3.6-fold). Thrombin generation assays showed peak thrombin and endogenous thrombin potential were reduced as much as similar to 60-fold. These effects likely result from a combination of the intermolecular functional defects plus reduced protein stability. Together, these results indicate that FVIII domains other than C2, likely C1, make significant contributions to membrane-binding and membrane-dependent function.	[Wakabayashi, Hironao; Griffiths, Amy E.; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Sch Med, Dept Biochem & Biophys, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL76213, HL38199]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199, R01HL076213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL76213 and HL38199. Portions of this work were presented at the annual meeting of the National Hemophilia Foundation, October 30, 2009, in San Francisco, CA.	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Blostein MD, 2003, J BIOL CHEM, V278, P31297, DOI 10.1074/jbc.M302840200; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; GILBERT GE, 1992, J BIOL CHEM, V267, P15861; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HEMKER HC, 1995, THROMB HAEMOSTASIS, V74, P134; Hsu TC, 2008, BLOOD, V111, P200, DOI 10.1182/blood-2007-01-068957; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Newell JL, 2009, J BIOL CHEM, V284, P11080, DOI 10.1074/jbc.M900234200; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nogami K, 2000, J BIOL CHEM, V275, P25774, DOI 10.1074/jbc.M002007200; OVER J, 1984, SCAND J HAEMATOL, V33, P13; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Saleh M, 2004, THROMB HAEMOSTASIS, V91, P16, DOI 10.1160/TH03-04-0222; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Wakabayashi H, 2005, BIOCHEMISTRY-US, V44, P10298, DOI 10.1021/bi050638t; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013	31	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25176	25184		10.1074/jbc.M110.106906	http://dx.doi.org/10.1074/jbc.M110.106906			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529839	hybrid, Green Published			2022-12-25	WOS:000280682400010
J	Murthy, S; Ryan, A; He, C; Mallampalli, RK; Carter, AB				Murthy, Shubha; Ryan, Alan; He, Chao; Mallampalli, Rama K.; Carter, A. Brent			Rac1-mediated Mitochondrial H2O2 Generation Regulates MMP-9 Gene Expression in Macrophages via Inhibition of SP-1 and AP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; MATRIX METALLOPROTEINASES; TNF-ALPHA; TRANSCRIPTIONAL ACTIVATION; SP1 PHOSPHORYLATION; SIGNAL-TRANSDUCTION; TISSUE INHIBITOR; BINDING-PROTEIN; IV COLLAGENASE	Aberrant matrix deposition is a hallmark of pulmonary fibrosis and is characterized by an imbalance between matrix deposition and degradation. We have previously shown that mice harboring a conditional deletion of the GTP-binding protein, Rac1, in macrophages are protected from asbestos-induced pulmonary fibrosis. To investigate the contribution of aberrant matrix degradation, we addressed the role of Rac1 in regulating expression of macrophage-specific MMP-9 (matrix metalloproteinase-9). We found that MMP-9 gene transcription was significantly greater in Rac1 null macrophages. Deletion and mutational analysis of the MMP-9 promoter revealed that both SP-1 and AP-1 are essential for MMP-9 transcription. Overexpression of constitutive active Rac1 (V12) revealed that H2O2 was derived from the mitochondria. Rac1-induced H2O2 generation down-regulated MMP-9 gene transcription, whereas catalase overexpression in WT cells enhanced MMP-9 expression. SP-1 interacted directly with both c-Jun and c-Fos, and H2O2 decreased this binding, suggesting that SP-1 and AP-1 function cooperatively to regulate MMP-9 transcription. Rac1-mediated H2O2 inhibited the ERK MAPK, which was essential for activation of SP-1 and AP-1. ERK activation and MMP-9 expression were recovered by overexpressing catalase or transfecting siRNA for the mitochondrial iron-sulfur protein, Rieske. These observations were recapitulated in vivo. MMP-9 mRNA was higher in alveolar macrophages isolated from Rac1 null mice and wild type mice given catalase. Rac1 regulates MMP-9 transcription via mitochondrial H2O2 generation, providing a potential mechanism by which Rac1 null mice fail to develop pulmonary fibrosis.	[Murthy, Shubha; Ryan, Alan; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [He, Chao; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Free Rad & Radiat Biol, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Dept Human Toxicol, Iowa City, IA 52242 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, C33 GH, Iowa City, IA 52242 USA.				National Institutes of Health [HL068135, HL081784, HL097376, ES015981, ES014871]; Department of Veterans Affairs, Office of Research and Development; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081784, R01HL068135, R01HL097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014871, R01ES015981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Office of Research and Development(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068135, HL081784, and HL097376 (to R. K. M.) and ES015981 and ES014871 (to A. B. C.). This work was also supported by a grant from the Department of Veterans Affairs, Office of Research and Development (to R. K. M.).	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Binker MG, 2009, BIOCHEM BIOPH RES CO, V386, P124, DOI 10.1016/j.bbrc.2009.05.136; Binker MG, 2009, BIOCHEM BIOPH RES CO, V379, P445, DOI 10.1016/j.bbrc.2008.12.080; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Brenneisen P, 2000, J BIOL CHEM, V275, P4336, DOI 10.1074/jbc.275.6.4336; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Carter AB, 2001, J BIOL CHEM, V276, P33826, DOI 10.1074/jbc.M100209200; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen XW, 2007, MOL CELL BIOL, V27, P3313, DOI 10.1128/MCB.01476-06; De Minicis S, 2007, ARCH BIOCHEM BIOPHYS, V462, P266, DOI 10.1016/j.abb.2007.04.016; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Engers R, 2006, FEBS J, V273, P4754, DOI 10.1111/j.1742-4658.2006.05476.x; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Monick MM, 1999, J BIOL CHEM, V274, P18075, DOI 10.1074/jbc.274.25.18075; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Ozaki M, 2000, J BIOL CHEM, V275, P35377, DOI 10.1074/jbc.M005287200; Ozaki M, 2000, FASEB J, V14, P418, DOI 10.1096/fasebj.14.2.418; PANUS PC, 1993, FREE RADICAL BIO MED, V14, P217, DOI 10.1016/0891-5849(93)90013-K; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Poitevin S, 2008, J THROMB HAEMOST, V6, P1586, DOI 10.1111/j.1538-7836.2008.03051.x; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; SATO H, 1993, J BIOL CHEM, V268, P23460; SETH A, 1992, J BIOL CHEM, V267, P24796; SHAPIRO SD, 1993, BIOCHEMISTRY-US, V32, P4286, DOI 10.1021/bi00067a018; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tephly LA, 2008, AM J RESP CELL MOL, V39, P113, DOI 10.1165/rcmb.2007-0356OC; Tephly LA, 2007, AM J RESP CELL MOL, V37, P366, DOI 10.1165/rcmb.2006-0268OC; Tsai LN, 2008, MOL CELL BIOL, V28, P4240, DOI 10.1128/MCB.01489-07; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Woo CH, 2002, J BIOL CHEM, V277, P8572, DOI 10.1074/jbc.M104766200; Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971; Yang JQ, 2002, MOL CARCINOGEN, V33, P206, DOI 10.1002/mc.10037; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621	57	65	69	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25062	25073		10.1074/jbc.M109.099655	http://dx.doi.org/10.1074/jbc.M109.099655			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529870	Green Published, hybrid			2022-12-25	WOS:000280542100079
J	Sancho, P; Fabregat, I				Sancho, Patricia; Fabregat, Isabel			NADPH Oxidase NOX1 Controls Autocrine Growth of Liver Tumor Cells through Up-regulation of the Epidermal Growth Factor Receptor Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; HEPATOCELLULAR-CARCINOMA; EPITHELIAL-CELLS; HEPATOMA-CELLS; TGF-BETA; SUPEROXIDE GENERATION; SIGNALING PATHWAYS; CATALYTIC SUBUNIT; FACTOR-ALPHA	FaO rat hepatoma cells proliferate in the absence of serum through a mechanism that requires activation of the epidermal growth factor receptor (EGFR) pathway. The aim of this work was to analyze the molecular mechanisms that control EGFR activation in these and other liver tumor cells. Reactive oxygen species production is observed a short time after serum withdrawal in FaO cells, coincident with up-regulation of the NADPH oxidase NOX1. NOX1-targeted knockdown, the use of antioxidants, or pharmacological inhibition of NADPH oxidase attenuates autocrine growth, coincident with lower mRNA levels of EGFR and its ligand transforming growth factor-alpha (TGF-alpha) and a decrease in phosphorylation of EGFR. EGFR-targeted knockdown induces similar effects on cell growth and downstream signals to those observed in NOX1-depleted cells. Early NOX1 activation induces both a feedback-positive loop via an Src-ERK pathway that up-regulates its own levels, and a parallel signaling pathway through p38 MAPK and AKT resulting in EGFR and TGF-alpha up-regulation. Human hepatocellular carcinoma cell lines, but not non-tumoral hepatocytes, show autocrine growth upon serum withdrawal, which is also coincident with NOX1 up-regulation that mediates EGFR and TGF-alpha expression. The use of antioxidants, or pharmacological inhibition of NADPH oxidase, effectively attenuates autocrine growth in hepatocellular carcinoma cell lines. In summary, results presented in this study indicate that NOX1 might control autocrine cell growth of liver tumor cells through regulation of the EGFR pathway.	[Sancho, Patricia; Fabregat, Isabel] Univ Barcelona, Oncol Mol Lab, Inst Invest Biomed Bellvitge, Barcelona 08907, Spain; [Fabregat, Isabel] Univ Barcelona, Dept Ciencies Fisiol 2, Inst Invest Biomed Bellvitge, Barcelona 08907, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Sancho, P (corresponding author), Univ Barcelona, Oncol Mol Lab, Inst Invest Biomed Bellvitge, Barcelona 08907, Spain.	psancho@idibell.cat	Sancho, Patricia/ABH-5258-2020; Fabregat, Isabel/H-7038-2015	Sancho, Patricia/0000-0002-1092-5395; Fabregat, Isabel/0000-0003-0136-8440	Ministerio de Ciencia e Innovacion, Spain [BFU2006-01036, BFU2009-07219]; ISCIII-RTICC [RD06/0020]; AGAUR-Generalitat de Catalunya [2005SGR-00549, 2009SGR-312]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII-RTICC(Instituto de Salud Carlos III); AGAUR-Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	This work was supported in part by Ministerio de Ciencia e Innovacion, Spain, Grants BFU2006-01036, BFU2009-07219, and ISCIII-RTICC RD06/0020 and AGAUR-Generalitat de Catalunya Grants 2005SGR-00549 and 2009SGR-312.	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Aslan M, 2003, ANTIOXID REDOX SIGN, V5, P781, DOI 10.1089/152308603770380089; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Brewer AC, 2006, FREE RADICAL BIO MED, V40, P260, DOI 10.1016/j.freeradbiomed.2005.08.022; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Caja L, 2009, CANCER RES, V69, P7595, DOI 10.1158/0008-5472.CAN-09-1482; Calvisi DF, 2004, J HEPATOL, V41, P815, DOI 10.1016/j.jhep.2004.07.030; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Carnesecchi S, 2006, EXP CELL RES, V312, P3413, DOI 10.1016/j.yexcr.2006.07.003; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cosgrove BD, 2008, HEPATOLOGY, V48, P276, DOI 10.1002/hep.22335; de Carvalho DD, 2008, INT J CANCER, V122, P1757, DOI 10.1002/ijc.23300; De Minicis S, 2007, ARCH BIOCHEM BIOPHYS, V462, P266, DOI 10.1016/j.abb.2007.04.016; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fan CY, 2005, FEBS LETT, V579, P1301, DOI 10.1016/j.febslet.2005.01.021; Fukuyama M, 2005, CANCER LETT, V221, P97, DOI 10.1016/j.canlet.2004.08.031; Hisaka T, 1999, INT J ONCOL, V14, P453; Hsieh HL, 2008, J CELL BIOCHEM, V103, P1732, DOI 10.1002/jcb.21563; Hsieh HL, 2009, ARTERIOSCL THROM VAS, V29, P1594, DOI 10.1161/ATVBAHA.109.185801; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Katsuyama M, 2005, BIOCHEM J, V386, P255, DOI 10.1042/BJ20041180; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Laurent A, 2005, CANCER RES, V65, P948; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Mukohara T, 2004, ANTICANCER RES, V24, P11; Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846; Nakai K, 2008, J DERMATOL SCI, V51, P181, DOI 10.1016/j.jdermsci.2008.03.004; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Ortiz C, 2008, BIOCHEM PHARMACOL, V75, P1935, DOI 10.1016/j.bcp.2008.02.015; Ranjan P, 2006, ANTIOXID REDOX SIGN, V8, P1447, DOI 10.1089/ars.2006.8.1447; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Sato Y, 2006, GUT, V55, P1801, DOI 10.1136/gut.2005.070417; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Shi DY, 2003, FEBS LETT, V542, P60, DOI 10.1016/S0014-5793(03)00338-7; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Teshima S, 2000, AM J PHYSIOL-GASTR L, V279, pG1169, DOI 10.1152/ajpgi.2000.279.6.G1169; Teufelhofer O, 2005, CARCINOGENESIS, V26, P319, DOI 10.1093/carcin/bgh320; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Yan FG, 2008, BIOCHEM BIOPH RES CO, V366, P513, DOI 10.1016/j.bbrc.2007.11.172	49	57	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24815	24824		10.1074/jbc.M110.114280	http://dx.doi.org/10.1074/jbc.M110.114280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20525691	Green Published, hybrid			2022-12-25	WOS:000280542100054
J	Swayne, LA; Sorbara, CD; Bennett, SAL				Swayne, Leigh Anne; Sorbara, Catherine D.; Bennett, Steffany A. L.			Pannexin 2 Is Expressed by Postnatal Hippocampal Neural Progenitors and Modulates Neuronal Commitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; PROTEIN; HEMICHANNELS; RECEPTORS; CHANNELS; FAMILY; PALMITOYLATION; RELEASE; BORN	The pannexins (Panx1, -2, and -3) are a mammalian family of putative single membrane channels discovered through homology to invertebrate gap junction-forming proteins, the innexins. Because connexin gap junction proteins are known regulators of neural stem and progenitor cell proliferation, migration, and specification, we asked whether pannexins, specifically Panx2, play a similar role in the postnatal hippocampus. We show that Panx2 protein is differentially expressed by multipotential progenitor cells and mature neurons. Both in vivo and in vitro, Type I and IIa stem-like neural progenitor cells express an S-palmitoylated Panx2 species localizing to Golgi and endoplasmic reticulum membranes. Protein expression is down-regulated during neurogenesis in neuronally committed Type IIb and III progenitor cells and immature neurons. Panx2 is re-expressed by neurons following maturation. Protein expressed by mature neurons is not palmitoylated and localizes to the plasma membrane. To assess the impact of Panx2 on neuronal differentiation, we used short hairpin RNA to suppress Panx2 expression in Neuro2a cells. Knockdown significantly accelerated the rate of neuronal differentiation. Neuritic extension and the expression of antigenic markers of mature neurons occurred earlier in stable lines expressing Panx2 short hairpin RNA than in controls. Together, these findings describe an endogenous post-translational regulation of Panx2, specific to early neural progenitor cells, and demonstrate that this expression plays a role in modulating the timing of their commitment to a neuronal lineage.	[Swayne, Leigh Anne] Univ Ottawa, Neural Regenerat Lab, Ottawa, ON K1M 1E5, Canada; Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON K1M 1E5, Canada	University of Ottawa; University of Ottawa	Swayne, LA (corresponding author), Univ Ottawa, Neural Regenerat Lab, 451 Smyth Rd, Ottawa, ON K1M 1E5, Canada.	lswayne@uottawa.ca			Canadian Institutes of Health Research (CIHR) [MOP-62826]; Heart and Stroke Foundation Centre; Genome Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation Centre; Genome Canada(Genome Canada)	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-62826, the Heart and Stroke Foundation Centre for Stroke Recovery, and Genome Canada operating support (to S.A.L.B.).	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Hogg RC, 2004, EUR J NEUROSCI, V19, P2410, DOI 10.1111/j.0953-816X.2004.03346.x; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Jiang H, 2007, BRIT J PHARMACOL, V151, P1033, DOI 10.1038/sj.bjp.0707311; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Li GN, 2010, CURR OPIN NEUROBIOL, V20, P126, DOI 10.1016/j.conb.2009.12.008; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Lin JHC, 2007, DEV BIOL, V302, P356, DOI 10.1016/j.ydbio.2006.09.017; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Melanson-Drapeau L, 2003, J NEUROSCI, V23, P1759; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Penuela S, 2008, CELL COMMUN ADHES, V15, P133, DOI 10.1080/15419060802014115; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Ray A, 2006, CEREBELLUM, V5, P189, DOI 10.1080/14734220500530082; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ryan SD, 2009, P NATL ACAD SCI USA, V106, P20936, DOI 10.1073/pnas.0905654106; Suadicani SO, 2009, ASN NEURO, V1, DOI 10.1042/AN20090001; Swayne LA, 2005, MOL CELL NEUROSCI, V30, P339, DOI 10.1016/j.mcn.2005.07.016; Thompson A, 2008, GENES BRAIN BEHAV, V7, P28, DOI 10.1111/j.1601-183X.2007.00379.x; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Thumser AE, 2007, MOL CELL BIOCHEM, V299, P67, DOI 10.1007/s11010-005-9041-2; Tole S, 1997, DEVELOPMENT, V124, P4959; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Wang XH, 2009, J COMP NEUROL, V512, P336, DOI 10.1002/cne.21898; Wegner F, 2008, J NEUROCHEM, V107, P1056, DOI 10.1111/j.1471-4159.2008.05688.x; Wu PY, 2009, CELL SIGNAL, V21, P881, DOI 10.1016/j.cellsig.2009.01.036; Yeh E, 2009, J NEUROSCI, V29, P5207, DOI 10.1523/JNEUROSCI.0637-09.2009; Zappala A, 2007, NEUROSCIENCE, V148, P653, DOI 10.1016/j.neuroscience.2007.06.028	49	78	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24977	24986		10.1074/jbc.M110.130054	http://dx.doi.org/10.1074/jbc.M110.130054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529862	hybrid, Green Published			2022-12-25	WOS:000280542100070
J	Tsay, JM; Sippy, J; delToro, D; Andrews, BT; Draper, B; Rao, V; Catalano, CE; Feiss, M; Smith, DE				Tsay, James M.; Sippy, Jean; delToro, Damian; Andrews, Benjamin T.; Draper, Bonnie; Rao, Venigalla; Catalano, Carlos E.; Feiss, Michael; Smith, Douglas E.			Mutations Altering a Structurally Conserved Loop-Helix-Loop Region of a Viral Packaging Motor Change DNA Translocation Velocity and Processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-LAMBDA TERMINASE; FORCE GENERATION; PORTAL MOTOR; LARGE SUBUNIT; ATPASE CENTER; MATURATION; MECHANISM; SUGGESTS; ENZYME	Many double-stranded DNA viruses employ ATP-driven motors to translocate their genomes into small, preformed viral capsids against large forces resisting confinement. Here, we show via direct single-molecule measurements that a mutation T194M downstream of the Walker B motif in the phage lambda gpA packaging motor causes an 8-fold reduction in translocation velocity without substantially changing processivity or force dependence, whereas the mutation G212S in the putative C (coupling) motif causes a 3-fold reduction in velocity and a 6-fold reduction in processivity. Meanwhile a T194M pseudorevertant (T194V) showed a near restoration of the wild-type dynamics. Structural comparisons and modeling show that these mutations are in a loop-helix-loop region that positions the key residues of the catalytic motifs, Walker B and C, in the ATPase center and is structurally homologous with analogous regions in chromosome transporters and SF2 RNA helicases. Together with recently published studies of SpoIIIE chromosome transporter and Ded1 RNA helicase mutants, these findings suggest the presence of a structurally conserved region that may be a part of the mechanism that determines motor velocity and processivity in several different types of nucleic acid translocases.	[Tsay, James M.; delToro, Damian; Smith, Douglas E.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Sippy, Jean; Feiss, Michael] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Andrews, Benjamin T.; Catalano, Carlos E.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Draper, Bonnie; Rao, Venigalla] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	University of California System; University of California San Diego; University of Iowa; University of Washington; University of Washington Seattle; Catholic University of America	Smith, DE (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	des@physics.ucsd.edu	Smith, Douglas E/A-3131-2017	Smith, Douglas E/0000-0002-8206-3632; Rao, Venigalla/0000-0002-0777-6587; Catalano, Carlos E./0000-0003-2349-5758	National Institutes of Health [F32GM083440, GM-51611, F32GM-905652, GM-063943]; National Science Foundation [MCB-0717620, PHY-0848905]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051611, R01GM063943, F32GM090565, F32GM083440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a National Institutes of Health Postdoctoral Fellowship Award F32GM083440.; Supported by National Institutes of Health Grant GM-51611 and National Science Foundation Grant MCB-0717620.; Supported by National Institutes of Health Postdoctoral Fellowship Award F32GM-905652.; Supported by National Institutes of Health Grant GM-063943.; Supported by National Science Foundation Grant PHY-0848905. To whom correspondence should be addressed. E-mail: des@physics.ucsd.edu.	Arber W., 1983, LAMBDA, P433; Banroques J, 2010, J MOL BIOL, V396, P949, DOI 10.1016/j.jmb.2009.12.025; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Campbell A. M., 2007, FIELDS VIROLOGY, P769; Catalano C.E., 2005, VIRAL GENOME PACKAGI; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Dhar A, 2005, J MOL BIOL, V354, P738, DOI 10.1016/j.jmb.2005.10.004; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; Duffy C, 2002, J MOL BIOL, V316, P547, DOI 10.1006/jmbi.2001.5368; Feiss Michael, 2005, P5; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; Hang JQ, 2000, J MOL BIOL, V302, P777, DOI 10.1006/jmbi.2000.4086; Hang Q, 1999, J BIOL CHEM, V274, P15305, DOI 10.1074/jbc.274.22.15305; Hwang Y, 1996, BIOCHEMISTRY-US, V35, P2796, DOI 10.1021/bi952322z; Maluf NK, 2006, BIOCHEMISTRY-US, V45, P15259, DOI 10.1021/bi0615036; Maluf NK, 2005, J MOL BIOL, V347, P523, DOI 10.1016/j.jmb.2005.01.016; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Ortega ME, 2007, J MOL BIOL, V373, P851, DOI 10.1016/j.jmb.2007.07.067; PAL SK, 1988, J BACTERIOL, V172, P2819; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rickgauer JR, 2007, BIOPHYS J, p48A; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Sisakova E, 2008, J MOL BIOL, V384, P1273, DOI 10.1016/j.jmb.2008.10.017; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Story RM, 2001, P NATL ACAD SCI USA, V98, P3624; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; TOMKA MA, 1993, J BIOL CHEM, V268, P3056; Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; [No title captured]	32	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24282	24289		10.1074/jbc.M110.129395	http://dx.doi.org/10.1074/jbc.M110.129395			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525695	hybrid, Green Published			2022-12-25	WOS:000280291400077
J	Perrot, P; Rousseau, J; Bouffaut, AL; Redini, F; Cassagnau, E; Deschaseaux, F; Heymann, MF; Heymann, D; Duteille, F; Trichet, V; Gouin, F				Perrot, Pierre; Rousseau, Julie; Bouffaut, Anne-Laure; Redini, Francoise; Cassagnau, Elisabeth; Deschaseaux, Frederic; Heymann, Marie-Francoise; Heymann, Dominique; Duteille, Franck; Trichet, Valerie; Gouin, Francois			Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence	PLOS ONE			English	Article							SOLUBLE RECEPTOR ACTIVATOR; OSTEOLYTIC BONE-DISEASE; BREAST-CANCER; NONMETASTATIC OSTEOSARCOMA; CONSERVATIVE TREATMENT; PULMONARY METASTASIS; PROGNOSTIC-FACTORS; MULTIPLE-MYELOMA; TUMOR DORMANCY; STROMAL CELLS	Background: Osteosarcoma is the most common malignant primary bone tumour in young adult treated by neo adjuvant chemotherapy, surgical tumor removal and adjuvant multidrug chemotherapy. For correction of soft tissue defect consecutive to surgery and/or tumor treatment, autologous fat graft has been proposed in plastic and reconstructive surgery. Principal Findings: We report here a case of a late local recurrence of osteosarcoma which occurred 13 years after the initial pathology and 18 months after a lipofilling procedure. Because such recurrence was highly unexpected, we investigated the possible relationship of tumor growth with fat injections and with mesenchymal stem/stromal cell like cells which are largely found in fatty tissue. Results obtained in osteosarcoma pre-clinical models show that fat grafts or progenitor cells promoted tumor growth. Significance: These observations and results raise the question of whether autologous fat grafting is a safe reconstructive procedure in a known post neoplasic context.	[Perrot, Pierre; Rousseau, Julie; Bouffaut, Anne-Laure; Redini, Francoise; Heymann, Marie-Francoise; Heymann, Dominique; Duteille, Franck; Trichet, Valerie; Gouin, Francois] INSERM, U957, Nantes, France; [Perrot, Pierre; Rousseau, Julie; Bouffaut, Anne-Laure; Redini, Francoise; Heymann, Marie-Francoise; Heymann, Dominique; Duteille, Franck; Trichet, Valerie; Gouin, Francois] Univ Nantes, Nantes Atlantique Univ, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, EA3822, Nantes, France; [Perrot, Pierre; Bouffaut, Anne-Laure; Duteille, Franck] Ctr Hosp Univ, Serv Chirurg Plast & Brules, Nantes, France; [Cassagnau, Elisabeth; Heymann, Marie-Francoise] Ctr Hosp Univ, Serv Anat Pathol, Nantes, France; [Deschaseaux, Frederic] Etab Francais du Sang Ctr Atlantique, EA3855, Tours, France; [Gouin, Francois] Ctr Hosp Univ, Serv Orthopedie Traumatol, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Perrot, P (corresponding author), INSERM, U957, Nantes, France.	francois.gouin@chu-nantes.fr	Heymann, Dominique/AAC-6014-2019; REDINI, Francoise/K-7981-2015; Trichet, Valérie/L-1553-2015; gouin, francois/L-1478-2015	Heymann, Dominique/0000-0001-7777-0669; Trichet, Valérie/0000-0003-4183-9032; Rousseau, Julie/0000-0002-8720-7877; Heymann, Marie-Francoise/0000-0002-5585-8261	Fondation pour l'Avenir de la Recherche Medicale Appliquee [ET 8-486]; Ligue contre le cancer/Canceropole Grand Ouest/Regions Bretagne, Centre, Pays de la Loire, Poitou-Charentes [DAFCG/7506]	Fondation pour l'Avenir de la Recherche Medicale Appliquee; Ligue contre le cancer/Canceropole Grand Ouest/Regions Bretagne, Centre, Pays de la Loire, Poitou-Charentes	This work was supported by Fondation pour l'Avenir de la Recherche Medicale Appliquee (study ET 8-486, Paris, France), Ligue contre le cancer/Canceropole Grand Ouest/Regions Bretagne, Centre, Pays de la Loire, Poitou-Charentes (convention DAFCG/7506, Nantes, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci G, 2000, J CLIN ONCOL, V18, P4016, DOI 10.1200/JCO.2000.18.24.4016; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; BILLS CE, 1971, JOHNS HOPKINS MED J, V128, P194; Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318; Chan CW, 2008, J PLAST RECONSTR AES, V61, P1438, DOI 10.1016/j.bjps.2008.08.006; Coleman SR, 1997, CLIN PLAST SURG, V24, P347; Coleman SR, 2007, PLAST RECONSTR SURG, V119, P775, DOI 10.1097/01.prs.0000252001.59162.c9; Croucher PI, 2001, BLOOD, V98, P3534, DOI 10.1182/blood.V98.13.3534; Damiens C, 2000, CYTOKINE, V12, P539, DOI 10.1006/cyto.1999.0593; Delay E, 2008, ANN CHIR PLAST ESTH, V53, P153, DOI 10.1016/j.anplas.2007.09.005; Demicheli R, 2007, NAT CLIN PRACT ONCOL, V4, P699, DOI 10.1038/ncponc0999; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Djouad F, 2006, TRANSPLANTATION, V82, P1060, DOI 10.1097/01.tp.0000236098.13804.0b; Ferrari S, 1997, ANN ONCOL, V8, P765, DOI 10.1023/A:1008221713505; Ferrari S, 2006, J PEDIAT HEMATOL ONC, V28, P418, DOI 10.1097/01.mph.0000212944.82361.1d; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Georges S, 2009, CYTOKINE GROWTH F R, V20, P29, DOI 10.1016/j.cytogfr.2008.11.005; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183; Gosset J, 2008, ANN CHIR PLAST ESTH, V53, P190, DOI 10.1016/j.anplas.2007.09.001; Heath DJ, 2007, CANCER RES, V67, P202, DOI 10.1158/0008-5472.CAN-06-1287; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kaya M, 2000, CLIN CANCER RES, V6, P572; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kim MS, 2007, CLIN ORTHOP RELAT R, P157, DOI 10.1097/BLO.0b013e318142b27d; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Koksal Y, 2008, PEDIATR HEMAT ONCOL, V25, P83, DOI 10.1080/08880010701621010; Lamoureux F, 2008, MOL CANCER THER, V7, P3389, DOI 10.1158/1535-7163.MCT-08-0497; Lamoureux F, 2007, CANCER RES, V67, P7308, DOI 10.1158/0008-5472.CAN-06-4130; Lamoureux F, 2009, CANCER RES, V69, P526, DOI 10.1158/0008-5472.CAN-08-2648; Lazennec G, 2008, STEM CELLS, V26, P1387, DOI 10.1634/stemcells.2007-1006; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; MEYERS PA, 1992, J CLIN ONCOL, V10, P5, DOI 10.1200/JCO.1992.10.1.5; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Missana MC, 2007, EJSO-EUR J SURG ONC, V33, P685, DOI 10.1016/j.ejso.2006.12.002; Mojallal A, 2009, J PLAST RECONSTR AES, V62, P708, DOI 10.1016/j.bjps.2009.01.037; Morony S, 2001, CANCER RES, V61, P4432; MOTRESCU ER, 2008, BIOL CHEM; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Nishimura T, 2000, LARYNGOSCOPE, V110, P1333, DOI 10.1097/00005537-200008000-00021; Ory B, 2005, CANCER-AM CANCER SOC, V104, P2522, DOI 10.1002/cncr.21530; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; SALGARELLO M, 2009, AESTHETIC PLAST SURG; Schwarz EM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2171; Spear SL, 2008, PLAST RECONSTR SURG, V122, P983, DOI 10.1097/PRS.0b013e31818237cf; Uesugi M, 2000, CANCER LETT, V155, P169, DOI 10.1016/S0304-3835(00)00424-9; VARANI J, 1981, J SURG ONCOL, V17, P9, DOI 10.1002/jso.2930170103; Vona-Davis L, 2009, CYTOKINE GROWTH F R, V20, P193, DOI 10.1016/j.cytogfr.2009.05.007; WALTER M, 2009, ONCOGENE; Wilson H, 2008, VET J, V175, P69, DOI 10.1016/j.tvjl.2007.07.025; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Zhang J, 2003, CANCER RES, V63, P7883	58	83	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10999	10.1371/journal.pone.0010999	http://dx.doi.org/10.1371/journal.pone.0010999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544017	Green Published, Green Accepted, gold			2022-12-25	WOS:000278494900011
J	Gui, JH; Wang, T; Jones, RPO; Trump, D; Zimmer, T; Lei, M				Gui, Junhong; Wang, Tao; Jones, Richard P. O.; Trump, Dorothy; Zimmer, Thomas; Lei, Ming			Multiple Loss-of-Function Mechanisms Contribute to SCN5A-Related Familial Sick Sinus Syndrome	PLOS ONE			English	Article							CARDIAC CONDUCTION DEFECT; SODIUM-CHANNEL MUTATIONS; LONG-QT SYNDROME; X-LINKED RETINOSCHISIS; ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; SCN5A MUTATION; BRUGADA-SYNDROME; ATRIAL STANDSTILL; NODE DYSFUNCTION	Background: To identify molecular mechanisms underlying SCN5A-related sick sinus syndrome (SSS), a rare type of SSS, in parallel experiments we elucidated the electrophysiological properties and the cell surface localization of thirteen human Na(v)1.5 (hNa(v)1.5) mutant channels previously linked to this disease. Methodology/Principal Findings: Mutant hNa(v)1.5 channels expressed by HEK293 cells and Xenopus oocytes were investigated by whole-cell patch clamp and two-microelectrode voltage clamp, respectively. HEK293 cell surface biotinylation experiments quantified the fraction of correctly targeted channel proteins. Our data suggested three distinct mutant channel subtypes: Group 1 mutants (L212P, P1298L, DelF1617, R1632H) gave peak current densities and cell surface targeting indistinguishable from wild-type hNa(v)1.5. Loss-of-function of these mutants resulted from altered channel kinetics, including a negative shift of steady-state inactivation and a reduced voltage dependency of open-state inactivation. Group 2 mutants (E161K, T220I, D1275N) gave significantly reduced whole-cell currents due to impaired cell surface localization (D1275N), altered channel properties at unchanged cell surface localization (T220I), or a combination of both (E161K). Group 3 mutant channels were non-functional, due to an almost complete lack of protein at the plasma membrane (T187I, W1421X, K1578fs/52, R1623X) or a probable gating/permeation defect with normal surface localisation (R878C, G1408R). Conclusions/Significance: This study indicates that multiple molecular mechanisms, including gating abnormalities, trafficking defects, or a combination of both, are responsible for SCN5A-related familial SSS.	[Gui, Junhong; Wang, Tao; Jones, Richard P. O.; Trump, Dorothy; Lei, Ming] Univ Manchester, Cardiovasc & Genet Med Res Grp, Sch Biomed, Manchester, Lancs, England; [Zimmer, Thomas] Univ Jena, Inst Physiol 2, Jena, Germany	University of Manchester; Friedrich Schiller University of Jena	Gui, JH (corresponding author), Univ Manchester, Cardiovasc & Genet Med Res Grp, Sch Biomed, Manchester, Lancs, England.	thomas.zimmer@mti.uni-jena.de; ming.lei@manchester.ac.uk	Lei, Ming/G-3686-2011; Lei, Ming/S-7209-2016	Lei, Ming/0000-0002-0928-341X	Wellcome Trust [081809, 081283]; British Heart Foundation [pG/08/006/24399]; Friedrich Schiller University of Jena [923409]; Dorothy Hodgkin Postgraduate Award	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Friedrich Schiller University of Jena; Dorothy Hodgkin Postgraduate Award	This work was supported by The Wellcome Trust (ML, grant numbers 081809 and 081283), and The British Heart Foundation (ML, pG/08/006/24399) and the Friedrich Schiller University of Jena (TZ, budget account No. 923409), JG is supported by a Dorothy Hodgkin Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Baroudi G, 2000, FEBS LETT, V467, P12, DOI 10.1016/S0014-5793(00)01099-1; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Blechschmidt S, 2008, PROG BIOPHYS MOL BIO, V98, P309, DOI 10.1016/j.pbiomolbio.2009.01.009; Brugada J, 1997, J CARDIOVASC ELECTR, V8, P325, DOI 10.1111/j.1540-8167.1997.tb00796.x; Brugada J, 1998, CIRCULATION, V97, P457; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chen TH, 2005, AM J PHYSIOL-HEART C, V288, pH2666, DOI 10.1152/ajpheart.00521.2004; DEMARNEFFE M, 1993, EUR HEART J, V14, P649, DOI 10.1093/eurheartj/14.5.649; FREEDMAN RA, 2001, CARDIAC ELECTROPHYSI, V5, P45; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7; GUI J, 2010, J CARDIOVAS IN PRESS; Kyndt F, 2001, CIRCULATION, V104, P3081, DOI 10.1161/hc5001.100834; Laitinen-Forsblom PJ, 2006, J CARDIOVASC ELECTR, V17, P480, DOI 10.1111/j.1540-8167.2006.00411.x; Lei M, 2005, J PHYSIOL-LONDON, V567, P387, DOI 10.1113/jphysiol.2005.083188; Lei M, 2007, CARDIOVASC RES, V74, P356, DOI 10.1016/j.cardiores.2007.01.009; Lei M, 2008, PROG BIOPHYS MOL BIO, V98, P171, DOI 10.1016/j.pbiomolbio.2008.10.003; LOWN B, 1967, BRIT HEART J, V29, P469; Makita N, 2005, HEART RHYTHM, V2, P1128, DOI 10.1016/j.hrthm.2005.06.032; Makiyama T, 2005, J AM COLL CARDIOL, V46, P2100, DOI 10.1016/j.jacc.2005.08.043; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; *NIH, NIH PUBL, V8523; Niu DM, 2006, J MED GENET, V43, P817, DOI 10.1136/jmg.2006.042192; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Otagiri T, 2008, PEDIATR RES, V64, P482, DOI 10.1203/PDR.0b013e3181841eca; RODRIGUEZ RD, 1990, GERIATRICS, V45, P26; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144; Smits JPP, 2005, J MOL CELL CARDIOL, V38, P969, DOI 10.1016/j.yjmcc.2005.02.024; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Veldkamp MW, 2003, CIRC RES, V92, P976, DOI 10.1161/01.RES.0000069689.09869.A8; Verkerk AO, 2009, INT J BIOL SCI, V5, P201; Wang Q, 1997, CURR OPIN CARDIOL, V12, P310, DOI 10.1097/00001573-199705000-00013; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang T, 2006, BRIT J OPHTHALMOL, V90, P81, DOI 10.1136/bjo.2005.078048; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Zhang Y, 2008, ACTA PHYSIOL, V194, P311, DOI 10.1111/j.1748-1716.2008.01883.x; Zimmer T, 2002, J GEN PHYSIOL, V120, P887, DOI 10.1085/jgp.20028703; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	42	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10985	10.1371/journal.pone.0010985	http://dx.doi.org/10.1371/journal.pone.0010985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539757	Green Submitted, Green Published, gold			2022-12-25	WOS:000278465900006
J	Becerril, S; Rodriguez, A; Catalan, V; Sainz, N; Ramirez, B; Collantes, M; Penuelas, I; Gomez-Ambrosi, J; Fruhbeck, G				Becerril, Sara; Rodriguez, Amaia; Catalan, Victoria; Sainz, Neira; Ramirez, Beatriz; Collantes, Maria; Penuelas, Ivan; Gomez-Ambrosi, Javier; Fruhbeck, Gema			Deletion of Inducible Nitric-Oxide Synthase in Leptin-Deficient Mice Improves Brown Adipose Tissue Function	PLOS ONE			English	Article							II-INDUCED VASOCONSTRICTION; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; MITOCHONDRIAL RESPIRATION; UNCOUPLING PROTEIN-1; METABOLIC REGULATOR; DEPENDENT MECHANISM; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; HYPERTENSIVE-RATS	Background: Leptin and nitric oxide (NO) on their own participate in the control of non-shivering thermogenesis. However, the functional interplay between both factors in this process has not been explored so far. Therefore, the aim of the present study was to analyze the impact of the absence of the inducible NO synthase (iNOS) gene in the regulation of energy balance in ob/ob mice. Methods and Findings: Double knockout (DBKO) mice simultaneously lacking the ob and iNOS genes were generated, and the expression of molecules involved in the control of brown fat cell function was analyzed by real-time PCR, western-blot and immunohistochemistry. Twelve week-old DBKO mice exhibited reduced body weight (p < 0.05), decreased amounts of total fat pads (p < 0.05), lower food efficiency rates (p < 0.05) and higher rectal temperature (p, 0.05) than ob/ob mice. Ablation of iNOS also improved the carbohydrate and lipid metabolism of ob/ob mice. DBKO showed a marked reduction in the size of brown adipocytes compared to ob/ob mutants. In this sense, in comparison to ob/ob mice, DBKO rodents showed an increase in the expression of PR domain containing 16 (Prdm16), a transcriptional regulator of brown adipogenesis. Moreover, iNOS deletion enhanced the expression of mitochondria-related proteins, such as peroxisome proliferator-activated receptor gamma coactivator-1 alpha (Pgc-1 alpha), sirtuin-1 (Sirt-1) and sirtuin-3 (Sirt-3). Accordingly, mitochondrial uncoupling proteins 1 and 3 (Ucp-1 and Ucp-3) were upregulated in brown adipose tissue (BAT) of DBKO mice as compared to ob/ob rodents. Conclusion: Ablation of iNOS improved the energy balance of ob/ob mice by decreasing food efficiency through an increase in thermogenesis. These effects may be mediated, in part, through the recovery of the BAT phenotype and brown fat cell function improvement.	[Becerril, Sara; Rodriguez, Amaia; Catalan, Victoria; Sainz, Neira; Ramirez, Beatriz; Gomez-Ambrosi, Javier; Fruhbeck, Gema] Univ Navarra Clin, Metab Res Lab, Pamplona, Spain; [Fruhbeck, Gema] Univ Navarra Clin, Dept Endocrinol, Pamplona, Spain; [Becerril, Sara; Rodriguez, Amaia; Catalan, Victoria; Sainz, Neira; Ramirez, Beatriz; Gomez-Ambrosi, Javier; Fruhbeck, Gema] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain; [Collantes, Maria; Penuelas, Ivan] Univ Navarra Clin, MicroPET Res Unit CIMA CUN, Pamplona, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra	Becerril, S (corresponding author), Univ Navarra Clin, Metab Res Lab, Pamplona, Spain.	gfruhbeck@unav.es	Penuelas, Ivan/I-6292-2013; Catalan, Victoria/H-3566-2017; Ramírez, Beatriz/I-1922-2017; Sáinz, Neira/AAA-4624-2019; Gómez-Ambrosi, Javier/D-2984-2017; Collantes, María/A-4641-2015; Rodriguez, Amaia/D-3044-2019	Penuelas, Ivan/0000-0001-8008-976X; Catalan, Victoria/0000-0002-7513-7509; Ramírez, Beatriz/0000-0003-3381-7220; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Collantes, María/0000-0003-1162-1470; Rodriguez, Amaia/0000-0002-2180-461X; Becerril, Sara/0000-0002-3441-1970	Departments of Industry and Education of the Gobierno de Navarra; Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo; Ministerio de Ciencia y Tecnologi-a; PIUNA foundation	Departments of Industry and Education of the Gobierno de Navarra; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Ministerio de Ciencia y Tecnologi-a(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PIUNA foundation	SB was recipient of doctoral training grants from the Departments of Industry and Education of the Gobierno de Navarra. This work was supported by grants from the Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo to G.F. and J.G.A; from the Ministerio de Ciencia y Tecnologi-a to G.F.; from the Department of Health of the Gobierno de Navarra to G.F. and J.G.A.; and from PIUNA foundation to G.F. CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN) is an initiative of the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Catalan V, 2009, OBES SURG, V19, P771, DOI 10.1007/s11695-009-9834-6; Chehab FF, 1997, SCIENCE, V275, P88, DOI 10.1126/science.275.5296.88; Chen W, 2009, MOL CELL, V35, P755, DOI 10.1016/j.molcel.2009.09.015; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Densmore VS, 2006, ENDOCRINOLOGY, V147, P4486, DOI 10.1210/en.2006-0106; Dixit VD, 2003, ENDOCRINOLOGY, V144, P5595, DOI 10.1210/en.2003-0600; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finocchietto PV, 2009, EXP BIOL MED, V234, P1020, DOI 10.3181/0902-MR-81; Fortuno A, 2002, ENDOCRINOLOGY, V143, P3555, DOI 10.1210/en.2002-220075; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Fruhbeck G, 2001, CELL SIGNAL, V13, P827, DOI 10.1016/S0898-6568(01)00211-X; Fruhbeck G, 1999, DIABETES, V48, P903, DOI 10.2337/diabetes.48.4.903; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Fruhbeck G, 2005, LANCET, V366, P615, DOI 10.1016/S0140-6736(05); Fruhbeck G, 2009, TRENDS CELL BIOL, V19, P141, DOI 10.1016/j.tcb.2009.01.007; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Giordano A, 2002, FEBS LETT, V514, P135, DOI 10.1016/S0014-5793(02)02245-7; Gomez-Ambrosi J, 2004, FEBS LETT, V577, P351, DOI 10.1016/j.febslet.2004.10.028; Gomez-Ambrosi J, 2001, MOL CELL ENDOCRINOL, V176, P85, DOI 10.1016/S0303-7207(01)00451-8; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Gullicksen PS, 2002, PHYSIOL BEHAV, V75, P473, DOI 10.1016/S0031-9384(02)00652-2; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; KLINGENBERG M, 1990, TRENDS BIOCHEM SCI, V15, P108, DOI 10.1016/0968-0004(90)90194-G; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; MacLean A, 1998, J GEN VIROL, V79, P825, DOI 10.1099/0022-1317-79-4-825; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Merial C, 2000, AM J PHYSIOL-CELL PH, V279, pC1100, DOI 10.1152/ajpcell.2000.279.4.C1100; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Nau K, 2008, J COMP PHYSIOL B, V178, P269, DOI 10.1007/s00360-007-0219-7; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nisoli E, 1997, ENDOCRINOLOGY, V138, P676, DOI 10.1210/en.138.2.676; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rodriguez A, 2008, LIFE SCI, V83, P540, DOI 10.1016/j.lfs.2008.07.022; Rodriguez A, 2006, J HYPERTENS, V24, P1589, DOI 10.1097/01.hjh.0000239295.17636.6e; Rodriguez A, 2007, ENDOCRINOLOGY, V148, P324, DOI 10.1210/en.2006-0940; Sahu A, 2004, ENDOCRINOLOGY, V145, P2613, DOI 10.1210/en.2004-0032; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; SCARPACE PJ, 1997, AM J PHYSIOL, V273, P226; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shiuchi T, 2001, ENDOCRINOLOGY, V142, P608, DOI 10.1210/en.142.2.608; Soszynski D, 2007, J PHYSIOL PHARMACOL, V58, P657; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Ueno N, 1998, MECH AGEING DEV, V100, P67, DOI 10.1016/S0047-6374(97)00123-1; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villarroya F, 2001, BIOCHEM SOC T, V29, P76; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Webber J, 2003, P NUTR SOC, V62, P539, DOI 10.1079/PNS2003256; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; White V, 2007, DIABETES-METAB RES, V23, P580, DOI 10.1002/dmrr.750; Zarrindast MR, 2003, EUR J PHARMACOL, V482, P205, DOI 10.1016/j.ejphar.2003.10.006; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	70	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10962	10.1371/journal.pone.0010962	http://dx.doi.org/10.1371/journal.pone.0010962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532036	Green Published, Green Submitted, gold			2022-12-25	WOS:000278380500008
J	Panchanathan, R; Shen, H; Zhang, X; Ho, SM; Choubey, D				Panchanathan, Ravichandran; Shen, Hui; Zhang, Xiang; Ho, Shuk-mei; Choubey, Divaker			Mutually Positive Regulatory Feedback Loop between Interferons and Estrogen Receptor-alpha in Mice: Implications for Sex Bias in Autoimmunity	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SUBTYPE-SELECTIVE AGONISTS; I-INTERFERON; IFN-GAMMA; GENE; EXPRESSION; DISEASE; GLOMERULONEPHRITIS; INDUCTION; PROMOTER	Background: Systemic lupus erythematosus (SLE), an autoimmune disease, predominantly affects women of childbearing age. Moreover, increased serum levels of interferon-alpha (IFN-alpha) are associated with the disease. Although, the female sex hormone estrogen (E2) is implicated in sex bias in SLE through up-regulation of IFN-gamma expression, the molecular mechanisms remain unknown. Here we report that activation of IFN (alpha or gamma)-signaling in immune cells up-regulates expression of estrogen receptor-alpha (ER alpha; encoded by the Esr1 gene) and stimulates expression of target genes. Methodology/Principal Findings: We found that treatment of mouse splenic cells and mouse cell lines with IFN (alpha or gamma) increased steady-state levels of ER alpha mRNA and protein. The increase in the ERa mRNA levels was primarily due to the transcriptional mechanisms and it was dependent upon the activation of signal transducer and activator of transcription-1 (STAT1) factor by IFN. Moreover, the IFN-treatment of cells also stimulated transcription of a reporter gene, expression of which was driven by the promoter region of the murine Esr1 gene. Notably, splenic cells from pre-autoimmune lupus-prone (NZB x NZW)F-1 female mice had relatively higher steady-state levels of mRNAs encoded by the IFN and ER alpha-responsive genes as compared to the age-matched males. Conclusions/Significance: Our observations identify a novel mutually positive regulatory feedback loop between IFNs and ERa in immune cells in mice and support the idea that activation of this regulatory loop contributes to sex bias in SLE.	[Panchanathan, Ravichandran; Shen, Hui; Zhang, Xiang; Ho, Shuk-mei; Choubey, Divaker] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Panchanathan, Ravichandran; Shen, Hui; Choubey, Divaker] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Choubey, D (corresponding author), Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA.	Divaker.choubey@uc.edu	Choubey, Divaker/A-4771-2008; Panchanathan, Ravichandran/E-1801-2015; Zhang, Xiang/D-3632-2009		National Institutes of Health [AI066261]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Work was supported by a grant (AI066261) from the National Institutes of Health to D. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bernier MO, 2009, ARTHRIT RHEUM-ARTHR, V61, P476, DOI 10.1002/art.24398; Bynote KK, 2008, GENES IMMUN, V9, P137, DOI 10.1038/sj.gene.6364458; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; CICATIELLO L, 1995, MOL ENDOCRINOL, V9, P1077, DOI 10.1210/me.9.8.1077; CLAYMAN CH, 1977, J VIROL, V23, P209, DOI 10.1128/JVI.23.1.209-212.1977; Cohen-Solal JFG, 2006, CURR TOP MICROBIOL, V305, P67, DOI 10.1007/3-540-29714-6_4; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Dai RJ, 2009, J IMMUNOL, V183, P6998, DOI 10.4049/jimmunol.0901737; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Erlandsson MC, 2001, IMMUNOLOGY, V103, P17, DOI 10.1046/j.1365-2567.2001.01212.x; Feng F, 2010, CLIN IMMUNOL, V134, P226, DOI 10.1016/j.clim.2009.10.004; Gourdy P, 2005, BLOOD, V105, P2415, DOI 10.1182/blood-2004-07-2819; Haas C, 1998, J IMMUNOL, V160, P3713; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Inui A, 2007, CLIN RHEUMATOL, V26, P1675, DOI 10.1007/s10067-007-0568-3; Ishibashi O, 2001, BBA-GENE STRUCT EXPR, V1519, P223, DOI 10.1016/S0167-4781(01)00232-9; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Kipp JJL, 2007, J BIOL CHEM, V282, P36755, DOI 10.1074/jbc.M705143200; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Li J, 2007, CLIN IMMUNOL, V123, P219, DOI 10.1016/j.clim.2007.01.008; Li J, 2006, INT IMMUNOPHARMACOL, V6, P1413, DOI 10.1016/j.intimp.2006.04.019; Lu Q, 2007, GENES IMMUN, V8, P590, DOI 10.1038/sj.gene.6364421; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Nakaya M, 2006, BIOSCI BIOTECH BIOCH, V70, P47, DOI 10.1271/bbb.70.47; Niewold TB, 2008, ARTHRITIS RHEUM-US, V58, P2113, DOI 10.1002/art.23619; Panchanathan R, 2009, J IMMUNOL, V183, P7031, DOI 10.4049/jimmunol.0802665; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rider V, 2001, INT IMMUNOPHARMACOL, V1, P1009, DOI 10.1016/S1567-5769(01)00046-7; ROUBINIAN JR, 1977, J CLIN INVEST, V59, P1066, DOI 10.1172/JCI108729; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P366, DOI 10.1016/j.autrev.2006.10.001	41	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10868	10.1371/journal.pone.0010868	http://dx.doi.org/10.1371/journal.pone.0010868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526365	gold, Green Submitted, Green Published			2022-12-25	WOS:000278222100004
J	Sharp, KH; Ritchie, KB; Schupp, PJ; Ritson-Williams, R; Paul, VJ				Sharp, Koty H.; Ritchie, Kim B.; Schupp, Peter J.; Ritson-Williams, Raphael; Paul, Valerie J.			Bacterial Acquisition in Juveniles of Several Broadcast Spawning Coral Species	PLOS ONE			English	Article							BLACK BAND DISEASE; VERTICAL TRANSMISSION; REPRODUCTIVE ISOLATION; MONTASTREA-ANNULARIS; SYMBIONTS; CYANOBACTERIA; POPULATIONS; DIVERSITY; PATHOGEN; BIVALVIA	Coral animals harbor diverse microorganisms in their tissues, including archaea, bacteria, viruses, and zooxanthellae. The extent to which coral-bacterial associations are specific and the mechanisms for their maintenance across generations in the environment are unknown. The high diversity of bacteria in adult coral colonies has made it challenging to identify species-specific patterns. Localization of bacteria in gametes and larvae of corals presents an opportunity for determining when bacterial-coral associations are initiated and whether they are dynamic throughout early development. This study focuses on the early onset of bacterial associations in the mass spawning corals Montastraea annularis, M. franksi, M. faveolata, Acropora palmata, A. cervicornis, Diploria strigosa, and A. humilis. The presence of bacteria and timing of bacterial colonization was evaluated in gametes, swimming planulae, and newly settled polyps by fluorescence in situ hybridization (FISH) using general eubacterial probes and laser-scanning confocal microscopy. The coral species investigated in this study do not appear to transmit bacteria via their gametes, and bacteria are not detectable in or on the corals until after settlement and metamorphosis. This study suggests that mass-spawning corals do not acquire, or are not colonized by, detectable numbers of bacteria until after larval settlement and development of the juvenile polyp. This timing lays the groundwork for developing and testing new hypotheses regarding general regulatory mechanisms that control bacterial colonization and infection of corals, and how interactions among bacteria and juvenile polyps influence the structure of bacterial assemblages in corals.	[Sharp, Koty H.; Ritson-Williams, Raphael; Paul, Valerie J.] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL USA; [Ritchie, Kim B.] Mote Marine Lab, Sarasota, FL 34236 USA; [Schupp, Peter J.] Univ Guam, Univ Guam Stn, Mangilao, GU USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Mote Marine Laboratory & Aquarium; University of Guam	Sharp, KH (corresponding author), Ocean Genome Legacy, Ipswich, MA USA.	kotysharp@gmail.com	Schupp, Peter j/D-3296-2015	Schupp, Peter Josef/0000-0003-4831-2751	Mote Marine Laboratory; Smithsonian Marine Science Network; NIH MBRS SCORE [S06-GM-44796]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM044796] Funding Source: NIH RePORTER	Mote Marine Laboratory; Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); NIH MBRS SCORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded primarily by the Mote Marine Laboratory "Protect Our Reefs'' License Plate Research Grant. K. S. was supported by the Smithsonian Marine Science Network Postdoctoral Fellowship. P.J.S. acknowledges partial support by NIH MBRS SCORE grant S06-GM-44796. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Benkendorff K, 2001, J INVERTEBR PATHOL, V78, P109, DOI 10.1006/jipa.2001.5047; CARY SC, 1994, EOS, V75, P60; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Gros O, 1999, INVERTEBR REPROD DEV, V36, P93, DOI 10.1080/07924259.1999.9652683; Haygood MG, 1997, APPL ENVIRON MICROB, V63, P4612, DOI 10.1128/AEM.63.11.4612-4616.1997; Hirose E, 2000, ZOOL SCI, V17, P233, DOI 10.2108/zsj.17.233; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Knowlton N, 1997, MAR BIOL, V127, P705, DOI 10.1007/s002270050061; Krueger DM, 1996, BIOL BULL, V190, P195, DOI 10.2307/1542539; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Loy A, 2003, NUCLEIC ACIDS RES, V31, P514, DOI 10.1093/nar/gkg016; Marquis CP, 2005, CORAL REEFS, V24, P248, DOI 10.1007/s00338-005-0473-7; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Olson ND, 2009, J EXP MAR BIOL ECOL, V371, P140, DOI 10.1016/j.jembe.2009.01.012; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; PAWLIK JR, 1988, J EXP MAR BIOL ECOL, V119, P99, DOI 10.1016/0022-0981(88)90225-0; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Schmitt S, 2007, APPL ENVIRON MICROB, V73, P2067, DOI 10.1128/AEM.01944-06; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P209, DOI 10.3354/meps109209; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x	43	61	62	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10898	10.1371/journal.pone.0010898	http://dx.doi.org/10.1371/journal.pone.0010898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526374	Green Published, Green Submitted, gold			2022-12-25	WOS:000278222100027
J	Goncalves, JT; Stuhmer, W				Goncalves, J. Tiago; Stuehmer, Walter			Calmodulin Interaction with hEAG1 Visualized by FRET Microscopy	PLOS ONE			English	Article							A-GO-GO; POTASSIUM CHANNELS; HUMAN ETHER; BINDING-SITE; BETA-SUBUNIT; K+ CHANNELS; N-TERMINUS; EAG; INHIBITION; DROSOPHILA	Background: Ca2+-mediated regulation of ion channels provides a link between intracellular signaling pathways and membrane electrical activity. Intracellular Ca2+ inhibits the voltage-gated potassium channel EAG1 through the direct binding of calmodulin (CaM). Three CaM binding sites (BD-C1: 674-683, BD-C2: 711-721, BD-N: 151-165) have been identified in a peptide screen and were proposed to mediate binding. The participation of the three sites in CaM binding to the native channel, however, remains unclear. Methodology/Principal Findings: Here we studied the binding of Ca2+/CaM to the EAG channel by visualizing the interaction between YFP-labeled CaM and Cerulean-labeled hEAG1 in mammalian cells by FRET. The results of our cellular approach substantiate that two CaM binding sites are predominantly involved; the high-affinity 1-8-14 based CaM binding domain in the N-terminus and the second C-terminal binding domain BD-C2. Mutations at these sites completely abolished CaM binding to hEAG1. Conclusions/Significance: We demonstrated that the BD-N and BD-C2 binding domains are sufficient for CaM binding to the native channel, and, therefore, that BD-C1 is unable to bind CaM independently.	[Goncalves, J. Tiago; Stuehmer, Walter] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Stuehmer, Walter] DFG Res Ctr Mol Physiol Brain, Gottingen, Germany	Max Planck Society; German Research Foundation (DFG)	Goncalves, JT (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	goncalves@ucla.edu	Stuehmer, Walter/A-2176-2009	Stuehmer, Walter/0000-0002-0642-7764; Goncalves, J. Tiago/0000-0003-2303-1822	Deutsche Forschungsgemeinschaft [406, 723]; Center for Molecular Physiology of the Brain	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Molecular Physiology of the Brain	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) through the following funding programs: Sonderforschungsbereich 406, Graduiertenkolleg 723 and Center for Molecular Physiology of the Brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Brueggemann Andrea, 1993, Nature (London), V365, P445; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; KAPLAN WD, 1969, GENETICS, V61, P399; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; Meyer R, 1999, J MEMBRANE BIOL, V171, P107, DOI 10.1007/s002329900563; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; Stansfeld CE, 1996, P NATL ACAD SCI USA, V93, P9910, DOI 10.1073/pnas.93.18.9910; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Valentin G, 2005, NAT METHODS, V2, P801, DOI 10.1038/nmeth1105-801; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	32	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10873	10.1371/journal.pone.0010873	http://dx.doi.org/10.1371/journal.pone.0010873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523736	Green Submitted, Green Published, gold			2022-12-25	WOS:000278221900019
J	Langenheder, S; Bulling, MT; Solan, M; Prosser, JI				Langenheder, Silke; Bulling, Mark T.; Solan, Martin; Prosser, James I.			Bacterial Biodiversity-Ecosystem Functioning Relations Are Modified by Environmental Complexity	PLOS ONE			English	Article							SPECIES-DIVERSITY; HETEROGENEITY; BIOMASS; COMPLEMENTARITY; ASSEMBLAGES; SELECTION; CONSUMER; RATHER	Background: With the recognition that environmental change resulting from anthropogenic activities is causing a global decline in biodiversity, much attention has been devoted to understanding how changes in biodiversity may alter levels of ecosystem functioning. Although environmental complexity has long been recognised as a major driving force in evolutionary processes, it has only recently been incorporated into biodiversity-ecosystem functioning investigations. Environmental complexity is expected to strengthen the positive effect of species richness on ecosystem functioning, mainly because it leads to stronger complementarity effects, such as resource partitioning and facilitative interactions among species when the number of available resource increases. Methodology/Principal Findings: Here we implemented an experiment to test the combined effect of species richness and environmental complexity, more specifically, resource richness on ecosystem functioning over time. We show, using all possible combinations of species within a bacterial community consisting of six species, and all possible combinations of three substrates, that diversity-functioning (metabolic activity) relationships change over time from linear to saturated. This was probably caused by a combination of limited complementarity effects and negative interactions among competing species as the experiment progressed. Even though species richness and resource richness both enhanced ecosystem functioning, they did so independently from each other. Instead there were complex interactions between particular species and substrate combinations. Conclusions/Significance: Our study shows clearly that both species richness and environmental complexity increase ecosystem functioning. The finding that there was no direct interaction between these two factors, but that instead rather complex interactions between combinations of certain species and resources underlie positive biodiversity ecosystem functioning relationships, suggests that detailed knowledge of how individual species interact with complex natural environments will be required in order to make reliable predictions about how altered levels of biodiversity will most likely affect ecosystem functioning.	[Langenheder, Silke; Prosser, James I.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Bulling, Mark T.; Solan, Martin] Univ Aberdeen, Oceanlab, Newburgh, Scotland	University of Aberdeen; University of Aberdeen	Langenheder, S (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	silke.langenheder@ebc.uu.se	Solan, Martin/E-9338-2012; Langenheder, Silke/C-9614-2017; Prosser, Jim/F-5280-2010	Solan, Martin/0000-0001-9924-5574; Langenheder, Silke/0000-0002-5245-9935; Prosser, Jim/0000-0003-1757-5102; Bulling, Mark/0000-0002-0742-256X	Marie Curie Fellowship [MEIF-CT-2005-23826]; Natural Environment Research Council [NE/E006795/1]; Natural Environment Research Council [NE/H017445/1] Funding Source: researchfish; NERC [NE/H017445/1, NE/E006795/1] Funding Source: UKRI	Marie Curie Fellowship(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Marie Curie Fellowship (Contract MEIF-CT-2005-23826) and by the Natural Environment Research Council (Grant NE/E006795/1), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barrett RDH, 2005, AM NAT, V166, P470, DOI 10.1086/444440; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Eriksson BK, 2006, ECOLOGY, V87, P246, DOI 10.1890/05-0090; Godbold JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007423; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; GOTTSCHAL JC, 1986, BACTERIA NATURE, V2; HARDER W, 1982, PHILOS T ROY SOC B, V297, P459, DOI 10.1098/rstb.1982.0055; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jiang L, 2007, ECOLOGY, V88, P1075, DOI 10.1890/06-1556; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MacLean R. Craig, 2005, Ecology Letters, V8, P38; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 2008, TRENDS ECOL EVOL, V23, P414, DOI 10.1016/j.tree.2008.05.003; Orwin KH, 2006, ECOLOGY, V87, P580, DOI 10.1890/05-0383; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Pinheiro J., 2006, NLME R PACKAGE FITTI; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Replansky T, 2009, OIKOS, V118, P233, DOI 10.1111/j.1600-0706.2008.16948.x; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tilman D, 1997, SCIENCE, V278, P1866; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Tokeshi M., 1999, SPECIES COEXSISTENCE; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Wacker L, 2008, BASIC APPL ECOL, V9, P467, DOI 10.1016/j.baae.2007.08.003; Weis JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002825; West B. T., 2007, LINEAR MIXED MODELS; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Zuur Alain F., 2009, P1	48	111	111	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10834	10.1371/journal.pone.0010834	http://dx.doi.org/10.1371/journal.pone.0010834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520808	gold, Green Published			2022-12-25	WOS:000278221500020
J	Li, H; Zhao, ZW; Wei, G; Yan, LB; Wang, DM; Zhang, H; Sandusky, GE; Turk, J; Xu, Y				Li, Hui; Zhao, Zhenwen; Wei, Gang; Yan, Libo; Wang, Dongmei; Zhang, Hong; Sandusky, George Earl; Turk, John; Xu, Yan			Group VIA phospholipase A(2) in both host and tumor cells is involved in ovarian cancer development	FASEB JOURNAL			English	Article						calcium-independent phospholipase A(2)beta; iPLA(2)beta(-/-) mice; lysophosphatidic acid; tumor microenvironment	LYSOPHOSPHATIDIC ACID PRODUCTION; LYSOPHOSPHOLIPASE-D; ACTIVATING FACTOR; ARACHIDONIC-ACID; EXPRESS GROUP; MIGRATION; INHIBITION; INVASION; MICE; PROLIFERATION	Host-tumor cell interactions are recognized to be critical in tumor development. We have shown that group VIA phospholipase A(2) [calcium-independent phospholipase A(2)beta (iPLA(2)beta)] is important in regulating extracellular lysophosphatidic acid (LPA) levels around human epithelial ovarian cancer (EOC) cells. To explore the role of iPLA(2)beta in host-tumor cell interactions, we have used immunocompetent iPLA(2)beta knockout (iPLA(2)beta(-/-)) mice and the mouse EOC cell line ID8. Tumorigenesis and ascites formation were reduced in iPLA(2)beta(-/-) mice compared with wild-type (WT) mice by more >50% and were reduced further when ID8 cell iPLA(2)beta levels were lowered (by>95%) with shRNA. LPA and lysophosphatidylcholine (LPC) levels in the tumor microenvironment were reduced to similar to 80% of WT levels in iPLA(2)beta(-/-) mice. LPA, but not LPC, stimulated ID8 cell migration and invasion with cells in which iPLA(2)beta expression had been down-regulated in vitro. LPA, but not LPC, also enhanced in vivo ascites formation (by similar to 5-fold) and tumorigenesis in iPLA(2)beta(-/-) mice. This is the first demonstration of a role for host cell iPLA(2)beta in cancer, and these findings suggest that iPLA(2)beta is a potential target for developing novel antineoplastic therapeutic strategies.-Li, H., Zhao, Z., Wei, G., Yan, L., Wang, D., Zhang, H., Sandusky, G. E., Turk, J., Xu, Y. Group VIA phospholipase A(2) in both host and tumor cells is involved in ovarian cancer development. FASEB J. 24, 4103-4116 (2010). www.fasebj.org	[Li, Hui; Zhao, Zhenwen; Wei, Gang; Yan, Libo; Wang, Dongmei; Zhang, Hong; Xu, Yan] Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Zhang, Hong; Sandusky, George Earl] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Zhang, Hong; Sandusky, George Earl] Jilin Univ, Dept Gen Surg, Hosp 2, Changchun 130023, Jilin, Peoples R China; [Turk, John] Washington Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Jilin University; Washington University (WUSTL)	Xu, Y (corresponding author), Indiana Univ, Dept Obstet & Gynecol, 975 W Walnut St,IB355A, Indianapolis, IN 46202 USA.	xu2@iupui.edu	yan, libo/H-9533-2013; Yan, Libo/H-2328-2012	Yan, Libo/0000-0002-4204-3397	U.S. National Institutes of Health [RO1 CA095042]; Indiana University Cancer Center; Mary Fendrich Hulman Charitable Trust; U.S. Public Health Service [R37-DK-34388, P41-RR-00954, P60-DK-20579, P30-DK-56341]; NATIONAL CANCER INSTITUTE [R01CA095042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, R37DK034388, P30DK056341] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Cancer Center; Mary Fendrich Hulman Charitable Trust; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by U.S. National Institutes of Health grant RO1 CA095042, an Indiana University Cancer Center Translational Research Acceleration Collaboration grant, and the Mary Fendrich Hulman Charitable Trust (to Y.X.). It was also supported by U.S. Public Health Service grants R37-DK-34388, P41-RR-00954, P60-DK-20579, R37-DK-34388, and P30-DK-56341 (to J.T). The authors declare no conflicts of interest.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bao SZ, 2004, DIABETES, V53, pS186, DOI 10.2337/diabetes.53.2007.S186; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bissell MJ, 1999, CANCER RES, V59, p1757S; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Chou CH, 2005, CARCINOGENESIS, V26, P45, DOI 10.1093/carcin/bgh301; Eder AM, 2000, CLIN CANCER RES, V6, P2482; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Fang XJ, 2004, J BIOL CHEM, V279, P9653, DOI 10.1074/jbc.M306662200; Gil OD, 2008, GYNECOL ONCOL, V108, P361, DOI 10.1016/j.ygyno.2007.10.027; Gupta GP, 2004, J CLIN INVEST, V114, P1691, DOI 10.1172/JCI200423823; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Holmes CE, 2009, CLIN EXP METASTAS, V26, P653, DOI 10.1007/s10585-009-9264-9; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Kim KS, 2006, CANCER RES, V66, P7983, DOI 10.1158/0008-5472.CAN-05-4381; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kudo I, 1999, Tanpakushitsu Kakusan Koso, V44, P1013; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Murph MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005583; Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Schmid G, 2007, J CELL BIOCHEM, V101, P259, DOI 10.1002/jcb.21181; Sengupta S, 2007, ONCOGENE, V26, P2894, DOI 10.1038/sj.onc.1210093; Sengupta S, 2003, FASEB J, V17, P1570, DOI 10.1096/fj.02-1145fje; Sengupta S, 2004, SEMIN CELL DEV BIOL, V15, P503, DOI 10.1016/j.semcdb.2004.05.003; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; Teo ST, 2009, IUBMB LIFE, V61, P791, DOI 10.1002/iub.220; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; VANCORVEN FJ, 1989, G PROTEINS, V59, P45; VARGAFTIG BB, 1973, NATURE-NEW BIOL, V244, P114, DOI 10.1038/newbio244114a0; Wang D, 2008, MOL CANCER THER, V7, P1993, DOI 10.1158/1535-7163.MCT-08-0088; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xiao YJ, 2000, ANN NY ACAD SCI, V905, P242; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Xu Y., 2006, CELL SCI REV, V3, P168; Xu Yan, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P23, DOI 10.2174/1568008033340414; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503; Zhao ZW, 2009, J CHROMATOGR B, V877, P3739, DOI 10.1016/j.jchromb.2009.08.032	51	42	43	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2010	24	10					4103	4116		10.1096/fj.10-161356	http://dx.doi.org/10.1096/fj.10-161356			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20530749	Green Published			2022-12-25	WOS:000285005900045
J	Saharia, A; Teasley, DC; Duxin, JP; Dao, B; Chiappinelli, KB; Stewart, SA				Saharia, Abhishek; Teasley, Daniel C.; Duxin, Julien P.; Dao, Benjamin; Chiappinelli, Katherine B.; Stewart, Sheila A.			FEN1 Ensures Telomere Stability by Facilitating Replication Fork Re-initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; DNA-REPLICATION; FLAP ENDONUCLEASE-1; WERNER-SYNDROME; WRN HELICASE; HOMOLOGOUS RECOMBINATION; SUBSTRATE-BINDING; FRAGILE SITES; BLM HELICASE; G4 DNA	Telomeres are terminal repetitive DNA sequences whose stability requires the coordinated actions of telomere-binding proteins and the DNA replication and repair machinery. Recently, we demonstrated that the DNA replication and repair protein Flap endonuclease 1 (FEN1) is required for replication of lagging strand telomeres. Here, we demonstrate for the first time that FEN1 is required for efficient re-initiation of stalled replication forks. At the telomere, we find that FEN1 depletion results in replicative stress as evidenced by fragile telomere expression and sister telomere loss. We show that FEN1 participation in Okazaki fragment processing is not required for efficient telomere replication. Instead we find that FEN1 gap endonuclease activity, which processes DNA structures resembling stalled replication forks, and the FEN1 interaction with the RecQ helicases are vital for telomere stability. Finally, we find that FEN1 depletion neither impacts cell cycle progression nor in vitro DNAreplication through non-telomeric sequences. Our finding that FEN1 is required for efficient replication fork re-initiation strongly suggests that the fragile telomere expression and sister telomere losses observed upon FEN1 depletion are the direct result of replication fork collapse. Together, these findings suggest that other nucleases compensate for FEN1 loss throughout the genome during DNA replication but fail to do so at the telomere. We propose that FEN1 maintains stable telomeres by facilitating replication through the G-rich lagging strand telomere, thereby ensuring high fidelity telomere replication.	[Saharia, Abhishek; Teasley, Daniel C.; Duxin, Julien P.; Dao, Benjamin; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Chiappinelli, Katherine B.] Washington Univ, Sch Med, Dept Surg, Div Endocrine & Oncol Surg, St Louis, MO 63110 USA; [Stewart, Sheila A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	sheila.stewart@wustl.edu		Stewart, Sheila/0000-0002-2260-9576	Children's Discovery Institute; Cellular, Biochemical, and Molecular Sciences Predoctoral Training Grant [T32 GM007067-35]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Children's Discovery Institute; Cellular, Biochemical, and Molecular Sciences Predoctoral Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Children's Discovery Institute (to S. A. S.) and Cellular, Biochemical, and Molecular Sciences Predoctoral Training Grant T32 GM007067-35 (to D. C. T.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Brush GS, 1995, METHOD ENZYMOL, V262, P522; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kang HY, 2000, GENETICS, V155, P1055; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Moreau S, 2001, GENETICS, V159, P1423; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Nikolova T, 2009, ANTICANCER RES, V29, P2453; Ohki R, 2004, NUCLEIC ACIDS RES, V32, P1627, DOI 10.1093/nar/gkh309; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Saharia A, 2009, ONCOGENE, V28, P1162, DOI 10.1038/onc.2008.458; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sharma S, 2005, NUCLEIC ACIDS RES, V33, P6769, DOI 10.1093/nar/gki1002; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Stucki M, 2001, PROG NUCLEIC ACID RE, V65, P261; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Undarmaa B, 2004, BIOCHEM BIOPH RES CO, V315, P51, DOI 10.1016/j.bbrc.2004.01.014; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wu L, 2002, MUTAT RES-FUND MOL M, V509, P35, DOI 10.1016/S0027-5107(02)00225-7; Xu L, 2007, MOL CELL, V28, P315, DOI 10.1016/j.molcel.2007.10.005; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	61	50	55	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27057	27066		10.1074/jbc.M110.112276	http://dx.doi.org/10.1074/jbc.M110.112276			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551483	Green Published, hybrid			2022-12-25	WOS:000281172700037
J	Scholz, R; Sidler, CL; Thali, RF; Winssinger, N; Cheung, PCF; Neumann, D				Scholz, Roland; Sidler, Corinne L.; Thali, Ramon F.; Winssinger, Nicolas; Cheung, Peter C. F.; Neumann, Dietbert			Autoactivation of Transforming Growth Factor beta-activated Kinase 1 Is a Sequential Bimolecular Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IL-1 SIGNALING PATHWAY; RESORCYLIC ACID LACTONES; PROTEIN-KINASE; TAK1 MAPKKK; TAK1-BINDING PROTEIN-1; TRANSDUCTION PATHWAY; STRUCTURAL BASIS; IN-VITRO; PHOSPHORYLATION	Transforming growth factor-beta-activated kinase 1 (TAK1), an MAP3K, is a key player in processing a multitude of inflammatory stimuli. TAK1 autoactivation involves the interplay with TAK1-binding proteins (TAB), e. g. TAB1 and TAB2, and phosphorylation of several activation segment residues. However, the TAK1 autoactivation is not yet fully understood on the molecular level due to the static nature of available x-ray structural data and the complexity of cellular systems applied for investigation. Here, we established a bacterial expression system to generate recombinant mammalian TAK1 complexes. Co-expression of TAK1 and TAB1, but not TAB2, resulted in a functional and active TAK1-TAB1 complex capable of directly activating full-length heterotrimeric mammalian AMP-activated protein kinase (AMPK) in vitro. TAK1-dependent AMPK activation was mediated via hydrophobic residues of the AMPK kinase domain alpha G-helix as observed in vitro and in transfected cell culture. Co-immunoprecipitation of differently epitope-tagged TAK1 from transfected cells and mutation of hydrophobic alpha G-helix residues in TAK1 point to an intermolecular mechanism of TAB1-induced TAK1 autoactivation, as TAK1 autophosphorylation of the activation segment was impaired in these mutants. TAB1 phosphorylation was enhanced in a subset of these mutants, indicating a critical role of alpha G-helix residues in this process. Analyses of phosphorylation site mutants of the activation segment indicate that autophosphorylation of Ser-192 precedes TAB1 phosphorylation and is followed by sequential phosphorylation of Thr-178, Thr-187, and finally Thr-184. Finally, we present a model for the chronological order of events governing TAB1-induced TAK1 autoactivation.	[Winssinger, Nicolas; Neumann, Dietbert] ETH, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Winssinger, Nicolas] Univ Strasbourg, CNRS, Inst Sci & Ingn Supramol, UMR7006, F-67000 Strasbourg, France; [Cheung, Peter C. F.] Nanyang Technol Univ, Sch Biol Sci, Div Mol & Cell Biol, Singapore 637551, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Winssinger, N (corresponding author), ETH, Dept Biol, Inst Cell Biol, Schafmattstr 18,HPMD23, CH-8093 Zurich, Switzerland.	dietbert.neumann@cell.biol.ethz.ch	Scholz, Roland W./AAH-8385-2020; Cheung, Peter/A-2213-2011; Winssinger, Nicolas/B-6710-2017	Scholz, Roland W./0000-0003-2506-3254; Neumann, Dietbert/0000-0002-4316-684X; Winssinger, Nicolas/0000-0003-1636-7766	Swiss National Science Foundation [3100A0-114137]; European Union [LSHM-CT-2004-005272, 36/05-3, 32/05-3]; Agence National de la Recherche; Agency for Science, Technology, and Research (A*STAR) Biomedical Research Council (BMRC) [07/1/22/19/523]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Agence National de la Recherche(French National Research Agency (ANR)); Agency for Science, Technology, and Research (A*STAR) Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR))	This work was supported in part by the Swiss National Science Foundation Grant 3100A0-114137, the European Union FP6 Contract LSHM-CT-2004-005272 (EXGENESIS), and Graduate Training Fellowships ETHIIRA 36/05-3 and 32/05-3 (for R. S. and R. F. T.).; Recipient of funding from the Agence National de la Recherche.; Supported by Agency for Science, Technology, and Research (A*STAR) Biomedical Research Council (BMRC) Grant 07/1/22/19/523.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Dakas PY, 2007, ANGEW CHEM INT EDIT, V46, P6899, DOI 10.1002/anie.200702406; Dakas PY, 2009, CHEM-EUR J, V15, P11490, DOI 10.1002/chem.200901373; Deak JC, 1997, BIOCHEM J, V322, P185, DOI 10.1042/bj3220185; Eisenberg D., 1982, FARADAY S CHEM SOC, V17, P109, DOI DOI 10.1039/FS9821700109; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Huang JH, 2003, BIOCHEM BIOPH RES CO, V303, P532, DOI 10.1016/S0006-291X(03)00387-5; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jogireddy R, 2009, CHEM-EUR J, V15, P11498, DOI 10.1002/chem.200901375; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Neumann D, 2003, BIOCHEM SOC T, V31, P169, DOI 10.1042/bst0310169; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Prickett TD, 2008, J BIOL CHEM, V283, P19245, DOI 10.1074/jbc.M800943200; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scholz R, 2009, J BIOL CHEM, V284, P27425, DOI 10.1074/jbc.M109.047670; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tu Z, 2003, CELL SIGNAL, V15, P65, DOI 10.1016/S0898-6568(02)00056-6; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200	61	65	67	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25753	25766		10.1074/jbc.M109.093468	http://dx.doi.org/10.1074/jbc.M109.093468			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538596	Green Published, hybrid			2022-12-25	WOS:000280682400068
J	Wang, YY; Brittain, JM; Jarecki, BW; Park, KD; Wilson, SM; Wang, B; Hale, R; Meroueh, SO; Cummins, TR; Khanna, R				Wang, Yuying; Brittain, Joel M.; Jarecki, Brian W.; Park, Ki Duk; Wilson, Sarah M.; Wang, Bo; Hale, Rachel; Meroueh, Samy O.; Cummins, Theodore R.; Khanna, Rajesh			In Silico Docking and Electrophysiological Characterization of Lacosamide Binding Sites on Collapsin Response Mediator Protein-2 Identifies a Pocket Important in Modulating Sodium Channel Slow Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; NEURONS; MECHANISMS; CURRENTS; FAMILY; AXONS	The anti-epileptic drug (R)-lacosamide ((2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide (LCM)) modulates voltage-gated sodium channels (VGSCs) by preferentially interacting with slow inactivated sodium channels, but the observation that LCM binds to collapsin response mediator protein 2 (CRMP-2) suggests additional mechanisms of action for LCM. We postulated that CRMP-2 levels affects the actions of LCM on VGSCs. CRMP-2 labeling by LCM analogs was competitively displaced by excess LCM in rat brain lysates. Manipulation of CRMP-2 levels in the neuronal model system CAD cells affected slow inactivation of VGSCs without any effects on other voltage-dependent properties. In silico docking was performed to identify putative binding sites in CRMP-2 that may modulate the effects of LCM on VGSCs. These studies identified five cavities in CRMP-2 that can accommodate LCM. CRMP-2 alanine mutants of key residues within these cavities were functionally similar to wildtype CRMP-2 as assessed by similar levels of enhancement in dendritic complexity of cortical neurons. Next, we examined the effects of expression of wild-type and mutant CRMP-2 constructs on voltage-sensitive properties of VGSCs in CAD cells: 1) steady-state voltage-dependent activation and fast-inactivation properties were not affected by LCM, 2) CRMP-2 single alanine mutants reduced the LCM-mediated effects on the ability of endogenous Na+ channels to transition to a slow inactivated state, and 3) a quintuplicate CRMP-2 alanine mutant further decreased this slow inactivated fraction. Collectively, these results identify key CRMP-2 residues that can coordinate LCM binding thus making it more effective on its primary clinical target.	[Wang, Yuying; Jarecki, Brian W.; Hale, Rachel; Cummins, Theodore R.; Khanna, Rajesh] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Wang, Bo; Meroueh, Samy O.] Indiana Univ, Sch Med, Dept Chem, Indianapolis, IN 46202 USA; [Wang, Bo; Meroueh, Samy O.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Wang, Bo; Meroueh, Samy O.] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Brittain, Joel M.; Wilson, Sarah M.; Wang, Bo; Meroueh, Samy O.; Cummins, Theodore R.; Khanna, Rajesh] Indiana Univ, Sch Med, Program Med Neurosci, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Park, Ki Duk] Univ N Carolina, Eshelman Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of North Carolina; University of North Carolina Chapel Hill	Khanna, R (corresponding author), 950 W Walnut St,R2,Rm 478, Indianapolis, IN 46202 USA.	khanna5@iupui.edu		Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health [CA135380, NS053422]; Indiana State Dept. of Health [A70-9-079138]; Spinal Cord and Brain Injury Fund [2286501]; NATIONAL CANCER INSTITUTE [R01CA135380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422, R56NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana State Dept. of Health; Spinal Cord and Brain Injury Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135380 (to S.O.M.) and NS053422 (to T. R. C.). This work was also supported by a grant from the Indiana State Dept. of Health (A70-9-079138, to R. K.), Spinal Cord and Brain Injury Fund (2286501, to R. K.).	Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bartolomei F, 1997, J NEUROCYTOL, V26, P667, DOI 10.1023/A:1018549928277; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; Casini S, 2010, CARDIOVASC RES, V85, P691, DOI 10.1093/cvr/cvp352; Castaneda-Castellanos DR, 2000, BRAIN RES, V866, P281, DOI 10.1016/S0006-8993(00)02297-6; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cavazos JE, 2006, EPILEPSY BEHAV, V8, P483, DOI 10.1016/j.yebeh.2006.01.011; Chae YC, 2009, CELL SIGNAL, V21, P1818, DOI 10.1016/j.cellsig.2009.07.017; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Choi D, 1996, J MED CHEM, V39, P1907, DOI 10.1021/jm9508705; Curia G, 2009, CNS DRUGS, V23, P555, DOI 10.2165/00023210-200923070-00002; Czech T, 2004, NEUROCHEM RES, V29, P2189, DOI 10.1007/s11064-004-7025-3; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Errington AC, 2006, NEUROPHARMACOLOGY, V50, P1016, DOI 10.1016/j.neuropharm.2006.02.002; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Harris JA, 2009, ANN PHARMACOTHER, V43, P1809, DOI 10.1345/aph.1M303; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; Klein JP, 2004, BRAIN RES, V1000, P102, DOI 10.1016/j.brainres.2003.11.051; Mechaly I, 2005, NEUROSCIENCE, V130, P389, DOI 10.1016/j.neuroscience.2004.09.034; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Park KD, 2009, J MED CHEM, V52, P6897, DOI 10.1021/jm9012054; Perucca E, 2008, NAT REV DRUG DISCOV, V7, P973, DOI 10.1038/nrd2764; RUDY B, 1978, J PHYSIOL-LONDON, V283, P1; Ryu MJ, 2008, J NEUROCHEM, V104, P1260, DOI 10.1111/j.1471-4159.2007.05100.x; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Sheets PL, 2008, J PHARMACOL EXP THER, V326, P89, DOI 10.1124/jpet.107.133413; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Tilz C, 2009, EPILEPSIA, V50, P35; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Wang H, 2000, J NEUROPHYSIOL, V84, P2888, DOI 10.1152/jn.2000.84.6.2888; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang Yuying, 2010, Commun Integr Biol, V3, P172; Webb J, 2009, PFLUG ARCH EUR J PHY, V457, P1253, DOI 10.1007/s00424-008-0600-8; Whitaker WRJ, 2001, NEUROSCIENCE, V106, P275, DOI 10.1016/S0306-4522(01)00212-3	50	68	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25296	25307		10.1074/jbc.M110.128801	http://dx.doi.org/10.1074/jbc.M110.128801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538611	Green Published, hybrid			2022-12-25	WOS:000280682400022
J	Oot, RA; Wilkens, S				Oot, Rebecca A.; Wilkens, Stephan			Domain Characterization and Interaction of the Yeast Vacuolar ATPase Subunit C with the Peripheral Stator Stalk Subunits E and G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOPHILUS H+-ATPASE/SYNTHASE; V-ATPASE; SACCHAROMYCES-CEREVISIAE; THERMUS-THERMOPHILUS; ELECTRON-MICROSCOPY; A(1)A(0)-ATP SYNTHASE; CRYSTAL-STRUCTURE; CROSS-LINKING; PROTON PUMP; G VMA10P	The proton pumping activity of the eukaryotic vacuolar ATPase (V-ATPase) is regulated by a unique mechanism that involves reversible enzyme dissociation. In yeast, under conditions of nutrient depletion, the soluble catalytic V-1 sector disengages from the membrane integral V-o, and at the same time, both functional units are silenced. Notably, during enzyme dissociation, a single V-1 subunit, C, is released into the cytosol. The affinities of the other V-1 and V-o subunits for subunit Care therefore of particular interest. The C subunit crystal structure shows that the subunit is elongated and dumbbell-shaped with two globular domains (C-head and C-foot) separated by a flexible helical neck region (Drory, O., Frolow, F., and Nelson, N. (2004) EMBO Rep. 5, 1148-1152). We have recently shown that subunit C is bound in the V-1-V-o interface where the subunit is in contact with two of the three peripheral stators (subunit EG heterodimers): one via C-head and one via C-foot (Zhang, Z., Zheng, Y., Mazon, H., Milgrom, E., Kitagawa, N., Kish-Trier, E., Heck, A. J., Kane, P. M., and Wilkens, S. (2008) J. Biol. Chem. 283, 3598335995). In vitro, however, subunit C binds only one EG heterodimer (Fethiere, J., Venzke, D., Madden, D. R., and Bottcher, B. (2005) Biochemistry 44, 15906-15914), implying that EG has different affinities for the two domains of the C subunit. To determine which subunit C domain binds EG with high affinity, we have generated C-head and C-foot and characterized their interaction with subunit EG heterodimer. Our findings indicate that the high affinity site for EGC interaction is C-head. In addition, we provide evidence that the EGC(head) interaction greatly stabilizes EG heterodimer. The vacuolar	[Oot, Rebecca A.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM58600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58600.	Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; FOURY F, 1990, J BIOL CHEM, V265, P18554; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kish-Trier E, 2009, J BIOL CHEM, V284, P12031, DOI 10.1074/jbc.M808962200; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; LAU SYM, 1984, J BIOL CHEM, V259, P3253; LAU WC, P NATL ACAD SCI US, V107, P1367; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Nicholls D., 2002, BIOENERGETICS, V3; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Saroussi S, 2009, J EXP BIOL, V212, P1604, DOI 10.1242/jeb.025866; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; SUPEKOVA L, 1995, J BIOL CHEM, V270, P13726; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001	54	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24654	24664		10.1074/jbc.M110.136960	http://dx.doi.org/10.1074/jbc.M110.136960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529855	Green Published, hybrid			2022-12-25	WOS:000280542100038
J	Xu, FL; Proft, J; Gibbs, S; Winkfein, B; Johnson, JN; Syed, N; Braun, JEA				Xu, Fenglian; Proft, Juliane; Gibbs, Sarah; Winkfein, Bob; Johnson, Jadah N.; Syed, Naweed; Braun, Janice E. A.			Quercetin Targets Cysteine String Protein (CSP alpha) and Impairs Synaptic Transmission	PLOS ONE			English	Article							CALCIUM CURRENT; DROSOPHILA; CA2+; VESICLES; COMPLEX; NEUROTRANSMITTER; SYNAPTOGENESIS; MODULATION; EXPRESSION; SECRETION	Background: Cysteine string protein (CSP alpha) is a synaptic vesicle protein that displays unique anti-neurodegenerative properties. CSP alpha is a member of the conserved J protein family, also called the Hsp40 (heat shock protein of 40 kDa) protein family, whose importance in protein folding has been recognized for many years. Deletion of the CSP alpha in mice results in knockout mice that are normal for the first 2-3 weeks of life followed by an unexplained presynaptic neurodegeneration and premature death. How CSP alpha prevents neurodegeneration is currently not known. As a neuroprotective synaptic vesicle protein, CSP alpha represents a promising therapeutic target for the prevention of neurodegenerative disorders. Methodology/Principal Findings: Here, we demonstrate that the flavonoid quercetin promotes formation of stable CSP alpha-CSP alpha dimers and that quercetin-induced dimerization is dependent on the unique cysteine string region. Furthermore, in primary cultures of Lymnaea neurons, quercetin induction of CSP alpha dimers correlates with an inhibition of synapse formation and synaptic transmission suggesting that quercetin interfers with CSP alpha function. Quercetin's action on CSP alpha is concentration dependent and does not promote dimerization of other synaptic proteins or other J protein family members and reduces the assembly of CSP alpha:Hsc70 units (70kDa heat shock cognate protein). Conclusions/Significance: Quercetin is a plant derived flavonoid and popular nutritional supplement proposed to prevent memory loss and altitude sickness among other ailments, although its precise mechanism(s) of action has been unclear. In view of the therapeutic promise of upregulation of CSP alpha and the undesired consequences of CSP alpha dysfunction, our data establish an essential proof of principle that pharmaceutical agents can selectively target the neuroprotective J protein CSP alpha.	[Xu, Fenglian; Syed, Naweed] Univ Calgary, Dept Anat & Cell Biol, Calgary, AB, Canada; [Proft, Juliane; Gibbs, Sarah; Winkfein, Bob; Johnson, Jadah N.; Braun, Janice E. A.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Xu, FL (corresponding author), Univ Calgary, Dept Anat & Cell Biol, Calgary, AB, Canada.	braunj@ucalgary.ca	Proft, Juliane/H-6549-2014; Xu, Fenglian/B-3961-2016	Proft, Juliane/0000-0003-0980-8930; 	CIHR [MOP-49476(JEAB) FRN-49600(NIS)]	CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded by CIHR MOP-49476(JEAB) FRN-49600(NIS). JEAB is an AHFMR senior scholar. FX is an AHFMR and HBI Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2004, J EXP BIOL, V207, P1323, DOI 10.1242/jeb.00898; Bai LP, 2007, BIOCHEM BIOPH RES CO, V352, P123, DOI 10.1016/j.bbrc.2006.10.178; BARZILAI A, 1983, BIOCHIM BIOPHYS ACTA, V730, P245, DOI 10.1016/0005-2736(83)90340-1; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen S, 2002, J PHYSIOL-LONDON, V538, P383, DOI 10.1113/jphysiol.2001.013397; Cogolludo A, 2007, CARDIOVASC RES, V73, P424, DOI 10.1016/j.cardiores.2006.09.008; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; Dawson-Scully K, 2007, SYNAPSE, V61, P1, DOI 10.1002/syn.20335; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Feng ZP, 1997, J NEUROSCI, V17, P7839; Feng ZP, 2000, J NEUROBIOL, V42, P357, DOI 10.1002/(SICI)1097-4695(20000215)42:3<357::AID-NEU7>3.0.CO;2-F; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Gibbs SJ, 2008, NEUROBIOL DIS, V32, P196, DOI 10.1016/j.nbd.2008.07.016; Gibbs SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004595; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Hamakawa T, 1999, J NEUROSCI, V19, P9306; Johnson JN, 2010, BIOCHEM CELL BIOL, V88, P157, DOI [10.1139/O09-124, 10.1139/o09-124]; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Miller LC, 2003, J CELL SCI, V116, P2967, DOI 10.1242/jcs.00595; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nie ZP, 1999, J NEUROSCI, V19, P10270; PATTNAIK BR, 2009, AM J PHYSL CELL PHYS; Ranjan R, 1998, J NEUROSCI, V18, P956; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Saponara S, 2002, BRIT J PHARMACOL, V135, P1819, DOI 10.1038/sj.bjp.0704631; Saponara S, 2008, EUR J PHARMACOL, V598, P75, DOI 10.1016/j.ejphar.2008.08.016; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; SHOSHAN V, 1981, J BIOL CHEM, V256, P887; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Swayne LA, 2006, BIOCHEM BIOPH RES CO, V348, P83, DOI 10.1016/j.bbrc.2006.07.033; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Umbach JA, 1998, J NEUROSCI, V18, P3233; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Umbach JA, 1997, J NEUROSCI, V17, P7203; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Woodin MA, 1999, LEARN MEMORY, V6, P307; Wu SN, 2003, J CELL PHYSIOL, V195, P298, DOI 10.1002/jcp.10244; Xu FL, 2009, J NEUROSCI, V29, P2167, DOI 10.1523/JNEUROSCI.4682-08.2009; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; [No title captured]	53	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11045	10.1371/journal.pone.0011045	http://dx.doi.org/10.1371/journal.pone.0011045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548785	Green Submitted, Green Published, gold			2022-12-25	WOS:000278599600006
J	Demetriou, VL; van de Vijver, DAMC; Kousiappa, I; Balotta, C; Clotet, B; Grossman, Z; Jorgensen, LB; Lepej, SZ; Levy, I; Nielsen, C; Paraskevis, D; Poljak, M; Roman, F; Ruiz, L; Schmidt, JC; Vandamme, AM; Van Laethem, K; Vercauteren, J; Kostrikis, LG				Demetriou, Victoria L.; van de Vijver, David A. M. C.; Kousiappa, Ioanna; Balotta, Claudia; Clotet, Bonaventura; Grossman, Zehava; Jorgensen, Louise B.; Lepej, Snjezana Z.; Levy, Itzchak; Nielsen, Claus; Paraskevis, Dimitrios; Poljak, Mario; Roman, Francois; Ruiz, Lidia; Schmidt, Jean-Claude; Vandamme, Anne-Mieke; Van Laethem, Kristel; Vercauteren, Jurgen; Kostrikis, Leondios G.			Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in Newly-Diagnosed Patients in Europe	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; DISEASE PROGRESSION; PERIPHERAL-BLOOD; VIRAL LOAD; TYPE-1 DNA; ANTIRETROVIRAL THERAPY; PRIMARY INFECTION; CORECEPTOR USAGE; FOLLOW-UP; RESERVOIR	Background: HIV-1 genotypic drug resistance is an important threat to the success of antiretroviral therapy and transmitted resistance has reached 9% prevalence in Europe. Studies have demonstrated that HIV-1 DNA load in peripheral blood mononuclear cells (PBMC) have a predictive value for disease progression, independently of CD4 counts and plasma viral load. Methodology/Principal Findings: Molecular-beacon-based real-time PCR was used to measure HIV-1 second template switch (STS) DNA in PBMC in newly-diagnosed HIV-1 patients across Europe. These patients were representative for the HIV-1 epidemic in the participating countries and were carrying either drug-resistant or sensitive viral strains. The assay design was improved from a previous version to specifically detect M-group HIV-1 and human CCR5 alleles. The findings resulted in a median of 3.32 log(10) HIV-1 copies/10(6) PBMC and demonstrated for the first time no correlation between cellular HIV-1 DNA load and transmitted drug-resistance. A weak association between cellular HIV-1 DNA levels with plasma viral RNA load and CD4(+) T-cell counts was also reconfirmed. Co-receptor tropism for 91% of samples, whether or not they conferred resistance, was CCR5. A comparison of pol sequences derived from RNA and DNA, resulted in a high similarity between the two. Conclusions/Significance: An improved molecular-beacon-based real-time PCR assay is reported for the measurement of HIV-1 DNA in PBMC and has investigated the association between cellular HIV-1 DNA levels and transmitted resistance to antiretroviral therapy in newly-diagnosed patients from across Europe. The findings show no correlation between these two parameters, suggesting that transmitted resistance does not impact disease progression in HIV-1 infected individuals. The CCR5 co-receptor tropism predominance implies that both resistant and non-resistant strains behave similarly in early infection. Furthermore, a correlation found between RNA-and DNA-derived sequences in the pol region suggests that genotypic drug-resistance testing could be carried out on either template.	[Demetriou, Victoria L.; Kousiappa, Ioanna; Kostrikis, Leondios G.] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [van de Vijver, David A. M. C.] Univ Med Ctr, Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Balotta, Claudia] Univ Milan, Inst Infect & Trop Dis, Milan, Italy; [Clotet, Bonaventura; Ruiz, Lidia] Hosp Badalona Germans Trias & Pujol, IrsiCaixa Fdn, Barcelona, Spain; [Grossman, Zehava] Chaim Sheba Med Ctr, Natl HIV Reference Lab, Publ Hlth Labs, MOH Cent Virol, Ramat Gan, Israel; [Jorgensen, Louise B.; Nielsen, Claus] Statens Serum Inst, Retrovirus Lab, Div Diagnost Microbiol, Dept Virol, DK-2300 Copenhagen, Denmark; [Lepej, Snjezana Z.] Univ Zagreb, Univ Hosp Infect Dis, Zagreb, Croatia; [Levy, Itzchak] Chaim Sheba Med Ctr, Infect Dis Unit, Ramat Gan, Israel; [Paraskevis, Dimitrios] Univ Athens, Sch Med, Natl Retrovirus Reference Ctr, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Roman, Francois; Schmidt, Jean-Claude] Ctr Hosp Luxembourg, Retrovirol Lab, Natl Serv Infect Dis, Luxembourg, Luxembourg; [Vandamme, Anne-Mieke; Van Laethem, Kristel; Vercauteren, Jurgen] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium	University of Cyprus; Erasmus University Rotterdam; Erasmus MC; University of Milan; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Chaim Sheba Medical Center; Statens Serum Institut; University of Zagreb; Chaim Sheba Medical Center; Athens Medical School; National & Kapodistrian University of Athens; University of Ljubljana; Luxembourg Hospital Center; KU Leuven	Demetriou, VL (corresponding author), Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus.	lkostrik@ucy.ac.cy	KOSTRIKIS, LEONDIOS G/A-5330-2016; Paraskevis, Dimitrios/H-5835-2019; Ruiz, Lidia/ABF-9720-2021; Vercauteren, Jurgen/P-7676-2019; Vandamme, Anne-Mieke/I-4127-2012; Van Laethem, Kristel/R-6282-2016; Balotta, Claudia/L-7295-2017	KOSTRIKIS, LEONDIOS G/0000-0002-5340-7109; Paraskevis, Dimitrios/0000-0001-6167-7152; Vercauteren, Jurgen/0000-0003-0698-4736; Vandamme, Anne-Mieke/0000-0002-6594-2766; Van Laethem, Kristel/0000-0001-6036-2271; Balotta, Claudia/0000-0002-1107-9119; Kousiappa, Ioanna/0000-0002-7491-5946; van de Vijver, David/0000-0001-5877-8526	University of Cyprus; Cyprus Research Promotion [PENEK/ENISX/0308/15]; European Commission [LSHP-CT-2006-518211]; Cyprus Research Promotion Foundation [KY-IT/0906/04]; Belgian Fonds voor Wetenschappelijk Onderzoek [G.0611.09]; Interuniversitaire Attractiepolen [P6/41]	University of Cyprus; Cyprus Research Promotion; European Commission(European CommissionEuropean Commission Joint Research Centre); Cyprus Research Promotion Foundation; Belgian Fonds voor Wetenschappelijk Onderzoek; Interuniversitaire Attractiepolen	The project was funded by the University of Cyprus. IK was funded by grants PENEK/ENISX/0308/15 from the Cyprus Research Promotion. Coordination aspects have been funded by the EuropeHIVResistance grant LSHP-CT-2006-518211 from the European Commission. Additional support was provided by grant KY-IT/0906/04 from the Cyprus Research Promotion Foundation, and for Belgium grants G.0611.09 (Belgian Fonds voor Wetenschappelijk Onderzoek) and P6/41 (Interuniversitaire Attractiepolen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Avettand-Fenoel V, 2008, J CLIN VIROL, V42, P399, DOI 10.1016/j.jcv.2008.03.013; Beloukas A, 2009, CURR HIV RES, V7, P255, DOI 10.2174/157016209788348001; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; Carr JM, 2007, J CLIN MICROBIOL, V45, P1288, DOI 10.1128/JCM.01926-06; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FERRE F, 1995, J ACQ IMMUN DEF SYND, V10, pS51; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Hatzakis A, 2000, LANCET, V355, P599, DOI 10.1016/S0140-6736(99)10311-8; Hatzakis AE, 2004, AIDS, V18, P2261, DOI 10.1097/00002030-200411190-00006; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Kabamba-Mukadi B, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-15; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kostrikis LG, 2002, J VIROL, V76, P10099, DOI 10.1128/JVI.76.20.10099-10108.2002; Kousiappa I, 2009, AIDS RES HUM RETROV, V25, P23, DOI 10.1089/aid.2008.0168; Kozal MJ, 2004, AIDS, V18, P2185, DOI 10.1097/00002030-200411050-00011; Minga AK, 2008, JAIDS-J ACQ IMM DEF, V48, P350, DOI 10.1097/QAI.0b013e3181775e55; Ngo-Giang-Huong N, 2001, AIDS, V15, P665, DOI 10.1097/00002030-200104130-00001; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Re MC, 2006, NEW MICROBIOL, V29, P81; RE MC, 2009, CLIN MICROBIOL INFEC; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rouzioux C, 2005, J INFECT DIS, V192, P46, DOI 10.1086/430610; Ruitenberg JJ, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-11; Russell RR, 2001, VIRAL IMMUNOL, V14, P379, DOI 10.1089/08828240152716628; Saitoh A, 2002, J INFECT DIS, V185, P1409, DOI 10.1086/340614; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sedaghat AR, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-2; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sing T, 2007, ANTIVIR THER, V12, P1097; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tierney C, 2003, J INFECT DIS, V187, P144, DOI 10.1086/345870; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; VANDEVIJVER D, 2007, THEORETICAL BIOL BIO, P17; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; VERHOFSTEDE C, 1994, AIDS, V8, P1421, DOI 10.1097/00002030-199410000-00008; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; 2009, STANFORD HIV RESISTA	54	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10976	10.1371/journal.pone.0010976	http://dx.doi.org/10.1371/journal.pone.0010976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544014	Green Published, gold			2022-12-25	WOS:000278494900005
J	Song, CNA; Fang, JG; Wang, C; Guo, L; Nicholas, KK; Ma, ZQ				Song, Changnian; Fang, Jinggui; Wang, Chen; Guo, Lei; Nicholas, Kibet Korir; Ma, Zhengqiang			MiR-RACE, a New Efficient Approach to Determine the Precise Sequences of Computationally Identified Trifoliate Orange (Poncirus trifoliata) MicroRNAs	PLOS ONE			English	Article							REGULATORY ROLES; SMALL RNAS; PCR; TARGETS	Background: Among the hundreds of genes encoding miRNAs in plants reported, much more were predicted by numerous computational methods. However, unlike protein-coding genes defined by start and stop codons, the ends of miRNA molecules do not have characteristics that can be used to define the mature miRNAs exactly, which made computational miRNA prediction methods often cannot predict the accurate location of the mature miRNA in a precursor with nucleotide-level precision. To our knowledge, there haven't been reports about comprehensive strategies determining the precise sequences, especially two termini, of these miRNAs. Methods: In this study, we report an efficient method to determine the precise sequences of computationally predicted microRNAs (miRNAs) that combines miRNA-enriched library preparation, two specific 5' and 3' miRNA RACE (miR-RACE) PCR reactions, and sequence-directed cloning, in which the most challenging step is the two specific gene specific primers designed for the two RACE reactions. miRNA-mediated mRNA cleavage by RLM-5' RACE and sequencing were carried out to validate the miRNAs detected. Real-time PCR was used to analyze the expression of each miRNA. Results: The efficiency of this newly developed method was validated using nine trifoliate orange (Poncirus trifoliata) miRNAs predicted computationally. The miRNAs computationally identified were validated by miR-RACE and sequencing. Quantitative analysis showed that they have variable expression. Eight target genes have been experimentally verified by detection of the miRNA-mediated mRNA cleavage in Poncirus trifoliate. Conclusion: The efficient and powerful approach developed herein can be successfully used to validate the sequences of miRNAs, especially the termini, which depict the complete miRNA sequence in the computationally predicted precursor.	[Song, Changnian; Fang, Jinggui; Wang, Chen; Guo, Lei; Nicholas, Kibet Korir] Nanjing Agr Univ, Coll Hort, Nanjing, Peoples R China; [Ma, Zhengqiang] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Fang, JG (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Peoples R China.	fanggg@njau.edu.cn	Ma, Zhengqiang/AAQ-9160-2021; Ma, Zhengqiang/AAI-9876-2020	Ma, Zhengqiang/0000-0003-4950-5387; Fang, Jinggui/0000-0003-1975-2715	NCET Program of China [NCET-08-0796]; China Ministry of Education [109084]	NCET Program of China(Program for New Century Excellent Talents in University (NCET)); China Ministry of Education(Ministry of Education, China)	This work was supported by the NCET Program of China (grant no. NCET-08-0796) and the Science and Technology Key Project of the China Ministry of Education (grant no. 109084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; CARTER P, 1986, BIOCHEM J, V237, P1; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Elbashir S.M., 2001, GENE DEV, V16, P1616; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; KOVALIC D, 1991, NUCLEIC ACIDS RES, V19, P4560, DOI 10.1093/nar/19.16.4560; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2008, TRENDS PLANT SCI, V13, P359, DOI 10.1016/j.tplants.2008.03.007; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Peng RH, 2006, APPL MICROBIOL BIOT, V73, P234, DOI 10.1007/s00253-006-0583-3; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruvkun Gary, 2004, Cell, VS116, pS93, DOI 10.1016/S0092-8674(04)00034-0; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	45	49	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10861	10.1371/journal.pone.0010861	http://dx.doi.org/10.1371/journal.pone.0010861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539756	Green Submitted, gold, Green Published			2022-12-25	WOS:000278465900001
J	Becker, MH; Harris, RN				Becker, Matthew H.; Harris, Reid N.			Cutaneous Bacteria of the Redback Salamander Prevent Morbidity Associated with a Lethal Disease	PLOS ONE			English	Article							CHYTRID BATRACHOCHYTRIUM-DENDROBATIDIS; SKIN PEPTIDE DEFENSES; YELLOW-LEGGED FROG; HYDROGEN-PEROXIDE; POPULATION DECLINES; INFECTIOUS-DISEASES; AMPHIBIAN PATHOGEN; PLETHODON-CINEREUS; CENTRAL-AMERICA; RANA-MUSCOSA	Chytridiomycosis, caused by the fungal pathogen Batrachochytrium dendrobatidis (Bd), is an infectious disease that causes population declines of many amphibians. Cutaneous bacteria isolated from redback salamanders, Plethodon cinereus, and mountain yellow-legged frogs, Rana muscosa, inhibit the growth of Bd in vitro. In this study, the bacterial community present on the skin of P. cinereus individuals was investigated to determine if it provides protection to salamanders from the lethal and sub-lethal effects of chytridiomycosis. When the cutaneous bacterial community was reduced prior to Bd exposure, salamanders experienced a significantly greater decrease in body mass, which is a symptom of the disease, when compared to infected individuals with a normal bacterial community. In addition, a greater proportion of infected individuals with a reduced bacterial community experienced limb-lifting, a behavior seen only in infected individuals. Overall, these results demonstrate that the cutaneous bacterial community of P. cinereus provides protection to the salamander from Bd and that alteration of this community can change disease resistance. Therefore, symbiotic microbes associated with this species appear to be an important component of its innate skin defenses.	[Becker, Matthew H.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Harris, Reid N.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA	Virginia Polytechnic Institute & State University; James Madison University	Becker, MH (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	mhbecker3@gmail.com			National Science Foundation [0640373]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (grant 0640373 to RNH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2009, AQUAT BIOL, V4, P289, DOI 10.3354/ab00102; Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Austin RM, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P451; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaustein AR, 2009, ECOHEALTH, V6, P373, DOI 10.1007/s10393-009-0266-5; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brook I, 1999, CRIT REV MICROBIOL, V25, P155, DOI 10.1080/10408419991299211; Brucker RM, 2008, J CHEM ECOL, V34, P1422, DOI 10.1007/s10886-008-9555-7; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; CHAN RCY, 1985, INFECT IMMUN, V47, P84, DOI 10.1128/IAI.47.1.84-89.1985; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; GILTURNES MS, 1992, BIOL BULL, V182, P105, DOI 10.2307/1542184; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; KENNEDY MJ, 1985, INFECT IMMUN, V49, P654, DOI 10.1128/IAI.49.3.654-663.1985; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Lumsden JS, 1998, J AQUAT ANIM HEALTH, V10, P230, DOI 10.1577/1548-8667(1998)010&lt;0230:UOHPTT&gt;2.0.CO;2; Matousek JL, 2002, VET DERMATOL, V13, P293, DOI 10.1046/j.1365-3164.2002.00312.x; Murphy PJ, 2009, ECOHEALTH, V6, P109, DOI 10.1007/s10393-009-0230-4; Pessier AP, 2002, SEMIN AVIAN EXOT PET, V11, P162, DOI 10.1053/saep.2002.123980; Rach JJ, 2003, N AM J AQUACULT, V65, P300, DOI 10.1577/C03-005; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Russo R, 2007, J AQUAT ANIM HEALTH, V19, P121, DOI 10.1577/H05-024.1; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sokal R. R., 2012, BIOMETRY; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Wilson, 2005, MICROBIAL INHABITANT, P375; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207; Wyngaard G.A., 1982, P485	51	130	135	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10957	10.1371/journal.pone.0010957	http://dx.doi.org/10.1371/journal.pone.0010957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532032	gold, Green Published, Green Submitted			2022-12-25	WOS:000278380500003
J	Mizoro, Y; Yamaguchi, Y; Kitazawa, R; Yamada, H; Matsuo, M; Fustin, JM; Doi, M; Okamura, H				Mizoro, Yasutaka; Yamaguchi, Yoshiaki; Kitazawa, Rena; Yamada, Hiroyuki; Matsuo, Masahiro; Fustin, Jean-Michel; Doi, Masao; Okamura, Hitoshi			Activation of AMPA Receptors in the Suprachiasmatic Nucleus Phase-Shifts the Mouse Circadian Clock In Vivo and In Vitro	PLOS ONE			English	Article							BIOLOGICAL CLOCK; MESSENGER-RNA; GLUTAMATE; LIGHT; RAT; NMDA; MPER1; ASPARTATE; CHANNELS; RHYTHMS	The glutamatergic neurotransmission in the suprachiasmatic nucleus (SCN) plays a central role in the entrainment of the circadian rhythms to environmental light-dark cycles. Although the glutamatergic effect operating via NMDAR (N-methyl D-aspartate receptor) is well elucidated, much less is known about a role of AMPAR (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor) in circadian entrainment. Here we show that, in the mouse SCN, GluR2 and GluR4 AMPAR subtypes are abundantly expressed in the retinorecipient area. In vivo microinjection of AMPA in the SCN during the early subjective night phase-delays the behavioral rhythm. In the organotypic SCN slice culture, AMPA application induces phase-dependent phase-shifts of core-clock gene transcription rhythms. These data demonstrate that activation of AMPAR is capable of phase-shifting the circadian clock both in vivo and in vitro, and are consistent with the hypothesis that activation of AMPA receptors is a critical step in the transmission of photic information to the SCN.	[Mizoro, Yasutaka; Yamaguchi, Yoshiaki; Yamada, Hiroyuki; Matsuo, Masahiro; Fustin, Jean-Michel; Doi, Masao; Okamura, Hitoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Kyoto, Japan; [Kitazawa, Rena; Okamura, Hitoshi] Kobe Univ, Grad Sch Med, Div Mol Brain Sci, Kobe, Hyogo 657, Japan	Kyoto University; Kobe University	Mizoro, Y (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Kyoto, Japan.	okamurah@pharm.kyoto-u.ac.jp	Fustin, Jean-Michel/R-6621-2019; Yamaguchi, Yoshiaki/K-9418-2013; Doi, Masao/J-9267-2019; Matsuo, Masahiro/L-9692-2013	Fustin, Jean-Michel/0000-0002-6200-6075; Yamaguchi, Yoshiaki/0000-0003-4126-542X; Doi, Masao/0000-0001-6264-9217; Matsuo, Masahiro/0000-0003-3283-3413; Mizoro, Yasutaka/0000-0002-5081-4884	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MECSSTJG); SRF; Kanae Foundation for the Promotion of Medical Science [MECSSTJG21790073]	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MECSSTJG)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SRF; Kanae Foundation for the Promotion of Medical Science	This work was supported by research grants to H.O. from Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MECSSTJG) and from SRF, and to Y.Y. from MECSSTJG21790073 and from Kanae Foundation for the Promotion of Medical Science (http://www.kanae-zaidan.com/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Akiyama M, 1999, J NEUROSCI, V19, P1115; Anderson CM, 2000, GLIA, V32, P1; Asai M, 2001, CURR BIOL, V11, P1524, DOI 10.1016/S0960-9822(01)00445-6; CAGAMPANG FRA, 1994, BRAIN RES, V639, P175, DOI 10.1016/0006-8993(94)91780-9; CLINE HT, 1991, NEURON, V6, P259, DOI 10.1016/0896-6273(91)90361-3; COLWELL CS, 1991, BRAIN RES, V554, P105, DOI 10.1016/0006-8993(91)90177-W; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; DEVRIES MJ, 1993, BRAIN RES, V612, P231, DOI 10.1016/0006-8993(93)91665-F; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; GANNON RL, 1994, MOL BRAIN RES, V23, P338, DOI 10.1016/0169-328X(94)90244-5; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Lee HS, 2003, J BIOL RHYTHM, V18, P435, DOI 10.1177/0748730403259106; Leone MJ, 2006, J NEUROSCI RES, V84, P1521, DOI 10.1002/jnr.21042; LIOU SY, 1986, BRAIN RES BULL, V16, P527, DOI 10.1016/0361-9230(86)90182-6; Masubuchi S, 2005, J NEUROSCI, V25, P4719, DOI 10.1523/JNEUROSCI.4761-04.2005; Mintz EM, 1999, J NEUROSCI, V19, P5124; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Moriya T, 2003, J NEUROCHEM, V85, P978, DOI 10.1046/j.1471-4159.2003.01758.x; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paul KN, 2003, NEUROSCIENCE, V119, P137, DOI 10.1016/S0306-4522(03)00098-8; Pickard GE, 1996, J NEUROSCI, V16, P8208; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360, DOI 10.1152/ajpregu.1994.267.2.R360; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; TOMINAGA K, 1994, NEUROSCIENCE, V59, P1025, DOI 10.1016/0306-4522(94)90303-4; VANDENPOL AN, 1991, J NEUROSCI, V11, P2087; Wakamatsu H, 2001, NEUROREPORT, V12, P127, DOI 10.1097/00001756-200101220-00033; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	34	24	24	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10951	10.1371/journal.pone.0010951	http://dx.doi.org/10.1371/journal.pone.0010951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532181	gold, Green Published, Green Submitted			2022-12-25	WOS:000278318700019
J	Reid, AJ; Ranea, JAG; Clegg, AB; Orengo, CA				Reid, Adam J.; Ranea, Juan A. G.; Clegg, Andrew B.; Orengo, Christine A.			CODA: Accurate Detection of Functional Associations between Proteins in Eukaryotic Genomes Using Domain Fusion	PLOS ONE			English	Article							GENE FUSION; SEMANTIC SIMILARITY; SEQUENCE; DATABASE	Background: In order to understand how biological systems function it is necessary to determine the interactions and associations between proteins. Gene fusion prediction is one approach to detection of such functional relationships. Its use is however known to be problematic in higher eukaryotic genomes due to the presence of large homologous domain families. Here we introduce CODA (Co-Occurrence of Domains Analysis), a method to predict functional associations based on the gene fusion idiom. Methodology/Principal Findings: We apply a novel scoring scheme which takes account of the genome-specific size of homologous domain families involved in fusion to improve accuracy in predicting functional associations. We show that CODA is able to accurately predict functional similarities in human with comparison to state-of-the-art methods and show that different methods can be complementary. CODA is used to produce evidence that a currently uncharacterised human protein may be involved in pathways related to depression and that another is involved in DNA replication. Conclusions/Significance: The relative performance of different gene fusion methodologies has not previously been explored. We find that they are largely complementary, with different methods being more or less appropriate in different genomes. Our method is the only one currently available for download and can be run on an arbitrary dataset by the user. The CODA software and datasets are freely available from ftp://ftp.biochem.ucl.ac.uk/pub/gene3d_data/v6.1.0/CODA/. Predictions are also available via web services from http://funcnet.eu/.	[Reid, Adam J.] Wellcome Trust Sanger Inst, Cambridge, England; [Ranea, Juan A. G.; Clegg, Andrew B.; Orengo, Christine A.] UCL, Res Dept Struct & Mol Biol, London, England; [Ranea, Juan A. G.] Univ Malaga, Dept Mol Biol & Biochem, E-29071 Malaga, Spain	Wellcome Trust Sanger Institute; University of London; University College London; Universidad de Malaga	Reid, AJ (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	ar11@sanger.ac.uk		Reid, Adam/0000-0002-5926-7768; Garcia Ranea, Juan Antonio/0000-0003-0327-1837	Biotechnology and Biological Sciences Research Council; Spanish Education and Science Ministry [RYC-2007-01649]; MED [SAF-09839]; European Union [LSHG-CT-2005-518254, LHSG-CT-2004-512092]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Education and Science Ministry(Spanish Government); MED; European Union(European Commission)	Funding: AJR acknowledges financial support from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/). JAGR acknowledges financial support from the Spanish Education and Science Ministry through the Ramon y Cajal program (RYC-2007-01649) (http://ciencia.micinn.fecyt.es/ciencia/jsp/plantilla.jsp?area=cajal&id=11), the Plan Nacional project (SAF-09839 Subprograma MED) (http://www.plannacionalidi.es/), and the European Union's ENFIN Network of Excellence (Experimental Network for Functional Integration, LSHG-CT-2005-518254) (http://www.enfin.org/). ABC acknowledges support from the European Union's EMBRACE Network of Excellence (European Model for Bioinformatics Research And Community Education, LHSG-CT-2004-512092) (http://www.embracegrid.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic G, 2001, Bioinformatics, V17 Suppl 1, pS83; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bellivier F, 2004, AM J MED GENET B, V124B, P87, DOI 10.1002/ajmg.b.20015; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Enright AJ, 2001, GENOME BIOL, V2; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Truong K, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-16; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298; Yeats C, 2008, NUCLEIC ACIDS RES, V36, pD414, DOI 10.1093/nar/gkm1019	22	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10908	10.1371/journal.pone.0010908	http://dx.doi.org/10.1371/journal.pone.0010908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532224	Green Published, Green Submitted, gold			2022-12-25	WOS:000278222400005
J	van't Hof, AE; Saccheri, IJ				van't Hof, Arjen E.; Saccheri, Ilik J.			Industrial Melanism in the Peppered Moth Is Not Associated with Genetic Variation in Canonical Melanisation Gene Candidates	PLOS ONE			English	Article							PROPHENOLOXIDASE-ACTIVATING PROTEINASE-1; MANDUCA-SEXTA HEMOLYMPH; BLACK-AND-WHITE; DROSOPHILA-MELANOGASTER; CUTICULAR MELANIZATION; ADAPTIVE PIGMENTATION; TOBACCO HORNWORM; PAPILIO-XUTHUS; BOMBYX-MORI; EVOLUTION	Industrial melanism in the peppered moth (Biston betularia) is an iconic case study of ecological genetics but the molecular identity of the gene determining the difference between the typical and melanic (carbonaria) morphs is entirely unknown. We applied the candidate gene approach to look for associations between genetic polymorphisms within sixteen a priori melanisation gene candidates and the carbonaria morph. The genes were isolated and sequence characterised in B. betularia using degenerate PCR and from whole-transcriptome sequence. The list of candidates contains all the genes previously implicated in melanisation pattern differences in other insects, including aaNAT, DOPA-decarboxylase, ebony, tan, tyrosine hydroxylase, yellow and yellow2 (yellow-fa). Co-segregation of candidate gene alleles and carbonaria morph was tested in 73 offspring of a carbonaria male-typical female backcross. Surprisingly, none of the sixteen candidate genes was in close linkage with the locus controlling the carbonaria-typical polymorphism. Our study demonstrates that the 'carbonaria gene' is not a structural variant of a canonical melanisation pathway gene, neither is it a cis-regulatory element of these enzyme-coding genes. The implication is either that we have failed to characterize an unknown enzyme-coding gene in the melanisation pathway, or more likely, that the 'carbonaria gene' is a higher level trans-acting factor which regulates the spatial expression of one or more of the melanisation candidates in this study to alter the pattern of melanin production.	[van't Hof, Arjen E.; Saccheri, Ilik J.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	van't Hof, AE (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	saccheri@liv.ac.uk	Van 't Hof, Arjen/AAE-8044-2022		Natural Environment Research Council [NE/C003101/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NE/C003101/1), http://www.nerc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227; BIESSMANN H, 1985, P NATL ACAD SCI USA, V82, P7369, DOI 10.1073/pnas.82.21.7369; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cook Laurence M., 2003, Entomologist's Gazette, V54, P211; Cook LM, 2003, Q REV BIOL, V78, P399, DOI 10.1086/378925; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Futahashi R, 2006, INSECT BIOCHEM MOLEC, V36, P63, DOI 10.1016/j.ibmb.2005.11.002; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gratten J, 2007, P ROY SOC B-BIOL SCI, V274, P619, DOI 10.1098/rspb.2006.3762; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Hartzer KL, 2005, ARCH INSECT BIOCHEM, V59, P67, DOI 10.1002/arch.20056; HIRUMA K, 1988, DEV BIOL, V130, P87, DOI 10.1016/0012-1606(88)90416-2; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; HORI M, 1984, INSECT BIOCHEM, V14, P267, DOI 10.1016/0020-1790(84)90059-3; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Koch PB, 2000, CURR BIOL, V10, P591, DOI 10.1016/S0960-9822(00)00494-2; Koch PB, 1998, DEVELOPMENT, V125, P2303; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Llopart A, 2002, EVOLUTION, V56, P2262; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; Mitchell A, 2000, SYST BIOL, V49, P202, DOI 10.1093/sysbio/49.2.202; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; RYCHLIK W, 2000, OLIGO PRIMER ANAL SO; SACCHERI IJ, 1993, J HERED, V84, P195, DOI 10.1093/oxfordjournals.jhered.a111316; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; Sugumaran M, 2009, PIGM CELL MELANOMA R, V22, P523, DOI 10.1111/j.1755-148X.2009.00608.x; Takahashi A, 2007, GENETICS, V177, P1233, DOI 10.1534/genetics.107.075283; Talloen W, 2004, EVOLUTION, V58, P360, DOI 10.1111/j.0014-3820.2004.tb01651.x; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Wang RG, 2001, EUR J BIOCHEM, V268, P895, DOI 10.1046/j.1432-1327.2001.01945.x; WIERNASZ DC, 1989, EVOLUTION, V43, P1672, DOI 10.1111/j.1558-5646.1989.tb02617.x; Wittkopp PJ, 2009, SCIENCE, V326, P540, DOI 10.1126/science.1176980; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Zou Z, 2005, INSECT BIOCHEM MOLEC, V35, P627, DOI 10.1016/j.ibmb.2005.02.004	52	23	24	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10889	10.1371/journal.pone.0010889	http://dx.doi.org/10.1371/journal.pone.0010889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526362	Green Published, gold, Green Submitted			2022-12-25	WOS:000278222100018
J	Hall, GBC; Doyle, KAR; Goldberg, J; West, D; Szatmari, P				Hall, Geoffrey B. C.; Doyle, Krissy A. R.; Goldberg, Jeremy; West, Dianne; Szatmari, Peter			Amygdala Engagement in Response to Subthreshold Presentations of Anxious Face Stimuli in Adults with Autism Spectrum Disorders: Preliminary Insights	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; PERVASIVE DEVELOPMENTAL DISORDERS; NEURAL RESPONSES; FUNCTIONAL NEUROANATOMY; GAZE-FIXATION; BRAIN; FEAR; INDIVIDUALS; MONKEY; INFORMATION	Current theoretical models of autism spectrum disorders (ASD) have proposed that impairments in the processing of social/emotional information may be linked to amygdala dysfunction. However, the extent to which amygdala functions are compromised in ASD has become a topic of debate in recent years. In a jittered functional magnetic resonance imaging study, sub-threshold presentations of anxious faces permitted an examination of amygdala recruitment in 12 high functioning adult males with ASD and 12 matched controls. We found heightened neural activation of the amygdala in both high functioning adults with ASD and matched controls. Neither the intensity nor the time-course of amygdala activation differed between the groups. However, the adults with ASD showed significantly lower levels of fusiform activation during the trials compared to controls. Our findings suggest that in ASD, the transmission of socially salient information along subcortical pathways is intact: and yet the signaling of this information to structures downstream may be impoverished, and the pathways that facilitate subsequent processing deficient.	[Hall, Geoffrey B. C.; Doyle, Krissy A. R.; Goldberg, Jeremy; West, Dianne; Szatmari, Peter] McMaster Univ, Fac Hlth Sci, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Hall, Geoffrey B. C.] St Josephs Healthcare, Brain Body Inst, Hamilton, ON, Canada; [Hall, Geoffrey B. C.; Szatmari, Peter] McMaster Univ, Offord Ctr Child Studies, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Hall, GBC (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada.	hallg@mcmaster.ca		/0000-0002-3398-6692				Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amaral DG, 2003, GENES BRAIN BEHAV, V2, P295, DOI 10.1034/j.1601-183X.2003.00043.x; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; BARBUR JL, 1980, BRAIN, V103, P905, DOI 10.1093/brain/103.4.905; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; BAUMAN M, 1985, NEUROLOGY, V35, P866, DOI 10.1212/WNL.35.6.866; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; BENEVENTO LA, 1975, J COMP NEUROL, V160, P339, DOI 10.1002/cne.901600306; Bernier R, 2005, J AUTISM DEV DISORD, V35, P575, DOI 10.1007/s10803-005-0002-0; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Courchesne E, 1999, NEUROLOGY, V52, P1057, DOI 10.1212/WNL.52.5.1057; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Deeley Q, 2006, BRIT J PSYCHIAT, V189, P533, DOI 10.1192/bjp.bp.106.021410; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Ekman P., 1976, PICTURES FACIAL AFFE; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Howard MA, 2000, NEUROREPORT, V11, P2931, DOI 10.1097/00001756-200009110-00020; Hubl D, 2003, NEUROLOGY, V61, P1232, DOI 10.1212/01.WNL.0000091862.22033.1A; JONES EG, 1976, BRAIN RES, V104, P142, DOI 10.1016/0006-8993(76)90654-5; LeDoux J, 1996, PROG BRAIN RES, V107, P437; LeDoux J. E., 1996, EMOTIONAL BRAIN; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lundqvist D., 1998, KAROLINSKA DIRECTED; MILLER M, 1980, J NEUROPHYSIOL, V43, P1510, DOI 10.1152/jn.1980.43.6.1510; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1997, P ROY SOC B-BIOL SCI, V264, P769, DOI 10.1098/rspb.1997.0109; Muller RA, 2007, MENT RETARD DEV D R, V13, P85, DOI 10.1002/mrdd.20141; Palmen SJMC, 2006, PSYCHOL MED, V36, P827, DOI 10.1017/S0033291706007215; Palmen SJMC, 2004, J NEURAL TRANSM, V111, P903, DOI 10.1007/s00702-003-0068-9; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Piggot J, 2004, J AM ACAD CHILD PSY, V43, P473, DOI 10.1097/00004583-200404000-00014; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Silvert L, 2007, NEUROIMAGE, V38, P357, DOI 10.1016/j.neuroimage.2007.07.023; Talairach J., 1988, COPLANAR STEREOTAXIC; Van Amelsvoort T, 2006, BRIT J PSYCHIAT, V189, P560, DOI 10.1192/bjp.bp.105.019876; van Kooten IAJ, 2008, BRAIN, V131, P987, DOI 10.1093/brain/awn033; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wickelgren A, 2005, SCIENCE, V308, P1856, DOI 10.1126/science.308.5730.1856; Williams MA, 2004, EXP BRAIN RES, V154, P403, DOI 10.1007/s00221-003-1740-x; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	65	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10804	10.1371/journal.pone.0010804	http://dx.doi.org/10.1371/journal.pone.0010804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601CE	20520836	Green Published, gold, Green Submitted			2022-12-25	WOS:000278034800004
J	Shin, DH; Cho, MH; Kim, TL; Yoo, J; Kim, JI; Han, YJ; Song, PS; Jeon, JS; Bhoo, SH; Hahn, TR				Shin, Dong Ho; Cho, Man-Ho; Kim, Tae-Lim; Yoo, Jihye; Kim, Jeong-Il; Han, Yun-Jeong; Song, Pill-Soon; Jeon, Jong-Seong; Bhoo, Seong Hee; Hahn, Tae-Ryong			A Small GTPase Activator Protein Interacts with Cytoplasmic Phytochromes in Regulating Root Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED POSITIVE PHOTOTROPISM; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ROP GTPASE; LIGHT; GROWTH; PLANTS; ELONGATION; AUXIN	Phytochromes enable plants to sense light information and regulate developmental responses. Phytochromes interact with partner proteins to transmit light signals to downstream components for plant development. PIRF1 (phytochrome-interacting ROP guanine-nucleotide exchange factor (RopGEF 1)) functions as a light-signaling switch regulating root development through the activation of ROPs (Rho-like GTPase of plant) in the cytoplasm. In vitro pulldown and yeast two-hybrid assays confirmed the interaction between PIRF1 and phytochromes. PIRF1 interacted with the N-terminal domain of phytochromes through its conserved PRONE (plant-specific ROP nucleotide exchanger) region. PIRF1 also interacted with ROPs and activated them in a phytochrome-dependent manner. The Pr form of phytochrome A enhanced the RopGEF activity of PIRF1, whereas the Pfr form inhibited it. A bimolecular fluorescence complementation analysis demonstrated that PIRF1 was localized in the cytoplasm and bound to the phytochromes in darkness but not in light. PIRF1 loss of function mutants (pirf1) of Arabidopsis thaliana showed a longer root phenotype in the dark. In addition, both PIRF1 overexpression mutants (PIRF1-OX) and phytochrome-null mutants (phyA-211 and phyB-9) showed retarded root elongation and irregular root hair formation, suggesting that PIRF1 is a negative regulator of phytochrome-mediated primary root development. We propose that phytochrome and ROP signaling are interconnected through PIRF1 in regulating the root growth and development in Arabidopsis.	[Jeon, Jong-Seong; Bhoo, Seong Hee; Hahn, Tae-Ryong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea; [Jeon, Jong-Seong; Bhoo, Seong Hee; Hahn, Tae-Ryong] Kyung Hee Univ, Plant Metab Res Ctr, Yongin 446701, South Korea; [Kim, Jeong-Il; Han, Yun-Jeong] Chonnam Natl Univ, Kumho Life Sci Lab, Kwangju 500757, South Korea; [Kim, Jeong-Il; Han, Yun-Jeong] Chonnam Natl Univ, Dept Biotechnol, Kwangju 500757, South Korea; [Song, Pill-Soon] Jeju Natl Univ, Fac Biotechnol, Cheju 690756, South Korea	Kyung Hee University; Kyung Hee University; Chonnam National University; Chonnam National University; Jeju National University		shbhoo@khu.ac.kr; trhahn@khu.ac.kr	Jeon, Jong-Seong/AAJ-2161-2020	Jeon, Jong-Seong/0000-0001-6221-4993	MOST/KOSEF from the Plant Metabolism Research Center, Kyung Hee University [R11-2000-081]; Plant Diversity Research Center [PF06302-02]; Biogreen21 Program [20080401034014]; KOSEF/NCRC [R15-2003-012-01003-0]; Rural Development Administration, Republic of Korea [200901FHT010407539]; Korean Ministry of Education, Science, and Technology [R33-2008-000-10168-0]	MOST/KOSEF from the Plant Metabolism Research Center, Kyung Hee University; Plant Diversity Research Center; Biogreen21 Program(Rural Development Administration (RDA), Republic of Korea); KOSEF/NCRC(Korea Science and Engineering Foundation); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the SRC program of MOST/KOSEF R11-2000-081 from the Plant Metabolism Research Center, Kyung Hee University. This work was also supported by the Plant Diversity Research Center of the 21st Century Frontier Research Program PF06302-02 (to J.-I. K.), in part by Biogreen21 Program Grant 20080401034014 and KOSEF/NCRC Grant R15-2003-012-01003-0 (to P.-S. S.), by Grant 200901FHT010407539 from the Biogreen 21 Program, Rural Development Administration, Republic of Korea (to S. H. B.), and by Grant R33-2008-000-10168-0 from the World Class University program of the Korean Ministry of Education, Science, and Technology (to J.-S.J.).	Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Berken A, 2006, CELL MOL LIFE SCI, V63, P2446, DOI 10.1007/s00018-006-6197-1; Boccalandro HE, 2008, PLANT PHYSIOL, V146, P108, DOI 10.1104/pp.107.106468; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; De Simone S, 2000, J PLANT RES, V113, P63, DOI 10.1007/PL00013917; Fankhauser C, 2008, TRENDS PLANT SCI, V13, P596, DOI 10.1016/j.tplants.2008.08.007; Galen C, 2007, NEW PHYTOL, V173, P91, DOI 10.1111/j.1469-8137.2006.01893.x; Gu Y, 2006, PLANT CELL, V18, P366, DOI 10.1105/tpc.105.036434; Hemm MR, 2004, PLANT J, V38, P765, DOI 10.1111/j.1365-313X.2004.02089.x; Huq E, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P151, DOI 10.1002/352760510X.ch7; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Kang JG, 2001, CELL, V105, P625, DOI 10.1016/S0092-8674(01)00370-1; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Kevei E, 2007, J EXP BOT, V58, P3113, DOI 10.1093/jxb/erm145; Kim JI, 2005, LIGHT SENSING IN PLANTS, P57, DOI 10.1007/4-431-27092-2_6; Kim JI, 2002, BIOCHEM BIOPH RES CO, V298, P457, DOI 10.1016/S0006-291X(02)02494-4; Kiss JZ, 2002, PLANT CELL PHYSIOL, V43, P35, DOI 10.1093/pcp/pcf017; Kiss JZ, 2003, PLANT PHYSIOL, V131, P1411, DOI 10.1104/pp.013847; Kost B, 2008, TRENDS CELL BIOL, V18, P119, DOI 10.1016/j.tcb.2008.01.003; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Lin RC, 2005, PLANT PHYSIOL, V138, P949, DOI 10.1104/pp.105.061572; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Montgomery BL, 2008, PLANT SIGNAL BEHAV, V3, P1053, DOI 10.4161/psb.3.12.6857; Nagatani A, 2005, LIGHT SENSING IN PLANTS, P69, DOI 10.1007/4-431-27092-2_7; Neff MM, 2000, GENE DEV, V14, P257; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Phee BK, 2008, BIOCHEM J, V415, P247, DOI 10.1042/BJ20071555; Phee BK, 2006, PROTEOMICS, V6, P3671, DOI 10.1002/pmic.200500222; Pratt Lee H., 1994, P163; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Reed JW, 1999, CURR OPIN PLANT BIOL, V2, P393, DOI 10.1016/S1369-5266(99)00011-4; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Rosler J, 2007, P NATL ACAD SCI USA, V104, P10737, DOI 10.1073/pnas.0703855104; Ruppel NJ, 2001, PLANTA, V212, P424, DOI 10.1007/s004250000410; Sakamoto K, 1996, PLANT J, V10, P859, DOI 10.1046/j.1365-313X.1996.10050859.x; Salisbury FJ, 2007, PLANT J, V50, P429, DOI 10.1111/j.1365-313X.2007.03059.x; Schultheiss H, 2005, PLANT PHYSIOL, V139, P353, DOI 10.1104/pp.105.066613; Shen Y, 2005, J BIOL CHEM, V280, P5740, DOI 10.1074/jbc.M408965200; Shin DH, 2009, PLANT BIOTECHNOL REP, V3, P183, DOI 10.1007/s11816-009-0090-y; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; SOMERS DE, 1995, PLANT J, V7, P413, DOI 10.1046/j.1365-313X.1995.7030413.x; Sun Q, 2005, J EXP BOT, V56, P191, DOI 10.1093/jxb/eri019; Tao LZ, 2005, PLANT CELL, V17, P2369, DOI 10.1105/tpc.105.032987; Tao LZ, 2002, PLANT CELL, V14, P2745, DOI 10.1105/tpc.006320; Tian Q, 2003, PLANT J, V36, P643, DOI 10.1046/j.1365-313X.2003.01909.x; WANG H, 2002, ARABIDOPSIS BOOK; Yang Z, 2007, CURR OPIN PLANT BIOL, V10, P490, DOI 10.1016/j.pbi.2007.07.005; Ying G, 2004, CURR OPIN PLANT BIOL, V7, P527, DOI 10.1016/j.pbi.2004.07.006; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104; ZHENG Y, 1995, METHOD ENZYMOL, V256, P77; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948; Zheng ZL, 2002, PLANT CELL, V14, P2787, DOI 10.1105/tpc.005611	61	18	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32151	32159		10.1074/jbc.M110.133710	http://dx.doi.org/10.1074/jbc.M110.133710			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20551316	Green Published, hybrid			2022-12-25	WOS:000282683000028
J	Bennett, JC; Roggero, CM; Mancifesta, FE; Mayorga, LS				Castillo Bennett, Jimena; Roggero, Carlos M.; Mancifesta, Franco E.; Mayorga, Luis S.			Calcineurin-mediated Dephosphorylation of Synaptotagmin VI Is Necessary for Acrosomal Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; DEPENDENT PROTEIN PHOSPHATASE; LYTIC GRANULE EXOCYTOSIS; PANCREATIC ALPHA-CELLS; MEMBRANE-FUSION; HUMAN SPERMATOZOA; HUMAN SPERM; INHIBITS EXOCYTOSIS; SNARE COMPLEX; CALCIUM	Regulated secretion is a fundamental process underlying the function of many cell types. In particular, acrosomal exocytosis in mammalian sperm is essential for egg fertilization. In general, exocytosis is initiated by a cytosolic calcium increase. In this report we show that calcium affects several factors during human sperm acrosomal exocytosis. By using an antibody that specifically recognizes synaptotagmin VI phosphorylated at the polybasic region of the C2B domain, we showed that a calcium-dependent dephosphorylation of this protein occurred at early stages of the acrosomal exocytosis in streptolysin O-permeabilized sperm. We identified the phosphatase as calcineurin and showed that the activity of this enzyme is absolutely required during the early steps of the secretory process. When added to sperm, an inhibitor-insensitive, catalytically active domain of calcineurin was able to rescue the effect of the specific calcineurin inhibitor cyclosporin A. This same domain dephosphorylated recombinant synaptotagmin VI C2B domain, validating this protein as a new substrate for calcineurin. When sperm were treated with catalytically active calcineurin before stimulation, exocytosis was inhibited, an effect that was rescued by the phosphomimetic synaptotagmin VI C2B-T418E,T419E mutant domain. These observations indicate that synaptotagmin must be dephosphorylated at a specific window of time and suggest that phosphorylated synaptotagmin has an active role at early stages of the acrosomal exocytosis.	[Castillo Bennett, Jimena; Roggero, Carlos M.; Mancifesta, Franco E.; Mayorga, Luis S.] Univ Nacl Cuyo, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Mayorga, LS (corresponding author), Casilla Correo 56, RA-5500 Mendoza, Argentina.	lmayorga@fcm.uncu.edu.ar	Roggero, Carlos/AAX-4354-2020	Mayorga, Luis S/0000-0002-5995-0671; Castillo Bennett, Jimena/0000-0001-8651-7083	Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Agencia Nacional de Promocion Cienti\fica y Tecnologica (Argentina)	Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cienti\fica y Tecnologica (Argentina)(ANPCyT)	This work was supported by grants from Universidad Nacional de Cuyo, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Agencia Nacional de Promocion Cienti\fica y Tecnologica (Argentina).	Ackermann F, 2009, J CELL SCI, V122, P4547, DOI 10.1242/jcs.058263; Ashizawa K, 2004, REPRODUCTION, V128, P783, DOI 10.1530/rep.1.00327; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Brachya G, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S4; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Catherine CR, 2005, MOL CELL NEUROSCI, V29, P462, DOI 10.1016/j.mcn.2005.03.015; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; CLIPSTONE NA, 1994, J BIOL CHEM, V269, P26431; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Gromada J, 2001, J PHYSIOL-LONDON, V535, P519, DOI 10.1111/j.1469-7793.2001.00519.x; Grybko MJ, 2007, J BIOL CHEM, V282, P18009, DOI 10.1074/jbc.M702222200; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hoy M, 2001, J BIOL CHEM, V276, P924, DOI 10.1074/jbc.M007562200; Hutt DM, 2005, J BIOL CHEM, V280, P20197, DOI 10.1074/jbc.M412920200; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Kee Y, 1996, J NEUROSCI, V16, P1975; Kuo WW, 2009, J MOL BIOL, V387, P284, DOI 10.1016/j.jmb.2009.01.064; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Liu P, 2005, BIOCHIMIE, V87, P215, DOI 10.1016/j.biochi.2004.10.009; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; MOMAYEZI M, 1987, J CELL BIOL, V105, P181, DOI 10.1083/jcb.105.1.181; MORIYA M, 1995, CELL TISSUE RES, V281, P273, DOI 10.1007/s004410050424; Pores-Fernando AT, 2009, IMMUNOL REV, V231, P160, DOI 10.1111/j.1600-065X.2009.00809.x; Pores-Fernando AT, 2009, CELL IMMUNOL, V254, P105, DOI 10.1016/j.cellimm.2008.07.004; Raufman JP, 1997, BBA-MOL CELL RES, V1357, P73, DOI 10.1016/S0167-4889(97)00023-2; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rodriguez A, 2005, J BIOL CHEM, V280, P9980, DOI 10.1074/jbc.C400401200; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Roggero CM, 2005, DEV BIOL, V285, P422, DOI 10.1016/j.ydbio.2005.07.007; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; TASH JS, 1988, J CELL BIOL, V106, P1625, DOI 10.1083/jcb.106.5.1625; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Yanagimachi R., 1994, P189; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200	52	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26269	26278		10.1074/jbc.M109.095752	http://dx.doi.org/10.1074/jbc.M109.095752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551332	hybrid, Green Published			2022-12-25	WOS:000280921000044
J	Bitew, T; Sveen, CE; Heyne, B; Zaremberg, V				Bitew, Teshager; Sveen, Christopher E.; Heyne, Belinda; Zaremberg, Vanina			Vitamin E Prevents Lipid Raft Modifications Induced by an Anti-cancer Lysophospholipid and Abolishes a Yap1-mediated Stress Response in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; BUDDING YEAST; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTOR; MASS-SPECTROMETRY; APOPTOSIS; CELLS	We have previously established that the anti-cancer lysophospholipid edelfosine (1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine, Et-18-OCH3) induces cell death in yeast by selective modification of lipid raft composition at the plasma membrane. In this study we determined that alpha-tocopherol protects cells from the edelfosine cytotoxic effect, preventing the internalization of sterols and the plasma membrane proton pump ATPase, Pma1p. Two non-mutually exclusive hypotheses were considered to explain the protective effect of alpha-tocopherol: (i) its classical antioxidant activity is necessary to break progression of lipid peroxidation, despite the fact Saccharomyces cerevisiae does not possess polyunsaturated fatty acids and (ii) due to its complementary cone shape, insertion of alpha-tocopherol could correct membrane curvature stress imposed by edelfosine (inverted cone shape). We then developed tools to distinguish between these two hypotheses and dissect the structural requirements that confer alpha-tocopherol its protective effect. Our results indicated its lipophilic nature and the H donating hydroxyl group from the chromanol ring are both required to counteract the cytotoxic effect of edelfosine, suggesting edelfosine induces oxidation of membrane components. To further support this finding and learn more about the early cellular response to edelfosine we investigated the role that known oxidative stress signaling pathways play in modulating sensitivity to the lipid drug. Our results indicate the transcription factors Yap1 and Skn7 as well as the major peroxiredoxin, Tsa1, mediate a response to edelfosine. Interestingly, the pathway differed from the one triggered by hydrogen peroxide and its activation (measured as Yap1 translocation to the nucleus) was abolished by co-treatment of the cells with alpha-tocopherol.	[Bitew, Teshager; Sveen, Christopher E.; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Sveen, Christopher E.; Heyne, Belinda] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Zaremberg, V (corresponding author), 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vzarembe@ucalgary.ca		Heyne, Belinda/0000-0003-1655-6719	National Sciences and Engineering Research Council (NSERC)	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by operating grants from the National Sciences and Engineering Research Council (NSERC) (to B. H. and V. Z.) and a University Faculty Award from NSERC (to V. Z.).	Atkinson J, 2008, FREE RADICAL BIO MED, V44, P739, DOI 10.1016/j.freeradbiomed.2007.11.010; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Bocking T, 2000, EUR J BIOCHEM, V267, P1607, DOI 10.1046/j.1432-1327.2000.01179.x; Busto JV, 2007, BBA-BIOMEMBRANES, V1768, P1855, DOI 10.1016/j.bbamem.2007.04.025; Busto Jon V, 2008, J Chem Biol, V1, P89, DOI 10.1007/s12154-008-0009-z; Cipak A, 2008, BBA-MOL CELL BIOL L, V1781, P283, DOI 10.1016/j.bbalip.2008.03.010; Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004; Fariss MW, 2001, FREE RADICAL BIO MED, V31, P530, DOI 10.1016/S0891-5849(01)00615-3; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; MUNDER PG, 1990, CHEM IMMUNOL, V49, P206; Neuzil H, 2002, BIOCHEM BIOPH RES CO, V293, P1309, DOI 10.1016/S0006-291X(02)00358-3; Neuzil J, 2005, BIOCHEM BIOPH RES CO, V327, P1024, DOI 10.1016/j.bbrc.2004.12.115; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Ricciarelli R, 1998, BIOCHEM J, V334, P243, DOI 10.1042/bj3340243; Ross SJ, 2000, MOL BIOL CELL, V11, P2631, DOI 10.1091/mbc.11.8.2631; Royer MC, 2009, J BIOL CHEM, V284, P15826, DOI 10.1074/jbc.M808641200; Sambrook J, 2001, MOL CLONING LAB MANU; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Tatchell K, 2002, METHOD ENZYMOL, V351, P661; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636; van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200; Vrablic AS, 2001, FASEB J, V15, P1739, DOI 10.1096/fj.00-0300com; Wagner BA, 1998, CANCER RES, V58, P2809; WAGNER BA, 1992, CANCER RES, V52, P6045; Wagner BA, 1996, ARCH BIOCHEM BIOPHYS, V334, P261, DOI 10.1006/abbi.1996.0454; Welscher YMT, 2008, J BIOL CHEM, V283, P6393, DOI 10.1074/jbc.M707821200; Wright MM, 2004, BIOCHEM CELL BIOL, V82, P18, DOI 10.1139/o03-092; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhang H, 2007, ACTA PHARMACOL SIN, V28, P888, DOI 10.1111/j.1745-7254.2007.00568.x	49	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25731	25742		10.1074/jbc.M110.122200	http://dx.doi.org/10.1074/jbc.M110.122200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538604	hybrid, Green Published			2022-12-25	WOS:000280682400066
J	Misumi, S; Inoue, M; Dochi, T; Kishimoto, N; Hasegawa, N; Takamune, N; Shoji, S				Misumi, Shogo; Inoue, Mutsumi; Dochi, Takeo; Kishimoto, Naoki; Hasegawa, Naomi; Takamune, Nobutoki; Shoji, Shozo			Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; CYCLE-DEPENDENT PHOSPHORYLATION; FLIGHT MASS-SPECTROMETRY; HIV-1 CAPSID PROTEIN; INTRACELLULAR TRAFFICKING; IN-VITRO; CELL; INFECTION; DOMAIN; GENE	The process by which the human immunodeficiency virus type 1 (HIV-1) conical core dissociates is called uncoating, but not much is known about this process. Here, we show that the uncoating process requires the interaction of the capsid (CA) protein with the peptidyl-prolyl isomerase Pin1 that specifically recognizes the phosphorylated serine/threonine residue followed by proline. We found that the HIV-1 core is composed of some isoforms of the CA protein with different isoelectric points, and one isoform is preferentially phosphorylated in the Ser(16)-Pro(17) motif. The mutant virus S16A/P17A shows a severely attenuated HIV-1 replication and an impaired reverse transcription. The S16A/P17A change increased the amount of particulate CA cores in the cytosol of target cells and correlated with the restriction of HIV-1 infection. Glutathione S-transferase pulldown assays demonstrated a direct interaction between Pin1 and the HIV-1 core via the Ser(16)-Pro(17) motif. Suppression of Pin1 expression by RNA interference in a target cell results in an attenuated HIV-1 replication and increases the amount of particulate CA cores in the cytosol of target cells. Furthermore, heat-inactivated, inhibitor-treated, or W34A/K63A Pin1 causes an attenuated in vitro uncoating of the HIV-1 core. The Pin1-dependent uncoating is inhibited by antisera raised against a CA peptide phosphorylated at Ser(16) or treatment of the HIV-1 core with alkaline phosphatase. These findings provide insights into this obscure uncoating process in the HIV-1 life cycle and a new cellular target for HIV-1 drug development.	[Misumi, Shogo; Shoji, Shozo] Kumamoto Univ, Dept Pharmaceut Biochem, Fac Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Shoji, Shozo] Kumamoto Hlth Sci Univ, Kumamoto 8615598, Japan	Kumamoto University; Kumamoto Health Science University	Misumi, S (corresponding author), Kumamoto Univ, Dept Pharmaceut Biochem, Fac Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	misumi@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Japan Society for the Promotion of Science [217212]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Health Science Research Grant from the Ministry of Health, Labour, and Welfare of Japan.; Recipient of Japan Society for the Promotion of Science for Young Scientists Research Fellowship 217212.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Auewarakul P, 2005, VIROLOGY, V337, P93, DOI 10.1016/j.virol.2005.02.028; Dvorin JD, 2003, CURR TOP MICROBIOL, V281, P179; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; Fuchigami T, 2002, BIOCHEM BIOPH RES CO, V293, P1107, DOI 10.1016/S0006-291X(02)00329-7; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Ikeda T, 2004, J VIROL, V78, P11563, DOI 10.1128/JVI.78.21.11563-11573.2004; Kawano Y, 1997, J VIROL, V71, P8456, DOI 10.1128/JVI.71.11.8456-8466.1997; LAURENT AG, 1989, J VIROL, V63, P4074, DOI 10.1128/JVI.63.9.4074-4078.1989; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; MERVIS RJ, 1988, J VIROL, V62, P3993, DOI 10.1128/JVI.62.11.3993-4002.1988; Misumi S, 2002, J VIROL, V76, P10000, DOI 10.1128/JVI.76.19.10000-10008.2002; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; VERONESE FD, 1988, J VIROL, V62, P795, DOI 10.1128/JVI.62.3.795-801.1988; Warrilow D, 2008, J VIROL, V82, P1425, DOI 10.1128/JVI.01808-07; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	30	50	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25185	25195		10.1074/jbc.M110.114256	http://dx.doi.org/10.1074/jbc.M110.114256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529865	Green Published, hybrid			2022-12-25	WOS:000280682400011
J	Pecheur, EI; Diaz, O; Molle, J; Icard, V; Bonnafous, P; Lambert, O; Andre, P				Pecheur, Eve-Isabelle; Diaz, Olivier; Molle, Jennifer; Icard, Vinca; Bonnafous, Pierre; Lambert, Olivier; Andre, Patrice			Morphological Characterization and Fusion Properties of Triglyceride-rich Lipoproteins Obtained from Cells Transduced with Hepatitis C Virus Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MEMBRANE-FUSION; CRYOELECTRON MICROSCOPY; PLASMA-LIPOPROTEINS; APOLIPOPROTEIN-B; PARTICLES; ASSOCIATION; DETERMINANTS; REPLICATION; RESISTANCE	The density of hepatitis C virus (HCV) particles circulating in the blood of chronically infected patients and of cell-culture produced HCV is heterogeneous. Specific infectivity and fusion of low density particles are higher than those of high density particles. We recently characterized hybrid particles produced by Caco-2 colon or Huh-7.5 liver cells transduced with HCV E1 and E2 envelope glycoproteins. Caco-2-derived particles, called empty lipo-viral particles (eLVP), are composed of triglyceride-rich lipoproteins positive for apolipoproteins B (i.e. apoB100 and apoB48) and contain HCV E1 and E2. Here we aimed at characterizing the morphology and in vitro fusion properties of eLVP using electron microscopy and fluorescence spectroscopy. They displayed the aspect of beta-lipoproteins, and immunogold labeling confirmed the presence of apoB and HCV E1 and E2 at their surface. These particles are able to fuse with lipid bilayers (liposomes) in a fusion process leading to the coalescence of internal contents of triglyceride-rich lipoproteins particles and liposomes. Fusion was pH-dependent and could be inhibited by either Z-fFG, a peptide known to inhibit viral fusion, or by monoclonal antibodies directed against HCV E2 or the apolipoprotein moiety of the hybrid particle. Interestingly, particles derived from Huh-7.5 cells failed to display equivalent efficient fusion. Optimal fusion activity is, thus, observed when HCV envelope proteins are associated to apoB-positive hybrid particles. Our results, therefore, point to a crucial role of the E1 and E2 proteins in HCV fusion with a subtle interplay with the apolipoprotein part of eLVP.	[Pecheur, Eve-Isabelle; Molle, Jennifer] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, Lyon BioSci Gerland IFR128,UMR 5086, F-69007 Lyon, France; [Bonnafous, Pierre; Lambert, Olivier] Univ Bordeaux 1, CNRS, Inst Europeen Chim & Biol, UMR 5248, F-33405 Talence, France; [Diaz, Olivier; Andre, Patrice] INSERM, Lyon BioSci Gerland IFR128, U851, F-69007 Lyon, France; [Icard, Vinca; Andre, Patrice] Hosp Civils Lyon, Lab Virol Nord, F-69004 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Pecheur, EI (corresponding author), Univ Lyon 1, CNRS, Inst Biol & Chim Prot, Lyon BioSci Gerland IFR128,UMR 5086, F-69007 Lyon, France.	patrice.andre@inserm.fr; patrice.andre@inserm.fr	André, Patrice/M-8139-2014; Bonnafous, Pierre/M-7845-2014; diaz, olivier/M-8112-2014	André, Patrice/0000-0002-5834-7395; diaz, olivier/0000-0002-3451-9914; Pecheur, Eve/0000-0002-8613-862X; Lambert, Olivier/0000-0002-5651-8082	CNRS; INSERM; Agence Nationale de Recherche contre le SIDA et les hepatites virales	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de Recherche contre le SIDA et les hepatites virales(French National Research Agency (ANR))	This work was supported by the CNRS, INSERM, and the Agence Nationale de Recherche contre le SIDA et les hepatites virales (to E.-I. P. and P. A.).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; BONNAFOUS P, 2010, J GEN VIROL IN PRESS; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; DENTINO AR, 1995, BBA-BIOMEMBRANES, V1235, P213, DOI 10.1016/0005-2736(95)80007-3; Diaz O, 2008, J MED VIROL, V80, P242, DOI 10.1002/jmv.21037; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Dupuy FP, 2005, J GENE MED, V7, P1158, DOI 10.1002/jgm.769; FORTE T, 1971, J CLIN INVEST, V50, P1141, DOI 10.1172/JCI106586; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; KELSEY DR, 1990, J BIOL CHEM, V265, P12178; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LINDENBACH BD, 2001, FIELDS VIROLOGY, V1, P991; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murphy D, 2007, HEPATOLOGY, V46, p623A; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Owens JA, 2009, J AM ACAD CHILD PSY, V48, P99, DOI [10.1097/CHI.0b013e3181930639, 10.1097/CHI.0b013e181930639]; PAWLOTSKY JM, 2010, GASTROENTEROLOGY, V138; Pumeechockchai W, 2002, J MED VIROL, V68, P335, DOI 10.1002/jmv.10208; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Segrest JP, 2001, J LIPID RES, V42, P1346; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SMITH LC, 1978, ANNU REV BIOCHEM, V47, P751, DOI 10.1146/annurev.bi.47.070178.003535; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; THEOLIS R, 1984, ARTERIOSCLEROSIS, V4, P498, DOI 10.1161/01.ATV.4.5.498; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; VANANTWERPEN R, 1994, J LIPID RES, V35, P2223; vanAntwerpen R, 1997, J LIPID RES, V38, P659; WILSCHUT J, 1979, NATURE, V281, P690, DOI 10.1038/281690a0; WILSCHUT J, 1980, BIOCHEMISTRY-US, V19, P6011, DOI 10.1021/bi00567a011; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	49	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25802	25811		10.1074/jbc.M110.131664	http://dx.doi.org/10.1074/jbc.M110.131664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551330	hybrid, Green Published			2022-12-25	WOS:000280682400072
J	Baluchamy, S; Ravichandran, P; Periyakaruppan, A; Ramesh, V; Hall, JC; Zhang, Y; Jejelowo, O; Gridley, DS; Wu, HL; Ramesh, GT				Baluchamy, Sudhakar; Ravichandran, Prabakaran; Periyakaruppan, Adaikkappan; Ramesh, Vani; Hall, Joseph C.; Zhang, Ye; Jejelowo, Olufisayo; Gridley, Daila S.; Wu, Honglu; Ramesh, Govindarajan T.			Induction of Cell Death through Alteration of Oxidants and Antioxidants in Lung Epithelial Cells Exposed to High Energy Protons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; OXIDATIVE STRESS; CARBON NANOTUBES; REACTIVE OXYGEN; APOPTOSIS; CANCER; DAMAGE	Radiation affects several cellular and molecular processes, including double strand breakage and modifications of sugar moieties and bases. In outer space, protons are the primary radiation source that poses a range of potential health risks to astronauts. On the other hand, the use of proton irradiation for tumor radiation therapy is increasing, as it largely spares healthy tissues while killing tumor tissues. Although radiation-related research has been conducted extensively, the molecular toxicology and cellular mechanisms affected by proton irradiation remain poorly understood. Therefore, in this study, we irradiated rat lung epithelial cells with different doses of protons and investigated their effects on cell proliferation and death. Our data show an inhibition of cell proliferation in proton-irradiated cells with a significant dose-dependent activation and repression of reactive oxygen species and antioxidants glutathione and superoxide dismutase, respectively, compared with control cells. In addition, the activities of apoptosis-related genes such as caspase-3 and -8 were induced in a dose-dependent manner with corresponding increased levels of DNA fragmentation in proton-irradiated cells compared with control cells. Together, our results show that proton irradiation alters oxidant and antioxidant levels in cells to activate the apoptotic pathway for cell death.	[Baluchamy, Sudhakar; Ravichandran, Prabakaran; Ramesh, Vani; Hall, Joseph C.; Ramesh, Govindarajan T.] Norfolk State Univ, Mol Toxicol Lab, Ctr Biotechnol & Biomed Sci, Dept Biol, Norfolk, VA 23504 USA; [Periyakaruppan, Adaikkappan; Jejelowo, Olufisayo] Texas So Univ, Dept Biol, Houston, TX 77004 USA; [Zhang, Ye; Wu, Honglu] NASA, Lyndon B Johnson Space Ctr, Radiat Biophys Lab, Houston, TX 77058 USA; [Zhang, Ye; Wu, Honglu] NASA, Lyndon B Johnson Space Ctr, Human Adaptat & Countermeasures Div, Houston, TX 77058 USA; [Gridley, Daila S.] Loma Linda Univ, Med Ctr, Dept Radiat Med, Loma Linda, CA 92354 USA	Norfolk State University; Texas Southern University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Loma Linda University	Ramesh, GT (corresponding author), Norfolk State Univ, Mol Toxicol Lab, Ctr Biotechnol & Biomed Sci, Dept Biol, Norfolk, VA 23504 USA.	gtramesh@nsu.edu	Gridley, Daila S/P-7711-2015; Periyakaruppan, Adaikkappan/B-7398-2013	Periyakaruppan, Adaikkappan/0000-0002-0395-6564	NIH [1P20MD001822-1]; NASA [NNX08BA47A, NCC-1-02038]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, by NIH (1P20MD001822-1) and NASA Grants NNX08BA47A and NCC-1-02038.	BALUCHAMY S, 2010, IN VITRO CELL DEV, DOI DOI 10.1007/S-11626-010-9330-2; Baluchamy S, 2010, MOL CELL BIOCHEM, V341, P207, DOI 10.1007/s11010-010-0451-4; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Di Pietro C, 2006, APOPTOSIS, V11, P57, DOI 10.1007/s10495-005-3346-1; Dominguez-Rodriguez JR, 2001, ANTICANCER RES, V21, P1869; Engel RH, 2006, FRONT BIOSCI-LANDMRK, V11, P300, DOI 10.2741/1798; Giedzinski E, 2005, RADIAT RES, V164, P540, DOI 10.1667/RR3369.1; Gridley DS, 2008, RADIAT RES, V169, P280, DOI 10.1667/RR1155.1; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; NCRP, 1989, 98 NCRP; Periyakaruppan A, 2007, ARCH TOXICOL, V81, P389, DOI 10.1007/s00204-006-0167-0; Ravichandran P, 2009, J BIOCHEM MOL TOXIC, V23, P333, DOI 10.1002/jbt.20296; Schimmerling Walter, 2003, Gravit Space Biol Bull, V16, P5; Sharma CS, 2007, J NANOSCI NANOTECHNO, V7, P2466, DOI 10.1166/jnn.2007.431; Stein TP, 2000, AM J PHYSIOL-ENDOC M, V278, pE375, DOI 10.1152/ajpendo.2000.278.3.E375; Wise KC, 2005, IN VITRO CELL DEV-AN, V41, P118; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; WOOD DH, 1991, RADIAT RES, V126, P132, DOI 10.2307/3577811; Zhao YF, 2001, ANTIOXID REDOX SIGN, V3, P375, DOI 10.1089/15230860152409022	20	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24769	24774		10.1074/jbc.M110.138099	http://dx.doi.org/10.1074/jbc.M110.138099			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538614	Green Published, hybrid			2022-12-25	WOS:000280542100049
J	Daiho, T; Danko, S; Yamasaki, K; Suzuki, H				Daiho, Takashi; Danko, Stefania; Yamasaki, Kazuo; Suzuki, Hiroshi			Stable Structural Analog of Ca2+-ATPase ADP-insensitive Phosphoenzyme with Occluded Ca2+ Formed by Elongation of A-domain/M1 '-linker and Beryllium Fluoride Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; 1ST TRANSMEMBRANE HELIX; CALCIUM-PUMP; A-DOMAIN; REACTION-MECHANISM; CRYSTAL-STRUCTURE; TIGHT-BINDING; ION-TRANSPORT; PROTEINASE-K; COS-1 CELLS	We have developed a stable analog for the ADP-insensitive phosphoenzyme intermediate with two occluded Ca2+ at the transport sites (E2PCa(2)) of sarcoplasmic reticulum Ca2+-ATPase. This is normally a transient intermediate state during phosphoenzyme isomerization from the ADP-sensitive to ADP-insensitive form and Ca2+ deocclusion/ release to the lumen; E1PCa(2) -> E2PCa(2) -> E2P + 2Ca(2+). Stabilization was achieved by elongation of the Glu(40)-Ser(48) loop linking the Actuator domain and M1 (1st transmembrane helix) with four glycine insertions at Gly(46)/Lys(47) and by binding of beryllium fluoride (BeFx) to the phosphorylation site of the Ca2+-bound ATPase (E1Ca(2)). The complex E2Ca(2)center dot BeF3- was also produced by lumenal Ca2+ binding to E2 center dot BeF3- (E2P ground state analog) of the elongated linker mutant. The complex was stable for at least 1 week at 25 degrees C. Only BeFx, but not AlFx or MgFx, produced the E2PCa(2) structural analog. Complex formation required binding of Mg2+, Mn2+, or Ca2+ at the catalytic Mg2+ site. Results reveal that the phosphorylation product E1PCa(2) and the E2P ground state (but not the transition states) become competent to produce the E2PCa(2) transient state during forward and reverse phosphoenzyme isomerization. Thus, isomerization and lumenal Ca2+ release processes are strictly coupled with the formation of the acylphosphate covalent bond at the catalytic site. Results also demonstrate the critical structural roles of the Glu(40)-Ser(48) linker and of Mg2+ at the catalytic site in these processes.	[Daiho, Takashi; Danko, Stefania; Yamasaki, Kazuo; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Daiho, T (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	daiho@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [21570127] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research (C) (to T.D.) and (B) (to H.S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Gonzalez DA, 2006, BIOPHYS CHEM, V124, P27, DOI 10.1016/j.bpc.2006.05.025; HASSELBACH W, 1981, FED PROC, V40, P2657; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Holdensen AN, 2009, J BIOL CHEM, V284, P12258, DOI 10.1074/jbc.M900977200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KANAZAWA T, 1975, J BIOL CHEM, V250, P113; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KUBOTA T, 1993, BIOCHIM BIOPHYS ACTA, V1163, P131, DOI 10.1016/0167-4838(93)90174-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; MURPHY AJ, 1993, J BIOL CHEM, V268, P23307; OGURUSU T, 1991, J BIOCHEM-TOKYO, V109, P472, DOI 10.1093/oxfordjournals.jbchem.a123406; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Peeraer Y, 2004, EUR J BIOCHEM, V271, P3421, DOI 10.1111/j.0014-2956.2004.04277.x; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; Seekoe T, 2001, J BIOL CHEM, V276, P46737, DOI 10.1074/jbc.M106320200; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMADA S, 1980, J BIOL CHEM, V255, P3108; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200	54	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24538	24547		10.1074/jbc.M110.144535	http://dx.doi.org/10.1074/jbc.M110.144535			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529842	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000280542100026
J	Peng, P; Zhao, J; Zhu, YY; Asami, T; Li, JM				Peng, Peng; Zhao, Jun; Zhu, Yongyou; Asami, Tadao; Li, Jianming			A Direct Docking Mechanism for a Plant GSK3-like Kinase to Phosphorylate Its Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE; REGULATED GENE-EXPRESSION; RECEPTOR KINASES; BIN2; GSK3; BZR1; PROTEINS; GROWTH; BES1; BRASSINOSTEROIDS	Glycogen synthase kinase 3 (GSK3) is a highly conserved serine/threonine protein kinase that plays important roles in a variety of physiological and developmental processes in animals. It is well known that the GSK3 kinase-catalyzed protein phosphorylation often requires a stable kinase-substrate docking interaction, which is achieved mainly by two mechanisms as follows: priming phosphorylation of a substrate by a distinct kinase to create a docking phosphate group and scaffold protein-mediated protein complex formation. Brassinosteroid-INsensitive 2 (BIN2) is an Arabidopsis GSK3-like kinase that negatively regulates brassinosteroid (BR) signaling by phosphorylating BES1 (bri1 EMS suppressor 1) and BZR1 (brassinazole-resistant 1), two highly similar transcription factors critical for bringing about characteristic BR responses. However, little is known about the biochemical mechanism by which BIN2 phosphorylates its substrates. Here, we show that BIN2 interacts directly with BZR1 through a 12-amino acid BIN2-docking motif adjacent to the C terminus of BZR1. Interestingly, this 12-amino acid motif is sufficient to allow a Drosophila GSK3 substrate Armadillo to be phosphorylated by BIN2 in vitro. Deletion of this motif inhibits the phosphorylation and subsequent degradation of BZR1 in vivo, resulting in phenotypic suppression of a hypermorphic bin2 mutation and enhanced resistance to a BR biosynthesis inhibitor. We thus concluded that BIN2 utilizes a direct kinase-substrate docking mechanism to phosphorylate BZR1 and regulate its protein stability.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Asami, Tadao] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Michigan System; University of Michigan; University of Tokyo	Li, JM (corresponding author), 4071B Nat Sci Bldg,830 N Univ, Ann Arbor, MI 48109 USA.	jian@umich.edu	Zhu, Yongyou/H-3791-2013; Li, Jianming/O-1772-2014	Li, Jianming/0000-0003-3231-0778	National Institutes of Health [GM060519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060519 (to J. L.).	Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; Claisse G, 2007, PLANT MOL BIOL, V64, P113, DOI 10.1007/s11103-007-9138-y; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dornelas MC, 2000, PLANT J, V21, P419, DOI 10.1046/j.1365-313x.2000.00691.x; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Jonak C, 2000, PLANT CELL, V12, P1467, DOI 10.1105/tpc.12.8.1467; Jonak C, 2002, TRENDS PLANT SCI, V7, P457, DOI 10.1016/S1360-1385(02)02331-2; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2005, CURR OPIN PLANT BIOL, V8, P526, DOI 10.1016/j.pbi.2005.07.009; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Li L, 2010, P NATL ACAD SCI USA, V107, P3918, DOI 10.1073/pnas.0909198107; Li L, 2009, PLANT J, V58, P275, DOI 10.1111/j.1365-313X.2008.03778.x; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Pai LM, 1997, DEVELOPMENT, V124, P2255; Peng P, 2008, MOL PLANT, V1, P338, DOI 10.1093/mp/ssn001; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Piao HL, 2001, PLANT J, V27, P305, DOI 10.1046/j.1365-313x.2001.01099.x; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 2001, SCI STKE, pRE12; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yan ZY, 2009, PLANT PHYSIOL, V150, P710, DOI 10.1104/pp.109.138099; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441; Zhao J, 2002, PLANT PHYSIOL, V130, P1221, DOI 10.1104/pp.102.010918	48	38	44	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24646	24653		10.1074/jbc.M110.142547	http://dx.doi.org/10.1074/jbc.M110.142547			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522560	hybrid, Green Published			2022-12-25	WOS:000280542100037
J	Wang, L; Barylko, B; Byers, C; Ross, JA; Jameson, DM; Albanesi, JP				Wang, Lei; Barylko, Barbara; Byers, Christopher; Ross, Justin A.; Jameson, David M.; Albanesi, Joseph P.			Dynamin 2 Mutants Linked to Centronuclear Myopathies Form Abnormally Stable Polymers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; GTPASE ACTIVITY; ACTIVATION; MUTATIONS	Mutations in the dynamin 2 gene have been identified in patients with autosomal dominant forms of centronuclear myopathy (CNM). Dynamin 2 is a ubiquitously expressed similar to 100kDa GTPase that assembles around the necks of vesiculating membranes and promotes their constriction and scission. It has also been implicated in regulation of the actin and microtubule cytoskeletons. At present, the cellular functions of dynamin 2 that are affected by CNM-linked mutations are not well defined, and the effects of these mutations on the physical and enzymatic properties of dynamin have been not examined. Here, we report the expression, purification, and characterization of four CNM-associated dynamin mutants. All four mutants display higher than wild-type GTPase activities, and more importantly, the mutants form high order oligomers that are significantly more resistant than wild-type dynamin 2 to disassembly by guanine nucleotides or high ionic strength. These observations suggest that the corresponding wild-type residues serve to prevent excessive or prolonged dynamin assembly on cellular membranes or inappropriate self-assembly in the cytoplasm. To our knowledge, this report contains the first identification of point mutations that enhance the stability of dynamin polymers without impairing their ability to bind and/or hydrolyze GTP. We envision that the formation of abnormally large and stable complexes of these dynamin mutants in vivo contributes to their role in CNM pathogenesis.	[Wang, Lei; Barylko, Barbara; Byers, Christopher; Albanesi, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Ross, Justin A.; Jameson, David M.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Hawaii System	Albanesi, JP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	joseph.albanesi@utsouthwestern.edu			National Institutes of Health [R01 GM076665]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076665.	Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Binns DD, 1999, J PROTEIN CHEM, V18, P277, DOI 10.1023/A:1021083211267; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Eccleston JF, 2002, EUR BIOPHYS J BIOPHY, V31, P275, DOI 10.1007/s00249-002-0226-2; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Jungbluth H, 2010, NEUROMUSCULAR DISORD, V20, P49, DOI 10.1016/j.nmd.2009.10.005; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lin HC, 1996, J BIOL CHEM, V271, P27979, DOI 10.1074/jbc.271.45.27979; Lin HC, 1997, J BIOL CHEM, V272, P25999, DOI 10.1074/jbc.272.41.25999; MATSUDAIRA PT, 1978, ANAL BIOCHEM, V87, P386, DOI 10.1016/0003-2697(78)90688-7; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Muhlberg AB, 2000, METHODS, V20, P475, DOI 10.1006/meth.2000.0960; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Scaife R, 1998, BIOCHEMISTRY-US, V37, P17673, DOI 10.1021/bi981180g; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yang ZY, 2001, J BIOL CHEM, V276, P4251, DOI 10.1074/jbc.M006371200	36	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22751	22755		10.1074/jbc.C110.130013	http://dx.doi.org/10.1074/jbc.C110.130013			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20529869	Green Published, hybrid			2022-12-25	WOS:000279999900006
J	Akimana, C; Al-Khodor, S; Abu Kwaik, Y				Akimana, Christine; Al-Khodor, Souhaila; Abu Kwaik, Yousef			Host Factors Required for Modulation of Phagosome Biogenesis and Proliferation of Francisella tularensis within the Cytosol	PLOS ONE			English	Article							LIVE VACCINE STRAIN; HUMAN MACROPHAGES; DROSOPHILA CELLS; RNAI SCREEN; INTRACELLULAR FATE; INFECTION; GROWTH; PATHOGENICITY; ESCAPE; SURVIVAL	Francisella tularensis is a highly infectious facultative intracellular bacterium that can be transmitted between mammals by arthropod vectors. Similar to many other intracellular bacteria that replicate within the cytosol, such as Listeria, Shigella, Burkholderia, and Rickettsia, the virulence of F. tularensis depends on its ability to modulate biogenesis of its phagosome and to escape into the host cell cytosol where it proliferates. Recent studies have identified the F. tularensis genes required for modulation of phagosome biogenesis and escape into the host cell cytosol within human and arthropod-derived cells. However, the arthropod and mammalian host factors required for intracellular proliferation of F. tularensis are not known. We have utilized a forward genetic approach employing genome-wide RNAi screen in Drosophila melanogaster-derived cells. Screening a library of similar to 21,300 RNAi, we have identified at least 186 host factors required for intracellular bacterial proliferation. We silenced twelve mammalian homologues by RNAi in HEK293T cells and identified three conserved factors, the PI4 kinase PI4KCA, the ubiquitin hydrolase USP22, and the ubiquitin ligase CDC27, which are also required for replication in human cells. The PI4KCA and USP22 mammalian factors are not required for modulation of phagosome biogenesis or phagosomal escape but are required for proliferation within the cytosol. In contrast, the CDC27 ubiquitin ligase is required for evading lysosomal fusion and for phagosomal escape into the cytosol. Although F. tularensis interacts with the autophagy pathway during late stages of proliferation in mouse macrophages, this does not occur in human cells. Our data suggest that F. tularensis utilizes host ubiquitin turnover in distinct mechanisms during the phagosomal and cytosolic phases and phosphoinositide metabolism is essential for cytosolic proliferation of F. tularensis. Our data will facilitate deciphering molecular ecology, patho-adaptation of F. tularensis to the arthropod vector and its role in bacterial ecology and patho-evolution to infect mammals.	[Akimana, Christine; Al-Khodor, Souhaila; Abu Kwaik, Yousef] Univ Louisville, Coll Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Abu Kwaik, Yousef] Univ Louisville, Dept Biol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Akimana, C (corresponding author), Univ Louisville, Coll Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	abukwaik@louisville.edu	Khodor, Souhaila Al/AAQ-6938-2020; Abu Kwaik, Yousef/A-2802-2012	Abu Kwaik, Yousef/0000-0002-2119-2078; Al Khodor, Souhaila/0000-0003-4858-7130	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI43965, R01AI069321]; Commonwealth of Kentucky Research Challenge Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069321, R01AI043965] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Commonwealth of Kentucky Research Challenge Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	YA is supported by Public Health Service Awards R01AI43965 and R01AI069321 from National Institute of Allergy and Infectious Diseases (NIAID) and by the Commonwealth of Kentucky Research Challenge Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Aperis G, 2007, MICROBES INFECT, V9, P729, DOI 10.1016/j.micinf.2007.02.016; ASARE R, 2010, ENV MICROBI IN PRESS; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; FRANCIS E., 1927, Public Health Reports, V42, P2763, DOI 10.2307/4578567; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; Hrstka R, 2005, MICROBES INFECT, V7, P619, DOI 10.1016/j.micinf.2004.12.020; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Koo IC, 2008, P NATL ACAD SCI USA, V105, P710, DOI 10.1073/pnas.0708110105; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Milne TS, 2007, J MED MICROBIOL, V56, P1268, DOI 10.1099/jmm.0.47190-0; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Read A, 2008, J MED ENTOMOL, V45, P1108, DOI 10.1603/0022-2585(2008)45[1108:FGRFRI]2.0.CO;2; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08; Santic M, 2009, ENVIRON MICROBIOL, V11, P1473, DOI 10.1111/j.1462-2920.2009.01875.x; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Titball RW, 2003, ASM NEWS, V69, P558; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Vonkavaara M, 2008, CELL MICROBIOL, V10, P1327, DOI 10.1111/j.1462-5822.2008.01129.x; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015	48	49	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11025	10.1371/journal.pone.0011025	http://dx.doi.org/10.1371/journal.pone.0011025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552012	Green Published, Green Submitted, gold			2022-12-25	WOS:000278662900008
J	Farnsworth, A; Flaman, AS; Prasad, SS; Gravel, C; Williams, A; Yauk, CL; Li, XG				Farnsworth, Aaron; Flaman, Anathea S.; Prasad, Shiv S.; Gravel, Caroline; Williams, Andrew; Yauk, Carole L.; Li, Xuguang			Acetaminophen Modulates the Transcriptional Response to Recombinant Interferon-beta	PLOS ONE			English	Article							NF-KAPPA-B; C-MYC EXPRESSION; GENE-EXPRESSION; LIVER-INJURY; ALPHA; ACTIVATION; INHIBITION; ASPIRIN; HEPATOTOXICITY; PARACETAMOL	Background: Recombinant interferon treatment can result in several common side effects including fever and injection-site pain. Patients are often advised to use acetaminophen or other over-the-counter pain medications as needed. Little is known regarding the transcriptional changes induced by such co-administration. Methodology/Principal Findings: We tested whether the administration of acetaminophen causes a change in the response normally induced by interferon-beta treatment. CD-1 mice were administered acetaminophen (APAP), interferon-beta (IFN-beta) or a combination of IFN-beta+APAP and liver and serum samples were collected for analysis. Differential gene expression was determined using an Agilent 22 k whole mouse genome microarray. Data were analyzed by several methods including Gene Ontology term clustering and Gene Set Enrichment Analysis. We observed a significant change in the transcription profile of hepatic cells when APAP was co-administered with IFN-beta. These transcriptional changes included a marked up-regulation of genes involved in signal transduction and cell differentiation and down-regulation of genes involved in cellular metabolism, trafficking and the I kappa BK/NF-kappa B cascade. Additionally, we observed a large decrease in the expression of several IFN-induced genes including Ifit-3, Isg-15, Oasl1, Zbp1 and predicted gene EG634650 at both early and late time points. Conclusions/Significance: A significant change in the transcriptional response was observed following co-administration of IFN-beta+APAP relative to IFN-beta treatment alone. These results suggest that administration of acetaminophen has the potential to modify the efficacy of IFN-beta treatment.	[Farnsworth, Aaron; Flaman, Anathea S.; Prasad, Shiv S.; Gravel, Caroline; Li, Xuguang] Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada; [Williams, Andrew; Yauk, Carole L.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada	Health Canada; Health Canada	Farnsworth, A (corresponding author), Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada.	Aaron_Farnsworth@hc-sc.gc.ca		Williams, Andrew/0000-0002-7637-7686; Yauk, Carole/0000-0002-6725-3454; Yauk, Carole/0000-0003-4919-876X	Health Canada (Canadian Regulatory Strategy for Biotechnology)	Health Canada (Canadian Regulatory Strategy for Biotechnology)	This work was funded by Health Canada (www.hc-sc.gc.ca/) (Canadian Regulatory Strategy for Biotechnology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 1999, J INTERF CYTOK RES, V19, P487, DOI 10.1089/107999099313938; Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; BEIERSCHMITT WP, 1989, TOXICOL APPL PHARM, V98, P517, DOI 10.1016/0041-008X(89)90180-4; Bekisz J, 2004, GROWTH FACTORS, V22, P243, DOI 10.1080/08977190400000833; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulares HA, 1999, TOXICOL SCI, V48, P264, DOI 10.1093/toxsci/48.2.264; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chernesky M, 1993, Clin Diagn Virol, V1, P129, DOI 10.1016/0928-0197(93)90021-V; Crocker JFS, 1998, CLIN INVEST MED, V21, P192; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EVANS LM, 1991, J IMMUNOTHER, V10, P39, DOI 10.1097/00002371-199102000-00006; Girouard Nathalie, 2008, Can J Neurosci Nurs, V30, P18; GRAHAM NMH, 1990, J INFECT DIS, V162, P1277, DOI 10.1093/infdis/162.6.1277; HENDRIX CW, 1995, ANTIVIR RES, V28, P121, DOI 10.1016/0166-3542(95)00043-L; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; KALABIS GM, 1990, J PHARMACOL EXP THER, V255, P1408; Kauffman MA, 2009, INT J CLIN PHARM TH, V47, P328; KELLOKUMPULEHTINEN P, 1989, LANCET, V1, P1143; Kerr MK, 2003, BIOMETRICS, V59, P822; Kerr MK, 2001, GENET RES, V77, P123; Liang YL, 2005, BIOINFORMATICS, V21, P3009, DOI 10.1093/bioinformatics/bti465; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Marques J, 2008, J GEN VIROL, V89, P2767, DOI 10.1099/vir.0.2008/003558-0; Martin-Saavedra FM, 2008, MOL IMMUNOL, V45, P4008, DOI 10.1016/j.molimm.2008.06.006; MILANESE C, 1990, J NEUROL NEUROSUR PS, V53, P554, DOI 10.1136/jnnp.53.7.554; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; OZAKI Y, 1987, BIOCHEM BIOPH RES CO, V144, P1147, DOI 10.1016/0006-291X(87)91431-8; Pappas DJ, 2009, PHYSIOL GENOMICS, V38, P362, DOI 10.1152/physiolgenomics.00058.2009; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; ROMERIL KR, 1989, NEW ZEAL MED J, V102, P186; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Schlee M, 2007, INT J CANCER, V120, P1387, DOI 10.1002/ijc.22372; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAKAOKI M, 1988, J INTERFERON RES, V8, P727, DOI 10.1089/jir.1988.8.727; Team RDC, 2005, R LANG ENV STAT COMP; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Tulley PN, 2004, BRIT J OPHTHALMOL, V88, P1563, DOI 10.1136/bjo.2003.033498; VISCO G, 1991, LANCET, V337, P741, DOI 10.1016/0140-6736(91)90333-K; Wang RP, 2008, MOL IMMUNOL, V45, P1926, DOI 10.1016/j.molimm.2007.10.034; Williams DP, 2004, CHEM RES TOXICOL, V17, P1551, DOI 10.1021/tx049846x; WITTER FR, 1988, CLIN PHARMACOL THER, V44, P239, DOI 10.1038/clpt.1988.143; Wu CF, 2003, BIOSENS BIOELECTRON, V19, P1, DOI 10.1016/S0956-5663(03)00118-0; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Yamaura K, 2002, BIOL PHARM BULL, V25, P201, DOI 10.1248/bpb.25.201; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuan TTT, 2001, GENE, V278, P41, DOI 10.1016/S0378-1119(01)00709-0; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	55	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11031	10.1371/journal.pone.0011031	http://dx.doi.org/10.1371/journal.pone.0011031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20544007	Green Published, gold, Green Submitted			2022-12-25	WOS:000278557600010
J	Huang, T; Shi, XH; Wang, P; He, ZS; Feng, KY; Hu, LL; Kong, XY; Li, YX; Cai, YD; Chou, KC				Huang, Tao; shi, Xiao-He; Wang, Ping; He, Zhisong; Feng, Kai-Yan; Hu, Lele; Kong, Xiangyin; Li, Yi-Xue; Cai, Yu-Dong; Chou, Kuo-Chen			Analysis and Prediction of the Metabolic Stability of Proteins Based on Their Sequential Features, Subcellular Locations and Interaction Networks	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; INFLUENZA-A VIRUS; FREQUENCY VIBRATIONS PHONONS; M2 PROTON CHANNEL; BIOLOGICAL FUNCTIONS; STRUCTURAL CLASSES; ALLOSTERIC TRANSITION; SECONDARY STRUCTURE; COLLECTIVE MOTION; BINDING MECHANISM	The metabolic stability is a very important idiosyncracy of proteins that is related to their global flexibility, intramolecular fluctuations, various internal dynamic processes, as well as many marvelous biological functions. Determination of protein's metabolic stability would provide us with useful information for in-depth understanding of the dynamic action mechanisms of proteins. Although several experimental methods have been developed to measure protein's metabolic stability, they are time-consuming and more expensive. Reported in this paper is a computational method, which is featured by (1) integrating various properties of proteins, such as biochemical and physicochemical properties, subcellular locations, network properties and protein complex property, (2) using the mRMR (Maximum Relevance & Minimum Redundancy) principle and the IFS (Incremental Feature Selection) procedure to optimize the prediction engine, and (3) being able to identify proteins among the four types: "short'', "medium'', "long'', and "extra-long'' half-life spans. It was revealed through our analysis that the following seven characters played major roles in determining the stability of proteins: (1) KEGG enrichment scores of the protein and its neighbors in network, (2) subcellular locations, (3) polarity, (4) amino acids composition, (5) hydrophobicity, (6) secondary structure propensity, and (7) the number of protein complexes the protein involved. It was observed that there was an intriguing correlation between the predicted metabolic stability of some proteins and the real half-life of the drugs designed to target them. These findings might provide useful insights for designing protein-stability-relevant drugs. The computational method can also be used as a large-scale tool for annotating the metabolic stability for the avalanche of protein sequences generated in the post-genomic age.	[Huang, Tao; Li, Yi-Xue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao; Feng, Kai-Yan; Li, Yi-Xue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [shi, Xiao-He; Wang, Ping; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [shi, Xiao-He; Wang, Ping; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [He, Zhisong] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Jiao Tong University; Fudan University	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; yxli@sibs.ac.cn; cai_yud@yahoo.com.cn; kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National High Technology Research and Development Program of China [2006AA02A301]; National Basic Research Program of China [2007CB512202]; Chinese Academy of Sciences [KSCX1-YW-R-74, KSCX2-YW-R-112]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National High Technology Research and Development Program of China (2006AA02A301), the National Basic Research Program of China (No. 2007CB512202), the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX1-YW-R-74) and Key Research Program (CAS) (KSCX2-YW-R-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; CHOU KC, 1984, BIOPHYS CHEM, V20, P61, DOI 10.1016/0301-4622(84)80005-8; CHOU KC, 1987, BIOPOLYMERS, V26, P285, DOI 10.1002/bip.360260209; CHOU KC, 1992, EUR J BIOCHEM, V207, P429, DOI 10.1111/j.1432-1033.1992.tb17067.x; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; CHOU KC, 1989, TRENDS BIOCHEM SCI, V14, P212, DOI 10.1016/0968-0004(89)90026-1; Chou KC, 2003, BIOCHEM BIOPH RES CO, V311, P743, DOI 10.1016/j.bbrc.2003.10.062; CHOU KC, 1992, PROTEIN SCI, V1, P810, DOI 10.1002/pro.5560010613; CHOU KC, 1988, BIOPOLYMERS, V27, P1795, DOI 10.1002/bip.360271109; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1994, J BIOL CHEM, V269, P22014; CHOU KC, 1977, SCI SINICA, V20, P447; CHOU KC, 1994, BIOPOLYMERS, V34, P143, DOI 10.1002/bip.360340114; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Cristian L, 2003, PROTEIN SCI, V12, P1732, DOI 10.1110/ps.0378603; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Du QS, 2009, J THEOR BIOL, V259, P159, DOI 10.1016/j.jtbi.2009.03.003; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Gong K, 2009, MED CHEM, V5, P242, DOI 10.2174/157340609788185936; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kamerzell TJ, 2008, J PHARM SCI-US, V97, P3494, DOI 10.1002/jps.21269; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Li L, 2007, BIOCHEM BIOPH RES CO, V358, P1102, DOI 10.1016/j.bbrc.2007.05.053; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lumry R, 2002, BIOPHYS CHEM, V101, P81, DOI 10.1016/S0301-4622(02)00156-4; Madkan A., 2009, NAT SCI, V1, P157, DOI [10.4236/ns.2009.13020, DOI 10.4236/NS.2009.13020]; MARTEL P, 1992, PROG BIOPHYS MOL BIO, V57, P129, DOI 10.1016/0079-6107(92)90023-Y; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Niu B, 2009, MOL DIVERS, V13, P313, DOI 10.1007/s11030-009-9116-1; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Shen H.-B., 2009, J BIOMED SCI ENG, V2, DOI DOI 10.4236/JBISE.2009.23024; Shen H.B., 2009, OPEN BIOINFORM J, V3, P31, DOI DOI 10.2174/1875036200903010031; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang JF, 2009, MED CHEM, V5, P263, DOI 10.2174/157340609788185954; Wang JF, 2009, PROTEIN ENG DES SEL, V22, P349, DOI 10.1093/protein/gzp012; Wang JF, 2009, CURR MED CHEM, V16, P232, DOI 10.2174/092986709787002727; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wei H, 2009, MED CHEM, V5, P305, DOI 10.2174/157340609788681430; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang TL, 2008, J THEOR BIOL, V250, P186, DOI 10.1016/j.jtbi.2007.09.014	72	158	161	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10972	10.1371/journal.pone.0010972	http://dx.doi.org/10.1371/journal.pone.0010972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532046	Green Published, gold			2022-12-25	WOS:000278380500016
J	Lucas, DM; Alinari, L; West, DA; Davis, ME; Edwards, RB; Johnson, AJ; Blum, KA; Hofmeister, CC; Freitas, MA; Parthun, MR; Wang, DS; Lehman, A; Zhang, XL; Jarjoura, D; Kulp, SK; Croce, CM; Grever, MR; Chen, CS; Baiocchi, RA; Byrd, JC				Lucas, David M.; Alinari, Lapo; West, Derek A.; Davis, Melanie E.; Edwards, Ryan B.; Johnson, Amy J.; Blum, Kristie A.; Hofmeister, Craig C.; Freitas, Michael A.; Parthun, Mark R.; Wang, Dasheng; Lehman, Amy; Zhang, Xiaoli; Jarjoura, David; Kulp, Samuel K.; Croce, Carlo M.; Grever, Michael R.; Chen, Ching-Shih; Baiocchi, Robert A.; Byrd, John C.			The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE; DEPSIPEPTIDE FR901228; APOPTOSIS; MOUSE; ACTIVATION; LYMPHOMA; SURVIVAL; LINES	Background: While deacetylase (DAC) inhibitors show promise for the treatment of B-cell malignancies, those introduced to date are weak inhibitors of class I and II DACs or potent inhibitors of class I DAC only, and have shown suboptimal activity or unacceptable toxicities. We therefore investigated the novel DAC inhibitor AR-42 to determine its efficacy in B-cell malignancies. Principal Findings: In mantle cell lymphoma (JeKo-1), Burkitt's lymphoma (Raji), and acute lymphoblastic leukemia (697) cell lines, the 48-hr IC50 (50% growth inhibitory concentration) of AR-42 is 0.61 mu M or less. In chronic lymphocytic leukemia (CLL) patient cells, the 48-hr LC50 (concentration lethal to 50%) of AR-42 is 0.76 mu M. AR-42 produces dose-and time-dependent acetylation both of histones and tubulin, and induces caspase-dependent apoptosis that is not reduced in the presence of stromal cells. AR-42 also sensitizes CLL cells to TNF-Related Apoptosis Inducing Ligand (TRAIL), potentially through reduction of c-FLIP. AR-42 significantly reduced leukocyte counts and/or prolonged survival in three separate mouse models of B-cell malignancy without evidence of toxicity. Conclusions/Significance: Together, these data demonstrate that AR-42 has in vitro and in vivo efficacy at tolerable doses. These results strongly support upcoming phase I testing of AR-42 in B-cell malignancies.	[Lucas, David M.; Alinari, Lapo; West, Derek A.; Davis, Melanie E.; Edwards, Ryan B.; Johnson, Amy J.; Blum, Kristie A.; Hofmeister, Craig C.; Grever, Michael R.; Baiocchi, Robert A.; Byrd, John C.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Freitas, Michael A.; Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Parthun, Mark R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Lucas, David M.; Wang, Dasheng; Kulp, Samuel K.; Grever, Michael R.; Chen, Ching-Shih; Byrd, John C.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Lehman, Amy; Zhang, Xiaoli; Jarjoura, David] Ohio State Univ, Ctr Biostat, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lucas, DM (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Young, Richard A/F-6495-2012; Johnson, Amy/A-5662-2009; Hofmeister, Craig/E-3256-2011; Freitas, Michael/C-8953-2009; Blum, Kristie/E-2768-2011; Lucas, David M/E-3555-2011; Hofmeister, Craig/O-4988-2019	Young, Richard A/0000-0001-8855-8647; Hofmeister, Craig/0000-0003-4816-1607; Freitas, Michael/0000-0002-3103-8410; Hofmeister, Craig/0000-0003-4816-1607	National Cancer Institute [P01 CA101956, P01 CA081534, P50 CA140158]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA140158, P01CA101956, R01CA107106, P01CA081534] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by the National Cancer Institute (P01 CA101956, P01 CA081534 and P50 CA140158) and a Specialized Center of Research grant from the Leukemia and Lymphoma Society (www.lls.org). Laboratory support was also provided by the V Foundation (www.jimmyv.org), the D. Warren Brown Foundation, and the Lymphoma Research Foundation (Mantle Cell Lymphoma Initiative) (www.lymphoma.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Aron JL, 2003, BLOOD, V102, P652, DOI 10.1182/blood-2002-12-3794; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; BLUM KA, 2009, BR J HAEMATOL; Blum KA, 2009, BRIT J HAEMATOL, V147, P507, DOI 10.1111/j.1365-2141.2009.07881.x; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; Byrd JC, 1999, BLOOD, V94, P1401, DOI 10.1182/blood.V94.4.1401.416k30_1401_1408; Byrd JC, 2007, BLOOD, V109, P399, DOI 10.1182/blood-2006-05-020735; CATTAN AR, 1994, LEUKEMIA RES, V18, P513, DOI 10.1016/0145-2126(94)90089-2; Dickinson M, 2009, BRIT J HAEMATOL, V147, P97, DOI 10.1111/j.1365-2141.2009.07837.x; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hernandez A, 2001, SURGERY, V130, P265, DOI 10.1067/msy.2001.115897; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Inoue H, 2002, INT J MOL MED, V9, P521; Inoue S, 2004, CELL DEATH DIFFER, V11, pS193, DOI 10.1038/sj.cdd.4401535; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; Jeon HJ, 1998, BRIT J HAEMATOL, V102, P1323, DOI 10.1046/j.1365-2141.1998.00911.x; Johnson AJ, 2006, BLOOD, V108, P1334, DOI 10.1182/blood-2005-12-011213; Kawada J, 2009, J BIOL CHEM, V284, P17102, DOI 10.1074/jbc.M809090200; KIRSCHBAUM M, 2008, BLOOD, V112, pA1564; Kisseberth WC, 2008, AM J VET RES, V69, P938, DOI 10.2460/ajvr.69.7.938; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kulp SK, 2006, CLIN CANCER RES, V12, P5199, DOI 10.1158/1078-0432.CCR-06-0429; Kummar S, 2007, CLIN CANCER RES, V13, P5411, DOI 10.1158/1078-0432.CCR-07-0791; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Lagneaux L, 2007, EXP HEMATOL, V35, P1527, DOI 10.1016/j.exphem.2007.06.014; Lee MJ, 2008, CURR OPIN ONCOL, V20, P639, DOI 10.1097/CCO.0b013e3283127095; LIN TY, BLOOD; LIU Q, 2010, CLIN CANC R IN PRESS; Lu Q, 2005, J MED CHEM, V48, P5530, DOI 10.1021/jm0503749; Lu Q, 2004, J MED CHEM, V47, P467, DOI 10.1021/jm0303655; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430; Lucas DM, 2004, LEUKEMIA, V18, P1207, DOI 10.1038/sj.leu.2403388; MacFarlane M, 2002, ONCOGENE, V21, P6809, DOI 10.1038/sj.onc.1205853; Medina V, 1997, CANCER RES, V57, P3697; Mitsiades N, 2003, BLOOD, V101, P4055, DOI 10.1182/blood-2002-11-3514; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Panayiotidis P, 1996, BRIT J HAEMATOL, V92, P97, DOI 10.1046/j.1365-2141.1996.00305.x; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Sargeant AM, 2008, CANCER RES, V68, P3999, DOI 10.1158/0008-5472.CAN-08-0203; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; TANAKA T, 1993, J EXP MED, V178, P1103, DOI 10.1084/jem.178.3.1103; Wu QL, 2009, J IMMUNOL, V182, P6771, DOI 10.4049/jimmunol.0801847; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOUNES A, 2007, BLOOD, V118, pA2571; Younes A, 2007, BLOOD, V110, p756A; Zelenetz AD, 2006, ANN ONCOL, V17, P12, DOI 10.1093/annonc/mdj992	58	46	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10941	10.1371/journal.pone.0010941	http://dx.doi.org/10.1371/journal.pone.0010941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532179	gold, Green Submitted, Green Published			2022-12-25	WOS:000278318700013
J	Mancini, G; D'Annessa, I; Coletta, A; Sanna, N; Chillemi, G; Desideri, A				Mancini, Giordano; D'Annessa, Ilda; Coletta, Andrea; Sanna, Nico; Chillemi, Giovanni; Desideri, Alessandro			Structural and Dynamical Effects Induced by the Anticancer Drug Topotecan on the Human Topoisomerase I - DNA Complex	PLOS ONE			English	Article							DOMAIN	Background: Human topoisomerase I catalyzes the relaxation of DNA supercoils in fundamental cell processes like transcription, replication and chromosomal segregation. It is the only target of the camptothecin family of anticancer drugs. Among these, topotecan has been used to treat lung and ovarian carcinoma for several years. Camptothecins reversibly binds to the covalent intermediate DNA-enzyme, stabilizing the cleavable complex and reducing the religation rate. The stalled complex then collides with the progression of the replication fork, producing lethal double strand DNA breaks and eventually cell death. Methodology/Principal Findings: Long lasting molecular dynamics simulations of the DNA-topoisomerase I binary complex and of the DNA-topoisomerase-topotecan ternary complex have been performed and compared. The conformational space sampled by the binary complex is reduced by the presence of the drug, as observed by principal component and cluster analyses. This conformational restraint is mainly due to the reduced flexibility of residues 633-643 (the region connecting the linker to the core domain) that causes an overall mobility loss in the ternary complex linker domain. During the simulation, DNA/drug stacking interactions are fully maintained, and hydrogen bonds are maintained with the enzyme. Topotecan keeps the catalytic residue Lys532 far from the DNA, making it unable to participate to the religation reaction. Arg364 is observed to interact with both the B and E rings of topotecan with two stable direct hydrogen bonds. An interesting constrain exerted by the protein on the geometrical arrangement of topotecan is also observed. Conclusions/Significance: Atomistic-scale understanding of topotecan interactions with the DNA-enzyme complex is fundamental to the explaining of its poisonous effect and of the drug resistance observed in several single residue topoisomerase mutants. We observed significant alterations due to topotecan in both short-range interactions and long-range protein domain communications.	[Mancini, Giordano; D'Annessa, Ilda; Sanna, Nico; Chillemi, Giovanni] CASPUR Interuniv Consortium Applicat Super Comp U, Rome, Italy; [D'Annessa, Ilda; Coletta, Andrea; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [D'Annessa, Ilda; Coletta, Andrea; Desideri, Alessandro] Univ Roma Tor Vergata, Ctr Bioinformat & Biostat, Rome, Italy	CINECA, Italy; University of Rome Tor Vergata; University of Rome Tor Vergata	Mancini, G (corresponding author), CASPUR Interuniv Consortium Applicat Super Comp U, Rome, Italy.	g.chillemi@caspur.it; desideri@uniroma2.it	Chillemi, Giovanni/E-5201-2010; Chillemi, Giovanni/O-2825-2019; Sanna, Nico/AAB-7170-2020; SANNA, Nico/R-8799-2016; Coletta, Andrea/GXF-2972-2022; Coletta, Andrea/H-9856-2012	Chillemi, Giovanni/0000-0003-3901-6926; Chillemi, Giovanni/0000-0003-3901-6926; Sanna, Nico/0000-0002-1947-7939; SANNA, Nico/0000-0002-1947-7939; Coletta, Andrea/0000-0003-4032-394X; D'Annessa, Ilda/0000-0002-6174-6899; desideri, alessandro/0000-0003-1541-4217	AIRC (Associazione Italiana Ricerca Cancro); CASPUR Supercomputing Consortium	AIRC (Associazione Italiana Ricerca Cancro)(Fondazione AIRC per la ricerca sul cancro); CASPUR Supercomputing Consortium	This work was partly supported by the grant to AD from AIRC (Associazione Italiana Ricerca Cancro) "Characterization of human topoisomerase mutants resistant to camptothecin and its derivatives". The authors acknowledge CASPUR Supercomputing Consortium for computational resources (Standard HPC grant 2009 "Studio dell'interazione topoisomerasi I-droghe antitumorali attraverso dinamica molecolare classica e calcoli ab-initio") and for financing a PhD grant to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BENEDETTI P, 1993, CANCER RES, V53, P4343; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; Chillemi G, 2005, NUCLEIC ACIDS RES, V33, P3339, DOI 10.1093/nar/gki642; Chillemi G, 2004, BIOPHYS J, V87, P4087, DOI 10.1529/biophysj.104.044925; CHILLEMI G, 2009, THEOR CHEM IN PRESS; Chillemi G, 2008, NUCLEIC ACIDS RES, V36, P5645, DOI 10.1093/nar/gkn558; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fiorani P, 1999, MOL PHARMACOL, V56, P1105, DOI 10.1124/mol.56.6.1105; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Fiorani P, 2009, NUCLEIC ACIDS RES, V37, P6849, DOI 10.1093/nar/gkp669; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Interthal H, 2004, J BIOL CHEM, V279, P2984, DOI 10.1074/jbc.M309959200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 2002, J BIOL CHEM, V277, P5711, DOI 10.1074/jbc.C100681200; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POMMIER Y, 1998, BIOCH BIOPHYS ACTA G, V1, P83; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; Sanna N, 2005, J AM CHEM SOC, V127, P15429, DOI 10.1021/ja052637u; Sanna N, 2009, J PHYS CHEM B, V113, P5369, DOI 10.1021/jp809801y; Siu FM, 2008, J AM CHEM SOC, V130, P17928, DOI 10.1021/ja806934y; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; Szklarczyk O, 2009, PROTEINS, V77, P420, DOI 10.1002/prot.22450; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; GRACE	45	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10934	10.1371/journal.pone.0010934	http://dx.doi.org/10.1371/journal.pone.0010934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532182	Green Published, Green Submitted, gold			2022-12-25	WOS:000278318700008
J	Wildschut, ED; de Hoog, M; Ahsman, MJ; Tibboel, D; Osterhaus, ADME; Fraaij, PLA				Wildschut, Enno D.; de Hoog, Matthijs; Ahsman, Maurice J.; Tibboel, Dick; Osterhaus, Albert D. M. E.; Fraaij, Pieter L. A.			Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation Support	PLOS ONE			English	Article							2009 INFLUENZA A(H1N1); PRODRUG OSELTAMIVIR; A H1N1; PHARMACOKINETICS	Introduction: To evaluate the effect of extracorporeal membrane oxygenation (ECMO) support on pharmacokinetics of oseltamivir and oseltamivir carboxylate (OC) in children. Methodology: Steady state 0-12 hour pharmacokinetic sampling was performed in new influenza A (H1N1) infected children treated with oseltamivir while on ECMO support. Cmax, Cmin and AUC(0-12) (h) were calculated. The age-specific oseltamivir dosage was doubled to counter expected decreased plasma drug concentrations due to increased volume of distribution on ECMO support. Principal Findings: Three patients were enrolled aged 15, 6 and 14 years in this pharmacokinetic case series. For two children the OC plasma concentrations were higher than those found in children and adults not on ECMO. These increased plasma concentrations related to the increased oseltamivir dosage and decreased kidney function. In one patient suboptimal plasma concentrations coincided with a decreased gastric motility. Conclusion: Oseltamivir pharmacokinetics do not appear to be significantly influenced by ECMO support. Caution is required in case of nasogastric administration and decreased gastric motility. Due to the limited number of (paediatric) patients available further multicenter studies are warranted.	[Wildschut, Enno D.; de Hoog, Matthijs; Tibboel, Dick; Fraaij, Pieter L. A.] Erasmus MC Sophia Childrens Hosp, Dept Paediat Surg, Rotterdam, Netherlands; [de Hoog, Matthijs] Erasmus MC Sophia Childrens Hosp, Dept Paediat, Rotterdam, Netherlands; [Ahsman, Maurice J.] Erasmus MC, Dept Hosp Pharm, Clin Pharmacol Unit, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.; Fraaij, Pieter L. A.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Wildschut, ED (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Paediat Surg, Rotterdam, Netherlands.	p.fraaij@erasmusmc.nl	Fraaij, Pieter/AAU-9783-2021; de Hoog, Matthijs/A-3882-2013	Osterhaus, Albert/0000-0002-6074-1172; Ahsman, Maurice/0000-0002-6084-2571	Viroclinics Biosciences BV	Viroclinics Biosciences BV	The study was funded by Viroclinics Biosciences BV through partime employment of Ab Osterhaus. Viroclinics Biosciences BV allows the manuscript, upon publication, as well as any accompanying materials, to be freely distributed, subject only to the condition of appropriate citation in any copies or derivative works. Ab Osterhaus (employed by Viroclinics Biosciences BV) was involved in manuscript preparation.	[Anonymous], 2009, PAND H1N1 2009 UPD 7; Ariano RE, 2010, CAN MED ASSOC J, V182, P357, DOI 10.1503/cmaj.092127; Buck ML, 2003, CLIN PHARMACOKINET, V42, P403, DOI 10.2165/00003088-200342050-00001; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Oo C, 2003, EUR J CLIN PHARMACOL, V59, P411, DOI 10.1007/s00228-003-0639-6; Oo C, 2001, Paediatr Drugs, V3, P229, DOI 10.2165/00128072-200103030-00005; Taylor WRJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003410; 2009, MMWR MORB MORTAL WKL, V58, P969	11	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10938	10.1371/journal.pone.0010938	http://dx.doi.org/10.1371/journal.pone.0010938			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532176	Green Published, Green Submitted, gold			2022-12-25	WOS:000278318700011
J	Unal, EB; Gursoy, A; Erman, B				Unal, E. Besray; Gursoy, Attila; Erman, Burak			VitAL: Viterbi Algorithm for de novo Peptide Design	PLOS ONE			English	Article							NETWORK-BASED PREDICTION; HIDDEN MARKOV-MODELS; GENETIC ALGORITHM; BINDING PEPTIDES; LIGAND; IDENTIFICATION; MOLECULES; DOCKING; COMPLEX; INTERACT	Background: Drug design against proteins to cure various diseases has been studied for several years. Numerous design techniques were discovered for small organic molecules for specific protein targets. The specificity, toxicity and selectivity of small molecules are hard problems to solve. The use of peptide drugs enables a partial solution to the toxicity problem. There has been a wide interest in peptide design, but the design techniques of a specific and selective peptide inhibitor against a protein target have not yet been established. Methodology/Principal Findings: A novel de novo peptide design approach is developed to block activities of disease related protein targets. No prior training, based on known peptides, is necessary. The method sequentially generates the peptide by docking its residues pair by pair along a chosen path on a protein. The binding site on the protein is determined via the coarse grained Gaussian Network Model. A binding path is determined. The best fitting peptide is constructed by generating all possible peptide pairs at each point along the path and determining the binding energies between these pairs and the specific location on the protein using AutoDock. The Markov based partition function for all possible choices of the peptides along the path is generated by a matrix multiplication scheme. The best fitting peptide for the given surface is obtained by a Hidden Markov model using Viterbi decoding. The suitability of the conformations of the peptides that result upon binding on the surface are included in the algorithm by considering the intrinsic Ramachandran potentials. Conclusions/Significance: The model is tested on known protein-peptide inhibitor complexes. The present algorithm predicts peptides that have better binding energies than those of the existing ones. Finally, a heptapeptide is designed for a protein that has excellent binding affinity according to AutoDock results.	[Unal, E. Besray; Gursoy, Attila; Erman, Burak] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey	Koc University	Unal, EB (corresponding author), Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey.	berman@ku.edu.tr	Gursoy, Attila/E-9565-2015; erman, burak/F-5900-2015; Gursoy, Attila/Z-4394-2019	Gursoy, Attila/0000-0002-2297-2113; erman, burak/0000-0002-2496-6059; Gursoy, Attila/0000-0002-2297-2113				Abe K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-451; *ACC INC, DS MOD 2 5; Ajay, 1998, J MED CHEM, V41, P3314, DOI 10.1021/jm970666c; [Anonymous], HYPERCHEM TM PROF 7; Belda I, 2005, J COMPUT AID MOL DES, V19, P585, DOI 10.1007/s10822-005-9015-1; Brusic V, 1998, BIOINFORMATICS, V14, P121, DOI 10.1093/bioinformatics/14.2.121; Budin N, 2001, COMB CHEM HIGH T SCR, V4, P661; Budin N, 2001, J COMPUT CHEM, V22, P1956, DOI 10.1002/jcc.1145; Budin N, 2001, BIOL CHEM, V382, P1365, DOI 10.1515/BC.2001.168; Bystroff Christopher, 2008, V413, P173; CHANDLER BE, 1995, SCH SYSTEM SPECIAL I, V2, P2; Ewens W.J., 2001, STAT METHODS BIOINFO; Fariselli P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S12; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; Fitzkee NC, 2005, PROTEINS, V58, P852, DOI 10.1002/prot.20394; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; FRENKEL D, 1995, J COMPUT AID MOL DES, V9, P213, DOI 10.1007/BF00124453; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Haack T, 1997, LETT PEPT SCI, V4, P377, DOI 10.1023/A:1008825727500; HALILOGLU T, 2010, PLOS COMPUTATI UNPUB; Haliloglu T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088103; Haliloglu T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228102; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HAMMER J, 1994, J EXP MED, V180, P2353, DOI 10.1084/jem.180.6.2353; HANAI T, 2000, GENOME INFORM, V11, P394; HARRISON LC, 1993, J LEUKOCYTE BIOL, P105; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Honeyman MC, 1998, NAT BIOTECHNOL, V16, P966, DOI 10.1038/nbt1098-966; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Juretic D, 2009, J CHEM INF MODEL, V49, P2873, DOI 10.1021/ci900327a; Kamphausen S, 2002, J COMPUT AID MOL DES, V16, P551, DOI 10.1023/A:1021928016359; Karplus PA, 1996, PROTEIN SCI, V5, P1406, DOI 10.1002/pro.5560050719; Kato R, 2003, ENZYME MICROB TECH, V33, P472, DOI 10.1016/S0141-0229(03)00150-9; Keskin O, 2004, PROTEINS, V55, P992, DOI 10.1002/prot.20100; Klepeis JL, 2004, IND ENG CHEM RES, V43, P3817, DOI 10.1021/ie0340995; KUMAR J, 2009, CRYSTAL STRUCTURE CO; Lin-Su Karen, 2002, Rev Endocr Metab Disord, V3, P313, DOI 10.1023/A:1020949507265; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Louis JM, 1998, BIOCHEMISTRY-US, V37, P2105, DOI 10.1021/bi972059x; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Moreau V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-71; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nam KH, 2009, BIOCHEM BIOPH RES CO, V381, P630, DOI 10.1016/j.bbrc.2009.02.113; Noguchi H, 2002, J BIOSCI BIOENG, V94, P264, DOI 10.1263/jbb.94.264; Noguchi H, 2001, J BIOSCI BIOENG, V92, P227, DOI 10.1263/jbb.92.227; OLDENBURG KR, 1992, P NATL ACAD SCI USA, V89, P5393, DOI 10.1073/pnas.89.12.5393; Pegg SCH, 2001, J COMPUT AID MOL DES, V15, P911, DOI 10.1023/A:1014389729000; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Riester D, 2005, P NATL ACAD SCI USA, V102, P8597, DOI 10.1073/pnas.0501983102; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Singh J, 1996, J AM CHEM SOC, V118, P1669, DOI 10.1021/ja953172i; Sonmez K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000258; SRAMEK R, 2009, LECT NOTES COMPUTER; Stein A, 2008, FEBS LETT, V582, P1245, DOI 10.1016/j.febslet.2008.02.020; Tuncbag N, 2009, MOL BIOSYST, V5, P1770, DOI [10.1039/b905661k, 10.1039/B905661K]; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Unal EB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036014; UNAL EB, 2010, 5 INT S HLTH INF BIO; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Zhang HF, 2001, J SUPERCRIT FLUID, V20, P65, DOI 10.1016/S0896-8446(01)00053-5	66	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10926	10.1371/journal.pone.0010926	http://dx.doi.org/10.1371/journal.pone.0010926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532195	Green Published, gold			2022-12-25	WOS:000278284700009
J	Bonilla, DL; Ly, LH; Fan, YY; Chapkin, RS; McMurray, DN				Bonilla, Diana L.; Ly, Lan H.; Fan, Yang-Yi; Chapkin, Robert S.; McMurray, David N.			Incorporation of a Dietary Omega 3 Fatty Acid Impairs Murine Macrophage Responses to Mycobacterium tuberculosis	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE PRODUCTION; CD4(+) T-CELLS; DOCOSAHEXAENOIC ACID; FISH-OIL; PHAGOSOME MATURATION; LISTERIA-MONOCYTOGENES; PULMONARY TUBERCULOSIS; EICOSAPENTAENOIC ACID	Background: Beside their health benefits, dietary omega 3 polyunsaturated fatty acids (n-3 PUFA) might impair host resistance to Mycobacterium tuberculosis (Mtb) by creating an immunosuppressive environment. We hypothesized that incorporation of n-3 PUFA suppresses activation of macrophage antimycobacterial responses and favors bacterial growth, in part, by modulating the IFN gamma-mediated signaling pathway. Methodology/Principal Findings: Murine macrophage-like J774A.1 cells were incubated with bovine serum albumin (BSA)-conjugated docosahexaenoic acid (DHA; 22:6n-3) or BSA alone, activated with recombinant IFN gamma, and infected with a virulent strain (H37Rv) of M. tuberculosis. The fatty acid composition of macrophage membranes was modified significantly by DHA treatment. DHA-treated macrophages were less effective in controlling intracellular mycobacteria and showed impaired oxidative metabolism and reduced phagolysosome maturation. Incorporation of DHA resulted in defective macrophage activation, as characterized by reduced production of pro-inflammatory cytokines (TNF alpha, IL-6 and MCP-1), and lower expression of co-stimulatory molecules (CD40 and CD86). DHA treatment impaired STAT1 phosphorylation and colocalization of the IFN gamma receptor with lipid rafts, without affecting surface expression of IFN gamma receptor. Conclusions/Significance: We conclude that DHA reduces the ability of J774A.1 cells to control M. tuberculosis in response to activation by IFN gamma, by modulation of IFN gamma receptor signaling and function, suggesting that n-3 PUFA-enriched diets may have a detrimental effect on host immunity to tuberculosis.	[Bonilla, Diana L.; Ly, Lan H.; McMurray, David N.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX USA; [Fan, Yang-Yi; Chapkin, Robert S.] Texas A&M Univ, Program Integrat Nutr & Complex Dis, College Stn, TX USA; [Fan, Yang-Yi; Chapkin, Robert S.; McMurray, David N.] Texas A&M Univ, Fac Nutr, College Stn, TX USA; [Chapkin, Robert S.; McMurray, David N.] Texas A&M Univ, Ctr Environm & Rural Hlth, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Bonilla, DL (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	bonilla@bcm.edu		Chapkin, Robert/0000-0002-6515-3898	National Institutes of Health [AI-15495, CA-129444, DK-071707, P30-ES09106]; NATIONAL CANCER INSTITUTE [R01CA129444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. Public Health Service Grant # AI-15495, CA-129444, DK-071707 and P30-ES09106 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Arrington JL, 2001, J NUTR, V131, P1147, DOI 10.1093/jn/131.4.1147; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; CALDER PC, 1990, BIOCHEM J, V269, P807, DOI 10.1042/bj2690807; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Changsen C, 2003, ANTIMICROB AGENTS CH, V47, P3682, DOI 10.1128/AAC.47.12.3682-3687.2003; Chapkin RS, 2008, CHEM PHYS LIPIDS, V153, P14, DOI 10.1016/j.chemphyslip.2008.02.011; Chapkin RS, 2008, BBA-BIOMEMBRANES, V1778, P466, DOI 10.1016/j.bbamem.2007.11.003; Chapkin RS, 2007, J NUTR, V137, p200S, DOI 10.1093/jn/137.1.200S; CHAPKIN RS, 1992, J NUTR BIOCHEM, V3, P599, DOI 10.1016/0955-2863(92)90054-M; CHAPKIN RS, 1991, J LIPID RES, V32, P1205; CHICUREL M, 1988, INFECT IMMUN, V56, P479, DOI 10.1128/IAI.56.2.479-483.1988; CINCO M, 1994, FEMS MICROBIOL LETT, V122, P187, DOI 10.1111/j.1574-6968.1994.tb07163.x; Cleland LG, 2003, DRUGS, V63, P845, DOI 10.2165/00003495-200363090-00001; CLOUVAMOLYVDAS P, 1992, JPEN-PARENTER ENTER, V16, P343, DOI 10.1177/0148607192016004343; Conquer JA, 1998, J LIPID RES, V39, P286; Courreges MC, 2001, NUTR RES, V21, P229, DOI 10.1016/S0271-5317(00)00260-8; Deretic V, 1997, ELECTROPHORESIS, V18, P2542, DOI 10.1002/elps.1150181409; Dewey A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004597.pub2; DIANA L, 2009, J INFECT DI IN PRESS; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Fan YY, 2003, CARCINOGENESIS, V24, P1541, DOI 10.1093/carcin/bgg110; Fan YY, 2004, J IMMUNOL, V173, P6151, DOI 10.4049/jimmunol.173.10.6151; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOWLER KH, 1993, J IMMUNOL, V151, P5186; Fritsche KL, 1997, CLIN SCI, V92, P95, DOI 10.1042/cs0920095; FUKUDA M, 1990, SEIKAGAKU, V62, P1225; GROVER AA, 1967, J BACTERIOL, V94, P832, DOI 10.1128/JB.94.4.832-835.1967; Hughes DA, 1997, CLIN EXP IMMUNOL, V110, P516, DOI 10.1046/j.1365-2249.1997.4351455.x; Irons R, 2005, J INFECT DIS, V191, P481, DOI 10.1086/427264; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; JORDAO L, 2008, MICROBES INFECT; KAPLAN GJ, 1972, AM REV RESPIR DIS, V105, P920; KhairElDin TA, 1996, AM J REPROD IMMUNOL, V36, P1; Kim W, 2008, J IMMUNOL, V181, P6236, DOI 10.4049/jimmunol.181.9.6236; Lasco TM, 2005, TUBERCULOSIS, V85, P245, DOI 10.1016/j.tube.2005.01.001; LESLIE CA, 1985, J EXP MED, V162, P1336, DOI 10.1084/jem.162.4.1336; Lu CY, 1998, J REPROD IMMUNOL, V38, P31, DOI 10.1016/S0165-0378(98)00005-9; Ly LH, 2005, CLIN EXP IMMUNOL, V139, P202, DOI 10.1111/j.1365-2249.2004.02685.x; Martens GW, 2008, INFECT IMMUN, V76, P3464, DOI 10.1128/IAI.00037-08; MAYATEPEK E, 1994, INFECTION, V22, P106, DOI 10.1007/BF01739016; Farland CT, 2008, J NUTR, V138, P2123, DOI 10.3945/jn.108.093740; McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8; MCMURRAY DN, 1989, INFECT IMMUN, V57, P1746, DOI 10.1128/IAI.57.6.1746-1749.1989; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Ng Y, 2005, CARCINOGENESIS, V26, P1914, DOI 10.1093/carcin/bgi163; Oarada M, 2003, BBA-GEN SUBJECTS, V1622, P151, DOI 10.1016/S0304-4165(03)00136-3; Paul KP, 1997, METABOLISM, V46, P619, DOI 10.1016/S0026-0495(97)90003-2; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Raza Shaikh S., 2007, Journal of Lipid Research, V48, P127, DOI 10.1194/jlr.M600365-JLR200; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Sawant KV, 2007, INFECT IMMUN, V75, P1870, DOI 10.1128/IAI.00858-06; SCHMIDT EB, 1992, SCAND J CLIN LAB INV, V52, P229, DOI 10.3109/00365519209088790; SHICHIRI G, 1993, ARCH BIOCHEM BIOPHYS, V303, P231, DOI 10.1006/abbi.1993.1277; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Switzer KC, 2004, J LIPID RES, V45, P1482, DOI 10.1194/jlr.M400028-JLR200; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Via LE, 1998, J CELL SCI, V111, P897; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Weldon SM, 2007, J NUTR BIOCHEM, V18, P250, DOI 10.1016/j.jnutbio.2006.04.003; Wiesenfeld PW, 2001, COMP BIOCHEM PHYS B, V128, P123, DOI 10.1016/S1096-4959(00)00305-5	65	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10878	10.1371/journal.pone.0010878	http://dx.doi.org/10.1371/journal.pone.0010878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526363	Green Published, gold, Green Submitted			2022-12-25	WOS:000278222100009
J	Fogal, B; McClaskey, C; Yan, S; Yan, HL; Rivkees, SA				Fogal, Birgit; McClaskey, Carolyn; Yan, Sha; Yan, Henglin; Rivkees, Scott A.			Diazoxide Promotes Oligodendrocyte Precursor Cell Proliferation and Myelination	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; WHITE-MATTER; ADENOSINE RECEPTORS; CHANNEL EXPRESSION; PROGENITOR; HYPOXIA; INFANTS; P27; MODULATION; REDUCTION	Background: Several clinical conditions are associated with white matter injury, including periventricular white matter injury (PWMI), which is a form of brain injury sustained by preterm infants. It has been suggested that white matter injury in this condition is due to altered oligodendrocyte (OL) development or death, resulting in OL loss and hypomyelination. At present drugs are not available that stimulate OL proliferation and promote myelination. Evidence suggests that depolarizing stimuli reduces OL proliferation and differentiation, whereas agents that hyperpolarize OLs stimulate OL proliferation and differentiation. Considering that the drug diazoxide activates K-ATP channels to hyperpolarize cells, we tested if this compound could influence OL proliferation and myelination. Methodology/Findings: Studies were performed using rat oligodendrocyte precursor cell (OPC) cultures, cerebellar slice cultures, and an in vivo model of PWMI in which newborn mice were exposed to chronic sublethal hypoxia (10% O-2). We found that K-ATP channel components Kir 6.1 and 6.2 and SUR2 were expressed in oligodendrocytes. Additionally, diazoxide potently stimulated OPC proliferation, as did other K-ATP activators. Diazoxide also stimulated myelination in cerebellar slice cultures. We also found that diazoxide prevented hypomyelination and ventriculomegaly following chronic sublethal hypoxia. Conclusions: These results identify KATP channel components in OLs and show that diazoxide can stimulate OL proliferation in vitro. Importantly we find that diazoxide can promote myelination in vivo and prevent hypoxia-induced PWMI.	[Fogal, Birgit; McClaskey, Carolyn; Yan, Sha; Yan, Henglin; Rivkees, Scott A.] Yale Univ, Sch Med, Dept Pediat, Sect Dev Biol & Endocrinol,Yale Child Hlth Res Ct, New Haven, CT 06510 USA	Yale University	Fogal, B (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Dev Biol & Endocrinol,Yale Child Hlth Res Ct, New Haven, CT 06510 USA.	scott.rivkees@yale.edu	Messier, Claude/A-2322-2008; McClaskey, Carolyn/AGH-4517-2022; McClaskey, Carolyn/ABE-8223-2021	Messier, Claude/0000-0002-4791-1763; McClaskey, Carolyn/0000-0002-0942-6281; McClaskey, Carolyn/0000-0002-0942-6281; Fogal, Birgit/0000-0002-1682-7729	Cerebral Palsy International Research Foundation; National Institutes of Health [1R43NS060188-01, 1R01NS068039]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS060188, R01NS068039] Funding Source: NIH RePORTER	Cerebral Palsy International Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a generous gift from Tony and Cynthia Petrello, the Cerebral Palsy International Research Foundation, and National Institutes of Health grants 1R43NS060188-01 and 1R01NS068039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi A, 2008, MOL PHARMACOL, V74, P736, DOI 10.1124/mol.108.048165; Akundi RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004739; ATWAL KS, 1994, J CARDIOVASC PHARM, V24, pS12, DOI 10.1097/00005344-199424014-00003; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 2000, J BIOL CHEM, V275, P717, DOI 10.1074/jbc.275.2.717; Back SA, 2006, ANN NEUROL, V60, P696, DOI 10.1002/ana.21008; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; Bodensteiner JB, 2006, J CHILD NEUROL, V21, P743, DOI 10.1177/08830738060210091101; Bolton S, 2006, EXP NEUROL, V202, P36, DOI 10.1016/j.expneurol.2006.05.009; Bouslama-Oueghlani L, 2003, J NEUROSCI, V23, P8318; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Desdouets C, 2000, PATHOL BIOL, V48, P203; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gipson K, 2002, J MEMBRANE BIOL, V189, P201, DOI 10.1007/s00232-002-1014-8; Gribble FM, 2002, BIOCHEM SOC T, V30, P333, DOI 10.1042/bst0300333; Groenendaal F, 1997, DEV MED CHILD NEUROL, V39, P373; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Kalsi AS, 2004, J ANAT, V204, P475, DOI 10.1111/j.0021-8782.2004.00288.x; KARSCHIN A, 1995, NEUROSCI LETT, V183, P135, DOI 10.1016/0304-3940(94)11133-4; Kinney H C, 1998, Semin Pediatr Neurol, V5, P180, DOI 10.1016/S1071-9091(98)80033-8; Kinney HC, 2005, J NEUROL SCI, V228, P190, DOI 10.1016/j.jns.2004.10.006; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Liu YG, 2001, MOL PHARMACOL, V59, P225, DOI 10.1124/mol.59.2.225; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Maysami S, 2006, NEUROREPORT, V17, P1187, DOI 10.1097/01.wnr.0000227985.92551.9a; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MCLAURIN J, 1995, NEUROL CLIN, V13, P23, DOI 10.1016/S0733-8619(18)30060-4; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Othman T, 2003, GLIA, V44, P166, DOI 10.1002/glia.10281; Pagano M, 2004, MOL CELL, V14, P414, DOI 10.1016/S1097-2765(04)00268-0; PAPPAS CA, 1994, NEUROREPORT, V6, P193, DOI 10.1097/00001756-199412300-00049; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rushing S, 2004, SEMIN PERINATOL, V28, P444, DOI 10.1053/j.semperi.2004.10.007; Simpson PB, 1998, J PHYSIOL-LONDON, V508, P413, DOI 10.1111/j.1469-7793.1998.413bq.x; Stange KC, 2006, ANN FAM MED, V4, P81, DOI 10.1370/afm.510; Tai KK, 2003, J NEUROCHEM, V84, P1193, DOI 10.1046/j.1471-4159.2003.01625.x; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; *US FDA, 2010, DIAZ; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Williamson AV, 1997, EUR J NEUROSCI, V9, P706, DOI 10.1111/j.1460-9568.1997.tb01419.x; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Yan HL, 2006, NEUROREPORT, V17, P55, DOI 10.1097/01.wnr.0000192733.00535.b6; Yan HL, 2002, J NEUROSCI RES, V69, P597, DOI 10.1002/jnr.10323; Ye P, 2002, J NEUROSCI, V22, P6041	54	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10906	10.1371/journal.pone.0010906	http://dx.doi.org/10.1371/journal.pone.0010906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531945	Green Submitted, gold, Green Published			2022-12-25	WOS:000278222100033
J	Mardaryev, AN; Ahmed, MI; Vlahov, NV; Fessing, MY; Gill, JH; Sharov, AA; Botchkareva, NV				Mardaryev, Andrei N.; Ahmed, Mohammed I.; Vlahov, Nikola V.; Fessing, Michael Y.; Gill, Jason H.; Sharov, Andrey A.; Botchkareva, Natalia V.			Micro-RNA-31 controls hair cycle-associated changes in gene expression programs of the skin and hair follicle	FASEB JOURNAL			English	Article							SMALL INTERFERING RNA; STEM-CELL ACTIVATION; COMPREHENSIVE GUIDE; GROWTH MODULATION; PROTEIN-SYNTHESIS; IN-VITRO; MICRORNA; MORPHOGENESIS; CLASSIFICATION; KERATINOCYTES	The hair follicle is a cyclic biological system that progresses through stages of growth, regression, and quiescence, which involves dynamic changes in a program of gene regulation. Micro-RNAs (miRNAs) are critically important for the control of gene expression and silencing. Here, we show that global miRNA expression in the skin markedly changes during distinct stages of the hair cycle in mice. Furthermore, we show that expression of miR-31 markedly increases during anagen and decreases during catagen and telogen. Administration of antisense miR-31 inhibitor into mouse skin during the early-and midanagen phases of the hair cycle results in accelerated anagen development, and altered differentiation of hair matrix keratinocytes and hair shaft formation. Microarray, qRT-PCR and Western blot analyses revealed that miR-31 negatively regulates expression of Fgf10, the components of Wnt and BMP signaling pathways Sclerostin and BAMBI, and Dlx3 transcription factor, as well as selected keratin genes, both in vitro and in vivo. Using luciferase reporter assay, we show that Krt16, Krt17, Dlx3, and Fgf10 serve as direct miR-31 targets. Thus, by targeting a number of growth regulatory molecules and cytoskeletal proteins, miR-31 is involved in establishing an optimal balance of gene expression in the hair follicle required for its proper growth and hair fiber formation.-Mardaryev, A. N., Ahmed, M. I., Vlahov, N. V., Fessing, M. Y., Gill, J. H., Sharov, A. A., and Botchkareva, N. V. Micro-RNA-31 controls hair cycle-associated changes in gene expression programs of the skin and hair follicle. FASEB J. 24, 3869-3881 (2010). www.fasebj.org	[Mardaryev, Andrei N.; Ahmed, Mohammed I.; Vlahov, Nikola V.; Fessing, Michael Y.; Botchkareva, Natalia V.] Univ Bradford, Ctr Skin Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Gill, Jason H.] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England; [Sharov, Andrey A.] Boston Univ, Dept Dermatol, Boston, MA 02215 USA	University of Bradford; University of Bradford; Boston University	Botchkareva, NV (corresponding author), Univ Bradford, Ctr Skin Sci, Sch Life Sci, Richmond Rd, Bradford BD7 1DP, W Yorkshire, England.	n.botchkareva@bradford.ac.uk	Ahmed, Mohammed/T-5898-2019; Mardaryev, Andrei/AAC-8944-2022; Ahmed, Mohammed/AAU-7535-2021	Mardaryev, Andrei/0000-0002-7826-5506; Ahmed, Mohammed/0000-0002-9051-7681; Gill, Jason/0000-0002-7564-7787; Fessing, Michael/0000-0002-3120-8707	Royal Society [2007/R2]; Wellcome Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR056771] Funding Source: NIH RePORTER	Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Royal Society (research grants 2007/R2 to N.V.B.) and the Wellcome Trust (vacation scholarship to N.V.V.). Prof. D. Tobin is acknowledged for his support and critical comments on the manuscript.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernot KM, 2002, J INVEST DERMATOL, V119, P1137, DOI 10.1046/j.1523-1747.2002.19518.x; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Botchkarev VA, 1999, J INVEST DERMATOL, V113, P878, DOI 10.1046/j.1523-1747.1999.00791.x; Botchkarev VA, 2003, J INVEST DERM SYMP P, V8, P46, DOI 10.1046/j.1523-1747.2003.12171.x; Botchkareva NV, 2000, AM J PATHOL, V156, P1041, DOI 10.1016/S0002-9440(10)64972-3; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fan W, 2003, EXP DERMATOL, V12, P832, DOI 10.1111/j.0906-6705.2003.00099.x; Fessing MY, 2006, AM J PATHOL, V169, P2075, DOI 10.2353/ajpath.2006.060227; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kurek D, 2007, DEVELOPMENT, V134, P261, DOI 10.1242/dev.02721; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lindner G, 1997, AM J PATHOL, V151, P1601; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Panteleyev AA, 1997, J INVEST DERMATOL, V108, P324, DOI 10.1111/1523-1747.ep12286476; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Peters EMJ, 2001, J INVEST DERMATOL, V116, P236, DOI 10.1046/j.1523-1747.2001.01232.x; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharov AA, 2006, P NATL ACAD SCI USA, V103, P18166, DOI 10.1073/pnas.0608899103; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Winkler DG, 2004, J BIOL CHEM, V279, P36293, DOI 10.1074/jbc.M400521200; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	64	125	142	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3869	3881		10.1096/fj.10-160663	http://dx.doi.org/10.1096/fj.10-160663			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20522784	Green Published			2022-12-25	WOS:000285005900025
J	Neumann, S; Geras-Raaka, E; Marcus-Samuels, B; Gershengorn, MC				Neumann, Susanne; Geras-Raaka, Elizabeth; Marcus-Samuels, Bernice; Gershengorn, Marvin C.			Persistent cAMP signaling by thyrotropin (TSH) receptors is not dependent on internalization	FASEB JOURNAL			English	Article						G-protein-coupled receptors; receptor-mediated endocytosis; sustained signaling; beta-arrestin-2; dynamin	HORMONE RECEPTOR; ENDOCYTOSIS; DYNAMIN; ALPHA	Evidence was presented that thyrotropin [thyroid-stimulating hormone (TSH)]-stimulated persistent cAMP signaling is dependent on receptor (with G-protein alpha subunits and adenylyl cyclase) internalization. Because it is not clear whether G proteins and adenylyl cyclase internalize with receptors, we tested whether persistent cAMP signaling by TSH receptor (TSHR) is dependent on internalization. We measured persistent TSHR signaling as an accumulation of cAMP in HEK-EM293 cells permanently expressing human TSHRs incubated with isobutylmethylxanthine for 30 min after washing the cells to remove unbound TSH, and TSHR internalization by fluorescence microscopy using Alexa-tagged TSH and binding assays using I-125-TSH. TSHRs, but not the closely related lutropin or follitropin receptors, exhibit persistent cAMP signaling. TSHRs were not internalized by 30 min incubation with unlabeled TSH; however, expression of beta-arrestin-2 promoted TSHR internalization that was inhibited by dynasore, a dynamin inhibitor. Expression of beta-arrestin-2 had no effect on TSHR cAMP signaling, dynasore inhibited TSHR cAMP signaling in the absence or presence of TSHR internalization, and expression of a dominant-negative mutant dynamin, which inhibited internalization, had no effect on persistent cAMP signaling. Persistent cAMP signaling was specifically inhibited by a small molecule TSHR antagonist. We conclude that TSHRs do not have to be internalized to exhibit persistent cAMP signaling.-Neumann, S., Geras-Raaka, E., Marcus-Samuels, B., Gershengorn, M. C. Persistent cAMP signaling by thyrotropin (TSH) receptors is not dependent on internalization. FASEB J. 24, 3992-3999 (2010). www.fasebj.org	[Neumann, Susanne; Geras-Raaka, Elizabeth; Marcus-Samuels, Bernice; Gershengorn, Marvin C.] NIDDK, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gershengorn, MC (corresponding author), NIDDK, Clin Endocrinol Branch, NIH, 50 South Dr, Bethesda, MD 20892 USA.	marving@intra.niddk.nih.gov			U.S. National Institutes of Health [1 Z01 DK011006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK011006, ZIADK011006] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the U.S. National Institutes of Health (1 Z01 DK011006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Frenzel R, 2006, ENDOCRINOLOGY, V147, P3114, DOI 10.1210/en.2005-0687; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; Jones BW, 2008, MOL PHARMACOL, V74, P195, DOI 10.1124/mol.108.045948; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Merlen C, 2006, FEBS LETT, V580, P5697, DOI 10.1016/j.febslet.2006.09.021; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; NEUMANN S, 2010, ENDOCRINOLOGY; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; Robbins J, 1978, Recent Prog Horm Res, V34, P477; Russell W, 2008, J CLIN ENDOCR METAB, V93, P2300, DOI 10.1210/jc.2007-2674; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	18	18	18	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3992	3999		10.1096/fj.10-161745	http://dx.doi.org/10.1096/fj.10-161745			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20538910	Green Published			2022-12-25	WOS:000285005900036
J	Winther, AML; Liu, HZ; Sonntag, Y; Olesen, C; le Maire, M; Soehoel, H; Olsen, CE; Christensen, SB; Nissen, P; Moller, JV				Winther, Anne-Marie L.; Liu, Huizhen; Sonntag, Yonathan; Olesen, Claus; le Maire, Marc; Soehoel, Helmer; Olsen, Carl-Erik; Christensen, S. Brogger; Nissen, Poul; Moller, Jesper V.			Critical Roles of Hydrophobicity and Orientation of Side Chains for Inactivation of Sarcoplasmic Reticulum Ca2+-ATPase with Thapsigargin and Thapsigargin Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ TRANSPORT ATPASE; CRYSTAL-STRUCTURE; CALCIUM-PUMP; KINETIC CHARACTERIZATION; CYCLOPIAZONIC ACID; INHIBITION; BINDING; CRYSTALLOGRAPHY; PERTURBATION; TOOL	Thapsigargin (Tg), a specific inhibitor of sarco/endoplasmic Ca2+-ATPases (SERCA), binds with high affinity to the E2 conformation of these ATPases. SERCA inhibition leads to elevated calcium levels in the cytoplasm, which in turn induces apoptosis. We present x-ray crystallographic and intrinsic fluorescence data to show how Tg and chemical analogs of the compound with modified or removed side chains bind to isolated SERCA 1a membranes. This occurs by uptake via the membrane lipid followed by insertion into a resident intramembranous binding site with few adaptative changes. Our binding data indicate that a balanced hydrophobicity and accurate positioning of the side chains, provided by the central guaianolide ring structure, defines a pharmacophore of Tg that governs both high affinity and access to the protein-binding site. Tg analogs substituted with long linkers at O-8 extend from the binding site between transmembrane segments to the putative N-terminal Ca2+ entry pathway. The long chain analogs provide a rational basis for the localization of the linker, the presence of which is necessary for enabling prostate-specific antigen to cleave peptide-conjugated prodrugs targeting SERCA of cancer cells (Denmeade, S. R., Jakobsen, C. M., Janssen, S., Khan, S. R., Garrett, E. S., Lilja, H., Christensen, S. B., and Isaacs, J. T. (2003) J. Natl. Cancer Inst. 95, 990-1000). Our study demonstrates the usefulness of a simple in vitro system to test and direct development toward the formulation of new Tg derivatives with improved properties for SERCA targeting. Finally, we propose that the Tg binding pocket may be a regulatory site that, for example, is sensitive to cholesterol.	[Winther, Anne-Marie L.; Sonntag, Yonathan; Olesen, Claus; Nissen, Poul; Moller, Jesper V.] Aarhus Univ, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; [Winther, Anne-Marie L.; Sonntag, Yonathan; Nissen, Poul] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Liu, Huizhen; Soehoel, Helmer; Christensen, S. Brogger] Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, DK-2100 Copenhagen O, Denmark; [Olesen, Claus; Moller, Jesper V.] Aarhus Univ, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark; [le Maire, Marc] Univ Paris Sud, SB2SM, Inst Biol & Technol Saclay, Commissariat Energie Atom, F-91191 Gif Sur Yvette, France; [le Maire, Marc] Univ Paris Sud, Lab Rech Associe 17V, F-91191 Gif Sur Yvette, France; [le Maire, Marc] CNRS, URA 2096, F-91191 Gif Sur Yvette, France; [Olsen, Carl-Erik] Univ Copenhagen, Fac Life Sci, Dept Nat Sci, DK-1780 Frederiksberg C, Denmark	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; University of Copenhagen; Aarhus University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen	Moller, JV (corresponding author), Aarhus Univ, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jvm@biophys.au.dk	Olsen, Carl E/H-3031-2014; Sonntag, Yonathan/GRF-4277-2022; Christensen, Søren Brøgger/H-4526-2019; Nissen, Poul/D-5774-2014	Olsen, Carl E/0000-0002-2275-0596; Sonntag, Yonathan/0000-0002-8063-0285; Christensen, Søren Brøgger/0000-0002-5773-6874; Olesen, Claus/0000-0002-0462-1686; Lund Winther, Anne-Marie/0000-0002-5776-0989; Nissen, Poul/0000-0003-0948-6628	Danish Medical Research Foundation; Danish Natural Science Foundation; Danish Cancer Society; Lundbeck Foundation; Aarhus University Research Foundation; Novo Nordisk Foundation; Carlsberg Foundation; Danish Research Council for Technical Sciences and Production; Faculty of Health Science, Aarhus University; Danish Research Council for Health Sciences; Commissariat a l'Energie Atomique; CNRS; ANR France	Danish Medical Research Foundation; Danish Natural Science Foundation(Danish Natural Science Research Council); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Aarhus University Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Danish Research Council for Technical Sciences and Production; Faculty of Health Science, Aarhus University; Danish Research Council for Health Sciences; Commissariat a l'Energie Atomique(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR France(French National Research Agency (ANR))	This work was supported in part by the Danish Medical Research Foundation, the Danish Natural Science Foundation (through the Dansync Program), the Danish Cancer Society, the Lundbeck Foundation, the Aarhus University Research Foundation, the Novo Nordisk Foundation, and the Carlsberg Foundation.; Recipient of a Ph.D. stipend through the Lundbeck Foundation and a postdoctoral fellowship from the Danish Research Council for Technical Sciences and Production.; Recipient of a Ph.D. stipend from the Faculty of Health Science, Aarhus University, and a postdoctoral fellowship from the Danish Research Council for Health Sciences.; Supported by Commissariat a l'Energie Atomique, CNRS, and ANR France.; Supported by a Hallas-Moller stipend from the Novo Nordisk Foundation.	ANDERSEN A, 1994, ACTA CHEM SCAND, V48, P340, DOI 10.3891/acta.chem.scand.48-0340; ANDERSEN JP, 1983, EUR J BIOCHEM, V134, P205, DOI 10.1111/j.1432-1033.1983.tb07552.x; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; Christensen SB, 2009, ANTI-CANCER AGENT ME, V9, P276, DOI 10.2174/1871520610909030276; CHRISTENSEN SB, 1985, J LABELLED COMPD RAD, V22, P71; Ciulli A, 2007, CURR OPIN BIOTECH, V18, P489, DOI 10.1016/j.copbio.2007.09.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEFORESTA B, 1992, EUR J BIOCHEM, V209, P1023, DOI 10.1111/j.1432-1033.1992.tb17378.x; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Denmeade SR, 1997, CANCER RES, V57, P4924; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jakobsen CM, 2001, J MED CHEM, V44, P4696, DOI 10.1021/jm010985a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Paula S, 2004, PROTEINS, V56, P595, DOI 10.1002/prot.20105; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Seekoe T, 2001, J BIOL CHEM, V276, P46737, DOI 10.1074/jbc.M106320200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SILVIUS Jr, 1984, BIOCHEMISTRY-US, V23, P538, DOI 10.1021/bi00298a022; SIMMONDS AC, 1982, BIOCHIM BIOPHYS ACTA, V693, P398, DOI 10.1016/0005-2736(82)90447-3; Sohoel H, 2006, BIOORGAN MED CHEM, V14, P2810, DOI 10.1016/j.bmc.2005.12.001; Sohoel H, 2005, J MED CHEM, V48, P7005, DOI 10.1021/jm058036v; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; WICTOME M, 1992, FEBS LETT, V304, P109, DOI 10.1016/0014-5793(92)80599-C; WICTOME M, 1994, BIOCHEM BIOPH RES CO, V199, P916, DOI 10.1006/bbrc.1994.1316; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Yu MH, 1998, J BIOL CHEM, V273, P3542, DOI 10.1074/jbc.273.6.3542	47	77	79	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28883	28892		10.1074/jbc.M110.136242	http://dx.doi.org/10.1074/jbc.M110.136242			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20551329	Green Published, hybrid			2022-12-25	WOS:000281594000053
J	Vaidyanathan, R; Taffet, SM; Vikstrom, KL; Anumonwo, JMB				Vaidyanathan, Ravi; Taffet, Steven M.; Vikstrom, Karen L.; Anumonwo, Justus M. B.			Regulation of Cardiac Inward Rectifier Potassium Current (I-K1) by Synapse-associated Protein-97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT VENTRICULAR MYOCYTES; RECTIFYING K+ CHANNELS; GUINEA-PIG; ANCHORING PROTEIN; SINGLE-CHANNEL; RECEPTOR INTERNALIZATION; CHOLINERGIC MODULATION; SAP97; KIR2.1; PSD-95	Synapse-associated protein-97 (SAP97) is a membrane-associated guanylate kinase scaffolding protein expressed in cardiomyocytes. SAP97 has been shown to associate and modulate voltage-gated potassium (Kv) channel function. In contrast to Kv channels, little information is available on interactions involving SAP97 and inward rectifier potassium (Kir2. x) channels that underlie the classical inward rectifier current, I-K1. To investigate the functional effects of silencing SAP97 on I-K1 in adult rat ventricular myocytes, SAP97 was silenced using an adenoviral short hairpin RNA vector. Western blot analysis showed that SAP97 was silenced by similar to 85% on day 3 post-infection. Immunostaining showed that Kir2.1 and Kir2.2 co-localize with SAP97. Co-immunoprecipitation (co-IP) results demonstrated that Kir2. x channels associate with SAP97. Voltage clamp experiments showed that silencing SAP97 reduced I-K1 whole cell density by similar to 55%. I-K1 density at -100 mV was -1.45 +/- 0.15 pA/picofarads (n = 6) in SAP97-silenced cells as compared with -3.03 +/- 0.37 pA/picofarads (n = 5) in control cells. Unitary conductance properties of IK1 were unaffected by SAP97 silencing. The major mechanism for the reduction of I-K1 density appears to be a decrease in Kir2. x channel abundance. Furthermore, SAP97 silencing impaired IK1 regulation by beta(1)-adrenergic receptor (beta(1)-AR) stimulation. In control, isoproterenol reduced I-K1 amplitude by similar to 75%, an effect that was blunted following SAP97 silencing. Our co-IP data show that beta(1)-AR associates with SAP97 and Kir2.1 and also that Kir2.1 co-IPs with protein kinase A and beta(1)-AR. SAP97 immunolocalizes with protein kinase A and beta(1)-AR in the cardiac myocytes. Our results suggest that in cardiac myocytes SAP97 regulates surface expression of channels underlying I-K1, as well as assembles a signaling complex involved in beta(1)-AR regulation of I-K1.	[Anumonwo, Justus M. B.] Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48108 USA; [Vaidyanathan, Ravi] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Taffet, Steven M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA	University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Anumonwo, JMB (corresponding author), Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, 5025 Venture Dr, Ann Arbor, MI 48108 USA.	anumonwo@umich.edu			National Institutes of Health, NIGMS [1R01-GM-076608]; NIH [PO1HL039707, PO1HL087226]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL039707, P01HL087226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076608] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01-GM-076608 from the NIGMS and Grants PO1HL039707 and PO1HL087226 from NIH.	Abi-Char J, 2008, AM J PHYSIOL-HEART C, V294, pH1851, DOI 10.1152/ajpheart.01045.2007; Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Dhamoon AS, 2004, CIRC RES, V94, P1332, DOI 10.1161/01.RES.0000128408.66946.67; El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Godreau D, 2002, CARDIOVASC RES, V56, P433, DOI 10.1016/S0008-6363(02)00602-8; Goult BT, 2007, BIOCHEMISTRY-US, V46, P14117, DOI 10.1021/bi701257z; Horackova M, 1997, EXP CELL RES, V237, P158, DOI 10.1006/excr.1997.3775; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; JOSEPHSON IR, 1986, J MEMBRANE BIOL, V94, P19, DOI 10.1007/BF01901010; JOSEPHSON IR, 1988, MOL CELL BIOCHEM, V80, P21; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Koumi S, 1995, J CLIN INVEST, V96, P2870, DOI 10.1172/JCI118358; KOUMI S, 1995, J PHYSIOL-LONDON, V486, P647, DOI 10.1113/jphysiol.1995.sp020841; KOUMI S, 1995, J PHYSIOL-LONDON, V486, P661, DOI 10.1113/jphysiol.1995.sp020842; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Leonoudakis D, 2001, J CELL SCI, V114, P987; Liu GX, 2004, J PHYSIOL-LONDON, V556, P401, DOI 10.1113/jphysiol.2003.059303; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; Luu T, 2006, J BIOL CHEM, V281, P35699, DOI 10.1074/jbc.M605590200; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Munoz V, 2007, HEART RHYTHM, V4, P487, DOI 10.1016/j.hrthm.2006.12.033; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Oxford EM, 2007, CIRC RES, V101, P703, DOI 10.1161/CIRCRESAHA.107.154252; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Rinne A, 2006, J MUSCLE RES CELL M, V27, P413, DOI 10.1007/s10974-006-9087-0; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Veldkamp MW, 1999, CARDIOVASC RES, V42, P424, DOI 10.1016/S0008-6363(99)00046-2; Vikstrom KL, 2009, AM J PHYSIOL-HEART C, V297, pH1387, DOI 10.1152/ajpheart.00638.2008; WAHLER GM, 1992, AM J PHYSIOL, V262, pC1266, DOI 10.1152/ajpcell.1992.262.5.C1266; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200	43	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28000	28009		10.1074/jbc.M110.110858	http://dx.doi.org/10.1074/jbc.M110.110858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20530486	Green Published, hybrid			2022-12-25	WOS:000281404100053
J	Biondi, MJ; Beilhartz, GL; McCormick, S; Gotte, M				Biondi, Mia J.; Beilhartz, Greg L.; McCormick, Suzanne; Gotte, Matthias			N348I in HIV-1 Reverse Transcriptase Can Counteract the Nevirapine-mediated Bias toward RNase H Cleavage during Plus-strand Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NONNUCLEOSIDE INHIBITORS; CONNECTION DOMAIN; DRUG-RESISTANCE; DNA-SYNTHESIS; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT; CONFERS ZIDOVUDINE; PRIMER UNBLOCKING; KINETIC ANALYSES; DUAL RESISTANCE	Drug resistance-associated mutations in HIV-1 reverse transcriptase (RT) can affect the balance between polymerase and ribonuclease H (RNase H) activities of the enzyme. We have recently demonstrated that the N348I mutation in the connection domain causes selective dissociation from RNase H-competent complexes, whereas the functional integrity of the polymerase-competent complex remains largely unaffected. N348I has been associated with resistance to the non-nucleoside RT inhibitor (NNRTI), nevirapine; however, a possible mechanism that links changes in RNase H activity to changes in NNRTI susceptibility remains to be established. To address this problem, we consider recent findings suggesting that NNRTIs may affect the orientation of RT on its nucleic acid substrate and increase RNase H activity. Here we demonstrate that RNase H-mediated primer removal is indeed more efficient in the presence of NNRTIs; however, the N348I mutant enzyme is able to counteract this effect. Efavirenz, a tight binding inhibitor, restricts the influence of the mutation. These findings provide strong evidence to suggest that N348I can thwart the inhibitory effects of nevirapine during initiation of (+)-strand DNA synthesis, which provides a novel mechanism for resistance. The data are in agreement with clinical data, which demonstrate a stronger effect of N348I on susceptibility to nevirapine as compared with efavirenz.	[Biondi, Mia J.; Beilhartz, Greg L.; McCormick, Suzanne; Gotte, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	McGill University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca			Canadian Institutes for Health Research (CIHR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research (CIHR).	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Archer RH, 2000, J VIROL, V74, P8390, DOI 10.1128/JVI.74.18.8390-8401.2000; Archer RH, 2001, BIOCHEMISTRY-US, V40, P4087, DOI 10.1021/bi002328a; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Arion D, 2000, J BIOL CHEM, V275, P9251, DOI 10.1074/jbc.275.13.9251; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Brehm JH, 2008, BIOCHEMISTRY-US, V47, P14020, DOI 10.1021/bi8014778; Coffin J, 1997, RETROVIRUSES; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; Delviks-Frankenberry KA, 2008, P NATL ACAD SCI USA, V105, P10943, DOI 10.1073/pnas.0804660105; Delviks-Frankenberry KA, 2007, J VIROL, V81, P6837, DOI 10.1128/JVI.02820-06; DING JP, 1995, NAT STRUCT BIOL, V2, P407, DOI 10.1038/nsb0595-407; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gerondelis P, 1999, J VIROL, V73, P5803, DOI 10.1128/JVI.73.7.5803-5813.1999; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Gotte M, 1999, ARCH BIOCHEM BIOPHYS, V365, P199, DOI 10.1006/abbi.1999.1209; Gotte M, 2000, J VIROL, V74, P3579, DOI 10.1128/JVI.74.8.3579-3585.2000; Grobler JA, 2007, J BIOL CHEM, V282, P8005, DOI 10.1074/jbc.M608274200; Gupta S, 2010, ANTIMICROB AGENTS CH, V54, P1973, DOI 10.1128/AAC.00870-09; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Hachiya A, 2009, ANTIVIR RES, V82, P115, DOI 10.1016/j.antiviral.2009.02.189; Hang JQ, 2007, BIOCHEM BIOPH RES CO, V352, P341, DOI 10.1016/j.bbrc.2006.11.018; Hsiou Y, 2001, J MOL BIOL, V309, P437, DOI 10.1006/jmbi.2001.4648; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Menendez-Arias L, 2010, ANTIVIR RES, V85, P210, DOI 10.1016/j.antiviral.2009.07.006; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2010, J VIROL, V84, P5238, DOI 10.1128/JVI.01545-09; Nikolenko GN, 2004, J VIROL, V78, P8761, DOI 10.1128/JVI.78.16.8761-8770.2004; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Radzio J, 2008, MOL PHARMACOL, V73, P601, DOI 10.1124/mol.107.038596; Ren J, 2001, J MOL BIOL, V312, P795, DOI 10.1006/jmbi.2001.4988; Ren JS, 2008, VIRUS RES, V134, P157, DOI 10.1016/j.virusres.2007.12.018; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; SMERDON SJ, 1994, P NATL ACAD SCI USA, V91, P3911, DOI 10.1073/pnas.91.9.3911; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; von Wyl V, 2010, J INFECT DIS, V201, P1054, DOI 10.1086/651168; Wang J, 2006, VIROLOGY, V348, P462, DOI 10.1016/j.virol.2006.01.014; Wang LZ, 2004, J BIOL CHEM, V279, P38424, DOI 10.1074/jbc.M406241200; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057; Xia Q, 2007, PROTEIN SCI, V16, P1728, DOI 10.1110/ps.072829007; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zelina S, 2008, ANTIMICROB AGENTS CH, V52, P157, DOI 10.1128/AAC.00904-07	51	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26966	26975		10.1074/jbc.M110.105775	http://dx.doi.org/10.1074/jbc.M110.105775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20530477	Green Published, hybrid			2022-12-25	WOS:000281172700028
J	Fieni, F; Parkar, A; Misgeld, T; Kerschensteiner, M; Lichtman, JW; Pasinelli, P; Trotti, D				Fieni, Francesca; Parkar, Anjum; Misgeld, Thomas; Kerschensteiner, Martin; Lichtman, Jeff W.; Pasinelli, Piera; Trotti, Davide			Voltage-dependent Inwardly Rectifying Potassium Conductance in the Outer Membrane of Neuronal Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX VOLUME; CHANNEL; PERMEABILITY; TRANSPORT; VDAC	Potassium fluxes integrate mitochondria into cellular activities, controlling their volume homeostasis and structural integrity in many pathophysiological mechanisms. The outer mitochondrial membrane (OMM) is thought to play a passive role in this process because K+ is believed to equilibrate freely between the cytosol and mitochondrial intermembrane space. By patch clamping mitochondria isolated from the central nervous systems of adult mitoCFP transgenic mice, we discovered the existence of I-OMMKi, a novel voltage-dependent inwardly rectifying K+ conductance located in the OMM. I-OMMKi is regulated by osmolarity, potentiated by cAMP, and activated at physiological negative potentials, allowing K+ to enter the mitochondrial intermembrane space in a controlled regulated fashion. The identification of I-OMMKi in the OMM supports the notion that a membrane potential could exist across this membrane in vivo and suggests that the OMM possesses regulated pathways for K+ uptake.	[Fieni, Francesca; Parkar, Anjum; Pasinelli, Piera; Trotti, Davide] Thomas Jefferson Univ, Dept Neurosci, Weinberg Unit ALS Res, Philadelphia, PA 19107 USA; [Fieni, Francesca; Parkar, Anjum; Pasinelli, Piera; Trotti, Davide] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Misgeld, Thomas; Kerschensteiner, Martin; Lichtman, Jeff W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Jefferson University; Jefferson University; Harvard University	Trotti, D (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Weinberg Unit ALS Res, 900 Walnut St, Philadelphia, PA 19107 USA.	davide.trotti@jefferson.edu		Trotti, Davide/0000-0001-6338-6404; Pasinelli, Piera/0000-0002-3385-2707	National Institutes of Health [RO1-NS064488, RO1-NS044942, RO1-NS051488]; ALS Association; Muscular Dystrophy Association; Christopher and Dana Reeve Foundation; Dana Foundation; Deutsche Forschungsgemeinschaft; Farber Family Foundation; Paralyzed Veterans of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051488, R01NS064488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; Muscular Dystrophy Association(Muscular Dystrophy Association); Christopher and Dana Reeve Foundation; Dana Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Farber Family Foundation; Paralyzed Veterans of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-NS064488 and RO1-NS044942 (to D. T.) and RO1-NS051488 (to P. P.). This work was also supported by the ALS Association (to P. P.) and the Muscular Dystrophy Association (to D. T.). The generation of the mitoCFP mice was supported by grants from the Christopher and Dana Reeve Foundation, the Dana Foundation, and the Deutsche Forschungsgemeinschaft. The Weinberg Unit for ALS Research is sponsored by the Farber Family Foundation.; Supported in part by a Paralyzed Veterans of America fellowship.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Bednarczyk P, 2008, BBA-BIOENERGETICS, V1777, P540, DOI 10.1016/j.bbabio.2008.04.018; Bednarczyk P, 2009, ACTA BIOCHIM POL, V56, P385; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bonanni L, 2006, J NEUROSCI, V26, P6851, DOI 10.1523/JNEUROSCI.5444-05.2006; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; Devin A, 1997, J BIOENERG BIOMEMBR, V29, P579, DOI 10.1023/A:1022435102552; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Hansson MJ, 2010, J BIOL CHEM, V285, P741, DOI 10.1074/jbc.M109.017731; HORN R, 1980, J GEN PHYSIOL, V75, P297, DOI 10.1085/jgp.75.3.297; HORN R, 1980, P NATL ACAD SCI-BIOL, V77, P6930, DOI 10.1073/pnas.77.11.6930; Jonas EA, 1999, SCIENCE, V286, P1347, DOI 10.1126/science.286.5443.1347; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Korge P, 2005, AM J PHYSIOL-HEART C, V289, pH66, DOI 10.1152/ajpheart.01296.2004; Lemeshko VV, 2002, BIOPHYS J, V82, P684, DOI 10.1016/S0006-3495(02)75431-3; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; Mannella CA, 2008, J BIOENERG BIOMEMBR, V40, P149, DOI 10.1007/s10863-008-9143-0; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; MORAN O, 1992, EUR BIOPHYS J BIOPHY, V20, P311, DOI 10.1007/BF00196590; MORAN O, 1992, J BIOENERG BIOMEMBR, V24, P91, DOI 10.1007/BF00769535; Nowikovsky K, 2009, BBA-BIOENERGETICS, V1787, P345, DOI 10.1016/j.bbabio.2008.10.006; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Smith SM, 2004, NEURON, V41, P243, DOI 10.1016/S0896-6273(03)00837-7; SORGATO MC, 1987, NATURE, V330, P498, DOI 10.1038/330498a0; SORGATO MC, 1993, CRIT REV BIOCHEM MOL, V28, P127; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; WUNDER UR, 1991, J MEMBRANE BIOL, V123, P83, DOI 10.1007/BF01993966; ZIZI M, 1994, J BIOL CHEM, V269, P1614	33	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27411	27417		10.1074/jbc.M110.131243	http://dx.doi.org/10.1074/jbc.M110.131243			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551319	Green Published, hybrid			2022-12-25	WOS:000281172700070
J	Manchinelly, SAS; Miller, JA; Su, L; Miyake, T; Palmer, L; Mikawa, M; Parsons, SJ				Manchinelly, Sergio A. Sanchez; Miller, Joyce Agati; Su, Ling; Miyake, Tsuyoshi; Palmer, Lisa; Mikawa, Masahito; Parsons, Sarah J.			Mitotic Down-regulation of p190RhoGAP Is Required for the Successful Completion of Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; RHO GTPASE; EXCHANGE FACTOR; HUMAN ECT2; P190; ACTIVATION; PROTEIN; PHOSPHORYLATION; DEGRADATION; LOCALIZATION	p190RhoGAP-A (p190) is a GTPase-activating protein known to regulate actin cytoskeleton dynamics by decreasing RhoGTP levels through activation of Rho intrinsic GTPase activity. We have previously shown that p190 protein levels are cell cycle-regulated, decreasing in mitosis, and that this decrease is mediated by the ubiquitin-proteasome pathway. In addition, overexpression of p190 results in decreased RhoGTP levels at the cleavage furrow during cytokinesis, p190 and the RhoGEF Ect2 play opposing roles in cytokinesis, and sustained levels of p190 in mitosis are associated with cytokinesis failure, all findings that suggest but do not directly demonstrate that completion of cytokinesis is dependent on reduced levels of p190. Here we report, using an RNAi reconstitution approach with a degradation- resistant mutant, that decreased p190 levels are required for successful cytokinesis. We also show that the multinucleation phenotype is dependent on p190 RhoGAP activity, determine that the N-terminal GBDS1 region is necessary and sufficient for p190 mitotic ubiquitination and degradation, and identify four N-terminal residues as necessary for the degradation of p190 in mitosis. Our data indicate that in addition to activation of RhoGEF(s), reduction of RhoGAP (p190) is a critical mechanism by which increased RhoGTP levels are achieved in late mitosis, thereby ensuring proper cell division.	[Parsons, Sarah J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Parsons, Sarah J.] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA; [Palmer, Lisa] Univ Virginia, Dept Pediat, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Parsons, SJ (corresponding author), Univ Virginia Hlth Syst, Dept Microbiol, POB 800734, Charlottesville, VA 22908 USA.	sap@virginia.edu			National Institutes of Health, NCI [R01CA039438]; NCI [CA039438-20S1, T32 CA009109]; NATIONAL CANCER INSTITUTE [T32CA009109, R01CA039438] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA039438 (to S. J. P.), supplemental Grant CA039438-20S1 (to S. A. S. M.), and Cancer Training Grant T32 CA009109 (to the University of Virginia Cancer Center), all from the NCI.	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Batonnet S, 2004, J BIOL CHEM, V279, P5413, DOI 10.1074/jbc.M310315200; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Fincham VJ, 1999, J CELL SCI, V112, P947; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Haskell MD, 2001, J CELL SCI, V114, P1699; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kim JH, 2008, BIOCHEM BIOPH RES CO, V366, P1036, DOI 10.1016/j.bbrc.2007.12.070; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Mikawa M, 2008, CELL CYCLE, V7, P2003, DOI 10.4161/cc.7.13.6128; Miller AL, 2008, BIOCHEM SOC T, V36, P378, DOI 10.1042/BST0360378; Moasser MM, 1999, CANCER RES, V59, P6145; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Nishimura Y, 1998, FEBS LETT, V441, P121, DOI 10.1016/S0014-5793(98)01531-2; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Su L, 2003, J CELL BIOL, V163, P571, DOI 10.1083/jcb.200308007; TAKAISHI K, 1995, ONCOGENE, V11, P39; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Welbourn S, 2009, J GEN VIROL, V90, P1071, DOI 10.1099/vir.0.009944-0; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	43	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26923	26932		10.1074/jbc.M110.103804	http://dx.doi.org/10.1074/jbc.M110.103804			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20534586	Green Published, hybrid			2022-12-25	WOS:000281172700024
J	Masuda, T; Esumi, N				Masuda, Tomohiro; Esumi, Noriko			SOX9, through Interaction with Microphthalmia-associated Transcription Factor (MITF) and OTX2, Regulates BEST1 Expression in the Retinal Pigment Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; AUTOSOMAL SEX REVERSAL; MYELIN PROTEIN ZERO; CAMPOMELIC DYSPLASIA; CRE RECOMBINASE; EYE DEVELOPMENT; VMD2 PROMOTER; NEURAL CREST; IN-VIVO; GENE	BEST1 is highly and preferentially expressed in the retinal pigment epithelium (RPE) and causes Best macular dystrophy when mutated. We previously demonstrated that the human BEST1 upstream region -154 to +38 bp is sufficient to direct expression in the RPE of transgenic mice, and microphthalmia-associated transcription factor (MITF) and OTX2 regulate this BEST1 promoter. However, a number of questions remained. Here, we show that yeast one-hybrid screen with bait corresponding to BEST1 -120 to -88 bp identified the SOX-E factors, SOX8, SOX9, and SOX10. A paired SOX site was found in this bait, and mutation of either of the paired sites significantly decreased BEST1 promoter activity in RPE primary cultures. Among the SOX-E genes, SOX9 is highly and preferentially expressed in the RPE, and chromatin immunoprecipitation with fresh RPE cells revealed binding of SOX9, but not SOX10, to the BEST1 region where the paired SOX site is located. BEST1 promoter activity was increased by SOX9 overexpression and decreased by siRNA-mediated SOX9 knockdown. Importantly, SOX9 physically interacted with MITF and OTX2 and orchestrated synergistic activation of the BEST1 promoter with the paired SOX site playing essential roles. A combination of the expression patterns of SOX9, MITF, and OTX2 yielded tissue distribution remarkably similar to that of BEST1. Lastly, the BEST1 promoter was also active in Sertoli cells of the testis in transgenic mice where SOX9 is highly expressed. These results define SOX9 as a key regulator of BEST1 expression and demonstrate for the first time its functional role in the RPE.	[Esumi, Noriko] Johns Hopkins Univ, Sch Med, Guerrieri Ctr Genet Engn & Mol Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Esumi, N (corresponding author), Johns Hopkins Univ, Sch Med, Guerrieri Ctr Genet Engn & Mol Ophthalmol, Wilmer Eye Inst, Smith Bldg,Rm 3041,400 N Broadway, Baltimore, MD 21287 USA.	nesumi1@jhmi.edu			National Institutes of Health [EY015410, EY016398, EY001765]; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY016398, R03EY015410, P30EY001765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY015410, EY016398, and EY001765. This work was also supported in part by unrestricted funds from Research to Prevent Blindness, Inc. and generous gifts from Mr. and Mrs. Robert and Clarice Smith and the Guerrieri Family Foundation.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Allikmets R, 1999, HUM GENET, V104, P449, DOI 10.1007/s004390050986; Barrionuevo F, 2010, INT J BIOCHEM CELL B, V42, P433, DOI 10.1016/j.biocel.2009.07.015; Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; BOK D, 1993, J CELL SCI, P189; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Bridgewater LC, 2003, NUCLEIC ACIDS RES, V31, P1541, DOI 10.1093/nar/gkg230; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Burgess R, 2008, AM J HUM GENET, V82, P19, DOI 10.1016/j.ajhg.2007.08.004; Chen SM, 2000, METHOD ENZYMOL, V316, P590; Davidson AE, 2009, AM J HUM GENET, V85, P581, DOI 10.1016/j.ajhg.2009.09.015; Duta V, 2004, FEBS LETT, V577, P551, DOI 10.1016/j.febslet.2004.10.068; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Esumi N, 2007, J BIOL CHEM, V282, P1838, DOI 10.1074/jbc.M609517200; Esumi N, 2009, HUM MOL GENET, V18, P128, DOI 10.1093/hmg/ddn323; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Goding CR, 2000, GENE DEV, V14, P1712; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Ida H, 2004, MOL VIS, V10, P439; Jang SW, 2009, J BIOL CHEM, V284, P20111, DOI 10.1074/jbc.M109.022426; Jiao ZX, 2004, PIGM CELL RES, V17, P352, DOI 10.1111/j.1600-0749.2004.00154.x; Kachi S, 2006, GENE THER, V13, P798, DOI 10.1038/sj.gt.3302700; Kellerer S, 2006, DEVELOPMENT, V133, P2875, DOI 10.1242/dev.02477; Koopman P, 2005, TRENDS GENET, V21, P367, DOI 10.1016/j.tig.2005.05.006; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; O'Bryan MK, 2008, DEV BIOL, V316, P359, DOI 10.1016/j.ydbio.2008.01.042; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Qian J, 2005, NUCLEIC ACIDS RES, V33, P3479, DOI 10.1093/nar/gki658; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Schepers G, 2003, J BIOL CHEM, V278, P28101, DOI 10.1074/jbc.M304067200; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Sock E, 2001, MOL CELL BIOL, V21, P6951, DOI 10.1128/MCB.21.20.6951-6959.2001; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; THUMANN G, 2001, RETINA, V3, P104; Ueki Y, 2009, VISION RES, V49, P615, DOI 10.1016/j.visres.2009.01.012; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Wistow G, 2002, MOL VIS, V8, P205; Yardley J, 2004, INVEST OPHTH VIS SCI, V45, P3683, DOI 10.1167/iovs.04-0550; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Zhang YW, 2010, HUM MOL GENET, V19, P1108, DOI 10.1093/hmg/ddp583	80	37	39	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26933	26944		10.1074/jbc.M110.130294	http://dx.doi.org/10.1074/jbc.M110.130294			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20530484	Green Published, hybrid			2022-12-25	WOS:000281172700025
J	Kashiwaya, Y; Pawlosky, R; Markis, W; King, MT; Bergman, C; Srivastava, S; Murray, A; Clarke, K; Veech, RL				Kashiwaya, Yoshihiro; Pawlosky, Robert; Markis, William; King, M. Todd; Bergman, Christian; Srivastava, Shireesh; Murray, Andrew; Clarke, Kieran; Veech, Richard L.			A Ketone Ester Diet Increases Brain Malonyl-CoA and Uncoupling Proteins 4 and 5 while Decreasing Food Intake in the Normal Wistar Rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-BETA-HYDROXYBUTYRATE; KETOGENIC DIET; ENERGY; INSULIN; BODIES; METABOLISM; EXPRESSION; D,L-3-HYDROXYBUTYRATE; LOCALIZATION; GLUTAMINASE	Three groups of male Wistar rats were pair fed NIH-31 diets for 14 days to which were added 30% of calories as corn starch, palm oil, or R-3-hydroxybutyrate-R-1,3-butanediol monoester (3HB-BD ester). On the 14th day, animal brains were removed by freeze-blowing, and brain metabolites measured. Animals fed the ketone ester diet had elevated mean blood ketone bodies of 3.5 mM and lowered plasma glucose, insulin, and leptin. Despite the decreased plasma leptin, feeding the ketone ester diet ad lib decreased voluntary food intake 2-fold for 6 days while brain malonyl-CoA was increased by about 25% in ketone-fed group but not in the palm oil fed group. Unlike the acute effects of ketone body metabolism in the perfused working heart, there was no increased reduction in brain free mitochondrial [NAD(+)]/[NADH] ratio nor in the free energy of ATP hydrolysis, which was compatible with the observed 1.5-fold increase in brain uncoupling proteins 4 and 5. Feeding ketone ester or palm oil supplemented diets decreased brain L-glutamate by 15-20% and GABA by about 34% supporting the view that fatty acids as well as ketone bodies can be metabolized by the brain.	[Veech, Richard L.] NIAAA, Lab Metab Control, NIH, DHHS, Rockville, MD 20852 USA; [Murray, Andrew] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Cambridge; University of Oxford	Veech, RL (corresponding author), NIAAA, Lab Metab Control, NIH, DHHS, 5625 Fishers Lane,Rm 2S28, Rockville, MD 20852 USA.	rveech@mail.nih.gov	Bergman, Carl/N-1444-2017; Bergman, Carl/AGH-0291-2022; Murray, Andrew/B-3130-2010; Bergman, Christian/D-8680-2012; Bergman, Christian/N-1444-2017	Bergman, Carl/0000-0003-0367-9031; Murray, Andrew/0000-0002-0929-9315; Bergman, Christian/0000-0002-5426-8593; Markis, William/0000-0002-1157-3627	Defense Advanced Research Projects Administration, United States Dept. of Defense; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000112, ZIAAA000113, ZIAAA000110] Funding Source: NIH RePORTER	Defense Advanced Research Projects Administration, United States Dept. of Defense; British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by the Defense Advanced Research Projects Administration, United States Dept. of Defense.	Alan L, 2009, J BIOENERG BIOMEMBR, V41, P71, DOI 10.1007/s10863-009-9201-2; AMIEL SA, 1991, CLIN SCI, V81, P189, DOI 10.1042/cs0810189; ARASE K, 1988, AM J PHYSIOL, V255, pE255, DOI 10.1152/ajpendo.1988.255.3.E255; BENZINGER T, 1959, BIOCHEM J, V71, P400, DOI 10.1042/bj0710400; BERL S, 1984, GLUTAMINE METABOLISM; Bisschop PH, 2001, AM J CLIN NUTR, V73, P554; CARPENTER RG, 1983, PHYSIOL BEHAV, V30, P57, DOI 10.1016/0031-9384(83)90038-0; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Conklin H. W., 1922, J AM OSTEOPATH ASSOC, V26, P11; Cruz F, 1999, NMR BIOMED, V12, P451, DOI 10.1002/(SICI)1099-1492(199911)12:7<451::AID-NBM571>3.0.CO;2-E; Cullingford TE, 2002, EPILEPSY RES, V49, P99, DOI 10.1016/S0920-1211(02)00011-6; DAVIS RJ, 1981, BIOCHEM J, V196, P133, DOI 10.1042/bj1960133; Erecinska M, 1996, J NEUROCHEM, V67, P2325; Freeman JM, 2007, PEDIATRICS, V119, P535, DOI 10.1542/peds.2006-2447; GUYNN RW, 1972, J BIOL CHEM, V247, P7325; HAWKINS RA, 1973, BIOCHEM J, V134, P1001, DOI 10.1042/bj1341001; HOGSTAD S, 1988, NEUROCHEM RES, V13, P383, DOI 10.1007/BF00972489; Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Ivanova MV, 2010, BIOCHEMISTRY-US, V49, P512, DOI 10.1021/bi901742g; Johnstone AM, 2008, AM J CLIN NUTR, V87, P44, DOI 10.1093/ajcn/87.1.44; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; KOPPELMAN R, 1958, J BIOL CHEM, V230, P73; Krebs H. A., 1969, ENERGY LEVEL METABOL, P329; KREBS HA, 1953, BIOCHEM J, V54, P82, DOI 10.1042/bj0540082; Kumar MV, 2002, P NATL ACAD SCI USA, V99, P1921, DOI 10.1073/pnas.042683699; Kwiterovich PO, 2003, JAMA-J AM MED ASSOC, V290, P912, DOI 10.1001/jama.290.7.912; LANGHANS W, 1983, PHYSIOL BEHAV, V31, P483, DOI 10.1016/0031-9384(83)90070-7; LUST WD, 1973, SCIENCE, V181, P280, DOI 10.1126/science.181.4096.280; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Mehlman MA., 1972, ENERGY METABOLISM RE, P171; MILLER AL, 1973, J NEUROCHEM, V20, P1393, DOI 10.1111/j.1471-4159.1973.tb00251.x; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; Pawlosky RJ, 2010, ALCOHOL CLIN EXP RES, V34, P375, DOI 10.1111/j.1530-0277.2009.01099.x; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rossi R, 2000, J VET MED A, V47, P9, DOI 10.1046/j.1439-0442.2000.00255.x; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; Smith QR, 2001, J MOL NEUROSCI, V16, P167, DOI 10.1385/JMN:16:2-3:167; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Van Hove JLK, 2003, LANCET, V361, P1433, DOI 10.1016/S0140-6736(03)13105-4; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; VEECH RL, 1994, ALCOHOL CLIN EXP RES, V18, P1040, DOI 10.1111/j.1530-0277.1994.tb00081.x; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Veech RL, 2001, IUBMB LIFE, V51, P241; VEECH RL, 1973, J NEUROCHEM, V20, P183, DOI 10.1111/j.1471-4159.1973.tb12115.x; VELOSO D, 1973, J BIOL CHEM, V248, P4811; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Woods JW, 2003, BRAIN RES, V975, P10, DOI 10.1016/S0006-8993(03)02515-0; Yudkoff M, 1997, J NEUROCHEM, V69, P682; Yudkoff M, 2007, ANNU REV NUTR, V27, P415, DOI 10.1146/annurev.nutr.27.061406.093722	58	63	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25950	25956		10.1074/jbc.M110.138198	http://dx.doi.org/10.1074/jbc.M110.138198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20529850	Green Published, hybrid			2022-12-25	WOS:000280921000009
J	Ling, L; Dombrowski, C; Foong, KM; Haupt, LM; Stein, GS; Nurcombe, V; van Wijnen, AJ; Cool, SM				Ling, Ling; Dombrowski, Christian; Foong, Kin Mun; Haupt, Larisa M.; Stein, Gary S.; Nurcombe, Victor; van Wijnen, Andre J.; Cool, Simon M.			Synergism between Wnt3a and Heparin Enhances Osteogenesis via a Phosphoinositide 3-Kinase/Akt/RUNX2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; ALKALINE-PHOSPHATASE EXPRESSION; FRIZZLED-RELATED PROTEIN-1; TRANSCRIPTION FACTOR RUNX2; RECEPTOR-RELATED PROTEIN-5; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; PHOSPHATIDYLINOSITOL 3-KINASE; SULFATE PROTEOGLYCANS; BIOLOGICAL-ACTIVITIES	A new strategy has emerged to improve healing of bone defects using exogenous glycosaminoglycans by increasing the effectiveness of bone-anabolic growth factors. Wnt ligands play an important role in bone formation. However, their functional interactions with heparan sulfate/heparin have only been investigated in non-osseous tissues. Our study now shows that the osteogenic activity of Wnt3a is cooperatively stimulated through physical interactions with exogenous heparin. N-Sulfation and to a lesser extent O-sulfation of heparin contribute to the physical binding and optimal co-stimulation of Wnt3a. Wnt3a-heparin signaling synergistically increases osteoblast differentiation with minimal effects on cell proliferation. Thus, heparin selectively reduces the effective dose of Wnt3a needed to elicit osteogenic, but not mitogenic responses. Mechanistically, Wnt3a-heparin signaling strongly activates the phosphoinositide 3-kinase/Akt pathway and requires the bone-related transcription factor RUNX2 to stimulate alkaline phosphatase activity, which parallels canonical beta-catenin signaling. Collectively, our findings establish the osteo-inductive potential of a heparin-mediated Wnt3a-phosphoinositide 3-kinase/Akt-RUNX2 signaling network and suggest that heparan sulfate supplementation may selectively reduce the therapeutic doses of peptide factors required to promote bone formation.	[Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Dept Cell Biol, Sch Med, Worcester, MA 01655 USA; [Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Ctr Canc, Sch Med, Worcester, MA 01655 USA; [Cool, Simon M.] Inst Med Biol, Singapore 138648, Singapore; [Nurcombe, Victor; Cool, Simon M.] Natl Univ Singapore, Dept Orthopaed Surg, Yong Loo Lin Sch Med, Singapore 119074, Singapore	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	van Wijnen, AJ (corresponding author), Univ Massachusetts, Dept Cell Biol, Sch Med, 55 Lake Ave N, Worcester, MA 01655 USA.	andre.vanwijnen@umassmed.edu; simon.cool@imb.a-star.edu.sg	Cool, Simon McKenzie/AAG-4346-2021; Cool, Simon/W-1257-2018; van Wijnen, Andre J./AAG-3578-2019; Haupt, Larisa M/C-6066-2017	Cool, Simon/0000-0001-8543-3056; van Wijnen, Andre J./0000-0002-4458-0946; Haupt, Larisa M/0000-0002-7735-8110	Singapore Agency for Science Technology and Research (A*STAR); Biomedical Research Council of Singapore; Institute of Medical Biology, Singapore; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER	Singapore Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Institute of Medical Biology, Singapore; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funding from the Singapore Agency for Science Technology and Research (A*STAR), the Biomedical Research Council of Singapore, and the Institute of Medical Biology, Singapore.	Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ambrosetti D, 2008, MOL CELL BIOL, V28, P4759, DOI 10.1128/MCB.01849-07; Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Colombres M, 2008, J CELL PHYSIOL, V216, P805, DOI 10.1002/jcp.21465; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P451, DOI 10.1093/glycob/4.4.451; Jackson RA, 2007, J CELL PHYSIOL, V210, P38, DOI 10.1002/jcp.20813; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kim HJ, 2003, DEV DYNAM, V227, P335, DOI 10.1002/dvdy.10319; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kumarasuriyar A, 2009, J CELL PHYSIOL, V218, P501, DOI 10.1002/jcp.21620; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Lee JY, 2007, J BIOMED MATER RES A, V83A, P970, DOI 10.1002/jbm.a.31351; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Ling L, 2006, J CELL PHYSIOL, V209, P811, DOI 10.1002/jcp.20760; Mahtouk K, 2004, BLOOD, V103, P1829, DOI 10.1182/blood-2003-05-1510; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Matsuzaki E, 2006, J BONE MINER RES, V21, P1307, DOI 10.1359/JBMR.060512; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; Mehta VB, 2005, J IMMUNOL, V175, P1911, DOI 10.4049/jimmunol.175.3.1911; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sobel M, 2001, J VASC SURG, V33, P587, DOI 10.1067/mva.2001.112696; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Teplyuk NM, 2009, J CELL BIOCHEM, V107, P144, DOI 10.1002/jcb.22108; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200; Zhong XT, 2007, J BIOL CHEM, V282, P20523, DOI 10.1074/jbc.M609096200	59	64	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26233	26244		10.1074/jbc.M110.122069	http://dx.doi.org/10.1074/jbc.M110.122069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547765	Green Published, hybrid			2022-12-25	WOS:000280921000040
J	Chiang, BY; Chen, TC; Pai, CH; Chou, CC; Chen, HH; Ko, TP; Hsu, WH; Chang, CY; Wu, WF; Wang, AHJ; Lin, CH				Chiang, Bing-Yu; Chen, Tzu-Chieh; Pai, Chien-Hua; Chou, Chi-Chi; Chen, Hsuan-He; Ko, Tzu-Ping; Hsu, Wen-Hung; Chang, Chun-Yang; Wu, Whei-Fen; Wang, Andrew H. -J.; Lin, Chun-Hung			Protein S-Thiolation by Glutathionylspermidine (Gsp) THE ROLE OF ESCHERICHIA COLI Gsp SYNTHETASE/AMIDASE IN REDOX REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE SULFENIC ACID; CRITHIDIA-FASCICULATA; GLUTATHIONYLATION; TRYPANOTHIONE; INTERMEDIATE; ENZYME; METABOLISM; SPERMIDINE; MECHANISM; BACTERIA	Certain bacteria synthesize glutathionylspermidine (Gsp), from GSH and spermidine. Escherichia coli Gsp synthetase/amidase (GspSA) catalyzes both the synthesis and hydrolysis of Gsp. Prior to the work reported herein, the physiological role(s) of Gsp or how the two opposing GspSA activities are regulated had not been elucidated. We report that Gsp-modified proteins from E. coli contain mixed disulfides of Gsp and protein thiols, representing a new type of post-translational modification formerly undocumented. The level of these proteins is increased by oxidative stress. We attribute the accumulation of such proteins to the selective inactivation of GspSA amidase activity. X-ray crystallography and a chemical modification study indicated that the catalytic cysteine thiol of the GspSA amidase domain is transiently inactivated by H2O2 oxidation to sulfenic acid, which is stabilized by a very short hydrogen bond with a water molecule. We propose a set of reactions that explains how the levels of Gsp and Gsp S-thiolated proteins are modulated in response to oxidative stress. The hypersensitivities of GspSA and GspSA/glutaredoxin null mutants to H2O2 support the idea that GspSA and glutaredoxin act synergistically to regulate the redox environment of E. coli.	[Chen, Hsuan-He; Chang, Chun-Yang; Wu, Whei-Fen] Natl Taiwan Univ, Dept Agr Chem, Taipei 10617, Taiwan; [Wu, Whei-Fen] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10617, Taiwan; [Chiang, Bing-Yu; Chen, Tzu-Chieh; Hsu, Wen-Hung; Wang, Andrew H. -J.; Lin, Chun-Hung] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Chiang, Bing-Yu; Chen, Tzu-Chieh; Pai, Chien-Hua; Ko, Tzu-Ping; Hsu, Wen-Hung; Wang, Andrew H. -J.; Lin, Chun-Hung] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Wang, Andrew H. -J.; Lin, Chun-Hung] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Chou, Chi-Chi] Acad Sinica, Natl Res Program Genome Med Core Facil Prote Res, Taipei 11529, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Wu, WF (corresponding author), Natl Taiwan Univ, Dept Agr Chem, Taipei 10617, Taiwan.	whifinwu@ntu.edu.tw; ahjwang@gate.sinica.edu.tw; chunhung@gate.sinica.edu.tw	Chou, Chi-Chi/X-6053-2019; Pai, Chien-Hua/C-2477-2011; Lin, Chun-Hung/AAM-9711-2021; Wu, Whei-Fen/AAS-6031-2021; Pai, Chien-Hua/ABG-2711-2020	Chou, Chi-Chi/0000-0002-7862-7757; Lin, Chun-Hung/0000-0002-6795-8825; Pai, Chien-Hua/0000-0003-2254-5928; WU, WHI-FIN/0000-0002-9526-6287	National Science Council of Taiwan [NSC97-2628-M-001-016-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grant NSC97-2628-M-001-016-MY3.	Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Chu F, 2001, CARCINOGENESIS, V22, P1221, DOI 10.1093/carcin/22.8.1221; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; GREENBERG JT, 1986, J BACTERIOL, V168, P1026, DOI 10.1128/jb.168.2.1026-1029.1986; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Katz BA, 2001, J MOL BIOL, V307, P1451, DOI 10.1006/jmbi.2001.4516; Koenig K, 1997, J BIOL CHEM, V272, P11908, DOI 10.1074/jbc.272.18.11908; KrauthSiegel RL, 1996, MOL BIOCHEM PARASIT, V80, P203, DOI 10.1016/0166-6851(96)02689-8; Lin CH, 1997, BIOCHEMISTRY-US, V36, P14930, DOI 10.1021/bi9714464; Lountos GT, 2006, BIOCHEMISTRY-US, V45, P9648, DOI 10.1021/bi060692p; Lundstrom-Ljung J, 1999, FEBS LETT, V443, P85, DOI 10.1016/S0014-5793(98)01698-6; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Nakamura T, 2008, P NATL ACAD SCI USA, V105, P6238, DOI 10.1073/pnas.0709822105; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Pai CH, 2006, EMBO J, V25, P5970, DOI 10.1038/sj.emboj.7601440; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Potamitou A, 2002, J BIOL CHEM, V277, P17775, DOI 10.1074/jbc.M201306200; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; SHIM H, 1988, J GEN MICROBIOL, V134, P807; SMITH K, 1995, BIOCHEM J, V312, P465, DOI 10.1042/bj3120465; TABOR H, 1975, J BIOL CHEM, V250, P2648; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004	31	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25345	25353		10.1074/jbc.M110.133363	http://dx.doi.org/10.1074/jbc.M110.133363			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530482	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000280682400027
J	Gao, P; Bauvy, C; Souquere, S; Tonelli, G; Liu, L; Zhu, YS; Qiao, ZZ; Bakula, D; Proikas-Cezanne, T; Pierron, G; Codogno, P; Chen, QA; Mehrpour, M				Gao, Ping; Bauvy, Chantal; Souquere, Sylvie; Tonelli, Giovanni; Liu, Lei; Zhu, Yushan; Qiao, Zhenzhen; Bakula, Daniela; Proikas-Cezanne, Tassula; Pierron, Gerard; Codogno, Patrice; Chen, Quan; Mehrpour, Maryam			The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-dependent and Beclin 1-independent Cytoprotective Autophagy in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARVATION-INDUCED AUTOPHAGY; LEUKEMIA-CELLS; DEATH; APOPTOSIS; SURVIVAL; THERAPY; PROTEIN; INHIBITION; GENE; MACROAUTOPHAGY	Gossypol, a natural Bcl-2 homology domain 3 mimetic compound isolated from cottonseeds, is currently being evaluated in clinical trials. Here, we provide evidence that gossypol induces autophagy followed by apoptotic cell death in both the MCF-7 human breast adenocarcinoma and HeLa cell lines. We first show that knockdown of the Bcl-2 homology domain 3-only protein Beclin 1 reduces gossypol-induced autophagy in MCF-7 cells, but not in HeLa cells. Gossypol inhibits the interaction between Beclin 1 and Bcl-2 (B-cell leukemia/lymphoma 2), antagonizes the inhibition of autophagy by Bcl-2, and hence stimulates autophagy. We then show that knockdown of Vps34 reduces gossypol-induced autophagy in both cell lines, and consistent with this, the phosphatidylinositol 3-phosphate-binding protein WIPI-1 is recruited to autophagosomal membranes. Further, Atg5 knockdown also reduces gossypol-mediated autophagy. We conclude that gossypol induces autophagy in both a canonical and a noncanonical manner. Notably, we found that gossypol-mediated apoptotic cell death was potentiated by treatment with the autophagy inhibitor wortmannin or with small interfering RNA against essential autophagy genes (Vps34, Beclin 1, and Atg5). Our findings support the notion that gossypol-induced autophagy is cytoprotective and not part of the cell death process induced by this compound.	[Gao, Ping; Liu, Lei; Chen, Quan] Chinese Acad Sci, Joint Lab Apoptosis & Canc Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Souquere, Sylvie; Pierron, Gerard] Inst Andre Lwoff, CNRS UPR, Lab Replicat Acide Desoxyribonucle & Ultrastruct, Villejuif, France; [Bauvy, Chantal; Tonelli, Giovanni; Codogno, Patrice; Mehrpour, Maryam] Univ Paris Sud, INSERM, U984, F-92296 Chatenay Malabry, France; [Bakula, Daniela; Proikas-Cezanne, Tassula; Chen, Quan] Univ Tubingen, Inst Cell Biol, Dept Mol Biol, Autophagy Lab, Tubingen, Germany; [Gao, Ping] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Zhu, Yushan; Qiao, Zhenzhen] Nankai Univ, Coll Life Sci, Tianjin 30007, Peoples R China	Chinese Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Eberhard Karls University of Tubingen; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nankai University	Chen, QA (corresponding author), Chinese Acad Sci, Lab Apoptosis & Canc Biol, IOZ, Beijing 100101, Peoples R China.	chenq@ioz.ac.cn; mehrpourmaryam@yahoo.fr	Mehrpour, Maryam/D-8640-2017; Codogno, Patrice/G-1384-2013	Codogno, Patrice/0000-0002-5492-3180; Chen, Quan/0000-0001-7539-8728; Bakula, Daniela/0000-0003-4107-1414; Proikas-Cezanne, Prof. Dr. Tassula/0000-0001-6934-132X	CAS; INSERM; PHC-PFCC Programme Francais de Cooperation avec la Chine; Ministry of Science and Technology [2007CB914800, 2009CB512800]; NSFC [30771080]; ARC; Deutsche Forschungsgemeinschaft [SFB 773]; Fondation Franco-Chinoise pour la Science et ses Applications	CAS(Chinese Academy of Sciences); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PHC-PFCC Programme Francais de Cooperation avec la Chine; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NSFC(National Natural Science Foundation of China (NSFC)); ARC(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fondation Franco-Chinoise pour la Science et ses Applications	This work was supported by CAS, INSERM, PHC-PFCC Programme Francais de Cooperation avec la Chine, the 973 program project from the Ministry of Science and Technology Grants 2007CB914800 and 2009CB512800, NSFC Grant 30771080, ARC, Grant SFB 773 from the Deutsche Forschungsgemeinschaft (to T. P.-C.), and the Fondation Franco-Chinoise pour la Science et ses Applications.	ADLAKHA RC, 1989, CANCER RES, V49, P2052; Alva AS, 2004, CELL DEATH DIFFER, V11, P1046, DOI 10.1038/sj.cdd.4401445; Azmi AS, 2009, J CELL PHYSIOL, V218, P13, DOI 10.1002/jcp.21567; Balakrishnan K, 2008, BLOOD, V112, P1971, DOI 10.1182/blood-2007-12-126946; Balci A, 1999, TOHOKU J EXP MED, V189, P51, DOI 10.1620/tjem.189.51; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Codogno Patrice, 2005, Journal de la Societe de Biologie, V199, P233, DOI 10.1051/jbio:2005024; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Etxebarria A, 2008, BIOCHEM PHARMACOL, V76, P1563, DOI 10.1016/j.bcp.2008.08.003; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Ligueros M, 1997, BRIT J CANCER, V76, P21, DOI 10.1038/bjc.1997.330; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo S, 2007, CELL DEATH DIFFER, V14, P1247, DOI 10.1038/sj.cdd.4402149; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moon DO, 2008, FEBS LETT, V582, P3367, DOI 10.1016/j.febslet.2008.08.029; Moon DO, 2008, CANCER LETT, V264, P192, DOI 10.1016/j.canlet.2008.01.030; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Scarlatti F, 2008, AUTOPHAGY, V4, P1083, DOI 10.4161/auto.7068; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SMITH DM, 2010, CELL DEATH IN PRESS; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Warr MR, 2008, CURR ONCOL, V15, P256; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang MC, 2007, LIFE SCI, V80, P767, DOI 10.1016/j.lfs.2006.11.004; Zhang MC, 2007, CLIN EXP PHARMACOL P, V34, P230, DOI 10.1111/j.1440-1681.2007.04577.x; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	54	100	102	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25570	25581		10.1074/jbc.M110.118125	http://dx.doi.org/10.1074/jbc.M110.118125			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529838	Green Published, hybrid			2022-12-25	WOS:000280682400051
J	Altenhofer, S; Witte, I; Teiber, JF; Wilgenbus, P; Pautz, A; Li, H; Daiber, A; Witan, H; Clement, AM; Forstermann, U; Horke, S				Altenhoefer, Sebastian; Witte, Ines; Teiber, John F.; Wilgenbus, Petra; Pautz, Andrea; Li, Huige; Daiber, Andreas; Witan, Heidrun; Clement, Albrecht M.; Foerstermann, Ulrich; Horke, Sven			One Enzyme, Two Functions PON2 PREVENTS MITOCHONDRIAL SUPEROXIDE FORMATION AND APOPTOSIS INDEPENDENT FROM ITS LACTONASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; PARAOXONASE-2; PON1; ATHEROSCLEROSIS; MITOCHONDRIA; ANTIOXIDANT	The human enzyme paraoxonase-2 (PON2) has two functions, an enzymatic lactonase activity and the reduction of intracellular oxidative stress. As a lactonase, it dominantly hydrolyzes bacterial signaling molecule 3OC12 and may contribute to the defense against pathogenic Pseudomonas aeruginosa. By its anti-oxidative effect, PON2 reduces cellular oxidative damage and influences redox signaling, which promotes cell survival. This may be appreciated but also deleterious given that high PON2 levels reduce atherosclerosis but may stabilize tumor cells. Here we addressed the unknown mechanisms and linkage of PON2 enzymatic and anti-oxidative function. We demonstrate that PON2 indirectly but specifically reduced superoxide release from the inner mitochondrial membrane, irrespective whether resulting from complex I or complex III of the electron transportchain. PON2 left O-2((center dot) over bar) dismutase activities and cytochrome c expression unaltered, and it did not oxidize O2((center dot) over bar) but rather prevented its formation, which implies that PON2 acts by modulating quinones. To analyze linkage to hydrolytic activity, we introduced several point mutations and show that residues His(114) and His(133) are essential for PON2 activity. Further, we mapped its glycosylation sites and provide evidence that glycosylation, but not a native polymorphism Ser/Cys(311), was critical to its activity. Importantly, none of these mutations altered the anti-oxidative/anti-apoptotic function of PON2, demonstrating unrelated activities of the same protein. Collectively, our study provides detailed mechanistic insight into the functions of PON2, which is important for its role in innate immunity, atherosclerosis, and cancer.	[Foerstermann, Ulrich; Horke, Sven] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, D-55131 Mainz, Germany; [Teiber, John F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, Dallas, TX 75390 USA; [Daiber, Andreas] Johannes Gutenberg Univ Mainz, Dept Internal Med 2, D-55101 Mainz, Germany; [Witan, Heidrun; Clement, Albrecht M.] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Horke, S (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	horke@uni-mainz.de	Li, Huige/M-2662-2013	Li, Huige/0000-0003-3458-7391	German Research Foundation (Deutsche Forschungsgemeinschaft) [HO3925/4-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by grants from intramural sources and the German Research Foundation (Deutsche Forschungsgemeinschaft; Grant HO3925/4-1) (to S. H.).	Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030; Camps J, 2009, CRIT REV CL LAB SCI, V46, P83, DOI 10.1080/10408360802610878; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Horke S, 2008, BIOCHEM J, V416, P395, DOI 10.1042/BJ20080775; Josse D, 1999, BIOCHEMISTRY-US, V38, P2816, DOI 10.1021/bi982281h; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Linnane AW, 2007, MITOCHONDRION, V7, P1, DOI 10.1016/j.mito.2006.11.009; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ng CJ, 2006, J BIOL CHEM, V281, P29491, DOI 10.1074/jbc.M605379200; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Orrenius S, 2005, NAT CHEM BIOL, V1, P188, DOI 10.1038/nchembio0905-188; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Rosenblat M, 2006, J BIOL CHEM, V281, P7657, DOI 10.1074/jbc.M512595200; Rothem L, 2007, FREE RADICAL BIO MED, V43, P730, DOI 10.1016/j.freeradbiomed.2007.05.003; Shiner M, 2004, FREE RADICAL BIO MED, V37, P2052, DOI 10.1016/j.freeradbiomed.2004.09.003; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Stoltz DA, 2009, J BIOL CHEM, V284, P35564, DOI 10.1074/jbc.M109.051706; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Teiber JF, 2007, ARCH BIOCHEM BIOPHYS, V461, P24, DOI 10.1016/j.abb.2007.02.015; Thomson MJ, 2007, CARDIOVASC DRUG THER, V21, P195, DOI 10.1007/s10557-007-6027-1; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	34	110	114	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24398	24403		10.1074/jbc.M110.118604	http://dx.doi.org/10.1074/jbc.M110.118604			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530481	hybrid, Green Published			2022-12-25	WOS:000280542100011
J	Artegiani, B; Labbaye, C; Sferra, A; Quaranta, MT; Torreri, P; Macchia, G; Ceccarini, M; Petrucci, TC; Macioce, P				Artegiani, Benedetta; Labbaye, Catherine; Sferra, Antonella; Quaranta, Maria Teresa; Torreri, Paola; Macchia, Gianfranco; Ceccarini, Marina; Petrucci, Tamara C.; Macioce, Pompeo			The Interaction with HMG20a/b Proteins Suggests a Potential Role for beta-Dystrobrevin in Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; KINESIN HEAVY-CHAIN; ALPHA-DYSTROBREVIN; GENOMIC ORGANIZATION; NUCLEAR-MATRIX; SYNAPSIN-I; EXPRESSION; DP71; GENE	alpha and beta dystrobrevins are cytoplasmic components of the dystrophin-associated protein complex that are thought to play a role as scaffold proteins in signal transduction and intracellular transport. In the search of new insights into the functions of beta-dystrobrevin, the isoform restricted to non-muscle tissues, we performed a two-hybrid screen of a mouse cDNA library to look for interacting proteins. Amongthe positive clones, one encodes iBRAF/ HMG20a, a high mobility group (HMG)-domain protein that activates REST (RE-1 silencing transcription factor)-responsive genes, playing a key role in the initiation of neuronal differentiation. We characterized the beta-dystrobrevin-iBRAF interaction by in vitro and in vivo association assays, localized the binding region of one protein to the other, and assessed the kinetics of the interaction as one of high affinity. We also found that beta-dystrobrevin directly binds to BRAF35/HMG20b, a close homologue of iBRAF and a member of a co-repressor complex required for the repression of neural specific genes in neuronal progenitors. In vitro assays indicated that beta-dystrobrevin binds to RE-1 and represses the promoter activity of synapsin I, a REST-responsive gene that is a marker for neuronal differentiation. Altogether, our data demonstrate a direct interaction of beta-dystrobrevin with the HMG20 proteins iBRAF and BRAF35 and suggest that beta-dystrobrevin may be involved in regulating chromatin dynamics, possibly playing a role in neuronal differentiation.	[Macchia, Gianfranco; Petrucci, Tamara C.; Macioce, Pompeo] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Labbaye, Catherine; Quaranta, Maria Teresa] Ist Super Sanita, Dept Haematol Oncol & Mol Med, I-00161 Rome, Italy; [Torreri, Paola; Ceccarini, Marina] Ist Super Sanita, Natl Ctr Rare Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Macioce, P (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	pompeo.macioce@iss.it	CECCARINI, MARINA/A-6637-2015; TORRERI, PAOLA/A-6656-2015; Macioce, Pompeo/H-2142-2016; Labbaye, Catherine/J-9930-2016; Quaranta, Maria Teresa/AAC-2134-2019; Sferra, Antonella/J-2774-2018	CECCARINI, MARINA/0000-0002-7021-4499; TORRERI, PAOLA/0000-0002-0488-956X; Macioce, Pompeo/0000-0002-1829-9448; Quaranta, Maria Teresa/0000-0002-5886-507X; Labbaye, Catherine/0000-0003-1255-4396; Sferra, Antonella/0000-0001-8701-3696	Italy-USA Collaborative Programme [7DR1]	Italy-USA Collaborative Programme	This work was supported in part by the Italy-USA Collaborative Programme (Grant Rare Diseases, 7DR1).	Albrecht DE, 2004, J BIOL CHEM, V279, P7014, DOI 10.1074/jbc.M312205200; Ambrose HJ, 1997, GENOMICS, V39, P359, DOI 10.1006/geno.1996.4515; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Benson MA, 2004, TRENDS NEUROSCI, V27, P516, DOI 10.1016/j.tins.2004.06.004; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Blake DJ, 1998, P NATL ACAD SCI USA, V95, P241, DOI 10.1073/pnas.95.1.241; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 1996, J BIOL CHEM, V271, P7802, DOI 10.1074/jbc.271.13.7802; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Ceccarini M, 2005, J MOL BIOL, V354, P872, DOI 10.1016/j.jmb.2005.09.069; Ceccarini M, 2002, NEUROMUSCULAR DISORD, V12, P36, DOI 10.1016/S0960-8966(01)00230-9; CIANETTI L, 1990, NUCLEIC ACIDS RES, V18, P4361, DOI 10.1093/nar/18.15.4361; Cyrulnik SE, 2008, NEUROSCI BIOBEHAV R, V32, P486, DOI 10.1016/j.neubiorev.2007.09.001; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Grady RM, 2006, J NEUROSCI, V26, P2841, DOI 10.1523/JNEUROSCI.4823-05.2006; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hsiao JC, 2006, J VIROL, V80, P7714, DOI 10.1128/JVI.00207-06; JUNG D, 1993, NEUROMUSCULAR DISORD, V3, P515, DOI 10.1016/0960-8966(93)90107-U; JUNGLING S, 1994, EUR J BIOCHEM, V226, P925, DOI 10.1111/j.1432-1033.1994.00925.x; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; Loh NY, 2001, MOL CELL BIOL, V21, P7442, DOI 10.1128/MCB.21.21.7442-7448.2001; Loh NY, 1998, MAMM GENOME, V9, P857, DOI 10.1007/s003359900883; Macioce P, 2003, J CELL SCI, V116, P4847, DOI 10.1242/jcs.00805; Marquez FG, 2003, NEUROSCIENCE, V118, P957, DOI 10.1016/S0306-4522(03)00063-0; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Nagano T, 2000, J NEUROCHEM, V75, P1, DOI 10.1046/j.1471-4159.2000.0750001.x; Peters MF, 1997, J BIOL CHEM, V272, P31561, DOI 10.1074/jbc.272.50.31561; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192; Rees MLJ, 2007, NEUROMUSCULAR DISORD, V17, P123, DOI 10.1016/j.nmd.2006.11.003; Rodriguez-Munoz R, 2008, BIOCHEM BIOPH RES CO, V375, P303, DOI 10.1016/j.bbrc.2008.07.135; Russo K, 2000, BIOCHEM BIOPH RES CO, V274, P93, DOI 10.1006/bbrc.2000.3103; SadouletPuccio HM, 1996, HUM MOL GENET, V5, P489, DOI 10.1093/hmg/5.4.489; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; Sumoy L, 2000, CYTOGENET CELL GENET, V88, P62, DOI 10.1159/000015486; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Veroni C, 2007, J NEUROSCI RES, V85, P2631, DOI 10.1002/jnr.21186; Waite A, 2009, ANN MED, V41, P344, DOI 10.1080/07853890802668522; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312	44	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24740	24750		10.1074/jbc.M109.090654	http://dx.doi.org/10.1074/jbc.M109.090654			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530487	Green Published, hybrid			2022-12-25	WOS:000280542100046
J	Watashi, K; Yeung, ML; Starost, MF; Hosmane, RS; Jeang, KT				Watashi, Koichi; Yeung, Man Lung; Starost, Matthew F.; Hosmane, Ramachandra S.; Jeang, Kuan-Teh			Identification of Small Molecules That Suppress MicroRNA Function and Reverse Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN TRBP; RNA-INTERFERENCE; EXPRESSION; GENE; DICER; HIV-1; KINASE; CELLS; LOCALIZATION; DEREGULATION	MicroRNAs (miRNAs) act in post-transcriptional gene silencing and are proposed to function in a wide spectrum of pathologies, including cancers and viral diseases. Currently, to our knowledge, no detailed mechanistic characterization of small molecules that interrupt miRNA pathways have been reported. In screening a small chemical library, we identified compounds that suppress RNA interference activity in cultured cells. Two compounds were characterized; one impaired Dicer activity while the other blocked small RNA-loading into an Argonaute 2 (AGO2) complex. We developed a cell-based model of miRNA-dependent tumorigenesis, and using this model, we observed that treatment of cells with either of the two compounds effectively neutralized tumor growth. These findings indicate that miRNA pathway-suppressing small molecules could potentially reverse tumorigenesis.	NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Starost, Matthew F.] NIH, Div Vet Resources, Bethesda, MD 20892 USA; [Hosmane, Ramachandra S.] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; University System of Maryland; University of Maryland Baltimore	Jeang, KT (corresponding author), 9000 Rockville Pike,Bldg 4,Rm 303A, Bethesda, MD 20892 USA.	kjeang@niaid.nih.gov	Jeang, Kuan-Teh/A-2424-2008; Yeung, Man Lung/E-9903-2010	Yeung, Man Lung/0000-0002-6117-7884	National Institutes of Health [1R01 GM087738-01A1]; NIAID; NIH; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 GM087738-01A1 (to R. S. H.) and by intramural funds from NIAID, NIH and the Intramural AIDS Targeted Antiviral Program from the office of the Director, NIH (to K.-T. J.).; A recipient of a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science.	Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bouzar AB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Garofalo M, 2008, CURR OPIN PHARMACOL, V8, P661, DOI 10.1016/j.coph.2008.06.005; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; Gou D, 2007, PHYSIOL GENOMICS, V31, P554, DOI 10.1152/physiolgenomics.00005.2007; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gumireddy K, 2008, ANGEW CHEM INT EDIT, V47, P7482, DOI 10.1002/anie.200801555; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Koesters R, 1999, GENOMICS, V61, P210, DOI 10.1006/geno.1999.5951; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leung AKL, 2006, COLD SPRING HARB SYM, V71, P29, DOI 10.1101/sqb.2006.71.049; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033	52	93	95	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24707	24716		10.1074/jbc.M109.062976	http://dx.doi.org/10.1074/jbc.M109.062976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529860	Green Published, hybrid			2022-12-25	WOS:000280542100043
J	Tchaicha, JH; Mobley, AK; Hossain, MG; Aldape, KD; McCarty, JH				Tchaicha, J. H.; Mobley, A. K.; Hossain, M. G.; Aldape, K. D.; McCarty, J. H.			A mosaic mouse model of astrocytoma identifies alpha v beta 8 integrin as a negative regulator of tumor angiogenesis	ONCOGENE			English	Article						glioma; glioblastoma multiforme; itgav; itgb8; TGF beta; astrocyte	GROWTH-FACTOR RECEPTOR; ALPHA-V INTEGRINS; NEURAL STEM-CELL; NEUROVASCULAR DEVELOPMENT; GLIOBLASTOMA-MULTIFORME; RADIAL GLIA; FACTOR-BETA; IN-VITRO; ACTIVATION; GLIOMA	Angiogenesis involves a complex set of cell-cell and cell-extracellular matrix (ECM) interactions that coordinately promote and inhibit blood vessel growth and sprouting. Although many factors that promote angiogenesis have been characterized, the identities and mechanisms of action of endogenous inhibitors of angiogenesis remain unclear. Furthermore, little is known about how cancer cells selectively circumvent the actions of these inhibitors to promote pathological angiogenesis, a requisite event for tumor progression. Using mosaic mouse models of the malignant brain cancer, astrocytoma, we report that tumor cells induce pathological angiogenesis by suppressing expression of the ECM protein receptor alpha v beta 8 integrin. Diminished integrin expression in astrocytoma cells leads to reduced activation of latent TGF beta s, resulting in impaired TGF beta receptor signaling in tumor-associated endothelial cells. These data reveal that astrocytoma cells manipulate their angiogenic balance by selectively suppressing avb8 integrin expression and function. Finally, these results show that an adhesion and signaling axis normally involved in developmental brain angiogenesis is pathologically exploited in adult brain tumors. Oncogene (2010) 29, 4460-4472; doi: 10.1038/onc.2010.199; published online 7 June 2010	[McCarty, J. H.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Canc Biol, Unit 173, Houston, TX 77030 USA; [Aldape, K. D.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	McCarty, JH (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Canc Biol, Unit 173, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jhmccarty@mdanderson.org			National Institutes of Neurological Disease and Stroke [R01NS059876]; National Cancer Institute [P50CA127001, CA-16672]; Ellison Medical Foundation [AG-NS-0324-06]; NATIONAL CANCER INSTITUTE [P50CA127001, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059876] Funding Source: NIH RePORTER	National Institutes of Neurological Disease and Stroke; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Nami McCarty for providing assistance with FACS analysis and Dr Russell Pieper for generously providing E6/E7 and <SUP>G12V</SUP>H-Ras plasmids. This research was supported by grants awarded to JHM from the National Institutes of Neurological Disease and Stroke (R01NS059876), the National Cancer Institute (P50CA127001) and the Ellison Medical Foundation (AG-NS-0324-06). This work was also supported in part by a National Cancer Institute core grant (CA-16672) awarded to The University of Texas MD Anderson Cancer Center.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; BOGLER O, 1995, CANCER RES, V55, P2746; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cheng SY, 1997, P NATL ACAD SCI USA, V94, P12081, DOI 10.1073/pnas.94.22.12081; Cheng SY, 1996, P NATL ACAD SCI USA, V93, P8502, DOI 10.1073/pnas.93.16.8502; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kanamori M, 2004, CANCER RES, V64, P2751, DOI 10.1158/0008-5472.CAN-03-3354; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McCarty JH, 2005, P NATL ACAD SCI USA, V102, P13479, DOI 10.1073/pnas.0506068102; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; McCarty JH, 2008, AM J PATHOL, V172, P1740, DOI 10.2353/ajpath.2008.070700; McCarty JH, 2009, CELL ADHES MIGR, V3, P211, DOI 10.4161/cam.3.2.7767; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Milner R, 2001, MOL CELL NEUROSCI, V18, P108, DOI 10.1006/mcne.2001.1003; Mobley AK, 2009, J CELL SCI, V122, P1842, DOI 10.1242/jcs.043257; Mori T, 2005, CURR TOP DEV BIOL, V69, P67, DOI 10.1016/S0070-2153(05)69004-7; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; Riemenschneider MJ, 2005, AM J PATHOL, V167, P1379, DOI 10.1016/S0002-9440(10)61225-4; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skuli N, 2009, CANCER RES, V69, P3308, DOI 10.1158/0008-5472.CAN-08-2158; Sonoda Y, 2003, CANCER RES, V63, P1962; Sonoda Y, 2001, CANCER RES, V61, P4956; Sonoda Y, 2001, CANCER RES, V61, P6674; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Uhrbom L, 2002, CANCER RES, V62, P5551; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhu JW, 2002, DEVELOPMENT, V129, P2891	47	31	31	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2010	29	31					4460	4472		10.1038/onc.2010.199	http://dx.doi.org/10.1038/onc.2010.199			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	634DG	20531304	Green Accepted			2022-12-25	WOS:000280559100009
J	Le, PU; Angers-Loustau, A; de Oliveira, RMW; Ajlan, A; Brassard, CL; Dudley, A; Brent, H; Siu, V; Trinh, G; Molenkamp, G; Wang, J; Sadr, MS; Bedell, B; Del Maestro, RF; Petrecca, K				Le, P. U.; Angers-Loustau, A.; de Oliveira, R. M. W.; Ajlan, A.; Brassard, C. L.; Dudley, A.; Brent, H.; Siu, V.; Trinh, G.; Moelenkamp, G.; Wang, J.; Sadr, M. Seyed; Bedell, B.; Del Maestro, R. F.; Petrecca, K.			DRR drives brain cancer invasion by regulating cytoskeletal-focal adhesion dynamics	ONCOGENE			English	Article						brain cancer; cytoskeleton; cell invasion	CELL INVASION; MYOSIN-II; MIGRATION; MORPHOGENESIS; MICROTUBULES; SRC	Malignant glioma invasion is a primary cause of brain cancer treatment failure, yet the molecular mechanisms underlying its regulation remain elusive. We developed a novel functional-screening strategy and identified downregulated in renal cell carcinoma (DRR) as a regulator of invasion. We show that DRR drives invasion in vitro and in vivo. We found that while DRR is not expressed in normal glial cells, it is highly expressed in the invasive component of gliomas. Exploring underlying mechanisms, we show that DRR associates with and organizes the actin and microtubular cytoskeletons and that these associations are essential for focal adhesion (FA) disassembly and cell invasion. These findings identify DRR as a new cytoskeletal crosslinker that regulates FA dynamics and cell movement. Oncogene (2010) 29, 4636-4647; doi:10.1038/onc.2010.216; published online 14 June 2010	[Le, P. U.; Angers-Loustau, A.; de Oliveira, R. M. W.; Ajlan, A.; Brassard, C. L.; Dudley, A.; Brent, H.; Siu, V.; Trinh, G.; Moelenkamp, G.; Wang, J.; Sadr, M. Seyed; Bedell, B.; Del Maestro, R. F.; Petrecca, K.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada	McGill University	Petrecca, K (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, 3801 Univ Ave,Suite 109C, Montreal, PQ H3A 2B4, Canada.	kevin.petrecca@mcgill.ca		Angers-Loustau, Alexandre/0000-0003-1425-4143	Goals for Lily; Alex Pavanel Family; Franco Di Giovanni Funds for Brain Tumor Research; Montreal English School Board; B-Strong Foundation; Montreal Neurological Institute; Canadian Institute of Health Research; National Cancer Institute of Canada	Goals for Lily; Alex Pavanel Family; Franco Di Giovanni Funds for Brain Tumor Research; Montreal English School Board; B-Strong Foundation; Montreal Neurological Institute; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS))	We are grateful to Carmen Sabau for her technical expertise. This work was supported by Goals for Lily, the Alex Pavanel Family, the Franco Di Giovanni Funds for Brain Tumor Research, the Montreal English School Board, the B-Strong Foundation to RFDM, and the Montreal Neurological Institute to KP. RMWO was supported by the Canadian Institute of Health Research doctoral fellowship. AAL was supported by the National Cancer Institute of Canada Terry Fox sStudentship.	Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fernandez C, 2003, NEUROSURGERY, V53, P544, DOI 10.1227/01.NEU.0000079330.01541.6E; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kleihues P, 2000, PATHOLOGY GENETICS T; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; LAUUFFENBURGER DA, 1996, CELL, V84, P359; Louis DN, 2002, CANCER CELL, V1, P125, DOI 10.1016/S1535-6108(02)00040-5; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; PEDERSEN PH, 1995, INT J CANCER, V62, P767, DOI 10.1002/ijc.2910620620; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Salhia B, 2006, EXPERT REV MOL DIAGN, V6, P613, DOI 10.1586/14737159.6.4.613; van den Boom J, 2006, INT J CANCER, V119, P2330, DOI 10.1002/ijc.22108; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Wang L, 2000, GENE CHROMOSOME CANC, V27, P1, DOI 10.1002/(SICI)1098-2264(200001)27:1<1::AID-GCC1>3.0.CO;2-6; Wang LM, 2008, PLOS BIOL, V6, P2496, DOI 10.1371/journal.pbio.0060289; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	29	24	28	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2010	29	33					4636	4647		10.1038/onc.2010.216	http://dx.doi.org/10.1038/onc.2010.216			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20543869				2022-12-25	WOS:000281127400003
J	Deghorain, M; Fontaine, L; David, B; Mainardi, JL; Courtin, P; Daniel, R; Errington, J; Sorokin, A; Bolotin, A; Chapot-Chartier, MP; Hallet, B; Hols, P				Deghorain, Marie; Fontaine, Laetitia; David, Blandine; Mainardi, Jean-Luc; Courtin, Pascal; Daniel, Richard; Errington, Jeff; Sorokin, Alexei; Bolotin, Alexander; Chapot-Chartier, Marie-Pierre; Hallet, Bernard; Hols, Pascal			Functional and Morphological Adaptation to Peptidoglycan Precursor Alteration in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL SYNTHESIS; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN RESISTANCE; IDENTIFICATION; MORPHOGENESIS; MUTANTS	Cell wall peptidoglycan assembly is a tightly regulated process requiring the combined action of multienzyme complexes. In this study we provide direct evidence showing that substrate transformations occurring at the different stages of this process play a crucial role in the spatial and temporal coordination of the cell wall synthesis machinery. Peptidoglycan substrate alteration was investigated in the Gram-positive bacterium Lactococcus lactis by substituting the peptidoglycan precursor biosynthesis genes of this bacterium for those of the vancomycin-resistant bacterium Lactobacillus plantarum. A set of L. lactis mutant strains in which the normal D-Ala-ended precursors were partially or totally replaced by D-Lac-ended precursors was generated. Incorporation of the altered precursor into the cell wall induced morphological changes arising from a defect in cell elongation and cell separation. Structural analysis of the muropeptides confirmed that the activity of multiple enzymes involved in peptidoglycan synthesis was altered. Optimization of this altered pathway was necessary to increase the level of vancomycin resistance conferred by the utilization of D-Lac-ended peptidoglycan precursors in the mutant strains. The implications of these findings on the control of bacterial cell morphogenesis and the mechanisms of vancomycin resistance are discussed.	[Hallet, Bernard] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium; [Mainardi, Jean-Luc] Ctr Rech Cordeliers, Equipe 12, INSERM, LRMA,U872, F-75006 Paris, France; [Mainardi, Jean-Luc] Univ Paris 06, UMR S 872, F-75006 Paris, France; [Mainardi, Jean-Luc] Univ Paris 05, UMR S872, F-75006 Paris, France; [Mainardi, Jean-Luc] Hop Europeen Georges Pompidou, AP HP, F-75015 Paris, France; [Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Daniel, Richard; Errington, Jeff] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Sorokin, Alexei; Bolotin, Alexander] CRJ INRA, TGU MICALIS, Genome Anal Team ANALGEN, F-78352 Jouy En Josas, France	Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Newcastle University - UK; INRAE	Hallet, B (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium.	Bernard.Hallet@uclouvain.be	Sorokin, Alexei/AAV-4666-2020; Errington, Jeff/G-1832-2011; Daniel, Richard A./I-2850-2019; MAINARDI, Jean-Luc/E-2714-2014; Bolotine, Alexandre/AAW-1156-2020	Sorokin, Alexei/0000-0002-8653-9896; Errington, Jeff/0000-0002-6977-9388; Daniel, Richard A./0000-0002-6483-5897; MAINARDI, Jean-Luc/0000-0002-4159-0129; Bolotine, Alexandre/0000-0002-5878-8270; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	Fonds Speciaux de la Recherche (Universite Catholique de Louvain); Fonds National de la Recherche Scientifique; Actions de Recherche Concertees (Communaute Francaise de Belgique); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; European Molecular Biology Organization; INRA	Fonds Speciaux de la Recherche (Universite Catholique de Louvain); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees (Communaute Francaise de Belgique); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); INRA	This work was supported by Fonds Speciaux de la Recherche (Universite Catholique de Louvain), Fonds National de la Recherche Scientifique, and Actions de Recherche Concertees (Communaute Francaise de Belgique). This work was also supported by a grant from the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom, and a short-term European Molecular Biology Organization fellowship (to M. D.).; We warmly thank J. Delcour for helpful discussions and scientific advice. We are grateful to M. Arthur for the MS/MS determination of muropeptides I and II and to A. Marnef for the construction of the MD006 strain. We thank Dr. S. Kulakauskas for help in L. lactis MD003-128 sequencing and Dr. S. Kennedy and N. Galleron (MetaQuant sequencing platform) for preparing the amplicon libraries and for preliminary data analysis. Sequencing of MD003-128 was supported in part by the program AIP BioRessources 2009 of INRA (project SOLIMUT).	Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Arthur M, 1996, MOL MICROBIOL, V21, P33, DOI 10.1046/j.1365-2958.1996.00617.x; ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; BEGG KJ, 1990, J BACTERIOL, V172, P6697, DOI 10.1128/jb.172.12.6697-6703.1990; BillotKlein D, 1996, BIOCHEM J, V313, P711, DOI 10.1042/bj3130711; Bouhss A, 2002, J BIOL CHEM, V277, P45935, DOI 10.1074/jbc.M207449200; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Carballido-Lopez R, 2007, CURR OPIN MICROBIOL, V10, P611, DOI 10.1016/j.mib.2007.09.008; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Deghorain M, 2007, J BACTERIOL, V189, P4332, DOI 10.1128/JB.01829-06; deJonge BLM, 1996, MICROB DRUG RESIST, V2, P225, DOI 10.1089/mdr.1996.2.225; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Ferain T, 1996, J BACTERIOL, V178, P5431, DOI 10.1128/JB.178.18.5431-5437.1996; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; LLEO MM, 1990, J BACTERIOL, V172, P3758, DOI 10.1128/jb.172.7.3758-3771.1990; Morlot C, 2004, MOL MICROBIOL, V51, P1641, DOI 10.1046/j.1365-2958.2003.03953.x; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; SCHUSTER C, 1990, J BACTERIOL, V172, P6499, DOI 10.1128/jb.172.11.6499-6505.1990; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Severin A, 2004, J BIOL CHEM, V279, P3398, DOI 10.1074/jbc.M309593200; Thibessard A, 2002, J BACTERIOL, V184, P2821, DOI 10.1128/JB.184.10.2821-2826.2002; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	36	8	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24003	24013		10.1074/jbc.M110.143636	http://dx.doi.org/10.1074/jbc.M110.143636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525686	hybrid, Green Published			2022-12-25	WOS:000280291400051
J	McCormick, N; Velasquez, V; Finney, L; Vogt, S; Kelleher, SL				McCormick, Nicholas; Velasquez, Vanessa; Finney, Lydia; Vogt, Stefan; Kelleher, Shannon L.			X-Ray Fluorescence Microscopy Reveals Accumulation and Secretion of Discrete Intracellular Zinc Pools in the Lactating Mouse Mammary Gland	PLOS ONE			English	Article							MITOCHONDRIAL-FUNCTION; MILK SECRETION; PROLACTIN PRL; IN-VIVO; PROSTATE; TRANSPORTER; EXPRESSION; SELENIUM; LOCALIZATION; PATHWAYS	Background: The mammary gland is responsible for the transfer of a tremendous amount of zinc (similar to 1-3 mg zinc/day) from maternal circulation into milk during lactation to support the growth and development of the offspring. When this process is compromised, severe zinc deficiency compromises neuronal development and immune function and increases infant morbidity and/or mortality. It remains unclear as to how the lactating mammary gland dynamically integrates zinc import from maternal circulation with the enormous amount of zinc that is secreted into milk. Methodology/Principal Findings: Herein we utilized X-ray fluorescence microscopy (XFM) which allowed for the visualization and quantification of the process of zinc transfer through the mammary gland of the lactating mouse. Our data illustrate that a large amount of zinc first accumulates in the mammary gland during lactation. Interestingly, this zinc is not cytosolic, but accumulated in large, discrete sub-cellular compartments. These zinc pools were then redistributed to small intracellular vesicles destined for secretion in a prolactin-responsive manner. Confocal microscopy identified mitochondria and the Golgi apparatus as the sub-cellular compartments which accumulate zinc; however, zinc pools in the Golgi apparatus, but not mitochondria are redistributed to vesicles destined for secretion during lactation. Conclusions/Significance: Our data directly implicate the Golgi apparatus in providing a large, mobilizable zinc storage pool to assist in providing for the tremendous amount of zinc that is secreted into milk. Interestingly, our study also provides compelling evidence that mitochondrial zinc pools expand in the mammary gland during lactation which we speculate may play a role in regulating mammary gland function.	[McCormick, Nicholas; Velasquez, Vanessa; Kelleher, Shannon L.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Finney, Lydia; Vogt, Stefan] Argonne Natl Lab, Argonne, IL 60439 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Argonne National Laboratory	McCormick, N (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA.	slk39@psu.edu	Vogt, Stefan/B-9547-2009; Vogt, Stefan/J-7937-2013	Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, HD058614]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058614] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357 and HD058614 to SLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLAND ML, 1992, J NUTR, V122, P1214, DOI 10.1093/jn/122.6.1214; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bratter P, 1997, J TRACE ELEM MED BIO, V11, P203; CAVALETTO M, 2008, MILK FAT GLOBULE MEM, P129; Cerveza PJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P451, DOI 10.1006/abbi.1999.1572; Chi ZH, 2006, NEUROREPORT, V17, P1807, DOI 10.1097/01.wnr.0000239968.06438.c5; Conesa C, 2008, COMP BIOCHEM PHYS B, V150, P131, DOI 10.1016/j.cbpb.2008.02.005; Cooke PS, 2004, TOXICOL APPL PHARM, V194, P309, DOI 10.1016/j.taap.2003.09.016; Costello LC, 2005, MITOCHONDRION, V5, P143, DOI 10.1016/j.mito.2005.02.001; Costello LC, 2000, J INORG BIOCHEM, V78, P161, DOI 10.1016/S0162-0134(99)00225-1; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; EIDE DJ, 2003, SLC39 FAMILY METAL I; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; FLINT DJ, 1994, ENDOCRINOLOGY, V135, P1119, DOI 10.1210/en.135.3.1119; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Guan ZX, 2003, J INORG BIOCHEM, V97, P199, DOI 10.1016/S0162-0134(03)00291-5; HISAYASU S, 1991, INT J HEMATOL, V54, P201; Hoac T, 2007, J AGR FOOD CHEM, V55, P4237, DOI 10.1021/jf070169x; Huang L, 2007, J BIOL CHEM, V282, P37053, DOI 10.1074/jbc.M706631200; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Jahn GA, 1997, BIOL REPROD, V57, P894, DOI 10.1095/biolreprod57.4.894; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kelleher SL, 2009, GENES NUTR, V4, P83, DOI 10.1007/s12263-009-0119-4; Kelleher SL, 2005, AM J PHYSIOL-CELL PH, V288, pC1042, DOI 10.1152/ajpcell.00471.2004; KELLEHER SL, 2009, NUTR TRANSFER MAMMAR, P15; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Leong WI, 2005, AM J CLIN NUTR, V81, P445; Leong WI, 2003, AM J PHYSIOL-GASTR L, V285, pG1153, DOI 10.1152/ajpgi.00107.2003; LINZELL JL, 1975, J PHYSIOL-LONDON, V253, P547, DOI 10.1113/jphysiol.1975.sp011206; Liu Y, 1997, PROSTATE, V30, P26, DOI 10.1002/(SICI)1097-0045(19970101)30:1<26::AID-PROS4>3.0.CO;2-J; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Matsuki N, 2005, J MEMBRANE BIOL, V203, P119, DOI 10.1007/s00232-005-0736-9; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; MICHALKE B, 1991, J TRACE ELEM ELECT H, V5, P251; Ortega R, 2009, TOXICOL LETT, V188, P26, DOI 10.1016/j.toxlet.2009.02.024; PALMITER RD, 2003, ABC SOLUTE CARRIERS; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Rofe AM, 1999, PANCREAS, V19, P69, DOI 10.1097/00006676-199907000-00011; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 2002, NEUROBIOL DIS, V10, P100, DOI 10.1006/nbdi.2002.0493; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Sorensen MB, 1997, PROSTATE, V31, P125, DOI 10.1002/(SICI)1097-0045(19970501)31:2<125::AID-PROS8>3.0.CO;2-M; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Taylor KM, 2008, BIOCHEM SOC T, V36, P1247, DOI 10.1042/BST0361247; Wellenreuther G, 2009, BIOCHEM BIOPH RES CO, V380, P198, DOI 10.1016/j.bbrc.2009.01.074; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106	53	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11078	10.1371/journal.pone.0011078	http://dx.doi.org/10.1371/journal.pone.0011078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552032	gold, Green Submitted, Green Published			2022-12-25	WOS:000278662900018
J	Bang, C; Sabo, JL; Faeth, SH				Bang, Christofer; Sabo, John L.; Faeth, Stanley H.			Reduced Wind Speed Improves Plant Growth in a Desert City	PLOS ONE			English	Article							URBAN HEAT-ISLAND; ENCELIA-FARINOSA; BOUNDARY-LAYER; MECHANICAL STIMULI; SPECIES RICHNESS; SONORAN DESERT; BIOMASS; TEMPERATURE; PUBESCENCE; SHRUB	Background: The often dramatic effects of urbanization on community and ecosystem properties, such as primary productivity, abundances, and diversity are now well-established. In most cities local primary productivity increases and this extra energy flows upwards to alter diversity and relative abundances in higher trophic levels. The abiotic mechanisms thought to be responsible for increases in urban productivity are altered temperatures and light regimes, and increased nutrient and water inputs. However, another abiotic factor, wind speed, is also influenced by urbanization and well known for altering primary productivity in agricultural systems. Wind effects on primary productivity have heretofore not been studied in the context of urbanization. Methodology/Principal Findings: We designed a field experiment to test if increased plant growth often observed in cities is explained by the sheltering effects of built structures. Wind speed was reduced by protecting Encelia farinosa (brittlebush) plants in urban, desert remnant and outlying desert localities via windbreaks while controlling for water availability and nutrient content. In all three habitats, we compared E. farinosa growth when protected by experimental windbreaks and in the open. E. farinosa plants protected against ambient wind in the desert and remnant areas grew faster in terms of biomass and height than exposed plants. As predicted, sheltered plants did not differ from unprotected plants in urban areas where wind speed is already reduced. Conclusion/Significance: Our results indicate that reductions in wind speed due to built structures in cities contribute to increased plant productivity and thus also to changes in abundances and diversity of higher trophic levels. Our study emphasizes the need to incorporate wind speed in future urban ecological studies, as well as in planning for green space and sustainable cities.	[Bang, Christofer] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Sabo, John L.] Arizona State Univ, Fac Ecol Evolut & Environm Sci, Sch Life Sci, Tempe, AZ USA; [Faeth, Stanley H.] Univ N Carolina, Greensboro, NC 27412 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of North Carolina; University of North Carolina Greensboro	Bang, C (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	christofer.bang@gmail.com	Bang, Christofer/I-5732-2012		National Science Foundation (NSF) [DEB-0423704, DEB 0444228]; Central Arizona - Phoenix Long-Term Ecological Research (CAP LTER); Division Of Environmental Biology [1026865] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Central Arizona - Phoenix Long-Term Ecological Research (CAP LTER); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DEB-0423704, Central Arizona - Phoenix Long-Term Ecological Research (CAP LTER) and NSF DEB 0444228 to SHF and JLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHALO PJ, 1993, PLANT CELL ENVIRON, V16, P771, DOI 10.1111/j.1365-3040.1993.tb00499.x; Baker Lawrence A., 2002, Urban Ecosystems, V6, P183, DOI 10.1023/A:1026101528700; Bejaran RA, 2003, THEOR APPL CLIMATOL, V74, P93, DOI 10.1007/s00704-002-0714-4; BROWN MA, 1910, P IOWA ACAD SCI, V17, P13; Cardskadden H, 1998, J ENVIRON MANAGE, V52, P183, DOI 10.1006/jema.1997.0170; CHANGNON SA, 1992, B AM METEOROL SOC, V73, P619, DOI 10.1175/1520-0477(1992)073<0619:IWMIUA>2.0.CO;2; Cleugh HA, 1998, AGROFOREST SYST, V41, P85, DOI 10.1023/A:1006067721039; Colding J, 2007, LANDSCAPE URBAN PLAN, V81, P46, DOI 10.1016/j.landurbplan.2006.10.016; Coutand C, 2008, ANN BOT-LONDON, V101, P1421, DOI 10.1093/aob/mcn054; Daudet FA, 1999, AGR FOREST METEOROL, V97, P171, DOI 10.1016/S0168-1923(99)00079-9; EHLERINGER J, 1982, AM J BOT, V69, P670, DOI 10.2307/2442956; EHLERINGER JR, 1978, OECOLOGIA, V36, P151, DOI 10.1007/BF00349805; EHLERINGER JR, 1978, OECOLOGIA, V37, P183, DOI 10.1007/BF00344990; Ellis AW, 2000, CLIMATE RES, V15, P13, DOI 10.3354/cr015013; Ennos AR, 1997, TRENDS ECOL EVOL, V12, P108, DOI 10.1016/S0169-5347(96)10066-5; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Fernandez P, 2007, BASIC APPL ECOL, V8, P97, DOI 10.1016/j.baae.2006.05.001; FINNELL H. H., 1928, JOUR AMER SOC AGRON, V20, P1206; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Gedge D., 2005, BIOLOGIST, V52, P161; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; Gober P., 2006, METROPOLITAN PHOENIX, DOI DOI 10.9783/9780812205824; Goyal P, 2002, ATMOS ENVIRON, V36, P2071, DOI 10.1016/S1352-2310(01)00458-7; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hodges L, 2004, HORTSCIENCE, V39, P996, DOI 10.21273/HORTSCI.39.5.996; Housman DC, 2002, AM J BOT, V89, P1303, DOI 10.3732/ajb.89.8.1303; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; JAFFE MJ, 1980, BIOSCIENCE, V30, P239, DOI 10.2307/1307878; Jongejans E, 2006, OECOLOGIA, V147, P369, DOI 10.1007/s00442-005-0325-8; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; KUNZE A, 1995, BIOCHEM SYST ECOL, V23, P355, DOI 10.1016/0305-1978(95)00028-S; Kuttler W., 2008, URBAN ECOLOGY INT PE, P233, DOI [10.1007/978-0-387-73412-5_13, DOI 10.1007/978-0-387-73412-5_13]; LANDSBERG HE, 1970, SCIENCE, V170, P1265, DOI 10.1126/science.170.3964.1265; LEE DO, 1979, ATMOS ENVIRON, V13, P1175, DOI 10.1016/0004-6981(79)90042-8; Lee SH, 2010, THEOR APPL CLIMATOL, V100, P227, DOI 10.1007/s00704-009-0247-1; Lewis DB, 2006, GLOBAL CHANGE BIOL, V12, P703, DOI 10.1111/j.1365-2486.2006.01126.x; Li F, 2008, EUR PHYS J D, V50, P75, DOI 10.1140/epjd/e2008-00201-5; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; MALIK MNA, 1981, AUST J PLANT PHYSIOL, V8, P285, DOI 10.1071/PP9810285; Martin CA, 2002, J ARID ENVIRON, V51, P235, DOI 10.1006/jare.2001.0946; MARTIN E. V., 1935, PLANT PHYSIOL, V10, P613, DOI 10.1104/pp.10.4.613; McGranahan G, 2005, MILLENNIUM ECOSYSTEM, V1; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Miao SG, 2009, ADV ATMOS SCI, V26, P1115, DOI 10.1007/s00376-009-7223-7; Miao SG, 2009, J APPL METEOROL CLIM, V48, P484, DOI 10.1175/2008JAMC1909.1; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; MOEN AN, 1974, ECOLOGY, V55, P1420, DOI 10.2307/1935471; MONSON RK, 1992, FUNCT ECOL, V6, P751, DOI 10.2307/2389973; MOONEY HA, 1976, SCIENCE, V194, P322, DOI 10.1126/science.194.4262.322; Morris CJG, 2001, J APPL METEOROL, V40, P169, DOI 10.1175/1520-0450(2001)040<0169:QOTIOW>2.0.CO;2; MURRAY RB, 1982, J RANGE MANAGE, V35, P451, DOI 10.2307/3898603; Nobel PS, 1997, ANN BOT-LONDON, V80, P731, DOI 10.1006/anbo.1997.0508; Nobel PS, 1998, PHOTOSYNTH RES, V56, P67, DOI 10.1023/A:1006079631961; NOWAK DJ, 1993, J ENVIRON MANAGE, V37, P207, DOI 10.1006/jema.1993.1017; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; RAO V. PANDURANGA, 1938, BULL TORREY BOT CLUB, V65, P229, DOI 10.2307/2480924; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Russell G., 1978, J APPL ECOL, V16, P507; Sandquist DR, 2003, AM J BOT, V90, P1481, DOI 10.3732/ajb.90.10.1481; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Snep R, 2009, LANDSCAPE URBAN PLAN, V91, P26, DOI 10.1016/j.landurbplan.2008.11.007; Stopa-Boryczka M, 1990, URBAN ECOLOGICAL STU, P26; Turbill C, 2008, J ZOOL, V276, P285, DOI 10.1111/j.1469-7998.2008.00487.x; UN, 2008, WORLD URB PROSP 2007; Van der Veken S, 2004, FLORA, V199, P516, DOI 10.1078/0367-2530-00180; von Stulpnagel A., 1990, URBAN ECOL, P175; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WHITEHEAD F. H., 1962, NEW PHYTOL, V61, P59, DOI 10.1111/j.1469-8137.1962.tb06274.x; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Williams NSG, 2009, J ECOL, V97, P4, DOI 10.1111/j.1365-2745.2008.01460.x; Wilson JD, 2003, BOUND-LAY METEOROL, V109, P191, DOI 10.1023/A:1025414805676; ZHANG HH, 1995, AUST J PLANT PHYSIOL, V22, P833, DOI 10.1071/PP9950833	76	32	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11061	10.1371/journal.pone.0011061	http://dx.doi.org/10.1371/journal.pone.0011061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548790	Green Published, gold			2022-12-25	WOS:000278599600018
J	Kita, Y; Gunji, A; Sakihara, K; Inagaki, M; Kaga, M; Nakagawa, E; Hosokawa, T				Kita, Yosuke; Gunji, Atsuko; Sakihara, Kotoe; Inagaki, Masumi; Kaga, Makiko; Nakagawa, Eiji; Hosokawa, Toru			Scanning Strategies Do Not Modulate Face Identification: Eye-Tracking and Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							OXYGENATED HEMOGLOBIN; PREFRONTAL CORTEX; UNFAMILIAR FACES; OWN FACE; SELF; RECOGNITION; AUTISM; FIXATION; FAMILIAR; CHILDREN	Background: During face identification in humans, facial information is sampled (seeing) and handled (processing) in ways that are influenced by the kind of facial image type, such as a self-image or an image of another face. However, the relationship between seeing and information processing is seldom considered. In this study, we aimed to reveal this relationship using simultaneous eye-tracking measurements and near-infrared spectroscopy (NIRS) in face identification tasks. Methodology/Principal Findings: 22 healthy adult subjects (8 males and 14 females) were shown facial morphing movies in which an initial facial image gradually changed into another facial image (that is, the subject's own face was changed to a familiar face). The fixation patterns on facial features were recorded, along with changes in oxyhemoglobin (oxyHb) levels in the frontal lobe, while the subjects identified several faces. In the self-face condition (self-face as the initial image), hemodynamic activity around the right inferior frontal gyrus (IFG) was significantly greater than in the familiar-face condition. On the other hand, the scanning strategy was similar in almost all conditions with more fixations on the eyes and nose than on other areas. Fixation time on the eye area did not correlate with changes in oxyHb levels, and none of the scanning strategy indices could estimate the hemodynamic changes. Conclusions/Significance: We conclude that hemodynamic activity, i.e., the means of processing facial information, is not always modulated by the face-scanning strategy, i.e., the way of seeing, and that the right IFG plays important roles in both self-other facial discrimination and self-evaluation.	[Kita, Yosuke; Hosokawa, Toru] Tohoku Univ, Grad Sch Educ, Sendai, Miyagi 980, Japan; [Kita, Yosuke] Japan Soc Promot Sci, Tokyo, Japan; [Kita, Yosuke; Gunji, Atsuko; Sakihara, Kotoe; Inagaki, Masumi; Kaga, Makiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Dev Disorders, Tokyo, Japan; [Nakagawa, Eiji] Natl Ctr Hosp Neurol & Psychiat, Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan	Tohoku University; Japan Society for the Promotion of Science; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Kita, Y (corresponding author), Tohoku Univ, Grad Sch Educ, Sendai, Miyagi 980, Japan.	kitay@ncnp.go.jp	Gunji, Atsuko/O-6323-2014	Gunji, Atsuko/0000-0001-8908-8739	Japan Society for the Promotion of Science (JSPS) [20-8503]; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [4002]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported in part by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for the JSPS research fellows (20-8503 to YK) and a Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) Grant-in-Aid for Scientific Research on Innovative Areas (4002 to Ryusuke Kakigi and MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Bookheimer SY, 2008, J INT NEUROPSYCH SOC, V14, P922, DOI 10.1017/S135561770808140X; Bredart S, 2006, Q J EXP PSYCHOL, V59, P46, DOI 10.1080/17470210500343678; BRUCE V, 1982, BRIT J PSYCHOL, V73, P105, DOI 10.1111/j.2044-8295.1982.tb01795.x; Bushnell I.W.R., 1998, DEV SENSORY MOTOR CO, P69; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Devue C, 2009, COGNITION, V111, P114, DOI 10.1016/j.cognition.2009.01.003; Druzgal TJ, 2001, NEURON, V32, P947, DOI 10.1016/S0896-6273(01)00519-0; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; Gunji A, 2009, BRAIN DEV-JPN, V31, P139, DOI 10.1016/j.braindev.2008.04.011; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Kawakubo Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006881; Keenan JP, 2000, NEUROPSYCHOLOGIA, V38, P1047, DOI 10.1016/S0028-3932(99)00145-1; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Leon-Carrion J, 2008, BEHAV BRAIN RES, V193, P248, DOI 10.1016/j.bbr.2008.06.013; Marumo K, 2009, NEUROSCI RES, V63, P89, DOI 10.1016/j.neures.2008.10.012; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Morris JP, 2007, SOC COGN AFFECT NEUR, V2, P31, DOI 10.1093/scan/nsl023; Morris JP, 2007, HUM BRAIN MAPP, V28, P691, DOI 10.1002/hbm.20301; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Platek SM, 2008, BRAIN RES, V1232, P173, DOI 10.1016/j.brainres.2008.07.010; Sadato N, 2008, BRAIN IMAGING BEHAV, V2, P335, DOI 10.1007/s11682-008-9044-1; Sadr J, 2003, PERCEPTION, V32, P285, DOI 10.1068/p5027; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Stacey PC, 2005, BRIT J PSYCHOL, V96, P407, DOI 10.1348/000712605X47422; Sugiura M, 2006, NEUROIMAGE, V32, P1905, DOI 10.1016/j.neuroimage.2006.05.026; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Toyoda H, 2008, NEUROIMAGE, V39, P997, DOI 10.1016/j.neuroimage.2007.09.053; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; van der Geest JN, 2002, J CHILD PSYCHOL PSYC, V43, P669, DOI 10.1111/1469-7610.00055; Vogeley K, 1999, CONSCIOUS COGN, V8, P343, DOI 10.1006/ccog.1999.0394; YOUNG AW, 1985, PERCEPTION, V14, P737, DOI 10.1068/p140737	42	24	24	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11050	10.1371/journal.pone.0011050	http://dx.doi.org/10.1371/journal.pone.0011050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608QA	20548791	Green Published, Green Submitted, gold			2022-12-25	WOS:000278599600011
J	Niida, A; Imoto, S; Yamaguchi, R; Nagasaki, M; Miyano, S				Niida, Atsushi; Imoto, Seiya; Yamaguchi, Rui; Nagasaki, Masao; Miyano, Satoru			Gene Set-Based Module Discovery Decodes cis-Regulatory Codes Governing Diverse Gene Expression across Human Multiple Tissues	PLOS ONE			English	Article							ELEMENTS; MOTIFS; MOUSE	Decoding transcriptional programs governing transcriptomic diversity across human multiple tissues is a major challenge in bioinformatics. To address this problem, a number of computational methods have focused on cis-regulatory codes driving overexpression or underexpression in a single tissue as compared to others. On the other hand, we recently proposed a different approach to mine cis-regulatory codes: starting from gene sets sharing common cis-regulatory motifs, the method screens for expression modules based on expression coherence. However, both approaches seem to be insufficient to capture transcriptional programs that control gene expression in a subset of all samples. Especially, this limitation would be serious when analyzing multiple tissue data. To overcome this limitation, we developed a new module discovery method termed BEEM (Biclusering-based Extraction of Expression Modules) in order to discover expression modules that are functional in a subset of tissues. We showed that, when applied to expression profiles of human multiple tissues, BEEM finds expression modules missed by two existing approaches that are based on the coherent expression and the single tissue-specific differential expression. From the BEEM results, we obtained new insights into transcriptional programs controlling transcriptomic diversity across various types of tissues. This study introduces BEEM as a powerful tool for decoding regulatory programs from a compendium of gene expression profiles.	[Niida, Atsushi; Imoto, Seiya; Yamaguchi, Rui; Nagasaki, Masao; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	University of Tokyo	Niida, A (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan.	aniida@ims.u-tokyo.ac.jp		Miyano, Satoru/0000-0002-1753-6616; Nagasaki, Masao/0000-0002-4292-8785	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for the Global COE Program "Center of Education and Research for the Advanced Genome-Based Medicine" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Cheng Y., 2000, P 8 INT C INT SYST M, P93; Jakt LM, 2001, GENOME RES, V11, P112, DOI 10.1101/gr.148301; Kim SY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-330; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Niida Atsushi, 2010, V22, P121; Niida A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-71; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Smith AD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100114; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e10910	10.1371/journal.pone.0010910	http://dx.doi.org/10.1371/journal.pone.0010910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20544005	Green Published, gold, Green Submitted			2022-12-25	WOS:000278557600002
J	Arab, HH; Wani, G; Ray, A; Shah, ZI; Zhu, QZ; Wani, AA				Arab, Hany H.; Wani, Gulzar; Ray, Alo; Shah, Zubair I.; Zhu, Qianzheng; Wani, Altaf A.			Dissociation of CAK from Core TFIIH Reveals a Functional Link between XP-G/CS and the TFIIH Disassembly State	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; COCKAYNE-SYNDROME; DNA-REPAIR; IN-VIVO; XERODERMA-PIGMENTOSUM; HUMAN-CELLS; INDUCED UBIQUITINATION	Transcription factor II H (TFIIH) is comprised of core TFIIH and Cdk-activating kinase (CAK) complexes. Here, we investigated the molecular and cellular manifestation of the TFIIH compositional changes by XPG truncation mutations. We showed that both core TFIIH and CAK are rapidly recruited to damage sites in repair-proficient cells. Chromatin immunoprecipitation against TFIIH and CAK components revealed a physical engagement of CAK in nucleotide excision repair (NER). While XPD recruitment to DNA damage was normal, CAK was not recruited in severe XP-G and XP-G/CS cells, indicating that the associations of CAK and XPD to core TFIIH are differentially affected. A CAK inhibition approach showed that CAK activity is not required for assembling pre-incision machinery in vivo or for removing genomic photolesions. Instead, CAK is involved in Ser5-phosphorylation and UV-induced degradation of RNA polymerase II. The CAK inhibition impaired transcription from undamaged and UV-damaged reporter, and partially decreased transcription of p53-dependent genes. The overall results demonstrated that a) XP-G/CS mutations affect the disassembly state of TFIIH resulting in the dissociation of CAK, but not XPD from core TFIIH, and b) CAK activity is not essential for global genomic repair but involved in general transcription and damage-induced RNA polymerase II degradation.	[Arab, Hany H.; Wani, Gulzar; Ray, Alo; Zhu, Qianzheng; Wani, Altaf A.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Shah, Zubair I.; Wani, Altaf A.] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Shah, Zubair I.; Wani, Altaf A.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA; [Wani, Altaf A.] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; King Saud University	Arab, HH (corresponding author), Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA.	zhu.49@osu.edu; wani.2@osu.edu	Zhu, Qianzheng/A-4902-2013; Arab, Hany/AAF-3652-2020	Arab, Hany/0000-0002-4195-6901	National Institute of Environmental Health Sciences [ES2388, ES12991]; National Cancer Institute [CA93413]; NATIONAL CANCER INSTITUTE [R01CA093413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002388, R01ES012991] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by Public Health Service Grants ES2388 and ES12991 from National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) and CA93413 from National Cancer Institute (http://www.cancer.gov/) to AAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Andressoo JO, 2005, ADV EXP MED BIOL, V570, P45, DOI 10.1007/1-4020-3764-3_3; Araujo SJ, 2000, GENE DEV, V14, P349; Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; Bradsher J, 2000, J BIOL CHEM, V275, P2532, DOI 10.1074/jbc.275.4.2532; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Clarkson SG, 2003, BIOCHIMIE, V85, P1113, DOI 10.1016/j.biochi.2003.10.014; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Dunand-Sauthier I, 2005, J BIOL CHEM, V280, P7030, DOI 10.1074/jbc.M412228200; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Escargueil AE, 2008, J CELL SCI, V121, P1275, DOI 10.1242/jcs.023259; Evans E, 1997, EMBO J, V16, P625, DOI 10.1093/emboj/16.3.625; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gervais V, 2004, NAT STRUCT MOL BIOL, V11, P616, DOI 10.1038/nsmb782; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Giglia-Mari G, 2006, PLOS BIOL, V4, P952, DOI 10.1371/journal.pbio.0040156; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hoogstraten D, 2002, MOL CELL, V10, P1163, DOI 10.1016/S1097-2765(02)00709-8; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Lalle P, 2002, J INVEST DERMATOL, V118, P344, DOI 10.1046/j.0022-202x.2001.01673.x; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Lee SK, 2002, CELL, V109, P823, DOI 10.1016/S0092-8674(02)00795-X; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Malik S, 2008, J BIOL CHEM, V283, P6897, DOI 10.1074/jbc.M707649200; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Matsuno M, 2007, GENES CELLS, V12, P1289, DOI 10.1111/j.1365-2443.2007.01133.x; MAYNE LV, 1982, CANCER RES, V42, P1473; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nouspikel T, 1997, P NATL ACAD SCI USA, V94, P3116, DOI 10.1073/pnas.94.7.3116; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Scharer OD, 2008, DNA REPAIR, V7, P339, DOI 10.1016/j.dnarep.2007.10.007; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Thorel F, 2004, MOL CELL BIOL, V24, P10670, DOI 10.1128/MCB.24.24.10670-10680.2004; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; Tornaletti S, 1997, J BIOL CHEM, V272, P31719, DOI 10.1074/jbc.272.50.31719; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; VENKATACHALAM S, 1995, CARCINOGENESIS, V16, P2029, DOI 10.1093/carcin/16.9.2029; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang QE, 2003, DNA REPAIR, V2, P483, DOI 10.1016/S1568-7864(03)00002-8; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249; Yokoi M, 2000, J BIOL CHEM, V275, P9870, DOI 10.1074/jbc.275.13.9870; Zotter A, 2006, MOL CELL BIOL, V26, P8868, DOI 10.1128/MCB.00695-06	63	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11007	10.1371/journal.pone.0011007	http://dx.doi.org/10.1371/journal.pone.0011007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543986	gold, Green Submitted, Green Published			2022-12-25	WOS:000278494900019
J	Nagarajan, H; Butler, JE; Klimes, A; Qiu, Y; Zengler, K; Ward, J; Young, ND; Methe, BA; Palsson, BO; Lovley, DR; Barrett, CL				Nagarajan, Harish; Butler, Jessica E.; Klimes, Anna; Qiu, Yu; Zengler, Karsten; Ward, Joy; Young, Nelson D.; Methe, Barbara A.; Palsson, Bernhard O.; Lovley, Derek R.; Barrett, Christian L.			De Novo Assembly of the Complete Genome of an Enhanced Electricity-Producing Variant of Geobacter sulfurreducens Using Only Short Reads	PLOS ONE			English	Article							DNA-SEQUENCES; ALGORITHMS; REDUCTION; MATTER	State-of-the-art DNA sequencing technologies are transforming the life sciences due to their ability to generate nucleotide sequence information with a speed and quantity that is unapproachable with traditional Sanger sequencing. Genome sequencing is a principal application of this technology, where the ultimate goal is the full and complete sequence of the organism of interest. Due to the nature of the raw data produced by these technologies, a full genomic sequence attained without the aid of Sanger sequencing has yet to be demonstrated. We have successfully developed a four-phase strategy for using only next-generation sequencing technologies (Illumina and 454) to assemble a complete microbial genome de novo. We applied this approach to completely assemble the 3.7 Mb genome of a rare Geobacter variant (KN400) that is capable of unprecedented current production at an electrode. Two key components of our strategy enabled us to achieve this result. First, we integrated the two data types early in the process to maximally leverage their complementary characteristics. And second, we used the output of different short read assembly programs in such a way so as to leverage the complementary nature of their different underlying algorithms or of their different implementations of the same underlying algorithm. The significance of our result is that it demonstrates a general approach for maximizing the efficiency and success of genome assembly projects as new sequencing technologies and new assembly algorithms are introduced. The general approach is a meta strategy, wherein sequencing data are integrated as early as possible and in particular ways and wherein multiple assembly algorithms are judiciously applied such that the deficiencies in one are complemented by another.	[Nagarajan, Harish] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Nagarajan, Harish; Qiu, Yu; Zengler, Karsten; Palsson, Bernhard O.; Barrett, Christian L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Butler, Jessica E.; Klimes, Anna; Ward, Joy; Young, Nelson D.; Lovley, Derek R.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Methe, Barbara A.] J Craig Venter Inst, Dept Microbial & Environm Genom, Rockville, MD USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Amherst; J. Craig Venter Institute	Nagarajan, H (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA.	cbarrett@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785; Zengler, Karsten/0000-0002-8062-3296; Butler, Jessica/0000-0003-2054-3777	Office of Science, Biological and Environmental Research (BER), United States Department of Energy [DE-FC02-02ER63446]	Office of Science, Biological and Environmental Research (BER), United States Department of Energy(United States Department of Energy (DOE))	This research was supported by the Office of Science, Biological and Environmental Research (BER), United States Department of Energy, Cooperative Agreement No. DE-FC02-02ER63446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aury JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-603; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2010, NUCLEIC ACIDS RES; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Croucher NJ, 2009, NAT REV MICROBIOL, V7, P621, DOI 10.1038/nrmicro2211; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Lovley DR, 2008, CURR OPIN BIOTECH, V19, P564, DOI 10.1016/j.copbio.2008.10.005; Mahadevan R, 2006, APPL ENVIRON MICROB, V72, P1558, DOI 10.1128/AEM.72.2.1558-1568.2006; Mehta T, 2005, APPL ENVIRON MICROB, V71, P8634, DOI 10.1128/AEM.71.12.8634-8641.2005; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; PEARSON WR, 1995, P NATL ACAD SCI USA, V85, P2444; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Salzberg SL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000186; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	23	28	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10922	10.1371/journal.pone.0010922	http://dx.doi.org/10.1371/journal.pone.0010922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544019	Green Published, gold, Green Submitted			2022-12-25	WOS:000278494900001
J	Yamashita, A; Nishikawa, S; Rancourt, DE				Yamashita, Akihiro; Nishikawa, Sandi; Rancourt, Derrick E.			Identification of Five Developmental Processes during Chondrogenic Differentiation of Embryonic Stem Cells	PLOS ONE			English	Article							IN-VITRO; ENDOCHONDRAL OSSIFICATION; TISSUE REGENERATION; CARTILAGE FORMATION; MOUSE; LINEAGE; CHONDROCYTES; COMMITMENT; COLLAGEN; BONE	Background: Chondrogenesis is the complex process that leads to the establishment of cartilage and bone formation. Due to their ability to differentiate in vitro and mimic development, embryonic stem cells (ESCs) show great potential for investigating developmental processes. In this study, we used chondrogenic differentiation of ESCs as a model to analyze morphogenetic events during chondrogenesis. Methodology/Principal Findings: ESCs were differentiated into the chondrocyte lineage, forming small cartilaginous aggregates in suspension. Differentiated ESCs showed that chondrogenesis was typically characterized by five overlapping stages. During the first stage, cell condensation and aggregate formation was observed. The second stage was characterized by differentiation into chondrocytes and fibril scaffold formation within spherical aggregates. Deposition of cartilaginous extracellular matrix and cartilage formation were hallmarks of the third stage. Apoptosis of chondrocytes, hypertrophy and/or degradation of cartilage occurred during the fourth stage. Finally, during the fifth stage, bone replacement with membranous calcified tissues took place. Conclusions/Significance: We demonstrate that ESCs show the chondrogenic differentiation pathway from the pluripotent stem cell to terminal skeletogenesis through these five stages in vitro. During each stage, morphological changes acquired in preceding stages played an important role in further development as a scaffold or template in subsequent stages. The study of chondrogenesis via ESC differentiation may be informative to our further understanding of skeletal growth and regeneration.	[Yamashita, Akihiro; Nishikawa, Sandi; Rancourt, Derrick E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary	Yamashita, A (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	rancourt@ucalgary.ca			Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Regenerative Medicine Team Grant. AY is an Alberta Heritage Foundation of Medical Research Postdoctoral Fellow (07) and Japan Society for the Promotion of Science Postdoctoral Fellow for Research Abroad (08-09). DER is an Alberta Heritage Foundation for Medical Research Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hegert C, 2002, J CELL SCI, V115, P4617, DOI 10.1242/jcs.00171; Hoffman UM, 2003, J BONE JOINT SURG AM, V85A, P124, DOI 10.2106/00004623-200300002-00017; Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; James CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008693; Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kino-Oka M, 2005, TISSUE ENG, V11, P597, DOI 10.1089/ten.2005.11.597; Kramer J, 2005, CELL BIOL INT, V29, P139, DOI 10.1016/j.cellbi.2004.10.003; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795; Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329; Sugiki T, 2007, J CELL BIOCHEM, V100, P1240, DOI 10.1002/jcb.21125; Wescoe KE, 2008, CELL BIOCHEM BIOPHYS, V52, P85, DOI 10.1007/s12013-008-9029-0; Yamashita A, 2006, CLONING STEM CELLS, V8, P3, DOI 10.1089/clo.2006.8.3; Yamashita A, 2009, CELL DEATH DIFFER, V16, P278, DOI 10.1038/cdd.2008.149; Yamashita A, 2006, FEBS LETT, V580, P4121, DOI 10.1016/j.febslet.2006.06.057; Yamashita A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009663; zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1	26	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10998	10.1371/journal.pone.0010998	http://dx.doi.org/10.1371/journal.pone.0010998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539759	Green Submitted, Green Published, gold			2022-12-25	WOS:000278465900013
J	Raymond, B; Shaffer, SA; Sokolov, S; Woehler, EJ; Costa, DP; Einoder, L; Hindell, M; Hosie, G; Pinkerton, M; Sagar, PM; Scott, D; Smith, A; Thompson, DR; Vertigan, C; Weimerskirch, H				Raymond, Ben; Shaffer, Scott A.; Sokolov, Serguei; Woehler, Eric J.; Costa, Daniel P.; Einoder, Luke; Hindell, Mark; Hosie, Graham; Pinkerton, Matt; Sagar, Paul M.; Scott, Darren; Smith, Adam; Thompson, David R.; Vertigan, Caitlin; Weimerskirch, Henri			Shearwater Foraging in the Southern Ocean: The Roles of Prey Availability and Winds	PLOS ONE			English	Article							SHORT-TAILED SHEARWATERS; CONTINUOUS PLANKTON RECORDER; CENTRAL-PLACE FORAGER; SOOTY SHEARWATERS; PUFFINUS-GRISEUS; INTRODUCED PREDATORS; SATELLITE TELEMETRY; MYCTOPHID FISHES; FEEDING ECOLOGY; STOMACH OIL	Background: Sooty (Puffinus griseus) and short-tailed (P. tenuirostris) shearwaters are abundant seabirds that range widely across global oceans. Understanding the foraging ecology of these species in the Southern Ocean is important for monitoring and ecosystem conservation and management. Methodology/Principal Findings: Tracking data from sooty and short-tailed shearwaters from three regions of New Zealand and Australia were combined with at-sea observations of shearwaters in the Southern Ocean, physical oceanography, near-surface copepod distributions, pelagic trawl data, and synoptic near-surface winds. Shearwaters from all three regions foraged in the Polar Front zone, and showed particular overlap in the region around 140 degrees E. Short-tailed shearwaters from South Australia also foraged in Antarctic waters south of the Polar Front. The spatial distribution of shearwater foraging effort in the Polar Front zone was matched by patterns in large-scale upwelling, primary production, and abundances of copepods and myctophid fish. Oceanic winds were found to be broad determinants of foraging distribution, and of the flight paths taken by the birds on long foraging trips to Antarctic waters. Conclusions/Significance: The shearwaters displayed foraging site fidelity and overlap of foraging habitat between species and populations that may enhance their utility as indicators of Southern Ocean ecosystems. The results highlight the importance of upwellings due to interactions of the Antarctic Circumpolar Current with large-scale bottom topography, and the corresponding localised increases in the productivity of the Polar Front ecosystem.	[Raymond, Ben; Einoder, Luke; Hosie, Graham] Australian Antarctic Div, Kingston, Tas, Australia; [Shaffer, Scott A.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Sokolov, Serguei] CSIRO Marine Res & Antarctic Climate & Ecosyst, CSIRO Wealth Oceans Natl Res Flagship, Cooperat Res Ctr, Hobart, Tas, Australia; [Woehler, Eric J.; Hindell, Mark; Vertigan, Caitlin] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Costa, Daniel P.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Pinkerton, Matt; Thompson, David R.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Sagar, Paul M.] Natl Inst Water & Atmospher Res Ltd, Christchurch, New Zealand; [Scott, Darren] Univ Otago, Dept Zool, Dunedin, New Zealand; [Smith, Adam] Massey Univ, Inst Informat & Math Sci, Auckland, New Zealand; [Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	Australian Antarctic Division; California State University System; San Jose State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; University of California System; University of California Santa Cruz; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Otago; Massey University; Centre National de la Recherche Scientifique (CNRS)	Raymond, B (corresponding author), Australian Antarctic Div, Kingston, Tas, Australia.	ben.raymond@aad.gov.au	Weimerskirch, Henri/K-7306-2019; Thompson, David R/E-2431-2018; Hindell, Mark A/K-1131-2013; Weimerskirch, Henri/F-5562-2013; Shaffer, Scott A/D-5015-2009; Costa, Daniel/E-2616-2013	Weimerskirch, Henri/0000-0002-0457-586X; Thompson, David R/0000-0001-8518-6307; Shaffer, Scott A/0000-0002-7751-5059; Woehler, Eric/0000-0002-1125-0748; Smith, Adam/0000-0003-0059-6206; Costa, Daniel/0000-0002-0233-5782; Hindell, Mark/0000-0002-7823-7185; Einoder, Luke/0000-0002-9122-7053	Alfred P. Sloan Foundation; Gordon Foundation; Betty Moore Foundation; David Foundation; Lucile Packard Foundation; Australian Antarctic Program [472, 681, 2208, 3227]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Gordon Foundation; Betty Moore Foundation(Gordon and Betty Moore Foundation); David Foundation; Lucile Packard Foundation(The David & Lucile Packard Foundation); Australian Antarctic Program	This work was conducted as part of the Census of Antarctic Marine Life (CAML) and Tagging of Pacific Pelagics (TOPP) projects, and was supported in part by the Alfred P. Sloan, Gordon and Betty Moore, and David and Lucile Packard Foundations, and the Australian Antarctic Program (Projects 472, 681, 2208, and 3227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2010, MAR BIOL, V157, P915, DOI 10.1007/s00227-009-1367-y; Adams J, 2009, NEW ZEAL J ZOOL, V36, P355, DOI 10.1080/03014220909510160; Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; Baduini CL, 2001, FISH OCEANOGR, V10, P117, DOI 10.1046/j.1365-2419.2001.00156.x; *BIOMASS WORK PART, 1982, BIOMASS HDB, V18; BLOMQVIST S, 1984, MAR ECOL PROG SER, V20, P85, DOI 10.3354/meps020085; Bost C.A., 2008, P121; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; BRIGGS KT, 1986, CONDOR, V88, P355, DOI 10.2307/1368883; Brodtkorb PA, 2000, INT OFFSHORE POLAR E, P343; BROWN RGB, 1978, CONDOR, V80, P123, DOI 10.2307/1367911; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; CAIRNS DK, 1992, CONDOR, V94, P811, DOI 10.2307/1369279; Catry P, 2004, AUK, V121, P1208, DOI 10.1642/0004-8038(2004)121[1208:SFTBAG]2.0.CO;2; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Cherel Y, 2005, OECOLOGIA, V145, P533, DOI 10.1007/s00442-005-0156-7; Clarke Rohan H., 2005, Marine Ornithology, V33, P7; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Connan M, 2005, MAR ECOL PROG SER, V290, P277, DOI 10.3354/meps290277; Connan M, 2007, LIMNOL OCEANOGR, V52, P2445, DOI 10.4319/lo.2007.52.6.2445; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Cruz JB, 2001, NEW ZEAL J MAR FRESH, V35, P817, DOI 10.1080/00288330.2001.9517044; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Duhamel G, 2000, POLAR BIOL, V23, P106, DOI 10.1007/s003000050015; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Einoder LD, 2005, T ROY SOC SOUTH AUST, V129, P209; Feldman G. C., 2010, OCEAN COLOR WEB SEAW; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Frederiksen M, 2007, MAR ECOL PROG SER, V352, P205, DOI 10.3354/meps07071; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Gordon HB, 2002, CSIRO MK3 CLIMATE SY; Hamer KC, 2001, MAR ECOL PROG SER, V224, P283, DOI 10.3354/meps224283; HARPER P C, 1987, Notornis, V34, P169; Hodges C. L., 1994, Marine Ornithology, V22, P205; Hosie GW, 2003, PROG OCEANOGR, V58, P263, DOI 10.1016/j.pocean.2003.08.007; Hulley P.A., 1990, P146; Hunt BPV, 2005, DEEP-SEA RES PT I, V52, P1241, DOI 10.1016/j.dsr.2004.11.019; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; JACKSON S, 1988, CONDOR, V90, P20, DOI 10.2307/1368428; KERRY KR, 1983, EMU, V83, P35, DOI 10.1071/MU9830035; Kitson JC, 2000, NEW ZEAL J ZOOL, V27, P347, DOI 10.1080/03014223.2000.9518244; Klomp NI, 2000, MAR ECOL PROG SER, V194, P307, DOI 10.3354/meps194307; Kozlov A.N., 1995, CCAMLR Science, V2, P71; Lawton K, 2008, AQUAT CONSERV, V18, P309, DOI 10.1002/aqc.857; Lee R.F., 1989, P73; LIECHTI F, 1994, J THEOR BIOL, V170, P219, DOI 10.1006/jtbi.1994.1181; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McKechnie S, 2006, NEW ZEAL J ZOOL, V33, P259, DOI 10.1080/03014223.2006.9518455; McLeod DJ, 2010, POLAR SCI, V4, P353, DOI 10.1016/j.polar.2010.03.004; Moller H, 2009, NEW ZEAL J ZOOL, V36, P325, DOI 10.1080/03014220909510158; Moller H, 2000, NEW ZEAL J ZOOL, V27, P255, DOI 10.1080/03014223.2000.9518233; Moller H, 2009, NEW ZEAL J ZOOL, V36, P211, DOI 10.1080/03014220909510152; Nicholls DG, 1997, EMU, V97, P240; Nicholls DG, 1998, EMU, V98, P79, DOI 10.1071/MU98007F; Pakhomov EA, 1996, MAR ECOL PROG SER, V134, P1, DOI 10.3354/meps134001; PARSLOW JS, 2001, J GEOPHYS RES, V106, P31557; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Phillips KL, 2001, MAR ECOL PROG SER, V215, P179, DOI 10.3354/meps215179; Phleger CF, 1999, ANTARCT SCI, V11, P436, DOI 10.1017/S0954102099000565; Phleger CF, 1997, ANTARCT SCI, V9, P258, DOI 10.1017/S0954102097000345; Pusch C, 2004, DEEP-SEA RES PT I, V51, P1685, DOI 10.1016/j.dsr.2004.06.008; Reda I, 2003, NRELTP56034302; Reid K, 2005, ICES J MAR SCI, V62, P366, DOI 10.1016/j.icesjms.2004.11.003; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; ROBERTSON J. S., 1957, EMU, V57, P191; Robison BH, 2003, J MAR BIOL ASSOC UK, V83, P639, DOI 10.1017/S0025315403007586h; Ropert-Coudert Y, 2004, BEHAV ECOL, V15, P824, DOI 10.1093/beheco/arh086; Rosen Mikael, 2001, Acta Ethologica, V3, P135, DOI 10.1007/s102110100039; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Schultz MA, 2000, J AVIAN BIOL, V31, P287, DOI 10.1034/j.1600-048X.2000.310303.x; Serventy DL., 1971, HDB AUSTR SEABIRDS; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; SKIRA IJ, 1986, BIOL CONSERV, V37, P225, DOI 10.1016/0006-3207(86)90083-2; Soehle I. S., 2007, Notornis, V54, P180; Sohle IS, 2003, EMU, V103, P373, DOI 10.1071/MU03035; Sokolov S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004072; Sokolov S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005108; Sokolov S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004329; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Staniland IJ, 2007, MAR BIOL, V152, P233, DOI 10.1007/s00227-007-0698-9; Taylor G. A., 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P89; Terauds A, 2006, AQUAT CONSERV, V16, P133, DOI 10.1002/aqc.709; Tremblay Y, 2009, MAR ECOL PROG SER, V391, P153, DOI 10.3354/meps08146; VEIT RR, 1991, AUK, V108, P790; Veit RR, 1997, GLOB CHANGE BIOL, V3, P23, DOI 10.1046/j.1365-2486.1997.d01-130.x; Wakefield ED, 2009, ECOL MONOGR, V79, P663, DOI 10.1890/07-2111.1; Warham J., 1977, Proceedings of the New Zealand Ecological Society, V24, P84; Waugh SM, 1999, MAR ECOL PROG SER, V177, P243, DOI 10.3354/meps177243; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1994, POLAR BIOL, V14, P123; Weimerskirch H, 1998, J ANIM ECOL, V67, P99, DOI 10.1046/j.1365-2656.1998.00180.x; Weimerskirch H, 1996, IBIS, V138, P786, DOI 10.1111/j.1474-919X.1996.tb08837.x; Weimerskirch H, 1998, MAR ECOL PROG SER, V167, P261, DOI 10.3354/meps167261; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wienecke B, 2006, POLAR BIOL, V29, P424, DOI 10.1007/s00300-005-0074-5; WILLIAMS R, 1988, Papers and Proceedings of the Royal Society of Tasmania, V122, P233; Williams R, 1990, ANARE RES NOTES, V75; WILLIAMS R, 1997, VOYAGE REPORT VOYAGE; Woehler EJ, 1997, POLAR BIOL, V17, P371, DOI 10.1007/PL00013379; WOEHLER EJ, 1995, THESIS U CALIFORNIA; WOEHLER EJ, 1980, DISTRIBUTION ABUNDAN; Woehler EJ, 2006, MAR ECOL PROG SER, V324, P261, DOI 10.3354/meps324261; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; YAMAGUCHI Y, 1982, T TOKYO U FISHERIES, V5, P111; [No title captured]	109	48	48	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10960	10.1371/journal.pone.0010960	http://dx.doi.org/10.1371/journal.pone.0010960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532034	Green Published, Green Submitted, gold			2022-12-25	WOS:000278380500006
J	Bertelli, C; Collyn, F; Croxatto, A; Ruckert, C; Polkinghorne, A; Kebbi-Beghdadi, C; Goesmann, A; Vaughan, L; Greub, G				Bertelli, Claire; Collyn, Francois; Croxatto, Antony; Rueckert, Christian; Polkinghorne, Adam; Kebbi-Beghdadi, Carole; Goesmann, Alexander; Vaughan, Lloyd; Greub, Gilbert			The Waddlia Genome: A Window into Chlamydial Biology	PLOS ONE			English	Article							ORDER CHLAMYDIALES; MEMBRANE-PROTEIN; FAM. NOV.; CHONDROPHILA; IDENTIFICATION; PEPTIDOGLYCAN; HOST; INFECTIONS; RICKETTSIA; SEQUENCES	Growing evidence suggests that a novel member of the Chlamydiales order, Waddlia chondrophila, is a potential agent of miscarriage in humans and abortion in ruminants. Due to the lack of genetic tools to manipulate chlamydia, genomic analysis is proving to be the most incisive tool in stimulating investigations into the biology of these obligate intracellular bacteria. 454/Roche and Solexa/Illumina technologies were thus used to sequence and assemble de novo the full genome of the first representative of the Waddliaceae family, W. chondrophila. The bacteria possesses a 2'116'312bp chromosome and a 15'593 bp low-copy number plasmid that might integrate into the bacterial chromosome. The Waddlia genome displays numerous repeated sequences indicating different genome dynamics from classical chlamydia which almost completely lack repetitive elements. Moreover, W. chondrophila exhibits many virulence factors also present in classical chlamydia, including a functional type III secretion system, but also a large complement of specific factors for resistance to host or environmental stresses. Large families of outer membrane proteins were identified indicating that these highly immunogenic proteins are not Chlamydiaceae specific and might have been present in their last common ancestor. Enhanced metabolic capability for the synthesis of nucleotides, amino acids, lipids and other co-factors suggests that the common ancestor of the modern Chlamydiales may have been less dependent on their eukaryotic host. The fine-detailed analysis of biosynthetic pathways brings us closer to possibly developing a synthetic medium to grow W. chondrophila, a critical step in the development of genetic tools. As a whole, the availability of the W. chondrophila genome opens new possibilities in Chlamydiales research, providing new insights into the evolution of members of the order Chlamydiales and the biology of the Waddliaceae.	[Bertelli, Claire; Collyn, Francois; Croxatto, Antony; Kebbi-Beghdadi, Carole; Greub, Gilbert] Univ Hosp Ctr, Inst Microbiol, Ctr Res Intracellular Bacteria, Lausanne, Switzerland; [Bertelli, Claire; Collyn, Francois; Croxatto, Antony; Kebbi-Beghdadi, Carole; Greub, Gilbert] Univ Lausanne, Lausanne, Switzerland; [Rueckert, Christian; Goesmann, Alexander] Univ Bielefeld, Ctr Biotechnol, Bielefeld, Germany; [Polkinghorne, Adam] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Polkinghorne, Adam; Vaughan, Lloyd] Univ Zurich, Inst Vet Pathol, Vetsuisse Fac, Zurich, Switzerland	University of Lausanne; University of Bielefeld; Queensland University of Technology (QUT); University of Zurich	Bertelli, C (corresponding author), Univ Hosp Ctr, Inst Microbiol, Ctr Res Intracellular Bacteria, Lausanne, Switzerland.	gilbert.greub@chuv.ch	Bertelli, Claire/H-9609-2015; Greub, Gilbert GG/K-5804-2017; Vaughan, Lloyd/GNP-4888-2022; Vaughan, L/E-6528-2011	Bertelli, Claire/0000-0003-0550-8981; Greub, Gilbert GG/0000-0001-9529-3317; Vaughan, L/0000-0003-3474-9426; Polkinghorne, Adam/0000-0002-6803-9222; Polkinghorne, Adam/0000-0002-6567-2962; Kebbi Beghdadi, Carole/0000-0003-1158-6361; Goesmann, Alexander/0000-0002-7086-2568; Ruckert-Reed, Christian/0000-0002-9722-4435	Infectigen Foundation [In010_2008]; Swiss National Science Foundation [310030-124843, 310030-130466]; Swiss State Secretariat for Education and Research (SER) [C07.0125]; Leenards Foundation	Infectigen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss State Secretariat for Education and Research (SER); Leenards Foundation	This project was funded by the grant number In010_2008 from the Infectigen Foundation and by grants no 310030-124843 and 310030-130466 from the Swiss National Science Foundation. This project was also partially supported by a COST grant from the Swiss State Secretariat for Education and Research (SER) (C07.0125). GG is supported by the Leenards Foundation through a career award entitled 'Bourse Leenards pour la releve academique en medecine clinique a Lausanne'. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], CHLAMYDIA GENOMICS P; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Borel N, 2007, EMERG INFECT DIS, V13, P1904, DOI 10.3201/eid1312.070655; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chopra I, 1998, MICROBIOL-UK, V144, P2673, DOI 10.1099/00221287-144-10-2673; Collyn F, 2007, FEMS MICROBIOL LETT, V271, P187, DOI 10.1111/j.1574-6968.2007.00714.x; Corsaro D, 2007, SYST APPL MICROBIOL, V30, P221, DOI 10.1016/j.syapm.2006.06.001; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; CROXATTO A, 2010, MICROBIOLOGY, P340; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DILBECK PM, 1990, J CLIN MICROBIOL, V28, P814, DOI 10.1128/JCM.28.4.814-816.1990; Dilbeck-Robertson P, 2003, J VET DIAGN INVEST, V15, P568, DOI 10.1177/104063870301500609; DODD IB, 1987, J MOL BIOL, V194, P557, DOI 10.1016/0022-2836(87)90681-4; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Eugster M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-231; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Fields KA, 2006, CHLAMYDIA GENOMICS P, P219; Findlay HE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-5; Friedman MG, 2003, MICROBES INFECT, V5, P1013, DOI 10.1016/S1286-4579(03)00188-6; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goy G, 2009, EUR J CLIN MICROBIOL, V28, P1483, DOI 10.1007/s10096-009-0804-7; Goy G, 2008, MICROBES INFECT, V10, P556, DOI 10.1016/j.micinf.2008.02.003; Goy G, 2009, ANTIMICROB AGENTS CH, V53, P2663, DOI 10.1128/AAC.00046-09; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Greub G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008423; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Hatch TP, 1996, J BACTERIOL, V178, P1; Henning K, 2002, VET MICROBIOL, V85, P285, DOI 10.1016/S0378-1135(01)00510-7; Herrmann B, 2008, EMERG INFECT DIS, V14, P1462, DOI 10.3201/eid1409.080153; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Igietseme Joseph U, 2003, Expert Rev Vaccines, V2, P129, DOI 10.1586/14760584.2.1.129; KOCAN KM, 1990, J BACTERIOL, V172, P5949, DOI 10.1128/jb.172.10.5949-5955.1990; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Linke Burkhard, 2006, Appl Bioinformatics, V5, P193, DOI 10.2165/00822942-200605030-00008; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Longbottom D, 1996, FEMS MICROBIOL LETT, V142, P277; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; McDonnell AV, 2006, PROTEINS, V63, P976, DOI 10.1002/prot.20942; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Michel R, 2004, ACTA PROTOZOOL, V43, P37; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rurangirwa FR, 1999, INT J SYST BACTERIOL, V49, P577, DOI 10.1099/00207713-49-2-577; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas V, 2006, ENVIRON MICROBIOL, V8, P2125, DOI 10.1111/j.1462-2920.2006.01094.x; Waldispuehl J, 2008, PROTEINS, V71, P1097, DOI 10.1002/prot.21788; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Yen TY, 2005, BIOCHEMISTRY-US, V44, P6250, DOI 10.1021/bi047775v; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	62	79	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10890	10.1371/journal.pone.0010890	http://dx.doi.org/10.1371/journal.pone.0010890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531937	Green Published, gold, Green Submitted			2022-12-25	WOS:000278222100019
J	Gall, WE; Beebe, K; Lawton, KA; Adam, KP; Mitchell, MW; Nakhle, PJ; Ryals, JA; Milburn, MV; Nannipieri, M; Camastra, S; Natali, A; Ferrannini, E				Gall, Walter E.; Beebe, Kirk; Lawton, Kay A.; Adam, Klaus-Peter; Mitchell, Matthew W.; Nakhle, Pamela J.; Ryals, John A.; Milburn, Michael V.; Nannipieri, Monica; Camastra, Stefania; Natali, Andrea; Ferrannini, Ele		RISC Study Grp	alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; 2-HYDROXYBUTYRIC ACID; SENSITIVITY; KETOBUTYRATE; PATHOGENESIS; RAT; HYPERINSULINEMIA; METABOLOMICS; METABOLISM; SECRETION	Background: Insulin resistance is a risk factor for type 2 diabetes and cardiovascular disease progression. Current diagnostic tests, such as glycemic indicators, have limitations in the early detection of insulin resistant individuals. We searched for novel biomarkers identifying these at-risk subjects. Methods: Using mass spectrometry, non-targeted biochemical profiling was conducted in a cohort of 399 nondiabetic subjects representing a broad spectrum of insulin sensitivity and glucose tolerance (based on the hyperinsulinemic euglycemic clamp and oral glucose tolerance testing, respectively). Results: Random forest statistical analysis selected alpha-hydroxybutyrate (alpha-HB) as the top-ranked biochemical for separating insulin resistant (lower third of the clamp-derived M-FFM = 33 [12] mu mol.min(-1).kg(FFM)(-1), median [interquartile range], n = 140) from insulin sensitive subjects (M-FFM = 66 [23] mu mol.min(-1).kg(FFM)(-1)) with a 76% accuracy. By targeted isotope dilution assay, plasma alpha-HB concentrations were reciprocally related to M-FFM; and by partition analysis, an alpha-HB value of 5 mu g/ml was found to best separate insulin resistant from insulin sensitive subjects. alpha-HB also separated subjects with normal glucose tolerance from those with impaired fasting glycemia or impaired glucose tolerance independently of, and in an additive fashion to, insulin resistance. These associations were also independent of sex, age and BMI. Other metabolites from this global analysis that significantly correlated to insulin sensitivity included certain organic acid, amino acid, lysophospholipid, acylcarnitine and fatty acid species. Several metabolites are intermediates related to alpha-HB metabolism and biosynthesis. Conclusions: alpha-hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation. The underlying biochemical mechanisms may involve increased lipid oxidation and oxidative stress.	[Gall, Walter E.; Beebe, Kirk; Lawton, Kay A.; Adam, Klaus-Peter; Mitchell, Matthew W.; Nakhle, Pamela J.; Ryals, John A.; Milburn, Michael V.] Metabolon Inc, Res Triangle Pk, NC USA; [Nannipieri, Monica; Camastra, Stefania; Natali, Andrea; Ferrannini, Ele] Univ Pisa, Sch Med, RISC Relationship Insulin Sensit Cardiovasc Coord, I-56100 Pisa, Italy	Metabolon; University of Pisa	Gall, WE (corresponding author), Metabolon Inc, Res Triangle Pk, NC USA.	wgall@metabolon.com	Natali, Andrea/N-5535-2015; Camastra, Stefania/Q-1200-2016; Nannipieri, Monica/AAA-1464-2019	Natali, Andrea/0000-0002-8465-7717; Nannipieri, Monica/0000-0003-1346-2813; Mitchell, Matthew/0000-0002-2681-4091; Camastra, Stefania/0000-0001-9015-7244	EGIR-RISC	EGIR-RISC	EGIR-RISC funding support came from Merck Serono and Astra Zeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metabolon, Inc. funded the retrospective analysis herein.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; BRASS EP, 1986, BIOCHIM BIOPHYS ACTA, V888, P18, DOI 10.1016/0167-4889(86)90065-0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; EVANS AM, 2009, ANAL CHEM; Ferrannini E, 2007, J CLIN ENDOCR METAB, V92, P2885, DOI 10.1210/jc.2007-0334; GINSBERG H, 1974, DIABETES, V23, P674, DOI 10.2337/diab.23.8.674; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; HARRIS MI, 1995, CLIN INVEST MED, V18, P231; Hills SA, 2004, DIABETOLOGIA, V47, P566, DOI 10.1007/s00125-004-1335-5; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Kim SH, 2008, DIABETES CARE, V31, P1433, DOI 10.2337/dc08-0045; LANDAAS S, 1975, CLIN CHIM ACTA, V58, P23, DOI 10.1016/0009-8981(75)90481-7; LANDAAS S, 1975, SCAND J CLIN LAB INV, V35, P259, DOI 10.3109/00365517509095738; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lord RS, 2008, ALTERN MED REV, V13, P205; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Natali A, 1997, CIRCULATION, V96, P849; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; PAOLISSO G, 1992, DIABETES CARE, V15, P1, DOI 10.2337/diacare.15.1.1; PETTERSEN JE, 1973, CLIN CHIM ACTA, V48, P213, DOI 10.1016/0009-8981(73)90367-7; Reaven G M, 1978, Adv Metab Disord, V9, P313; REAVEN GM, 1983, AM J MED, V75, P85, DOI 10.1016/0002-9343(83)90258-9; Reaven GM, 1999, ANN NY ACAD SCI, V892, P45, DOI 10.1111/j.1749-6632.1999.tb07784.x; ROSALKI SB, 1960, NATURE, V188, P1110, DOI 10.1038/1881110a0; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; SHEN SW, 1970, J CLIN INVEST, V49, P2151, DOI 10.1172/JCI106433; Silva AR, 2001, BRAZ J MED BIOL RES, V34, P627, DOI 10.1590/S0100-879X2001000500010; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; YANG W, 1985, CLIN CHIM ACTA, V145, P173, DOI 10.1016/0009-8981(85)90284-0; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773	40	458	478	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10883	10.1371/journal.pone.0010883	http://dx.doi.org/10.1371/journal.pone.0010883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526369	Green Published, gold, Green Submitted			2022-12-25	WOS:000278222100012
J	Lorain, S; Peccate, C; Le Hir, M; Garcia, L				Lorain, Stephanie; Peccate, Cecile; Le Hir, Maeva; Garcia, Luis			Exon Exchange Approach to Repair Duchenne Dystrophin Transcripts	PLOS ONE			English	Article							MESSENGER-RNA; GENE-THERAPY; MUSCULAR-DYSTROPHY; MOLECULAR-BASIS; MOUSE MODEL; MDX MOUSE; RESTORATION; PROTEIN; MICE; ENHANCER	Background: Trans-splicing strategies for mRNA repair involve engineered transcripts designed to anneal target mRNAs in order to interfere with their natural splicing, giving rise to mRNA chimeras where endogenous mutated exons have been replaced by exogenous replacement sequences. A number of trans-splicing molecules have already been proposed for replacing either the 59 or the 39 part of transcripts to be repaired. Here, we show the feasibility of RNA surgery by using a double trans-splicing approach allowing the specific substitution of a given mutated exon. Methodology/Principal Findings: As a target we used a minigene encoding a fragment of the mdx dystrophin gene enclosing the mutated exon (exon 23). This minigene was cotransfected with a variety of exon exchange constructions, differing in their annealing domains. We obtained accurate and efficient replacement of exon 23 in the mRNA target. Adding up a downstream intronic splice enhancer DISE in the exon exchange molecule enhanced drastically its efficiency up to 25-45% of repair depending on the construction in use. Conclusions/Significance: These results demonstrate the possibility to fix up mutated exons, refurbish deleted exons and introduce protein motifs, while keeping natural untranslated sequences, which are essential for mRNA stability and translation regulation. Conversely to the well-known exon skipping, exon exchange has the advantage to be compatible with almost any type of mutations and more generally to a wide range of genetic conditions. In particular, it allows addressing disorders caused by dominant mutations.	[Lorain, Stephanie; Peccate, Cecile; Le Hir, Maeva; Garcia, Luis] Univ Paris 06, CNRS, INSERM, Inst Myol,UMR S 974,U974,UMR 7215, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Lorain, S (corresponding author), Univ Paris 06, CNRS, INSERM, Inst Myol,UMR S 974,U974,UMR 7215, Paris, France.	stephanie.lorain@upmc.fr	García, Luis V/GQA-9712-2022	Peccate, Cecile/0000-0002-4125-3616; Peccate, Cecile/0000-0001-8895-5087; Lorain, Stephanie/0000-0001-5266-9994	Association Francaise contre les Myopathies; Association Mongasque contre les Myopathies; Duchenne Parent Project France; FP7 MyoAMP; ANR GENESPLICE	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association Mongasque contre les Myopathies; Duchenne Parent Project France; FP7 MyoAMP; ANR GENESPLICE(French National Research Agency (ANR))	This work was supported by Association Francaise contre les Myopathies, Association Mongasque contre les Myopathies, Duchenne Parent Project France, FP7 MyoAMP and ANR GENESPLICE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchaouir R, 2007, CELL STEM CELL, V1, P646, DOI 10.1016/j.stem.2007.09.016; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Chao HJ, 2003, NAT MED, V9, P1015, DOI 10.1038/nm900; Coady TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003468; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; Garcia-Blanco MA, 2003, J CLIN INVEST, V112, P474, DOI 10.1172/JCI200319462; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Kierlin-Duncan MN, 2007, RNA, V13, P1317, DOI 10.1261/rna.525607; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Liu XM, 2005, HUM GENE THER, V16, P1116, DOI 10.1089/hum.2005.16.1116; Mansfield SG, 2000, GENE THER, V7, P1885, DOI 10.1038/sj.gt.3301307; Mansfield SG, 2003, RNA, V9, P1290, DOI 10.1261/rna.5101903; Mansfield SG, 2004, TRENDS MOL MED, V10, P263, DOI 10.1016/j.molmed.2004.04.007; McCarthy EMS, 1998, HUM MOL GENET, V7, P1491, DOI 10.1093/hmg/7.9.1491; Mitchell LG, 2005, GENE THER, V12, P1477, DOI 10.1038/sj.gt.3302596; Puttaraju M, 1999, NAT BIOTECHNOL, V17, P246, DOI 10.1038/6986; Puttaraju M, 2001, MOL THER, V4, P105, DOI 10.1006/mthe.2001.0426; Rodriguez-Martin T, 2005, P NATL ACAD SCI USA, V102, P15659, DOI 10.1073/pnas.0503150102; Seth P, 2008, J BIOL CHEM, V283, P10058, DOI 10.1074/jbc.M800087200; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; Tahara M, 2004, NAT MED, V10, P835, DOI 10.1038/nm1086; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x	26	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10894	10.1371/journal.pone.0010894	http://dx.doi.org/10.1371/journal.pone.0010894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531943	gold, Green Published, Green Submitted			2022-12-25	WOS:000278222100023
J	Bongaerts, P; Riginos, C; Ridgway, T; Sampayo, EM; van Oppen, MJH; Englebert, N; Vermeulen, F; Hoegh-Guldberg, O				Bongaerts, Pim; Riginos, Cynthia; Ridgway, Tyrone; Sampayo, Eugenia M.; van Oppen, Madeleine J. H.; Englebert, Norbert; Vermeulen, Francisca; Hoegh-Guldberg, Ove			Genetic Divergence across Habitats in the Widespread Coral Seriatopora hystrix and Its Associated Symbiodinium	PLOS ONE			English	Article							GREAT-BARRIER-REEF; LARGE DEPTH RANGES; ECOLOGICAL SPECIATION; POCILLOPORA-DAMICORNIS; MONTASTRAEA-ANNULARIS; SYMPATRIC SPECIATION; POPULATION-STRUCTURE; SCLERACTINIAN CORAL; COMMUNITY STRUCTURE; ACROPORA-PALIFERA	Background: Coral reefs are hotspots of biodiversity, yet processes of diversification in these ecosystems are poorly understood. The environmental heterogeneity of coral reef environments could be an important contributor to diversification, however, evidence supporting ecological speciation in corals is sparse. Here, we present data from a widespread coral species that reveals a strong association of host and symbiont lineages with specific habitats, consistent with distinct, sympatric gene pools that are maintained through ecologically-based selection. Methodology/Principal Findings: Populations of a common brooding coral, Seriatopora hystrix, were sampled from three adjacent reef habitats (spanning a similar to 30 m depth range) at three locations on the Great Barrier Reef (n = 336). The populations were assessed for genetic structure using a combination of mitochondrial (putative control region) and nuclear (three microsatellites) markers for the coral host, and the ITS2 region of the ribosomal DNA for the algal symbionts (Symbiodinium). Our results show concordant genetic partitioning of both the coral host and its symbionts across the different habitats, independent of sampling location. Conclusions/Significance: This study demonstrates that coral populations and their associated symbionts can be highly structured across habitats on a single reef. Coral populations from adjacent habitats were found to be genetically isolated from each other, whereas genetic similarity was maintained across similar habitat types at different locations. The most parsimonious explanation for the observed genetic partitioning across habitats is that adaptation to the local environment has caused ecological divergence of distinct genetic groups within S. hystrix.	[Bongaerts, Pim; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Bongaerts, Pim; Ridgway, Tyrone; Sampayo, Eugenia M.; Englebert, Norbert; Vermeulen, Francisca] Univ Queensland, Ctr Marine Studies, St Lucia, Qld, Australia; [Bongaerts, Pim; Sampayo, Eugenia M.; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Riginos, Cynthia] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Ridgway, Tyrone] Great Barrier Reef Marine Pk Author, Climate Change Grp, Townsville, Qld, Australia; [Sampayo, Eugenia M.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [van Oppen, Madeleine J. H.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Vermeulen, Francisca] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Australian Institute of Marine Science; James Cook University; Victoria University Wellington	Bongaerts, P (corresponding author), Univ Queensland, Global Change Inst, St Lucia, Qld, Australia.	pim@uq.edu.au	van Oppen, Madeleine JH/C-3261-2008; Hoegh-Guldberg, Ove/ABA-5420-2020; Riginos, Cynthia/G-3320-2010; Hoegh-Guldberg, Ove/H-6169-2011	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Riginos, Cynthia/0000-0002-5485-4197; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Bongaerts, Pim/0000-0001-6747-6044; van Oppen, Madeleine/0000-0003-4607-0744	Australian Research Council (ARC) Centre; Project Aware Foundation; Professional Association of Diving Instructors (PADI) Foundation	Australian Research Council (ARC) Centre(Australian Research Council); Project Aware Foundation; Professional Association of Diving Instructors (PADI) Foundation	This study was funded by the Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies (www.coralcoe.org.au), the Project Aware Foundation (www.projectaware.org) and the Professional Association of Diving Instructors (PADI) Foundation (www.padifoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRE DJ, 1991, CORAL REEFS, V10, P13, DOI 10.1007/BF00301901; AYRE DJ, 1994, EVOLUTION, V48, P1183, DOI 10.1111/j.1558-5646.1994.tb05304.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; Bak RPM, 1977, AAPG STUD GEOL, V4, P3, DOI 10.1306/St4393; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bradshaw A.D., 1965, ADV GENET, V13, P15; Carlon DB, 2002, EVOLUTION, V56, P2227; Chen C, 2008, MOL PHYLOGENET EVOL, V46, P19, DOI 10.1016/j.ympev.2007.09.013; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conde-Padin P, 2007, EVOL ECOL, V21, P635, DOI 10.1007/s10682-006-9142-8; Coyne JA, 2004, SPECIATION, V37; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Diekmann OE, 2003, CORAL REEFS, V22, P29, DOI 10.1007/s00338-002-0273-2; Diekmann OE, 2001, MAR BIOL, V139, P221; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Flot JF, 2008, CORAL REEFS, V27, P789, DOI 10.1007/s00338-008-0407-2; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; Frade PR, 2008, LIMNOL OCEANOGR, V53, P2711, DOI 10.4319/lo.2008.53.6.2711; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HUNTER CL, 1993, EVOLUTION, V47, P1213, DOI 10.1111/j.1558-5646.1993.tb02148.x; Hunter CL, 1997, P 8 INT COR REEF S, V2, P1599; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; Johannesson K, 2003, J SEA RES, V49, P107, DOI 10.1016/S1385-1101(02)00218-6; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; KNOWLTON N, 1992, SCIENCE, V255, P330, DOI 10.1126/science.255.5042.330; KNOWLTON N, 1994, TRENDS ECOL EVOL, V1, P7; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Lopez JV, 1999, BIOL BULL-US, V196, P80, DOI 10.2307/1543170; Maier E, 2005, MAR BIOL, V147, P1109, DOI 10.1007/s00227-005-0013-6; Maier E, 2009, CORAL REEFS, V28, P751, DOI 10.1007/s00338-009-0497-5; MAYR E, 1954, EVOLUTION, V8, P1, DOI 10.2307/2405661; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; PEAKALL R, 2001, GENAIEX V5 GENETIC A; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Richmond JQ, 2002, EVOLUTION, V56, P1498, DOI 10.1111/j.0014-3820.2002.tb01461.x; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle Howard D., 2004, P192; Rutzler K, 2007, MAR ECOL-EVOL PERSP, V28, P95; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Sampayo EM, 2007, THESIS U QUEENSLAND; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Tonnis B, 2005, P ROY SOC B-BIOL SCI, V272, P819, DOI 10.1098/rspb.2004.3030; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Underwood JN, 2006, MOL ECOL NOTES, V6, P176, DOI 10.1111/j.1471-8286.2005.01183.x; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; VANMOORSEL GWNM, 1983, MAR ECOL PROG SER, V13, P273, DOI 10.3354/meps013273; Vermeij MJA, 2003, B MAR SCI, V73, P725; Vermeij MJA, 2002, MAR ECOL PROG SER, V233, P105, DOI 10.3354/meps233105; VERON J E N, 1976, Australian Institute of Marine Science Monograph Series, V1, P1; Veron J. E. N., 2000, CORALS WORLD, V2; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x	88	132	135	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10871	10.1371/journal.pone.0010871	http://dx.doi.org/10.1371/journal.pone.0010871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523735	gold, Green Published, Green Accepted			2022-12-25	WOS:000278221900017
J	Wu, Q; Xu, FFL; Li, YJ; Prochownik, EV; Saunders, WS				Wu, Qian; Xu, Fengfeng L.; Li, Youjun; Prochownik, Edward V.; Saunders, William S.			The c-Myc Target Glycoprotein1b alpha Links Cytokinesis Failure to Oncogenic Signal Transduction Pathways in Cultured Human Cells	PLOS ONE			English	Article							GENOMIC INSTABILITY; FILAMIN-A; ACTIN-FILAMENTS; IB-ALPHA; ACTIVATION; COMPLEX; CANCER; RHO; TRANSFORMATION; TUMORIGENESIS	An increase in chromosome number, or polyploidization, is associated with a variety of biological changes including breeding of cereal crops and flowers, terminal differentiation of specialized cells such as megakaryocytes, cellular stress and oncogenic transformation. Yet it remains unclear how cells tolerate the major changes in gene expression, chromatin organization and chromosome segregation that invariably accompany polyploidization. We show here that cancer cells can initiate increases in chromosome number by inhibiting cell division through activation of glycoprotein1b alpha (Gp1b alpha), a component of the c-Myc signaling pathway. We are able to recapitulate cytokinesis failure in primary cells by overexpression of Gp1b alpha in a p53-deficient background. Gp1b alpha was found to localize to the cleavage furrow by microscopy analysis and, when overexpressed, to interfere with assembly of the cellular cortical contraction apparatus and normal division. These results indicate that cytokinesis failure and tetraploidy in cancer cells are directly linked to cellular hyperproliferation via c-Myc induced overexpression of Gp1b alpha.	[Wu, Qian; Xu, Fengfeng L.; Saunders, William S.] Univ Pittsburgh, Dept Biol, Pittsburgh, PA 15260 USA; [Li, Youjun; Prochownik, Edward V.] Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Prochownik, Edward V.; Saunders, William S.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, Q (corresponding author), Univ Pittsburgh, Dept Biol, 4200 5th Ave, Pittsburgh, PA 15260 USA.	wsaund@pitt.edu			NIH [ROI DE 016086-01, RO1 CA105033]; NATIONAL CANCER INSTITUTE [R01CA105033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is support by the NIH grants ROI DE 016086-01 to WSS and RO1 CA105033 to EVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RK, 1997, INT J BIOCHEM CELL B, V29, P91, DOI 10.1016/S1357-2725(96)00122-7; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Hau PM, 2006, FEBS LETT, V580, P4727, DOI 10.1016/j.febslet.2006.07.059; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Kruse K, 2000, PHYS REV LETT, V85, P1778, DOI 10.1103/PhysRevLett.85.1778; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Li YJ, 2007, P NATL ACAD SCI USA, V104, P3490, DOI 10.1073/pnas.0610163104; Li YJ, 2009, J BIOL CHEM, V284, P1410, DOI 10.1074/jbc.M806222200; LOEB LA, 1991, CANCER RES, V51, P3075; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; NUNNALLY MH, 1980, J CELL BIOL, V87, P219, DOI 10.1083/jcb.87.1.219; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Rogulski K, 2005, ONCOGENE, V24, P7524, DOI 10.1038/sj.onc.1208897; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Srsen V, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-26; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Tanaka-Takiguchi Y, 2004, J MOL BIOL, V341, P467, DOI 10.1016/j.jmb.2004.06.019; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Watanabe N, 2004, EXP CELL RES, V301, P16, DOI 10.1016/j.yexcr.2004.08.020; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10819	10.1371/journal.pone.0010819	http://dx.doi.org/10.1371/journal.pone.0010819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520840	gold, Green Published, Green Accepted			2022-12-25	WOS:000278034800014
J	Yokoyama, JS; Erdman, CA; Hamilton, SP				Yokoyama, Jennifer S.; Erdman, Carolyn A.; Hamilton, Steven P.			Array-Based Whole-Genome Survey of Dog Saliva DNA Yields High Quality SNP Data	PLOS ONE			English	Article							WIDE ASSOCIATION; DOMESTIC DOG; LARGE-SCALE; MUTATION	Background: Genome-wide association scans for genetic loci underlying both Mendelian and complex traits are increasingly common in canine genetics research. However, the demand for high-quality DNA for use on such platforms creates challenges for traditional blood sample ascertainment. Though the use of saliva as a means of collecting DNA is common in human studies, alternate means of DNA collection for canine research have instead been limited to buccal swabs, from which dog DNA is of insufficient quality and yield for use on most high-throughput array-based systems. We thus investigated an animal-based saliva collection method for ease of use and quality of DNA obtained and tested the performance of saliva-extracted canine DNA on genome-wide genotyping arrays. Methodology/Principal Findings: Overall, we found that saliva sample collection using this method was efficient. Extractions yielded high concentrations (similar to 125 ng/ul) of high-quality DNA that performed equally well as blood-extracted DNA on the Illumina Infinium canine genotyping platform, with average call rates >99%. Concordance rates between genotype calls of saliva-versus blood-extracted DNA samples from the same individual were also >99%. Additionally, in silico calling of copy number variants was successfully performed and verified by PCR. Conclusions/Significance: Our findings validate the use of saliva-obtained samples for genome-wide association studies in canines, highlighting an alternative means of collecting samples in a convenient and non-invasive manner.	[Hamilton, Steven P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yokoyama, JS (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	Steve.Hamilton@ucsf.edu	Fiumefreddo, Andrea/T-2977-2019	Hamilton, Steven/0000-0001-8106-6260	NIMH [5 T32 MH20006-12]; National Institute of Mental Health [R21 MH084149]; American Kennel Club (ACORN) [850-A]; McKnight Foundation; Hellman Family Fund; University of California San Francisco; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020006, R21MH084149] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Kennel Club (ACORN); McKnight Foundation; Hellman Family Fund; University of California San Francisco(University of California System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by Predoctoral Training Consortium in Affective Science Research Fellowship (NIMH-Predoctoral NRSA Type 5 T32 MH20006-12 to J.S.Y.); National Institute of Mental Health (R21 MH084149), the American Kennel Club (ACORN award 850-A), the McKnight Foundation, the Hellman Family Fund, and a University of California San Francisco bridge funding award (S. P. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Chang ML, 2007, J HERED, V98, P428, DOI 10.1093/jhered/esm044; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Hansen TVO, 2007, CANCER EPIDEM BIOMAR, V16, P2072, DOI 10.1158/1055-9965.EPI-07-0611; IWASIOW RM, 2009, QUALITY YIELD PERFOR; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Nishita DM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-71; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Short AD, 2005, J HERED, V96, P829, DOI 10.1093/jhered/esi126; Wiik AC, 2009, ANIM GENET, V40, P572, DOI 10.1111/j.1365-2052.2009.01877.x	16	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10809	10.1371/journal.pone.0010809	http://dx.doi.org/10.1371/journal.pone.0010809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520842	Green Submitted, gold, Green Published			2022-12-25	WOS:000278034800007
J	Mukherjee, R; Colbath, GP; Justus, CD; Bruce, JA; Allen, CM; Hewett, KW; Saul, JP; Gourdie, RG; Spinale, FG				Mukherjee, Rupak; Colbath, Gregory P.; Justus, Charles D.; Bruce, James A.; Allen, Claire M.; Hewett, Kenneth W.; Saul, J. Philip; Gourdie, Robert G.; Spinale, Francis G.			Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury	FASEB JOURNAL			English	Article						myocardial injury; structure; remodeling	MATRIX-METALLOPROTEINASE INHIBITION; LEFT-VENTRICULAR ENLARGEMENT; TARGETED DELETION; TISSUE INHIBITOR; CARDIAC RUPTURE; GAP-JUNCTIONS; INFARCTION; EXPRESSION; CONDUCTION; FIBROSIS	Radiofrequency (RF) ablation of the myocardium causes discrete sites of injury. RF scars can expand, altering the extracellular matrix (ECM) structure and the continuity of the electrical syncytium of the adjacent myocardium. Matrix metalloproteinases (MMPs), such as MMP-9, contribute to ECM remodeling. However, whether and to what degree transcriptional induction of MMP-9 occurs after myocardial RF injury and the association with electrical conduction patterns after RF injury remains unexplored. This study examined MMP-9 gene promoter (M9PROM) activation after myocardial RF injury using mice in which the M9PROM was fused to a beta-galactosidase (beta-gal) reporter. RF lesions (0.5-mm probe, 80 degrees C, 30 s) were created on the left ventricular (LV) epicardium of M9PROM mice (n=62) and terminally studied at 1 h, 1 d, 3 d, 7 d, 14 d, and 28 d after RF injury. M9PROM activation was localized through beta-gal staining. The RF scar area and the area of beta-gal staining were measured and normalized to LV area (planimetry). RF scar size increased from 1 h post-RF-injury values by 7 d and remained higher at 28 d. M9PROM activation became evident at 3 d and peaked at 7 d. Electrical conduction was measured (potentiometric dye mapping) at 7 d after RF injury. Heterogeneities in action potentials and electrical impulse propagation coincident with M9PROM activation were observed after RF injury. For example, conduction proximal to the RF site was slower than that in the remote myocardium (0.15+/-0.02 vs. 0.83+/-0.08 mm/ms, P<0.05). Thus, a unique spatiotemporal pattern of MMP-9 transcriptional activation occurred after discrete myocardial injury, which was associated with the development of electrical heterogeneity. Therefore, these findings suggest that changes in a key determinant of extracellular matrix remodeling, in addition to changes in myocardial structure, can contribute to arrhythmogenesis around the region of myocardial injury.-Mukherjee, R., Colbath, G. P., Justus, C. D., Bruce, J. A., Allen, C. M., Hewett, K. W., Saul, J. P., Gourdie, R. G., Spinale, F. G. Spatiotemporal induction of matrix metalloproteinase-9 transcription following discrete myocardial injury. FASEB J. 24, 3819-3828 (2010). www.fasebj.org	[Mukherjee, Rupak; Colbath, Gregory P.; Spinale, Francis G.] Med Univ S Carolina, Div Cardiothorac Surg, Charleston, SC 29425 USA; [Mukherjee, Rupak; Bruce, James A.; Allen, Claire M.; Saul, J. Philip; Spinale, Francis G.] Med Univ S Carolina, Div Pediat Cardiol, Charleston, SC 29425 USA; [Justus, Charles D.; Hewett, Kenneth W.; Gourdie, Robert G.] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Spinale, Francis G.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mukherjee, R (corresponding author), Med Univ S Carolina, Div Cardiothorac Surg, Strom Thurmond Res Bldg,770 MUSC Complex,Ste 625, Charleston, SC 29425 USA.	mukherr@musc.edu			U.S. National Institutes of Health [HL-66029, HL-45024, HL-97012, P01-48788, HL-56728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066029, R03HL097012, R29HL045024, R01HL056728] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by U.S. National Institutes of Health grants HL-66029 (to R.M.), HL-45024, HL-97012, and P01-48788 (to F.G.S.), and HL-56728 (to R.G.G.).	Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Cavasin MA, 2006, AM J PHYSIOL-HEART C, V290, pH2043, DOI 10.1152/ajpheart.01121.2005; Cavasin MA, 2004, LIFE SCI, V75, P2181, DOI 10.1016/j.lfs.2004.04.024; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Cleutjens JPM, 2002, J CARD FAIL, V8, pS344, DOI 10.1054/jcaf.2002.129261; CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Danik SB, 2004, CIRC RES, V95, P1035, DOI 10.1161/01.RES.0000148664.33695.2a; Danik SB, 2008, FASEB J, V22, P1204, DOI 10.1096/fj.07-8974com; DOLBER PC, 1992, J MOL CELL CARDIOL, V24, P1443, DOI 10.1016/0022-2828(92)91085-J; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Hewett KW, 2005, CARDIOVASC RES, V67, P548, DOI 10.1016/j.cardiores.2005.04.002; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; Jalife J, 1998, J CARDIOVASC ELECTR, V9, P1358, DOI 10.1111/j.1540-8167.1998.tb00111.x; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Li XP, 2008, MED HYPOTHESES, V70, P317, DOI 10.1016/j.mehy.2007.04.046; Lindsey ML, 2006, CIRCULATION, V113, P2919, DOI 10.1161/CIRCULATIONAHA.106.612960; Lindsey ML, 2002, CIRCULATION, V105, P753, DOI 10.1161/hc0602.103674; Mohan R, 1998, J BIOL CHEM, V273, P25903, DOI 10.1074/jbc.273.40.25903; Mukherjee R, 2005, J MOL CELL CARDIOL, V39, P259, DOI 10.1016/j.yjmcc.2005.03.012; Mukherjee R, 2004, AM J PHYSIOL-HEART C, V286, pH1242, DOI 10.1152/ajpheart.00437.2003; Mukherjee R, 2003, CIRCULATION, V107, P618, DOI 10.1161/01.CIR.0000046449.36178.00; Mukherjee R, 2006, AM J PHYSIOL-HEART C, V291, pH2216, DOI 10.1152/ajpheart.01343.2005; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; PETERS NS, 1995, J MOL CELL CARDIOL, V27, P37, DOI 10.1016/S0022-2828(08)80005-3; Peters NS, 1997, CIRCULATION, V95, P988; Peterson JT, 2000, CARDIOVASC RES, V46, P307, DOI 10.1016/S0008-6363(00)00029-8; Poelzing S, 2004, AM J PHYSIOL-HEART C, V287, pH1762, DOI 10.1152/ajpheart.00346.2004; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Spach MS, 2007, CIRC RES, V101, P743, DOI 10.1161/CIRCRESAHA.107.163956; Spach MS, 2001, J ELECTROCARDIOL, V34, P69, DOI 10.1054/jelc.2001.28833; Strom M, 2010, AM J PHYSIOL-HEART C, V298, pH787, DOI 10.1152/ajpheart.00887.2009; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Tao ZY, 2004, LIFE SCI, V74, P1561, DOI 10.1016/j.lfs.2003.09.042; Vaidya D, 2001, CIRC RES, V88, P1196, DOI 10.1161/hh1101.091107; van Veen TAB, 2005, CIRCULATION, V112, P1927, DOI 10.1161/CIRCULATIONAHA.105.539072; Wilson EM, 2003, CIRCULATION, V107, P2857, DOI 10.1161/01.CIR.0000068375.40887.FA	41	8	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3819	3828		10.1096/fj.10-155531	http://dx.doi.org/10.1096/fj.10-155531			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20530752	Green Published			2022-12-25	WOS:000285005900020
J	Mohamed, JS; Lopez, MA; Boriek, AM				Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.			Mechanical Stretch Up-regulates MicroRNA-26a and Induces Human Airway Smooth Muscle Hypertrophy by Suppressing Glycogen Synthase Kinase-3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; KINASE 3-BETA; SKELETAL-MUSCLE; GENE-EXPRESSION; TRANSCRIPTION; CANCER; MECHANOTRANSDUCTION; PHOSPHORYLATION; DIFFERENTIATION; IDENTIFICATION	Airway smooth muscle hypertrophy is one of the hallmarks of airway remodeling in severe asthma. Several human diseases have been now associated with dysregulated microRNA (miRNA) expression. miRNAs are a class of small non-coding RNAs, which negatively regulate gene expression at the post-transcriptional level. Here, we identify miR-26a as a hypertrophic miRNA of human airway smooth muscle cells (HASMCs). We show that stretch selectively induces the transcription of miR-26a located in the locus 3p21.3 of human chromosome 3. The transcription factor CCAAT enhancer-binding protein alpha (C/EBP alpha) directly activates miR-26a expression through the transcriptional machinery upon stretch. Furthermore, stretch or enforced expression of miR-26a induces HASMC hypertrophy, and miR-26 knockdown reverses this effect, suggesting that miR-26a is a hypertrophic gene. We identify glycogen synthase kinase-3 beta (GSK-3 beta), an anti-hypertrophic protein, as a target gene of miR-26a. Luciferase reporter assays demonstrate that miR-26a directly interact with the 3'-untranslated repeat of the GSK-3 beta mRNA. Stretch or enforced expression of miR-26a attenuates the endogenous GSK-3 beta protein levels followed by the induction of HASMC hypertrophy. miR-26 knockdown reverses this effect, suggesting that miR-26a-induced hypertrophy occurs via its target gene GSK-3 beta. Overall, as a first time, our study unveils that miR-26a is a mechanosensitive gene, and it plays an important role in the regulation of HASMC hypertrophy.	[Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	boriek@bcm.tmc.edu	Mohamed, Junaith/AAC-4050-2020; Lopez, Michael A./AAT-2145-2021	Lopez, Michael A./0000-0002-3029-0761	NHLBI [HL63134, HL-072839]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072839, R01HL063134] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63134 and HL-072839 from NHLBI. This work was also supported by a grant from the National Science Foundation.	Adachi R, 2003, ZOOL SCI, V20, P557, DOI 10.2108/zsj.20.557; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bentley JK, 2009, AM J PHYSIOL-LUNG C, V296, pL176, DOI 10.1152/ajplung.90376.2008; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Deng H, 2008, J BIOL CHEM, V283, P10198, DOI 10.1074/jbc.M800624200; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; Galvin DJ, 2002, AM J PHYSIOL-RENAL, V283, pF1192, DOI 10.1152/ajprenal.00168.2002; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Guo CJ, 2009, APOPTOSIS, V14, P1331, DOI 10.1007/s10495-009-0401-3; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; HASANEEN NA, 2005, FASEB J; Hays SR, 2005, THORAX, V60, P226, DOI 10.1136/thx.2004.028340; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Ito S, 2008, AM J RESP CELL MOL, V38, P407, DOI 10.1165/rcmb.2007-0259OC; Ito S, 2006, EUR J PHARMACOL, V552, P135, DOI 10.1016/j.ejphar.2006.08.067; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kanefsky J, 2006, AM J RESP CELL MOL, V34, P417, DOI 10.1165/rcmb.2005-0326OC; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; KOMURO I, 1991, J BIOL CHEM, V266, P1265; Komuro I, 2000, JPN HEART J, V41, P117, DOI 10.1536/jhj.41.117; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kumar A, 2003, J BIOL CHEM, V278, P18868, DOI 10.1074/jbc.M212777200; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lin S. Y., 2006, J BIOMED BIOTECHNOL, V4, P1; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Regamey N, 2008, AM J RESP CRIT CARE, V177, P837, DOI 10.1164/rccm.200707-977OC; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; SADOSHIMA J, 1993, J RECEPTOR RES, V13, P777, DOI 10.3109/10799899309073692; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sasai N, 2010, MUSCLE NERVE, V41, P100, DOI 10.1002/mus.21473; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Smith PG, 1997, AM J PHYSIOL-LUNG C, V272, pL20, DOI 10.1152/ajplung.1997.272.1.L20; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Sugden PH, 2001, CIRCULATION, V103, P1375, DOI 10.1161/01.CIR.103.10.1375; Tschumperlin DJ, 2001, AM J RESP CRIT CARE, V164, pS90, DOI 10.1164/ajrccm.164.supplement_2.2106060; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VAN ROOIJ E, 2006, P NATL ACAD SCI USA, V103, P18255; VANDENBURGH H, 1979, SCIENCE, V203, P265, DOI 10.1126/science.569901; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	68	169	183	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29336	29347		10.1074/jbc.M110.101147	http://dx.doi.org/10.1074/jbc.M110.101147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20525681	Green Published, hybrid			2022-12-25	WOS:000281740100036
J	Aluvila, S; Kotaria, R; Sun, JK; Mayor, JA; Walters, DE; Harrison, DHT; Kaplan, RS				Aluvila, Sreevidya; Kotaria, Rusudan; Sun, Jiakang; Mayor, June A.; Walters, D. Eric; Harrison, David H. T.; Kaplan, Ronald S.			The Yeast Mitochondrial Citrate Transport Protein MOLECULAR DETERMINANTS OF ITS SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; TRANSMEMBRANE DOMAIN-III; FATTY-ACID SYNTHESIS; TRANSLOCATION PATHWAY; SECONDARY STRUCTURE; EXCHANGE REACTIONS; MEMBRANE-PROTEINS; LIKELY COMPRISE; TRICARBOXYLATE; IDENTIFICATION	The objective of this study was to identify the role of individual amino acid residues in determining the substrate specificity of the yeast mitochondrial citrate transport protein (CTP). Previously, we showed that the CTP contains at least two substrate-binding sites. In this study, utilizing the overexpressed, single-Cys CTP-binding site variants that were functionally reconstituted in liposomes, we examined CTP specificity from both its external and internal surfaces. Upon mutation of residues comprising the more external site, the CTP becomes less selective for citrate with numerous external anions able to effectively inhibit [C-14] citrate/citrate exchange. Thus, the site 1 variants assume the binding characteristics of a nonspecific anion carrier. Comparison of [C-14] citrate uptake in the presence of various internal anions versus water revealed that, with the exception of the R189C mutant, the other site 1 variants showed substantial uniport activity relative to exchange. Upon mutation of residues comprising site 2, we observed two types of effects. The K37C mutant displayed a markedly enhanced selectivity for external citrate. In contrast, the other site 2 mutants displayed varying degrees of relaxed selectivity for external citrate. Examination of internal substrates revealed that, in contrast to the control transporter, the R181C variant exclusively functioned as a uniporter. This study provides the first functional information on the role of specific binding site residues in determining mitochondrial transporter substrate selectivity. We interpret our findings in the context of our homology-modeled CTP as it cycles between the outward-facing, occluded, and inward-facing states.	[Aluvila, Sreevidya; Kotaria, Rusudan; Sun, Jiakang; Mayor, June A.; Walters, D. Eric; Kaplan, Ronald S.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago Med Sch, N Chicago, IL 60064 USA; [Harrison, David H. T.] Rosalind Franklin Univ Med & Sci, Dept Pharmaceut Sci, Coll Pharm, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Kaplan, RS (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago Med Sch, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	ronald.kaplan@rosalindfranklin.edu	Mayor, June/AAP-1544-2021; Walters, D. Eric/C-9626-2010	Walters, D. Eric/0000-0002-1513-3522; KAPLAN, RONALD/0000-0001-9164-0297	National Institutes of Health [GM-054642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-054642 (to R. S. K.).	Aluvila S, 2010, MOL PHARMACOL, V77, P26, DOI 10.1124/mol.109.058750; BRUNENGR.H, 1973, FEBS LETT, V36, P130, DOI 10.1016/0014-5793(73)80353-9; BUCHANAN BB, 1976, P NATL ACAD SCI USA, V73, P2280, DOI 10.1073/pnas.73.7.2280; CONOVER TE, 1987, TRENDS BIOCHEM SCI, V12, P88, DOI 10.1016/0968-0004(87)90042-9; ENDEMANN G, 1982, J BIOL CHEM, V257, P3434; Eriks LR, 2003, ANAL BIOCHEM, V323, P234, DOI 10.1016/j.ab.2003.09.002; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KAPLAN RS, 1989, ANION CARRIERS OF MITOCHONDRIAL MEMBRANES, P59; KAPLAN RS, 1990, ARCH BIOCHEM BIOPHYS, V280, P181, DOI 10.1016/0003-9861(90)90534-6; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Kaplan RS, 2000, J BIOL CHEM, V275, P12009, DOI 10.1074/jbc.275.16.12009; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; KAPLAN RS, 1982, CANCER RES, V42, P4399; KAPLAN RS, 1990, J BIOL CHEM, V265, P13379; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; Ma CL, 2007, J BIOL CHEM, V282, P17210, DOI 10.1074/jbc.M611268200; Ma CL, 2006, BBA-BIOENERGETICS, V1757, P1271, DOI 10.1016/j.bbabio.2006.06.011; Ma CL, 2005, J BIOL CHEM, V280, P2331, DOI 10.1074/jbc.M411474200; Ma CL, 2004, J BIOL CHEM, V279, P1533, DOI 10.1074/jbc.M310866200; Mayor JA, 2010, J BIOENERG BIOMEMBR, V42, P99, DOI 10.1007/s10863-010-9280-0; PALMIERI F, 1972, EUR J BIOCHEM, V26, P587, DOI 10.1111/j.1432-1033.1972.tb01801.x; PALMIERI F, 1977, STRUCTURE FUNCTION E, P251; Pebay-Peyroula E, 2004, CURR OPIN STRUC BIOL, V14, P420, DOI 10.1016/j.sbi.2004.06.009; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; ROBINSON BH, 1971, J BIOL CHEM, V246, P5280; ROBINSON BH, 1971, EUR J BIOCHEM, V20, P65, DOI 10.1111/j.1432-1033.1971.tb01363.x; Rudnick G., 2002, TRANSMEMBRANE TRANSP, P125; VANWINKLE LJ, 1999, BIOMEMBRANE TRANSPOR, P90; Walters DE, 2004, BIOPHYS J, V87, P907, DOI 10.1529/biophysj.104.042127; WATSON JA, 1970, J BIOL CHEM, V245, P5993; Xu Y, 2000, J BIOL CHEM, V275, P7117, DOI 10.1074/jbc.275.10.7117; XU Y, 1995, BIOCHEM BIOPH RES CO, V207, P783, DOI 10.1006/bbrc.1995.1255	39	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27314	27326		10.1074/jbc.M110.137364	http://dx.doi.org/10.1074/jbc.M110.137364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551333	Green Published, hybrid			2022-12-25	WOS:000281172700061
J	Walstab, J; Hammer, C; Lasitschka, F; Moller, D; Connolly, CN; Rappold, G; Bruss, M; Bonish, H; Niesler, B				Walstab, Jutta; Hammer, Christian; Lasitschka, Felix; Moeller, Dorothee; Connolly, Christopher N.; Rappold, Gudrun; Bruess, Michael; Boenish, Heinz; Niesler, Beate			RIC-3 Exclusively Enhances the Surface Expression of Human Homomeric 5-Hydroxytryptamine Type 3A (5-HT(3)A) Receptors Despite Direct Interactions with 5-HT3A, -C, -D, and -E Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; ENDOPLASMIC-RETICULUM CHAPERONE; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; SEROTONIN; PROTEIN; GENE; TRAFFICKING; MATURATION	Although five 5-hydroxytryptamine type 3 (5-HT3) subunits (A-E) have been cloned, knowledge on the regulation of their assembly is limited. RIC-3 has been identified as a chaperone specific for the pentameric ligand-gated nicotinic acetylcholine and 5-HT3 receptors. Therefore, we examined the impact of RIC-3 on differently composed 5-HT3 receptors with the focus on 5-HT3C, -D, and -E subunits. The influence of RIC-3 on these receptor subtypes is supported by the presence of RIC3 mRNA in tissues expressing at least one of the subunits 5-HT3C, -D, and -E. Furthermore, immunocytochemical studies on transfected mammalian cells revealed co-localization in the endoplasmic reticulum and direct interaction of RIC-3 with 5-HT3A, -C, -D, and -E. Functional and pharmacological characterization was performed using HEK293 cells expressing 5-HT3A or 5-HT3A + 5-HT3B (or -C, -D, or -E) in the presence or absence of RIC-3. Ca2+ influx analyses revealed that RIC-3 does not influence the 5-HT concentration-response relationship on 5-HT(3)A receptors but leads to differential increases of 5-HT-induced maximum response (E-max) on cells expressing different subunits. Increases of E-max were due to analogously enhanced B-max values for binding of the 5-HT3 receptor antagonist [H-3]GR65630. The observed enhanced cell surface expression of the tested 5-HT3 subunit combinations correlated with the increased surface expression of 5-HT3A as determined by flow cytometry. In conclusion, we showed that RIC-3 can interact with 5-HT3A, -C, -D, and -E subunits and predominantly enhances the surface expression of homomeric 5-HT(3)A receptors in HEK293 cells. These data implicate a possible role of RIC-3 in determining 5-HT3 receptor composition in vivo.	[Niesler, Beate] Heidelberg Univ, Dept Human Mol Genet, Inst Human Genet, D-69120 Heidelberg, Germany; [Walstab, Jutta; Bruess, Michael; Boenish, Heinz] Univ Bonn, Inst Pharmacol & Toxicol, D-53113 Bonn, Germany; [Lasitschka, Felix] Heidelberg Univ, Inst Pathol, D-69120 Heidelberg, Germany; [Connolly, Christopher N.] Univ Dundee, Ninewells Med Sch, Div Med Sci, Ctr Neurosci, Dundee DD1 9SY, Scotland	Ruprecht Karls University Heidelberg; University of Bonn; Ruprecht Karls University Heidelberg; University of Dundee	Niesler, B (corresponding author), Heidelberg Univ, Dept Human Mol Genet, Inst Human Genet, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	beate.niesler@med.uni-heidelberg.de	Hammer, Christian/C-5827-2014	Hammer, Christian/0000-0003-4548-7548; Connolly, Christopher/0000-0002-0445-8874	German Federal Ministry for Education and Research [BMBF0313320]; National Genome Research Network [NGFN-2 EP-S19T02, 01GS0482]; German Cancer Aid Grants [107229, 107262]; Wellcome Trust [085141]; Biotechnology and Biological Sciences Research Council [C18896] Funding Source: researchfish	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); National Genome Research Network; German Cancer Aid Grants; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by German Federal Ministry for Education and Research Grant BMBF0313320 (to B. N.) in the National Genome Research Network (NGFN-2 EP-S19T02; Grant 01GS0482), by German Cancer Aid Grants 107229 (to B. N.) and 107262 (to H. B.), and the Wellcome Trust (to C. N. C.; Grant 085141).	ALEXANDER JK, 2007, ANN M SOC NEUR SAN D; Belelli D, 1995, MOL PHARMACOL, V48, P1054; Ben-Ami HC, 2009, BIOCHEMISTRY-US, V48, P12329, DOI 10.1021/bi901234a; Ben-Ami HC, 2005, J BIOL CHEM, V280, P28053, DOI 10.1074/jbc.M504369200; BLOUNT P, 1991, J CELL BIOL, V113, P1125, DOI 10.1083/jcb.113.5.1125; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Cheng A, 2007, J BIOL CHEM, V282, P26158, DOI 10.1074/jbc.M703899200; Cheng AX, 2005, J BIOL CHEM, V280, P22502, DOI 10.1074/jbc.M414341200; Chetty N, 2009, NEUROGASTROENT MOTIL, V21, P564, DOI 10.1111/j.1365-2982.2008.01223.x; Chetty N, 2009, NEUROGASTROENT MOTIL, V21, pe14; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Cooper ST, 1997, J NEUROCHEM, V68, P2140; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; Exley R, 2006, J NEUROCHEM, V98, P876, DOI 10.1111/j.1471-4159.2006.03915.x; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Holbrook JD, 2009, J NEUROCHEM, V108, P384, DOI 10.1111/j.1471-4159.2008.05775.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Karnovsky AM, 2003, GENE, V319, P137, DOI 10.1016/S0378-1119(03)00803-5; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Lansdell SJ, 2008, J NEUROCHEM, V105, P1573, DOI 10.1111/j.1471-4159.2008.05235.x; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; MIYAKE A, 1995, MOL PHARMACOL, V48, P407; Monk SA, 2004, BIOCHEM PHARMACOL, V68, P1787, DOI 10.1016/j.bcp.2004.06.034; NGUYEN M, 1995, GENETICS, V140, P527; Niesler B, 2003, GENE, V310, P101, DOI 10.1016/S0378-1119(03)00503-1; Niesler B, 2007, MOL PHARMACOL, V72, P8, DOI 10.1124/mol.106.032144; Seredenina T, 2008, BIOSCIENCE REP, V28, P299, DOI 10.1042/BSR20080055; Severance EG, 2007, NEUROSCIENCE, V148, P454, DOI 10.1016/j.neuroscience.2007.06.008; Shteingauz A, 2009, J CELL SCI, V122, P807, DOI 10.1242/jcs.036343; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; WALSTAB J, 2010, PHARM THER IN PRESS; Walstab J, 2008, PHARMACOGENET GENOM, V18, P793, DOI 10.1097/FPC.0b013e3283050117; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Wang Y, 2009, J NEUROSCI, V29, P12625, DOI 10.1523/JNEUROSCI.1776-09.2009; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200	44	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26956	26965		10.1074/jbc.M110.122838	http://dx.doi.org/10.1074/jbc.M110.122838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20522555	hybrid, Green Published			2022-12-25	WOS:000281172700027
J	Kim, Y; Park, H; Park, D; Lee, YS; Choe, J; Hahn, JH; Lee, H; Kim, YM; Jeoung, D				Kim, Youngmi; Park, Hyunmi; Park, Deokbum; Lee, Yun-Sil; Choe, Jongseon; Hahn, Jang-Hee; Lee, Hansoo; Kim, Young-Myeong; Jeoung, Dooil			Cancer/Testis Antigen CAGE Exerts Negative Regulation on p53 Expression through HDAC2 and Confers Resistance to Anti-cancer Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; DOWN-REGULATION; TUMOR-GROWTH; P53-MEDIATED APOPTOSIS; GENE; CELASTROL; TRANSCRIPTION; CELLS; DNMT1; HYPOMETHYLATION	The role of the cancer/testis antigen CAGE in drug resistance was investigated. The drug-resistant human melanoma Malme3M (Malme3M(R)) and the human hepatic cancer cell line SNU387 (SNU387(R)) showed in vivo drug resistance and CAGE induction. Induction of CAGE resulted from decreased expression and thereby displacement of DNA methyltransferase 1(DNMT1) from CAGE promoter sequences. Various drugs induce expression of CAGE by decreasing expression of DNMT1, and hypomethylation of CAGE was correlated with the increased expression of CAGE. Down-regulation of CAGE in these cell lines decreased invasion and enhanced drug sensitivity resulting from increased apoptosis. Down-regulation of CAGE also led to decreased anchorage-independent growth. Down-regulation of CAGE led to increased expression of p53, suggesting that CAGE may act as a negative regulator of p53. Down-regulation of p53 enhanced resistance to drugs and prevented drugs from exerting apoptotic effects. In SNU387R cells, CAGE induced the interaction between histone deacetylase 2 (HDAC2) and Snail, which exerted a negative effect on p53 expression. Chromatin immunoprecipitation assay showed that CAGE, through interaction with HDAC2, exerted a negative effect on p53 expression in Malme3MR cells. These results suggest that CAGE confers drug resistance by regulating expression of p53 through HDAC2. Taken together, these results show the potential value of CAGE as a target for the development of cancer therapeutics.	[Kim, Youngmi; Park, Hyunmi; Park, Deokbum; Lee, Hansoo; Jeoung, Dooil] Kangwon Natl Univ, Coll Nat Sci, Sch Biol Sci, Chunchon 200701, South Korea; [Lee, Yun-Sil] Korea Inst Radiol & Med Sci, Div Radiat Biol, Lab Radiat Effect, Seoul 139706, South Korea; [Choe, Jongseon; Hahn, Jang-Hee; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Chunchon 200701, South Korea	Kangwon National University; Korea Institute of Radiological & Medical Sciences; Kangwon National University	Jeoung, D (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Sch Biol Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	Korea Research Foundation [C1001478-01-01, C1006272-01-01, 2009-0063908]; Ministry of Science & Technology in Korea [FG06-2-23]; National Research Foundation [C00016]; Korean Government (MEST)	Korea Research Foundation(National Research Foundation of Korea); Ministry of Science & Technology in Korea(Ministry of Science & Technology (MOST), Republic of Korea); National Research Foundation; Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by grants from the Korea Research Foundation (C1001478-01-01, C1006272-01-01, and 2009-0063908) and by a grant (FG06-2-23) from the 21C Frontier Functional Human Genome Project from the Ministry of Science & Technology in Korea. This work was also supported by a grant from the National Research Foundation (C00016, to Y. K.) and by the Korea Research Foundation Grant funded by the Korean Government (MEST) (The Regional Research Universities Program/Medical & Bio-Materials Research Center).	Aprelikova O, 2009, CANCER RES, V69, P616, DOI 10.1158/0008-5472.CAN-08-0811; Bheda A, 2008, ONCOGENE, V27, P4315, DOI 10.1038/onc.2008.65; Cho B, 2002, BIOCHEM BIOPH RES CO, V292, P715, DOI 10.1006/bbrc.2002.6701; Cho BS, 2003, BIOCHEM BIOPH RES CO, V307, P52, DOI 10.1016/S0006-291X(03)01121-5; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Iwata T, 2005, CLIN CANCER RES, V11, P3949, DOI 10.1158/1078-0432.CCR-04-1702; James SR, 2006, ONCOGENE, V25, P6975, DOI 10.1038/sj.onc.1209678; Karim R, 2009, CLIN CANCER RES, V15, P6341, DOI 10.1158/1078-0432.CCR-09-1652; Kim EH, 2007, CANCER RES, V67, P6333, DOI 10.1158/0008-5472.CAN-06-4344; Kim SN, 2009, MOL CANCER RES, V7, P735, DOI 10.1158/1541-7786.MCR-08-0296; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kunze E, 2007, INT J MOL MED, V20, P557; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Laj A, 1999, MOL CELL BIOL, V19, P6632; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Lee TS, 2006, ANN NY ACAD SCI, V1091, P218, DOI 10.1196/annals.1378.068; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Liu Y, 2008, ONCOGENE, V27, P6729, DOI 10.1038/onc.2008.322; Loriot A, 2006, J BIOL CHEM, V281, P10118, DOI 10.1074/jbc.M510469200; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Mishra MV, 2008, MOL CANCER RES, V6, P243, DOI 10.1158/1541-7786.MCR-07-0373; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Muscella A, 2009, BRIT J PHARMACOL, V156, P751, DOI 10.1111/j.1476-5381.2008.00049.x; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Park S, 2003, BBA-GENE STRUCT EXPR, V1625, P173, DOI 10.1016/S0167-4781(02)00620-6; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Purow BW, 2008, CARCINOGENESIS, V29, P918, DOI 10.1093/carcin/bgn079; Rho JK, 2007, CANCER RES, V67, P1163, DOI 10.1158/0008-5472.CAN-06-2037; Rotem-Dai N, 2009, EXP CELL RES, V315, P2616, DOI 10.1016/j.yexcr.2009.06.004; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shankar E, 2008, ONCOGENE, V27, P3957, DOI 10.1038/onc.2008.39; Shim E, 2006, BIOTECHNOL LETT, V28, P515, DOI 10.1007/s10529-006-0008-5; Shim H, 2006, MOL CELLS, V21, P367; Song JH, 2009, INT J CANCER, V125, P1074, DOI 10.1002/ijc.24386; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Villar J, 2009, CANCER RES, V69, P102, DOI 10.1158/0008-5472.CAN-08-2922; Vitali R, 2008, CLIN CANCER RES, V14, P4622, DOI 10.1158/1078-0432.CCR-07-5210; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang JM, 2003, MOL CANCER RES, V1, P420	50	43	44	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25957	25968		10.1074/jbc.M109.095950	http://dx.doi.org/10.1074/jbc.M109.095950			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20534591	Green Published, hybrid			2022-12-25	WOS:000280921000010
J	Palou, G; Palou, R; Guerra-Moreno, A; Duch, A; Travesa, A; Quintana, DG				Palou, Gloria; Palou, Roger; Guerra-Moreno, Angel; Duch, Alba; Travesa, Anna; Quintana, David G.			Cyclin Regulation by the S Phase Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; STALLED REPLICATION FORKS; DNA-DAMAGE CHECKPOINT; CELL-CYCLE; BUDDING YEAST; PROTEIN-KINASE; DISTINCT MECHANISMS; SWI6 PROTEIN; G1 PHASE; TRANSCRIPTION	In eukaryotic cells a surveillance mechanism, the S phase checkpoint, detects and responds to DNA damage and replication stress, protecting DNA replication and arresting cell cycle progression. We show here that the S phase cyclins Clb5 and Clb6 are regulated in response to genotoxic stress in the budding yeast Saccharomyces cerevisiae. Clb5 and Clb6 are responsible for the activation of the specific Cdc28 cyclin-dependent kinase activity that drives the onset and progression of the S phase. Intriguingly, Clb5 and Clb6 are regulated by different mechanisms. Thus, the presence of Clb6, which is eliminated early in an unperturbed S phase, is stabilized when replication is compromised by replication stress or DNA damage. Such stabilization depends on the checkpoint kinases Mec1 and Rad53. The stabilization of Clb6 levels is a dynamic process that requires continued de novo protein synthesis, because the cyclin remains subject to degradation. It also requires the activity of the G(1) transcription factor Mlu1 cell cycle box-binding factor (MBF) in the S phase, whereas Dun1, the checkpoint kinase characteristically responsible for the transcriptional response to genotoxic stress, is dispensable in this case. On the other hand, two subpopulations of endogenous Clb5 can be distinguished according to turnover in an unperturbed S phase. In the presence of replication stress, the unstable Clb5 pool is stabilized, and such stabilization requires neither MBF transcriptional activity nor de novo protein synthesis.	[Quintana, David G.] Univ Autonoma Barcelona, Sch Med, Biophys Unit, Dept Biochem & Mol Biol, Bellaterra 08193, Catalonia, Spain; Univ Autonoma Barcelona, Ctr Biophys Studies, Bellaterra 08193, Catalonia, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Quintana, DG (corresponding author), Univ Autonoma Barcelona, Sch Med, Biophys Unit, Dept Biochem & Mol Biol, Bellaterra 08193, Catalonia, Spain.	davidg.quintana@uab.cat	Duch, Alba/AGI-1035-2022; Angel, Guerra-Moreno/AAF-7135-2021; Quintana, David G/M-5628-2018; Guerra-Moreno, Angel/K-6258-2015	Duch, Alba/0000-0001-6041-1360; Angel, Guerra-Moreno/0000-0003-2321-1129; Guerra-Moreno, Angel/0000-0003-2321-1129; Quintana, David G./0000-0002-4909-6686	Ministerio de Ciencia e Innovacion [BFU2008-03778]; Ministerio de Educacion y Ciencia [BFU2006-06833]; Generalitat de Catalunya; Ministerio de Educacion y Ciencia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Educacion y Ciencia(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by Grant BFU2008-03778 from the Ministerio de Ciencia e Innovacion and Grant BFU2006-06833 from the Ministerio de Educacion y Ciencia (to D. G. Q.), a Formacio d'Investigadors fellowship from the Generalitat de Catalunya (to G. P.), and Formacion de Personal Investigador fellowships from the Ministerio de Educacion y Ciencia (to A. D. and A. T.).	Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; BASCO RD, 1995, MOL CELL BIOL, V15, P5030; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; DIRICK L, 1992, NATURE, V357, P508, DOI 10.1038/357508a0; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Germain D, 1997, J CELL SCI, V110, P1813; Geymonat M, 2004, MOL CELL BIOL, V24, P2277, DOI 10.1128/MCB.24.6.2277-2285.2004; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jackson LP, 2006, MOL CELL BIOL, V26, P2456, DOI 10.1128/MCB.26.6.2456-2466.2006; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; KUHNE C, 1993, EMBO J, V12, P3437, DOI 10.1002/j.1460-2075.1993.tb06018.x; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Liu H, 2006, MOL BIOL CELL, V17, P2746, DOI 10.1091/mbc.E05-11-1093; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; LOWNDES NF, 1992, NATURE, V357, P505, DOI 10.1038/357505a0; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pati D, 1997, MOL CELL BIOL, V17, P3037, DOI 10.1128/MCB.17.6.3037; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Queralt E, 2003, MOL CELL BIOL, V23, P3126, DOI 10.1128/MCB.23.9.3126-3140.2003; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; SANTOCANALE C, 1995, J MOL BIOL, V254, P595, DOI 10.1006/jmbi.1995.0641; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sari F, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703744200; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sidorova JM, 2003, MOL CELL BIOL, V23, P3405, DOI 10.1128/MCB.23.10.3405-3416.2003; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; SIKORSKI RS, 1989, GENETICS, V122, P19; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	73	12	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26431	26440		10.1074/jbc.M110.138669	http://dx.doi.org/10.1074/jbc.M110.138669			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538605	hybrid, Green Published			2022-12-25	WOS:000280921000061
J	Mizrahi, A; Berdichevsky, Y; Casey, PJ; Pick, E				Mizrahi, Ariel; Berdichevsky, Yevgeny; Casey, Patrick J.; Pick, Edgar			A Prenylated p47(phox)-p67(phox)-Rac1 Chimera Is a Quintessential NADPH Oxidase Activator MEMBRANE ASSOCIATION AND FUNCTIONAL CAPACITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; DEPENDENT SUPEROXIDE-PRODUCTION; SODIUM DODECYL-SULFATE; SRC HOMOLOGY-3 DOMAINS; SH3 DOMAIN; PHAGOCYTE MEMBRANES; MOLECULAR-BASIS; RAC; P67(PHOX); P47(PHOX)	The superoxide-generating NADPH oxidase complex of resting phagocytes includes cytochrome b(559), a membrane-associated heterodimer composed of two subunits (Nox2 and p22(phox)), and four cytosolic proteins (p47(phox), p67(phox), Rac, and p40(phox)). Upon stimulation, the cytosolic components translocate to the membrane, as the result of a series of interactions among the cytosolic components and among the cytosolic components and cytochrome b(559) and its phospholipid environment. Wedescribed the construction of a tripartite chimera (trimera) consisting of strategic domains of p47(phox), p67(phox), and Rac1, in which interactions among cytosolic components were replaced by fusion (Berdichevsky, Y., Mizrahi, A., Ugolev, Y., Molshanski-Mor, S., and Pick, E. (2007) J. Biol. Chem. 282, 22122-22139). We now fused green fluorescent protein (GFP) to the N terminus of the trimera and found the following. 1) The GFP-p47(phox)-p67(phox)-Rac1 trimera activates the oxidase in amphiphile-dependent and -independent (anionic phospholipid-enriched membrane) cell-free systems. 2) Geranylgeranylation of the GFP-trimera makes it a potent oxidase activator in unmodified (native) membranes and in the absence of amphiphile. 3) Prenylated GFP-trimera binds spontaneously to native membranes (as assessed by gel filtration and in-line fluorometry), forming a tight complex capable of NADPH-dependent, activator-independent superoxide production at rates similar to those measured in canonical cell-free systems. 4) Prenylation of the GFP-trimera supersedes completely the dependence of oxidase activation on the p47(phox) phox homology domain and, partially, on the Rac1 polybasic domain, but the requirement for Trp(193) in p47(phox) persists. Prenylated GFP-p47(phox)-p67(phox)-Rac1 trimera acts as a quintessential single molecule oxidase activator of potential use in high throughput screening of inhibitors.	[Mizrahi, Ariel; Berdichevsky, Yevgeny; Pick, Edgar] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Julius Friedrich Cohnheim Lab Phagocyte Res, IL-69978 Tel Aviv, Israel; [Casey, Patrick J.] Duke Natl Univ Singapore, Grad Sch Med, Singapore 169857, Singapore	Tel Aviv University; Sackler Faculty of Medicine; National University of Singapore	Pick, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Julius Friedrich Cohnheim Lab Phagocyte Res, IL-69978 Tel Aviv, Israel.	epick@post.tau.ac.il	; Pick, Edgar/B-1795-2008	Casey, Patrick/0000-0002-7366-9309; Pick, Edgar/0000-0003-4625-3233; Berdichevsky, Yevgeny/0000-0002-5038-6816	National Institutes of Health [GM46372]; Israel Science Foundation [19/05, 49/09]; David and Natalie Roberts Chair in Immunopharmacology; Julius Friedrich Cohnheim-Minerva Center for Phagocyte Research; Ela Kodesz Institute of Host Defense against Infectious Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); David and Natalie Roberts Chair in Immunopharmacology; Julius Friedrich Cohnheim-Minerva Center for Phagocyte Research; Ela Kodesz Institute of Host Defense against Infectious Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46372 (to P.J.C.). This work was also supported by Israel Science Foundation Grants 19/05 and 49/09, the David and Natalie Roberts Chair in Immunopharmacology, the Julius Friedrich Cohnheim-Minerva Center for Phagocyte Research, and the Ela Kodesz Institute of Host Defense against Infectious Diseases (to E.P.).	Alloul N, 2001, BIOCHEMISTRY-US, V40, P14557, DOI 10.1021/bi0117347; Berdichevsky Y, 2007, J BIOL CHEM, V282, P22122, DOI 10.1074/jbc.M701497200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; CASEY PJ, 1991, P NATL ACAD SCI USA, V88, P8631, DOI 10.1073/pnas.88.19.8631; DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1; deMendez I, 1996, EMBO J, V15, P1211, DOI 10.1002/j.1460-2075.1996.tb00462.x; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Diebold BA, 2004, J BIOL CHEM, V279, P28136, DOI 10.1074/jbc.M313891200; Ebisu K, 2001, J BIOL CHEM, V276, P24498, DOI 10.1074/jbc.M101122200; Gorzalczany Y, 2002, J BIOL CHEM, V277, P18605, DOI 10.1074/jbc.M202114200; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; HARPER AM, 1984, BIOCHEM J, V219, P519, DOI 10.1042/bj2190519; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kao YY, 2008, J BIOL CHEM, V283, P12736, DOI 10.1074/jbc.M801010200; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Marcoux J, 2009, FEBS LETT, V583, P835, DOI 10.1016/j.febslet.2009.01.046; Miyano K, 2001, BIOCHEMISTRY-US, V40, P14089, DOI 10.1021/bi010882u; Miyano K, 2009, BIOCHEM J, V422, P373, DOI 10.1042/BJ20082182; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Mizrahi A, 2006, J LEUKOCYTE BIOL, V79, P881, DOI 10.1189/jlb.1005553; Molshanski-Mor Shahar, 2007, V412, P385, DOI 10.1007/978-1-59745-467-4_25; Morozov I, 1998, J BIOL CHEM, V273, P15435, DOI 10.1074/jbc.273.25.15435; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; PICK E, 1987, J BIOL CHEM, V262, P16476; Pick E, 2010, J LEUKOCYTE BIOL, V87, P537, DOI 10.1189/jlb.1109710; Sambrook J, 2001, MOL CLONING LAB MANU; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Shen K, 2008, BIOCHEMISTRY-US, V47, P8855, DOI 10.1021/bi8005847; SHPUNGIN S, 1989, J BIOL CHEM, V264, P9195; Sigal N, 2003, INFLAMMATION, V27, P147, DOI 10.1023/A:1023869828688; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Taura M, 2009, BIOCHEM J, V419, P329, DOI 10.1042/BJ20082028; Taylor RA, 2007, BIOCHEMISTRY-US, V46, P14291, DOI 10.1021/bi701626p; Toporik A, 1998, BIOCHEMISTRY-US, V37, P7147, DOI 10.1021/bi9800404; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; Ugolev Y, 2006, J BIOL CHEM, V281, P19204, DOI 10.1074/jbc.M600042200; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; ZHANG FL, 1994, J BIOL CHEM, V269, P23465	47	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25485	25499		10.1074/jbc.M110.113779	http://dx.doi.org/10.1074/jbc.M110.113779			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529851	hybrid, Green Published			2022-12-25	WOS:000280682400042
J	Larson, Y; Liu, JY; Stevens, PD; Li, X; Li, J; Evers, BM; Gao, TY				Larson, Yan; Liu, Jianyu; Stevens, Payton D.; Li, Xin; Li, Jing; Evers, B. Mark; Gao, Tianyan			Tuberous Sclerosis Complex 2 (TSC2) Regulates Cell Migration and Polarity through Activation of CDC42 and RAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR GENE-PRODUCT; FOCAL ADHESION; RHO; MTOR; GROWTH; AKT; GTPASES; CYTOSKELETON; PROTRUSION; INTERPLAY	The phosphatidylinositol 3-kinase (PI3K)/AKT pathway plays important roles in regulating cell motility. TSC2, a downstream target of AKT, is a central player in negatively controlling cell proliferation and protein translation through suppressing the activity of mTOR (mammalian target of rapamycin). However, the function of TSC2 in regulating cell migration remains unclear. Here, we show that TSC2 plays a critical role in the control of cell spreading, polarity, and migration. TSC2-deficient fibroblast cells were impaired in their ability to spread and alter actin cytoskeleton upon stimulation with insulin-like growth factor-1. Using scratch-induced polarization assay, we demonstrate that TSC2((-/-)) fibroblast cells polarized poorly toward the wound compared with wild-type cells. Similarly, knockdown of TSC2 expression in colon cancer cells resulted in a marked decrease in cell motility. Functionally, the activation of CDC42-and RAC1-GTPase was largely reduced in TSC2 knock-out fibroblast and TSC2 knockdown cancer cells. Furthermore, overexpression of an activating p110 alpha mutant or short term rapamycin treatment rescued the cell polarization defect in TSC2((-/-)) fibroblast cells. Concurrently, the activation of CDC42 and RAC1 increased. The defect in cell migration and CDC42 and RAC1 activation was reversed by reintroducing TSC2 back into TSC2((-/-)) fibroblast cells. Taken together, we identified a novel role of TSC2 in controlling cell polarity and migration by regulating CDC42 and RAC1 activation.	[Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Larson, Yan] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Liu, Jianyu; Stevens, Payton D.; Li, Xin; Li, Jing; Evers, B. Mark; Gao, Tianyan] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Li, Jing; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA	University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Kentucky; University of Kentucky	Gao, TY (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tianyan.gao@uky.edu			National Institutes of Health [R01CA133429, R01CA104748]; American Cancer Society Research Scholar [RSG0822001TBE]; NATIONAL CANCER INSTITUTE [R01CA104748, R01CA133429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA133429 (to T. G.). This work was also supported by American Cancer Society Research Scholar Grant RSG0822001TBE (to T.G.) and NIH Grant R01CA104748(to B. M. E.).	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955	29	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24987	24998		10.1074/jbc.M109.096917	http://dx.doi.org/10.1074/jbc.M109.096917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530489	Green Published, hybrid			2022-12-25	WOS:000280542100071
J	Noetzel, E; Rose, M; Sevinc, E; Hilgers, RD; Hartmann, A; Naami, A; Knuchel, R; Dahl, E				Noetzel, E.; Rose, M.; Sevinc, E.; Hilgers, R-D; Hartmann, A.; Naami, A.; Knuechel, R.; Dahl, E.			Intermediate filament dynamics and breast cancer: Aberrant promoter methylation of the Synemin gene is associated with early tumor relapse	ONCOGENE			English	Article						tumor suppressor gene; SYNM; promoter methylation; epigenetics; recurrence-free survival; pyrosequencing	PROTEIN SYNEMIN; VIMENTIN FILAMENTS; MYOEPITHELIAL CELL; DNA METHYLATION; EXPRESSION; HYPERMETHYLATION; IDENTIFICATION; MARKER; DISEASE	Synemin (SYNM) is a type IV intermediate filament that has recently been shown to interact with the LIM domain protein zyxin, thereby possibly modulating cell adhesion and cell motility. Owing to this multiplicity of potential functions relevant to cancer development, we initiated a study to decipher SYNM expression and regulation in benign human breast tissue and breast cancer. Dot blot array analysis showed significant SYNM mRNA downregulation in 86% (n = 100, P < 0.001) of breast cancers compared with their normal tissue counterparts, a result that was confirmed by real-time PCR analysis (n = 36, P < 0.0001). Immunohistochemistry analysis showed abundant SYNM protein expression in healthy myoepithelial breast cells, whereas SYNM expression loss was evident in 57% (n = 37, P < 0.001) of breast cancer specimens. Next, we analyzed methylation of the SYNM promoter to clarify whether the SYNM gene can be silenced by epigenetic means. Indeed, methylation-specific PCR analysis showed tumor-specific SYNM promoter methylation in 27% (n = 195) of breast cancers. As expected, SYNM promoter methylation was tightly associated (P < 0.0001) with SYNM expression loss. In-depth analysis of the SYNM promoter by pyrosequencing showed extensive CpG methylation of DNA elements supposed to regulate gene transcription. Demethylating treatment of SYNM methylated breast cancer cell lines with 5-aza-2-deoxycytidine clearly reestablished the SYNM expression. Statistical analysis of the patient cohort showed a close association between SYNM promoter methylation and unfavorable recurrence-free survival (hazard ratio = 2.941, P = 0.0282). Furthermore, SYNM methylation positively correlated with lymph node metastases (P = 0.0177) and advanced tumor grade (P = 0.0275), suggesting that SYNM methylation is associated with aggressive forms of breast cancer. This is the first study on the epigenetic regulation of the SYNM gene in a cancer entity. We provide first hints that SYNM could represent a novel putative breast tumor suppressor gene that is prone to epigenetic silencing. SYNM promoter methylation may become a useful predictive biomarker to stratify breast cancer patients' risk for tumor relapse. Oncogene (2010) 29, 4814-4825; doi:10.1038/onc.2010.229; published online 14 June 2010	[Noetzel, E.; Rose, M.; Sevinc, E.; Naami, A.; Knuechel, R.; Dahl, E.] Rhein Westfal TH Aachen, Fac Med, Mol Oncol Grp, Inst Pathol, Aachen, Germany; [Hilgers, R-D] Rhein Westfal TH Aachen, Dept Med Stat, Aachen, Germany; [Hartmann, A.] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany	RWTH Aachen University; RWTH Aachen University; University of Erlangen Nuremberg	Dahl, E (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Mol Oncol Grp, Inst Pathol, Pauwelsstr 30, D-52074 Aachen, Germany.	edahl@ukaachen.de	Noetzel-Reiss, Erik/GYV-0999-2022; Hilgers, Ralf-Dieter/C-7090-2013	Noetzel-Reiss, Erik/0000-0003-3163-6848; Hilgers, Ralf-Dieter/0000-0002-5945-1119	BMBF [01KW0401]	BMBF(Federal Ministry of Education & Research (BMBF))	We thank Sonja von Serenyi and Sevim Alkaya for excellent technical assistance and Monika Klinkhammer-Schalke, as well as Armin Pauer from the Tumor Registry Regensburg for continuous help in obtaining clinical follow-up data. We are thankful to Professor Matthias Durst (Friedrich-Schiller University Jena, Germany) for kindly providing patient samples and follow-up data. This work is a research project within the German Human Genome Project and has been supported by the BMBF Grants 01KW0401 to ED.	[Anonymous], 1997, J CLIN PATHOL; BECKERLE MC, 1986, J CELL BIOL, V103, P1679, DOI 10.1083/jcb.103.5.1679; Bellin RM, 1999, J BIOL CHEM, V274, P29493, DOI 10.1074/jbc.274.41.29493; Bellin RM, 2001, J BIOL CHEM, V276, P32330, DOI 10.1074/jbc.M104005200; Bharadwaj S, 2005, ONCOGENE, V24, P8291, DOI 10.1038/sj.onc.1208993; Bilak SR, 1998, ARCH BIOCHEM BIOPHYS, V355, P63, DOI 10.1006/abbi.1998.0702; Blake DJ, 2002, TRENDS CARDIOVAS MED, V12, P224, DOI 10.1016/S1050-1738(02)00166-4; Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433; Caldeira JRF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-48; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Dahl E, 2005, J PATHOL, V205, P21, DOI 10.1002/path.1687; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Deugnier MA, 2002, BREAST CANCER RES, V4, P224, DOI 10.1186/bcr459; Dobrovic A, 1997, CANCER RES, V57, P3347; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; ETIENNE J, 1990, ANN BIOL CLIN-PARIS, V48, P681; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; GRANGER BL, 1980, CELL, V22, P727, DOI 10.1016/0092-8674(80)90549-8; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Hirako Y, 2003, CELL TISSUE RES, V313, P195, DOI 10.1007/s00441-003-0732-2; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; Lakhani SR, 2001, BREAST CANCER RES, V3, P1, DOI 10.1186/bcr260; Luscher B, 2001, GENE, V277, P1, DOI 10.1016/S0378-1119(01)00697-7; Mizuno Y, 2001, P NATL ACAD SCI USA, V98, P6156, DOI 10.1073/pnas.111153298; Mook S, 2009, BREAST CANCER RES TR, V116, P295, DOI 10.1007/s10549-008-0130-2; Nguyen M, 2000, ONCOGENE, V19, P3449, DOI 10.1038/sj.onc.1203677; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Pan YH, 2008, FASEB J, V22, P3196, DOI 10.1096/fj.08-106187; REMMELE W, 1987, PATHOLOGE, V8, P138; Schmitt-Graeff A, 2006, HUM PATHOL, V37, P1200, DOI 10.1016/j.humpath.2006.04.017; Sun N, 2010, EXP CELL RES, V316, P491, DOI 10.1016/j.yexcr.2009.10.015; Tang XM, 2000, JNCI-J NATL CANCER I, V92, P1511, DOI 10.1093/jnci/92.18.1511; Tawk M, 2003, EXP NEUROL, V183, P499, DOI 10.1016/S0014-4886(03)00240-1; Titeux M, 2001, EUR J BIOCHEM, V268, P6435, DOI 10.1046/j.0014-2956.2001.02594.x; Van Rossen E, 2009, HISTOCHEM CELL BIOL, V131, P313, DOI 10.1007/s00418-008-0544-2; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Veeck J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-83; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Wiesmann F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2319; Yang X, 2001, ENDOCR-RELAT CANCER, V8, P115, DOI 10.1677/erc.0.0080115	46	39	39	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	34					4814	4825		10.1038/onc.2010.229	http://dx.doi.org/10.1038/onc.2010.229			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	643VB	20543860				2022-12-25	WOS:000281326400007
J	Schutzer, SE; Liu, T; Natelson, BH; Angel, TE; Schepmoes, AA; Purvine, SO; Hixson, KK; Lipton, MS; Camp, DG; Coyle, PK; Smith, RD; Bergquist, J				Schutzer, Steven E.; Liu, Tao; Natelson, Benjamin H.; Angel, Thomas E.; Schepmoes, Athena A.; Purvine, Samuel O.; Hixson, Kim K.; Lipton, Mary S.; Camp, David G., II; Coyle, Patricia K.; Smith, Richard D.; Bergquist, Jonas			Establishing the Proteome of Normal Human Cerebrospinal Fluid	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; TIME TAG APPROACH; ACCURATE MASS; MULTIDIMENSIONAL CHROMATOGRAPHY; PROTEINS; PEPTIDE; IDENTIFICATIONS; STRATEGY; MS/MS; TOOL	Background: Knowledge of the entire protein content, the proteome, of normal human cerebrospinal fluid (CSF) would enable insights into neurologic and psychiatric disorders. Until now technologic hurdles and access to true normal samples hindered attaining this goal. Methods and Principal Findings: We applied immunoaffinity separation and high sensitivity and resolution liquid chromatography-mass spectrometry to examine CSF from healthy normal individuals. 2630 proteins in CSF from normal subjects were identified, of which 56% were CSF-specific, not found in the much larger set of 3654 proteins we have identified in plasma. We also examined CSF from groups of subjects previously examined by others as surrogates for normals where neurologic symptoms warranted a lumbar puncture but where clinical laboratory were reported as normal. We found statistically significant differences between their CSF proteins and our non-neurological normals. We also examined CSF from 10 volunteer subjects who had lumbar punctures at least 4 weeks apart and found that there was little variability in CSF proteins in an individual as compared to subject to subject. Conclusions: Our results represent the most comprehensive characterization of true normal CSF to date. This normal CSF proteome establishes a comparative standard and basis for investigations into a variety of diseases with neurological and psychiatric features.	[Schutzer, Steven E.; Natelson, Benjamin H.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Schutzer, Steven E.; Natelson, Benjamin H.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol, Newark, NJ 07103 USA; [Liu, Tao; Angel, Thomas E.; Schepmoes, Athena A.; Purvine, Samuel O.; Hixson, Kim K.; Lipton, Mary S.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Coyle, Patricia K.] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA; [Bergquist, Jonas] Uppsala Univ, Dept Phys & Analyt Chem, Uppsala, Sweden	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Uppsala University	Schutzer, SE (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA.	schutzer@umdnj.edu	Hixson, Kim/AAW-2332-2020; Bergquist, Jonas/C-5894-2015; Smith, Richard D/J-3664-2012; Purvine, Samuel O/O-3358-2017; Hixson, Kim/AAJ-7714-2020; Liu, Tao/A-9020-2013; Lipton, Mary S/H-3913-2012	Hixson, Kim/0000-0003-3915-7040; Smith, Richard D/0000-0002-2381-2349; Purvine, Samuel O/0000-0002-2257-2400; Hixson, Kim/0000-0003-3716-0326; Liu, Tao/0000-0001-9529-6550; Bergquist, Jonas/0000-0002-4597-041X	National Institutes of Health, through National Institute on Drug Abuse (NIDA) [DA021071]; National Center for Research Resources [RR018522]; Swedish Research Council [621-2005-5379, 621-2008-3562]; Uppsala Berzelii Technology Center for Neurodiagnostics; Department of Energy (DOE) [DE-AC05-76RL0 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021071] Funding Source: NIH RePORTER	National Institutes of Health, through National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Berzelii Technology Center for Neurodiagnostics; Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the National Institutes of Health, through National Institute on Drug Abuse (NIDA) (grant DA021071), the National Center for Research Resources (RR018522), the Swedish Research Council (621-2005-5379, 621-2008-3562) and Uppsala Berzelii Technology Center for Neurodiagnostics for support of portions of the research. Pacific Northwest National Laboratory units are located in the Environmental Molecular Sciences Laboratory, a national scientific user facility, sponsored by the Department of Energy (DOE), operated by Battelle Memorial Institute for the DOE under Contract DE-AC05-76RL0 1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergquist J, 2002, MASS SPECTROM REV, V21, P2, DOI 10.1002/mas.10016; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Ekegren T, 2008, J MASS SPECTROM, V43, P559, DOI 10.1002/jms.1409; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Jing Z, 2005, NEUROBIOL AGING, V26, P207, DOI 10.1016/j.neurobiolaging.2004.03.012; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Maccarrone G, 2004, ELECTROPHORESIS, V25, P2402, DOI 10.1002/elps.200305909; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pan S, 2007, PROTEOMICS, V7, P469, DOI 10.1002/pmic.200600756; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Petyuk VA, 2007, GENOME RES, V17, P328, DOI 10.1101/gr.5799207; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2009, J PROTEOME RES, V8, P290, DOI 10.1021/pr800467r; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Ramstrom M, 2005, J PROTEOME RES, V4, P410, DOI 10.1021/pr049812a; Ransohoff RM, 2009, NATURE, V457, P155, DOI 10.1038/457155a; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; Shaffer SA, 1997, RAPID COMMUN MASS SP, V11, P1813; Sickmann A, 2000, ELECTROPHORESIS, V21, P2721, DOI 10.1002/1522-2683(20000701)21:13<2721::AID-ELPS2721>3.0.CO;2-3; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Wenner BR, 2004, J PROTEOME RES, V3, P97, DOI 10.1021/pr034070r; Xu J, 2006, INT REV NEUROBIOL, V73, P29, DOI 10.1016/S0074-7742(06)73002-1; Yuan XL, 2005, PROTEOMICS, V5, P541, DOI 10.1002/pmic.200400934; Yuan XL, 2002, ELECTROPHORESIS, V23, P1185, DOI 10.1002/1522-2683(200204)23:7/8<1185::AID-ELPS1185>3.0.CO;2-G; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071; Zougman A, 2008, J PROTEOME RES, V7, P386, DOI 10.1021/pr070501k; Zubarev R, 2007, MOL CELL PROTEOMICS, V6, P377, DOI 10.1074/mcp.M600380-MCP200	32	148	153	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e10980	10.1371/journal.pone.0010980	http://dx.doi.org/10.1371/journal.pone.0010980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552007	Green Published, Green Submitted, gold			2022-12-25	WOS:000278662900004
J	Shao, L; Wu, LH; Fang, H; Tong, WD; Fan, XH				Shao, Li; Wu, Leihong; Fang, Hong; Tong, Weida; Fan, Xiaohui			Does Applicability Domain Exist in Microarray-Based Genomic Research?	PLOS ONE			English	Article							GENE-EXPRESSION DATA; BREAST-CANCER; OLIGONUCLEOTIDE MICROARRAY; ESTROGEN-RECEPTOR; DNA MICROARRAYS; PREDICTION; CLASSIFICATION; MODELS; CHEMOTHERAPY; VALIDATION	Constructing an accurate predictive model for clinical decision-making on the basis of a relatively small number of tumor samples with high-dimensional microarray data remains a very challenging problem. The validity of such models has been seriously questioned due to their failure in clinical validation using independent samples. Besides the statistical issues such as selection bias, some studies further implied the probable reason was improper sample selection that did not resemble the genomic space defined by the training population. Assuming that predictions would be more reliable for interpolation than extrapolation, we set to investigate the impact of applicability domain (AD) on model performance in microarray-based genomic research by evaluating and comparing model performance for samples with different extrapolation degrees. We found that the issue of applicability domain may not exist in microarray-based genomic research for clinical applications. Therefore, it is not practicable to improve model validity based on applicability domain.	[Shao, Li; Wu, Leihong; Fan, Xiaohui] Zhejiang Univ, Pharmaceut Informat Inst, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Hong] US FDA, Z Tech Corp, Natl Ctr Toxicol Res, Jefferson, AR USA	Zhejiang University; US Food & Drug Administration (FDA)	Fan, XH (corresponding author), Zhejiang Univ, Pharmaceut Informat Inst, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn	FAN, Xiaohui/F-6458-2010; Wu, Leihong/AAM-9483-2020	FAN, Xiaohui/0000-0002-6336-3007; Wu, Leihong/0000-0002-4093-3708	National Science Foundation of China [30801556, 30830121]; Science Foundation of Chinese University [2009QNA7031]; Zhejiang Provincial Natural Science Foundation of China [R2080693]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Science Foundation of China (No. 30801556 and 30830121), Science Foundation of Chinese University (No. 2009QNA7031) and the Zhejiang Provincial Natural Science Foundation of China (No. R2080693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; DeRisi J, 1996, NAT GENET, V14, P457; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Kolossov E, 2007, SAR QSAR ENVIRON RES, V18, P89, DOI 10.1080/10629360601053984; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; *MAQC CONS, 2009, MAQC 2 PROJ COMPR ST; Mariadason JM, 2003, CANCER RES, V63, P8791; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Merseburger AS, 2003, ONCOL REP, V10, P223; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mukhopadhyay A, 2009, PATTERN RECOGN, V42, P2744, DOI 10.1016/j.patcog.2009.04.018; Mulligan AM, 2008, CLIN CANCER RES, V14, P4168, DOI 10.1158/1078-0432.CCR-07-4543; Netzeva TI, 2005, ATLA-ALTERN LAB ANIM, V33, P155, DOI 10.1177/026119290503300209; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Reid JF, 2005, JNCI-J NATL CANCER I, V97, P927, DOI 10.1093/jnci/dji153; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; SACKETT DL, 1987, J GEN INTERN MED, V2, P40, DOI 10.1007/BF02596250; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; Tong WD, 2004, ENVIRON HEALTH PERSP, V112, P1249, DOI 10.1289/txg.7125; Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11055	10.1371/journal.pone.0011055	http://dx.doi.org/10.1371/journal.pone.0011055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548774	Green Published, gold, Green Submitted			2022-12-25	WOS:000278599600015
J	Yu, KD; Li, JJ; Di, GH; Wu, J; Shen, ZZ; Shao, ZM				Yu, Ke-Da; Li, Jun-Jie; Di, Gen-Hong; Wu, Jiong; Shen, Zhen-Zhou; Shao, Zhi-Ming			A Straightforward but Not Piecewise Relationship between Age and Lymph Node Status in Chinese Breast Cancer Patients	PLOS ONE			English	Article							FOLLOW-UP; TUMOR CHARACTERISTICS; AXILLARY DISSECTION; RANDOMIZED-TRIAL; ELDERLY-WOMEN; MANAGEMENT; MICROMETASTASES; RADIOTHERAPY; CARCINOMAS; BIOPSY	Purpose: To investigate the relationship between age and axillary lymph node (LN) involvement in Chinese breast cancer patients, and to replicate a recently identified piecewise relationship between age and LN involvement. Methods: A dataset, consisting of 3,715 patients (with complete information on study variables) with operable breast cancer consecutively surgically treated between 1996 and 2006, was derived from the database of Shanghai Cancer Hospital. Univariate and multivariate logistic regression were employed to analyze the relationship between age and LN. We subsequently performed a similar analysis on another dataset including 1,832 consecutive patients treated between 2007 and 2008 to replicate our findings in the first dataset. Results: A U-shaped relationship (previously observed in two European populations) between age and LN status failed to be replicated in our dataset of Chinese patients. Instead, we observed a linear rather than piecewise relationship. After multivariate adjustment, the linear relationship was still present. Moreover, the interaction between age and LN involvement was not modified by tumor size. The odds of LN involvement decreased by 1.5% for each year increase in age (OR 0.985, 95% CI 0.979-0.991, P<0.001). Breast cancer subtypes were also associated with LN status. Proportions of basal-like and ERBB2+ subtypes decreased with increasing age. The observations in the first dataset were successfully replicated in a second independent dataset. Conclusion: We confirmed a straightforward but not piecewise relationship between age and LN status in Chinese patients. The different pattern between Chinese and European elderly patients should be considered when making clinical decisions.	[Yu, Ke-Da; Li, Jun-Jie; Di, Gen-Hong; Wu, Jiong; Shen, Zhen-Zhou; Shao, Zhi-Ming] Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai 200433, Peoples R China; [Yu, Ke-Da; Li, Jun-Jie; Di, Gen-Hong; Wu, Jiong; Shen, Zhen-Zhou; Shao, Zhi-Ming] Fudan Univ, Inst Canc, Shanghai 200433, Peoples R China; [Yu, Ke-Da; Li, Jun-Jie; Di, Gen-Hong; Wu, Jiong; Shen, Zhen-Zhou; Shao, Zhi-Ming] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Yu, KD (corresponding author), Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com		Di, Genhong/0000-0003-1171-7907	National Basic Research Program of China [2006CB910501]; Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; National Natural Science Foundation of China [30971143, 30972936]	National Basic Research Program of China(National Basic Research Program of China); Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by grants from the National Basic Research Program of China (2006CB910501), 2009 Youth Foundation of Shanghai Public Health Bureau, 2009 Youth Foundation of Shanghai Medical College, and the National Natural Science Foundation of China (30971143, 30972936). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertucci F, 2009, INT J CANCER, V124, P1338, DOI 10.1002/ijc.24055; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Crivellari D, 2007, J CLIN ONCOL, V25, P1882, DOI 10.1200/JCO.2006.10.2079; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; Diab SG, 1999, J CLIN ONCOL, V17, P1442, DOI 10.1200/JCO.1999.17.5.1442; Diab SG, 2000, J NATL CANCER I, V92, P550, DOI 10.1093/jnci/92.7.550; Fan L, 2009, BREAST CANC IN PRESS; Fisher B, 2002, NEW ENGL J MED, V347, P567, DOI 10.1056/NEJMoa020128; Giuliano AE, 2010, ANN SURG, V251, P601, DOI 10.1097/SLA.0b013e3181d6115f; Hogan BV, 2010, SURG ONCOL, V19, P11, DOI 10.1016/j.suronc.2008.12.009; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Lee JH, 2010, CANCER RES TREAT, V42, P30, DOI 10.4143/crt.2010.42.1.30; Louis-Sylvestre C, 2004, J CLIN ONCOL, V22, P97, DOI 10.1200/JCO.2004.12.108; Ma CD, 2009, CRIT REV ONCOL HEMAT, V71, P258, DOI 10.1016/j.critrevonc.2008.11.005; Mamounas EP, 2009, J CLIN ONCOL, V27, P2900, DOI 10.1200/JCO.2009.22.0509; Martelli G, 2003, CANCER-AM CANCER SOC, V97, P1156, DOI 10.1002/cncr.11173; Martin J, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/007; Molino A, 2006, CRIT REV ONCOL HEMAT, V59, P226, DOI 10.1016/j.critrevonc.2006.01.007; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2009, BREAST CANCER RES TR, V113, P411, DOI 10.1007/s10549-008-9952-1; Rutgers EJT, 2008, J CLIN ONCOL, V26, P698, DOI 10.1200/JCO.2007.14.4667; Singh R, 2004, CANCER-AM CANCER SOC, V100, P1807, DOI 10.1002/cncr.20206; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Takei H, 2010, BREAST CANCER-TOKYO, V17, P9, DOI 10.1007/s12282-009-0154-4; Veronesi U, 2005, ANN ONCOL, V16, P383, DOI 10.1093/annonc/mdi089; Wildiers H, 2009, J CLIN ONCOL, V27, P2931, DOI 10.1200/JCO.2008.16.7619; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0; Yu KD, 2008, J CANCER RES CLIN, V134, P1347, DOI 10.1007/s00432-008-0414-2; Yu KD, 2007, BREAST, V16, P307, DOI 10.1016/j.breast.2006.12.011; Yu KD, 2007, ANN SURG ONCOL, V14, P2502, DOI 10.1245/s10434-007-9436-2	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11035	10.1371/journal.pone.0011035	http://dx.doi.org/10.1371/journal.pone.0011035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543953	Green Submitted, Green Published, gold			2022-12-25	WOS:000278557600013
J	Xu, YQ; Krause, A; Hamai, H; Harvey, BG; Worgall, TS; Worgall, S				Xu, Yaqin; Krause, Anja; Hamai, Hiroko; Harvey, Ben-Gary; Worgall, Tilla S.; Worgall, Stefan			Proinflammatory Phenotype and Increased Caveolin-1 in Alveolar Macrophages with Silenced CFTR mRNA	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NF-KAPPA-B; RESPIRATORY EPITHELIAL-CELLS; MUTANT CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; LIPID-METABOLISM; INDUCED APOPTOSIS; IN-VIVO; EXPRESSION; GENE	The inflammatory milieu in the respiratory tract in cystic fibrosis (CF) has been linked to the defective expression of the cystic transmembrane regulator (CFTR) in epithelial cells. Alveolar macrophages (AM), important contibutors to inflammatory responses in the lung, also express CFTR. The present study analyzes the phenotype of human AM with silenced CFTR. Expression of CFTR mRNA and the immature form of the CFTR protein decreased 100-fold and 5.2-fold, respectively, in AM transfected with a CFTR specific siRNA (CFTR-siRNA) compared to controls. Reduction of CFTR expression in AM resulted in increased secretion of IL-8, increased phosphorylation of NF-kappa B, a positive regulator of IL-8 expression, and decreased expression of I kappa B-alpha, the inhibitory protein of NF-kappa B activation. AM with silenced CFTR expression also showed increased apoptosis. We hypothesized that caveolin-1 (Cav1), a membrane protein that is colocalized with CFTR in lipid rafts and that is related to inflammation and apoptosis in macrophages, may be affected by decreased CFTR expression. Messenger RNA and protein levels of Cav1 were increased in AM with silenced CFTR. Expression and transcriptional activity of sterol regulatory element binding protein (SREBP), a negative transcriptional regulator of Cav1, was decreased in AM with silenced CFTR, but total and free cholesterol mass did not change. These findings indicate that silencing of CFTR in human AM results in an inflammatory phenotype and apoptosis, which is associated to SREBP-mediated regulation of Cav1.	[Xu, Yaqin; Worgall, Stefan] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Krause, Anja; Harvey, Ben-Gary; Worgall, Stefan] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Hamai, Hiroko; Worgall, Tilla S.] Columbia Univ, Dept Pathol, New York, NY USA	Cornell University; Cornell University; Columbia University	Xu, YQ (corresponding author), Weill Cornell Med Coll, Dept Pediat, New York, NY USA.	stw2006@med.cornell.edu			Cystic Fibrosis Foundation, Bethesda, MD;  [R21 HL077557]	Cystic Fibrosis Foundation, Bethesda, MD; 	These studies were supported, in part, by R21 HL077557 (http://grants.nih.gov/grants/oer.htm) and the Cystic Fibrosis Foundation, Bethesda, MD (http://www.cff.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali BR, 2009, MED HYPOTHESES, V72, P55, DOI 10.1016/j.mehy.2008.07.058; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Blaisdell CJ, 2004, AM J PHYSIOL-LUNG C, V286, pL420, DOI 10.1152/ajplung.00113.2003; Brennan S, 2009, EUR RESPIR J, V34, P655, DOI 10.1183/09031936.00178508; Brennan S, 2008, PAEDIATR RESPIR REV, V9, P271, DOI 10.1016/j.prrv.2008.05.008; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; Dakin CJ, 2002, AM J RESP CRIT CARE, V165, P904, DOI 10.1164/ajrccm.165.7.2010139; del Fresno C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002667; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; DiMagno MJ, 2005, GASTROENTEROLOGY, V129, P665, DOI 10.1053/j.gastro.2005.05.059; Gargalovic P, 2003, J LIPID RES, V44, P1622, DOI 10.1194/jlr.M300140-JLR200; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P3587, DOI 10.1073/pnas.93.8.3587; Hamai H, 2009, J LIPID RES, V50, P1101, DOI 10.1194/jlr.M800427-JLR200; Heda GD, 2000, BIOCHEM BIOPH RES CO, V271, P659, DOI 10.1006/bbrc.2000.2684; Hubeau C, 2001, J ALLERGY CLIN IMMUN, V108, P524, DOI 10.1067/mai.2001.118516; Jacquot J, 2008, INT J BIOCHEM CELL B, V40, P1703, DOI 10.1016/j.biocel.2008.02.002; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Knight RA, 1997, CLIN EXP IMMUNOL, V107, P542, DOI 10.1046/j.1365-2249.1997.d01-954.x; L'hoste S, 2009, FREE RADICAL BIO MED, V46, P1017, DOI 10.1016/j.freeradbiomed.2008.12.009; Li J, 2008, EXP EYE RES, V86, P684, DOI 10.1016/j.exer.2008.01.017; Li TB, 2006, AM J PHYSIOL-LUNG C, V290, pL649, DOI 10.1152/ajplung.00205.2005; Mailhot G, 2009, AM J PHYSIOL-GASTR L, V297, pG1239, DOI 10.1152/ajpgi.00206.2009; Maiuri L, 1997, FEBS LETT, V408, P225, DOI 10.1016/S0014-5793(97)00347-5; MCDONALD TV, 1992, J BIOL CHEM, V267, P3242; Moriceau S, 2010, J INNATE IMMUN, V2, P260, DOI 10.1159/000295791; Moss RB, 2000, CLIN EXP IMMUNOL, V120, P518, DOI 10.1046/j.1365-2249.2000.01232.x; Moss RB, 2004, CLIN EXP IMMUNOL, V135, P358, DOI 10.1111/j.1365-2249.2003.02389.x; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Noe J, 2009, AM J RESP CELL MOL, V41, P314, DOI 10.1165/rcmb.2008-0264OC; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Puchelle Edith, 2002, Paediatr Respir Rev, V3, P115, DOI 10.1016/S1526-0550(02)00005-7; Rajan S, 2000, AM J RESP CELL MOL, V23, P304, DOI 10.1165/ajrcmb.23.3.4098; Rottner M, 2007, FASEB J, V21, P2939, DOI 10.1096/fj.06-7614com; Russi TJ, 1997, LUNG SCI FDN, V1, P371; Tabary O, 2000, J IMMUNOL, V164, P3377, DOI 10.4049/jimmunol.164.6.3377; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; White NM, 2007, AM J PHYSIOL-LUNG C, V292, pL476, DOI 10.1152/ajplung.00262.2006; White NM, 2004, AM J RESP CELL MOL, V31, P538, DOI 10.1165/rcmb.2004-0117OC; Worgall S, 2005, INFECT IMMUN, V73, P5262, DOI 10.1128/IAI.73.8.5262-5268.2005; Worgall TS, 2009, CURR OPIN CLIN NUTR, V12, P105, DOI 10.1097/MCO.0b013e32832595b7; Xu YQ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-26; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417; Zaidi T, 2008, INVEST OPHTH VIS SCI, V49, P1000, DOI 10.1167/iovs.07-0993; Zaman MM, 2004, CLIN DIAGN LAB IMMUN, V11, P819, DOI 10.1128/CDLI.11.5.819-824.2004	58	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11004	10.1371/journal.pone.0011004	http://dx.doi.org/10.1371/journal.pone.0011004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543983	Green Published, Green Submitted, gold			2022-12-25	WOS:000278494900016
J	Granjon, T; Maniti, O; Auchli, Y; Dahinden, P; Buchet, R; Marcillat, O; Dimroth, P				Granjon, Thierry; Maniti, Ofelia; Auchli, Yolanda; Dahinden, Pius; Buchet, Rene; Marcillat, Olivier; Dimroth, Peter			Structure-Function Relations in Oxaloacetate Decarboxylase Complex. Fluorescence and Infrared Approaches to Monitor Oxomalonate and Na+ Binding Effect	PLOS ONE			English	Article							RED-EDGE-EXCITATION; PROTEIN SECONDARY STRUCTURE; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; COUPLING MECHANISM; VIBRIO-CHOLERAE; BETA-SUBUNIT; PUMP; ION; SPECTROSCOPY	Background: Oxaloacetate decarboxylase (OAD) is a member of the Na+ transport decarboxylase enzyme family found exclusively in anaerobic bacteria. OAD of Vibrio cholerae catalyses a key step in citrate fermentation, converting the chemical energy of the decarboxylation reaction into an electrochemical gradient of Na+ ions across the membrane, which drives endergonic membrane reactions such as ATP synthesis, transport and motility. OAD is a membrane-bound enzyme composed of alpha, beta and gamma subunits. The a subunit contains the carboxyltransferase catalytic site. Methodology/Principal Findings: In this report, spectroscopic techniques were used to probe oxomalonate (a competitive inhibitor of OAD with respect to oxaloacetate) and Na+ effects on the enzyme tryptophan environment and on the secondary structure of the OAD complex, as well as the importance of each subunit in the catalytic mechanism. An intrinsic fluorescence approach, Red Edge Excitation Shift (REES), indicated that solvent molecule mobility in the vicinity of OAD tryptophans was more restricted in the presence of oxomalonate. It also demonstrated that, although the structure of OAD is sensitive to the presence of NaCl, oxomalonate was able to bind to the enzyme even in the absence of Na+. REES changes due to oxomalonate binding were also observed with the alpha gamma and alpha subunits. Infrared spectra showed that OAD, alpha gamma and alpha subunits have a main component band centered between 1655 and 1650 cm(-1) characteristic of a high content of alpha helix structures. Addition of oxomalonate induced a shift of the amide-I band of OAD toward higher wavenumbers, interpreted as a slight decrease of beta sheet structures and a concomitant increase of alpha helix structures. Oxomalonate binding to alpha gamma and alpha subunits also provoked secondary structure variations, but these effects were negligible compared to OAD complex. Conclusion: Oxomalonate binding affects the tryptophan environment of the carboxyltransferase subunit, whereas Na+ alters the tryptophan environment of the beta subunit, consistent with the function of these subunits within the enzyme complex. Formation of a complex between OAD and its substrates elicits structural changes in the alpha-helical as well as beta-strand secondary structure elements.	[Granjon, Thierry; Auchli, Yolanda; Dahinden, Pius; Dimroth, Peter] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Granjon, Thierry; Maniti, Ofelia; Buchet, Rene; Marcillat, Olivier] Univ Lyon 1, CNRS, Inst Chim & Biochim Mol & Supramol, UMR 5246, F-69622 Villeurbanne, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Granjon, T (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	thierry.granjon@univ-lyon1.fr	Maniti, Ofélia/AAQ-5624-2021; Rene, Buchet/I-9781-2019	Rene, Buchet/0000-0002-7966-3856	Swiss National Science Foundation; University of Lyon; CNRS; Rhone-Alpes region	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lyon; CNRS(Centre National de la Recherche Scientifique (CNRS)); Rhone-Alpes region(Region Auvergne-Rhone-Alpes)	This work was supported by Swiss National Science Foundation, University of Lyon, CNRS, Rhone-Alpes region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Birks J., 1970, PHOTOPHYSICS AROMATI, DOI DOI 10.1002/BBPC.19700741223; Bott M, 1997, ARCH MICROBIOL, V167, P78, DOI 10.1007/s002030050419; Buckel W, 2001, BBA-BIOENERGETICS, V1505, P15, DOI 10.1016/S0005-2728(00)00273-5; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chattopadhyay A, 2003, CHEM PHYS LIPIDS, V122, P3, DOI 10.1016/S0009-3084(02)00174-3; CHATTOPADHYAY A, 1993, FEBS LETT, V335, P341, DOI 10.1016/0014-5793(93)80415-Q; CLADERA J, 1992, BIOCHEMISTRY-US, V31, P12363, DOI 10.1021/bi00164a010; Dahinden P, 2005, FEBS J, V272, P846, DOI 10.1111/j.1742-4658.2004.04524.x; Dahinden P, 2005, ARCH MICROBIOL, V183, P121, DOI 10.1007/s00203-004-0754-5; Dahinden P, 2004, ARCH MICROBIOL, V182, P414, DOI 10.1007/s00203-004-0706-0; Demchenko AP, 2002, LUMINESCENCE, V17, P19, DOI 10.1002/bio.671; DEMCHENKO AP, 1988, EUR BIOPHYS J BIOPHY, V16, P121, DOI 10.1007/BF00255522; DEMCHENKO AP, 1982, BIOPHYS CHEM, V15, P101, DOI 10.1016/0301-4622(82)80022-7; Dimroth P, 1998, ARCH MICROBIOL, V170, P69, DOI 10.1007/s002030050616; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; DIMROTH P, 1988, EUR J BIOCHEM, V175, P175, DOI 10.1111/j.1432-1033.1988.tb14180.x; DIMROTH P, 1986, EUR J BIOCHEM, V156, P157, DOI 10.1111/j.1432-1033.1986.tb09561.x; DIMROTH P, 1983, EUR J BIOCHEM, V137, P107, DOI 10.1111/j.1432-1033.1983.tb07802.x; FABIAN H, 1992, BIOCHEMISTRY-US, V31, P6532, DOI 10.1021/bi00143a024; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GOORMAGHTIGH E, 1994, ASSIGNMENTS MODELS C, P329; Granjon T, 2001, BIOCHEMISTRY-US, V40, P6016, DOI 10.1021/bi002293e; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jockel P, 2000, BIOCHEMISTRY-US, V39, P2307, DOI 10.1021/bi992261v; Jockel P, 2000, BIOCHEMISTRY-US, V39, P4320, DOI 10.1021/bi992817e; Jockel P, 1999, BIOCHEMISTRY-US, V38, P13461, DOI 10.1021/bi990303+; LAKOWICZ JR, 1984, BIOCHEMISTRY-US, V23, P3013, DOI 10.1021/bi00308a026; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MUKHERJEE S, 1994, BIOCHEMISTRY-US, V33, P5089, DOI 10.1021/bi00183a012; Rawat SS, 2004, BIOPHYS J, V87, P831, DOI 10.1529/biophysj.104.041715; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmid M, 2002, BIOCHEMISTRY-US, V41, P1285, DOI 10.1021/bi015764l; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Susi H, 1972, Methods Enzymol, V26, P455; Tatulian SA, 1997, J MOL BIOL, V268, P809, DOI 10.1006/jmbi.1997.1014; TORRES J, 1995, BIOPHYS J, V68, P2049, DOI 10.1016/S0006-3495(95)80383-8; WOEHLKE G, 1992, J BIOL CHEM, V267, P22798	44	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10935	10.1371/journal.pone.0010935	http://dx.doi.org/10.1371/journal.pone.0010935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20543879	Green Published, Green Submitted, gold			2022-12-25	WOS:000278318700009
J	Lataillade, M; Chiarella, J; Yang, R; Schnittman, S; Wirtz, V; Uy, J; Seekins, D; Krystal, M; Mancini, M; McGrath, D; Simen, B; Egholm, M; Kozal, M				Lataillade, Max; Chiarella, Jennifer; Yang, Rong; Schnittman, Steven; Wirtz, Victoria; Uy, Jonathan; Seekins, Daniel; Krystal, Mark; Mancini, Marco; McGrath, Donnie; Simen, Birgitte; Egholm, Michael; Kozal, Michael			Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naive Subjects in the CASTLE Study	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; REVERSE-TRANSCRIPTASE; VIROLOGICAL FAILURE; TREATMENT OUTCOMES; VIRAL VARIANTS; THERAPY; ATAZANAVIR/RITONAVIR; INHIBITORS; EFFICACY; TRANSMISSION	Background: CASTLE compared the efficacy of atazanavir/ritonavir with lopinavir/ritonavir, each in combination with tenofovir-emtricitabine in ARV-naive subjects from 5 continents. Objectives: Determine the baseline rate and clinical significance of TDR mutations using ultra-deep sequencing (UDS) in ARV-naive subjects in CASTLE. Methods: A case control study was performed on baseline samples for all 53 subjects with virologic failures (VF) at Week 48 and 95 subjects with virologic successes (VS) randomly selected and matched by CD4 count and viral load. UDS was performed using 454 Life Sciences/Roche technology. Results: Of 148 samples, 141 had successful UDS (86 subtype B, 55 non-B subtypes). Overall, 30.5% of subjects had a TDR mutation at baseline; 15.6% only had TDR(s) at <20% of the viral population. There was no difference in the rate of TDRs by B (30.2%) or non-B subtypes (30.9%). VF (51) and VS (90) had similar rates of any TDRs (25.5% vs. 33.3%), NNRTI TDRs (11.1% vs. 11.8%) and NRTI TDRs (24.4% vs. 25.5%). Of 9 (6.4%) subjects with M184V/I (7 at <20% levels), 6 experienced VF. 16 (11.3%) subjects had multiple TAMs, and 7 experienced VF. 3 (2.1%) subjects had both multiple TAMs+M184V, and all experienced VF. Of 14 (9.9%) subjects with PI TDRs (11 at <20% levels): only 1 experienced virologic failure. The majority of PI TDRs were found in isolation (e. g. 46I) at <20% levels, and had low resistance algorithm scores. Conclusion: Among a representative sample of ARV-naive subjects in CASTLE, TDR mutations were common (30.5%); B and non-B subtypes had similar rates of TDRs. Subjects with multiple PI TDRs were infrequent. Overall, TDRs did not affect virologic response for subjects on a boosted PI by week 48; however, a small subset of subjects with extensive NRTI backbone TDR patterns experienced virologic failure.	[Lataillade, Max; Yang, Rong; Schnittman, Steven; Wirtz, Victoria; Uy, Jonathan; Seekins, Daniel; Krystal, Mark; Mancini, Marco; McGrath, Donnie] Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA; [Lataillade, Max; Kozal, Michael] Yale Univ, Sch Med & Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; [Simen, Birgitte; Egholm, Michael] 454 Life Sci, Branford, CT USA	Bristol-Myers Squibb; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Lataillade, M (corresponding author), Bristol Myers Squibb Co, Global Dev & Med Affairs, 5 Res Pkwy, Wallingford, CT 06492 USA.	Michael.kozal@yale.edu		Simen, Birgitte/0000-0003-0503-0973; Kozal, Michael/0000-0002-3100-8254; , Michael/0000-0002-7719-7396	Bristol-Myers Squibb; Roche; VA MERIT Award	Bristol-Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); VA MERIT Award(US Department of Veterans Affairs)	Bristol-Myers Squibb funded the study and Roche contributed to the funding of this study by the employment of Drs. Simen and Egholm. This study was a Bristol-Myers Squibb funded resistance study of the parent CASTLE study which was also funded by Bristol-Myers Squibb. Bristol-Myers Squibb had a role in the initial study design, data collection and analysis. The ultra-deep sequencing analysis was performed at Yale/VA under the direction of Dr. Kozal and the decision to prepare and publish the manuscript of the ultra-deep substudy was the decision of Dr. Kozal. Dr. Kozal was supported by a VA MERIT Award.	Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Fleiss Joseph L, 1981, STAT METHODS RATES P; Goodman DD, 2009, ANTIVIR THER, V14, pA43; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; HUPPLERHULLSIEK K, 2008, VIROLOGIC SUCCESS DI; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kozal MJ, 2009, CLIN MICROBIOL INFEC, V15, P69, DOI 10.1111/j.1469-0691.2008.02687.x; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Lanier R, 2007, ANTIVIR THER, V12, pS150; Lataillade M, 2008, ANTIVIR THER, V13, pA135; Lataillade M, 2008, J INT AIDS SOC S1, V11, pP180; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Marcelin G, 2006, JAIDS-J ACQ IMM DEF, V42, P127; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McGrath D, 2006, ANTIVIR THER, V11, pS97; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Molina JM, 2008, 48 ANN ICAAC IDSA 46; Naeger LK, 2006, AIDS, V20, P847, DOI 10.1097/01.aids.0000218548.77457.76; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stenman J, 2003, BIOTECHNIQUES, V34, P172, DOI 10.2144/03341dd05; Svarovskaia ES, 2007, JAIDS-J ACQ IMM DEF, V46, P174, DOI 10.1097/QAI.0b013e31814258c0; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307	35	102	107	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10952	10.1371/journal.pone.0010952	http://dx.doi.org/10.1371/journal.pone.0010952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532178	Green Published, gold, Green Submitted			2022-12-25	WOS:000278318700020
J	Colinet, H; Lee, SF; Hoffmann, A				Colinet, Herve; Lee, Siu Fai; Hoffmann, Ary			Functional Characterization of the Frost Gene in Drosophila melanogaster: Importance for Recovery from Chill Coma	PLOS ONE			English	Article							PYRRHOCORIS-APTERUS; OXIDATIVE STRESS; ION HOMEOSTASIS; COLD; EXPRESSION; INSECTS; SHOCK; RESISTANCE; INJURY; HOST	Background: Almost all animals, including insects, need to adapt to temperature fluctuations. The molecular basis of thermal adaptation is not well understood, although a number of candidate genes have been proposed. However, a functional link between candidate genes and thermal tolerance has rarely been established. The gene Frost (Fst)was first discovered when Drosophila flies were exposed to cold stress, but the biological function(s) of Fst has so far not been characterized. Because Fst is up-regulated after a cold stress, we tested whether it was essential for chill-coma recovery. Methodology/Principal Findings: A marked increase in Fst expression was detected (by RT-PCR) during recovery from cold stress, peaking at 42-fold after 2 h. The GAL4/UAS system was used to knock down expression of Fst and recovery ability was assessed in transgenic adults following 12 h of chill coma at 0 degrees C. The ability to recover from cold stress (short-, medium- and long-term) was significantly altered in the transgenic adults that had Fst silenced. These findings show that Fst plays an essential role in the recovery from chill coma in both males and females. Conclusions/Significance: The Frost gene is essential for cold tolerance in Drosophila melanogaster and may play an important role in thermal adaptation.	[Colinet, Herve] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium; [Colinet, Herve; Lee, Siu Fai; Hoffmann, Ary] Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Inst Bio21, Parkville, Vic 3052, Australia	Universite Catholique Louvain; University of Melbourne	Colinet, H (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium.	herve.colinet@uclouvain.be	Hoffmann, Ary/C-2961-2011; Lee, Siu Fai/L-4690-2018; Colinet, hervé/B-3677-2019; Hoffmann, Ary/R-2972-2019; colinet, hervé/K-8768-2019	Colinet, hervé/0000-0002-8806-3107; Hoffmann, Ary/0000-0001-9497-7645; Lee, Siu Fai/0000-0001-6234-4819	Fonds de la Recherche Scientifique (FNRS) from Belgium; Australian Research Council; Commonwealth Environmental Research Fund	Fonds de la Recherche Scientifique (FNRS) from Belgium(Fonds de la Recherche Scientifique - FNRS); Australian Research Council(Australian Research Council); Commonwealth Environmental Research Fund	This study was supported by Fonds de la Recherche Scientifique (FNRS) from Belgium, and the Australian Research Council and the Commonwealth Environmental Research Fund. This paper is number BRC 169 of the Biodiversity Research Centre (UCL-Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck JG, 2006, TOXICOL SCI, V89, P495, DOI 10.1093/toxsci/kfj036; Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Carsten LD, 2005, MOL ECOL, V14, P3203, DOI 10.1111/j.1365-294X.2005.02654.x; Chamilos G, 2008, P NATL ACAD SCI USA, V105, P9367, DOI 10.1073/pnas.0709578105; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Denlinger DL, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P55; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Goto SG, 2001, GENE, V270, P259, DOI 10.1016/S0378-1119(01)00465-6; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2002, EVOLUTION, V56, P1068, DOI 10.1111/j.0014-3820.2002.tb01418.x; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hosler JS, 2000, J INSECT PHYSIOL, V46, P621, DOI 10.1016/S0022-1910(99)00148-1; Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x; Jensen LT, 2008, CELL STRESS CHAPERON, V13, P177, DOI 10.1007/s12192-008-0020-x; Kostal V, 2007, COMP BIOCHEM PHYS A, V147, P231, DOI 10.1016/j.cbpa.2006.12.033; Kostal V, 2006, COMP BIOCHEM PHYS B, V143, P171, DOI 10.1016/j.cbpb.2005.11.005; Kostal V, 2004, J EXP BIOL, V207, P1509, DOI 10.1242/jeb.00923; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; Laayouni H, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-42; Lee RE, 2006, CRYOBIOLOGY, V52, P459, DOI 10.1016/j.cryobiol.2006.03.003; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minois N, 1999, MECH AGEING DEV, V109, P53, DOI 10.1016/S0047-6374(99)00025-1; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rojas RR, 1996, CRYOBIOLOGY, V33, P447, DOI 10.1006/cryo.1996.0045; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Takeyama K, 2000, J IMMUNOL, V164, P1546, DOI 10.4049/jimmunol.164.3.1546; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69	44	45	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10925	10.1371/journal.pone.0010925	http://dx.doi.org/10.1371/journal.pone.0010925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532197	gold, Green Published			2022-12-25	WOS:000278284700008
J	Cornes, BK; Tang, CS; Leon, TYY; Hui, KJWS; So, MT; Miao, XP; Cherny, SS; Sham, PC; Tam, PKH; Garcia-Barcelo, MM				Cornes, Belinda K.; Tang, Clara S.; Leon, Thomas Y. Y.; Hui, Kenneth J. W. S.; So, Man-Ting; Miao, Xiaoping; Cherny, Stacey S.; Sham, Pak C.; Tam, Paul K. H.; Garcia-Barcelo, Maria-Merce			Haplotype Analysis Reveals a Possible Founder Effect of RET Mutation R114H for Hirschsprung's Disease in the Chinese Population	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; ASSOCIATION; GENE; RECONSTRUCTION; SUSCEPTIBILITY; ENHANCER; LOCUS	Background: Hirschsprung's disease (HSCR) is a congenital disorder associated with the lack of intramural ganglion cells in the myenteric and sub-mucosal plexuses along varying segments of the gastrointestinal tract. The RET gene is the major gene implicated in this gastrointestinal disease. A highly recurrent mutation in RET (RET(R114H)) has recently been identified in similar to 6-7% of the Chinese HSCR patients which, to date, has not been found in Caucasian patients or controls nor in Chinese controls. Due to the high frequency of RET(R114H) in this population, we sought to investigate whether this mutation may be a founder HSCR mutation in the Chinese population. Methodology and Principal Findings: To test whether all RET(R114) were originated from a single mutational event, we predicted the approximate age of RET(R114H) by applying a Bayesian method to RET SNPs genotyped in 430 Chinese HSCR patients (of whom 25 individuals had the mutation) to be between 4-23 generations old depending on growth rate. We reasoned that if RET(R114H) was a founder mutation then those with the mutation would share a haplotype on which the mutation resides. Including SNPs spanning 509.31 kb across RET from a recently obtained 500 K genome-wide dataset for a subset of 181 patients (14 RET(R114H) patients), we applied haplotype estimation methods to determine whether there were any segments shared between patients with RET(R114H) that are not present in those without the mutation or controls. Analysis yielded a 250.2 kb (51 SNP) shared segment over the RET gene (and downstream) in only those patients with the mutation with no similar segments found among other patients. Conclusions: This suggests that RET(R114H) is a founder mutation for HSCR in the Chinese population.	[Cornes, Belinda K.; Leon, Thomas Y. Y.; Hui, Kenneth J. W. S.; So, Man-Ting; Miao, Xiaoping; Tam, Paul K. H.; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Paediat Surg Div, Dept Surg, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Tang, Clara S.; Cherny, Stacey S.; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Cornes, BK (corresponding author), Univ Hong Kong, Paediat Surg Div, Dept Surg, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.	mmgarcia@hkucc.hku.hk	miao, xiaoping/C-4336-2011; Cherny, Stacey S/B-3315-2008; /C-4405-2009	miao, xiaoping/0000-0002-6818-9722; Cherny, Stacey S/0000-0002-0269-3352; Tang, Clara/0000-0003-0265-2638; /0000-0001-6231-3035	Hong Kong Research Grants Council [765407M, 775907M]; University of Hong Kong [200611159028]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by research grants from the Hong Kong Research Grants Council (765407M and 775907M to MMGB and PT respectively) and the University of Hong Kong Seed Funding Programme for Basic Research to MMGB (200611159028). Support was also obtained from the University of Hong Kong Strategic Research Theme of Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; EMISON ES, SNP INTRON 1 E UNPUB; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Garcia-Barcelo M, 2004, CLIN CHEM, V50, P93, DOI 10.1373/clinchem.2003.022061; Garcia-Barcelo MM, 2008, EUR J HUM GENET, V16, P833, DOI 10.1038/ejhg.2008.18; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Garcia-Barcelo MM, 2003, J MED GENET, V40; GILKS W, MARKOV CHAIN MONTE C; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Lantieri F, 2006, ANN HUM GENET, V70, P12, DOI 10.1111/j.1529-8817.2005.00196.x; Li N, 2003, GENETICS, V165, P2213; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Maksymowych WP, 2006, ARTHRITIS RHEUM-US, V54, P974, DOI 10.1002/art.21642; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; SCHUCHARDT A, 1995, J INTERN MED, V238, P327, DOI 10.1111/j.1365-2796.1995.tb01206.x; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501	22	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10918	10.1371/journal.pone.0010918	http://dx.doi.org/10.1371/journal.pone.0010918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532249	Green Published, Green Submitted, gold			2022-12-25	WOS:000278284700004
J	Ramer, MS; Cabrera, MAC; Alan, N; Scott, ALM; Inskip, JA				Ramer, Matt S.; Cabrera, Mario A. Cruz; Alan, Nima; Scott, Angela L. M.; Inskip, Jessica A.			A New Organellar Complex in Rat Sympathetic Neurons	PLOS ONE			English	Article							DRAGONFLY CORDULIA-AENEA; ANNULATE LAMELLAE; PELVIC GANGLION; GAMMA-TUBULIN; GENE-PRODUCTS; CYTOKINESIS; CELLS; EXPRESSION; CALCIUM; OOCYTES	Membranous compartments of neurons such as axons, dendrites and modified primary cilia are defining features of neuronal phenotype. This is unlike organelles deep to the plasma membrane, which are for the most part generic and not related directly to morphological, neurochemical or functional specializations. However, here we use multi-label immunohistochemistry combined with confocal and electron microscopy to identify a very large (similar to 6 microns in diameter), entirely intracellular neuronal organelle which occurs singly in a ubiquitous but neurochemically distinct and morphologically simple subset of sympathetic ganglion neurons. Although usually toroidal, it also occurs as twists or rods depending on its intracellular position: tori are most often perinuclear whereas rods are often found in axons. These 'loukoumasomes' (doughnut-like bodies) bind a monoclonal antibody raised against beta-III-tubulin (SDL.3D10), although their inability to bind other beta-III-tubulin monoclonal antibodies indicate that the responsible antigen is not known. Position-morphology relationships within neurons and their expression of non-muscle heavy chain myosin suggest a dynamic structure. They associate with nematosomes, enigmatic nucleolus-like organelles present in many neural and non-neural tissues, which we now show to be composed of filamentous actin. Loukoumasomes also separately interact with mother centrioles forming the basal body of primary cilia. They express gamma tubulin, a microtubule nucleator which localizes to non-neuronal centrosomes, and cenexin, a mother centriole-associated protein required for ciliogenesis. These data reveal a hitherto undescribed organelle, and depict it as an intracellular transport machine, shuttling material between the primary cilium, the nematosome, and the axon.	[Ramer, Matt S.; Cabrera, Mario A. Cruz; Alan, Nima; Scott, Angela L. M.; Inskip, Jessica A.] Univ British Columbia, ICORD, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Ramer, MS (corresponding author), Univ British Columbia, ICORD, Vancouver, BC V5Z 1M9, Canada.	ramer@icord.org			Michael Smith Foundation for Health Research [CI-SSH-00043(05-1)]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was funded by the Michael Smith Foundation for Health Research (www.msfhr.org), grant #CI-SSH-00043(05-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Alberts B, 2008, MOL BIOL CELL; Anderson CR, 1998, CLIN EXP PHARMACOL P, V25, P449, DOI 10.1111/j.1440-1681.1998.tb02232.x; Anderson CR, 2002, NEUROSCIENCE, V109, P329, DOI 10.1016/S0306-4522(01)00497-3; BANERJEE A, 1990, J BIOL CHEM, V265, P1794; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; BOWERS CW, 1984, NEUROSCIENCE, V13, P87, DOI 10.1016/0306-4522(84)90261-6; Burgess DR, 2005, CURR BIOL, V15, pR310, DOI 10.1016/j.cub.2005.04.008; Chanthaphavong RS, 2004, CELL TISSUE RES, V317, P165, DOI 10.1007/s00441-004-0888-4; Corns RA, 2000, NEUROSCI LETT, V292, P91, DOI 10.1016/S0304-3940(00)01442-7; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Davies AM, 2009, AUTON NEUROSCI-BASIC, V151, P39, DOI 10.1016/j.autneu.2009.07.011; DEZEEUW CI, 1995, J NEUROSCI, V15, P1587; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; FLUCK RA, 1991, J CELL BIOL, V115, P1259, DOI 10.1083/jcb.115.5.1259; Gabella Giorgio, 1995, P81; GRILLO MA, 1970, J CELL BIOL, V45, P100, DOI 10.1083/jcb.45.1.100; HALKKA L, 1975, J CELL SCI, V19, P103; HALKKA L, 1977, J CELL SCI, V26, P217; Hannan AJ, 1998, NEUROPHARMACOLOGY, V37, P593, DOI 10.1016/S0028-3908(98)00056-2; Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Janig W, 2003, ACTA PHYSIOL SCAND, V177, P255, DOI 10.1046/j.1365-201X.2003.01088.x; JULIAN M, 1993, J CELL SCI, V105, P145; KANERVA L, 1972, Z ZELLFORSCH MIK ANA, V129, P161, DOI 10.1007/BF00306933; KEAST JR, 1991, CELL TISSUE RES, V266, P405, DOI 10.1007/BF00318197; KESSEL RG, 1969, J CELL BIOL, V42, P185, DOI 10.1083/jcb.42.1.185; Kind PC, 1997, J NEUROSCI, V17, P1471; Leask A, 1997, NEUROSCI LETT, V229, P17, DOI 10.1016/S0304-3940(97)00412-6; Li C, 2006, J NEUROPHYSIOL, V95, P187, DOI 10.1152/jn.00779.2005; Li SH, 2000, MOL CELL NEUROSCI, V16, P168, DOI 10.1006/mcne.2000.0858; Liang P, 1997, J CELL SCI, V110, P1431; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; OCKLEFORD CD, 1987, J CELL SCI, V87, P27; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Peters A., 1991, FINE STRUCTURE NERVO; Richardson RJ, 2006, CELL TISSUE RES, V324, P9, DOI 10.1007/s00441-005-0105-0; Rivkin E, 2008, MOL REPROD DEV, V75, P1591, DOI 10.1002/mrd.20911; ROSE RD, 1988, J COMP NEUROL, V272, P365; Schatten H, 2008, HISTOCHEM CELL BIOL, V129, P667, DOI 10.1007/s00418-008-0427-6; SHU HB, 1995, J CELL SCI, V108, P2955; Silver RB, 1996, CELL CALCIUM, V20, P161, DOI 10.1016/S0143-4160(96)90105-0; SUZUKI K, 1995, BIOL BULL-US, V189, P201; TABATABAI M, 1986, BRAIN RES, V382, P61, DOI 10.1016/0006-8993(86)90111-3; Tilney LG, 1996, J CELL BIOL, V133, P61, DOI 10.1083/jcb.133.1.61; Webb SE, 2008, PHILOS T R SOC B, V363, P1363, DOI 10.1098/rstb.2007.2253; WILLISON K, 1989, CELL, V57, P621, DOI 10.1016/0092-8674(89)90131-1; Wolf E, 1999, J NEUROBIOL, V40, P366, DOI 10.1002/(SICI)1097-4695(19990905)40:3<366::AID-NEU8>3.0.CO;2-B; Young HM, 2004, AUTON NEUROSCI-BASIC, V112, P1, DOI 10.1016/j.autneu.2004.02.008	51	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e1000872	10.1371/journal.pone.0010872	http://dx.doi.org/10.1371/journal.pone.0010872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20531934	gold, Green Submitted, Green Published			2022-12-25	WOS:000278221900018
J	O'Brien, SK; Cao, H; Nathans, R; Ali, A; Rana, TM				O'Brien, Siobhan K.; Cao, Hong; Nathans, Robin; Ali, Akbar; Rana, Tariq M.			P-TEFb Kinase Complex Phosphorylates Histone H1 to Regulate Expression of Cellular and HIV-1 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; VIRUS TYPE-1 REPLICATION; TRANSCRIPTIONAL ELONGATION; CHROMATIN-STRUCTURE; LIVING CELLS; 7SK SNRNA; IN-VIVO; RECRUITMENT; BINDING	Transcription of HIV-1 genes depends on the RNA polymerase II kinase and elongation factor positive transcription elongation factor b (P-TEFb), the complex of cyclin T1 and CDK9. Recent evidence suggests that regulation of transcription by P-TEFb involves chromatin binding and modifying factors. To determine how P-TEFb may connect chromatin remodeling to transcription, we investigated the relationship between P-TEFb and histone H1. We identify histone H1 as a substrate for P-TEFb involved in cellular and HIV-1 transcription. We show that P-TEFb interacts with H1 and that P-TEFb inhibition by RNAi, flavopiridol, or dominant negative CDK9 expression correlates with loss of phosphorylation and mobility of H1 in vivo. Importantly, P-TEFb directs H1 phosphorylation in response to wild-type HIV-1 infection, but not Tat-mutant HIV-1 infection. Our results show that P-TEFb phosphorylates histone H1 at a specific C-terminal phosphorylation site. Expression of a mutant H1.1 that cannot be phosphorylated by P-TEFb also disrupts Tat transactivation in an HIV reporter cell line as well as transcription of the c-fos and hsp70 genes in HeLa cells. We identify histone H1 as a novel P-TEFb substrate, and our results suggest new roles for P-TEFb in both cellular and HIV-1 transcription.	Univ Massachusetts, Dept Mol Pharmacol & Biochem, Sch Med, Worcester, MA 01605 USA; [Rana, Tariq M.] Sanford Burnham Med Res Inst, Program RNA Biol, La Jolla, CA 92037 USA	University of Massachusetts System; University of Massachusetts Worcester; Sanford Burnham Prebys Medical Discovery Institute	Rana, TM (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	trana@sanfordburnham.org			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by grants from the National Institutes of Health.	Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Amini S, 2002, ONCOGENE, V21, P5797, DOI 10.1038/sj.onc.1205754; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bhattacharjee RN, 2006, VIROLOGY, V346, P1, DOI 10.1016/j.virol.2005.12.034; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chiu YL, 2004, J VIROL, V78, P2517, DOI 10.1128/JVI.78.5.2517-2529.2004; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; Garriga J, 1996, BIOCHEM J, V320, P983, DOI 10.1042/bj3200983; Gondeau C, 2005, J BIOL CHEM, V280, P13793, DOI 10.1074/jbc.M413690200; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lis JT, 2000, GENE DEV, V14, P792; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Romanowicz L, 2010, INT J EXP PATHOL, V91, P1, DOI 10.1111/j.1365-2613.2009.00675.x; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Verhoef K, 2001, J VIROL, V75, P979, DOI 10.1128/JVI.75.2.979-987.2001; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Xie A, 2007, MOL CELL, V27, P178, DOI 10.1016/j.molcel.2007.07.005; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	43	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29713	29720		10.1074/jbc.M110.125997	http://dx.doi.org/10.1074/jbc.M110.125997			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20551309	hybrid, Green Published			2022-12-25	WOS:000281984300006
J	Chamoux, E; Bisson, M; Payet, MD; Roux, S				Chamoux, Estelle; Bisson, Martine; Payet, Marcel Daniel; Roux, Sophie			TRPV-5 Mediates a Receptor Activator of NF-kappa B (RANK) Ligand-induced Increase in Cytosolic Ca2+ in Human Osteoclasts and Down-regulates Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DIFFERENTIATION; RAT OSTEOCLASTS; RESORBING ACTIVITY; KINASE-ACTIVITY; ACID-SECRETION; CALCIUM; CHANNELS; ORGANIZATION; CALCITONIN; CELL	Most of the signaling effectors located downstream of receptor activator of NF-kappa B (RANK) activation are calcium-sensitive. However, the early signaling events that lead to the mobilization of intracellular calcium in human osteoclasts are still poorly understood. The Ca2+-sensitive fluorescent probe Fura2 was used to detect changes in the intracellular concentration of Ca2+ ([Ca2+](i)) in a model of human osteoclasts. Stimulating these cells with receptor activator of NF-kappa B ligand (RANKL) induced a rapid and significant increase in [Ca2+](i). Adding extracellular Ca2+ chelators, depleting intracellular stores, and the use of a phospholipase C inhibitor all indicated that the Ca2+ was of extracellular origin, suggesting the involvement of a Ca2+ channel. We showed that none of the classical Ca2+ channels (L-, T-, or R-type) were involved in the RANKL-induced Ca2+ spike. However, the effect of high doses of Gd3+ did suggest that TRP family channels were present in human osteoclasts. The TRPV-5 channel was expressed in osteoclasts and was mainly located in the cellular area in contact with the bone surface. Furthermore, the RNA inactivation of TRPV-5 channel completely inhibited the RANKL-induced increase in [Ca2+](i), which was accompanied in the long term by marked activation of bone resorption. Overall, our results show that RANKL induced a significant increase in [Ca2+](i) of extracellular origin, probably as a result of the opening of TRPV-5 calcium channels on the surface of human osteoclasts. Our findings suggest that TRPV-5 contributes to maintaining the homeostasis of the human skeleton via a negative feedback loop in RANKL-induced bone resorption.	[Chamoux, Estelle; Bisson, Martine; Roux, Sophie] Univ Sherbrooke, Fac Med, Div Rheumatol, Sherbrooke, PQ J1H 5N4, Canada; [Payet, Marcel Daniel] Univ Sherbrooke, Fac Med, Div Physiol & Biophys, Sherbrooke, PQ J1H 5N4, Canada; [Chamoux, Estelle] Bishops Univ, Div Nat Sci & Math, Sherbrooke, PQ J1M 1Z7, Canada	University of Sherbrooke; University of Sherbrooke; Bishops University	Roux, S (corresponding author), 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	sophie.roux@usherbrooke.ca			Canadian Institutes of Health Research; Bishop's University Senate Research Committee; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bishop's University Senate Research Committee; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research and from Bishop's University Senate Research Committee grants and from the Fonds de la Recherche en Sante du Quebec (to S. R.).	Bennett BD, 2001, ENDOCRINOLOGY, V142, P1968, DOI 10.1210/en.142.5.1968; Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Kajiya H, 2003, AM J PHYSIOL-CELL PH, V285, pC457, DOI 10.1152/ajpcell.00033.2003; Kajiya H, 2000, J CELL PHYSIOL, V183, P83, DOI 10.1002/(SICI)1097-4652(200004)183:1<83::AID-JCP10>3.0.CO;2-W; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Komarova SV, 2003, CALCIFIED TISSUE INT, V73, P265, DOI 10.1007/s00223-002-1051-4; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Mangashetti LS, 2005, J IMMUNOL, V175, P917, DOI 10.4049/jimmunol.175.2.917; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Micelli S, 2006, FRONT BIOSCI-LANDMRK, V11, P2035, DOI 10.2741/1945; Michou L, 2010, BONE, V46, P598, DOI 10.1016/j.bone.2009.11.012; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; MIYAUCHI A, 1990, J CELL BIOL, V111, P2543, DOI 10.1083/jcb.111.6.2543; MIYAUCHI A, 1993, OSTEOPOROS INT S1, V3, P132; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; RADDING W, 1994, J CELL PHYSIOL, V160, P17, DOI 10.1002/jcp.1041600104; Roux S, 2005, BIOCHEM BIOPH RES CO, V333, P42, DOI 10.1016/j.bbrc.2005.05.092; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Supanchart C, 2008, ARCH BIOCHEM BIOPHYS, V473, P161, DOI 10.1016/j.abb.2008.03.029; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teti A, 1990, Boll Soc Ital Biol Sper, V66, P1; Tousova K, 2005, MOL CELL NEUROSCI, V30, P207, DOI 10.1016/j.mcn.2005.07.004; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Tsuzuki T, 2000, JPN J PHYSIOL, V50, P67, DOI 10.2170/jjphysiol.50.67; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; VANEPPSFUNG C, 1994, BIOCHEM BIOPH RES CO, V204, P565, DOI 10.1006/bbrc.1994.2496; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391	34	41	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25354	25362		10.1074/jbc.M109.075234	http://dx.doi.org/10.1074/jbc.M109.075234			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547482	Green Published, hybrid			2022-12-25	WOS:000280682400028
J	Goupil, E; Tassy, D; Bourguet, C; Quiniou, C; Wisehart, V; Petrin, D; Le Gouill, C; Devost, D; Zingg, HH; Bouvier, M; Saragovi, HU; Chemtob, S; Lubell, WD; Claing, A; Hebert, TE; Laporte, SA				Goupil, Eugenie; Tassy, Danae; Bourguet, Carine; Quiniou, Christiane; Wisehart, Veronica; Petrin, Darlaine; Le Gouill, Christian; Devost, Dominic; Zingg, Hans H.; Bouvier, Michel; Saragovi, Horacio Uri; Chemtob, Sylvain; Lubell, William D.; Claing, Audrey; Hebert, Terence E.; Laporte, Stephane A.			A Novel Biased Allosteric Compound Inhibitor of Parturition Selectively Impedes the Prostaglandin F2 alpha-mediated Rho/ROCK Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND EXTRACELLULAR LOOP; PROTEIN-COUPLED RECEPTOR; BOVINE LUTEAL CELLS; AMINO-ACIDS; F RECEPTOR; RHO-KINASE; MUSCARINIC RECEPTORS; PRETERM LABOR; MICE LACKING; ACTIVATION	The prostaglandin F2 alpha (PGF2 alpha) receptor (FP) is a key regulator of parturition and a target for pharmacological management of preterm labor. However, an incomplete understanding of signaling pathways regulating myometrial contraction hinders the development of improved therapeutics. Here we used a peptidomimetic inhibitor of parturition in mice, PDC113.824, whose structure was based on the NH2-terminal region of the second extracellular loop of FP receptor, to gain mechanistic insight underlying FP receptor-mediated cell responses in the context of parturition. We show that PDC113.824 not only delayed normal parturition in mice but also that it inhibited both PGF2 alpha- and lipopolysaccharide-induced preterm labor. PDC113.824 inhibited PGF2 alpha-mediated, G alpha(12)-dependent activation of the Rho/ROCK signaling pathways, actin remodeling, and contraction of human myometrial cells likely by acting as a non-competitive, allosteric modulator of PGF2 alpha binding. In contrast to its negative allosteric modulating effects on Rho/ROCK signaling, PDC113.824 acted as a positive allosteric modulator on PGF2 alpha-mediated protein kinase C and ERK1/2 signaling. This bias in receptor-dependent signaling was explained by an increase in FP receptor coupling to G alpha(q), at the expense of coupling to G alpha(12). Our findings regarding the allosteric and biased nature of PDC113.824 offer new mechanistic insights into FP receptor signaling relevant to parturition and suggest novel therapeutic opportunities for the development of new tocolytic drugs.	[Goupil, Eugenie; Petrin, Darlaine; Devost, Dominic; Zingg, Hans H.; Saragovi, Horacio Uri; Chemtob, Sylvain; Hebert, Terence E.; Laporte, Stephane A.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Goupil, Eugenie; Wisehart, Veronica; Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H3A 1A1, Canada; [Tassy, Danae; Claing, Audrey] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Bourguet, Carine; Lubell, William D.] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Le Gouill, Christian; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Quiniou, Christiane; Chemtob, Sylvain] CHU St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Hebert, TE (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	terence.hebert@mcgill.ca; stephane.laporte@mcgill.ca	Zingg, Hans/GPS-9984-2022; Bouvier, Michel/H-2758-2014; Laporte, Stephane/ABC-4228-2021; Laporte, Stephane A/F-3282-2012	Bouvier, Michel/0000-0003-1128-0100; Laporte, Stephane/0000-0002-0633-543X; Lubell, William/0000-0002-3080-2712; Goupil, Eugenie/0000-0001-5554-8717	Canadian Institutes of Health (CIHR) Research Team [CTP 79848]; CIHR [MOP-36279, PRG-82673, MOP-74603]	Canadian Institutes of Health (CIHR) Research Team(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health (CIHR) Research Team Grant in GPCR Allosteric Regulation (CTiGAR, CTP 79848, to H. U. S., W. D. L., S. C., A. C., T. E. H., S. A. L., and M. B.) and CIHR Grants MOP-36279 (to T. E. H.) and PRG-82673 and MOP-74603 (to S. A. L.).	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Birdsall NJM, 1999, MOL PHARMACOL, V55, P778; Birdsall NJM, 1996, PROG BRAIN RES, V109, P147; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bourguet CB, 2009, ADV EXP MED BIOL, V611, P271, DOI 10.1007/978-0-387-73657-0_122; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chen DB, 2001, ENDOCRINOLOGY, V142, P887, DOI 10.1210/en.142.2.887; Christopoulos A, 2004, BIOCHEM SOC T, V32, P873, DOI 10.1042/BST0320873; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Cluzeau J, 2005, BIOPOLYMERS, V80, P98, DOI 10.1002/bip.20213; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; DAVIS JS, 1987, P NATL ACAD SCI USA, V84, P3728, DOI 10.1073/pnas.84.11.3728; de Asua LJ, 1997, ADV EXP MED BIOL, V400, P531; Devost D, 2007, AM J PHYSIOL-ENDOC M, V292, pE1, DOI 10.1152/ajpendo.00529.2005; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Hanessian S, 1997, TETRAHEDRON, V53, P12789, DOI 10.1016/S0040-4020(97)00476-6; Ito K, 2003, J PHYSIOL-LONDON, V546, P823, DOI 10.1113/jphysiol.2002.030775; ITO S, 1994, BIOCHEM BIOPH RES CO, V200, P756, DOI 10.1006/bbrc.1994.1515; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joseph KS, 1998, NEW ENGL J MED, V339, P1434, DOI 10.1056/NEJM199811123392004; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lanzafame A, 2004, J PHARMACOL EXP THER, V308, P830, DOI 10.1124/jpet.103.060590; Lartey J, 2007, BIOL REPROD, V76, P971, DOI 10.1095/biolreprod.106.058982; Lartey J, 2009, REPRODUCTION, V138, P407, DOI 10.1530/REP-09-0160; Lombart HG, 1996, J ORG CHEM, V61, P9437, DOI 10.1021/jo961872f; Maillet EL, 2007, FASEB J, V21, P2124, DOI 10.1096/fj.06-7683com; Makino S, 2007, SEMIN REPROD MED, V25, P60, DOI 10.1055/s-2006-956776; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Ohmichi M, 1997, ENDOCRINOLOGY, V138, P3103, DOI 10.1210/en.138.8.3103; Olson DM, 2003, PLACENTA, V24, pS47, DOI 10.1053/plac.2002.0938; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Phillippe M, 1997, AM J PHYSIOL-ENDOC M, V273, pE665, DOI 10.1152/ajpendo.1997.273.4.E665; Pierce KL, 1997, J BIOL CHEM, V272, P883, DOI 10.1074/jbc.272.2.883; Pierce KL, 1999, J BIOL CHEM, V274, P35944, DOI 10.1074/jbc.274.50.35944; Podlech J., 2002, ORG SYNTH, V79, P154; Pryde Peter G, 2004, Expert Opin Drug Saf, V3, P639, DOI 10.1517/14740338.3.6.639; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schaafsma D, 2004, BRIT J PHARMACOL, V143, P477, DOI 10.1038/sj.bjp.0705903; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; SPETH RC, 2000, ANGIOTENSIN PROTOCOL, P275; Sugimoto Y, 1998, ADV EXP MED BIOL, V449, P317; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Tahara M, 2005, AM J OBSTET GYNECOL, V192, P903, DOI 10.1016/j.ajog.2004.09.016; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; Tateyama M, 2006, P NATL ACAD SCI USA, V103, P1124, DOI 10.1073/pnas.0505925103; Thornton S, 2001, EXP PHYSIOL, V86, P297, DOI 10.1113/eph8602186; Valant C, 2009, MOL INTERV, V9, P125, DOI 10.1124/mi.9.3.6; Vauquelin G, 2002, TRENDS PHARMACOL SCI, V23, P514, DOI 10.1016/S0165-6147(02)02081-3	59	77	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25624	25636		10.1074/jbc.M110.115196	http://dx.doi.org/10.1074/jbc.M110.115196			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551320	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000280682400056
J	Hasegawa, H; Kido, S; Tomomura, M; Fujimoto, K; Ohi, M; Kiyomura, M; Kanegae, H; Inaba, A; Sakagami, H; Tomomura, A				Hasegawa, Hiroya; Kido, Seisui; Tomomura, Mineko; Fujimoto, Kengo; Ohi, Michi; Kiyomura, Masaru; Kanegae, Haruhide; Inaba, Akemi; Sakagami, Hiroshi; Tomomura, Akito			Serum Calcium-decreasing Factor, Caldecrin, Inhibits Osteoclast Differentiation by Suppression of NFATc1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BONE HOMEOSTASIS; GENE-EXPRESSION; ESTROGEN DEFICIENCY; MOLECULAR-CLONING; CA2+ OSCILLATION; T-CELLS; ACTIVATION; RECEPTOR; RANKL	Caldecrin/chymotrypsin C is a novel secretory-type serine protease that was originally isolated as a serum calcium-decreasing factor from the pancreas. Previously, we reported that caldecrin suppressed the bone-resorbing activity of rabbit mature osteoclasts (Tomomura, A., Yamada, H., Fujimoto, K., Inaba, A., and Katoh, S. (2001) FEBS Lett. 508, 454-458). Here, we investigated the effects of caldecrin on mouse osteoclast differentiation induced by macrophage-colony stimulating factor and the receptor activator of NF-kappa B ligand (RANKL) from the monocyte/macrophage cell lineage of bone marrow cells. Wildtype and protease-deficient mutant caldecrin dose-dependently inhibited RANKL-stimulated tartrate-resistant acid phosphatase-positive osteoclast formation from bone marrow cells. Caldecrin did not affect macrophage colony formation from monocyte/macrophage lineage cells or osteoclast progenitor generation in cultures of bone marrow cells. Caldecrin inhibited accumulation of the RANKL-stimulated nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) mRNA in bone marrow cells, which is a key transcription factor for the differentiation of osteoclasts. Caldecrin also suppressed RANKL-induced differentiation of the RAW264.7 monocyte/macrophage cell line into osteoclasts. Caldecrin reduced the transcriptional activity of NFATc1 in RAW264.7 cells, whereas those of NF-kappa B and c-Fos, which are also transcription factors involved in osteoclast differentiation, were unaffected. Caldecrin inhibited RANKL-stimulated nuclear translocation of NFATc1 and the activity of the calcium/calmodulin-dependent phosphatase, calcineurin. Caldecrin inhibited phospholipase C gamma 1-mediated Ca2+ oscillation evoked by RANKL stimulation. RANKL-stimulated phosphorylation of spleen tyrosine kinase (Syk) was also attenuated by caldecrin. Taken together, these results indicate that caldecrin inhibits osteoclastogenesis, without its protease activity, by preventing a phospholipase C gamma 1-mediated Ca2+ oscillation-calcineurin-NFATc1 pathway.	[Tomomura, Mineko; Fujimoto, Kengo; Inaba, Akemi; Tomomura, Akito] Meikai Univ, Sch Dent, Dept Oral Biol & Tissue Engn, Div Biochem, Sakado, Saitama 3500283, Japan; [Kido, Seisui; Kiyomura, Masaru; Kanegae, Haruhide] Meikai Univ, Sch Dent, Dept Human Dev & Fostering, Div Orthodont, Sakado, Saitama 3500283, Japan; Meikai Univ, Sch Dent, Grad Sch Dent, Dept Orthodont, Sakado, Saitama 3500283, Japan; [Tomomura, Mineko; Sakagami, Hiroshi] Meikai Univ, Sch Dent, Meikai Pharmacomed Lab, Sakado, Saitama 3500283, Japan	Meikai University; Meikai University; Meikai University; Meikai University	Tomomura, M (corresponding author), Meikai Univ, Sch Dent, Dept Oral Biol & Tissue Engn, Div Biochem, 1-1 Keyakidai, Sakado, Saitama 3500283, Japan.	mineko-t@dent.meikai.ac.jp; atomomu@dent.meikai.ac.jp		Sakagami, Hiroshi/0000-0001-8001-2121	Ministry of Education, Culture, Sports, Science, and Technology of JAPAN [C14571773, C16591864]	Ministry of Education, Culture, Sports, Science, and Technology of JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research C14571773 (to M. K.) and C16591864 (to A. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of JAPAN.	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; CHAMBERS TJ, 1984, J CELL SCI, V66, P383; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DE KP, 1998, SCIENCE, V279, P227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; HARRIS ML, 1992, PHARMACOL THERAPEUT, V53, P375, DOI 10.1016/0163-7258(92)90057-7; Hayashi S, 1997, J CELL PHYSIOL, V170, P241, DOI 10.1002/(SICI)1097-4652(199703)170:3<241::AID-JCP4>3.0.CO;2-O; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Moreno JL, 2003, BLOOD, V102, P1078, DOI 10.1182/blood-2002-11-3437; Mori Y, 2008, J IMMUNOL, V181, P4742, DOI 10.4049/jimmunol.181.7.4742; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Raeder EMB, 1999, J IMMUNOL, V163, P6785; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sato T, 2001, J BONE MINER RES, V16, P2215, DOI 10.1359/jbmr.2001.16.12.2215; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; SZILYAGI L, 1998, HDB PROTEOLYTIC ENZY, P38; TAKAHASHI N, 2005, PRINCIPLES BONE BIOL, P109; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; TOMOMURA A, 1993, FEBS LETT, V335, P213, DOI 10.1016/0014-5793(93)80732-A; Tomomura A, 2001, FEBS LETT, V508, P454, DOI 10.1016/S0014-5793(01)03107-6; Tomomura A, 1996, FEBS LETT, V386, P26, DOI 10.1016/0014-5793(96)00377-8; Tomomura A, 1995, J BIOL CHEM, V270, P30315, DOI 10.1074/jbc.270.51.30315; TOMOMURA A, 1992, FEBS LETT, V301, P277, DOI 10.1016/0014-5793(92)80256-G; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; XU LX, 1995, J CELL PHYSIOL, V165, P624, DOI 10.1002/jcp.1041650321; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoshino-Yasuda I, 1998, J BIOCHEM, V123, P546; Zhu LL, 2005, BIOCHEM BIOPH RES CO, V326, P131, DOI 10.1016/j.bbrc.2004.10.212; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	53	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25448	25457		10.1074/jbc.M109.068742	http://dx.doi.org/10.1074/jbc.M109.068742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547767	hybrid, Green Published			2022-12-25	WOS:000280682400038
J	Schmidt, F; Treiber, N; Zocher, G; Bjelic, S; Steinmetz, MO; Kalbacher, H; Stehle, T; Dodt, G				Schmidt, Friederike; Treiber, Nora; Zocher, Georg; Bjelic, Sasa; Steinmetz, Michel O.; Kalbacher, Hubert; Stehle, Thilo; Dodt, Gabriele			Insights into Peroxisome Function from the Structure of PEX3 in Complex with a Soluble Fragment of PEX19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; ZELLWEGER-SYNDROME; IMPORT RECEPTOR; BIOGENESIS; COMPLEMENTATION; IDENTIFICATION; CHAPERONE; ABSENCE; CLONING	The human peroxins PEX3 and PEX19 play a central role in peroxisomal membrane biogenesis. The membrane-anchored PEX3 serves as the receptor for cytosolic PEX19, which in turn recognizes newly synthesized peroxisomal membrane proteins. After delivering these proteins to the peroxisomal membrane, PEX19 is recycled to the cytosol. The molecular mechanisms underlying these processes are not well understood. Here, we report the crystal structure of the cytosolic domain of PEX3 in complex with a PEX19-derived peptide. PEX3 adopts a novel fold that is best described as a large helical bundle. A hydrophobic groove at the membrane-distal end of PEX3 engages the PEX19 peptide with nanomolar affinity. Mutagenesis experiments identify phenylalanine 29 in PEX19 as critical for this interaction. Because key PEX3 residues involved in complex formation are highly conserved across species, the observed binding mechanism is of general biological relevance.	[Stehle, Thilo; Dodt, Gabriele] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Treiber, Nora] Univ Freiburg, Inst Organ Chem & Biochem, D-79106 Freiburg, Germany; [Bjelic, Sasa; Steinmetz, Michel O.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; University of Freiburg; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Vanderbilt University	Stehle, T (corresponding author), Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany.	thilo.stehle@uni-tuebingen.de; gabriele.dodt@uni-tuebingen.de	Steinmetz, Michel O/AAA-3349-2022; Bjelic, Sasa/N-1348-2019; Bjelic, Sasa/G-6849-2011	Steinmetz, Michel O/0000-0001-6157-3687; Bjelic, Sasa/0000-0002-9805-3201; Bjelic, Sasa/0000-0002-9805-3201	Deutsche Forschungsgemeinschaft [Do492/2, SFB685]; BESSY (Berlin, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BESSY (Berlin, Germany)	This work was supported by Deutsche Forschungsgemeinschaft Grants Do492/2 (to G. D.) and SFB685 (to H. K.).; We thank the beamline staff of BESSY (Berlin, Germany) for support during data collection. The structure determination of PEX3 was initiated in the laboratory of Prof. Dr. Georg E. Schulz (University of Freiburg, Germany). ITC measurements of PEX3 with full-length PEX19 were carried out by Dr. Carsten Kintscher at the Max-Planck Institute for Developmental Biology in Tubingen, Germany.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Geuze HJ, 2003, MOL BIOL CELL, V14, P2900, DOI 10.1091/mbc.E02-11-0734; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huybrechts SJ, 2009, TRAFFIC, V10, P1722, DOI 10.1111/j.1600-0854.2009.00970.x; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kammerer S, 1998, FEBS LETT, V429, P53, DOI 10.1016/S0014-5793(98)00557-2; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lutzner N, 2009, BIOCHEM BIOPH RES CO, V380, P554, DOI 10.1016/j.bbrc.2009.01.140; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; Muntau AC, 2000, AM J HUM GENET, V67, P967, DOI 10.1086/303071; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Pinto MP, 2009, BBA-MOL CELL RES, V1793, P1669, DOI 10.1016/j.bbamcr.2009.08.007; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rucktaschel R, 2009, J BIOL CHEM, V284, P20885, DOI 10.1074/jbc.M109.016584; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Sato Y, 2008, J BIOL CHEM, V283, P6136, DOI 10.1074/jbc.M706139200; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Soukupova M, 1999, EUR J CELL BIOL, V78, P357, DOI 10.1016/S0171-9335(99)80078-8; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tabak HF, 2006, BBA-MOL CELL RES, V1763, P1647, DOI 10.1016/j.bbamcr.2006.08.045; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Toro A, 2007, BIOL RES, V40, P231, DOI 10.4067/S0716-97602007000200014; Toro AA, 2009, J CELL BIOCHEM, V107, P1083, DOI 10.1002/jcb.22210; TREIBER N, 2008, THESIS ALBERTLUDWIGS; Voorn-Brouwer T, 2001, J CELL SCI, V114, P2199; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424	55	43	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25410	25417		10.1074/jbc.M110.138503	http://dx.doi.org/10.1074/jbc.M110.138503			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554521	Green Published, hybrid			2022-12-25	WOS:000280682400034
J	Abella, JV; Parachoniak, CA; Sangwan, V; Park, M				Abella, Jasmine V.; Parachoniak, Christine A.; Sangwan, Veena; Park, Morag			Dorsal Ruffle Microdomains Potentiate Met Receptor Tyrosine Kinase Signaling and Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL MORPHOGENESIS DOWNSTREAM; EPIDERMAL-GROWTH-FACTOR; JUXTAMEMBRANE DOMAIN; PLASMA-MEMBRANE; BINDING-SITE; C-MET; MACROPINOCYTOSIS; PROTEIN; MUTATIONS; ENDOCYTOSIS	Dorsal ruffles are apical protrusions induced in response to many growth factors, yet their function is poorly understood. Here we report that downstream from the hepatocyte growth factor (HGF) receptor tyrosine kinase (RTK), Met, dorsal ruffles function as both a localized signaling microdomain as well as a platform from which the Met RTK internalizes and traffics to a degradative compartment. In response to HGF, colonies of epithelial Madin-Darby canine kidney cells form dorsal ruffles for up to 20 min. Met is transcytosed from the basolateral membrane on Rab4 endosomes, to the apical surface where Met, as well as a Met substrate and scaffold protein, Gab1, localize to the dorsal ruffle membrane. This results in activation of downstream signaling proteins, as evidenced by localization of phospho-ERK1/2 to dorsal ruffles. As dorsal ruffles collapse, Met is internalized into EEA1- and Rab5-positive endosomes and is targeted for degradation through delivery to an Hrs-positive sorting compartment. Enhancing HGF-dependent dorsal ruffle formation, through overexpression of Gab1 or activated Pak1 kinase, promotes more efficient degradation of the Met RTK. Conversely, the ablation of dorsal ruffle formation, by pre-treatment with SITS (4-acetamido-4'-isothiocyabatostilbene-2',2disulfonicacid) or expression of a Gab1 mutant, impairs Met degradation. Taken together, these data support a function for dorsal ruffles as a biologically relevant signaling microenvironment and a mechanism for Met receptor internalization and degradation.	McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; [Abella, Jasmine V.; Parachoniak, Christine A.; Sangwan, Veena; Park, Morag] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University; McGill University	Park, M (corresponding author), Room 511,1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	morag.park@mcgill.ca			United States Department of Defense Breast Cancer [DAMD17-99-1-9284]; Canadian Institutes of Health Research Canada Graduate Scholarship (CGS); Canadian Cancer Society Research Institute	United States Department of Defense Breast Cancer(United States Department of Defense); Canadian Institutes of Health Research Canada Graduate Scholarship (CGS)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by United States Department of Defense Breast Cancer Research Initiative Fellowship DAMD17-99-1-9284 (to J.V.A.), a Canadian Institutes of Health Research Canada Graduate Scholarship (CGS) Doctoral Award (to C.A.P.), and an operating grant from the Canadian Cancer Society Research Institute (to M.P.).	Abella JV, 2010, J CELL SCI, V123, P1306, DOI 10.1242/jcs.062570; Abella JV, 2009, AM J PHYSIOL-ENDOC M, V296, pE973, DOI 10.1152/ajpendo.90857.2008; Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Araki N, 2000, J CELL SCI, V113, P3329; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; CREPALDI T, 1994, J CELL BIOL, V125, P313, DOI 10.1083/jcb.125.2.313; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Frigault MM, 2008, J CELL PHYSIOL, V214, P694, DOI 10.1002/jcp.21264; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gibson A, 1998, J CELL BIOL, V143, P81, DOI 10.1083/jcb.143.1.81; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Grassart A, 2008, EMBO REP, V9, P356, DOI 10.1038/embor.2008.28; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lamorte L, 2002, J BIOL CHEM, V277, P37904, DOI 10.1074/jbc.M201743200; Li N, 2005, TRAFFIC, V6, P459, DOI 10.1111/j.1600-0854.2005.00290.x; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma PC, 2003, CANCER RES, V63, P6272; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Mohrmann K, 2002, J BIOL CHEM, V277, P10474, DOI 10.1074/jbc.M111237200; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wu RF, 2003, J BIOL CHEM, V278, P36830, DOI 10.1074/jbc.M302251200; Yamazaki T, 2002, J CELL SCI, V115, P1791	55	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24956	24967		10.1074/jbc.M110.127985	http://dx.doi.org/10.1074/jbc.M110.127985			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529867	Green Published, hybrid			2022-12-25	WOS:000280542100068
J	Vaarmann, A; Gandhi, S; Abramov, AY				Vaarmann, Annika; Gandhi, Sonia; Abramov, Andrey Y.			Dopamine Induces Ca2+ Signaling in Astrocytes through Reactive Oxygen Species Generated by Monoamine Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; INTRACELLULAR CALCIUM; NEURONS; RELEASE; INHIBITION; METABOLISM; ACTIVATION; RECEPTORS; CHANNELS; CELLS	Dopamine is a neurotransmitter that plays a major role in a variety of brain functions, as well as in disorders such as Parkinson disease and schizophrenia. In cultured astrocytes, we have found that dopamine induces sporadic cytoplasmic calcium ([Ca2+](c)) signals. Importantly, we show that the dopamine-induced calcium signaling is receptor-independent in midbrain, cortical, and hippocampal astrocytes. We demonstrate that the calcium signal is initiated by the metabolism of dopamine by monoamine oxidase, which produces reactive oxygen species and induces lipid peroxidation. This stimulates the activation of phospholipase C and subsequent release of calcium from the endoplasmic reticulum via the inositol 1,4,5-trisphosphate receptor mechanism. These findings have major implications on the function of astrocytes that are exposed to dopamine and may contribute to understanding the physiological role of dopamine.	[Vaarmann, Annika; Gandhi, Sonia; Abramov, Andrey Y.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England	University of London; University College London	Abramov, AY (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.	a.abramov@ucl.ac.uk	Abramov, Andrey Y/H-9053-2012; Vaarmann, Annika/AAH-7289-2021; Abramov, Andrey/AAC-6712-2019	Abramov, Andrey Y/0000-0002-7646-7235; Vaarmann, Annika/0000-0003-0296-8325; Abramov, Andrey/0000-0002-7646-7235	Parkinson&apos;s UK [F-0806] Funding Source: Medline; Parkinson&quot;s UK [F-0806] Funding Source: researchfish	Parkinson&apos;s UK(Parkinson&apos;s UK); Parkinson&quot;s UK(Parkinson&apos;s UK)		Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Abramov AY, 2003, J NEUROSCI, V23, P5088; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Cantuti-Castelvetri I, 1999, FREE RADICAL BIO MED, V27, P1393, DOI 10.1016/S0891-5849(99)00188-4; Chinta SJ, 2008, BBA-GEN SUBJECTS, V1780, P1362, DOI 10.1016/j.bbagen.2008.02.005; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Gonzalez A, 2006, NEUROCHEM RES, V31, P741, DOI 10.1007/s11064-006-9078-y; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hidalgo C, 2000, BIOL RES, V33, P113; KOTTER R, 1994, PROG NEUROBIOL, V44, P163, DOI 10.1016/0301-0082(94)90037-X; LIN CW, 1995, MOL PHARMACOL, V47, P131; Liu J, 2009, CELL MOL NEUROBIOL, V29, P317, DOI 10.1007/s10571-008-9323-9; Matyash M, 2001, FASEB J, V15, P84, DOI 10.1096/fj.01-0380fje; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; NEMEROFF CB, 1988, ANN NY ACAD SCI, V537, P273, DOI 10.1111/j.1749-6632.1988.tb42113.x; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Peuchen S, 1996, NEUROSCIENCE, V71, P871, DOI 10.1016/0306-4522(95)00515-3; Sulzer D, 2007, NEURON, V55, P8, DOI 10.1016/j.neuron.2007.06.023; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Tang TS, 2004, J BIOL CHEM, V279, P42082, DOI 10.1074/jbc.M407389200; Teschemacher AG, 2005, ADV DRUG DELIVER REV, V57, P79, DOI 10.1016/j.addr.2004.05.004; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464; Zhang XH, 2009, J NEUROSCI, V29, P7766, DOI 10.1523/JNEUROSCI.0389-09.2009	27	83	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25018	25023		10.1074/jbc.M110.111450	http://dx.doi.org/10.1074/jbc.M110.111450			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20547771	Green Published, hybrid			2022-12-25	WOS:000280542100074
J	Shibata, T; Kokubu, A; Miyamoto, M; Hosoda, F; Gotoh, M; Tsuta, K; Asamura, H; Matsuno, Y; Kondo, T; Imoto, I; Inazawa, J; Hirohashi, S				Shibata, T.; Kokubu, A.; Miyamoto, M.; Hosoda, F.; Gotoh, M.; Tsuta, K.; Asamura, H.; Matsuno, Y.; Kondo, T.; Imoto, I.; Inazawa, J.; Hirohashi, S.			DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung	ONCOGENE			English	Article						lung cancer; cancer stem cell; DEK; neuroendocrine	COMPARATIVE GENOMIC HYBRIDIZATION; ACUTE MYELOID-LEUKEMIA; CANCER STEM-CELLS; CHROMOSOMAL TRANSLOCATION; PROTEIN DEK; HEPATOCELLULAR-CARCINOMA; PROTOONCOGENE; EXPRESSION; CHROMATIN; DIFFERENTIATION	Lung cancer shows diverse histological subtypes. Large-cell neuroendocrine cell carcinoma and small-cell lung carcinoma show similar histological features and clinical behaviors, and can be classified as high-grade neuroendocrine carcinoma (HGNEC) of the lung. Here we elucidated the molecular classification of pulmonary endocrine tumors by copy-number profiling. We compared alterations of copy number with the clinical outcome of HGNEC and identified a chromosomal gain of the DEK oncogene locus (6p22.3) that was significantly associated with poor prognosis. We further confirmed that DEK overexpression was associated with poor prognosis in a larger set of HGNEC. Downregulation of DEK by small hairpin RNA led to a marked reduction of in vitro colony formation, in vivo tumorigenicity and chemo-resistance, and was associated with loss of lung cancer stem cell markers. Gene expression profiling revealed that DEK downregulation was associated with altered expression of transcriptional regulators, which specifically include known targets of interchromosomal translocations in hematopoietic tumors, and knockdown of these epigenetic modifiers affected colony formation activity. Our study showed that DEK overexpression, partly through an increase in its gene dose, mediates the activity of global transcriptional regulators and is associated with tumor initiation activity and poor prognosis in HGNEC. Oncogene (2010) 29, 4671-4681; doi:10.1038/onc.2010.217; published online 14 June 2010	[Shibata, T.; Kokubu, A.; Miyamoto, M.; Hosoda, F.; Hirohashi, S.] Natl Canc Ctr, Canc Genom Project, Res Inst, Chuo Ku, Tokyo 1040045, Japan; [Shibata, T.; Gotoh, M.; Hirohashi, S.] Natl Canc Ctr, Div Pathol, Res Inst, Chuo Ku, Tokyo 1040045, Japan; [Tsuta, K.] Natl Canc Ctr, Clin Lab Div, Chuo Ku, Tokyo, Japan; [Asamura, H.] Natl Canc Ctr, Div Thorac Surg, Chuo Ku, Tokyo, Japan; [Matsuno, Y.] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan; [Kondo, T.] Natl Canc Ctr, Proteome Bioinfomat Project, Res Inst, Chuo Ku, Tokyo 1040045, Japan; [Imoto, I.; Inazawa, J.] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Imoto, I.; Inazawa, J.] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Tokyo, Japan; [Imoto, I.; Inazawa, J.] Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Hokkaido University; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Shibata, T (corresponding author), Natl Canc Ctr, Canc Genom Project, Res Inst, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tashibat@ncc.go.jp	imoto, Issei/D-8065-2012; Shibata, Tatsuhiro/AAO-1278-2021; Kondo, Tadashi/I-4819-2019; Imoto, Issei/AAD-5799-2020; Shibata, Tatsuhiro/ABA-8234-2020	Kondo, Tadashi/0000-0001-6405-7792; 	Ministry of Health, Labor and Welfare of Japan; New Energy and Industrial Technology Development Organization (NEDO), Japan; National Institute of Biomedical Innovation (NiBio)	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation)	We thank Dr Weixia Peng for the initial work of array CGH and Dr Yukihiro Yoshida for the help of clinical data analysis. We thank Dr S Diane Hayward at the Johns Hopkins University for generously providing the CBF1 reporter constructs (4xwtCBF1Luc and 4xmtCBF1Luc). This work was supported in part by Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan, a grant from the New Energy and Industrial Technology Development Organization (NEDO), Japan and a grant for the program for promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio).	Alexiadis V, 2000, GENE DEV, V14, P1308; Asamura H, 2006, J CLIN ONCOL, V24, P70, DOI 10.1200/JCO.2005.04.1202; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P1571, DOI 10.1093/nar/gkg247; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Cleary J, 2005, J BIOL CHEM, V280, P31760, DOI 10.1074/jbc.M500884200; Collins EC, 2002, MOL CELL BIOL, V22, P7313, DOI 10.1128/MCB.22.20.7313-7324.2002; D'Adda T, 2005, MODERN PATHOL, V18, P795, DOI 10.1038/modpathol.3800353; Fu GK, 1997, P NATL ACAD SCI USA, V94, P1811, DOI 10.1073/pnas.94.5.1811; Fujita K, 2009, J HUM GENET, V54, P355, DOI 10.1038/jhg.2009.40; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gustafsson BI, 2008, CANCER-AM CANCER SOC, V113, P5, DOI 10.1002/cncr.23542; Han SY, 2009, PATHOL INT, V59, P443, DOI 10.1111/j.1440-1827.2009.02392.x; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Hsieh JJD, 1997, J VIROL, V71, P1938, DOI 10.1128/JVI.71.3.1938-1945.1997; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Jones MH, 2004, LANCET, V363, P775, DOI 10.1016/S0140-6736(04)15693-6; Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07; Kappes F, 2004, MOL CELL BIOL, V24, P6011, DOI 10.1128/MCB.24.13.6011-6020.2004; Katoh H, 2007, GASTROENTEROLOGY, V133, P1475, DOI 10.1053/j.gastro.2007.08.038; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Ko SI, 2006, FEBS LETT, V580, P3217, DOI 10.1016/j.febslet.2006.04.081; Kondoh N, 1999, CANCER RES, V59, P4990; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Peacock CD, 2008, J CLIN ONCOL, V26, P2883, DOI 10.1200/JCO.2007.15.2702; Peng WX, 2005, CANCER SCI, V96, P661, DOI 10.1111/j.1349-7006.2005.00092.x; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Righi L, 2007, VIRCHOWS ARCH, V451, pS51, DOI 10.1007/s00428-007-0445-0; Sammons M, 2006, J BIOL CHEM, V281, P26802, DOI 10.1074/jbc.M600915200; Sattler M, 2003, SEMIN ONCOL, V30, P57, DOI 10.1053/sonc.2003.50019; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Sriuranpong V, 2001, CANCER RES, V61, P3200; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Travis W.D., 2004, PATHOLOGY GENETICS T, P341; TRAVIS WD, 1991, AM J SURG PATHOL, V15, P529, DOI 10.1097/00000478-199106000-00003; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Walch AK, 1998, AM J PATHOL, V153, P1089, DOI 10.1016/S0002-9440(10)65653-2; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Wise-Draper TM, 2009, AM J PATHOL, V174, P71, DOI 10.2353/ajpath.2009.080330	54	50	57	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	33					4671	4681		10.1038/onc.2010.217	http://dx.doi.org/10.1038/onc.2010.217			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20543864				2022-12-25	WOS:000281127400006
J	Ryan, PE; Sivadasan-Nair, N; Nau, MM; Nicholas, S; Lipkowitz, S				Ryan, Philip E.; Sivadasan-Nair, Nina; Nau, Marion M.; Nicholas, Sarah; Lipkowitz, Stanley			The N Terminus of Cbl-c Regulates Ubiquitin Ligase Activity by Modulating Affinity for the Ubiquitin-conjugating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; EGF RECEPTOR; PROTEIN UBIQUITINATION; ALLOSTERIC ACTIVATION; ANTIGEN RECEPTOR; DOWN-REGULATION; BINDING-SITE; RING-TYPE; V-SRC	Cbl proteins are ubiquitin ligases (E3s) that play a significant role in regulating tyrosine kinase signaling. There are three mammalian family members: Cbl, Cbl-b, and Cbl-c. All have a highly conserved N-terminal tyrosine kinase binding domain, a catalytic RING finger domain, and a C-terminal proline-rich domain that mediates interactions with Src homology 3 (SH3) containing proteins. Although both Cbl and Cbl-b have been studied widely, little is known about Cbl-c. Published reports have demonstrated that the N terminus of Cbl and Cbl-b have an inhibitory effect on their respective E3 activity. However, the mechanism for this inhibition is still unknown. In this study we demonstrate that the N terminus of Cbl-c, like that of Cbl and Cbl-b, inhibits the E3 activity of Cbl-c. Furthermore, we map the region responsible for the inhibition to the EF-hand and SH2 domains. Phosphorylation of a critical tyrosine (Tyr-341) in the linker region of Cbl-c by Src or a phosphomimetic mutation of this tyrosine (Y341E) is sufficient to increase the E3 activity of Cbl-c. We also demonstrate for the first time that phosphorylation of Tyr-341 or the Y341E mutation leads to a decrease in affinity for the ubiquitin-conjugating enzyme (E2), UbcH5b. The decreased affinity of the Y341E mutant Cbl-c for UbcH5b results in a more rapid turnover of bound UbcH5b coincident with the increased E3 activity. These data suggest that the N terminus of Cbl-c contributes to the binding to the E2 and that phosphorylation of Tyr-341 leads to a decrease in affinity and an increase in the E3 activity of Cbl-c.	[Ryan, Philip E.; Sivadasan-Nair, Nina; Nau, Marion M.; Nicholas, Sarah; Lipkowitz, Stanley] NCI, LCMB, CCR, NIH, Bethesda, MD 20892 USA; [Ryan, Philip E.] George Washington Univ, Inst Biomed Sci, Washington, DC 20037 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University	Lipkowitz, S (corresponding author), NCI, LCMB, CCR, NIH, Bldg 37,Rm 2066,37 Convent Dr, Bethesda, MD 20892 USA.	lipkowis@mail.nih.gov			National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010977] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research.	BLAKE TJ, 1991, ONCOGENE, V6, P653; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Christensen DE, 2009, FEBS J, V276, P5381, DOI 10.1111/j.1742-4658.2009.07249.x; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Davies GC, 2006, ONCOGENE, V25, P6497, DOI 10.1038/sj.onc.1209662; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; LANGDON WY, 1990, CURR TOP MICROBIOL, V166, P159; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lupher ML, 1998, INT J BIOCHEM CELL B, V30, P439, DOI 10.1016/S1357-2725(97)00075-7; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Nau M.M., 2008, CBL PROTEINS, V1, P3; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Odai H, 1995, JPN J CANCER RES, V86, P1119, DOI 10.1111/j.1349-7006.1995.tb03303.x; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; RIVEROLEZCANO OM, 1994, J BIOL CHEM, V269, P17363; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; TANAKA S, 1995, J BIOL CHEM, V270, P14347, DOI 10.1074/jbc.270.24.14347; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 1997, ONCOGENE, V15, P2909, DOI 10.1038/sj.onc.1201468; Tsui CC, 2008, J NEUROSCI, V28, P8789, DOI 10.1523/JNEUROSCI.2738-08.2008; TSYGANKOV A, 2008, CBL PROTEINS; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yang XA, 2004, PROTEIN EXPRES PURIF, V33, P332, DOI 10.1016/j.pep.2003.10.006; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	30	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23687	23698		10.1074/jbc.M109.091157	http://dx.doi.org/10.1074/jbc.M109.091157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525694	Green Published, hybrid			2022-12-25	WOS:000280291400019
J	Shi, WX; Bohon, J; Han, DP; Habte, H; Qin, YL; Cho, MW; Chance, MR				Shi, Wuxian; Bohon, Jen; Han, Dong P.; Habte, Habtom; Qin, Yali; Cho, Michael W.; Chance, Mark R.			Structural Characterization of HIV gp41 with the Membrane-proximal External Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; ANTIBODY 2F5; RADIOLYTIC MODIFICATION; MONOCLONAL-ANTIBODY; ECTODOMAIN REGION; CRYSTAL-STRUCTURE; ATOMIC-STRUCTURE; GLYCOPROTEIN; EPITOPE; FUSION	Human immunodeficiency virus, type 1 (HIV-1) envelope glycoprotein (gp120/gp41) plays a critical role in virus infection and pathogenesis. Three of the six monoclonal antibodies considered to have broadly neutralizing activities (2F5, 4E10, and Z13e1) bind to the membrane-proximal external region (MPER) of gp41. This makes the MPER a desirable template for developing immunogens that can elicit antibodies with properties similar to these monoclonal antibodies, with a long term goal of developing antigens that could serve as novel HIV vaccines. In order to provide a structural basis for rational antigen design, an MPER construct, HR1-54Q, was generated for x-ray crystallographic and x-ray footprinting studies to provide both high resolution atomic coordinates and verification of the solution state of the antigen, respectively. The crystal structure of HR1-54Q reveals a trimeric, coiled-coil six-helical bundle, which probably represents a postfusion form of gp41. The MPER portion extends from HR2 in continuation of a slightly bent long helix and is relatively flexible. The structures observed for the 2F5 and 4E10 epitopes agree well with existing structural data, and enzyme-linked immunosorbent assays indicate that the antigen binds well to antibodies that recognize the above epitopes. Hydroxyl radical-mediated protein footprinting of the antigen in solution reveals specifically protected and accessible regions consistent with the predictions based on the trimeric structure from the crystallographic data. Overall, the HR1-54Q antigen, as characterized by crystallography and footprinting, represents a postfusion, trimeric form of HIV gp41, and its structure provides a rational basis for gp41 antigen design suitable for HIV vaccine development.	[Shi, Wuxian; Bohon, Jen; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Shi, Wuxian; Bohon, Jen; Chance, Mark R.] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA; [Chance, Mark R.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Han, Dong P.; Habte, Habtom; Qin, Yali; Cho, Michael W.] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Iowa State University	Shi, WX (corresponding author), Case Western Reserve Univ, Ctr Prote & Bioinformat, 930 BRB,10900 Euclid Ave, Cleveland, OH 44106 USA.	wushi@bnl.gov		Cho, Michael/0000-0003-0522-345X; Bohon, Jen/0000-0002-7664-9899	National Institutes of Health [P01-AI-074286]; NIBIB, National Institutes of Health [P30-EB-09998]; office of Basic Energy Sciences of the United States Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIBIB, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-AI-074286.; Data for this study were collected at beamlines X29A and X28C of the National Synchrotron Light Source, Brookhaven National Laboratory. Financial support for the operation of these beamlines comes principally from NIBIB, National Institutes of Health, Grant P30-EB-09998, and the office of Basic Energy Sciences of the United States Department of Energy.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Guan JQ, 2005, TRENDS BIOCHEM SCI, V30, P583, DOI 10.1016/j.tibs.2005.08.007; Guan JQ, 2004, ACCOUNTS CHEM RES, V37, P221, DOI 10.1021/ar0302235; Gupta S, 2007, J SYNCHROTRON RADIAT, V14, P233, DOI 10.1107/S0909049507013118; HUNTER E, 1990, CURR TOP MICROBIOL, V157, P187; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kaur P, 2009, ANAL CHEM, V81, P8141, DOI 10.1021/ac9013644; Kiselar JG, 2002, INT J RADIAT BIOL, V78, P101, DOI 10.1080/09553000110094805; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Liu J, 2010, J VIROL, V84, P201, DOI 10.1128/JVI.01558-09; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Penn-Nicholson A, 2008, VIROLOGY, V372, P442, DOI 10.1016/j.virol.2007.11.009; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sullivan MR, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2839027; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Xu GZ, 2005, ANAL CHEM, V77, P4549, DOI 10.1021/ac050299+; Xu GZ, 2005, ANAL CHEM, V77, P3029, DOI 10.1021/ac048282z; Xu GZ, 2004, ANAL CHEM, V76, P1213, DOI 10.1021/ac035422g; Yu H, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-93; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	45	32	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24290	24298		10.1074/jbc.M110.111351	http://dx.doi.org/10.1074/jbc.M110.111351			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525690	Green Published, hybrid			2022-12-25	WOS:000280291400078
J	Rouge, C; Butel, MJ; Piloquet, H; Ferraris, L; Legrand, A; Vodovar, M; Voyer, M; de la Cochetiere, MF; Darmaun, D; Roze, JC				Rouge, Carole; Butel, Marie-Jose; Piloquet, Hugues; Ferraris, Laurent; Legrand, Arnaud; Vodovar, Michel; Voyer, Marcel; de la Cochetiere, Marie-France; Darmaun, Dominique; Roze, Jean-Christophe			Fecal Calprotectin Excretion in Preterm Infants during the Neonatal Period	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BIRTH-WEIGHT INFANTS; NECROTIZING ENTEROCOLITIS; INTESTINAL PERMEABILITY; PROTEIN; CHILDREN; FECES; L1; SUPPLEMENTATION; COLONIZATION	Background: Fecal calprotectin has been proposed as a non-invasive marker of intestinal inflammation in inflammatory bowel disease in adults and children. Fecal calprotectin levels have been reported to be much higher in both healthy fullterm and preterm infants than in children and adults. Objective: To determine the time course of fecal calprotectin (f-calprotectin) excretion in preterm infants from birth until hospital discharge and to identify factors influencing f-calprotectin levels in the first weeks of life, including bacterial establishment in the gut. Methodology: F-calprotectin was determined using an ELISA assay in 147 samples obtained prospectively from 47 preterm infants (gestational age, and birth-weight interquartiles 27-29 weeks, and 880-1320 g, respectively) at birth, and at 2-week intervals until hospital discharge. Principal Findings: Although median f-calprotectin excretion was 138 mg/g, a wide range of inter-and intra-individual variation in f-calprotectin values (from day 3 to day 78) was observed (86% and 67%, respectively). In multivariate regression analysis, f-calprotectin correlated negatively with ante and per natal antibiotic treatment (p = 0.001), and correlated positively with the volume of enteral feeding (mL/kg/d) (p = 0.009), the need to interrupt enteral feeding (p = 0.001), and prominent gastrointestinal colonization by Clostridium sp (p = 0.019) and Staphylococcus sp (p = 0.047). Conclusion: During the first weeks of life, the high f-calprotectin values observed in preterm infants could be linked to the gut bacterial establishment.	[Rouge, Carole; Piloquet, Hugues; Darmaun, Dominique; Roze, Jean-Christophe] Univ Nantes, INRA, UMR 1280, CRNH, Nantes, France; [Rouge, Carole; Piloquet, Hugues; Darmaun, Dominique; Roze, Jean-Christophe] CHU Nantes, IMAD, F-44035 Nantes 01, France; [Butel, Marie-Jose; Ferraris, Laurent] Univ Paris 05, Fac Sci Pharmaceut & Biol, EA 4065, Paris, France; [Piloquet, Hugues; Legrand, Arnaud; Roze, Jean-Christophe] CHU Nantes, INSERM, Hop Mere Et Enfant, Neonatal Intens Care Unit,CIC 0004, F-44035 Nantes, France; [Vodovar, Michel; Voyer, Marcel] Inst Puericulture, Neonatal Intens Care Unit, Paris, France; [de la Cochetiere, Marie-France] Therapeut Clin & Expt Malad Infectieuses, EA 3826, Nantes, France	INRAE; Nantes Universite; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Rouge, C (corresponding author), Univ Nantes, INRA, UMR 1280, CRNH, Nantes, France.	ddarmaun@chu-nantes.fr	roze, jean christophe/B-5433-2012; Rozé, Jean-Christophe/AAS-1314-2021; Darmaun, Dominique/X-8453-2018	Darmaun, Dominique/0000-0002-0366-3227; Roze, Jean-Christophe/0000-0003-3367-512X	Nestle; French Ministry of Health; Delegation a la Recherche Clinique [DRC 2004]; CHU de Nantes	Nestle(Nestle SA); French Ministry of Health; Delegation a la Recherche Clinique; CHU de Nantes	Carole Rouge was the recipient of a doctoral research fellowship from Nestle (Vers-chez-les-Blanc, Switzerland). Part of this work was supported by grants from: the Programme Hospitalier de Recherche Clinique (PHRC 2004) from the French Ministry of Health, and the Delegation a la Recherche Clinique (DRC 2004), CHU de Nantes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berni CR, 2004, DIGEST LIVER DIS, V36, P467, DOI DOI 10.1016/j.dld.2004.02.009; BERNTZEN HB, 1990, SCAND J CLIN LAB INV, V50, P769, DOI 10.3109/00365519009091071; Berstad A, 2000, SCAND J GASTROENTERO, V35, P64; Bjorkstrom MV, 2009, ACTA PAEDIATR, V98, P1762, DOI 10.1111/j.1651-2227.2009.01471.x; BRUN JG, 1994, SCAND J IMMUNOL, V40, P675, DOI 10.1111/j.1365-3083.1994.tb03523.x; Butel MJ, 1998, J MED MICROBIOL, V47, P391, DOI 10.1099/00222615-47-5-391; Campeotto F, 2004, ARCH DIS CHILD-FETAL, V89, pF353, DOI 10.1136/adc.2002.022368; Campeotto F, 2007, ACTA PAEDIATR, V96, P1531, DOI 10.1111/j.1651-2227.2007.00457.x; Campeotto F, 2009, J PEDIATR GASTR NUTR, V48, P507, DOI 10.1097/MPG.0b013e318186c4a6; Carroll D, 2003, LANCET, V361, P310, DOI 10.1016/S0140-6736(03)12333-1; Fagerberg UL, 2005, J PEDIATR GASTR NUTR, V40, P450, DOI 10.1097/01.MPG.0000154657.08994.94; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Jaureguy F, 2004, J CLIN MICROBIOL, V42, P5184, DOI 10.1128/JCM.42.11.5184-5188.2004; Johne B., 1997, Molecular Pathology, V50, P113, DOI 10.1136/mp.50.3.113; Josefsson S, 2007, J PEDIATR GASTR NUTR, V44, P407, DOI 10.1097/MPG.0b013e3180320643; Jousimies-Somer HR, 2002, ANAEROBIC BACTERIOLO; Kok RG, 1996, APPL ENVIRON MICROB, V62, P3668, DOI 10.1128/AEM.62.10.3668-3672.1996; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Laforgia N, 2003, ACTA PAEDIATR, V92, P463; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Mohan R, 2008, PEDIATR RES, V64, P418, DOI 10.1203/PDR.0b013e318181b7fa; Nissen AC, 2004, J PEDIATR GASTR NUTR, V38, P107, DOI 10.1097/00005176-200401000-00025; Olafsdottir E, 2002, ACTA PAEDIATR, V91, P45, DOI 10.1080/080352502753457932; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Roudiere L, 2009, J MICROBIOL METH, V79, P156, DOI 10.1016/j.mimet.2009.08.005; Rouge C, 2009, AM J CLIN NUTR, V89, P1828, DOI 10.3945/ajcn.2008.26919; Rugtveit J, 2002, J PEDIATR GASTR NUTR, V34, P323, DOI 10.1097/00005176-200203000-00022; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; Splichal I, 2005, IMMUNOBIOLOGY, V209, P681, DOI 10.1016/j.imbio.2004.09.009; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Ton H, 2000, CLIN CHIM ACTA, V292, P41, DOI 10.1016/S0009-8981(99)00206-5; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236; Yang Q, 2008, NEONATOLOGY, V94, P267, DOI 10.1159/000151645	34	42	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11083	10.1371/journal.pone.0011083	http://dx.doi.org/10.1371/journal.pone.0011083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552029	Green Published, gold, Green Submitted			2022-12-25	WOS:000278662900021
J	Weiss, G; Rasmussen, S; Fink, LN; Jarmer, H; Nielsen, BN; Frokiaer, H				Weiss, Gudrun; Rasmussen, Simon; Fink, Lisbeth Nielsen; Jarmer, Hanne; Nielsen, Birgit Nohr; Frokiaer, Hanne			Bifidobacterium bifidum Actively Changes the Gene Expression Profile Induced by Lactobacillus acidophilus in Murine Dendritic Cells	PLOS ONE			English	Article							JUN DIMERIZATION PROTEIN-2; LACTIC-ACID BACTERIA; SURFACE-MARKERS; INTERFERON; CYTOKINES; INTERLEUKIN-12; RECOGNITION; RESISTANCE; INDUCTION; RESPOND	Dendritic cells (DC) play a pivotal regulatory role in activation of both the innate as well as the adaptive immune system by responding to environmental microorganisms. We have previously shown that Lactobacillus acidophilus induces a strong production of the pro-inflammatory and Th1 polarizing cytokine IL-12 in DC, whereas bifidobacteria do not induce IL-12 but inhibit the IL-12 production induced by lactobacilli. In the present study, genome-wide microarrays were used to investigate the gene expression pattern of murine DC stimulated with Lactobacillus acidophilus NCFM and Bifidobacterium bifidum Z9. L. acidophilus NCFM strongly induced expression of interferon (IFN)-beta, other virus defence genes, and cytokine and chemokine genes related to the innate and the adaptive immune response. By contrast, B. bifidum Z9 up-regulated genes encoding cytokines and chemokines related to the innate immune response. Moreover, B. bifidum Z9 inhibited the expression of the Th1-promoting genes induced by L. acidophilus NCFM and had an additive effect on genes of the innate immune response and Th2 skewing genes. The gene encoding Jun dimerization protein 2 (JDP2), a transcription factor regulating the activation of JNK, was one of the few genes only induced by B. bifidum Z9. Neutralization of IFN-beta abrogated L. acidophilus NCFM-induced expression of Th1-skewing genes, and blocking of the JNK pathway completely inhibited the expression of IFN-beta. Our results indicate that B. bifidum Z9 actively inhibits the expression of genes related to the adaptive immune system in murine dendritic cells and that JPD2 via blocking of IFN-beta plays a central role in this regulatory mechanism.	[Weiss, Gudrun; Nielsen, Birgit Nohr; Frokiaer, Hanne] Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, Frederiksberg, Denmark; [Rasmussen, Simon; Fink, Lisbeth Nielsen; Jarmer, Hanne] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Weiss, G (corresponding author), Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, Frederiksberg, Denmark.	hafr@life.ku.dk	Fink, Lisbeth/AAN-7830-2020; Fink, Lisbeth N/F-8344-2010; Rasmussen, Simon/AAA-2308-2020; Rasmussen, Simon/G-6258-2016	Fink, Lisbeth N/0000-0003-3621-8098; Rasmussen, Simon/0000-0001-6323-9041; Rasmussen, Simon/0000-0001-6323-9041; Frokiaer, Hanne/0000-0003-1472-9698; Weiss, Gudrun/0000-0001-7879-7054	Danish Ministry of Food, Agriculture and Fisheries; Danish Food Industry Agency [3304-FSE-06-0501-1]	Danish Ministry of Food, Agriculture and Fisheries; Danish Food Industry Agency	This study was supported by the Danish Ministry of Food, Agriculture and Fisheries, and The Danish Food Industry Agency (J.nr.3304-FSE-06-0501-1; www.dffe.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Fink LN, 2007, FEMS IMMUNOL MED MIC, V51, P535, DOI 10.1111/j.1574-695X.2007.00333.x; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Romagnani S, 2002, MOL IMMUNOL, V38, P881, DOI 10.1016/S0161-5890(02)00013-5; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; WORKMAN C, 2002, GENOME BIOL, V0003; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x	42	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11065	10.1371/journal.pone.0011065	http://dx.doi.org/10.1371/journal.pone.0011065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548777	gold, Green Submitted, Green Published			2022-12-25	WOS:000278599600021
J	Irvin, DK; Jouanneau, E; Duvall, G; Zhang, XX; Zhai, YY; Sarayba, D; Seksenyan, A; Panwar, A; Black, KL; Wheeler, CJ				Irvin, Dwain K.; Jouanneau, Emmanuel; Duvall, Gretchen; Zhang, Xiao-xue; Zhai, Yuying; Sarayba, Danielle; Seksenyan, Akop; Panwar, Akanksha; Black, Keith L.; Wheeler, Christopher J.			T Cells Enhance Stem-Like Properties and Conditional Malignancy in Gliomas	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSE; VACCINATION; INHIBITION; SURVIVAL; GROWTH; TUMORS; IDENTIFICATION; ACTIVATION; MECHANISMS	Background: Small populations of highly tumorigenic stem-like cells (cancer stem cells; CSCs) can exist within, and uniquely regenerate cancers including malignant brain tumors (gliomas). Many aspects of glioma CSCs (GSCs), however, have been characterized in non-physiological settings. Methods: We found gene expression similarity superiorly defined glioma "stemness", and revealed that GSC similarity increased with lower tumor grade. Using this method, we examined stemness in human grade IV gliomas (GBM) before and after dendritic cell (DC) vaccine therapy. This was followed by gene expression, phenotypic and functional analysis of murine GL26 tumors recovered from nude, wild-type, or DC-vaccinated host brains. Results: GSC similarity was specifically increased in post-vaccine GBMs, and correlated best to vaccine-altered gene expression and endogenous anti-tumor T cell activity. GL26 analysis confirmed immune alterations, specific acquisition of stem cell markers, specifically enhanced sensitivity to anti-stem drug (cyclopamine), and enhanced tumorigenicity in wildtype hosts, in tumors in proportion to anti-tumor T cell activity. Nevertheless, vaccine-exposed GL26 cells were no more tumorigenic than parental GL26 in T cell-deficient hosts, though they otherwise appeared similar to GSCs enriched by chemotherapy. Finally, vaccine-exposed GBM and GL26 exhibited relatively homogeneous expression of genes expressed in progenitor cells and/or differentiation. Conclusions: T cell activity represents an inducible physiological process capable of proportionally enriching GSCs in human and mouse gliomas. Stem-like gliomas enriched by strong T cell activity, however, may differ from other GSCs in that their stem-like properties may be disassociated from increased tumor malignancy and heterogeneity under specific host immune conditions.	[Irvin, Dwain K.; Jouanneau, Emmanuel; Duvall, Gretchen; Zhang, Xiao-xue; Zhai, Yuying; Sarayba, Danielle; Seksenyan, Akop; Panwar, Akanksha; Black, Keith L.; Wheeler, Christopher J.] Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Irvin, DK (corresponding author), Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA.	wheelerc@cshs.org		Black, Keith/0000-0002-0546-4934	Maxine Dunitz Neurosurgical Institute; National Institutes of Health [NS048959-01S1, NS054162-01]; California Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054162, R56NS048959, R01NS048959] Funding Source: NIH RePORTER	Maxine Dunitz Neurosurgical Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Maxine Dunitz Neurosurgical Institute, the National Institutes of Health [NS048959-01S1 to D. K. I. and NS054162-01 to C.J.W.]; and, in part, by The California Endowment to D.K.I.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Calzascia T, 2005, IMMUNITY, V22, P175, DOI 10.1016/j.immuni.2004.12.008; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jiao ZX, 2006, DEV BIOL, V296, P396, DOI 10.1016/j.ydbio.2006.06.006; Jouanneau E, 2006, CANCER IMMUNOL IMMUN, V55, P254, DOI 10.1007/s00262-005-0040-7; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu GT, 2005, ONCOGENE, V24, P5226, DOI 10.1038/sj.onc.1208519; Mao Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2252, DOI 10.2741/2227; Masson F, 2007, J IMMUNOL, V179, P845, DOI 10.4049/jimmunol.179.2.845; MINAMI M, 1986, J IMMUNOL, V136, P3341; Oliver TG, 2004, NEURON, V42, P885, DOI 10.1016/j.neuron.2004.06.011; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Prins RM, 2004, J IMMUNOL, V172, P1602, DOI 10.4049/jimmunol.172.3.1602; Prins RM, 2003, CANCER RES, V63, P8487; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Riffaud L, 2009, J NEUROSURG, V111, P478, DOI 10.3171/2009.1.JNS081004; RUIZ IAA, 2004, CANC LETT, V204, P145; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sanchez P, 2005, MECH DEVELOP, V122, P223, DOI 10.1016/j.mod.2004.10.002; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SCHNECK J, 1989, CELL, V56, P47, DOI 10.1016/0092-8674(89)90982-3; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Souweidane MM, 2009, NEUROSURGERY, V65, P72, DOI 10.1227/01.NEU.0000348011.98625.43; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; STUPP R, 2003, J CLIN ONCOL, V1091, P779; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973; Wheeler CJ, 1998, J IMMUNOL, V160, P4199; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; Xu QJ, 2009, STEM CELLS, V27, P1734, DOI 10.1002/stem.102; Xu QJ, 2008, STEM CELLS, V26, P3018, DOI 10.1634/stemcells.2008-0459; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505	44	25	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10974	10.1371/journal.pone.0010974	http://dx.doi.org/10.1371/journal.pone.0010974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539758	Green Submitted, Green Published, gold			2022-12-25	WOS:000278465900002
J	Hao, Q; Yin, P; Yan, CY; Yuan, XQ; Li, WQ; Zhang, ZP; Liu, L; Wang, JW; Yan, NE				Hao, Qi; Yin, Ping; Yan, Chuangye; Yuan, Xiaoqiu; Li, Wenqi; Zhang, Zhiping; Liu, Lei; Wang, Jiawei; Yan, Nieng			Functional Mechanism of the Abscisic Acid Agonist Pyrabactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Pyrabactin is a synthetic abscisic acid (ABA) agonist that selectively inhibits seed germination. The use of pyrabactin was pivotal in the identification of the PYR1/PYL/RCAR family (PYL) of proteins as the ABA receptor. Although they both act through PYL proteins, pyrabactin and ABA share no apparent chemical or structural similarity. It remains unclear how pyrabactin functions as an ABA agonist. Here, we report the crystal structure of pyrabactin in complex with PYL1 at 2.4 angstrom resolution. Structural and biochemical analyses revealed that recognition of pyrabactin by the pocket residues precedes the closure of switch loop CL2. Structural comparison between pyrabactin- and ABA-bound PYL1 reveals a general principle in the arrangements of function groups of the two distinct ligands. The study provides a framework for the development of novel ABA agonists that may have applicable potentials in agriculture.	[Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Hao, Qi; Yin, Ping; Yuan, Xiaoqiu; Li, Wenqi; Yan, Nieng] Tsinghua Univ, Sch Med, Struct Biol Ctr, Beijing 100084, Peoples R China; [Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Zhiping; Liu, Lei] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Rm C329,Med Sci Bldg, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021	Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2009CB918802]; Tsinghua University; Yuyuan Foundation; National Science Foundation of China [20932006]; Li Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; Yuyuan Foundation; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Foundation	This work was supported by Ministry of Science and Technology Grant 2009CB918802, Tsinghua University 985 Phase II funds, the Yuyuan Foundation, National Science Foundation of China Grant 20932006, and the Li Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEDOROFF NV, 2002, SCI STKE, pRE10; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; LESLIE AG, 1992, JOINT CCP4ESF EAMCB, V26; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Schroeder JI, 2006, CELL, V126, P1023, DOI 10.1016/j.cell.2006.09.001; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhao Y, 2007, NAT CHEM BIOL, V3, P716, DOI 10.1038/nchembio.2007.32	18	39	47	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28946	28952		10.1074/jbc.M110.149005	http://dx.doi.org/10.1074/jbc.M110.149005			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20554531	Green Published, hybrid			2022-12-25	WOS:000281594000059
J	Pinheiro, AS; Proell, M; Eibl, C; Page, R; Schwarzenbacher, R; Peti, W				Pinheiro, Anderson S.; Proell, Martina; Eibl, Clarissa; Page, Rebecca; Schwarzenbacher, Robert; Peti, Wolfgang			Three-dimensional Structure of the NLRP7 Pyrin Domain INSIGHT INTO PYRIN-PYRIN-MEDIATED EFFECTOR DOMAIN SIGNALING IN INNATE IMMUNITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; NF-KAPPA-B; REPRODUCTIVE WASTAGE; HYDATIDIFORM MOLES; PROTEIN; DEATH; MUTATIONS; APOPTOSIS; DYNAMICS; NALP7	The innate immune system provides an initial line of defense against infection. Nucleotide-binding domain-and leucine-rich repeat-containing protein (NLR or (NOD-like)) receptors play a critical role in the innate immune response by surveying the cytoplasm for traces of intracellular invaders and endogenous stress signals. NLRs themselves are multi-domain proteins. Their N-terminal effector domains (typically a pyrin or caspase activation and recruitment domain) are responsible for driving downstream signaling and initiating the formation of inflammasomes, multi-component complexes necessary for cytokine activation. However, the currently available structures of NLR effector domains have not yet revealed the mechanism of their differential modes of interaction. Here, we report the structure and dynamics of the N-terminal pyrin domain of NLRP7 (NLRP7 PYD) obtained by NMR spectroscopy. The NLRP7 PYD adopts a six-alpha-helix bundle death domain fold. A comparison of conformational and dynamics features of the NLRP7 PYD with other PYDs showed distinct differences for helix alpha 3 and loop alpha 2-alpha 3, which, in NLRP7, is stabilized by a strong hydrophobic cluster. Moreover, the NLRP7 and NLRP1 PYDs have different electrostatic surfaces. This is significant, because death domain signaling is driven by electrostatic contacts and stabilized by hydrophobic interactions. Thus, these results provide new insights into NLRP signaling and provide a first molecular understanding of inflammasome formation.	[Pinheiro, Anderson S.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Proell, Martina; Eibl, Clarissa; Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Brown University; Brown University; Salzburg University	Peti, W (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	wolfgang_peti@brown.edu	Peti, Wolfgang/L-3492-2014; Pinheiro, Anderson/AAL-5299-2021; Pinheiro, Anderson S/B-6350-2014	Pinheiro, Anderson/0000-0001-5118-6931; Eibl, Clarissa/0000-0001-8248-5133	National Institutes of Health [R01NS056128, S10-RR017269]; European Union [MCEXT-033534]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS056128 (to W. P.) and S10-RR017269. This work was also supported by the European Union Grant MCEXT-033534 (to R. S.).	Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deveault C, 2009, HUM MOL GENET, V18, P888, DOI 10.1093/hmg/ddn418; Djuric U, 2006, HUM GENET, V120, P390, DOI 10.1007/s00439-006-0192-3; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Espejo F, 2006, BIOCHEM BIOPH RES CO, V340, P860, DOI 10.1016/j.bbrc.2005.12.087; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Kinoshita T, 2006, INT IMMUNOL, V18, P1701, DOI 10.1093/intimm/dxl104; Kohl A, 2004, CR BIOL, V327, P1077, DOI 10.1016/j.crvi.2004.08.006; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lich JD, 2007, MICROBES INFECT, V9, P672, DOI 10.1016/j.micinf.2007.01.018; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Liu T, 2003, PROTEIN SCI, V12, P1872, DOI 10.1110/ps.0359603; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Ohno S, 2008, ANTICANCER RES, V28, P2493; Okada K, 2004, CANCER SCI, V95, P949, DOI 10.1111/j.1349-7006.2004.tb03182.x; PALMER AG, 1992, J AM CHEM SOC, V114, P9059, DOI 10.1021/ja00049a043; Park HH, 2006, J MOL BIOL, V357, P358, DOI 10.1016/j.jmb.2005.12.082; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pelupessy P, 2003, J MAGN RESON, V161, P258, DOI 10.1016/S1090-7807(02)00190-8; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pinheiro AD, 2009, BIOMOL NMR ASSIGN, V3, P207, DOI 10.1007/s12104-009-9176-2; Puechberty J, 2009, CLIN GENET, V75, P298, DOI 10.1111/j.1399-0004.2008.01098.x; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Slim R, 2007, CLIN GENET, V71, P25, DOI 10.1111/j.1399-0004.2006.00697.x; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Staub E, 2001, TRENDS BIOCHEM SCI, V26, P83, DOI 10.1016/S0968-0004(00)01717-5; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang CY, 2003, MAGN RESON CHEM, V41, P866, DOI 10.1002/mrc.1262; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Yeretssian G, 2008, CYTOKINE, V43, P380, DOI 10.1016/j.cyto.2008.07.015; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	63	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27402	27410		10.1074/jbc.M110.113191	http://dx.doi.org/10.1074/jbc.M110.113191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20547486	hybrid, Green Published			2022-12-25	WOS:000281172700069
J	Chen, X; Lu, L; Qi, Z; Lu, H; Wang, J; Yu, XX; Chen, YH; Jiang, SB				Chen, Xi; Lu, Lu; Qi, Zhi; Lu, Hong; Wang, Ji; Yu, Xiaoxia; Chen, Yinghua; Jiang, Shibo			Novel Recombinant Engineered gp41 N-terminal Heptad Repeat Trimers and Their Potential as Anti-HIV-1 Therapeutics or Microbicides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INHIBITORS TARGETING GP41; HIV-1 TRANSMEMBRANE GLYCOPROTEIN; D-PEPTIDE INHIBITORS; FUSION INHIBITOR; COILED-COIL; ENTRY INHIBITORS; CORE STRUCTURE; ENFUVIRTIDE RESISTANCE; ENVELOPE GLYCOPROTEINS	Peptides derived from N-terminal heptad repeat (NHR) of the HIV-1 gp41 are generally poor inhibitors of HIV-1 entry, because they tend to aggregate and do not form a trimeric coiled-coil. In this study, we have fused portions of gp41 NHR, e. g. N36 or N28, to the T4 fibritin trimerization domain, Foldon (Fd), thus constructing novel NHR trimers, designated N36Fd or N28Fd, which could be expressed in Escherichia coli cells. The purified N36Fd and N28Fd exhibited SDS-resistant trimeric coiled-coil conformation with improved alpha-helicity compared with the corresponding N-peptides. They could interact with a C-peptide (e.g. C34) to form stable six-helix bundle and possessed potent anti-HIV-1 activity against a broad spectrum of HIV-1 strains. N28Fd was effective against T20-resistant HIV-1 variants and more resistant to proteinase K compared with T20 (enfuvirtide), a C-peptide-based HIV fusion inhibitor. Therefore, N28Fd trimer has great potentials for further development as an affordable therapeutic or microbicide for treatment and prevention of HIV-1 infection.	[Chen, Xi; Wang, Ji; Chen, Yinghua] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Chen, Xi; Lu, Lu; Qi, Zhi; Lu, Hong; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Yu, Xiaoxia] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; New York Blood Center; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, YH (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	chenyh@mail.tsinghua.edu.cn; sjiang@nybloodcenter.org	lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022; Lu, Lu/K-7070-2014; chen, ying/HHS-8254-2022; Jiang, Shibo/L-4500-2014	Lu, Lu/0000-0002-2255-0391; Jiang, Shibo/0000-0001-8283-7135	National Institutes of Health [AI046221]; China Scholarship Council [973-2006CB504203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046221, R01AI046221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI046221 (to S.J.). This work was also supported by Grant 973-2006CB504203 (to Y.C.) and a scholarship from the China Scholarship Council (to X.C.).	Antonelli G, 1999, EUR CYTOKINE NETW, V10, P413; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Cai LF, 2007, ANTIMICROB AGENTS CH, V51, P2388, DOI 10.1128/AAC.00150-07; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Dey AK, 2008, VIROLOGY, V372, P187, DOI 10.1016/j.virol.2007.10.018; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Gisselquist D, 2003, INT J STD AIDS, V14, P162, DOI 10.1258/095646203762869160; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; Hanley JP, 1998, LEUKEMIA LYMPHOMA, V29, P257, DOI 10.3109/10428199809068563; Harrison PF, 2003, CLIN INFECT DIS, V36, P1290, DOI 10.1086/374834; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; Hildinger M, 2001, J VIROL, V75, P3038, DOI 10.1128/JVI.75.6.3038-3042.2001; Holguin A, 2007, AIDS RES HUM RETROV, V23, P1067, DOI 10.1089/aid.2006.0256; Huang JH, 2007, BIOCHEM J, V403, P565, DOI 10.1042/BJ20061275; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jacobs A, 2004, PROTEIN SCI, V13, P2811, DOI 10.1110/ps.04916704; Jenabian MA, 2009, J ANTIMICROB CHEMOTH, V64, P1192, DOI 10.1093/jac/dkp380; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Kilby JM, 2002, AIDS RES HUM RETROV, V18, P685, DOI 10.1089/088922202760072294; Laue T, 2001, CURR OPIN STRUC BIOL, V11, P579, DOI 10.1016/S0959-440X(00)00250-5; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Liu SW, 2004, CURR PHARM DESIGN, V10, P1827, DOI 10.2174/1381612043384466; Liu SW, 2003, J BIOMOL SCREEN, V8, P685, DOI 10.1177/1087057103259155; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; Lu H, 2006, AIDS RES HUM RETROV, V22, P411, DOI 10.1089/aid.2006.22.411; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Pang W, 2008, VIROLOGY, V377, P80, DOI 10.1016/j.virol.2008.04.013; Papanikolopoulou K, 2004, J BIOL CHEM, V279, P8991, DOI 10.1074/jbc.M311791200; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Veazey RS, 2008, P NATL ACAD SCI USA, V105, P10531, DOI 10.1073/pnas.0802666105; Walmsley S, 2003, J INFECT DIS, V188, P1827, DOI 10.1086/379810; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welch BD, 2007, P NATL ACAD SCI USA, V104, P16828, DOI 10.1073/pnas.0708109104; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xu Y, 2007, J ORG CHEM, V72, P6700, DOI 10.1021/jo070836l; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yap ML, 2010, J MOL BIOL, V395, P349, DOI 10.1016/j.jmb.2009.10.071; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	64	47	55	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25506	25515		10.1074/jbc.M110.101170	http://dx.doi.org/10.1074/jbc.M110.101170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538590	hybrid, Green Published			2022-12-25	WOS:000280682400044
J	Deng, XY; Lee, J; Michael, AJ; Tomchick, DR; Goldsmith, EJ; Phillips, MA				Deng, Xiaoyi; Lee, Jeongmi; Michael, Anthony J.; Tomchick, Diana R.; Goldsmith, Elizabeth J.; Phillips, Margaret A.			Evolution of Substrate Specificity within a Diverse Family of beta/alpha-Barrel-fold Basic Amino Acid Decarboxylases X-RAY STRUCTURE DETERMINATION OF ENZYMES WITH SPECIFICITY FOR L-ARGININE AND CARBOXYNORSPERMIDINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC ORNITHINE DECARBOXYLASES; MULTIPLE PROTEIN-SEQUENCE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DIAMINOPIMELATE DECARBOXYLASE; TRYPANOSOMA-BRUCEI; STRUCTURE ALIGNMENTS; VIBRIO-CHOLERAE; BINDING; CRYSTALLIZATION	Pyridoxal 5'-phosphate (PLP)-dependent basic amino acid decarboxylases from the beta/alpha-barrel-fold class (group IV) exist in most organisms and catalyze the decarboxylation of diverse substrates, essential for polyamine and lysine biosynthesis. Herein we describe the first x-ray structure determination of bacterial biosynthetic arginine decarboxylase (ADC) and carboxynorspermidine decarboxylase (CANSDC) to 2.3- and 2.0-angstrom resolution, solved as product complexes with agmatine and norspermidine. Despite low overall sequence identity, the monomeric and dimeric structures are similar to other enzymes in the family, with the active sites formed between the beta/alpha-barrel domain of one subunit and the beta-barrel of the other. ADC contains both a unique interdomain insertion (4-helical bundle) and a C-terminal extension (3-helical bundle) and it packs as a tetramer in the asymmetric unit with the insertions forming part of the dimer and tetramer interfaces. Analytical ultracentrifugation studies confirmed that the ADC solution structure is a tetramer. Specificity for different basic amino acids appears to arise primarily from changes in the position of, and amino acid replacements in, a helix in the beta-barrel domain we refer to as the "specificity helix." Additionally, in CANSDC a key acidic residue that interacts with the distal amino group of other substrates is replaced by Leu(314), which interacts with the aliphatic portion of norspermidine. Neither product, agmatine in ADC nor norspermidine in CANSDC, form a Schiff base to pyridoxal 5'-phosphate, suggesting that the product complexes may promote product release by slowing the back reaction. These studies provide insight into the structural basis for the evolution of novel function within a common structural-fold.	[Deng, Xiaoyi; Michael, Anthony J.; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Tomchick, Diana R.; Goldsmith, Elizabeth J.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Lee, Jeongmi] Sungkyunkwan Univ, Coll Pharm, Suwon 440747, Gyeonggi Do, South Korea	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sungkyunkwan University (SKKU)	Phillips, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	margaret.phillips@UTSouthwestern.edu	Lee, Jeongmi/AAJ-7720-2020; Tomchick, Diana/HGV-2018-2022; Deng, Xiaoyi/E-4394-2011	Lee, Jeongmi/0000-0002-9948-7554; Tomchick, Diana/0000-0002-7529-4643	National Institutes of Health [R01AI34432, R37AI34432]; Welch Foundation [I-1257]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034432, R37AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI34432 and R37AI34432 (to M. A. P.) and Welch Foundation Grant I-1257 (to M. A. P.).; We thank Bruce Pearson of the Institute of Food Research, Norwich, for the C. jejuni CANSDC clone. The structures described in this report were derived from work performed on beamline 19-ID at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by the University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Andrell J, 2009, BIOCHEMISTRY-US, V48, P3915, DOI 10.1021/bi900075d; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fries D.S., 2003, BURGERS MED CHEM DRU, P1033; Gokulan K, 2003, J BIOL CHEM, V278, P18588, DOI 10.1074/jbc.M301549200; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15513, DOI 10.1021/bi001651a; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Laskowski RA, 2007, BIOINFORMATICS, V23, P1824, DOI 10.1093/bioinformatics/btm085; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Liu XY, 2009, ACTA CRYSTALLOGR F, V65, P282, DOI 10.1107/S1744309109003856; MOMANY C, 1995, PROTEIN SCI, V4, P849; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osterman AL, 1997, BIOCHEMISTRY-US, V36, P4558, DOI 10.1021/bi962916h; Osterman AL, 1999, BIOCHEMISTRY-US, V38, P11814, DOI 10.1021/bi9906221; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Patel CN, 2004, ACTA CRYSTALLOGR D, V60, P2396, DOI 10.1107/S0907444904027180; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Poole AM, 2006, CURR OPIN STRUC BIOL, V16, P508, DOI 10.1016/j.sbi.2006.06.013; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; RODRIGUEZ BR, 1994, ACTA CRYSTALLOGR D, V50, P175, DOI 10.1107/S0907444993009989; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; Shah R, 2007, BIOCHEMISTRY-US, V46, P2831, DOI 10.1021/bi6023447; Song JP, 2010, MOL BIOL REP, V37, P1823, DOI 10.1007/s11033-009-9617-0; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Weyand Simone, 2009, Journal of Structural and Functional Genomics, V10, P209, DOI 10.1007/s10969-009-9065-z; YAMAMOTO S, 1994, MICROBIOL-UK, V140, P3117, DOI 10.1099/13500872-140-11-3117	51	22	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25708	25719		10.1074/jbc.M110.121137	http://dx.doi.org/10.1074/jbc.M110.121137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534592	Green Published, hybrid			2022-12-25	WOS:000280682400064
J	Chen, QA; Pinon, DI; Miller, LJ; Dong, MQ				Chen, Quan; Pinon, Delia I.; Miller, Laurence J.; Dong, Maoqing			Spatial Approximations between Residues 6 and 12 in the Amino-terminal Region of Glucagon-like Peptide 1 and Its Receptor A REGION CRITICAL FOR BIOLOGICAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOAFFINITY CROSS-LINKING; PROTEIN-COUPLED-RECEPTOR; 1ST EXTRACELLULAR LOOP; CORTICOTROPIN-RELEASING-FACTOR; PARATHYROID-HORMONE PTH; CALCITONIN RECEPTOR; SECRETIN RECEPTOR; AGONIST-BINDING; MOLECULAR RECOGNITION; DIRECT IDENTIFICATION	Understanding the molecular basis of natural ligand binding and activation of the glucagon-like peptide 1 (GLP1) receptor may facilitate the development of agonist drugs useful for the management of type 2 diabetes mellitus. We previously reported molecular approximations between carboxyl-terminal residues 24 and 35 within GLP1 and its receptor. In this work, we have focused on the amino-terminal region of GLP1, known to be critical for receptor activation. We developed two high-affinity, full agonist photolabile GLP1 probes having sites of covalent attachment in positions 6 and 12 of the 30-residue peptide (GLP1(7-36)). Both probes bound to the receptor specifically and covalently labeled single distinct sites. Chemical and protease cleavage of the labeled receptor identified the juxtamembrane region of its amino-terminal domain as the region of covalent attachment of the position 12 probe, whereas the region of labeling by the position 6 probe was localized to the first extracellular loop. Radiochemical sequencing identified receptor residue Tyr(145), adjacent to the first transmembrane segment, as the site of labeling by the position 12 probe, and receptor residue Tyr(205), within the first extracellular loop, as the site of labeling by the position 6 probe. These data provide support for a common mechanism for natural ligand binding and activation of family B G protein-coupled receptors. This region of interaction of peptide amino-terminal domains with the receptor may provide a pocket that can be targeted by small molecule agonists.	[Chen, Quan; Pinon, Delia I.; Miller, Laurence J.; Dong, Maoqing] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Dong, MQ (corresponding author), 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	dongmq@mayo.edu			National Institutes of Health [DK46577]; American Diabetes Association [1-08-RA-42]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577 and American Diabetes Association Grant 1-08-RA-42.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Behar V, 2000, J BIOL CHEM, V275, P9, DOI 10.1074/jbc.275.1.9; Behar V, 1999, ENDOCRINOLOGY, V140, P4251, DOI 10.1210/en.140.9.4251; Beinborn M, 2005, REGUL PEPTIDES, V130, P1, DOI 10.1016/j.regpep.2005.05.001; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; Ceraudo E, 2008, MOL ENDOCRINOL, V22, P147, DOI 10.1210/me.2007-0361; Ceraudo E, 2008, J MOL NEUROSCI, V36, P245, DOI 10.1007/s12031-008-9073-7; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2009, J BIOL CHEM, V284, P21839, DOI 10.1074/jbc.M109.011924; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; Drucker DJ, 2005, NAT CLIN PRACT ENDOC, V1, P22, DOI 10.1038/ncpendmet0017; Du K, 1997, BIOCHEM BIOPH RES CO, V230, P289, DOI 10.1006/bbrc.1996.5949; Estall JL, 2006, CURR PHARM DESIGN, V12, P1731, DOI 10.2174/138161206776873671; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Greenberg Z, 2000, BIOCHEMISTRY-US, V39, P8142, DOI 10.1021/bi000195n; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Monaghan P, 2008, BIOCHEMISTRY-US, V47, P5889, DOI 10.1021/bi800122f; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Piserchio A, 2000, BIOCHEMISTRY-US, V39, P8153, DOI 10.1021/bi000196f; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; Tokuyama Y, 2004, DIABETES RES CLIN PR, V66, P63, DOI 10.1016/j.diabres.2004.02.004; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644	60	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24508	24518		10.1074/jbc.M110.135749	http://dx.doi.org/10.1074/jbc.M110.135749			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529866	Green Published, hybrid			2022-12-25	WOS:000280542100023
J	Singh, K; Gitti, RK; Diouf, A; Zhou, H; Gowda, DC; Miura, K; Ostazeski, SA; Fairhurst, RM; Garboczi, DN; Long, CA				Singh, Kavita; Gitti, Rossitza K.; Diouf, Ababacar; Zhou, Hong; Gowda, D. Channe; Miura, Kazutoyo; Ostazeski, Stanley A.; Fairhurst, Rick M.; Garboczi, David N.; Long, Carole A.			Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3x Is Identified as a Minimal Chondroitin Sulfate A-binding Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION-BLOCKING ANTIBODIES; PREGNANCY-ASSOCIATED MALARIA; VARIANT SURFACE-ANTIGENS; N-TERMINAL DOMAIN; INFECTED ERYTHROCYTES; PARASITE ADHESION; PLACENTAL MALARIA; VAR GENE; RECEPTOR; NMR	Molecular interactions between the VAR2CSA protein, expressed on the surface of Plasmodium falciparum-infected erythrocytes, and placental chondroitin sulfate A (CSA) are primarily responsible for pregnancy-associated malaria (PAM). Interrupting these interactions may prevent or ameliorate the severity of PAM. Several of the Duffy binding-like (DBL) domains of VAR2CSA, including the DBL3x domain, have been shown to bind CSA in vitro, but a more detailed understanding of how DBL domains bind CSA is needed. In this study, we demonstrate that subdomain 3 (S3), one of the three subdomains of VAR2CSA DBL3x by itself, is the major contributor toward CSA binding. NMR spectroscopy and flow cytometry analyses show that S3 and the intact DBL3x domain bind CSA similarly. Mutations within the S3 portion of DBL3x markedly affect CSA binding. Both recombinant molecules, S3 and DBL3x, are recognized by antibodies in the plasma of previously pregnant women living in malaria-endemic regions of Mali, but much less so by plasma from men of the same regions. As the S3 sequence is highly conserved in all known VAR2CSA proteins expressed by different parasite isolates obtained from various malaria endemic areas of the world, the identification of S3 as an independent CSA-binding region provides a compelling molecular basis for designing interventions against PAM.	[Garboczi, David N.] NIAID, Struct Biol Sect, Res Technol Branch, NIH, Rockville, MD 20852 USA; [Gitti, Rossitza K.; Ostazeski, Stanley A.] Edgewood Chem Biol Ctr, Forens Analyt Branch, Aberdeen Proving Ground, MD 21010 USA; [Diouf, Ababacar; Zhou, Hong; Miura, Kazutoyo; Fairhurst, Rick M.; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health		ksingh@niaid.nih.gov; clong@niaid.nih.gov	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432; Gowda, Channe/0000-0002-6860-5108	NIAID, National Institutes of Health [AI45086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI045086, R01AI045086, ZIAAI001000, ZICAI001051, ZIAAI001020] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Grant AI45086 from NIAID, National Institutes of Health and the Division of Intramural Research of the NIAID, National Institutes of Health.	Achur RN, 2003, J BIOL CHEM, V278, P11705, DOI 10.1074/jbc.M211015200; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Blanchard V, 2007, BIOCHEMISTRY-US, V46, P1167, DOI 10.1021/bi061971f; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; CLORE GM, 1982, EUR J BIOCHEM, V128, P113; Cosman M, 2005, METH MOL B, V300, P141; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Fried M, 2000, EXP PARASITOL, V95, P75, DOI 10.1006/expr.2000.4510; Fried M, 1998, J MOL MED-JMM, V76, P162, DOI 10.1007/s001090050205; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gamain B, 2001, P NATL ACAD SCI USA, V98, P2664, DOI 10.1073/pnas.041602598; GLAUDEMANS CPJ, 1990, BIOCHEMISTRY-US, V29, P10906, DOI 10.1021/bi00501a007; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; SCHERF T, 1993, BIOPHYS J, V64, P754, DOI 10.1016/S0006-3495(93)81436-X; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; SODEOKA M, 1993, BIOORG MED CHEM LETT, V3, P1089, DOI 10.1016/S0960-894X(00)80293-0; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; TOIDA T, 1993, ANAL SCI, V9, P53, DOI 10.2116/analsci.9.53; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	39	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24855	24862		10.1074/jbc.M110.118612	http://dx.doi.org/10.1074/jbc.M110.118612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529864	Green Published, hybrid			2022-12-25	WOS:000280542100058
J	Strijbis, K; van Roermund, CW; van den Burg, J; van den Berg, M; Hardy, GPM; Wanders, RJ; Distel, B				Strijbis, Karin; van Roermund, Carlo W.; van den Burg, Janny; van den Berg, Marlene; Hardy, Guy P. M.; Wanders, Ronald J.; Distel, Ben			Contributions of Carnitine Acetyltransferases to Intracellular Acetyl Unit Transport in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID BETA-OXIDATION; YEAST SACCHAROMYCES-CEREVISIAE; PEROXISOMAL FATTY-ACID; GLYOXYLATE CYCLE; CARBON-SOURCES; COA; PROTEIN; CHAIN; IDENTIFICATION; MITOCHONDRIAL	Transport of acetyl-CoA between intracellular compartments is mediated by carnitine acetyltransferases (Cats) that reversibly link acetyl units to the carrier molecule carnitine. The genome of the opportunistic pathogenic yeast Candida albicans encodes several (putative) Cats: the peroxisomal and mitochondrial Cat2 isoenzymes encoded by a single gene and the carnitine acetyltransferase homologs Yat1 and Yat2. To determine the contributions of the individual Cats, various carnitine acetyltransferase mutant strains were constructed and subjected to phenotypic and biochemical analyses on different carbon sources. We show that mitochondrial Cat2 is required for the intramitochondrial conversion of acetylcarnitine to acetyl-CoA, which is essential for a functional tricarboxylic acid cycle during growth on oleate, acetate, ethanol, and citrate. Yat1 is cytosolic and contributes to acetyl-CoA transport from the cytosol during growth on ethanol or acetate, but its activity is not required for growth on oleate. Yat2 is also cytosolic, but we were unable to attribute any function to this enzyme. Surprisingly, peroxisomal Cat2 is essential neither for export of acetyl units during growth on oleate nor for the import of acetyl units during growth on acetate or ethanol. Oxidation of fatty acids still takes place in the absence of peroxisomal Cat2, but biomass formation is absent, and the strain displays a growth delay on acetate and ethanol that can be partially rescued by the addition of carnitine. Based on our results, we present a model for the intracellular flow of acetyl units under various growth conditions and the roles of each of the Cats in this process.	[Strijbis, Karin; van den Burg, Janny; van den Berg, Marlene; Hardy, Guy P. M.; Distel, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [van Roermund, Carlo W.; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Dept Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Distel, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	b.distel@amc.uva.nl		Strijbis, Karin/0000-0001-9167-7137	Academic Medical Center, Amsterdam	Academic Medical Center, Amsterdam	This work was supported by a grant from the Academic Medical Center, Amsterdam.	BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; DEJONGGUBBELS P, 1995, YEAST, V11, P407, DOI 10.1002/yea.320110503; ELGERSMA Y, 1995, EMBO J, V14, P3472, DOI 10.1002/j.1460-2075.1995.tb07353.x; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Franken J, 2008, CURR GENET, V53, P347, DOI 10.1007/s00294-008-0191-0; GRUNAU S, 2009, PLOS ONE, V276, P1698; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hooks MA, 2007, BIOCHEM J, V406, P399, DOI 10.1042/BJ20070258; HOVIK R, 1991, J LIPID RES, V32, P993; KISPAL G, 1993, J BIOL CHEM, V268, P1824; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Klein ATJ, 2001, J BIOL CHEM, V276, P15034, DOI 10.1074/jbc.M010776200; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Kunze M, 2002, EUR J BIOCHEM, V269, P915, DOI 10.1046/j.0014-2956.2001.02727.x; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Maeting I, 1999, FEBS LETT, V444, P15, DOI 10.1016/S0014-5793(99)00017-4; NAKANISHI Y, 1994, J BIOCHEM-TOKYO, V115, P328, DOI 10.1093/oxfordjournals.jbchem.a124337; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; OSMUNDSEN H, 1980, INT J BIOCHEM, V12, P625, DOI 10.1016/0020-711X(80)90015-4; Piekarska K, 2008, MICROBIOL-SGM, V154, P3061, DOI 10.1099/mic.0.2008/020289-0; Piekarska K, 2006, EUKARYOT CELL, V5, P1847, DOI 10.1128/EC.00093-06; Prigneau O, 2004, FUNGAL GENET BIOL, V41, P783, DOI 10.1016/j.fgb.2004.04.001; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; SCHMALIX W, 1993, J BIOL CHEM, V268, P27428; Strijbis K, 2008, EUKARYOT CELL, V7, P610, DOI 10.1128/EC.00017-08; Strijbis K, 2009, FASEB J, V23, P2349, DOI 10.1096/fj.08-127985; Swiegers JH, 2001, YEAST, V18, P585, DOI 10.1002/yea.712; van Roermund CWT, 2001, MOL CELL BIOL, V21, P4321, DOI 10.1128/MCB.21.13.4321-4329.2001; van Roermund CWT, 1998, EMBO J, V17, P677, DOI 10.1093/emboj/17.3.677; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Velot C, 1999, BIOCHEMISTRY-US, V38, P16195, DOI 10.1021/bi991695n; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; WANDERS RJA, 1990, J INHERIT METAB DIS, V13, P311, DOI 10.1007/BF01799383; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; WILCKE M, 1994, EUR J BIOCHEM, V222, P803, DOI 10.1111/j.1432-1033.1994.tb18927.x; Zhou H, 2008, MICROBIOL-SGM, V154, P500, DOI 10.1099/mic.0.2007/014555-0	44	17	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24335	24346		10.1074/jbc.M109.094250	http://dx.doi.org/10.1074/jbc.M109.094250			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522553	hybrid, Green Published			2022-12-25	WOS:000280542100005
J	Ribeiro, SP; Rosa, DS; Fonseca, SG; Mairena, EC; Postol, E; Oliveira, SC; Guilherme, L; Kalil, J; Cunha-Neto, E				Ribeiro, Susan Pereira; Rosa, Daniela Santoro; Fonseca, Simone Goncalves; Mairena, Eliane Conti; Postol, Edilberto; Oliveira, Sergio Costa; Guilherme, Luiza; Kalil, Jorge; Cunha-Neto, Edecio			A Vaccine Encoding Conserved Promiscuous HIV CD4 Epitopes Induces Broad T Cell Responses in Mice Transgenic to Multiple Common HLA Class II Molecules	PLOS ONE			English	Article							IN-VIVO; IMMUNE-RESPONSE; INFECTION; STEP; PROTECTION; IMMUNOGENICITY; IDENTIFICATION; PROLIFERATION; REPLICATION; SPECIFICITY	Current HIV vaccine approaches are focused on immunogens encoding whole HIV antigenic proteins that mainly elicit cytotoxic CD8+ responses. Mounting evidence points toward a critical role for CD4+ T cells in the control of immunodeficiency virus replication, probably due to cognate help. Vaccine-induced CD4+ T cell responses might, therefore, have a protective effect in HIV replication. In addition, successful vaccines may have to elicit responses to multiple epitopes in a high proportion of vaccinees, to match the highly variable circulating strains of HIV. Using rational vaccine design, we developed a DNA vaccine encoding 18 algorithm-selected conserved, "promiscuous" ( multiple HLA-DR-binding) B-subtype HIV CD4 epitopes - previously found to be frequently recognized by HIV-infected patients. We assessed the ability of the vaccine to induce broad T cell responses in the context of multiple HLA class II molecules using different strains of HLA class II-transgenic mice (-DR2, -DR4, -DQ6 and -DQ8). Mice displayed CD4+ and CD8+ T cell responses of significant breadth and magnitude, and 16 out of the 18 encoded epitopes were recognized. By virtue of inducing broad responses against conserved CD4+ T cell epitopes that can be recognized in the context of widely diverse, common HLA class II alleles, this vaccine concept may cope both with HIV genetic variability and increased population coverage. The vaccine may thus be a source of cognate help for HIV-specific CD8+ T cells elicited by conventional immunogens, in a wide proportion of vaccinees.	[Ribeiro, Susan Pereira; Rosa, Daniela Santoro; Fonseca, Simone Goncalves; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Div Clin Immunol & Allergy,Dept Med, Sao Paulo, Brazil; [Fonseca, Simone Goncalves; Mairena, Eliane Conti; Postol, Edilberto; Guilherme, Luiza; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Ribeiro, Susan Pereira; Rosa, Daniela Santoro; Mairena, Eliane Conti; Postol, Edilberto; Guilherme, Luiza; Kalil, Jorge; Cunha-Neto, Edecio] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Oliveira, Sergio Costa] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Ribeiro, SP (corresponding author), Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Div Clin Immunol & Allergy,Dept Med, Sao Paulo, Brazil.	edecunha@gmail.com	Cunha-Neto, Edecio/B-4157-2009; Rosa, Daniela S/D-2190-2012; FONSECA, SIMONE GONÇALVES/U-9278-2019; Oliveira, Sergio Costa/AAG-5408-2021; Guglielmi, Luiza G/E-7676-2013; KALIL, JORGE/C-8029-2012	Cunha-Neto, Edecio/0000-0002-3699-3345; Rosa, Daniela S/0000-0003-4536-891X; Oliveira, Sergio Costa/0000-0003-4062-5577; KALIL, JORGE/0000-0001-8415-4274	Brazilian National Research Council (CNPq); Sao Paulo State Research Funding Agency (FAPESP); International Centre of Genetic Engineering and Biotechnology (ICGEB); Brazilian Ministry of Health (Brazil)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Centre of Genetic Engineering and Biotechnology (ICGEB); Brazilian Ministry of Health (Brazil)	This research was supported by the Brazilian National Research Council (CNPq), Sao Paulo State Research Funding Agency (FAPESP), International Centre of Genetic Engineering and Biotechnology (ICGEB) and from the Brazilian Ministry of Health (Brazil). S. P. Ribeiro and D. S. Rosa are recipients of a Sao Paulo State Research Funding Agency (FAPESP) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; ATHERTON ND, 1989, CLIN CHEM, V35, P975; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bian HJ, 2004, METHODS, V34, P468, DOI 10.1016/j.ymeth.2004.06.002; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Call MJ, 2009, J IMMUNOL, V182, P6342, DOI 10.4049/jimmunol.0803464; Chapoval SP, 1998, J IMMUNOL, V161, P2032; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; DaSilva L, 2002, J INFECT DIS, V185, P1754, DOI 10.1086/340828; Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f; Fuller DH, 2007, VIROLOGY, V364, P245, DOI 10.1016/j.virol.2007.02.024; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Garcia TCM, 2008, ACTA TROP, V106, P162, DOI 10.1016/j.actatropica.2008.03.003; Gauduin MC, 2006, J EXP MED, V203, P2661, DOI 10.1084/jem.20060134; Geluk A, 1998, P NATL ACAD SCI USA, V95, P10797, DOI 10.1073/pnas.95.18.10797; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; GonzalezGay MA, 1996, HUM IMMUNOL, V50, P54, DOI 10.1016/0198-8859(96)00123-1; Gregory SH, 2009, VACCINE, V27, P5299, DOI 10.1016/j.vaccine.2009.06.101; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Ishioka GY, 1999, J IMMUNOL, V162, P3915; Iwai LK, 2003, MOL MED, V9, P209, DOI 10.1007/BF03402131; Kawamura K, 2000, J CLIN INVEST, V105, P977, DOI 10.1172/JCI8407; Khanolkar A, 2007, IMMUNOL RES, V39, P94, DOI 10.1007/s12026-007-0081-4; KORBER BTM, 2006, THEORETICAL BIOL BIO; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499; Martinez V, 2005, J INFECT DIS, V191, P2053, DOI 10.1086/430320; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; OCONNOR SL, SCI TRANSL MED, V22; Pan SC, 1998, J IMMUNOL, V161, P2925; Pancre V, 2007, VACCINE, V25, P5927, DOI 10.1016/j.vaccine.2007.05.038; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; Rosa DS, 2006, MICROBES INFECT, V8, P2130, DOI 10.1016/j.micinf.2006.03.012; Rosa DS, 2010, ARCH IMMUNOL THER EX, V58, P121, DOI 10.1007/s00005-010-0067-0; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Suhrbier Andreas, 2002, Expert Rev Vaccines, V1, P207, DOI 10.1586/14760584.1.2.207; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Vaccari M, 2008, MUCOSAL IMMUNOL, V1, P497, DOI 10.1038/mi.2008.60; Vaccari M, 2008, J VIROL, V82, P9629, DOI 10.1128/JVI.00893-08; Watkins DI, 2008, MEM I OSWALDO CRUZ, V103, P119, DOI 10.1590/S0074-02762008000200001; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wong FS, 2004, DIABETOLOGIA, V47, P1476, DOI 10.1007/s00125-004-1505-5; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	58	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11072	10.1371/journal.pone.0011072	http://dx.doi.org/10.1371/journal.pone.0011072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552033	Green Submitted, Green Published, gold			2022-12-25	WOS:000278662900012
J	Rose, AMC; Mueller, JE; Gerstl, S; Njanpop-Lafourcade, BM; Page, AL; Nicolas, P; Traore, RO; Caugant, DA; Guerin, PJ				Rose, Angela M. C.; Mueller, Judith E.; Gerstl, Sibylle; Njanpop-Lafourcade, Berthe-Marie; Page, Anne-Laure; Nicolas, Pierre; Traore, Ramata Ouedraogo; Caugant, Dominique A.; Guerin, Philippe J.			Meningitis Dipstick Rapid Test: Evaluating Diagnostic Performance during an Urban Neisseria meningitidis Serogroup A Outbreak, Burkina Faso, 2007	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PCR-BASED IDENTIFICATION; MENINGOCOCCAL MENINGITIS; BACTERIAL-MENINGITIS; FIELD-EVALUATION; MULTIPLEX PCR; NIGER; BELT; SURVEILLANCE; EPIDEMIC	Meningococcal meningitis outbreaks occur every year during the dry season in the "meningitis belt" of sub-Saharan Africa. Identification of the causative strain is crucial before launching mass vaccination campaigns, to assure use of the correct vaccine. Rapid agglutination (latex) tests are most commonly available in district-level laboratories at the beginning of the epidemic season; limitations include a short shelf-life and the need for refrigeration and good technical skills. Recently, a new dipstick rapid diagnostic test (RDT) was developed to identify and differentiate disease caused by meningococcal serogroups A, W135, C and Y. We evaluated the diagnostic performance of this dipstick RDT during an urban outbreak of meningitis caused by N. meningitidis serogroup A in Ouagadougou, Burkina Faso; first against an in-country reference standard of culture and/or multiplex PCR; and second against culture and/or a highly sensitive nested PCR technique performed in Oslo, Norway. We included 267 patients with suspected acute bacterial meningitis. Using the in-country reference standard, 50 samples (19%) were positive. Dipstick RDT sensitivity (N = 265) was 70% (95% CI 55-82) and specificity 97% (95% CI 93-99). Using culture and/or nested PCR, 126/259 (49%) samples were positive; dipstick RDT sensitivity (N = 257) was 32% (95% CI 24-41), and specificity was 99% (95% CI 95-100). We found dipstick RDT sensitivity lower than values reported from (i) assessments under ideal laboratory conditions (>90%), and (ii) a prior field evaluation in Niger [89% (95% CI 80-95)]. Specificity, however, was similar to (i), and higher than (ii) [62% (95% CI 48-75)]. At this stage in development, therefore, other tests (e. g., latex) might be preferred for use in peripheral health centres. We highlight the value of field evaluations for new diagnostic tests, and note relatively low sensitivity of a reference standard using multiplex vs. nested PCR. Although the former is the current standard for bacterial meningitis surveillance in the meningitis belt, nested PCR performed in a certified laboratory should be used as an absolute reference when evaluating new diagnostic tests.	[Rose, Angela M. C.; Gerstl, Sibylle; Page, Anne-Laure; Guerin, Philippe J.] Epictr, Paris, France; [Rose, Angela M. C.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Mueller, Judith E.; Njanpop-Lafourcade, Berthe-Marie] Agence Med Prevent, Paris, France; [Nicolas, Pierre] World Hlth Org Collaborating Ctr Reference & Res, IMTSSA, Marseille, France; [Traore, Ramata Ouedraogo] Ctr Hosp Univ Pediat Charles de Gaulle, Biol Lab, Ouagadougou, Burkina Faso; [Caugant, Dominique A.] Norwegian Inst Publ Hlth, World Hlth Org Collaborating Ctr Reference & Res, Oslo, Norway; [Caugant, Dominique A.] Univ Oslo, Inst Gen Practice & Community Med, N-0316 Oslo, Norway	University West Indies Mona Jamaica; University of the West Indies Open Campus; Agence de Medecine Preventive; World Health Organization; Norwegian Institute of Public Health (NIPH); World Health Organization; University of Oslo	Rose, AMC (corresponding author), Epictr, Paris, France.	angela.rose@cavehill.uwi.edu	Guerin, Philippe/AAH-8873-2021; , dcaugant/AAH-6843-2019; Rose, Angela/I-5584-2014; Rose, Angela MC/O-1645-2019	, dcaugant/0000-0003-2765-9844; Rose, Angela/0000-0002-2493-8082; Rose, Angela MC/0000-0002-2493-8082; Guerin, Philippe/0000-0002-6008-2963	Medecins Sans Frontieres - Luxembourg	Medecins Sans Frontieres - Luxembourg	This work was financially supported by Medecins Sans Frontieres - Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Wkly Epidemiol Rec, V78, P294; Boisier P, 2009, TROP MED INT HEALTH, V14, P111, DOI 10.1111/j.1365-3156.2008.02192.x; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Borel T, 2006, T ROY SOC TROP MED H, V100, P964, DOI 10.1016/j.trstmh.2006.03.002; CAMPAGNE G, 1981, B WHO, V77; Caugant DA, 1996, SCAND J INFECT DIS, V28, P149, DOI 10.3109/00365549609049066; Chanteau S, 2006, T ROY SOC TROP MED H, V100, P677, DOI 10.1016/j.trstmh.2005.09.006; Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337; Chanteau S, 2007, VACCINE, V25, pA30, DOI 10.1016/j.vaccine.2007.04.037; Djibo S, 2003, TROP MED INT HEALTH, V8, P1118, DOI 10.1046/j.1360-2276.2003.01126.x; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; FERMON F, 2004, MANAGEMENT EPIDEMIC; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Lafourcade BMN, 2010, J CLIN MICROBIOL, V48, P612, DOI 10.1128/JCM.01402-09; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Nathan N, 2005, LANCET, V366, P308, DOI 10.1016/S0140-6736(05)66792-X; Nathan N, 2007, EMERG INFECT DIS, V13, P920, DOI 10.3201/eid1306.060940; NI HL, 1992, LANCET, V340, P1432, DOI 10.1016/0140-6736(92)92622-M; NJANPOPLAFOURCA.BM, 2005, REV FANCAISE LAB, V372, P33; Okoko BJ, 2009, VACCINE, V27, P2023, DOI 10.1016/j.vaccine.2008.11.092; Richardson DC, 2003, J CLIN MICROBIOL, V41, P3851, DOI 10.1128/JCM.41.8.3851-3853.2003; Rose AMC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007326; SPERBER G, 1992, B WORLD HEALTH ORGAN, V70, P359; Taha MK, 2005, J CLIN MICROBIOL, V43, P144, DOI 10.1128/JCM.43.1.144-149.2005; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; *US CTR DIS CONTR, 2009, MAL RAP DIAGN TEST P; *WHO, WHOCDSEDC997EN	27	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11086	10.1371/journal.pone.0011086	http://dx.doi.org/10.1371/journal.pone.0011086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552035	Green Published, Green Submitted, gold			2022-12-25	WOS:000278662900023
J	Gharaibeh, RZ; Newton, JM; Weller, JW; Gibas, CJ				Gharaibeh, Raad Z.; Newton, Joshua M.; Weller, Jennifer W.; Gibas, Cynthia J.			Application of Equilibrium Models of Solution Hybridization to Microarray Design and Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; DNA MICROARRAYS; OLIGONUCLEOTIDE HYBRIDIZATION; MOLECULAR-INTERACTIONS; OPTIMIZATION; INFORMATION; PRINCIPLES; DISCOVERY; SOFTWARE; KINETICS	Background: The probe percent bound value, calculated using multi-state equilibrium models of solution hybridization, is shown to be useful in understanding the hybridization behavior of microarray probes having 50 nucleotides, with and without mismatches. These longer oligonucleotides are in widespread use on microarrays, but there are few controlled studies of their interactions with mismatched targets compared to 25-mer based platforms. Principal Findings: 50-mer oligonucleotides with centrally placed single, double and triple mismatches were spotted on an array. Over a range of target concentrations it was possible to discriminate binding to perfect matches and mismatches, and the type of mismatch could be predicted accurately in the concentration midrange (100 pM to 200 pM) using solution hybridization modeling methods. These results have implications for microarray design, optimization and analysis methods. Conclusions: Our results highlight the importance of incorporating biophysical factors in both the design and the analysis of microarrays. Use of the probe "percent bound" value predicted by equilibrium models of hybridization is confirmed to be important for predicting and interpreting the behavior of long oligonucleotide arrays, as has been shown for short oligonucleotide arrays.	[Gharaibeh, Raad Z.; Weller, Jennifer W.; Gibas, Cynthia J.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Newton, Joshua M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Phys Assistant Studies, Winston Salem, NC USA	University of North Carolina; University of North Carolina Charlotte; Wake Forest University; Wake Forest Baptist Medical Center	Gharaibeh, RZ (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	cgibas@uncc.edu		Gibas, Cynthia/0000-0002-1288-9543	National Institutes of Health [1R01GM072619-01]; UNC-Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC-Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health grant 1R01GM072619-01 to C.J.G and J.W.W. and by the UNC-Charlotte GASP program to R.Z.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl435; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Chou CC, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh099; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Dong YM, 2001, APPL ENVIRON MICROB, V67, P1911, DOI 10.1128/AEM.67.4.1911-1921.2001; Dorris DR, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-6; Dufva M, 2005, BIOMOL ENG, V22, P173, DOI 10.1016/j.bioeng.2005.09.003; Fish DJ, 2007, NUCLEIC ACIDS RES, V35, P7197, DOI 10.1093/nar/gkm865; Forman JE, 1998, ACS SYM SER, V682, P206; Gao Y, 2006, NUCLEIC ACIDS RES, V34, P3370, DOI 10.1093/nar/gkl422; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gharaibeh RZ, 2007, COMPUT BIOL CHEM, V31, P92, DOI 10.1016/j.compbiolchem.2007.02.008; Gharaibeh RZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-452; Gibbs A, 1998, J VIROL METHODS, V74, P67, DOI 10.1016/S0166-0934(98)00070-6; Glazer M, 2006, ANAL BIOCHEM, V358, P225, DOI 10.1016/j.ab.2006.07.042; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gong P, 2008, P NATL ACAD SCI USA, V105, P5301, DOI 10.1073/pnas.0709416105; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Held GA, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl122; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; KNUDTSON KL, 2003, CURRENT PROFILE MICR; Kreil DP, 2006, METHOD ENZYMOL, V410, P73, DOI 10.1016/S0076-6879(06)10004-X; Li SZ, 2008, NUCLEIC ACIDS RES, V36, P6585, DOI 10.1093/nar/gkn740; LIMA WF, 1992, BIOCHEMISTRY-US, V31, P12055, DOI 10.1021/bi00163a013; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Murphy D, 2002, ADV PHYSIOL EDUC, V26, P256, DOI 10.1152/advan.00043.2002; Naef F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011906; Nordberg EK, 2005, BIOINFORMATICS, V21, P1365, DOI 10.1093/bioinformatics/bti182; Peterson AW, 2002, J AM CHEM SOC, V124, P14601, DOI 10.1021/ja0279996; R Development Core Team, 2007, R LANG ENV STAT COMP; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Relogio A, 2005, J BIOL CHEM, V280, P4779, DOI 10.1074/jbc.M411976200; Relogio A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e51; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SantaLucia John Jr., 2007, V402, P3; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Stoughton RB, 2005, ANNU REV BIOCHEM, V74, P53, DOI 10.1146/annurev.biochem.74.082803.133212; Tomiuk S, 2001, Brief Bioinform, V2, P329, DOI 10.1093/bib/2.4.329; Weckx S, 2007, J PHYS CHEM B, V111, P13583, DOI 10.1021/jp075197x; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836	55	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11048	10.1371/journal.pone.0011048	http://dx.doi.org/10.1371/journal.pone.0011048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548788	Green Published, Green Submitted, gold			2022-12-25	WOS:000278599600009
J	Lee, JH; Kishikawa, M; Kumazoe, M; Yamada, K; Tachibana, H				Lee, Ju Hye; Kishikawa, Mutsumi; Kumazoe, Motofumi; Yamada, Koji; Tachibana, Hirofumi			Vitamin A Enhances Antitumor Effect of a Green Tea Polyphenol on Melanoma by Upregulating the Polyphenol Sensing Molecule 67-kDa Laminin Receptor	PLOS ONE			English	Article							TRANS-RETINOIC ACID; EPSILON-RI EXPRESSION; LEUKEMIA-CELLS; CANCER PREVENTION; NUCLEAR RECEPTORS; DIFFERENTIATION; EPIGALLOCATECHIN-3-O-GALLATE; INHIBITION; EGCG; (-)-EPIGALLOCATECHIN-3-O-GALLATE	Background: Green tea consumption has been shown to have cancer preventive qualities. Among the constituents of green tea, (-)-Epigallocatechin-3-O-gallate (EGCG) is the most effective at inhibiting carcinogenesis. However, the concentrations of EGCG that are required to elicit the anticancer effects in a variety of cancer cell types are much higher than the peak plasma concentration that occurs after drinking an equivalent of 2-3 cups of green tea. To obtain the anticancer effects of EGCG when consumed at a reasonable concentration in daily life, we investigated the combination effect of EGCG and food ingredient that may enhance the anticancer activity of EGCG on subcutaneous tumor growth in C57BL/6N mice challenged with B16 melanoma cells. Methodology/Principal Findings: All-trans-retinoic acid (ATRA) enhanced the expression of the 67-kDa laminin receptor (67LR) and increased EGCG-induced cell growth inhibition in B16 melanoma cells. The cell growth inhibition seen with the combined EGCG and ATRA treatment was abolished by treatment with an anti-67LR antibody. In addition, the combined EGCG and ATRA treatment significantly suppressed the melanoma tumor growth in mice. Expression of 67LR in the tumor increased upon oral administration of ATRA or a combined treatment of EGCG and ATRA treatment. Furthermore, RNAi-mediated silencing of the retinoic acid receptor (RAR) alpha attenuated the ATRA-induced enhancement of 67LR expression in the melanoma cells. An RAR agonist enhanced the expression levels of 67LR and increased EGCG-induced cell growth inhibition. Conclusions/Significance: Our findings provide a molecular basis for the combination effect seen with dietary components, and indicate that ATRA may be a beneficial food component for cancer prevention when combined with EGCG.	[Lee, Ju Hye; Kishikawa, Mutsumi; Kumazoe, Motofumi; Yamada, Koji; Tachibana, Hirofumi] Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Hakozaki, Japan; [Tachibana, Hirofumi] Kyushu Univ, Lab Funct Food Design, Dept Funct Metab Design, Bioarchitecture Ctr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Lee, JH (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Hakozaki, Japan.	tatibana@agr.kyushu-u.ac.jp	Komsa, Ildiko/G-7751-2011	Kumazoe, Motofumi/0000-0002-3002-2994	Kieikai research foundation;  [18208012]	Kieikai research foundation(Kieikai Research Foundation); 	This work was supported in part by grants-in-aid for scientific research (A) (Grant 18208012) (to H. T.) and Kieikai research foundation (to H. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BOLLAG W, 1992, ANN ONCOL, V3, P513, DOI 10.1093/oxfordjournals.annonc.a058252; Britschgi A, 2010, BRIT J HAEMATOL, V149, P55, DOI 10.1111/j.1365-2141.2009.08040.x; Fujiki H, 2002, CANCER LETT, V188, P9, DOI 10.1016/S0304-3835(02)00379-8; Fujimura Y, 2005, BIOCHEM BIOPH RES CO, V336, P674, DOI 10.1016/j.bbrc.2005.08.146; Fujimura Y, 2004, FEBS LETT, V556, P204, DOI 10.1016/S0014-5793(03)01432-7; Fujimura Y, 2007, BIOCHEM BIOPH RES CO, V364, P79, DOI 10.1016/j.bbrc.2007.09.095; Fujimura Y, 2006, BIOCHEM BIOPH RES CO, V348, P524, DOI 10.1016/j.bbrc.2006.07.086; Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Gudas Lorraine J., 1994, P443; Haque A, 2007, NEUROCHEM RES, V32, P2203, DOI 10.1007/s11064-007-9420-z; Huang HW, 2009, EUR J HAEMATOL, V83, P191, DOI 10.1111/j.1600-0609.2009.01277.x; Jimenez-Saenz M, 2006, J HEPATOL, V44, P616, DOI 10.1016/j.jhep.2005.11.041; Karmakar S., 2007, CANCER, V112, P596; LANCILLOTTI F, 1992, CANCER RES, V52, P6144; LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393; Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465; Lin YL, 1996, J AGR FOOD CHEM, V44, P1387, DOI 10.1021/jf950652k; LIPPMAN SM, 1995, J CELL BIOCHEM, P1; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Martin PJ, 2005, NUCLEIC ACIDS RES, V33, P4311, DOI 10.1093/nar/gki745; Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; Okada N, 2009, BIOMED RES-TOKYO, V30, P201, DOI 10.2220/biomedres.30.201; Ozer EA, 2005, PEDIATR PULM, V39, P35, DOI 10.1002/ppul.20131; Ozpolat B, 2003, J PHARM PHARM SCI, V6, P292; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; TALLMAN MS, 1992, J CLIN PHARMACOL, V32, P868, DOI 10.1002/j.1552-4604.1992.tb04633.x; Umeda D, 2005, BIOCHEM BIOPH RES CO, V333, P628, DOI 10.1016/j.bbrc.2005.05.108; Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200; WANG ZY, 1989, MUTAT RES, V223, P273, DOI 10.1016/0165-1218(89)90120-1; Witcher M, 2003, BLOOD, V102, P237, DOI 10.1182/blood-2002-09-2725; Xia L, 2006, LEUKEMIA, V20, P1009, DOI 10.1038/sj.leu.2404198; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Yano S, 2007, J AGR FOOD CHEM, V55, P7144, DOI 10.1021/jf071176o; Zhao J, 2008, EUR J PHARMACOL, V589, P127, DOI 10.1016/j.ejphar.2008.04.063	42	44	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11051	10.1371/journal.pone.0011051	http://dx.doi.org/10.1371/journal.pone.0011051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548792	Green Submitted, gold, Green Published			2022-12-25	WOS:000278599600012
J	Atik, B; Johnston, SC; Dean, D				Atik, Berna; Johnston, S. Claiborne; Dean, Deborah			Association of Carotid Plaque Lp-PLA(2) with Macrophages and Chlamydia pneumoniae Infection among Patients at Risk for Stroke	PLOS ONE			English	Article							ACTIVATING-FACTOR ACETYLHYDROLASE; CORONARY-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; C-REACTIVE PROTEIN; LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE-A2; LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL-CELLS; ATHEROSCLEROSIS RISK; ADHESION MOLECULES; WALL THICKNESS	Background: We previously showed that the burden of Chlamydia pneumoniae in carotid plaques was significantly associated with plaque interleukin (IL)-6, and serum IL-6 and C-reactive protein (CRP), suggesting that infected plaques contribute to systemic inflammatory markers in patients with stroke risk. Since lipoprotein-associated phospholipase A2 (Lp-PLA(2)) mediates inflammation in atherosclerosis, we hypothesized that serum Lp-PLA(2) mass and activity levels and plaque Lp-PLA(2) may be influenced by plaque C. pneumoniae infection. Methodology/Principal Findings: Forty-two patients underwent elective carotid endarterectomy. Tissue obtained at surgery was stained by immunohistochemistry for Lp-PLA(2) grade, macrophages, IL-6, C. pneumoniae and CD4+ and CD8+ cells. Serum Lp-PLA(2) activity and mass were measured using the colorimetric activity method (CAM (TM)) and ELISA, respectively. Serum homocysteine levels were measured by HPLC. Eleven (26.2%) patients were symptomatic with transient ischemic attacks. There was no correlation between patient risk factors (smoking, coronary artery disease, elevated cholesterol, diabetes, obesity, hypertension and family history of genetic disorders) for atherosclerosis and serum levels or plaque grade for Lp-PLA(2). Plaque Lp-PLA(2) correlated with serum homocysteine levels (p=0.013), plaque macrophages (p<0.01), and plaque C. pneumoniae (p<0.001), which predominantly infected macrophages, co-localizing with Lp-PLA(2). Conclusions: The significant association of plaque Lp-PLA(2) with plaque macrophages and C. pneumoniae suggests an interactive role in accelerating inflammation in atherosclerosis. A possible mechanism for C. pneumoniae in the atherogenic process may involve infection of macrophages that induce Lp-PLA(2) production leading to upregulation of inflammatory mediators in plaque tissue. Additional in vitro and in vivo research will be needed to advance our understanding of specific C. pneumoniae and Lp-PLA(2) interactions in atherosclerosis.	[Atik, Berna; Dean, Deborah] Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Johnston, S. Claiborne] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Dean, Deborah] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Atik, B (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA.	ddean@chori.org	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Pacific Vascular Research Foundation; National Institutes of Health [R01 AI039499]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039499] Funding Source: NIH RePORTER	Pacific Vascular Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Pacific Vascular Research Foundation (www.pvrf.org), the National Institutes of Health, R01 AI039499 (to DD) in addition to reagents from diaDexus (www.diadexus.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger A, 1997, CELL STRESS CHAPERON, V2, P94, DOI 10.1379/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2; Antoniades C, 2009, EUR HEART J, V30, P6, DOI 10.1093/eurheartj/ehn515; Apfalter P, 2000, EUR J CLIN MICROBIOL, V19, P305, DOI 10.1007/s100960050481; Asano K, 1999, BIOCHEM BIOPH RES CO, V261, P511, DOI 10.1006/bbrc.1999.1066; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Blessing E, 2005, J ANTIMICROB CHEMOTH, V55, P1037, DOI 10.1093/jac/dki128; Bunk S, 2008, J IMMUNOL, V180, P5490, DOI 10.4049/jimmunol.180.8.5490; Caini P, 2007, J VIRAL HEPATITIS, V14, P22, DOI 10.1111/j.1365-2893.2006.00766.x; Carlquist JF, 2007, EXPERT REV MOL DIAGN, V7, P511, DOI 10.1586/14737159.7.5.511; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chang MY, 2003, ARTERIOSCL THROM VAS, V23, P809, DOI 10.1161/01.ATV.0000069208.20268.D0; Chiu B, 1997, CIRCULATION, V96, P2144; de Kruif MD, 2005, CARDIOVASC RES, V65, P317, DOI 10.1016/j.cardiores.2004.09.031; Furberg CD, 2008, J AM GERIATR SOC, V56, P792, DOI 10.1111/j.1532-5415.2008.01667.x; Gieffers J, 2001, CARDIOVASC DRUG THER, V15, P259, DOI 10.1023/A:1011972424529; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; Hakkinen T, 1999, ARTERIOSCL THROM VAS, V19, P2909, DOI 10.1161/01.ATV.19.12.2909; Hauer AD, 2006, CARDIOVASC RES, V69, P280, DOI 10.1016/j.cardiores.2005.07.011; Hogdahl M, 2008, APMIS, V116, P1082, DOI 10.1111/j.1600-0463.2008.01145.x; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Jitsuiki K, 2006, CIRC J, V70, P815, DOI 10.1253/circj.70.815; Johnston SC, 2005, ARTERIOSCL THROM VAS, V25, P2648, DOI 10.1161/01.ATV.0000189157.88630.d1; Johnston SC, 2001, STROKE, V32, P2748, DOI 10.1161/hs1201.099631; Kalayoglu MV, 1999, J INFECT DIS, V180, P780, DOI 10.1086/314931; Kardys I, 2006, ARTERIOSCL THROM VAS, V26, P631, DOI 10.1161/01.ATV.0000201289.83256.cf; Kiortsis DN, 2005, ANGIOLOGY, V56, P451, DOI 10.1177/000331970505600413; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P1586, DOI 10.1161/01.ATV.0000222983.73369.c8; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; KUO CC, 1995, P NATL ACAD SCI USA, V92, P6911, DOI 10.1073/pnas.92.15.6911; LaBiche R, 2001, STROKE, V32, P855, DOI 10.1161/01.STR.32.4.855; Laitinen K, 1997, INFECT IMMUN, V65, P4832, DOI 10.1128/IAI.65.11.4832-4835.1997; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Mayr M, 2000, CIRCULATION, V102, P833; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Muhlestein JB, 1999, AM HEART J, V138, pS514, DOI 10.1016/S0002-8703(99)70289-9; Oldgren J, 2007, EUR HEART J, V28, P699, DOI 10.1093/eurheartj/ehl565; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Persson M, 2008, ATHEROSCLEROSIS, V200, P191, DOI 10.1016/j.atherosclerosis.2007.12.001; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; Rajavashisth TB, 1999, CIRCULATION, V99, P3103, DOI 10.1161/01.CIR.99.24.3103; Ramirez JA, 1996, ANN INTERN MED, V125, P979, DOI 10.7326/0003-4819-125-12-199612150-00008; Rodel J, 2000, INFECT IMMUN, V68, P3635, DOI 10.1128/IAI.68.6.3635-3641.2000; SAIKKU P, 1992, J INFECTION, V25, P27, DOI 10.1016/0163-4453(92)91913-V; Sessa R, 2009, INT J IMMUNOPATH PH, V22, P9, DOI 10.1177/039463200902200102; TARBET EB, 1991, J BIOL CHEM, V266, P16667; Tsimikas S, 2009, EUR HEART J, V30, P107, DOI 10.1093/eurheartj/ehn502; VADAS P, 1993, AM J TROP MED HYG, V49, P455, DOI 10.4269/ajtmh.1993.49.455; Van Lenten BJ, 2001, CIRCULATION, V103, P2283	48	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11026	10.1371/journal.pone.0011026	http://dx.doi.org/10.1371/journal.pone.0011026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543948	Green Published, gold, Green Submitted			2022-12-25	WOS:000278557600005
J	Boyd, AS; Wood, KJ				Boyd, Ashleigh S.; Wood, Kathryn J.			Characteristics of the Early Immune Response Following Transplantation of Mouse ES Cell Derived Insulin-Producing Cell Clusters	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN ISLETS; T-CELLS; EXPRESSION; COMPLEMENT; PRIVILEGE; IMMUNOGENICITY; ENGRAFTMENT; REJECTION; TARGETS		[Boyd, Ashleigh S.; Wood, Kathryn J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England; [Boyd, Ashleigh S.] Boston Univ, Sch Med, Roger Williams Hosp, NIH Ctr Biomed Res Excellence COBRE Tissue Repair, Providence, RI USA	University of Oxford; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Roger Williams Medical Center	Boyd, AS (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England.	aboyd@rwmc.org; kathryn.wood@nds.ox.ac.uk			Medical Research Council; BD Preanalytical Systems Europe; NIH [P20RR018757]; NIH COBRE; Wellcome Trust; European Union; Royal Society Wolfson Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018757] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BD Preanalytical Systems Europe; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); European Union(European Commission); Royal Society Wolfson Research(Royal Society of London); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this project was provided to ASB by the Medical Research Council and BD Preanalytical Systems Europe through a Collaborative Studentship and by NIH grant P20RR018757. Additional support was provided by the NIH COBRE administrative core at Roger Williams Medical Center, Wellcome Trust and European Union through the Optistem Network. KJW holds a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1996, TRANSPLANTATION, V61, P817, DOI 10.1097/00007890-199603150-00024; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Blyszczuk P, 2004, INT J DEV BIOL, V48, P1095, DOI 10.1387/ijdb.041904pb; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Boyd AS, 2005, ADV DRUG DELIVER REV, V57, P1944, DOI 10.1016/j.addr.2005.08.004; Boyd AS, 2008, STEM CELLS, V26, P1128, DOI 10.1634/stemcells.2007-0762; Boyd AS, 2009, TRANSPLANTATION, V87, P1300, DOI 10.1097/TP.0b013e3181a19421; Burns WR, 2005, AM J TRANSPLANT, V5, P1226, DOI 10.1111/j.1600-6143.2005.00892.x; Carvalho-Gaspar M, 2005, J IMMUNOL METHODS, V301, P41, DOI 10.1016/j.jim.2005.03.003; El-Sawy T, 2005, CIRCULATION, V112, P320, DOI 10.1161/CIRCULATIONAHA.104.516708; El-Sawy T, 2004, AM J PATHOL, V165, P147, DOI 10.1016/S0002-9440(10)63283-X; Game DS, 2002, TRANSPL IMMUNOL, V10, P101, DOI 10.1016/S0966-3274(02)00055-2; Johansson U, 2003, BIOCHEM BIOPH RES CO, V308, P474, DOI 10.1016/S0006-291X(03)01392-5; Jones ND, 2006, J IMMUNOL, V176, P2316, DOI 10.4049/jimmunol.176.4.2316; Kapoor A, 2000, TRANSPLANT P, V32, P793, DOI 10.1016/S0041-1345(00)00985-4; Koch CA, 2004, J IMMUNOL, V172, P5143, DOI 10.4049/jimmunol.172.9.5143; Kondo T, 2000, TRANSPLANTATION, V69, P969; Kuttler B, 2002, TRANSPLANTATION, V74, P440, DOI 10.1097/00007890-200208270-00003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; Marsh JE, 1999, CURR OPIN NEPHROL HY, V8, P557, DOI 10.1097/00041552-199909000-00004; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Nicolls MR, 2001, CRIT REV IMMUNOL, V21, P87; Olszewski Waldemar L, 2005, Ann Transplant, V10, P5; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Quigg RJ, 2003, J IMMUNOL, V171, P3319, DOI 10.4049/jimmunol.171.7.3319; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; SACKS SH, 1993, LANCET, V342, P1273, DOI 10.1016/0140-6736(93)92362-W; Socha-Urbanek K, 1998, Ann Transplant, V3, P5; Turvey SE, 2000, TRANSPLANTATION, V69, P1972, DOI 10.1097/00007890-200005150-00043; Wu DC, 2008, STEM CELLS, V26, P1939, DOI 10.1634/stemcells.2008-0078; Yasunami Y, 2005, J EXP MED, V202, P913, DOI 10.1084/jem.20050448	33	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10965	10.1371/journal.pone.0010965	http://dx.doi.org/10.1371/journal.pone.0010965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532031	Green Submitted, gold, Green Published			2022-12-25	WOS:000278380500010
J	Hastings, PJ; Hersh, MN; Thornton, PC; Fonville, NC; Slack, A; Frisch, RL; Ray, MP; Harris, RS; Leal, SM; Rosenberg, SM				Hastings, P. J.; Hersh, Megan N.; Thornton, P. C.; Fonville, Natalie C.; Slack, Andrew; Frisch, Ryan L.; Ray, Mellanie P.; Harris, Reuben S.; Leal, Suzanne M.; Rosenberg, Susan M.			Competition of Escherichia coli DNA Polymerases I, II and III with DNA Pol IV in Stressed Cells	PLOS ONE			English	Article							DEPENDENT ADAPTIVE MUTATION; FRAMESHIFT MUTATION; SLIDING-CLAMP; SOS RESPONSE; GENETIC REQUIREMENTS; INDUCED MUTAGENESIS; REPLICATION FORK; LESION-BYPASS; RECOMBINATION; FIDELITY	Escherichia coli has five DNA polymerases, one of which, the low-fidelity Pol IV or DinB, is required for stress-induced mutagenesis in the well-studied Lac frameshift-reversion assay. Although normally present at similar to 200 molecules per cell, Pol IV is recruited to acts of DNA double-strand-break repair, and causes mutagenesis, only when at least two cellular stress responses are activated: the SOS DNA-damage response, which upregulates DinB similar to 10-fold, and the RpoS-controlled general-stress response, which upregulates Pol IV about 2-fold. DNA Pol III was also implicated but its role in mutagenesis was unclear. We sought in vivo evidence on the presence and interactions of multiple DNA polymerases during stress-induced mutagenesis. Using multiply mutant strains, we provide evidence of competition of DNA Pols I, II and III with Pol IV, implying that they are all present at sites of stress-induced mutagenesis. Previous data indicate that Pol V is also present. We show that the interactions of Pols I, II and III with Pol IV result neither from, first, induction of the SOS response when particular DNA polymerases are removed, nor second, from proofreading of DNA Pol IV errors by the editing functions of Pol I or Pol III. Third, we provide evidence that Pol III itself does not assist with but rather inhibits Pol IV-dependent mutagenesis. The data support the remaining hypothesis that during the acts of DNA double-strand-break (DSB) repair, shown previously to underlie stress-induced mutagenesis in the Lac system, there is competition of DNA polymerases I, II and III with DNA Pol IV for action at the primer terminus. Up-regulation of Pol IV, and possibly other stress-response-controlled factor(s), tilt the competition in favor of error-prone Pol IV at the expense of more accurate polymerases, thus producing stress-induced mutations. This mutagenesis assay reveals the DNA polymerases operating in DSB repair during stress and also provides a sensitive indicator for DNA polymerase competition and choice in vivo.	[Hastings, P. J.; Hersh, Megan N.; Thornton, P. C.; Fonville, Natalie C.; Slack, Andrew; Frisch, Ryan L.; Ray, Mellanie P.; Harris, Reuben S.; Leal, Suzanne M.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Fonville, Natalie C.; Rosenberg, Susan M.] Baylor Coll Med, Interdept Grad Program Cell & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Hastings, PJ (corresponding author), LaserGen Inc, Houston, TX USA.	hastings@bcm.edu	Romesberg, Floyd/M-2821-2017	Romesberg, Floyd/0000-0001-6317-1315; Rosenberg, Susan M./0000-0003-1444-473X	National Institutes of Health [R01-GM64022, R01-GM53158, T32-GM07526]; DOD; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158, T32GM007526, R01GM064022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-GM64022 (PJH) and R01-GM53158 (SMR), a DOD Breast Cancer Research Postdoctoral Fellowship to MNH, and National Institutes of Health training grant T32-GM07526 to RLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Banach-Orlowska M, 2005, MOL MICROBIOL, V58, P61, DOI 10.1111/j.1365-2958.2005.04805.x; BATES H, 1989, J BACTERIOL, V171, P2480, DOI 10.1128/jb.171.5.2480-2484.1989; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; CAIRNS J, 1991, GENETICS, V128, P695; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Courcelle J, 2001, GENETICS, V158, P41; Curti E, 2009, MOL MICROBIOL, V71, P315, DOI 10.1111/j.1365-2958.2008.06526.x; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; ELLEDGE SJ, 1983, J MOL BIOL, V164, P175, DOI 10.1016/0022-2836(83)90074-8; ESCARCELLER M, 1994, J BACTERIOL, V176, P6221, DOI 10.1128/jb.176.20.6221-6228.1994; FIJALKOWSKA IJ, 1993, GENETICS, V134, P1023; Fijalkowska IJ, 1997, J BACTERIOL, V179, P7435, DOI 10.1128/jb.179.23.7435-7445.1997; FOSTER PL, 1995, P NATL ACAD SCI USA, V92, P7951, DOI 10.1073/pnas.92.17.7951; Foster PL, 1996, GENETICS, V142, P25; FOSTER PL, 1994, SCIENCE, V265, P407, DOI 10.1126/science.8023164; Foster PL, 2000, COLD SPRING HARB SYM, V65, P21, DOI 10.1101/sqb.2000.65.21; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Fujii S, 2004, EMBO J, V23, P4342, DOI 10.1038/sj.emboj.7600438; Furukohri A, 2008, J BIOL CHEM, V283, P11260, DOI 10.1074/jbc.M709689200; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Galhardo RS, 2009, GENETICS, V182, P55, DOI 10.1534/genetics.109.100735; Gawel D, 2008, J BACTERIOL, V190, P1730, DOI 10.1128/JB.01463-07; Harris RS, 1997, MUTAT RES-FUND MOL M, V375, P19, DOI 10.1016/S0027-5107(96)00244-8; Harris RS, 1996, GENETICS, V142, P681; HARRIS RS, 1994, SCIENCE, V264, P258, DOI 10.1126/science.8146657; Harris RS, 1997, THESIS U ALBERTA EDM; Hastings PJ, 2004, PLOS BIOL, V2, P2220, DOI 10.1371/journal.pbio.0020399; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; He AS, 2006, DNA REPAIR, V5, P258, DOI 10.1016/j.dnarep.2005.10.006; Heltzel JMH, 2009, P NATL ACAD SCI USA, V106, P12664, DOI 10.1073/pnas.0903460106; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; JOYCE CM, 1985, J MOL BIOL, V186, P283, DOI 10.1016/0022-2836(85)90105-6; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kuban W, 2005, J BACTERIOL, V187, P6862, DOI 10.1128/JB.187.19.6862-6866.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layton JC, 2003, MOL MICROBIOL, V50, P549, DOI 10.1046/j.1365-2958.2003.03704.x; Lombardo MJ, 2004, GENETICS, V166, P669, DOI 10.1534/genetics.166.2.669; MARSH L, 1985, J BACTERIOL, V162, P155, DOI 10.1128/JB.162.1.155-161.1985; Maul RW, 2005, J BACTERIOL, V187, P7607, DOI 10.1128/JB.187.22.7607-7618.2005; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Pages V, 2005, J MOL BIOL, V352, P501, DOI 10.1016/j.jmb.2005.07.063; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Petrosino JF, 2009, J BACTERIOL, V191, P5881, DOI 10.1128/JB.00732-09; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Prieto AI, 2006, GENETICS, V174, P575, DOI 10.1534/genetics.106.060889; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; SLATER SC, 1994, J BACTERIOL, V171, P3139; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Sutton MD, 2004, J BACTERIOL, V186, P6738, DOI 10.1128/JB.186.20.6738-6748.2004; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Torkelson J, 1997, EMBO J, V16, P3303, DOI 10.1093/emboj/16.11.3303; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104	70	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10862	10.1371/journal.pone.0010862	http://dx.doi.org/10.1371/journal.pone.0010862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523737	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221900012
J	Pfenning, AR; Kim, TK; Spotts, JM; Hemberg, M; Su, D; West, AE				Pfenning, Andreas R.; Kim, Tae-Kyung; Spotts, James M.; Hemberg, Martin; Su, Dan; West, Anne E.			Genome-Wide Identification of Calcium-Response Factor (CaRF) Binding Sites Predicts a Role in Regulation of Neuronal Signaling Pathways	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; EPHRIN-AS; BDNF TRANSCRIPTION; GENE; EXPRESSION; PLASTICITY; RECEPTORS; MAPS	Calcium-Response Factor (CaRF) was first identified as a transcription factor based on its affinity for a neuronal-selective calcium-response element (CaRE1) in the gene encoding Brain-Derived Neurotrophic Factor (BDNF). However, because CaRF shares no homology with other transcription factors, its properties and gene targets have remained unknown. Here we show that the DNA binding domain of CaRF has been highly conserved across evolution and that CaRF binds DNA directly in a sequence-specific manner in the absence of other eukaryotic cofactors. Using a binding site selection screen we identify a high-affinity consensus CaRF response element (cCaRE) that shares significant homology with the CaRE1 element of Bdnf. In a genome-wide chromatin immunoprecipitation analysis (ChIP-Seq), we identified 176 sites of CaRF-specific binding (peaks) in neuronal genomic DNA. 128 of these peaks are within 10kB of an annotated gene, and 60 are within 1kB of an annotated transcriptional start site. At least 138 of the CaRF peaks contain a common 10-bp motif with strong statistical similarity to the cCaRE, and we provide evidence predicting that CaRF can bind independently to at least 64.5% of these motifs in vitro. Analysis of this set of putative CaRF targets suggests the enrichment of genes that regulate intracellular signaling cascades. Finally we demonstrate that expression of a subset of these target genes is altered in the cortex of Carf knockout (KO) mice. Together these data strongly support the characterization of CaRF as a unique transcription factor and provide the first insight into the program of CaRF-regulated transcription in neurons.	[Pfenning, Andreas R.] Duke Univ, Med Ctr, Program Computat Biol & Bioinformat, Durham, NC 27710 USA; [Kim, Tae-Kyung] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Spotts, James M.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA; [Spotts, James M.] Childrens Hosp Boston, Dept Neurol, Boston, MA USA; [Spotts, James M.] Childrens Hosp Boston, Dept Neurobiol, Boston, MA USA; [Hemberg, Martin] Childrens Hosp Boston, Dept Ophthalmol, Boston, MA USA; [Su, Dan; West, Anne E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Duke University	Pfenning, AR (corresponding author), Duke Univ, Med Ctr, Program Computat Biol & Bioinformat, Durham, NC 27710 USA.	west@neuro.duke.edu	Kim, Tae-Kyung/AAX-4230-2020	Kim, Tae-Kyung/0000-0001-5161-9864; /0000-0002-3447-9801	NIH [R01 DA022202]; Harvard Medical School; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by NIH grant R01 DA022202 (A.E.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are deeply grateful to Michael E. Greenberg of Harvard Medical School for his support of this project and for the generous contribution of reagents.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davidson HT, 2009, EUR J NEUROSCI, V29, P42, DOI 10.1111/j.1460-9568.2008.06563.x; Efron B, 2008, STAT SCI, V23, P1, DOI 10.1214/07-STS236; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; MCDOWELL KA, 2010, J NEUROSCI IN PRESS; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Narlikar L, 2007, PLOS COMPUT BIOL, V3, P2199, DOI 10.1371/journal.pcbi.0030215; Narlikar L, 2006, BIOINFORMATICS, V22, pE384, DOI 10.1093/bioinformatics/btl251; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; POLLOCK RM, 2001, CURR PROTOC MOL BIOL, pCH12; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; SKELLAM JG, 1946, J ROY STAT SOC A STA, V109, P296, DOI 10.2307/2981372; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	47	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10870	10.1371/journal.pone.0010870	http://dx.doi.org/10.1371/journal.pone.0010870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523734	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221900016
J	Yang, CC; Liang, W; Cai, Y; Shi, SH; Takasu, F; Moller, AP; Antonov, A; Fossoy, F; Moksnes, A; Roskaft, E; Stokke, BG				Yang, Canchao; Liang, Wei; Cai, Yan; Shi, Suhua; Takasu, Fugo; Moller, Anders P.; Antonov, Anton; Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard G.			Coevolution in Action: Disruptive Selection on Egg Colour in an Avian Brood Parasite and Its Host	PLOS ONE			English	Article							CUCKOO CUCULUS-CANORUS; NEST PREDATION; COMMON CUCKOO; REED WARBLERS; RAPID DECLINE; OIL DROPLETS; EVOLUTION; BIRDS; APPEARANCE; REJECTION	Background: Trait polymorphism can evolve as a consequence of frequency-dependent selection. Coevolutionary interactions between hosts and parasites may lead to selection on both to evolve extreme phenotypes deviating from the norm, through disruptive selection. Methodology/Principal finding: Here, we show through detailed field studies and experimental procedures that the ashy-throated parrotbill (Paradoxornis alphonsianus) and its avian brood parasite, the common cuckoo (Cuculus canorus), have both evolved egg polymorphism manifested in discrete immaculate white, pale blue, and blue egg phenotypes within a single population. In this host-parasite system the most common egg colours were white and blue, with no significant difference in parasitism rates between hosts laying eggs of either colour. Furthermore, selection on parasites for countering the evolution of host egg types appears to be strong, since ashy-throated parrotbills have evolved rejection abilities for even partially mimetic eggs. Conclusions/Significance: The parrotbill-cuckoo system constitutes a clear outcome of disruptive selection on both host and parasite egg phenotypes driven by coevolution, due to the cost of parasitism in the host and by host defences in the parasite. The present study is to our knowledge the first to report the influence of disruptive selection on evolution of discrete phenotypes in both parasite and host traits in an avian brood parasitism system.	[Yang, Canchao; Shi, Suhua] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Canchao; Liang, Wei; Cai, Yan] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China; [Takasu, Fugo] Nara Womens Univ, Dept Informat & Comp Sci, Nara 630, Japan; [Moller, Anders P.] Univ Paris Sud, Lab Ecol Systemat & Evolut, Orsay, France; [Antonov, Anton; Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard G.] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Yang, Canchao; Liang, Wei; Takasu, Fugo; Moller, Anders P.; Antonov, Anton; Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard G.] CAS, Oslo, Norway	Sun Yat Sen University; Hainan Normal University; Nara Womens University; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Norwegian University of Science & Technology (NTNU)	Yang, CC (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	Bard.Stokke@bio.ntnu.no	Moller, Anders/O-6665-2016; Røskaft, Eivin/N-7476-2019; Fossoy, Frode/O-3073-2017	Moller, Anders/0000-0003-3739-4675; Røskaft, Eivin/0000-0003-0262-8443; Fossoy, Frode/0000-0002-7535-9574	Program for New Century Excellent Talents in University [NCET-10-0111]; Norwegian Research Council [i77709/V40]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Program for New Century Excellent Talents in University (NCET-10-0111) to LW, and from the Norwegian Research Council (No. i77709/V40) to ER, AM, FF and BGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamik P, 2009, ARDEA, V97, P17, DOI 10.5253/078.097.0103; Alvarez F, 2000, IBIS, V142, P683, DOI 10.1111/j.1474-919X.2000.tb04470.x; ALVAREZ F, 1994, J AVIAN BIOL, V25, P239, DOI 10.2307/3677081; Antonov A, 2007, NATURWISSENSCHAFTEN, V94, P307, DOI 10.1007/s00114-006-0189-8; Aviles JM, 2006, J EVOLUTION BIOL, V19, P1901, DOI 10.1111/j.1420-9101.2006.01166.x; Aviles JM, 2006, EVOL ECOL RES, V8, P493; BROOKE MD, 1987, J ANIM ECOL, V56, P873, DOI 10.2307/4954; Brooke MD, 1998, P ROY SOC B-BIOL SCI, V265, P1277, DOI 10.1098/rspb.1998.0430; BROOKE MD, 1988, NATURE, V335, P630; Cherry MI, 2007, J EVOLUTION BIOL, V20, P1218, DOI 10.1111/j.1420-9101.2007.01308.x; Cook LM, 1999, P ROY SOC B-BIOL SCI, V266, P293, DOI 10.1098/rspb.1999.0636; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DECHAVIGNY J, 1938, ALAUDA, V10, P91; Duffy MA, 2009, J ANIM ECOL, V78, P1106, DOI 10.1111/j.1365-2656.2009.01568.x; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Galeotti P, 2004, BIOL J LINN SOC, V82, P237, DOI 10.1111/j.1095-8312.2004.00355.x; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; GOLDSMITH TH, 1984, VISION RES, V24, P1661, DOI 10.1016/0042-6989(84)90324-9; GOTMARK F, 1992, BEHAV ECOL SOCIOBIOL, V30, P245, DOI 10.1007/BF00166709; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAYS H, 1971, WILSON BULL, V83, P425; HOLM S, 1979, SCAND J STAT, V6, P65; HOYT DF, 1979, AUK, V96, P73; JAENIKE J, 1978, Evolutionary Theory, V3, P191; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Kettlewell H.B.D., 1973, EVOLUTION MELANISM; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kim CH, 1995, AUK, V112, P831; LACK DAVID, 1958, IBIS, V100, P145; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; Lee Jin-Won, 2004, Korean Journal of Biological Sciences, V8, P77; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; MacKinnon J, 2000, FIELD GUIDE BIRDS CH; Majerus M, 1998, MELANISM EVOLUTION A; Marchetti K, 2000, ANIM BEHAV, V59, P877, DOI 10.1006/anbe.1999.1388; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin-Vivaldi M, 2002, J AVIAN BIOL, V33, P295, DOI 10.1034/j.1600-048X.2002.330311.x; Miller MR, 2005, J THEOR BIOL, V236, P198, DOI 10.1016/j.jtbi.2005.03.005; MOKSNES A, 1992, ORNIS SCAND, V23, P17, DOI 10.2307/3676422; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; MOKSNES A, 1987, ORNIS SCAND, V18, P168, DOI 10.2307/3676762; MOLLER AP, 1990, OIKOS, V57, P237, DOI 10.2307/3565945; OIEN IJ, 1995, BEHAV ECOL, V6, P166, DOI 10.1093/beheco/6.2.166; Payne RB, 2005, THE CUCKOOS; PETRIE M, 1991, TRENDS ECOL EVOL, V6, P315, DOI 10.1016/0169-5347(91)90038-Y; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Robson C, 2007, HDB BIRDS WORLD, V12, P292; Rothstein SI, 1998, PARASITIC BIRDS THEI; Seddon N, 2010, AUK, V127, P283, DOI 10.1525/auk.2009.09070; Soler JJ, 1999, EVOLUTION, V53, P947, DOI 10.1111/j.1558-5646.1999.tb05388.x; Soler JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-88; SPOTTISWOODE CN, 2010, P NATL ACAD SCI US; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Stokke BG, 2008, BEHAV ECOL, V19, P612, DOI 10.1093/beheco/arn007; Stokke BG, 2007, EVOLUTION, V61, P2212, DOI 10.1111/j.1558-5646.2007.00176.x; Stokke BG, 2007, OIKOS, V116, P913, DOI 10.1111/j.0030-1299.2007.15832.x; Stokke BG, 2002, EVOLUTION, V56, P199; Takasu F, 2003, EVOL ECOL RES, V5, P345; Takasu F, 1998, AM NAT, V151, P193, DOI 10.1086/286111; Takasu Fugo, 2005, Ornithological Science, V4, P1, DOI 10.2326/osj.4.1; Thompson J. N., 2005, INTERSPEC INTERACT; Underwood TJ, 2002, OX ORN SER, V13, P280; Vikan JR, 2009, ETHOLOGY, V115, P840, DOI 10.1111/j.1439-0310.2009.01679.x; VIKAN JR, 2010, EVOL ECOL IN PRESS; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Weidinger K, 2001, BEHAV ECOL SOCIOBIOL, V49, P456, DOI 10.1007/s002650100324; Westmoreland D, 2008, J FIELD ORNITHOL, V79, P263, DOI 10.1111/j.1557-9263.2008.00172.x; Westmoreland D, 2007, J AVIAN BIOL, V38, P682, DOI 10.1111/j.2007.0908-8857.04066.x; Wolinska J, 2009, EVOLUTION, V63, P1893, DOI 10.1111/j.1558-5646.2009.00663.x; Wyllie I., 1981, CUCKOO	76	83	104	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10816	10.1371/journal.pone.0010816	http://dx.doi.org/10.1371/journal.pone.0010816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520815	Green Submitted, Green Published, gold			2022-12-25	WOS:000278221500011
J	Moonen, RMJ; Reyes, I; Cavallaro, G; Gonzalez-Luis, G; Bakker, JA; Villamor, E				Moonen, Rob M. J.; Reyes, Iballa; Cavallaro, Giacomo; Gonzalez-Luis, Gema; Bakker, Jaap A.; Villamor, Eduardo			The T1405N Carbamoyl Phosphate Synthetase Polymorphism Does Not Affect Plasma Arginine Concentrations in Preterm Infants	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BIRTH-WEIGHT INFANTS; ASYMMETRIC DIMETHYLARGININE; NECROTIZING ENTEROCOLITIS; ENDOGENOUS INHIBITOR; ENHANCED METABOLISM; PREMATURE-INFANTS; AMINO-ACIDS; RISK-FACTOR; GLUTAMINE	Background: A C-to-A nucleotide transversion (T1405N) in the gene that encodes carbamoyl-phosphate synthetase 1 (CPS1) has been associated with changes in plasma concentrations of L-arginine in term and near term infants but not in adults. In preterm infants homozygosity for the CPS1 Thr1405 variant (CC genotype) was associated with an increased risk of having necrotizing enterocolitis (NEC). Plasma L-arginine concentrations are decreased in preterm infants with NEC. Aim: To examine the putative association between the CPS1 T1405N polymorphism and plasma arginine concentrations in preterm infants. Methods: Prospective multicenter cohort study. Plasma and DNA samples were collected from 128 preterm infants (, 30 weeks) between 6 and 12 hours after birth. Plasma amino acid and CPS1 T1405N polymorphism analysis were performed. Results: Distribution of genotypes did not differ between the preterm (CC:CA:AA = 55.5%: 33.6%: 10.9%, n = 128) and term infants (CC:CA:AA = 54.2%: 35.4%: 10.4%, n = 96). There was no association between the CPS1 genotype and plasma L-arginine or L-citrulline concentration, or the ornithine to citrulline ratio, which varies inversely with CPS1 activity. Also the levels of asymmetric dimethylarginine, and symmetric dimethylarginine were not significantly different among the three genotypes. Conclusions: The present study in preterm infants did not confirm the earlier reported association between CPS1 genotype and L-arginine levels in term infants.	[Moonen, Rob M. J.; Villamor, Eduardo] Maastricht Univ Med Ctr, Dept Pediat, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands; [Moonen, Rob M. J.] Atrium Med Ctr Parkstad, Dept Pediat, Heerlen, Netherlands; [Reyes, Iballa; Gonzalez-Luis, Gema] Hosp Univ Materno Infantil Canarias, Dept Pediat, Las Palmas Gran Canaria, Spain; [Cavallaro, Giacomo] Univ Milan, Inst Pediat & Neonatol, Fdn IRCCS, Osped Maggiore Policlin Mangiagalli & Regina Elen, Milan, Italy; [Bakker, Jaap A.] Maastricht Univ Med Ctr, Dept Clin Genet, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Atrium Medical Center; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Maastricht University; Maastricht University Medical Centre (MUMC)	Moonen, RMJ (corresponding author), Maastricht Univ Med Ctr, Dept Pediat, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands.	e.villamor@mumc.nl	Bakker, J. A./H-7910-2019; Cavallaro, Giacomo/F-5660-2011	Cavallaro, Giacomo/0000-0002-4921-1437; Bakker, Jaap A./0000-0002-2918-7361	Fundacion de Investigacion Medica Mutua Madrilena; Sociedad Espanola de Neonatologia	Fundacion de Investigacion Medica Mutua Madrilena; Sociedad Espanola de Neonatologia	This work was supported by grants from: 1) Fundacion de Investigacion Medica Mutua Madrilena, URL: http://www.mutua-mad.es/FundMM/jsp/Fhome.jsp, 2) Sociedad Espanola de Neonatologia, URL: http://www.se-neonatal.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HJ, 2002, J PEDIATR-US, V140, P425, DOI 10.1067/mpd.2002.123289; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; Chauhan M, 2008, ARCH DIS CHILD-FETAL, V93, pF162, DOI 10.1136/adc.2007.115824; Chokshi NK, 2008, SEMIN PERINATOL, V32, P92, DOI 10.1053/j.semperi.2008.01.002; Colonna VDG, 2009, MED SCI MONITOR, V15, pRA91; Crenn P, 2000, GASTROENTEROLOGY, V119, P1496, DOI 10.1053/gast.2000.20227; Figueras-Aloy J, 2003, ACTA PAEDIATR, V92, P582; Flynn NE, 1999, J NUTR, V129, P799, DOI 10.1093/jn/129.4.799; Flynn NE, 1997, AM J PHYSIOL-GASTR L, V272, pG474, DOI 10.1152/ajpgi.1997.272.3.G474; Flynn NE, 1997, J NUTR, V127, P732, DOI 10.1093/jn/127.5.732; Gordon PV, 2007, J PERINATOL, V27, P661, DOI 10.1038/sj.jp.7211782; Henderson G, 2009, ARCH DIS CHILD-FETAL, V94, pF124, DOI 10.1136/adc.2007.119933; Kallianpur AR, 2005, BONE MARROW TRANSPL, V35, P1155, DOI 10.1038/sj.bmt.1704943; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Maeda T, 2003, J SOC GYNECOL INVEST, V10, P2, DOI 10.1016/S1071-5576(02)00192-2; Martens-Lobenhoffer J, 2007, J CHROMATOGR B, V851, P30, DOI 10.1016/j.jchromb.2006.07.038; Mittermayer F, 2006, EARLY HUM DEV, V82, P421, DOI 10.1016/j.earlhumdev.2005.08.005; Moonen RMJ, 2007, PEDIATR RES, V62, P188, DOI 10.1203/PDR.0b013e3180a0324e; Nowicki PT, 2006, PEDIATR RES, V59, P500, DOI 10.1203/01.pdr.0000203094.27615.5f; Obladen M, 2009, NEONATOLOGY, V96, P203, DOI 10.1159/000215590; Pearson DL, 2001, NEW ENGL J MED, V344, P1832, DOI 10.1056/NEJM200106143442404; Pierce Christine M, 2004, Pediatr Crit Care Med, V5, P517, DOI 10.1097/01.PCC.0000144715.03515.55; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Reber KM, 2002, CLIN PERINATOL, V29, P23, DOI 10.1016/S0095-5108(03)00063-0; Rees CM, 2008, ARCH DIS CHILD-FETAL, V93, pF395, DOI 10.1136/adc.2007.136994; Richir MC, 2007, BRIT J NUTR, V97, P906, DOI 10.1017/S0007114507669268; Richir MC, 2008, PEDIATR PULM, V43, P1161, DOI 10.1002/ppul.20886; Schnabl KL, 2008, WORLD J GASTROENTERO, V14, P2142, DOI 10.3748/wjg.14.2142; Siroen MPC, 2006, ANNU REV NUTR, V26, P203, DOI 10.1146/annurev.nutr.26.061505.111320; Summar ML, 2004, HYPERTENSION, V43, P186, DOI 10.1161/01.HYP.0000112424.06921.52; Upperman Jeffrey S, 2005, Semin Pediatr Surg, V14, P159, DOI 10.1053/j.sempedsurg.2005.05.004; van den Berg A, 2005, J PEDIATR GASTR NUTR, V41, P66, DOI 10.1097/01.mpg.0000167497.55321.65; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; Vida G, 2007, NEONATOLOGY, V92, P8, DOI 10.1159/000098411; Vida G, 2009, ACTA PAEDIATR, V98, P437, DOI 10.1111/j.1651-2227.2008.01115.x; Waterval WAH, 2009, CLIN CHIM ACTA, V407, P36, DOI 10.1016/j.cca.2009.06.023; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Young C, 2009, PEDIATR RES, V65, p91R, DOI 10.1203/PDR.0b013e31819dba7d; Zamora SA, 1997, J PEDIATR-US, V131, P226, DOI 10.1016/S0022-3476(97)70158-6	42	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10792	10.1371/journal.pone.0010792	http://dx.doi.org/10.1371/journal.pone.0010792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520828	Green Published, Green Submitted, gold			2022-12-25	WOS:000278034800002
J	Norum, M; Tang, E; Chavoshi, T; Schwarz, H; Linke, D; Uv, A; Moussian, B				Norum, Michaela; Tang, Erika; Chavoshi, Tina; Schwarz, Heinz; Linke, Dirk; Uv, Anne; Moussian, Bernard			Trafficking through COPII Stabilises Cell Polarity and Drives Secretion during Drosophila Epidermal Differentiation	PLOS ONE			English	Article							APICAL EXTRACELLULAR-MATRIX; ENDOPLASMIC-RETICULUM; MICROTUBULE ORGANIZATION; CUTICLE DIFFERENTIATION; PLASMA-MEMBRANE; LARVAL CUTICLE; ZYGOTIC LOCI; MELANOGASTER; PROTEINS; CHITIN	Background: The differentiation of an extracellular matrix (ECM) at the apical side of epithelial cells implies massive polarised secretion and membrane trafficking. An epithelial cell is hence engaged in coordinating secretion and cell polarity for a correct and efficient ECM formation. Principal Findings: We are studying the molecular mechanisms that Drosophila tracheal and epidermal cells deploy to form their specific apical ECM during differentiation. In this work we demonstrate that the two genetically identified factors haunted and ghost are essential for polarity maintenance, membrane topology as well as for secretion of the tracheal luminal matrix and the cuticle. We show that they code for the Drosophila COPII vesicle-coating components Sec23 and Sec24, respectively, that organise vesicle transport from the ER to the Golgi apparatus. Conclusion: Taken together, epithelial differentiation during Drosophila embryogenesis is a concerted action of ECM formation, plasma membrane remodelling and maintenance of cell polarity that all three rely mainly, if not absolutely, on the canonical secretory pathway from the ER over the Golgi apparatus to the plasma membrane. Our results indicate that COPII vesicles constitute a central hub for these processes.	[Norum, Michaela; Moussian, Bernard] Univ Tubingen, Interfac Inst Cell Biol, Tubingen, Germany; [Tang, Erika; Chavoshi, Tina; Uv, Anne] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden; [Schwarz, Heinz; Linke, Dirk] Max Planck Inst Dev Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Gothenburg; Max Planck Society	Norum, M (corresponding author), Univ Tubingen, Interfac Inst Cell Biol, Tubingen, Germany.	bernard.moussian@medgen.gu.se	Linke, Dirk/F-9147-2010	Linke, Dirk/0000-0003-3150-6752; Moussian, Bernard/0000-0002-2854-9500	Deutsche Forschungsgemeinschaft (DFG) [MO 1714/2-1]; Gothenburg University; Vetenskapsradet (VR); Wenner Gren Foundation; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gothenburg University; Vetenskapsradet (VR)(Swedish Research Council); Wenner Gren Foundation; Max Planck Society(Max Planck Society)	Funding: MN and BM were supported by the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de, MO 1714/2-1) and the Gothenburg University. ET, TC and AU were supported by the Vetenskapsradet (VR; www.vr.se) and by the Gothenborg University. BM and AU were additionally supported by the Wenner Gren Foundation (www.swgc.org). HS and DL were supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; Ashburner M., 2004, DROSOPHILA LAB HDB; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Denef N, 2008, DEV CELL, V14, P354, DOI 10.1016/j.devcel.2007.12.012; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Forster D, 2010, CURR BIOL, V20, P62, DOI 10.1016/j.cub.2009.11.062; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Giesen K, 2003, MECH DEVELOP, V120, P401, DOI 10.1016/S0925-4773(03)00009-1; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Harris TJC, 2007, DEV CELL, V12, P727, DOI 10.1016/j.devcel.2007.02.011; Hartenstein V., 1985, EMBRYONIC DEV DROSOP; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KONIKOFF C, 2009, FLYEXPRESS PLATFORM; LaFerriere H, 2008, GENETICS, V178, P1895, DOI 10.1534/genetics.107.084582; LAYNE E, 1957, SPECTROPHOTOMETRIC T, P447; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Locke M, 2001, J INSECT PHYSIOL, V47, P495, DOI 10.1016/S0022-1910(00)00123-2; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2005, DEV DYNAM, V233, P1056, DOI 10.1002/dvdy.20389; Moussian B, 2007, MATRIX BIOL, V26, P337, DOI 10.1016/j.matbio.2007.02.001; Moussian B, 2006, ARTHROPOD STRUCT DEV, V35, P137, DOI 10.1016/j.asd.2006.05.003; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833; Roeth JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007634; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Schimmelpfeng K, 2006, MECH DEVELOP, V123, P487, DOI 10.1016/j.mod.2006.03.004; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Schotman H, 2009, J CELL SCI, V122, P2662, DOI 10.1242/jcs.039347; SORROSAL G, 2010, EMBO REP; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Strating JRPM, 2009, BIOL CELL, V101, P207, DOI 10.1042/BC20080075; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Tonning A, 2006, DEVELOPMENT, V133, P331, DOI 10.1242/dev.02206; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yasothornsrikul S, 1997, GENE, V198, P17, DOI 10.1016/S0378-1119(97)00274-6; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zhu MY, 2005, GENETICS, V170, P767, DOI 10.1534/genetics.104.039750	66	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10802	10.1371/journal.pone.0010802	http://dx.doi.org/10.1371/journal.pone.0010802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520821	Green Submitted, gold, Green Published			2022-12-25	WOS:000278034600021
J	Yu, J; Peng, H; Ruan, Q; Fatima, A; Getsios, S; Lavker, RM				Yu, Jia; Peng, Han; Ruan, Qing; Fatima, Anees; Getsios, Spiro; Lavker, Robert M.			MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2	FASEB JOURNAL			English	Article						cell signaling; cell survival; corneal epithelium; epidermis	BREAST-CANCER METASTASIS; CELL-MIGRATION; ERM PROTEINS; ACTIN DYNAMICS; TYROSINE PHOSPHORYLATION; 5'-INOSITOL PHOSPHATASE; MESENCHYMAL TRANSITION; DOWN-REGULATION; HUMAN PROSTATE; MAMMALIAN EYE	microRNA-205 (miR-205) and miR-184 coordinately regulate the lipid phosphatase SHIP2 for Akt survival signaling in keratinocytes. As the PI3K-Akt pathway has also been implicated in regulating the actin cytoskeleton and cell motility, we investigated the role that these 2 miRNAs play in keratinocyte migration. We used antagomirs (antago) to reduce the levels of miR-205 and miR-184 in primary human epidermal keratinocytes (HEKs) and corneal epithelial keratinocytes (HCEKs) as well as direct SHIP2 silencing using siRNA oligos. Treatment of HEKs and HCEKs with antago-205 increased SHIP2 levels and impaired the ability of these cells to seal linear scratch wounds compared with untreated or irrelevant-antago treatments. In contrast, AKT signaling was enhanced and wounds sealed faster in HCEKs where miR-184 was suppressed, enabling miR-205 to inhibit SHIP2. Similar increases in migration were observed following direct SHIP2 silencing in HEKs. Furthermore, down-regulation of miR-205 resulted in an increase in Rho-ROCKI activity, phosphorylation of the actin severing protein cofilin, and a corresponding diminution of filamentous actin. The connection among miR-205, RhoA-ROCKI-cofilin inactivation, and the actin cytoskeleton represents a novel post-translational mechanism for the regulation of normal human keratinocyte migration.-Yu, J., Peng, H., Ruan, Q., Fatima, A., Getsios, S., Lavker, R. M. MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2. FASEB J. 24, 3950-3959 (2010). www.fasebj.org	[Yu, Jia; Peng, Han; Ruan, Qing; Fatima, Anees; Getsios, Spiro; Lavker, Robert M.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Lavker, RM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 303 E Chicago Ave,Ward 9-124, Chicago, IL 60611 USA.	r-lavker@northwestern.edu	Peng, Han/I-1922-2012	Peng, Han/0000-0002-1105-8254; fatima, anees/0000-0003-3329-2284; Yu, Jia/0000-0003-3499-5133	NIH [EY017536, EY019463]; U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30AR057216]; Dermatology Foundation; NATIONAL EYE INSTITUTE [R01EY019463, R21EY017536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatology Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank members of the laboratory of Kathleen Green for input and advice, in particular Adi Dubash for assistance in determining the status of activated Rho. The authors thank Nihal Kaplan for critical reading of the manuscript and helpful discussions. Primary epidermal keratinocyte cultures were obtained from the Northwestern University Skin Disease Research Center Keratinocyte Core Facility with support from the U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant P30AR057216. This research is supported by NIH grants EY017536 and EY019463 (R.M.L.) and a Dermatology Foundation Career Development Award (S.G.).	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Darmellah A, 2009, CARDIOVASC RES, V81, P294, DOI 10.1093/cvr/cvn320; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Atsuko H, 2007, J MUSCLE RES CELL M, V28, P183, DOI 10.1007/s10974-007-9117-6; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lampugnani MG, 1999, METH MOL B, V96, P177; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lavker Robert M., 2009, Human Genomics, V3, P332; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Prasad N, 2002, J CELL SCI, V115, P3807, DOI 10.1242/jcs.00070; Prasad NK, 2009, INT J ONCOL, V34, P97, DOI 10.3892/ijo_00000133; Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ryan D, 2006, MOL VIS, V12, P1175; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sharrard RM, 2007, CELL SIGNAL, V19, P129, DOI 10.1016/j.cellsig.2006.05.029; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Song HS, 2009, BIOCHEM BIOPH RES CO, V388, P400, DOI 10.1016/j.bbrc.2009.08.020; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Trinkaus-Randall V, 2000, J CELL PHYSIOL, V184, P385, DOI 10.1002/1097-4652(200009)184:3<385::AID-JCP14>3.0.CO;2-7; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Yurko MA, 2001, J CELL PHYSIOL, V188, P24, DOI 10.1002/jcp.1093	69	119	131	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3950	3959		10.1096/fj.10-157404	http://dx.doi.org/10.1096/fj.10-157404			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20530248	Green Published			2022-12-25	WOS:000285005900032
J	Amadi, ST; Koteiche, HA; Mishra, S; Mchaourab, HS				Amadi, Sepan T.; Koteiche, Hanane A.; Mishra, Sanjay; Mchaourab, Hassane S.			Structure, Dynamics, and Substrate-induced Conformational Changes of the Multidrug Transporter EmrE in Liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMMON BINDING-SITE; LABELED SIDE-CHAINS; ESCHERICHIA-COLI; PROTEIN-STRUCTURE; T4 LYSOZYME; TOPOLOGY; DOMAIN; MODEL; MSBA; MOTION	EmrE, a member of the small multidrug transporters superfamily, extrudes positively charged hydrophobic compounds out of Escherichia coli cytoplasm in exchange for inward movement of protons down their electrochemical gradient. Although its transport mechanism has been thoroughly characterized, the structural basis of energy coupling and the conformational cycle mediating transport have yet to be elucidated. In this study, EmrE structure in liposomes and the substrate-induced conformational changes were investigated by systematic spin labeling and EPR analysis. Spin label mobilities and accessibilities describe a highly dynamic ligand-free (apo) conformation. Dipolar coupling between spin labels across the dimer reveals at least two spin label populations arising from different packing interfaces of the EmrE dimer. One population is consistent with antiparallel arrangement of the monomers, although the EPR parameters suggest deviations from the crystal structure of substrate-bound EmrE. Resolving these discrepancies requires an unusual disposition of TM3 relative to the membrane-water interface and a kink in its backbone that enables bending of its C-terminal part. Binding of the substrate tetraphenylphosphonium changes the environment of spin labels and their proximity in three transmembrane helices. The underlying conformational transition involves repacking of TM1, tilting of TM2, and changes in the backbone configurations of TM3 and the adjacent loop connecting it to TM4. A dynamic apo conformation is necessary for the polyspecificity of EmrE allowing the binding of structurally diverse substrates. The flexibility of TM3 may play a critical role in movement of substrates across the membrane.	[Amadi, Sepan T.; Koteiche, Hanane A.; Mishra, Sanjay; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Mchaourab, HS (corresponding author), 2215 Garland Ave,741 Light Hall, Nashville, TN 37232 USA.	Hassane.mchaourab@vanderbilt.edu	Mishra, Sanjay/ABF-9252-2021	Mishra, Sanjay/0000-0002-7775-9600	NIGMS, National Institutes of Health [GM077659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077659 from the NIGMS.	Alexander N, 2008, STRUCTURE, V16, P181, DOI 10.1016/j.str.2007.11.015; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Chung Y J, 2001, Curr Opin Drug Discov Devel, V4, P237; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Edwards RA, 1998, BIOCHEM CELL BIOL, V76, P791, DOI 10.1139/bcb-76-5-791; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Gottschalk KE, 2004, BIOPHYS J, V86, P3335, DOI 10.1529/biophysj.103.034546; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Koteiche HA, 2002, FEBS LETT, V519, P16, DOI 10.1016/S0014-5793(02)02688-1; Mchaourab HS, 2008, BIOCHEMISTRY-US, V47, P7980, DOI 10.1021/bi800628d; Mchaourab HS, 1999, BIOCHEMISTRY-US, V38, P2947, DOI 10.1021/bi9826310; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rotem D, 2006, J BIOL CHEM, V281, P18715, DOI 10.1074/jbc.M602088200; Schuldiner S, 1997, J EXP BIOL, V200, P335; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schuldiner S, 2007, TRENDS BIOCHEM SCI, V32, P252, DOI 10.1016/j.tibs.2007.04.002; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Sharoni M, 2005, J BIOL CHEM, V280, P32849, DOI 10.1074/jbc.M504910200; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; Tate CG, 2001, EMBO J, V20, P77, DOI 10.1093/emboj/20.1.77; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	42	42	43	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26710	26718		10.1074/jbc.M110.132621	http://dx.doi.org/10.1074/jbc.M110.132621			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551331	Green Published, hybrid			2022-12-25	WOS:000280921000085
J	He, Y; Wortmann, A; Burke, LJ; Reid, JC; Adams, MN; Abdul-Jabbar, I; Quigley, JP; Leduc, R; Kirchhofer, D; Hooper, JD				He, Yaowu; Wortmann, Andreas; Burke, Les J.; Reid, Janet C.; Adams, Mark N.; Abdul-Jabbar, Ibtissam; Quigley, James P.; Leduc, Richard; Kirchhofer, Daniel; Hooper, John D.			Proteolysis-induced N-terminal Ectodomain Shedding of the Integral Membrane Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Is Accompanied by Tyrosine Phosphorylation of Its C-terminal Domain and Recruitment of Src and PKC delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; PROSTATE-CANCER; TUMOR-CELLS; SUBSTRATE TRASK; MATRIPTASE; EXPRESSION; HEPSIN; IDENTIFICATION; GROWTH; INHIBITORS	CUB-domain-containing protein 1 (CDCP1) is an integral membrane glycoprotein with potential as a marker and therapeutic target for a number of cancers. Here we examine mechanisms regulating cellular processing of CDCP1. By analyzing cell lines exclusively passaged non-enzymatically and through use of a panel of protease inhibitors, we demonstrate that full-length 135 kDa CDCP1 is post-translationally processed in a range of cell lines by a mechanism involving serine protease activity, generating a C-terminal 70-kDa fragment. Immunopurification and N-terminal sequencing of this cell-retained fragment and detailed mutagenesis, show that proteolytic processing of CDCP1 occurs at two sites, Arg-368 and Lys-369. We show that the serine protease matriptase is an efficient, but not essential, cellular processor of CDCP1 at Arg-368. Importantly, we also demonstrate that proteolysis induces tyrosine phosphorylation of 70-kDa CDCP1 and recruitment of Src and PKC delta to this fragment. In addition, Western blot and mass spectroscopy analyses show that an N-terminal 65-kDa CDCP1 ectodomain is shed intact from the cell surface. These data provide new insights into mechanisms regulating CDCP1 and suggest that the biological role of this protein and, potentially, its function in cancer, may be mediated by both 70-kDa cell retained and 65-kDa shed fragments, as well as the full-length 135-kDa protein.	[He, Yaowu; Wortmann, Andreas; Burke, Les J.; Reid, Janet C.; Adams, Mark N.; Hooper, John D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Abdul-Jabbar, Ibtissam] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [Quigley, James P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Leduc, Richard] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Kirchhofer, Daniel] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Queensland University of Technology (QUT); University of Queensland; Scripps Research Institute; University of Sherbrooke; Roche Holding; Genentech	Hooper, JD (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.	jhooper@mmri.mater.org.au	Hooper, John/C-1481-2016; Reid, Janet/AAI-6631-2021; Hooper, John/B-4153-2011; Wortmann, Dr Andreas/D-2074-2012; Adams, Mark/AAE-1209-2021	Hooper, John/0000-0003-1054-8486; Reid, Janet/0000-0002-4512-3026; Adams, Mark/0000-0003-1906-5018; HE, Yaowu/0000-0002-7828-263X; Burke, Lez/0000-0002-2932-6843	National Health and Medical Research Council of Australia [339732]; Canadian Institutes of Health Research (CIHR); Cancer & Bowel Research Trust; Australian Government National Collaborative Research Infrastructure Strategy (NCRIS); NATIONAL CANCER INSTITUTE [R01CA129484, R01CA105412] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer & Bowel Research Trust; Australian Government National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council of Australia (Fellowship 339732 to J.D.H.), by a Canadian Institutes of Health Research (CIHR) grant (to R.L.), and by funding supplied by the Cancer & Bowel Research Trust (scholarship to A.W.).; We thank Dr. Georgina Giannikopoulos and Dr. Bernie McInerney for performing N-terminal sequencing, which was facilitated by access to the Australian Proteome Analysis Facility which is supported under the Australian Government National Collaborative Research Infrastructure Strategy (NCRIS). We also thank Carina Walpole and Dr. Sally-Anne Stephenson (Queensland University of Technology) for providing breast cancer cell lines, and James Broadbent for assistance with mass spectroscopy analysis.	Ahmed S, 2006, FEBS J, V273, P615, DOI 10.1111/j.1742-4658.2005.05094.x; Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; Coote K, 2009, J PHARMACOL EXP THER, V329, P764, DOI 10.1124/jpet.108.148155; Cowan FM, 2002, CELL BIOL TOXICOL, V18, P175, DOI 10.1023/A:1015511720481; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Desilets A, 2008, J BIOL CHEM, V283, P10535, DOI 10.1074/jbc.M707012200; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; HULTSCH T, 1988, AGENTS ACTIONS, V23, P198, DOI 10.1007/BF02142539; Ikeda JI, 2006, J PATHOL, V210, P75, DOI 10.1002/path.2026; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; KAZAMA Y, 1995, J BIOL CHEM, V270, P66, DOI 10.1074/jbc.270.1.66; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Perry SE, 2007, FEBS LETT, V581, P1137, DOI 10.1016/j.febslet.2007.02.025; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; SMITH RA, 1988, BIOCHEMISTRY-US, V27, P6568, DOI 10.1021/bi00417a056; Spassov DS, 2009, AM J PATHOL, V174, P1756, DOI 10.2353/ajpath.2009.080890; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; TAKAHASHI K, 1976, J BIOCHEM-TOKYO, V80, P497, DOI 10.1093/oxfordjournals.jbchem.a131304; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Umezawa H, 1976, Methods Enzymol, V45, P678; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Xuan JA, 2006, CANCER RES, V66, P3611, DOI 10.1158/0008-5472.CAN-05-2983; Zhukov A, 1997, BBA-PROTEIN STRUCT M, V1337, P85, DOI 10.1016/S0167-4838(96)00152-5	50	54	54	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26162	26173		10.1074/jbc.M109.096453	http://dx.doi.org/10.1074/jbc.M109.096453			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551327	Green Published, hybrid			2022-12-25	WOS:000280921000033
J	Nagy, S; Rock, RS				Nagy, Stanislav; Rock, Ronald S.			Structured Post-IQ Domain Governs Selectivity of Myosin X for Fascin-Actin Bundles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE STEP-SIZE; PROCESSIVE MYOSIN; SINGLE-MOLECULE; OPTICAL TRAPS; LEVER-ARM; MOTOR; VI; BINDING; MODEL; NUCLEOTIDE	Without guidance cues, cytoskeletal motors would traffic components to the wrong destination with disastrous consequences for the cell. Recently, we identified a motor protein, myosin X, that identifies bundled actin filaments for transport. These bundles direct myosin X to a unique destination, the tips of cellular filopodia. Because the structural and kinetic features that drive bundle selection are unknown, we employed a domain-swapping approach with the nonselective myosin V to identify the selectivity module of myosin X. We found a surprising role of the myosin X tail region (post-IQ) in supporting long runs on bundles. Moreover, the myosin X head is adapted for initiating processive runs on bundles. We found that the tail is structured and biases the orientation of the two myosin X heads because a targeted insertion that introduces flexibility in the tail abolishes selectivity. Together, these results suggest how myosin motors may manage to read cellular addresses.	[Nagy, Stanislav; Rock, Ronald S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Rock, RS (corresponding author), 929 E 57th St,GCIS W240, Chicago, IL 60637 USA.	rrock@uchicago.edu	Nagy, Stanislav/T-5247-2017; Nagy, Stanislav/GXW-2342-2022		National Institutes of Health [GM078450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM078450 (to R. S. R.).	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Huang J, 2009, BIOCHEMISTRY-US, V48, P11834, DOI 10.1021/bi901756n; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mehta AD, 1998, METHOD ENZYMOL, V298, P436, DOI 10.1016/S0076-6879(98)98039-9; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; RICCA BL, 2010, BIOPHYS J IN PRESS; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Robblee JP, 2004, J BIOL CHEM, V279, P38608, DOI 10.1074/jbc.M403504200; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Vilfan A, 2005, BIOPHYS J, V88, P3792, DOI 10.1529/biophysj.104.046763; Visscher K, 1996, IEEE J SEL TOP QUANT, V2, P1066, DOI 10.1109/2944.577338; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Wuhr M, 2008, CURR BIOL, V18, pR912, DOI 10.1016/j.cub.2008.08.043; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	37	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26608	26617		10.1074/jbc.M110.104661	http://dx.doi.org/10.1074/jbc.M110.104661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538587	Green Published, hybrid			2022-12-25	WOS:000280921000076
J	Zhu, Y; Kim, YM; Li, SB; Zhuang, YA				Zhu, Yi; Kim, Young-Mi; Li, Shibo; Zhuang, Yuan			Generation and Analysis of Partially Haploid Cells with Cre-mediated Chromosome Deletion in the Lymphoid System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MITOTIC RECOMBINATION; MOUSE BONE-MARROW; MOSAIC ANALYSIS; DOUBLE MARKERS; MICE; E2A; REARRANGEMENTS; CONSORTIUM; TRANSPOSON; PROTEINS	The fast accumulation of mutant mouse strains in recent years has provided an invaluable resource for phenotype-based genetic screens. However, study of lymphoid phenotypes can be obscured or impractical if homozygous mutations cause early embryonic defects. To aid phenotype screening of germ line mutations in the lymphoid system, we developed a method to induce loss of heterozygosity (LOH) in developing lymphocytes through chromosome deletion. Chromosome deletion was triggered by Cre/loxP-mediated inverse sister chromatid recombination in the G(2)/M phase of the cell cycle, leading to the generation of daughter cells missing part of or the entire recombinant chromosome. We show that the resulting cells were viable and capable of additional rounds of cell division, thus providing raw materials for subsequent phenotypic assessment. We used the recombination system to induce LOH at the E2A locus in developing B cells. A significant loss of pro-B and pre-B cells was observed when the wild-type allele was removed by chromosome deletion from the E2A heterozygous mice, a result consistent with the required role for E2A in B cell development. We also demonstrated the effectiveness of Cre-mediated chromosome deletion in the LOH assay for HEB function in T cell development. Thus, the Cre-mediated chromosome deletion provides a new and effective method for genome-wide assessment of germ line mutations in the lymphoid system.	[Zhu, Yi; Zhuang, Yuan] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Zhu, Yi; Zhuang, Yuan] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Kim, Young-Mi; Li, Shibo] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73014 USA	Duke University; Fudan University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhuang, YA (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	yzhuang@duke.edu		zhuang, yuan/0000-0002-2964-3654	National Basic Research Program of China [2006CB806700]; National Hi-tech Research and Development Program of China [2007AA022101]; Stewart Trust; Duke University Medical Center Bridge; National Institutes of Health [AG034457, CA72433, GM059638]; NATIONAL CANCER INSTITUTE [R01CA072433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034457] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China); Stewart Trust; Duke University Medical Center Bridge; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Basic Research Program of China Grant 2006CB806700 and National Hi-tech Research and Development Program of China Grant 2007AA022101 (to Fudan University) and by the Stewart Trust Fund, the Duke University Medical Center Bridge Fund, and National Institutes of Health Grants AG034457, CA72433, and GM059638 (to Y. Z.).	BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bult CJ, 2010, NUCLEIC ACIDS RES, V38, pD586, DOI 10.1093/nar/gkp880; Collins FS, 2007, CELL, V129, P235, DOI 10.1016/j.cell.2007.04.007; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; CUMANO A, 1990, EUR J IMMUNOL, V20, P2183, DOI 10.1002/eji.1830201006; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Gregoire D, 2008, P NATL ACAD SCI USA, V105, P14492, DOI 10.1073/pnas.0807484105; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lazorchak A, 2005, TRENDS IMMUNOL, V26, P334, DOI 10.1016/j.it.2005.03.011; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Otsuji T, 2008, J MOL BIOL, V378, P328, DOI 10.1016/j.jmb.2008.01.065; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; Sun L, 2008, P NATL ACAD SCI USA, V105, P4237, DOI 10.1073/pnas.0800798105; Sun LV, 2008, NUCLEIC ACIDS RES, V36, pD729, DOI 10.1093/nar/gkm790; Tada M, 2009, CHROMOSOME RES, V17, P443, DOI 10.1007/s10577-009-9035-0; Wang W, 2007, P NATL ACAD SCI USA, V104, P4501, DOI 10.1073/pnas.0607953104; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	31	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26005	26012		10.1074/jbc.M110.139196	http://dx.doi.org/10.1074/jbc.M110.139196			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551312	Green Published, hybrid			2022-12-25	WOS:000280921000015
J	Lachmann, P; Huang, YF; Reimann, J; Flock, U; Adelroth, P				Lachmann, Peter; Huang, Yafei; Reimann, Joachim; Flock, Ulrika; Adelroth, Pia			Substrate Control of Internal Electron Transfer in Bacterial Nitric-oxide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; HEME-COPPER OXIDASE; PARACOCCUS-DENITRIFICANS; PROTON-TRANSFER; ACTIVE-SITE; SPECTROSCOPIC CHARACTERIZATION; DINUCLEAR CENTER; CARBON-MONOXIDE; NO REDUCTION; PATHWAY	Nitric-oxide reductase (NOR) from Paracoccus denitrificans catalyzes the reduction of nitric oxide (NO) to nitrous oxide (N2O) (2NO + 2H(+) + 2e(-) -> N2O + H2O) by a poorly understood mechanism. NOR contains two low spin hemes c and b, one high spin heme b(3), and a non-heme iron Fe-B. Here, we have studied the reaction between fully reduced NOR and NO using the "flow-flash" technique. Fully (four-electron) reduced NOR is capable of two turnovers with NO. Initial binding of NO to reduced heme b(3) occurs with a time constant of similar to 1 mu s at 1.5 mM NO, in agreement with earlier studies. This reaction is [NO]-dependent, ruling out an obligatory binding of NO to FeB before ligation to heme b(3). Oxidation of hemes b and c occurs in a biphasic reaction with rate constants of 50 s(-1) and 3 s(-1) at 1.5 mM NO and pH 7.5. Interestingly, this oxidation is accelerated as [NO] is lowered; the rate constants are 120 s(-1) and 12 s(-1) at 75 mu M NO. Protons are taken up from solution concomitantly with oxidation of the low spin hemes, leading to an acceleration at low pH. This effect is, however, counteracted by a larger degree of substrate inhibition at low pH. Our data thus show that substrate inhibition in NOR, previously observed during multiple turnovers, already occurs during a single oxidative cycle. Thus, NO must bind to its inhibitory site before electrons redistribute to the active site. The further implications of our data for the mechanism of NO reduction by NOR are discussed.	[Lachmann, Peter; Huang, Yafei; Reimann, Joachim; Flock, Ulrika; Adelroth, Pia] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Adelroth, P (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	piaa@dbb.su.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Swedish Research Council.	ARMOR JN, 1974, J CHEM ENG DATA, V19, P82, DOI 10.1021/je60060a013; BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Blomberg LM, 2006, BBA-BIOENERGETICS, V1757, P240, DOI 10.1016/j.bbabio.2006.04.008; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Brzezinski P, 1998, J BIOENERG BIOMEMBR, V30, P99, DOI 10.1023/A:1020567729941; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Field SJ, 2002, J BIOL CHEM, V277, P20146, DOI 10.1074/jbc.M112202200; Flock U, 2005, BIOCHEMISTRY-US, V44, P10711, DOI 10.1021/bi050524h; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Flock U, 2009, J INORG BIOCHEM, V103, P845, DOI 10.1016/j.jinorgbio.2009.02.008; GIBSON QH, 1963, BIOCHEM J, V86, P541, DOI 10.1042/bj0860541; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Giuffre A, 1999, P NATL ACAD SCI USA, V96, P14718, DOI 10.1073/pnas.96.26.14718; Gronberg KLC, 1999, BIOCHEMISTRY-US, V38, P13780, DOI 10.1021/bi9916426; Hendriks J, 1998, BIOCHEMISTRY-US, V37, P13102, DOI 10.1021/bi980943x; Hendriks JHM, 2001, BIOCHEMISTRY-US, V40, P13361, DOI 10.1021/bi011428t; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Huang YF, 2008, P NATL ACAD SCI USA, V105, P20257, DOI 10.1073/pnas.0805429106; Kumita H, 2004, J BIOL CHEM, V279, P55247, DOI 10.1074/jbc.M409996200; Moenne-Loccoz P, 2000, J AM CHEM SOC, V122, P9344, DOI 10.1021/ja0016295; Moenne-Loccoz P, 1998, J AM CHEM SOC, V120, P5147, DOI 10.1021/ja973671e; Moenne-Loccoz P, 2007, NAT PROD REP, V24, P610, DOI 10.1039/B604194A; Namslauer A, 2002, BIOCHEMISTRY-US, V41, P10369, DOI 10.1021/bi025976y; Pinakoulaki E, 2002, J BIOL CHEM, V277, P23407, DOI 10.1074/jbc.M201913200; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; Sakurai T, 2005, BIOCHEM BIOPH RES CO, V333, P483, DOI 10.1016/j.bbrc.2005.05.149; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; Stubauer G, 1998, BIOCHEM BIOPH RES CO, V245, P459, DOI 10.1006/bbrc.1998.8457; Thorndycroft FH, 2007, BIOCHEM J, V401, P111, DOI 10.1042/BJ20060856; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Watmough NJ, 2009, BIOCHEM SOC T, V37, P392, DOI 10.1042/BST0370392; Watmough NJ, 1998, J BIOENERG BIOMEMBR, V30, P55, DOI 10.1023/A:1020507511285; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	34	30	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25531	25537		10.1074/jbc.M110.123984	http://dx.doi.org/10.1074/jbc.M110.123984			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547487	Green Published, hybrid			2022-12-25	WOS:000280682400047
J	Marcucci, H; Paoletti, L; Jackowski, S; Banchio, C				Marcucci, Hebe; Paoletti, Luciana; Jackowski, Suzanne; Banchio, Claudia			Phosphatidylcholine Biosynthesis during Neuronal Differentiation and Its Role in Cell Fate Determination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; RAT SYMPATHETIC NEURONS; NEURITE OUTGROWTH; RETINOIC ACID; PHOSPHOLIPID BIOSYNTHESIS; CHOLINE KINASE; MEMBRANE EXPANSION; ARACHIDONIC-ACID; MAMMALIAN-CELLS; PC12 CELLS	Neuronal differentiation is characterized by neuritogenesis and neurite outgrowth, processes that are dependent on membrane biosynthesis. Thus, the production of phosphatidylcholine (PtdCho), the major membrane phospholipid, should be stimulated during neuronal differentiation. We demonstrate that during retinoic acid (RA)-induced differentiation of Neuro-2a cells, PtdCho synthesis was promoted by an ordered and sequential activation of choline kinase alpha(CK alpha) and choline cytidylyltransferase alpha(CCT alpha). Early after RA stimulation, the increase in PtdCho synthesis is mainly governed by the biochemical activation of CCT alpha. Later, the transcription of CK alpha and CCT alpha-encoding genes was induced. Both PtdCho biosynthesis and neuronal differentiation are dependent on ERK activation. A novel mechanism is proposed by which PtdCho biosynthesis is coordinated during neuronal differentiation. Enforced expression of either CK alpha or CCT alpha increased the rate of synthesis and the amount of PtdCho, and these cells initiated differentiation without RA stimulation, as evidenced by cell morphology and the expression of genes associated with neuritogenesis. The differentiation resulting from enforced expression of CCT alpha or CK alpha was dependent on persistent ERK activation. These results indicate that elevated PtdCho synthesis could mimic the RA signals and thus determine neuronal cell fate. Moreover, they could explain the key role that PtdCho plays during neuronal regeneration.	[Marcucci, Hebe; Paoletti, Luciana; Banchio, Claudia] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario,Dept Ciencias Bio, RA-2000 Rosario, Santa Fe, Argentina; [Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; St Jude Children's Research Hospital	Banchio, C (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario,Dept Ciencias Bio, Suipacha 531, RA-2000 Rosario, Santa Fe, Argentina.	banchio@ibr.gov.ar	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina; Agencia de Promocion Cientifica y Tecnologica (ANPCyT), Argentina [PICT 01-38027]; American Lebanese and Syrian Associated Charity; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT); American Lebanese and Syrian Associated Charity; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina, Agencia de Promocion Cientifica y Tecnologica (ANPCyT), Argentina, Grant PICT 01-38027 (to C. B.), and by the American Lebanese and Syrian Associated Charity (to S. J.).	Adibhatla RM, 2006, AAPS J, V8, pE314; Adibhatla RM, 2006, J BIOL CHEM, V281, P6718, DOI 10.1074/jbc.M512112200; Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Anderson DH, 2006, PROG LIPID RES, V45, P102, DOI 10.1016/j.plipres.2005.12.003; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Aoyama C, 2007, BBA-MOL CELL BIOL L, V1771, P1148, DOI 10.1016/j.bbalip.2007.07.003; Araki W, 1997, P NATL ACAD SCI USA, V94, P11946, DOI 10.1073/pnas.94.22.11946; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Bakovic M, 1999, BBA-MOL CELL BIOL L, V1438, P147, DOI 10.1016/S1388-1981(99)00042-6; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Cansev M, 2008, ALZHEIMERS DEMENT, V4, pS153, DOI 10.1016/j.jalz.2007.10.005; Carter JM, 2003, J BIOL CHEM, V278, P44988, DOI 10.1074/jbc.M307336200; Carter JM, 2008, J BIOL CHEM, V283, P202, DOI 10.1074/jbc.M706531200; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; DECHAVES EP, 1995, J CELL BIOL, V128, P913, DOI 10.1083/jcb.128.5.913; DEHAUT F, 1993, NEUROSCI LETT, V161, P133, DOI 10.1016/0304-3940(93)90277-R; EASTER SS, 1993, J NEUROSCI, V13, P285; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Ikemoto A, 1999, ARCH BIOCHEM BIOPHYS, V364, P67, DOI 10.1006/abbi.1999.1110; INFANTE JP, 1978, BIOCHEM J, V176, P631, DOI 10.1042/bj1760631; INFANTE JP, 1977, BIOCHEM J, V167, P847, DOI 10.1042/bj1670847; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jansen SM, 2001, J BIOL CHEM, V276, P18722, DOI 10.1074/jbc.M101817200; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Katsetos CD, 1998, ANAT RECORD, V250, P351; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Marcucci H, 2008, BBA-MOL CELL BIOL L, V1781, P254, DOI 10.1016/j.bbalip.2008.03.006; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; OKUDA S, 1994, NEUROSCIENCE, V63, P691, DOI 10.1016/0306-4522(94)90515-0; Pitson SM, 2009, NEUROSIGNALS, V17, P242, DOI 10.1159/000231891; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Sato C, 2002, J BIOL CHEM, V277, P45299, DOI 10.1074/jbc.M206046200; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SHEA TB, 1985, DEV BRAIN RES, V21, P307, DOI 10.1016/0165-3806(85)90220-2; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Vance DE, 1998, CURR OPIN LIPIDOL, V9, P125, DOI 10.1097/00041433-199804000-00008; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; VANCE JE, 1994, J NEUROCHEM, V62, P329; VANCE JE, 1995, NEUROBIOL AGING, V16, P493, DOI 10.1016/0197-4580(94)00180-9; VANCE JE, 1991, J CELL BIOL, V115, P1061, DOI 10.1083/jcb.115.4.1061; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; WILLIAM WCC, 2003, LIPIDS ANAL; WILLIAMS EJ, 1994, J NEUROCHEM, V62, P1231; YALCIN A, 2010, J ONCOGENE, V29, P139; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035	58	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25382	25393		10.1074/jbc.M110.139477	http://dx.doi.org/10.1074/jbc.M110.139477			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20525991	hybrid, Green Published			2022-12-25	WOS:000280682400031
J	Choi, EJ; Kim, DH; Kim, JG; Kim, DY; Kim, JD; Seol, OJ; Jeong, CS; Park, JW; Choi, MY; Kang, SG; Costa, ME; Ojeda, SR; Lee, BJ				Choi, Eun Jung; Kim, Dong Hee; Kim, Jae Geun; Kim, Dong Yeol; Kim, Jung Dae; Seol, Ok Ju; Jeong, Choon Soo; Park, Jeong Woo; Choi, Min Young; Kang, Sung Goo; Costa, Maria E.; Ojeda, Sergio R.; Lee, Byung Ju			Estrogen-dependent Transcription of the NEL-like 2 (NELL2) Gene and Its Role in Protection from Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEXUALLY DIMORPHIC NUCLEUS; FACTOR RECEPTOR GENE; EGF-LIKE REPEATS; PROMOTER REGION; PREOPTIC AREA; RAT-BRAIN; IN-VITRO; MEDIATED NEUROPROTECTION; RESPONSE ELEMENTS; MAMMALIAN-CELLS	NELL2 (neural tissue-specific epidermal growth factor-like repeat domain-containing protein) is a secreted glycoprotein that is predominantly expressed in neural tissues. We reported previously that NELL2 mRNA abundance in brain is increased by estrogen (E2) treatment and that NELL2 is involved in the E2-dependent organization of a sexually dimorphic nucleus in the preoptic area. In this study we cloned the mouse NELL2 promoter and found it to contain two half-E2 response elements. Electrophoretic mobility shift assays and promoter assays showed that E2 and its receptors (ER alpha and ER beta) stimulated NELL2 transcription by binding to the two half-E2 response elements. Hippocampal neuroprogenitor HiB5 cells expressing recombinant NELL2 showed increased cell survival under cell death-inducing conditions. Blockade of endogenous synthesis of NELL2 in HiB5 cells abolished the cell survival effect of E2 and resulted in a decrease in phosphorylation of extracellular signal-regulated kinase 1 and 2 (ERK1/2). These data suggest that the NELL2 gene is trans-activated by E2 and contributes to mediating the survival promoting effects of E2 via intracellular signaling pathway of ERK.	[Park, Jeong Woo; Lee, Byung Ju] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Choi, Min Young] Gyeongsang Natl Univ, Dept Life Sci & Appl Life Sci, Jinju 660701, South Korea; [Kang, Sung Goo] Inje Univ, Sch Biotechnol & Biomed Sci, Kimhae 621749, South Korea; [Costa, Maria E.; Ojeda, Sergio R.] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA	University of Ulsan; Gyeongsang National University; Inje University; Oregon Health & Science University; Oregon National Primate Research Center	Lee, BJ (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea.	bjlee@ulsan.ac.kr		Kim, Jung Dae/0000-0002-4750-6856	National Institutes of Health [HD25123]; Eunice Kennedy Shriver NICHD [U54 HD18185]; Brain Research Center of 21st Century Frontier Research Program [2009K001268];  [RR000163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD018185, R01HD025123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000163, P51RR000163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Brain Research Center of 21st Century Frontier Research Program; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant HD25123, by the Eunice Kennedy Shriver NICHD through cooperative agreement U54 HD18185 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research, and by Grant RR000163 for the operation of the Oregon National Primate Research Center 9to M. E. C. and S. R. O.). This work was also supported by the Brain Research Center of 21st Century Frontier Research Program Research Grant 2009K001268.	Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARAI Y, 1994, HORM BEHAV, V28, P313, DOI 10.1006/hbeh.1994.1027; BEHL C, 1992, BIOCHEM BIOPH RES CO, V186, P944, DOI 10.1016/0006-291X(92)90837-B; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; BISHOP J, 1994, MOL CELL NEUROSCI, V5, P303, DOI 10.1006/mcne.1994.1036; BROOKS AR, 1991, J BIOL CHEM, V266, P7848; Choi EJ, 2001, MOL BRAIN RES, V97, P115, DOI 10.1016/S0169-328X(01)00302-3; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; Ediger TR, 2002, MOL ENDOCRINOL, V16, P1828, DOI 10.1210/me.2001-0290; Fitzpatrick JL, 2002, J NEUROCHEM, V82, P674, DOI 10.1046/j.1471-4159.2002.01000.x; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gorski R A, 1985, J Anim Sci, V61 Suppl 3, P38; Green PS, 1997, J NEUROSCI, V17, P511; Ha CM, 2008, NEUROENDOCRINOLOGY, V88, P199, DOI 10.1159/000139579; HOFFMAN EK, 1987, MOL CELL BIOL, V7, P2592, DOI 10.1128/MCB.7.7.2592; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jeong JK, 2008, MOL CELLS, V26, P186; Jeong JK, 2008, J NEUROCHEM, V106, P1604, DOI 10.1111/j.1471-4159.2008.05505.x; Kim H, 2002, J NEUROCHEM, V83, P1389, DOI 10.1046/j.1471-4159.2002.01245.x; Kim MS, 2002, J BIOL CHEM, V277, P36863, DOI 10.1074/jbc.M206443200; KLINGE CM, 1992, CANCER RES, V52, P1073; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; KUHN R, 1991, MOL CELL BIOL, V11, P4642, DOI 10.1128/MCB.11.9.4642; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P752, DOI 10.1006/bbrc.1999.1753; LANS MS, 1994, J BIOL CHEM, V269, P14170; Li C, 2001, ENDOCRINOLOGY, V142, P1546, DOI 10.1210/en.142.4.1546; Martini PGV, 2001, ENDOCRINOLOGY, V142, P3493, DOI 10.1210/en.142.8.3493; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; MCCUBREY JA, 2010, BIOCHIM BIOPHYS ACTA, V1773, P1263; Mize AL, 2003, ENDOCRINOLOGY, V144, P306, DOI 10.1210/en.2002-220698; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Oyasu M, 2000, MOL BRAIN RES, V76, P151, DOI 10.1016/S0169-328X(99)00342-3; Qin CH, 1999, ENDOCRINOLOGY, V140, P2501, DOI 10.1210/en.140.6.2501; Rabadan-Diehl C, 2000, J NEUROENDOCRINOL, V12, P437; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; RHEES RW, 1990, DEV BRAIN RES, V52, P17, DOI 10.1016/0165-3806(90)90217-M; RISHI AK, 1995, CANCER RES, V55, P4999; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Singer CA, 1998, NEUROREPORT, V9, P2565, DOI 10.1097/00001756-199808030-00025; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; Voigtlander T, 1999, HYPERTENSION, V33, P303, DOI 10.1161/01.HYP.33.1.303; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628	49	25	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25074	25084		10.1074/jbc.M110.100545	http://dx.doi.org/10.1074/jbc.M110.100545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538601	Green Published, hybrid			2022-12-25	WOS:000280542100080
J	Zhang, L; Chopp, M; Zhang, RL; Wang, L; Zhang, J; Wang, Y; Toh, Y; Santra, M; Lu, M; Zhang, ZG				Zhang, Li; Chopp, Michael; Zhang, Rui Lan; Wang, Lei; Zhang, Jing; Wang, Ying; Toh, Yier; Santra, Manoranjan; Lu, Mei; Zhang, Zheng Gang			Erythropoietin Amplifies Stroke-Induced Oligodendrogenesis in the Rat	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; PROGENITOR CELLS; SUBVENTRICULAR ZONE; WHITE-MATTER; ADULT-RAT; NEUROLOGICAL FUNCTION; CORTICAL ISCHEMIA; BRAIN-INJURY; OLIGODENDROCYTES; IDENTIFICATION	Background: Erythropoietin (EPO), a hematopoietic cytokine, enhances neurogenesis and angiogenesis during stroke recovery. In the present study, we examined the effect of EPO on oligodendrogenesis in a rat model of embolic focal cerebral ischemia. Methodology and Principal Findings: Recombinant human EPO (rhEPO) at a dose of 5,000 U/kg (n = 18) or saline (n = 18) was intraperitoneally administered daily for 7 days starting 24 h after stroke onset. Treatment with rhEPO augmented actively proliferating oligodendrocyte progenitor cells (OPCs) measured by NG2 immunoreactive cells within the peri-infarct white matter and the subventricular zone (SVZ), but did not protect against loss of myelinating oligodendrocytes measured by cyclic nucleotide phosphodiesterase (CNPase) positive cells 7 days after stroke. However, 28 and 42 days after stroke, treatment with rhEPO significantly increased myelinating oligodendrocytes and myelinated axons within the peri-infarct white matter. Using lentivirus to label subventricular zone (SVZ) neural progenitor cells, we found that in addition to the OPCs generated in the peri-infarct white matter, SVZ neural progenitor cells contributed to rhEPO-increased OPCs in the peri-infarct area. Using bromodeoxyuridine (BrdU) for birth-dating cells, we demonstrated that myelinating oligodendrocytes observed 28 days after stroke were derived from OPCs. Furthermore, rhEPO significantly improved neurological outcome 6 weeks after stroke. In vitro, rhEPO increased differentiation of adult SVZ neural progenitor cells into oligodendrocytes and enhanced immature oligodendrocyte cell proliferation. Conclusions: Our in vivo and in vitro data indicate that EPO amplifies stroke-induced oligodendrogenesis that could facilitate axonal re-myelination and lead to functional recovery after stroke.	[Zhang, Li; Chopp, Michael; Zhang, Rui Lan; Wang, Lei; Zhang, Jing; Wang, Ying; Toh, Yier; Santra, Manoranjan; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Lu, Mei] Henry Ford Hosp, Div Biostat & Res Epidemiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University; Henry Ford Health System; Henry Ford Hospital	Zhang, L (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		National Institute of Neurological Disorders and Stroke (NINDS) [PO1 NS23393, RO1 HL64766, RO1 NS62832]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023393, R01NS062832] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) grants PO1 NS23393, RO1 HL64766, and RO1 NS62832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Carroll WM, 1998, BRAIN, V121, P293, DOI 10.1093/brain/121.2.293; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Gregersen R, 2001, EXP BRAIN RES, V138, P384, DOI 10.1007/s002210100715; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Horner PJ, 2000, J NEUROSCI, V20, P2218; IMAMOTO K, 1978, J COMP NEUROL, V180, P139, DOI 10.1002/cne.901800109; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Iwai M, 2010, STROKE, V41, P1032, DOI 10.1161/STROKEAHA.109.570325; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Komitova M, 2006, EXP NEUROL, V199, P113, DOI 10.1016/j.expneurol.2005.12.007; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Li L, 2009, STROKE, V40, P936, DOI 10.1161/STROKEAHA.108.527713; Mandai K, 1997, NEUROSCIENCE, V77, P849, DOI 10.1016/S0306-4522(97)00517-4; MATHEWS MB, 1984, NATURE, V309, P374, DOI 10.1038/309374a0; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mizuno K, 2008, NEONATOLOGY, V94, P255, DOI 10.1159/000151644; Ness JK, 2005, GLIA, V50, P321, DOI 10.1002/glia.20206; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Norton WT, 1996, NEUROCHEM RES, V21, P495, DOI 10.1007/BF02527715; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; REYNOLDS R, 1988, DEVELOPMENT, V102, P409; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Santra M, 2006, CANCER RES, V66, P11726, DOI 10.1158/0008-5472.CAN-06-1978; Sargin D, 2009, GLIA, V57, P693, DOI 10.1002/glia.20797; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Tanaka K, 2003, BRAIN RES, V989, P172, DOI 10.1016/S0006-8993(03)03317-1; TANIGUCHI Y, 2009, J NEUROSCI RES; van der Kooij MA, 2009, NEUROSCI LETT, V451, P109, DOI 10.1016/j.neulet.2008.12.013; VERITY AN, 1993, J NEUROCHEM, V60, P577, DOI 10.1111/j.1471-4159.1993.tb03188.x; Vitellaro-Zuccarello L, 2007, NEUROSCIENCE, V144, P865, DOI 10.1016/j.neuroscience.2006.10.023; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yam PS, 1998, J NEUROTRAUM, V15, P441, DOI 10.1089/neu.1998.15.441; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x	53	68	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11016	10.1371/journal.pone.0011016	http://dx.doi.org/10.1371/journal.pone.0011016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552017	Green Submitted, gold, Green Published			2022-12-25	WOS:000278662900005
J	Lee, J; Moon, S; Cha, Y; Chung, YD				Lee, Jeongmi; Moon, Sungjin; Cha, Yoonseok; Chung, Yun Doo			Drosophila TRPN(=NOMPC) Channel Localizes to the Distal End of Mechanosensory Cilia	PLOS ONE			English	Article							HEARING; TRANSDUCTION; MECHANOTRANSDUCTION; NEURONS; EYES	Background: A TRPN channel protein is essential for sensory transduction in insect mechanosensory neurons and in vertebrate hair cells. The Drosophila TRPN homolog, NOMPC, is required to generate mechanoreceptor potentials and currents in tactile bristles. NOMPC is also required, together with a TRPV channel, for transduction by chordotonal neurons of the fly's antennal ear, but the TRPN or TRPV channels have distinct roles in transduction and in regulating active antennal mechanics. The evidence suggests that NOMPC is a primary mechanotransducer channel, but its subcellular location-key for understanding its exact role in transduction-has not yet been established. Methodology/Principal Findings: Here, by immunostaining, we locate NOMPC at the tips of mechanosensory cilia in both external and chordotonal sensory neurons, as predicted for a mechanotransducer channel. In chordotonal neurons, the TRPN and TRPV channels are respectively segregated into distal and proximal ciliary zones. This zonal separation is demarcated by and requires the ciliary dilation, an intraciliary assembly of intraflagellar transport (IFT) proteins. Conclusions: Our results provide a strong evidence for NOMPC as a primary transduction channel in Drosophila mechansensory organs. The data also reveals a structural basis for the model of auditory chordotonal transduction in which the TRPN and TRPV channels play sequential roles in generating and amplifying the receptor potential, but have opposing roles in regulating active ciliary motility.	[Lee, Jeongmi; Moon, Sungjin; Cha, Yoonseok; Chung, Yun Doo] Univ Seoul, Dept Life Sci, Seoul, South Korea	University of Seoul	Lee, J (corresponding author), Univ Seoul, Dept Life Sci, Seoul, South Korea.	ydchung@uos.ac.kr			National Research Foundation of Korea [KRF-2005-C00065, 2009-0070904]; Korean Ministry of Education, Science and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was funded by the grants to Y.D.C. from the National Research Foundation of Korea (KRF-2005-C00065 and 2009-0070904). J.L., S. M. and Y.C. are supported by BK 21 Research Fellowship from Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gopfert MC, 2003, P NATL ACAD SCI USA, V100, P5514, DOI 10.1073/pnas.0737564100; Gopfert MC, 2005, P NATL ACAD SCI USA, V102, P325, DOI 10.1073/pnas.0405741102; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Lee E, 2008, CURR BIOL, V18, P1899, DOI 10.1016/j.cub.2008.11.020; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; RUSCH A, 1990, HEARING RES, V48, P247, DOI 10.1016/0378-5955(90)90065-W; Shin JB, 2005, P NATL ACAD SCI USA, V102, P12572, DOI 10.1073/pnas.0502403102; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	23	65	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11012	10.1371/journal.pone.0011012	http://dx.doi.org/10.1371/journal.pone.0011012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543979	Green Submitted, Green Published, gold			2022-12-25	WOS:000278494900024
J	Dell'Orco, D; Lundqvist, M; Oslakovic, C; Cedervall, T; Linse, S				Dell'Orco, Daniele; Lundqvist, Martin; Oslakovic, Cecilia; Cedervall, Tommy; Linse, Sara			Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid	PLOS ONE			English	Article							COPOLYMER NANOPARTICLES; PLASMA PROTEOME; ADSORPTION; LIPOPROTEINS; SUBFRACTIONS; SIZE	Background: Nanoparticles in contact with biological fluids interact with proteins and other biomolecules, thus forming a dynamic corona whose composition varies over time due to continuous protein association and dissociation events. Eventually equilibrium is reached, at which point the continued exchange will not affect the composition of the corona. Results: We developed a simple and effective dynamic model of the nanoparticle protein corona in a body fluid, namely human plasma. The model predicts the time evolution and equilibrium composition of the corona based on affinities, stoichiometries and rate constants. An application to the interaction of human serum albumin, high density lipoprotein (HDL) and fibrinogen with 70 nm N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles is presented, including novel experimental data for HDL. Conclusions: The simple model presented here can easily be modified to mimic the interaction of the nanoparticle protein corona with a novel biological fluid or compartment once new data will be available, thus opening novel applications in nanotoxicity and nanomedicine.	[Dell'Orco, Daniele] Carl von Ossietzky Univ Oldenburg, Biochem Sect, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany; [Lundqvist, Martin] Lund Univ, Ctr Chem, Ctr Mol Prot Sci, Dept Biophys Chem, Lund, Sweden; [Oslakovic, Cecilia] Lund Univ, Malmo Univ Hosp, Sect Clin Chem, Dept Lab Med, Malmo, Sweden; [Cedervall, Tommy; Linse, Sara] Lund Univ, Ctr Chem, Ctr Mol Prot Sci, Dept Biochem, Lund, Sweden	Carl von Ossietzky Universitat Oldenburg; Lund University; Lund University; Skane University Hospital; Lund University	Dell'Orco, D (corresponding author), Carl von Ossietzky Univ Oldenburg, Biochem Sect, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany.	daniele.dellorco@uni-oldenburg.de	Cedervall, Tommy/AAT-9766-2021; Lundqvist, Martin/K-3908-2012	Cedervall, Tommy/0000-0003-2255-8446; Lundqvist, Martin/0000-0003-1175-9103; DELL'ORCO, Daniele/0000-0002-3724-3044; Linse, Sara/0000-0001-9629-7109	EU; European Science Foundation [2828]	EU(European Commission); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by EU FP6 Strep Nanointeract. DDO was supported by a short-visit grant n. 2828 by the European Science Foundation within the project 'Mapping the detailed composition of Surface-Absorbed Protein Layers on Biomaterials and Nanoparticles'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Argani H, 2005, NEPHRON CLIN PRACT, V101, pC174, DOI 10.1159/000087411; Bakogianni MC, 2001, J DIABETES COMPLICAT, V15, P265, DOI 10.1016/S1056-8727(01)00159-3; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; Dell'Orco D, 2009, MOL BIOSYST, V5, P1232, DOI 10.1039/b908123b; EISENBERG S, 1991, PRIMARY HYPERLIPOPRO, P23; GOTTO AMJ, METHODS ENZYMOLOGY, P3; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hortin GL, 2006, CLIN CHEM, V52, P1223, DOI 10.1373/clinchem.2006.069252; Lagogianni I, 2005, CLIN BIOCHEM, V38, P286, DOI 10.1016/j.clinbiochem.2004.10.006; Lindman S, 2007, NANO LETT, V7, P914, DOI 10.1021/nI062743+; LUNDQVIST M, UNPUB; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Oslakovic C, 2009, J BIOL CHEM, V284, P5896, DOI 10.1074/jbc.M807286200; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799	20	248	248	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10949	10.1371/journal.pone.0010949	http://dx.doi.org/10.1371/journal.pone.0010949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532175	Green Published, Green Submitted, gold			2022-12-25	WOS:000278318700018
J	Li, JH; Miyamoto, K; Sayeed, S; McClane, BA				Li, Jihong; Miyamoto, Kazuaki; Sayeed, Sameera; McClane, Bruce A.			Organization of the cpe Locus in CPE-Positive Clostridium perfringens Type C and D Isolates	PLOS ONE			English	Article							INTRAVENOUS-INJECTION MODEL; HUMAN GASTROINTESTINAL-DISEASES; PCR GENOTYPING ASSAY; ENTEROTOXIN GENE CPE; EPSILON-TOXIN; ENCODING PLASMIDS; BETA-TOXIN; BORNE; IDENTIFICATION; RESISTANCE	Clostridium perfringens enterotoxin (encoded by the cpe gene) contributes to several important human, and possibly veterinary, enteric diseases. The current study investigated whether cpe locus organization in type C or D isolates resembles one of the three (one chromosomal and two plasmid-borne) cpe loci commonly found amongst type A isolates. Multiplex PCR assays capable of detecting sequences in those type A cpe loci failed to amplify products from cpe-positive type C and D isolates, indicating these isolates possess different cpe locus arrangements. Therefore, restriction fragments containing the cpe gene were cloned and sequenced from two type C isolates and one type D isolate. The obtained cpe locus sequences were then used to construct an overlapping PCR assay to assess cpe locus diversity amongst other cpe-positive type C and D isolates. All seven surveyed cpe-positive type C isolates had a plasmid-borne cpe locus partially resembling the cpe locus of type A isolates carrying a chromosomal cpe gene. In contrast, all eight type D isolates shared the same plasmid-borne cpe locus, which differed substantially from the cpe locus present in other C. perfringens by containing two copies of an ORF with 67% identity to a transposase gene (COG4644) found in Tn1546, but not previously associated with the cpe gene. These results identify greater diversity amongst cpe locus organization than previously appreciated, providing new insights into cpe locus evolution. Finally, evidence for cpe gene mobilization was found for both type C and D isolates, which could explain their cpe plasmid diversity.	[Li, Jihong; Sayeed, Sameera; McClane, Bruce A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Miyamoto, Kazuaki] Wakayama Med Univ, Sch Med, Dept Microbiol, Wakayama, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wakayama Medical University	Li, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	bamcc@pitt.edu			National Institute of Allergy and Infectious Diseases [R37-AI19844-27, R01-AI05617706]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019844, R01AI056177] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was generously supported by grants R37-AI19844-27 and R01-AI05617706 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Billington SJ, 1998, INFECT IMMUN, V66, P4531; BOS J, 2005, CLIN INFECT DIS, V15, P78; Brynestad S, 1999, FEMS MICROBIOL LETT, V170, P281, DOI 10.1016/S0378-1097(98)00557-6; Brynestad S, 1997, MICROBIOL-UK, V143, P2109, DOI 10.1099/00221287-143-7-2109; Brynestad S, 2001, INFECT IMMUN, V69, P3483, DOI 10.1128/IAI.69.5.3483-3487.2001; Carmichael LM, 1997, BIODEGRADATION, V8, P1, DOI 10.1023/A:1008258720649; Collie RE, 1998, ANAEROBE, V4, P69, DOI 10.1006/anae.1998.0152; Collie RE, 1998, J CLIN MICROBIOL, V36, P30, DOI 10.1128/JCM.36.1.30-36.1998; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; CZECZULIN JR, 1993, INFECT IMMUN, V61, P3429, DOI 10.1128/IAI.61.8.3429-3439.1993; Deguchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005598; Fernandez-Miyakawa ME, 2007, INFECT IMMUN, V75, P1443, DOI 10.1128/IAI.01672-06; Fisher DJ, 2006, INFECT IMMUN, V74, P5200, DOI 10.1128/IAI.00534-06; Fisher DJ, 2005, MOL MICROBIOL, V56, P747, DOI 10.1111/j.1365-2958.2005.04573.x; Grant KA, 2008, FOODBORNE PATHOG DIS, V5, P629, DOI 10.1089/fpd.2007.0066; HLKINHELMO A, 2006, EMERG INFECT DIS, V12, P1724; Jost BH, 2005, INFECT IMMUN, V73, P652, DOI 10.1128/IAI.73.1.652-656.2005; KOKAIKUN JF, 1994, J CLIN MICROBIOL, V32, P2533, DOI 10.1128/JCM.32.10.2533-2539.1994; Lawrence GW, 1997, CLOSTRIDIA MOL GENET, P198; Li JH, 2007, APPL ENVIRON MICROB, V73, P7218, DOI 10.1128/AEM.01075-07; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; McClane B.A., 2006, PROKARYOTES, V3rd ed., P688; McClane BA., 2009, RES ADV APPL ENV MIC, V2, P1; McClane BA, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P423; Miki Y, 2008, APPL ENVIRON MICROB, V74, P5366, DOI 10.1128/AEM.00783-08; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Miyamoto K, 2002, INFECT IMMUN, V70, P4261, DOI 10.1128/IAI.70.8.4261-4272.2002; Miyamoto K, 2008, J BACTERIOL, V190, P7178, DOI 10.1128/JB.00939-08; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Sayeed S, 2005, INFECT IMMUN, V73, P7413, DOI 10.1128/IAI.73.11.7413-7421.2005; Sayeed S, 2008, MOL MICROBIOL, V67, P15, DOI 10.1111/j.1365-2958.2007.06007.x; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Titball RV, 1999, ANAEROBE, V5, P51, DOI 10.1006/anae.1999.0191; Wen QY, 2003, J CLIN MICROBIOL, V41, P1494, DOI 10.1128/JCM.41.4.1494-1498.2003	38	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10932	10.1371/journal.pone.0010932	http://dx.doi.org/10.1371/journal.pone.0010932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532170	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000278318700006
J	Tobler, U; Schmidt, BR				Tobler, Ursina; Schmidt, Benedikt R.			Within- and Among-Population Variation in Chytridiomycosis-Induced Mortality in the Toad Alytes obstetricans	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; AMPHIBIAN CHYTRID FUNGUS; BATRACHOCHYTRIUM-DENDROBATIDIS; DAPHNIA-MAGNA; RESISTANCE; EXTINCTION; ECOLOGY; EVOLUTION; SELECTION; PARASITE	Background: Chytridiomycosis is a fungal disease linked to local and global extinctions of amphibians. Susceptibility to chytridiomycosis varies greatly between amphibian species, but little is known about between-and within-population variability. However, this kind of variability is the basis for the evolution of tolerance and resistance evolution to disease. Methodology/Principal Findings: In a common garden experiment, we measured mortality after metamorphosis of Alytes obstetricans naturally infected with Batrachochytrium dendrobatidis. Mortality rates differed significantly among populations and ranged from 27 to 90%. Within populations, mortality strongly depended on mass at and time through metamorphosis. Conclusions/Significance: Although we cannot rule out that the differences observed resulted from differences in skin microbiota, different pathogen strains or environmental effects experienced by the host or the pathogen prior to the start of the experiment, we argue that genetic differences between populations are a likely source of at least part of this variation. To our knowledge, this is the first study showing differences in survival between and within populations under constant laboratory conditions. Assuming that some of this intraspecific variation has a genetic basis, this may suggest that there is the potential for the evolution of resistance or tolerance, which might allow population persistence.	[Tobler, Ursina; Schmidt, Benedikt R.] Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland; [Schmidt, Benedikt R.] KARCH, Neuchatel, Switzerland	University of Zurich	Tobler, U (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland.	ursina.tobler@ieu.uzh.ch	Schmidt, Benedikt R./B-8491-2008	Schmidt, Benedikt R./0000-0002-4023-1001	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Poehn Stiftung; Basler Stiftung fuer biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zuerich; Gruen Stadt Zuerich; European Union of Aquarium Curators; Zuercher Tierschutz; Natural Environment Research Council [NE/G001944/1] Funding Source: researchfish; NERC [NE/G001944/1] Funding Source: UKRI	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Poehn Stiftung; Basler Stiftung fuer biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zuerich; Gruen Stadt Zuerich; European Union of Aquarium Curators(European Commission); Zuercher Tierschutz; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was financed by the following institutions and foundations: the Zoological Institute and the Forschungskredit of the University of Zurich, Vontobel Stiftung, Janggen-Poehn Stiftung, Basler Stiftung fuer biologische Forschung, Stiftung Dr. Joachim De Giacomi, Zoo Zuerich, Gruen Stadt Zuerich, European Union of Aquarium Curators, and Zuercher Tierschutz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, AM NAT, V172, pE67, DOI 10.1086/588077; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; BOSCH J, 2008, IUCN 2009 IUCN RED L; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Cory JS, 2009, J ANIM ECOL, V78, P646, DOI 10.1111/j.1365-2656.2008.01519.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Ebert D, 2000, OECOLOGIA, V122, P200, DOI 10.1007/PL00008847; Ebert D, 1998, P ROY SOC B-BIOL SCI, V265, P2127, DOI 10.1098/rspb.1998.0549; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Garner TWJ, 2009, DIS AQUAT ORGAN, V83, P257, DOI 10.3354/dao02008; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Gomulkiewicz R, 2009, AM NAT, V174, pE218, DOI 10.1086/645086; Gosner K. L., 1960, Herpetologica, V16, P183; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Haag CR, 2004, P ROY SOC B-BIOL SCI, V271, P2149, DOI 10.1098/rspb.2004.2841; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hels T, 2002, ECOGRAPHY, V25, P730, DOI 10.1034/j.1600-0587.2002.250609.x; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kilpatrick AM, 2006, BIOL CONSERV, V128, P475, DOI 10.1016/j.biocon.2005.10.014; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; Laugen AT, 2005, GENET RES, V86, P161, DOI 10.1017/S0016672305007810; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Miller MP, 2008, EVOL APPL, V1, P336, DOI 10.1111/j.1752-4571.2008.00018.x; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; NSW National Parks and Wildlife Service, 2001, 6 NSW NPWS; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; R Core Team, 2022, R LANG ENV STAT COMP; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; SCHMIDT B. R., 2009, METHODEN FELDHERPETO, P229; SCHMIDT BR, 2005, ROTE LISTE GEFA HRDE; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Teacher AGF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004616; Tennessen JA, 2008, MOL BIOL EVOL, V25, P2669, DOI 10.1093/molbev/msn208; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Van Buskirk J, 2002, EVOLUTION, V56, P361; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Zbinden M, 2008, J EVOLUTION BIOL, V21, P1068, DOI 10.1111/j.1420-9101.2008.01541.x	57	90	91	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10927	10.1371/journal.pone.0010927	http://dx.doi.org/10.1371/journal.pone.0010927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532196	Green Published, gold, Green Submitted			2022-12-25	WOS:000278284700010
J	Wei, B; Gao, JM; Huang, XP; Jin, JP				Wei, Bin; Gao, Jimin; Huang, Xu-Pei; Jin, J. -P.			Mutual Rescues between Two Dominant Negative Mutations in Cardiac Troponin I and Cardiac Troponin T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL TRUNCATION; FUNCTIONAL ADAPTATION; THIN-FILAMENTS; CARDIOMYOPATHY; DOMAIN	Troponin T (TnT) and troponin I (TnI) are two evolutionarily and functionally linked subunits of the troponin complex that regulates striated muscle contraction. We previously reported a single amino acid substitution in the highly conserved TnT-binding helix of cardiac TnI (cTnI) in wild turkey hearts in concurrence with an abnormally spliced myopathic cardiac TnT (cTnT) (Biesiadecki, B. J., Schneider, K. L., Yu, Z. B., Chong, S. M., and Jin, J. P. (2004) J. Biol. Chem. 279, 13825-13832). To investigate the functional effect of this cTnI mutation and its potential value in compensating for the cTnT abnormality, we developed transgenic mice expressing the mutant cTnI (K118C) in the heart with or without the deletion of the endogenous cTnI gene to mimic the homozygote and heterozygote of wild turkeys. Double and triple transgenic mice were created by crossing the cTnI-K118C lines with transgenic mice overexpressing the myopathic cTnT (exon 7 deletion). Functional studies of ex vivo working hearts found that cTnI-K118C alone had a dominantly negative effect on diastolic function and blunted the inotropic responses of cardiac muscle to beta-adrenergic stimuli without abolishing the protein kinase A-dependent phosphorylation of cTnI. When co-expressed with the cTnT mutation, cTnI-K118C corrected the significant depression of systolic function caused by cTnT exon 7 deletion, and the co-existence of exon 7-deleted cTnT minimized the diastolic abnormality of cTnI-K118C. Characterization of this naturally selected pair of mutually rescuing mutations demonstrated that TnI-TnT interaction is a critical link in the Ca2+ signaling and beta-adrenergic regulation in cardiac muscle, suggesting a potential target for the treatment of troponin cardiomyopathies and heart failure.	[Wei, Bin; Gao, Jimin; Jin, J. -P.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Wei, Bin; Gao, Jimin; Jin, J. -P.] Northwestern Univ, ENH Res Inst, Evanston, IL 60201 USA; [Huang, Xu-Pei] Florida Atlantic Univ, Sch Biomed Sci, Boca Raton, FL 33431 USA	Wayne State University; Northwestern University; State University System of Florida; Florida Atlantic University	Jin, JP (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.	jjin@med.wayne.edu	Wei, Bin/M-2017-2014; Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063	National Institutes of Health [HL-078773, AR-048816]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-078773 and AR-048816.	Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Biesiadecki BJ, 2004, J BIOL CHEM, V279, P13825, DOI 10.1074/jbc.M314225200; Biesiadecki BJ, 2002, J BIOL CHEM, V277, P50275, DOI 10.1074/jbc.M206369200; Biesiadecki BJ, 2002, J BIOL CHEM, V277, P18459, DOI 10.1074/jbc.M200788200; Boussouf SE, 2007, ADV EXP MED BIOL, V592, P99; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; Feng HZ, 2008, J PHYSIOL-LONDON, V586, P3537, DOI 10.1113/jphysiol.2008.153577; Feng HZ, 2009, ARCH BIOCHEM BIOPHYS, V487, P36, DOI 10.1016/j.abb.2009.05.001; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; How OJ, 2005, AM J PHYSIOL-HEART C, V288, pH2979, DOI 10.1152/ajpheart.00084.2005; Huang XP, 1999, CIRC RES, V84, P1; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 2000, AM J PHYSIOL-CELL PH, V279, pC1067, DOI 10.1152/ajpcell.2000.279.4.C1067; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kronert WA, 1999, J CELL BIOL, V144, P989, DOI 10.1083/jcb.144.5.989; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Zhang ZL, 2006, BIOCHEMISTRY-US, V45, P11681, DOI 10.1021/bi060273s	27	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27806	27816		10.1074/jbc.M110.137844	http://dx.doi.org/10.1074/jbc.M110.137844			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20551314	hybrid, Green Published			2022-12-25	WOS:000281404100036
J	Yeh, LK; Liu, CY; Kao, WWY; Huang, CJ; Hu, FR; Chien, CL; Wang, IJ				Yeh, Lung-Kun; Liu, Chia-Yang; Kao, Winston W. -Y.; Huang, Chang-Jen; Hu, Fung-Rong; Chien, Chung-Liang; Wang, I-Jong			Knockdown of Zebrafish Lumican Gene (zlum) Causes Scleral Thinning and Increased Size of Scleral Coats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; LEUCINE-RICH PROTEOGLYCANS; TREE SHREW SCLERA; HIGH MYOPIA; CHROMOSOMAL LOCALIZATION; EYE ENLARGEMENT; EXPRESSION; PIRENZEPINE; RECEPTORS; ATROPINE	The lumican gene (lum), which encodes one of the major keratan sulfate proteoglycans (KSPGs) in the vertebrate cornea and sclera, has been linked to axial myopia in humans. In this study, we chose zebrafish (Danio rerio) as an animal model to elucidate the role of lumican in the development of axial myopia. The zebrafish lumican gene (zlum) spans similar to 4.6 kb of the zebrafish genome. Like human (hLUM) and mouse (mlum), zlum consists of three exons, two introns, and a TATA box-less promoter at the 5'-flanking region of the transcription initiation site. Sequence analysis of the cDNA predicts that zLum encodes 344 amino acids. zLum shares 51% amino acid sequence identity with human lumican. Similar to hLUM and mlum, zlum mRNA is expressed in the eye and many other tissues, such as brain, muscle, and liver as well. Transgenic zebrafish harboring an enhanced GFP reporter gene construct downstream of a 1.7-kb zlum 5'-flanking region displayed enhanced GFP expression in the cornea and sclera, as well as throughout the body. Downregulation of zlum expression by antisense zlum morpholinos manifested ocular enlargement resembling axial myopia due to disruption of the collagen fibril arrangement in the sclera and resulted in scleral thinning. Administration of muscarinic receptor antagonists, e. g. atropine and pirenzepine, effectively subdued the ocular enlargement caused by morpholinos in in vivo zebrafish larvae assays. The observation suggests that zebrafish can be used as an in vivo model for screening compounds in treating myopia.	[Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 100, Taiwan; [Yeh, Lung-Kun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linko, Dept Ophthalmol, Tao Yuan 333, Taiwan; [Liu, Chia-Yang; Kao, Winston W. -Y.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Kao, Winston W. -Y.] Univ Cincinnati, Coll Med, Dept Cell Biol Neurosci & Anat, Cincinnati, OH 45267 USA; [Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 100, Taiwan	National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Chien, CL (corresponding author), Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Sec 1,Jen Ai Rd, Taipei 100, Taiwan.	chien@ntu.edu.tw; ijong@ms8.hinet.net		Liu, Chia-yang/0000-0002-8398-5516; Wang, I-Jong/0000-0002-3045-0614; CHIEN, CHUNG-LIANG/0000-0001-9806-486X; HU, FUNG-RONG/0000-0002-2102-5317	National Institutes of Health, NEI [EY12486, EY011845]; National Science Council [923112B002004, 933112B002031, 943112B002007, 932314B002090, 942314B002043, 952314B002149MY3, 972314B182A059, 982314B182A029MY3, 983112B002040]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY011845, R01EY012486] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Council(Ministry of Science and Technology, Taiwan); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY12486 from NEI (to C.-Y.L.) and EY011845 (to W. W.Y.K.). This work was also supported in part by National Science Council Grants 923112B002004, 933112B002031, 943112B002007, 932314B002090, 942314B002043, 952314B002149MY3, 972314B182A059, 982314B182A029MY3, and 983112B002040, Research to Prevent Blindness, and Ohio Lions Eye Research Foundation.	Austin BA, 2002, INVEST OPHTH VIS SCI, V43, P1695; Barathi VA, 2009, MOL VIS, V15, P1277; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen ZTY, 2009, OPHTHALMOLOGY, V116, P1920, DOI 10.1016/j.ophtha.2009.03.023; Chou AC, 1997, J OCUL PHARMACOL TH, V13, P61, DOI 10.1089/jop.1997.13.61; CONRAD GW, 2000, CARBOHYDRATES CHEM 2, V4, P717; Cottriall CL, 1996, INVEST OPHTH VIS SCI, V37, P1368; Cottriall CL, 1999, OPHTHAL PHYSL OPT, V19, P327, DOI 10.1016/S0275-5408(98)00079-9; Deere M, 1996, GENOMICS, V38, P399, DOI 10.1006/geno.1996.0643; FISHER LW, 1991, J BIOL CHEM, V266, P14371; FUNDERBURGH JL, 1991, BIOCHEM SOC T, V19, P871, DOI 10.1042/bst0190871; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P24773; FUNDERBURGH JL, 1987, J BIOL CHEM, V262, P11634; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; GROVER J, 1995, J BIOL CHEM, V270, P21942, DOI 10.1074/jbc.270.37.21942; Iozzo RV, 1999, PROG NUCLEIC ACID RE, V62, P19; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Johnson J, 2006, MOL VIS, V12, P1057; Kao WWY, 2006, CORNEA, V25, pS7, DOI 10.1097/01.ico.0000247207.55520.a4; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; LIU CY, 1994, J BIOL CHEM, V269, P24627; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; LIU O, 2007, MOL VIS, V13, P1234; Luft WA, 2003, INVEST OPHTH VIS SCI, V44, P1330, DOI 10.1167/iovs.02-0796; Majava M, 2007, HUM MUTAT, V28, P336, DOI 10.1002/humu.20444; MCBRIEN NA, 1993, INVEST OPHTH VIS SCI, V34, P205; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; Morel L, 2004, PLOS BIOL, V2, P1061, DOI 10.1371/journal.pbio.0020241; Moring AG, 2007, INVEST OPHTH VIS SCI, V48, P2947, DOI 10.1167/iovs.06-0906; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Paluru PC, 2004, MOL VIS, V10, P917; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; PULKKINEN L, 1992, CYTOGENET CELL GENET, V60, P107, DOI 10.1159/000133314; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Raouf A, 2002, MATRIX BIOL, V21, P361, DOI 10.1016/S0945-053X(02)00027-6; Saika S, 2003, INVEST OPHTH VIS SCI, V44, P2094, DOI 10.1167/iovs.02-1059; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; SCHWARTZ M, 1990, CLIN GENET, V38, P281; Shih YF, 2001, ACTA OPHTHALMOL SCAN, V79, P233, DOI 10.1034/j.1600-0420.2001.790304.x; Siegwart JT, 1999, VISION RES, V39, P387, DOI 10.1016/S0042-6989(98)00150-3; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; STONE RA, 1991, EXP EYE RES, V52, P755, DOI 10.1016/0014-4835(91)90027-C; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tan DTH, 2005, OPHTHALMOLOGY, V112, P84, DOI 10.1016/j.ophtha.2004.06.038; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; Wang IJ, 2006, MOL VIS, V12, P852; Westerfield M, 1995, ZEBRAFISH BOOK; Williams FE, 2004, COMP BIOCHEM PHYS C, V137, P349, DOI 10.1016/j.cca.2004.03.002; Xu YS, 2000, J BIOL CHEM, V275, P24645, DOI 10.1074/jbc.M001159200; Yeh LK, 2008, J BIOL CHEM, V283, P506, DOI 10.1074/jbc.M707656200; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306; Young TL, 1998, AM J HUM GENET, V63, P1419, DOI 10.1086/302111	61	31	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28141	28155		10.1074/jbc.M109.043679	http://dx.doi.org/10.1074/jbc.M109.043679			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20551313	Green Published, hybrid			2022-12-25	WOS:000281404100057
J	de Castro, RO; Zhang, J; Jamur, MC; Oliver, C; Siraganian, RP				de Castro, Rodrigo O.; Zhang, Juan; Jamur, Maria C.; Oliver, Constance; Siraganian, Reuben P.			Tyrosines in the Carboxyl Terminus Regulate Syk Kinase Activity and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; CELL ANTIGEN RECEPTOR; PHOSPHOTYROSINE-BINDING DOMAIN; BASOPHILIC LEUKEMIA-CELLS; ACTIVATION LOOP TYROSINES; PROTEIN-COUPLED RECEPTOR; MAST-CELLS; SIGNAL-TRANSDUCTION; IMMUNOGLOBULIN-E	The Syk tyrosine kinase family plays an essential role in immunoreceptor tyrosine-based activation motif (ITAM) signaling. The binding of Syk to tyrosine-phosphorylated ITAM subunits of immunoreceptors, such as Fc epsilon RI on mast cells, results in a conformational change, with an increase of enzymatic activity of Syk. This conformational change exposes the COOH-terminal tail of Syk, which has three conserved Tyr residues (Tyr-623, Tyr-624, and Tyr-625 of rat Syk). To understand the role of these residues in signaling, wild-type and mutant Syk with these three Tyr mutated to Phe was expressed in Syk-deficient mast cells. There was decreased Fc epsilon RI-induced degranulation, nuclear factor for T cell activation and NF kappa B activation with the mutated Syk together with reduced phosphorylation of MAP kinases p38 and p42/44 ERK. In non-stimulated cells, the mutated Syk was more tyrosine phosphorylated predominantly as a result of autophosphorylation. In vitro, there was reduced binding of mutated Syk to phosphorylated ITAM due to this increased phosphorylation. This mutated Syk from non-stimulated cells had significantly reduced kinase activity toward an exogenous substrate, whereas its autophosphorylation capacity was not affected. However, the kinase activity and the autophosphorylation capacity of this mutated Syk were dramatically decreased when the protein was dephosphorylated before the in vitro kinase reaction. Furthermore, mutation of these tyrosines in the COOH-terminal region of Syk transforms it to an enzyme, similar to its homolog ZAP-70, which depends on other tyrosine kinases for optimal activation. In testing Syk mutated singly at each one of the tyrosines, Tyr-624 but especially Tyr-625 had the major role in these reactions. Therefore, these results indicate that these tyrosines in the tail region play a critical role in regulating the kinase activity and function of Syk.	[Siraganian, Reuben P.] Natl Inst Dent & Craniofacial Res, Receptors & Signal Transduct Sect, NIH, Bethesda, MD 20892 USA; [de Castro, Rodrigo O.; Jamur, Maria C.; Oliver, Constance] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol & Pathogen Bioagents, BR-14049900 Sao Paulo, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Universidade de Sao Paulo	Siraganian, RP (corresponding author), Natl Inst Dent & Craniofacial Res, Receptors & Signal Transduct Sect, NIH, Bldg 49,Rm 1A16,NIDCR, Bethesda, MD 20892 USA.	rs53x@nih.gov	Jamur, Maria Celia/L-5520-2016	Jamur, Maria Celia/0000-0001-7065-8543	NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000696] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIDCR.	Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; BENHAMOU M, 1992, IMMUNOL TODAY, V13, P195, DOI 10.1016/0167-5699(92)90152-W; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN AC, 1994, J IMMUNOL, V152, P4758; Chen T, 1996, J BIOL CHEM, V271, P25308, DOI 10.1074/jbc.271.41.25308; Cho SH, 2004, J ALLERGY CLIN IMMUN, V114, P1085, DOI 10.1016/j.jaci.2004.07.035; Costello PS, 1996, ONCOGENE, V13, P2595; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Fodor S, 2006, IMMUNOL LETT, V104, P29, DOI 10.1016/j.imlet.2005.11.001; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Grodzki ACG, 2009, MOL IMMUNOL, V46, P2539, DOI 10.1016/j.molimm.2009.05.013; Hamawy MM, 1997, BIOCHEM BIOPH RES CO, V239, P670, DOI 10.1006/bbrc.1997.7532; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; HIRASAWA N, 1995, J BIOL CHEM, V270, P10960, DOI 10.1074/jbc.270.18.10960; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Hsueh Robert C, 2002, BMC Immunol, V3, P16, DOI 10.1186/1471-2172-3-16; HUTCHINSON LE, 1995, J BIOL CHEM, V270, P16333, DOI 10.1074/jbc.270.27.16333; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Keshvara LM, 1997, J BIOL CHEM, V272, P10377; Kettner A, 2003, MOL CELL BIOL, V23, P2395, DOI 10.1128/MCB.23.7.2395-2406.2003; Kimura T, 1996, J BIOL CHEM, V271, P27962, DOI 10.1074/jbc.271.44.27962; Kimura T, 1996, MOL CELL BIOL, V16, P1471; Klemm S, 2006, IMMUNOBIOLOGY, V211, P815, DOI 10.1016/j.imbio.2006.07.001; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Latour S, 1998, EMBO J, V17, P2584, DOI 10.1093/emboj/17.9.2584; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; SHIUE L, 1995, MOL CELL BIOL, V15, P272, DOI 10.1128/MCB.15.1.272; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TAYLOR JA, 1995, MOL CELL BIOL, V15, P4149; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; van Oers N S, 1995, Semin Immunol, V7, P227, DOI 10.1006/smim.1995.0027; Wu JN, 2004, J IMMUNOL, V172, P6768, DOI 10.4049/jimmunol.172.11.6768; Yamashita T, 1998, J BIOCHEM, V123, P1199; YANAGI S, 1995, CELL SIGNAL, V7, P185, DOI 10.1016/0898-6568(94)00088-S; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71; Zhang J, 1998, J IMMUNOL, V161, P4366; Zhang J, 2007, J BIOL CHEM, V282, P37669, DOI 10.1074/jbc.M705168200; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105; Zhao QH, 1996, MOL CELL BIOL, V16, P6765	65	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26674	26684		10.1074/jbc.M110.134262	http://dx.doi.org/10.1074/jbc.M110.134262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554527	hybrid, Green Published			2022-12-25	WOS:000280921000082
J	Kasahara, T; Kasahara, M				Kasahara, Toshiko; Kasahara, Michihiro			Identification of a Key Residue Determining Substrate Affinity in the Yeast Glucose Transporter Hxt7 A TWO-DIMENSIONAL COMPREHENSIVE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; COMPREHENSIVE CHIMERIC ANALYSIS; SACCHAROMYCES-CEREVISIAE; HEXOSE TRANSPORTER; ESCHERICHIA-COLI; SCANNING MUTAGENESIS; LACTOSE PERMEASE; BINDING-SITE; HELIX VII; GLUT1	We previously identified Asn(331) in transmembrane segment 7 (TM7) as a key residue determining substrate affinity in Hxt2, a moderately high-affinity facilitative glucose transporter of Saccharomyces cerevisiae. To gain further insight into the structural basis of substrate recognition by yeast glucose transporters, we have now studied Hxt7, whose affinity for glucose is the highest among the major hexose transporters. The functional role of Asp(340) in Hxt7, the residue corresponding to Asn(331) of Hxt2, was examined by replacing it with each of the other 19 amino acids. Such replacement of Asp(340) generated transporters with various affinities for glucose, with the affinity of the Cys(340) mutant surpassing that of the wild-type Hxt7. To examine the structural role of Asp(340) in the substrate translocation pathway, we performed cysteine-scanning mutagenesis of the 21 residues in TM7 of a functional Cys-less Hxt7 mutant in conjunction with exposure to the hydrophilic sulfhydryl reagent p-chloromercuribenzenesulfonate (pCMBS). The transport activity of the D340C mutant of Cys-less Hxt7, in which Asp(340) is replaced with Cys, was completely inhibited by pCMBS, indicating that Asp(340) is located in a water-accessible position. This D340C mutant showed a sensitivity to pCMBS that was similar to 70 times that of the wild-type Hxt7, and it was protected from pCMBS inhibition by the substrates D-glucose and 2-deoxy-D-glucose but not by L-glucose. These results indicate that Asp(340) is situated at or close to a substrate recognition site and is a key residue determining high-affinity glucose transport by Hxt7, supporting the notion that yeast glucose transporters share a common mechanism for substrate recognition.	[Kasahara, Toshiko; Kasahara, Michihiro] Teikyo Univ, Biophys Lab, Sch Med, Tokyo 1920395, Japan; [Kasahara, Michihiro] Teikyo Univ, Genome Res Ctr, Tokyo 1920395, Japan	Teikyo University; Teikyo University	Kasahara, M (corresponding author), Teikyo Univ, Biophys Lab, Sch Med, Tokyo 1920395, Japan.	kasahara@main.teikyo-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Teikyo University	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Teikyo University	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from Teikyo University.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; AMBERG DC, 2005, METHODS YEAST GENETI, P200; Diderich JA, 2001, YEAST, V18, P1515, DOI 10.1002/yea.779; Elbing K, 2004, APPL ENVIRON MICROB, V70, P5323, DOI 10.1128/AEM.70.9.5323-5330.2004; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Hruz PW, 1999, J BIOL CHEM, V274, P36176, DOI 10.1074/jbc.274.51.36176; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kasahara M, 1997, J BIOL CHEM, V272, P16721, DOI 10.1074/jbc.272.27.16721; Kasahara T, 2004, J BIOL CHEM, V279, P30274, DOI 10.1074/jbc.M403762200; Kasahara T, 2003, BIOCHEM J, V372, P247, DOI 10.1042/BJ20030044; Kasahara T, 1996, BIOCHEM J, V315, P177, DOI 10.1042/bj3150177; Kasahara T, 2007, J BIOL CHEM, V282, P13146, DOI 10.1074/jbc.C700041200; Kasahara T, 2006, J BIOL CHEM, V281, P18532, DOI 10.1074/jbc.M602123200; Kasahara T, 2009, BBA-BIOMEMBRANES, V1788, P1051, DOI 10.1016/j.bbamem.2009.01.014; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; Manolescu A, 2005, J BIOL CHEM, V280, P42978, DOI 10.1074/jbc.M508678200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; NISHIZAWA K, 1995, J BIOL CHEM, V270, P2423, DOI 10.1074/jbc.270.6.2423; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Venkatesan P, 2000, BIOCHEMISTRY-US, V39, P10641, DOI 10.1021/bi000438b; Will A, 1998, J BIOL CHEM, V273, P11456, DOI 10.1074/jbc.273.19.11456; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Ye L, 2001, YEAST, V18, P1257, DOI 10.1002/yea.771.abs; Ye L, 1999, J BACTERIOL, V181, P4673, DOI 10.1128/JB.181.15.4673-4675.1999; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	27	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26263	26268		10.1074/jbc.M110.149716	http://dx.doi.org/10.1074/jbc.M110.149716			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20525688	hybrid, Green Published			2022-12-25	WOS:000280921000043
J	Boyd, M; Hansen, M; Jensen, TGK; Perearnau, A; Olsen, AK; Bram, LL; Bak, M; Tommerup, N; Olsen, J; Troelsen, JT				Boyd, Mette; Hansen, Morten; Jensen, Tine G. K.; Perearnau, Anna; Olsen, Anders K.; Bram, Lotte L.; Bak, Mads; Tommerup, Niels; Olsen, Jorgen; Troelsen, Jesper T.			Genome-wide Analysis of CDX2 Binding in Intestinal Epithelial Cells (Caco-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS TRANSCRIPTION FACTORS; CAUDAL-RELATED HOMEOBOX; GENE-EXPRESSION; BETA-CATENIN; DIFFERENTIAL EXPRESSION; PROTEINS; ACTIVATION; BOX; HEPATOCYTE-NUCLEAR-FACTOR-4-ALPHA; PHOSPHORYLATION	The CDX2 transcription factor is known to play a crucial role in inhibiting proliferation, promoting differentiation and the expression of intestinal specific genes in intestinal cells. The overall effect of CDX2 in intestinal cells has previously been investigated in conditional knock-out mice, revealing a critical role of CDX2 in the formation of the normal intestinal identity. The identification of direct targets of transcription factors is a key problem in the study of gene regulatory networks. The ChIP-seq technique combines chromatin immunoprecipitation (ChIP) with next generation sequencing resulting in a high throughput experimental method of identifying direct targets of specific transcription factors. The method was applied to CDX2, leading to the identification of the direct binding of CDX2 to several known and novel target genes in the intestinal cell. Examination of the transcript levels of selected genes verified the regulatory role of CDX2 binding. The results place CDX2 as a key node in a transcription factor network controlling the proliferation and differentiation of intestinal cells.	[Bak, Mads; Tommerup, Niels; Troelsen, Jesper T.] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Troelsen, JT (corresponding author), Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, Bldg 6-4,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	troelsen@sund.ku.dk	Troelsen, Jesper Thorvald T/B-6264-2013; Olsen, Jørgen/K-5355-2019; Tommerup, Niels/T-8776-2017	Troelsen, Jesper Thorvald T/0000-0002-4177-3267; Olsen, Jørgen/0000-0003-1974-6446; Tommerup, Niels/0000-0003-2304-0112; Perearnau, Anna/0000-0002-7925-2942; Bak, Mads/0000-0003-2762-1002	Novo Nordisk Foundation; Lundbeck Foundation; Danish Research Council; Lundbeck Foundation [R13-2007-1172] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Research Council(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Novo Nordisk Foundation, the Lundbeck Foundation, and the Danish Research Council.	Arbel-Goren R, 2005, J BIOL CHEM, V280, P19105, DOI 10.1074/jbc.M502060200; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; Balakrishnan A, 2008, SURGERY, V144, P168, DOI 10.1016/j.surg.2008.03.010; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Benahmed F, 2008, GASTROENTEROLOGY, V135, P1238, DOI 10.1053/j.gastro.2008.06.045; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boulanger J, 2005, J BIOL CHEM, V280, P18095, DOI 10.1074/jbc.M502184200; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fang RX, 2006, GENE EXPR PATTERNS, V6, P426, DOI 10.1016/j.modgep.2005.09.003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Gautier-Stein A, 2003, NUCLEIC ACIDS RES, V31, P5238, DOI 10.1093/nar/gkg747; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; Guo RJ, 2010, CARCINOGENESIS, V31, P159, DOI 10.1093/carcin/bgp213; Hadari YR, 2000, J CELL SCI, V113, P2385; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Houde M, 2001, J BIOL CHEM, V276, P21885, DOI 10.1074/jbc.M100236200; JAMES R, 1991, J BIOL CHEM, V266, P3246; Jedlicka P, 2009, AM J PATHOL, V174, P1280, DOI 10.2353/ajpath.2009.080409; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jonckheere N, 2007, J BIOL CHEM, V282, P22638, DOI 10.1074/jbc.M700905200; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Krasinski SD, 2001, AM J PHYSIOL-GASTR L, V281, pG69, DOI 10.1152/ajpgi.2001.281.1.G69; Laprise P, 2002, J BIOL CHEM, V277, P8226, DOI 10.1074/jbc.M110235200; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Lottaz D, 1999, CANCER RES, V59, P1127; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Mitchelmore C, 2000, BIOCHEM J, V346, P529, DOI 10.1042/0264-6021:3460529; Okochi H, 1999, J CLIN GASTROENTEROL, V29, P63, DOI 10.1097/00004836-199907000-00016; OKUDA T, 1995, GENOMICS, V29, P623, DOI 10.1006/geno.1995.9957; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Polakis P, 2000, GENE DEV, V14, P1837; Rings EHHM, 2001, GASTROENTEROLOGY, V121, P1437, DOI 10.1053/gast.2001.29618; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sauvaget D, 2002, J BIOL CHEM, V277, P34540, DOI 10.1074/jbc.M206074200; Schjoldager KTBG, 2008, AM J PHYSIOL-GASTR L, V294, pG1335, DOI 10.1152/ajpgi.00265.2007; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimizu T, 2006, DEVELOPMENT, V133, P4709, DOI 10.1242/dev.02660; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Suh E, 1996, MOL CELL BIOL, V16, P619; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; Troelsen JT, 2003, GENE, V305, P101, DOI 10.1016/S0378-1119(02)01232-5; Valente AJ, 2008, FREE RADICAL BIO MED, V44, P430, DOI 10.1016/j.freeradbiomed.2007.10.035; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wang LY, 2004, AM J PHYSIOL-GASTR L, V287, pG943, DOI 10.1152/ajpgi.00121.2004; Xu FH, 1999, J BIOL CHEM, V274, P34310, DOI 10.1074/jbc.274.48.34310	62	60	61	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25115	25125		10.1074/jbc.M109.089516	http://dx.doi.org/10.1074/jbc.M109.089516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551321	hybrid, Green Published			2022-12-25	WOS:000280682400003
J	Yamasaki-Mann, M; Demuro, A; Parker, I				Yamasaki-Mann, Michiko; Demuro, Angelo; Parker, Ian			Modulation of Endoplasmic Reticulum Ca2+ Store Filling by Cyclic ADP-ribose Promotes Inositol Trisphosphate (IP3)-evoked Ca2+ Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; 1,4,5-TRISPHOSPHATE RECEPTOR; CYTOSOLIC CA2+; LUMINAL CA2+; CALCIUM STORES; IP3 RECEPTORS; RELEASE; CHANNEL; ACTIVATION; SINGLE	In addition to its well established function in activating Ca2+ release from the endoplasmic reticulum (ER) through ryanodine receptors (RyR), the second messenger cyclic ADP-ribose (cADPR) also accelerates the activity of SERCA pumps, which sequester Ca2+ into the ER. Here, we demonstrate a potential physiological role for cADPR in modulating cellular Ca2+ signals via changes in ER Ca2+ store content, by imaging Ca2+ liberation through inositol trisphosphate receptors (IP3R) in Xenopus oocytes, which lack RyR. Oocytes were injected with the non-metabolizable analog 3-deaza-cADPR, and cytosolic [Ca2+] was transiently elevated by applying voltage-clamp pulses to induce Ca2+ influx through expressed plasmalemmal nicotinic channels. We observed a subsequent potentiation of global Ca2+ signals evoked by strong photorelease of IP3, and increased numbers of local Ca2+ puffs evoked by weaker photorelease. These effects were not evident with cADPR alone or following cytosolic Ca2+ elevation alone, indicating that they did not arise through direct actions of cADPR or Ca2+ on the IP3R, but likely resulted from enhanced ER store filling. Moreover, the appearance of a new population of puffs with longer latencies, prolonged durations, and attenuated amplitudes suggests that luminal ER Ca2+ may modulate IP3R function, in addition to simply determining the size of the available store and the electrochemical driving force for release.	[Yamasaki-Mann, Michiko; Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Parker, Ian] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Yamasaki-Mann, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 635 Charles Young Dr S, Los Angeles, CA 90095 USA.	michikomann@ucla.edu			National Institutes of Health [GM48071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048071, R37GM048071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM48071 (to I. P.) from the National Institutes of Health.	Albrecht MA, 2002, J GEN PHYSIOL, V119, P211, DOI 10.1085/jgp.119.3.211; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERS DM, 1995, AM J PHYSIOL-CELL PH, V268, pC271, DOI 10.1152/ajpcell.1995.268.1.C271; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Bruzzone S, 2003, J CELL BIOL, V163, P837, DOI 10.1083/jcb.200307016; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; Ching LL, 2000, CIRC RES, V87, P201, DOI 10.1161/01.RES.87.3.201; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Demuro A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846074; Friel D, 2004, BIOL RES, V37, P665, DOI 10.4067/s0716-97602004000400024; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; HIROSE K, 1994, NATURE, V372, P791; HORNE JH, 1995, BIOCHEMISTRY-US, V34, P12738, DOI 10.1021/bi00039a033; Lukyanenko V, 2001, CIRC RES, V89, P614, DOI 10.1161/hh1901.098066; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MISSIAEN L, 1992, J BIOL CHEM, V267, P22961; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MORGAN AJ, 2002, CYCLIC ADP RIBOSE NA; OLDERSHAW KA, 1993, BIOCHEM J, V292, P631, DOI 10.1042/bj2920631; Olson ML, 2010, J BIOL CHEM, V285, P2040, DOI 10.1074/jbc.M109.027094; PARYS JB, 1992, J BIOL CHEM, V267, P18776; PARYS JB, 1993, J BIOL CHEM, V268, P25206; Patterson M, 2007, J GEN PHYSIOL, V129, P29, DOI 10.1085/jgp.200609660; Petersen OH, 2001, TRENDS NEUROSCI, V24, P271, DOI 10.1016/S0166-2236(00)01787-2; Pozzo-Miller LD, 2000, J PHYSIOL-LONDON, V525, P53, DOI 10.1111/j.1469-7793.2000.t01-1-00053.x; Rose HJ, 2006, BIOPHYS J, V91, P4024, DOI 10.1529/biophysj.106.088872; Shuai JW, 2007, BIOPHYS J, V93, P1151, DOI 10.1529/biophysj.107.108795; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; SITSAPESAN R, 1995, J MEMBRANE BIOL, V146, P133, DOI 10.1007/BF00238004; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; Swatton JE, 2002, J BIOL CHEM, V277, P17571, DOI 10.1074/jbc.M200524200; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Yamasaki-Mann M, 2009, CELL CALCIUM, V45, P293, DOI 10.1016/j.ceca.2008.11.008; Yano K, 2004, BIOCHEM J, V383, P353, DOI 10.1042/BJ20040629; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538	45	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25053	25061		10.1074/jbc.M109.095257	http://dx.doi.org/10.1074/jbc.M109.095257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538594	hybrid, Green Published			2022-12-25	WOS:000280542100078
J	Lee, S; Donehower, LA; Herron, AJ; Moore, DD; Fu, LN				Lee, Susie; Donehower, Lawrence A.; Herron, Alan J.; Moore, David D.; Fu, Loning			Disrupting Circadian Homeostasis of Sympathetic Signaling Promotes Tumor Development in Mice	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; BREAST-CANCER RISK; GENE-EXPRESSION; GROWTH-HORMONE; SHIFT WORK; CLOCK; LIGHT; MELATONIN; LEPTIN; RECEPTOR	Background: Cell proliferation in all rapidly renewing mammalian tissues follows a circadian rhythm that is often disrupted in advanced-stage tumors. Epidemiologic studies have revealed a clear link between disruption of circadian rhythms and cancer development in humans. Mice lacking the circadian genes Period1 and 2 (Per) or Cryptochrome1 and 2 (Cry) are deficient in cell cycle regulation and Per2 mutant mice are cancer-prone. However, it remains unclear how circadian rhythm in cell proliferation is generated in vivo and why disruption of circadian rhythm may lead to tumorigenesis. Methodology/Principal Findings: Mice lacking Per1 and 2, Cry1 and 2, or one copy of Bmal1, all show increased spontaneous and radiation-induced tumor development. The neoplastic growth of Per-mutant somatic cells is not controlled cell-autonomously but is dependent upon extracellular mitogenic signals. Among the circadian output pathways, the rhythmic sympathetic signaling plays a key role in the central-peripheral timing mechanism that simultaneously activates the cell cycle clock via AP1-controlled Myc induction and p53 via peripheral clock-controlled ATM activation. Jet-lag promptly desynchronizes the central clock-SNS-peripheral clock axis, abolishes the peripheral clock-dependent ATM activation, and activates myc oncogenic potential, leading to tumor development in the same organ systems in wild-type and circadian gene-mutant mice. Conclusions/Significance: Tumor suppression in vivo is a clock-controlled physiological function. The central circadian clock paces extracellular mitogenic signals that drive peripheral clock-controlled expression of key cell cycle and tumor suppressor genes to generate a circadian rhythm in cell proliferation. Frequent disruption of circadian rhythm is an important tumor promoting factor.	[Lee, Susie; Fu, Loning] Baylor Coll Med, Childrens Nutr Res Ctr, ARS, USDA,Dept Pediat, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Donehower, Lawrence A.; Moore, David D.; Fu, Loning] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Herron, Alan J.] Baylor Coll Med, Ctr Comparat Med, Dept Pathol, Houston, TX 77030 USA; [Donehower, Lawrence A.; Moore, David D.; Fu, Loning] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lee, S (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, ARS, USDA,Dept Pediat, Houston, TX 77030 USA.	loningf@bcm.edu			National Institutes of Health (NIH) [CA107821-01A1]; United States Department of Agriculture (USDA) [CRIS 6250-51000-049, CRIS 6250-51000-055]; NATIONAL CANCER INSTITUTE [R03CA107821] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant CA107821-01A1, and United States Department of Agriculture (USDA) grants CRIS 6250-51000-049 and CRIS 6250-51000-055 to L. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2005, CANCER RES, V65, P2565, DOI 10.1158/0008-5472.CAN-04-4283; Appleton DR, 2002, CELL PROLIFERAT, V35, P68, DOI 10.1046/j.1365-2184.35.s1.7.x; AUBERT C, 1980, J NEURAL TRANSM, V47, P121, DOI 10.1007/BF01670163; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BEVILACQUA M, 1991, CANCER, V67, P2543, DOI 10.1002/1097-0142(19910515)67:10<2543::AID-CNCR2820671026>3.0.CO;2-L; Bjarnason GA, 2000, PROG CELL CYC RES, V4, P193; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Dang CV, 2005, CANCER CELL, V8, P177, DOI 10.1016/j.ccr.2005.08.005; Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; ECHAVELLANOS JM, 1970, JNCI-J NATL CANCER I, V44, P581; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Filipski E, 2002, J NATL CANCER I, V94, P690; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Furness JB, 2006, AUTON NEUROSCI-BASIC, V130, P1, DOI 10.1016/j.autneu.2006.05.003; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Gery S, 2005, BLOOD, V106, P2827, DOI 10.1182/blood-2005-01-0358; Gery S, 2007, CLIN CANCER RES, V13, P1399, DOI 10.1158/1078-0432.CCR-06-1730; Giglio Pierre, 2005, Curr Oncol Rep, V7, P61, DOI 10.1007/s11912-005-0027-8; HAMILTON T, 1969, BRIT J SURG, V56, P764, DOI 10.1002/bjs.1800561018; Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hoffman AE, 2009, CANCER RES, V69, P3605, DOI 10.1158/0008-5472.CAN-08-4572; HOSHINO S, 1994, J NEUROSURG, V80, P919, DOI 10.3171/jns.1994.80.5.0919; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Iwakuma T, 2003, MOL CANCER RES, V1, P993; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kiba T, 2004, PANCREAS, V29, pE51, DOI 10.1097/00006676-200408000-00019; Kim M, 1998, J NEURO-ONCOL, V36, P85, DOI 10.1023/A:1005716408970; KLEVECZ RR, 1987, CHRONOBIOL INT, V4, P513, DOI 10.3109/07420528709078543; Kloog I, 2009, CHRONOBIOL INT, V26, P108, DOI 10.1080/07420520802694020; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; KRISS VM, 1995, SKELETAL RADIOL, V24, P633; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; Levi FA, 2008, IEEE ENG MED BIOL, V27, P17, DOI 10.1109/MEMB.2007.907361; Li JC, 1997, BIOL SIGNAL, V6, P77; Lin YM, 2008, MOL CARCINOGEN, V47, P925, DOI 10.1002/mc.20446; Marino JL, 2008, EPIDEMIOLOGY, V19, P477, DOI 10.1097/EDE.0b013e31816b7378; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; MHATRE MC, 1984, JNCI-J NATL CANCER I, V72, P1411; OPARIL S, 1987, CAN J PHYSIOL PHARM, V65, P1548, DOI 10.1139/y87-244; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panzer A, 1997, MED HYPOTHESES, V48, P523, DOI 10.1016/S0306-9877(97)90123-7; Pogue-Geile KL, 2006, CANCER LETT, V243, P55, DOI 10.1016/j.canlet.2005.11.049; Rao JM, 2008, MED HYPOTHESES, V71, P442, DOI 10.1016/j.mehy.2008.03.039; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Renehan AG, 2008, BEST PRACT RES CL EN, V22, P639, DOI 10.1016/j.beem.2008.08.011; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RYDELL R, 1990, In Vivo (Attiki), V4, P385; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schemhammer ES, 2006, ENDOCR-RELAT CANCER, V13, P583, DOI 10.1677/erc.1.01149; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; SCHOENBERG BS, 1977, CANCER, V40, P1961, DOI 10.1002/1097-0142(197710)40:4+<1961::AID-CNCR2820400831>3.0.CO;2-G; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; SHAH PN, 1984, CANCER RES, V44, P3403; Shih MC, 2006, MOL CARCINOGEN, V45, P732, DOI 10.1002/mc.20198; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Smaaland R, 1996, Prog Cell Cycle Res, V2, P241; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tokunaga H, 2008, ACTA OBSTET GYN SCAN, V87, P1060, DOI 10.1080/00016340802348286; Touitou Y, 1996, BRIT J CANCER, V74, P1248, DOI 10.1038/bjc.1996.524; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; van den Heiligenberg S, 1999, LIFE SCI, V64, P2523, DOI 10.1016/S0024-3205(99)00210-6; Viswanathan AN, 2009, CANCER LETT, V281, P1, DOI 10.1016/j.canlet.2008.11.002; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Wood PA, 2008, MOL CANCER RES, V6, P1786, DOI 10.1158/1541-7786.MCR-08-0196; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zhu Y, 2007, INT J CANCER, V120, P432, DOI 10.1002/ijc.22321; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	83	168	181	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10995	10.1371/journal.pone.0010995	http://dx.doi.org/10.1371/journal.pone.0010995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539819	gold, Green Published, Green Submitted			2022-12-25	WOS:000278465900012
J	Lima, VD; Hogg, RS; Montaner, JSG				Lima, Viviane D.; Hogg, Robert S.; Montaner, Julio S. G.			Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV PREVENTION; SCALING-UP; TRANSMISSION; ACCESS; IMPACT; INFECTION; GROWTH; CURB	Background: In 2008, the IAS-USA published the revised guidelines for the use of HAART in adults substantially increasing the number of individuals eligible for HAART. The epidemic in British Columbia (BC) is mainly among men who have sex with men and those with injection drug use. Here, we explored the potential impact of different HAART coverage scenarios, based on the new guidelines, on the HIV-related incidence, morbidity and mortality in BC, Canada. Methodology: We built a mathematical transmission model to investigate different HAART coverage scenarios (50%, 60%, 75% and 100%) of those medically eligible to receive HAART under the 2008 IAS guidelines. All new scenarios were compared to the current coverage in BC under the 2006 IAS guidelines (i.e. baseline scenario). In BC, it is estimated that 25-30% of individuals are unaware of their status. Costs were drug-related and reported in Canadian dollars. HIV-related morbidity and mortality were estimated based on the disability-adjusted life years (DALY) methodology. Principal Findings: Currently, there are 4379 individuals on HAART under the IAS 2006 guidelines and 6781 individuals who qualify for treatment based on the new guidelines. Within 5 years, increasing HAART coverage decreased yearly new infections by at least 44.8%. In the 50% scenario, in 5 years, DALY decreased by 53% corresponding to 4155 averted DALYs, and in 25 years it decreased by 66% corresponding to 5837 averted DALYs. The effect was even stronger if the 75% scenario was chosen instead. Compared to the 100% expansion scenario, we observed an excess in annual direct treatment expenditures at the end of 5 years of approximately 1 million dollars in the 75% scenario, and of approximately 2 million dollars in the 50% scenario. Conclusions/Significance: The individual and public health benefits of these new guidelines are immense. The results show that by increasing the number of individuals on HAART save lives, it is cost averting, and it positively impacts society by decreasing the number of new HIV infections. Thus, public health community should consider incremental gains when considering guidelines and policy.	[Lima, Viviane D.; Hogg, Robert S.; Montaner, Julio S. G.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Lima, Viviane D.; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Dept Med, Div Aids, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Simon Fraser University	Lima, VD (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	vlima@cfenet.ubc.ca	Hogg, Robert S/B-2783-2012; Montaner, Julio/K-7621-2012	Hogg, Robert S/0000-0003-3463-5488; 	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; National Institute on Drug Abuse at the US National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Institute on Drug Abuse at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Canadian Institutes of Health Research and Michael Smith Foundation for Health Research through fellowship awards to Dr. Lima. Dr. Montaner is a recipient of an Avant-Garde Award from the National Institute on Drug Abuse at the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; [Anonymous], 14 C RETR OPP INF FE; [Anonymous], GLOB BURD DIS 2004 U; *BRIT COL CTR DIS, 2008, STI HIV ANN REP 2008; *BRIT COL CTR DIS, 2007, HIV AIDS ANN REP 200; *BRIT COL CTR EXC, 2010, HIV PREV BRIT COL; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; De Cock KM, 2009, LANCET, V373, P7, DOI 10.1016/S0140-6736(08)61732-8; DeCruttola V, 2008, AIDS, V22, P2554, DOI 10.1097/QAD.0b013e32831940d3; Dube S, 2008, JAIDS-J ACQ IMM DEF, V48, P72, DOI 10.1097/QAI.0b013e31816bcdbb; Egger M, 2008, LANCET, V371, P1558, DOI 10.1016/S0140-6736(08)60669-8; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg Robert S, 2005, Harm Reduct J, V2, P26, DOI 10.1186/1477-7517-2-26; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Lagakos SW, 2008, NEW ENGL J MED, V358, P1543, DOI 10.1056/NEJMp0802028; LIMA V, 2009, 5 IAS C HIV PATH TRE; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Markel H, 2005, NEW ENGL J MED, V353, P753, DOI 10.1056/NEJMp058146; Marshall BDL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-7; Martinez V, 2008, CURR OPIN INFECT DIS, V21, P42, DOI 10.1097/QCO.0b013e3282f3d9d3; McInnes CW, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-5; Montaner J, 2009, AIDS, V23, P1031, DOI 10.1097/QAD.0b013e32832a128b; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Public Health Agency of Canada, 2007, HIV AIDS EP UPD NOV; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; SPAAR A, 2009, 5 IAS C HIV PATH TRE; *STAT CAN, 2010, CANSIM; Steinbrook R, 2008, NEW ENGL J MED, V359, P885, DOI 10.1056/NEJMp0805761; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; TOVANABUTRA S, 2002, J ACQ IMMUN DEF SYND, V3, P275; UNAIDS, 2008, REP GLOB AIDS EP; VERMUND SH, 2009, HIV AIDS, V4, P266; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; 2009, AIDS READ, V19, P229; 2010, SEEK TREAT OPTIMAL P	45	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10991	10.1371/journal.pone.0010991	http://dx.doi.org/10.1371/journal.pone.0010991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539817	Green Submitted, Green Published, gold			2022-12-25	WOS:000278465900009
J	Minea, RO; Helchowski, CM; Zidovetzki, SJ; Costa, FK; Swenson, SD; Markland, FS				Minea, Radu O.; Helchowski, Corey M.; Zidovetzki, Samuel J.; Costa, Fritz K.; Swenson, Stephen D.; Markland, Francis S., Jr.			Vicrostatin - An Anti-Invasive Multi-Integrin Targeting Chimeric Disintegrin with Tumor Anti-Angiogenic and Pro-Apoptotic Activities	PLOS ONE			English	Article							SNAKE-VENOM DISINTEGRIN; AGKISTRODON-CONTORTRIX-CONTORTRIX; ALPHA-V INTEGRINS; BREAST-CANCER; CELL-ADHESION; TYROSINE PHOSPHORYLATION; HOMODIMERIC DISINTEGRIN; ENDOGENOUS INHIBITORS; EXTRACELLULAR-MATRIX; DIMERIC DISINTEGRIN	Similar to other integrin-targeting strategies, disintegrins have previously shown good efficacy in animal cancer models with favorable pharmacological attributes and translational potential. Nonetheless, these polypeptides are notoriously difficult to produce recombinantly due to their particular structure requiring the correct pairing of multiple disulfide bonds for biological activity. Here, we show that a sequence-engineered disintegrin (called vicrostatin or VCN) can be reliably produced in large scale amounts directly in the oxidative cytoplasm of Origami B E. coli. Through multiple integrin ligation (i.e., alpha v beta 3, alpha v beta 5, and alpha 5 beta 1), VCN targets both endothelial and cancer cells significantly inhibiting their motility through a reconstituted basement membrane. Interestingly, in a manner distinct from other integrin ligands but reminiscent of some ECM-derived endogenous anti-angiogenic fragments previously described in the literature, VCN profoundly disrupts the actin cytoskeleton of endothelial cells (EC) inducing a rapid disassembly of stress fibers and actin reorganization, ultimately interfering with EC's ability to invade and form tubes (tubulogenesis). Moreover, here we show for the first time that the addition of a disintegrin to tubulogenic EC sandwiched in vitro between two Matrigel layers negatively impacts their survival despite the presence of abundant haptotactic cues. A liposomal formulation of VCN (LVCN) was further evaluated in vivo in two animal cancer models with different growth characteristics. Our data demonstrate that LVCN is well tolerated while exerting a significant delay in tumor growth and an increase in the survival of treated animals. These results can be partially explained by potent tumor anti-angiogenic and pro-apoptotic effects induced by LVCN.	[Minea, Radu O.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Minea, RO (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	markland@usc.edu	Markland, Frank/D-5073-2012		Army Ovarian Cancer Research Program [W81XWH-07-1-0298]; National Institutes of Health [1R41CA121452, 1R41CA126001]; California Breast Cancer Research Program [12IB-0153];  [BCTR0707423]; NATIONAL CANCER INSTITUTE [R41CA121452, R41CA126001] Funding Source: NIH RePORTER	Army Ovarian Cancer Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research Program; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grant support to FSM (Susan G. Komen, http://ww5.komen.org, grant #BCTR0707423; Army Ovarian Cancer Research Program, http://cdmrp.army.mil/ocrp/default.htm, grant #W81XWH-07-1-0298; National Institutes of Health, www.nih.gov, grants #1R41CA121452 and 1R41CA126001), and to SDS (California Breast Cancer Research Program, http://www.cbcrp.org/, grant #12IB-0153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Artoni A, 2004, P NATL ACAD SCI USA, V101, P13114, DOI 10.1073/pnas.0404201101; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Clamp AR, 2005, BRIT J CANCER, V93, P967, DOI 10.1038/sj.bjc.6602820; Contois L, 2009, SEMIN CANCER BIOL, V19, P318, DOI 10.1016/j.semcancer.2009.05.002; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Dixelius J, 2002, CANCER RES, V62, P1944; Eble JA, 2010, MATRIX BIOL, V29, P239, DOI 10.1016/j.matbio.2010.01.004; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ellis LM, 2009, NATURE, V458, P290, DOI 10.1038/458290a; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fox SB, 2004, APMIS, V112, P413, DOI 10.1111/j.1600-0463.2004.apm11207-0803.x; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Golubkov Vladislav, 2003, Angiogenesis, V6, P213, DOI 10.1023/B:AGEN.0000021396.47009.b0; Goodman SL, 2002, J MED CHEM, V45, P1045, DOI 10.1021/jm0102598; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hariharan S, 2007, ANN ONCOL, V18, P1400, DOI 10.1093/annonc/mdm140; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang TF, 2001, HAEMOSTASIS, V31, P192; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Juarez P, 2008, MOL BIOL EVOL, V25, P2391, DOI 10.1093/molbev/msn179; Jurasz P, 2004, BRIT J PHARMACOL, V143, P819, DOI 10.1038/sj.bjp.0706013; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; McCarty JH, 2008, AM J PATHOL, V172, P1740, DOI 10.2353/ajpath.2008.070700; McLane MA, 1998, P SOC EXP BIOL MED, V219, P109, DOI 10.3181/00379727-219-44322; McLane MA, 2008, FRONT BIOSCI-LANDMRK, V13, P6617, DOI 10.2741/3177; Minea R, 2005, PATHOPHYSIOL HAEMO T, V34, P177, DOI 10.1159/000092419; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Moiseeva N, 2008, ACTA CRYSTALLOGR D, V64, P466, DOI 10.1107/S0907444908002370; Napione L, 2007, AUTOIMMUN REV, V7, P18, DOI 10.1016/j.autrev.2007.03.007; Nash GF, 2002, LANCET ONCOL, V3, P425, DOI 10.1016/S1470-2045(02)00789-1; Nemeth JA, 2007, CANCER INVEST, V25, P632, DOI 10.1080/07357900701522638; OSBORNE CK, 1985, CANCER RES, V45, P584; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park Sang-Hyun, 2004, Methods Mol Biol, V261, P161; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petrelli A, 2009, EXPERT OPIN PHARMACO, V10, P589, DOI [10.1517/14656560902781907, 10.1517/14656560902781907 ]; PRICE JE, 1990, CANCER RES, V50, P717; PROTOPAPA E, 1993, EUR J CANCER, V29A, P1391, DOI 10.1016/0959-8049(93)90008-4; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Ritter MR, 2001, TOXICON, V39, P283, DOI 10.1016/S0041-0101(00)00126-4; Ritter MR, 2000, J CELL BIOCHEM, V79, P28, DOI 10.1002/1097-4644(2000)79:1<28::AID-JCB40>3.0.CO;2-Y; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; Schmitmeier S, 2005, NEUROSURGERY, V57, P141, DOI 10.1227/01.NEU.0000163426.25227.56; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Serini G, 2008, CURR OPIN HEMATOL, V15, P235, DOI 10.1097/MOH.0b013e3282fa745b; Serini G, 2009, ANGIOGENESIS, V12, P187, DOI 10.1007/s10456-009-9138-4; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Sund M, 2005, P NATL ACAD SCI USA, V102, P2934, DOI 10.1073/pnas.0500180102; Swenson S, 2004, MOL CANCER THER, V3, P499; TRIKHA M, 1994, THROMB RES, V73, P39, DOI 10.1016/0049-3848(94)90052-3; TRIKHA M, 1994, CANCER RES, V54, P4993; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Varner J A, 1999, Angiogenesis, V3, P53, DOI 10.1023/A:1009019223744; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Wierzbicka-Patynowski I, 1999, J BIOL CHEM, V274, P37809, DOI 10.1074/jbc.274.53.37809; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; Zhou Q, 2000, BREAST CANCER RES TR, V61, P249, DOI 10.1023/A:1006457903545; Zhou Q, 1999, Angiogenesis, V3, P259, DOI 10.1023/A:1009059210733; Zhou Q, 2000, BIOCHEM BIOPH RES CO, V267, P350, DOI 10.1006/bbrc.1999.1965	87	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10929	10.1371/journal.pone.0010929	http://dx.doi.org/10.1371/journal.pone.0010929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532165	Green Published, Green Submitted, gold			2022-12-25	WOS:000278318700003
J	Ieronimakis, N; Balasundaram, G; Rainey, S; Srirangam, K; Yablonka-Reuveni, Z; Reyes, M				Ieronimakis, Nicholas; Balasundaram, Gayathri; Rainey, Sabrina; Srirangam, Kiran; Yablonka-Reuveni, Zipora; Reyes, Morayma			Absence of CD34 on Murine Skeletal Muscle Satellite Cells Marks a Reversible State of Activation during Acute Injury	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; GENE-EXPRESSION; PAX7; QUIESCENT; PROGENITORS; MYOGENESIS; DIFFERENTIATION; SPECIFICATION; HETEROGENEITY	Background: Skeletal muscle satellite cells are myogenic progenitors that reside on myofiber surface beneath the basal lamina. In recent years satellite cells have been identified and isolated based on their expression of CD34, a sialomucin surface receptor traditionally used as a marker of hematopoietic stem cells. Interestingly, a minority of satellite cells lacking CD34 has been described. Methodology/Principal Findings: In order to elucidate the relationship between CD34+ and CD34- satellite cells we utilized fluorescence-activated cell sorting (FACS) to isolate each population for molecular analysis, culture and transplantation studies. Here we show that unless used in combination with alpha 7 integrin, CD34 alone is inadequate for purifying satellite cells. Furthermore, the absence of CD34 marks a reversible state of activation dependent on muscle injury. Conclusions/Significance: Following acute injury CD34- cells become the major myogenic population whereas the percentage of CD34+ cells remains constant. In turn activated CD34- cells can reverse their activation to maintain the pool of CD34+ reserve cells. Such activation switching and maintenance of reserve pool suggests the satellite cell compartment is tightly regulated during muscle regeneration.	[Ieronimakis, Nicholas; Balasundaram, Gayathri; Rainey, Sabrina; Srirangam, Kiran; Reyes, Morayma] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Yablonka-Reuveni, Zipora] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ieronimakis, N (corresponding author), Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.	morayma@u.washington.edu		Rainey, Sabrina/0000-0001-9717-7248	Jain Foundation, Inc.; University of Washington's Departments of Pathology and Lab Medicine; National Institutes of Health [5R03AR054955, 1R01AG035377, 5R01AG21566, 5R01AG013798, 1R21AR057794]; Muscular Dystrophy Association [135908]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054955, R21AR057794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035377, R01AG013798, R01AG021566] Funding Source: NIH RePORTER	Jain Foundation, Inc.; University of Washington's Departments of Pathology and Lab Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful for the financial support provided by the Jain Foundation, Inc., the University of Washington's Departments of Pathology and Lab Medicine, and National Institutes of Health grant 5R03AR054955 to M. R., and NIH grants 1R01AG035377 and 5R01AG21566 to Z.Y.-R., all of which made this research possible. Z.Y.-R. acknowledges additional support from the NIH (5R01AG013798, 1R21AR057794) and the Muscular Dystrophy Association (135908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903; Gnocchi VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005205; Graves DC, 2000, J HISTOCHEM CYTOCHEM, V48, P1173, DOI 10.1177/002215540004800902; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Ieronimakis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001753; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kastner S, 2000, J HISTOCHEM CYTOCHEM, V48, P1079, DOI 10.1177/002215540004800805; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Kirillova I, 2007, DEV BIOL, V311, P449, DOI 10.1016/j.ydbio.2007.08.056; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lanza F, 2001, J BIOL REG HOMEOS AG, V15, P1; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rooney JE, 2009, AM J PATHOL, V174, P256, DOI 10.2353/ajpath.2009.080522; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Springer ML, 2002, CELL MOTIL CYTOSKEL, V51, P177, DOI 10.1002/cm.10022; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yao CC, 1997, J CELL SCI, V110, P1477; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x	51	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10920	10.1371/journal.pone.0010920	http://dx.doi.org/10.1371/journal.pone.0010920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532193	Green Published, gold, Green Submitted			2022-12-25	WOS:000278284700005
J	Liu, Q; Kim, DI; Syme, J; LuValle, P; Burke, B; Roux, KJ				Liu, Qian; Kim, Dae In; Syme, Janet; LuValle, Phyllis; Burke, Brian; Roux, Kyle J.			Dynamics of Lamin-A Processing Following Precursor Accumulation	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; PROTEASE INHIBITORS BLOCK; NUCLEAR-MEMBRANE PROTEIN; PRELAMIN-A; MOUSE MODEL; RESTRICTIVE DERMOPATHY; SYNDROME MUTATION; IN-VITRO; ZMPSTE24; DISEASE	Lamin A (LaA) is a component of the nuclear lamina, an intermediate filament meshwork that underlies the inner nuclear membrane (INM) of the nuclear envelope (NE). Newly synthesized prelamin A (PreA) undergoes extensive processing involving C-terminal farnesylation followed by proteolysis yielding non-farnesylated mature lamin A. Different inhibitors of these processing events are currently used therapeutically. Hutchinson-Gilford Progeria Syndrome (HGPS) is most commonly caused by mutations leading to an accumulation of a farnesylated LaA isoform, prompting a clinical trial using farnesyltransferase inhibitors (FTI) to reduce this modification. At therapeutic levels, HIV protease inhibitors (PI) can unexpectedly inhibit the final processing step in PreA maturation. We have examined the dynamics of LaA processing and associated cellular effects during PI or FTI treatment and following inhibitor washout. While PI reversibility was rapid, with respect to both LaA maturation and associated cellular phenotype, recovery from FTI treatment was more gradual. FTI reversibility is influenced by both cell type and rate of proliferation. These results suggest a less static lamin network than has previously been observed.	[Liu, Qian] Shandong Univ, Dept Histol & Embryol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Liu, Qian; Kim, Dae In; Syme, Janet; LuValle, Phyllis; Burke, Brian; Roux, Kyle J.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA; [Burke, Brian] Inst Med Biol, Singapore, Singapore	Shandong University; State University System of Florida; University of Florida; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Liu, Q (corresponding author), Shandong Univ, Dept Histol & Embryol, Sch Med, Jinan 250100, Shandong, Peoples R China.	kroux@ufl.edu	Roux, Kyle/AAH-2019-2021; Kim, Dae In/G-7291-2012	Roux, Kyle/0000-0001-7530-5528; 	Bankhead-Coley New Investigator Research (NIR) [08BN-05]; National Institutes of Health (NIH) [RO1 5R01GM084085-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084085] Funding Source: NIH RePORTER	Bankhead-Coley New Investigator Research (NIR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Bankhead-Coley New Investigator Research (NIR) 08BN-05 to K.J.R. (http://www.floridabiomed.com/funding_bc.html) and National Institutes of Health (NIH) RO1 5R01GM084085-02 to B. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrowman J, 2008, MOL BIOL CELL, V19, P5398, DOI 10.1091/mbc.E08-07-0704; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capanni C, 2005, HUM MOL GENET, V14, P1489, DOI 10.1093/hmg/ddi158; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Coffinier C, 2008, J BIOL CHEM, V283, P9797, DOI 10.1074/jbc.M709629200; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Colakoglu G, 2009, J CELL BIOL, V185, P769, DOI 10.1083/jcb.200809166; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; DUNNIGAN MG, 1974, Q J MED, V43, P33; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; GERACE L, 1984, J CELL SCI, P137; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Hudon SE, 2008, BIOCHEM BIOPH RES CO, V374, P365, DOI 10.1016/j.bbrc.2008.07.033; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; Kilic F, 1997, J BIOL CHEM, V272, P5298, DOI 10.1074/jbc.272.8.5298; KOBBERLING J, 1975, HUMANGENETIK, V29, P111, DOI 10.1007/BF00430347; LEE R, HUM MOL GENET, V19, P1603; LIN F, 1993, J BIOL CHEM, V268, P16321; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Raharjo WH, 2001, J CELL SCI, V114, P4447; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Sarkar PK, 2001, J CLIN PHARM THER, V26, P247, DOI 10.1046/j.1365-2710.2001.00349.x; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Sevenants L, 2005, EUR J PEDIATR, V164, P283, DOI 10.1007/s00431-005-1635-x; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, BBA-MOL CELL BIOL L, V1781, P36, DOI 10.1016/j.bbalip.2007.11.003	51	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10874	10.1371/journal.pone.0010874	http://dx.doi.org/10.1371/journal.pone.0010874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526372	Green Published, gold, Green Submitted			2022-12-25	WOS:000278222100006
J	Weete, JD; Abril, M; Blackwell, M				Weete, John D.; Abril, Maritza; Blackwell, Meredith			Phylogenetic Distribution of Fungal Sterols	PLOS ONE			English	Article							FATTY-ACIDS; LIQUID-CHROMATOGRAPHY; CRONARTIUM-FUSIFORME; TAPHRINA-DEFORMANS; ERGOSTEROL; YEAST; BIOSYNTHESIS; ZYGOMYCOTA	Background: Ergosterol has been considered the "fungal sterol'' for almost 125 years; however, additional sterol data superimposed on a recent molecular phylogeny of kingdom Fungi reveals a different and more complex situation. Methodology/Principal Findings: The interpretation of sterol distribution data in a modern phylogenetic context indicates that there is a clear trend from cholesterol and other Delta(5) sterols in the earliest diverging fungal species to ergosterol in later diverging fungi. There are, however, deviations from this pattern in certain clades. Sterols of the diverse zoosporic and zygosporic forms exhibit structural diversity with cholesterol and 24-ethyl -Delta(5) sterols in zoosporic taxa, and 24-methyl sterols in zygosporic fungi. For example, each of the three monophyletic lineages of zygosporic fungi has distinctive major sterols, ergosterol in Mucorales, 22-dihydroergosterol in Dimargaritales, Harpellales, and Kickxellales (DHK clade), and 24-methyl cholesterol in Entomophthorales. Other departures from ergosterol as the dominant sterol include: 24-ethyl cholesterol in Glomeromycota, 24-ethyl cholest-7-enol and 24-ethyl-cholesta-7,24(28)-dienol in rust fungi, brassicasterol in Taphrinales and hypogeous pezizalean species, and cholesterol in Pneumocystis. Conclusions/Significance: Five dominant end products of sterol biosynthesis (cholesterol, ergosterol, 24-methyl cholesterol, 24-ethyl cholesterol, brassicasterol), and intermediates in the formation of 24-ethyl cholesterol, are major sterols in 175 species of Fungi. Although most fungi in the most speciose clades have ergosterol as a major sterol, sterols are more varied than currently understood, and their distribution supports certain clades of Fungi in current fungal phylogenies. In addition to the intellectual importance of understanding evolution of sterol synthesis in fungi, there is practical importance because certain antifungal drugs (e. g., azoles) target reactions in the synthesis of ergosterol. These findings also invalidate use of ergosterol as an indicator of biomass of certain fungal taxa (e. g., Glomeromycota). Data from this study are available from the Assembling the Fungal Tree of Life (AFTOL) Structural and Biochemical Database: http://aftol.umn.edu.	[Weete, John D.] Auburn Res & Technol Fdn, Auburn, AL USA; [Abril, Maritza; Blackwell, Meredith] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Weete, JD (corresponding author), Auburn Res & Technol Fdn, Auburn, AL USA.	mblackwell@lsu.edu			NSF [NSF-0732671]	NSF(National Science Foundation (NSF))	The authors acknowledge support from NSF-0732671 (AFTOL: Resolving the Evolutionary History of the Fungi) to M. Blackwell (see NSF.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benny GL, 2001, TRICHOMYCETES OTHER, P39; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; CAMBIE RC, 1966, J CHEM SOC C, P72, DOI 10.1039/j39660000072; DEBIEU D, 1995, PHYTOCHEMISTRY, V39, P293, DOI 10.1016/0031-9422(95)00015-Y; Fontaine J, 2001, LIPIDS, V36, P1357, DOI 10.1007/s11745-001-0852-z; Grandmougin-Ferjani A, 1999, PHYTOCHEMISTRY, V50, P1027, DOI 10.1016/S0031-9422(98)00636-0; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; LOEFFLER RST, 1992, PHYTOCHEMISTRY, V31, P1561, DOI 10.1016/0031-9422(92)83106-9; Mendoza L, 2002, ANNU REV MICROBIOL, V56, P315, DOI 10.1146/annurev.micro.56.012302.160950; Moss S. T., 1998, Botanical Journal of Scotland, V50, P137; Moss S.T., 1979, P175; NES WR, 1978, J BIOL CHEM, V253, P6218; NEWELL SY, 1988, APPL ENVIRON MICROB, V54, P1876, DOI 10.1128/AEM.54.7.1876-1879.1988; PETIT GR, 1962, J ORG CHEM, V27, P2696; RAMGOPAL M, 1983, P NATL ACAD SCI-BIOL, V80, P712, DOI 10.1073/pnas.80.3.712; RODRIGUEZ RJ, 1982, BIOCHEM BIOPH RES CO, V106, P435, DOI 10.1016/0006-291X(82)91129-9; RODRIGUEZ RJ, 1985, BIOCHIM BIOPHYS ACTA, V837, P336, DOI 10.1016/0005-2760(85)90057-8; SALMANOWICZ B, 1988, EUR J FOREST PATHOL, V18, P291; SINGH P, 1966, CURR SCI, V20, P515; Tanret C, 1889, CR SEANCES ACAD SCI, V108, P98; Wallander H, 1997, SOIL BIOL BIOCHEM, V29, P45, DOI 10.1016/S0038-0717(96)00263-5; WARNER SA, 1982, PHYTOCHEMISTRY, V21, P2135, DOI 10.1016/0031-9422(82)83069-0; Weete J. D., 1980, LIPID BIOCH FUNGI OT, P388; WEETE JD, 1989, EXP MYCOL, V13, P183, DOI 10.1016/0147-5975(89)90023-6; Weete JD, 1997, LIPIDS, V32, P1309, DOI 10.1007/s11745-006-0169-y; WEETE JD, 1979, CAN J MICROBIOL, V25, P1481, DOI 10.1139/m79-230; Weete JD, 1999, MYCOLOGIA, V91, P642, DOI 10.2307/3761250; WEETE JD, 1977, LIPIDS, V12, P398, DOI 10.1007/BF02533645; WEETE JD, 1991, LIPIDS, V26, P669, DOI 10.1007/BF02536434; WEETE JD, 1983, BIOCHIM BIOPHYS ACTA, V752, P19, DOI 10.1016/0005-2760(83)90228-X; Weete JD, 1989, ADV LIPID RES, V23, P484; WEETE JD, 1985, J MICROBIOL, V313, P1127; White MM, 2006, MYCOLOGIA, V98, P872, DOI 10.3852/mycologia.98.6.872	36	180	182	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10899	10.1371/journal.pone.0010899	http://dx.doi.org/10.1371/journal.pone.0010899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526375	Green Published, Green Submitted, gold			2022-12-25	WOS:000278222100028
J	Poplawski, NJ; Shirinifard, A; Agero, U; Gens, JS; Swat, M; Glazier, JA				Poplawski, Nikodem J.; Shirinifard, Abbas; Agero, Ubirajara; Gens, J. Scott; Swat, Maciej; Glazier, James A.			Front Instabilities and Invasiveness of Simulated 3D Avascular Tumors	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LUNG BRANCHING MORPHOGENESIS; CELLULAR-AUTOMATON MODEL; HEPATOCYTE GROWTH-FACTOR; B-16 MELANOMA-CELLS; MATHEMATICAL-MODEL; NONLINEAR SIMULATION; EMBRYONIC-TISSUES; SCATTER-FACTOR; EXTRACELLULAR-MATRIX	We use the Glazier-Graner-Hogeweg model to simulate three-dimensional (3D), single-phenotype, avascular tumors growing in an homogeneous tissue matrix (TM) supplying a single limiting nutrient. We study the effects of two parameters on tumor morphology: a diffusion-limitation parameter defined as the ratio of the tumor-substrate consumption rate to the substrate-transport rate, and the tumor-TM surface tension. This initial model omits necrosis and oxidative/hypoxic metabolism effects, which can further influence tumor morphology, but our simplified model still shows significant parameter dependencies. The diffusion-limitation parameter determines whether the growing solid tumor develops a smooth (noninvasive) or fingered (invasive) interface, as in our earlier two-dimensional (2D) simulations. The sensitivity of 3D tumor morphology to tumor-TM surface tension increases with the size of the diffusion-limitation parameter, as in 2D. The 3D results are unexpectedly close to those in 2D. Our results therefore may justify using simpler 2D simulations of tumor growth, instead of more realistic but more computationally expensive 3D simulations. While geometrical artifacts mean that 2D sections of connected 3D tumors may be disconnected, the morphologies of 3D simulated tumors nevertheless correlate with the morphologies of their 2D sections, especially for low-surface-tension tumors, allowing the use of 2D sections to partially reconstruct medically-important 3D-tumor structures.	[Poplawski, Nikodem J.; Shirinifard, Abbas; Gens, J. Scott; Swat, Maciej; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA; [Poplawski, Nikodem J.; Shirinifard, Abbas; Gens, J. Scott; Swat, Maciej; Glazier, James A.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Agero, Ubirajara] Univ Fed Minas Gerais, Dept Fis, BR-30161 Belo Horizonte, MG, Brazil	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universidade Federal de Minas Gerais	Poplawski, NJ (corresponding author), Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA.	nipoplaw@indiana.edu	Agero, Ubirajara/B-2254-2010; Complexos, INCT Fluidos/H-9172-2013	Agero, Ubirajara/0000-0002-4987-9031; Glazier, James Alexander/0000-0003-3634-190X	National Institutes of Health, National Institute of General Medical Sciences [R01 GM76692, R01 GM077138]; Biocomplexity Institute at Indiana University; Indiana University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biocomplexity Institute at Indiana University; Indiana University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health, National Institute of General Medical Sciences grants R01 GM76692 and R01 GM077138, the Biocomplexity Institute at Indiana University and the Indiana University Faculty Research Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; AndersonAR ChaplainMA, 2000, J THEORETICAL MED, V2, P129, DOI DOI 10.1080/10273660008833042; BALTER A, 2007, SINGLE CELL BASED MO; Bello L, 2001, CANCER RES, V61, P8730; Beysens DA, 2000, CAN J PHYS, V78, P243, DOI 10.1139/cjp-78-3-243; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; BYRNE HM, 1999, J THEOR MED, V1, P275; CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chaplain MAJ, 1996, MATH COMPUT MODEL, V23, P47, DOI 10.1016/0895-7177(96)00019-2; CHAPLAIN MAJ, 1993, J MATH BIOL, V31, P431, DOI 10.1007/BF00173886; Chaturvedi R, 2005, J R SOC INTERFACE, V2, P237, DOI 10.1098/rsif.2005.0033; Chaturvedi R, 2004, LECT NOTES COMPUT SC, V3305, P543; Chaturvedi R, 2003, LECT NOTES COMPUT SC, V2659, P39; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; CICKOVSKI TM, 2005, ACM T COMP BIOL BIOI, V2, P1; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Cristini V, 2005, CLIN CANCER RES, V11, P6772, DOI 10.1158/1078-0432.CCR-05-0852; Cristini V, 2003, J MATH BIOL, V46, P191, DOI 10.1007/s00285-002-0174-6; Cristini V, 2009, J MATH BIOL, V58, P723, DOI 10.1007/s00285-008-0215-x; Debruyne PR, 2002, ONCOGENE, V21, P6740, DOI 10.1038/sj.onc.1205729; Deisboeck TS, 2008, MED HYPOTHESES, V71, P186, DOI 10.1016/j.mehy.2008.02.010; DORMANN S, 2002, SILICO BIOL, V2, P35; Duchting W, 1996, EUR J CANCER, V32A, P1283, DOI 10.1016/0959-8049(96)00075-5; DUCHTING W, 1990, COMPUT GRAPH, V14, P505, DOI 10.1016/0097-8493(90)90073-7; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Foty RA, 1996, DEVELOPMENT, V122, P1611; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Glazier J. A., 2007, SINGLE CELL BASED MO; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Guiot C, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-4; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hartmann D, 2006, J THEOR BIOL, V242, P862, DOI 10.1016/j.jtbi.2006.05.009; HOLM EA, 1991, PHYS REV A, V43, P2662, DOI 10.1103/PhysRevA.43.2662; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; KIMMEL M, 1991, J THEOR BIOL, V153, P157, DOI 10.1016/S0022-5193(05)80420-5; KLOMINEK J, 1993, CANCER RES, V53, P4376; LACOVARA J, 1984, CANCER RES, V44, P1657; Lawrence JA, 1996, WORLD J UROL, V14, P124; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li XR, 2007, DISCRETE CONT DYN-B, V7, P581; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; LIOTTA LA, 1983, LAB INVEST, V49, P636; Macklin P, 2007, J THEOR BIOL, V245, P677, DOI 10.1016/j.jtbi.2006.12.004; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; MCCARTHY JB, 1984, J CELL BIOL, V98, P1474, DOI 10.1083/jcb.98.4.1474; MELICOW MM, 1982, J THEOR BIOL, V94, P471, DOI 10.1016/0022-5193(82)90322-8; Miura T, 2002, MECH DEVELOP, V116, P29, DOI 10.1016/S0925-4773(02)00132-6; Moore MG, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.030601; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; Orme ME, 1996, MATH COMPUT MODEL, V23, P43, DOI 10.1016/0895-7177(96)00053-2; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Perumpanani AJ, 1996, INVAS METAST, V16, P209; Plank MJ, 2004, B MATH BIOL, V66, P1785, DOI 10.1016/j.bulm.2004.04.001; Popawski NJ, 2009, B MATH BIOL, V71, P1189, DOI 10.1007/s11538-009-9399-5; Poplawski NJ, 2008, MATH BIOSCI ENG, V5, P355; Poplawski NJ, 2007, PHYSICA A, V373, P521, DOI 10.1016/j.physa.2006.05.028; QI AS, 1993, J THEOR BIOL, V161, P1, DOI 10.1006/jtbi.1993.1035; QUIGLEY JP, 1983, J CELL BIOL, V97, pA450; Rejniak KA, 2005, MATH BIOSCI ENG, V2, P643, DOI 10.3934/mbe.2005.2.643; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; SHERRATT JA, 1992, P ROY SOC B-BIOL SCI, V248, P261, DOI 10.1098/rspb.1992.0071; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SMOLLE J, 1993, J THEOR BIOL, V160, P63, DOI 10.1006/jtbi.1993.1004; STETLERSTEVENSO.WG, 1996, CANC BIOL, V7, P147; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Swat Maciej H., 2009, V500, P361, DOI 10.1007/978-1-59745-525-1_13; Tracqui P, 1995, ACTA BIOTHEOR, V43, P443, DOI 10.1007/BF00713564; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Turner S, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021910; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298; Wang ZH, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-50; Wang ZH, 2009, BIOINFORMATICS, V25, P2389, DOI 10.1093/bioinformatics/btp416; Weinberg RA, 2006, BIOL CANC; WHELDON TE, 1986, MATH METHODS MED; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	101	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10641	10.1371/journal.pone.0010641	http://dx.doi.org/10.1371/journal.pone.0010641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520818	gold, Green Published, Green Submitted			2022-12-25	WOS:000278221500003
J	Ataide, R; Hasang, W; Wilson, DW; Beeson, JG; Mwapasa, V; Molyneux, ME; Meshnick, SR; Rogerson, SJ				Ataide, Ricardo; Hasang, Wina; Wilson, Danny W.; Beeson, James G.; Mwapasa, Victor; Molyneux, Malcolm E.; Meshnick, Steven R.; Rogerson, Stephen J.			Using an Improved Phagocytosis Assay to Evaluate the Effect of HIV on Specific Antibodies to Pregnancy-Associated Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CHONDROITIN-SULFATE-A; VARIANT SURFACE-ANTIGENS; INFECTED ERYTHROCYTES; PARASITIZED ERYTHROCYTES; CELLS; ADHESION; DIFFERENTIATION; PATHOGENESIS; PROTECTION	Background: Pregnant women residing in malaria endemic areas are highly susceptible to Plasmodium falciparum malaria, particularly during their first pregnancy, resulting in low birth weight babies and maternal anaemia. This susceptibility is associated with placental sequestration of parasitised red blood cells expressing pregnancy-specific variant surface antigens. Acquisition of antibodies against these variant surface antigens may protect women and their offspring. Functions of such antibodies may include prevention of placental sequestration or opsonisation of parasitised cells for phagocytic clearance. Methodology/Findings: Here we report the development and optimisation of a new high-throughput flow cytometry-based phagocytosis assay using undifferentiated Thp-1 cells to quantitate the amount of opsonizing antibody in patient sera, and apply this assay to measure the impact of HIV on the levels of antibodies to a pregnancy malaria-associated parasite line in a cohort of Malawian primigravid women. The assay showed high reproducibility, with inter-experimental correlation of r(2) = 0.99. In primigravid women, concurrent malaria infection was associated with significantly increased antibodies, whereas HIV decreased the ability to acquire opsonising antibodies (Mann-Whitney ranksum: p = 0.013). This decrease was correlated with HIV-induced immunosuppression, with women with less than 350x10(6) CD4+ T-cells/L having less opsonising antibodies (coef: -11.95, P = 0.002). Levels of antibodies were not associated with protection from low birth weight or anaemia. Conclusions/Significance: This flow cytometry-based phagocytosis assay proved to be efficient and accurate for the measurement of Fc-receptor mediated phagocytosis-inducing antibodies in large cohorts. HIV was found to affect mainly the acquisition of antibodies to pregnancy-specific malaria in primigravidae. Further studies of the relationship between opsonising antibodies to malaria in pregnancy and HIV are indicated.	[Ataide, Ricardo; Hasang, Wina; Rogerson, Stephen J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Ataide, Ricardo] Univ Porto, GABBA, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal; [Wilson, Danny W.; Beeson, James G.] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Melbourne, Vic 3050, Australia; [Mwapasa, Victor; Molyneux, Malcolm E.] Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, Blantyre, Malawi; [Mwapasa, Victor] Univ Malawi, Dept Community Hlth, Univ Med, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Meshnick, Steven R.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of Melbourne; Universidade do Porto; Walter & Eliza Hall Institute; University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill	Ataide, R (corresponding author), Univ Melbourne, Dept Med, PO Royal Melbourne Hosp, Melbourne, Vic, Australia.	sroger@unimelb.edu.au	Wilson, Danny W/E-6186-2019; Ataide, Ricardo/B-7307-2017	Wilson, Danny W/0000-0002-5073-1405; Ataide, Ricardo/0000-0002-1014-0432; Rogerson, Stephen/0000-0003-4287-1982; Mwapasa, Victor/0000-0002-2748-8902; Hasang, Wina/0000-0001-8664-7558	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/32985/2006]; NIH [AI 49084]; National Health and Medical Research Council, Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049084] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RA is supported by Fundacao para a Ciencia e Tecnologia, Portugal, reference SFRH/BD/32985/2006. The study was supported by a grant from NIH to SRM (NIH RO1 award number AI 49084). JGB and DWW were supported by the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio M, 1996, J BIOL CHEM, V271, P1770, DOI 10.1074/jbc.271.3.1770; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Cox SE, 2005, INFECT IMMUN, V73, P2841, DOI 10.1128/IAI.73.5.2841-2847.2005; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; FLEIT HB, 1991, HUMAN MONOCYTE CELL, P556; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Garnham P. C. C., 1938, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V32, P13, DOI 10.1016/S0035-9203(38)90094-X; Healey G, 2007, J IMMUNOL METHODS, V322, P50, DOI 10.1016/j.jim.2007.01.024; Idemyor V, 2007, HIV CLIN TRIALS, V8, P246, DOI 10.1310/hct0804-246; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Onyenekwe C. C., 2007, Journal of Vector Borne Diseases, V44, P250; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Serra-Casas E, 2010, J INFECT DIS, V201, P123, DOI 10.1086/648595; Slutsker L, 2007, CURR OPIN INFECT DIS, V20, P3, DOI 10.1097/QCO.0b013e328012c5cd; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Tippett E, 2007, J IMMUNOL METHODS, V325, P42, DOI 10.1016/j.jim.2007.05.012; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; TSUCHIYA MYY, 1980, ESTABLISHMENT CHARAC, P171; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Van Geertruyden JP, 2007, TRENDS PARASITOL, V23, P465, DOI 10.1016/j.pt.2007.08.006	33	44	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10807	10.1371/journal.pone.0010807	http://dx.doi.org/10.1371/journal.pone.0010807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520838	Green Published, gold			2022-12-25	WOS:000278034800005
J	Alekseyenko, OV; Lee, C; Kravitz, EA				Alekseyenko, Olga V.; Lee, Carol; Kravitz, Edward A.			Targeted Manipulation of Serotonergic Neurotransmission Affects the Escalation of Aggression in Adult Male Drosophila melanogaster	PLOS ONE			English	Article							NERVOUS-SYSTEM; TYROSINE-HYDROXYLASE; L-DOPA; CEREBRAL MONOAMINES; GENETIC DISSECTION; ECTOPIC EXPRESSION; AGONISTIC BEHAVIOR; COURTSHIP BEHAVIOR; NEURONS; MUTANTS	Dopamine (DA) and serotonin (5HT) are reported to serve important roles in aggression in a wide variety of animals. Previous investigations of 5HT function in adult Drosophila behavior have relied on pharmacological manipulations, or on combinations of genetic tools that simultaneously target both DA and 5HT neurons. Here, we generated a transgenic line that allows selective, direct manipulation of serotonergic neurons and asked whether DA and 5HT have separable effects on aggression. Quantitative morphological examination demonstrated that our newly generated tryptophan hydroxylase (TRH)-Gal4 driver line was highly selective for 5HT-containing neurons. This line was used in conjunction with already available Gal4 driver lines that target DA or both DA and 5HT neurons to acutely alter the function of aminergic systems. First, we showed that acute impairment of DA and 5HT neurotransmission using expression of a temperature sensitive form of dynamin completely abolished mid-and high-level aggression. These flies did not escalate fights beyond brief low-intensity interactions and therefore did not yield dominance relationships. We showed next that manipulation of either 5HT or DA neurotransmission failed to duplicate this phenotype. Selective disruption of 5HT neurotransmission yielded flies that fought, but with reduced ability to escalate fights, leading to fewer dominance relationships. Acute activation of 5HT neurons using temperature sensitive dTrpA1 channel expression, in contrast, resulted in flies that escalated fights faster and that fought at higher intensities. Finally, acute disruption of DA neurotransmission produced hyperactive flies that moved faster than controls, and rarely engaged in any social interactions. By separately manipulating 5HT- and DA- neuron systems, we collected evidence demonstrating a direct role for 5HT in the escalation of aggression in Drosophila.	[Alekseyenko, Olga V.; Kravitz, Edward A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Lee, Carol] Albert Einstein Coll Med, New York, NY USA	Harvard University; Harvard Medical School; Yeshiva University	Alekseyenko, OV (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	olga_alekseenko@hms.harvard.edu			National Institute of General Medical Sciences [GM-067645, GM-074675]; Brooks Fellowship; Neurobiology Department, Harvard Medical School [T32]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067645, R01GM074675] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Brooks Fellowship; Neurobiology Department, Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by grants from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/; GM-067645; GM-074675 to E. A. K.), Brooks Fellowship and T32 training grant from the Neurobiology Department, Harvard Medical School (to O.V.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2000, J NEUROGENET, V14, P227, DOI 10.3109/01677060009084500; ARAI R, 1994, BRAIN RES, V667, P295, DOI 10.1016/0006-8993(94)91511-3; BELTZ BS, 1990, J NEUROBIOL, V21, P521, DOI 10.1002/neu.480210402; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; BLACK BC, 1987, MOL GEN GENET, V209, P306, DOI 10.1007/BF00329658; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1987, J NEUROGENET, V4, P309, DOI 10.3109/01677068709102351; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; CLARK AG, 1984, GENETICS, V108, P181; COCCARO EF, 1989, BRIT J PSYCHIAT, V155, P52, DOI 10.1192/S0007125000291769; Coleman CM, 2005, ARCH INSECT BIOCHEM, V59, P12, DOI 10.1002/arch.20050; de Almeida RMM, 2005, EUR J PHARMACOL, V526, P51, DOI 10.1016/j.ejphar.2005.10.004; de Boer SF, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.052.2009; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Doernberg SB, 2001, J COMP PHYSIOL A, V187, P91, DOI 10.1007/s003590000178; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gibert P, 2001, EVOLUTION, V55, P205, DOI 10.1111/j.0014-3820.2001.tb01286.x; GLOVER JC, 1987, J NEUROSCI, V7, P581; GOLDBERG JI, 1989, DEV BIOL, V131, P483, DOI 10.1016/S0012-1606(89)80019-3; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HADLER NM, 1964, GENETICS, V50, P1269; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hing ALY, 1996, J NEUROBIOL, V30, P454; HIRSH J, 1981, MOL CELL BIOL, V1, P475, DOI 10.1128/MCB.1.6.475; HOLLISTER AS, 1979, J PHARMACOL EXP THER, V208, P37; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KONIG N, 1988, J NEUROSCI RES, V20, P212, DOI 10.1002/jnr.490200210; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; KULKARNI SJ, 1987, GENETICS, V115, P461; Lauder J M, 1983, Monogr Neural Sci, V9, P3; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; LIVINGSTONE MS, 1983, NATURE, V303, P67, DOI 10.1038/303067a0; MICZEK KA, 1994, NEUROSCI BIOBEHAV R, V18, P97, DOI 10.1016/0149-7634(94)90040-X; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Mundiyanapurath S, 2009, FLY, V3, P179, DOI 10.4161/fly.3.3.8989; NASSEL DR, 1985, NEUROSCIENCE, V15, P293, DOI 10.1016/0306-4522(85)90136-8; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; NECKAMEYER WS, 1992, J BIOL CHEM, V267, P4199; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; NG KY, 1971, NATURE, V230, P331, DOI 10.1038/230331a0; NG KY, 1970, SCIENCE, V170, P76, DOI 10.1126/science.170.3953.76; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Nilsson EE, 2000, J NEUROGENET, V13, P213, DOI 10.3109/01677060009084495; Olivier B, 2004, ANN NY ACAD SCI, V1036, P382, DOI 10.1196/annals.1330.022; Panksepp JB, 2002, J NEUROBIOL, V50, P276, DOI 10.1002/neu.10035; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Park SK, 2006, J NEUROBIOL, V66, P452, DOI 10.1002/neu.20222; PETER D, 1995, J NEUROSCI, V15, P6179; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Simon AF, 2009, GENETICS, V181, P525, DOI 10.1534/genetics.108.094110; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sykes PA, 2005, DEV BIOL, V286, P207, DOI 10.1016/j.ydbio.2005.07.025; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; VALLES AM, 1986, J NEUROSCI, V6, P1482; WALLACE JA, 1985, J COMP NEUROL, V236, P443, DOI 10.1002/cne.902360403; WRIGHT TRF, 1976, GENETICS, V84, P287; Yarali A, 2009, J NEUROGENET, V23, P235, DOI 10.1080/01677060802441372; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525	71	152	153	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10806	10.1371/journal.pone.0010806	http://dx.doi.org/10.1371/journal.pone.0010806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520823	Green Published, gold, Green Submitted			2022-12-25	WOS:000278034600023
J	Bawa-Khalfe, T; Cheng, J; Lin, SH; Ittmann, MM; Yeh, ETH				Bawa-Khalfe, Tasneem; Cheng, Jinke; Lin, Sue-Hwa; Ittmann, Michael M.; Yeh, Edward T. H.			SENP1 Induces Prostatic Intraepithelial Neoplasia through Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ANDROGEN RECEPTOR EXPRESSION; SUMO-SPECIFIC PROTEASE-1; DEPENDENT TRANSCRIPTION; UP-REGULATION; CANCER; ANGIOGENESIS; DESUMOYLATION; INCREASES; GROWTH	SUMOylation has been shown to modulate DNA replication/repair, cell cycle progression, signal transduction, and the hypoxic response. SUMO (small ubiquitin-like modifier)-specific proteases regulate SUMOylation, but how changes in the expression of these proteases contribute to physiological and/or pathophysiological events remains undefined. Here, we show that SENP1 (sentrin/SUMO-specific protease 1) is highly expressed in human prostate cancer specimens and correlates with hypoxia-inducing factor 1 alpha (HIF1 alpha) expression. Mechanistic studies in a mouse model indicate that androgen-driven expression of murine SENP1 leads to HIF1 alpha stabilization, enhanced vascular endothelial growth factor production, and angiogenesis. Further pathological assessment of the mouse indicates that SENP1 overexpression induces transformation of the normal prostate gland and gradually facilitates the onset of high-grade prostatic intraepithelial neoplasia. Consistent with cell culture studies, SENP1 enhances prostate epithelial cell proliferation via modulating the androgen receptor and cyclin D-1. These results demonstrate that deSUMOylation plays a critical role in prostate pathogenesis through induction of HIF1 alpha-dependent angiogenesis and enhanced cell proliferation.	[Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Unit 449, Houston, TX 77030 USA; [Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Yeh, Edward T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Ittmann, Michael M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Cheng, Jinke] Shanghai Jiao Tong Univ, Dept Biochem, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ, Shanghai 200025, Peoples R China; [Cheng, Jinke] Shanghai Jiao Tong Univ, Dept Mol & Cell Biol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ, Shanghai 200025, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute; Baylor College of Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yeh, ETH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Unit 449, 1515 Holcombe Blvd, Houston, TX 77030 USA.	etyeh@mdanderson.org			National Institutes of Health [CA139520, P50CA058204]; NCI [CA111479]; United States Department of Defense [PC040121, PC060932]; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [F32CA110620, P50CA058204, R01CA111479, R01CA139520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense(United States Department of Defense); University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was also supported, in whole or in part, by National Institutes of Health Grants CA139520 (to E.T.H.Y.), P50CA058204 (to the Baylor Prostate Cancer SPORE, M. M. I.), and CA111479 (to S.-H. L.) from NCI. This work was also supported by United States Department of Defense Grants PC040121 (to E.T.H.Y.) and PC060932 (to J.C.) and the Prostate Cancer Development Award from The University of Texas MD Anderson Cancer Center (to E.T.H.Y.).	Alqawi O, 2007, FREE RADICAL RES, V41, P788, DOI 10.1080/10715760701361531; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Bawa-Khalfe T, 2010, SUBCELL BIOCHEM, V54, P170, DOI 10.1007/978-1-4419-6676-6_14; Chan Norman, 2007, Future Oncol, V3, P329, DOI 10.2217/14796694.3.3.329; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Dai JL, 1996, MOL ENDOCRINOL, V10, P1582, DOI 10.1210/me.10.12.1582; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ghafar MA, 2003, PROSTATE, V54, P58, DOI 10.1002/pros.10162; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huss WJ, 2001, CANCER RES, V61, P2736; Jacques C, 2005, J CLIN ENDOCR METAB, V90, P2314, DOI 10.1210/jc.2004-1337; Knudsen KE, 1999, CANCER RES, V59, P2297; Leav I, 1996, PROSTATE, V29, P137, DOI 10.1002/1097-0045(199609)29:3<137::AID-PROS2990290302>3.0.CO;2-Z; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Lekas A, 2006, ANTICANCER RES, V26, P2989; Mazzucchelli R, 2000, PROSTATE, V45, P72; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Montironi R, 2002, ANN NY ACAD SCI, V963, P169; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Pallares J, 2006, HISTOL HISTOPATHOL, V21, P857, DOI 10.14670/HH-21.857; Petre-Draviam CE, 2005, ONCOGENE, V24, P431, DOI 10.1038/sj.onc.1208200; Reutens AT, 2001, MOL ENDOCRINOL, V15, P797, DOI 10.1210/me.15.5.797; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Sweat SD, 1999, J UROLOGY, V161, P1229, DOI 10.1016/S0022-5347(01)61644-6; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009	34	85	91	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25859	25866		10.1074/jbc.M110.134874	http://dx.doi.org/10.1074/jbc.M110.134874			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551310	Green Published, hybrid			2022-12-25	WOS:000280682400078
J	Sanchez-Cenizo, L; Formentini, L; Aldea, M; Ortega, AD; Garcia-Huerta, P; Sanchez-Arago, M; Cuezva, JM				Sanchez-Cenizo, Laura; Formentini, Laura; Aldea, Marcos; Ortega, Alvaro D.; Garcia-Huerta, Paula; Sanchez-Arago, Maria; Cuezva, Jose M.			Up-regulation of the ATPase Inhibitory Factor 1 (IF1) of the Mitochondrial H+-ATP Synthase in Human Tumors Mediates the Metabolic Shift of Cancer Cells to a Warburg Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-F1-ATPASE MESSENGER-RNA; BIOENERGETIC SIGNATURE; F1FO-ATPASE INHIBITOR; DOWN-REGULATION; PROTEIN; PROGRESSION; MECHANISM; PHOSPHORYLATION; TRANSLATION; CARCINOMAS	The H+-ATP synthase is a reversible engine of mitochondria that synthesizes or hydrolyzes ATP upon changes in cell physiology. ATP synthase dysfunction is involved in the onset and progression of diverse human pathologies. During ischemia, the ATP hydrolytic activity of the enzyme is inhibited by the ATPase inhibitory factor 1 (IF1). The expression of IF1 in human tissues and its participation in the development of human pathology are unknown. Here, we have developed monoclonal antibodies against human IF1 and determined its expression in paired normal and tumor biopsies of human carcinomas. We show that the relative mitochondrial content of IF1 increases significantly in carcinomas, suggesting the participation of IF1 in oncogenesis. The expression of IF1 varies significantly in cancer cell lines. To investigate the functional activity of IF1 in cancer, we have manipulated its cellular content. Overexpression of IF1 or of its pH-insensitive H49K mutant in cells that express low levels of IF1 triggers the up-regulation of aerobic glycolysis and the inhibition of oxidative phosphorylation with concurrent mitochondrial hyperpolarization. Treatment of the cells with the H+-ATP synthase inhibitor oligomycin mimicked the effects of IF1 overexpression. Conversely, small interfering RNA-mediated silencing of IF1 in cells that express high levels of IF1 promotes the down-regulation of aerobic glycolysis and the increase in oxidative phosphorylation. Overall, these findings support that the mitochondrial content of IF1 controls the activity of oxidative phosphorylation mediating the shift of cancer cells to an enhanced aerobic glycolysis, thus supporting an oncogenic role for the de-regulated expression of IF1 in cancer.	[Sanchez-Cenizo, Laura; Formentini, Laura; Aldea, Marcos; Ortega, Alvaro D.; Garcia-Huerta, Paula; Sanchez-Arago, Maria; Cuezva, Jose M.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Mol,ISCIII, Consejo Super Invest Cient,Ctr Invest Biomed Red, E-28049 Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto de Salud Carlos III	Cuezva, JM (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Mol,ISCIII, Consejo Super Invest Cient,Ctr Invest Biomed Red, E-28049 Madrid, Spain.	jmcuezva@cbm.uam.es	Cuezva, Jose M/F-8381-2011; Cuezva, Jose M/AAR-5392-2020; Aldea, Marcos/H-8154-2015; Ortega, Alvaro Dario/K-5394-2018	Aldea, Marcos/0000-0003-2146-2733; Ortega, Alvaro Dario/0000-0003-0691-7154; Cuezva Marcos, Jose Manuel/0000-0003-1118-248X; Formentini, Laura/0000-0001-5641-821X	Ministerio de Educacion y Ciencia [BFU2007-65253]; Centro de Investigacion Biomedica en Red de Enfermedades Raras and Comunidad de Madrid, Spain [S-GEN-0269]	Ministerio de Educacion y Ciencia(Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Raras and Comunidad de Madrid, Spain	This work was supported by Ministerio de Educacion y Ciencia Grant BFU2007-65253 and the Centro de Investigacion Biomedica en Red de Enfermedades Raras and Comunidad de Madrid Grant S-GEN-0269, Spain.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Acebo P, 2009, TRANSL ONCOL, V2, P138, DOI 10.1593/tlo.09106; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Cuezva JM, 2009, BBA-MOL BASIS DIS, V1792, P1145, DOI 10.1016/j.bbadis.2009.01.006; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; de Heredia ML, 2000, J BIOL CHEM, V275, P7430, DOI 10.1074/jbc.275.10.7430; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hernlund E, 2009, MOL CANCER THER, V8, P1916, DOI 10.1158/1535-7163.MCT-09-0179; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012; Li RJ, 2010, ANN ONCOL, V21, P1506, DOI 10.1093/annonc/mdp569; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; ORTEGA AD, 2010, J CELL SCI IN PRESS; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Santamaria G, 2006, CARCINOGENESIS, V27, P925, DOI 10.1093/carcin/bgi315; Shen L, 2009, CELL DEATH DIFFER, V16, P603, DOI 10.1038/cdd.2008.184; Shin YK, 2005, CANCER RES, V65, P3162, DOI 10.1158/0008-5472.CAN-04-3300; Tomiyama A, 2006, JNCI-J NATL CANCER I, V98, P1462, DOI 10.1093/jnci/djj395; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Willers IM, 2010, BIOCHEM J, V426, P319, DOI 10.1042/BJ20091570; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	39	153	159	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25308	25313		10.1074/jbc.M110.146480	http://dx.doi.org/10.1074/jbc.M110.146480			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538613	Green Published, hybrid			2022-12-25	WOS:000280682400023
J	Luker, KE; Steele, JM; Mihalko, LA; Ray, P; Luker, GD				Luker, K. E.; Steele, J. M.; Mihalko, L. A.; Ray, P.; Luker, G. D.			Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands	ONCOGENE			English	Article						breast cancer; chemokines; chemokine receptors; bioluminescence imaging; luciferase; protein fragment complementation	TUMOR-GROWTH; RECEPTOR; PROTEIN; MIGRATION; CXCL12; DIMERIZATION; CHEMOTAXIS; INHIBITION; EXPRESSION; SURFACE	CXCR7 is a receptor for chemokines including CXCL12 (stromal-derived factor-1), a molecule that promotes tumor growth and metastasis in breast cancer and other malignancies. Building on the recent observation that CXCR7 sequesters CXCL12, we investigated mechanisms for CXCR7-dependent uptake of chemokines. Breast cancer cells expressing CXCR7 accumulated chemokines CXCL12 and CXC11 present at concentrations < 1ng/ml, unlike cells expressing CXCR4. CXCR7-dependent accumulation of chemokines was reduced by inhibitors of clathrin-mediated endocytosis. After CXCR7-mediated internalization, CXCL12 trafficked to lysosomes and was degraded, although levels of CXCR7 remained stable. CXCR7 reduced CXCL12 in the extracellular space, limiting the amounts of chemokine available to acutely stimulate signaling through CXCR4. CXCR7 constitutively internalized and recycled to the cell membrane even in the absence of ligand, and addition of chemokines did not significantly enhance receptor internalization. Chemokines at concentrations less than the Kd values for ligand-receptor binding did not alter levels of CXCR7 at the cell surface. Higher concentrations of chemokine ligands reduced the total cell surface expression of CXCR7 without affecting receptor internalization, indicating that receptor recycling was inhibited. CXCR7dependent uptake of chemokines and receptor trafficking were regulated by beta-arrestin 2. These studies establish mechanisms through which CXCR7 regulates the availability of chemokine ligands in the extracellular space. Oncogene (2010) 29, 4599-4610; doi: 10.1038/onc.2010.212; published online 7 June 2010	[Luker, G. D.] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Luker, K. E.; Steele, J. M.; Mihalko, L. A.; Ray, P.; Luker, G. D.] Ctr Mol Imaging, Dept Radiol, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Luker, GD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ctr Mol Imaging, 109 Zina Pitcher Pl,A526 BSRB, Ann Arbor, MI 48109 USA.	gluker@umich.edu		luker, gary/0000-0001-6832-2581	NIH [R01CA136553, R01CA136829, P50CA093990]; NATIONAL CANCER INSTITUTE [P50CA093990, R01CA136829, R01CA136553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by NIH grants R01CA136553, R01CA136829 and P50CA093990. We thank ChemoCentryx for mAb 11G8 and CCX733.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Atanackovic D, 2008, TUMOR BIOL, V29, P93, DOI 10.1159/000135689; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Fermas S, 2008, GLYCOBIOLOGY, V18, P1054, DOI 10.1093/glycob/cwn088; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hansell CAH, 2006, BIOCHEM SOC T, V34, P1009, DOI 10.1042/BST0341009; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KELLY K, 2006, MOL IMAGING BIOL, V8, P1536; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Sharma V, 1996, J MED CHEM, V39, P3483, DOI 10.1021/jm950823c; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Wu FY, 2008, MOL CANCER RES, V6, P1276, DOI 10.1158/1541-7786.MCR-07-2108; Yang XL, 2006, VACCINE, V24, P2966, DOI 10.1016/j.vaccine.2005.12.004; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zhang GB, 2007, CHINA COMMUN, V4, P46; Zhao M, 2008, BREAST CANCER RES TR, V110, P211, DOI 10.1007/s10549-007-9712-7	53	170	170	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 12	2010	29	32					4599	4610		10.1038/onc.2010.212	http://dx.doi.org/10.1038/onc.2010.212			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	638AQ	20531309	Green Accepted			2022-12-25	WOS:000280862300010
J	Lacruz, RS; Nanci, A; White, SN; Wen, X; Wang, HJ; Zalzal, SF; Luong, VQ; Schuetter, VL; Conti, PS; Kurtz, I; Paine, ML				Lacruz, Rodrigo S.; Nanci, Antonio; White, Shane N.; Wen, Xin; Wang, HongJun; Zalzal, Sylvia F.; Luong, Vivian Q.; Schuetter, Verna L.; Conti, Peter S.; Kurtz, Ira; Paine, Michael L.			The Sodium Bicarbonate Cotransporter (NBCe1) Is Essential for Normal Development of Mouse Dentition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTINO-ENAMEL JUNCTION; RENAL TUBULAR-ACIDOSIS; EXPRESSION; LOCALIZATION; MECHANISMS; AE2; PH	Proximal renal tubular acidosis (pRTA) is a syndrome caused by abnormal proximal tubule reabsorption of bicarbonate resulting in metabolic acidosis. Patients with mutations to the SLC4A4 gene (coding for the sodium bicarbonate cotransporter NBCe1), have pRTA, growth delay, ocular defects, and enamel abnormalities. In an earlier report, we provided the first evidence that enamel cells, the ameloblasts, express NBCe1 in a polarized fashion, thereby contributing to trans-cellular bicarbonate transport. To determine whether NBCe1 plays a critical role in enamel development, we studied the expression of NBCe1 at various stages of enamel formation in wild-type mice and characterized the biophysical properties of enamel in NBCe1(-/-) animals. The enamel of NBCe1(-/-) animals was extremely hypomineralized and weak with an abnormal prismatic architecture. The expression profile of amelogenin, a known enamel-specific gene, was not altered in NBCe1(-/-) animals. Our results show for the first time that NBCe1 expression is required for the development of normal enamel. This study provides a mechanistic model to account for enamel abnormalities in certain patients with pRTA.	[Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Nanci, Antonio; Zalzal, Sylvia F.] Univ Montreal, Fac Dent, Lab Study Calcified Tissues & Biomat, Montreal, PQ H3C 3J7, Canada; [White, Shane N.; Luong, Vivian Q.; Schuetter, Verna L.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA; [Conti, Peter S.] Univ Calif Los Angeles, Dept Radiol, Mol Imaging Ctr, Keck Sch Med, Los Angeles, CA 90033 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Southern California; Universite de Montreal; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Paine, ML (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	paine@usc.edu	Lacruz, Rodrigo/AGY-8090-2022	Nanci, Antonio/0000-0003-0616-843X; LACRUZ, RODRIGO/0000-0002-0776-6143	National Institutes of Health [DE013404, DE019629, DK058563, DK077162, S10RR019253]; Canadian Institutes of Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058563, R01DK077162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DE013404 and DE019629 (to M. L. P.), DK058563 and DK077162 (to I. K.), and S10RR019253 (to P. S. C.). This work was also supported by the Canadian Institutes of Health Research (to A. N.).; We thank Malcolm L. Snead (University of Southern California) and Charles E. Smith (Universite de Montreal and McGill University) for valuable discussions on this topic and support of this project. We thank Dr. Gary E. Shull (Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio) for breeding pairs of the NBCe1<SUP>+/-</SUP> animals and Alicia Thompson from the Scanning Electron Microscope and Analysis Center at University of Southern California. We thank Ryan Park, Archana Tank, and Grant Dagliyan of University of Southern California Molecular Imaging Center for assistance in the collection of the micro-CT data.	ATKINSON ME, 1972, J PERIODONTAL RES, V7, P255, DOI 10.1111/j.1600-0765.1972.tb01112.x; Bevensee MO, 2000, AM J PHYSIOL-CELL PH, V278, pC1200, DOI 10.1152/ajpcell.2000.278.6.C1200; Brandes A, 2007, AM J PHYSIOL-REG I, V293, pR2400, DOI 10.1152/ajpregu.00208.2007; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Elizabeth J, 2007, J ORAL PATHOL MED, V36, P625, DOI 10.1111/j.1600-0714.2007.00615.x; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Huang Z, 2008, J BONE MINER RES, V23, P1995, DOI 10.1359/JBMR.080705; Inatomi J, 2004, PFLUG ARCH EUR J PHY, V448, P438, DOI 10.1007/s00424-004-1278-1; KOPPANG HS, 1984, SCAND J DENT RES, V92, P489; Lacruz RS, 2010, BIOCHEM BIOPH RES CO, V393, P883, DOI 10.1016/j.bbrc.2010.02.116; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; LIN HM, 1994, CALCIFIED TISSUE INT, V55, P38, DOI 10.1007/BF00310167; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; NANCI A, 2008, 10 CATES ORAL HISTOL, P147; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 2006, EUR J ORAL SCI, V114, P147, DOI 10.1111/j.1600-0722.2006.00273.x; Sui W, 2003, J DENT RES, V82, P388, DOI 10.1177/154405910308200512; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Toyosawa S, 1996, CELL TISSUE RES, V285, P217, DOI 10.1007/s004410050639; Wen X, 2008, ANAT REC, V291, P1246, DOI 10.1002/ar.20751; White SN, 2007, J BIOL CHEM, V282, P5340, DOI 10.1074/jbc.M604814200; White SN, 2005, J PROSTHET DENT, V94, P330, DOI 10.1016/j.prosdent.2005.08.013; White SN, 2000, J AM CERAM SOC, V83, P238, DOI 10.1111/j.1151-2916.2000.tb01181.x; White SN, 2001, J DENT RES, V80, P321, DOI 10.1177/00220345010800010501; WINSNES A, 1979, ACTA PAEDIATR SCAND, V68, P861	30	61	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24432	24438		10.1074/jbc.M110.115188	http://dx.doi.org/10.1074/jbc.M110.115188			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529845	Green Published, hybrid			2022-12-25	WOS:000280542100015
J	Tardif, S; Wilson, MD; Wagner, R; Hunt, P; Gertsenstein, M; Nagy, A; Lobe, C; Koop, BF; Hardy, DM				Tardif, Steve; Wilson, Michael D.; Wagner, Rebecca; Hunt, Peter; Gertsenstein, Marina; Nagy, Andras; Lobe, Corrinne; Koop, Ben F.; Hardy, Daniel M.			Zonadhesin Is Essential for Species Specificity of Sperm Adhesion to the Egg Zona Pellucida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERM; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; ZP3-BINDING PROTEIN; MEMBRANE-PROTEIN; BINDING-ACTIVITY; IN-VITRO; FERTILIZATION; IDENTIFICATION; CAPACITATION	Interaction of rapidly evolving molecules imparts species specificity to sperm-egg recognition in marine invertebrates, but it is unclear whether comparable interactions occur during fertilization in any vertebrate species. In mammals, the sperm acrosomal protein zonadhesin is a rapidly evolving molecule with species-specific binding activity for the egg zona pellucida (ZP). Here we show using null mice produced by targeted disruption of Zan that zonadhesin confers species specificity to sperm-ZP adhesion. Sperm capacitation selectively exposed a partial von Willebrand D domain of mouse zonadhesin on the surface of living, motile cells. Antibodies to the exposed domain inhibited adhesion of wild-type spermatozoa to the mouse ZP but did not inhibit adhesion of spermatozoa lacking zonadhesin. Zan(-/-) males were fertile, and their spermatozoa readily fertilized mouse eggs in vitro. Remarkably, however, loss of zonadhesin increased adhesion of mouse spermatozoa to pig, cow, and rabbit ZP but not mouse ZP. We conclude that zonadhesin mediates species-specific ZP adhesion, and Zan(-/-) males are fertile because their spermatozoa retain adhesion capability that is not species-specific. Mammalian sperm-ZP adhesion is therefore molecularly robust, and species-specific egg recognition by a protein in the sperm acrosome is conserved between invertebrates and vertebrates, even though the adhesion molecules themselves are unrelated.	[Hardy, Daniel M.] Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA; [Wilson, Michael D.; Wagner, Rebecca; Hunt, Peter; Koop, Ben F.] Univ Victoria, Ctr Biomed Res, Dept Biol, Victoria, BC V8P 5C2, Canada; [Gertsenstein, Marina; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Lobe, Corrinne] Sunnybrook Hlth Sci Ctr, Mol & Cellular Biol Div, Toronto, ON M4N 3M5, Canada	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Victoria; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Hardy, DM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Stop 6540,3601 4th St, Lubbock, TX 79430 USA.	Daniel.Hardy@ttuhsc.edu	Hardy, Daniel/AAP-5823-2020; Koop, Ben F./A-8151-2008; Nagy, Andras/G-6465-2013; Wilson, Michael D/K-6294-2014	Hardy, Daniel/0000-0002-7297-3093; Koop, Ben F./0000-0003-0045-5200; Nagy, Andras/0000-0003-4311-0413; Wilson, Michael D/0000-0002-4015-3066	National Institutes of Health [HD35166]; Texas Department of Agriculture; Lalor Foundation; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council; Michael Smith Foundation; "Le Fonds quebecois de la recherche sur la nature et les technologies"; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD035166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Department of Agriculture; Lalor Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation(Michael Smith Foundation for Health Research); "Le Fonds quebecois de la recherche sur la nature et les technologies"(FQRNT); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported, in whole or in part, by grants from the National Institutes of Health (Grant HD35166) and the Texas Department of Agriculture (to D.M.H.), by postdoctoral fellowships from "Le Fonds quebecois de la recherche sur la nature et les technologies" and the Lalor Foundation (to S.T.), by Canadian Institutes for Health Research and Natural Sciences and Engineering Research Council grants (to B.F.K.), and by a Michael Smith Foundation for Health Research trainee award (to M.D.W.).	Baba D, 2002, J BIOL CHEM, V277, P30310, DOI 10.1074/jbc.M204596200; BABA T, 1994, J BIOL CHEM, V269, P31845; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; BI M, 2002, FERTILIZATION, P153; BLEIL JD, 1990, P NATL ACAD SCI USA, V87, P5563, DOI 10.1073/pnas.87.14.5563; Buffone MG, 2008, J BIOL CHEM, V283, P12438, DOI 10.1074/jbc.M706421200; Dean J, 2004, BIOESSAYS, V26, P29, DOI 10.1002/bies.10412; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; FRASER LR, 1993, METHOD ENZYMOL, V225, P239; Gao Z, 1998, J BIOL CHEM, V273, P3415, DOI 10.1074/jbc.273.6.3415; Gasper J, 2006, AM J HUM GENET, V79, P820, DOI 10.1086/508473; Gerton G L., 2002, FERTILIZATION, P265; Hailer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003333; HARDY DM, 1991, BIOCHEM J, V275, P759, DOI 10.1042/bj2750759; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; HARDY DM, 1994, J BIOL CHEM, V269, P19000; Herlyn H, 2008, INT J DEV BIOL, V52, P781, DOI 10.1387/ijdb.082626hh; Hickox JR, 2001, J BIOL CHEM, V276, P41502, DOI 10.1074/jbc.M106795200; Honda A, 2002, HUM REPROD UPDATE, V8, P405, DOI 10.1093/humupd/8.5.405; Jaiswal BS, 2002, FERTILIZATION, P57, DOI DOI 10.1016/B978-012311629-1/50005-X; Kim E, 2008, INT J DEV BIOL, V52, P677, DOI 10.1387/ijdb.072528ek; Lu QX, 1997, DEVELOPMENT, V124, P4121; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; Nagy A., 2003, MANIPULATING MOUSE E; Olson GE, 2004, BIOL REPROD, V71, P1128, DOI 10.1095/biolreprod.104.029975; ORAND MG, 1988, GAMETE RES, V19, P315, DOI 10.1002/mrd.1120190402; Shur BD, 2006, MOL CELL ENDOCRINOL, V250, P137, DOI 10.1016/j.mce.2005.12.037; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tardif S, 1999, MOL REPROD DEV, V54, P292, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;292::AID-MRD10&gt;3.0.CO;2-F; Tardif S, 2001, BIOL REPROD, V65, P784, DOI 10.1095/biolreprod65.3.784; Tardif S, 2010, BIOL REPROD, V82, P413, DOI 10.1095/biolreprod.109.077891; VACQUIER VD, 1990, P NATL ACAD SCI USA, V87, P5792, DOI 10.1073/pnas.87.15.5792; VACQUIER VD, 1977, P NATL ACAD SCI USA, V74, P2456, DOI 10.1073/pnas.74.6.2456; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; Wilson MD, 2001, NUCLEIC ACIDS RES, V29, P1352, DOI 10.1093/nar/29.6.1352; Yanagimachi R., 1994, P189	37	58	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24863	24870		10.1074/jbc.M110.123125	http://dx.doi.org/10.1074/jbc.M110.123125			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529856	hybrid, Green Published			2022-12-25	WOS:000280542100059
J	Torii, T; Miyamoto, Y; Sanbe, A; Nishimura, K; Yamauchi, J; Tanoue, A				Torii, Tomohiro; Miyamoto, Yuki; Sanbe, Atsushi; Nishimura, Kohji; Yamauchi, Junji; Tanoue, Akito			Cytohesin-2/ARNO, through Its Interaction with Focal Adhesion Adaptor Protein Paxillin, Regulates Preadipocyte Migration via the Downstream Activation of Arf6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; DOMAIN-CONTAINING PROTEIN; GTP-BINDING PROTEINS; ACTIN CYTOSKELETON; NEURITE OUTGROWTH; VALPROIC ACID; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; PLASMA-MEMBRANE; CELL-MIGRATION	The formation of primitive adipose tissue is the initial process in adipose tissue development followed by the migration of preadipocytes into adipocyte clusters. Comparatively little is known about the molecular mechanism controlling preadipocyte migration. Here, we show that cytohesin-2, the guanine-nucleotide exchange factor for the Arf family GTP-binding proteins, regulates migration of mouse preadipocyte 3T3-L1 cells through Arf6. SecinH3, a specific inhibitor of the cytohesin family, markedly inhibits migration of 3T3-L1 cells. 3T3-L1 cells express cytohesin-2 and cytohesin-3, and knockdown of cytohesin-2 with its small interfering RNA effectively decreases cell migration. Cytohesin-2 preferentially acts upstream of Arf6 in this signaling pathway. Furthermore, we find that the focal adhesion protein paxillin forms a complex with cytohesin-2. Paxillin colocalizes with cytohesin-2 at the leading edges of migrating cells. This interaction is mediated by the LIM2 domain of paxillin and the isolated polybasic region of cytohesin-2. Importantly, migration is inhibited by expression of the constructs containing these regions. These results suggest that cytohesin-2, through a previously unexplored complex formation with paxillin, regulates preadipocyte migration and that paxillin plays a previously unknown role as a scaffold protein of Arf guanine-nucleotide exchange factor.	[Torii, Tomohiro; Miyamoto, Yuki; Sanbe, Atsushi; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo 1578535, Japan; [Yamauchi, Junji] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Tanoue, Akito] Japan Hlth Sci Fdn, Chuo Ku, Tokyo 1030001, Japan; [Nishimura, Kohji] Shimane Univ, Dept Mol & Funct Genom, Matsue, Shimane 6908504, Japan	National Center for Child Health & Development - Japan; Tokyo Institute of Technology; Shimane University	Yamauchi, J (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	jyamauchi@nch.go.jp		Torii, Tomohiro/0000-0002-0039-923X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare; Japan Health Science Foundation; Ministry of Human Health and Welfare; Human Health Sciences Foundation; Naito Foundation; Suzuken Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation; Ministry of Human Health and Welfare; Human Health Sciences Foundation; Naito Foundation(Naito Memorial Foundation); Suzuken Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to J. Y.) and from the Ministry of Health, Labor, and Welfare, by the Japan Health Science Foundation and the Ministry of Human Health and Welfare (to Y. M., J. Y., and A. T.) and by research grants from the Human Health Sciences Foundation (to J. Y.), the Naito Foundation (to J. Y.), the Suzuken Foundation (to J. Y.), and the Takeda Science Foundation (to J. Y.).	Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Bryan BA, 2005, MOL CELL BIOL, V25, P11089, DOI 10.1128/MCB.25.24.11089-11101.2005; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Galvez BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004444; Goda N, 2000, BBA-GENE STRUCT EXPR, V1493, P195, DOI 10.1016/S0167-4781(00)00160-3; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KAHN RA, 1991, J BIOL CHEM, V266, P2606; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Klarlund JK, 2001, J BIOL CHEM, V276, P40065, DOI 10.1074/jbc.M105260200; Koga H, 2004, DNA RES, V11, P293, DOI 10.1093/dnares/11.4.293; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Luton F, 2004, MOL BIOL CELL, V15, P1134, DOI 10.1091/mbc.E03-10-0751; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mansour M, 2002, J BIOL CHEM, V277, P32302, DOI 10.1074/jbc.M202898200; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Murphy JA, 2006, BRAIN RES, V1120, P35, DOI 10.1016/j.brainres.2006.08.096; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shen X, 2007, P NATL ACAD SCI USA, V104, P1230, DOI 10.1073/pnas.0610535104; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tang PT, 2002, P NATL ACAD SCI USA, V99, P2625, DOI 10.1073/pnas.052712999; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; WASSERMANN F, 1965, HDB PHYSL 5, P87; Yamauchi J, 2008, EXP CELL RES, V314, P2279, DOI 10.1016/j.yexcr.2008.03.019; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yamauchi J, 2007, EXP CELL RES, V313, P1886, DOI 10.1016/j.yexcr.2007.02.019; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016; Yamauchi J, 2009, EXP CELL RES, V315, P2043, DOI 10.1016/j.yexcr.2009.03.012; Yano H, 2008, MOL BIOL CELL, V19, P822, DOI 10.1091/mbc.E07-08-0763; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200	57	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24270	24281		10.1074/jbc.M110.125658	http://dx.doi.org/10.1074/jbc.M110.125658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525696	Green Published, hybrid			2022-12-25	WOS:000280291400076
J	Lu, Y; Futtner, C; Rock, JR; Xu, X; Whitworth, W; Hogan, BLM; Onaitis, MW				Lu, Yun; Futtner, Christopher; Rock, Jason R.; Xu, Xia; Whitworth, Walter; Hogan, Brigid L. M.; Onaitis, Mark W.			Evidence That SOX2 Overexpression Is Oncogenic in the Lung	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; EMBRYONIC STEM-CELLS; BREAST-CANCER; MOUSE TRACHEA; DIFFERENTIATION; EXPRESSION; REGULATOR; ANTIGENS; TUMORS; ADULT	Background: SOX2 (Sry-box 2) is required to maintain a variety of stem cells, is overexpressed in some solid tumors, and is expressed in epithelial cells of the lung. Methodology/Principal Findings: We show that SOX2 is overexpressed in human squamous cell lung tumors and some adenocarcinomas. We have generated mouse models in which Sox2 is upregulated in epithelial cells of the lung during development and in the adult. In both cases, overexpression leads to extensive hyperplasia. In the terminal bronchioles, a trachea-like pseudostratified epithelium develops with p63-positive cells underlying columnar cells. Over 12-34 weeks, about half of the mice expressing the highest levels of Sox2 develop carcinoma. These tumors resemble adenocarcinoma but express the squamous marker, Trp63 (p63). Conclusions: These findings demonstrate that Sox2 overexpression both induces a proximal phenotype in the distal airways/alveoli and leads to cancer.	[Lu, Yun; Futtner, Christopher; Xu, Xia; Whitworth, Walter; Onaitis, Mark W.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Rock, Jason R.; Hogan, Brigid L. M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Lu, Y (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	mark.onaitis@duke.edu		Xu, Xia/0000-0002-1982-7062	National Institutes of Health (NIH) [2T32HL007538-26, R01 HL071303, K12-CA100639-03]; Howard Hughes Medical Institute; Gary Hock Fund; NATIONAL CANCER INSTITUTE [K12CA100639] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071303, R37HL071303, T32HL007538] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gary Hock Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	JRR is supported by National Institutes of Health (NIH) Interdisciplinary Training Program in Lung Disease 2T32HL007538-26, and research in BLMH's lab is supported by NIH R01 HL071303. MWO is supported by NIH K12-CA100639-03, a Howard Hughes Medical Institute Early Career Grant, and the Gary Hock Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2010, HISTOPATHOLOGY, V56, P265, DOI 10.1111/j.1365-2559.2009.03463.x; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BASS AJ, 2009, NATURE GENETICS; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Comtesse N, 2005, P NATL ACAD SCI USA, V102, P9601, DOI 10.1073/pnas.0500404102; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Li XL, 2004, INT J ONCOL, V24, P257; Maeshima AM, 2006, LUNG CANCER, V52, P53, DOI 10.1016/j.lungcan.2005.11.010; Nikitin AY, 2004, CANCER RES, V64, P3725; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Sattler HP, 2000, PROSTATE, V45, P207, DOI 10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sholl LM, 2010, APPL IMMUNOHISTO M M, V18, P55, DOI 10.1097/PAI.0b013e3181b16b88; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	35	158	167	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11022	10.1371/journal.pone.0011022	http://dx.doi.org/10.1371/journal.pone.0011022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548776	Green Submitted, Green Published, gold			2022-12-25	WOS:000278599600002
J	Scotcher, MC; Cheng, LW; Stanker, LH				Scotcher, Miles C.; Cheng, Luisa W.; Stanker, Larry H.			Detection of Botulinum Neurotoxin Serotype B at Sub Mouse LD50 Levels by a Sandwich Immunoassay and Its Application to Toxin Detection in Milk	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; DODECYL-SULFATE; SEQUENCE; BINDING; PROTEIN; REGION; IDENTIFICATION; OUTBREAK; TETANUS	Background: Botulinum neurotoxin (BoNT), the causative agent of botulism, a serious neuroparylatic disease, is produced by the anaerobic bacterium Clostridium botulinum and consists of a family of seven serotypes (A-H). We previously reported production of high-affinity monoclonal antibodies to BoNT serotype A. Methods and Findings: Recombinant peptide fragments of the light chain, the transmembrane and receptor-binding domains of the heavy chain of botulinum neurotoxin type B (BoNT/B) were expressed in Escherichia coli as GST-fusion proteins and purified. These proteins were used to immunize BALB/cJ mice for the generation of monoclonal antibodies (mAbs). Antibody-producing hybridomas were detected using either a direct binding ELISA binding to plate-immobilized BoNT/B, or with a capture-capture ELISA whereby the capacity of the antibody to capture BoNT/B from solution was tested. A total of five mAbs were selected, two of which bound the toxin light chain and three bound the receptor-binding domain of BoNT/B heavy chain. MAb MCS6-27 was identified via capture-capture ELISA and was the only mAb able to bind BoNT/B in solution under physiological conditions. MAbs F24-1, F26-16, F27-33 and F29-40 were identified via direct binding ELISA, and were able to capture BoNT/B in solution only in the presence of 0.5-0.9 mM sodium dodecyl sulphate (SDS). MAb MCS6-27 and an anti-BoNT/B polyclonal antibody were incorporated into a sandwich ELISA that did not require SDS. Conclusions: We report here the generation of monoclonal antibodies to serotype B and the subsequent development of a sensitive sandwich immunoassay. This immunoassay has a detection limit of 100 fg BoNT/B, fifty times more sensitive than the mouse bioassay detection limit of 5 pg BoNT/B. Additionally, this assay detected as little as 39 pg/mL of toxin in skim, 2% and whole milk.	[Scotcher, Miles C.; Cheng, Luisa W.; Stanker, Larry H.] ARS, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	Scotcher, MC (corresponding author), ARS, Western Reg Res Ctr, USDA, Albany, CA USA.	larry.stanker@ars.usda.gov	Pacific-Southwest, RCE/B-6155-2009		United States Department of Agriculture, Agriculture Research Service, CRIS [5325-42000-043-00D]; U.S. Public Health Service [U54 AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	United States Department of Agriculture, Agriculture Research Service, CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the United States Department of Agriculture, Agriculture Research Service, CRIS project 5325-42000-043-00D and the U.S. Public Health Service Grant U54 AI065359. The funders had no role in sudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, HDB EP CLIN LAB WORK; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BHUYAN AK, 2009, MECH SDS INDUCED PRO; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; CAMPBELL K, 1993, BIOCHIM BIOPHYS ACTA, V1216, P487, DOI 10.1016/0167-4781(93)90020-E; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; LAMANNA C, 1959, SCIENCE, V130, P763, DOI 10.1126/science.130.3378.763; Livesay DR, 2004, PROTEIN ENG DES SEL, V17, P463, DOI 10.1093/protein/gzh058; Miller J.H., 1972, EXPT MOL GENETICS; MIYAZAWA K, 1984, INT J COSMETIC SCI, V6, P33, DOI 10.1111/j.1467-2494.1984.tb00356.x; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; MORRISON S, 2002, CURRENT PROTOCOLS IM; *NAT BOT SURV, 2001, BOT SURV SUMM COUNC; OMAHONY M, 1990, EPIDEMIOL INFECT, V104, P389, DOI 10.1017/S0950268800047403; REYNOLDS JA, 1970, P NATL ACAD SCI USA, V66, P1002, DOI 10.1073/pnas.66.3.1002; ROBINSON NC, 1975, BIOCHEMISTRY-US, V14, P369, DOI 10.1021/bi00673a025; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Scotcher MC, 2009, HYBRIDOMA, V28, P315, DOI 10.1089/hyb.2009.0022; Scotcher MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004924; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; TERRANOVA W, 1978, AM J EPIDEMIOL, V108, P150, DOI 10.1093/oxfordjournals.aje.a112599; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; WOOD DL, 1984, P NATL ACAD SCI-BIOL, V81, P4756, DOI 10.1073/pnas.81.15.4756	27	35	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11047	10.1371/journal.pone.0011047	http://dx.doi.org/10.1371/journal.pone.0011047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548779	Green Published, Green Submitted, gold			2022-12-25	WOS:000278599600008
J	Guillaumot, P; Luquain, C; Malek, M; Huber, AL; Brugiere, S; Garin, J; Grunwald, D; Regnier, D; Petrilli, V; Lefai, E; Manie, SN				Guillaumot, Patricia; Luquain, Celine; Malek, Mouhannad; Huber, Anne-Laure; Brugiere, Sabine; Garin, Jerome; Grunwald, Didier; Regnier, Daniel; Petrilli, Virginie; Lefai, Etienne; Manie, Serge N.			Pdro, a Protein Associated with Late Endosomes and Lysosomes and Implicated in Cellular Cholesterol Homeostasis	PLOS ONE			English	Article							ACTIN-FILAMENTS; MACROPINOCYTOSIS; TRAFFICKING; METABOLISM; ACTIVATION; MEMBRANES; DYNAMICS; MOTILITY; DEPENDS	Background: Cellular cholesterol is a vital component of the cell membrane. Its concentration is tightly controlled by mechanisms that remain only partially characterized. In this study, we describe a late endosome/lysosomes-associated protein whose expression level affects cellular free cholesterol content. Methodology/Principal Findings: Using a restricted proteomic analysis of detergent-resistant membranes (DRMs), we have identified a protein encoded by gene C11orf59. It is mainly localized to late endosome/lysosome (LE/LY) compartment through N-terminal myristoylation and palmitoylation. We named it Pdro for protein associated with DRMs and endosomes. Very recently, three studies have reported on the same protein under two other names: the human p27RF-Rho that regulates RhoA activation and actin dynamics, and its rodent orthologue p18 that controls both LE/LY dynamics through the MERK-ERK pathway and the lysosomal activation of mammalian target of rapamycin complex 1 by amino acids. We found that, consistent with the presence of sterol-responsive element consensus sequences in the promoter region of C11orf59, Pdro mRNA and protein expression levels are regulated positively by cellular cholesterol depletion and negatively by cellular cholesterol loading. Conversely, Pdro is involved in the regulation of cholesterol homeostasis, since its depletion by siRNA increases cellular free cholesterol content that is accompanied by an increased cholesterol efflux from cells. On the other hand, cells stably overexpressing Pdro display reduced cellular free cholesterol content. Pdro depletion-mediated excess cholesterol results, at least in part, from a stimulated low-density lipoprotein (LDL) uptake and an increased cholesterol egress from LE/LY. Conclusions/Significance: LDL-derived cholesterol release involves LE/LY motility that is linked to actin dynamics. Because Pdro regulates these two processes, we propose that modulation of Pdro expression in response to sterol levels regulates LDL-derived cholesterol through both LDL uptake and LE/LY dynamics, to ultimately control free cholesterol homeostasis.	[Guillaumot, Patricia; Malek, Mouhannad; Huber, Anne-Laure; Regnier, Daniel; Petrilli, Virginie; Manie, Serge N.] Ctr Leon Berard, CNRS, UMR 5201, F-69373 Lyon, France; [Luquain, Celine] INSERM Insa Lyon, UMR 870, Villeurbanne, France; [Brugiere, Sabine; Garin, Jerome] CEA, INSERM, UJF, Lab Chim Proteines,ERM 201, Grenoble, France; [Grunwald, Didier] Inst Rech Technol & Sci Vivant, DSV, CEA, INSERM,U873,Lab Transduct Signal, Grenoble, France; [Lefai, Etienne] INSERM, U870, UMR 1235, INRA, Oullins, France	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Guillaumot, P (corresponding author), Ctr Leon Berard, CNRS, UMR 5201, F-69373 Lyon, France.	manie@lyon.fnclcc.fr	Manie, Serge/ABC-8331-2021; Petrilli, Virginie/ABI-8199-2020; Lefai, Etienne/L-7961-2019; Lefai, Etienne/E-9615-2019	Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; Sabine, BRUGIERE/0000-0002-0757-0968; Huber, Anne-Laure/0000-0002-3433-766X; manie, serge/0000-0002-9168-1977; Petrilli, Virginie/0000-0001-8502-6979	CNRS; Association pour la Recherche contre le Cancer (ARC) [SM 3811, 4915]; Fondation De France (FDF) [2002 010 893]; Ligue Nationale Contre le Cancer Comite du Rhone	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Fondation De France (FDF)(Fondation de France); Ligue Nationale Contre le Cancer Comite du Rhone(Ligue nationale contre le cancer)	This work was supported by institutional grants from CNRS and additional support from Association pour la Recherche contre le Cancer (ARC: SM 3811 and 4915), Fondation De France (FDF: 2002 010 893) and Ligue Nationale Contre le Cancer Comite du Rhone. CL was supported by fellowships from FDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anczukow O, 2008, GENE CHROMOSOME CANC, V47, P418, DOI 10.1002/gcc.20546; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Berger AC, 2007, J CELL SCI, V120, P3640, DOI 10.1242/jcs.03487; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHAZOTTE B, 2008, CLOD SPRING HARB PRO; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Delton-Vandenbroucke I, 2007, J LIPID RES, V48, P543, DOI 10.1194/jlr.M600266-JLR200; Durrbach A, 1996, J CELL SCI, V109, P457; ENDO A, 1985, J MED CHEM, V28, P401, DOI 10.1021/jm00382a001; Ferro M, 2000, ELECTROPHORESIS, V21, P3517; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kauppi M, 2002, J CELL SCI, V115, P899; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kritharides L, 1998, ARTERIOSCL THROM VAS, V18, P1589, DOI 10.1161/01.ATV.18.10.1589; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Pelletier L, 2006, CANCER RES, V66, P3681, DOI 10.1158/0008-5472.CAN-05-3870; Qin CB, 2006, ARTERIOSCL THROM VAS, V26, P372, DOI 10.1161/01.ATV.0000197848.67999.e1; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; VANDEURS B, 1995, EUR J CELL BIOL, V66, P309; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; XU XX, 1991, J BIOL CHEM, V266, P17040; Yao WQ, 2009, ACTA BIOCH BIOPH SIN, V41, P773, DOI 10.1093/abbs/gmp066	38	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10977	10.1371/journal.pone.0010977	http://dx.doi.org/10.1371/journal.pone.0010977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544018	Green Published, gold, Green Submitted			2022-12-25	WOS:000278494900006
J	Wu, DD; Jin, W; Hao, XD; Tang, NLS; Zhang, YP				Wu, Dong-Dong; Jin, Wei; Hao, Xiao-Dan; Tang, Nelson Leung Sang; Zhang, Ya-Ping			Evidence for Positive Selection on the Osteogenin (BMP3) Gene in Human Populations	PLOS ONE			English	Article							HUMAN GENOME; HAPLOTYPE RECONSTRUCTION; LACTASE-PERSISTENCE; DARWINIAN SELECTION; STATISTICAL-METHOD; SKIN PIGMENTATION; DNA POLYMORPHISM; BRAIN SIZE; SIGNATURES; HITCHHIKING	Background: Human skeletal system has evolved rapidly since the dispersal of modern humans from Africa, potentially driven by selection and adaptation. Osteogenin (BMP3) plays an important role in skeletal development and bone osteogenesis as an antagonist of the osteogenic bone morphogenetic proteins, and negatively regulates bone mineral density. Methodology/Principal Findings: Here, we resequenced the BMP3 gene from individuals in four geographically separated modern human populations. Features supportive of positive selection in the BMP3 gene were found including the presence of an excess of nonsynonymous mutations in modern humans, and a significantly lower genetic diversity that deviates from neutrality. The prevalent haplotypes of the first exon region in Europeans demonstrated features of long-range haplotype homogeneity. In contrast with findings in European, the derived allele SNP Arg192Gln shows higher extended haplotype homozygosity in East Asian. The worldwide allele frequency distribution of SNP shows not only a high-derived allele frequency in Asians, but also in Americans, which is suggestive of functional adaptation. Conclusions/Significance: In conclusion, we provide evidence for recent positive selection operating upon a crucial gene in skeletal development, which may provide new insight into the evolution of the skeletal system and bone development.	[Wu, Dong-Dong; Hao, Xiao-Dan; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Jin, Wei; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming 650091, Peoples R China; [Wu, Dong-Dong; Hao, Xiao-Dan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Tang, Nelson Leung Sang; Zhang, Ya-Ping] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Peoples R China; [Tang, Nelson Leung Sang] Chinese Univ Hong Kong, Fac Med, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson Leung Sang] Chinese Univ Hong Kong, Lab Genet Dis Susceptibil, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong	Wu, DD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Wu, Dong-Dong/AAR-5615-2020; hao, xiaodan/ABD-7161-2021; Tang, Nelson L/P-5018-2017	Tang, Nelson L/0000-0002-3607-5819; Hao, Xiao-dan/0000-0002-4611-8325	National Basic Research Program of China (973 Program) [2007CB411600]; National Natural Science Foundation of China [30621092, 30430110]; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province	This work was supported by grants from the National Basic Research Program of China (973 Program, 2007CB411600), the National Natural Science Foundation of China (30621092, 30430110), and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Cann HM, 2002, SCIENCE, V296, P261; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Fay JC, 2000, GENETICS, V155, P1405; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; FUN YX, 1997, GENETICS, V14, P915; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; LAURA WG, 2008, DEV DYNAM, V237, P1691; LAURA WG, 2009, DEV DYNAM, V238, P2374; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WU DD, 2010, HUM MOL GENET; Wu DD, 2008, CHINESE SCI BULL, V53, P1457, DOI 10.1007/s11434-008-0202-z; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10959	10.1371/journal.pone.0010959	http://dx.doi.org/10.1371/journal.pone.0010959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532035	Green Published, Green Submitted, gold			2022-12-25	WOS:000278380500005
J	Netzer, WJ; Powell, C; Nong, Y; Blundell, J; Wong, LL; Duff, K; Flajolet, M; Greengard, P				Netzer, William J.; Powell, Craig; Nong, Yi; Blundell, Jacqueline; Wong, Lili; Duff, Karen; Flajolet, Marc; Greengard, Paul			Lowering beta-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITORS; ALZHEIMERS-DISEASE; TS65DN MOUSE; IN-VIVO; DEFICITS; PROTEIN; MICE; TRAFFICKING; BRAIN; CHROMOSOME-21	beta-amyloid levels are elevated in Down syndrome (DS) patients throughout life and are believed to cause Alzheimer's disease (AD) in adult members of this population. However, it is not known if beta-amyloid contributes to intellectual disability in younger individuals. We used a gamma-secretase inhibitor to lower beta-amyloid levels in young mice that model DS. This treatment corrected learning deficits characteristic of these mice, suggesting that beta-amyloid-lowering therapies might improve cognitive function in young DS patients.	[Netzer, William J.; Nong, Yi; Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Powell, Craig; Blundell, Jacqueline] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Powell, Craig; Blundell, Jacqueline] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Wong, Lili; Duff, Karen] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA	Rockefeller University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University	Netzer, WJ (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA.	netzerw@rockefeller.edu	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Powell, Craig/0000-0001-5451-2165; Duff, Karen/0000-0002-6177-868X	U.S. National Institutes of Health [AG09464, R01MH081164, R21HD065290]; Fisher Center for Alzheimer's Disease Research Foundation; F.M. Kirby Foundation, Inc.; Lowe Foundation (Erma Lowe Laboratory for Alzheimer's Disease Research); Crystal Charity Ball Program for the Prevention of Complications in Children with Down's Syndrome; Van Beber Family; David M. Crowley Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081164, K08MH065975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fisher Center for Alzheimer's Disease Research Foundation; F.M. Kirby Foundation, Inc.; Lowe Foundation (Erma Lowe Laboratory for Alzheimer's Disease Research); Crystal Charity Ball Program for the Prevention of Complications in Children with Down's Syndrome; Van Beber Family; David M. Crowley Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health Grants AG09464 (to P. G), R01MH081164, R21HD065290 (to C. M. P.), The Fisher Center for Alzheimer's Disease Research Foundation (http://www.alzinfo.org) and the F.M. Kirby Foundation, Inc. (to P. G.), the Lowe Foundation (Erma Lowe Laboratory for Alzheimer's Disease Research), the Crystal Charity Ball Program for the Prevention of Complications in Children with Down's Syndrome, the Van Beber Family and the David M. Crowley Foundation (to C. M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson EC, 2001, CYTOGENET CELL GENET, V93, P270, DOI 10.1159/000056997; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; CHOI JH, 2009, J NEUROCHEM; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; EPSTEIN CJ, 1990, AM J MED GENET, P31; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; GODRIDGE H, 1987, J NEUROL NEUROSUR PS, V50, P775, DOI 10.1136/jnnp.50.6.775; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; HYMAN BT, 1992, PROG CLIN BIOL RES, V379, P123; Imbimbo BP, 2008, CURR TOP MED CHEM, V8, P54, DOI 10.2174/156802608783334015; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Savage MJ, 1998, J NEUROSCI, V18, P1743; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WISHART JG, 1993, J INTELL DISABIL RES, V37, P389; Wolvetang EW, 2003, BBA-GENE STRUCT EXPR, V1628, P105, DOI 10.1016/S0167-4781(03)00121-0	36	56	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10943	10.1371/journal.pone.0010943	http://dx.doi.org/10.1371/journal.pone.0010943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532168	Green Submitted, Green Published, gold			2022-12-25	WOS:000278318700015
J	Sela, N; Mersch, B; Hotz-Wagenblatt, A; Ast, G				Sela, Noa; Mersch, Britta; Hotz-Wagenblatt, Agnes; Ast, Gil			Characteristics of Transposable Element Exonization within Human and Mouse	PLOS ONE			English	Article							SELECTION PRESSURE; RNA SURVEILLANCE; GENOMES REVEALS; REPBASE UPDATE; EXON CREATION; MESSENGER-RNA; ANTISENSE RNA; ALU REPEATS; EVOLUTIONARY; DATABASE	Insertion of transposed elements within mammalian genes is thought to be an important contributor to mammalian evolution and speciation. Insertion of transposed elements into introns can lead to their activation as alternatively spliced cassette exons, an event called exonization. Elucidation of the evolutionary constraints that have shaped fixation of transposed elements within human and mouse protein coding genes and subsequent exonization is important for understanding of how the exonization process has affected transcriptome and proteome complexities. Here we show that exonization of transposed elements is biased towards the beginning of the coding sequence in both human and mouse genes. Analysis of single nucleotide polymorphisms (SNPs) revealed that exonization of transposed elements can be population-specific, implying that exonizations may enhance divergence and lead to speciation. SNP density analysis revealed differences between Alu and other transposed elements. Finally, we identified cases of primate-specific Alu elements that depend on RNA editing for their exonization. These results shed light on TE fixation and the exonization process within human and mouse genes.	[Sela, Noa; Ast, Gil] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet, IL-69978 Tel Aviv, Israel; [Mersch, Britta; Hotz-Wagenblatt, Agnes] German Canc Res Ctr, Dept Mol Biophys, D-6900 Heidelberg, Germany	Tel Aviv University; Sackler Faculty of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Sela, N (corresponding author), Univ Munich, Fac Biol, Dept Bot, Munich, Germany.	hotz-wagenblatt@dkfz-heidelberg.de; gilast@post.tau.ac.il	Sela, Noa/C-5133-2008	Sela, Noa/0000-0002-8282-215X	Israel Science Foundation [ISF 61/09]; DKFZ/MOST [ca-139]; Deutsche-Israel Project [DIP MI-1317]; Israel Cancer Research Foundation (ICRF); LMUexcellence fellowship	Israel Science Foundation(Israel Science Foundation); DKFZ/MOST; Deutsche-Israel Project; Israel Cancer Research Foundation (ICRF); LMUexcellence fellowship	Funding: This work was supported by a grant from the Israel Science Foundation (ISF 61/09), Joint Germany-Israeli Research Program (ca-139), Deutsche-Israel Project (DIP MI-1317), and Israel Cancer Research Foundation (ICRF). B.M. and A.H.-W. were supported by the Joint Germany-Israeli Research Program (ca-139) (DKFZ/MOST). N.S. is supported by the LMUexcellence fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-109; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen WL, 2008, BRAIN RES, V1233, P176, DOI 10.1016/j.brainres.2008.07.096; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Corvelo A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r141; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; DEININGER PL, 1993, EVOL BIOL, V27, P157; Gal-Mark N, 2008, NUCLEIC ACIDS RES, V36, P2012, DOI 10.1093/nar/gkn024; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gerber A, 1997, RNA, V3, P453; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goren A, 2008, GENOME RES, V18, P214, DOI 10.1101/gr.6661308; GRAVELEY BR, 2007, TRENDS GENET; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; KISTER KP, 1987, NUCLEIC ACIDS RES, V15, P1905, DOI 10.1093/nar/15.5.1905; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Krull M, 2007, GENOME RES, V17, P1139, DOI 10.1101/gr.6320607; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; LIN L, 2009, HUM MOL GENET; Lin L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000225; Liu CN, 2005, NUCLEIC ACIDS RES, V33, pD112, DOI 10.1093/nar/gki041; Lo WS, 2004, MOL PSYCHIATR, V9, P603, DOI 10.1038/sj.mp.4001461; Magen A, 2005, NUCLEIC ACIDS RES, V33, P5574, DOI 10.1093/nar/gki858; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Mersch B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-78; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Moller-Krull M, 2008, J MOL BIOL, V382, P601, DOI 10.1016/j.jmb.2008.07.014; Nakabayashi K, 2002, HUM MOL GENET, V11, P1743, DOI 10.1093/hmg/11.15.1743; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Ng SK, 2006, GENE, V368, P110, DOI 10.1016/j.gene.2005.10.034; Ram O, 2008, MOL CELL BIOL, V28, P3513, DOI 10.1128/MCB.02279-07; Resch A, 2004, NUCLEIC ACIDS RES, V32, P1261, DOI 10.1093/nar/gkh284; Roy M, 2008, RNA, V14, P2261, DOI 10.1261/rna.1024908; Schwartz S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000300; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singer SS, 2004, J MOL BIOL, V341, P883, DOI 10.1016/j.jmb.2004.06.070; Sironi M, 2005, TRENDS GENET, V21, P484, DOI 10.1016/j.tig.2005.06.009; Sironi M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r120; SMIT AFA, VERSION OPEN 3 2 7; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; XIE H, 2009, NUCL ACIDS RES; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yang JO, 2009, HUM MUTAT, V30, pE1010, DOI 10.1002/humu.21128; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103	73	51	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10907	10.1371/journal.pone.0010907	http://dx.doi.org/10.1371/journal.pone.0010907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532223	gold, Green Published, Green Submitted			2022-12-25	WOS:000278222400004
J	Gerardin, P; El Amrani, R; Cyrille, B; Gabriele, M; Guillermin, P; Boukerrou, M; Boumahni, B; Randrianaivo, H; Winer, A; Rouanet, JF; Bohrer, M; Jaffar-Bandjee, MC; Robillard, PY; Barau, G; Michault, A				Gerardin, Patrick; El Amrani, Rachid; Cyrille, Beatrice; Gabriele, Marc; Guillermin, Philippe; Boukerrou, Malik; Boumahni, Brahim; Randrianaivo, Hanitra; Winer, Arnaud; Rouanet, Jean-Fabien; Bohrer, Michel; Jaffar-Bandjee, Marie-Christine; Robillard, Pierre-Yves; Barau, Georges; Michault, Alain			Low Clinical Burden of 2009 Pandemic Influenza A (H1N1) Infection during Pregnancy on the Island of La Reunion	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; A(H1N1) INFECTION; NEONATAL OUTCOMES; H5N1 INFECTION; VIRUS; WOMEN; NEURAMINIDASE; SURVEILLANCE; TRANSMISSION; PATHOGENESIS	Background: Pregnant women have been identified as a group at risk, both for respiratory complications than for the admissions to the Intensive Care Unit (ICU) during the 2009 H1N1 influenza pandemic (pdm). The purpose of this prospective register-based cohort-study was to characterize the clinical virulence of the pdm (H1N1/09)v during pregnancy in La Reunion. Methods/Principal Findings: Over a twelve-week pdm wave (13 July to 3 October 2009), 294 pregnant women presented with an influenza-like illness (ILI) to one of the three maternity departments of the South Reunion area, Indian Ocean. Out of these, 278 were checked by RT-PCR for influenza viruses (157 positive and 121 negative, of whom, 141 with pdm flu and 132 with ILIs of non pdm origin, 5 untyped). The median body temperature was higher in women experiencing pdm flu than in those with non pdm ILI (38.9 degrees C versus 38.3 degrees C, P<0.0001), without evidence linked to circulating viremia. Oseltamivir was given for 86% of pdm flu cases in a median time inferior than 48 hrs (range 0-7 days). The hospitalization rate for pdm flu was of 60% and not associated with underlying conditions. Six viral pneumonia and fourteen asthma attacks were observed among 84 hospitalized pdm flu cases, of whom, only one led to the ICU for an acute lung injury. No maternal death occurred during the pdm wave. None adverse pregnancy outcome was associated with pdm flu. No congenital birth defect, nor early-onset neonatal influenza infection was attributable to pdm flu exposure. Conclusions/Significance: This report mitigates substantially the presumed severity of pandemic H1N1/09 influenza infection during pregnancy. The reasons for which the clinical burden of H1N1/09 influenza virus may differ worldwide raise questions about a differential local viral-strain effect and public health preparedness, notably in timely access to special care and antiviral treatments.	[Gerardin, Patrick; Boumahni, Brahim; Robillard, Pierre-Yves] CHR, Neonatal & Pediat Intens Care Unit, St Pierre, La Reunion, France; [Gerardin, Patrick] Ctr Clin Invest Clin Epidemiol Reunion, INSERM, CHR, URMLR, St Pierre, La Reunion, France; [Gerardin, Patrick] AP HP, INSERM, UMR S953, Paris, France; [El Amrani, Rachid; Cyrille, Beatrice; Gabriele, Marc; Guillermin, Philippe; Boukerrou, Malik; Barau, Georges] CHR, Obstet & Gynecol Unit, St Pierre, La Reunion, France; [Randrianaivo, Hanitra] CHR, Fetopathol Unit, St Pierre, La Reunion, France; [Winer, Arnaud] CHR, Intens Care Unit, St Pierre, La Reunion, France; [Rouanet, Jean-Fabien] CHR, Dept Med Informat, St Pierre, La Reunion, France; [Bohrer, Michel] CHR, Dept Med Informat, St Denis, La Reunion, France	CHU Reunion; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion	Gerardin, P (corresponding author), CHR, Neonatal & Pediat Intens Care Unit, St Pierre, La Reunion, France.	patrick.gerardin@chr-reunion.fr	Robillard, Pierre-Yves/AAD-9774-2021	Winer, Arnaud/0000-0002-1188-082X	Centre Hospitalier Regional (CHR) of La Reunion	Centre Hospitalier Regional (CHR) of La Reunion	The Centre Hospitalier Regional (CHR) of La Reunion, the funding source for this study, employs the study authors, who were responsibile for study design, data collection and analysis and interpretation of the findings. The report received the approval for publication from Institut National de la Sante Et de la Recherche Medicale (INSERM). Additionally, some study authors are employed by the REPERE (REseau PErinatal REunion) network and Institut National de la Sante Et de la Recherche Medicale (INSERM), which report public health information to the CHR of La Reunion. The CHR of La Reunion had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. P Gerardin, G Barau and A Michault had full access to all data and the final responsibility for the decision to submit for publication.	Chien YS, 2010, J INFECTION, V60, P168, DOI 10.1016/j.jinf.2009.12.012; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x; D'Ortenzio E, 2009, EUROSURVEILLANCE, V14; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; DORTENZIO E, 2009, EUROSURVEILLANCE, V14, P19257; FLAHAULT A, 2009, PLOS CURR INFLUENZA; Flahault Antoine, 2009, PLoS Curr, V1, pRRN1010; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; FUHRMAN C, 2009, EURO SURVEIL, V15; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Greer LG, 2010, OBSTET GYNECOL, V115, P711, DOI 10.1097/AOG.0b013e3181d44752; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Irving WL, 2000, BRIT J OBSTET GYNAEC, V107, P1282, DOI 10.1111/j.1471-0528.2000.tb11621.x; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kawachi S, 2009, J INFECT DIS, V200, P510, DOI 10.1086/605034; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; LECHAT MF, 1993, ENVIRON HEALTH PERSP, V101, P153, DOI 10.2307/3431389; Lim ML, 2010, BJOG-INT J OBSTET GY, V117, P551, DOI 10.1111/j.1471-0528.2010.02522.x; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nichols JE, 2001, J VIROL, V75, P5921, DOI 10.1128/JVI.73.13.5921-5929.2001; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; RENAULT P, 2010, PLOS CURR INFLUENZA; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Vivet-Lefebure A, 2007, GYNECOL OBSTET FERTI, V35, P530, DOI 10.1016/j.gyobfe.2007.04.010; Wallace LA, 2004, J CLIN VIROL, V31, P40, DOI 10.1016/j.jcv.2003.12.003; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Whitley RJ, 2006, J INFECT DIS, V194, pS133, DOI 10.1086/507548; Zarychanski Ryan, 2010, CMAJ, V182, P257, DOI 10.1503/cmaj.091884; Zou SM, 2006, TRANSFUS MED REV, V20, P181, DOI 10.1016/j.tmrv.2006.03.001; 2009, J GYNECOL OBSTET BIO, V38, P606	49	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10896	10.1371/journal.pone.0010896	http://dx.doi.org/10.1371/journal.pone.0010896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531946	Green Submitted, Green Published, gold			2022-12-25	WOS:000278222100025
J	Marley, A; von Zastrow, M				Marley, Aaron; von Zastrow, Mark			DISC1 Regulates Primary Cilia That Display Specific Dopamine Receptors	PLOS ONE			English	Article							CENTROSOME; DISRUPTED-IN-SCHIZOPHRENIA-1; SCHIZOPHRENIA; LOCALIZATION; EXPRESSION; PROTEINS; TRANSLOCATION; CANDIDATE; MEMBRANE; DISEASE	Background: Mutations in the DISC1 gene are strongly associated with major psychiatric syndromes such as schizophrenia. DISC1 encodes a cytoplasmic protein with many potential interaction partners, but its cellular functions remain poorly understood. We identified a role of DISC1 in the cell biology of primary cilia that display disease-relevant dopamine receptors. Methodology/Principal Findings: A GFP-tagged DISC1 construct expressed in NIH3T3 cells and rat striatal neurons localized near the base of primary cilia. RNAi-mediated knockdown of endogenous DISC1 resulted in a marked reduction in the number of cells expressing a primary cilium. FLAG-tagged versions of the cloned human D1, D2 and D5 dopamine receptors concentrated highly on the ciliary surface, and this reflects a specific targeting mechanism specific because D3 and D4 receptors localized to the plasma membrane but were not concentrated on cilia. Conclusions/Significance: These results identify a role of DISC1 in regulating the formation and/or maintenance of primary cilia, and establish subtype-specific targeting of dopamine receptors to the ciliary surface. Our findings provide new insight to receptor cell biology and suggest a relationship between DISC1 and neural dopamine signaling.	[Marley, Aaron] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marley, A (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	mark.vonzastrow@ucsf.edu			NIH [DA012864, DA010711]; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010711, R01DA012864, R01DA010711, R37DA010711] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NIH DA012864 and DA010711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; BANKER G, 1998, CULTURING NERVE CELL; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; DAHL HA, 1963, Z ZELLFORSCH MIK ANA, V60, P369, DOI 10.1007/BF00336612; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; DELCERRO MP, 1969, ANAT RECORD, V165, P127, DOI 10.1002/ar.1091650202; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; EASTWOOD SL, 2010, HUM MOL GEN IN PRESS; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Grimaldi B, 1998, N-S ARCH PHARMACOL, V357, P393, DOI 10.1007/PL00005184; Grunder G, 2009, NAT REV DRUG DISCOV, V8, P197, DOI 10.1038/nrd2806; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Harvey PD, 2006, SCHIZOPHRENIA BULL, V32, P250, DOI 10.1093/schbul/sbj011; Ishizuka K, 2007, MOL PSYCHIATR, V12, P897, DOI 10.1038/sj.mp.4002024; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Meyer KD, 2008, GENE EXPR PATTERNS, V8, P494, DOI 10.1016/j.gep.2008.06.005; Millar JK, 2005, MOL CELL NEUROSCI, V30, P477, DOI 10.1016/j.mcn.2005.08.021; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Porteous D, 2008, CURR OPIN GENET DEV, V18, P229, DOI 10.1016/j.gde.2008.07.005; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schwab SG, 2009, CURR OPIN PSYCHIATR, V22, P147, DOI 10.1097/YCO.0b013e328325a598; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tamminga CA, 2006, J CLIN PSYCHIAT, V67, P9; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Wong DF, 2009, NEUROPSYCHOPHARMACOL, V34, P187, DOI 10.1038/npp.2008.166; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Yoder BK, 1995, P ASSOC AM PHYSICIAN, V107, P314	47	67	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10902	10.1371/journal.pone.0010902	http://dx.doi.org/10.1371/journal.pone.0010902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531939	Green Submitted, Green Published, gold			2022-12-25	WOS:000278222100031
J	Bar, N; Dikstein, R				Bar, Nadav; Dikstein, Rivka			miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; EXPRESSION; MICRORNAS; PROMOTER; MIRNAS; TRANSLATION; INHIBITION; ELEMENT; IMPACT	Background: The tumor suppressor PTEN (phosphatase and tensin homolog) is a lipid phosphatase that converts PIP3 into PIP2 and downregulates the kinase AKT and its proliferative and anti-apoptotic activities. The FoxO transcription factors are PTEN downstream effectors whose activity is negatively regulated by AKT-mediated phosphorylation. PTEN activity is frequently lost in many types of cancer, leading to increased cell survival and cell cycle progression. Principal Findings: Here we characterize the widely expressed miR-22 and report that miR-22 is a novel regulatory molecule in the PTEN/AKT pathway. miR-22 downregulates PTEN levels acting directly through a specific site on PTEN 3'UTR. Interestingly, miR-22 itself is upregulated by AKT, suggesting that miR-22 forms a feed-forward circuit in this pathway. Time-resolved live imaging of AKT-dependent FoxO1 phosphorylation revealed that miR-22 accelerated AKT activity upon growth factor stimulation, and attenuated its down regulation by serum withdrawal. Conclusions: Our results suggest that miR-22 acts to fine-tune the dynamics of PTEN/AKT/FoxO1 pathway.	[Bar, Nadav; Dikstein, Rivka] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bar, N (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	rivka.dikstein@weizmann.ac.il			Wolfson Family Trust for MicroRNA Research at the Weizmann Institute; Israel Cancer Research Fund	Wolfson Family Trust for MicroRNA Research at the Weizmann Institute; Israel Cancer Research Fund	This work was supported by grants from the Wolfson Family Trust for MicroRNA Research at the Weizmann Institute and from the Israel Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Elfakess R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003094; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Sheng XY, 2002, BIOCHEM BIOPH RES CO, V292, P422, DOI 10.1006/bbrc.2002.6662; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; [No title captured]	31	117	123	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10859	10.1371/journal.pone.0010859	http://dx.doi.org/10.1371/journal.pone.0010859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523723	gold, Green Published, Green Submitted			2022-12-25	WOS:000278221900010
J	Carter, GG; Ratcliffe, JM; Galef, BG				Carter, Gerald G.; Ratcliffe, John M.; Galef, Bennett G.			Flower Bats (Glossophaga soricina) and Fruit Bats (Carollia perspicillata) Rely on Spatial Cues over Shapes and Scents When Relocating Food	PLOS ONE			English	Article							MEMORY; INFORMATION; DISCRIMINATION; STIMULUS; PREY	Background: Natural selection can shape specific cognitive abilities and the extent to which a given species relies on various cues when learning associations between stimuli and rewards. Because the flower bat Glossophaga soricina feeds primarily on nectar, and the locations of nectar-producing flowers remain constant, G. soricina might be predisposed to learn to associate food with locations. Indeed, G. soricina has been observed to rely far more heavily on spatial cues than on shape cues when relocating food, and to learn poorly when shape alone provides a reliable cue to the presence of food. Methodology/Principal Findings: Here we determined whether G. soricina would learn to use scent cues as indicators of the presence of food when such cues were also available. Nectar-producing plants fed upon by G. soricina often produce distinct, intense odors. We therefore expected G. soricina to relocate food sources using scent cues, particularly the flower-produced compound, dimethyl disulfide, which is attractive even to G. soricina with no previous experience of it. We also compared the learning of associations between cues and food sources by G. soricina with that of a related fruit-eating bat, Carollia perspicillata. We found that ( 1) G. soricina did not learn to associate scent cues, including dimethyl disulfide, with feeding sites when the previously rewarded spatial cues were also available, and ( 2) both the fruit-eating C. perspicillata and the flower-feeding G. soricina were significantly more reliant on spatial cues than associated sensory cues for relocating food. Conclusions/Significance: These findings, taken together with past results, provide evidence of a powerful, experience-independent predilection of both species to rely on spatial cues when attempting to relocate food.	[Carter, Gerald G.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Ratcliffe, John M.] Univ So Denmark, Inst Biol, Odense, Denmark; [Galef, Bennett G.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	University System of Maryland; University of Maryland College Park; University of Southern Denmark; McMaster University	Carter, GG (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	gcarter@umd.edu	Galef, Bennett G/A-5678-2008		Natural Science and Engineering Council of Canada (NSERC); Danish Natural Science Research Council (FNU)	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Danish Natural Science Research Council (FNU)(Danish Natural Science Research Council)	This research was funded by Natural Science and Engineering Council of Canada (NSERC) grants to B. G. G. and Danish Natural Science Research Council (FNU) grants to J.M.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCOMBE JP, 1990, ANIM BEHAV, V39, P960, DOI 10.1016/S0003-3472(05)80961-3; Batty ER, 2009, ANIM COGN, V12, P633, DOI 10.1007/s10071-009-0222-3; BRODBECK DR, 1995, J EXP PSYCHOL ANIM B, V21, P64, DOI 10.1037/0097-7403.21.1.64; BRODBECK DR, 1994, ANIM LEARN BEHAV, V22, P119, DOI 10.3758/BF03199912; Burns JG, 2006, BEHAV ECOL, V17, P48, DOI 10.1093/beheco/arj002; CLAYTON NS, 1994, J COMP PHYSIOL A, V174, P371; Day LB, 2003, J COMP PSYCHOL, V117, P440, DOI 10.1037/0735-7036.117.4.440; Fleming T.H., 1988, SHORT TAILED FRUIT B; Gould KL, 2010, PHILOS T R SOC B, V365, P901, DOI 10.1098/rstb.2009.0214; GUSTIN MK, 1987, ANIM BEHAV, V35, P13, DOI 10.1016/S0003-3472(87)80205-1; Hurly TA, 1996, ANIM BEHAV, V51, P177; KAMIN LJ, 1969, FUNDAMENTAL ISSUES A; KAMIN LJ, 1969, PUNISHMENT AVERSIVE, P597; Kanngiesser P, 2010, ANIM COGN, V13, P419, DOI 10.1007/s10071-009-0291-3; MACKINTOSH NJ, 1970, J COMP PHYSIOL PSYCH, V73, P78, DOI 10.1037/h0030021; MCCRACKEN GF, 1984, SCIENCE, V223, P1090, DOI 10.1126/science.223.4640.1090; Page RA, 2005, P ROY SOC B-BIOL SCI, V272, P841, DOI 10.1098/rspb.2004.2998; Page RA, 2006, CURR BIOL, V16, P1201, DOI 10.1016/j.cub.2006.04.038; Pavlov I.P., 1927, CONDITIONED REFLEXES; Ratcliffe JM, 2005, BIOL LETTERS, V1, P72, DOI 10.1098/rsbl.2004.0252; Ratcliffe JM, 2009, BEHAV PROCESS, V80, P247, DOI 10.1016/j.beproc.2008.12.010; Rescorla R. A., 1972, CLASSICAL CONDITIONI; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Siemers BM, 2001, ACTA CHIROPTEROL, V3, P211; Smulders TV, 2010, PHILOS T R SOC B, V365, P883, DOI 10.1098/rstb.2009.0211; Stich KP, 2006, J EXP BIOL, V209, P4802, DOI 10.1242/jeb.02574; TENNANT WA, 1975, J EXP PSYCHOL-ANIM B, V104, P22; Thiele J, 2005, ANIM BEHAV, V69, P315, DOI 10.1016/j.anbehav.2004.05.012; Vargas JP, 2004, J COMP PSYCHOL, V118, P206, DOI 10.1037/0735-7036.118.2.206; von Helversen O, 2003, BAT ECOLOGY, P346; von Helversen O, 2000, J COMP PHYSIOL A, V186, P143, DOI 10.1007/s003590050014; Winter Y, 2005, J EXP BIOL, V208, P539, DOI 10.1242/jeb.01416; Winter Y, 2003, J MAMMAL, V84, P886, DOI 10.1644/BWG-032; Winter Y, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P148, DOI 10.1017/CBO9780511542268.009; York HA, 2009, J MAMMAL, V90, P1469, DOI 10.1644/08-MAMM-A-382R.1	35	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10808	10.1371/journal.pone.0010808	http://dx.doi.org/10.1371/journal.pone.0010808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520841	gold, Green Published, Green Submitted			2022-12-25	WOS:000278034800006
J	Kalujnaia, S; Mcvee, J; Kasciukovic, T; Stewart, AJ; Cramb, G				Kalujnaia, Svetlana; McVee, Jill; Kasciukovic, Taciana; Stewart, Alan J.; Cramb, Gordon			A role for inositol monophosphatase 1 (IMPA1) in salinity adaptation in the euryhaline eel (Anguilla anguilla)	FASEB JOURNAL			English	Article						European eel; teleost; osmolyte; chondrocyte; osmoregulation	EUROPEAN EEL; MYOINOSITOL MONOPHOSPHATASE; ORGANIC OSMOLYTES; OSMOREGULATORY TISSUES; SENSITIVE ENZYME; ATLANTIC SALMON; MESSENGER-RNA; FISH GILL; EXPRESSION; LITHIUM	This study investigated the expression and tissue distribution of inositol monophosphatase (IMPA1) and characterized its role in salinity adaptation in the eel. The coding sequence of eel IMPA1 was determined and confirmed to be orthologous to the mammalian gene/enzyme by phylogenetic analysis and structural modeling. Quantitative real-time PCR and Western blot techniques indicated up to 17-fold increases in mRNA expression and 2-fold increases in protein abundance in major osmoregulatory tissues following transfer of fish to seawater (SW). This was accompanied by up to 5-fold increases in enzyme activity, and 1.8- and 3-fold increases in inositol contents within the gill and kidney, respectively. Immunohistological studies revealed that IMPA1 protein expression predominated in SW-acclimated fish within basal epithelial/epidermal layers of the gill, esophagus, intestine, skin, and fins. SW transfer also induced a 10-fold increase in inositol content in the fin. IMPA1 immunoreactivity was also identified in chondrocytes within the cartilagenous matrix of the gills and fins, as well as in clusters of interstitial cells surrounding the kidney tubules. The observed increases in expression of IMPA1 highlight a protective role for inositol within various eel tissues following SW acclimation. This constitutes an adaptive mechanism in teleost fish naturally exposed to hypertonic environments.-Kalujnaia, S., McVee, J., Kasciukovic, T., Stewart, A. J., Cramb, G. A role for inositol monophosphatase 1 (IMPA1) in salinity adaptation in the euryhaline eel (Anguilla anguilla). FASEB J. 24, 3981-3991 (2010). www.fasebj.org	[Kalujnaia, Svetlana; McVee, Jill; Kasciukovic, Taciana; Stewart, Alan J.; Cramb, Gordon] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland	University of St Andrews	Cramb, G (corresponding author), Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland.	gc@st-andrews.ac.uk	Stewart, Alan J/B-6569-2008	Stewart, Alan J/0000-0003-4580-1840	Natural Environment Research Council [NE/E015514, NE/F001401]; NERC [NE/E015514/1, NE/F001401/1] Funding Source: UKRI; Natural Environment Research Council [NE/F001401/1, NE/E015514/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank Caroline J. Osborne and Brian Powell for technical support. The work was supported by project grants from the Natural Environment Research Council (NE/E015514 and NE/F001401).	Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Amlund H, 2004, COMP BIOCHEM PHYS C, V138, P507, DOI 10.1016/j.cca.2004.08.010; Aoki M, 2003, J EXP BIOL, V206, P3495, DOI 10.1242/jeb.00579; Ashizawa N, 2000, J BIOCHEM BIOPH METH, V44, P89, DOI 10.1016/S0165-022X(00)00069-5; ATACK JR, 1995, FEBS LETT, V361, P1, DOI 10.1016/0014-5793(95)00063-F; Beck F X, 1992, Curr Opin Nephrol Hypertens, V1, P43, DOI 10.1097/00041552-199210000-00007; Beck FX, 2006, CONTRIB NEPHROL, V152, P181, DOI 10.1159/000096323; Bissonnette P, 2008, AM J PHYSIOL-CELL PH, V295, pC791, DOI 10.1152/ajpcell.00390.2007; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Evans TG, 2008, J EXP BIOL, V211, P3636, DOI 10.1242/jeb.022160; Farnum CE, 2002, BONE, V30, P574, DOI 10.1016/S8756-3282(01)00710-4; Fiess JC, 2007, COMP BIOCHEM PHYS A, V146, P252, DOI 10.1016/j.cbpa.2006.10.027; Gill R, 2005, ACTA CRYSTALLOGR D, V61, P545, DOI 10.1107/S0907444905004038; HALL AC, 1995, J PHYSIOL-LONDON, V484, P755, DOI 10.1113/jphysiol.1995.sp020701; Hazon N, 2003, COMP BIOCHEM PHYS B, V136, P685, DOI 10.1016/S1096-4959(03)00280-X; Kalujnaia S, 2009, ANN NY ACAD SCI, V1163, P433, DOI 10.1111/j.1749-6632.2009.04457.x; Kalujnaia S, 2009, GEN COMP ENDOCR, V161, P103, DOI 10.1016/j.ygcen.2008.11.005; Kalujnaia S, 2007, PHYSIOL GENOMICS, V31, P385, DOI 10.1152/physiolgenomics.00059.2007; Kalujnaia S, 2010, FASEB J, V24; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lignot JH, 2002, J EXP BIOL, V205, P2653; Lopez F, 1999, MOL MICROBIOL, V31, P1255, DOI 10.1046/j.1365-2958.1999.01267.x; Lopez-Coronado JM, 1999, J BIOL CHEM, V274, P16034, DOI 10.1074/jbc.274.23.16034; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Marshall William S., 2006, P177; Martinez AS, 2005, AM J PHYSIOL-REG I, V288, pR1733, DOI 10.1152/ajpregu.00747.2004; McCormick SD, 2003, J EXP BIOL, V206, P4575, DOI 10.1242/jeb.00711; McDonald MD, 2006, J MEMBRANE BIOL, V212, P93, DOI 10.1007/s00232-006-0869-5; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Ohnishi T, 2007, J BIOL CHEM, V282, P637, DOI 10.1074/jbc.M604474200; OLSON KR, 1991, J ELECTRON MICR TECH, V19, P389, DOI 10.1002/jemt.1060190402; Roberts SJ, 2004, BIOCHEM J, V382, P59, DOI 10.1042/BJ20040511; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAGUCHI H, 1993, AM J PHYSIOL, V265, pR474, DOI 10.1152/ajpregu.1993.265.2.R474; Takeuchi K, 2000, BBA-BIOMEMBRANES, V1464, P219, DOI 10.1016/S0005-2736(00)00158-9; TIERNEY ML, 1995, GEN COMP ENDOCR, V100, P39, DOI 10.1006/gcen.1995.1130; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P8916, DOI 10.1073/pnas.92.19.8916; Weltzien FA, 2006, ENDOCRINOLOGY, V147, P2964, DOI 10.1210/en.2005-1477; YAMAUCHI A, 1994, J AM SOC NEPHROL, V5, P62; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; YORK JD, 1994, BIOCHEMISTRY-US, V33, P13164, DOI 10.1021/bi00249a002	47	22	23	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3981	3991		10.1096/fj.10-161000	http://dx.doi.org/10.1096/fj.10-161000			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20547660				2022-12-25	WOS:000285005900035
J	Lu, LD; Sun, Q; Fan, XY; Zhong, Y; Yao, YF; Zhao, GP				Lu, Liang-dong; Sun, Qing; Fan, Xiao-yong; Zhong, Yi; Yao, Yu-feng; Zhao, Guo-Ping			Mycobacterial MazG Is a Novel NTP Pyrophosphohydrolase Involved in Oxidative Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TUBERCULOSIS H37RV; SURVIVAL; PROTEIN; MACROPHAGES; ADAPTATION; REGULATOR	MazG nucleoside triphosphate pyrophosphohydrolase (NTP-PPase, EC 3.6.1.8) from the avirulent Mycobacterium tuberculosis H37Ra contains a spontaneous mutation on a highly conserved residue, resulting in an A219E substitution (MtMazG[A219E]). In this work, we show that mycobacterial MazG from either the virulent M. tuberculosis H37Rv (MtMazG) or the fast-growing Mycobacterium smegmatis (MsMazG) is a potent NTP-PPase capable of hydrolyzing all canonical (d) NTPs, as well as the mutagenic dUTP and 8-oxo-7,8-dihydro-2'-dGTP. However, this hydrolysis activity is diminished by the MtMazG[A219E] mutation. Moreover, deletion of mazG in M. smegmatis rendered the mycobacteria defective in response to oxidative stress. Importantly, expression of the wildtype MtMazG, but not the A219E mutant, restored cell viability under oxidative stress. Intriguingly, under oxidative stress, both the mazG-null and MtMazG[A219E]-expressing M. smegmatis strains failed to elevate relA, while retaining their ability to up-regulate sigE, suggesting a specific role for the MazGNTP-PPase activity in oxidative stress-triggered, transcriptional activation of relA. The MtMazG is a homotetramer with each subunit containing a single MazG core domain flanked by two regions, both of which are essential for NTP-PPase activity. Taken together, these results demonstrate that the mycobacterial MazG is a potent NTP-PPase and that this activity is required to maintain the full capacity of the mycobacteria to respond to oxidative stress. Our work implicates a role for the MazG activity in the virulence of M. tuberculosis.	[Lu, Liang-dong; Sun, Qing; Yao, Yu-feng] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200025, Peoples R China; [Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Fan, Xiao-yong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China; [Zhong, Yi; Zhao, Guo-Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Yao, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200025, Peoples R China.	yfyao@sjtu.edu.cn; gpzhao@sibs.ac.cn	sun, qingshen/U-9700-2018; Lyu, Liangdong/C-6557-2014	sun, qingshen/0000-0001-7282-4330; Lyu, Liangdong/0000-0001-6391-6030; Zhao, Guo-Ping/0000-0002-7621-6620	National Natural Science Foundation of China [30830002, 30970077]; Science and Technology Commission of Shanghai Municipality [09QA1403600]; State Key Development Programs for Basic Research of China (973 Program) [2009CB522605]; Shanghai Institutions of Higher Learning	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); State Key Development Programs for Basic Research of China (973 Program)(National Basic Research Program of China); Shanghai Institutions of Higher Learning	This work was supported by grants from the National Natural Science Foundation of China (No. 30830002 and No. 30970077), Shanghai Rising-Star Program, Science and Technology Commission of Shanghai Municipality (No. 09QA1403600), the State Key Development Programs for Basic Research of China (973 Program No. 2009CB522605), and the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Fernandes ND, 1999, J BACTERIOL, V181, P4266, DOI 10.1128/JB.181.14.4266-4274.1999; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gao Q, 2004, TUBERCULOSIS, V84, P188, DOI 10.1016/j.tube.2003.12.013; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; He XY, 2003, MICROBES INFECT, V5, P851, DOI 10.1016/S1286-4579(03)00179-5; Hu YM, 2004, FEMS MICROBIOL LETT, V237, P415, DOI 10.1016/j.femsle.2004.07.005; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Lari N, 1999, MICROB PATHOGENESIS, V26, P281, DOI 10.1006/mpat.1998.0270; Lee S, 2008, J BIOL CHEM, V283, P15232, DOI 10.1074/jbc.M800479200; MACKANESS GB, 1954, AM REV TUBERC PULM, V69, P479; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Moroz OV, 2005, J MOL BIOL, V347, P243, DOI 10.1016/j.jmb.2005.01.030; Mostowy S, 2004, TUBERCULOSIS, V84, P197, DOI 10.1016/j.tube.2004.02.002; Payandeh J, 2006, J BIOL CHEM, V281, P6070, DOI 10.1074/jbc.M509377200; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Robinson A, 2007, MOL MICROBIOL, V66, P610, DOI 10.1111/j.1365-2958.2007.05932.x; Sambrook J, 1989, MOL CLONING LABORATO; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; STREEKEN W, 1946, AM REV TUBERC, V54, P62; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Tassotto ML, 2002, J BIOL CHEM, V277, P15807, DOI 10.1074/jbc.M200965200; Walker J M, 1994, Methods Mol Biol, V32, P5; Wu BL, 2007, J MOL BIOL, V367, P1405, DOI 10.1016/j.jmb.2007.01.057; Wu QL, 1997, J BACTERIOL, V179, P2922, DOI 10.1128/jb.179.9.2922-2929.1997; Zhang JJ, 2003, J BIOL CHEM, V278, P21408, DOI 10.1074/jbc.M213294200; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	42	37	51	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28076	28085		10.1074/jbc.M109.088872	http://dx.doi.org/10.1074/jbc.M109.088872			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20529853	Green Published, hybrid			2022-12-25	WOS:000288742300006
J	Chen, YL; Eriksson, S; Chang, ZF				Chen, Yen-Ling; Eriksson, Staffan; Chang, Zee-Fen			Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOTIDE REDUCTASE R2; MOUSE ERYTHROLEUKEMIA-CELLS; COLON-CANCER CELLS; GENE-EXPRESSION; CYCLE CHECKPOINT; MAMMALIAN-CELLS; P53 STATUS; AGENTS; RECOVERY; PATHWAY	Cellular supply of dNTPs is essential in the DNA replication and repair processes. Here we investigated the regulation of thymidine kinase 1 (TK1) in response to DNA damage and found that genotoxic insults in tumor cells cause up-regulation and nuclear localization of TK1. During recovery from DNA damage, TK1 accumulates in p53-null cells due to a lack of mitotic proteolysis as these cells are arrested in the G(2) phase by checkpoint activation. We show that in p53-proficient cells, p21 expression in response to DNA damage prohibits G(1)/S progression, resulting in a smaller G(2) fraction and less TK1 accumulation. Thus, the p53 status of tumor cells affects the level of TK1 after DNA damage through differential cell cycle control. Furthermore, it was shown that in HCT-116 p53(-/-) cells, TK1 is dispensable for cell proliferation but crucial for dTTP supply during recovery from DNA damage, leading to better survival. Depletion of TK1 decreases the efficiency of DNA repair during recovery from DNA damage and generates more cell death. Altogether, our data suggest that more dTTP synthesis via TK1 take place after genotoxic insults in tumor cells, improving DNA repair during G(2) arrest.	[Chang, Zee-Fen] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chen, Yen-Ling; Chang, Zee-Fen] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan; [Eriksson, Staffan] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Biomed Ctr, S-75123 Uppsala, Sweden	National Yang Ming Chiao Tung University; National Taiwan University; Swedish University of Agricultural Sciences	Chang, ZF (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155,Sec 2,Linong St, Taipei 112, Taiwan.	ZFCHANG@ym.edu.tw			National Health Research Institute [NHRI-EX99-9701B]; National Health Research Institute and National Science Council, Taiwan [NSC99-3112-B-010-021]; Ministry of Education, Taiwan; Swedish Research Council	National Health Research Institute(National Health Research Institutes - Taiwan); National Health Research Institute and National Science Council, Taiwan; Ministry of Education, Taiwan(Ministry of Education, Taiwan); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by Grants NHRI-EX99-9701B and NSC99-3112-B-010-021 from National Health Research Institute and National Science Council, Taiwan, respectively, and a grant from Aim for the Top University plan in National Yang-Ming University supported by the Ministry of Education, Taiwan.; Supported by grants from the Swedish Research Council.	ALNABULSI I, 1994, CANCER RES, V54, P5614; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; BELLO LJ, 1974, EXP CELL RES, V89, P263, DOI 10.1016/0014-4827(74)90790-3; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; BOOTHMAN DA, 1994, INT J RADIAT ONCOL, V30, P391, DOI 10.1016/0360-3016(94)90019-1; Brockenbrough JS, 2009, J HISTOCHEM CYTOCHEM, V57, P1087, DOI 10.1369/jhc.2009.952804; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; CHANG ZF, 1994, J BIOL CHEM, V269, P21249; Chang ZF, 1999, J CELL BIOCHEM, V75, P300, DOI 10.1002/(SICI)1097-4644(19991101)75:2<300::AID-JCB12>3.0.CO;2-Z; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; ECKSTEIN H, 1974, Z NATURFORSCH C, VC 29, P272; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; Gasparri F, 2009, EUR J CELL BIOL, V88, P779, DOI 10.1016/j.ejcb.2009.06.005; GOULIAN M, 1980, J BIOL CHEM, V255, P630; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hu CM, 2008, CANCER RES, V68, P2831, DOI 10.1158/0008-5472.CAN-07-3069; HUANG SH, 1994, DNA CELL BIOL, V13, P461, DOI 10.1089/dna.1994.13.461; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Lin ZP, 2007, BIOCHEM PHARMACOL, V73, P760, DOI 10.1016/j.bcp.2006.11.014; Lin ZP, 2004, J BIOL CHEM, V279, P27030, DOI 10.1074/jbc.M402056200; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Longley DB, 2002, CANCER RES, V62, P2644; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; MCKENNA PG, 1981, CELL BIOL INT REP, V5, P555, DOI 10.1016/S0309-1651(81)80006-9; MCKENNA PG, 1988, MUTAT RES, V200, P231, DOI 10.1016/0027-5107(88)90087-5; MCKENNA PG, 1985, SOMAT CELL MOLEC GEN, V11, P239, DOI 10.1007/BF01534680; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; NAVALGUND LG, 1980, J BIOL CHEM, V255, P7386; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; ROEHL HH, 1990, MOL CELL BIOL, V10, P3834, DOI 10.1128/MCB.10.7.3834; Sarkaria JN, 1999, CANCER RES, V59, P4375; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wakazono Y, 1996, MUTAT RES-DNA REPAIR, V362, P119, DOI 10.1016/0921-8777(95)00042-9; Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yamaguchi T, 2001, CANCER RES, V61, P8256; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020	56	57	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27327	27335		10.1074/jbc.M110.137042	http://dx.doi.org/10.1074/jbc.M110.137042			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20554529	hybrid, Green Published			2022-12-25	WOS:000281172700062
J	Dettmer, U; Kuhn, PH; Abou-Ajram, C; Lichtenthaler, SF; Kruger, M; Kremmer, E; Haass, C; Haffner, C				Dettmer, Ulf; Kuhn, Peer-Hendrik; Abou-Ajram, Claudia; Lichtenthaler, Stefan F.; Krueger, Marcus; Kremmer, Elisabeth; Haass, Christian; Haffner, Christof			Transmembrane Protein 147 (TMEM147) Is a Novel Component of the Nicalin-NOMO Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE COMPLEX; INTRAMEMBRANE PROTEOLYSIS; SIGNALING PATHWAY; BETA-APP; NICASTRIN; PRESENILIN; APH-1; NOTCH; ENDOPROTEOLYSIS; EXPRESSION	Nicastrin and its relative Nicalin (Nicastrin-like protein) are both members of larger protein complexes, namely gamma-secretase and the Nicalin-NOMO (Nodal modulator) complex. The gamma-secretase complex, which contains Presenilin, APH-1, and PEN-2 in addition to Nicastrin, catalyzes the proteolytic cleavage of the transmembrane domain of various proteins including the beta-amyloid precursor protein and Notch. Nicalin and its binding partner NOMO form a complex that was shown to modulate Nodal signaling in developing zebrafish embryos. Because its experimentally determined native size (200-220 kDa) could not be satisfyingly explained by the molecular masses of Nicalin (60 kDa) and NOMO(130 kDa), we searched in affinity-purified complex preparations for additional components in the low molecular mass range. A similar to 22-kDa protein was isolated and identified by mass spectrometry as transmembrane protein 147 (TMEM147), a novel, highly conserved membrane protein with a putative topology similar to APH-1. Like Nicalin and NOMO, it localizes to the endoplasmic reticulum and is expressed during early zebrafish development. Overexpression and knockdown experiments in cultured cells demonstrate a close relationship between the three proteins and suggest that they are components of the same complex. We present evidence that, similar to gamma-secretase, its assembly is hierarchical starting with the formation of a Nicalin-NOMO intermediate. Nicalin appears to represent the limiting factor regulating the assembly rate by stabilizing the other two components. We conclude that TMEM147 is a novel core component of the Nicalin-NOMO complex, further emphasizing its similarity with gamma-secretase.	[Haass, Christian; Haffner, Christof] Univ Munich, German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Haass, Christian; Haffner, Christof] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Krueger, Marcus] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Max Planck Society; Helmholtz Association	Haffner, C (corresponding author), Univ Munich, Inst Stroke & Dementia Res, Klinikum Grosshadern, Max Lebsche Pl 30, D-81377 Munich, Germany.	chaffner@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016; Haffner, Christof/AAG-6676-2020	Lichtenthaler, Stefan F/0000-0003-2211-2575; Kuhn, Peer-Hendrik/0000-0001-7891-5102; Dettmer, Ulf/0000-0001-6676-0107	Deutsche Forschungsgemeinschaft [596]; Bundesministerium fur Bildung und Forschung (BMBF); Centre for Integrated Protein Science Munich; Ludwig-Maximilians-University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Centre for Integrated Protein Science Munich; Ludwig-Maximilians-University	This work was supported by the Deutsche Forschungsgemeinschaft (Leibniz Award to C. Haass, Sonderforschungsbereich 596 to C. Haass and S. F. L.), the Bundesministerium fur Bildung und Forschung (BMBF) through the competence network "Degenerative dementias" (to S. F. L. and C. Haass), the Centre for Integrated Protein Science Munich, a Ph. D. scholarship of the "Stiftung Stipendien-Fonds des Verbandes der chemischen Industrie" (to U. D.), and a "Forschungsprofessur" of the Ludwig-Maximilians-University (to C. Haass).	Almedom RB, 2009, EMBO J, V28, P2636, DOI 10.1038/emboj.2009.204; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haffner C, 2004, EMBO J, V23, P3041, DOI 10.1038/sj.emboj.7600307; Haffner C, 2007, J BIOL CHEM, V282, P10632, DOI 10.1074/jbc.M611033200; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; THISSE C, 1993, DEVELOPMENT, V119, P1203; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200	35	28	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26174	26181		10.1074/jbc.M110.132548	http://dx.doi.org/10.1074/jbc.M110.132548			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538592	Green Published, hybrid			2022-12-25	WOS:000280921000034
J	Boyd, JM; Clark, DD; Kofoed, MA; Ensign, SA				Boyd, Jeffrey M.; Clark, Daniel D.; Kofoed, Melissa A.; Ensign, Scott A.			Mechanism of Inhibition of Aliphatic Epoxide Carboxylation by the Coenzyme M Analog 2-Bromoethanesulfonate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE OXIDOREDUCTASE; STRUCTURAL BASIS; ACTIVE-SITE; M REDUCTASE; METHANOGENESIS; DEHYDROGENASE; ENZYMES; PATHWAY; GROWTH; FAMILY	The bacterial metabolism of epoxypropane formed from propylene oxidation uses the atypical cofactor coenzyme M (CoM, 2-mercaptoethanesulfonate) as the nucleophile for epoxide ring opening and as a carrier of intermediates that undergo dehydrogenation, reductive cleavage, and carboxylation to form acetoacetate in a three-step metabolic pathway. 2-Ketopropyl-CoM carboxylase/oxidoreductase (2-KPCC), the terminal enzyme of this pathway, is the only known member of the disulfide oxidoreductase family of enzymes that is a carboxylase. In the present work, the CoM analog 2-bromoethanesulfonate (BES) is shown to be a reversible inhibitor of 2-KPCC and hydroxypropyl-CoM dehydrogenase but not of epoxyalkane: CoM transferase. Further investigations revealed that BES is a time-dependent inactivator of dithiothreitol-reduced 2-KPCC, where the redox active cysteines are in the free thiol forms. BES did not inactivate air-oxidized 2-KPCC, where the redox active cysteine pair is in the disulfide form. The inactivation of 2-KPCC exhibited saturation kinetics, and CoM slowed the rate of inactivation. Mass spectral analysis demonstrated that BES inactivation of reduced 2-KPCC occurs with covalent modification of the interchange thiol (Cys(82)) by a group with a molecular mass identical to that of ethylsulfonate. The flavin thiol Cys(87) was not alkylated by BES under reducing conditions, and no amino acid residues were modified by BES in the oxidized enzyme. The UV-visible spectrum of BES-modifed 2-KPCC showed the characteristic charge transfer absorbance expected with alkylation at Cys(82). These results identify BES as a reactive CoM analog that specifically alkylates the interchange thiol that facilitates thioether bond cleavage and enolacetone formation during catalysis.	[Boyd, Jeffrey M.; Kofoed, Melissa A.; Ensign, Scott A.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Clark, Daniel D.] Calif State Univ Chico, Dept Chem, Chico, CA 95929 USA	Utah System of Higher Education; Utah State University; California State University System; California State University Chico	Ensign, SA (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	scott.ensign@usu.edu		Boyd, Jeffrey/0000-0001-7721-3926	National Institutes of Health [GM51805]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051805, R01GM051805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51805.	Aliverti A, 1999, METH MOL B, V131, P9; Allen JR, 1999, P NATL ACAD SCI USA, V96, P8432, DOI 10.1073/pnas.96.15.8432; Allen JR, 1997, J BACTERIOL, V179, P3110, DOI 10.1128/jb.179.10.3110-3115.1997; Boyd JM, 2006, J BACTERIOL, V188, P8062, DOI 10.1128/JB.00947-06; Cleland W W, 1979, Methods Enzymol, V63, P103; Copeland R. A., 2000, ENZYMES, V2nd; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Ensign SA, 2003, ANNU REV BIOCHEM, V72, P55, DOI 10.1146/annurev.biochem.72.121801.161820; Ensign SA, 2001, BIOCHEMISTRY-US, V40, P5845, DOI 10.1021/bi015523d; FOX BS, 1983, BIOCHEMISTRY-US, V22, P4082, DOI 10.1021/bi00286a014; Goenrich M, 2004, J BIOL INORG CHEM, V9, P691, DOI 10.1007/s00775-004-0552-1; GUNSALUS RP, 1978, BIOCHEMISTRY-US, V17, P2374, DOI 10.1021/bi00605a019; Hinderberger D, 2006, ANGEW CHEM INT EDIT, V45, P3602, DOI 10.1002/anie.200600366; Krishnakumar AM, 2006, BIOCHEMISTRY-US, V45, P8831, DOI 10.1021/bi0603569; Kruger K, 1999, APPL MICROBIOL BIOT, V52, P666, DOI 10.1007/s002530051576; Kunz RC, 2008, BIOCHEMISTRY-US, V47, P2661, DOI 10.1021/bi701942w; Kunz RC, 2006, J BIOL CHEM, V281, P34663, DOI 10.1074/jbc.M606715200; Nocek B, 2002, BIOCHEMISTRY-US, V41, P12907, DOI 10.1021/bi026580p; Pai EF, 1991, CURR OPIN STRUC BIOL, V1, P796, DOI 10.1016/0959-440X(91)90181-R; Pandey AS, 2006, BIOCHEMISTRY-US, V45, P113, DOI 10.1021/bi051518o; SPARLING R, 1987, CAN J MICROBIOL, V33, P1132, DOI 10.1139/m87-199; TAYLOR CD, 1974, J BACTERIOL, V120, P974, DOI 10.1128/JB.120.2.974-975.1974; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; WOLFE RS, 1991, ANNU REV MICROBIOL, V45, P1, DOI 10.1146/annurev.mi.45.100191.000245; ZINDER SH, 1984, APPL ENVIRON MICROB, V47, P1343, DOI 10.1128/AEM.47.6.1343-1345.1984	25	10	10	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25232	25242		10.1074/jbc.M110.144410	http://dx.doi.org/10.1074/jbc.M110.144410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551308	Green Published, hybrid			2022-12-25	WOS:000280682400016
J	Kamitani, S; Kitadokoro, K; Miyazawa, M; Toshima, H; Fukui, A; Abe, H; Miyake, M; Horiguchi, Y				Kamitani, Shigeki; Kitadokoro, Kengo; Miyazawa, Masayuki; Toshima, Hirono; Fukui, Aya; Abe, Hiroyuki; Miyake, Masami; Horiguchi, Yasuhiko			Characterization of the Membrane-targeting C1 Domain in Pasteurella multocida Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POTENT MITOGEN; PROTEIN; ACTIVATION; IDENTIFICATION; LOCALIZATION; CLEAVAGE; FRAGMENT; DEPENDS	Pasteurella multocida toxin (PMT) is a virulence factor responsible for the pathogenesis of some forms of pasteurellosis. The toxin activates G(q)- and G(12/13)-dependent pathways through the deamidation of a glutamine residue in the alpha-subunit of heterotrimeric GTPases. We recently reported the crystal structure of the C terminus (residues 575-1285) of PMT (C-PMT), which is composed of three domains (C1, C2, and C3), and that the C1 domain is involved in the localization of C-PMT to the plasma membrane, and the C3 domain possesses a cysteine protease-like catalytic triad. In this study, we analyzed the membrane-targeting function of the C1 domain in detail. The C1 domain consists of seven helices of which the first four (residues 590670), showing structural similarity to the N terminus of Clostridium difficile toxin B, were found to be involved in the recruitment of C-PMT to the plasma membrane. C-PMT lacking these helices (C-PMT Delta C1(4H)) neither localized to the plasma membrane nor stimulated the G(q/12/13)-dependent signaling pathways. When the membrane-targeting property was complemented by a peptide tag with an N-myristoylation motif, C-PMT Delta C1(4H) recovered the PMT activity. Direct binding between the C1 domain and liposomes containing phospholipids was evidenced by surface plasmon resonance analyses. These results indicate that the C1 domain of C-PMT functions as a targeting signal for the plasma membrane.	[Miyake, Masami; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kitadokoro, Kengo] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Kyoto 6068585, Japan; [Miyake, Masami] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Environm Sci, Osaka 5998531, Japan	Osaka University; Kyoto Institute of Technology; Osaka Metropolitan University		skami@biken.osaka-u.ac.jp		Kitadokoro, Kengo/0000-0001-5969-7939; Kamitani, Shigeki/0000-0002-1268-4652	Ministry of Education, Culture, Science, and Technology of Japan	Ministry of Education, Culture, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Science, and Technology of Japan.	Baldwin MR, 2004, MOL MICROBIOL, V54, P239, DOI 10.1111/j.1365-2958.2004.04264.x; Brandish PE, 2003, ANAL BIOCHEM, V313, P311, DOI 10.1016/S0003-2697(02)00630-9; Busch C, 2001, INFECT IMMUN, V69, P3628, DOI 10.1128/IAI.69.6.3628-3634.2001; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Essler M, 1998, J IMMUNOL, V161, P5640; FALBO V, 1993, INFECT IMMUN, V61, P4909, DOI 10.1128/IAI.61.11.4909-4914.1993; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Hanajima-Ozawa M, 2007, INFECT IMMUN, V75, P565, DOI 10.1128/IAI.01479-06; HIGGINS TE, 1992, P NATL ACAD SCI USA, V89, P4240, DOI 10.1073/pnas.89.10.4240; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; Lacerda HM, 1996, J BIOL CHEM, V271, P439, DOI 10.1074/jbc.271.1.439; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; Miyazawa M, 2006, ACTA CRYSTALLOGR F, V62, P906, DOI 10.1107/S1744309106030375; Mullan PB, 1996, INFECT IMMUN, V64, P959, DOI 10.1128/IAI.64.3.959-965.1996; MURPHY AC, 1992, J BIOL CHEM, V267, P25296; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Orth JHC, 2004, J BIOL CHEM, V279, P34150, DOI 10.1074/jbc.M405353200; Orth JHC, 2003, BIOCHEMISTRY-US, V42, P4971, DOI 10.1021/bi0272959; Orth JHC, 2008, J BIOL CHEM, V283, P23288, DOI 10.1074/jbc.M803435200; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; OSWALD E, 1994, P NATL ACAD SCI USA, V91, P3814, DOI 10.1073/pnas.91.9.3814; Pullinger GD, 2001, INFECT IMMUN, V69, P7839, DOI 10.1128/IAI.69.12.7839-7850.2001; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; ROZENGURT E, 1990, P NATL ACAD SCI USA, V87, P123, DOI 10.1073/pnas.87.1.123; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; STADDON JM, 1991, J BIOL CHEM, V266, P4840; Ward PN, 1998, INFECT IMMUN, V66, P5636, DOI 10.1128/IAI.66.12.5636-5642.1998; Wilson BA, 1997, J BIOL CHEM, V272, P1268, DOI 10.1074/jbc.272.20.12961; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	35	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25467	25475		10.1074/jbc.M110.102285	http://dx.doi.org/10.1074/jbc.M110.102285			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534589	Green Published, hybrid			2022-12-25	WOS:000280682400040
J	Wilson, CH; McIntyre, RE; Arends, MJ; Adams, DJ				Wilson, C. H.; McIntyre, R. E.; Arends, M. J.; Adams, D. J.			The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways	ONCOGENE			English	Article						cAMP; colorectal cancer; GNAS	MCCUNE-ALBRIGHT-SYNDROME; STIMULATORY G-PROTEIN; K-RAS; ADRENAL-HYPERPLASIA; COLORECTAL-CANCER; HUMAN BREAST; CELL-GROWTH; A33 ANTIGEN; EXPRESSION; CAMP	Somatically acquired, activating mutations of GNAS, the gene encoding the stimulatory G-protein Gsa subunit, have been identified in kidney, thyroid, pituitary, leydig cell, adrenocortical and, more recently, in colorectal tumours, suggesting that mutations such as R201C may be oncogenic in these tissues. To study the role of GNAS in intestinal tumourigenesis, we placed GNAS R201C under the control of the A33-antigen promoter (Gpa33), which is almost exclusively expressed in the intestines. The GNAS R201C mutation has been shown to result in the constitutive activation of Gs alpha and adenylate cyclase and to lead to the autonomous synthesis of cyclic adenosine monophosphate (cAMP). Gpa33(tm1(GnasR201C) Wtsi/+) mice showed significantly elevated cAMP levels and a compensatory upregulation of cAMP-specific phosphodiesterases in the intestinal epithelium. GNAS R201C alone was not sufficient to induce tumourigenesis by 12 months, but there was a significant increase in adenoma formation when Gpa(33tm1(GnasR201C) Wtsi/+) mice were bred onto an Apc(Min/+) background. GNAS R201C expression was associated with elevated expression of Wnt and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase (ERK1/2 MAPK) pathway target genes, increased phosphorylation of ERK1/2 MAPK and increased immunostaining for the proliferation marker Ki67. Furthermore, the effects of GNAS R201C on the Wnt pathway were additive to the inactivation of Apc. Our data strongly suggest that activating mutations of GNAS cooperate with inactivation of APC and are likely to contribute to colorectal tumourigenesis. Oncogene (2010) 29, 4567-4575; doi: 10.1038/onc.2010.202; published online 7 June 2010	[Wilson, C. H.; McIntyre, R. E.; Adams, D. J.] Sanger Inst, Wellcome Trust, Hinxton CB10 1SA, England; [Arends, M. J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Adams, DJ (corresponding author), Sanger Inst, Wellcome Trust, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	da1@sanger.ac.uk		Adams, David/0000-0001-9490-0306; Wilson, Catherine/0000-0002-5333-0295	Cancer Research UK (CR-UK); Wellcome Trust	Cancer Research UK (CR-UK)(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	Work in the DJ Adams Laboratory and the MJ Arends Laboratory is funded by Cancer Research UK (CR-UK) and the Wellcome Trust. We thank Dr Mattias Ernst for providing the Gpa33 targeting vector.	Abud HE, 2000, MECH DEVELOP, V98, P111, DOI 10.1016/S0925-4773(00)00438-X; Araki Y, 2003, CANCER RES, V63, P728; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1989, CANCER RES, V49, P4682; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen CJ, 2004, J PEDIATR ENDOCR MET, V17, P365; Collins MT, 2003, J CLIN ENDOCR METAB, V88, P4413, DOI 10.1210/jc.2002-021642; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Fragoso MCBV, 1998, J CLIN ENDOCR METAB, V83, P2074, DOI 10.1210/jc.83.6.2074; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; HAPPLE R, 1986, CLIN GENET, V29, P321; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Horvath A, 2008, EUR J HUM GENET, V16, P1245, DOI 10.1038/ejhg.2008.85; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Johnstone CN, 2000, AM J PHYSIOL-GASTR L, V279, pG500, DOI 10.1152/ajpgi.2000.279.3.G500; Kalfa N, 2006, J UROLOGY, V176, P891, DOI 10.1016/j.juro.2006.04.023; Kirk JMW, 1999, J PEDIATR-US, V134, P789, DOI 10.1016/S0022-3476(99)70302-1; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kotoula V, 2009, ENDOCR-RELAT CANCER, V16, P565, DOI 10.1677/ERC-08-0101; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LEVY DB, 1994, CANCER RES, V54, P5953; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo F, 2007, ONCOGENE, V26, P4415, DOI 10.1038/sj.onc.1210231; Luo FJ, 2009, INT J EXP PATHOL, V90, P558, DOI 10.1111/j.1365-2613.2009.00667.x; MacMahon H E, 1971, Pathol Annu, V6, P81; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Orner GA, 2002, MUTAT RES-FUND MOL M, V506, P121, DOI 10.1016/S0027-5107(02)00158-6; Palos-Paz F, 2008, EUR J ENDOCRINOL, V159, P623, DOI 10.1530/EJE-08-0313; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rudolph JA, 2004, J BIOL CHEM, V279, P14828, DOI 10.1074/jbc.M310289200; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Sieber OM, 2000, MOL MED TODAY, V6, P462; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Stratakis CA, 2003, TRENDS ENDOCRIN MET, V14, P404, DOI 10.1016/j.tem.2003.08.005; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Taboada GF, 2009, PITUITARY, V12, P165, DOI 10.1007/s11102-008-0136-0; Taketo MM, 2006, CANCER SCI, V97, P355, DOI 10.1111/j.1349-7006.2006.00190.x; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Wilkins JA, 2008, CANCER RES, V68, P4963, DOI 10.1158/0008-5472.CAN-07-5558; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang GCH, 1999, MODERN PATHOL, V12, P969; Zhang T, 2001, CANCER RES, V61, P8664	54	81	83	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 12	2010	29	32					4567	4575		10.1038/onc.2010.202	http://dx.doi.org/10.1038/onc.2010.202			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	638AQ	20531296	Green Accepted, Green Submitted			2022-12-25	WOS:000280862300007
J	Shibagaki, N; Grossman, AR				Shibagaki, Nakako; Grossman, Arthur R.			Binding of Cysteine Synthase to the STAS Domain of Sulfate Transporter and Its Regulatory Consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL SERINE ACETYLTRANSFERASE; O-ACETYLSERINE SULFHYDRYLASE; ARABIDOPSIS-THALIANA; NITRATE TRANSPORTER; GENE FAMILY; SULFUR NUTRITION; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; SALMONELLA-TYPHIMURIUM; BIOCHEMICAL-ANALYSIS	The sulfate ion (SO42-) is transported into plant root cells by SO42- transporters and then mostly reduced to sulfide (S2-). The S2- is then bonded to O-acetylserine through the activity of cysteine synthase (O-acetylserine (thiol) lyase or OASTL) to form cysteine, the first organic molecule of the SO42- assimilation pathway. Here, we show that a root plasma membrane SO42- transporter of Arabidopsis, SULTR1;2, physically interacts with OASTL. The interaction was initially demonstrated using a yeast two-hybrid system and corroborated by both in vivo and in vitro binding assays. The domain of SULTR1;2 shown to be important for association with OASTL is called the STAS domain. This domain is at the C terminus of the transporter and extends from the plasma membrane into the cytoplasm. The functional relevance of the OASTL-STAS interaction was investigated using yeast mutant cells devoid of endogenous SO42- uptake activity but co-expressing SULTR1;2 and OASTL. The analysis of SO42- transport in these cells suggests that the binding of OASTL to the STAS domain in this heterologous system negatively impacts transporter activity. In contrast, the activity of purified OASTL measured in vitro was enhanced by co-incubation with the STAS domain of SULTR1;2 but not with the analogous domain of the SO42- transporter isoform SULTR1;1, even though the SULTR1;1 STAS peptide also interacts with OASTL based on the yeast two-hybrid system and in vitro binding assays. These observations suggest a regulatory model in which interactions between SULTR1;2 and OASTL coordinate internalization of SO42- with the energetic/metabolic state of plant root cells.	[Shibagaki, Nakako; Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Shibagaki, N (corresponding author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	nshibagaki@mls.eng.osaka-u.ac.jp			National Science Foundation [MCB0235878, MCB-0824469]; Carnegie Institution for Science	National Science Foundation(National Science Foundation (NSF)); Carnegie Institution for Science	This work was supported by National Science Foundation Grants MCB0235878 and MCB-0824469 (to A. R. G.) and by The Carnegie Institution for Science.	Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Blaszczyk A, 1999, PLANT J, V20, P237, DOI 10.1046/j.1365-313x.1999.00596.x; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Burke D, 2000, METHODS YEAST GENETI, P103; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Cherest H, 1997, GENETICS, V145, P627; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; FLAVIN M, 1965, BIOCHEMISTRY-US, V4, P1370, DOI 10.1021/bi00883a022; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gotor C, 1997, PLANT J, V11, P347, DOI 10.1046/j.1365-313X.1997.11020347.x; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Harms K, 2000, PLANT J, V22, P335, DOI 10.1046/j.1365-313x.2000.00743.x; Heeg C, 2008, PLANT CELL, V20, P168, DOI 10.1105/tpc.107.056747; Hell R, 2002, AMINO ACIDS, V22, P245, DOI 10.1007/s007260200012; HESSE H, 1995, PLANT PHYSIOL, V108, P851, DOI 10.1104/pp.108.2.851; Hirai MY, 2003, PLANT J, V33, P651, DOI 10.1046/j.1365-313X.2003.01658.x; Ho MS, 2003, J BIOL CHEM, V278, P20898, DOI 10.1074/jbc.M302305200; Hopkins L, 2005, PLANT PHYSIOL, V138, P433, DOI 10.1104/pp.104.057521; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jost R, 2000, GENE, V253, P237, DOI 10.1016/S0378-1119(00)00261-4; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18816, DOI 10.1073/pnas.0604711103; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Martin Y, 2008, PLANT MOL BIOL, V68, P215, DOI 10.1007/s11103-008-9363-z; Maruyama-Nakashita A, 2004, J EXP BOT, V55, P1843, DOI 10.1093/jxb/erh175; Maruyama-Nakashita A, 2004, PLANT CELL PHYSIOL, V45, P340, DOI 10.1093/pcp/pch029; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Mulet JM, 2004, YEAST, V21, P303, DOI 10.1002/yea.1076; Nakae H, 2007, CHINA FOUNDRY, V4, P34; Navarro FJ, 2006, J BIOL CHEM, V281, P13268, DOI 10.1074/jbc.M601253200; Navarro FJ, 2008, J BIOL CHEM, V283, P31208, DOI 10.1074/jbc.M802170200; Noji M, 2002, AMINO ACIDS, V22, P231, DOI 10.1007/s007260200011; Rouached H, 2008, PLANT PHYSIOL, V147, P897, DOI 10.1104/pp.108.118612; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schuetze Katia, 2009, V479, P189, DOI 10.1007/978-1-59745-289-2_12; Shibagaki N, 2002, PLANT J, V29, P475, DOI 10.1046/j.0960-7412.2001.01232.x; Shibagaki N, 2004, J BIOL CHEM, V279, P30791, DOI 10.1074/jbc.M403248200; Shibagaki N, 2006, J BIOL CHEM, V281, P22964, DOI 10.1074/jbc.M603462200; SORENSEN MA, 1991, J BACTERIOL, V173, P5244, DOI 10.1128/jb.173.16.5244-5246.1991; Tanaka N, 2008, CANCER SCI, V99, P1293, DOI 10.1111/j.1349-7006.2008.00825.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Warrilow AGS, 1998, J EXP BOT, V49, P1625, DOI 10.1093/jexbot/49.327.1625; Watanabe M, 2008, PLANT CELL, V20, P2484, DOI 10.1105/tpc.108.060335; Watanabe M, 2008, PLANT PHYSIOL, V146, P310, DOI 10.1104/pp.107.106831; Wirtz M, 2003, AMINO ACIDS, V24, P195, DOI 10.1007/s00726-002-0313-9; Yoshimoto N, 2002, PLANT J, V29, P465, DOI 10.1046/j.0960-7412.2001.01231.x; Yoshimoto N, 2007, PLANT PHYSIOL, V145, P378, DOI 10.1104/pp.107.105742; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	51	41	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25094	25102		10.1074/jbc.M110.126888	http://dx.doi.org/10.1074/jbc.M110.126888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529854	Green Published, hybrid			2022-12-25	WOS:000280542100082
J	Chu, WK; Hanada, K; Kanaar, R; Hickson, ID				Chu, W. K.; Hanada, K.; Kanaar, R.; Hickson, I. D.			BLM has early and late functions in homologous recombination repair in mouse embryonic stem cells	ONCOGENE			English	Article						Rad54; gene targeting; mitomycin C; sister chromatid exchanges; DNA crosslinking agents	SISTER-CHROMATID EXCHANGES; BLOOMS-SYNDROME HELICASE; DNA-DAMAGE; RESECT DNA; D-LOOPS; RAD54; PROTEIN; PROMOTES; SGS1; DISRUPTION	BLM is a RecQ family helicase that is defective in individuals with the cancer predisposition disorder, Bloom's syndrome (BS). At the cellular level, BS is characterized by hyper-recombination manifested as excessive sister chromatid exchange and loss of heterozygosity. However, the precise function of BLM remains unclear. Multiple roles have been proposed for BLM in the homologous recombination (HR) repair pathway, including 'early' functions, such as the stimulation of resection of DNA double-strand break ends or displacement of the invading strand of DNA displacement loops, and 'late' roles, such as dissolution of double Holliday junctions. However, most of the evidence for these putative roles comes from in vitro biochemical data. In this study, we report the characterization of mouse embryonic stem cells with disruption of Blm and/or Rad54 genes. We show that Blm has roles both upstream and downstream of the Rad54 protein, a core HR factor. Disruption of Rad54 in the Blm-mutant background reduced the elevated level of gene targeting and of sister chromatid exchanges, implying that Blm primarily functions downstream of Rad54 in the HR pathway. Conversely, however, mutation of Blm in Rad54(-/-) cells rescued their mitomycin C (MMC) sensitivity, and decreased both the level of DNA damage and cell cycle perturbation induced by MMC, suggesting an early role for Blm. Our data are consistent with Blm having at least two roles in HR repair in mammalian cells. Oncogene (2010) 29, 4705-4714; doi:10.1038/onc.2010.214; published online 7 June 2010	[Chu, W. K.; Hanada, K.; Hickson, I. D.] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; [Hanada, K.; Kanaar, R.] Erasmus MC, Dept Cell Biol & Genet, Canc Genom Ctr, Dept Radiat Oncol, Rotterdam, Netherlands; [Hickson, I. D.] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark	University of Oxford; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Copenhagen	Hickson, ID (corresponding author), Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England.	hickson@imm.ox.ac.uk	Chu, Wai Kit/F-9405-2016; Hickson, Ian/AAJ-7548-2020	Chu, Wai Kit/0000-0003-2903-3247; Hanada, Katsuhiro/0000-0003-0429-1899; Hickson, Ian/0000-0002-0583-566X	Cancer Research UK; Bloom's Syndrome Foundation; Netherlands Genomic Initiative/The Netherlands Organization for Scientific Research; Anita Mui 'True Heart' Charity Foundation; K P Tin Foundation Limited; China Oxford Scholarship	Cancer Research UK(Cancer Research UK); Bloom's Syndrome Foundation; Netherlands Genomic Initiative/The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Anita Mui 'True Heart' Charity Foundation; K P Tin Foundation Limited; China Oxford Scholarship	We thank Dr A Bradley for Blm<SUP>m3/m4</SUP> cells, and Drs H te Riele and D Adams for the targeting vectors. We also thank Drs L Wu, P McHugh and CZ Bachrati for helpful comments on the paper, Mr PS North for advice on SCE assays and Miss P White for preparing the paper. This work was supported by Cancer Research UK and by The Bloom's Syndrome Foundation (IDH), and by The Netherlands Genomic Initiative/The Netherlands Organization for Scientific Research (RK). WK Chu was supported by the Anita Mui 'True Heart' Charity Foundation, the K P Tin Foundation Limited and the China Oxford Scholarship Fund.	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; DILLEHAY LE, 1989, MUTAT RES, V215, P15, DOI 10.1016/0027-5107(89)90213-3; Dronkert MLG, 2000, MOL CELL BIOL, V20, P3147, DOI 10.1128/MCB.20.9.3147-3156.2000; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Marple T, 2006, MUTAT RES-FUND MOL M, V602, P110, DOI 10.1016/j.mrfmmm.2006.08.005; Mazina OM, 2008, P NATL ACAD SCI USA, V105, P18249, DOI 10.1073/pnas.0807016105; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Otsuki M, 2007, J CELL BIOL, V179, P53, DOI 10.1083/jcb.200702183; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Wang WS, 2000, EMBO J, V19, P3428, DOI 10.1093/emboj/19.13.3428; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Zhang R, 2005, CANCER RES, V65, P2526, DOI 10.1158/0008-5472.CAN-04-2421; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	46	30	30	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	33					4705	4714		10.1038/onc.2010.214	http://dx.doi.org/10.1038/onc.2010.214			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20531307				2022-12-25	WOS:000281127400009
J	Hrstka, R; Nenutil, R; Fourtouna, A; Maslon, MM; Naughton, C; Langdon, S; Murray, E; Larionov, A; Petrakova, K; Muller, P; Dixon, MJ; Hupp, TR; Vojtesek, B				Hrstka, R.; Nenutil, R.; Fourtouna, A.; Maslon, M. M.; Naughton, C.; Langdon, S.; Murray, E.; Larionov, A.; Petrakova, K.; Muller, P.; Dixon, M. J.; Hupp, T. R.; Vojtesek, B.			The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers	ONCOGENE			English	Article						AGR2; tamoxifen; letrozole; estrogen receptor; breast cancer	HUMAN ESTROGEN-RECEPTOR; PROGESTERONE RECEPTORS; RESPONSE ELEMENT; HUMAN HOMOLOG; GENE XAG-2; CELL-LINES; EXPRESSION; AGR2; RESISTANCE; HYBRIDIZATION	Transcriptomic screens in breast cancer cell lines have identified a protein named anterior gradient-2 (AGR2) as a potentially novel oncogene overexpressed in estrogen receptor (ER) positive tumours. As targeting the ER is responsible for major improvements in cure rates and prevention of breast cancers, we have evaluated the prooncogenic function of AGR2 in anti-hormone therapeutic responses. We show that AGR2 expression promotes cancer cell survival in clonogenic assays and increases cell proliferation and viability in a range of cancer cell lines. Chromatin immunoprecipitation and reporter assays indicate that AGR2 is transcriptionally activated by estrogen through ER alpha. However, we also found that AGR2 expression is elevated rather than inhibited in response to tamoxifen, thus identifying a novel mechanism to account for an agonistic effect of the drug on a specific pro-oncogenic pathway. Consistent with these data, clinical analysis indicates that AGR2 expression is related to treatment failure in ER alpha-positive breast cancers treated with tamoxifen. In contrast, AGR2 is one of the most highly suppressed genes in cancers of responding patients treated with the anti-hormonal drug letrozole. These data indicate that the AGR2 pathway represents a novel pro-oncogenic pathway for evaluation as anti-cancer drug developments, especially therapies that by-pass the agonist effects of tamoxifen. Oncogene (2010) 29, 4838-4847; doi:10.1038/onc.2010.228; published online 7 June 2010	[Hrstka, R.; Nenutil, R.; Petrakova, K.; Muller, P.; Vojtesek, B.] Masaryk Mem Canc Inst, Dept Oncol & Expt Pathol, Brno 65653, Czech Republic; [Fourtouna, A.; Maslon, M. M.; Naughton, C.; Langdon, S.; Murray, E.; Hupp, T. R.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Fourtouna, A.; Maslon, M. M.; Naughton, C.; Langdon, S.; Murray, E.; Hupp, T. R.] Univ Edinburgh, Canc Res UK Signal Transduct Labs P53, Edinburgh, Midlothian, Scotland; [Larionov, A.; Dixon, M. J.] Western Gen Hosp, Edinburgh Breast Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Masaryk Memorial Cancer Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Vojtesek, B (corresponding author), Masaryk Mem Canc Inst, Dept Oncol & Expt Pathol, Zluty Kopec 7, Brno 65653, Czech Republic.	vojtesek@mou.cz	Muller, Petr/AAK-5014-2021; Maslon, Magdalena/AAB-9609-2020; Muller, Petr/F-7762-2015; Larionov, Alexey/A-5088-2010; Hrstka, Roman/AAM-4430-2020; Maslon, Magdalena/AAC-4790-2022; RASOR, Scotland/A-3274-2011	Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Larionov, Alexey/0000-0001-6374-9391; Hrstka, Roman/0000-0002-6139-2664; Maslon, Magdalena/0000-0002-1050-1306; Naughton, Catherine/0000-0002-9576-5983; Nenutil, Rudolf/0000-0003-0068-9760	GACR [P301/10/1615]; IGA MZCR [NS/9812-4, MZ0MOU2005]; Cancer Research UK [C483/A10706, C483/A6354]; Breast Cancer Campaign Garfield Weston PhD studentship on AGR2 pathway regulation; BBSRC; Breakthrough Breast Cancer	GACR(Grant Agency of the Czech Republic); IGA MZCR; Cancer Research UK(Cancer Research UK); Breast Cancer Campaign Garfield Weston PhD studentship on AGR2 pathway regulation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Breakthrough Breast Cancer	We thank Tamara Smerdova and Sona Babcanova for their excellent technical assistance and Larry Hayward for critical discussions. This work was supported by the GACR P301/10/1615, IGA MZCR NS/9812-4 and MZ0MOU2005. Ted Hupp was supported by grants C483/A10706 and C483/A6354 from the Cancer Research UK, a Breast Cancer Campaign Garfield Weston PhD studentship on AGR2 pathway regulation (AF), and the BBSRC (EM). Mike Dixon was supported by Breakthrough Breast Cancer.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Anderson I, 2000, BIOCHEMISTRY-US, V39, P3842, DOI 10.1021/bi9924516; Barraclough DL, 2009, AM J PATHOL, V175, P1848, DOI 10.2353/ajpath.2009.090246; Barraclough DL, 2010, CELL ONCOL, V32, P87, DOI 10.3233/CLO-2009-0499; Brunner N, 1997, CANCER RES, V57, P3486; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Goetz MP, 2003, JNCI-J NATL CANCER I, V95, P1734, DOI 10.1093/jnci/djg129; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Gunthert AR, 2005, EUR J ENDOCRINOL, V153, P613, DOI 10.1530/eje.1.01996; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Innes HE, 2006, BRIT J CANCER, V94, P1057, DOI 10.1038/sj.bjc.6603065; JACQUEMIER JD, 1990, BREAST CANCER RES TR, V15, P109, DOI 10.1007/BF01810783; Johnston SRD, 1997, ANTI-CANCER DRUG, V8, P911, DOI 10.1097/00001813-199711000-00002; Katzenellenbogen BS, 2004, SEMIN ONCOL, V31, P28, DOI 10.1053/j.seminoncol.2004.01.004; Kim NS, 2007, J BIOCHEM MOL BIOL, V40, P212; Knowlden JM, 2005, ENDOCRINOLOGY, V146, P4609, DOI 10.1210/en.2005-0247; Kondrakhin Yury V, 2008, In Silico Biol, V8, P383; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Lee S, 2006, ONCOL REP, V16, P747; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Mackay A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1732; METZGER D, 1995, J BIOL CHEM, V270, P9535, DOI 10.1074/jbc.270.16.9535; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; Petek E, 2000, CYTOGENET CELL GENET, V89, P141, DOI 10.1159/000015594; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Robertson JFR, 1996, INT J BIOL MARKER, V11, P29, DOI 10.1177/172460089601100106; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Stendahl M, 2004, BRIT J CANCER, V90, P1942, DOI 10.1038/sj.bjc.6601831; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Tyulmenkov VV, 2001, MOL CELL ENDOCRINOL, V182, P109, DOI 10.1016/S0303-7207(01)00508-1; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Zhang Y, 2007, PROSTATE CANCER P D, V10, P293, DOI 10.1038/sj.pcan.4500960; Zheng W, 2006, GENES IMMUN, V7, P11, DOI 10.1038/sj.gene.6364263; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020; Zweitzig DR, 2007, MOL CELL BIOCHEM, V306, P255, DOI 10.1007/s11010-007-9562-y	43	76	79	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2010	29	34					4838	4847		10.1038/onc.2010.228	http://dx.doi.org/10.1038/onc.2010.228			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	643VB	20531310				2022-12-25	WOS:000281326400009
J	Jones, RA; Petrik, JJ; Moorehead, RA				Jones, R. A.; Petrik, J. J.; Moorehead, R. A.			Preneoplastic changes persist after IGF-IR downregulation and tumor regression	ONCOGENE			English	Article						mammary tumorigenesis; IGF-IR; tumor regression; tumor recurrence; dormant tumor cells	BREAST-CANCER-CELLS; TRANSGENIC MICE; NEOADJUVANT CHEMOTHERAPY; SOMATOMEDIN RECEPTOR; MAMMARY-TUMORS; GROWTH; OVEREXPRESSION; TUMORIGENESIS; EXPRESSION; RESISTANCE	Despite our incomplete understanding of the function of the type I insulin-like growth factor receptor (IGF-IR) in tumorigenesis, IGF-IR targeting agents have entered clinical trials for the treatment of human cancers. Previously, we have shown that downregulation of IGF-IR transgene in mammary tumors in MTB-IGFIR transengic mice results in tumor regression in a majority of the mice and most of these mice do not develop recurrent mammary tumors. In this study, we examined mammary tissue of mice that did not develop recurrent tumors. Areas of tumor regression were visible macroscopically and microscopically these lesions contained cell debris, individual cells, lipofuscin and doxycycline crystals. Three of the 12 mice also presented with considerable lobuloalveolar development. The re-expression of the IGF-IR transgene in mammary tissue with stably regressed tumors resulted in the rapid re-emergence of mammary tumors, some of which seemed to originate from the regressed mammary lesions. Thus, despite stable tumor regression after IGF-IR downregulation, mammary tissue contained preneoplastic lesions and tumors rapidly re-appear upon re-overexpression of IGF-IR transgene. Therefore, IGF-IR-targeting agents may be effective at regressing mammary tumors expressing IGF-IR, but these agents will not completely eradicate all tumor cells or restore the mammary stromal environment. Oncogene (2010) 29, 4779-4786; doi:10.1038/onc.2010.231; published online 14 June 2010	[Jones, R. A.; Petrik, J. J.; Moorehead, R. A.] Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON N5A 7Z1, Canada	University of Guelph	Moorehead, RA (corresponding author), Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, 50 Stone Rd E, Guelph, ON N5A 7Z1, Canada.	rmoorehe@uoguelph.ca		, Roger/0000-0001-9539-6295; Jones, Robert/0000-0001-7665-9301	Cancer Research Society; Canadian Institutes of Health Research	Cancer Research Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a Cancer Research Society grant and a Canadian Institutes of Health Research grant to RAM.	ARTEAGA CL, 1989, J CLIN INVEST, V84, P1418, DOI 10.1172/JCI114315; ARTEAGA CL, 1989, CANCER RES, V49, P6237; Bahri S, 2009, ANN SURG ONCOL, V16, P1619, DOI 10.1245/s10434-009-0441-5; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; BATES P, 1995, BRIT J CANCER, V72, P1189, DOI 10.1038/bjc.1995.484; Bohula EA, 2003, J BIOL CHEM, V278, P15991, DOI 10.1074/jbc.M300714200; Bol DK, 1997, ONCOGENE, V14, P1725, DOI 10.1038/sj.onc.1201011; Carboni JM, 2005, CANCER RES, V65, P3781, DOI 10.1158/0008-5472.CAN-04-4602; Chernicky CL, 2002, J CLIN PATHOL-MOL PA, V55, P102, DOI 10.1136/mp.55.2.102; Denys H, 2009, CURR PHARM DESIGN, V15, P1373, DOI 10.2174/138161209787846711; DiGiovanni J, 2000, P NATL ACAD SCI USA, V97, P3455, DOI 10.1073/pnas.97.7.3455; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hadsell DL, 2000, ONCOGENE, V19, P889, DOI 10.1038/sj.onc.1203386; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955; Jones RA, 2009, ONCOGENE, V28, P2152, DOI 10.1038/onc.2009.79; Kaplan-Lefko PJ, 2008, ONCOGENE, V27, P2868, DOI 10.1038/sj.onc.1210943; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Linnerth NM, 2009, NEOPLASIA, V11, P672, DOI 10.1593/neo.09310; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Miranda MB, 2008, LEUKEMIA, V22, P1624, DOI 10.1038/leu.2008.28; Moorehead RA, 2003, ONCOGENE, V22, P853, DOI 10.1038/sj.onc.1206188; Morris GJ, 2010, SEMIN ONCOL, V37, P1, DOI 10.1053/j.seminoncol.2009.12.001; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Peintinger F, 2008, BRIT J SURG, V95, P433, DOI 10.1002/bjs.6044; Pravtcheva DD, 1998, J EXP ZOOL, V281, P43, DOI 10.1002/(SICI)1097-010X(19980501)281:1<43::AID-JEZ7>3.3.CO;2-3; Pure E, 2009, EXPERT OPIN THER TAR, V13, P967, DOI 10.1517/14728220903103841; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Surmacz E, 2003, ONCOGENE, V22, P6589, DOI 10.1038/sj.onc.1206772; Surmacz E, 2000, J MAMMARY GLAND BIOL, V5, P95, DOI 10.1023/A:1009523501499; Wilker E, 2005, MOL CARCINOGEN, V44, P137, DOI 10.1002/mc.20132; Wise TL, 2006, CANCER RES, V66, P1327, DOI 10.1158/0008-5472.CAN-05-3107; Zhang DW, 2009, CLIN CANCER RES, V15, P6639, DOI 10.1158/1078-0432.CCR-09-0951	36	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	34					4779	4786		10.1038/onc.2010.231	http://dx.doi.org/10.1038/onc.2010.231			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	643VB	20543862				2022-12-25	WOS:000281326400004
J	Kim, EH; Park, AK; Dong, SM; Ahn, JH; Park, WY				Kim, E-H; Park, A-K; Dong, S. M.; Ahn, J-H; Park, W-Y			Global analysis of CpG methylation reveals epigenetic control of the radiosensitivity in lung cancer cell lines	ONCOGENE			English	Article						CpG methylation; ionizing radiation; microarray; radiosensitivity	DNA METHYLATION; PROSTATE-CANCER; ATM PROMOTER; EXPRESSION; RADIORESISTANCE; CARCINOMA; MASPIN; BASONUCLIN; DISCOVERY; BREAST	Epigenetic regulation by CpG methylation has an important role in tumorigenesis as well as in the response to cancer therapy. To analyze the mechanism of epigenetic control of radiosensitivity, the CpG methylation profiles of radiosensitive H460 and radioresistant H1299 human non-small cell lung cancer (NSCLC) cell lines were analyzed using microarray profiling. These analyses revealed 1091 differentially methylated genes (DMG) (absolute difference of mean beta-values, |Delta(beta) over bar > 0.5), including genes involved in cell adhesion, cell communication, signal transduction and transcriptional regulation. Among the 747 genes hypermethylated in radioresistant H1299 cells, CpG methylation of SERPINB5 and S100A6 in radioresistant H1299 cells was confirmed by methylation-specific PCR. Reverse transcriptase-PCR showed higher expression of these two genes in radiosensitive H460 cells compared with radioresistant H1299 cells. Downregulation of SERPINB5 or S100A6 by small interfering RNA in H460 cells increased the resistance of these cells to ionizing radiation. In contrast, promoter CpG sites of 344 genes, including CAT and BNC1, were hypomethylated in radioresistant H1299 cells. Suppression of CAT or BNC1 mRNA expression in H1299 cells also reduced the resistance of these cells to ionizing radiation. Thus, we identified DMGs by genome-wide CpG methylation profiling in two NSCLC cell lines with different responses to ionizing radiation, and our data indicated that these differences may be critical for epigenetic regulation of radiosensitivity in lung cancer cells. Oncogene (2010) 29, 4725-4731; doi:10.1038/onc.2010.223; published online 7 June 2010	[Kim, E-H; Park, A-K; Park, W-Y] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Kim, E-H; Park, A-K; Park, W-Y] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 110799, South Korea; [Park, A-K; Park, W-Y] Seoul Natl Univ, Coll Med, Genom Core Lab, Seoul 110799, South Korea; [Dong, S. M.] Natl Canc Ctr, Div Translat & Clin Res 1, Res Inst, Seoul, South Korea; [Ahn, J-H] Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); Ewha Womans University	Park, WY (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 103 Daehakro, Seoul 110799, South Korea.	wypark@snu.ac.kr	park, woongyang/D-5727-2012; Kim, Eunhye/ABG-2184-2021	Kim, Eunhye/0000-0002-9225-5865	Korea Science and Engineering Foundation (KOSEF); Ministry of Education, Science and Technology, Korea [M20706000020- 07M0600-02010]; Brain Korea21 (BK21) Program	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea21 (BK21) Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was supported by a grant from the Korea Science and Engineering Foundation (KOSEF), the Ministry of Education, Science and Technology, Korea (M20706000020- 07M0600-02010 to WYP), and the Brain Korea21 (BK21) Program (WYP).	Amundson SA, 2005, ONCOGENE, V24, P4572, DOI 10.1038/sj.onc.1208653; An JH, 2006, J RADIAT RES, V47, P147, DOI 10.1269/jrr.47.147; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Ding S, 2004, WORLD J GASTROENTERO, V10, P3433; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Epperly MW, 2009, RADIAT RES, V171, P588, DOI 10.1667/RR1424.1; Esteller M, 2002, SCIENCE, V297, P1807; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang KH, 2009, CLIN CANCER RES, V15, P4174, DOI 10.1158/1078-0432.CCR-08-2929; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kron K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004830; Maass N, 2000, ACTA ONCOL, V39, P931; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Nagtegaal ID, 2005, VIRCHOWS ARCH, V446, P127, DOI 10.1007/s00428-004-1160-8; Orre LM, 2007, MOL CELL PROTEOMICS, V6, P2122, DOI 10.1074/mcp.M700202-MCP200; Park WY, 2002, ONCOGENE, V21, P8521, DOI 10.1038/sj.onc.1205977; Rehman I, 2004, BRIT J CANCER, V91, P739, DOI 10.1038/sj.bjc.6602034; RIBIERAS S, 1994, J CELL BIOCHEM, V56, P86, DOI 10.1002/jcb.240560113; Roy K, 2006, BIOCHEM BIOPH RES CO, V344, P821, DOI 10.1016/j.bbrc.2006.03.222; Sakakura C, 2007, ONCOGENE, V26, P5927, DOI 10.1038/sj.onc.1210403; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Skvortsova I, 2008, PROTEOMICS, V8, P4521, DOI 10.1002/pmic.200800113; TSENG H, 1994, J CELL BIOL, V126, P495, DOI 10.1083/jcb.126.2.495; Wang L, 2008, MOL PHARMACOL, V73, P119, DOI 10.1124/mol.107.040873; Zhang XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001087; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051	32	42	48	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2010	29	33					4725	4731		10.1038/onc.2010.223	http://dx.doi.org/10.1038/onc.2010.223			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20531302				2022-12-25	WOS:000281127400011
J	Labrosse, B; Tourdjman, M; Porcher, R; LeGoff, J; de Lamballerie, X; Simon, F; Molina, JM; Clavel, F				Labrosse, Beatrice; Tourdjman, Mathieu; Porcher, Raphael; LeGoff, Jerome; de Lamballerie, Xavier; Simon, Francois; Molina, Jean-Michel; Clavel, Francois			Detection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay	PLOS ONE			English	Article								Background: Cross-immunity between seasonal and pandemic A/H1N1 influenza viruses remains uncertain. In particular, the extent that previous infection or vaccination by seasonal A/H1N1 viruses can elicit protective immunity against pandemic A/H1N1 is unclear. Methodology/Principal Findings: Neutralizing titers against seasonal A/H1N1 (A/Brisbane/59/2007) and against pandemic A/H1N1 (A/California/04/2009) were measured using an HIV-1-based pseudovirus neutralization assay. Using this highly sensitive assay, we found that a large fraction of subjects who had never been exposed to pandemic A/H1N1 express high levels of pandemic A/H1N1 neutralizing titers. A significant correlation was seen between neutralization of pandemic A/H1N1 and neutralization of a standard seasonal A/H1N1 strain. Significantly higher pandemic A/H1N1 neutralizing titers were measured in subjects who had received vaccination against seasonal influenza in 2008-2009. Higher pandemic neutralizing titers were also measured in subjects over 60 years of age. Conclusions/Significance: Our findings reveal that the extent of protective cross-immunity between seasonal and pandemic A/H1N1 influenza viruses may be more important than previously estimated. This cross-immunity could provide a possible explanation of the relatively mild profile of the recent influenza pandemic.	[Labrosse, Beatrice; Clavel, Francois] Univ Paris Diderot, Inst Univ Hematol, Paris, France; [Labrosse, Beatrice; Clavel, Francois] INSERM, U941, Paris, France; [Tourdjman, Mathieu; Molina, Jean-Michel] Hop St Louis, Assistance Publ Hop Paris, Serv Malad Infect, Paris, France; [Porcher, Raphael] Hop St Louis, Assistance Publ Hop Paris, Dept Biostat, Paris, France; [LeGoff, Jerome; Simon, Francois; Clavel, Francois] Hop St Louis, Assistance Publ Hop Paris, Microbiol Lab, Paris, France; [de Lamballerie, Xavier] Univ Aix Marseille 2, F-13284 Marseille 07, France; [de Lamballerie, Xavier] Inst Rech Dev, Marseille, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Labrosse, B (corresponding author), Univ Paris Diderot, Inst Univ Hematol, Paris, France.	francois.clavel@inserm.fr	le goff, jerome/B-3447-2016; LeGoff, jerome/AAP-7880-2021; LABROSSE, Béatrice/M-9920-2017	le goff, jerome/0000-0001-7111-1865; LABROSSE, Béatrice/0000-0002-0658-4903; Porcher, Raphael/0000-0002-5277-4679	Institut National de la Sante et de la Recherche Medicale (Inserm)	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brammer L., 2009, Morbidity and Mortality Weekly Report, V58, P1236; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Del Giudice G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000564; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; GREENBERG ME, 2009, N ENGL J MED; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; *I VEILL SAN, 2009, B GRIPP A, V66, P1; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; World Health Organization(WHO), 2009, CHAR EM INFL H1N1 VI; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685	18	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11036	10.1371/journal.pone.0011036	http://dx.doi.org/10.1371/journal.pone.0011036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543954	Green Published, gold, Green Submitted			2022-12-25	WOS:000278557600014
J	Mason-Gamer, RJ; Burns, MM; Naum, M				Mason-Gamer, Roberta J.; Burns, Melissa M.; Naum, Marianna			Reticulate Evolutionary History of a Complex Group of Grasses: Phylogeny of Elymus StStHH Allotetraploids Based on Three Nuclear Genes	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE GENE; BOUND STARCH SYNTHASE; DNA-SEQUENCES; GENOME ANALYSIS; ALLOPOLYPLOID SPECIATION; THINOPYRUM-INTERMEDIUM; HYBRID ORIGIN; RIBOSOMAL DNA; POACEAE; TRITICEAE	Background: Elymus (Poaceae) is a large genus of polyploid species in the wheat tribe Triticeae. It is polyphyletic, exhibiting many distinct allopolyploid genome combinations, and its history might be further complicated by introgression and lineage sorting. We focus on a subset of Elymus species with a tetraploid genome complement derived from Pseudoroegneria (genome St) and Hordeum (H). We confirm the species' allopolyploidy, identify possible genome donors, and pinpoint instances of apparent introgression or incomplete lineage sorting. Methodology/Principal Findings: We sequenced portions of three unlinked nuclear genes-phosphoenolpyruvate carboxylase, beta-amylase, and granule-bound starch synthase I-from 27 individuals, representing 14 Eurasian and North American StStHH Elymus species. Elymus sequences were combined with existing data from monogenomic representatives of the tribe, and gene trees were estimated separately for each data set using maximum likelihood. Trees were examined for evidence of allopolyploidy and additional reticulate patterns. All trees confirm the StStHH genome configuration of the Elymus species. They suggest that the StStHH group originated in North America, and do not support separate North American and European origins. Our results point to North American Pseudoroegneria and Hordeum species as potential genome donors to Elymus. Diploid P. spicata is a prospective St-genome donor, though conflict among trees involving P. spicata and the Eurasian P. strigosa suggests either introgression of GBSSI sequences from P. strigosa into North American Elymus and Pseudoroegneria, or incomplete lineage sorting of ancestral GBSSI polymorphism. Diploid H. californicum and/or allotetraploid H. jubatum are possible H-genome donors; direct involvement of an allotetraploid Hordeum species would simultaneously introduce two distinct H genomes to Elymus, consistent with some of the relationships among H-genome sequences in Hordeum and Elymus. Conclusions/Significance: Comparisons among molecular phylogenetic trees confirm allopolyploidy, identify potential genome donors, and highlight cases of apparent introgression or incomplete lineage sorting. The complicated history of this group emphasizes an inherent problem with interpreting conflicts among bifurcating trees-identifying introgression and determining its direction depend on which tree is chosen as a starting point of comparison. In spite of difficulties with interpretation, differences among gene trees allow us to identify reticulate species and develop hypotheses about underlying evolutionary processes.	[Mason-Gamer, Roberta J.; Burns, Melissa M.; Naum, Marianna] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mason-Gamer, RJ (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	robie@uic.edu			National Science Foundation [DEB-9974181]	National Science Foundation(National Science Foundation (NSF))	The work was supported by National Science Foundation DEB-9974181 to RJMG (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arnheim N., 1983, P38; Blattner FR, 2004, MOL PHYLOGENET EVOL, V33, P289, DOI 10.1016/j.ympev.2004.05.012; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; Brysting AK, 2007, SYST BIOL, V56, P467, DOI 10.1080/10635150701424553; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; Cronn R, 2003, EVOLUTION, V57, P2475, DOI 10.1111/j.0014-3820.2003.tb01493.x; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Davis Jerrold I., 2007, Aliso, V23, P335; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; DEWEY DR, 1970, AM J BOT, V57, P861, DOI 10.2307/2441345; DEWEY DR, 1967, AM J BOT, V54, P93, DOI 10.2307/2440890; DEWEY DR, 1975, AM J BOT, V62, P524, DOI 10.2307/2441961; DEWEY DR, 1968, AM J BOT, V55, P1133, DOI 10.2307/2440735; DEWEY DR, 1974, BOT GAZ, V135, P80, DOI 10.1086/336733; DEWEY DR, 1984, STADLER GENET S, V16, P209, DOI DOI 10.1007/978-1-4613-2429-4_; DEWEY DR, 1982, GRASSES GRASSLANDS S, P51; Doust AN, 2007, SYST BOT, V32, P531, DOI 10.1600/036364407782250670; Doyle JJ, 2002, EVOLUTION, V56, P1388, DOI 10.1111/j.0014-3820.2002.tb01452.x; Emshwiller E, 2002, AM J BOT, V89, P1042, DOI 10.3732/ajb.89.7.1042; Garcia PE, 2009, MOL PHYLOGENET EVOL, V50, P226, DOI 10.1016/j.ympev.2008.10.015; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frati F, 1997, J MOL EVOL, V44, P145, DOI 10.1007/PL00006131; Friar EA, 2008, SYST BOT, V33, P589, DOI 10.1600/036364408785679815; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Gonzalez MC, 2002, PLANT SCI, V162, P233, DOI 10.1016/S0168-9452(01)00548-9; *GRASS PHYL WORK G, 2001, ANN MISSOURI BOT GAR, V88, P372; Guggisberg A, 2006, SYST BOT, V31, P368, DOI 10.1600/036364406777585937; Hamby R. K., 1992, MOL SYSTEMATICS PLAN, P50, DOI DOI 10.1086/661633; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Helfgott DM, 2004, SYST BOT, V29, P850, DOI 10.1600/0363644042451017; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Hughes CE, 2002, AM J BOT, V89, P1057, DOI 10.3732/ajb.89.7.1057; JAASKA V, 1992, HEREDITAS, V117, P11, DOI 10.1111/j.1601-5223.1992.tb00002.x; Jaaska V, 1998, TRITICEAE III, P209; Jarvinen P, 2004, AM J BOT, V91, P1834, DOI 10.3732/ajb.91.11.1834; JENSEN KB, 1990, BOT GAZ, V151, P245, DOI 10.1086/337824; Jensen KB, 1996, INT J PLANT SCI, V157, P136, DOI 10.1086/297330; JENSEN KB, 1993, GENOME, V36, P72, DOI 10.1139/g93-010; Joly S, 2006, AM J BOT, V93, P412, DOI 10.3732/ajb.93.3.412; JORGENSEN RA, 1988, ANN MO BOT GARD, V75, P1238, DOI 10.2307/2399282; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kellogg EA, 1996, SYST BOT, V21, P321, DOI 10.2307/2419662; Kim ST, 2008, AM J BOT, V95, P1122, DOI 10.3732/ajb.0700008; Kim SC, 2008, J PLANT RES, V121, P357, DOI 10.1007/s10265-008-0166-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLEINHOFS A, 1997, BARLEY GENET NEWSL, V27, P105; Korzun V, 1997, THEOR APPL GENET, V95, P468, DOI 10.1007/s001220050584; LEPINIEC L, 1993, PLANT MOL BIOL, V21, P487, DOI 10.1007/BF00028806; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; LINDELAURSEN I, 1994, PLANT SYST EVOL, V192, P165, DOI 10.1007/BF00986250; Liu SC, 2009, J PLANT RES, V122, P305, DOI 10.1007/s10265-009-0223-y; LIU ZW, 1993, GENOME, V36, P102, DOI 10.1139/g93-014; Love A., 1984, Feddes Repertorium, V95, P425; LU BR, 1991, EUPHYTICA, V58, P81, DOI 10.1007/BF00035343; LU BR, 1995, PLANT SYST EVOL, V197, P1, DOI 10.1007/BF00984628; LU BR, 1993, PLANT SYST EVOL, V185, P35, DOI 10.1007/BF00937719; Mansion G, 2005, TAXON, V54, P931, DOI 10.2307/25065479; Mason-Gamer RJ, 2005, AM J BOT, V92, P1045, DOI 10.3732/ajb.92.6.1045; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; Mason-Gamer RJ, 2001, SYST BOT, V26, P757; Mason-Gamer RJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-92; Mason-Gamer RJ, 2008, MOL PHYLOGENET EVOL, V47, P598, DOI 10.1016/j.ympev.2008.02.008; Mason-Gamer RJ, 2010, MOL PHYLOGENET EVOL, V54, P10, DOI 10.1016/j.ympev.2009.10.002; Mason-Gamer Roberta J., 2007, Aliso, V23, P372; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Mummenhoff K, 1997, CAN J BOT, V75, P469, DOI 10.1139/b97-051; Popp M, 2005, SYST BOT, V30, P302, DOI 10.1600/0363644054223648; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez F, 2009, SYST BOT, V34, P207, DOI 10.1600/036364409787602195; ROHDE W, 1988, NUCLEIC ACIDS RES, V16, P7185, DOI 10.1093/nar/16.14.7185; SALOMON B, 1993, GENOME, V36, P899, DOI 10.1139/g93-118; SALOMON B, 1994, PLANT SYST EVOL, V191, P199, DOI 10.1007/BF00984665; SALOMON B, 1992, PLANT SYST EVOL, V180, P1, DOI 10.1007/BF00940394; Seelanan T, 1997, SYST BOT, V22, P259, DOI 10.2307/2419457; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Smedmark JEE, 2005, ORG DIVERS EVOL, V5, P275, DOI 10.1016/j.ode.2004.12.003; Stefanovic S, 2008, BOTANY, V86, P791, DOI 10.1139/B08-033; Sullivan J, 1997, SYST BIOL, V46, P426, DOI 10.2307/2413690; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; TSUJIMOTO H, 1991, GENOME, V34, P782, DOI 10.1139/g91-122; Vander Stappen J, 2002, PLANT SYST EVOL, V234, P27, DOI 10.1007/s00606-002-0193-1; WAGNER A, 1994, SYST BIOL, V43, P250, DOI 10.2307/2413465; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Widmer A, 1999, AM J BOT, V86, P1282, DOI 10.2307/2656776; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zhang XY, 1996, GENOME, V39, P1062, DOI 10.1139/g96-133; Ziegler P, 1999, J CEREAL SCI, V29, P195, DOI 10.1006/jcrs.1998.0238; Zwickl D., 2006, GARLI GENETIC ALGORI	94	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e10989	10.1371/journal.pone.0010989	http://dx.doi.org/10.1371/journal.pone.0010989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543952	Green Published, Green Submitted, gold			2022-12-25	WOS:000278557600004
J	Boettcher, M; Kischkel, F; Hoheisel, JD				Boettcher, Michael; Kischkel, Frank; Hoheisel, Joerg D.			High-Definition DNA Methylation Profiles from Breast and Ovarian Carcinoma Cell Lines with Differing Doxorubicin Resistance	PLOS ONE			English	Article							TOPOISOMERASE-II-ALPHA; CANCER-CELLS; EPIGENETIC REGULATION; PROGNOSTIC MARKER; MDR1 PROMOTER; MCJ GENE; EXPRESSION; CHEMOTHERAPY; ANTHRACYCLINES; TUMORS	Acquired drug resistance represents a frequent obstacle which hampers efficient chemotherapy of cancers. The contribution of aberrant DNA methylation to the development of drug resistant tumor cells has gained increasing attention over the past decades. Hence, the objective of the presented study was to characterize DNA methylation changes which arise from treatment of tumor cells with the chemotherapeutic drug doxorubicin. DNA methylation levels from CpG islands (CGIs) linked to twenty-eight genes, whose expression levels had previously been shown to contribute to resistance against DNA double strand break inducing drugs or tumor progression in different cancer types were analyzed. High-definition DNA methylation profiles which consisted of methylation levels from 800 CpG sites mapping to CGIs around the transcription start sites of the selected genes were determined. In order to investigate the influence of CGI methylation on the expression of associated genes, their mRNA levels were investigated via qRT-PCR. It was shown that the employed method is suitable for providing highly accurate methylation profiles, comparable to those obtained via clone sequencing, the gold standard for high-definition DNA methylation studies. In breast carcinoma cells with acquired resistance against the double strand break inducing drug doxorubicin, changes in methylation of specific cytosines from CGIs linked to thirteen genes were detected. Moreover, similarities between methylation profiles obtained from breast and ovarian carcinoma cell lines with acquired doxorubicin resistance were found. The expression levels of a subset of analyzed genes were shown to be linked to the methylation levels of the analyzed CGIs. Our results provide detailed DNA methylation information from two separate model systems for acquired doxorubicin resistance and suggest the occurrence of similar methylation changes in both systems upon exposure to the drug.	[Boettcher, Michael; Hoheisel, Joerg D.] Deutsch Krebsforschungszentrum, Div Funct Genome Anal, D-6900 Heidelberg, Germany; [Kischkel, Frank] TherapySelect GmbH & Co KG, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Boettcher, M (corresponding author), Deutsch Krebsforschungszentrum, Div Funct Genome Anal, D-6900 Heidelberg, Germany.	m.boettcher@dkfz.de		Boettcher, Michael/0000-0003-0986-4465	German Ministry of Education and Research (BMBF) [0313869]; company TherapySelect GmbH Co	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); company TherapySelect GmbH Co	This work has been supported by the German Ministry of Education and Research (BMBF) within the project 0313869. The BMBF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work has further been supported by the company TherapySelect GmbH & Co. KG. Doxorubicin was suggested by TherapySelect GmbH & Co. KG as a compound of biomedical interest but other than that, the company had no role in study design, data collection and analysis or decision to publish.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Baum M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng151; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Calcagno AM, 2008, BRIT J CANCER, V98, P1515, DOI 10.1038/sj.bjc.6604334; Chau BN, 2009, CANCER RES, V69, P1368, DOI 10.1158/0008-5472.CAN-08-2742; Chekhun VF, 2007, MOL CANCER THER, V6, P1089, DOI 10.1158/1535-7163.MCT-06-0663; Chekhun VF, 2006, CANCER LETT, V231, P87, DOI 10.1016/j.canlet.2005.01.038; Cheng XS, 1997, CANCER, V79, P521, DOI 10.1002/(SICI)1097-0142(19970201)79:3<521::AID-CNCR14>3.0.CO;2-5; David GL, 2004, CANCER BIOL THER, V3, P540, DOI 10.4161/cbt.3.6.845; Dejeux E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-68; Di Leo A, 2008, EUR J CANCER, V44, P2791, DOI 10.1016/j.ejca.2008.09.014; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Greenberg RA, 2008, CHROMOSOMA, V117, P305, DOI 10.1007/s00412-008-0154-8; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Hatle KM, 2007, MOL CELL BIOL, V27, P2952, DOI 10.1128/MCB.01804-06; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; Jarvinen TAH, 1998, BRIT J CANCER, V77, P2267, DOI 10.1038/bjc.1998.377; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kantharidis P, 1997, CLIN CANCER RES, V3, P2025; KEITH WN, 1990, BRIT J CANCER, V61, P712, DOI 10.1038/bjc.1990.160; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liscovitch M, 2007, CANCER LETT, V245, P350, DOI 10.1016/j.canlet.2006.01.013; Masanek U, 1997, ANTI-CANCER DRUG, V8, P189, DOI 10.1097/00001813-199702000-00010; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Muller HM, 2003, CANCER RES, V63, P7641; Muller HM, 2004, ANN NY ACAD SCI, V1022, P44, DOI 10.1196/annals.1318.008; Mund C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni072; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Paige AJW, 2008, PHARMACOGENOMICS, V9, P1825, DOI 10.2217/14622416.9.12.1825; Pakneshan P, 2004, CLIN CANCER RES, V10, P3035, DOI 10.1158/1078-0432.CCR-03-0545; Pisano Carmela, 2009, Ther Clin Risk Manag, V5, P421; Rathi A, 2002, CLIN CANCER RES, V8, P3324; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sharma D, 2004, CANCER BIOL THER, V3, P549, DOI 10.4161/cbt.3.6.1041; Strathdee G, 2005, GYNECOL ONCOL, V97, P898, DOI 10.1016/j.ygyno.2005.03.023; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Tian KG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-327; Tian KG, 2005, CANCER RES, V65, P10024, DOI 10.1158/0008-5472.CAN-05-1944; Tubbs R, 2009, J CLIN ONCOL, V27, P3881, DOI 10.1200/JCO.2008.20.1566; Verma S, 2008, CANCER TREAT REV, V34, P391, DOI 10.1016/j.ctrv.2008.01.008; Yu YC, 2006, CLIN EXP METASTAS, V23, P65, DOI 10.1007/s10585-006-9020-3	48	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11002	10.1371/journal.pone.0011002	http://dx.doi.org/10.1371/journal.pone.0011002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544021	Green Submitted, Green Published, gold			2022-12-25	WOS:000278494900014
J	Aguilar-Valles, A; Flores, C; Luheshi, GN				Aguilar-Valles, Argel; Flores, Cecilia; Luheshi, Giamal N.			Prenatal Inflammation-Induced Hypoferremia Alters Dopamine Function in the Adult Offspring in Rat: Relevance for Schizophrenia	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; NEURODEVELOPMENTAL ANIMAL-MODEL; IRON-DEFICIENCY; FETAL-BRAIN; PHARMACOLOGICAL CHANGES; PREPULSE INHIBITION; PEPTIDE HEPCIDIN; INFECTION; PREGNANCY; AMPHETAMINE	Maternal infection during pregnancy has been associated with increased incidence of schizophrenia in the adult offspring. Mechanistically, this has been partially attributed to neurodevelopmental disruption of the dopamine neurons, as a consequence of exacerbated maternal immunity. In the present study we sought to target hypoferremia, a cytokine-induced reduction of serum non-heme iron, which is common to all types of infections. Adequate iron supply to the fetus is fundamental for the development of the mesencephalic dopamine neurons and disruption of this following maternal infection can affect the offspring's dopamine function. Using a rat model of localized injury induced by turpentine, which triggers the innate immune response and inflammation, we investigated the effects of maternal iron supplementation on the offspring's dopamine function by assessing behavioral responses to acute and repeated administration of the dopamine indirect agonist, amphetamine. In addition we measured protein levels of tyrosine hydroxylase, and tissue levels of dopamine and its metabolites, in ventral tegmental area, susbtantia nigra, nucleus accumbens, dorsal striatum and medial prefrontal cortex. Offspring of turpentine-treated mothers exhibited greater responses to a single amphetamine injection and enhanced behavioral sensitization following repeated exposure to this drug, when compared to control offspring. These behavioral changes were accompanied by increased baseline levels of tyrosine hydroxylase, dopamine and its metabolites, selectively in the nucleus accumbens. Both, the behavioral and neurochemical changes were prevented by maternal iron supplementation. Localized prenatal inflammation induced a deregulation in iron homeostasis, which resulted in fundamental alterations in dopamine function and behavioral alterations in the adult offspring. These changes are characteristic of schizophrenia symptoms in humans.	[Aguilar-Valles, Argel; Flores, Cecilia; Luheshi, Giamal N.] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University	Aguilar-Valles, A (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	giamal.luheshi@mcgill.ca	Aguilar-Valles, Argel/B-4259-2009; Flores, Cecilia/N-7799-2017	Aguilar-Valles, Argel/0000-0002-2272-1138; Flores, Cecilia/0000-0001-8606-5910	Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Canadian Bureau for International Education	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Bureau for International Education	This study was supported by the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/) and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). AAV was the recipient of a Government of Canada Award from the Canadian Bureau for International Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Aguilar-Valles A, 2007, J PHYSIOL-LONDON, V583, P391, DOI 10.1113/jphysiol.2007.132829; Archer T, 2007, NEUROCHEM RES, V32, P1625, DOI 10.1007/s11064-007-9358-1; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Babulas V, 2006, AM J PSYCHIAT, V163, P927, DOI 10.1176/appi.ajp.163.5.927; Baharnoori M, 2009, SCHIZOPHR RES, V107, P99, DOI 10.1016/j.schres.2008.10.003; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Beard JL, 2006, BEHAV BRAIN RES, V170, P224, DOI 10.1016/j.bbr.2006.02.024; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; Brown A. S, 2010, AM J PSYCHIAT; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Burhans MS, 2006, PHYSIOL BEHAV, V87, P917, DOI 10.1016/j.physbeh.2006.02.014; Burhans MS, 2005, NUTR NEUROSCI, V8, P31, DOI 10.1080/10284150500047070; Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013; Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S; Chambers RA, 2001, BIOL PSYCHIAT, V50, P71, DOI 10.1016/S0006-3223(01)01134-9; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Connor JR, 2009, BRAIN, V132, P2403, DOI 10.1093/brain/awp125; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; Coyle P, 2009, BEHAV BRAIN RES, V197, P210, DOI 10.1016/j.bbr.2008.08.022; Cui K, 2009, SCHIZOPHR RES, V113, P288, DOI 10.1016/j.schres.2009.05.003; De Domenico I, 2007, J CLIN INVEST, V117, P1755, DOI 10.1172/JCI32701; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Ellman LM, 2009, NEURON, V64, P25, DOI 10.1016/j.neuron.2009.09.024; Featherstone RE, 2007, PROG NEURO-PSYCHOPH, V31, P1556, DOI 10.1016/j.pnpbp.2007.08.025; Feleder C, 2010, BIOL PSYCHIAT, V67, P386, DOI 10.1016/j.biopsych.2009.09.028; Felt BT, 2006, BEHAV BRAIN RES, V171, P261, DOI 10.1016/j.bbr.2006.04.001; Flores C, 2000, J NEUROSCI, V20; Flores C, 2005, MOL PSYCHIATR, V10, P606, DOI 10.1038/sj.mp.4001607; Fortier ME, 2007, BEHAV BRAIN RES, V181, P270, DOI 10.1016/j.bbr.2007.04.016; Fortier ME, 2004, J PSYCHIATR RES, V38, P335, DOI 10.1016/j.jpsychires.2003.10.001; Gambling L, 2002, BIOL REPROD, V66, P516, DOI 10.1095/biolreprod66.2.516; Gambling L, 2009, AM J PHYSIOL-REG I, V296, pR1063, DOI 10.1152/ajpregu.90793.2008; Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003; Grant A, 2009, EUR J NEUROSCI, V30, P1318, DOI 10.1111/j.1460-9568.2009.06919.x; GRIEGER TA, 1978, J PHYSIOL-LONDON, V279, P187, DOI 10.1113/jphysiol.1978.sp012339; Gruper Y, 2005, J CELL PHYSIOL, V204, P901, DOI 10.1002/jcp.20349; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Jiang H, 2007, NEUROCHEM INT, V51, P32, DOI 10.1016/j.neuint.2007.03.006; KLUGER MJ, 1979, SCIENCE, V203, P374, DOI 10.1126/science.760197; Kwik-Uribe CL, 2000, J NUTR, V130, P2821, DOI 10.1093/jn/130.11.2821; Laruelle M, 1999, BIOL PSYCHIAT, V46, P56, DOI 10.1016/S0006-3223(99)00067-0; Lebel E, 2000, ENDOCRINOLOGY, V141, P3749, DOI 10.1210/en.141.10.3749; Lee MS, 2005, HUM VACCINES, V1, P6, DOI 10.4161/hv.1.1.1424; Legssyer R, 2003, BIOMETALS, V16, P425, DOI 10.1023/A:1022547819506; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Liverman CS, 2006, NEUROSCI LETT, V399, P220, DOI 10.1016/j.neulet.2006.01.064; Lowe GC, 2008, AM J PHYSIOL-REG I, V295, pR1563, DOI 10.1152/ajpregu.90350.2008; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; McArdle HJ, 2006, PLACENTA, V27, pS56, DOI 10.1016/j.placenta.2006.01.014; McArdle HJ, 2003, BIOMETALS, V16, P161, DOI 10.1023/A:1020714915767; Meyer U, 2008, MOL PSYCHIATR, V13, P208, DOI 10.1038/sj.mp.4002042; Meyer U, 2008, NEUROSCIENCE, V154, P701, DOI 10.1016/j.neuroscience.2008.04.031; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Millard KN, 2004, GUT, V53, P655, DOI 10.1136/gut.2003.031153; Mok H, 2004, DEVELOPMENT, V131, P4871, DOI 10.1242/dev.01342; Mok H, 2004, DEVELOPMENT, V131, P1859, DOI 10.1242/dev.01081; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; MURRAY MJ, 1971, J NUTR, V101, P1583, DOI 10.1093/jn/101.11.1583; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; POHL J, 2009, ENDOCRINOLOGY; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Rees GS, 1999, CYTOKINE, V11, P95, DOI 10.1006/cyto.1998.0408; ROMERO E, 2006, NEUROPSYCHOPHARMACOL; ROMERO E, 2008, MOL PSYCHIAT; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Sorensen HJ, 2009, SCHIZOPHRENIA BULL, V35, P631, DOI 10.1093/schbul/sbn121; SULZER D, 1995, J NEUROSCI, V15, P4102; Unger EL, 2007, J NUTR, V137, P118, DOI 10.1093/jn/137.1.118; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; WUSTEMAN M, 1990, AM J PHYSIOL, V259, pE763, DOI 10.1152/ajpendo.1990.259.6.E763; Yetnikoff L, 2007, NEUROSCIENCE, V150, P764, DOI 10.1016/j.neuroscience.2007.09.069; Youdim M B, 1984, Adv Neurol, V40, P159; Zuckerman L, 2005, J PSYCHIATR RES, V39, P311, DOI 10.1016/j.jpsychires.2004.08.008; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	94	52	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10967	10.1371/journal.pone.0010967	http://dx.doi.org/10.1371/journal.pone.0010967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532043	Green Published, Green Submitted, gold			2022-12-25	WOS:000278380500012
J	Takeuchi, A; Hosokawa, M; Nojima, T; Hagiwara, M				Takeuchi, Akihide; Hosokawa, Motoyasu; Nojima, Takayuki; Hagiwara, Masatoshi			Splicing Reporter Mice Revealed the Evolutionally Conserved Switching Mechanism of Tissue-Specific Alternative Exon Selection	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-2; IN-VIVO; PREMESSENGER RNA; BINDING-PROTEIN; FACTOR FAMILY; FGFR2; IIIB; CELLS; IDENTIFICATION; ACTIVATION	Since alternative splicing of pre-mRNAs is essential for generating tissue-specific diversity in proteome, elucidating its regulatory mechanism is indispensable to understand developmental process or tissue-specific functions. We have been focusing on tissue-specific regulation of mutually exclusive selection of alternative exons because this implies the typical molecular mechanism of alternative splicing regulation and also can be good examples to elicit general rule of "splice code''. So far, mutually exclusive splicing regulation has been explained by the outcome from the balance of multiple regulators that enhance or repress either of alternative exons discretely. However, this "balance'' model is open to questions of how to ensure the selection of only one appropriate exon out of several candidates and how to switch them. To answer these questions, we generated an original bichromatic fluorescent splicing reporter system for mammals using fibroblast growth factor-receptor 2 (FGFR2) gene as model. By using this splicing reporter, we demonstrated that FGFR2 gene is regulated by the "switch-like'' mechanism, in which key regulators modify the ordered splice-site recognition of two mutually exclusive exons, eventually ensure single exon selection and their distinct switching. Also this finding elucidated the evolutionally conserved "splice code,'' in which combination of tissue-specific and broadly expressed RNA binding proteins regulate alternative splicing of specific gene in a tissue-specific manner. These findings provide the significant cue to understand how a number of spliced genes are regulated in various tissue-specific manners by a limited number of regulators, eventually to understand developmental process or tissue-specific functions.	[Takeuchi, Akihide; Nojima, Takayuki; Hagiwara, Masatoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Bunkyo Ku, Tokyo, Japan; [Hosokawa, Motoyasu; Nojima, Takayuki; Hagiwara, Masatoshi] Tokyo Med & Dent Univ, Gene Express Lab, Sch Biomed Sci, Bunkyo Ku, Tokyo, Japan; [Takeuchi, Akihide; Hagiwara, Masatoshi] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Sakyo Ku, Kyoto, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University	Takeuchi, A (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Bunkyo Ku, Tokyo, Japan.	m.hagiwara.end@mri.tmd.ac.jp	Takeuchi, Akihide/AAT-4675-2020	Takeuchi, Akihide/0000-0002-2781-0180; Nojima, Takayuki/0000-0003-1236-4162	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency (JST); New Energy and Industrial Technology Development Organization (NEDO); National Institute of Biomedical Innovation (NIBI)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation (NIBI)(National Institute of Biomedical Innovation)	This work was supported by Grants-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to A. T. and M. H.), Japan Science and Technology Agency (JST) (to M. H), New Energy and Industrial Technology Development Organization (NEDO) (to M. H), and the National Institute of Biomedical Innovation (NIBI) (to M. H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniak AP, 2006, MOL CELL BIOL, V26, P1209, DOI 10.1128/MCB.26.4.1209-1222.2006; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonano VI, 2006, RNA, V12, P2073, DOI 10.1261/rna.248506; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen XH, 2004, CELL BIOL INT, V28, P791, DOI 10.1016/j.cellbi.2004.07.009; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; DELGATTO F, 1995, MOL CELL BIOL, V15, P4825; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; GILBERT E, 1993, MOL CELL BIOL, V13, P5461, DOI 10.1128/MCB.13.9.5461; Heyd F, 2009, MOL CELL, V33, P674, DOI 10.1016/j.molcel.2009.03.001; Hovhannisyan RH, 2005, MOL CELL BIOL, V25, P250, DOI 10.1128/MCB.25.1.250-263.2005; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; Kuroyanagi H, 2007, MOL CELL BIOL, V27, P8612, DOI 10.1128/MCB.01508-07; Kuroyanagi H, 2006, NAT METHODS, V3, P909, DOI 10.1038/NMETH944; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Newman EA, 2006, RNA, V12, P1129, DOI 10.1261/rna.34906; Ohno G, 2008, GENE DEV, V22, P360, DOI 10.1101/gad.1620608; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; SAVAGNER P, 1994, MOL BIOL CELL, V5, P851, DOI 10.1091/mbc.5.8.851; SAWA H, 1992, GENE DEV, V6, P244, DOI 10.1101/gad.6.2.244; Takeuchi A, 2006, J NEUROSCI, V26, P4460, DOI 10.1523/JNEUROSCI.4935-05.2006; Takeuchi A, 2003, NAT GENET, V33, P172, DOI 10.1038/ng1072; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; Wagner EJ, 2005, J BIOL CHEM, V280, P14017, DOI 10.1074/jbc.M414492200; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Zahler Alan M, 2005, WormBook, P1; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	42	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10946	10.1371/journal.pone.0010946	http://dx.doi.org/10.1371/journal.pone.0010946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532173	Green Published, gold, Green Submitted			2022-12-25	WOS:000278318700017
J	Ghebremichael, S; Groenheit, R; Pennhag, A; Koivula, T; Andersson, E; Bruchfeld, J; Hoffner, S; Romanus, V; Kallenius, G				Ghebremichael, Solomon; Groenheit, Ramona; Pennhag, Alexandra; Koivula, Tuija; Andersson, Emmi; Bruchfeld, Judith; Hoffner, Sven; Romanus, Victoria; Kallenius, Gunilla			Drug Resistant Mycobacterium tuberculosis of the Beijing Genotype Does Not Spread in Sweden	PLOS ONE			English	Article							WESTERN CAPE PROVINCE; MOLECULAR EPIDEMIOLOGY; RIFAMPICIN-RESISTANCE; ISONIAZID RESISTANCE; GENOMIC DELETIONS; STRAIN FAMILY; MAJOR CAUSE; MUTATIONS; LINEAGE; PREDOMINANCE	Background: Drug resistant (DR) and multi-drug resistant (MDR) tuberculosis (TB) is increasing worldwide. In some parts of the world 10% or more of new TB cases are MDR. The Beijing genotype is a distinct genetic lineage of Mycobacterium tuberculosis, which is distributed worldwide, and has caused large outbreaks of MDR-TB. It has been proposed that certain lineages of M. tuberculosis, such as the Beijing lineage, may have specific adaptive advantages. We have investigated the presence and transmission of DR Beijing strains in the Swedish population. Methodology/Principal Findings: All DR M. tuberculosis complex isolates between 1994 and 2008 were studied. Isolates that were of Beijing genotype were investigated for specific resistance mutations and phylogenetic markers. Seventy (13%) of 536 DR strains were of Beijing genotype. The majority of the patients with Beijing strains were foreign born, and their country of origin reflects the countries where the Beijing genotype is most prevalent. Multidrug-resistance was significantly more common in Beijing strains than in non-Beijing strains. There was a correlation between the Beijing genotype and specific resistance mutations in the katG gene, the mabA-inhA-promotor and the rpoB gene. By a combined use of RD deletions, spoligotyping, IS1547, mutT gene polymorphism and Rv3135 gene analysis the Beijing strains could be divided into 11 genomic sublineages. Of the patients with Beijing strains 28 (41%) were found in altogether 10 clusters (2-5 per cluster), as defined by RFLP IS6110, while 52% of the patients with non-Beijing strains were in clusters. By 24 loci MIRU-VNTR 31 (45%) of the patients with Beijing strains were found in altogether 7 clusters (2-11 per cluster). Contact tracing established possible epidemiological linkage between only two patients with Beijing strains. Conclusions/Significance: Although extensive outbreaks with non-Beijing TB strains have occurred in Sweden, Beijing strains have not taken hold, in spite of the proximity to high prevalence countries such as Russia and the Baltic countries. The Beijing sublineages so far introduced in Sweden may not be adapted to spread in the Scandinavian population.	[Ghebremichael, Solomon; Groenheit, Ramona; Pennhag, Alexandra; Hoffner, Sven] Swedish Inst Infect Dis Control, Dept Bacteriol, Solna, Sweden; [Ghebremichael, Solomon; Groenheit, Ramona] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Koivula, Tuija] Swedish Inst Infect Dis Control, Ctr Microbiol Preparedness, Solna, Sweden; [Koivula, Tuija; Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Andersson, Emmi] Karolinska Univ Hosp Huddinge, Unit Clin Microbiol F68, Stockholm, Sweden; [Bruchfeld, Judith] Karolinska Univ Hosp, Infect Dis Unit, Dept Med, Solna, Sweden; [Romanus, Victoria] Swedish Inst Infect Dis Control, Dept Epidemiol, Solna, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Swedish Institute for Infectious Disease Control	Ghebremichael, S (corresponding author), Swedish Inst Infect Dis Control, Dept Bacteriol, Solna, Sweden.	gunilla.kallenius@ki.se	Källenius, Gunilla/AGZ-3956-2022; Andersson, Emmi/AAG-3350-2020	Groenheit, Ramona/0000-0003-2696-437X; Kallenius, Gunilla/0000-0002-8921-0551	Swedish Heart Lung Foundation; Swedish Research Council	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants to Gunilla Kallenius from the Swedish Heart Lung Foundation and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bifani P, 2008, J INFECT DIS, V198, P90, DOI 10.1086/588822; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chan MY, 2001, EPIDEMIOL INFECT, V127, P169, DOI 10.1017/S0950268801005659; COLE ST, 1995, EUR RESPIR J, V8, pS701; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; Dahle UR, 2003, J CLIN MICROBIOL, V41, P67, DOI 10.1128/JCM.41.1.67-72.2003; Das S, 2004, INT J TUBERC LUNG D, V8, P267; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Drobniewski F, 2002, EMERG INFECT DIS, V8, P1320, DOI 10.3201/eid0811.020507; Fang ZG, 1997, J CLIN MICROBIOL, V35, P479, DOI 10.1128/JCM.35.2.479-481.1997; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Frieden TR, 1996, TUBERCLE LUNG DIS, V77, P407, DOI 10.1016/S0962-8479(96)90112-4; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Ghebremichael S, 2008, MICROBES INFECT, V10, P699, DOI 10.1016/j.micinf.2008.03.006; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2005, EMERG INFECT DIS, V11, P150, DOI 10.3201/eid1101.040869; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hanekom M, 2007, J CLIN MICROBIOL, V45, P2263, DOI 10.1128/JCM.02354-06; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1161; Hillemann D, 2005, ANTIMICROB AGENTS CH, V49, P1229, DOI 10.1128/AAC.49.3.1229-1231.2005; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Jureen P, 2004, TUBERCULOSIS, V84, P311, DOI 10.1016/j.tube.2003.12.001; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kan B, 2008, INT J TUBERC LUNG D, V12, P199; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Kubica T, 2004, INT J TUBERC LUNG D, V8, P1107; Li WM, 2005, INT J TUBERC LUNG D, V9, P1314; Lillebaek T, 2004, INT J TUBERC LUNG D, V8, P1001; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Lipin MY, 2007, CLIN MICROBIOL INFEC, V13, P620, DOI 10.1111/j.1469-0691.2007.01711.x; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Mokrousov I, 2003, EUR J CLIN MICROBIOL, V22, P342, DOI 10.1007/s10096-003-0944-0; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; Mokrousov I, 2002, J CLIN MICROBIOL, V40, P1504, DOI 10.1128/JCM.40.4.1504-1507.2002; Moss AR, 1997, INT J TUBERC LUNG D, V1, P115; Musser JM, 2000, GENETICS, V155, P7; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Nikolayevskyy VV, 2007, CLIN MICROBIOL INFEC, V13, P129, DOI 10.1111/j.1469-0691.2006.01583.x; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Park YK, 2005, J MICROBIOL METH, V63, P165, DOI 10.1016/j.mimet.2005.03.002; Prammananan T, 2008, CLIN MICROBIOL INFEC, V14, P446, DOI 10.1111/j.1469-0691.2008.01951.x; Prodinger WM, 2001, EMERG INFECT DIS, V7, P483, DOI 10.3201/eid0703.017330; Puustinen K, 2003, J CLIN MICROBIOL, V41, P1525, DOI 10.1128/JCM.41.4.1525-1528.2003; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Richardson M, 2002, INT J TUBERC LUNG D, V6, P1001; Rindi L, 2009, INFECT GENET EVOL, V9, P48, DOI 10.1016/j.meegid.2008.09.006; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Streicher EM, 2004, J CLIN MICROBIOL, V42, P891, DOI 10.1128/JCM.42.2.891-894.2004; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Suresh N, 2006, INFECT GENET EVOL, V6, P474, DOI 10.1016/j.meegid.2006.03.001; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	74	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10893	10.1371/journal.pone.0010893	http://dx.doi.org/10.1371/journal.pone.0010893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531942	Green Submitted, gold, Green Published			2022-12-25	WOS:000278222100022
J	Heg, D; Taborsky, M				Heg, Dik; Taborsky, Michael			Helper Response to Experimentally Manipulated Predation Risk in the Cooperatively Breeding Cichlid Neolamprologus pulcher	PLOS ONE			English	Article							GROUP-SIZE; BROODCARE HELPERS; DOMINANT MALES; NEST DEFENSE; COHO SALMON; REFUGE USE; BEHAVIOR; FISH; EVOLUTION; PAY	Background: We manipulated predation risk in a field experiment with the cooperatively breeding cichlid Neolamprologus pulcher by releasing no predator, a medium- or a large-sized fish predator inside underwater cages enclosing two to three natural groups. We assessed whether helpers changed their helping behaviour, and whether within-group conflict changed, depending on these treatments, testing three hypotheses: 'pay-to-stay' PS, 'risk avoidance' RA, or (future) reproductive benefits RB. We also assessed whether helper food intake was reduced under risk, because this might reduce investments in other behaviours to save energy. Methodology/Principal Findings: Medium and large helpers fed less under predation risk. Despite this effect helpers invested more in territory defence, but not territory maintenance, under the risk of predation (supporting PS). Experimentally covering only the breeding shelter with sand induced more helper digging under predation risk compared to the control treatment (supporting PS). Aggression towards the introduced predator did not differ between the two predator treatments and increased with group member size and group size (supporting PS and RA). Large helpers increased their help ratio (helping effort/breeder aggression received, 'punishment' by the dominant pair in the group) in the predation treatments compared to the control treatment, suggesting they were more willing to PS. Medium helpers did not show such effects. Large helpers also showed a higher submission ratio (submission/breeder aggression received) in all treatments, compared to the medium helpers (supporting PS). Conclusions/Significance: We conclude that predation risk reduces helper food intake, but despite this effect, helpers were more willing to support the breeders, supporting PS. Effects of breeder punishment suggests that PS might be more important for large compared to the medium helpers. Evidence for RA was also detected. Finally, the results were inconsistent with RB.	[Heg, Dik; Taborsky, Michael] Univ Bern, Inst Ecol & Evolut, Dept Behav Ecol, Hinterkappelen, Switzerland	University of Bern	Heg, D (corresponding author), Univ Bern, Inst Ecol & Evolut, Dept Behav Ecol, Hinterkappelen, Switzerland.	dik.heg@iee.unibe.ch	Taborsky, Michael/F-8420-2013	Taborsky, Michael/0000-0002-1357-4316; Heg, Dik/0000-0002-8766-7945	Swiss National Science Foundation (SNSF) [3100-064396, 3100A0-108473]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The project was supported by the Swiss National Science Foundation (SNSF grant 3100-064396 to M. T.). D. H. was supported by SNSF grant 3100A0-108473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KE, 2000, ETHOLOGY, V106, P385, DOI 10.1046/j.1439-0310.2000.00545.x; AUSTAD SN, 1985, BEHAV ECOL SOCIOBIOL, V17, P19, DOI 10.1007/BF00299423; Baglione V, 2002, ANIM BEHAV, V64, P887, DOI 10.1006/anbe.2002.2007; Balshine S, 2001, BEHAV ECOL SOCIOBIOL, V50, P134, DOI 10.1007/s002650100343; Balshine-Earn S, 1998, BEHAV ECOL, V9, P432, DOI 10.1093/beheco/9.5.432; Bednekoff PA, 2004, P ROY SOC B-BIOL SCI, V271, P1491, DOI 10.1098/rspb.2004.2739; Bednekoff PA, 1998, P ROY SOC B-BIOL SCI, V265, P2021, DOI 10.1098/rspb.1998.0535; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bergmuller R, 2005, P ROY SOC B-BIOL SCI, V272, P325, DOI 10.1098/rspb.2004.2960; Bergmuller R, 2005, ANIM BEHAV, V69, P19, DOI 10.1016/j.anbehav.2004.05.009; Brouwer L, 2005, BEHAV ECOL, V16, P667, DOI 10.1093/beheco/ari042; Bruintjes R, 2008, ANIM BEHAV, V75, P1843, DOI 10.1016/j.anbehav.2007.12.004; Candolin U, 1998, ANIM BEHAV, V56, P1205, DOI 10.1006/anbe.1998.0892; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Courchamp F, 2000, OIKOS, V91, P311, DOI 10.1034/j.1600-0706.2000.910212.x; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; Desiardins JK, 2008, ANIM BEHAV, V75, P595, DOI 10.1016/j.anbehav.2007.05.025; Dierkes P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1581, DOI 10.1007/s00265-008-0587-3; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Dierkes P, 1999, BEHAV ECOL, V10, P510, DOI 10.1093/beheco/10.5.510; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; Field J, 2006, NATURE, V441, P214, DOI 10.1038/nature04560; GAROFALO CA, 1992, INSECT SOC, V39, P301, DOI 10.1007/BF01323950; Gashagaza M.M., 1988, African Study Monographs, V9, P1; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Grand TC, 1999, ANIM BEHAV, V58, P443, DOI 10.1006/anbe.1999.1174; Grantner A, 1998, J COMP PHYSIOL B, V168, P427, DOI 10.1007/s003600050162; HAILMAN JP, 1994, ETHOLOGY, V97, P119; Hamilton IM, 2005, BEHAVIOUR, V142, P1591, DOI 10.1163/156853905774831846; Hamilton IM, 2002, CAN J ZOOL, V80, P2164, DOI 10.1139/Z02-199; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P445, DOI 10.1098/rspb.2004.2961; Heg D, 2008, ENVIRON BIOL FISH, V83, P191, DOI 10.1007/s10641-007-9317-3; Heg D, 2006, BEHAV ECOL, V17, P419, DOI 10.1093/beheco/arj056; Heg D, 2005, BEHAVIOUR, V142, P1615, DOI 10.1163/156853905774831891; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, pS505, DOI 10.1098/rsbl.2004.0232; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Heg D, 2008, BIOL LETTERS, V4, P606, DOI 10.1098/rsbl.2008.0365; Heg D, 2008, MOL ECOL, V17, P4359, DOI 10.1111/j.1365-294X.2008.03920.x; Heg D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1249, DOI 10.1007/s00265-008-0553-0; Heg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005458; Heinsohn R, 1996, P ROY SOC B-BIOL SCI, V263, P475, DOI 10.1098/rspb.1996.0071; Hill RA, 1998, BEHAVIOUR, V135, P411; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Janson CH, 1998, BEHAVIOUR, V135, P389, DOI 10.1163/156853998793066177; Johnsson JI, 2004, BEHAV ECOL SOCIOBIOL, V56, P388, DOI 10.1007/s00265-004-0791-8; Johnsson JI, 2003, J FISH BIOL, V63, P863, DOI 10.1046/j.1095-8649.2003.00187.x; KALAS K, 1975, THESIS U GIESSEN GER; Kokko H, 2002, BEHAV ECOL, V13, P291, DOI 10.1093/beheco/13.3.291; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Krause J, 1998, P ROY SOC B-BIOL SCI, V265, P2373, DOI 10.1098/rspb.1998.0586; Krause J., 2002, LIVING GROUPS, P210; Kukuk PF, 1998, NATURWISSENSCHAFTEN, V85, P445, DOI 10.1007/s001140050528; Lima SL, 1999, ANIM BEHAV, V58, P537, DOI 10.1006/anbe.1999.1182; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIMBERGER D, 1983, Z TIERPSYCHOL, V62, P115; MAGNHAGEN C, 1995, ANIM BEHAV, V50, P1123, DOI 10.1016/0003-3472(95)80111-1; MAGURRAN AE, 1991, BEHAVIOUR, V118, P214, DOI 10.1163/156853991X00292; Maklakov AA, 2002, BEHAV ECOL SOCIOBIOL, V52, P372, DOI 10.1007/s00265-002-0528-5; MAPPES J, 1995, BEHAV ECOL SOCIOBIOL, V36, P343, DOI 10.1007/BF00167795; MARTEL G, 1995, ETHOLOGY, V99, P139; Mitchell JS, 2009, BEHAVIOUR, V146, P1665, DOI 10.1163/000579509X12459328580026; Mitchell JS, 2009, ETHOLOGY, V115, P1162, DOI 10.1111/j.1439-0310.2009.01705.x; MULDER RA, 1993, ANIM BEHAV, V45, P830, DOI 10.1006/anbe.1993.1100; Norusis M.J, 2007, SPSS 15 0 ADV STAT P; RASA OAE, 1987, ADV STUD BEHAV, V17, P121, DOI 10.1016/S0065-3454(08)60178-3; Shreeves G, 2003, P ROY SOC B-BIOL SCI, V270, P1617, DOI 10.1098/rspb.2003.2409; SIH A, 1988, AM NAT, V132, P463, DOI 10.1086/284865; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Skubic E, 2004, J THEOR BIOL, V227, P487, DOI 10.1016/j.jtbi.2003.11.021; Steele MA, 1998, OECOLOGIA, V115, P222, DOI 10.1007/s004420050511; Stiver KA, 2009, J FISH BIOL, V74, P1129, DOI 10.1111/j.1095-8649.2009.02173.x; Stiver KA, 2006, ANIM BEHAV, V71, P449, DOI 10.1016/j.anbehav.2005.06.011; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; STRASSMANN JE, 1988, ECOLOGY, V69, P1497, DOI 10.2307/1941647; TABORSKY M, 1984, ANIM BEHAV, V32, P1236, DOI 10.1016/S0003-3472(84)80241-9; Taborsky M, 1998, ANIM BEHAV, V56, P1375, DOI 10.1006/anbe.1998.0918; TABORSKY M, 1981, BEHAV ECOL SOCIOBIOL, V8, P143, DOI 10.1007/BF00300826; TABORSKY M, 1986, Koninklijk Museum voor Midden-Afrika Tervuren Belgie Annalen Zoologische Wetenschappen, V251, P7; TABORSKY M, 1985, BEHAVIOUR, V95, P45, DOI 10.1163/156853985X00046; van der Veen IT, 1999, BEHAV ECOL, V10, P545, DOI 10.1093/beheco/10.5.545; Werner NY, 2003, BEHAV ECOL, V14, P749, DOI 10.1093/beheco/arg067	83	48	48	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10784	10.1371/journal.pone.0010784	http://dx.doi.org/10.1371/journal.pone.0010784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520816	Green Published, gold			2022-12-25	WOS:000278221500007
J	Inoue, E; Yamashita, A; Inoue, H; Sekiguchi, M; Shiratori, A; Yamamoto, Y; Tadokoro, T; Ishimi, Y; Yamauchi, J				Inoue, Erina; Yamashita, Aoi; Inoue, Hirofumi; Sekiguchi, Mariko; Shiratori, Asuka; Yamamoto, Yuji; Tadokoro, Tadahiro; Ishimi, Yoshiko; Yamauchi, Jun			Identification of Glucose Transporter 4 Knockdown-dependent Transcriptional Activation Element on the Retinol Binding Protein 4 Gene Promoter and Requirement of the 20 S Proteasome Subunit for Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; VITAMIN-A; NUCLEAR-LOCALIZATION; 3T3-L1 ADIPOCYTES; DIABETIC SUBJECTS; CELLULAR UPTAKE; HUMAN HOMOLOG; IN-VITRO; EXPRESSION; RECEPTOR	Retinol binding protein 4 (RBP4) is the transport protein that carries retinol in blood. RBP4 was described recently as a new adipokine that reduced insulin sensitivity. Mice lacking glucose transporter 4 (GLUT4) in adipocytes have enhanced Rbp4 gene expression; however, the molecular mechanism is unknown. We found a G4KA (GLUT4 knockdown-dependent transcriptional activation) element located similar to 1.3 kb upstream of the Rbp4 promoter. Mutations within the G4KA sequence significantly reduced expression of the Rbp4 promoter-reporter construct in G4KD-L1 (GLUT4 knockdown 3T3-L1) adipocyte cells. In a yeast one-hybrid screen of a G4KD-L1 cell cDNA library, using the G4KA element as bait, we identified subunits of the 20 S proteasome, PSMB1 and PSMA4, as binding partners. In chromatin immunoprecipitation assays, both subunits bound to the G4KA element; however, only PSMB1 was tightly bound in the GLUT4 knockdown model. PSMB1 RNA interference, but not PSMA4, significantly inhibited Rbp4 transcription. Nuclear transportation of PSMB1 was increased in G4KD-L1 cells. These results provide evidence for an exclusive proteasome subunit-related mechanism for transcriptional activation of RBP4 within a GLUT4 knockdown model.	[Yamauchi, Jun] Natl Inst Hlth & Nutr, Food Funct & Labeling Program, Nutr Epidemiol Program, Shinjyuku Ku, Tokyo 1628636, Japan; [Inoue, Hirofumi; Shiratori, Asuka; Yamamoto, Yuji; Tadokoro, Tadahiro] Tokyo Univ Agr, Dept Appl Biol & Chem, Setagaya Ku, Tokyo 1568502, Japan	National Institute of Health & Nutrition - Japan; Tokyo University of Agriculture	Yamauchi, J (corresponding author), Natl Inst Hlth & Nutr, Food Funct & Labeling Program, Nutr Epidemiol Program, Shinjyuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	junyama@nih.go.jp			Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare (to J.Y.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (to J.Y.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Akiyama H, 2005, MATRIX BIOL, V23, P499, DOI 10.1016/j.matbio.2004.10.002; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; BLOMHOFF R, 1991, PHYSIOL REV, V71, P951, DOI 10.1152/physrev.1991.71.4.951; Catlow K, 2007, J BIOL CHEM, V282, P17069, DOI 10.1074/jbc.M611421200; Chang TL, 2009, METABOLISM, V58, P1643, DOI 10.1016/j.metabol.2009.05.020; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; COLANTUONI V, 1987, EMBO J, V6, P631, DOI 10.1002/j.1460-2075.1987.tb04801.x; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; DONOFRIO C, 1985, EMBO J, V4, P1981, DOI 10.1002/j.1460-2075.1985.tb03881.x; Gottlicher M, 1996, STEROIDS, V61, P257, DOI 10.1016/0039-128X(96)00032-3; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; HAGIWARA M, 2009, BIOCHEM BIOPH RES CO, V389, P171; Hammarstedt A, 2008, J INTERN MED, V263, P440, DOI 10.1111/j.1365-2796.2007.01914.x; Imamura T, 1999, MOL CELL BIOL, V19, P6765; Imhof MO, 1996, MOL CELL BIOL, V16, P2594; Inoue E, 2006, BIOCHEM BIOPH RES CO, V351, P793, DOI 10.1016/j.bbrc.2006.10.124; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakamura A, 2006, NEUROSCI LETT, V406, P43, DOI 10.1016/j.neulet.2006.07.050; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; NORUM KR, 1992, AM J CLIN NUTR, V56, P735, DOI 10.1093/ajcn/56.4.735; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Tamori Y, 2006, NAT MED, V12, P30, DOI 10.1038/nm0106-30; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; VOM BE, 1996, EMBO J, V15, P110; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	44	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25545	25553		10.1074/jbc.M109.079152	http://dx.doi.org/10.1074/jbc.M109.079152			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530491	Green Published, hybrid			2022-12-25	WOS:000280682400049
J	Gao, X; Pang, J; Li, LY; Liu, WP; Di, JM; Sun, QP; Fang, YQ; Liu, XP; Pu, XY; He, D; Li, MT; Su, ZL; Li, BY				Gao, X.; Pang, J.; Li, L-Y; Liu, W-P; Di, J-M; Sun, Q-P; Fang, Y-Q; Liu, X-P; Pu, X-Y; He, D.; Li, M-T; Su, Z-L; Li, B-Y			Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer	ONCOGENE			English	Article						prostate cancer; proteomics; collapsin response mediator protein-4; metastasis-suppressor gene; methylation	UNC-33-LIKE PHOSPHOPROTEIN GENE; LYMPH-NODE METASTASIS; GROWTH CONE COLLAPSE; TRANSCRIPTION FACTORS; METHYLATION; PROMOTER; INVASION; CELLS; MICROMETASTASES; NEUROBLASTOMA	Metastasis is the chief cause of mortality from cancer, but the mechanisms leading to metastasis are poorly understood. We used a proteomics approach to screen for metastasis-associated proteins and found that collapsin response mediator protein-4 (CRMP4) expression was inversely associated with the lymph node metastasis of prostate cancer (PCa). Subsequent in vitro and in vivo studies revealed that overexpression of CRMP4 not only suppressed the invasion ability of PCa cells, but also strongly inhibited tumor metastasis in an animal model. Furthermore, methylation of a CpG island within the promoter region of the CRMP4 gene is responsible for downregulation of CRMP4 expression. Thus, in this study, we show new function of CRMP4 as a metastasis-suppressor in PCa. The findings provide new mechanistic insights into metastasis and therapeutic potential for this most common male cancer. Oncogene (2010) 29, 4555-4566; doi: 10.1038/onc.2010.213; published online 14 June 2010	[Gao, X.; Pang, J.; Li, L-Y; Liu, W-P; Di, J-M; Sun, Q-P; Fang, Y-Q; Liu, X-P; Pu, X-Y] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510630, Guangdong, Peoples R China; [He, D.; Su, Z-L] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Li, M-T] Sun Yat Sen Univ, Prote Ctr, Zhongshan Sch Medcine, Guangzhou 510275, Guangdong, Peoples R China; [Li, B-Y] Univ Kansas, Med Ctr, Dept Urol, Kansas City, KS 66103 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Kansas; University of Kansas Medical Center	Gao, X (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Tianhe Rd 600, Guangzhou 510630, Guangdong, Peoples R China.	Xin.Gao.zsu@gmail.com	Pang, Jun/AAY-3407-2021	Pang, Jun/0000-0003-0024-9415; li, liaoyuan/0000-0002-5328-6802	Chinese National Natural Science Foundation [30772178, 30973011, 30901496]; Guangdong Provincial Science and Technology Research [7117362]; Chinese Ministry of Health; Chinese National Hi-Tech Research and Development Program [2007AA021906]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Research; Chinese Ministry of Health; Chinese National Hi-Tech Research and Development Program(National High Technology Research and Development Program of China)	We thank Professor Quentin Liu (State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University) for providing excellent technical assistances. Special thanks to Professor Zhou Zhu (Johns Hopkins University, School of Medicine, USA) for valuable suggestions and critical reading of this paper. This work was supported by Chinese National Natural Science Foundation 30772178, 30973011, 30901496, Key Project of Guangdong Provincial Science and Technology Research 7117362, Key Project of Chinese Ministry of Health and Chinese National Hi-Tech Research and Development Program 2007AA021906.	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Cai CQ, 2008, ONCOGENE, V27, P3201, DOI 10.1038/sj.onc.1210983; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; Chi AS, 2009, ONCOLOGIST, V14, P621, DOI 10.1634/theoncologist.2008-0272; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fu HJ, 2007, J PROTEOME RES, V6, P2435, DOI 10.1021/pr060615g; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Gaetano C, 1997, J BIOL CHEM, V272, P12195, DOI 10.1074/jbc.272.18.12195; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jackson D, 2006, PROTEOMICS, V6, P3901, DOI 10.1002/pmic.200500794; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Klein CA, 2008, SCIENCE, V321, P1785, DOI 10.1126/science.1164853; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Loberg RD, 2005, J CLIN ONCOL, V23, P8232, DOI 10.1200/JCO.2005.03.0841; Matsuo T, 2000, J BIOL CHEM, V275, P16560, DOI 10.1074/jbc.M001312200; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Miyake H, 2007, CLIN CANCER RES, V13, P1192, DOI 10.1158/1078-0432.CCR-05-2706; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Rinker-Schaeffer CW, 2006, CLIN CANCER RES, V12, P3882, DOI 10.1158/1078-0432.CCR-06-1014; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Schewe DM, 2005, CLIN CANCER RES, V11, P8538, DOI 10.1158/1078-0432.CCR-05-0786; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shaffer DR, 2006, NAT MED, V12, P14, DOI 10.1038/nm0106-14; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Uzawa K, 2002, CLIN CANCER RES, V8, P828; Wang LH, 1997, J NEUROCHEM, V69, P2261; Yacoub M, 2009, HISTOPATHOLOGY, V55, P392, DOI 10.1111/j.1365-2559.2009.03406.x; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Zilberman D, 2007, NAT GENET, V39, P442, DOI 10.1038/ng0407-442	47	50	53	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 12	2010	29	32					4555	4566		10.1038/onc.2010.213	http://dx.doi.org/10.1038/onc.2010.213			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	638AQ	20543870				2022-12-25	WOS:000280862300006
J	Mitra, A; Menezes, ME; Shevde, LA; Samant, RS				Mitra, Aparna; Menezes, Mitchell E.; Shevde, Lalita A.; Samant, Rajeev S.			DNAJB6 Induces Degradation of beta-Catenin and Causes Partial Reversal of Mesenchymal Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; DROSOPHILA TUMOR-SUPPRESSOR; HEAT-SHOCK PROTEINS; WNT SIGNALING PATHWAY; E-CADHERIN; MIR-200 FAMILY; HUMAN HOMOLOG; TRANSCRIPTION FACTORS; MALIGNANT ACTIVITY; MDA-MB-435 CELLS	We showed that expression of MRJ (DNAJB6) protein is lost in invasive ductal carcinoma, and restoration of MRJ(L) restricts malignant behavior of breast cancer and melanoma cells. However, the signaling pathways influenced by MRJ(L) are largely unknown. Our observations revealed that MRJ(L) expression causes changes in cell morphology concomitant with down-regulation of several mesenchymal markers, viz. vimentin, N-cadherin, Twist, and Slug, and up-regulation of epithelial marker keratin 18. Importantly, MRJ(L) expression led to reduced levels of beta-catenin, an epithelial mesenchymal transition marker, and a critical player in the Wnt pathway. We found that MRJ(L) up-regulates expression of DKK1, a well known Wnt/beta-catenin signaling inhibitor, that causes degradation of beta-catenin. Re-expression of DNAJB6 alters the Wnt/beta-catenin signaling in cancer cells, leading to partial reversal of the mesenchymal phenotype. Thus, MRJ(L) may play a role in maintaining an epithelial phenotype, and inhibition of the Wnt/beta-catenin pathway may be one of the potential mechanisms contributing to the restriction of malignant behavior by MRJ(L).	[Mitra, Aparna; Menezes, Mitchell E.; Shevde, Lalita A.; Samant, Rajeev S.] Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36604 USA	University of South Alabama	Samant, RS (corresponding author), Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	rsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	National Institutes of Health [1R01CA140472-01A1]; University of South Alabama-Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA140472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Alabama-Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA140472-01A1 (to R. S. S.).; We thank "The Shawn and Leyla Esfahani Breast Cancer Research Endowment" for their invaluable support to breast cancer research at the University of South Alabama-Mitchell Cancer Institute.	Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Azios NG, 2007, NEOPLASIA, V9, P147, DOI 10.1593/neo.06778; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng XG, 2008, J VIROL, V82, P1229, DOI 10.1128/JVI.00540-07; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Cowling VH, 2007, CELL CYCLE, V6, P2625, DOI 10.4161/cc.6.21.4880; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Georgakis Georgios V, 2005, Future Oncol, V1, P273; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Izawa I, 2000, J BIOL CHEM, V275, P34521, DOI 10.1074/jbc.M003492200; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim SW, 2005, CANCER RES, V65, P8784, DOI 10.1158/0008-5472.CAN-04-4422; Kim SW, 2004, CANCER RES, V64, P7732, DOI 10.1158/0008-5472.CAN-04-1323; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Matijasevic Z, 1998, ONCOL RES, V10, P605; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Mikheev AM, 2008, BREAST CANCER RES TR, V112, P263, DOI 10.1007/s10549-007-9867-2; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Mitra A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1874; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Moon RT, 1997, CELL, V88, P725, DOI 10.1016/S0092-8674(00)81915-7; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rae JM, 2004, CLIN EXP METASTAS, V21, P543, DOI 10.1007/s10585-004-3759-1; Rylander MN, 2005, ANN NY ACAD SCI, V1066, P222, DOI 10.1196/annals.1363.009; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schafer C, 2000, J GASTROENTEROL, V35, P1; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Syken J, 2003, ONCOGENE, V22, P4636, DOI 10.1038/sj.onc.1206569; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; Trentin GA, 2004, FEBS LETT, V578, P323, DOI 10.1016/j.febslet.2004.11.034; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang CC, 2005, ONCOGENE, V24, P4081, DOI 10.1038/sj.onc.1208573; Wang CC, 2007, CANCER RES, V67, P4816, DOI 10.1158/0008-5472.CAN-07-0504; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; XIE X, 1992, CLIN EXP METASTAS, V10, P201, DOI 10.1007/BF00132752; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316	71	43	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24686	24694		10.1074/jbc.M109.094847	http://dx.doi.org/10.1074/jbc.M109.094847			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522561	Green Published, hybrid			2022-12-25	WOS:000280542100041
J	Nili, M; Shinde, U; Rotwein, P				Nili, Mahta; Shinde, Ujwal; Rotwein, Peter			Soluble Repulsive Guidance Molecule c/Hemojuvelin Is a Broad Spectrum Bone Morphogenetic Protein (BMP) Antagonist and Inhibits both BMP2-and BMP6-mediated Signaling and Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPCIDIN EXPRESSION; IRON-METABOLISM; TGF-BETA; JUVENILE HEMOCHROMATOSIS; HEMOJUVELIN; FAMILY; RECEPTORS; OVERLOAD; NEOGENIN; COMPLEX	Inactivating mutations in hemojuvelin/repulsive guidance molecule c (HJV/RGMc) cause juvenile hemochromatosis (JH), a rapidly progressive iron overload disorder in which expression of hepcidin, a key liver-derived iron-regulatory hormone, is severely diminished. Several growth factors in the bone morphogenetic protein (BMP) family, including BMP2 and BMP6, can stimulate production of hepcidin, a biological effect that may be modified by RGMc. Here we demonstrate that soluble RGMc proteins are potent BMP inhibitors. Wefind that 50- and 40-kDa RGMc isoforms, when added to cells as highly purified IgG Fc fusion proteins, are able to block the acute effects of both BMP2 and BMP6 at the levels of Smad induction and gene activation, and thus represent a potentially unique class of broad-spectrum BMP antagonists. Whole transcript microarray analysis revealed that BMP2 and BMP6 each stimulated expression of a nearly identical cohort of similar to 40 mRNAs in Hep3B cells and demonstrated that 40-kDa RGMc was an effective inhibitor of both growth factors, although its potency was less than that of the known BMP2-selective antagonist, Noggin. We additionally show that JH-linked RGMc mutant proteins that retain the ability to bind BMPs are also able to function as BMP inhibitors, and like the wild type soluble RGMc species, can block BMP-activated hepcidin gene expression. The latter results raise the question of whether disease severity in JH will vary depending on the ability of a given mutant RGMc protein to interact with BMPs.	[Nili, Mahta; Shinde, Ujwal; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Rotwein, P (corresponding author), 3181 SW Sam Jackson Pk Rd,Mail Code L224, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [R01 DK042748, F31 HL095271, WSF 0746589]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL095271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grants R01 DK042748 (to P. R.), F31 HL095271 (to M. N.), and WSF 0746589 (to U. S.).	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; ASCHAFFENBURG R, 1979, J MOL BIOL, V135, P1033, DOI 10.1016/0022-2836(79)90528-X; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Beutler E, 2006, ANNU REV MED, V57, P331, DOI 10.1146/annurev.med.57.121304.131310; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Halbrooks Peter J, 2007, J Mol Signal, V2, P4, DOI 10.1186/1750-2187-2-4; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kuninger D, 2004, GENOMICS, V84, P876, DOI 10.1016/j.ygeno.2004.07.013; Kuninger D, 2006, J CELL SCI, V119, P3273, DOI 10.1242/jcs.03074; Kuninger David, 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-9; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Winkler DG, 2004, J BIOL CHEM, V279, P36293, DOI 10.1074/jbc.M400521200; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	48	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24783	24792		10.1074/jbc.M110.130286	http://dx.doi.org/10.1074/jbc.M110.130286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530805	Green Published, hybrid			2022-12-25	WOS:000280542100051
J	Rui, Z; Petrickova, K; Skanta, F; Pospisil, S; Yang, YL; Chen, CY; Tsai, SF; Floss, HG; Petricek, M; Yu, TW				Rui, Zhe; Petrickova, Katerina; Skanta, Frantisek; Pospisil, Stanislav; Yang, Yanling; Chen, Chung-Yung; Tsai, Shih-Feng; Floss, Heinz G.; Petricek, Miroslav; Yu, Tin-Wein			Biochemical and Genetic Insights into Asukamycin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NODOSUS SUBSP ASUKAENSIS; FATTY-ACID SYNTHASE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; HETEROLOGOUS EXPRESSION; II THIOESTERASE; STREPTOMYCES; POLYKETIDE; CLUSTER; PATHWAY	Asukamycin, a member of the manumycin family metabolites, is an antimicrobial and potential antitumor agent isolated from Streptomyces nodosus subsp. asukaensis. The entire asukamycin biosynthetic gene cluster was cloned, assembled, and expressed heterologously in Streptomyces lividans. Bioinformatic analysis and mutagenesis studies elucidated the biosynthetic pathway at the genetic and biochemical level. Four gene sets, asuA-D, govern the formation and assembly of the asukamycin building blocks: a 3-amino-4-hydroxybenzoic acid core component, a cyclohexane ring, two triene polyketide chains, and a 2-amino3- hydroxycyclopent-2-enone moiety to form the intermediate protoasukamycin. AsuE1 and AsuE2 catalyze the conversion of protoasukamycin to 4-hydroxyprotoasukamycin, which is epoxidized at C5-C6 by AsuE3 to the final product, asukamycin. Branched acyl CoA starter units, derived from Val, Leu, and Ile, can be incorporated by the actions of the polyketide synthase III (KSIII) AsuC3/C4 as well as the cellular fatty acid synthase FabH to produce the asukamycin congeners A2-A7. In addition, the type II thioesterase AsuC15 limits the cellular level of omega-cyclohexyl fatty acids and likely maintains homeostasis of the cellular membrane.	[Petrickova, Katerina; Skanta, Frantisek; Pospisil, Stanislav; Petricek, Miroslav] Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague 4, Czech Republic; [Yu, Tin-Wein] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Chen, Chung-Yung] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli 32023, Taiwan; [Tsai, Shih-Feng] Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan; [Floss, Heinz G.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Louisiana State University System; Louisiana State University; Chung Yuan Christian University; National Yang Ming Chiao Tung University; University of Washington; University of Washington Seattle	Petricek, M (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Videnska 1083, CR-14220 Prague 4, Czech Republic.	petras@biomed.cas.cz; tin.laorchid@gmail.com	Chen, Chung-Yung/AAJ-2111-2020; Petříček, Miroslav/H-8417-2014; yang, yan/M-2875-2013; Rui, Zhe/D-9541-2013; Petrickova, Katerina/H-2426-2014; Pospisil, Stanislav/H-3051-2014; Škanta, František/H-7931-2014; Yang, Yanling/F-5954-2014	Petříček, Miroslav/0000-0001-8757-2404; Rui, Zhe/0000-0001-8113-2694; Petrickova, Katerina/0000-0003-3719-354X; Petrickova, Katerina/0000-0002-0994-4038	National Institutes of Health [CA76461]; Czech Ministry of Education [2B06154]; Institutional Scientific Program [AV0Z50200510]; Louisiana State University; Louisiana State Economic Development; NATIONAL CANCER INSTITUTE [R01CA076461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Institutional Scientific Program; Louisiana State University; Louisiana State Economic Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA76461 (to T.-W.Y.). This work was also supported by Czech Ministry of Education Grant 2B06154, Institutional Scientific Program AV0Z50200510 (to M.P.), a Louisiana State University Faculty Startup Fellowship (to T.-W.Y.), and a Louisiana State Economic Development Assistantship (to T.-W.Y. and Z.R.).	Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; BEALE JM, 1986, J AM CHEM SOC, V108, P331, DOI 10.1021/ja00262a043; Bernier M, 2006, J BIOL CHEM, V281, P2551, DOI 10.1074/jbc.M511878200; Binz TM, 2008, CHEMBIOCHEM, V9, P447, DOI 10.1002/cbic.200700549; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Cole LJ, 2005, BIOCHEMISTRY-US, V44, P8047, DOI 10.1021/bi050108x; Cropp TA, 2000, NAT BIOTECHNOL, V18, P980, DOI 10.1038/79479; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Gerber R, 2009, J AM CHEM SOC, V131, P3148, DOI 10.1021/ja8091054; Groban ES, 2009, J MOL BIOL, V390, P380, DOI 10.1016/j.jmb.2009.05.007; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hu YD, 2004, J AM CHEM SOC, V126, P3837, DOI 10.1021/ja039336+; Hu YD, 1997, J AM CHEM SOC, V119, P4301, DOI 10.1021/ja9701016; Hu YD, 2001, J ANTIBIOT, V54, P340, DOI 10.7164/antibiotics.54.340; Hu YD, 2006, HETEROCYCLES, V69, P133; Hu YF, 2008, CHEMBIOCHEM, V9, P1603, DOI 10.1002/cbic.200800029; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; KAKINUMA K, 1979, J AM CHEM SOC, V101, P3402, DOI 10.1021/ja00506a056; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Kitani S, 2008, GENE, V425, P9, DOI 10.1016/j.gene.2008.07.043; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Kotowska M, 2009, APPL ENVIRON MICROB, V75, P887, DOI 10.1128/AEM.01371-08; NAKAGAWA A, 1985, J CHEM SOC CHEM COMM, P519, DOI 10.1039/c39850000519; Nasser W, 2007, ANAL BIOANAL CHEM, V387, P381, DOI 10.1007/s00216-006-0702-0; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; OMURA S, 1976, J ANTIBIOT, V29, P876, DOI 10.7164/antibiotics.29.876; Ostash B, 2007, CHEM BIOL, V14, P257, DOI 10.1016/j.chembiol.2007.01.008; Pacholec M, 2005, BIOCHEMISTRY-US, V44, P4949, DOI 10.1021/bi047303g; Palaniaappan N, 2003, J BIOL CHEM, V278, P35552, DOI 10.1074/jbc.M305082200; Pan H, 2002, STRUCTURE, V10, P1559, DOI 10.1016/S0969-2126(02)00889-4; Petricek M, 2006, J BACTERIOL, V188, P5113, DOI 10.1128/JB.01919-05; Pfennig F, 1999, J BIOL CHEM, V274, P12508, DOI 10.1074/jbc.274.18.12508; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Sattler I, 1998, NAT PROD REP, V15, P221, DOI 10.1039/a815221y; Schmutz E, 2003, EUR J BIOCHEM, V270, P4413, DOI 10.1046/j.1432-1033.2003.03830.x; Shipley PR, 2009, INT J MOL MED, V24, P711, DOI 10.3892/ijmm_00000283; Simbahan J, 2004, INT J SYST EVOL MICR, V54, P1703, DOI 10.1099/ijs.0.03012-0; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Suzuki H, 2006, J BIOL CHEM, V281, P36944, DOI 10.1074/jbc.M608103200; Tang Y, 2003, BIOCHEMISTRY-US, V42, P6588, DOI 10.1021/bi0341962; Tang YY, 2006, BIOCHEMISTRY-US, V45, P14085, DOI 10.1021/bi061187v; THIERICKE R, 1989, J CHEM SOC CHEM COMM, P402, DOI 10.1039/c39890000402; THIERICKE R, 1990, J AM CHEM SOC, V112, P3979, DOI 10.1021/ja00166a039; van der Werf MJ, 1999, APPL ENVIRON MICROB, V65, P2092; VINEIS P, 1994, NATURE, V369, P154, DOI 10.1038/369154a0; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Wolpert M, 2008, CHEMBIOCHEM, V9, P603, DOI 10.1002/cbic.200700483; Yeh E, 2004, CHEMBIOCHEM, V5, P1290, DOI 10.1002/cbic.200400077; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; Zhang WJ, 2010, J AM CHEM SOC, V132, P6402, DOI 10.1021/ja1002845; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zheng ZH, 2007, J ENZYM INHIB MED CH, V22, P43, DOI 10.1080/14756360600988781; Zhou Z, 2007, P NATL ACAD SCI USA, V104, P11621, DOI 10.1073/pnas.0705122104	62	47	48	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24915	24924		10.1074/jbc.M110.128850	http://dx.doi.org/10.1074/jbc.M110.128850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522559	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000280542100064
J	Salmeen, A; Park, BO; Meyer, T				Salmeen, A.; Park, B. O.; Meyer, T.			The NADPH oxidases NOX4 and DUOX2 regulate cell cycle entry via a p53-dependent pathway	ONCOGENE			English	Article						NADPH oxidases; redox signaling; p53; NOX4; DUOX2	SMOOTH-MUSCLE-CELLS; EPIDERMAL-GROWTH-FACTOR; REACTIVE OXYGEN; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION REPRESSION; RETINOBLASTOMA PROTEIN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; NAD(P)H OXIDASE	Reactive oxygen species (ROS) are produced in growth factor-signaling pathways leading to cell proliferation, but the mechanisms leading to ROS generation and the targets of ROS signals are not well understood. Using a focused siRNA screen to identify redox-related proteins required for growth factor-induced cell cycle entry, we show that two ROS-generating proteins, the NADPH oxidases NOX4 and DUOX2, are required for platelet-derived growth factor (PDGF) induced retinoblastoma protein (Rb) phosphorylation in normal human fibroblasts. Unexpectedly, NOX4 and DUOX2 knockdown did not inhibit the early signaling pathways leading to cyclin D1 upregulation. However, hours after growth factor stimulation, NOX4 and DUOX2 knockdown reduced ERK1 phosphorylation and increased levels of the tumor suppressor protein p53 and a cell cycle inhibitor protein p21 (Waf1/Cip1) that is transcriptionally regulated by p53. Co-knockdown of NOX4 or DUOX2 with either p53 or with p21 overcame the inhibition of Rb phosphorylation that occurred with NOX4 or DUOX2 knockdown alone. Our results argue that rather than primarily affecting growth factor receptor signaling, NOX4 and DUOX2 regulate cell cycle entry as part of a p53-dependent checkpoint for proliferation. Oncogene (2010) 29, 4473-4484; doi: 10.1038/onc.2010.200; published online 7 June 2010	[Salmeen, A.; Park, B. O.; Meyer, T.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Clark Ctr W200, Stanford, CA 94305 USA	Stanford University	Salmeen, A (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Clark Ctr W200, 318 Campus Dr, Stanford, CA 94305 USA.	tobias1@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	Burroughs Wellcome Fund; Helen Hay Whitney Foundation/Paul Sigler Agouron Institute; NIH [R33 CA 120732]; NATIONAL CANCER INSTITUTE [R33CA120732] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Helen Hay Whitney Foundation/Paul Sigler Agouron Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Won Do Heo for his assistance with the cell cycle entry assay, Dr Dan Kaplan, Dr Sean Collins and Dr Karlene Cimprich for their critical reading of the article and members of the Meyer lab and Renee Paulsen for helpful discussions. This work was supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (AS), by a Helen Hay Whitney Foundation/Paul Sigler Agouron Institute post-doctoral fellowship (AS) and by an NIH grant R33 CA 120732 (TM).	Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Burch PM, 2005, ANTIOXID REDOX SIGN, V7, P741, DOI 10.1089/ars.2005.7.741; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Hainaut P, 2001, ANTIOXID REDOX SIGN, V3, P611, DOI 10.1089/15230860152542961; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Laurent E, 2008, INT J CANCER, V123, P100, DOI 10.1002/ijc.23423; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu YX, 2008, MOL CANCER RES, V6, P624, DOI 10.1158/1541-7786.MCR-07-2019; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Park HS, 2005, DIABETES, V54, P3175, DOI 10.2337/diabetes.54.11.3175; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Ranjan P, 2006, ANTIOXID REDOX SIGN, V8, P1447, DOI 10.1089/ars.2006.8.1447; Rhee S G, 2000, Sci STKE, V2000, ppe1; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Sturrock A, 2007, AM J PHYSIOL-LUNG C, V292, pL1543, DOI 10.1152/ajplung.00430.2006; Sun XZ, 2003, ANTIOXID REDOX SIGN, V5, P655, DOI 10.1089/152308603770310338; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Wilkinson DS, 2008, MOL CELL BIOL, V28, P1988, DOI 10.1128/MCB.01442-07; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	43	38	38	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2010	29	31					4473	4484		10.1038/onc.2010.200	http://dx.doi.org/10.1038/onc.2010.200			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	634DG	20531308	Green Accepted			2022-12-25	WOS:000280559100010
J	Casado, C; Colombo, S; Rauch, A; Martinez, R; Gunthard, HF; Garcia, S; Rodriguez, C; del Romero, J; Telenti, A; Lopez-Galindez, C				Casado, Concepcion; Colombo, Sara; Rauch, Andri; Martinez, Raquel; Guenthard, Huldrych F.; Garcia, Soledad; Rodriguez, Carmen; del Romero, Jorge; Telenti, Amalio; Lopez-Galindez, Cecilio			Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG-TERM NONPROGRESSORS; REPLICATION CAPACITY; EVOLUTION; CONTROLLERS; CONTRIBUTE; INFECTION; VIREMIA; RNA	Background: Various patterns of HIV-1 disease progression are described in clinical practice and in research. There is a need to assess the specificity of commonly used definitions of long term non-progressor (LTNP) elite controllers (LTNP-EC), viremic controllers (LTNP-VC), and viremic non controllers (LTNP-NC), as well as of chronic progressors (P) and rapid progressors (RP). Methodology and Principal Findings: We re-evaluated the HIV-1 clinical definitions, summarized in Table 1, using the information provided by a selected number of host genetic markers and viral factors. There is a continuous decrease of protective factors and an accumulation of risk factors from LTNP-EC to RP. Statistical differences in frequency of protective HLA-B alleles (p-0.01), HLA-C rs9264942 (p-0.06), and protective CCR5/CCR2 haplotypes (p-0.02) across groups, and the presence of viruses with an ancestral genotype in the "viral dating" (i.e., nucleotide sequences with low viral divergence from the most recent common ancestor) support the differences among principal clinical groups of HIV-1 infected individuals. Conclusions: A combination of host genetic and viral factors supports current clinical definitions that discriminate among patterns of HIV-1 progression. The study also emphasizes the need to apply a standardized and accepted set of clinical definitions for the purpose of disease stratification and research.	[Casado, Concepcion; Lopez-Galindez, Cecilio] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Colombo, Sara; Martinez, Raquel; Telenti, Amalio] Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Rauch, Andri] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Guenthard, Huldrych F.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Garcia, Soledad; Rodriguez, Carmen; del Romero, Jorge] IMSALUD Comunidad Autonoma Madrid, Ctr Sanitario Sandoval, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of Lausanne; University of Bern; University Hospital of Bern; University of Bern; University of Zurich	Casado, C (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	amalio.telenti@chuv.ch; clopez@isciii.es	Vandamme, Anne-Mieke/I-4127-2012; Casado, Concepcion/F-3060-2016; Rauch, Andri/E-9948-2017; gunthard, huldrych f/F-1724-2011; Telenti, Amalio/AAY-1674-2021; Lopez-Galindez, Cecilio/A-3603-2008	Vandamme, Anne-Mieke/0000-0002-6594-2766; Casado, Concepcion/0000-0003-3412-2877; Rauch, Andri/0000-0001-5297-6062; gunthard, huldrych f/0000-0002-1142-6723; Lopez-Galindez, Cecilio/0000-0002-2324-9584	Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [36558/06, 36641/07, 36779/08, 360766/09]; Swiss National Science Foundation [33CSC0-108787]; SHCS research foundation;  [SAF 2007-61036]	Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SHCS research foundation; 	CLG is supported by grant SAF 2007-61036, by Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) grant 36558/06, 36641/07, 36779/08, 360766/09 and in part by the Red Tematica Cooperativa de Investigacion en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss). AT is supported by the Swiss National Science Foundation. This work has been partially financed within the framework of the Swiss HIV Cohort Study (SHCS) funded by the Swiss National Science Foundation (grant no# 33CSC0-108787) and by the SHCS research foundation. The funders had no role in study design, data collection and analysisis, decision, or preparation of the manuscript.	Bailey JR, 2007, J INFECT DIS, V196, P50, DOI 10.1086/518515; Bello G, 2005, J GEN VIROL, V86, P355, DOI 10.1099/vir.0.80410-0; Bello G, 2004, ARCH VIROL, V149, P1761, DOI 10.1007/s00705-004-0322-y; Bello G, 2007, VIROLOGY, V362, P294, DOI 10.1016/j.virol.2006.11.039; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Dalmau J, 2009, CLIN INFECT DIS, V48, P229, DOI 10.1086/595704; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; FELLAY J, 2007, WHOLE GENOME ASS STU, P944; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fischer M, 2003, AIDS, V17, P195, DOI 10.1097/00002030-200301240-00009; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; GROENINK M, 1993, SCIENCE, V260, P1513, DOI 10.1126/science.8502996; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hunt PW, 2009, J INFECT DIS, V200, P1636, DOI 10.1086/646610; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Joos B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Sandonis V, 2009, VIROLOGY, V391, P73, DOI 10.1016/j.virol.2009.05.022; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Urban TJ, 2009, NAT MED, V15, P1110, DOI 10.1038/nm1009-1110	30	75	80	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11079	10.1371/journal.pone.0011079	http://dx.doi.org/10.1371/journal.pone.0011079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552027	Green Published, gold, Green Submitted			2022-12-25	WOS:000278662900019
J	Ribelayga, C; Mangel, SC				Ribelayga, Christophe; Mangel, Stuart C.			Identification of a Circadian Clock-Controlled Neural Pathway in the Rabbit Retina	PLOS ONE			English	Article							HORIZONTAL CELLS; MAMMALIAN RETINA; ELECTRICAL SYNAPSES; RESPONSE PROPERTIES; AII AMACRINE; MOUSE RETINA; CONE INPUT; CAT RETINA; ROD; DOPAMINE	Background: Although the circadian clock in the mammalian retina regulates many physiological processes in the retina, it is not known whether and how the clock controls the neuronal pathways involved in visual processing. Methodology/Principal Findings: By recording the light responses of rabbit axonless (A-type) horizontal cells under dark-adapted conditions in both the day and night, we found that rod input to these cells was substantially increased at night under control conditions and following selective blockade of dopamine D(2), but not D(1), receptors during the day, so that the horizontal cells responded to very dim light at night but not in the day. Using neurobiotin tracer labeling, we also found that the extent of tracer coupling between rabbit rods and cones was more extensive during the night, compared to the day, and more extensive in the day following D(2) receptor blockade. Because A-type horizontal cells make synaptic contact exclusively with cones, these observations indicate that the circadian clock in the mammalian retina substantially increases rod input to A-type horizontal cells at night by enhancing rod-cone coupling. Moreover, the clock-induced increase in D(2) receptor activation during the day decreases rod-cone coupling so that rod input to A-type horizontal cells is minimal. Conclusions/Significance: Considered together, these results identify the rod-cone gap junction as a key site in mammals through which the retinal clock, using dopamine activation of D(2) receptors, controls signal flow in the day and night from rods into the cone system.	[Ribelayga, Christophe; Mangel, Stuart C.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Ribelayga, C (corresponding author), Univ Texas Med Sch, Dept Ophthalmol & Visual Sci, Houston, TX USA.	mangel.1@osu.edu			National Institutes of Health [R01 EY005102]; NATIONAL EYE INSTITUTE [R01EY018640, R01EY005102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grant R01 EY005102 to S. C. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Barlow R, 2001, Prog Brain Res, V131, P487; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BLOOMFIELD SA, 1982, J COMP NEUROL, V208, P288, DOI 10.1002/cne.902080306; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Cameron MA, 2009, EUR J NEUROSCI, V29, P761, DOI 10.1111/j.1460-9568.2009.06631.x; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; DMITRIEV AV, J NEUROSCI, V21, P2897; Dowling J. E., 1987, RETINA APPROACHABLE; DOWNING JEG, 1989, J COMP NEUROL, V289, P537, DOI 10.1002/cne.902890402; FAMIGLIETTI EV, 1995, VISUAL NEUROSCI, V12, P1151, DOI 10.1017/S0952523800006799; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Li HY, 2009, J NEUROSCI, V29, P15178, DOI 10.1523/JNEUROSCI.3517-09.2009; LIEBMAN PA, 1964, J OPT SOC AM, V54, P1451, DOI 10.1364/JOSA.54.001451; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Mangel S C, 2001, Prog Brain Res, V131, P505; McMahon D G, 2001, Prog Brain Res, V131, P419; MILLS SL, 1994, VISUAL NEUROSCI, V11, P549, DOI 10.1017/S0952523800002455; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; NELSON R, 1977, J COMP NEUROL, V172, P109, DOI 10.1002/cne.901720106; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; RAVIOLA E, 1983, VISION RES, V23, P1221, DOI 10.1016/0042-6989(83)90097-4; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; RAVIOLA E, 1990, J NEUROCYTOL, V19, P731, DOI 10.1007/BF01188041; Ribelayga C, 2004, J PHYSIOL-LONDON, V554, P467, DOI 10.1113/jphysiol.2003.053710; Ribelayga C, 2003, J COMP NEUROL, V467, P243, DOI 10.1002/cne.10927; Ribelayga C, 2002, J PHYSIOL-LONDON, V544, P801, DOI 10.1113/jphysiol.2002.023671; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; SMITH RG, 1986, J NEUROSCI, V6, P3505; STEINBERG RH, 1969, VISION RES, V9, P1331, DOI 10.1016/0042-6989(69)90070-4; STELL WK, 1975, J COMP NEUROL, V159, P473, DOI 10.1002/cne.901590404; Sterling P., 2004, SYNAPTIC ORG BRAIN, P217; Trexler EB, 2005, J NEUROPHYSIOL, V93, P1476, DOI 10.1152/jn.00597.2004; Wang Y, 1996, P NATL ACAD SCI USA, V93, P4655, DOI 10.1073/pnas.93.10.4655; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Weiler R, 2000, BRAIN RES REV, V32, P121, DOI 10.1016/S0165-0173(99)00071-5; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Xin DY, 1999, J COMP NEUROL, V405, P75, DOI 10.1002/(SICI)1096-9861(19990301)405:1<75::AID-CNE6>3.0.CO;2-D; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105	49	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11020	10.1371/journal.pone.0011020	http://dx.doi.org/10.1371/journal.pone.0011020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548772	Green Submitted, Green Published, gold			2022-12-25	WOS:000278599600001
J	Zimmermann, HW; Seidler, S; Nattermann, J; Gassler, N; Hellerbrand, C; Zernecke, A; Tischendorf, JJW; Luedde, T; Weiskirchen, R; Trautwein, C; Tacke, F				Zimmermann, Henning W.; Seidler, Sebastian; Nattermann, Jacob; Gassler, Nikolaus; Hellerbrand, Claus; Zernecke, Alma; Tischendorf, Jens J. W.; Luedde, Tom; Weiskirchen, Ralf; Trautwein, Christian; Tacke, Frank			Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14(+)CD16(+) Monocytes to Inflammation and Human Liver Fibrosis	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; STELLATE CELLS; BONE-MARROW; IMMUNE PARALYSIS; DENDRITIC CELLS; SUBSETS; CCR2; HETEROGENEITY; MACROPHAGES; ACTIVATION	Background: Monocyte-derived macrophages critically perpetuate inflammatory responses after liver injury as a prerequisite for organ fibrosis. Experimental murine models identified an essential role for the CCR2-dependent infiltration of classical Gr1/Ly6C(+) monocytes in hepatic fibrosis. Moreover, the monocyte-related chemokine receptors CCR1 and CCR5 were recently recognized as important fibrosis modulators in mice. In humans, monocytes consist of classical CD14(+)CD16(-) and non-classical CD14(+)CD16(+) cells. We aimed at investigating the relevance of monocyte subpopulations for human liver fibrosis, and hypothesized that 'non-classical' monocytes critically exert inflammatory as well as profibrogenic functions in patients during liver disease progression. Methodology/Principal Findings: We analyzed circulating monocyte subsets from freshly drawn blood samples of 226 patients with chronic liver disease (CLD) and 184 healthy controls by FACS analysis. Circulating monocytes were significantly expanded in CLD-patients compared to controls with a marked increase of the non-classical CD14(+)CD16(+) subset that showed an activated phenotype in patients and correlated with proinflammatory cytokines and clinical progression. Correspondingly, CD14(+)CD16(+) macrophages massively accumulated in fibrotic/cirrhotic livers, as evidenced by immunofluorescence and FACS. Ligands of monocyte-related chemokine receptors CCR2, CCR1 and CCR5 were expressed at higher levels in fibrotic and cirrhotic livers, while CCL3 and CCL4 were also systemically elevated in CLD-patients. Isolated monocyte/macrophage subpopulations were functionally characterized regarding cytokine/chemokine expression and interactions with primary human hepatic stellate cells (HSC) in vitro. CD14(+)CD16(+) monocytes released abundant proinflammatory cytokines. Furthermore, CD14(+)CD16(+), but not CD14(+)CD16-monocytes could directly activate collagen-producing HSC. Conclusions/Significance: Our data demonstrate the expansion of CD14(+)CD16(+) monocytes in the circulation and liver of CLD-patients upon disease progression and suggest their functional contribution to the perpetuation of intrahepatic inflammation and profibrogenic HSC activation in liver cirrhosis. The modulation of monocyte-subset recruitment into the liver via chemokines/chemokine receptors and their subsequent differentiation may represent promising approaches for therapeutic interventions in human liver fibrosis.	[Zimmermann, Henning W.; Seidler, Sebastian; Tischendorf, Jens J. W.; Luedde, Tom; Trautwein, Christian; Tacke, Frank] Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Nattermann, Jacob] Univ Bonn, Dept Med 1, D-5300 Bonn, Germany; [Gassler, Nikolaus] Univ Hosp Aachen, Inst Pathol, Aachen, Germany; [Hellerbrand, Claus] Univ Regensburg, Dept Med 1, Regensburg, Germany; [Zernecke, Alma] Univ Hosp Aachen, Inst Mol Cardiovasc Res, Aachen, Germany; [Weiskirchen, Ralf] Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Bonn; RWTH Aachen University; RWTH Aachen University Hospital; University of Regensburg; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Zimmermann, HW (corresponding author), Univ Hosp Aachen, Dept Med 3, Aachen, Germany.	frank.tacke@gmx.net	Luedde, Tom/AAE-9135-2022; Tacke, Frank/ABF-2212-2020; Weiskirchen, Ralf/O-1734-2018	Luedde, Tom/0000-0002-6288-8821; Weiskirchen, Ralf/0000-0003-3888-0931	German Research Foundation [DFG Ta434/2-1, DFG SFB/TRR 57]; START-Program; Interdisciplinary Centre for Clinical Research (IZKF), Faculty of Medicine at the RWTH Aachen University	German Research Foundation(German Research Foundation (DFG)); START-Program(Austrian Science Fund (FWF)); Interdisciplinary Centre for Clinical Research (IZKF), Faculty of Medicine at the RWTH Aachen University	This work was supported by the German Research Foundation (DFG Ta434/2-1 to F. T., DFG SFB/TRR 57), by the START-Program and the Interdisciplinary Centre for Clinical Research (IZKF) within the Faculty of Medicine at the RWTH Aachen University (to H.W.Z and F. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hellerbrand C, 1996, HEPATOLOGY, V24, P670; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; Imamura M, 2005, GASTROENTEROLOGY, V128, P138, DOI 10.1053/j.gastro.2004.10.005; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Leicester KL, 2006, LIVER INT, V26, P559, DOI 10.1111/j.1478-3231.2006.01255.x; Lin CY, 2007, J HEPATOL, V46, P816, DOI 10.1016/j.jhep.2006.12.018; Marra F, 1998, AM J PATHOL, V152, P423; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Panasiuk A, 2005, WORLD J GASTROENTERO, V11, P2754, DOI 10.3748/wjg.v11.i18.2754; Roderfeld M, 2010, HEPATOLOGY, V51, P267, DOI 10.1002/hep.23274; SAKAGAMI M, 2006, J LARYNGOL OTOL, V14, P1; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Tacke F, 2003, J HEPATOL, V38, P447, DOI 10.1016/S0168-8278(02)00438-5; Tacke F, 2007, DIGEST DIS SCI, V52, P3404, DOI 10.1007/s10620-007-9758-8; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	37	234	244	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11049	10.1371/journal.pone.0011049	http://dx.doi.org/10.1371/journal.pone.0011049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548789	Green Submitted, Green Published, gold			2022-12-25	WOS:000278599600010
J	Gurevich, V; Kassir, Y				Gurevich, Vyacheslav; Kassir, Yona			A Switch from a Gradient to a Threshold Mode in the Regulation of a Transcriptional Cascade Promotes Robust Execution of Meiosis in Budding Yeast	PLOS ONE			English	Article							MEIOTIC RECOMBINATION CHECKPOINT; PREMEIOTIC DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; MIDDLE SPORULATION; NEGATIVE FEEDBACK; S-PHASE; PACHYTENE CHECKPOINT; HISTONE DEACETYLASE; POSITIVE REGULATOR; GENE-EXPRESSION	Tight regulation of developmental pathways is of critical importance to all organisms, and is achieved by a transcriptional cascade ensuring the coordinated expression of sets of genes. We aimed to explore whether a strong signal is required to enter and complete a developmental pathway, by using meiosis in budding yeast as a model. We demonstrate that meiosis in budding yeast is insensitive to drastic changes in the levels of its consecutive positive regulators (Ime1, Ime2, and Ndt80). Entry into DNA replication is not correlated with the time of transcription of the early genes that regulate this event. Entry into nuclear division is directly regulated by the time of transcription of the middle genes, as premature transcription of their activator NDT80, leads to a premature entry into the first meiotic division, and loss of coordination between DNA replication and nuclear division. We demonstrate that Cdk1/Cln3 functions as a negative regulator of Ime2, and that ectopic expression of Cln3 delays entry into nuclear division as well as NDT80 transcription. Because Ime2 functions as a positive regulator for premeiotic DNA replication and NDT80 transcription, as well as a negative regulator of Cdk/Cln, we suggest that a double negative feedback loop between Ime2 and Cdk1/Cln3 promotes a bistable switch from the cell cycle to meiosis. Moreover, our results suggest a regulatory mode switch that ensures robust meiosis as the transcription of the early meiosis-specific genes responds in a graded mode to Ime1 levels, whereas that of the middle and late genes as well as initiation of DNA replication, are regulated in a threshold mode.	[Gurevich, Vyacheslav; Kassir, Yona] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Gurevich, V (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	ykassir@tx.technion.ac.il						Baugh LR, 2005, DEVELOPMENT, V132, P1843, DOI 10.1242/dev.01782; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bolte M, 2002, P NATL ACAD SCI USA, V99, P4385, DOI 10.1073/pnas.072385099; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, SCIENCE, V282, P1421; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Colomina N, 1999, EMBO J, V18, P320, DOI 10.1093/emboj/18.2.320; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Foiani M, 1996, MOL GEN GENET, V253, P278, DOI 10.1007/s004380050323; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Guttmann-Raviv N, 2001, GENETICS, V159, P1547; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Leu JY, 1999, MOL CELL, V4, P805, DOI 10.1016/S1097-2765(00)80390-1; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Pak J, 2002, MOL CELL BIOL, V22, P6430, DOI 10.1128/MCB.22.18.6430-6440.2002; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Raithatha SA, 2005, GENETICS, V169, P1329, DOI 10.1534/genetics.104.036103; Raithatha SA, 2008, YEAST, V25, P259, DOI 10.1002/yea.1585; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Rose MD., 1990, METHODS YEAST GENETI; Rubinstein A, 2007, P NATL ACAD SCI USA, V104, P6241, DOI 10.1073/pnas.0611168104; Schindler K, 2003, MOL CELL BIOL, V23, P8718, DOI 10.1128/MCB.23.23.8718-8728.2003; Schindler K, 2006, J BIOL CHEM, V281, P18307, DOI 10.1074/jbc.M602349200; SHEFERVAIDA M, 1995, DEV GENET, V16, P219, DOI 10.1002/dvg.1020160302; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; Sopko R, 2002, MOL CELL BIOL, V22, P7024, DOI 10.1128/MCB.22.20.7024-7040.2002; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Szwarcwort-Cohen M, 2009, CELL CYCLE, V8, P647, DOI 10.4161/cc.8.4.7843; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Xing JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002140	48	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11005	10.1371/journal.pone.0011005	http://dx.doi.org/10.1371/journal.pone.0011005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543984	Green Published, Green Submitted, gold			2022-12-25	WOS:000278494900017
J	Varghese, V; Wang, E; Babrzadeh, F; Bachmann, MH; Shahriar, R; Liu, T; Mappala, SJM; Gharizadeh, B; Fessel, WJ; Katzenstein, D; Kassaye, S; Shafer, RW				Varghese, Vici; Wang, Elijah; Babrzadeh, Farbod; Bachmann, Michael H.; Shahriar, Rajin; Liu, Tommy; Mappala, Svetlana Jean M.; Gharizadeh, Baback; Fessel, W. Jeffrey; Katzenstein, David; Kassaye, Seble; Shafer, Robert W.			Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; SUBTYPE-C; K65R RESISTANCE; PROTEASE; POSITIONS; TENOFOVIR	Background: The HIV-1 nucleoside RT inhibitor (NRTI)-resistance mutation, K65R confers intermediate to high-level resistance to the NRTIs abacavir, didanosine, emtricitabine, lamivudine, and tenofovir; and low-level resistance to stavudine. Several lines of evidence suggest that K65R is more common in HIV-1 subtype C than subtype B viruses. Methods and Findings: We performed ultra-deep pyrosequencing (UDPS) and clonal dideoxynucleotide sequencing of plasma virus samples to assess the prevalence of minority K65R variants in subtype B and C viruses from untreated individuals. Although UDPS of plasma samples from 18 subtype C and 27 subtype B viruses showed that a higher proportion of subtype C viruses contain K65R (1.04% vs. 0.25%; p < 0.001), limiting dilution clonal sequencing failed to corroborate its presence in two of the samples in which K65R was present in >1.5% of UDPS reads. We therefore performed UDPS on clones and site-directed mutants containing subtype B- and C-specific patterns of silent mutations in the conserved KKK motif encompassing RT codons 64 to 66 and found that subtype-specific nucleotide differences were responsible for increased PCR-induced K65R mutation in subtype C viruses. Conclusions: This study shows that the RT KKK nucleotide template in subtype C viruses can lead to the spurious detection of K65R by highly sensitive PCR-dependent sequencing techniques. However, the study is also consistent with the subtype C nucleotide template being inherently responsible for increased polymerization-induced K65R mutations in vivo.	[Varghese, Vici; Shahriar, Rajin; Liu, Tommy; Mappala, Svetlana Jean M.; Katzenstein, David; Kassaye, Seble; Shafer, Robert W.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Wang, Elijah; Babrzadeh, Farbod; Gharizadeh, Baback] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Bachmann, Michael H.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Fessel, W. Jeffrey] Kaiser Permanente Med Care Program No Calif, Clin Trials Unit, San Francisco, CA USA	Stanford University; Stanford University; Stanford University; Kaiser Permanente	Varghese, V (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	viciv@stanford.edu	Bachmann, Michael Hubertus/N-9339-2016	Bachmann, Michael Hubertus/0000-0002-0204-3720; katzenstein, david/0000-0002-8593-4560; varghese, vici/0000-0003-2669-5966	NIH [AI46148]; California HIV Research Program [D08-ST-033]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066922, R01AI046148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	VV, TL, MHB, SJM, and RWS were supported by NIH grants AI46148. VV and RWS were also partly supported by grant D08-ST-033 from the California HIV Research Program [D08-ST-033]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Gallant JE, 2005, J INFECT DIS, V192, P1921, DOI 10.1086/498069; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Harrigan PR, 2008, AIDS, V22, P2501, DOI 10.1097/QAD.0b013e328318f16c; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Invernizzi CF, 2009, J INFECT DIS, V200, P1202, DOI 10.1086/605894; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Learn GH, 1996, J VIROL, V70, P5720, DOI 10.1128/JVI.70.8.5720-5730.1996; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Parikh UM, 2005, ANTIMICROB AGENTS CH, V49, P1139, DOI 10.1128/AAC.49.3.1139-1144.2005; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Shafer RW, 2001, J CLIN MICROBIOL, V39, P1522, DOI 10.1128/JCM.39.4.1522-1529.2001; TURNER D, 2004, ANTIVIR THER, V9, pS99	16	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10992	10.1371/journal.pone.0010992	http://dx.doi.org/10.1371/journal.pone.0010992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539818	Green Published, gold, Green Submitted			2022-12-25	WOS:000278465900010
J	Collings, CK; Fernandez, AG; Pitschka, CG; Hawkins, TB; Anderson, JN				Collings, Clayton K.; Fernandez, Alfonso G.; Pitschka, Chad G.; Hawkins, Troy B.; Anderson, John N.			Oligonucleotide Sequence Motifs as Nucleosome Positioning Signals	PLOS ONE			English	Article							DEPENDENT DNA-STRUCTURE; T-G-G; HIGH-RESOLUTION; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL MAPS; DINUCLEOTIDE STEPS; HUMAN GENOME; CORE DNA; B-DNA	To gain a better understanding of the sequence patterns that characterize positioned nucleosomes, we first performed an analysis of the periodicities of the 256 tetranucleotides in a yeast genome-wide library of nucleosomal DNA sequences that was prepared by in vitro reconstitution. The approach entailed the identification and analysis of 24 unique tetranucleotides that were defined by 8 consensus sequences. These consensus sequences were shown to be responsible for most if not all of the tetranucleotide and dinucleotide periodicities displayed by the entire library, demonstrating that the periodicities of dinucleotides that characterize the yeast genome are, in actuality, due primarily to the 8 consensus sequences. A novel combination of experimental and bioinformatic approaches was then used to show that these tetranucleotides are important for preferred formation of nucleosomes at specific sites along DNA in vitro. These results were then compared to tetranucleotide patterns in genome-wide in vivo libraries from yeast and C. elegans in order to assess the contributions of DNA sequence in the control of nucleosome residency in the cell. These comparisons revealed striking similarities in the tetranucleotide occurrence profiles that are likely to be involved in nucleosome positioning in both in vitro and in vivo libraries, suggesting that DNA sequence is an important factor in the control of nucleosome placement in vivo. However, the strengths of the tetranucleotide periodicities were 3-4 fold higher in the in vitro as compared to the in vivo libraries, which implies that DNA sequence plays less of a role in dictating nucleosome positions in vivo. The results of this study have important implications for models of sequence-dependent positioning since they suggest that a defined subset of tetranucleotides is involved in preferred nucleosome occupancy and that these tetranucleotides are the major source of the dinucleotide periodicities that are characteristic of positioned nucleosomes.	[Collings, Clayton K.; Pitschka, Chad G.; Anderson, John N.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Fernandez, Alfonso G.] NCI, NIH, Bethesda, MD 20892 USA; [Hawkins, Troy B.] Indiana Univ Purdue Univ, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Indiana University System; Indiana University-Purdue University Indianapolis	Collings, CK (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	andersjn@purdue.edu			Department of Biological Sciences at Purdue University;  [R01LM8626]; NATIONAL LIBRARY OF MEDICINE [R01LM008626] Funding Source: NIH RePORTER	Department of Biological Sciences at Purdue University; ; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The Department of Biological Sciences at Purdue University provided the sources of funding that have supported the project. http://www.bio.purdue.edu/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the two anonymous reviewers for helpful suggestions and Dr. Peter Waddell for the use of computing resources, which were funded by R01LM8626 and used for the analysis of the C. elegans data.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Caserta M, 2009, NUCLEIC ACIDS RES, V37, P5309, DOI 10.1093/nar/gkp574; Choi JK, 2009, NAT GENET, V41, P498, DOI 10.1038/ng.319; Chung HR, 2009, J MOL BIOL, V386, P1411, DOI 10.1016/j.jmb.2008.11.049; COSTANZO G, 1990, J MOL BIOL, V216, P363, DOI 10.1016/S0022-2836(05)80327-4; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; ElHassan MA, 1997, PHILOS T R SOC A, V355, P43, DOI 10.1098/rsta.1997.0002; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fitzgerald DJ, 1999, J MOL BIOL, V293, P477, DOI 10.1006/jmbi.1999.3171; FITZGERALD DJ, 1994, J BIOL CHEM, V269, P21303; Fitzgerald DJ, 1998, NUCLEIC ACIDS RES, V26, P2526, DOI 10.1093/nar/26.11.2526; Fitzgerald DJ, 1999, J BIOL CHEM, V274, P27128, DOI 10.1074/jbc.274.38.27128; FITZGERALD DJ, 1999, GENE THEOR MOL BIOL, V4, P349; Gardiner EJ, 2003, J MOL BIOL, V332, P1025, DOI 10.1016/j.jmb.2003.08.006; GOODSELL DS, 1994, J MOL BIOL, V239, P79, DOI 10.1006/jmbi.1994.1352; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; HSIEH CH, 1988, CELL, V52, P535, DOI 10.1016/0092-8674(88)90466-7; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu HD, 2008, BIOPHYS J, V94, P4597, DOI 10.1529/biophysj.107.117028; LOWMAN H, 1990, BIOPOLYMERS, V30, P861, DOI 10.1002/bip.360300902; MAVRICH TN, 2008, NATURE, V45; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; PRIVE GG, 1991, J MOL BIOL, V217, P177, DOI 10.1016/0022-2836(91)90619-H; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; RHODES D, 1979, NUCLEIC ACIDS RES, V6, P1805, DOI 10.1093/nar/6.5.1805; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Salih F, 2007, J BIOMOL STRUCT DYN, V24, P489, DOI 10.1080/07391102.2007.10507137; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schnitzler GR, 2008, CELL BIOCHEM BIOPHYS, V51, P67, DOI 10.1007/s12013-008-9015-6; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Scipioni A, 2004, BIOPHYS CHEM, V107, P7, DOI 10.1016/S0301-4622(03)00214-X; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Segal MR, 2008, STAT APPL GENET MOL, V7; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Steffen N R, 2002, Bioinformatics, V18 Suppl 1, pS22; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Urpi L, 1996, NAT STRUCT BIOL, V3, P325, DOI 10.1038/nsb0496-325; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; van Holde KE., 1989, SPRINGER SERIES MOL; van Vugt JJFA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006345; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	72	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10933	10.1371/journal.pone.0010933	http://dx.doi.org/10.1371/journal.pone.0010933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532171	Green Published, Green Submitted, gold			2022-12-25	WOS:000278318700007
J	Homeier, T; Semmler, T; Wieler, LH; Ewers, C				Homeier, Timo; Semmler, Torsten; Wieler, Lothar H.; Ewers, Christa			The GimA Locus of Extraintestinal Pathogenic E. coli: Does Reductive Evolution Correlate with Habitat and Pathotype?	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CELLS IN-VITRO; ENTEROCYTE EFFACEMENT; GENE LOCUS; STRAINS; INVASION; ISLANDS; CONTRIBUTES; IDENTIFICATION; VIRULENCE	IbeA (invasion of brain endothelium), which is located on a genomic island termed GimA, is involved in the pathogenesis of several extraintestinal pathogenic E. coli (ExPEC) pathotypes, including newborn meningitic E. coli (NMEC) and avian pathogenic E. coli (APEC). To unravel the phylogeny of GimA and to investigate its island character, the putative insertion locus of GimA was determined via Long Range PCR and DNA-DNA hybridization in 410 E. coli isolates, including APEC, NMEC, uropathogenic (UPEC), septicemia-associated E. coli (SEPEC), and human and animal fecal isolates as well as in 72 strains of the E. coli reference (ECOR) collection. In addition to a complete GimA (similar to 20.3 kb) and a locus lacking GimA we found a third pattern containing a 342 bp remnant of GimA in this strain collection. The presence of GimA was almost exclusively detected in strains belonging to phylogenetic group B2. In addition, the complete GimA was significantly more frequent in APEC and NMEC strains while the GimA remnant showed a higher association with UPEC strains. A detailed analysis of the ibeA sequences revealed the phylogeny of this gene to be consistent with that obtained by Multi Locus Sequence Typing of the strains. Although common criteria for genomic islands are partially fulfilled, GimA rather seems to be an ancestral part of phylogenetic group B2, and it would therefore be more appropriate to term this genomic region GimA locus instead of genomic island. The existence of two other patterns reflects a genomic rearrangement in a reductive evolution-like manner.	[Homeier, Timo; Semmler, Torsten; Wieler, Lothar H.; Ewers, Christa] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, D-1000 Berlin, Germany; [Homeier, Timo] Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, Fac Vet Med, Leipzig, Germany	Free University of Berlin; Leipzig University	Homeier, T (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, D-1000 Berlin, Germany.	ewers.christa@vetmed.fu-berlin.de	Ewers, Christa/AAL-9186-2020; Semmler, Torsten/O-9540-2019; Semmler, Torsten/Q-7716-2018	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Wieler, Lothar H./0000-0003-4365-3717; Ewers, Christa/0000-0001-6167-1340	German Research Foundation [DFG-WI1436/5-3]; Federal Ministry of Education and Research (FBI-Zoo) [01KI07120]; Studienstiftung des Deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research (FBI-Zoo)(Federal Ministry of Education & Research (BMBF)); Studienstiftung des Deutschen Volkes	Financial support was provided by the German Research Foundation (DFG-WI1436/5-3) and the Federal Ministry of Education and Research (FBI-Zoo, 01KI07120). TH was supported by a grant of the Studienstiftung des Deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Antao EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007796; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonacorsi S, 2005, INT J MED MICROBIOL, V295, P373, DOI 10.1016/j.ijmm.2005.07.011; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chi F, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/520283; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Culham DE, 2000, J BACTERIOL, V182, P6272, DOI 10.1128/JB.182.21.6272-6276.2000; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; GROSS RJ, 1983, J HYG-CAMBRIDGE, V90, P195, DOI 10.1017/S0022172400028850; Gross W. G., 1994, P237; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hejnova J, 2005, MICROBIOL-SGM, V151, P385, DOI 10.1099/mic.0.27469-0; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Hoffman JA, 2000, INFECT IMMUN, V68, P5062, DOI 10.1128/IAI.68.9.5062-5067.2000; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Huang Sheng-he, 2001, Functional and Integrative Genomics, V1, P312, DOI 10.1007/s101420100039; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Jores J, 2004, INT J MED MICROBIOL, V294, P103, DOI 10.1016/j.ijmm.2004.06.024; Jores J, 2001, FEMS MICROBIOL LETT, V204, P75, DOI 10.1111/j.1574-6968.2001.tb10866.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2002, J INFECT DIS, V186, pS220, DOI 10.1086/344284; Leib SL, 1999, INFECT DIS CLIN N AM, V13, P527, DOI 10.1016/S0891-5520(05)70093-3; Meseguer MA, 2003, INFECT GENET EVOL, V3, P47, DOI 10.1016/S1567-1348(02)00151-X; Mora A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-132; Mordhorst IL, 2009, ENVIRON MICROBIOL, V11, P3154, DOI 10.1111/j.1462-2920.2009.02019.x; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Sandner L, 2001, MICROBIOL-SGM, V147, P3149, DOI 10.1099/00221287-147-11-3149; Sankar TS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000405; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Tamames J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r94; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA T, 1989, MOL BIOL EVOL, V6, P447; Tartof SY, 2007, J MED MICROBIOL, V56, P1363, DOI 10.1099/jmm.0.47262-0; Threlfall EJ, 1998, INT J ANTIMICROB AG, V9, P201, DOI 10.1016/S0924-8579(97)00055-1; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Wang DD, 2001, J BACTERIOL, V183, P4210, DOI 10.1128/JB.183.14.4210-4216.2001; Wang Y, 1999, INFECT IMMUN, V67, P4751, DOI 10.1128/IAI.67.9.4751-4756.1999; Weissman SJ, 2006, MOL MICROBIOL, V59, P975, DOI 10.1111/j.1365-2958.2005.04985.x; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zhang R, 2004, BIOINFORMATICS, V20, P612, DOI 10.1093/bioinformatics/btg453; Zou YM, 2008, MED MICROBIOL IMMUN, V197, P337, DOI 10.1007/s00430-007-0065-y	69	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10877	10.1371/journal.pone.0010877	http://dx.doi.org/10.1371/journal.pone.0010877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526361	gold, Green Published, Green Submitted			2022-12-25	WOS:000278222100008
J	Liao, CZ; Luo, YQ; Fang, CM; Li, B				Liao, Chengzhang; Luo, Yiqi; Fang, Changming; Li, Bo			Ecosystem Carbon Stock Influenced by Plantation Practice: Implications for Planting Forests as a Measure of Climate Change Mitigation	PLOS ONE			English	Article							SOIL CARBON; PINE PLANTATIONS; LAND-USE; TREE PLANTATIONS; SOUTHERN CHINA; CONVERSION; STORAGE; NITROGEN; METAANALYSIS; DYNAMICS	Uncertainties remain in the potential of forest plantations to sequestrate carbon (C). We synthesized 86 experimental studies with paired-site design, using a meta-analysis approach, to quantify the differences in ecosystem C pools between plantations and their corresponding adjacent primary and secondary forests (natural forests). Totaled ecosystem C stock in plant and soil pools was 284 Mg C ha(-1) in natural forests and decreased by 28% in plantations. In comparison with natural forests, plantations decreased aboveground net primary production, litterfall, and rate of soil respiration by 11, 34, and 32%, respectively. Fine root biomass, soil C concentration, and soil microbial C concentration decreased respectively by 66, 32, and 29% in plantations relative to natural forests. Soil available N, P and K concentrations were lower by 22, 20 and 26%, respectively, in plantations than in natural forests. The general pattern of decreased ecosystem C pools did not change between two different groups in relation to various factors: stand age (<25 years vs. <= 25 years), stand types (broadleaved vs. coniferous and deciduous vs. evergreen), tree species origin (native vs. exotic) of plantations, land-use history (afforestation vs. reforestation) and site preparation for plantations (unburnt vs. burnt), and study regions (tropic vs. temperate). The pattern also held true across geographic regions. Our findings argued against the replacement of natural forests by the plantations as a measure of climate change mitigation.	[Liao, Chengzhang; Luo, Yiqi; Fang, Changming; Li, Bo] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Coastal Ecosyst Res Stn Yangtze River Estuary,Min, Shanghai 200433, Peoples R China; [Luo, Yiqi] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	Fudan University; University of Oklahoma System; University of Oklahoma - Norman	Liao, CZ (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Coastal Ecosyst Res Stn Yangtze River Estuary,Min, Shanghai 200433, Peoples R China.	031023079@fudan.edu.cn	Li, Bo/B-8016-2010; Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-0439-5666; Li, Bo/0000-0002-7294-6888	National Basic Research Program of China [2006CB403305]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (grant no. 2006CB403305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo CBM, 2009, FOREST ECOL MANAG, V257, P1776, DOI 10.1016/j.foreco.2009.01.034; Ashagrie Y, 2005, AGR ECOSYST ENVIRON, V106, P89, DOI 10.1016/j.agee.2004.07.015; Berg B., 2003, DECOMPOSITION PROCES; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Borken W, 2003, GLOBAL CHANGE BIOL, V9, P956, DOI 10.1046/j.1365-2486.2003.00631.x; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen GS, 2005, ANN FOREST SCI, V62, P659, DOI 10.1051/forest:2005073; Chen Sha, 2007, Zhiwu Shengtai Xuebao, V31, P431; Cromack K, 1999, SOIL SCI SOC AM J, V63, P232, DOI 10.2136/sssaj1999.03615995006300010034x; CUEVAS E, 1991, PLANT SOIL, V135, P257, DOI 10.1007/BF00010914; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Goma-Tchimbakala J, 2006, FOREST ECOL MANAG, V229, P304, DOI 10.1016/j.foreco.2006.04.009; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; HARMON ME, 1990, SCIENCE, V247, P699, DOI 10.1126/science.247.4943.699; Ishizuka S, 2005, NUTR CYCL AGROECOSYS, V71, P17, DOI 10.1007/s10705-004-0382-0; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Kasel S, 2007, GEODERMA, V137, P401, DOI 10.1016/j.geoderma.2006.09.002; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Lemenih M, 2004, FOREST ECOL MANAG, V194, P1, DOI 10.1016/j.foreco.2004.01.050; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; LIAO CZ, 2010, GLOBAL CHAN IN PRESS; Liu S., 1997, WETLANDS ECOLOGY MAN, V4, P257; Livesley SJ, 2009, GLOBAL CHANGE BIOL, V15, P425, DOI 10.1111/j.1365-2486.2008.01759.x; Luo Yand, 2006, SOIL RESP ENV; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Luo Yun-jian, 2006, Forest Research, V19, P791; Morishita T, 2007, SOIL SCI PLANT NUTR, V53, P678, DOI 10.1111/j.1747-0765.2007.00181.x; NIHLGARD B, 1972, OIKOS, V23, P69, DOI 10.2307/3543928; Ordonez JAB, 2008, FOREST ECOL MANAG, V255, P2074, DOI 10.1016/j.foreco.2007.12.024; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Pypker TG, 2005, AGR FOREST METEOROL, V130, P113, DOI 10.1016/j.agrformet.2005.03.003; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Smith CK, 2002, FOREST ECOL MANAG, V164, P257, DOI 10.1016/S0378-1127(01)00599-0; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Tateno R, 2007, FOREST ECOL MANAG, V241, P84, DOI 10.1016/j.foreco.2006.12.026; van Dijk AIJM, 2007, FOREST ECOL MANAG, V251, P1, DOI 10.1016/j.foreco.2007.06.010; Wall A, 2005, PLANT SOIL, V275, P247, DOI 10.1007/s11104-005-1869-4; Winjum JK, 1997, AGR FOREST METEOROL, V84, P153, DOI 10.1016/S0168-1923(96)02383-0; Yang YS, 2005, FOREST ECOL MANAG, V216, P216, DOI 10.1016/j.foreco.2005.05.030; Zheng H, 2008, FOREST ECOL MANAG, V255, P1113, DOI 10.1016/j.foreco.2007.10.015	40	96	103	8	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10867	10.1371/journal.pone.0010867	http://dx.doi.org/10.1371/journal.pone.0010867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523733	Green Published, gold			2022-12-25	WOS:000278221900015
J	Tondo, ML; Petrocelli, S; Ottado, J; Orellano, EG				Laura Tondo, Maria; Petrocelli, Silvana; Ottado, Jorgelina; Orellano, Elena G.			The Monofunctional Catalase KatE of Xanthomonas axonopodis pv. citri Is Required for Full Virulence in Citrus Plants	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; SUPEROXIDE-DISMUTASE; GROWTH-PHASE; HRP CLUSTER; OXYGEN; PHYTOPATHOGEN; VESICATORIA; EXPRESSION; RESISTANCE; RESPONSES	Background: Xanthomonas axonopodis pv. citri (Xac) is an obligate aerobic phytopathogen constantly exposed to hydrogen peroxide produced by normal aerobic respiration and by the plant defense response during plant-pathogen interactions. Four putative catalase genes have been identified in silico in the Xac genome, designated as katE, catB, srpA (monofunctional catalases) and katG (bifunctional catalase). Methodology/Principal Findings: Xac catalase activity was analyzed using native gel electrophoresis and semi-quantitative RT-PCR. We demonstrated that the catalase activity pattern was regulated in different growth stages displaying the highest levels during the stationary phase. KatE was the most active catalase in this phase of growth. At this stage cells were more resistant to hydrogen peroxide as was determined by the analysis of CFU after the exposition to different H2O2 concentrations. In addition, Xac exhibited an adaptive response to hydrogen peroxide, displaying higher levels of catalase activity and H2O2 resistance after treatment with sub-lethal concentrations of the oxidant. In the plant-like medium XVM2 the expression of KatE was strongly induced and in this medium Xac was more resistant to H2O2. A XackatE mutant strain was constructed by insertional mutagenesis. We observed that catalase induction in stationary phase was lost meanwhile the adaptive response to peroxide was maintained in this mutant. Finally, the XackatE strain was assayed in planta during host plant interaction rendering a less aggressive phenotype with a minor canker formation. Conclusions: Our results confirmed that in contrast to other Xanthomonas species, Xac catalase-specific activity is induced during the stationary phase of growth in parallel with the bacterial resistance to peroxide challenge. Moreover, Xac catalases expression pattern is modified in response to any stimuli associated with the plant or the microenvironment it provides. The catalase KatE has been shown to have an important function for the colonization and survival of the bacterium in the citrus plant during the pathogenic process. Our work provides the first genetic evidence to support a monofunctional catalase as a virulence factor in Xac.	[Laura Tondo, Maria; Petrocelli, Silvana; Ottado, Jorgelina; Orellano, Elena G.] Univ Nacl Rosario, Div Mol Biol, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn,Inst Biol Mol &, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Tondo, ML (corresponding author), Univ Nacl Rosario, Div Mol Biol, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn,Inst Biol Mol &, RA-2000 Rosario, Santa Fe, Argentina.	orellano@ibr.gov.ar		Tondo, Maria Laura/0000-0002-0160-1882	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 01-12783]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	Funding: This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 01-12783 to Elena G. Orellano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EGO and JO are staff members and MLT and SP are Fellows of the Consejo Nacional de Investigaciones Cienti-ficas y Tecnologicas Tecnicas (CONICET, Argentina).	BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; BEERS RF, 1952, J BIOL CHEM, V195, P133; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Cabiscol Elisa, 2000, International Microbiology, V3, P3; CHAMNONGPOL S, 1995, APPL ENVIRON MICROB, V61, P393, DOI 10.1128/AEM.61.1.393-396.1995; Chauvatcharin N, 2003, CURR MICROBIOL, V46, P83, DOI 10.1007/s00284-002-3812-8; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Hanyu M, 2009, J BACTERIOL, V191, P1463, DOI 10.1128/JB.01583-08; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; KLOTZ MG, 1992, APPL ENVIRON MICROB, V58, P2468, DOI 10.1128/AEM.58.8.2468-2473.1992; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LOEWEN PC, 1997, OXIDATIVE STRESS MOL, P273; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mongkolsuk S, 1997, FEMS MICROBIOL LETT, V146, P217, DOI 10.1111/j.1574-6968.1997.tb10196.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCANDALIOS JG, 1968, ANN NY ACAD SCI, V151, P274, DOI 10.1111/j.1749-6632.1968.tb11896.x; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SWITALA J, 1990, CAN J MICROBIOL, V36, P728, DOI 10.1139/m90-123; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Vattanaviboon P, 2000, GENE, V241, P259, DOI 10.1016/S0378-1119(99)00483-7; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996	34	50	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10803	10.1371/journal.pone.0010803	http://dx.doi.org/10.1371/journal.pone.0010803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20520822	Green Submitted, gold, Green Published			2022-12-25	WOS:000278034600022
J	Azzi, J; Tang, L; Moore, R; Tong, R; El Haddad, N; Akiyoshi, T; Mfarrej, B; Yang, SM; Jurewicz, M; Ichimura, T; Lindeman, N; Cheng, JJ; Abdi, R				Azzi, Jamil; Tang, Li; Moore, Robert; Tong, Rong; El Haddad, Najib; Akiyoshi, Takurin; Mfarrej, Bechara; Yang, Sunmi; Jurewicz, Mollie; Ichimura, Takaharu; Lindeman, Neal; Cheng, Jianjun; Abdi, Reza			Polylactide-cyclosporin A nanoparticles for targeted immunosuppression	FASEB JOURNAL			English	Article						CsA toxicity; dendritic cells; targeted delivery	DENDRITIC CELLS; DRUG-DELIVERY; BIODEGRADABLE NANOPARTICLES; FORMULATION; POLYMERIZATION; BIODISTRIBUTION; TRANSPLANTATION; LACTIDE	Polymeric nanoparticles (NPs), prepared via coprecipitation of drugs and polymers, are promising drug delivery vehicles for treating diseases with improved efficacy and reduced toxicity. Here, we report an unprecedented strategy for preparing polylactide-cyclosporine A (PLA-CsA) NPs (termed CsA-NPs) through CsA-initiated ring-opening polymerization of lactide (LA) followed by nanoprecipitation. The resulting CsA-NPs have sub-100 nm sizes and narrow particle size distributions, and release CsA in a sustained manner without a "burst"-release effect. Both free CsA and CsA-NPs displayed comparable suppression of T-cell proliferation and production of inflammatory cytokines in various T-cell assays in a dose-dependent manner. The IC50 values for CsA and CsA-NPs were 27.5 and 72.0 ng/ml, respectively. As lymph nodes are the main loci for T-cell activation, we coupled dendritic cells (DCs) with CsA-NPs and successfully delivered CsA selectively to the lymph nodes. Our studies indicated that CsA-NPs could be internalized in the DCs with a sustained release of CsA to the culture medium, suppressing alloreactive T-cell proliferation. Allogeneic DCs loaded with CsA-NPs were able to migrate to the draining lymph nodes where the T-cell priming was significantly reduced without any systemic release. This innovative nanoparticulate CsA delivery technology constitutes a strong basis for future targeted delivery of immunosuppressive drugs with improved efficiency and reduced toxicity.-Azzi, J., Tang, L., Tong, R., El Haddad, N., Akiyoshi, T., Mfarrej, B., Moore, R., Yang, S., Jurewicz, M., Ichimura, T., Lindeman, N., Cheng, J., Abdi, R. Polylactide-cyclosporin A nanoparticles for targeted immunosuppression. FASEB J. 24, 3927-3938 (2010). www.fasebj.org	[Azzi, Jamil; Moore, Robert; El Haddad, Najib; Akiyoshi, Takurin; Mfarrej, Bechara; Yang, Sunmi; Jurewicz, Mollie; Ichimura, Takaharu; Abdi, Reza] Brigham & Womens Hosp, Transplantat Res Ctr, Div Renal, Boston, MA 02115 USA; [Lindeman, Neal] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Azzi, Jamil; Moore, Robert; El Haddad, Najib; Akiyoshi, Takurin; Mfarrej, Bechara; Yang, Sunmi; Jurewicz, Mollie; Abdi, Reza] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Tang, Li; Tong, Rong; Cheng, Jianjun] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Illinois System; University of Illinois Urbana-Champaign	Abdi, R (corresponding author), Brigham & Womens Hosp, Transplant Res Ctr, 221 Longwood Ave, Boston, MA 02115 USA.	jianjunc@illinois.edu; rabdi@rics.bwh.harvard.edu	Mfarrej, Bechara/AAE-9616-2021; Tang, Li/A-6844-2013; Tong, Rong/A-4100-2013; Cheng, Jianjun/AAF-4301-2019	Mfarrej, Bechara/0000-0002-8361-5240; Tong, Rong/0000-0002-2034-9272; Cheng, Jianjun/0000-0003-2561-9291; Jurewicz, Mollie/0000-0001-8482-3060; Tang, Li/0000-0002-6393-982X	National Kidney Foundation; Roche Organ Transplantation Research Foundation; Juvenile Diabetes Research Foundation; John Merrill Transplant Scholar grant; National Science Foundation [DMR-0748834]; U.S. National Institutes of Health [1R21CA139329-01, 1R21EB009486-01]; Siteman Center for Cancer Nanotechnology Excellence (SCCNE; Washington University, St. Louis, MO, USA); Prostate Cancer Foundation; Center for Nanoscale Science and Technology (CNST; University of Illinois at Urbana-Champaign); NATIONAL CANCER INSTITUTE [R21CA139329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009486] Funding Source: NIH RePORTER	National Kidney Foundation; Roche Organ Transplantation Research Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); John Merrill Transplant Scholar grant; National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siteman Center for Cancer Nanotechnology Excellence (SCCNE; Washington University, St. Louis, MO, USA); Prostate Cancer Foundation; Center for Nanoscale Science and Technology (CNST; University of Illinois at Urbana-Champaign); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank Elizabeth Glidden for her assistance in measuring CsA. This work was supported by a National Kidney Foundation clinical scientist award, a Roche Organ Transplantation Research Foundation grant, a Juvenile Diabetes Research Foundation regular grant, a John Merrill Transplant Scholar grant (to R.A.), National Science Foundation Career Program grant DMR-0748834 (to J.C.), U.S. National Institutes of Health grants 1R21CA139329-01 and 1R21EB009486-01(to J.C.), the Siteman Center for Cancer Nanotechnology Excellence (SCCNE; Washington University, St. Louis, MO, USA), the Center for Nanoscale Science and Technology (CNST; University of Illinois at Urbana-Champaign; to J.C.), and a Prostate Cancer Foundation Competitive Award Program grant (to J.C.).	Abdi R, 2002, DIABETES, V51, P2489, DOI 10.2337/diabetes.51.8.2489; Alvarez-Lorenzo C, 2008, MINI-REV MED CHEM, V8, P1065, DOI 10.2174/138955708785909952; Caliceti P, 2003, ADV DRUG DELIVER REV, V55, P1261, DOI 10.1016/S0169-409X(03)00108-X; Chamberlain BM, 2001, J AM CHEM SOC, V123, P3229, DOI 10.1021/ja003851f; Chaney EJ, 2010, MOL IMAGING, V9, P153, DOI 10.2310/7290.2010.00012; Chapman JR, 2006, NEPHROL DIAL TRANSPL, V21, P2060, DOI 10.1093/ndt/gfl219; Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047; Fahmy TM, 2007, NANOMED-NANOTECHNOL, V3, P75, DOI 10.1016/j.nano.2006.11.010; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Fiorina P, 2008, TRANSPLANTATION, V85, P1030, DOI 10.1097/TP.0b013e31816843a0; Galindo-Rodriguez S, 2004, PHARM RES-DORDR, V21, P1428, DOI 10.1023/B:PHAM.0000036917.75634.be; Giannoukakis N, 2008, PEDIATR DIABETES, V9, P4, DOI 10.1111/j.1399-5448.2008.00401.x; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Izawa A, 2007, J AM SOC NEPHROL, V18, P2929, DOI 10.1681/ASN.2006111261; Kaplan B, 2004, J AM SOC NEPHROL, V15, P3270, DOI 10.1097/01.ASN.0000146569.59482.8C; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Matsumura Y, 2004, BRIT J CANCER, V91, P1775, DOI 10.1038/sj.bjc.6602204; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Musumeci T, 2006, INT J PHARMACEUT, V325, P172, DOI 10.1016/j.ijpharm.2006.06.023; Neto AB, 1999, TRANSPLANT INT, V12, P208, DOI 10.1111/j.1432-2277.1999.tb00608.x; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Sakuma S, 2001, INT IMMUNOPHARMACOL, V1, P749, DOI 10.1016/S1567-5769(01)00008-X; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/s0168-3659(00)00339-4; Tong R, 2008, ANGEW CHEM INT EDIT, V47, P4830, DOI 10.1002/anie.200800491; Tong R, 2007, POLYM REV, V47, P345, DOI 10.1080/15583720701455079; Tong R, 2010, BIOMATERIALS, V31, P3043, DOI 10.1016/j.biomaterials.2010.01.009; Tong R, 2010, BIOCONJUGATE CHEM, V21, P111, DOI 10.1021/bc900356g; Tong R, 2009, J AM CHEM SOC, V131, P4744, DOI 10.1021/ja8084675; Wang X, 2007, J VIROL, V81, P10009, DOI 10.1128/JVI.00489-07; Wong WC, 2005, TRANSPLANTATION, V80, P289, DOI 10.1097/01.tp.0000168436.76784.45; Xu MQ, 2004, WORLD J GASTROENTERO, V10, P2361; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937	32	66	78	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3927	3938		10.1096/fj.10-154690	http://dx.doi.org/10.1096/fj.10-154690			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20547662	Green Published			2022-12-25	WOS:000285005900030
J	Durham, WJ; Casperson, SL; Dillon, EL; Keske, MA; Paddon-Jones, D; Sanford, AP; Hickner, RC; Grady, JJ; Sheffield-Moore, M				Durham, William J.; Casperson, Shanon L.; Dillon, Edgar L.; Keske, Michelle A.; Paddon-Jones, Douglas; Sanford, Arthur P.; Hickner, Robert C.; Grady, James J.; Sheffield-Moore, Melinda			Age-related anabolic resistance after endurance-type exercise in healthy humans	FASEB JOURNAL			English	Article						amino acids; blood flow; microdialysis ethanol; contrast-enhanced ultrasound; microcirculation	MUSCLE PROTEIN-SYNTHESIS; NUTRITIVE BLOOD-FLOW; HUMAN SKELETAL-MUSCLE; AMINO-ACID-TRANSPORT; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MICROVASCULAR RECRUITMENT; DIETARY REQUIREMENTS; ETHANOL TECHNIQUE; REDOX STATE	Age-related skeletal muscle loss is thought to stem from suboptimal nutrition and resistance to anabolic stimuli. Impaired microcirculatory (nutritive) blood flow may contribute to anabolic resistance by reducing delivery of amino acids to skeletal muscle. In this study, we employed contrast-enhanced ultrasound, microdialysis sampling of skeletal muscle interstitium, and stable isotope methodology, to assess hemodynamic and metabolic responses of older individuals to endurance type (walking) exercise during controlled amino acid provision. We hypothesized that older individuals would exhibit reduced microcirculatory blood flow, interstitial amino acid concentrations, and amino acid transport when compared with younger controls. We report for the first time that aging induces anabolic resistance following endurance exercise, manifested as reduced (by similar to 40%) efficiency of muscle protein synthesis. Despite lower (by similar to 40-45%) microcirculatory flow in the older than in the younger participants, circulating and interstitial amino acid concentrations and phenylalanine transport into skeletal muscle were all equal or higher in older individuals than in the young, comprehensively refuting our hypothesis that amino acid availability limits postexercise anabolism in older individuals. Our data point to alternative mediators of age-related anabolic resistance and importantly suggest correction of these impairments may reduce requirements for, and increase the efficacy of, dietary protein in older individuals. Durham, W. J., Casperson, S. L., Dillon, E. L., Keske, M. A., Paddon-Jones, D., Sanford, A. P., Hickner, R. C., Grady, J. J., Sheffield-Moore, M. Age-related anabolic resistance after endurance-type exercise in healthy humans. FASEB J. 24, 4117-4127 (2010). www.fasebj.org	[Durham, William J.; Casperson, Shanon L.; Dillon, Edgar L.; Paddon-Jones, Douglas; Sheffield-Moore, Melinda] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Paddon-Jones, Douglas] Univ Texas Med Branch, Dept Phys Therapy, Galveston, TX 77555 USA; [Sanford, Arthur P.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Grady, James J.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Hickner, Robert C.] E Carolina Univ, Human Performance Lab, Greenville, NC 27858 USA; [Keske, Michelle A.] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of North Carolina; East Carolina University; University of Tasmania; Menzies Institute for Medical Research	Sheffield-Moore, M (corresponding author), Univ Texas Med Branch, Dept Internal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	melmoore@utmb.edu	Casperson, Shanon L/AAY-3904-2021; Casperson, Shanon L/AAW-6512-2021; /B-2495-2008; Sheffield-Moore, Melinda/A-9794-2016	Casperson, Shanon L/0000-0002-6954-9523; /0000-0002-0513-5399; Sheffield-Moore, Melinda/0000-0001-6579-4655; hickner, Robert/0000-0002-2683-1617; Keske, Michelle/0000-0003-4214-7628; Paddon-Jones, Douglas/0000-0002-3762-5130	National Institutes of Health/National Institute on Aging [R01 AG21539, R21 AG19209]; Claude D. Pepper Older Americans Independence Center [P30 AG024832]; National Center for Research Resources, National Institutes of Health, U.S. Public Health Service [M01 RR 00073]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG019209, P30AG024832, R01AG021539] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Claude D. Pepper Older Americans Independence Center; National Center for Research Resources, National Institutes of Health, U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the study volunteers, General Clinical Research Center (GCRC) nurses, and the Sealy Center on Aging recruitment coordinators, Sue Minello and Roxana Hirst. The authors thank Chuan Hong for assistance with the statistical analysis. The authors thank the Biomolecular Resource Facility and the University of Texas Medical Branch (UTMB) Protein Chemistry Lab for assistance with plasma and interstitial amino acid analysis. This research was supported by National Institutes of Health/National Institute on Aging grants R01 AG21539 (M.S.-M.) and R21 AG19209 (R.H.) and Claude D. Pepper Older Americans Independence Center grant P30 AG024832 (J.G.). The authors thank Bristol-Myers Squibb (New York, NY, USA) for providing the Definity contrast agent for this study. Studies were conducted at the GCRC, UTMB at Galveston, funded by grant M01 RR 00073 from the National Center for Research Resources, National Institutes of Health, U.S. Public Health Service.	Adams F, 2005, HORM METAB RES, V37, P68, DOI 10.1055/s-2005-861156; Alway SE, 2008, EXERC SPORT SCI REV, V36, P51, DOI 10.1097/JES.0b013e318168e9dc; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; BAUMANN PQ, 1994, AM J PHYSIOL, V267, pE203, DOI 10.1152/ajpendo.1994.267.2.E203; Bergman RN, 1997, RECENT PROG HORM RES, V52, P359; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Bodine SC, 2006, MED SCI SPORT EXER, V38, P1950, DOI 10.1249/01.mss.0000233797.24035.35; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Borsheim E, 2006, AM J PHYSIOL-ENDOC M, V290, pE643, DOI 10.1152/ajpendo.00267.2005; CAMERA DM, 2010, MED SCI SPORTS EXERC; CARRARO F, 1990, AM J PHYSIOL, V259, pE470, DOI 10.1152/ajpendo.1990.259.4.E470; Clark MG, 2008, AM J PHYSIOL-ENDOC M, V295, pE732, DOI 10.1152/ajpendo.90477.2008; Clark MG, 2006, CURR OPIN CLIN NUTR, V9, P185, DOI 10.1097/01.mco.0000222097.90890.c2; Clerk LH, 2006, DIABETES, V55, P1436, DOI 10.2337/db05-1373; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Drummond MJ, 2008, J APPL PHYSIOL, V104, P1452, DOI 10.1152/japplphysiol.00021.2008; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1374, DOI 10.1152/japplphysiol.91397.2008; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Fujita S, 2007, DIABETES, V56, P1615, DOI 10.2337/db06-1566; Gore DC, 2007, AM J PHYSIOL-ENDOC M, V292, pE319, DOI 10.1152/ajpendo.00399.2005; Graham TE, 1998, MED SCI SPORT EXER, V30, P34, DOI 10.1097/00005768-199801000-00006; Hack V, 1997, FASEB J, V11, P84, DOI 10.1096/fasebj.11.1.9034170; Hack V, 1998, BLOOD, V92, P59, DOI 10.1182/blood.V92.1.59.413a05_59_67; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hasten DL, 2000, AM J PHYSIOL-ENDOC M, V278, pE620, DOI 10.1152/ajpendo.2000.278.4.E620; Hellsten Y, 1999, J PHYSIOL-LONDON, V520, P909, DOI 10.1111/j.1469-7793.1999.00909.x; HICKNER RC, 1992, ACTA PHYSIOL SCAND, V146, P87, DOI 10.1111/j.1748-1716.1992.tb09396.x; Hickner RC, 2003, J GERONTOL A-BIOL, V58, P20; HICKNER RC, 1995, J APPL PHYSIOL, V79, P638, DOI 10.1152/jappl.1995.79.2.638; Hickner RC, 1997, AM J PHYSIOL-HEART C, V273, pH405, DOI 10.1152/ajpheart.1997.273.1.H405; Hildebrandt W, 2002, MECH AGEING DEV, V123, P1269, DOI 10.1016/S0047-6374(02)00013-1; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Hood DA, 2009, APPL PHYSIOL NUTR ME, V34, P465, DOI 10.1139/H09-045; Jackson MJ, 2008, IUBMB LIFE, V60, P497, DOI 10.1002/iub.72; Johnston APW, 2008, APPL PHYSIOL NUTR ME, V33, P191, DOI 10.1139/H07-141; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; JORFELDT L, 1971, CLIN SCI, V41, P459, DOI 10.1042/cs0410459; Kumar V, 2009, J APPL PHYSIOL, V106, P2026, DOI 10.1152/japplphysiol.91481.2008; Lee R, 2010, ANAL CHEM, V82, P2959, DOI 10.1021/ac9029746; LEWIS SEM, 1984, BIOCHEM J, V217, P517, DOI 10.1042/bj2170517; McBride T, 2000, MECH AGEING DEV, V115, P127, DOI 10.1016/S0047-6374(00)00111-1; McIver KL, 2006, PAIN, V120, P161, DOI 10.1016/j.pain.2005.10.032; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Miller S, 2004, AM J PHYSIOL-ENDOC M, V287, pE136, DOI 10.1152/ajpendo.00092.2004; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Newman JMB, 2001, AM J PHYSIOL-HEART C, V281, pH2731, DOI 10.1152/ajpheart.2001.281.6.H2731; Paddon-Jones D, 2008, AM J CLIN NUTR, V87, p1558S, DOI 10.1093/ajcn/87.5.1558S; Pikosky MA, 2006, J NUTR, V136, P379, DOI 10.1093/jn/136.2.379; PLUSKAL MG, 1984, J GERONTOL, V39, P385, DOI 10.1093/geronj/39.4.385; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Reid MB, 2002, ANN NY ACAD SCI, V959, P108, DOI 10.1111/j.1749-6632.2002.tb02087.x; Rennie MJ, 2009, APPL PHYSIOL NUTR ME, V34, P377, DOI 10.1139/H09-012; Roberts JL, 2005, J PHYSIOL-LONDON, V563, P213, DOI 10.1113/jphysiol.2003.056531; SAS Institute, 2008, SAS STAT US GUID; Schiffelers SLH, 2003, INT J OBESITY, V27, P227, DOI 10.1038/sj.ijo.802230; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sheffield-Moore M, 2004, AM J PHYSIOL-ENDOC M, V287, pE513, DOI 10.1152/ajpendo.00334.2003; Sheffield-Moore M, 1999, J CLIN ENDOCR METAB, V84, P2705, DOI 10.1210/jc.84.8.2705; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003; Symons TB, 2007, AM J CLIN NUTR, V86, P451, DOI 10.1093/ajcn/86.2.451; Symons TB, 2009, J AM DIET ASSOC, V109, P1582, DOI 10.1016/j.jada.2009.06.369; Thomson DM, 2009, J PHYSIOL-LONDON, V587, P2077, DOI 10.1113/jphysiol.2008.166512; Tipton KD, 2008, ESSAYS BIOCHEM, V44, P85, DOI 10.1042/BSE0440085; Van Pelt RE, 2006, OBESITY, V14, P2163, DOI 10.1038/oby.2006.253; VANHALL G, 1995, J PHYSIOL-LONDON, V489, P251, DOI 10.1113/jphysiol.1995.sp021047; Vary TC, 2007, J NUTR, V137, P1835, DOI 10.1093/jn/137.8.1835; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Vincent MA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1191, DOI 10.1152/ajpendo.00497.2005; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Volpi E, 2000, J CLIN ENDOCR METAB, V85, P4481, DOI 10.1210/jc.85.12.4481; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; Wei K, 1998, CIRCULATION, V97, P473; WELLE S, 1995, AM J PHYSIOL-ENDOC M, V268, pE422, DOI 10.1152/ajpendo.1995.268.3.E422; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Williamson JR, 1996, J APPL PHYSIOL, V80, P747, DOI 10.1152/jappl.1996.80.3.747; Wolfe RR, 1992, RADIOACTIVE STABLE I; Yarasheski KE, 1999, AM J PHYSIOL-ENDOC M, V277, pE118, DOI 10.1152/ajpendo.1999.277.1.E118; YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210; YOUNG VR, 1978, FED PROC, V37, P2291; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	86	64	65	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					4117	4127		10.1096/fj.09-150177	http://dx.doi.org/10.1096/fj.09-150177			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20547663	Green Published			2022-12-25	WOS:000285005900046
J	Bhat, KP; Truax, AD; Greer, SF				Bhat, Kavita Purnanda; Truax, Agnieszka Dorota; Greer, Susanna Fletcher			Phosphorylation and Ubiquitination of Degron Proximal Residues Are Essential for Class II Transactivator (CIITA) Transactivation and Major Histocompatibility Class II Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; GENE; PROTEIN; TRANSCRIPTION; ACTIVATION; PROMOTERS; BINDING; ACCUMULATION; ACETYLATION; COACTIVATOR	Major histocompatibility (MHC) class II molecules are cell surface glycoproteins that present extracellular antigens to CD4(+) T cells and are essential for initiation of the adaptive immune response. MHC class II expression requires recruitment of a master regulator, the class II transactivator (CIITA), to the MHC class II promoter. Post-translational modifications to CIITA play important roles in modulating CIITA mediated transcription of various genes in different cell types. We have previously linked regulation of CIITA to the Ubiquitin Proteasome System (UPS), and we and others have demonstrated that mono-ubiquitination of CIITA dramatically increases its transactivity whereas poly-ubiquitination leads to CIITA degradation. Here we identify three degron proximal lysine residues, Lys-315, Lys-330, and Lys-333, and a phosphorylation site, Ser-280, located within the CIITA degron, that regulate CIITA ubiquitination, stability, and MHC class II expression. Together, these findings contribute to the developing post-translational modification code for CIITA.	[Greer, Susanna Fletcher] Georgia State Univ, Dept Biol, Coll Arts & Sci, Div Cellular & Mol Biol & Physiol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Greer, SF (corresponding author), Georgia State Univ, Dept Biol, Coll Arts & Sci, Div Cellular & Mol Biol & Physiol, POB 4010, Atlanta, GA 30302 USA.	sgreer@gsu.edu			American Cancer Society; Georgia Cancer Coalition; Georgia Research Alliance; Georgia State University Molecular Basis of Disease Area of Focus	American Cancer Society(American Cancer Society); Georgia Cancer Coalition; Georgia Research Alliance; Georgia State University Molecular Basis of Disease Area of Focus	This work was supported by grants from the American Cancer Society, the Georgia Cancer Coalition, the Georgia Research Alliance (to S. F. G.) and by a Ph.D. fellowship from the Georgia State University Molecular Basis of Disease Area of Focus (to K. P. B. and A. D. T.).	Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Archer CT, 2008, J BIOL CHEM, V283, P12614, DOI 10.1074/jbc.M801050200; Barbash O, 2009, ONCOGENE, V28, P4317, DOI 10.1038/onc.2009.287; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Berghuis D, 2009, J PATHOL, V218, P222, DOI 10.1002/path.2537; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; BHAT KP, 2010, IMMUNOL CEL IN PRESS; Buttice G, 2006, CIRC RES, V98, P472, DOI 10.1161/01.RES.0000204725.46332.97; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Cressman DE, 2001, J IMMUNOL, V167, P3626, DOI 10.4049/jimmunol.167.7.3626; Drozina G, 2006, J BIOL CHEM, V281, P39963, DOI 10.1074/jbc.M608538200; Friese MA, 2005, TRENDS IMMUNOL, V26, P559, DOI 10.1016/j.it.2005.08.011; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; Gourley TS, 2001, J IMMUNOL, V166, P2917, DOI 10.4049/jimmunol.166.5.2917; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Greer SF, 2004, J IMMUNOL, V173, P376, DOI 10.4049/jimmunol.173.1.376; Holling TM, 2006, BIOCHEM PHARMACOL, V72, P1570, DOI 10.1016/j.bcp.2006.06.034; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Li GX, 2001, MOL CELL BIOL, V21, P4626, DOI 10.1128/MCB.21.14.4626-4635.2001; Masternak K, 2000, GENE DEV, V14, P1156; Matheux F, 2004, NEWS PHYSIOL SCI, V19, P154, DOI 10.1152/nips.01462.2003; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Ramesh S, 2009, CELL CYCLE, V8, P11, DOI 10.4161/cc.8.1.7291; Satoh A, 2004, ONCOGENE, V23, P8876, DOI 10.1038/sj.onc.1208144; Schnappauf F, 2003, EUR J IMMUNOL, V33, P2337, DOI 10.1002/eji.200323490; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; Sisk TJ, 2003, INT IMMUNOL, V15, P1195, DOI 10.1093/intimm/dxg116; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; Tosi G, 2002, EMBO J, V21, P5467, DOI 10.1093/emboj/cdf557; Voong LN, 2008, J BIOL CHEM, V283, P9031, DOI 10.1074/jbc.M706487200; Wang RF, 2003, METHODS, V29, P227, DOI 10.1016/S1046-2023(02)00345-6; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu XY, 2009, MOL CELL BIOL, V29, P5639, DOI 10.1128/MCB.00661-09; Xu Y, 2008, J BIOL CHEM, V283, P1243, DOI 10.1074/jbc.M707180200; Yee CSK, 2005, J IMMUNOL, V174, P1222, DOI 10.4049/jimmunol.174.3.1222; Yee CSK, 2004, J IMMUNOL, V172, P5528, DOI 10.4049/jimmunol.172.9.5528; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	45	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25893	25903		10.1074/jbc.M110.127746	http://dx.doi.org/10.1074/jbc.M110.127746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538595	Green Published, hybrid			2022-12-25	WOS:000280921000004
J	Fang, XH; Neyrinck, AP; Matthay, MA; Lee, JW				Fang, Xiaohui; Neyrinck, Arne P.; Matthay, Michael A.; Lee, Jae W.			Allogeneic Human Mesenchymal Stem Cells Restore Epithelial Protein Permeability in Cultured Human Alveolar Type II Cells by Secretion of Angiopoietin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; ENDOTHELIAL-CELLS; BARRIER FUNCTION; IN-VIVO; PROGENITOR CELLS; TIGHT JUNCTIONS; TIE2 RECEPTOR; STROMAL CELLS; GENE-THERAPY	Acute lung injury is characterized by injury to the lung epithelium that leads to impaired resolution of pulmonary edema and also facilitates accumulation of protein-rich edema fluid and inflammatory cells in the distal airspaces of the lung. Recent in vivo and in vitro studies suggest that mesenchymal stem cells (MSC) may have therapeutic value for the treatment of acute lung injury. Here we tested the ability of human allogeneic mesenchymal stem cells to restore epithelial permeability to protein across primary cultures of polarized human alveolar epithelial type II cells after an inflammatory insult. Alveolar epithelial type II cells were grown on a Transwell plate with an air-liquid interface and injured by cytomix, a combination of IL-1 beta, TNF alpha, and IFN gamma. Protein permeability measured by I-131-labeled albumin flux was increased by 5-fold over 24 h after cytokine-induced injury. Co-culture of human MSC restored type II cell epithelial permeability to protein to control levels. Using siRNA knockdown of potential paracrine soluble factors, we found that angiopoietin-1 secretion was responsible for this beneficial effect in part by preventing actin stress fiber formation and claudin 18 disorganization through suppression of NF kappa B activity. This study provides novel evidence for a beneficial effect of MSC on alveolar epithelial permeability to protein.	[Matthay, Michael A.; Lee, Jae W.] Univ Calif San Francisco, Dept Anesthesiol, San Francisco, CA 94143 USA; [Fang, Xiaohui; Neyrinck, Arne P.; Matthay, Michael A.; Lee, Jae W.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lee, JW (corresponding author), Univ Calif San Francisco, Dept Anesthesiol, 505 Parnassus Ave,Box 0648, San Francisco, CA 94143 USA.	leejw@anesthesia.ucsf.edu		Lee, Jae/0000-0002-6521-8647	National Institutes of Health [HL-51856, HL-51854, HL-093026]; Foundation of Anesthesia Education and Research; National Institutes of Health, National Center for Research Resources [P40RR017447]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051856, K08HL093026, R01HL051856, R01HL051854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of Anesthesia Education and Research; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-51856 and HL-51854 (NHLBI; to M. A. M.) and HL-093026 (NHLBI, to J.W.L.). This work was also supported by the Foundation of Anesthesia Education and Research ( to J.W.L.).; We thank Dr. Naveen Gupta, University of Pittsburgh, for help with the permeability experiments. We thank the Northern California Transplant Donor Network as well as all the transplant coordinators involved for assistance in obtaining human research lungs for the isolation of human alveolar epithelial type II cells. Some of the materials (human allogeneic mesenchymal stem cells) employed in this work were provided by the Tulane Center for Gene Therapy through a National Institutes of Health Grant P40RR017447 (National Center for Research Resources).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Kotton DN, 2004, EXP HEMATOL, V32, P340, DOI 10.1016/j.exphem.2004.01.009; Koval M, 2010, AM J RESP CELL MOL, V42, P172, DOI 10.1165/rcmb.2008-0270OC; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee JW, 2007, J BIOL CHEM, V282, P24109, DOI 10.1074/jbc.M700821200; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Liebler JM, 2008, AM J PHYSIOL-LUNG C, V295, pL285, DOI 10.1152/ajplung.00222.2007; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259; Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Spees JL, 2007, AM J RESP CRIT CARE, V176, P385, DOI 10.1164/rccm.200607-1004OC; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wang YH, 2004, J CELL PHYSIOL, V198, P53, DOI 10.1002/jcp.10386; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wray C, 2009, AM J PHYSIOL-LUNG C, V297, pL219, DOI 10.1152/ajplung.00043.2009; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; Zhen GH, 2008, FRONT BIOSCI, V13, P3415	54	196	210	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26211	26222		10.1074/jbc.M110.119917	http://dx.doi.org/10.1074/jbc.M110.119917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554518	hybrid, Green Published			2022-12-25	WOS:000280921000038
J	Saxena, K; Schieborr, U; Anderka, O; Duchardt-Ferner, E; Elshorst, B; Gande, SL; Janzon, J; Kudlinzki, D; Sreeramulu, S; Dreyer, MK; Wendt, KU; Herbert, C; Duchaussoy, P; Bianciotto, M; Driguez, PA; Lassalle, G; Savi, P; Mohammadi, M; Bono, F; Schwalbe, H				Saxena, Krishna; Schieborr, Ulrich; Anderka, Oliver; Duchardt-Ferner, Elke; Elshorst, Bettina; Gande, Santosh Lakshmi; Janzon, Julia; Kudlinzki, Denis; Sreeramulu, Sridhar; Dreyer, Matthias K.; Wendt, K. Ulrich; Herbert, Corentin; Duchaussoy, Philippe; Bianciotto, Marc; Driguez, Pierre-Alexandre; Lassalle, Gilbert; Savi, Pierre; Mohammadi, Moosa; Bono, Francoise; Schwalbe, Harald			Influence of Heparin Mimetics on Assembly of the FGF center dot FGFR4 Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR; CRYSTAL-STRUCTURE; FACTOR FGF; STRUCTURAL BASIS; HOMOLOGOUS FACTORS; BINDING DOMAIN; SULFATE; PROTEIN; LIGAND	Fibroblast growth factor (FGF) signaling regulates mammalian development and metabolism, and its dysregulation is implicated in many inherited and acquired diseases, including cancer. Heparan sulfate glycosaminoglycans (HSGAGs) are essential for FGF signaling as they promote FGF center dot FGF receptor (FGFR) binding and dimerization. Using novel organic synthesis protocols to prepare homogeneously sulfated heparin mimetics (HM), including hexasaccharide (HM6), octasaccharide (HM8), and decasaccharide (HM10), we tested the ability of these HM to support FGF1 and FGF2 signaling through FGFR4. Biological assays show that both HM8 and HM10 are significantly more potent than HM6 in promoting FGF2-mediated FGFR4 signaling. In contrast, all three HM have comparable activity in promoting FGF1 center dot FGFR4 signaling. To understand the molecular basis for these differential activities in FGF1/2 center dot FGFR4 signaling, we used NMR spectroscopy, isothermal titration calorimetry, and size-exclusion chromatography to characterize binding interactions of FGF1/2 with the isolated Ig-domain 2 (D2) of FGFR4 in the presence of HM, and binary interactions of FGFs and D2 with HM. Our data confirm the existence of both a secondary FGF1 center dot FGFR4 interaction site and a direct FGFR4 center dot FGFR4 interaction site thus supporting the formation of the symmetric mode of FGF center dot FGFR dimerization in solution. Moreover, our results show that the observed higher activity of HM8 relative to HM6 in stimulating FGF2 center dot FGFR4 signaling correlates with the higher affinity of HM8 to bind and dimerize FGF2. Notably FGF2 center dot HM8 exhibits pronounced positive binding cooperativity. Based on our findings we propose a refined symmetric FGF center dot FGFR dimerization model, which incorporates the differential ability of HM to dimerize FGFs.	[Gande, Santosh Lakshmi; Janzon, Julia; Kudlinzki, Denis; Sreeramulu, Sridhar; Schwalbe, Harald] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Ctr Biomol Magnet Resonance, D-60439 Frankfurt, Germany; [Dreyer, Matthias K.; Wendt, K. Ulrich] Sanofi Aventis Res & Dev, CAS Struct Biol, D-65926 Frankfurt, Germany; [Herbert, Corentin; Duchaussoy, Philippe; Driguez, Pierre-Alexandre; Lassalle, Gilbert; Savi, Pierre; Bono, Francoise] Sanofi Aventis Res & Dev, Thrombosis & Angiogenesis, F-31036 Toulouse, France; [Bianciotto, Marc] Sanofi Aventis Res & Dev, CAS Drug Design, F-31036 Toulouse, France; [Mohammadi, Moosa] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	Goethe University Frankfurt; Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; New York University	Schwalbe, H (corresponding author), Ctr Biomol Magnet Resonance, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany.	schwalbe@nmr.uni-frankfurt.de	kasaei, fahime/T-7197-2018; Mohammadi, Moosa/ABA-6745-2020; Schwalbe, Harald J/F-9023-2010; Schwalbe, Harald/AAB-3143-2020	Mohammadi, Moosa/0000-0003-2434-9437; Schwalbe, Harald J/0000-0001-5693-7909; Schwalbe, Harald/0000-0001-5693-7909; Dreyer, Matthias K./0000-0001-6011-9124	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE013686] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Anderka O, 2008, J BIOL CHEM, V283, P31333, DOI 10.1074/jbc.M805434200; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Beer HD, 2000, J BIOL CHEM, V275, P16091, DOI 10.1074/jbc.275.21.16091; Bellosta P, 2001, MOL CELL BIOL, V21, P5946, DOI 10.1128/MCB.21.17.5946-5957.2001; Canales A, 2005, J AM CHEM SOC, V127, P5778, DOI 10.1021/ja043363y; de Paz JL, 2007, CHEM BIOL, V14, P879, DOI 10.1016/j.chembiol.2007.07.007; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; GAO GX, 1995, EMBO J, V14, P2183, DOI 10.1002/j.1460-2075.1995.tb07212.x; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Griffith BR, 2004, J AM CHEM SOC, V126, P1608, DOI 10.1021/ja037646m; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Hung KW, 2005, BIOCHEMISTRY-US, V44, P15787, DOI 10.1021/bi051030n; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kalinina J, 2009, MOL CELL BIOL, V29, P4663, DOI 10.1128/MCB.01780-08; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kiselyov VV, 2006, PROTEIN SCI, V15, P2318, DOI 10.1110/ps.062206106; Kiselyov VV, 2006, PROTEIN SCI, V15, P1512, DOI 10.1110/ps.062207906; Kochoyan A, 2008, FEBS LETT, V582, P3374, DOI 10.1016/j.febslet.2008.08.033; Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002; Kwan CP, 2001, J BIOL CHEM, V276, P23421, DOI 10.1074/jbc.M010786200; Lin XH, 1999, DEVELOPMENT, V126, P3715; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Martin G, 2001, BIOESSAYS, V23, P865, DOI 10.1002/bies.1126; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; MOY FJ, 1995, J BIOMOL NMR, V6, P245; Ogura K, 1999, J BIOMOL NMR, V13, P11, DOI 10.1023/A:1008330622467; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Osslund TD, 1998, PROTEIN SCI, V7, P1681, DOI 10.1002/pro.5560070803; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Plotnikov AN, 2001, J BIOL CHEM, V276, P4322, DOI 10.1074/jbc.M006502200; Popovici C, 2005, BIOESSAYS, V27, P849, DOI 10.1002/bies.20261; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; Ryu EK, 2006, PROTEIN EXPRES PURIF, V49, P15, DOI 10.1016/j.pep.2006.04.008; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shimizu A, 2001, J BIOL CHEM, V276, P11031, DOI 10.1074/jbc.M003535200; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Tabeur C, 1999, BIOORGAN MED CHEM, V7, P2003, DOI 10.1016/S0968-0896(99)00113-3; VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005; WANG F, 1995, J BIOL CHEM, V270, P10231, DOI 10.1074/jbc.270.17.10231; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Wu ZLL, 2004, J BIOL CHEM, V279, P1861, DOI 10.1074/jbc.M311398200; Wuechner C, 1996, INT J DEV BIOL, V40, P1185; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; ZHU XT, 1993, STRUCTURE, V1, P27, DOI 10.1016/0969-2126(93)90006-3	78	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26628	26640		10.1074/jbc.M109.095109	http://dx.doi.org/10.1074/jbc.M109.095109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547770	Green Published, hybrid			2022-12-25	WOS:000280921000078
J	Darwech, I; Otero, JE; Alhawagri, MA; Abu-Amer, Y				Darwech, Isra; Otero, Jesse E.; Alhawagri, Muhammad A.; Abu-Amer, Yousef			Tyrosine Phosphorylation Is Required for I kappa B Kinase-beta (IKK beta) Activation and Function in Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; BINDING DOMAIN PEPTIDE; C-SRC; BLOCKS OSTEOCLASTOGENESIS; BONE LOSS; INFLAMMATION; COMPLEX; INHIBITION; EXPRESSION; MECHANISM	The transcription factor NF-kappa B is crucial for numerous cellular functions such as survival, differentiation, immunity, and inflammation. A key function of this family of transcription factors is regulation of osteoclast differentiation and function, which in turn controls skeletal homeostasis. The I kappa B kinase (IKK) complex, which contains IKK alpha, IKK beta, and IKK gamma, is required for activation of NF-kappa B, and deletion of either IKK alpha or IKK beta resulted with defective osteoclast differentiation and survival. We have recently investigated the details of the mechanisms governing the role of IKK beta in osteoclastogenesis and found that constitutively active IKK beta in which serine residues 177/181 were mutated into negatively charged glutamic acids instigates spontaneous bona fide receptor activator of NF-kappa B ligand (RANKL)-independent osteoclastogenesis. To better understand and define the functional role of IKK beta domains capable of regulating the osteoclastogenic activity of IKK, we investigated key motifs in the activation T loop of IKK beta, which are potentially capable of modulating its osteoclastogenic activity. We discovered that dual serine (traditional serine residues 177/181) and tyrosine (188/199) phosphorylation events are crucial for IKK beta activation. Mutation of the latter tyrosine residues blunted the NF-kappa B activity of wild type and constitutively active IKK beta, and tyrosine 188/199-deficient IKK beta inhibited osteoclastogenesis. Thus, tyrosines 188/199 are a novel target for regulating IKK beta activity, at least in osteoclasts.	[Darwech, Isra; Otero, Jesse E.; Alhawagri, Muhammad A.; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA; [Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Abu-Amer, Y (corresponding author), Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA.	abuamery@wustl.edu		Darwech, Isra/0000-0002-5042-3568	National Institutes of Health [AR055392, AR049192, AR054326]; Shriners Hospital for Children [8570, 8510]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047443, F31AR055392, R01AR049192, R01AR054326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055392 (to J.E.O.), AR049192, and AR054326 (to Y.A.-A.). This work was also supported by Shriners Hospital for Children Grants 8570 and 8510.	Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; Abu-Amer Y, 2001, J BIOL CHEM, V276, P30499, DOI 10.1074/jbc.M104725200; Abu-Amer Y., 2006, FUTURE MED, V1, P133, DOI DOI 10.2217/17460816.1.1.133; Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; AbuAmer Y, 1997, NAT MED, V3, P1189, DOI 10.1038/nm1197-1189; ABUAMER Y, 2003, MOL BIOL ORTHOPEDICS, P229; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mukhopadhyay A, 2000, J BIOL CHEM, V275, P8549, DOI 10.1074/jbc.275.12.8549; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Otero JE, 2008, J BIOL CHEM, V283, P24546, DOI 10.1074/jbc.M800434200; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Shibata W, 2007, J IMMUNOL, V179, P2681, DOI 10.4049/jimmunol.179.5.2681; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Zhang ZY, 2003, J IMMUNOL, V171, P3620, DOI 10.4049/jimmunol.171.7.3620	43	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25522	25530		10.1074/jbc.M110.121533	http://dx.doi.org/10.1074/jbc.M110.121533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534585	Green Published, hybrid			2022-12-25	WOS:000280682400046
J	Lyons, DM; O'Brien, PJ				Lyons, Derek M.; O'Brien, Patrick J.			Human Base Excision Repair Creates a Bias Toward-1 Frameshift Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYLADENINE DNA GLYCOSYLASE; HUMAN 3-METHYLADENINE-DNA GLYCOSYLASE; SINGLE-STRANDED-DNA; MISMATCH REPAIR; MICROSATELLITE INSTABILITY; MUTATOR PHENOTYPE; POLYMERASE-BETA; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE SUBSTITUTION; INTERCALATING AGENTS	Frameshift mutations are particularly deleterious to protein function and play a prominent role in carcinogenesis. Most commonly these mutations involve the insertion or omission of a single nucleotide by a DNA polymerase that slips on a damaged or undamaged template. The mismatch DNA repair pathway can repair these nascent polymerase errors. However, overexpression of enzymes of the base excision repair (BER) pathway is known to increase the frequency of frameshift mutations suggesting competition between these pathways. We have examined the fate of DNA containing single nucleotide bulges in human cell extracts and discovered that several deaminated or alkylated nucleotides are efficiently removed by BER. Because single nucleotide bulges are more highly exposed we anticipate that they would be highly susceptible to spontaneous DNA damage. As a model for this, we have shown that chloroacetaldehyde reacts more than 18-fold faster with an A-bulge than with a stable A center dot T base pair to create alkylated DNA adducts that can be removed by alkyladenine DNA glycosylase. Reconstitution of the BER pathway using purified components establishes that bulged DNA is efficiently processed. Single nucleotide deletion is predicted to repair +1 frameshift events, but to make -1 frameshift events permanent. Therefore, these findings suggest an additional factor contributing to the bias toward deletion mutations.	[Lyons, Derek M.; O'Brien, Patrick J.] Univ Michigan, Chem Biol Program, Ann Arbor, MI 48109 USA; [Lyons, Derek M.; O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu	zhang, huidong/B-5667-2011		United States Public Health Service [R01 CA122254]; NATIONAL CANCER INSTITUTE [R01CA122254] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA122254 from the United States Public Health Service.	Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; Bolt HM, 2005, CRIT REV TOXICOL, V35, P307, DOI 10.1080/10408440490915975; Cerda SR, 1998, FEBS LETT, V431, P12, DOI 10.1016/S0014-5793(98)00697-8; Chan K, 2007, MUTAGENESIS, V22, P183, DOI 10.1093/mutage/gel070; Colgin LM, 2002, P NATL ACAD SCI USA, V99, P1437, DOI 10.1073/pnas.032655699; Connor EE, 2002, CHEM BIOL, V9, P1033, DOI 10.1016/S1074-5521(02)00215-6; COQUERELLE T, 1995, MUTAT RES-DNA REPAIR, V336, P9, DOI 10.1016/0921-8777(94)00035-5; David SS, 1998, CHEM REV, V98, P1221, DOI 10.1021/cr980321h; Efrati E, 1997, J BIOL CHEM, V272, P2559; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Frosina G, 2000, EUR J BIOCHEM, V267, P2135, DOI 10.1046/j.1432-1327.2000.01266.x; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; Greene CN, 2001, GENETICS, V159, P65; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hang B, 1997, P NATL ACAD SCI USA, V94, P12869, DOI 10.1073/pnas.94.24.12869; Hitchcock TM, 2004, J BIOL CHEM, V279, P38177, DOI 10.1074/jbc.M405882200; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jackson AL, 1998, GENETICS, V148, P1483; JOSHUATOR L, 1988, NATURE, V334, P82, DOI 10.1038/334082a0; Karimi-Busheri F, 1998, NUCLEIC ACIDS RES, V26, P4395, DOI 10.1093/nar/26.19.4395; Karran P, 1996, SEMIN CANCER BIOL, V7, P15, DOI 10.1006/scbi.1996.0003; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Klapacz J, 2010, MOL CELL, V37, P843, DOI 10.1016/j.molcel.2010.01.038; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; KUNKEL TA, 1990, BIOCHEMISTRY-US, V29, P8003, DOI 10.1021/bi00487a001; Levine RL, 2000, CANCER RES, V60, P4098; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Loeb LA, 2001, CANCER RES, V61, P3230; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Marenstein DR, 2004, DNA REPAIR, V3, P527, DOI 10.1016/j.dnarep.2004.01.010; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; Okochi E, 2002, MUTAT RES-FUND MOL M, V506, P101, DOI 10.1016/S0027-5107(02)00156-2; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; PATEL DJ, 1982, BIOCHEMISTRY-US, V21, P445, DOI 10.1021/bi00532a004; Posnick LM, 1999, J BACTERIOL, V181, P6763, DOI 10.1128/JB.181.21.6763-6771.1999; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; RYDBERG B, 1991, P NATL ACAD SCI USA, V88, P6839, DOI 10.1073/pnas.88.15.6839; SCHARER OD, 1995, J AM CHEM SOC, V117, P10781, DOI 10.1021/ja00148a036; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; SHEARMAN CW, 1983, J BIOL CHEM, V258, P4485; SHEARMAN CW, 1983, J BIOL CHEM, V258, P4477; SINGER B, 1992, P NATL ACAD SCI USA, V89, P9386, DOI 10.1073/pnas.89.20.9386; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; VICKERS MA, 1993, P NATL ACAD SCI USA, V90, P3437, DOI 10.1073/pnas.90.8.3437; Visnes T, 2009, PHILOS T R SOC B, V364, P563, DOI 10.1098/rstb.2008.0186; WANG ZG, 1988, J BACTERIOL, V170, P1082, DOI 10.1128/jb.170.3.1082-1091.1988; Werneburg BG, 1996, BIOCHEMISTRY-US, V35, P7041, DOI 10.1021/bi9527202; Wolfe AE, 2009, BIOCHEMISTRY-US, V48, P11357, DOI 10.1021/bi9015082; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang HD, 2009, J BIOL CHEM, V284, P35144, DOI 10.1074/jbc.M109.067397; Zhang QM, 2005, DNA REPAIR, V4, P263, DOI 10.1016/j.dnarep.2004.10.004; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745; Zhao XB, 2010, BIOCHEMISTRY-US, V49, P1658, DOI 10.1021/bi901852q	71	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25203	25212		10.1074/jbc.M110.118596	http://dx.doi.org/10.1074/jbc.M110.118596			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547483	Green Published, hybrid			2022-12-25	WOS:000280682400013
J	Matranga, C; Pyle, AM				Matranga, Christian; Pyle, Anna Marie			Double-stranded RNA-dependent ATPase DRH-3 INSIGHT INTO ITS ROLE IN RNA SILENCING IN CAENORHABDITIS ELEGANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; C-ELEGANS; BOX HELICASE; DROSOPHILA; BINDING; PATHWAYS; SENSOR; VIRUS; DNA; RESPONSES	RNA helicases are proteins essential to almost every facet of RNA metabolism, including the gene-silencing pathways that employ small RNAs. A phylogenetically related group of helicases is required for the RNA-silencing mechanism in Caenorhabditis elegans. Dicer-related helicase 3 (DRH-3) is a Dicer-RIG-I family protein that is essential for RNA silencing and germline development in nematodes. Here we performed a biochemical characterization of the ligand binding and catalytic activities of DRH-3 in vitro. We identify signature motifs specific to this family of RNA helicases. We find that DRH-3 binds both single-stranded and double-stranded RNAs with high affinity. However, the ATPase activity of DRH-3 is stimulated only by double-stranded RNA. DRH-3 is a robust RNA-stimulated ATPase with a k(cat) value of 500/min when stimulated with short RNA duplexes. The DRH-3 ATPase may have allosteric regulation in cis that is controlled by the stoichiometry of double-stranded RNA to enzyme. We observe that the DRH-3 ATPase is stimulated only by duplexes containing RNA, suggesting a role for DRH-3 during or after transcription. Our findings provide clues to the role of DRH-3 during the RNA interference response in vivo.	[Matranga, Christian; Pyle, Anna Marie] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), 266 Whitney Ave,Bass Bldg,Rm 334, New Haven, CT 06520 USA.	anna.pyle@yale.edu		Matranga, Christian/0000-0002-9037-5468	National Institutes of Health National Research Service [F32GM086949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086949] Funding Source: NIH RePORTER	National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health National Research Service Award fellowship (F32GM086949) (to C. M.).	Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Bowie AG, 2007, TRENDS IMMUNOL, V28, P147, DOI 10.1016/j.it.2007.02.002; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Laggerbauer B, 1996, NUCLEIC ACIDS RES, V24, P868, DOI 10.1093/nar/24.5.868; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li DN, 1997, EMBO J, V16, P1103, DOI 10.1093/emboj/16.5.1103; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nakamura M, 2007, GENES CELLS, V12, P997, DOI 10.1111/j.1365-2443.2007.01111.x; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; SEGEL IH, 1993, ENZYME KINETICS, P242; She XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000624; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tsu CA, 1998, BIOCHEMISTRY-US, V37, P16989, DOI 10.1021/bi981837y; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	39	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25363	25371		10.1074/jbc.M110.117010	http://dx.doi.org/10.1074/jbc.M110.117010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529861	Green Published, hybrid			2022-12-25	WOS:000280682400029
J	Roger, JE; Nellissery, J; Kim, DS; Swaroop, A				Roger, Jerome E.; Nellissery, Jacob; Kim, Douglas S.; Swaroop, Anand			Sumoylation of bZIP Transcription Factor NRL Modulates Target Gene Expression during Photoreceptor Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NR2E3; HOMEOBOX GENE; SUBUNIT GENE; MOUSE RETINA; CELL-FATE; IN-VIVO; ROD; CRX; PHOSPHORYLATION; SUMO	Development of rod photoreceptors in the mammalian retina is critically dependent on the basic motif-leucine zipper transcription factor NRL (neural retina leucine zipper). In the absence of NRL, photoreceptor precursors in mouse retina produce only cones that primarily express S-opsin. Conversely, ectopic expression of NRL in post-mitotic precursors leads to a rod-only retina. To explore the role of signaling molecules in modulating NRL function, we identified putative sites of post-translational modification in the NRL protein by in silico analysis. Here, we demonstrate the sumoylation of NRL in vivo and in vitro, with two small ubiquitin-like modifier (SUMO) molecules attached to the Lys-20 residue. NRL-K20R and NRL-K20R/K24R sumoylation mutants show reduced transcriptional activation of Nr2e3 and rhodopsin promoters (two direct targets of NRL) in reporter assays when compared with wild-type NRL. Consistent with this, in vivo electroporation of the NRL-K20R/K24R mutant into newborn Nrl(-/-) mouse retina leads to reduced Nr2e3 activation and only a partial rescue of the Nrl(-/-) phenotype in contrast to the wild-type NRL that is able to convert cones to rod photoreceptors. Although PIAS3 (protein inhibitor of activated STAT3), an E3-SUMO ligase implicated in photoreceptor differentiation, can be immunoprecipitated with NRL, there appears to be redundancy in E3 ligases, and PIAS3 does not seem to be essential for NRL sumoylation. Our studies suggest an important role of sumoylation in fine-tuning the activity of NRL and thereby incorporating yet another layer of control in gene regulatory networks involved in photoreceptor development and homeostasis.	[Roger, Jerome E.; Nellissery, Jacob; Kim, Douglas S.; Swaroop, Anand] NEI, N NRL, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Swaroop, A (corresponding author), NEI, N NRL, NIH, 6 Ctr Dr,MSC0610, Bethesda, MD 20892 USA.	swaroopa@nei.nih.gov	Roger, Jerome/F-6225-2019; roger, jerome/P-3670-2019	Roger, Jerome/0000-0002-5061-230X; roger, jerome/0000-0002-5061-230X; NELLISSERY, JACOB/0000-0002-1209-664X; Kim, Douglas/0000-0001-9029-314X; Swaroop, Anand/0000-0002-1975-1141	National Institutes of Health through NEI; NATIONAL EYE INSTITUTE [ZIAEY000450] Funding Source: NIH RePORTER	National Institutes of Health through NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by a National Institutes of Health Grant through the NEI.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Bradford RL, 2005, DEV BIOL, V286, P31, DOI 10.1016/j.ydbio.2005.07.002; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Friedman JS, 2004, J BIOL CHEM, V279, P47233, DOI 10.1074/jbc.M408298200; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hwang EJ, 2009, BIOCHEM BIOPH RES CO, V378, P513, DOI 10.1016/j.bbrc.2008.11.072; Jacobson SG, 2004, HUM MOL GENET, V13, P1893, DOI 10.1093/hmg/ddh198; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Kanda A, 2007, HUM MUTAT, V28, P589, DOI 10.1002/humu.20488; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Leavenworth JW, 2009, J IMMUNOL, V183, P1110, DOI 10.4049/jimmunol.0803671; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Levine EM, 2000, CELL MOL LIFE SCI, V57, P224, DOI 10.1007/PL00000686; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; Morrow EM, 1998, J NEUROSCI, V18, P3738; Nasonkin I., 2010, ENCY EYE, V3, P332; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Nishiguchi KM, 2004, P NATL ACAD SCI USA, V101, P17819, DOI 10.1073/pnas.0408183101; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Pittler SJ, 2004, J BIOL CHEM, V279, P19800, DOI 10.1074/jbc.M401864200; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Roger J, 2006, DEV BIOL, V298, P527, DOI 10.1016/j.ydbio.2006.07.003; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shao CL, 2009, J BIOL CHEM, V284, P3117, DOI 10.1074/jbc.M806286200; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	63	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25637	25644		10.1074/jbc.M110.142810	http://dx.doi.org/10.1074/jbc.M110.142810			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551322	Green Published, hybrid			2022-12-25	WOS:000280682400057
J	Daher, Z; Boulay, PL; Desjardins, F; Gratton, JP; Claing, A				Daher, Zeinab; Boulay, Pierre-Luc; Desjardins, Fanny; Gratton, Jean-Philippe; Claing, Audrey			Vascular Endothelial Growth Factor Receptor-2 Activates ADP-ribosylation Factor 1 to Promote Endothelial Nitric-oxide Synthase Activation and Nitric Oxide Release from Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS STIMULATES PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; INDUCED ANGIOGENESIS; PROTEIN; ARF6; VEGF; AKT; MIGRATION; SURVIVAL; NO	Vascular endothelial growth factor (VEGF) induces angiogenesis and regulates endothelial function via production and release of nitric oxide (NO), an important signaling molecule. The molecular basis leading to NO production involves phosphatidylinositiol-3 kinase (PI3K), Akt, and endothelial nitricoxide synthase (eNOS) activation. In this study, we have examined whether small GTP-binding proteins of the ADP-ribosylation factor (ARF) family act as molecular switches to regulate signaling cascades activated by VEGF in endothelial cells. Our results show that this growth factor can promote the rapid and transient activation of ARF1. In endothelial cells, this GTPase is present on dynamic plasma membrane ruffles. Inhibition of ARF1 expression, using RNA interference, markedly impaired VEGF-dependent eNOS phosphorylation and NO production by preventing the activation of the PI3K/Akt signaling axis. Furthermore, our data indicate that phosphorylation of Tyr(801), on VEGF receptor 2, is essential for activating Src- and ARF1-dependent signaling events leading to NO release from endothelial cells. Lastly, this mediator is known to regulate a broad variety of endothelial cell functions. Depletion of ARF1 markedly inhibits VEGF-dependent increase of vascular permeability as well as capillary tubule formation, a process important for angiogenesis. Taken together, our data indicate that ARF1 is a novel modulator of VEGF-stimulatedNOrelease and signaling in endothelial cells.	[Daher, Zeinab; Claing, Audrey] Univ Montreal, Dept Biochem, Fac Med, Montreal, PQ H3C 3J7, Canada; [Boulay, Pierre-Luc; Gratton, Jean-Philippe; Claing, Audrey] Univ Montreal, Dept Pharmacol, Fac Med, Montreal, PQ H3C 3J7, Canada; [Daher, Zeinab; Boulay, Pierre-Luc; Claing, Audrey] Univ Montreal, Grp Etud Prot Membranaires, Fac Med, Montreal, PQ H3C 3J7, Canada; [Desjardins, Fanny; Gratton, Jean-Philippe] Inst Rech Clin Montreal, Lab Endothelial Cell Biol, Montreal, PQ H2W 1R7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Claing, A (corresponding author), Univ Montreal, Dept Biochem, Fac Med, Montreal, PQ H3C 3J7, Canada.	audrey.claing@umontreal.ca		Gratton, Jean-Philippe/0000-0001-9877-8520	Canadian Institutes of Health Research (CIHR) [MOP-79470]; Heart and Stoke Foundation of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stoke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Canadian Institutes of Health Research (CIHR) Grant MOP-79470 and a Heart and Stoke Foundation of Canada grant (to A.C.).	Bednarek SY, 1996, TRENDS CELL BIOL, V6, P468, DOI 10.1016/0962-8924(96)84943-9; Blanes MG, 2007, J BIOL CHEM, V282, P10660, DOI 10.1074/jbc.M609048200; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Collins NT, 2006, ARTERIOSCL THROM VAS, V26, P62, DOI 10.1161/01.ATV.0000194097.92824.b3; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Duval M, 2007, MOL BIOL CELL, V18, P4659, DOI 10.1091/mbc.E07-05-0467; ELAZAR Z, 1994, J CELL BIOL, V124, P415, DOI 10.1083/jcb.124.4.415; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Gonzalez E, 2002, J BIOL CHEM, V277, P39554, DOI 10.1074/jbc.M207299200; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Li HS, 2003, BMC CELL BIOL, V4, P1, DOI 10.1186/1471-2121-4-13; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871	54	17	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24591	24599		10.1074/jbc.M110.115311	http://dx.doi.org/10.1074/jbc.M110.115311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529868	hybrid, Green Published			2022-12-25	WOS:000280542100031
J	Dudek, KA; Lafont, JE; Martinez-Sanchez, A; Murphy, CL				Dudek, Katarzyna A.; Lafont, Jerome E.; Martinez-Sanchez, Aida; Murphy, Christopher L.			Type II Collagen Expression Is Regulated by Tissue-specific miR-675 in Human Articular Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H19 NONCODING RNA; TRANSCRIPTION FACTORS; GENE; DIFFERENTIATION; PHENOTYPE; CARTILAGE; MICRORNA; SOX9; OSTEOARTHRITIS; ENHANCER	miRNAs have been shown to be essential for normal cartilage development in the mouse. However, the role of specific miRNAs in cartilage function is unknown. Using rarely available healthy human chondrocytes ( obtained from 8 to 50 year old patients), we detected a most highly abundant primary miRNA H19, whose expression was heavily dependent on cartilage master regulator SOX9. Across a range of murine tissues, expression of both H19- and H19-derived miR-675 mirrored that of cartilage-specific SOX9. miR-675 was shown to up-regulate the essential cartilage matrix component COL2A1, and overexpression of miR-675 rescued COL2A1 levels in H19- or SOX9-depleted cells. Wethus provide evidence that SOX9 positively regulates COL2A1 in human articular chondrocytes via a previously unreported miR-675-dependent mechanism. This represents a novel pathway regulating cartilage matrix production and identifies miR-675 as a promising new target for cartilage repair.	[Dudek, Katarzyna A.; Lafont, Jerome E.; Martinez-Sanchez, Aida; Murphy, Christopher L.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London W6 8LH, England	Imperial College London; University of Oxford	Murphy, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, 65 Aspenlea Rd, London W6 8LH, England.	c.murphy@imperial.ac.uk	Sanchez, Aida Martinez/ABH-5957-2020; Lafont, Jerome E/AAY-2277-2020	Sanchez, Aida Martinez/0000-0001-5142-2527; Lafont, Jerome E/0000-0001-8313-9873	Arthritis Research UK; Biotechnology and Biological Sciences Research Council (United Kingdom) [BB/G006555/1]; BBSRC [BB/G006555/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G006555/1] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Arthritis Research UK and Biotechnology and Biological Sciences Research Council (United Kingdom) Grant BB/G006555/1.	Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; GOSHEN R, 1993, MOL REPROD DEV, V34, P374, DOI 10.1002/mrd.1080340405; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hurst LD, 1999, TRENDS GENET, V15, P134, DOI 10.1016/S0168-9525(99)01696-0; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; LUSTIG O, 1994, MOL REPROD DEV, V38, P239, DOI 10.1002/mrd.1080380302; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; OWEN RD, 1993, CELL GROWTH DIFFER, V4, P1013; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamasaki K, 2009, ARTHRITIS RHEUM-US, V60, P1035, DOI 10.1002/art.24404	31	117	134	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24381	24387		10.1074/jbc.M110.111328	http://dx.doi.org/10.1074/jbc.M110.111328			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529846	Green Published, hybrid			2022-12-25	WOS:000280542100009
J	Durlu-Kandilci, NT; Ruas, M; Chuang, KT; Brading, A; Parrington, J; Galione, A				Durlu-Kandilci, Nezahat Tugba; Ruas, Margarida; Chuang, Kai-Ting; Brading, Alison; Parrington, John; Galione, Antony			TPC2 Proteins Mediate Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)- and Agonist-evoked Contractions of Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-ACINAR-CELLS; MOBILIZES CA2+; INTRACELLULAR CALCIUM; 2-POOL MECHANISM; NAADP RECEPTORS; TRIGGER ZONE; BETA-CELLS; STORES; CADPR; RAT	Agonists such as those acting at muscarinic receptors are thought to induce contraction of smooth muscle primarily through inositol 1,4,5-trisphosphate production and release of Ca2+ from sarcoplasmic reticulum. However, the additional Ca2+ mobilizing messengers cyclic adenosine diphosphate ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) may also be involved in this process, the former acting on the sarcoplasmic reticulum, the latter acting on lysosome-related organelles. In this study, we provide the first systematic analysis of the capacity of inositol 1,4,5-trisphosphate, cADPR, and NAADP to cause contraction in smooth muscle. Using permeabilized guinea pig detrusor and taenia caecum, we show that all three Ca2+ mobilizing messengers cause contractions in both types of smooth muscle. We demonstrate that cADPR and NAADP play differential roles in mediating contraction in response to muscarinic receptor activation, with a sizeable role for NAADP and acidic calcium stores in detrusor muscle but not in taenia caecum, underscoring the heterogeneity of smooth muscle signal transduction systems. Two-pore channel proteins (TPCs) have recently been shown to be key components of the NAADP receptor. We show that contractile responses to NAADP were completely abolished, and agonist-evoked contractions were reduced and now became independent of acidic calcium stores in Tpcn2(-/-) mouse detrusor smooth muscle. Our findings provide the first evidence that TPC proteins mediate a key NAADP-regulated tissue response brought about by agonist activation of a cell surface receptor.	[Durlu-Kandilci, Nezahat Tugba; Ruas, Margarida; Chuang, Kai-Ting; Brading, Alison; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Durlu-Kandilci, Nezahat Tugba] Hacettepe Univ, Fac Pharm, Dept Pharmacol, TR-06100 Ankara, Turkey	University of Oxford; Hacettepe University	Galione, A (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	antony.galione@pharm.ox.ac.uk	KANDILCI, NEZAHAT TUGBA/J-1080-2013; Galione, Antony/E-5884-2011	KANDILCI, NEZAHAT TUGBA/0000-0001-7236-2041; Ruas, Margarida/0000-0002-4872-7618; Galione, Antony/0000-0002-4132-7646	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Programme Grant (to A.G. and J.P.).	Aley PK, 2010, J PHARMACOL EXP THER, V333, P726, DOI 10.1124/jpet.110.165837; Barone F, 2002, FASEB J, V16, DOI 10.1096/fj.01-0749com; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Boittin FX, 2003, J BIOL CHEM, V278, P9602, DOI 10.1074/jbc.M204891200; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Durlu-Kandilci NT, 2007, EUR J PHARMACOL, V566, P172, DOI 10.1016/j.ejphar.2007.03.041; Endo M, 1977, EXCITATION CONTRACTI, P199; Evans AM, 2005, PHARMACOL THERAPEUT, V107, P286, DOI 10.1016/j.pharmthera.2005.03.003; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Gambara G, 2008, J CELL PHYSIOL, V216, P396, DOI 10.1002/jcp.21407; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; IACOVOU JW, 1990, J UROLOGY, V144, P775, DOI 10.1016/S0022-5347(17)39590-3; Iizuka K, 1998, J PHYSIOL-LONDON, V511, P915, DOI 10.1111/j.1469-7793.1998.915bg.x; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Jude Joseph A, 2008, Proc Am Thorac Soc, V5, P15, DOI 10.1513/pats.200704-047VS; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; Li PL, 2003, ACTA PHYSIOL SCAND, V179, P339, DOI 10.1046/j.0001-6772.2003.01216.x; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF510, DOI 10.1152/ajprenal.00116.2009; Wray S, 2010, PHYSIOL REV, V90, P113, DOI 10.1152/physrev.00018.2008; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yusufi ANK, 2002, EXP BIOL MED, V227, P36, DOI 10.1177/153537020222700107; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	36	61	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24925	24932		10.1074/jbc.M110.129833	http://dx.doi.org/10.1074/jbc.M110.129833			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20547763	Green Published, hybrid			2022-12-25	WOS:000280542100065
J	Undurraga, EA; Eisenberg, DTA; Magvanjav, O; Wang, RX; Leonard, WR; McDade, TW; Reyes-Garcia, V; Nyberg, C; Tanner, S; Huanca, T; Godoy, RA				Undurraga, Eduardo A.; Eisenberg, Dan T. A.; Magvanjav, Oyunbileg; Wang, Ruoxue; Leonard, William R.; McDade, Thomas W.; Reyes-Garcia, Victoria; Nyberg, Colleen; Tanner, Susan; Huanca, Tomas; Godoy, Ricardo A.		TAPS Bolivia Study Team	Human's Cognitive Ability to Assess Facial Cues from Photographs: A Study of Sexual Selection in the Bolivian Amazon	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; HEALTH; SYMMETRY; BEAUTY; FACE; INCOME; INTELLIGENCE; COMPETITION; EVOLUTION; ACCURACY	Background: Evolutionary theory suggests that natural selection favors the evolution of cognitive abilities which allow humans to use facial cues to assess traits of others. The use of facial and somatic cues by humans has been studied mainly in western industrialized countries, leaving unanswered whether results are valid across cultures. Methodology/Principal Findings: Our objectives were to test (i) if previous finding about raters' ability to get accurate information about an individual by looking at his facial photograph held in low-income non western rural societies and (ii) whether women and men differ in this ability. To answer the questions we did a study during July-August 2007 among the Tsimane', a native Amazonian society of foragers-farmers in Bolivia. We asked 40 females and 40 males 16-25 years of age to rate four traits in 93 facial photographs of other Tsimane' males. The four traits were based on sexual selection theory, and included health, dominance, knowledge, and sociability. The rating scale for each trait ranged from one (least) to four (most). The average rating for each trait was calculated for each individual in the photograph and regressed against objective measures of the trait from the person in the photograph. We found that (i) female Tsimane' raters were able to assess facial cues related to health, dominance, and knowledge and (ii) male Tsimane' raters were able to assess facial cues related to dominance, knowledge, and sociability. Conclusions/Significance: Our results support the existence of a human ability to identify objective traits from facial cues, as suggested by evolutionary theory.	[Undurraga, Eduardo A.; Magvanjav, Oyunbileg; Reyes-Garcia, Victoria; Godoy, Ricardo A.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA; [Eisenberg, Dan T. A.; Leonard, William R.; McDade, Thomas W.; Nyberg, Colleen] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Wang, Ruoxue] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, ICREA, E-08193 Barcelona, Spain; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, E-08193 Barcelona, Spain; [Tanner, Susan] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Huanca, Tomas] CBIDSI, San Borja, Bolivia; [TAPS Bolivia Study Team] Tsimane Amazonian Panel Study, San Borja, Bolivia	Brandeis University; Northwestern University; Brandeis University; Autonomous University of Barcelona; ICREA; Autonomous University of Barcelona; University System of Georgia; University of Georgia	Undurraga, EA (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA.	eundurra@brandeis.edu	Eisenberg, Dan T.A./D-7691-2011; van Lent, Laurence/G-5298-2010; Undurraga, Eduardo/I-3739-2014; Leonard, William R./I-5981-2019; Tanner, Susan/F-6687-2012; Reyes-Garcia, Victoria/C-4552-2008	Eisenberg, Dan T.A./0000-0003-0812-1862; van Lent, Laurence/0000-0002-9354-0932; Undurraga, Eduardo/0000-0002-4425-1253; Reyes-Garcia, Victoria/0000-0002-2914-8055; Leonard, William/0000-0002-6233-604X	National Science Foundation (NSF) [BCS-0134225, BCS-0200767, BCS-0322380]; Gran Consejo Tsimane'; ICREA Funding Source: Custom	National Science Foundation (NSF)(National Science Foundation (NSF)); Gran Consejo Tsimane'; ICREA(ICREA)	The Cultural and Physical Anthropology Programs, National Science Foundation (NSF) (BCS-0134225, BCS-0200767, BCS-0322380), provided funding for this research. DTAE is supported by an NSF Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Institutional Review Board for research with human subjects of Brandeis University approved the study protocol. The Great Tsimane' Council also approved the study. Thanks go to the Gran Consejo Tsimane' for their continuous support throughout this research project, to Jose Cari for helping to collect the data in the field, and to L. Zebrowitz for comments on earlier versions.	Anderson SL, 2008, J PERS SOC PSYCHOL, V95, P352, DOI 10.1037/0022-3514.95.2.352; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; ARNOLD D, 2006, INTRO WOMENS STUDIES; BERMAN P, 1988, MORE EFFICACY CHILD, P1; BIDDLE J, 1998, J LABOR EC, V16; Brabec M, 2007, AM J HUM BIOL, V19, P459, DOI 10.1002/ajhb.20606; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Buss D.M., 2006, EVOLUTION SOCIAL PSY, P263; Byron E., 2003, MARKET INTEGRATION H; Carels C, 2001, Clin Orthod Res, V4, P130, DOI 10.1034/j.1600-0544.2001.040303.x; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; David M. Buss, 2007, [心理学报, Acta Psychologica Sinica], V39, P502; DAWKINS MS, 1991, ANIM BEHAV, V41, P865, DOI 10.1016/S0003-3472(05)80353-7; DEBRUINE LM, 2010, P ROYAL SOC; DURHAM WH, 1976, Q REV BIOL, V51, P385, DOI 10.1086/409471; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; Folland S, 2007, SOC SCI MED, V64, P2342, DOI 10.1016/j.socscimed.2007.03.003; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Foster Z, 2005, AM J PHYS ANTHROPOL, V126, P343, DOI 10.1002/ajpa.20098; Frisancho AR, 1990, ANTHROPOMETRIC STAND; Gangestad SW, 2005, ANNU REV ANTHROPOL, V34, P523, DOI 10.1146/annurev.anthro.33.070203.143733; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; GIL DG, 1992, UNRAVELLING SOCIAL P; Godoy R, 2005, ECON EDUC REV, V24, P45, DOI 10.1016/j.econedurev.2003.11.008; GODOY RA, 2004, HUMAN ECOLOGY, V32; Godoy RA, 2006, SOC SCI MED, V63, P359, DOI 10.1016/j.socscimed.2006.01.021; Grammer K, 2005, PSYCHOL BULL, V131, P658, DOI 10.1037/0033-2909.131.5.658; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Gurven M, 2009, HUM NATURE-INT BIOS, V20, P151, DOI 10.1007/s12110-009-9062-8; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hess Ursula, 2008, Affective Computing. Focus on Emotion Expression, Synthesis and Recognition, P45; Hess U., 2002, EMPIRICAL REFLECTION, P187; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Honekopp J, 2004, HUM NATURE-INT BIOS, V15, P147, DOI 10.1007/s12110-004-1018-4; Huanca Tomas, 2008, TSIMANE ORAL TRADITI; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; JONES D, 1995, CURR ANTHROPOL, V36, P723, DOI 10.1086/204427; Kalick SM, 1998, PSYCHOL SCI, V9, P8, DOI 10.1111/1467-9280.00002; KAPLAN RM, 1978, SEX ROLES, V4, P195, DOI 10.1007/BF00287500; Kenrick D., 2006, EVOLUTION SOCIAL PSY, P211; KRAUT RE, 1979, J PERS SOC PSYCHOL, V37, P1539, DOI 10.1037/0022-3514.37.9.1539; Kumagai Yukie, 2008, Nihon Eiseigaku Zasshi, V63, P636, DOI 10.1265/jjh.63.636; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Leonard WR, 2008, ECON HUM BIOL, V6, P299, DOI 10.1016/j.ehb.2008.04.001; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Little AC, 2007, P ROY SOC B-BIOL SCI, V274, P3113, DOI 10.1098/rspb.2007.0895; LUCKER GW, 1981, J PSYCHOL, V107, P69, DOI 10.1080/00223980.1981.9915206; LUNDSTROM A, 1988, EUR J ORTHODONT, V10, P27, DOI 10.1093/ejo/10.1.27; Martinez-Rodriguez M.R., 2009, THESIS U GEORGIA; MAZUR A, 1994, ETHOL SOCIOBIOL, V15, P87, DOI 10.1016/0162-3095(94)90019-1; McDade TW, 2007, P NATL ACAD SCI USA, V104, P6134, DOI 10.1073/pnas.0609123104; Miller G, 2000, Novartis Found Symp, V233, P260; MINCER J, 1958, J POLIT ECON, V66, P281, DOI 10.1086/258055; Overing J., 2007, ANTHR LOVE ANGER AES; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Reis VA, 2001, BRAIN COGNITION, V46, P240, DOI 10.1016/S0278-2626(01)80075-0; Reyes-Garcia V, 2006, ECON BOT, V60, P62, DOI 10.1663/0013-0001(2006)60[62:CPAEVO]2.0.CO;2; Reyes-Garcia V, 2008, EVOL HUM BEHAV, V29, P275, DOI 10.1016/j.evolhumbehav.2008.02.002; Reyes-Garcia V, 2008, J DEV STUD, V44, P217, DOI 10.1080/00220380701789901; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; RUBIO K, 2009, MODERNIZATION CULTUR; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Rule NO, 2009, J EXP SOC PSYCHOL, V45, P1245, DOI 10.1016/j.jesp.2009.07.010; Rule NO, 2009, SEX ROLES, V61, P644, DOI 10.1007/s11199-009-9658-9; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Sober E., 1998, OTHERS EVOLUTION PSY; Sundie J. M., 2006, EVOLUTION SOCIAL PSY, P287; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; TAYLOR S, 2009, EVOLUTION SOCIAL PSY, P211; Von Rueden C., 2008, EVOLUTION HUMAN BEHA, V29; Wayland C, 2001, MED ANTHROPOL Q, V15, P171, DOI 10.1525/maq.2001.15.2.171; Weber M., 1947, THEORY SOCIAL EC ORG; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; Wolfe B., 2001, CONTRIBUTION HUMAN S, P221; Zaidel DW, 2005, BRAIN COGNITION, V57, P261, DOI 10.1016/j.bandc.2004.08.056; Zebrowitz LA, 2004, J NONVERBAL BEHAV, V28, P167, DOI 10.1023/B:JONB.0000039648.30935.1b; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009	87	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11027	10.1371/journal.pone.0011027	http://dx.doi.org/10.1371/journal.pone.0011027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608BX	20543956	Green Published, gold, Green Submitted			2022-12-25	WOS:000278557600006
J	Bennett, SM; Mercer, JM; Noor, MAF				Bennett, Sarah M.; Mercer, John M.; Noor, Mohamed A. F.			Slip-Sliding Away: Serial Changes and Homoplasy in Repeat Number in the Drosophila yakuba Homolog of Human Cancer Susceptibility Gene BRCA2	PLOS ONE			English	Article							DIRECTED REPAIR; DNA-REPAIR; RECOMBINATION; MUTATION; BREAST	Several recent studies have examined the function and evolution of a Drosophila homolog to the human breast cancer susceptibility gene BRCA2, named dmbrca2. We previously identified what appeared to be a recent expansion in the RAD51-binding BRC-repeat array in the ancestor of Drosophila yakuba. In this study, we examine patterns of variation and evolution of the dmbrca2 BRC-repeat array within D. yakuba and its close relatives. We develop a model of how unequal crossing over may have produced the expanded form, but we also observe short repeat forms, typical of other species in the D. melanogaster group, segregating within D. yakuba and D. santomea. These short forms do not appear to be identical-by-descent, suggesting that the history of dmbrca2 in the D. melanogaster subgroup has involved repeat unit contractions resulting in homoplasious forms. We conclude that the evolutionary history of dmbrca2 in D. yakuba and perhaps in other Drosophila species may be more complicated than can be inferred from examination of the published single genome sequences per species.	[Bennett, Sarah M.; Mercer, John M.; Noor, Mohamed A. F.] Duke Univ, Dept Biol, Durham, NC 27706 USA	Duke University	Bennett, SM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	noor@duke.edu		Noor, Mohamed/0000-0002-5400-4408	National Science Foundation [0509780, 0715484]; National Institutes of Health [GM076051, GM086445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076051, R01GM086445] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Science Foundation awards 0509780 and 0715484, and National Institutes of Health awards GM076051 and GM086445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard KR, 2008, HYDROMETALLURGY, V91, P1, DOI 10.1016/j.hydromet.2007.11.002; Bennett SM, 2009, GENETICA, V137, P213, DOI 10.1007/s10709-009-9376-9; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Brough R, 2008, DNA REPAIR, V7, P10, DOI 10.1016/j.dnarep.2007.07.013; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Carmon A, 2010, J MOL EVOL, V70, P260, DOI 10.1007/s00239-010-9327-1; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Coyne JA, 2002, EVOLUTION, V56, P2424, DOI 10.1111/j.0014-3820.2002.tb00168.x; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Gundmundsdottir K, 2006, ONCOGENE, V25, P5864; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r28; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; Lo T, 2003, DNA REPAIR, V2, P1015, DOI 10.1016/S1568-7864(03)00097-1; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2005, GENETICS, V171, P2143, DOI 10.1534/genetics.105.043786; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Warren M, 2002, HUM MOL GENET, V11, P841, DOI 10.1093/hmg/11.7.841; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11006	10.1371/journal.pone.0011006	http://dx.doi.org/10.1371/journal.pone.0011006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543987	gold, Green Published, Green Submitted			2022-12-25	WOS:000278494900018
J	Loudon, PT; Yager, EJ; Lynch, DT; Narendran, A; Stagnar, C; Franchini, AM; Fuller, JT; White, PA; Nyuandi, J; Wiley, CA; Murphey-Corb, M; Fuller, DH				Loudon, Peter T.; Yager, Eric J.; Lynch, Debbie T.; Narendran, Amithi; Stagnar, Cristy; Franchini, Anthony M.; Fuller, James T.; White, Phil A.; Nyuandi, Julia; Wiley, Clayton A.; Murphey-Corb, Michael; Fuller, Deborah H.			GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-VACCINE; ANTIBODY-SECRETING CELLS; IMMUNE-RESPONSES; A VIRUS; DENDRITIC CELLS; HETEROSUBTYPIC IMMUNITY; TRANSCUTANEOUS IMMUNIZATION; GENETIC IMMUNIZATION; ENHANCED PROTECTION; POWDER IMMUNIZATION	Background: The recent H5N1 avian and H1N1 swine-origin influenza virus outbreaks reaffirm that the threat of a worldwide influenza pandemic is both real and ever-present. Vaccination is still considered the best strategy for protection against influenza virus infection but a significant challenge is to identify new vaccine approaches that offer accelerated production, broader protection against drifted and shifted strains, and the capacity to elicit anti-viral immune responses in the respiratory tract at the site of viral entry. As a safe alternative to live attenuated vaccines, the mucosal and systemic immunogenicity of an H1N1 influenza (A/New Caledonia/20/99) HA DNA vaccine administered by particle-mediated epidermal delivery (PMED or gene gun) was analyzed in rhesus macaques. Methodology/Principal Findings: Macaques were immunized at weeks 0, 8, and 16 using a disposable single-shot particle-mediated delivery device designed for clinical use that delivers plasmid DNA directly into cells of the epidermis. Significant levels of hemagglutination inhibiting (HI) antibodies and cytokine-secreting HA-specific T cells were observed in the periphery of macaques following 1-3 doses of the PMED HA DNA vaccine. In addition, HA DNA vaccination induced detectable levels of HA-specific mucosal antibodies and T cells in the lung and gut-associated lymphoid tissues of vaccinated macaques. Importantly, co-delivery of a DNA encoding the rhesus macaque GM-CSF gene was found to significantly enhance both the systemic and mucosal immunogenicity of the HA DNA vaccine. Conclusions/Significance: These results provide strong support for the development of a particle-mediated epidermal DNA vaccine for protection against respiratory pathogens such as influenza and demonstrate, for the first time, the ability of skin-delivered GM-CSF to serve as an effective mucosal adjuvant for vaccine induction of immune responses in the gut and respiratory tract.	[Loudon, Peter T.; Lynch, Debbie T.; White, Phil A.] PowderMed Ltd, Oxford, England; [Yager, Eric J.; Narendran, Amithi; Stagnar, Cristy; Franchini, Anthony M.; Fuller, Deborah H.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Fuller, James T.] Recombiworks Ltd, Clifton Pk, NY USA; [Nyuandi, Julia; Murphey-Corb, Michael] Univ Pittsburgh, Sch Med, Dept Med Microbiol & Mol Genet, Pittsburgh, PA USA; [Wiley, Clayton A.] Univ Pittsburgh, Med Ctr, Dept Pathol, Div Neuropathol, Pittsburgh, PA USA	Pfizer; Albany Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Loudon, PT (corresponding author), Pfizer PGRD, Sandwich, Kent, England.	FullerD@mail.amc.edu		White, Phil/0000-0002-6078-9061; Fuller, Deborah/0000-0001-7315-2441; Franchini, Anthony/0000-0003-3576-3211; Yager, Eric/0000-0001-6118-7487	National Institute of Allergy and Infectious Diseases, U.S.A; PowderMed, Ltd., Oxford, U.K.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074509] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, U.S.A(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PowderMed, Ltd., Oxford, U.K.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This study was jointly funded by grant U01 AI074509 (DHF) from the National Institute of Allergy and Infectious Diseases, U.S.A (http://www3.niaid.nih.gov/) and by PowderMed, Ltd., Oxford, U.K. PowderMed Ltd funded experiments supporting this study at Recombiworks, Ltd. PowderMed employees (PTL, DTL, PAW) were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The Recombiworks employee (JTF) was involved in data collection and analysis and preparation of the manuscript but not in study design or the decision to publish.	Arrington J, 2002, J VIROL, V76, P4536, DOI 10.1128/JVI.76.9.4536-4546.2002; Baek KM, 2003, VACCINE, V21, P3684, DOI 10.1016/S0264-410X(03)00378-5; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Bruder D, 2006, VIRAL IMMUNOL, V19, P147, DOI 10.1089/vim.2006.19.147; Calarota SA, 1999, J IMMUNOL, V163, P2330; Chen DX, 2004, VIRUS RES, V103, P147, DOI 10.1016/j.virusres.2004.02.027; Chen DX, 2001, J VIROL, V75, P7956, DOI 10.1128/JVI.75.17.7956-7965.2001; Chen DX, 2000, NAT MED, V6, P1187, DOI 10.1038/80538; Chen Z, 1999, VACCINE, V17, P653, DOI 10.1016/S0264-410X(98)00247-3; Chen Z, 2001, VACCINE, V19, P1446, DOI 10.1016/S0264-410X(00)00351-0; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Condon C, 1996, NAT MED, V2, P1122, DOI 10.1038/nm1096-1122; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Daynes RA, 1996, INFECT IMMUN, V64, P1100, DOI 10.1128/IAI.64.4.1100-1109.1996; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; Demberg T, 2009, INT REV IMMUNOL, V28, P20, DOI 10.1080/08830180802684331; Drape R.J., 2005, VACCINE; EISENBRAUN MD, 1993, DNA CELL BIOL, V12, P791, DOI 10.1089/dna.1993.12.791; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Epstein SL, 1997, J IMMUNOL, V158, P1222; Falo LD, 1999, P ASSOC AM PHYSICIAN, V111, P211; Fuller DH, 2006, VIROLOGY, V348, P200, DOI 10.1016/j.virol.2005.12.008; Fuller DH, 2002, J VIROL, V76, P3309, DOI 10.1128/JVI.76.7.3309-3317.2002; Fuller DH, 1997, VACCINE, V15, P924, DOI 10.1016/S0264-410X(96)00271-X; FULLER DH, 2006, METHODS IN PRESS; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Glenn GM, 1998, J IMMUNOL, V161, P3211; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hasegawa H, 2007, EXPERT REV VACCINES, V6, P193, DOI 10.1586/14760584.6.2.193; Hutchinson KL, 2001, J MED VIROL, V65, P561, DOI 10.1002/jmv.2073; Ito R, 2003, VACCINE, V21, P2362, DOI 10.1016/S0264-410X(03)00078-1; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; JONES PD, 1987, CELL IMMUNOL, V109, P53, DOI 10.1016/0008-8749(87)90291-7; JONES PD, 1986, J VIROL, V60, P614, DOI 10.1128/JVI.60.2.614-619.1986; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Jonuleit H, 1996, ARCH DERMATOL RES, V289, P1, DOI 10.1007/s004030050144; JUSTEWICZ DM, 1995, J VIROL, V69, P7712, DOI 10.1128/JVI.69.12.7712-7717.1995; Kim JJ, 1999, J INTERF CYTOK RES, V19, P77, DOI 10.1089/107999099314441; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Lai L, 2007, VIROLOGY, V369, P153, DOI 10.1016/j.virol.2007.07.017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen DL, 1998, J VIROL, V72, P1704, DOI 10.1128/JVI.72.2.1704-1708.1998; Lee SW, 1999, VACCINE, V17, P490, DOI 10.1016/S0264-410X(98)00223-0; Lena P, 2002, VACCINE, V20, pA69, DOI 10.1016/S0264-410X(02)00391-2; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Looney RJ, 2001, J CLIN IMMUNOL, V21, P30, DOI 10.1023/A:1006736931381; MacGregor RR, 1998, J INFECT DIS, V178, P92, DOI 10.1086/515613; MacGregor RR, 2000, J INFECT DIS, V181, P406, DOI 10.1086/315199; Macklin MD, 1998, J VIROL, V72, P1491, DOI 10.1128/JVI.72.2.1491-1496.1998; Mitchell JA, 2003, VACCINE, V21, P902, DOI 10.1016/S0264-410X(02)00539-X; Murphey-Corb M, 1999, J IMMUNOL, V162, P540; NDHLOVU ZM, P NATL ACAD SCI US; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Olsen CW, 2000, VET MICROBIOL, V74, P149, DOI 10.1016/S0378-1135(00)00175-9; Operschall E, 1999, J CLIN VIROL, V13, P17, DOI 10.1016/S1386-6532(99)00008-6; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Robinson Harriet L., 1997, Journal of Infectious Diseases, V176, pS50, DOI 10.1086/514176; Robinson HL, 2006, VIROLOGY, V352, P285, DOI 10.1016/j.virol.2006.02.011; Roy MJ, 2000, VACCINE, V19, P764, DOI 10.1016/S0264-410X(00)00302-9; RUTIGLIANO JA, J VIROL, V84, P1047; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Slingluff CL, 2009, CLIN CANCER RES, V15, P7036, DOI 10.1158/1078-0432.CCR-09-1544; WAGNER DK, 1987, J CLIN MICROBIOL, V25, P559, DOI 10.1128/JCM.25.3.559-562.1987; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; WEBSTER RG, 1994, VACCINE, V12, P1495, DOI 10.1016/0264-410X(94)90071-X; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103; Yager EJ, 2009, EXPERT REV VACCINES, V8, P1205, DOI [10.1586/erv.09.82, 10.1586/ERV.09.82]	69	54	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11021	10.1371/journal.pone.0011021	http://dx.doi.org/10.1371/journal.pone.0011021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544035	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000278494900030
J	Kuijk, EW; de Gier, J; Lopes, SMCD; Chambers, I; van Pelt, AMM; Colenbrander, B; Roelen, BAJ				Kuijk, Ewart W.; de Gier, Jeffrey; Lopes, Susana M. Chuva de Sousa; Chambers, Ian; van Pelt, Ans M. M.; Colenbrander, Ben; Roelen, Bernard A. J.			A Distinct Expression Pattern in Mammalian Testes Indicates a Conserved Role for NANOG in Spermatogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INHIBITOR TRICHOSTATIN-A; GERM-CELLS; MOUSE TESTIS; PLURIPOTENCY; GENERATION; GENES; CARCINOMA; CLONING; FETAL	Background: NANOG is a key player in pluripotency and its expression is restricted to pluripotent cells of the inner cell mass, the epiblast and to primordial germ cells. Spermatogenesis is closely associated with pluripotency, because through this process highly specialized sperm cells are produced that contribute to the formation of totipotent zygotes. Nevertheless, it is unknown if NANOG plays a role in this process. Methodology/Principal Findings: In the current study, NANOG expression was examined in testes of various mammals, including mouse and human. Nanog mRNA and NANOG protein were detected by RT-PCR, immunohistochemistry, and western blotting. Furthermore, eGFP expression was detected in the testis of a transgenic Nanog eGFP-reporter mouse. Surprisingly, although NANOG expression has previously been associated with undifferentiated cells with stem cell potential, expression in the testis was observed in pachytene spermatocytes and in the first steps of haploid germ cell maturation (spermiogenesis). Weak expression in type A spermatogonia was also observed. Conclusions: The findings of the current study strongly suggest a conserved role for NANOG in meiotic and post-meiotic stages of male germ cell development.	[Kuijk, Ewart W.; Colenbrander, Ben; Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Kuijk, Ewart W.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Kuijk, Ewart W.] Hubrecht Inst KNAW, Utrecht, Netherlands; [de Gier, Jeffrey] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Lopes, Susana M. Chuva de Sousa] Leiden Univ, Leiden Univ Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Chambers, Ian] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, Med Res Council Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [van Pelt, Ans M. M.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Edinburgh; University of Amsterdam; Academic Medical Center Amsterdam	Kuijk, EW (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.	b.a.j.roelen@uu.nl	Chambers, Ian/H-5416-2011; Kuijk, Ewart/I-2569-2019	Chambers, Ian/0000-0003-2605-1597; Kuijk, Ewart/0000-0002-1385-6516; van Pelt, Ans/0000-0001-9155-548X	Netherlands Organization for Scientific Research (NWO) [916.76.015]; Medical Research Council [G0700711B] Funding Source: researchfish	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SMCDSL was financed by the Netherlands Organization for Scientific Research (NWO), VENI grant 916.76.015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fenic I, 2004, J ANDROL, V25, P811; Fenic I, 2008, J ANDROL, V29, P172, DOI 10.2164/jandrol.107.003848; Goel S, 2008, REPRODUCTION, V135, P785, DOI 10.1530/REP-07-0476; Golestaneh N, 2009, STEM CELLS DEV, V18, P1115, DOI 10.1089/scd.2008.0347; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hoei-Hansen CE, 2005, HISTOPATHOLOGY, V47, P48, DOI 10.1111/j.1365-2559.2005.02182.x; Izadyar F, 2008, REPRODUCTION, V135, P771, DOI 10.1530/REP-07-0479; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Robertson M, 2006, MAMM GENOME, V17, P732, DOI 10.1007/s00335-005-0131-y; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaguchi S, 2009, DEVELOPMENT, V136, P4011, DOI 10.1242/dev.041160; Zamudio NM, 2008, REPRODUCTION, V136, P131, DOI 10.1530/REP-07-0576	31	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10987	10.1371/journal.pone.0010987	http://dx.doi.org/10.1371/journal.pone.0010987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539761	Green Published, Green Submitted, gold			2022-12-25	WOS:000278465900007
J	Marozin, S; De Toni, EN; Rizzani, A; Altomonte, J; Junger, A; Schneider, G; Thasler, WE; Kato, N; Schmid, RM; Ebert, O				Marozin, Sabrina; De Toni, Enrico N.; Rizzani, Antonia; Altomonte, Jennifer; Junger, Alexandra; Schneider, Guenter; Thasler, Wolfgang E.; Kato, Nobuyuki; Schmid, Roland M.; Ebert, Oliver			Cell Cycle Progression or Translation Control Is Not Essential for Vesicular Stomatitis Virus Oncolysis of Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HERPES-SIMPLEX-VIRUS; PROTEIN-SYNTHESIS; CANCER-CELLS; HUMAN HEPATOCYTES; STEM-CELLS; INITIATION; REPLICATION; INTERFERON; THERAPY	The intrinsic oncolytic specificity of vesicular stomatitis virus (VSV) is currently being exploited to develop alternative therapeutic strategies for hepatocellular carcinoma (HCC). Identifying key regulators in diverse transduction pathways that define VSV oncolysis in cancer cells represents a fundamental prerequisite to engineering more effective oncolytic viral vectors and adjusting combination therapies. After having identified defects in the signalling cascade of type I interferon induction, responsible for attenuated antiviral responses in human HCC cell lines, we have now investigated the role of cell proliferation and translation initiation. Cell cycle progression and translation initiation factors eIF4E and eIF2B epsilon have been recently identified as key regulators of VSV permissiveness in T-lymphocytes and immortalized mouse embryonic fibroblasts, respectively. Here, we show that in HCC, decrease of cell proliferation by cell cycle inhibitors or siRNA-mediated reduction of G(1) cyclin-dependent kinase activities (CDK4) or cyclin D1 protein expression, do not significantly alter viral growth. Additionally, we demonstrate that translation initiation factors eIF4E and eIF2B epsilon are negligible in sustaining VSV replication in HCC. Taken together, these results indicate that cellular proliferation and the initiation phase of cellular protein synthesis are not essential for successful VSV oncolysis of HCC. Moreover, our observations indicate the importance of cell-type specificity for VSV oncolysis, an important aspect to be considered in virotherapy applications in the future.	[Marozin, Sabrina; Altomonte, Jennifer; Junger, Alexandra; Schneider, Guenter; Schmid, Roland M.; Ebert, Oliver] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-8000 Munich, Germany; [De Toni, Enrico N.; Rizzani, Antonia] Univ Munich, Klinikum Grosshadern, Med Klin & Poliklin 2, D-8000 Munich, Germany; [Thasler, Wolfgang E.] Univ Munich, Klinikum Grosshadern, Chirurg Klin & Poliklin, D-8000 Munich, Germany; [Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Biol, Okayama, Japan	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Munich; Okayama University	Marozin, S (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-8000 Munich, Germany.	oliver.ebert@lrz.tum.de	Marozin, Sabrina/N-7033-2014; De Toni, Enrico N/C-6496-2008	Marozin, Sabrina/0000-0003-1650-9488; Altomonte, Jennifer/0000-0003-1079-3633	German Research Aid; Federal Ministry of Education and Research [01GU0505]; German Research Foundation, Bonn, Germany (DFG) [SFB 824 (Sonderforschungsbereich 824)]	German Research Aid; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation, Bonn, Germany (DFG)(German Research Foundation (DFG))	This work was supported in part by the German Research Aid (Max-Eder Research Program), the Federal Ministry of Education and Research (Grant 01GU0505) and the SFB 824 (DFG Sonderforschungsbereich 824), German Research Foundation, Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Cascone T, 2008, J CELL PHYSIOL, V216, P698, DOI 10.1002/jcp.21444; Chakraborty P, 2009, EMBO REP, V10, P1154, DOI 10.1038/embor.2009.179; CHIANG PC, 2009, BIOCH PHARM; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Cripe TP, 2009, MOL THER, V17, P1677, DOI 10.1038/mt.2009.193; Dancey JE, 2006, CANCER BIOL THER, V5, P1065, DOI 10.4161/cbt.5.9.3175; Dansako H, 2003, VIRUS RES, V97, P17, DOI 10.1016/S0168-1702(03)00218-1; Dansako H, 2007, FEBS J, V274, P4161, DOI 10.1111/j.1742-4658.2007.05942.x; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; DUNN EF, 2009, J VIROL; Ebert O, 2003, CANCER RES, V63, P3605; Ebert O, 2004, CANCER GENE THER, V26, P26; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Gallagher JW, 2008, CANCER RES, V68, P8752, DOI 10.1158/0008-5472.CAN-08-1042; Hallenbeck PL, 1999, HUM GENE THER, V10, P1721, DOI 10.1089/10430349950017725; Hamid NA, 2009, CELL MOL LIFE SCI, V66, P1700, DOI 10.1007/s00018-009-8631-7; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kato N, 1996, JPN J CANCER RES, V87, P787, DOI 10.1111/j.1349-7006.1996.tb02101.x; Kemeny N, 2006, HUM GENE THER, V17, P1214, DOI 10.1089/hum.2006.17.1214; Kjellerup RB, 2008, EXP DERMATOL, V17, P498, DOI 10.1111/j.1600-0625.2007.00672.x; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lun XQ, 2009, CLIN CANCER RES, V15, P2777, DOI 10.1158/1078-0432.CCR-08-2342; Marozin S, 2008, MOL THER, V16, P1789, DOI 10.1038/mt.2008.201; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Newell P, 2009, J HEPATOL, V51, P725, DOI 10.1016/j.jhep.2009.03.028; Nguyen TLA, 2009, CELL MICROBIOL, V11, P889, DOI 10.1111/j.1462-5822.2009.01317.x; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Oliere S, 2008, J VIROL, V82, P5735, DOI 10.1128/JVI.02601-07; Orlando JS, 2006, J VIROL, V80, P4005, DOI 10.1128/JVI.80.8.4005-4016.2006; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Schang Luis M, 2003, Prog Cell Cycle Res, V5, P103; Sei S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-47; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shinozaki K, 2005, HEPATOLOGY, V41, P196, DOI 10.1002/hep.20536; Shinozaki K, 2004, MOL THER, V9, P368, DOI 10.1016/j.ymthe.2003.12.004; Silva RLA, 2008, CELL CYCLE, V7, P553, DOI 10.4161/cc.7.5.5486; Sun M, 2008, J VIROL, V82, P105, DOI 10.1128/JVI.01520-07; Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang F, 2009, J VIROL, V83, P5928, DOI 10.1128/JVI.02587-08; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Yang SX, 2007, ONCOL REP, V17, P281	51	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10988	10.1371/journal.pone.0010988	http://dx.doi.org/10.1371/journal.pone.0010988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539760	Green Published, Green Submitted, gold			2022-12-25	WOS:000278465900008
J	Pansiot, J; Loron, G; Olivier, P; Fontaine, R; Charriaut-Marlangue, C; Mercier, JC; Gressens, P; Baud, O				Pansiot, Julien; Loron, Gauthier; Olivier, Paul; Fontaine, Romain; Charriaut-Marlangue, Christiane; Mercier, Jean-Christophe; Gressens, Pierre; Baud, Olivier			Neuroprotective Effect of Inhaled Nitric Oxide on Excitotoxic-Induced Brain Damage in Neonatal Rat	PLOS ONE			English	Article							WHITE-MATTER INJURY; ISCHEMIC BRAIN; PERIVENTRICULAR LEUKOMALACIA; RESPIRATORY-FAILURE; PREMATURE-INFANTS; GENE-EXPRESSION; NERVOUS-SYSTEM; OLIGODENDROCYTES; GLUTAMATE; LESIONS	Background: Inhaled nitric oxide (iNO) is one of the most promising therapies used in neonates. However, little information is known about its impact on the developing brain submitted to excitotoxic challenge. Methodology/Principal Findings: We investigated here the effect of iNO in a neonatal model of excitotoxic brain lesions. Rat pups and their dams were placed in a chamber containing 20 ppm NO during the first week of life. At postnatal day (P) 5, rat pups were submitted to intracranial injection of glutamate agonists. At P10, rat pups exposed to iNO exhibited a significant decrease of lesion size in both the white matter and cortical plate compared to controls. Microglia activation and astrogliosis were found significantly decreased in NO-exposed animals. This neuroprotective effect was associated with a significant decrease of several glutamate receptor subunits expression at P5. iNO was associated with an early (P1) downregulation of pCREB/pAkt expression and induced an increase in pAkt protein concentration in response to excitotoxic challenge (P7). Conclusion: This study is the first describe and investigate the neuroprotective effect of iNO in neonatal excitotoxic-induced brain damage. This effect may be mediated through CREB pathway and subsequent modulation of glutamate receptor subunits expression.	[Pansiot, Julien; Loron, Gauthier; Olivier, Paul; Charriaut-Marlangue, Christiane; Gressens, Pierre; Baud, Olivier] Hop Robert Debre, INSERM, UMR 676, F-75019 Paris, France; [Fontaine, Romain] Univ Paris 06, INSERM, UMR 711, Fac Med,Hop Salpetriere, Paris, France; [Mercier, Jean-Christophe] Hop Robert Debre, AP HP, Emergency Dept, F-75019 Paris, France; [Gressens, Pierre; Baud, Olivier] Hop Robert Debre, AP HP, Neonatal Intens Care Unit, F-75019 Paris, France; [Baud, Olivier] PremUP Fdn, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Baud, O (corresponding author), Hop Robert Debre, INSERM, UMR 676, F-75019 Paris, France.	olivier.baud@rdb.aphp.fr	gressens, pierre/M-7557-2017; , CHARRIAUT-MARLANGUE/H-3249-2019	gressens, pierre/0000-0002-0909-4221; LORON, Gauthier/0000-0001-9536-9510	Ikaria, Inc.; INSERM; INSERM AVENIR; Mairie de Paris; Ikaria (iNOTherapeutics)	Ikaria, Inc.; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INSERM AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mairie de Paris(Region Ile-de-France); Ikaria (iNOTherapeutics)	Funding: The experimental research program of Dr. Olivier Baud and his coworkers concerning iNO is partially supported by Ikaria, Inc. This study was financially supported by the INSERM, the INSERM AVENIR Program and the Mairie de Paris. Paul Olivier and Gauthier Loron were financially supported by Ikaria (iNOTherapeutics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arul N, 2009, CLIN PERINATOL, V36, P43, DOI 10.1016/j.clp.2008.09.002; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Barrington KJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000509.pub2; Baud O, 2004, EUR J NEUROSCI, V20, P1713, DOI 10.1111/j.1460-9568.2004.03616.x; Baud O, 2004, BRAIN PATHOL, V14, P1; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cheung PY, 1998, LANCET, V351, P1181, DOI 10.1016/S0140-6736(05)79127-3; Chiueh CC, 1999, ANN NY ACAD SCI, V890, P301, DOI 10.1111/j.1749-6632.1999.tb08007.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dommergues MA, 2000, ANN NEUROL, V47, P54, DOI 10.1002/1531-8249(200001)47:1<54::AID-ANA10>3.3.CO;2-P; Fontaine RH, 2008, P NATL ACAD SCI USA, V105, P16779, DOI 10.1073/pnas.0803004105; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Haynes RL, 2005, BRAIN PATHOL, V15, P225; Husson I, 2002, ANN NEUROL, V51, P82, DOI 10.1002/ana.10072; Iadecola C, 1997, J NEUROSCI, V17, P9157; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kinsella JP, 2006, NEW ENGL J MED, V355, P354, DOI 10.1056/NEJMoa060442; Kinsella JP, 1999, LANCET, V354, P1061, DOI 10.1016/S0140-6736(99)03558-8; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Lau GC, 2004, J NEUROCHEM, V88, P564, DOI 10.1046/j.1471-4159.2003.02156.x; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; MARGAILL I, 1994, BRIT J PHARMACOL, V651, P92; MARRET S, 1995, J NEUROPATH EXP NEUR, V54, P358, DOI 10.1097/00005072-199505000-00009; Mayhan WG, 2000, BRAIN RES, V866, P101, DOI 10.1016/S0006-8993(00)02254-X; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; Mesples B, 2005, ACTA PAEDIATR, V94, P185, DOI 10.1080/08035250410022378; Mestan KKL, 2005, NEW ENGL J MED, V353, P23, DOI 10.1056/NEJMoa043514; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rani CSS, 2005, MOL PHARMACOL, V67, P2126, DOI 10.1124/mol.104.007872; Rosenberg PA, 1999, J NEUROCHEM, V73, P476, DOI 10.1046/j.1471-4159.1999.0730476.x; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; Shouman B, 2006, BRIT J PHARMACOL, V148, P442, DOI 10.1038/sj.bjp.0706755; Steinhorn RH, 2007, CURR OPIN PEDIATR, V19, P137, DOI 10.1097/MOP.0b013e328082e2ed; YAMAMOTO S, 1992, J CEREBR BLOOD F MET, V12, P717, DOI 10.1038/jcbfm.1992.102; ZAHARCHUK G, 1997, MAGN RESON MED, V17, P9157	42	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10916	10.1371/journal.pone.0010916	http://dx.doi.org/10.1371/journal.pone.0010916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532231	Green Published, gold, Green Submitted			2022-12-25	WOS:000278222400011
J	Hueber, SD; Weiller, GF; Djordjevic, MA; Frickey, T				Hueber, Stefanie D.; Weiller, Georg F.; Djordjevic, Michael A.; Frickey, Tancred			Improving Hox Protein Classification across the Major Model Organisms	PLOS ONE			English	Article							HOMEOTIC GENES; FUNCTIONAL EQUIVALENCE; DROSOPHILA EMBRYOS; SEGMENTAL IDENTITY; EVOLUTION; SEQUENCE; ORGANIZATION; SPECIFICITY; EXPRESSION; COMPLEX	The family of Hox-proteins has been a major focus of research for over 30 years. Hox-proteins are crucial to the correct development of bilateral organisms, however, some uncertainty remains as to which Hox-proteins are functionally equivalent across different species. Initial classification of Hox-proteins was based on phylogenetic analysis of the 60 amino acid homeodomain. This approach was successful in classifying Hox-proteins with differing homeodomains, but the relationships of Hox-proteins with nearly identical homeodomains, yet distinct biological functions, could not be resolved. Correspondingly, these 'problematic' proteins were classified into one large unresolved group. Other classifications used the relative location of the Hox-protein coding genes on the chromosome (synteny) to further resolve this group. Although widely used, this synteny-based classification is inconsistent with experimental evidence from functional equivalence studies. These inconsistencies led us to re-examine and derive a new classification for the Hox-protein family using all Hox-protein sequences available in the GenBank non-redundant protein database (NCBI-nr). We compare the use of the homeodomain, the homeodomain with conserved flanking regions (the YPWM and linker region), and full length Hox-protein sequences as a basis for classification of Hox-proteins. In contrast to previous attempts, our approach is able to resolve the relationships for the 'problematic' as well as ABD-B-like Hox-proteins. We highlight differences to previous classifications and clarify the relationships of Hox-proteins across the five major model organisms, Caenorhabditis elegans, Drosophila melanogaster, Branchiostoma floridae, Mus musculus and Danio rerio. Comparative and functional analysis of Hox-proteins, two fields crucial to understanding the development of bilateral organisms, have been hampered by difficulties in predicting functionally equivalent Hox-proteins across species. Our classification scheme offers a higher-resolution classification that is in accordance with phylogenetic as well as experimental data and, thereby, provides a novel basis for experiments, such as comparative and functional analyses of Hox-proteins.	[Hueber, Stefanie D.; Weiller, Georg F.; Djordjevic, Michael A.; Frickey, Tancred] Australian Natl Univ, Genom Interact Grp, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia	Australian National University	Hueber, SD (corresponding author), Australian Natl Univ, Genom Interact Grp, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia.	georg.weiller@anu.edu.au	Djordjevic, Michael/C-9945-2009; Weiller, Georg F/C-9911-2009	Djordjevic, Michael/0000-0002-9819-1372	Australian Research Council [CEO348212]	Australian Research Council(Australian Research Council)	Funding for this work has been provided by the Australian Research Council, Center for Excellence Grant (CEO348212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI N, 1991, MECH DEVELOP, V35, P55, DOI 10.1016/0925-4773(91)90041-4; ALTSHUL SF, 1997, NUCLEIC ACIDS RES, V25, P402; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Biggin MD, 1997, DEVELOPMENT, V124, P4425; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Chauvet S, 2000, P NATL ACAD SCI USA, V97, P4064, DOI 10.1073/pnas.070046997; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrier DEK, 2000, EVOL DEV, V2, P284, DOI 10.1046/j.1525-142x.2000.00070.x; Foronda D, 2009, INT J DEV BIOL, V53, P1409, DOI 10.1387/ijdb.072462df; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; FRICKEY T, 2009, ALNEDIT RSBS BIOINFO; Frickey T, 2007, BIOINFORMATICS, V23, P1170, DOI 10.1093/bioinformatics/btm079; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gehring WJ, 2009, CURR TOP DEV BIOL, V88, P35, DOI 10.1016/S0070-2153(09)88002-2; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; HARDING K, 1985, SCIENCE, V229, P1236, DOI 10.1126/science.3898362; HEUER JG, 1992, DEVELOPMENT, V115, P35; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; HUNTER CP, 1995, NATURE, V377, P229, DOI 10.1038/377229a0; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KRUMLAUF R, 1992, BIOESSAYS, V14, P245, DOI 10.1002/bies.950140408; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lewis EB, 2003, CURR BIOL, V13, pR587, DOI 10.1016/S0960-9822(03)00520-7; Lutz B, 1996, GENE DEV, V10, P176, DOI 10.1101/gad.10.2.176; MALICKI J, 1990, CELL, V63, P961, DOI 10.1016/0092-8674(90)90499-5; MALICKI J, 1993, MECH DEVELOP, V42, P139, DOI 10.1016/0925-4773(93)90003-G; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1994, SCI AM, V270, P58, DOI 10.1038/scientificamerican0294-58; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Merabet S, 2009, BIOESSAYS, V31, P500, DOI 10.1002/bies.200800229; Minguillon C, 2005, INT J BIOL SCI, V1, P19; Monteiro AS, 2006, INT J BIOL SCI, V2, P95; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Percival-Smith A, 2005, GENOME, V48, P712, DOI 10.1139/G05-021; Prince VE, 2002, DEV BIOL, V249, P1, DOI 10.1006/dbio.2002.0745; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; REED HC, 2009, GENETICS; RUDDLE FH, 1994, ANNU REV GENET, V28, P423, DOI 10.1146/annurev.ge.28.120194.002231; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; Veraksa A, 2000, MOL GENET METAB, V69, P85, DOI 10.1006/mgme.2000.2963; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Zakany J, 1996, DEV BIOL, V176, P325, DOI 10.1006/dbio.1996.0137; ZHAO JJ, 1993, GENE DEV, V7, P343, DOI 10.1101/gad.7.3.343	57	19	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10820	10.1371/journal.pone.0010820	http://dx.doi.org/10.1371/journal.pone.0010820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520839	Green Published, gold			2022-12-25	WOS:000278034800015
J	Liu, J; Luo, XJ; Xiong, AW; Zhang, ZD; Yue, S; Zhu, MS; Cheng, SY				Liu, Jun; Luo, Xiao-ju; Xiong, An-wen; Zhang, Zeng-di; Yue, Shen; Zhu, Ming-sheng; Cheng, Steven Y.			MicroRNA-214 Promotes Myogenic Differentiation by Facilitating Exit from Mitosis via Down-regulation of Proto-oncogene N-ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC MICRORNA; TUMOR-SUPPRESSOR SUFU; SKELETAL-MUSCLE; TERMINAL DIFFERENTIATION; STEM-CELLS; MYOD; EXPRESSION; PROLIFERATION; DEGRADATION; TARGETS	Vertebrate muscle differentiation is coordinated by an intricate network of transcription factors requiring proliferating myogenic precursors to withdraw irreversibly from the cell cycle. Recent studies have implicated a large number of microRNAs exerting another layer of control in many aspects of muscle differentiation. By annealing to short recognition sequences in the 3'-untranslated region, microRNAs attenuate target gene expression through translation repression or mRNA degradation. Here, we show that miR-214 promotes myogenic differentiation in mouse C2C12 myoblasts at a step preceding the induction of p21 and myogenin. Blocking miR-214 function with a 2'-O-methylated double-stranded inhibitor maintained C2C12 cells in the active cell cycle, thereby inhibiting the myogenic differentiation. By global gene expression profiling, we identified the proto-oncogene N-ras as one of miR-214 targets. Furthermore, manipulating the N-Ras level with small interfering RNA or adenovirus-mediated forced expression either augmented or attenuated the effect of miR-214, respectively. Thus, our data uncovered a novel microRNA-mediated mechanism that controls myogenic differentiation.	[Liu, Jun; Luo, Xiao-ju; Xiong, An-wen; Zhang, Zeng-di; Yue, Shen; Cheng, Steven Y.] Nanjing Med Univ, Dept Dev Genet, Ctr Canc Res, Nanjing 210029, Jiangsu, Peoples R China; [Liu, Jun; Luo, Xiao-ju; Xiong, An-wen; Zhang, Zeng-di; Yue, Shen; Cheng, Steven Y.] Nanjing Med Univ, Ctr Regenerat Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhu, Ming-sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 21006, Jiangsu, Peoples R China; [Zhu, Ming-sheng] Nanjing Univ, Minist Educ, Key Lab Model Anim & Dis Study, Nanjing 21006, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University; Nanjing University	Cheng, SY (corresponding author), Nanjing Med Univ, Dept Dev Genet, Ctr Canc Res, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	sycheng@njmu.edu.cn			Chinese National Science Foundation [30871401]; 973 National Basic Research Program of China [2009CB942602]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); 973 National Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by Chinese National Science Foundation Grant 30871401 (to S. Y. C.) and 973 National Basic Research Program of China Grant 2009CB942602 (to M.-s. Z.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Brennecke J, 2005, GENE DEV, V19, P2261, DOI 10.1101/gad.1363905; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2008, CURR OPIN GENET DEV, V18, P330, DOI 10.1016/j.gde.2008.06.005; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; De Falco G, 2006, ONCOGENE, V25, P5244, DOI 10.1038/sj.onc.1209623; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; Polesskaya A, 2002, DEV CELL, V3, P757, DOI 10.1016/S1534-5807(02)00372-6; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Watanabe T, 2008, DEV DYNAM, V237, P3738, DOI 10.1002/dvdy.21787; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ying SX, 2003, J BIOL CHEM, V278, P39029, DOI 10.1074/jbc.M301193200; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	40	71	77	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26599	26607		10.1074/jbc.M110.115824	http://dx.doi.org/10.1074/jbc.M110.115824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20534588	Green Published, hybrid			2022-12-25	WOS:000280921000075
J	Neerincx, A; Lautz, K; Menning, M; Kremmer, E; Zigrino, P; Hosel, M; Buning, H; Schwarzenbacher, R; Kufer, TA				Neerincx, Andreas; Lautz, Katja; Menning, Maureen; Kremmer, Elisabeth; Zigrino, Paola; Hoesel, Marianna; Buening, Hildegard; Schwarzenbacher, Robert; Kufer, Thomas A.			A Role for the Human Nucleotide-binding Domain, Leucine-rich Repeat-containing Family Member NLRC5 in Antiviral Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; PATTERN-RECOGNITION; SIGNALING PATHWAYS; IMMUNE-RESPONSES; EPITHELIAL-CELLS; VIRAL-INFECTION; INNATE IMMUNITY; ACTIVATION; GENE	Proteins of the nucleotide-binding domain, leucine-rich repeat (NLR)-containing family recently gained attention as important components of the innate immune system. Although over 20 of these proteins are present in humans, only a few members including the cytosolic pattern recognition receptors NOD1, NOD2, and NLRP3 have been analyzed extensively. These NLRs were shown to be pivotal for mounting innate immune response toward microbial invasion. Here we report on the characterization of human NLRC5 and provide evidence that this NLR has a function in innate immune responses. We found that NLRC5 is a cytosolic protein expressed predominantly in hematopoetic cells. NLRC5 mRNA and protein expression was inducible by the double-stranded RNA analog poly(I.C) and Sendai virus. Overexpression of NLRC5 failed to trigger inflammatory responses such as the NF-kappa B or interferon pathways in HEK293T cells. However, knockdown of endogenous NLRC5 reduced Sendai virus-and poly(I.C)-mediated type I interferon pathway-dependent responses in THP-1 cells and human primary dermal fibroblasts. Taken together, this defines a function for NLRC5 in anti-viral innate immune responses.	[Neerincx, Andreas; Lautz, Katja; Menning, Maureen; Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Zigrino, Paola] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Hoesel, Marianna; Buening, Hildegard] Univ Cologne, Innere Med Klin 1, D-50937 Cologne, Germany; [Hoesel, Marianna; Buening, Hildegard] Univ Cologne, Zentrum Mol Biol Koln, D-50931 Cologne, Germany; [Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	University of Cologne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cologne; University of Cologne; University of Cologne; Salzburg University	Kufer, TA (corresponding author), Joseph Stelzmann Str 9,Geb 37, D-50931 Cologne, Germany.	thomas.kufer@uk-koeln.de	Kufer, Thomas A/I-5146-2015; Buening, Hildegard/AAV-9928-2021; Buening, Hildegard/AAJ-2352-2020	Kufer, Thomas A/0000-0003-4563-0412; Buening, Hildegard/0000-0002-3365-6933; Zigrino, Paola/0000-0002-7470-0064	Deutsche Forschungsgemeinschaft [SFB670-N01, SFB670-TP8]; European Commission [MEXT-CT-2006-033534]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB670-N01 (to T.A.K.) and SFB670-TP8 (to M.H. and H.B.) and European Commission Grant MEXT-CT-2006-033534 (to R.S. and A.N.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bielig H, 2009, MOL IMMUNOL, V46, P2647, DOI 10.1016/j.molimm.2009.04.022; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Hua J, 1996, J LEUKOCYTE BIOL, V60, P125, DOI 10.1002/jlb.60.1.125; Hughes AL, 2006, IMMUNOGENETICS, V58, P785, DOI 10.1007/s00251-006-0148-8; Inohara N, 2000, J BIOL CHEM, V275, P27823; Istomin AY, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-48; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Lin RT, 1999, MOL CELL BIOL, V19, P959; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; Matsukura S, 1998, AM J RESP CELL MOL, V18, P255, DOI 10.1165/ajrcmb.18.2.2822; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh HM, 2005, CELL IMMUNOL, V237, P37, DOI 10.1016/j.cellimm.2005.09.006; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Quasdorff M, 2008, CELL MICROBIOL, V10, P1478, DOI 10.1111/j.1462-5822.2008.01141.x; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Vijay-Kumar M, 2005, J IMMUNOL, V174, P6322, DOI 10.4049/jimmunol.174.10.6322; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Zigrino P, 2001, EUR J CELL BIOL, V80, P68, DOI 10.1078/0171-9335-00134	38	125	137	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26223	26232		10.1074/jbc.M110.109736	http://dx.doi.org/10.1074/jbc.M110.109736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538593	Green Published, hybrid			2022-12-25	WOS:000280921000039
J	Blais, DR; Lyn, RK; Joyce, MA; Rouleau, Y; Steenbergen, R; Barsby, N; Zhu, LF; Pegoraro, AF; Stolow, A; Tyrrell, DL; Pezacki, JP				Blais, David R.; Lyn, Rodney K.; Joyce, Michael A.; Rouleau, Yanouchka; Steenbergen, Rineke; Barsby, Nicola; Zhu, Lin-Fu; Pegoraro, Adrian F.; Stolow, Albert; Tyrrell, David L.; Pezacki, John Paul			Activity-based Protein Profiling Identifies a Host Enzyme, Carboxylesterase 1, Which Is Differentially Active during Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAMAN-SCATTERING MICROSCOPY; CHOLESTERYL ESTER HYDROLASE; ACTIVITY-BASED PROBES; LIPID DROPLETS; TRIACYLGLYCEROL HYDROLASE; CORE PROTEIN; IN-VIVO; ENDOPLASMIC-RETICULUM; CARS MICROSCOPY; RNA REPLICATION	Hepatitis C virus (HCV) relies on many interactions with host cell proteins for propagation. Successful HCV infection also requires enzymatic activity of host cell enzymes for key post-translational modifications. To identify such enzymes, we have applied activity-based protein profiling to examine the activity of serine hydrolases during HCV replication. Profiling of hydrolases in Huh7 cells replicating HCV identified CES1 (carboxylesterase 1) as a differentially active enzyme. CES1 is an endogenous liver protein involved in processing of triglycerides and cholesterol. We observe that CES1 expression and activity were altered in the presence of HCV. The knockdown of CES1 with siRNA resulted in lower levels of HCV replication, and up-regulation of CES1 was observed to favor HCV propagation, implying an important role for this host cell protein. Experiments in HCV JFH1-infected cells suggest that CES1 facilitates HCV release because less intracellular HCV core protein was observed, whereas HCV titers remained high. CES1 activity was observed to increase the size and density of lipid droplets, which are necessary for the maturation of very low density lipoproteins, one of the likely vehicles for HCV release. In transgenic mice containing human-mouse chimeric livers, HCV infection also correlates with higher levels of endogenous CES1, providing further evidence that CES1 has an important role in HCV propagation.	[Blais, David R.; Lyn, Rodney K.; Rouleau, Yanouchka; Pegoraro, Adrian F.; Stolow, Albert; Pezacki, John Paul] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Chem & Biochem, Ottawa, ON K1N 6N5, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Microbiol, Ottawa, ON K1N 6N5, Canada; [Joyce, Michael A.; Steenbergen, Rineke; Barsby, Nicola; Zhu, Lin-Fu; Tyrrell, David L.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Pegoraro, Adrian F.; Stolow, Albert] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Immunol, Ottawa, ON K1N 6N5, Canada	National Research Council Canada; University of Ottawa; University of Ottawa; University of Alberta; Queens University - Canada; University of Ottawa	Pezacki, JP (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	john.pezacki@nrc-cnrc.gc.ca	Stolow, Albert/AAN-5609-2020	Pegoraro, Adrian/0000-0003-3334-227X	Canadian Liver Foundation; Canadian Institutes for Health Research; National Research Council Genomics and Health Initiative	Canadian Liver Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Research Council Genomics and Health Initiative	This work was supported by the Canadian Liver Foundation, the Canadian Institutes for Health Research, and the National Research Council Genomics and Health Initiative.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Barglow KT, 2008, BIOCHEMISTRY-US, V47, P13514, DOI 10.1021/bi801786y; Beckman M, 2006, SCIENCE, V311, P1232, DOI 10.1126/science.311.5765.1232; Blais DR, 2010, J PROTEOME RES, V9, P912, DOI 10.1021/pr900788a; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Cheng JX, 2002, BIOPHYS J, V83, P502, DOI 10.1016/S0006-3495(02)75186-2; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gilham D, 2005, MOL BIOL CELL, V16, P984, DOI 10.1091/mbc.e04-03-0224; Gilham D, 2003, FASEB J, V17, P1685, DOI 10.1096/fj.02-0728fje; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lehner R, 1999, BIOCHEM J, V338, P761, DOI 10.1042/0264-6021:3380761; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Listenberger LL, 2008, CURR BIOL, V18, pR237, DOI 10.1016/j.cub.2008.01.010; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nan XL, 2006, CHEMBIOCHEM, V7, P1895, DOI 10.1002/cbic.200600330; Noestheden M, 2007, ORG BIOMOL CHEM, V5, P2380, DOI 10.1039/b704812b; Patton HM, 2004, J HEPATOL, V40, P484, DOI 10.1016/j.jhep.2003.11.004; Pegoraro AF, 2009, OPT EXPRESS, V17, P2984, DOI 10.1364/OE.17.002984; Pezacki JP, 2010, MOL BIOSYST, V6, P1131, DOI 10.1039/b924668c; Potma EO, 2003, J RAMAN SPECTROSC, V34, P642, DOI 10.1002/jrs.1045; Potter PM, 1998, CANCER RES, V58, P3627; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Rakic B, 2006, CHEM BIOL, V13, P23, DOI 10.1016/j.chembiol.2005.10.006; ROBBI M, 1991, J BIOL CHEM, V266, P20498; Sagan SM, 2006, BIOCHEM CELL BIOL, V84, P67, DOI 10.1139/O05-149; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Singaravelu R, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-5; Steinkuhler C, 1998, BIOCHEMISTRY-US, V37, P8899, DOI 10.1021/bi980313v; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Taketani M, 2007, LIFE SCI, V81, P924, DOI 10.1016/j.lfs.2007.07.026; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Wang H, 2007, J BIOL CHEM, V282, P33218, DOI 10.1074/jbc.M706841200; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Yang ZM, 2009, BIOORGAN MED CHEM, V17, P1071, DOI 10.1016/j.bmc.2008.02.089; Zhao B, 2005, J LIPID RES, V46, P2114, DOI 10.1194/jlr.M500207-JLR200; Zhao B, 2005, PHYSIOL GENOMICS, V23, P304, DOI 10.1152/physiolgenomics.00187.2005	63	52	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25602	25612		10.1074/jbc.M110.135483	http://dx.doi.org/10.1074/jbc.M110.135483			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530478	hybrid, Green Published			2022-12-25	WOS:000280682400054
J	Anyatonwu, G; Khan, MT; Schug, ZT; da Fonseca, PCA; Morris, EP; Joseph, SK				Anyatonwu, Georgia; Khan, M. Tariq; Schug, Zachary T.; da Fonseca, Paula C. A.; Morris, Edward P.; Joseph, Suresh K.			Calcium-dependent Conformational Changes in Inositol Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SITE; 1,4,5-TRISPHOSPHATE RECEPTOR; IP3 RECEPTORS; CRYSTAL-STRUCTURE; CA2+ RELEASE; DOMAIN; APOPTOSIS; CELLS; PORE; PHOSPHORYLATION	We have used limited trypsin digestion and reactivity with PEG-maleimides (MPEG) to study Ca2+-induced conformational changes of IP(3)Rs in their native membrane environment. We found that Ca2+ decreased the formation of the 95-kDa C-terminal tryptic fragment when detected by an Ab directed at a C-terminal epitope (CT-1) but not with an Ab recognizing a protected intraluminal epitope. This suggests that Ca2+ induces a conformational change in the IP3R that allows trypsin to cleave the C-terminal epitope. Half-maximal effects of Ca2+ were observed at similar to 0.5 mu M and was sensitive to inhibition by IP3. Ca2+ also stimulated the reaction of MPEG-5 with an endogenous thiol in the 95-kDa fragment. This effect was eliminated when six closely spaced cysteine residues proximal to the transmembrane domains were mutated (C2000S, C2008S, C2010S, C2043S, C2047S, and C2053S) or when the N-terminal suppressor domain (amino acids 1-225) was deleted. A cysteine substitution mutant introduced at the C-terminal residue (A2749C) was freely accessible to MPEG-5 or MPEG-20 in the absence of Ca2+. However, cysteine substitution mutants in the interior of the tail were poorly reactive with MPEG-5, although reactivity was enhanced by Ca2+. We conclude the following: a) that large conformational changes induced by Ca2+ can be detected in IP(3)Rs in situ; b) these changes may be driven by Ca2+ binding to the N-terminal suppressor domain and expose a group of closely spaced endogenous thiols in the channel domain; and c) that the C-terminal cytosol-exposed tail of the IP3R may be relatively inaccessible to regulatory proteins unless Ca2+ is present.	[Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [da Fonseca, Paula C. A.; Morris, Edward P.] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England	Jefferson University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 230A,JAH,1020 Locust St, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu		da Fonseca, Paula/0000-0001-8656-5747; Morris, Edward/0000-0003-3544-0041; Schug, Zachary/0000-0003-4197-8227	National Institutes of Health [DK34804, T32-AA-7463]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant DK34804 (to S. K. J.) and Training Grant T32-AA-7463 (to G. A.).	Anyatonwu G, 2009, J BIOL CHEM, V284, P8093, DOI 10.1074/jbc.M806932200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; da Fonseca PCA, 2003, P NATL ACAD SCI USA, V100, P3936, DOI 10.1073/pnas.0536251100; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Galvan DL, 2002, J BIOL CHEM, V277, P48248, DOI 10.1074/jbc.M209990200; Hamada K, 2003, J BIOL CHEM, V278, P52881, DOI 10.1074/jbc.M309743200; Hamada K, 2002, J BIOL CHEM, V277, P21115, DOI 10.1074/jbc.C200244200; Howorka S, 2000, J AM CHEM SOC, V122, P2411, DOI 10.1021/ja993221h; Joseph SK, 2006, BIOCHEM J, V393, P575, DOI 10.1042/BJ20050889; Joseph SK, 2005, CELL CALCIUM, V38, P539, DOI 10.1016/j.ceca.2005.07.007; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; Kawaai K, 2009, J BIOL CHEM, V284, P372, DOI 10.1074/jbc.M805828200; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Khan MT, 2003, BIOCHEM J, V375, P603, DOI 10.1042/BJ20030828; LIN JK, 1987, BIOTECHNOL BIOENG, V29, P976, DOI 10.1002/bit.260290809; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Serysheva II, 2003, J BIOL CHEM, V278, P21319, DOI 10.1074/jbc.C300148200; Shirakawa H, 2006, BIOCHEM BIOPH RES CO, V345, P781, DOI 10.1016/j.bbrc.2006.04.133; Sienaert I, 2002, BIOCHEM J, V365, P269, DOI 10.1042/BJ20020144; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Vanderheyden V, 2009, CELL CALCIUM, V46, P56, DOI 10.1016/j.ceca.2009.04.004; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Yoshikawa F, 1999, J BIOL CHEM, V274, P328, DOI 10.1074/jbc.274.1.328; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Zhang SB, 2009, J BIOL CHEM, V284, P29158, DOI 10.1074/jbc.M109.041509	46	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25085	25093		10.1074/jbc.M110.123208	http://dx.doi.org/10.1074/jbc.M110.123208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530483	Green Published, hybrid			2022-12-25	WOS:000280542100081
J	Huang, F; Chandrasekharan, MB; Chen, YC; Bhaskara, S; Hiebert, SW; Sun, ZW				Huang, Fu; Chandrasekharan, Mahesh B.; Chen, Yi-Chun; Bhaskara, Srividya; Hiebert, Scott W.; Sun, Zu-Wen			The JmjN Domain of Jhd2 Is Important for Its Protein Stability, and the Plant Homeodomain (PHD) Finger Mediates Its Chromatin Association Independent of H3K4 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; SACCHAROMYCES-CEREVISIAE; HISTONE DEMETHYLATION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; BUDDING YEAST; JARID1C GENE; UBIQUITINATION; REPRESSION; FAMILY	Histone lysine methylation is a dynamic process that plays an important role in regulating chromatin structure and gene expression. Recent studies have identified Jhd2, a JmjC domain-containing protein, as an H3K4-specific demethylase in budding yeast. However, important questions regarding the regulation and functions of Jhd2 remain unanswered. In this study, we show that Jhd2 has intrinsic activity to remove all three states of H3K4 methylation in vivo and can dynamically associate with chromatin to modulate H3K4 methylation levels on both active and repressed genes and at the telomeric regions. We found that the plant homeodomain (PHD) finger of Jhd2 is important for its chromatin association in vivo. However, this association is not dependent on H3K4 methylation and the H3 N-terminal tail, suggesting the presence of an alternative mechanism by which Jhd2 binds nucleosomes. We also provide evidence that the JmjN domain and its interaction with the JmjC catalytic domain are important for Jhd2 function and that Not4 (an E3 ligase) monitors the structural integrity of this interdomain interaction to maintain the overall protein levels of Jhd2. We show that the S451R mutation in human SMCX (a homolog of Jhd2), which has been linked to mental retardation, and the homologous T359R mutation in Jhd2 affect the protein stability of both of these proteins. Therefore, our findings provide a mechanistic explanation for the observed defects in patients harboring this SMCX mutant and suggest the presence of a conserved pathway involving Not4 that modulates the protein stability of both yeast Jhd2 and human SMCX.	[Sun, Zu-Wen] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Sun, ZW (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 613C Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	zuwen.sun@vanderbilt.edu	Chandrasekharan, Mahesh/AAF-4793-2020; Hu, Ruogu/B-2203-2008	Chandrasekharan, Mahesh/0000-0002-9956-8354; Bhaskara, Srividya/0000-0002-2182-9585; Huang, Fu/0000-0001-9549-8937	National Institutes of Health [RO1 CA109355]; Vanderbilt-Ingram Cancer Center; Kleberg Foundation; NATIONAL CANCER INSTITUTE [R01CA109355, T32CA009582, R01CA141071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center; Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA109355. This work was also supported by the Vanderbilt-Ingram Cancer Center and the Kleberg Foundation.	Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Beranger F, 1997, NUCLEIC ACIDS RES, V25, P2035, DOI 10.1093/nar/25.10.2035; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Durchschlag E, 2004, J BIOL CHEM, V279, P55425, DOI 10.1074/jbc.M407264200; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ingvarsdottir K, 2007, MOL CELL BIOL, V27, P7856, DOI 10.1128/MCB.00801-07; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kim TD, 2008, BIOCHEM BIOPH RES CO, V366, P563, DOI 10.1016/j.bbrc.2007.12.013; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Osborne EA, 2009, NAT GENET, V41, P800, DOI 10.1038/ng.402; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; SCHULLER HJ, 1992, NUCLEIC ACIDS RES, V20, P5955, DOI 10.1093/nar/20.22.5955; Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	53	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24548	24561		10.1074/jbc.M110.117333	http://dx.doi.org/10.1074/jbc.M110.117333			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538609	hybrid, Green Published			2022-12-25	WOS:000280542100027
J	Zhang, Y; Tang, WW; Jones, MC; Xu, WW; Halene, S; Wu, DQ				Zhang, Yong; Tang, Wenwen; Jones, Matthew C.; Xu, Wenwen; Halene, Stephanie; Wu, Dianqing			Different Roles of G Protein Subunits beta(1) and beta(2) in Neutrophil Function Revealed by Gene Expression Silencing in Primary Mouse Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA INTERFERENCE; INFLAMMATION	Neutrophils play important roles in host innate immunity and various inflammation-related diseases. In addition, neutrophils represent an excellent system for studying directional cell migration. However, neutrophils are terminally differentiated cells that are short lived and refractory to transfection; thus, they are not amenable for existing gene silencing techniques. Here we describe the development of a method to silence gene expression efficiently in primary mouse neutrophils. A mouse stem cell virus-based retroviral vector was modified to express short hairpin RNAs and fluorescent marker protein at high levels in hematopoietic cells and used to infect mouse bone marrow cells prior to reconstitution of the hematopoietic system in lethally irradiated mice. This method was used successfully to silence the expression of G beta(1) and/or G beta(2) in mouse neutrophils. Knockdown of G beta(2) appeared to affect primarily the directionality of neutrophil chemotaxis rather than motility, whereas knockdown of G beta(1) had no significant effect. However, knockdown of both G beta(1) and G beta(2) led to significant reduction in motility and responsiveness. In addition, knockdown of G beta(1) but not G beta(2) inhibited the ability of neutrophils to kill ingested bacteria, and only double knockdown resulted in significant reduction in bacterial phagocytosis. Therefore, we have developed a short hairpin RNA-based method to effectively silence gene expression in mouse neutrophils for the first time, which allowed us to uncover divergent roles of G beta(1) and G beta(2) in the regulation of neutrophil functions.	[Zhang, Yong; Tang, Wenwen; Jones, Matthew C.; Xu, Wenwen; Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Zhang, Yong; Tang, Wenwen; Jones, Matthew C.; Xu, Wenwen; Wu, Dianqing] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Halene, Stephanie] Yale Univ, Sch Med, Dept Med, Sect Hematol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Wu, DQ (corresponding author), Yale Univ, Sch Med, Program Vasc Biol & Therapeut, 333 Cedar St, New Haven, CT 06520 USA.	dan.wu@yale.edu	Tang, Wenwen/J-2011-2012	Jones, Matthew/0000-0003-4723-3277	National Institutes of Health [HL 080706, HL070694]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706, P01HL070694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 080706 and HL070694.	Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Buonocore S, 2002, TRANSPLANTATION, V73, pS27, DOI 10.1097/00007890-200201151-00010; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Dinauer Mary C., 2007, V412, P489, DOI 10.1007/978-1-59745-467-4_30; Dong XM, 2006, METHOD ENZYMOL, V406, P605, DOI 10.1016/S0076-6879(06)06047-2; He WJ, 2006, HUM GENE THER, V17, P949, DOI 10.1089/hum.2006.17.949; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Hwang JI, 2005, P NATL ACAD SCI USA, V102, P9493, DOI 10.1073/pnas.0503503102; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Komiya E, 2006, PLACENTA, V27, P934, DOI 10.1016/j.placenta.2006.02.007; Leimig T, 2002, BLOOD, V99, P3169, DOI 10.1182/blood.V99.9.3169; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Owens BM, 2004, METH MOLEC MED, V105, P311; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Swift S., 2001, CURRENT PROTOCOLS IM; Taher TE, 2008, GENE THER, V15, P998, DOI 10.1038/gt.2008.33; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wu DQ, 2005, CELL RES, V15, P52, DOI 10.1038/sj.cr.7290265; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98; Zicha D, 1997, Methods Mol Biol, V75, P449; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	30	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24805	24814		10.1074/jbc.M110.142885	http://dx.doi.org/10.1074/jbc.M110.142885			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20525682	Green Published, hybrid			2022-12-25	WOS:000280542100053
J	Yao, JH; Zhou, JY; Liu, QL; Lu, DR; Wang, L; Qiao, XJ; Jia, W				Yao, Jihua; Zhou, Jingyao; Liu, Qiaoling; Lu, Daru; Wang, Lu; Qiao, Xiaojing; Jia, William			Atoh8, a bHLH Transcription Factor, Is Required for the Development of Retina and Skeletal Muscle in Zebrafish	PLOS ONE			English	Article							CELL FATE SPECIFICATION; NERVOUS-SYSTEM; EXPRESSION; GENES; MATH6; DIFFERENTIATION; NETWORK; MODEL; MYOD	Background: Math6/atoh8, a bHLH transcription factor, is thought to be indispensable for early embryonic development and likely has important roles in vertebrate tissue-specific differentiation. However, the function of Atoh8 during early development is not clear because homozygous knockout causes embryonic lethality in mice. We have examined the effects of the atoh8 gene on the differentiation of retina and skeletal muscle during early development in zebrafish. Results: We isolated a Math6 homologue in zebrafish, designated as zebrafish atoh8. Whole -mount in situ hybridization analysis showed that zebrafish atoh8 is dynamically expressed mainly in developing retina and skeletal muscle. Atoh8-MO knock-down resulted in reduced eye size with disorganization of retinal lamination. The reduction of atoh8 function also affected the arrangement of paraxial cells and differentiated muscle fibers during somite morphogenesis. Conclusion: Our results show that Atoh8 is an important regulator for the development of both the retina and skeletal muscles necessary for neural retinal cell and myogenic differentiation during zebrafish embryogenesis.	[Yao, Jihua; Zhou, Jingyao; Lu, Daru; Wang, Lu; Qiao, Xiaojing; Jia, William] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Liu, Qiaoling] Shanghai Res Ctr Biomodel Organisms, Pathol Lab, Shanghai, Peoples R China; [Jia, William] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	Fudan University; University of British Columbia	Yao, JH (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	yaojh1@gmail.com; wjia@interchange.ubc.ca	JIA, WILLIAM/AAE-4322-2020		National Natural Science Foundation of China [30771112]; State High Technology Development Program (863) [2006AA02Z161]; Natural Science Foundation of Shanghai, China [10ZR1403100]; Canadian Institute of Health Research [20R92354]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State High Technology Development Program (863)(National High Technology Research and Development Program of China); Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the National Natural Science Foundation of China (30771112), the State High Technology Development Program (863, 2006AA02Z161), the Natural Science Foundation of Shanghai, China (10ZR1403100) for J. Yao and Canadian Institute of Health Research (20R92354) for W. Jia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai L, 2000, DEVELOPMENT, V127, P3021; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hojo M, 2000, DEVELOPMENT, V127, P2515; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lakowski J, 2007, DEV BIOL, V307, P498, DOI 10.1016/j.ydbio.2007.04.015; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Ma QF, 1997, J NEUROSCI, V17, P3644; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; Matter-Sadzinski L, 2005, DEVELOPMENT, V132, P3907, DOI 10.1242/dev.01960; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rohmann KN, 2007, DEV NEUROBIOL, V67, P1, DOI 10.1002/dneu.20303; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yan RT, 2005, MOL NEUROBIOL, V32, P157, DOI 10.1385/MN:32:2:157	25	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10945	10.1371/journal.pone.0010945	http://dx.doi.org/10.1371/journal.pone.0010945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532172	Green Published, gold, Green Submitted			2022-12-25	WOS:000278318700016
J	Chia, N; Cann, I; Olsen, GJ				Chia, Nicholas; Cann, Isaac; Olsen, Gary J.			Evolution of DNA Replication Protein Complexes in Eukaryotes and Archaea	PLOS ONE			English	Article							MCM HELICASE ACTIVITY; CLAMP-LOADER COMPLEX; BIOCHEMICAL-CHARACTERIZATION; SULFOLOBUS-SOLFATARICUS; PYROCOCCUS-FURIOSUS; METHANOSARCINA-ACETIVORANS; MAXIMUM-LIKELIHOOD; AEROPYRUM-PERNIX; HEXAMERIC RING; GENE FAMILY	Background: The replication of DNA in Archaea and eukaryotes requires several ancillary complexes, including proliferating cell nuclear antigen (PCNA), replication factor C (RFC), and the minichromosome maintenance (MCM) complex. Bacterial DNA replication utilizes comparable proteins, but these are distantly related phylogenetically to their archaeal and eukaryotic counterparts at best. Methodology/Principal Findings: While the structures of each of the complexes do not differ significantly between the archaeal and eukaryotic versions thereof, the evolutionary dynamic in the two cases does. The number of subunits in each complex is constant across all taxa. However, they vary subtly with regard to composition. In some taxa the subunits are all identical in sequence, while in others some are homologous rather than identical. In the case of eukaryotes, there is no phylogenetic variation in the makeup of each complex-all appear to derive from a common eukaryotic ancestor. This is not the case in Archaea, where the relationship between the subunits within each complex varies taxon-to-taxon. We have performed a detailed phylogenetic analysis of these relationships in order to better understand the gene duplications and divergences that gave rise to the homologous subunits in Archaea. Conclusion/Significance: This domain level difference in evolution suggests that different forces have driven the evolution of DNA replication proteins in each of these two domains. In addition, the phylogenies of all three gene families support the distinctiveness of the proposed archaeal phylum Thaumarchaeota.	[Chia, Nicholas; Cann, Isaac; Olsen, Gary J.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Chia, Nicholas] Univ Illinois, Loomis Lab Phys, Urbana, IL 61801 USA; [Chia, Nicholas] Univ Illinois, Phys Frontier Ctr, Urbana, IL 61801 USA; [Cann, Isaac; Olsen, Gary J.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cann, Isaac] Univ Illinois, Lab Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chia, N (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	chian@uiuc.edu		Chia, Nicholas/0000-0001-9652-691X	Department of Energy [DOE-2005-05818]; National Science Foundation [NSF-0526747, MCB-0238451]; Institute for Genomic Biology	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Institute for Genomic Biology	The authors acknowledge partial support from Department of Energy grant number DOE-2005-05818 and National Science Foundation grant numbers NSF-0526747 and MCB-0238451. NC is supported by the Institute for Genomic Biology Postdoctoral Fellows Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul S.F., 1997, NUCLEIC ACIDS RES, V25, P3390; Atanassova N, 2008, BIOCHEMISTRY-US, V47, P13362, DOI 10.1021/bi801479s; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Berthon J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r71; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bouzat JL, 2000, J MOL EVOL, V51, P532, DOI 10.1007/s002390010117; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Cann IKO, 2001, J BACTERIOL, V183, P2614, DOI 10.1128/JB.183.8.2614-2623.2001; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; CARROLL SB, 2005, ENDLESS FORMS MOST B; Chen YH, 2005, J BIOL CHEM, V280, P41852, DOI 10.1074/jbc.M508684200; Chen YH, 2009, J BACTERIOL, V191, P6539, DOI 10.1128/JB.00414-09; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Costa A, 2006, NUCLEIC ACIDS RES, V34, P5829, DOI 10.1093/nar/gkl708; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haugland GT, 2006, NUCLEIC ACIDS RES, V34, P6337, DOI 10.1093/nar/gkl864; HOLLAND PWH, 1994, DEVELOPMENT S, V120, P125; HUNT LT, 1972, BIOCHEM BIOPH RES CO, V47, P699, DOI 10.1016/0006-291X(72)90548-7; Imamura K, 2007, MOL MICROBIOL, V64, P308, DOI 10.1111/j.1365-2958.2007.05645.x; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kanter DM, 2008, J BIOL CHEM, V283, P31172, DOI 10.1074/jbc.M804686200; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Kauffman S.A., 1993, ORIGINS ORDER; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Kornberg A., 1992, DNA REPLICATION; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lin LJ, 2010, J MOL BIOL, V397, P13, DOI 10.1016/j.jmb.2010.01.007; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Lu SH, 2008, BIOCHEM BIOPH RES CO, V376, P369, DOI 10.1016/j.bbrc.2008.08.150; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; MIYACHI K, 1978, J IMMUNOL, V121, P2228; Morowitz H.J., 1993, BEGINNINGS CELLULAR; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA T, 1991, J MOL EVOL, V33, P34, DOI 10.1007/BF02100193; Olendzenski Lorraine, 1998, P165; Oparin A.I., 1964, CHEM ORIGIN LIFE; Oyama T, 2001, MOL CELL, V8, P455, DOI 10.1016/S1097-2765(01)00328-8; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Pisani FM, 2000, J MOL BIOL, V301, P61, DOI 10.1006/jmbi.2000.3964; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shin JH, 2009, J BIOL CHEM, V284, P540, DOI 10.1074/jbc.M806803200; Skaer N, 2002, TRENDS GENET, V18, P399, DOI 10.1016/S0168-9525(02)02747-6; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WALTERS AD, 2010, MICROBIOLOG IN PRESS; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yoshimochi T, 2008, J BIOL CHEM, V283, P1601, DOI 10.1074/jbc.M707654200; You ZY, 1999, MOL CELL BIOL, V19, P8003; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; ZIPKAS D, 1975, P NATL ACAD SCI USA, V72, P1354, DOI 10.1073/pnas.72.4.1354	67	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10866	10.1371/journal.pone.0010866	http://dx.doi.org/10.1371/journal.pone.0010866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532250	Green Published, gold			2022-12-25	WOS:000278284700002
J	Prost, S; Smirnov, N; Fedorov, VB; Sommer, RS; Stiller, M; Nagel, D; Knapp, M; Hofreiter, M				Prost, Stefan; Smirnov, Nickolay; Fedorov, Vadim B.; Sommer, Robert S.; Stiller, Mathias; Nagel, Doris; Knapp, Michael; Hofreiter, Michael			Influence of Climate Warming on Arctic Mammals? New Insights from Ancient DNA Studies of the Collared Lemming Dicrostonyx torquatus	PLOS ONE			English	Article							POPULATION-DYNAMICS; LATE PLEISTOCENE; SHORT-TERM; DIVERSITY; COALESCENT; INFERENCE; LEMMUS; VARIABILITY; DEMOGRAPHY; DISPERSAL	Background: Global temperature increased by approximately half a degree (Celsius) within the last 150 years. Even this moderate warming had major impacts on Earth's ecological and biological systems, especially in the Arctic where the magnitude of abiotic changes even exceeds those in temperate and tropical biomes. Therefore, understanding the biological consequences of climate change on high latitudes is of critical importance for future conservation of the species living in this habitat. The past 25,000 years can be used as a model for such changes, as they were marked by prominent climatic changes that influenced geographical distribution, demographic history and pattern of genetic variation of many extant species. We sequenced ancient and modern DNA of the collared lemming (Dicrostonyx torquatus), which is a key species of the arctic biota, from a single site (Pymva Shor, Northern Pre Urals, Russia) to see if climate warming events after the Last Glacial Maximum had detectable effects on the genetic variation of this arctic rodent species, which is strongly associated with a cold and dry climate. Results: Using three dimensional network reconstructions we found a dramatic decline in genetic diversity following the LGM. Model-based approaches such as Approximate Bayesian Computation and Markov Chain Monte Carlo based Bayesian inference show that there is evidence for a population decline in the collared lemming following the LGM, with the population size dropping to a minimum during the Greenland Interstadial 1 (Bolling/Allerod) warming phase at 14.5 kyrs BP. Conclusion: Our results show that previous climate warming events had a strong influence on genetic diversity and population size of collared lemmings. Due to its already severely compromised genetic diversity a similar population reduction as a result of the predicted future climate change could completely abolish the remaining genetic diversity in this population. Local population extinctions of collared lemmings would have severe effects on the arctic ecosystem, as collared lemmings are a key species in the trophic interactions and ecosystem processes in the Arctic.	[Prost, Stefan; Stiller, Mathias; Knapp, Michael; Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, Res Grp Mol Ecol, Leipzig, Germany; [Prost, Stefan; Nagel, Doris] Univ Vienna, Dept Paleontol, Vienna, Austria; [Smirnov, Nickolay] Russian Acad Sci, Inst Plant & Anim Ecol, Ekaterinburg, Russia; [Fedorov, Vadim B.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Sommer, Robert S.] Univ Kiel, Ctr Ecol, Kiel, Germany	Max Planck Society; University of Vienna; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of Alaska System; University of Alaska Fairbanks; University of Kiel	Prost, S (corresponding author), Gregor Mendel Inst Mol Plant Biol, Vienna, Austria.	stefan.prost@gmi.oeaw.ac.at	Smirnov, Nikolay/Y-8256-2018; Hofreiter, Michael/A-3996-2017	Knapp, Michael/0000-0002-0937-5664; Prost, Stefan/0000-0002-6229-3596; Hofreiter, Michael/0000-0003-0441-4705	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The authors' work was funded by the Max Planck Society (http://www.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGADJANIAN AK, 1976, RUSSIAN TRANSLATION, V28, P379; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Andreassen HP, 2001, ECOLOGY, V82, P2911, DOI 10.2307/2679970; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; BATZLI GO, 1980, HERBIVORE BASED TROP, P335; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA., 2008, SIMULATION GENETICS, P134; Blackburn GS, 1998, CAN J ZOOL, V76, P2255, DOI 10.1139/cjz-76-12-2255; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Callaghan TV, 2004, AMBIO, V33, P436, DOI 10.1639/0044-7447(2004)033[0436:EOTSOA]2.0.CO;2; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DANSGAARD W, 1989, NATURE, V339, P532, DOI 10.1038/339532a0; De MacPhee R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-49; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DRUMMOND AJ, TRACER V1 4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ehrich D, 2005, J MAMMAL, V86, P380, DOI 10.1644/BER-126.1; ENINGER B, 2007, CALPAL 2007 COLOGNE; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Fedorov VB, 1999, J EVOLUTION BIOL, V12, P134; Fedorov VB, 2002, P ROY SOC B-BIOL SCI, V269, P2071, DOI 10.1098/rspb.2002.2126; Fedorov VB, 1999, HEREDITAS, V130, P301, DOI 10.1111/j.1601-5223.1999.00301.x; Fedorov VB, 2001, P ROY SOC B-BIOL SCI, V268, P809, DOI 10.1098/rspb.2001.1584; Fedorov VB, 1999, P ROY SOC B-BIOL SCI, V266, P621, DOI 10.1098/rspb.1999.0681; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Golovachov IB, 2009, QUATERN INT, V201, P37, DOI 10.1016/j.quaint.2008.05.029; Graham RW, 1996, SCIENCE, V272, P1601; Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604; GUTHRIE RD, 1968, ARCTIC, V21, P223; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; HALL TA, 1999, NUCL ACIDS S SERIES, V44, P211; Hofreiter M, 2002, MOL BIOL EVOL, V19, P1244, DOI 10.1093/oxfordjournals.molbev.a004185; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Hoye TT, 2007, CURR BIOL, V17, pR449, DOI 10.1016/j.cub.2007.04.047; Hubberten HW, 2004, QUATERNARY SCI REV, V23, P1333, DOI 10.1016/j.quascirev.2003.12.012; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Ims RA, 2000, NATURE, V408, P194, DOI 10.1038/35041562; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Kowalski Kazimierz, 1995, Acta Zoologica Cracoviensia, V38, P85; LEHMAN SJ, 1992, NATURE, V356, P757, DOI 10.1038/356757a0; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Lin YTK, 2001, ECOL MONOGR, V71, P245, DOI 10.1890/0012-9615(2001)071[0245:TIOHQO]2.0.CO;2; Lindqvist C, 2010, P NATL ACAD SCI USA, V107; MACLEAN S F JR, 1974, Arctic and Alpine Research, V6, P1, DOI 10.2307/1550365; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markova Anastasia K., 1997, Paleontologia i Evolucio, V28-29, P5; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; OGNEV S, 1967, MAMMALS USSR ADJACEN, V6; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; PEARSON OP, 1966, J ANIM ECOL, V35, P217, DOI 10.2307/2698; Pereira SL, 2004, GENOME, V47, P535, DOI 10.1139/G04-009; PITELKA FA, 1957, COLD SPRING HARB SYM, V22, P237, DOI 10.1101/SQB.1957.022.01.023; PITELKA FA, 1993, BIOL LEMMINGS, P214; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Ramakrishnan U, 2005, MOL ECOL, V14, P2915, DOI 10.1111/j.1365-294X.2005.02586.x; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; RODGERS AR, 1986, CAN J ZOOL, V64, P2717, DOI 10.1139/z86-396; Rompler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84; ROHLAND N, 2009, MOL ECOL RESOURCES; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sittler B, 2000, ARCTIC, V53, P53; Sommer RS, 2009, J BIOGEOGR, V36, P2013, DOI 10.1111/j.1365-2699.2009.02187.x; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Tzedakis PC, 1997, EARTH PLANET SC LETT, V150, P171, DOI 10.1016/S0012-821X(97)00078-2; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wilson DJ, 1999, OIKOS, V87, P382, DOI 10.2307/3546754; Zazhigin V.S., 1976, P280	85	42	42	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10447	10.1371/journal.pone.0010447	http://dx.doi.org/10.1371/journal.pone.0010447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523724	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221900001
J	Smout, S; Asseburg, C; Matthiopoulos, J; Fernandez, C; Redpath, S; Thirgood, S; Harwood, J				Smout, Sophie; Asseburg, Christian; Matthiopoulos, Jason; Fernandez, Carmen; Redpath, Stephen; Thirgood, Simon; Harwood, John			The Functional Response of a Generalist Predator	PLOS ONE			English	Article							HARRIER CIRCUS-CYANEUS; SINGLE-SPECIES MODELS; FISHERIES MANAGEMENT; SCIENTIFIC BASIS; HEN HARRIERS; PREY; CONSERVATION; SENSITIVITY; ASSUMPTIONS; ADVICE	Background: Predators can have profound impacts on the dynamics of their prey that depend on how predator consumption is affected by prey density (the predator's functional response). Consumption by a generalist predator is expected to depend on the densities of all its major prey species (its multispecies functional response, or MSFR), but most studies of generalists have focussed on their functional response to only one prey species. Methodology and principal findings: Using Bayesian methods, we fit an MSFR to field data from an avian predator (the hen harrier Circus cyaneus) feeding on three different prey species. We use a simple graphical approach to show that ignoring the effects of alternative prey can give a misleading impression of the predator's effect on the prey of interest. For example, in our system, a "predator pit'' for one prey species only occurs when the availability of other prey species is low. Conclusions and significance: The Bayesian approach is effective in fitting the MSFR model to field data. It allows flexibility in modelling over-dispersion, incorporates additional biological information into the parameter priors, and generates estimates of uncertainty in the model's predictions. These features of robustness and data efficiency make our approach ideal for the study of long-lived predators, for which data may be sparse and management/conservation priorities pressing.	[Smout, Sophie; Matthiopoulos, Jason; Harwood, John] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Smout, Sophie; Matthiopoulos, Jason; Harwood, John] Univ St Andrews, Ctr Res Environm & Ecol Modelling, St Andrews, Fife, Scotland; [Asseburg, Christian] Univ Eastern Finland, Ctr Pharmaceut Policy & Econ CEPPE, Kuopio, Finland; [Fernandez, Carmen] Inst Espanol Oceanog, Vigo, Spain; [Redpath, Stephen] Univ Aberdeen, Sch Biol Sci, Aberdeen Ctr Environm Sustainabil, Aberdeen, Scotland; [Redpath, Stephen; Thirgood, Simon] Macaulay Inst, Aberdeen, Scotland	University of St Andrews; University of St Andrews; University of Eastern Finland; Spanish Institute of Oceanography; University of Aberdeen; James Hutton Institute	Smout, S (corresponding author), Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland.	scs10@st-andrews.ac.uk	Asseburg, Christian/AAK-2903-2020; Matthiopoulos, Jason/N-9808-2013; Redpath, Stephen/B-4640-2012	Asseburg, Christian/0000-0001-7196-3363; Matthiopoulos, Jason/0000-0003-3639-8172; Redpath, Stephen/0000-0001-5399-9477	Scottish Higher Education Funding Council; Natural Environment Research Council; Nuffield Foundation; Natural Environment Research Council [smru10001] Funding Source: researchfish	Scottish Higher Education Funding Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Nuffield Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Christian Asseburg and Sophie Smout were supported by studentships from the Scottish Higher Education Funding Council (http://www.sfc.ac.uk/) and the Natural Environment Research Council (www.nerc.ac.uk) respectively. Carmen Fernandez was supported by a Nuffield Foundation grant (www.nuffieldfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; [Anonymous], 2001, RESOLVING HUMAN WILD; ASSEBURG C, 2006, BAYESIAN APPROACH MO; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Essington TE, 2004, B MAR SCI, V74, P563; Etheridge B, 1997, J APPL ECOL, V34, P1081, DOI 10.2307/2405296; Forrester GE, 2004, ECOLOGY, V85, P1332, DOI 10.1890/03-0184; Gascoigne JC, 2004, J APPL ECOL, V41, P801, DOI 10.1111/j.0021-8901.2004.00944.x; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; HILBORN R, 1992; Hilborn Ray, 1997, V28; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Hollowed AB, 2000, ICES J MAR SCI, V57, P707, DOI 10.1006/jmsc.2000.0734; Jost C, 2005, J ANIM ECOL, V74, P809, DOI 10.1111/j.1365-2656.2005.00977.x; JULIANO AA, 2001, NONLINEAR CURVE FITT; King R., 2009, BAYESIAN ANAL POPULA; Koen-Alonso M, 2005, CAN J FISH AQUAT SCI, V62, P1490, DOI 10.1139/F05-087; KOENALONSO M, 2007, ENERGETICS ECOSYSTEM; Lindstrom U, 2009, DEEP-SEA RES PT II, V56, P2068, DOI 10.1016/j.dsr2.2008.11.017; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacCallum H., 2000, METHODS IN ECOLOGY; Mangel M, 1996, ECOL APPL, V6, P338, DOI 10.2307/2269369; Matthiopoulos J, 2008, MAMMAL REV, V38, P167, DOI 10.1111/j.1365-2907.2008.00123.x; Matthiopoulos J, 2007, ECOLOGY, V88, P2576, DOI 10.1890/06-0483.1; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; New LF, 2009, AM NAT, V174, P399, DOI 10.1086/603625; Perry DA, 1998, ANNU REV ECOL SYST, V29, P435, DOI 10.1146/annurev.ecolsys.29.1.435; PICOZZI N, 1978, IBIS, V120, P498, DOI 10.1111/j.1474-919X.1978.tb06814.x; Plaganyi EE, 2004, AFR J MAR SCI, V26, P261, DOI 10.2989/18142320409504061; REAL LA, 1977, AM NAT, V111, P289, DOI 10.1086/283161; Redpath S, 1998, BIRD STUDY, V45, P51, DOI 10.1080/00063659809461077; Redpath SM, 1999, J ANIM ECOL, V68, P879, DOI 10.1046/j.1365-2656.1999.00340.x; REDPATH SM, 1991, J APPL ECOL, V28, P659, DOI 10.2307/2404574; Redpath SM, 2002, IBIS, V144, pE33, DOI 10.1046/j.0019-1019.2001.00032.x; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; Schenk D, 2002, J ANIM ECOL, V71, P524, DOI 10.1046/j.1365-2656.2002.00620.x; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Smout S, 2007, MAR ECOL PROG SER, V341, P277, DOI 10.3354/meps341277; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thirgood SJ, 2000, J ANIM ECOL, V69, P504, DOI 10.1046/j.1365-2656.2000.00413.x; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; YODZIS P, 1994, ECOL APPL, V4, P51, DOI 10.2307/1942114; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x; Zabel RW, 2003, AM SCI, V91, P150	53	70	70	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10761	10.1371/journal.pone.0010761	http://dx.doi.org/10.1371/journal.pone.0010761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523722	Green Accepted, Green Published, gold			2022-12-25	WOS:000278221900006
J	Volz, T; Nega, M; Buschmann, J; Kaesler, S; Guenova, E; Peschel, A; Rocken, M; Gotz, F; Biedermann, T				Volz, Thomas; Nega, Mulugeta; Buschmann, Julia; Kaesler, Susanne; Guenova, Emmanuella; Peschel, Andreas; Roecken, Martin; Goetz, Friedrich; Biedermann, Tilo			Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals	FASEB JOURNAL			English	Article						innate immunity; dendritic cells; atopic dermatitis; Th1 cells; Th17 cells	BACTERIAL CELL-WALLS; LIPOTEICHOIC ACID; DENDRITIC CELLS; O-ACETYLTRANSFERASE; LYSOZYME RESISTANCE; RECOGNITION; LIPOPROTEINS; INFECTIONS; RECEPTORS; RESPONSES	Innate immune sensing of Staphylococcus aureus unravels basic mechanisms leading to either effective antibacterial immune responses or harmful inflammation. The nature and properties of S. aureus-derived pathogen-associated molecular pattern (PAMPs) are still not completely understood. We investigated the innate immune sensing of peptidoglycan (PGN) structures and subsequent immune consequences. Macromolecular PGN (PGN(polymer)) preparations activated NF-kappa B through human Toll-like receptors 2 (TLR2), as shown by luciferase reporter assays, and induced murine dendritic cell (DC) maturation and cytokine production. In contrast, PGN(polymer) from lgt-mutant S. aureus failed to stimulate human TLR2, demonstrating that lipoproteins within the macromolecular structures of PGN(polymer), but not PGN itself, activate TLR2. Thus, HPLC-purified monomeric PGN (PGN(monomer)) structures were investigated. Strikingly, PGN(monomer) completely lacked NF-kappa B activation, lacked TLR2 activity, and failed to functionally activate murine DCs. However, PGN(monomer) in concert with various TLR ligands most effectively stimulated DCs to up-regulate IL-12p70 and IL-23 by >= 3- to 5-fold. Consequently, DCs coactivated by PGN(monomer) markedly up-regulated Th1 and Th17 while suppressing Th2 cell priming. Notably, PGN(monomer) failed to coactivate NOD2(-/-) DCs. This demonstrates that PGN(monomer) is a natural ligand of NOD2, which was previously only demonstrated for synthetic compounds like muramyl dipeptide. Interestingly, murine DCs lacking TLR2 remained mute in response to the combinative immune sensing of S. aureus-derived PAMPs, including PGN(monomer), providing for the first time an explanation of why S. aureus can colonize the nasal mucosa in the absence of inflammation. This is very likely based on the lack of TLR2 expression in mucosal epithelial cells under normal conditions, which determines the unresponsiveness to S. aureus PAMPs.-Volz, T., Nega, M., Buschmann, J., Kaesler, S., Guenova, E., Peschel, A., Rocken, M., Gotz, F., Biedermann, T. Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulator of the innate immune system exclusively in the presence of TLR signals. FASEB J. 24, 4089-4102 (2010). www.fasebj.org	[Volz, Thomas; Kaesler, Susanne; Guenova, Emmanuella; Roecken, Martin; Biedermann, Tilo] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Nega, Mulugeta; Buschmann, Julia; Goetz, Friedrich] Univ Tubingen, Dept Microbial Genet, D-72076 Tubingen, Germany; [Peschel, Andreas] Univ Tubingen, Dept Med Microbiol & Hyg, Cellular & Mol Microbiol Sect, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Biedermann, T (corresponding author), Univ Tubingen, Dept Dermatol, Liebermeisterstr 25, D-72076 Tubingen, Germany.	friedrich.goetz@uni-tuebingen.de; tilo.biedermann@med.uni-tuebingen.de	Guenova, Emmanuella/G-7441-2017	Guenova, Emmanuella/0000-0001-5478-8735; Rocken, Martin/0000-0003-3795-7001; Biedermann, Tilo/0000-0002-5352-5105	Deutsche Forschungsgemeinschaft [DFG Bi 696/3-3, DFG Bi 696/5-1, SFB 685 A6, SFB 766]; Landesstiftung Baden-Wurttemberg [P-LS-AL2/4]; IZKF-Verbundprojekt [1596-0-0]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesstiftung Baden-Wurttemberg; IZKF-Verbundprojekt	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG Bi 696/3-3; DFG Bi 696/5-1, SFB 685 A6 and SFB 766), Landesstiftung Baden-Wurttemberg (P-LS-AL2/4), IZKF-Verbundprojekt 1596-0-0, and the IZKF-FACS core facility. The authors thank Jennifer Rottenberger, Regine Stemmler, Ulrike Schmidt, and Sandra Schmitz for technical assistance. The authors acknowledge the expert technical assistance of Cornelia Grimmel from the FACS core facility of the interdisciplinary center for clinical research of the University Hospital of Tubingen.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Asong J, 2009, J BIOL CHEM, V284, P8634, DOI 10.1074/jbc.M806633200; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Baker BS, 2006, CLIN EXP IMMUNOL, V144, P1, DOI 10.1111/j.1365-2249.2005.02980.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2006, INFECT IMMUN, V74, P4598, DOI 10.1128/IAI.00301-06; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Biedermann T, 2006, ACTA DERM-VENEREOL, V86, P99, DOI 10.2340/00015555-047; Biedermann T, 2004, J INVEST DERM SYMP P, V9, P5, DOI 10.1111/j.1087-0024.2004.00829.x; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11255; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Eyerich K, 2009, J ALLERGY CLIN IMMUN, V123, P59, DOI 10.1016/j.jaci.2008.10.031; GILPIN RW, 1974, J BACTERIOL, V119, P672, DOI 10.1128/JB.119.3.672-676.1974; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; GREWE M, 1995, J INVEST DERMATOL, V105, P407, DOI 10.1111/1523-1747.ep12321078; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Kraus D, 2007, INFECT IMMUN, V75, P2084, DOI 10.1128/IAI.01576-06; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Roll A, 2004, CURR OPIN ALLERGY CL, V4, P373, DOI 10.1097/00130832-200410000-00008; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Traub S, 2006, J ENDOTOXIN RES, V12, P69, DOI 10.1179/096805106X89044; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Langevelde P, 1998, ANTIMICROB AGENTS CH, V42, P3073, DOI 10.1128/AAC.42.12.3073; Wang JE, 2003, SHOCK, V20, P402, DOI 10.1097/01.shk.0000092268.01859.0d; Weindl G, 2007, J CLIN INVEST, V117, P3664, DOI 10.1172/JCI28115; WONG W, 1974, J BACTERIOL, V120, P837, DOI 10.1128/JB.120.2.837-843.1974; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	58	84	86	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					4089	4102		10.1096/fj.09-151001	http://dx.doi.org/10.1096/fj.09-151001			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20522786				2022-12-25	WOS:000285005900044
J	Sun, P; Nallar, SC; Raha, A; Kalakonda, S; Velalar, CN; Reddy, SP; Kalvakolanu, DV				Sun, Peng; Nallar, Shreeram C.; Raha, Abhijit; Kalakonda, Sudhakar; Velalar, Chidambaram N.; Reddy, Sekhar P.; Kalvakolanu, Dhananjaya V.			GRIM-19 and p16(INK4a) Synergistically Regulate Cell Cycle Progression and E2F1-responsive Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; TUMOR-SUPPRESSOR; COMPLEX-I; SOMATIC MUTATIONS; SIGNAL TRANSDUCER; EPITHELIAL-CELLS; CDK INHIBITORS; DEATH; E2F; GROWTH	GRIM-19 (Gene associated with Retinoid-IFN-induced Mortality-19) was originally isolated as a growth suppressor in a genome-wide knockdown screen with antisense libraries. Like classical tumor suppressors, mutations, and/or loss of GRIM-19 expression occur in primary human tumors; and it is inactivated by viral gene products. Our search for potential GRIM-19-binding proteins, using mass spectrometry, that permit its antitumor actions led to the inhibitor of cyclin-dependent kinase 4, CDKN2A. The GRIM-19/CDKN2A synergistically suppressed cell cycle progression via inhibiting E2F1-driven gene expression. The N terminus of GRIM-19 and the fourth ankyrin repeat of CDKN2A are crucial for their interaction. The biological relevance of these interactions is underscored by observations that GRIM-19 promotes the inhibitory effect of CDKN2A on CDK4; and mutations from primary tumors disrupt its ability to interact with GRIM-19 and suppress E2F1-driven gene expression.	[Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Mol & Cellular Canc Biol Grad Program, Baltimore, MD 21201 USA; [Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Nallar, Shreeram C.; Raha, Abhijit; Kalakonda, Sudhakar; Velalar, Chidambaram N.; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Reddy, Sekhar P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Mol & Cellular Canc Biol Grad Program, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu			NCI, National Institutes of Health [CA105005, CA78282]; NATIONAL CANCER INSTITUTE [R01CA078282, R01CA105005] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105005 and CA78282 from the NCI (to D. V. K.).	Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Choubey D, 1996, EMBO J, V15, P5668, DOI 10.1002/j.1460-2075.1996.tb00951.x; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HAYASHI N, 1994, BIOCHEM BIOPH RES CO, V202, P1426, DOI 10.1006/bbrc.1994.2090; Hu JD, 2002, J INTERF CYTOK RES, V22, P1017, DOI 10.1089/107999002760624242; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kalakonda S, 2007, AM J PATHOL, V171, P1352, DOI 10.2353/ajpath.2007.070241; Kalakonda S, 2007, CANCER RES, V67, P6212, DOI 10.1158/0008-5472.CAN-07-0031; Kalvakolanu DV, 2004, CYTOKINE GROWTH F R, V15, P169, DOI 10.1016/j.cytogfr.2004.01.002; KUMAR R, 1992, P NATL ACAD SCI USA, V89, P6599, DOI 10.1073/pnas.89.14.6599; Kyritsis AP, 1996, ONCOGENE, V12, P63; Lee HY, 1998, J CLIN INVEST, V101, P1012, DOI 10.1172/JCI1329; Lindner DJ, 1997, CLIN CANCER RES, V3, P931; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Ma X, 2007, ONCOGENE, V26, P4842, DOI 10.1038/sj.onc.1210287; Maximo V, 2005, BRIT J CANCER, V92, P1892, DOI 10.1038/sj.bjc.6602547; MELAMED D, 1993, MOL CELL BIOL, V13, P5255, DOI 10.1128/MCB.13.9.5255; NEVINS JR, 1992, SCIENCE, V258, P424; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Seo T, 2002, J VIROL, V76, P8797, DOI 10.1128/JVI.76.17.8797-8807.2002; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Simpson RJ, 2003, PROTEINS PROTEOMICS; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Sun P, 2009, ONCOGENE, V28, P1339, DOI 10.1038/onc.2008.480; XU L, 1994, CANCER RES, V54, P5262; Yang J, 2005, CANCER RES, V65, P939; Yuan CH, 2000, PROTEIN SCI, V9, P1120, DOI 10.1110/ps.9.6.1120; Zhang B, 1996, J BIOL CHEM, V271, P28734, DOI 10.1074/jbc.271.46.28734; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2008, CLIN CANCER RES, V14, P559, DOI 10.1158/1078-0432.CCR-07-1176; Zhou Y, 2009, J INTERF CYTOK RES, V29, P695, DOI 10.1089/jir.2009.0003	45	21	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27545	27552		10.1074/jbc.M110.105767	http://dx.doi.org/10.1074/jbc.M110.105767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20522552	Green Published, hybrid			2022-12-25	WOS:000281404100009
J	Courson, DS; Rock, RS				Courson, David S.; Rock, Ronald S.			Actin Cross-link Assembly and Disassembly Mechanics for alpha-Actinin and Fascin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URCHIN EGG EXTRACTS; FILOPODIA FORMATION; STRUCTURAL PROTEIN; FILAMENT NETWORKS; BINDING PROTEINS; STRIATED MUSCLE; STRESS FIBERS; SMOOTH-MUSCLE; CELL MOTILITY; MYOSIN-X	Self-assembly of complex structures is commonplace in biology but often poorly understood. In the case of the actin cytoskeleton, a great deal is known about the components that include higher order structures, such as lamellar meshes, filopodial bundles, and stress fibers. Each of these cytoskeletal structures contains actin filaments and cross-linking proteins, but the role of cross-linking proteins in the initial steps of structure formation has not been clearly elucidated. We employ an optical trapping assay to investigate the behaviors of two actin cross-linking proteins, fascin and alpha-actinin, during the first steps of structure assembly. Here, we show that these proteins have distinct binding characteristics that cause them to recognize and cross-link filaments that are arranged with specific geometries. alpha-Actinin is a promiscuous cross-linker, linking filaments over all angles. It retains this flexibility after cross-links are formed, maintaining a connection even when the link is rotated. Conversely, fascin is extremely selective, only cross-linking filaments in a parallel orientation. Surprisingly, bundles formed by either protein are extremely stable, persisting for over 0.5 h in a continuous wash. However, using fluorescence recovery after photobleaching and fluorescence decay experiments, we find that the stable fascin population can be rapidly competed away by free fascin. We present a simple avidity model for this crosslink dissociation behavior. Together, these results place constraints on how cytoskeletal structures assemble, organize, and disassemble in vivo.	[Courson, David S.; Rock, Ronald S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60615 USA	University of Chicago	Rock, RS (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, GCIS W240,929 E 57th St, Chicago, IL 60615 USA.	rrock@uchicago.edu			National Institutes of Health [GM078450]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078450 (to R. S. R.). This work was also supported by an American Heart Association predoctoral fellowship (to D. S. C.).	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Aratyn YS, 2007, MOL BIOL CELL, V18, P3928, DOI 10.1091/mbc.E07-04-0346; Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; BURRIDGE K, 1981, NATURE, V294, P565, DOI 10.1038/294565a0; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Courson DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006479; EBASHI S, 1965, J BIOCHEM-TOKYO, V58, P20, DOI 10.1093/oxfordjournals.jbchem.a128159; EBASHI S, 1965, J BIOCHEM-TOKYO, V58, P7, DOI 10.1093/oxfordjournals.jbchem.a128167; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; GOLL DE, 1969, BIOCHIM BIOPHYS ACTA, V175, P174, DOI 10.1016/0005-2795(69)90156-1; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hampton CM, 2007, J MOL BIOL, V368, P92, DOI 10.1016/j.jmb.2007.01.071; HEGGENESS MH, 1977, P NATL ACAD SCI USA, V74, P3883, DOI 10.1073/pnas.74.9.3883; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; KANE RE, 1975, J CELL BIOL, V66, P305, DOI 10.1083/jcb.66.2.305; KANE RE, 1976, J CELL BIOL, V71, P704, DOI 10.1083/jcb.71.3.704; Kee AJ, 2008, ADV EXP MED BIOL, V644, P143; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; MARUYAMA K, 1965, J BIOCHEM-TOKYO, V58, P13, DOI 10.1093/oxfordjournals.jbchem.a128158; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Miyata H, 1996, BBA-GEN SUBJECTS, V1290, P83, DOI 10.1016/0304-4165(96)00003-7; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pelletier O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148102; Rafelski SM, 2004, ANNU REV BIOCHEM, V73, P209, DOI 10.1146/annurev.biochem.73.011303.073844; Schmoller KM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118102; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Skoko D, 2006, J MOL BIOL, V364, P777, DOI 10.1016/j.jmb.2006.09.043; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Taylor KA, 2000, J CELL BIOL, V149, P635, DOI 10.1083/jcb.149.3.635; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Vignjevic D, 2006, METHOD ENZYMOL, V406, P727, DOI 10.1016/S0076-6879(06)06057-5; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; WACHSSTOCK DH, 1994, BIOPHYS J, V66, P801, DOI 10.1016/S0006-3495(94)80856-2; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0	52	77	78	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26350	26357		10.1074/jbc.M110.123117	http://dx.doi.org/10.1074/jbc.M110.123117			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551315	Green Published, hybrid			2022-12-25	WOS:000280921000053
J	Nunes-Xavier, CE; Tarrega, C; Cejudo-Marin, R; Frijhoff, J; Sandin, A; Ostman, A; Pulido, R				Nunes-Xavier, Caroline E.; Tarrega, Celine; Cejudo-Marin, Rocio; Frijhoff, Jeroen; Sandin, Asa; Ostman, Arne; Pulido, Rafael			Differential Up-regulation of MAP Kinase Phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun Converge in the Control of the Growth Arrest Versus Proliferation Response of MCF-7 Breast Cancer Cells to Phorbol Ester	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASES; MAMMARY-GLAND DEVELOPMENT; GENE-EXPRESSION; TRANSCRIPTION TARGET; FEEDBACK-REGULATION; CARCINOMA-CELLS; DOWN-REGULATION; FACTOR-BINDING; CYCLE ARREST; ACTIVATION	Different levels of regulation account for the inactivation of MAP kinases by MAPK phosphatases (MKPs), in a cell type-and stimuli-dependent manner. MCF-7 human breast carcinoma cells treated with the phorbol 12-myristate 13-acetate (PMA) suffer growth arrest and show morphological alterations, which depend on the activation of the ERK1/2 MAP kinases. MKP3/DUSP6 and DUSP5 MAP kinase phosphatases, two negative regulators of ERK1/2, were specifically up-regulated in MCF-7 and SKBR3 cells in response to PMA. MKP3 and DUSP5 up-regulation required the prolonged activation of the ERK1/2 pathway, and correlated with the shutdown of this route. MKP3 induction relied on the activation of the Ets2 transcription factor, whereas DUSP5 induction depended on the activation of c-Jun. Diminishing the expression of MKP3 and DUSP5 raised the activation of ERK1/2, and accelerated growth arrest of PMA-treated MCF-7 cells. Conversely, MCF-7 cell lines expressing high levels of MKP3 or DUSP5 did not undergo PMA-triggered growth arrest, displayed a migratory phenotype, and formed colonies in soft agar. We propose that the differential up-regulation of MKP3 by Ets2 and of DUSP5 by c-Jun may converge in similar functional roles for these MAP kinase phosphatases in the growth arrest versus proliferation decisions of breast cancer cells.	[Nunes-Xavier, Caroline E.; Tarrega, Celine; Cejudo-Marin, Rocio; Pulido, Rafael] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Frijhoff, Jeroen; Sandin, Asa; Ostman, Arne] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, S-17176 Stockholm, Sweden	Prince Felipe Research Center; Karolinska Institutet	Pulido, R (corresponding author), Ctr Invest Principe Felipe, Avda Autopista Saler 16-3, Valencia 46013, Spain.	rpulido@cipf.es	Cejudo, Rocio/I-2794-2015; Nunes-Xavier, Caroline E./R-5893-2018	Nunes-Xavier, Caroline E./0000-0002-1875-6645; Frijhoff, Jeroen/0000-0001-8953-3054; Cejudo Marin, Rocio/0000-0001-5389-7200; Pulido, Rafael/0000-0001-9100-248X	Ministerio de Educacion y Ciencia [SAF2006-08319]; Ministerio de Ciencia e Innovacion [SAF2009-10226]; (Spain and Fondo Europeo de Desarrollo Regional, FEDER) Generalitat Valenciana [AP-117/08, AP-040/10, ACOMP/2009/363, ACOMP/2010/222]; Instituto de Salud Carlos III [ISCIII-RETICS RD06/0020/0049]; European Union [MRTN-CT-2006-035830]	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); (Spain and Fondo Europeo de Desarrollo Regional, FEDER) Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union(European Commission)	This work was supported in part by Ministerio de Educacion y Ciencia Grant SAF2006-08319 and by Ministerio de Ciencia e Innovacion Grant SAF2009-10226 (Spain and Fondo Europeo de Desarrollo Regional, FEDER) Generalitat Valenciana Grants AP-117/08, AP-040/10, ACOMP/2009/363, and ACOMP/2010/222, Instituto de Salud Carlos III (Spain and Fondo Europeo de Desarrollo Regional, FEDER) Grant ISCIII-RETICS RD06/0020/0049, and European Union Research Training Network Grant MRTN-CT-2006-035830. 1 Both authors were supported by the European Union Marie Curie Research Training Programme.	ABE M, 1986, J CELL PHYSIOL, V126, P126, DOI 10.1002/jcp.1041260117; Alblas J, 1998, ONCOGENE, V16, P131, DOI 10.1038/sj.onc.1201485; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; Buggy Y, 2006, EUR J CANCER, V42, P485, DOI 10.1016/j.ejca.2005.10.018; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cui YK, 2006, CANCER RES, V66, P5950, DOI 10.1158/0008-5472.CAN-05-3243; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; Dowd S, 1998, J CELL SCI, V111, P3389; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; ElAshry D, 1997, ONCOGENE, V15, P423, DOI 10.1038/sj.onc.1201198; Fortino V, 2008, CANCER INVEST, V26, P13, DOI 10.1080/07357900701637949; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; Furukawa T, 2008, BIOCHEM BIOPH RES CO, V377, P317, DOI 10.1016/j.bbrc.2008.10.003; Gee JMW, 2000, INT J CANCER, V89, P177, DOI 10.1002/(SICI)1097-0215(20000320)89:2<177::AID-IJC13>3.0.CO;2-0; Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Grill C, 2004, BIOCHEM J, V381, P635, DOI 10.1042/BJ20031688; GUILBAUD NF, 1990, J CELL PHYSIOL, V145, P162, DOI 10.1002/jcp.1041450122; Herrera R, 1998, EXP CELL RES, V238, P407, DOI 10.1006/excr.1997.3847; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Kim SC, 1999, BLOOD, V93, P3893, DOI 10.1182/blood.V93.11.3893.407k14_3893_3899; KOGA M, 1990, CANCER RES, V50, P4849; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Mester J, 2008, ANTI-CANCER AGENT ME, V8, P872, DOI 10.2174/187152008786847747; Miller DV, 2004, MODERN PATHOL, V17, P756, DOI 10.1038/modpathol.3800114; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Park SK, 2009, CARCINOGENESIS, V30, P1225, DOI 10.1093/carcin/bgp111; Pulido R, 2008, FEBS J, V275, P848, DOI 10.1111/j.1742-4658.2008.06250.x; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; REE AH, 1992, ENDOCRINOLOGY, V131, P1810, DOI 10.1210/en.131.4.1810; Reffas S, 2000, BIOCHEM J, V352, P701, DOI 10.1042/0264-6021:3520701; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rojo F, 2009, CLIN CANCER RES, V15, P3530, DOI 10.1158/1078-0432.CCR-08-2070; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schaar D, 2006, CANCER CHEMOTH PHARM, V57, P789, DOI 10.1007/s00280-005-0125-1; Schaar DG, 2005, LEUKEMIA RES, V29, P1171, DOI 10.1016/j.leukres.2005.02.019; Sebolt-Leopold Judith S., 2007, V172, P155; Shanmugam M, 1999, MOL CELL ENDOCRINOL, V148, P109, DOI 10.1016/S0303-7207(98)00229-9; Shi YY, 2006, BREAST CANCER RES TR, V100, P33, DOI 10.1007/s10549-006-9232-x; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Small GW, 2004, MOL PHARMACOL, V66, P1478, DOI 10.1124/mol.104.003400; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tarrega C, 2005, J BIOL CHEM, V280, P37885, DOI 10.1074/jbc.M504366200; Thottassery JV, 2004, CANCER RES, V64, P4637, DOI 10.1158/0008-5472.CAN-03-2645; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Ueda K, 2003, ONCOGENE, V22, P5586, DOI 10.1038/sj.onc.1206845; VALETTE A, 1987, CANCER RES, V47, P1615; Venditti M, 2002, INT J CANCER, V99, P35, DOI 10.1002/ijc.10269; Visvader JE, 2003, INT J BIOCHEM CELL B, V35, P1034, DOI 10.1016/S1357-2725(03)00030-X; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Warmka JK, 2004, J BIOL CHEM, V279, P33085, DOI 10.1074/jbc.M403120200; Weldon CB, 2005, INT J ONCOL, V26, P763; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Woessmann W, 2001, EXP CELL RES, V264, P193, DOI 10.1006/excr.2000.5124; Wu J, 2007, ONCOGENE, V26, P6526, DOI 10.1038/sj.onc.1210484; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Zeliadt NA, 2008, TOXICOL APPL PHARM, V232, P408, DOI 10.1016/j.taap.2008.08.007; Zhang Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-145; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	72	43	44	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26417	26430		10.1074/jbc.M110.121830	http://dx.doi.org/10.1074/jbc.M110.121830			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554528	hybrid, Green Published			2022-12-25	WOS:000280921000060
J	Zwolak, A; Fujiwara, I; Hammer, JA; Tjandra, N				Zwolak, Adam; Fujiwara, Ikuko; Hammer, John A., III; Tjandra, Nico			Structural Basis for Capping Protein Sequestration by Myotrophin (V-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT BARBED END; 4-DIMENSIONAL NMR-SPECTROSCOPY; CHEMICAL-SHIFT ASSIGNMENTS; NUCLEAR-MAGNETIC-RESONANCE; CAPPED ACTIN-FILAMENTS; SECONDARY STRUCTURE; ARP2/3 COMPLEX; IN-VITRO; MYOSIN-I; BINDING	Capping protein (CP) is a ubiquitously expressed, heterodimeric 62-kDa protein that binds the barbed end of the actin filament with high affinity to block further filament elongation. Myotrophin (V-1) is a 13-kDa ankyrin repeat-containing protein that binds CP tightly, sequestering it in a totally inactive complex in vitro. Here, we elucidate the molecular interaction between CP and V-1 by NMR. Specifically, chemical shift mapping and intermolecular paramagnetic relaxation enhancement experiments reveal that the ankyrin loops of V-1, which are essential for V-1/CP interaction, bind the basic patch near the joint of the alpha tentacle of CP shown previously to drive most of the association of CP with and affinity for the barbed end. Consistently, site-directed mutagenesis of CP shows that V-1 and the strong electrostatic binding site for CP on the barbed end compete for this basic patch on CP. These results can explain how V-1 inactivates barbed end capping by CP and why V-1 is incapable of uncapping CP-capped actin filaments, the two signature biochemical activities of V-1.	[Fujiwara, Ikuko; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Zwolak, Adam] NYU, Sch Med, Sackler Inst Biomed Sci, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); New York University	Hammer, JA (corresponding author), NHLBI, Cell Biol Lab, NIH, 50 South Dr,Bldg 50,Rm 2306, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov; tjandran@nhlbi.nih.gov	Fujiwara, Ikuko/H-5717-2016	Fujiwara, Ikuko/0000-0002-9361-636X; Hammer, John/0000-0002-2496-5179	NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048, ZIAHL006120] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health grants from Intramural Research Program, NHLBI (to J. A. H. III and N. T.).	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; AMATRUDA JF, 1990, NATURE, V344, P352, DOI 10.1038/344352a0; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Anderson KM, 1999, J MOL CELL CARDIOL, V31, P705, DOI 10.1006/jmcc.1998.0903; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Gardner KH, 1998, J AM CHEM SOC, V120, P11738, DOI 10.1021/ja982019w; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; Kitazawa M, 2005, BIOCHEM BIOPH RES CO, V331, P181, DOI 10.1016/j.bbrc.2005.03.127; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOUYAMA T, 1980, EUR J BIOCHEM, V105, P279, DOI 10.1111/j.1432-1033.1980.tb04499.x; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Remmert K, 2009, PROTEIN EXPRES PURIF, V67, P113, DOI 10.1016/j.pep.2009.05.002; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sivasubramanian N, 1996, J BIOL CHEM, V271, P2812, DOI 10.1074/jbc.271.5.2812; Sizonenko GI, 1996, MOL BIOL CELL, V7, P1; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; XU P, 1995, J BIOL CHEM, V270, P25316, DOI 10.1074/jbc.270.43.25316; Xu P, 1997, P NATL ACAD SCI USA, V94, P3685, DOI 10.1073/pnas.94.8.3685; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Yang DW, 1999, J AM CHEM SOC, V121, P2571, DOI 10.1021/ja984056t; Yang YW, 1998, STRUCTURE, V6, P619, DOI 10.1016/S0969-2126(98)00063-X; Yang YW, 1997, PROTEIN SCI, V6, P1347, DOI 10.1002/pro.5560060625	62	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25767	25781		10.1074/jbc.M110.135848	http://dx.doi.org/10.1074/jbc.M110.135848			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538588	Green Published, hybrid			2022-12-25	WOS:000280682400069
J	Mendelson, K; Swendeman, S; Saftig, P; Blobel, CP				Mendelson, Karen; Swendeman, Steven; Saftig, Paul; Blobel, Carl P.			Stimulation of Platelet-derived Growth Factor Receptor beta (PDGFR beta) Activates ADAM17 and Promotes Metalloproteinase-dependent Cross-talk between the PDGFR beta and Epidermal Growth Factor Receptor (EGFR) Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CONVERTASE TACE; PROTEIN; DISINTEGRIN; CLEAVAGE; CELLS; MICE; TRANSACTIVATION; COMPONENTS; MIGRATION	Binding of the platelet-derived growth factor (PDGF)-B to its receptor PDGFR beta promotes proliferation, migration, and recruitment of pericytes and smooth muscle cells to endothelial cells, serving to stabilize developing blood vessels. The main goals of this study were to determine whether the extracellular domain of the PDGFR beta can be proteolytically released from cell membranes and, if so, to identify the responsible sheddase and determine whether activation of the PDGFR beta stimulates its shedding and potentially that of other membrane proteins. We found that the PDGFR beta is shed from cells by a metalloproteinase and used loss-of-function experiments to identify ADAM10 as the sheddase responsible for constitutive and ionomycin-stimulated processing of the PDGFR beta. Moreover, we showed that ligand-dependent activation of the PDGFR beta does not trigger its own shedding by ADAM10, but instead it stimulates ADAM17 and shedding of substrates of ADAM17, including tumor necrosis factor alpha and transforming growth factor alpha. Finally, we demonstrated that treatment of mouse embryonic fibroblasts with PDGF-B triggers a metalloproteinase-dependent cross-talk between the PDGFR beta and the epidermal growth factor receptor (EGFR)/ERK1/2 signaling axis that is also critical for PDGF-B-stimulated cell migration, most likely via ADAM17-dependent release and activation of ligands of the EGFR. This study identifies the principal sheddase for the PDGFR beta and provides new insights into the mechanism of PDGFR beta-dependent signal transduction and cross-talk with the EGFR.	[Mendelson, Karen; Swendeman, Steven; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Mendelson, Karen; Blobel, Carl P.] Cornell Univ, Weill Med Coll, Physiol Biophys & Syst Biol Program, New York, NY 10021 USA; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Cornell University; University of Kiel; Cornell University	Blobel, CP (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, Caspary Res Bldg,Rm 426,535 E 70th St, New York, NY 10021 USA.	blobelc@hss.edu	Saftig, Paul/A-7966-2010		National Institutes of Health [GM64750, EY015719]; Deutsche Forschungsgemeinschaft [SFB 877]; European Union-DeZenit; NATIONAL EYE INSTITUTE [R01EY015719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union-DeZenit; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM64750 and EY015719 (to C.P.B.) and the Deutsche Forschungsgemeinschaft SFB 877 and the European Union-DeZenit (to P.S.).	Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Cain JA, 2004, BLOOD, V104, P561, DOI 10.1182/blood-2003-11-3801; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; CLAESSONWELSH L, 1987, P NATL ACAD SCI USA, V84, P8796, DOI 10.1073/pnas.84.24.8796; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KEATING MT, 1987, J BIOL CHEM, V262, P7932; KELLY JD, 1991, J BIOL CHEM, V266, P8987; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Sahin Umut, 2006, V327, P99; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Toffalini F, 2010, J BIOL CHEM, V285, P12268, DOI 10.1074/jbc.M109.076638; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	36	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25024	25032		10.1074/jbc.M110.102566	http://dx.doi.org/10.1074/jbc.M110.102566			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529858	Green Published, hybrid			2022-12-25	WOS:000280542100075
J	Burnside, K; Lembo, A; de los Reyes, M; Iliuk, A; BinhTran, NT; Connelly, JE; Lin, WJ; Schmidt, BZ; Richardson, AR; Fang, FC; Tao, WA; Rajagopal, L				Burnside, Kellie; Lembo, Annalisa; de los Reyes, Melissa; Iliuk, Anton; BinhTran, Nguyen-Thao; Connelly, James E.; Lin, Wan-Jung; Schmidt, Byron Z.; Richardson, Anthony R.; Fang, Ferric C.; Tao, Weiguo Andy; Rajagopal, Lakshmi			Regulation of Hemolysin Expression and Virulence of Staphylococcus aureus by a Serine/Threonine Kinase and Phosphatase	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; GROUP-B STREPTOCOCCUS; GROUP-A STREPTOCOCCUS; ALPHA-TOXIN; BETA-TOXIN; EUKARYOTIC-TYPE; PROTEIN-A; SURFACE-PROTEINS; INNATE IMMUNITY; DELTA-LYSIN	Exotoxins, including the hemolysins known as the alpha (alpha) and beta (beta) toxins, play an important role in the pathogenesis of Staphylococcus aureus infections. A random transposon library was screened for S. aureus mutants exhibiting altered hemolysin expression compared to wild type. Transposon insertions in 72 genes resulting in increased or decreased hemolysin expression were identified. Mutations inactivating a putative cyclic di-GMP synthetase and a serine/threonine phosphatase (Stp1) were found to reduce hemolysin expression, and mutations in genes encoding a two component regulator PhoR, LysR family transcriptional regulator, purine biosynthetic enzymes and a serine/threonine kinase (Stk1) increased expression. Transcription of the hla gene encoding alpha toxin was decreased in a Dstp1 mutant strain and increased in a Delta stk1 strain. Microarray analysis of a Delta stk1 mutant revealed increased transcription of additional exotoxins. A Delta stp1 strain is severely attenuated for virulence in mice and elicits less inflammation and IL-6 production than the Delta stk1 strain. In vivo phosphopeptide enrichment and mass spectrometric analysis revealed that threonine phosphorylated peptides corresponding to Stk1, DNA binding histone like protein (HU), serine-aspartate rich fibrinogen/bone sialoprotein binding protein (SdrE) and a hypothetical protein (NWMN_1123) were present in the wild type and not in the Delta stk1 mutant. Collectively, these studies suggest that Stk1 mediated phosphorylation of HU, SrdE and NWMN_1123 affects S. aureus gene expression and virulence.	[Burnside, Kellie; Lembo, Annalisa; de los Reyes, Melissa; BinhTran, Nguyen-Thao; Connelly, James E.; Lin, Wan-Jung; Schmidt, Byron Z.; Rajagopal, Lakshmi] Univ Washington, Dept Pediat Infect Dis, Seattle, WA 98195 USA; [Burnside, Kellie; Lembo, Annalisa; de los Reyes, Melissa; BinhTran, Nguyen-Thao; Connelly, James E.; Lin, Wan-Jung; Schmidt, Byron Z.; Rajagopal, Lakshmi] Seattle Childrens Hosp Res Inst, Seattle, WA USA; [Iliuk, Anton; Tao, Weiguo Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Richardson, Anthony R.; Fang, Ferric C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Richardson, Anthony R.; Fang, Ferric C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Burnside, K (corresponding author), Univ Washington, Dept Pediat Infect Dis, Seattle, WA 98195 USA.	lakshmi.rajagopal@seattlechildrens.org	Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020	Tao, Weiguo/0000-0002-5535-5517; Fang, Ferric/0000-0002-3243-110X; Iliuk, Anton/0000-0002-2914-1363	Seattle Children's Research Institute; Deion Branch Athletic Foundation; National Institutes of Health (NIH) [AI070749, GM088317-01A1]; NSF [AI39557]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039557, R56AI070749, R01AI070749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317] Funding Source: NIH RePORTER	Seattle Children's Research Institute; Deion Branch Athletic Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from Seattle Children's Research Institute, the Deion Branch Athletic Foundation and the National Institutes of Health (NIH) Grant AI070749 to L. R., NIH GM088317-01A1 and NSF-CAREER award to W. A. T. and AI39557 to F. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2007, INFECT IMMUN, V75, P4534, DOI 10.1128/IAI.00679-07; Altemeier WA, 2007, J LEUKOCYTE BIOL, V82, P721, DOI 10.1189/jlb.1006652; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bartlett AH, 2008, J INFECT DIS, V198, P1529, DOI 10.1086/592758; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Benton BM, 2004, J BACTERIOL, V186, P8478, DOI 10.1128/JB.186.24.8478-8489.2004; Berner Reinhard, 2004, Expert Rev Anti Infect Ther, V2, P427, DOI 10.1586/14787210.2.3.427; BERNHEIM.AW, 1974, ANN NY ACAD SCI, V236, P292, DOI 10.1111/j.1749-6632.1974.tb41499.x; BHAKDI S, 1989, INFECT IMMUN, V57, P3512, DOI 10.1128/IAI.57.11.3512-3519.1989; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BHAKOO M, 1982, BIOCHEMISTRY-US, V21, P6879, DOI 10.1021/bi00269a039; Buist G, 2006, MICROBIOL-SGM, V152, P2867, DOI 10.1099/mic.0.29113-0; CALLEGAN MC, 1994, INFECT IMMUN, V62, P2478, DOI 10.1128/IAI.62.6.2478-2482.1994; Cerutti H, 2009, EPIGENETICS-US, V4, P71, DOI 10.4161/epi.4.2.7781; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; DeLeo FR, 2008, J EXP MED, V205, P271, DOI 10.1084/jem.20080167; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Dragneva Y, 2001, INFECT IMMUN, V69, P2630, DOI 10.1128/IAI.69.4.2630-2635.2001; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; FREER JH, 1982, J THEOR BIOL, V94, P535, DOI 10.1016/0022-5193(82)90299-5; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Giraudo AT, 2003, CURR MICROBIOL, V46, P246, DOI 10.1007/s00284-002-3853-z; Glenny AT, 1935, J PATHOL BACTERIOL, V40, P201, DOI 10.1002/path.1700400202; Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394; HERBERT S, INFECT IMMUNITY; HOCH J, 2 COMPONENT SIGNAL T; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Hume EBH, 2000, INFECT IMMUN, V68, P6052, DOI 10.1128/IAI.68.10.6052-6055.2000; Huseby M, 2007, J BACTERIOL, V189, P8719, DOI 10.1128/JB.00741-07; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; ILIUK A, 2009, METHOD MOL BIOL, V527, pR9; Iliuk Anton, 2009, V527, P117, DOI 10.1007/978-1-60327-834-8_10; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kim CS, 2000, LARYNGOSCOPE, V110, P2085; Kim J, 2000, CELL STRESS CHAPERON, V5, P267, DOI 10.1379/1466-1268(2000)005<0267:SDPEAT>2.0.CO;2; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Krishna R.G., 1998, PROTEINS ANAL DESIGN, P121; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manna AC, 2003, INFECT IMMUN, V71, P343, DOI 10.1128/IAI.71.1.343-353.2003; McNamara PJ, 2005, INFECT IMMUN, V73, P3806, DOI 10.1128/IAI.73.6.3806-3809.2005; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Oberto J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004367; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; OKADA N, 1993, MOL MICROBIOL, V7, P893, DOI 10.1111/j.1365-2958.1993.tb01180.x; Onogawa T, 2002, FEMS IMMUNOL MED MIC, V33, P15, DOI 10.1111/j.1574-695X.2002.tb00566.x; Otto M, 2010, MED RES REV, V30, P1, DOI 10.1002/med.20160; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; PROJAN SJ, 1989, NUCLEIC ACIDS RES, V17, P3305, DOI 10.1093/nar/17.8.3305; Raggiaschi R, 2005, BIOSCIENCE REP, V25, P33, DOI 10.1007/s10540-005-2846-0; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Sabat A, 2006, J CLIN MICROBIOL, V44, P1135, DOI 10.1128/JCM.44.3.1135-1138.2006; Said-Salim B, 2003, J BACTERIOL, V185, P610, DOI 10.1128/JB.185.2.610-619.2003; Schafer D, 2009, J BACTERIOL, V191, P7306, DOI 10.1128/JB.00630-09; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Silvestroni A, 2009, J PROTEOME RES, V8, P2563, DOI 10.1021/pr900069n; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Styers David, 2006, Ann Clin Microbiol Antimicrob, V5, P2; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; WISEMAN GM, 1975, BACTERIOL REV, V39, P317, DOI 10.1128/MMBR.39.4.317-344.1975; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442	98	113	116	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11071	10.1371/journal.pone.0011071	http://dx.doi.org/10.1371/journal.pone.0011071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552019	Green Published, Green Submitted, gold			2022-12-25	WOS:000278662900011
J	Marshall, KM; Bradshaw, M; Johnson, EA				Marshall, Kristin M.; Bradshaw, Marite; Johnson, Eric A.			Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum	PLOS ONE			English	Article							INFANT BOTULISM; GENOME SEQUENCE; COMPLEX GENES; HALL-A; STRAINS; IDENTIFICATION; PERFRINGENS; EXPRESSION; DIVERSITY; PCW3	Background: Clostridium botulinum produces seven distinct serotypes of botulinum neurotoxins (BoNTs). The genes encoding different subtype neurotoxins of serotypes A, B, F and several dual neurotoxin-producing strains have been shown to reside on plasmids, suggesting that intra-and interspecies transfer of BoNT-encoding plasmids may occur. The objective of the present study was to determine whether these C. botulinum BoNT-encoding plasmids are conjugative. Methodology/Principal Findings: C. botulinum BoNT-encoding plasmids pBotCDC-A3 (strain CDC-A3), pCLJ (strain 657Ba) and pCLL (strain Eklund 17B) were tagged with the erythromycin resistance marker (Erm) using the ClosTron mutagenesis system by inserting a group II intron into the neurotoxin genes carried on these plasmids. Transfer of the tagged plasmids from the donor strains CDC-A3, 657Ba and Eklund 17B to tetracycline-resistant recipient C. botulinum strains was evaluated in mating experiments. Erythromycin and tetracycline resistant transconjugants were isolated from donor: recipient mating pairs tested. Transfer of the plasmids to the transconjugants was confirmed by pulsed-field gel electrophoresis (PFGE) and Southern hybridizations. Transfer required cell-to-cell contact and was DNase resistant. This indicates that transfer of these plasmids occurs via a conjugation mechanism. Conclusions/Significance: This is the first evidence supporting conjugal transfer of native botulinum neurotoxin-encoding plasmids in C. botulinum, and provides a probable mechanism for the lateral distribution of BoNT-encoding plasmids to other C. botulinum strains. The potential transfer of C. botulinum BoNT-encoding plasmids to other bacterial hosts in the environment or within the human intestine is of great concern for human pathogenicity and necessitates further characterization of these plasmids.	[Marshall, Kristin M.; Bradshaw, Marite; Johnson, Eric A.] Univ Wisconsin, Coll Agr & Life Sci, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Marshall, KM (corresponding author), US FDA, Natl Ctr Food Safety & Technol, Summit, NJ USA.	eajohnso@wisc.edu	Pacific-Southwest, RCE/B-6155-2009		Food Research Institute of the University of Wisconsin-Madison; NIH/NIAID Regional Center of Excellence; NIH [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, U54AI057153] Funding Source: NIH RePORTER	Food Research Institute of the University of Wisconsin-Madison; NIH/NIAID Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the Food Research Institute of the University of Wisconsin-Madison and by the NIH/NIAID Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership and support from the Pacific Southwest Regional Center of Excellence grant U54 AI065359 and from the Region V "Great Lakes" Regional center of Excellence (NIH award 1-U54-AI-057153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt JW, 2006, J MOL BIOL, V362, P733, DOI 10.1016/j.jmb.2006.07.040; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; BEVERLEY SM, 1988, NUCLEIC ACIDS RES, V16, P925, DOI 10.1093/nar/16.3.925; Blaiotta G, 2000, LETT APPL MICROBIOL, V31, P343, DOI 10.1046/j.1472-765x.2000.00801.x; Bradshaw M, 2004, ANAEROBE, V10, P321, DOI 10.1016/j.anaerobe.2004.07.001; Bradshaw M, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P238; Brynestad S, 2001, INFECT IMMUN, V69, P3483, DOI 10.1128/IAI.69.5.3483-3487.2001; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dineen SS, 2000, APPL ENVIRON MICROB, V66, P5480, DOI 10.1128/AEM.66.12.5480-5483.2000; Dover N, 2009, J CLIN MICROBIOL, V47, P2349, DOI 10.1128/JCM.00799-09; EKLUND MW, 1967, J BACTERIOL, V93, P1461, DOI 10.1128/JB.93.4.1461-1462.1967; Franciosa G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004829; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; HATHEWAY CL, 1981, J CLIN MICROBIOL, V14, P607, DOI 10.1128/JCM.14.6.607-611.1981; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Hughes ML, 2007, J BACTERIOL, V189, P7531, DOI 10.1128/JB.00767-07; Jacobson MJ, 2008, MICROBIOL-SGM, V154, P2408, DOI 10.1099/mic.0.2008/016915-0; Johnson EA, 1997, CLIN INFECT DIS, V25, pS168, DOI 10.1086/516239; Johnson EA, 2005, J CLIN MICROBIOL, V43, P2602, DOI 10.1128/JCM.43.6.2602-2607.2005; Johnson Eric A, 2008, Handb Clin Neurol, V91, P333, DOI 10.1016/S0072-9752(07)01511-4; LIN WJ, 1991, APPL ENVIRON MICROB, V57, P2946, DOI 10.1128/AEM.57.10.2946-2950.1991; LYNT RK, 1982, J FOOD PROTECT, V45, P466, DOI 10.4315/0362-028X-45.5.466; MARSHALL KM, 2009, THESIS U WISCONSIN M; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; NEVE H, 1984, J BACTERIOL, V157, P833, DOI 10.1128/JB.157.3.833-838.1984; Peck MW, 2009, ADV MICROB PHYSIOL, V55, P183, DOI 10.1016/S0065-2911(09)05503-9; Rood JI, 2004, PLASMID BIOLOGY, P413; ROOD JI, 1978, PLASMID, V1, P563, DOI 10.1016/0147-619X(78)90013-6; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Sambrook J, 2001, MOL CLONING LAB MANU; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; Wang XM, 2000, APPL ENVIRON MICROB, V66, P4992, DOI 10.1128/AEM.66.11.4992-4997.2000; Ward AB, 2007, CLINICAL USES OF BOTULINUM TOXINS, P1, DOI 10.1017/CBO9780511544842; ZHOU YT, 1995, INFECT IMMUN, V63, P2087, DOI 10.1128/IAI.63.5.2087-2091.1995	44	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11087	10.1371/journal.pone.0011087	http://dx.doi.org/10.1371/journal.pone.0011087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552020	Green Submitted, Green Published, gold			2022-12-25	WOS:000278662900024
J	Hedrick, T; Waters, J				Hedrick, Tristan; Waters, Jack			Physiological Properties of Cholinergic and Non-Cholinergic Magnocellular Neurons in Acute Slices from Adult Mouse Nucleus Basalis	PLOS ONE			English	Article							HYPERPOLARIZATION-ACTIVATED CURRENT; GUINEA-PIG BRAIN; FOREBRAIN NEURONS; SEPTAL NEURONS; IN-VITRO; ELECTROPHYSIOLOGICAL PROPERTIES; DISCHARGE PROPERTIES; IMMUNOHISTOCHEMICAL EVIDENCE; MEMBRANE-PROPERTIES; ALZHEIMERS-DISEASE	Background: The basal forebrain is a series of nuclei that provides cholinergic input to much of the forebrain. The most posterior of these nuclei, nucleus basalis, provides cholinergic drive to neocortex and is involved in arousal and attention. The physiological properties of neurons in anterior basal forebrain nuclei, including medial septum, the diagonal band of Broca and substantia innominata, have been described previously. In contrast the physiological properties of neurons in nucleus basalis, the most posterior nucleus of the basal forebrain, are unknown. Methodology/Principal Findings: Here we investigate the physiological properties of neurons in adult mouse nucleus basalis. We obtained cell-attached and whole-cell recordings from magnocellular neurons in slices from P42-54 mice and compared cholinergic and non-cholinergic neurons, distinguished retrospectively by anti-choline acetyltransferase immunocytochemistry. The majority (70-80%) of cholinergic and non-cholinergic neurons were silent at rest. Spontaneously active cholinergic and non-cholinergic neurons exhibited irregular spiking at 3 Hz and at 0.3 to 13.4 Hz, respectively. Cholinergic neurons had smaller, broader action potentials than non-cholinergic neurons (amplitudes 64 +/- 3.4 and 75 +/- 2 mV; half widths 0.52 +/- 0.04 and 0.33 +/- 0.02 ms). Cholinergic neurons displayed a more pronounced slow after-hyperpolarization than non-cholinergic neurons (13.3 +/- 2.2 and 3.6 +/- 0.5 mV) and were unable to spike at high frequencies during tonic current injection (maximum frequencies of similar to 20 Hz and >120 Hz). Conclusions/Significance: Our results indicate that neurons in nucleus basalis share similar physiological properties with neurons in anterior regions of the basal forebrain. Furthermore, cholinergic and non-cholinergic neurons in nucleus basalis can be distinguished by their responses to injected current. To our knowledge, this is the first description of the physiological properties of cholinergic and non-cholinergic neurons in the posterior aspects of the basal forebrain complex and the first study of basal forebrain neurons from the mouse.	[Hedrick, Tristan; Waters, Jack] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hedrick, T (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	jackwaters@northwestern.edu			Whitehall Foundation [2006-12-31]; National Institute on Aging [5T32AG020418-09, 5T32AG020418]; National Institute of Mental Health [2T32MH067564-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085117, T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020418] Funding Source: NIH RePORTER	Whitehall Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the Whitehall Foundation (2006-12-31), National Institute on Aging (5T32AG020418-09 and 5T32AG020418) and National Institute of Mental Health (2T32MH067564-06) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN TGJ, 1993, J PHYSIOL-LONDON, V466, P173; Alonso A, 1996, EUR J NEUROSCI, V8, P169, DOI 10.1111/j.1460-9568.1996.tb01178.x; ALONSO A, 1994, J NEUROSCI, V14, P5778; Bengtson CP, 2000, J NEUROPHYSIOL, V83, P2649, DOI 10.1152/jn.2000.83.5.2649; Cape EG, 2000, J NEUROSCI, V20, P8452, DOI 10.1523/JNEUROSCI.20-22-08452.2000; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DETOLEDO GA, 1988, J PHYSIOL-LONDON, V396, P399, DOI 10.1113/jphysiol.1988.sp016969; DILSAVER SC, 1986, BRAIN RES REV, V11, P285, DOI 10.1016/0165-0173(86)90016-0; FORT P, 1995, EUR J NEUROSCI, V7, P1502, DOI 10.1111/j.1460-9568.1995.tb01145.x; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gorelova N, 1996, J NEUROPHYSIOL, V75, P707, DOI 10.1152/jn.1996.75.2.707; Gorelova N, 1996, J NEUROPHYSIOL, V75, P695, DOI 10.1152/jn.1996.75.2.695; GRIFFITH WH, 1991, ADV EXP MED BIOL, V295, P143; GRIFFITH WH, 1994, J NEUROPHYSIOL, V71, P2359, DOI 10.1152/jn.1994.71.6.2359; GRIFFITH WH, 1986, NEUROSCI LETT, V71, P169, DOI 10.1016/0304-3940(86)90553-7; GRIFFITH WH, 1988, J NEUROPHYSIOL, V59, P1590, DOI 10.1152/jn.1988.59.5.1590; Gritti I, 2003, J COMP NEUROL, V458, P11, DOI 10.1002/cne.10505; Han SH, 2005, MOL BRAIN RES, V134, P226, DOI 10.1016/j.molbrainres.2004.10.041; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; Henny P, 2008, EUR J NEUROSCI, V27, P654, DOI 10.1111/j.1460-9568.2008.06029.x; KHATEB A, 1993, EUR J NEUROSCI, V5, P541, DOI 10.1111/j.1460-9568.1993.tb00519.x; KHATEB A, 1995, NEUROSCIENCE, V69, P495, DOI 10.1016/0306-4522(95)00264-J; KHATEB A, 1992, NEUROSCIENCE, V51, P489, DOI 10.1016/0306-4522(92)90289-E; Kilgard M, 2003, NEURON, V38, P678, DOI 10.1016/S0896-6273(03)00327-1; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Lee MG, 2004, J NEUROPHYSIOL, V92, P1182, DOI 10.1152/jn.01003.2003; LOPEZBARNEO J, 1985, BRAIN RES, V347, P358, DOI 10.1016/0006-8993(85)90199-4; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Manns ID, 2003, J NEUROPHYSIOL, V89, P1057, DOI 10.1152/jn.00938.2002; Manns ID, 2000, J NEUROSCI, V20, P1505; Manns ID, 2001, NEUROSCIENCE, V107, P249, DOI 10.1016/S0306-4522(01)00302-5; MARKRAM H, 1990, BRAIN RES, V513, P171, DOI 10.1016/0006-8993(90)91106-Q; MATTHEWS RT, 1991, NEUROSCIENCE, V42, P451, DOI 10.1016/0306-4522(91)90388-5; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; MESULAM MM, 1995, SEMIN NEUROSCI, V7, P297, DOI 10.1006/smns.1995.0033; MURRAY CL, 1985, NEUROSCIENCE, V14, P1025, DOI 10.1016/0306-4522(85)90273-8; NAKAJIMA Y, 1985, P NATL ACAD SCI USA, V82, P6325, DOI 10.1073/pnas.82.18.6325; PAGE KJ, 1995, EUR J NEUROSCI, V7, P1012, DOI 10.1111/j.1460-9568.1995.tb01089.x; SEGAL M, 1986, J PHYSIOL-LONDON, V379, P309, DOI 10.1113/jphysiol.1986.sp016255; Sim JA, 1998, J NEUROPHYSIOL, V80, P1653, DOI 10.1152/jn.1998.80.4.1653; STANFIELD PR, 1985, NATURE, V315, P498, DOI 10.1038/315498a0; SUSZKIW JB, 1992, BRAIN RES, V588, P246, DOI 10.1016/0006-8993(92)91582-Y; WAINER BH, 1990, ASCENDING CHOLINERGI, P65; Waters DJ, 1998, J PHYSIOL-LONDON, V508, P453, DOI 10.1111/j.1469-7793.1998.453bq.x; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341	47	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11046	10.1371/journal.pone.0011046	http://dx.doi.org/10.1371/journal.pone.0011046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548784	Green Submitted, gold, Green Published			2022-12-25	WOS:000278599600007
J	Shiino, T; Okabe, N; Yasui, Y; Sunagawa, T; Ujike, M; Obuchi, M; Kishida, N; Xu, H; Takashita, E; Anraku, A; Ito, R; Doi, T; Ejima, M; Sugawara, H; Horikawa, H; Yamazaki, S; Kato, Y; Oguchi, A; Fujita, N; Odagiri, T; Tashiro, M; Watanabe, H				Shiino, Teiichiro; Okabe, Nobuhiko; Yasui, Yoshinori; Sunagawa, Tomimasa; Ujike, Makoto; Obuchi, Masatsugu; Kishida, Noriko; Xu, Hong; Takashita, Emi; Anraku, Akane; Ito, Reiko; Doi, Teruko; Ejima, Miho; Sugawara, Hiromi; Horikawa, Hiroshi; Yamazaki, Shuji; Kato, Yumiko; Oguchi, Akio; Fujita, Nobuyuki; Odagiri, Takato; Tashiro, Masato; Watanabe, Haruo			Molecular Evolutionary Analysis of the Influenza A(H1N1)pdm, May-September, 2009: Temporal and Spatial Spreading Profile of the Viruses in Japan	PLOS ONE			English	Article							A H1N1; EPIDEMIOLOGY	Background: In March 2009, pandemic influenza A(H1N1) (A(H1N1)pdm) emerged in Mexico and the United States. In Japan, since the first outbreak of A(H1N1) pdm in Osaka and Hyogo Prefectures occurred in the middle of May 2009, the virus had spread over 16 of 47 prefectures as of June 4, 2009. Methods/Principal Findings: We analyzed all-segment concatenated genome sequences of 75 isolates of A(H1N1) pdm viruses in Japan, and compared them with 163 full-genome sequences in the world. Two analyzing methods, distance-based and Bayesian coalescent MCMC inferences were adopted to elucidate an evolutionary relationship of the viruses in the world and Japan. Regardless of the method, the viruses in the world were classified into four distinct clusters with a few exceptions. Cluster 1 was originated earlier than cluster 2, while cluster 2 was more widely spread around the world. The other two clusters (clusters 1.2 and 1.3) were suggested to be distinct reassortants with different types of segment assortments. The viruses in Japan seemed to be a multiple origin, which were derived from approximately 28 transported cases. Twelve cases were associated with monophyletic groups consisting of Japanese viruses, which were referred to as micro-clade. While most of the micro-clades belonged to the cluster 2, the clade of the first cases of infection in Japan originated from cluster 1.2. Micro-clades of Osaka/Kobe and the Fukuoka cases, both of which were school-wide outbreaks, were eradicated. Time of most recent common ancestor (tMRCA) for each micro-clade demonstrated that some distinct viruses were transmitted in Japan between late May and early June, 2009, and appeared to spread nation-wide throughout summer. Conclusions: Our results suggest that many viruses were transmitted from abroad in late May 2009 irrespective of preventive actions against the pandemic influenza, and that the influenza A(H1N1) pdm had become a pandemic stage in June 2009 in Japan.	[Shiino, Teiichiro; Okabe, Nobuhiko; Yasui, Yoshinori; Sunagawa, Tomimasa; Watanabe, Haruo] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Ujike, Makoto; Obuchi, Masatsugu; Kishida, Noriko; Xu, Hong; Takashita, Emi; Anraku, Akane; Ito, Reiko; Doi, Teruko; Ejima, Miho; Sugawara, Hiromi; Odagiri, Takato; Tashiro, Masato] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan; [Horikawa, Hiroshi; Yamazaki, Shuji; Kato, Yumiko; Oguchi, Akio; Fujita, Nobuyuki] Natl Inst Technol & Evaluat, Dept Biotechnol, Genome Anal Ctr, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Shiino, T (corresponding author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan.	tshiino@nih.go.jp	Ujike, Makoto/W-3508-2019	Ujike, Makoto/0000-0002-7145-7126	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fereidouni SR, 2009, EUROSURVEILLANCE, V14, P2; *HLTH WELF STAT FU, 2009, FIELD EP INV NOV INF; *INF DIS SURV CTR, 2010, IASR, V31, P69; Kawaguchi R, 2009, EMERG INFECT DIS, V15, P1685, DOI 10.3201/eid1510.091029; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; *MIN HLTH LAW, 2008, OFF NOT AM PREV CAR; *MIN HLTH LAW, 2009, OFF NOT; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Rambaut A., 2007, TRACER V1 4; Shimada T, 2009, EUROSURVEILLANCE, V14; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *WHO, 2009, INFL A H1N1 UPD 40; YAHATA Y, 2009, FIELD EPIDEMIOLOGICA	24	37	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11057	10.1371/journal.pone.0011057	http://dx.doi.org/10.1371/journal.pone.0011057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548780	Green Published, gold, Green Submitted			2022-12-25	WOS:000278599600016
J	Kellner, H; Zak, DR; Vandenbol, M				Kellner, Harald; Zak, Donald R.; Vandenbol, Micheline			Fungi Unearthed: Transcripts Encoding Lignocellulolytic and Chitinolytic Enzymes in Forest Soil	PLOS ONE			English	Article							NITROGEN DEPOSITION; LACCASE GENES; INTEGRATED DATABASE; CARBON; DIVERSITY; LIGNIN; ECTOMYCORRHIZAL; DEGRADATION; PEROXIDASE; CLASSIFICATION	Background: Fungi are the main organisms responsible for the degradation of biopolymers such as lignin, cellulose, hemicellulose, and chitin in forest ecosystems. Soil surveys largely target fungal diversity, paying less attention to fungal activity. Methodology/Principal Findings: Here we have focused on the organic horizon of a hardwood forest dominated by sugar maple that spreads widely across Eastern North America. The sampling site included three plots receiving normal atmospheric nitrogen deposition and three that received an extra 3 g nitrogen m(2) y(1) in form of sodium nitrate pellets since 1994, which led to increased accumulation of organic matter in the soil. Our aim was to assess, in samples taken from all six plots, transcript-level expression of fungal genes encoding lignocellulolytic and chitinolytic enzymes. For this we collected RNA from the forest soil, reverse-transcribed it, and amplified cDNAs of interest, using both published primer pairs as well as 23 newly developed ones. We thus detected transcript-level expression of 234 genes putatively encoding 26 different groups of fungal enzymes, notably major ligninolytic and diverse aromatic-oxidizing enzymes, various cellulose-and hemicellulose-degrading glycoside hydrolases and carbohydrate esterases, enzymes involved in chitin breakdown, N-acetylglucosamine metabolism, and cell wall degradation. Among the genes identified, 125 are homologous to known ascomycete genes and 105 to basidiomycete genes. Transcripts corresponding to all 26 enzyme groups were detected in both control and nitrogen-supplemented plots. Conclusions/Significance: Many of these enzyme groups are known to be important in soil turnover processes, but the contribution of some is probably underestimated. Our data highlight the importance of ascomycetes, as well as basidiomycetes, in important biogeochemical cycles. In the nitrogen-supplemented plots, we have detected no transcript-level gap likely to explain the observed increased carbon storage, which is more likely due to community changes and perhaps transcriptional and/or post-transcriptional down-regulation of relevant genes.	[Kellner, Harald; Vandenbol, Micheline] Univ Liege, Unite Biol Anim & Microbienne, Gembloux, Belgium; [Zak, Donald R.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Zak, Donald R.] Univ Michigan, Dep Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Liege; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kellner, H (corresponding author), Univ Liege, Unite Biol Anim & Microbienne, Gembloux, Belgium.	mail@haraldkellner.com	Kellner, Harald/B-8729-2009; Zak, Donald R/C-6004-2012		Belgian Research Foundation (FNRS) [2.4503.08]; Direct For Biological Sciences [0814623] Funding Source: National Science Foundation	Belgian Research Foundation (FNRS)(Fonds de la Recherche Scientifique - FNRS); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Grant was received from the Belgian Research Foundation (FNRS, http://www2.frs-fnrs.be/, grant no. 2.4503.08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Baldrian P, 2008, BR MYCOL SY, V28, P19; Baldrian P, 2009, OECOLOGIA, V161, P657, DOI 10.1007/s00442-009-1433-7; Berg B, 1997, EUR EAT DISORD REV, V5, P25, DOI 10.1002/(SICI)1099-0968(199703)5:1<25::AID-ERV186>3.0.CO;2-2; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; BOOMINATHAN K, 1990, ARCH MICROBIOL, V153, P521, DOI 10.1007/BF00245259; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burke RM, 2002, MYCORRHIZA, V12, P105, DOI 10.1007/s00572-002-0162-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Courty PE, 2008, APPL ENVIRON MICROB, V74, P6598, DOI 10.1128/AEM.00584-08; Coutinho PM, 1999, ROY SOC CH, P3; Cullings K, 2009, OECOLOGIA, V161, P661, DOI 10.1007/s00442-009-1434-6; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; de Vries W, 2008, NATURE, V451, pE1, DOI 10.1038/nature06579; Deacon JW., 2005, FUNGAL BIOL; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Dighton J., 2005, FUNGAL COMMUNITY ITS, V3rd; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Halaouli S, 2006, J APPL MICROBIOL, V100, P219, DOI 10.1111/j.1365-2672.2006.02866.x; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hoegger P., 2007, WOOD PRODUCTION WOOD, P383; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Jacobsen J, 2005, J MICROBIOL METH, V60, P63, DOI 10.1016/j.mimet.2004.08.013; Kellner H, 2009, SOIL BIOL BIOCHEM, V41, P1380, DOI 10.1016/j.soilbio.2009.03.012; Kellner H, 2009, SOIL BIOL BIOCHEM, V41, P1344, DOI 10.1016/j.soilbio.2009.02.033; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Luis P, 2005, MICROB ECOL, V50, P570, DOI 10.1007/s00248-005-5047-2; Luis P, 2005, GEODERMA, V128, P18, DOI 10.1016/j.geoderma.2004.12.023; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; Lyons JI, 2003, MICROB ECOL, V45, P270, DOI 10.1007/s00248-002-1055-7; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; MORRIS DR, 1966, J BIOL CHEM, V241, P1763; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Naumann A, 2007, WOOD PRODUCTION WOOD, ppp179; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; RIEBLE S, 1994, J BACTERIOL, V176, P4838, DOI 10.1128/jb.176.16.4838-4844.1994; Schulze WX, 2005, OECOLOGIA, V142, P335, DOI 10.1007/s00442-004-1698-9; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sutton MA, 2008, GLOBAL CHANGE BIOL, V14, P2057, DOI 10.1111/j.1365-2486.2008.01636.x; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; Tian XJ, 2000, EUR J SOIL BIOL, V36, P81, DOI 10.1016/S1164-5563(00)01049-9; Ullrich R, 2005, FEBS LETT, V579, P6247, DOI 10.1016/j.febslet.2005.10.014; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; VANDERWOUDE MW, 1993, ARCH MICROBIOL, V160, P1; Zak DR, 2008, ECOL APPL, V18, P2016, DOI 10.1890/07-1743.1	55	75	76	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10971	10.1371/journal.pone.0010971	http://dx.doi.org/10.1371/journal.pone.0010971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532045	Green Published, gold, Green Submitted			2022-12-25	WOS:000278380500015
J	Vellaichamy, A; Dezso, Z; JeBailey, L; Chinnaiyan, AM; Sreekumar, A; Nesvizhskii, AI; Omenn, GS; Bugrim, A				Vellaichamy, Adaikkalam; Dezso, Zoltan; JeBailey, Lellean; Chinnaiyan, Arul M.; Sreekumar, Arun; Nesvizhskii, Alexey I.; Omenn, Gilbert S.; Bugrim, Andrej			"Topological Significance" Analysis of Gene Expression and Proteomic Profiles from Prostate Cancer Cells Reveals Key Mechanisms of Androgen Response	PLOS ONE			English	Article							GROWTH-FACTOR; BINDING-PROTEIN; RECEPTOR EXPRESSION; MESSENGER-RNA; PATHWAY; ANTIGEN; LNCAP; MICROARRAY; ENRICHMENT; BETA	Background: The problem of prostate cancer progression to androgen independence has been extensively studied. Several studies systematically analyzed gene expression profiles in the context of biological networks and pathways, uncovering novel aspects of prostate cancer. Despite significant research efforts, the mechanisms underlying tumor progression are poorly understood. We applied a novel approach to reconstruct system-wide molecular events following stimulation of LNCaP prostate cancer cells with synthetic androgen and to identify potential mechanisms of androgen-independent progression of prostate cancer. Methodology/Principal Findings: We have performed concurrent measurements of gene expression and protein levels following the treatment using microarrays and iTRAQ proteomics. Sets of up-regulated genes and proteins were analyzed using our novel concept of "topological significance''. This method combines high-throughput molecular data with the global network of protein interactions to identify nodes which occupy significant network positions with respect to differentially expressed genes or proteins. Our analysis identified the network of growth factor regulation of cell cycle as the main response module for androgen treatment in LNCap cells. We show that the majority of signaling nodes in this network occupy significant positions with respect to the observed gene expression and proteomic profiles elicited by androgen stimulus. Our results further indicate that growth factor signaling probably represents a "second phase'' response, not directly dependent on the initial androgen stimulus. Conclusions/Significance: We conclude that in prostate cancer cells the proliferative signals are likely to be transmitted from multiple growth factor receptors by a multitude of signaling pathways converging on several key regulators of cell proliferation such as c-Myc, Cyclin D and CREB1. Moreover, these pathways are not isolated but constitute an interconnected network module containing many alternative routes from inputs to outputs. If the whole network is involved, a precisely formulated combination therapy may be required to fight the tumor growth effectively.	[Vellaichamy, Adaikkalam; Chinnaiyan, Arul M.; Sreekumar, Arun; Nesvizhskii, Alexey I.; Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Vellaichamy, Adaikkalam; Chinnaiyan, Arul M.; Sreekumar, Arun; Nesvizhskii, Alexey I.; Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Vellaichamy, Adaikkalam; Chinnaiyan, Arul M.; Sreekumar, Arun; Nesvizhskii, Alexey I.; Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Dezso, Zoltan; JeBailey, Lellean; Bugrim, Andrej] GeneGo Inc, St Joseph, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Vellaichamy, A (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	andrej@genego.com	Nesvizhskii, Alexey/A-5410-2012; Vellaichamy, Adaikkalam/GWN-0713-2022	Nesvizhskii, Alexey/0000-0002-2806-7819; Vellaichamy, Adaikkalam/0000-0002-1740-1252; Omenn, Gilbert S./0000-0002-8976-6074	Michigan Proteomic Alliance for Cancer Research; National Institutes of Health (NIH) [CA134175-01, R01CA126239]; GeneGo, Inc; NATIONAL CANCER INSTITUTE [R01CA133458, R01CA126239, R43CA134175, R44CA134175] Funding Source: NIH RePORTER	Michigan Proteomic Alliance for Cancer Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GeneGo, Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Michigan Proteomic Alliance for Cancer Research by National Institutes of Health (NIH) grant CA134175-01, grant R01CA126239 and by GeneGo, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Greenbaum D, 2002, BIOINFORMATICS, V18, P585, DOI 10.1093/bioinformatics/18.4.585; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Krueckl SL, 2004, CANCER RES, V64, P8620, DOI 10.1158/0008-5472.CAN-04-2446; Maeda H, 2009, BIOCHEM BIOPH RES CO, V381, P311, DOI 10.1016/j.bbrc.2009.01.096; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Okabe E, 1999, FEBS LETT, V447, P87, DOI 10.1016/S0014-5793(99)00275-6; Oosterhoff JK, 2005, ENDOCR-RELAT CANCER, V12, P135, DOI 10.1677/erc.1.00897; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Rehault S, 2001, EUR J BIOCHEM, V268, P2960, DOI 10.1046/j.1432-1327.2001.02185.x; Rosini P, 2002, PROSTATE, V53, P310, DOI 10.1002/pros.10164; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Sorlie T, 2004, EUR J CANCER, V40, P2667, DOI 10.1016/j.ejca.2004.08.021; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutkowski DM, 1999, JNCI-J NATL CANCER I, V91, P1663, DOI 10.1093/jnci/91.19.1663; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Waters Katrina M., 2006, Briefings in Functional Genomics & Proteomics, V5, P261, DOI 10.1093/bfgp/ell019; Zhu B, 2005, CANC TREAT, V126, P157, DOI 10.1007/0-387-24361-5_7; Zhu ML, 2008, PROSTATE, V68, P287, DOI 10.1002/pros.20698	35	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10936	10.1371/journal.pone.0010936	http://dx.doi.org/10.1371/journal.pone.0010936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532174	Green Published, Green Submitted, gold			2022-12-25	WOS:000278318700010
J	Oberbach, A; Schlichting, N; Bluher, M; Kovacs, P; Till, H; Stolzenburg, JU; Neuhaus, J				Oberbach, Andreas; Schlichting, Nadine; Blueher, Matthias; Kovacs, Peter; Till, Holger; Stolzenburg, Jens-Uwe; Neuhaus, Jochen			Palmitate Induced IL-6 and MCP-1 Expression in Human Bladder Smooth Muscle Cells Provides a Link between Diabetes and Urinary Tract Infections	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; 3T3-L1 ADIPOCYTES; INSULIN-RESISTANCE; FATTY-ACIDS; TRANSCRIPTION FACTOR; INTERLEUKIN-6; DISEASE; ATHEROSCLEROSIS	Background: Urinary tract infections (UTI) are more frequent in type-2 diabetes mellitus patients than in subjects with normal glucose metabolism. The mechanisms underlying this higher prevalence of UTI are unknown. However, cytokine levels are altered in diabetic patients and may thus contribute to the development of UTI. Increased levels of free fatty acids (FFA), as observed in obese patients, can induce IL-6 production in various cell types. Therefore we studied the effects of the free fatty acid palmitate and bacterial lipopolysaccharide (LPS) on interleukin-6 (IL-6) and monocyte chemotactic protein-1 (MCP-1) expression and secretion in cultured human bladder smooth muscle cells (hBSMC). Methodology/Principal Findings: Biopsies were taken from patients undergoing cystectomy due to bladder cancer. Palmitate or LPS stimulated hBSMC were analysed for the production and secretion of the IL-6, gp80, gp80soluble, gp130, MCP-1, pSTAT3, SOCS3, NF-kappa B and SHP2 by quantitative PCR, ELISA, Western blotting, and confocal immunofluorescence. In signal transduction inhibition experiments we evaluated the involvement of NF-kB and MEK1 in IL-6 and MCP-1 regulation. Palmitate upregulates IL-6 mRNA expression and secretion via NF-kB dependent pathways in a concentration-and time-dependent manner. MCP-1 was moderately upregulated by palmitate but was strongly upregulated by LPS involving NF-kB and MEK1 dependent pathways. Soluble IL-6 receptor (gp80soluble) was downregulated by palmitate and LPS, while membrane-bound gp80 was moderately upregulated. LPS increased SOCS3 and SHP2, whereas palmitate only induced SOCS3. Secondary finding: most of the IL-6 is secreted. Conclusions/Significance: Bacterial infection (LPS) or metabolic alterations (palmitate) have distinct effects on IL-6 expression in hBSMC, (i) short term LPS induced autocrine JAK/STAT signaling and (ii) long-term endocrine regulation of IL-6 by palmitate. Induction of IL-6 in human bladder smooth muscle cells by fatty acids may represent a pathogenetic factor underlying the higher frequency and persistence of urinary tract infections in patients with metabolic diseases.	[Oberbach, Andreas; Schlichting, Nadine; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Till, Holger] Univ Leipzig, Dept Pediat Surg, Leipzig, Germany; [Schlichting, Nadine; Stolzenburg, Jens-Uwe; Neuhaus, Jochen] Univ Leipzig, Dept Urol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Oberbach, A (corresponding author), Univ Leipzig, Dept Med, Leipzig, Germany.	jochen.neuhaus@medizin.uni-leipzig.de		Kovacs, Peter/0000-0002-0290-5423	Deutsche Forschungsgemeinschaft (DFG) [BL 580/3-1]; Clinical Research group "Atherobesity'' [KFO 152, BL 833/1-1]; Interdisciplinary Centre of Clinical Research (IZKF), University of Leipzig [N06, B24]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Clinical Research group "Atherobesity''(German Research Foundation (DFG)); Interdisciplinary Centre of Clinical Research (IZKF), University of Leipzig	This work was supported by grants from Deutsche Forschungsgemeinschaft (DFG) BL 580/3-1 (MB), the Clinical Research group "Atherobesity'' KFO 152: project BL 833/1-1 (MB), the Interdisciplinary Centre of Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig (Project N06 to PK and project B24 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Benfield T, 2007, DIABETOLOGIA, V50, P549, DOI 10.1007/s00125-006-0570-3; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; Bouchelouche K, 2006, J UROLOGY, V175, P760, DOI 10.1016/S0022-5347(05)00167-9; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Davis JE, 2009, HORM METAB RES, V41, P523, DOI 10.1055/s-0029-1202852; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Festa A, 2002, DIABETIC MED, V19, P939, DOI 10.1046/j.1464-5491.2002.00824.x; Geerlings SE, 2000, DIABETES CARE, V23, P1737, DOI 10.2337/diacare.23.12.1737; Harding GKM, 2002, NEW ENGL J MED, V347, P1576, DOI 10.1056/NEJMoa021042; Hoepelman AIM, 2003, INT J ANTIMICROB AG, V22, pS35, DOI 10.1016/S0924-8579(03)00234-6; Ishikado A, 2009, ATHEROSCLEROSIS, V205, P404, DOI 10.1016/j.atherosclerosis.2009.01.010; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lim JH, 2009, EXP MOL MED, V41, P757, DOI 10.3858/emm.2009.41.10.082; Otto G, 1999, J INFECT DIS, V179, P172, DOI 10.1086/314534; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saban MR, 2001, PHYSIOL GENOMICS, V5, P147, DOI 10.1152/physiolgenomics.2001.5.3.147; Schneeberger C, 2008, DIABETES CARE, V31, P1380, DOI 10.2337/dc07-2188; Staiger H, 2004, DIABETES, V53, P3209, DOI 10.2337/diabetes.53.12.3209; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V275, P1929, DOI 10.1001/jama.275.24.1929; Stapleton A, 2002, AM J MED, V113, p80S; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; Yohannes E, 2008, MOL CELL PROTEOMICS, V7, P1270, DOI 10.1074/mcp.M700563-MCP200; Zhao S, 2004, J CELL PHYSIOL, V199, P47, DOI 10.1002/jcp.10453	31	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10882	10.1371/journal.pone.0010882	http://dx.doi.org/10.1371/journal.pone.0010882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526368	gold, Green Published, Green Submitted			2022-12-25	WOS:000278222100011
J	Busco, G; Cardone, RA; Greco, MR; Bellizzi, A; Colella, M; Antelmi, E; Mancini, MT; Dell'Aquila, ME; Casavola, V; Paradiso, A; Reshkin, SJ				Busco, Giovanni; Cardone, Rosa A.; Greco, Maria R.; Bellizzi, Antonia; Colella, Matilde; Antelmi, Ester; Mancini, Maria T.; Dell'Aquila, Maria E.; Casavola, Valeria; Paradiso, Angelo; Reshkin, Stephan J.			NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space	FASEB JOURNAL			English	Article						metastasis; pHe; MDA-MB-231; breast cancer	CANCER-CELL INVASION; EXTRACELLULAR-MATRIX DEGRADATION; BREAST-TUMOR CELLS; H EXCHANGER NHE1; NA+/H+ EXCHANGER; MELANOMA-CELLS; CATHEPSIN-B; PERICELLULAR PROTEOLYSIS; PH; METASTASIS	Extracellular matrix (ECM) degradation is a critical process in tumor cell invasion and requires membrane and released proteases focalized at membrane structures called invadopodia. While extracellular acidification is important in driving tumor invasion, the structure/function mechanisms underlying this regulation are still unknown. Invadopodia are similar in structure and function to osteoclast podosomes responsible for bone degradation, and extracellular acidification is central to podosome action, suggesting that it could also be for invadopodial function. Here, utilizing a novel system for in situ zymography in native matrices, we show that the Na+/H+ exchanger (NHE1) and NHE1-generated extracellular acidification are localized at and necessary for invadopodial-dependent ECM degradation, thereby promoting tumor invasion. Stimulation with EGF increased both NHE1-dependent proton secretion and ECM degradation. Manipulation of the NHE1 expression by RNA interference or activity via either transport-deficient mutation or the specific inhibitor cariporide confirmed that NHE1 expression and activity are required for invadopodia-mediated ECM degradation. Taken together, our data show a concordance among NHE1 localization, the generation of a well-defined acidic extracellular pH in the nanospace surrounding invadopodia, and matrix-degrading activity at invadopodia of human malignant breast carcinoma cells, providing a structural basis for the role of NHE1 in invasion and identifying NHE1 as a strategic target for therapeutic intervention.-Busco, G., Cardone, R. A., Greco, M. R., Bellizzi, A., Colella, M., Antelmi, E., Mancini, M. T., Dell'Aquila, M. E., Casavola, V., Paradiso, A., Reshkin, S. J. NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. FASEB J. 24, 3903-3915 (2010). www.fasebj.org	[Busco, Giovanni; Cardone, Rosa A.; Greco, Maria R.; Colella, Matilde; Antelmi, Ester; Mancini, Maria T.; Casavola, Valeria; Reshkin, Stephan J.] Univ Bari, Dept Gen & Environm Physiol, I-70126 Bari, Italy; [Dell'Aquila, Maria E.] Univ Bari, Dept Anim Prod, I-70126 Bari, Italy; [Bellizzi, Antonia; Paradiso, Angelo] Natl Canc Inst Giovanni Paolo II, Clin Expt Oncol Lab, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II	Reshkin, SJ (corresponding author), Univ Bari, Dept Gen & Environm Physiol, Via Amendola 165-A, I-70126 Bari, Italy.	reshkin@biologia.uniba.it	Antelmi, Elena/K-3252-2018; paradiso, angelo V/J-9457-2018; Colella, Matilde/G-9246-2011; Busco, Giovanni/F-2711-2018; Reshkin, Stephan/AAI-6680-2020	Colella, Matilde/0000-0002-9584-7030; Busco, Giovanni/0000-0001-6859-9468; Reshkin, Stephan/0000-0001-9757-5908; GRECO, Maria Raffaella/0000-0001-7454-8990; CASAVOLA, Valeria/0000-0003-4471-4948; Antelmi, Elena/0000-0003-1739-6139; Dell'Aquila, Maria Elena/0000-0003-3629-7005; Antelmi, Ester/0000-0003-0685-4827	Italian Association for Cancer Research [5167]	Italian Association for Cancer Research	The authors thank the Italian Association for Cancer Research (grant 5167) for supporting this work. The authors' laboratory is part of the Italian network Istituto Nazionale Biostrutture e Biosistemi. The authors thank Prof. Diane Barber (University of California, San Francisco, CA, USA) for kindly supplying the construct containing the ion transport dead E226I-NHE1 mutant and Sanofi-Aventis (Paris, France) for supplying cariporide (HOE642). The authors also thank Dr. Roberto Buccione (Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy) for teaching the basics of the invadopodia isolation technique.	Albini A, 2004, INT J DEV BIOL, V48, P563, DOI 10.1387/ijdb.041822aa; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Arnett TR, 1996, BONE, V18, P277, DOI 10.1016/8756-3282(95)00486-6; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Briozzo P, 1998, STRUCTURE, V6, P1517, DOI 10.1016/S0969-2126(98)00150-6; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Caldieri G, 2009, INT REV CEL MOL BIO, V275, P1, DOI 10.1016/S1937-6448(09)75001-4; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Chen WT, 2008, J CHIN MED ASSOC, V71, P128, DOI 10.1016/S1726-4901(08)70004-2; Chen WT, 2003, CANCER METAST REV, V22, P259, DOI 10.1023/A:1023055600919; Chiang YH, 2008, J CELL PHYSIOL, V214, P810, DOI 10.1002/jcp.21277; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Demou ZN, 2005, CANCER RES, V65, P5674, DOI 10.1158/0008-5472.CAN-04-1682; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; Enderling H, 2008, BIOPHYS J, V95, P2203, DOI 10.1529/biophysj.108.133199; Frederiks WM, 2004, J HISTOCHEM CYTOCHEM, V52, P711, DOI 10.1369/jhc.4R6251.2004; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gatenby RA, 2006, INT J EPIDEMIOL, V35, P1165, DOI 10.1093/ije/dyl192; Giusti I, 2008, NEOPLASIA, V10, P481, DOI 10.1593/neo.08178; GOLDHABER P, 1987, AM J PHYSIOL, V253, pE90, DOI 10.1152/ajpendo.1987.253.1.E90; Huang WC, 2008, CURR BIOL, V18, P781, DOI 10.1016/j.cub.2008.04.049; KATO Y, 1992, J BIOL CHEM, V267, P11424; Kindzelskii AL, 2004, HISTOCHEM CELL BIOL, V121, P299, DOI 10.1007/s00418-004-0639-3; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Kraus M, 1996, TUMOR BIOL, V17, P133, DOI 10.1159/000217977; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Lunt SJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-2; Makale M, 2008, METHOD ENZYMOL, V444, P175, DOI 10.1016/S0076-6879(08)02808-5; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; Moellering RE, 2008, CLIN EXP METASTAS, V25, P411, DOI 10.1007/s10585-008-9145-7; MONTCOURRIER P, 1994, J CELL SCI, V107, P2381; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Rofstad EK, 2000, INT J RADIAT BIOL, V76, P589, DOI 10.1080/095530000138259; Rofstad EK, 2003, CANCER RES, V63, P4055; ROZHIN J, 1994, CANCER RES, V54, P6517; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sameni M, 2000, NEOPLASIA, V2, P496, DOI 10.1038/sj.neo.7900116; SCHLAPPACK OK, 1991, BRIT J CANCER, V64, P663, DOI 10.1038/bjc.1991.378; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Taves J, 2008, ARCH BIOCHEM BIOPHYS, V477, P60, DOI 10.1016/j.abb.2008.05.007; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wolf K, 2005, BIOCHIMIE, V87, P315, DOI 10.1016/j.biochi.2004.10.016; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076	64	166	167	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3903	3915		10.1096/fj.09-149518	http://dx.doi.org/10.1096/fj.09-149518			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20547664	Green Submitted			2022-12-25	WOS:000285005900028
J	Dhayalan, A; Rajavelu, A; Rathert, P; Tamas, R; Jurkowska, RZ; Ragozin, S; Jeltsch, A				Dhayalan, Arunkumar; Rajavelu, Arumugam; Rathert, Philipp; Tamas, Raluca; Jurkowska, Renata Z.; Ragozin, Sergey; Jeltsch, Albert			The Dnmt3a PWWP Domain Reads Histone 3 Lysine 36 Trimethylation and Guides DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; STRUCTURAL BASIS; METHYLTRANSFERASES DNMT3A; MAMMALIAN DEVELOPMENT; H3K36 TRIMETHYLATION; DEACETYLASE COMPLEX; HUMAN GENOME; CHROMATIN; RECOGNITION; H3	The Dnmt3a DNA methyltransferase contains in its N-terminal part a PWWP domain that is involved in chromatin targeting. Here, we have investigated the interaction of the PWWP domain with modified histone tails using peptide arrays and show that it specifically recognizes the histone 3 lysine 36 trimethylation mark. H3K36me3 is known to be a repressive modification correlated with DNA methylation in mammals and heterochromatin in Schizosaccharomyces pombe. These results were confirmed by equilibrium peptide binding studies and pulldown experiments with native histones and purified native nucleosomes. The PWWP-H3K36me3 interaction is important for the subnuclear localization of enhanced yellow fluorescent protein-fused Dnmt3a. Furthermore, the PWWP-H3K36me3 interaction increases the activity of Dnmt3a for methylation of nucleosomal DNA as observed using native nucleosomes isolated from human cells after demethylation of the DNA with 5-aza-2'-deoxycytidine as substrate for methylation with Dnmt3a. These data suggest that the interaction of the PWWP domain with H3K36me3 is involved in targeting of Dnmt3a to chromatin carrying that mark, a model that is in agreement with several studies on the genome-wide distribution of DNA methylation and H3K36me3.	[Ragozin, Sergey; Jeltsch, Albert] Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, D-28759 Bremen, Germany; [Tamas, Raluca] Jacobs Univ Bremen, Sch Sci & Engn, MoLife Grad Program, D-28759 Bremen, Germany; [Rathert, Philipp] Act Motif Europe, BE-1330 Rixensart, Belgium	Jacobs University; Jacobs University	Jeltsch, A (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, Campus Ring 1, D-28759 Bremen, Germany.	a.jeltsch@jacobs-university.de	Jurkowska, Renata/AAE-2504-2020; Rajavelu, Arumugam/B-7832-2013; Jeltsch, Albert/O-7404-2014	Jurkowska, Renata/0000-0002-4507-2222; Jeltsch, Albert/0000-0001-6113-9290; Rajavelu, Arumugam/0000-0001-6666-8925; Rathert, Philipp/0000-0003-1477-136X; Dhayalan, Arunkumar/0000-0003-2588-9865	National Institutes of Health [GM068680, DK082678]; Deutsche Forschungsgemeinschaft [JE 252/6-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK082678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068680 and DK082678. This work was also supported by Deutsche Forschungsgemeinschaft Grant JE 252/6-1.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hata K, 2002, DEVELOPMENT, V129, P1983; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Jeltsch Albert, 2002, Methods Mol Biol, V182, P85; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rohde C, 2009, BIOTECHNIQUES, V47, P781, DOI 10.2144/000113196; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shikauchi Y, 2009, MOL CELL BIOL, V29, P1944, DOI 10.1128/MCB.00840-08; Shirohzu H, 2002, AM J MED GENET, V112, P31, DOI 10.1002/ajmg.10658; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; ZHANG Y, 2010, NUCL ACIDS IN PRESS; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	51	343	355	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26114	26120		10.1074/jbc.M109.089433	http://dx.doi.org/10.1074/jbc.M109.089433			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547484	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000280921000028
J	Ding, L; Feng, HJ; Macdonald, RL; Botzolakis, EJ; Hu, NN; Gallagher, MJ				Ding, Li; Feng, Hua-Jun; Macdonald, Robert L.; Botzolakis, Emanuel J.; Hu, Ningning; Gallagher, Martin J.			GABA(A) Receptor alpha 1 Subunit Mutation A322D Associated with Autosomal Dominant Juvenile Myoclonic Epilepsy Reduces the Expression and Alters the Composition of Wild Type GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHILDHOOD ABSENCE EPILEPSY; ENDOPLASMIC-RETICULUM; MESSENGER-RNAS; KNOCKOUT MICE; SEIZURE THRESHOLD; ASSEMBLY SIGNALS; CELL-SURFACE; A RECEPTORS; RAT-BRAIN; IN-VITRO	A GABA(A) receptor (GABA(A)R) alpha 1 subunit mutation, A322D (AD), causes an autosomal dominant form of juvenile myoclonic epilepsy (ADJME). Previous studies demonstrated that the mutation caused alpha 1(AD) subunit misfolding and rapid degradation, reducing its total and surface expression substantially. Here, we determined the effects of the residual alpha 1(AD) subunit expression on wild type GABA(A)R expression to determine whether the AD mutation conferred a dominant negative effect. We found that although the alpha 1(AD) subunit did not substitute for wild type alpha 1 subunits on the cell surface, it reduced the surface expression of alpha 1 beta 2 gamma 2 and alpha 3 beta 2 gamma 2 receptors by associating with the wild type subunits within the endoplasmic reticulum and preventing them from trafficking to the cell surface. The alpha 1(AD) subunit reduced surface expression of alpha 3 beta 2 gamma 2 receptors by a greater amount than alpha 1 beta 2 gamma 2 receptors, thus altering cell surface GABAAR composition. When transfected into cultured cortical neurons, the alpha 1(AD) subunit altered the time course of miniature inhibitory postsynaptic current kinetics and reduced miniature inhibitory postsynaptic current amplitudes. These findings demonstrated that, in addition to causing a heterozygous loss of function of alpha 1(AD) subunits, this epilepsy mutation also elicited a modest dominant negative effect that likely shapes the epilepsy phenotype.	[Ding, Li; Feng, Hua-Jun; Macdonald, Robert L.; Botzolakis, Emanuel J.; Hu, Ningning; Gallagher, Martin J.] Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Gallagher, MJ (corresponding author), Vanderbilt Univ, Dept Neurol, 6140 Med Res Bldg 3,465 21st Ave S, Nashville, TN 37232 USA.	Martin.Gallagher@Vanderbilt.edu		Feng, Huajun/0000-0003-1544-4248; Gallagher, Martin/0000-0002-3537-4200	National Institutes of Health [NS055979, NS33300]; USPHS [NS51590]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NCRR [5UL1 RR024975-03]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033300, K02NS055979, R01NS051590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055979 (to M. J. G.), NS33300 (to R. L. M.), and NS51590 (to R. L. M.) from the USPHS.; We thank Dr. Bruce Carter (Vanderbilt University) for helpful comments concerning this manuscript. Flow cytometry experiments were performed in the VMC Flow Cytometry Shared Resource. The Vanderbilt University Medical Center Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center Grant P30 CA68485 and the Vanderbilt Digestive Disease Research Center Grant DK058404. Flow cytometry was supported in part by National Institutes of Health Vanderbilt CTSA Grant 5UL1 RR024975-03 from NCRR.	Alfradique I, 2007, ARQ NEURO-PSIQUIAT, V65, P1266, DOI 10.1590/S0004-282X2007000700036; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Berry RB, 2009, NEUROSCI LETT, V455, P84, DOI 10.1016/j.neulet.2009.03.046; Bollan K, 2003, BIOCHEM SOC T, V31, P875, DOI 10.1042/bst0310875; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; Bosman LWJ, 2005, J NEUROPHYSIOL, V94, P338, DOI 10.1152/jn.00084.2005; Bradley CA, 2008, J BIOL CHEM, V283, P22043, DOI 10.1074/jbc.M801708200; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brooks-Kayal AR, 1998, J NEUROCHEM, V70, P1017; Chiu C, 2008, ANN NEUROL, V64, P284, DOI 10.1002/ana.21440; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Eugene E, 2007, J NEUROSCI, V27, P14108, DOI 10.1523/JNEUROSCI.2618-07.2007; Fisher JL, 2004, NEUROPHARMACOLOGY, V46, P629, DOI 10.1016/j.neuropharm.2003.11.015; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Hales TG, 2005, MOL CELL NEUROSCI, V29, P120, DOI 10.1016/j.mcn.2005.01.002; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jones A, 1997, J NEUROSCI, V17, P1350; Kang JQ, 2009, J NEUROSCI, V29, P2833, DOI 10.1523/JNEUROSCI.4512-08.2009; Klausberger T, 2001, J NEUROSCI, V21, P9124, DOI 10.1523/JNEUROSCI.21-23-09124.2001; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Kralic JE, 2002, NEUROPHARMACOLOGY, V43, P685, DOI 10.1016/S0028-3908(02)00174-0; Krampfl K, 2005, EUR J NEUROSCI, V22, P10, DOI 10.1111/j.1460-9568.2005.04168.x; Kumar A, 2009, METHOD ENZYMOL, V460, P379, DOI 10.1016/S0076-6879(09)05219-7; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; Ogris W, 2006, J NEUROCHEM, V96, P136, DOI 10.1111/j.1471-4159.2005.03509.x; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; Picton AJ, 2007, BRAIN RES, V1165, P40, DOI 10.1016/j.brainres.2007.06.050; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; POULTER MO, 1992, J NEUROSCI, V12, P2888, DOI 10.1523/JNEUROSCI.12-08-02888.1992; Saliba RS, 2008, J BIOL CHEM, V283, P18538, DOI 10.1074/jbc.M802077200; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; Thomas EA, 2009, ARCH NEUROL-CHICAGO, V66, P1225, DOI 10.1001/archneurol.2009.219; Tretter V, 1997, J NEUROSCI, V17, P2728; Vlainic J, 2009, NEUROPHARMACOLOGY, V56, P1124, DOI 10.1016/j.neuropharm.2009.03.010; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Zeiger SLH, 2009, FREE RADICAL BIO MED, V47, P1422, DOI 10.1016/j.freeradbiomed.2009.08.011; Zhang JL, 2008, MOL PHARMACOL, V74, P941, DOI 10.1124/mol.108.048710; Zhao JL, 2008, J NEUROSCI, V28, P13938, DOI 10.1523/JNEUROSCI.4668-08.2008	53	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26390	26405		10.1074/jbc.M110.142299	http://dx.doi.org/10.1074/jbc.M110.142299			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551311	hybrid, Green Published			2022-12-25	WOS:000280921000058
J	Kang, SA; Lee, ES; Yoon, HY; Randazzo, PA; Lee, ST				Kang, Shin-Ae; Lee, Eun-Saem; Yoon, Hye-Young; Randazzo, Paul A.; Lee, Seung-Taek			PTK6 Inhibits Down-regulation of EGF Receptor through Phosphorylation of ARAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; BREAST-TUMOR KINASE; NONRECEPTOR TYROSINE KINASE; MAMMARY EPITHELIAL-CELLS; INDEPENDENT ENDOCYTOSIS; GASTROINTESTINAL-TRACT; STAT3 ACTIVATION; PLASMA-MEMBRANE; FAMILY KINASES; ARF GAPS	PTK6 (also known as Brk) is a non-receptor-tyrosine kinase containing SH3, SH2, and catalytic domains, that is expressed in more than 60% of breast carcinomas but not in normal mammary tissues. To analyze PTK6-interacting proteins, we have expressed Flag-tagged PTK6 in HEK293 cells and performed co-immunoprecipitation assays with Flag antibody-conjugated agarose. A 164-kDa protein in the precipitated fraction was identified as ARAP1 (also known as centaurin delta-2) by MALDI-TOF mass analysis. ARAP1 associated with PTK6 in an EGF/EGF receptor (EGFR)-dependent manner. In addition, the SH2 domain of PTK6, particularly the Arg(105) residue that contacts the phosphate group of the tyrosine residue, was essential for the association. Moreover, PTK6 phosphorylated residue Tyr(231) in the N-terminal domain of ARAP1. Expression of ARAP1, but not of the Y231F mutant, inhibited the down-regulation of EGFR in HEK293 cells expressing PTK6. Silencing of endogenous PTK6 expression in breast carcinoma cells decreased EGFR levels. These results demonstrate that PTK6 enhances EGFR signaling by inhibition of EGFR down-regulation through phosphorylation of ARAP1 in breast cancer cells.	[Kang, Shin-Ae; Lee, Eun-Saem; Lee, Seung-Taek] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Yoon, Hye-Young; Randazzo, Paul A.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Yonsei University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lee, ST (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	stlee@yonsei.ac.kr		Lee, Seung-Taek/0000-0001-7300-9784	Seoul Research and Business Development [10527]; Korea Science and Engineering Foundation; Brain Korea 21 trainee program; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	Seoul Research and Business Development(Seoul RBD program); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Brain Korea 21 trainee program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Seoul Research and Business Development Grant 10527, the project for Studies on Ubiquitome Functions from the Korea Science and Engineering Foundation, and the Brain Korea 21 trainee program.	BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Campa F, 2009, J BIOL CHEM, V284, P28069, DOI 10.1074/jbc.M109.028266; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daniele T, 2008, TRAFFIC, V9, P2221, DOI 10.1111/j.1600-0854.2008.00823.x; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Haegebarth A, 2005, CELL CYCLE, V4, P1239, DOI 10.4161/cc.4.9.1965; Haegebarth A, 2004, J BIOL CHEM, V279, P54398, DOI 10.1074/jbc.M409579200; He H, 2001, J BIOL CHEM, V276, P26741, DOI 10.1074/jbc.C100229200; Hwang IK, 2004, BBA-PROTEINS PROTEOM, V1702, P79, DOI 10.1016/j.bbapap.2004.08.001; Ikeda O, 2009, BIOCHEM BIOPH RES CO, V384, P71, DOI 10.1016/j.bbrc.2009.04.076; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kasprzycka M, 2006, AM J PATHOL, V168, P1631, DOI 10.2353/ajpath.2006.050521; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Kim HI, 2005, J BIOL CHEM, V280, P28973, DOI 10.1074/jbc.M504568200; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lee HY, 1998, MOL CELLS, V8, P401; LEE ST, 1993, ONCOGENE, V8, P3403; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Llor X, 1999, CLIN CANCER RES, V5, P1767; Lukong KE, 2008, CELL SIGNAL, V20, P432, DOI 10.1016/j.cellsig.2007.11.003; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Mitchell PJ, 2000, ONCOGENE, V19, P4273, DOI 10.1038/sj.onc.1203775; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Petro BJ, 2004, ORAL ONCOL, V40, P1040, DOI 10.1016/j.oraloncology.2004.05.010; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; SORKIN A, 1995, J BIOL CHEM, V270, P619, DOI 10.1074/jbc.270.2.619; Stacey TTI, 2004, J CELL SCI, V117, P6071, DOI 10.1242/jcs.01526; Vasioukhin V, 1997, P NATL ACAD SCI USA, V94, P14477, DOI 10.1073/pnas.94.26.14477; VASIOUKHIN V, 1995, ONCOGENE, V10, P349; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200	49	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26013	26021		10.1074/jbc.M109.088971	http://dx.doi.org/10.1074/jbc.M109.088971			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554524	Green Published, hybrid			2022-12-25	WOS:000280921000016
J	Ohnesorge, N; Viemann, D; Schmidt, N; Czymai, T; Spiering, D; Schmolke, M; Ludwig, S; Roth, J; Goebeler, M; Schmidt, M				Ohnesorge, Nils; Viemann, Dorothee; Schmidt, Nicole; Czymai, Tobias; Spiering, Desiree; Schmolke, Mirco; Ludwig, Stephan; Roth, Johannes; Goebeler, Matthias; Schmidt, Marc			Erk5 Activation Elicits a Vasoprotective Endothelial Phenotype via Induction of Kruppel-like Factor 4 (KLF4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-5; NF-KAPPA-B; PROINFLAMMATORY GENE-EXPRESSION; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATION; SHEAR-STRESS; 1 BMK1; CELLS; STATINS; DIFFERENTIATION	The MEK5/Erk5 MAPK cascade has recently been implicated in the regulation of endothelial integrity and represents a candidate pathway mediating the beneficial effects of laminar flow, a major factor preventing vascular dysfunction and disease. Here we expressed a constitutively active mutant of MEK5 (MEK5D) to study the transcriptional and functional responses to Erk5 activation in human primary endothelial cells. We provide evidence that constitutive Erk5 activation elicits an overall protective phenotype characterized by increased apoptosis resistance and a decreased angiogenic, migratory, and inflammatory potential. This is supported by bioinformatic microarray analysis, which uncovered a statistical overrepresentation of corresponding functional clusters as well as a significant induction of anti-thrombotic, hemostatic, and vasodilatory genes. We identify KLF4 as a novel Erk5 target and demonstrate a critical role of this transcription factor downstream of Erk5. We show that KLF4 expression largely reproduces the protective phenotype in endothelial cells, whereas KLF4 siRNA suppresses expression of various Erk5 targets. Additionally, we show that vasoprotective statins potently induce KLF4 and KLF4-dependent gene expression via activation of Erk5. Our data underscore a major protective function of the MEK5/Erk5/KLF4 module in ECs and implicate agonistic Erk5 activation as potential strategy for treatment of vascular diseases.	[Goebeler, Matthias; Schmidt, Marc] Heidelberg Univ, Dept Dermatol, Univ Hosp Mannheim, D-68167 Mannheim, Germany; [Viemann, Dorothee; Roth, Johannes] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Viemann, Dorothee; Roth, Johannes] Univ Munster, Inst Mol Virol, D-48149 Munster, Germany; [Spiering, Desiree; Schmolke, Mirco; Ludwig, Stephan] Univ Munster, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Ohnesorge, Nils; Goebeler, Matthias; Schmidt, Marc] Univ Giessen, Univ Hosp Giessen, Dept Dermatol, D-35392 Giessen, Germany	Ruprecht Karls University Heidelberg; University of Munster; University of Munster; University of Munster; Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Schmidt, M (corresponding author), Univ Giessen, Dept Dermatol, Gaffkystr 14, D-35392 Giessen, Germany.	marc.schmidt@derma.med.uni-giessen.de	Goebeler, Matthias/P-3612-2019; Goebeler, Matthias/F-7118-2013; Schmidt, Marc/E-8821-2010; Schmolke, Mirco/AAI-9081-2020	Schmidt, Marc/0000-0002-8643-1615; Schmolke, Mirco/0000-0002-2491-3029; Ludwig, Stephan/0000-0003-4490-3052; Viemann, Dorothee/0000-0002-9009-3559	Deutsche Forschungsgemeinschaft [GO 811/1-5]; Deutsche Forschungsgemeinschaft, International Research Training Group Vascular Medicine [GRK880/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, International Research Training Group Vascular Medicine(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft Grants GO 811/1-5 (to M. G.) and GRK880/3 (International Research Training Group Vascular Medicine, Graduiertenkolleg 880/3 (to M. S. and M. G.)).	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Atkins GB, 2008, CIRC RES, V103, P690, DOI 10.1161/CIRCRESAHA.108.184663; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; Eccles KA, 2008, ATHEROSCLEROSIS, V200, P69, DOI 10.1016/j.atherosclerosis.2007.12.018; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kawashima S, 2004, ARTERIOSCL THROM VAS, V24, P998, DOI 10.1161/01.ATV.0000125114.88079.96; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; Muller V, 2007, J IMMUNOL, V179, P8435, DOI 10.4049/jimmunol.179.12.8435; Nakamura K, 2006, MOL CELL BIOL, V26, P2065, DOI 10.1128/MCB.26.6.2065-2079.2006; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Schonbeck U, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000129505.34151.23; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Spiering D, 2009, J BIOL CHEM, V284, P24972, DOI 10.1074/jbc.M109.042911; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Zakkar M, 2008, CIRC RES, V103, P726, DOI 10.1161/CIRCRESAHA.108.183913	49	99	101	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26199	26210		10.1074/jbc.M110.103127	http://dx.doi.org/10.1074/jbc.M110.103127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551324	Green Published, hybrid			2022-12-25	WOS:000280921000037
J	Schelter, F; Kobuch, J; Moss, ML; Becherer, JD; Comoglio, PM; Boccaccio, C; Kruger, A				Schelter, Florian; Kobuch, Julia; Moss, Marcia L.; Becherer, J. David; Comoglio, Paolo M.; Boccaccio, Carla; Krueger, Achim			A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; TYROSINE KINASE RECEPTOR; NECROSIS-FACTOR-ALPHA; C-MET; DOWN-REGULATION; SCATTER FACTOR; PROTEIN; CANCER; METASTASIS; INHIBITORS	Met, the tyrosine kinase receptor for the hepatocyte growth factor is a prominent regulator of cancer cell invasiveness and has emerged as a promising therapeutic target. Binding of the anti-Met monoclonal antibody DN30 to its epitope induces the proteolytic cleavage of Met, thereby impairing the invasive growth of tumors. The molecular mechanism controlling this therapeutic shedding process has so far been unknown. Here, we report that A Disintegrin And Metalloproteinase (ADAM)-10, but not ADAM-17, is required for DN30-induced Met shedding. Knockdown of ADAM-10 in different tumor cell lines or abrogation of its proteolytic activity by natural or synthetic inhibitors abolished Met down-regulation on the cell surface as well as reduction of Met activation. Moreover, hepatocyte growth factor-induced tumor cell migration and invasion were impaired upon ADAM-10 knockdown. Thus, the therapeutic effect of DN30 involves ADAM-10-dependent Met shedding, linking for the first time a specific metalloprotease to target therapy against a receptor tyrosine kinase.	[Schelter, Florian; Kobuch, Julia; Krueger, Achim] Tech Univ Munich, Klinikums Rechts Isar, Inst Expt Onkol & Therapieforsch, D-81675 Munich, Germany; [Moss, Marcia L.] BioZyme, Apex, NC 27523 USA; [Becherer, J. David] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA; [Comoglio, Paolo M.; Boccaccio, Carla] Univ Turin, Inst Canc Res & Treatment, I-10060 Candiolo, Italy	Technical University of Munich; GlaxoSmithKline; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Kruger, A (corresponding author), Tech Univ Munich, Klinikums Rechts Isar, Inst Expt Onkol & Therapieforsch, Ismaninger Str 22, D-81675 Munich, Germany.	achim.krueger@lrz.tu-muenchen.de	Boccaccio, Carla/AHE-7875-2022	Boccaccio, Carla/0000-0003-2620-9083; Comoglio, Paolo/0000-0002-7056-5328	Framework Programme 7 Project [HEALTH-2007-201279]; Deutsche Forschungsgemeinschaft [KR2047/1-1]	Framework Programme 7 Project; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Framework Programme 7 Project HEALTH-2007-201279, Microenvimet (to C. B., P. M. C., and A. K.) and Deutsche Forschungsgemeinschaft Grant KR2047/1-1 (to A. K.).	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1999, ANN NY ACAD SCI, V878, P728, DOI 10.1111/j.1749-6632.1999.tb07774.x; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Arlt M, 2002, CANCER RES, V62, P5543; BENJAMIN DC, 1992, BIOCHEMISTRY-US, V31, P9539, DOI 10.1021/bi00155a005; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; DIRENZO MF, 1991, ONCOGENE, V6, P1997; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; Gentile A, 2004, INT J DEV BIOL, V48, P451, DOI 10.1387/ijdb.041799ag; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P2, DOI 10.2174/138920108783497613; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; NALDINI L, 1991, MOL CELL BIOL, V11, P1793, DOI 10.1128/MCB.11.4.1793; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; PONZETTO C, 1991, ONCOGENE, V6, P553; Prat M, 1998, J CELL SCI, V111, P237; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Takeda S, 2009, SEMIN CELL DEV BIOL, V20, P146, DOI 10.1016/j.semcdb.2008.07.009; Vigna E, 2008, CANCER RES, V68, P9176, DOI 10.1158/0008-5472.CAN-08-1688; Zarnegar R, 1993, EXS, V65, P181	32	56	58	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26335	26340		10.1074/jbc.M110.106435	http://dx.doi.org/10.1074/jbc.M110.106435			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554517	hybrid, Green Published			2022-12-25	WOS:000280921000051
J	Cerutti, N; Mendelow, BV; Napier, GB; Papathanasopoulos, MA; Killick, M; Khati, M; Stevens, W; Capovilla, A				Cerutti, Nichole; Mendelow, Barry V.; Napier, Grant B.; Papathanasopoulos, Maria A.; Killick, Mark; Khati, Makobetsa; Stevens, Wendy; Capovilla, Alexio			Stabilization of HIV-1 gp120-CD4 Receptor Complex through Targeted Interchain Disulfide Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4 BINDING-SITE; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; PROTEIN; INHIBITOR; IMMUNOGENICITY; PURIFICATION; EXPRESSION; INDUCTION	HIV-1 enters cells via interaction between the trimeric envelope (Env) glycoprotein gp120/gp41 and the host cell surface receptor molecule CD4. The requirement of CD4 for viral entry has rationalized the development of recombinant CD4-based proteins as competitive viral attachment inhibitors and immunotherapeutic agents. In this study, we describe a novel recombinant CD4 protein designed to bind gp120 through a targeted disulfide-exchange mechanism. According to structural models of the gp120-CD4 receptor complex, substitution of Ser(60) on the CD4 domain 1 alpha-helix with Cys positions a thiol in proximity of the gp120 V1/V2 loop disulfide (Cys(126)-Cys(196)), satisfying the stereochemical and geometric conditions for redox exchange between CD4 Cys(60) and gp120 Cys(126), and the consequent formation of an interchain disulfide bond. In this study, we provide experimental evidence for this effect by describing the expression, purification, refolding, receptor binding and antiviral activity analysis of a recombinant two-domain CD4 variant containing the S60C mutation (2dCD4-S60C). We show that 2dCD4-S60C binds HIV-1 gp120 with a significantly higher affinity than wild-type protein under conditions that facilitate disulfide exchange and that this translates into a corresponding increase in the efficacy of CD4-mediated viral entry inhibition. We propose that targeted redox exchange between conserved gp120 disulfides and nucleophilic moieties positioned strategically on CD4 (or CD4-like scaffolds) conceptualizes a new strategy in the development of high affinity HIV-1 Env ligands, with important implications for therapy and vaccine development. More generally, this chalcogen substitution approach provides a general means of stabilizing receptor-ligand complexes where the structural and biophysical conditions for disulfide exchange are satisfied.	[Capovilla, Alexio] Elevat Biotech, ZA-2193 Johannesburg, South Africa; [Mendelow, Barry V.; Papathanasopoulos, Maria A.; Stevens, Wendy; Capovilla, Alexio] Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Haematol, ZA-2193 Johannesburg, South Africa; [Khati, Makobetsa] CSIR, ZA-0001 Pretoria, South Africa	University of Witwatersrand; Council for Scientific & Industrial Research (CSIR) - South Africa	Capovilla, A (corresponding author), Elevat Biotech, 8 Blackwood Ave, ZA-2193 Johannesburg, South Africa.	alexio.capovilla@wits.ac.za			Technology Innovation Agency of the South African Department of Science and Technology; Poliomyelitis Research Foundation; National Research Foundation	Technology Innovation Agency of the South African Department of Science and Technology; Poliomyelitis Research Foundation; National Research Foundation	This work was supported by funding from the Technology Innovation Agency of the South African Department of Science and Technology, the Poliomyelitis Research Foundation, and the National Research Foundation.	ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; ASHKENAZI A, 1991, P NATL ACAD SCI USA, V88, P7056, DOI 10.1073/pnas.88.16.7056; Auwerx J, 2009, INT J BIOCHEM CELL B, V41, P1269, DOI 10.1016/j.biocel.2008.10.031; Berkower I, 2008, VIROLOGY, V377, P330, DOI 10.1016/j.virol.2008.03.040; Burioni R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003423; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Dorgham K, 2005, AIDS RES HUM RETROV, V21, P82, DOI 10.1089/aid.2005.21.82; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Ferrer M, 1999, J VIROL, V73, P5795, DOI 10.1128/JVI.73.7.5795-5802.1999; Ferrer M, 1997, J IMMUNOL METHODS, V210, P215, DOI 10.1016/S0022-1759(97)00195-6; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Fouts T, 2002, P NATL ACAD SCI USA, V99, P11842, DOI 10.1073/pnas.182412199; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; GARLICK RL, 1990, AIDS RES HUM RETROV, V6, P465, DOI 10.1089/aid.1990.6.465; Hammonds J, 2005, J VIROL, V79, P14804, DOI 10.1128/JVI.79.23.14804-14814.2005; HAYNES BF, 1993, J IMMUNOL, V151, P1646; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Jacobson JM, 2000, J INFECT DIS, V182, P326, DOI 10.1086/315698; KANG CY, 1994, J VIROL, V68, P5854, DOI 10.1128/JVI.68.9.5854-5862.1994; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lagenaur LA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-11; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Matthias LJ, 2003, ANTIOXID REDOX SIGN, V5, P133, DOI 10.1089/152308603321223621; Meyuhas R, 2009, BIOCHEM BIOPH RES CO, V386, P402, DOI 10.1016/j.bbrc.2009.06.057; Moroder L, 2005, J PEPT SCI, V11, P187, DOI 10.1002/psc.654; Osburne MS, 1999, J IMMUNOL METHODS, V224, P19, DOI 10.1016/S0022-1759(99)00002-2; PAIN RH, 2001, CURR PROTOC PROTEIN, V1; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Seaman MS, 2007, VIROLOGY, V367, P175, DOI 10.1016/j.virol.2007.05.024; Seaman MS, 2005, J VIROL, V79, P2956, DOI 10.1128/JVI.79.5.2956-2963.2005; Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; THOMAS DJ, 1991, J VIROL, V65, P3797, DOI 10.1128/JVI.65.7.3797-3803.1991; van Anken E, 2008, MOL BIOL CELL, V19, P4298, DOI 10.1091/mbc.E07-12-1282; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Wang WC, 1997, BIOCHEM BIOPH RES CO, V240, P530, DOI 10.1006/bbrc.1997.7688; West AP, 2010, J VIROL, V84, P261, DOI 10.1128/JVI.01528-09; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiao P, 2008, AIDS, V22, P1749, DOI 10.1097/QAD.0b013e328308937c; Xiao XD, 2003, VACCINE, V21, P4275, DOI 10.1016/S0264-410X(03)00494-8; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	49	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25743	25752		10.1074/jbc.M110.144121	http://dx.doi.org/10.1074/jbc.M110.144121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538591	Green Published, hybrid			2022-12-25	WOS:000280682400067
J	Kapinas, K; Kessler, C; Ricks, T; Gronowicz, G; Delany, AM				Kapinas, Kristina; Kessler, Catherine; Ricks, Tinisha; Gronowicz, Gloria; Delany, Anne M.			miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BONE CELLS; OSTEOGENIC DIFFERENTIATION; MICRORNA EXPRESSION; STEM-CELLS; TRANSCRIPTION; PROLIFERATION; OSTEOCALCIN; MATURATION; SKELETAL; LINEAGE	Differentiation of human mesenchymal stem cells into osteoblasts is controlled by extracellular cues. Canonical Wnt signaling is particularly important for maintenance of bone mass in humans. Post-transcriptional regulation of gene expression, mediated by microRNAs, plays an essential role in the control of osteoblast differentiation. Here, we find that miR-29a is necessary for human osteoblast differentiation, and miR-29a is increased during differentiation in the mesenchymal precursor cell line hFOB1.19 and in primary cultures of human osteoblasts. Furthermore, the promoter of the expressed sequence tag containing the human miR-29a gene is induced by canonical Wnt signaling. This effect is mediated, at least in part, by two T-cell factor/LEF-binding sites within the proximal promoter. Furthermore, we show that the negative regulators of Wnt signaling, Dikkopf-1 (Dkk1), Kremen2, and secreted frizzled related protein 2 (sFRP2), are direct targets of miR-29a. Endogenous protein levels for these Wnt antagonists are increased in cells transfected with synthetic miR-29a inhibitor. In contrast, transfection with miR-29a mimic decreases expression of these antagonists and potentiates Wnt signaling. Overall, we demonstrate that miR-29 and Wnt signaling are involved in a regulatory circuit that can modulate osteoblast differentiation. Specifically, canonical Wnt signaling induces miR-29a transcription. The subsequent down-regulation of key Wnt signaling antagonists, Dkk1, Kremen2, and sFRP2, by miR-29a potentiates Wnt signaling, contributing to a gene expression program important for osteoblast differentiation. This novel regulatory circuit provides additional insight into how microRNAs interact with signaling molecules during osteoblast differentiation, allowing for fine-tuning of intricate cellular processes.	[Delany, Anne M.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA; [Gronowicz, Gloria] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Delany, AM (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	adelany@uchc.edu		Gronowicz, Gloria/0000-0001-7158-3598	National Institutes of Health [AR44877]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR044877, R01AR044877, R29AR044877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR44877 from NIAMS (to A.M.D.).	Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; AUBIN JE, 1993, CELLULAR MOL BIOL BO, P10; AUFMKOLK B, 1985, CALCIFIED TISSUE INT, V37, P228, DOI 10.1007/BF02554868; Barker N, 2000, ADV CANCER RES, V77, P1; Baron Roland, 2007, Curr Osteoporos Rep, V5, P73; BERESFORD JN, 1984, METAB BONE DIS RELAT, V5, P229, DOI 10.1016/0221-8747(84)90064-X; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; CHAVASSIEUX PM, 1990, J BONE MINER RES, V5, P337, DOI 10.1002/jbmr.5650050406; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Foshay Kara M, 2007, Curr Stem Cell Res Ther, V2, P264, DOI 10.2174/157488807782793781; FRIEDENSTEIN A, 1971, TRANSPLANTATION, V12, P99, DOI 10.1097/00007890-197108000-00001; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Krause C., 2008, PRIMER METABOLIC BON, V7, P10; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; KURIHARA N, 1984, BIOCHEM BIOPH RES CO, V119, P767, DOI 10.1016/S0006-291X(84)80316-2; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Leucht P, 2008, SEMIN CELL DEV BIOL, V19, P434, DOI 10.1016/j.semcdb.2008.09.002; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liang RQ, 2009, CURR GENOMICS, V10, P184, DOI 10.2174/138920209788185225; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Rauner M, 2008, AGE, V30, P273, DOI 10.1007/s11357-008-9069-9; Rawadi G, 2005, EXPERT OPIN THER TAR, V9, P1063, DOI 10.1517/14728222.9.5.1063; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ryves WJ, 2002, BIOCHEM BIOPH RES CO, V290, P967, DOI 10.1006/bbrc.2001.6305; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Song L, 2005, STEM CELLS DEV, V14, P712, DOI 10.1089/scd.2005.14.712; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang K, 2008, J BIOL CHEM, V283, P23371, DOI 10.1074/jbc.M802376200; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhang H, 2004, J ORTHOP RES, V22, P30, DOI 10.1016/S0736-0266(03)00155-4; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	75	330	365	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25221	25231		10.1074/jbc.M110.116137	http://dx.doi.org/10.1074/jbc.M110.116137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551325	hybrid, Green Published			2022-12-25	WOS:000280682400015
J	Charbonneau, NL; Carlson, EJ; Tufa, S; Sengle, G; Manalo, EC; Carlberg, VM; Ramirez, F; Keene, DR; Sakai, LY				Charbonneau, Noe L.; Carlson, Eric J.; Tufa, Sara; Sengle, Gerhard; Manalo, Elise C.; Carlberg, Valerie M.; Ramirez, Francesco; Keene, Douglas R.; Sakai, Lynn Y.			In Vivo Studies of Mutant Fibrillin-1 Microfibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARFAN-SYNDROME; EXTRACELLULAR-MATRIX; CALCIUM-BINDING; FBN1 MUTATIONS; EXPRESSION; GENE; PATHOGENESIS; PHENOTYPE; COMPONENT; ANEURYSM	In humans, mutations in fibrillin-1 result in a variety of genetic disorders with distinct clinical phenotypes. While most of the known mutations in fibrillin-1 cause Marfan syndrome, a number of other mutations lead to clinical features unrelated to Marfan syndrome. Pathogenesis of Marfan syndrome is currently thought to be driven by mechanisms due to haploinsufficiency of wild-type fibrillin-1. However, haploinsufficiency-driven mechanisms cannot explain the distinct phenotypes found in other fibrillinopathies. To test the hypothesis that mutations in fibrillin-1 cause disorders through primary effects on microfibril structure, two different mutations were generated in Fbn1 in mice. One mutation leads to a truncated fibrillin-1 molecule that is tagged with green fluorescent protein, allowing visualization of mutant fibrillin-1 incorporated into microfibrils. In heterozygosity, these mutant mice demonstrate progressive fragmentation of the aortic elastic lamellae and also display fragmentation of microfibrils in other tissues. Fibrillin-2 epitopes are also progressively revealed in these mice, suggesting that fibrillin-2 immunoreactivity can serve as a marker for microfibril degradation. In contrast, a second mutation (inframe deletion of the first hybrid domain) in fibrillin-1 results in stable microfibrils, demonstrating that fibrillin-1 molecules are not required to be in perfect register for microfibril structure and function and that the first hybrid domain is dispensable for microfibril assembly. Taken together, these results suggest that perturbation of microfibril structure may underlie one of the major features of the Marfan syndrome: fragmentation of aortic elastic lamellae.	[Charbonneau, Noe L.; Carlson, Eric J.; Tufa, Sara; Keene, Douglas R.; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Sengle, Gerhard; Manalo, Elise C.; Carlberg, Valerie M.; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Oregon Health & Science University; Oregon Health & Science University; Icahn School of Medicine at Mount Sinai	Sakai, LY (corresponding author), Oregon Hlth & Sci Univ, Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org		Manalo, Elise/0000-0003-2752-5280; Tufa, Sara/0000-0002-6447-8041	National Institutes of Health [RO1 AR46811, RC1HL100608-01, P01 AR049698, RO1 AR42044]; Shriners Hospitals for Children; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR046811, R01AR042044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR46811 and RC1HL100608-01 (to L.Y.S.), P01 AR049698 (to F.R. and L.Y.S.), and RO1 AR42044 (to F.R.). This work was also supported by the Shriners Hospitals for Children (to D.R.K. and to L.Y.S.).	AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau NL, 2010, J BIOL CHEM, V285, P20242, DOI 10.1074/jbc.M109.087031; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; Dingemans KP, 2000, ANAT REC, V258, P1; ELDADAH ZA, 1995, J CLIN INVEST, V95, P874, DOI 10.1172/JCI117737; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P441, DOI 10.1177/39.4.2005373; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	33	64	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24943	24955		10.1074/jbc.M110.130021	http://dx.doi.org/10.1074/jbc.M110.130021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529844	Green Published, hybrid			2022-12-25	WOS:000280542100067
J	Condliffe, SB; Corradini, I; Pozzi, D; Verderio, C; Matteoli, M				Condliffe, Steven B.; Corradini, Irene; Pozzi, Davide; Verderio, Claudia; Matteoli, Michela			Endogenous SNAP-25 Regulates Native Voltage-gated Calcium Channels in Glutamatergic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; HIPPOCAMPAL-NEURONS; SUBCELLULAR-DISTRIBUTION; ALPHA(1A) SUBUNITS; PROTEIN SNAP-25; MOUSE; SCHIZOPHRENIA; EXPRESSION; SYNTAXIN; SNARE	In addition to its primary role as a fundamental component of the SNARE complex, SNAP-25 also modulates voltage-gated calcium channels (VGCCs) in various overexpression systems. Although these studies suggest a potential negative regulatory role of SNAP-25 on VGCC activity, the effects of endogenous SNAP-25 on native VGCC function in neurons are unclear. In the present study, we investigated the VGCC properties of cultured glutamatergic and GABAergic rat hippocampal neurons. Glutamatergic currents were dominated by P/Q-type channels, whereas GABAergic cells had a dominant L-type component. Also, glutamatergic VGCC current densities were significantly lower with enhanced inactivation rates and shifts in the voltage dependence of activation and inactivation curves compared with GABAergic cells. Silencing endogenous SNAP-25 in glutamatergic neurons did not alter P/Q-type channel expression or localization but led to increased VGCC current density without changes in the VGCC subtype proportions. Isolation of the P/Qtype component indicated that increased current in the absence of SNAP-25 was correlated with a large depolarizing shift in the voltage dependence of inactivation. Overexpressing SNAP-25 in GABAergic neurons reduced current density without affecting the VGCC subtype proportion. Accordingly, VGCC current densities in glutamatergic neurons from Snap-25(+/-) mice were significantly elevated compared with wild type glutamatergic neurons. Overall, this study demonstrates that endogenous SNAP-25 negatively regulates native VGCCs in glutamatergic neurons which could have important implications for neurological diseases associated with altered SNAP-25 expression.	Univ Milan, Dept Med Pharmacol, I-20129 Milan, Italy; Univ Milan, CNR, Inst Neurosci, I-20129 Milan, Italy; [Matteoli, Michela] IRCCS Fdn Don Gnocchi, I-20122 Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus	Condliffe, SB (corresponding author), Univ Otago, Dept Physiol, POB 913, Dunedin 9054, New Zealand.	steven.condliffe@otago.ac.nz	Matteoli, Michela/K-4526-2018; Tuluc, Petronel/C-2527-2011; Pozzi, Davide/A-7021-2016; Verderio, Claudia/K-4415-2016; Corradini, Irene/J-5320-2018	Matteoli, Michela/0000-0002-3569-7843; Pozzi, Davide/0000-0001-6436-0556; Verderio, Claudia/0000-0001-7216-5873; Corradini, Irene/0000-0001-7128-9209	European Union [HEALTH F2-2009-241498, Cariplo 2008.2338, Cariplo 2006.0948]; Compagnia di S.Paolo Program [2005.1964]	European Union(European Commission); Compagnia di S.Paolo Program(Compagnia di San Paolo)	This work was supported by the European Union 7th Framework Program Grant HEALTH F2-2009-241498 (EUROSPIN Project), EUSynapse Integrated Project, Cariplo 2008.2338, Cariplo 2006.0948, and Compagnia di S.Paolo Program 2005.1964 (to M. M.).	Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Fan HP, 2006, J BIOL CHEM, V281, P28174, DOI 10.1074/jbc.M601382200; Garbelli R, 2008, J COMP NEUROL, V506, P373, DOI 10.1002/cne.21505; Grumelli C, 2008, MOL CELL NEUROSCI, V39, P314, DOI 10.1016/j.mcn.2008.07.011; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jeans AF, 2007, P NATL ACAD SCI USA, V104, P2431, DOI 10.1073/pnas.0610222104; Ji JZ, 2002, J BIOL CHEM, V277, P20195, DOI 10.1074/jbc.M201034200; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Mill J, 2004, MOL PSYCHIATR, V9, P801, DOI 10.1038/sj.mp.4001482; Mott DD, 1997, J NEUROSCI, V17, P3990; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Pravettoni E, 2000, DEV BIOL, V227, P581, DOI 10.1006/dbio.2000.9872; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SUCHER NJ, 1995, NEURON, V14, P1095, DOI 10.1016/0896-6273(95)90257-0; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tafoya LCR, 2006, J NEUROSCI, V26, P7826, DOI 10.1523/JNEUROSCI.1866-06.2006; Tafoya LCR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-105; Tao-Cheng JH, 2000, J NEUROCYTOL, V29, P67, DOI 10.1023/A:1007168231323; Taverna E, 2002, J CELL SCI, V115, P3909, DOI 10.1242/jcs.00072; Taverna E, 2007, J NEUROCHEM, V100, P664, DOI 10.1111/j.1471-4159.2006.04225.x; Thompson PM, 1998, BIOL PSYCHIAT, V43, P239, DOI 10.1016/S0006-3223(97)00204-7; Thompson PM, 2003, PROG NEURO-PSYCHOPH, V27, P411, DOI 10.1016/S0278-5846(03)00027-7; Timmermann DB, 2002, J NEUROSCI RES, V67, P48, DOI 10.1002/jnr.10074; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Verderio C, 1999, EUR J NEUROSCI, V11, P2793, DOI 10.1046/j.1460-9568.1999.00697.x; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Young CE, 1998, CEREB CORTEX, V8, P261, DOI 10.1093/cercor/8.3.261; Zhang Y, 2004, J NEUROSCI, V24, P5239, DOI 10.1523/JNEUROSCI.0992-04.2004; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	42	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24968	24976		10.1074/jbc.M110.145813	http://dx.doi.org/10.1074/jbc.M110.145813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522554	Green Published, hybrid			2022-12-25	WOS:000280542100069
J	Dejima, K; Murata, D; Mizuguchi, S; Nomura, KH; Izumikawa, T; Kitagawa, H; Gengyo-Ando, K; Yoshina, S; Ichimiya, T; Nishihara, S; Mitani, S; Nomura, K				Dejima, Katsufumi; Murata, Daisuke; Mizuguchi, Souhei; Nomura, Kazuko H.; Izumikawa, Tomomi; Kitagawa, Hiroshi; Gengyo-Ando, Keiko; Yoshina, Sawako; Ichimiya, Tomomi; Nishihara, Shoko; Mitani, Shohei; Nomura, Kazuya			Two Golgi-resident 3 '-Phosphoadenosine 5 '-Phosphosulfate Transporters Play Distinct Roles in Heparan Sulfate Modifications and Embryonic and Larval Development in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE 3'-PHOSPHATE 5'-PHOSPHOSULFATE; VULVAL MORPHOGENESIS; EARLY EMBRYOGENESIS; MOLECULAR-CLONING; NERVOUS-SYSTEM; GENE; IDENTIFICATION; EXPRESSION; PAPS; DROSOPHILA	Synthesis of extracellular sulfated molecules requires active 3 '-phosphoadenosine 5 '-phosphosulfate (PAPS). For sulfation to occur, PAPS must pass through the Golgi membrane, which is facilitated by Golgi-resident PAPS transporters. Caenorhabditis elegans PAPS transporters are encoded by two genes, pst-1 and pst-2. Using the yeast heterologous expression system, we characterized PST-1 and PST-2 as PAPS transporters. We created deletion mutants to study the importance of PAPS transporter activity. The pst-1 deletion mutant exhibited defects in cuticle formation, post-embryonic seam cell development, vulval morphogenesis, cell migration, and embryogenesis. The pst-2 mutant exhibited a wildtype phenotype. The defects observed in the pst-1 mutant could be rescued by transgenic expression of pst-1 and hPAPST1 but not pst-2 or hPAPST2. Moreover, the phenotype of a pst-1; pst-2 double mutant were similar to those of the pst-1 single mutant, except that larval cuticle formation was more severely defected. Disaccharide analysis revealed that heparan sulfate from these mutants was undersulfated. Gene expression reporter analysis revealed that these PAPS transporters exhibited different tissue distributions and subcellular localizations. These data suggest that pst-1 and pst-2 play different physiological roles in heparan sulfate modification and development.	[Dejima, Katsufumi; Murata, Daisuke; Mizuguchi, Souhei; Nomura, Kazuko H.; Nomura, Kazuya] Kyushu Univ, Dept Biol, Fac Sci 33, Fukuoka 8128581, Japan; [Dejima, Katsufumi; Murata, Daisuke; Mizuguchi, Souhei; Nomura, Kazuko H.; Izumikawa, Tomomi; Kitagawa, Hiroshi; Gengyo-Ando, Keiko; Yoshina, Sawako; Mitani, Shohei; Nomura, Kazuya] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Izumikawa, Tomomi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Gengyo-Ando, Keiko; Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Sch Med, Tokyo 1628666, Japan; [Ichimiya, Tomomi; Nishihara, Shoko] Soka Univ, Cell Biol Lab, Dept Bioinformat, Fac Engn, Tokyo 1928577, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kobe Pharmaceutical University; Tokyo Women's Medical University; Soka University	Nomura, K (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan.	knomuscb@kyushu-u.org	Gengyo-Ando, Keiko/B-2753-2012; Kitagawa, Hiroshi/AAJ-1344-2020; Gengyo-Ando, Keiko/AAC-4504-2019	Kitagawa, Hiroshi/0000-0002-9307-7079; Nishihara, Shoko/0000-0002-1668-2603	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [B-21390025, B-20370051]; Japan Science and Technology Corp.; National Institutes of Health, NCRR	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corp.(Japan Science & Technology Agency (JST)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant-in-aid from the Japan Society for the Promotion of Science Fellows (to K. D.), a grant-in-aid for young scientists (B) (to S. M.), and Grant-in-Aid for Scientific Research B-21390025 (to H. K.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This research was also supported by MEXT Grant-in-Aid for Scientific Research B-20370051 (to S. N.) and by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Corp. (to K. N.).; We thank Dr. K. Fukushima and Prof. K. Yamashita (Tokyo Institute of Technology, Yokohama, Japan) for providing the mammalian total cDNA. We also thank the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health, NCRR, for the worms and E. coli strains. We also thank Adam Kleinschmit for useful comments.	Ali RA, 2005, DEV GENES EVOL, V215, P537, DOI 10.1007/s00427-005-0010-2; Bender AM, 2007, DEV BIOL, V302, P448, DOI 10.1016/j.ydbio.2006.09.051; Berninsone P. M., 2006, WORMBOOK, DOI [10.1895/wormbook.1.125.1, DOI 10.1895/WORMBOOK.1.125.1]; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Bhattacharya R, 2009, J CELL SCI, V122, P4492, DOI 10.1242/jcs.050732; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BRENNER S, 1974, GENETICS, V77, P71; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Burdine RD, 1998, DEVELOPMENT, V125, P1083; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Carroll BT, 2006, J BIOL CHEM, V281, P35989, DOI 10.1074/jbc.M606086200; Chisholm A. D., 2005, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.35.1; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Dejima K, 2009, FASEB J, V23, P2215, DOI 10.1096/fj.08-123737; Dick G, 2008, GLYCOBIOLOGY, V18, P53, DOI 10.1093/glycob/cwm121; Eisenmann D.M., 2005, WORMBOOK, DOI [DOI 10.1895/WORMBOOK.1.7.1, 10.1895/wormbook.1.7.1]; Franks DM, 2006, DEV BIOL, V296, P409, DOI 10.1016/j.ydbio.2006.06.008; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Goda E, 2006, J BIOL CHEM, V281, P28508, DOI 10.1074/jbc.M605045200; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Gumienny TL, 2007, CURR BIOL, V17, P159, DOI 10.1016/j.cub.2006.11.065; Gupta BP, 2002, DEV BIOL, V247, P102, DOI 10.1006/dbio.2002.0688; Hattori K, 2006, J BIOCHEM, V139, P355, DOI 10.1093/jb/mvj041; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Hoflich J, 2004, J BIOL CHEM, V279, P30440, DOI 10.1074/jbc.M402429200; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; Kim TH, 2005, FEBS LETT, V579, P53, DOI 10.1016/j.febslet.2004.11.044; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; MANDON EC, 1994, P NATL ACAD SCI USA, V91, P10707, DOI 10.1073/pnas.91.22.10707; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Minniti AN, 2004, J CELL SCI, V117, P5179, DOI 10.1242/jcs.01394; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizuguchi S, 2009, TRENDS GLYCOSCI GLYC, V21, P179, DOI 10.4052/tigg.21.179; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Morio H, 2003, BIOCHEM BIOPH RES CO, V301, P317, DOI 10.1016/S0006-291X(02)03031-0; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Nabetani T, 2006, PROTEOMICS, V6, P4456, DOI 10.1002/pmic.200500916; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Ozeran JD, 1996, BIOCHEMISTRY-US, V35, P3695, DOI 10.1021/bi951303m; Ozeran JD, 1996, BIOCHEMISTRY-US, V35, P3685, DOI 10.1021/bi951302u; ROBBINS PW, 1958, J BIOL CHEM, V233, P681; ROBBINS PW, 1957, J BIOL CHEM, V229, P837; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; SCHWARZ JK, 1984, J BIOL CHEM, V259, P3554; Sherman T, 2005, AM J PHYSIOL-CELL PH, V289, pC341, DOI 10.1152/ajpcell.00071.2005; Silbert JE, 1995, BBA-REV BIOMEMBRANES, V1241, P371, DOI 10.1016/0304-4157(95)00011-9; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102; ZARUBA ME, 1988, BIOCHEM BIOPH RES CO, V155, P1271, DOI 10.1016/S0006-291X(88)81278-6; Zhang HQ, 2006, ANN NY ACAD SCI, V1086, P81, DOI 10.1196/annals.1377.014	75	13	15	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24717	24728		10.1074/jbc.M109.088229	http://dx.doi.org/10.1074/jbc.M109.088229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529843	Green Published, hybrid			2022-12-25	WOS:000280542100044
J	Yeh, YC; Xie, LP; Langdon, JM; Myers, AC; Oh, SY; Zhu, Z; MacDonald, SM				Yeh, Yueh-Chiao; Xie, Liping; Langdon, Jacqueline M.; Myers, Allen C.; Oh, Sun-Young; Zhu, Zhou; MacDonald, Susan M.			The Effects of Overexpression of Histamine Releasing Factor (HRF) in a Transgenic Mouse Model	PLOS ONE			English	Article							CONTROLLED TUMOR PROTEIN; HUMAN BASOPHILS; MOLECULAR-IDENTIFICATION; CALCIUM-BINDING; MESSENGER-RNA; IN-VITRO; IGE; CELLS; SECRETION; HOMOLOG	Background: Asthma is a disease that affects all ages, races and ethnic groups. Its incidence is increasing both in Westernized countries and underdeveloped countries. It involves inflammation, genetics and environment and therefore, proteins that exacerbate the asthmatic, allergic phenotype are important. Our laboratory purified and cloned a histamine releasing factor (HRF) that was a complete stimulus for histamine and IL-4 secretion from a subpopulation of allergic donors' basophils. Throughout the course of studying HRF, it was uncovered that HRF enhances or primes histamine release and IL-13 production from all anti-IgE antibody stimulated basophils. In order to further delineate the biology of HRF, we generated a mouse model. Methodology/Principal Findings: We constructed an inducible transgenic mouse model with HRF targeted to lung epithelial cells, via the Clara cells. In antigen naive mice, overproduction of HRF yielded increases in BAL macrophages and statistical increases in mRNA levels for MCP-1 in the HRF transgenic mice compared to littermate controls. In addition to demonstrating intracellular HRF in the lung epithelial cells, we have also been able to document HRF's presence extracellularly in the BAL fluid of these transgenic mice. Furthermore, in the OVA challenged model, we show that HRF exacerbates the allergic, asthmatic responses. We found statistically significant increases in serum and BAL IgE, IL-4 protein and eosinophils in transgenic mice compared to controls. Conclusions/Significance: This mouse model demonstrates that HRF expression enhances allergic, asthmatic inflammation and can now be used as a tool to further dissect the biology of HRF.	[Yeh, Yueh-Chiao] Nanhua Univ, Grad Inst Nat Healing Sci, Chiayi, Taiwan; [Langdon, Jacqueline M.; Myers, Allen C.; Oh, Sun-Young; Zhu, Zhou] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Xie, Liping] Aurora Sinai Med Ctr, Milwaukee, WI USA; [MacDonald, Susan M.] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA	Nanhua University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Yeh, YC (corresponding author), Nanhua Univ, Grad Inst Nat Healing Sci, Chiayi, Taiwan.	smacdona@jhmi.edu		Yeh, Yueh-Chiao/0000-0002-6488-7144	National Institutes of Health Allergy, Immunology (AI) and Heart Lung (HL) [AI3265, HL079349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079349] Funding Source: NIH RePORTER	National Institutes of Health Allergy, Immunology (AI) and Heart Lung (HL); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health Allergy, Immunology (AI) AI3265 and Heart Lung (HL) HL079349. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Bheekha-Escura R, 2000, BLOOD, V96, P2191; Bheekha-Escura R, 1999, J ALLERGY CLIN IMMUN, V103, P937, DOI 10.1016/S0091-6749(99)70442-2; Brusselle GG, 1997, AM J RESP CELL MOL, V17, P767, DOI 10.1165/ajrcmb.17.6.2820; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; CHITPATIMA ST, 1988, NUCLEIC ACIDS RES, V16, P2350, DOI 10.1093/nar/16.5.2350; Cohn L, 1998, J IMMUNOL, V161, P3813; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; ILIOPOULOS O, 1990, J ALLERGY CLIN IMMUN, V86, P851, DOI 10.1016/S0091-6749(05)80146-0; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Langdon JM, 2004, BBA-MOL BASIS DIS, V1688, P232, DOI 10.1016/j.bbadis.2003.12.007; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; MACDONALD SM, 1993, ALLERGY PRINCIPLES P, P1; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Rao KVN, 2002, J BIOL CHEM, V277, P31207, DOI 10.1074/jbc.M204114200; SAMPSON HA, 1989, NEW ENGL J MED, V321, P228, DOI 10.1056/NEJM198907273210405; Schroeder JT, 1997, J IMMUNOL, V159, P447; Schroeder JT, 1996, J EXP MED, V183, P1265, DOI 10.1084/jem.183.3.1265; Schroeder JT, 2001, J ALLERGY CLIN IMMUN, V107, P265, DOI 10.1067/mai.2001.112846; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Teshima S, 1998, J IMMUNOL, V161, P6356; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Vonakis BM, 2003, J IMMUNOL, V171, P3742, DOI 10.4049/jimmunol.171.7.3742; Wantke F, 1999, J ALLERGY CLIN IMMUN, V103, P642, DOI 10.1016/S0091-6749(99)70237-X; WARNER JA, 1986, J IMMUNOL, V136, P2583; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197; Yoneda K, 2004, AM J PHYSIOL-LUNG C, V286, pL174, DOI 10.1152/ajplung.00118.2003; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	37	8	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11077	10.1371/journal.pone.0011077	http://dx.doi.org/10.1371/journal.pone.0011077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552026	Green Submitted, Green Published, gold			2022-12-25	WOS:000278662900017
J	Torchia, MLG; Ciaglia, E; Masci, AM; Vitiello, L; Fogli, M; la Sala, A; Mavilio, D; Racioppi, L				Torchia, Maria Letizia Giardino; Ciaglia, Elena; Masci, Anna Maria; Vitiello, Laura; Fogli, Manuela; la Sala, Andrea; Mavilio, Domenico; Racioppi, Luigi			Dendritic Cells/Natural Killer Cross-Talk: A Novel Target for Human Immunodeficiency Virus Type-1 Protease Inhibitors	PLOS ONE			English	Article							ATHEROSCLEROTIC LESION FORMATION; HIV-1 PROTEASE; ANTIRETROVIRAL THERAPY; NK CELLS; T-CELLS; INFECTION; MACROPHAGES; DIFFERENTIATION; DYSLIPIDEMIA; ANTIFUNGAL	Background: HIV-1 Protease Inhibitors, namely PIs, originally designed to inhibit HIV-1 aspartic protease, can modulate the immune response by mechanisms largely unknown, and independent from their activity on viral replication. Here, we analyzed the ability of PIs to interfere with differentiation program of monocytes toward dendritic cell (DCs) lineage, a key process in the inflammatory response. Methodology/Principal Findings: Monocytes from healthy donors were isolated and induced to differentiate in vitro in the presence or absence of saquinavir, ritonavir, nelfinavir, indinavir or amprenavir (sqv, rtv, nlfv, idv, apv, respectively). These drugs demonstrated a differential ability to sustain the generation of immature DCs (iDCs) with an altered phenotype, including low levels of CD1a, CD86, CD36 and CD209. DCs generated in the presence of rtv also failed to acquire the typical phenotype of mature DCs (mDCs), and secreted lower amounts of IL-12 and IL-15. Accordingly, these aberrant mDCs failed to support activation of autologous Natural Killer (NK) cells, and resulted highly susceptible to NK cell-mediated cytotoxicity. Conclusions/Significance: Our findings uncover novel functional properties of PIs within the DC-NK cell cross-talk, unveiling the heterogeneous ability of members of this class drugs to drive the generation of atypical monocyte-derived DCs (MDDCs) showing an aberrant phenotype, a failure to respond appropriately to bacterial endotoxin, a weak ability to prime autologous NK cells, and a high susceptibility to NK cell killing. These unexpected properties might contribute to limit inflammation and viral spreading in HIV-1 infected patients under PIs treatment, and open novel therapeutical perspectives for this class drugs as immunomodulators in autoimmunity and cancer.	[Torchia, Maria Letizia Giardino; Ciaglia, Elena; Masci, Anna Maria; Vitiello, Laura; Racioppi, Luigi] Univ Naples Federico 2, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Masci, Anna Maria; Vitiello, Laura; la Sala, Andrea] IRCCS San Raffaele Pisana, Dept Med Sci & Rehabil, Lab Mol & Cellular Immunol, Rome, Italy; [Fogli, Manuela] Univ Brescia, Microbiol Sect, Dept Expt & Appl Med, Brescia, Italy; [Mavilio, Domenico] Ist Clin Humanitas, IRCCS, Clin & Expt Immunol Lab, Milan, Italy; [Racioppi, Luigi] Univ Naples Federico 2, CISI, Naples, Italy	University of Naples Federico II; IRCCS San Raffaele Pisana; University of Brescia; IRCCS Humanitas Research Hospital; University of Naples Federico II	Torchia, MLG (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA.	racioppi@unina.it	racioppi, luigi/GNP-0349-2022; Vitiello, Laura/AAB-8836-2019; Ciaglia, E/AAA-7924-2019; Vitiello, Laura/G-7326-2014; la Sala, Andrea/A-3228-2009; racioppi, luigi/AGB-8665-2022; Mavilio, Domenico/E-5194-2017	racioppi, luigi/0000-0002-9207-6752; Vitiello, Laura/0000-0003-0776-3601; Ciaglia, E/0000-0002-8035-4583; Vitiello, Laura/0000-0003-0776-3601; la Sala, Andrea/0000-0003-1268-6516; Mavilio, Domenico/0000-0001-6147-0952; Masci, Anna Maria/0000-0003-1940-6740				Andre P, 1998, P NATL ACAD SCI USA, V95, P13120, DOI 10.1073/pnas.95.22.13120; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; BUGELSKI PJ, 1994, J LEUKOCYTE BIOL, V56, P374, DOI 10.1002/jlb.56.3.374; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Dash C, 2003, CRIT REV BIOCHEM MOL, V38, P89, DOI 10.1080/713609213; DEGAETANO DK, 2004, LANCET INFECT DIS, V4, P213, DOI DOI 10.1016/S1473-3099(04)00971-5; Dressman J, 2003, J CLIN INVEST, V111, P389, DOI 10.1172/JCI200316261; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Gruber A, 2001, J BIOL CHEM, V276, P47840, DOI 10.1074/jbc.M105582200; Hosseini H, 2001, J NEUROIMMUNOL, V118, P233, DOI 10.1016/S0165-5728(01)00352-6; Hui DY, 2003, J CLIN INVEST, V111, P317, DOI 10.1172/JCI200317746; Katoh N, 2006, CLIN EXP IMMUNOL, V146, P354, DOI 10.1111/j.1365-2249.2006.03197.x; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lagathu C, 2007, ANTIVIR THER, V12, P489; Lambert C, 2008, J IMMUNOL, V181, P8288, DOI 10.4049/jimmunol.181.12.8288; Lu W, 2000, BLOOD, V96, P250, DOI 10.1182/blood.V96.1.250.013k28_250_258; Mancino A, 2008, BLOOD, V112, P3723, DOI 10.1182/blood-2008-02-142091; Masci AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-70; Mastrolorenzo A, 2007, CURR MED CHEM, V14, P2734, DOI 10.2174/092986707782360141; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Meroni L, 2005, JAIDS-J ACQ IMM DEF, V38, P310; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Pao V, 2008, CURR ATHEROSCLER REP, V10, P61, DOI 10.1007/s11883-008-0010-6; Pericolini E, 2008, J LEUKOCYTE BIOL, V83, P1286, DOI 10.1189/jlb.0707454; Phenix BN, 2001, BLOOD, V98, P1078, DOI 10.1182/blood.V98.4.1078; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Serghides L, 2002, AIDS, V16, P353, DOI 10.1097/00002030-200202150-00006; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Tasca S, 2003, AIDS, V17, P2291, DOI 10.1097/00002030-200311070-00003; Thomas CM, 2007, CURR OPIN LIPIDOL, V18, P561, DOI 10.1097/MOL.0b013e3282ef604f; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Weichold FF, 1999, J HUMAN VIROL, V2, P261; Whelan KT, 2003, EUR J IMMUNOL, V33, P2520, DOI 10.1002/eji.200323646; Zeldin RK, 2004, J ANTIMICROB CHEMOTH, V53, P4, DOI 10.1093/jac/dkh029	41	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11052	10.1371/journal.pone.0011052	http://dx.doi.org/10.1371/journal.pone.0011052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548796	gold, Green Published, Green Submitted			2022-12-25	WOS:000278599600013
J	Spirig, R; Djafarzadeh, S; Regueira, T; Shaw, SG; von Garnier, C; Takala, J; Jakob, SM; Rieben, R; Lepper, PM				Spirig, Rolf; Djafarzadeh, Siamak; Regueira, Tomas; Shaw, Sidney G.; von Garnier, Christophe; Takala, Jukka; Jakob, Stephan M.; Rieben, Robert; Lepper, Philipp M.			Effects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1 alpha and Dendritic Cell Maturation under Normoxic Conditions	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; HEPARAN-SULFATE; ENDOTHELIAL GLYCOCALYX; GROWTH-FACTOR; ACTIVATION; HYALURONAN; EXPRESSION; RECEPTOR; TOLL-LIKE-RECEPTOR-4; LIPOPOLYSACCHARIDE	Dendritic cells (DC) are professional antigen presenting cells that represent an important link between innate and adaptive immunity. Danger signals such as toll-like receptor (TLR) agonists induce maturation of DC leading to a T-cell mediated adaptive immune response. In this study, we show that exogenous as well as endogenous inflammatory stimuli for TLR4 and TLR2 induce the expression of HIF-1 alpha in human monocyte-derived DC under normoxic conditions. On the functional level, inhibition of HIF-1 alpha using chetomin (CTM), YC-1 and digoxin lead to no consistent effect on MoDC maturation, or cytokine secretion despite having the common effect of blocking HIF-1 alpha stabilization or activity through different mechanisms. Stabilization of HIF-1 alpha protein by hypoxia or CoCl2 did not result in maturation of human DC. In addition, we could show that TLR stimulation resulted in an increase of HIF-1 alpha controlled VEGF secretion. These results show that stimulation of human MoDC with exogenous as well as endogenous TLR agonists induces the expression of HIF-1 alpha in a time-dependent manner. Hypoxia alone does not induce maturation of DC, but is able to augment maturation after TLR ligation. Current evidence suggests that different target genes may be affected by HIF-1 alpha under normoxic conditions with physiological roles that differ from those induced by hypoxia.	[Spirig, Rolf; Rieben, Robert] Univ Bern, Dept Clin Res, Cardiovasc Res Lab, Bern, Switzerland; [Djafarzadeh, Siamak; Regueira, Tomas; Takala, Jukka; Jakob, Stephan M.; Lepper, Philipp M.] Univ Bern, Dept Clin Res, Lab Intens Care, Bern, Switzerland; [Shaw, Sidney G.] Univ Bern, Dept Clin Res, Lab Vasoact Peptides, Bern, Switzerland; [von Garnier, Christophe] Univ Hosp Bern, Dept Pneumol, CH-3010 Bern, Switzerland; [Djafarzadeh, Siamak; Regueira, Tomas; Takala, Jukka; Jakob, Stephan M.; Lepper, Philipp M.] Univ Hosp Bern, Dept Intens Care Med, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Spirig, R (corresponding author), Univ Bern, Dept Clin Res, Cardiovasc Res Lab, Bern, Switzerland.	philipp.lepper@gmx.de	; Rieben, Robert/D-7044-2017	spirig, rolf/0000-0002-0304-8726; von Garnier, Christophe/0000-0003-3585-9176; Rieben, Robert/0000-0003-4179-8891	Foundation for Research in Anaesthesia and Intensive Care Medicine; EU; Swiss National Science Foundation [3200B0-116618]	Foundation for Research in Anaesthesia and Intensive Care Medicine; EU(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Foundation for Research in Anaesthesia and Intensive Care Medicine (to PL, to SD), the EU 6th Framework Integrated Research Project "Reprogramming the Immune System for the Establishment of Tolerance" (RISET) and the Swiss National Science Foundation grant no. 3200B0-116618 (to RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chin K, 1997, ONCOGENE, V15, P437, DOI 10.1038/sj.onc.1201201; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Elia AR, 2008, J LEUKOCYTE BIOL, V84, P1472, DOI 10.1189/jlb.0208082; Feliers D, 2006, AM J PHYSIOL-RENAL, V290, pF927, DOI 10.1152/ajprenal.00331.2005; Hua F, 2008, J NEUROIMMUNOL, V199, P75, DOI 10.1016/j.jneuroim.2008.05.009; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Huang YT, 2005, MOL CANCER THER, V4, P1628, DOI 10.1158/1535-7163.MCT-05-0090; Ihrcke NS, 1996, J CELL PHYSIOL, V168, P625, DOI 10.1002/(SICI)1097-4652(199609)168:3<625::AID-JCP15>3.3.CO;2-A; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kaczorowski DJ, 2007, TRANSPLANTATION, V84, P1279, DOI 10.1097/01.tp.0000287597.87571.17; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Luke HJ, 1999, BIOCHEM J, V343, P71, DOI 10.1042/0264-6021:3430071; MANCINO A, BLOOD, V112, P3734; Mansfield KD, 2004, J APPL PHYSIOL, V97, P1358, DOI 10.1152/japplphysiol.00449.2004; MENTZER SJ, 1986, CELL IMMUNOL, V101, P312, DOI 10.1016/0008-8749(86)90144-9; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Obregon C, 2006, AM J PATHOL, V169, P2127, DOI 10.2353/ajpath.2006.060453; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; PLATT JL, 1991, EUR J IMMUNOL, V21, P2887, DOI 10.1002/eji.1830211135; PLATT JL, 1990, J EXP MED, V171, P1363, DOI 10.1084/jem.171.4.1363; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Regamey N, 2007, AM J RESP CELL MOL, V37, P75, DOI 10.1165/rcmb.2006-0235OC; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Slupski M, 2007, TRANSPL P, V39, P1350, DOI 10.1016/j.transproceed.2007.02.079; Spirig R, 2008, J IMMUNOL, V181, P878, DOI 10.4049/jimmunol.181.2.878; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Thomson AW, 1999, TRANSPLANTATION, V68, P1; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WU H, J CLIN INVEST, V117, P2847; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	49	66	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e0010983	10.1371/journal.pone.0010983	http://dx.doi.org/10.1371/journal.pone.0010983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539755	Green Published, gold, Green Submitted			2022-12-25	WOS:000278465900005
J	Burch, N; Arnold, AS; Item, F; Summermatter, S; Santos, GBS; Christe, M; Boutellier, U; Toigo, M; Handschin, C				Burch, Nathalie; Arnold, Anne-Sophie; Item, Flurin; Summermatter, Serge; Santos, Gesa Brochmann Santana; Christe, Martine; Boutellier, Urs; Toigo, Marco; Handschin, Christoph			Electric Pulse Stimulation of Cultured Murine Muscle Cells Reproduces Gene Expression Changes of Trained Mouse Muscle	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; MAMMALIAN SKELETAL-MUSCLE; MESSENGER-RNA EXPRESSION; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; MYOSIN ISOFORMS; FIBER TYPES; ERR-ALPHA; EXERCISE; PGC-1-ALPHA	Adequate levels of physical activity are at the center of a healthy lifestyle. However, the molecular mechanisms that mediate the beneficial effects of exercise remain enigmatic. This gap in knowledge is caused by the lack of an amenable experimental model system. Therefore, we optimized electric pulse stimulation of muscle cells to closely recapitulate the plastic changes in gene expression observed in a trained skeletal muscle. The exact experimental conditions were established using the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) as a marker for an endurance-trained muscle fiber. We subsequently compared the changes in the relative expression of metabolic and myofibrillar genes in the muscle cell system with those observed in mouse muscle in vivo following either an acute or repeated bouts of treadmill exercise. Importantly, in electrically stimulated C2C12 mouse muscle cells, the qualitative transcriptional adaptations were almost identical to those in trained muscle, but differ from the acute effects of exercise on muscle gene expression. In addition, significant alterations in the expression of myofibrillar proteins indicate that this stimulation could be used to modulate the fiber-type of muscle cells in culture. Our data thus describe an experimental cell culture model for the study of at least some of the transcriptional aspects of skeletal muscle adaptation to physical activity. This system will be useful for the study of the molecular mechanisms that regulate exercise adaptation in muscle.	[Burch, Nathalie; Arnold, Anne-Sophie; Item, Flurin; Summermatter, Serge; Boutellier, Urs; Toigo, Marco; Handschin, Christoph] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Burch, Nathalie; Arnold, Anne-Sophie; Item, Flurin; Summermatter, Serge; Boutellier, Urs; Toigo, Marco; Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Burch, Nathalie; Item, Flurin; Boutellier, Urs; Toigo, Marco] ETH, Inst Human Movement Sci, Zurich, Switzerland; [Arnold, Anne-Sophie; Summermatter, Serge; Santos, Gesa Brochmann Santana; Christe, Martine; Handschin, Christoph] Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, Basel, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Burch, N (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	christoph.handschin@unibas.ch	Item, Flurin/GSN-0308-2022; Arnold, Anne-Sophie/A-9234-2014; Handschin, Christoph/E-6886-2015; Boutellier, Urs/A-8749-2011; Item, Flurin/H-9870-2012	Arnold, Anne-Sophie/0000-0002-2435-0297; Handschin, Christoph/0000-0003-0603-1097; Summermatter, Serge/0000-0003-4870-0148	Swiss National Science Foundation [SNF PP00A-110746]; Muscular Dystrophy Association USA [MDA68442]; SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung''; Swiss Society for Research on Muscle Diseases (SSEM); United Mitochondrial Disease Foundation (UMDF); Association Francaise contre les myopathies (AFM); University Research Priority Program; Hartmann Muller-Stiftung fur medizinische Forschung; Universities of Basel, Zurich; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Muscular Dystrophy Association USA(Muscular Dystrophy Association); SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung''; Swiss Society for Research on Muscle Diseases (SSEM); United Mitochondrial Disease Foundation (UMDF); Association Francaise contre les myopathies (AFM)(Association Francaise contre les Myopathies); University Research Priority Program; Hartmann Muller-Stiftung fur medizinische Forschung; Universities of Basel, Zurich; ETH Zurich(ETH Zurich)	The research described in this manuscript was supported by grants from the Swiss National Science Foundation (SNF PP00A-110746 to CH), the Muscular Dystrophy Association USA (MDA68442 to CH), the SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung'' to CH, the Swiss Society for Research on Muscle Diseases (SSEM) to CH, the United Mitochondrial Disease Foundation (UMDF) to CH, the Association Francaise contre les myopathies (AFM) to CH, the University Research Priority Program "Integrative Human Physiology'' at the University of Zurich to UB, MT and CH, the "Hartmann Muller-Stiftung fur medizinische Forschung'' to MT, and the Universities of Basel, Zurich and the ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Cairns SP, 2007, J APPL PHYSIOL, V103, P359, DOI 10.1152/japplphysiol.01267.2006; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Coffey VG, 2006, INT J SPORT PHYSIOL, V1, P284, DOI 10.1123/ijspp.1.3.284; Coffey VG, 2006, AM J PHYSIOL-ENDOC M, V290, pE849, DOI 10.1152/ajpendo.00299.2005; Consitt LA, 2009, IUBMB LIFE, V61, P47, DOI 10.1002/iub.142; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Ebeling P, 1998, FEBS LETT, V436, P301, DOI 10.1016/S0014-5793(98)01149-1; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; HANDSCHIN C, 2010, J RECEPT SI IN PRESS; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; HOH JFY, 1991, NEWS PHYSIOL SCI, V6, P1; Holloway GP, 2009, APPL PHYSIOL NUTR ME, V34, P440, DOI 10.1139/H09-028; Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182; HOWALD H, 1982, INT J SPORTS MED, V3, P1, DOI 10.1055/s-2008-1026053; Huang YC, 2006, AM J PHYSIOL-CELL PH, V291, pC11, DOI 10.1152/ajpcell.00366.2005; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; IVY JL, 1991, SPORTS MED, V11, P6, DOI 10.2165/00007256-199111010-00002; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Marotta M, 2004, BIOTECHNIQUES, V36, P68, DOI 10.2144/04361ST01; Matsuoka Y, 2008, CELL TISSUE RES, V332, P123, DOI 10.1007/s00441-008-0582-z; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; NAUMANN K, 1994, DIFFERENTIATION, V55, P203, DOI 10.1046/j.1432-0436.1994.5530203.x; NEDACHI T, 2009, AM J PHYSL ENDOCRINO; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nielsen JN, 2003, ACTA PHYSIOL SCAND, V178, P309, DOI 10.1046/j.1365-201X.2003.01165.x; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Park H, 2008, J TISSUE ENG REGEN M, V2, P279, DOI 10.1002/term.93; Partridge T, 2005, J PHYSIOL-LONDON, V562, P646, DOI 10.1113/jphysiol.2004.080671; Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, pH1620, DOI 10.1152/ajpheart.00610.2003; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Pilegaard H, 2005, METABOLISM, V54, P1048, DOI 10.1016/j.metabol.2005.03.008; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Putman CT, 2000, AM J PHYSIOL-CELL PH, V279, pC682, DOI 10.1152/ajpcell.2000.279.3.C682; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Santos JM, 2008, INT J SPORTS MED, V29, P785, DOI 10.1055/s-2008-1038404; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010; Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Staron RS, 1997, CAN J APPL PHYSIOL, V22, P307, DOI 10.1139/h97-020; Stern-Straeter J, 2005, J CELL MOL MED, V9, P883, DOI 10.1111/j.1582-4934.2005.tb00386.x; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Thelen MHM, 1997, BIOCHEM J, V321, P845, DOI 10.1042/bj3210845; THOMAS PE, 1993, MUSCLE NERVE, V16, P193, DOI 10.1002/mus.880160213; Vissing K, 2004, FASEB J, V18, P94, DOI 10.1096/fj.04-2084fje; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAMAGUCHI T, 2009, AM J PHYSL CELL PHYS	71	59	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10970	10.1371/journal.pone.0010970	http://dx.doi.org/10.1371/journal.pone.0010970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532042	Green Accepted, Green Published, gold			2022-12-25	WOS:000278380500014
J	Harp, JR; Onami, TM				Harp, John R.; Onami, Thandi M.			Naive T Cells Re-Distribute to the Lungs of Selectin Ligand Deficient Mice	PLOS ONE			English	Article							LEUKOCYTE-ADHESION-DEFICIENCY; FUCOSYL-TRANSFERASE-VII; NONLYMPHOID TISSUES; P-SELECTIN; TH1 CELLS; INTERLEUKIN-7 RECEPTOR; IMMUNE-RESPONSES; BONE-MARROW; FUC-TVII; EXPRESSION		[Harp, John R.; Onami, Thandi M.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Harp, JR (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	tonami@utk.edu			University of Tennessee;  [AI05771901]	University of Tennessee; 	This work was supported by AI05771901 and University of Tennessee start-up funds to Thandi M. Onami and in part by the NIGMS Consortium for Functional Glycomics. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdian S, 2006, AM J PHYSIOL-LUNG C, V291, pL828, DOI 10.1152/ajplung.00120.2006; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Beeh KM, 2006, PULM PHARMACOL THER, V19, P233, DOI 10.1016/j.pupt.2005.07.004; Benner R., 1981, IMMUNOLOGICAL METHOD, VII, P247; Cai YH, 2006, J IMMUNOL, V176, P6568, DOI 10.4049/jimmunol.176.11.6568; Clark JG, 2004, AM J RESP CELL MOL, V30, P220, DOI 10.1165/rcmb.2003-0208OC; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; Cox DP, 2008, ORAL SURG ORAL MED O, V105, P86, DOI 10.1016/j.tripleo.2007.02.026; Curtis JL, 2002, J IMMUNOL, V169, P2570, DOI 10.4049/jimmunol.169.5.2570; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Doerschuk C M, 2000, Respir Res, V1, P136, DOI 10.1186/rr24; DOERSCHUK CM, 1993, J APPL PHYSIOL, V74, P3040, DOI 10.1152/jappl.1993.74.6.3040; Erdmann I, 2002, J IMMUNOL, V168, P2139, DOI 10.4049/jimmunol.168.5.2139; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Greter M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000109; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Hofmann M, 2006, INT IMMUNOPHARMACOL, V6, P1902, DOI 10.1016/j.intimp.2006.07.030; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kocks JR, 2007, J EXP MED, V204, P723, DOI 10.1084/jem.20061424; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Luettig B, 2001, AM J RESP CELL MOL, V25, P69, DOI 10.1165/ajrcmb.25.1.4414; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Movahedi M, 2007, J CLIN IMMUNOL, V27, P302, DOI 10.1007/s10875-006-9069-4; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Naess A, 1999, SCAND J INFECT DIS, V31, P600, DOI 10.1080/00365549950164535; Onami TM, 2002, J IMMUNOL, V168, P6022, DOI 10.4049/jimmunol.168.12.6022; Pabst R, 2002, J ALLERGY CLIN IMMUN, V110, P209, DOI 10.1067/mai.2002.126836; Pabst R, 1988, Adv Exp Med Biol, V237, P553; Pabst R., 2008, ALLERGY ALLERGIC DIS, P1214; Piccio L, 2005, J IMMUNOL, V174, P5805, DOI 10.4049/jimmunol.174.9.5805; Ravnic DJ, 2007, J THORAC CARDIOV SUR, V133, P97, DOI 10.1016/j.jtcvs.2006.08.054; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Romano Suzanne J, 2005, Treat Respir Med, V4, P85, DOI 10.2165/00151829-200504020-00002; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schreiber T, 2006, J IMMUNOL, V176, P1131, DOI 10.4049/jimmunol.176.2.1131; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Sikora L, 2003, AM J PATHOL, V162, P2019, DOI 10.1016/S0002-9440(10)64334-9; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; Suvas PK, 2007, J IMMUNOL, V179, P8122, DOI 10.4049/jimmunol.179.12.8122; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tschernig Thomas, 2009, BMC Pulm Med, V9, P39, DOI 10.1186/1471-2466-9-39; Underhill GH, 2005, BLOOD, V106, P3867, DOI 10.1182/blood-2005-03-0984; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Weninger W, 2003, SEMIN IMMUNOL, V15, P257, DOI 10.1016/j.smim.2003.08.007; Westermann J, 2001, IMMUNOL REV, V184, P20, DOI 10.1034/j.1600-065x.2001.1840103.x; Westermann J, 2001, ANN INTERN MED, V135, P279, DOI 10.7326/0003-4819-135-4-200108210-00013; White SJ, 2001, J IMMUNOL, V167, P628, DOI 10.4049/jimmunol.167.2.628; Wolber FM, 1998, J IMMUNOL, V161, P4396; Yakubenia S, 2008, BLOOD, V112, P1472, DOI 10.1182/blood-2008-01-132035; Yakubenia S, 2006, FEBS J, V273, P4390, DOI 10.1111/j.1742-4658.2006.05438.x	69	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10973	10.1371/journal.pone.0010973	http://dx.doi.org/10.1371/journal.pone.0010973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532047	gold, Green Published			2022-12-25	WOS:000278380500017
J	Es-Salah-Lamoureux, Z; Fougere, R; Xiong, PY; Robertson, GA; Fedida, D				Es-Salah-Lamoureux, Zeineb; Fougere, Robert; Xiong, Ping Yu; Robertson, Gail A.; Fedida, David			Fluorescence-Tracking of Activation Gating in Human ERG Channels Reveals Rapid S4 Movement and Slow Pore Opening	PLOS ONE			English	Article							HERG K+ CHANNELS; VOLTAGE-CLAMP FLUOROMETRY; GATED POTASSIUM CHANNEL; CONFORMATIONAL-CHANGES; CARDIAC-ARRHYTHMIA; ION CHANNELS; INACTIVATION; SENSOR; MECHANISM; CURRENTS	Background: hERG channels are physiologically important ion channels which mediate cardiac repolarization as a result of their unusual gating properties. These are very slow activation compared with other mammalian voltage-gated potassium channels, and extremely rapid inactivation. The mechanism of slow activation is not well understood and is investigated here using fluorescence as a direct measure of S4 movement and pore opening. Methods and Findings: Tetramethylrhodamine-5-maleimide (TMRM) fluorescence at E519 has been used to track S4 voltage sensor movement, and channel opening and closing in hERG channels. Endogenous cysteines (C445 and C449) in the S1-S2 linker bound TMRM, which caused a 10 mV hyperpolarization of the V(1/2) of activation to -27.5 +/- 2.0 mV, and showed voltage-dependent fluorescence signals. Substitution of S1-S2 linker cysteines with valines allowed unobstructed recording of S3-S4 linker E519C and L520C emission signals. Depolarization of E519C channels caused rapid initial fluorescence quenching, fit with a double Boltzmann relationship, F-V(ON), with V(1/2),(1) = -37.8 +/- 1.7 mV, and V(1/2,2) = 43.5 +/- 7.9 mV. The first phase, VK(1/2,1), was similar to 20 mV negative to the conductance-voltage relationship measured from ionic tail currents (G-V(1/2) = -18.3 +/- 1.2 mV), and relatively unchanged in a non-inactivating E519C:S620T mutant (V(1/2) = -34.4 +/- 1.5 mV), suggesting the fast initial fluorescence quenching tracked S4 voltage sensor movement. The second phase of rapid quenching was absent in the S620T mutant. The E519C fluorescence upon repolarization (V(1/2) = -20.6 +/- 1.2, k = 11.4 mV) and L520C quenching during depolarization (V(1/2) = 226.8 +/- 1.0, k = 13.3 mV) matched the respective voltage dependencies of hERG ionic tails, and deactivation time constants from -40 to -110 mV, suggesting they detected pore-S4 rearrangements related to ionic current flow during pore opening and closing. Conclusion: The data indicate: 1) that rapid environmental changes occur at the outer end of S4 in hERG channels that underlie channel activation gating, and 2) that secondary slower changes reflect channel pore opening during sustained depolarizations, and channel closing upon repolarization. 3) No direct evidence was obtained of conformational changes related to inactivation from fluorophores attached at the outer end of S4.	[Es-Salah-Lamoureux, Zeineb; Fougere, Robert; Xiong, Ping Yu; Fedida, David] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Robertson, Gail A.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA	University of British Columbia; University of Wisconsin System; University of Wisconsin Madison	Es-Salah-Lamoureux, Z (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	fedida@interchange.ubc.ca	Es-Salah-Lamoureux, Zeineb/D-3908-2015	Es-Salah-Lamoureux, Zeineb/0000-0003-4530-6655; Robertson, Gail/0000-0003-4694-5790	Canadian Institutes of Health Research; Heart and the Stroke Foundation of British Columbia and Yukon; National Institutes of Health [HL081780]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081780] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and the Stroke Foundation of British Columbia and Yukon; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Canadian Institutes of Health Research and the Heart and the Stroke Foundation of British Columbia and Yukon to D. Fedida, and by the National Institutes of Health grant HL081780 to G. A. Robertson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anumonwo JMB, 1999, BIOPHYS J, V77, P282, DOI 10.1016/S0006-3495(99)76889-X; Bannister JPA, 2005, P NATL ACAD SCI USA, V102, P18718, DOI 10.1073/pnas.0505766102; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Choveau FS, 2009, BIOPHYS J, V97, P1323, DOI 10.1016/j.bpj.2009.05.060; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; Claydon TW, 2007, BIOCHEM SOC T, V35, P1080, DOI 10.1042/BST0351080; Claydon TW, 2007, J GEN PHYSIOL, V129, P437, DOI 10.1085/jgp.200709774; Claydon TW, 2007, J PHARMACOL EXP THER, V320, P162, DOI 10.1124/jpet.106.110411; Elliott DJS, 2009, MOL MEMBR BIOL, V26, P435, DOI 10.3109/09687680903321081; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Hesketh JC, 1999, AM J PHYSIOL-HEART C, V277, pH1956, DOI 10.1152/ajpheart.1999.277.5.H1956; Hill AP, 2007, BIOPHYS J, V92, P3915, DOI 10.1529/biophysj.106.101956; Horne AJ, 2009, CAN J PHYSIOL PHARM, V87, P411, DOI [10.1139/y09-024, 10.1139/Y09-024]; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jiang M, 1999, AM J PHYSIOL-HEART C, V277, pH1283, DOI 10.1152/ajpheart.1999.277.4.H1283; Johnson JP, 1999, J GEN PHYSIOL, V113, P565, DOI 10.1085/jgp.113.4.565; Johnson JP, 2001, J NEUROSCI, V21, P4143, DOI 10.1523/JNEUROSCI.21-12-04143.2001; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Nakajima T, 1999, CARDIOVASC RES, V44, P283, DOI 10.1016/S0008-6363(99)00195-9; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Smith PL, 2002, J GEN PHYSIOL, V119, P275, DOI 10.1085/jgp.119.3.275; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; Thomas D, 2004, BRIT J PHARMACOL, V142, P485, DOI 10.1038/sj.bjp.0705795; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vaid M, 2008, J GEN PHYSIOL, V132, P209, DOI 10.1085/jgp.200809978; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhang M, 2005, J MEMBRANE BIOL, V207, P169, DOI 10.1007/s00232-005-0812-1; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zhao JT, 2009, J CARDIOVASC ELECTR, V20, P923, DOI 10.1111/j.1540-8167.2009.01468.x; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241; Zou AR, 1998, J PHYSIOL-LONDON, V509, P129, DOI 10.1111/j.1469-7793.1998.129bo.x	47	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10876	10.1371/journal.pone.0010876	http://dx.doi.org/10.1371/journal.pone.0010876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526358	Green Published, gold, Green Submitted			2022-12-25	WOS:000278222100007
J	Wang, YH; Gorvel, JP; Chu, YT; Wu, JJ; Lei, HY				Wang, Ya-Hui; Gorvel, Jean-Pierre; Chu, Yen-Ting; Wu, Jiunn-Jong; Lei, Huan-Yao			Helicobacter pylori Impairs Murine Dendritic Cell Responses to Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; HOMOTYPIC PHAGOSOME FUSION; GASTRIC EPITHELIAL-CELLS; MACROPHAGES; INDUCTION; TOLL-LIKE-RECEPTOR-4; PHAGOCYTOSIS; INFLAMMATION; CHOLESTEROL; INHIBITION	Background: Helicobacter pylori, a human pathogen associated with chronic gastritis, peptic ulcer and gastric malignancies, is generally viewed as an extracellular microorganism. Here, we show that H. pylori replicates in murine bone marrow derived-dendritic cells (BMDCs) within autophagosomes. Methodology/Principal Findings: A 10-fold increase of CFU is found between 2 h and 6 h p.i. in H. pylori-infected BMDCs. Autophagy is induced around the bacterium and participates at late time points of infection for the clearance of intracellular H. pylori. As a consequence of infection, LC3, LAMP1 and MHC class II molecules are retained within the H. pylori-containing vacuoles and export of MHC class II molecules to cell surface is blocked. However, formalin-fixed H. pylori still maintain this inhibitory activity in BMDC derived from wild type mice, but not in from either TLR4 or TLR2-deficient mice, suggesting the involvement of H. pylori-LPS in this process. TNF-alpha, IL-6 and IL-10 expression was also modulated upon infection showing a TLR2-specific dependent IL-10 secretion. No IL-12 was detected favoring the hypothesis of a down modulation of DC functions during H. pylori infection. Furthermore, antigen-specific T cells proliferation was also impaired upon infection. Conclusions/Significance: H. pylori can infect and replicate in BMDCs and thereby affects DC-mediated immune responses. The implication of this new finding is discussed for the biological life cycle of H. pylori in the host.	[Wang, Ya-Hui] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Gorvel, Jean-Pierre] Aix Marseille Univ, Fac Sci Luminy, CIMI, UMR6546, Marseille, France; [Gorvel, Jean-Pierre] INSERM, U631, F-13258 Marseille, France; [Gorvel, Jean-Pierre] CNRS, UMR6102, Marseille, France; [Chu, Yen-Ting; Lei, Huan-Yao] Natl Cheng Kung Univ, Dept Microbiol, Tainan 70101, Taiwan; [Chu, Yen-Ting; Lei, Huan-Yao] Natl Cheng Kung Univ, Dept Immunol, Tainan 70101, Taiwan; Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan	National Cheng Kung University; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Wang, YH (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan.	hylei@mail.ncku.edu.tw	Wu, Jiunn-Jong/E-6075-2011; Gorvel, Jean-Pierre/O-1332-2018	Gorvel, Jean-Pierre/0000-0002-2829-9804	National Science Council, Taiwan [NSC95-2320-B-006-063-MY2, NSC98-2320-B006-031-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by NSC95-2320-B-006-063-MY2 and NSC98-2320-B006-031-MY2 from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115; Allen LAH, 2007, CELL MICROBIOL, V9, P817, DOI 10.1111/j.1462-5822.2007.00906.x; Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Gong J, 2010, J STRUCT BIOL, V169, P323, DOI 10.1016/j.jsb.2009.12.007; Guiney DG, 2003, INFECT IMMUN, V71, P4163, DOI 10.1128/IAI.71.7.4163-4166.2003; Hafsi N, 2004, J IMMUNOL, V173, P1249, DOI 10.4049/jimmunol.173.2.1249; Kao JY, 2006, AM J PHYSIOL-GASTR L, V291, pG73, DOI 10.1152/ajpgi.00139.2005; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Kranzer K, 2004, INFECT IMMUN, V72, P4416, DOI 10.1128/IAI.72.8.4416-4423.2004; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Lai CH, 2008, INFECT IMMUN, V76, P3293, DOI 10.1128/IAI.00365-08; Lepper PM, 2005, CELL MICROBIOL, V7, P519, DOI 10.1111/j.1462-5822.2005.00482.x; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Mitchell P, 2007, INFECT IMMUN, V75, P810, DOI 10.1128/IAI.00228-06; Molinari M, 1998, J EXP MED, V187, P135, DOI 10.1084/jem.187.1.135; Moran AP, 2008, CARBOHYD RES, V343, P1952, DOI 10.1016/j.carres.2007.12.012; Obonyo M, 2007, INFECT IMMUN, V75, P2408, DOI 10.1128/IAI.01794-06; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Petersen AM, 2003, FEMS IMMUNOL MED MIC, V36, P117, DOI 10.1016/S0928-8244(03)00020-8; PHILIP S, 2000, INFECT IMMUN, V68, P4802; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rittig MG, 2003, CELL MICROBIOL, V5, P887, DOI 10.1046/j.1462-5822.2003.00328.x; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Schwartz JT, 2006, J LEUKOCYTE BIOL, V79, P1214, DOI 10.1189/jlb.0106030; Sendide K, 2005, J IMMUNOL, V175, P5324, DOI 10.4049/jimmunol.175.8.5324; Shiratsuchi A, 2004, J IMMUNOL, V172, P2039, DOI 10.4049/jimmunol.172.4.2039; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tan MP, 2008, INFECT IMMUN, V76, P1289, DOI 10.1128/IAI.00779-07; Uno K, 2007, AM J PHYSIOL-GASTR L, V293, pG1004, DOI 10.1152/ajpgi.00096.2007; Wang YH, 2009, EXP BIOL MED, V234, P171, DOI 10.3181/0808-RM-252; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Yokota SI, 2007, FEMS IMMUNOL MED MIC, V51, P140, DOI 10.1111/j.1574-695X.2007.00288.x; Zheng PY, 2003, CELL MICROBIOL, V5, P25, DOI 10.1046/j.1462-5822.2003.00250.x	49	19	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10844	10.1371/journal.pone.0010844	http://dx.doi.org/10.1371/journal.pone.0010844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523725	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221900007
J	Gajewski, KM; Schulz, RA				Gajewski, Kathleen M.; Schulz, Robert A.			CF2 Represses Actin 88F Gene Expression and Maintains Filament Balance during Indirect Flight Muscle Development in Drosophila	PLOS ONE			English	Article							TRANSCRIPTION FACTOR CF2; HEAVY-CHAIN GENE; ENHANCER FACTOR-2; MELANOGASTER; MUTANT; OVEREXPRESSION; OOGENESIS; ISOFORMS; DEFECTS; PROTEIN	The zinc finger protein CF2 is a characterized activator of muscle structural genes in the body wall muscles of the Drosophila larva. To investigate the function of CF2 in the indirect flight muscle (IFM), we examined the phenotypes of flies bearing five homozygous viable mutations. The gross structure of the IFM was not affected, but the stronger hypomorphic alleles caused an increase of up to 1.5X in the diameter of the myofibrils. This size increase did not cause any disruption of the hexameric arrangement of thick and thin filaments. RT-PCR analysis revealed an increase in the transcription of several structural genes. Ectopic overexpression of CF2 in the developing IFM disrupts muscle formation. While our results indicate a role for CF2 as a direct negative regulator of the thin filament protein gene Actin 88F (Act88F), effects on levels of transcripts of myosin heavy chain (mhc) appear to be indirect. This role is in direct contrast to that described in the larval muscles, where CF2 activates structural gene expression. The variation in myofibril phenotypes of CF2 mutants suggest the CF2 may have separate functions in fine-tuning expression of structural genes to insure proper filament stoichiometry, and monitoring and/or controlling the final myofibril size.	[Gajewski, Kathleen M.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Schulz, Robert A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Texas System; UTMD Anderson Cancer Center; University of Notre Dame	Gajewski, KM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	kmgajews@mdanderson.org			NIH [CA16672, HL059151]; AHA SDG; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059151] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA SDG(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The MD Anderson EM Core and MD Anderson DNA Sequencing Core are supported by NIH grant CA16672. KMG was supported by an AHA SDG. RAS was supported by NIH grant HL059151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo JJ, 2001, J BIOL CHEM, V276, P8278, DOI 10.1074/jbc.M009302200; Bagni C, 2002, MECH DEVELOP, V117, P265, DOI 10.1016/S0925-4773(02)00176-4; BARBAS JA, 1993, MOL CELL BIOL, V13, P1433, DOI 10.1128/MCB.13.3.1433; BARTHMAIER P, 1995, DEV BIOL, V169, P770, DOI 10.1006/dbio.1995.1186; BEALL CJ, 1989, GENE DEV, V3, P131, DOI 10.1101/gad.3.2.131; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; CRIPPS RM, 1994, J CELL BIOL, V126, P689, DOI 10.1083/jcb.126.3.689; Gajewski K, 2000, GENESIS, V28, P36, DOI 10.1002/1526-968X(200009)28:1<36::AID-GENE50>3.0.CO;2-4; Gajewski KM, 2006, DEV BIOL, V289, P17, DOI 10.1016/j.ydbio.2005.09.039; Garcia-Zaragoza E, 2008, MECH DEVELOP, V125, P617, DOI 10.1016/j.mod.2008.03.003; GOGOS JA, 1992, SCIENCE, V257, P1951, DOI 10.1126/science.1290524; Hess NK, 2007, GENE EXPR PATTERNS, V7, P413, DOI 10.1016/j.modgep.2006.11.007; Hsu T, 1996, GENE DEV, V10, P1411, DOI 10.1101/gad.10.11.1411; HSU T, 1992, SCIENCE, V257, P1946, DOI 10.1126/science.1411512; Kelly KK, 2002, MECH DEVELOP, V110, P39, DOI 10.1016/S0925-4773(01)00586-X; KOANA T, 1978, J EMBRYOL EXP MORPH, V45, P123; Lin MH, 1996, P NATL ACAD SCI USA, V93, P4623, DOI 10.1073/pnas.93.10.4623; Mantrova EY, 1998, GENE DEV, V12, P1166; Marco-Ferreres R, 2005, BIOCHEM J, V386, P145, DOI 10.1042/BJ20041240; Marin MC, 2004, MOL BIOL CELL, V15, P1185, DOI 10.1091/mbc.E03-09-0663; Nongthomba U, 2001, J MUSCLE RES CELL M, V22, P111, DOI 10.1023/A:1010308326890; ODONNELL PT, 1988, J CELL BIOL, V107, P2601, DOI 10.1083/jcb.107.6.2601; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; REEDY MC, 1993, DEV BIOL, V160, P443, DOI 10.1006/dbio.1993.1320; Tanaka KKK, 2008, MOL CELL BIOL, V28, P1616, DOI 10.1128/MCB.01169-07; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314	26	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10713	10.1371/journal.pone.0010713	http://dx.doi.org/10.1371/journal.pone.0010713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520827	gold, Green Submitted, Green Published			2022-12-25	WOS:000278034800001
J	Kovalenko, OA; Kaplunov, J; Herbig, U; Detoledo, S; Azzam, EI; Santos, JH				Kovalenko, Olga A.; Kaplunov, Jessica; Herbig, Utz; deToledo, Sonia; Azzam, Edouard I.; Santos, Janine H.			Expression of (NES-)hTERT in Cancer Cells Delays Cell Cycle Progression and Increases Sensitivity to Genotoxic Stress	PLOS ONE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; MITOCHONDRIAL-DNA DAMAGE; HUMAN BREAST-CANCER; HUMAN TUMOR-CELLS; IONIZING-RADIATION; INDUCED APOPTOSIS; HUMAN FIBROBLASTS; MTDNA DAMAGE; NECK-CANCER; S-PHASE	Telomerase is a reverse transcriptase associated with cellular immortality through telomere maintenance. This enzyme is activated in 90% of human cancers, and inhibitors of telomerase are currently in clinical trials to counteract tumor growth. Many aspects of telomerase biology have been investigated for therapy, particularly inhibition of the enzyme, but little was done regarding its subcellular shuttling. We have recently shown that mutations in the nuclear export signal of hTERT, the catalytic component of telomerase, led to a mutant ((NES-)hTERT) that failed to immortalize cells despite nuclear localization and catalytic activity. Expression of (NES-)hTERT in primary fibroblast resulted in telomere-based premature senescence and mitochondrial dysfunction. Here we show that expression of (NES-)hTERT in LNCaP, SQ20B and HeLa cells rapidly and significantly decreases their proliferation rate and ability to form colonies in soft agar while not interfering with endogenous telomerase activity. The cancer cells showed increased DNA damage at telomeric and extra-telomeric sites, and became sensitive to ionizing radiation and hydrogen peroxide exposures. Our data show that expression of (NES-)hTERT efficiently counteracts cancer cell growth in vitro in at least two different ways, and suggest manipulation with the NES of hTERT or its subcellular shuttling as a new strategy for cancer treatment.	[Kovalenko, Olga A.; Santos, Janine H.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Kovalenko, Olga A.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol, Newark, NJ 07103 USA; [Kaplunov, Jessica; Herbig, Utz] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [deToledo, Sonia; Azzam, Edouard I.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kovalenko, OA (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	santosja@umdnj.edu			New Jersey Commission on Cancer Research (NJCCR) [808033, 09-1124-CCR-EO, 10-2412-CCR-E0]; Army Research Office [56027LS]; Ellison Medical Foundation [AG-NS-0387-07]	New Jersey Commission on Cancer Research (NJCCR); Army Research Office; Ellison Medical Foundation(Lawrence Ellison Foundation)	This study was supported by The New Jersey Commission on Cancer Research (NJCCR), grant number 808033 (J.H.S.), 09-1124-CCR-EO (U. H.) and 10-2412-CCR-E0 (J.F.), the Army Research Office, grant number 56027LS (J.H.S.), the Ellison Medical Foundation grant AG-NS-0387-07 (U. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Akiyama M, 2002, CANCER LETT, V178, P187, DOI 10.1016/S0304-3835(01)00838-2; Armbruster BN, 2004, MOL CELL BIOL, V24, P3552, DOI 10.1128/MCB.24.8.3552-3561.2004; Azzam EI, 2000, CANCER RES, V60, P2623; Boix-Chornet M, 2006, J BIOL CHEM, V281, P13540, DOI 10.1074/jbc.M601136200; BRACHMAN DG, 1993, CANCER RES, V53, P3667; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cerone MA, 2006, MOL CANCER THER, V5, P1669, DOI 10.1158/1535-7163.MCT-06-0033; Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725; Corey DR, 2002, ONCOGENE, V21, P631, DOI 10.1038/sj.onc.1205063; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Dahlberg WK, 1999, CANCER RES, V59, P5365; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; Del Bufalo D, 2005, CELL DEATH DIFFER, V12, P1429, DOI 10.1038/sj.cdd.4401670; Fennell M, 2006, J BIOMOL SCREEN, V11, P296, DOI 10.1177/1087057105284618; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gellert GC, 2006, BREAST CANCER RES TR, V96, P73, DOI 10.1007/s10549-005-9043-5; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Gorbunova V, 2003, J BIOL CHEM, V278, P7692, DOI 10.1074/jbc.M212944200; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; HERMAN JG, 1995, CANCER RES, V55, P4525; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Holt SE, 1999, MOL CARCINOGEN, V25, P241, DOI 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.0.CO;2-9; Hurley LH, 2000, PHARMACOL THERAPEUT, V85, P141, DOI 10.1016/S0163-7258(99)00068-6; Jerome KR, 2001, J IMMUNOL, V167, P3928, DOI 10.4049/jimmunol.167.7.3928; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kaufmann WK, 2007, CELL CYCLE, V6, P1460; Kelland LR, 2001, LANCET ONCOL, V2, P95, DOI 10.1016/S1470-2045(00)00226-6; Kovalenko Olga A, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1901s62; Kovalenko OA, 2010, AGING CELL, V9, P203, DOI 10.1111/j.1474-9726.2010.00551.x; Kraemer K, 2003, CLIN CANCER RES, V9, P3794; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; Lu CB, 2001, DEV BRAIN RES, V131, P167, DOI 10.1016/S0165-3806(01)00237-1; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; MESSINA JP, 1989, J IMMUNOL, V143, P1974; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Nakamura M, 2005, HUM GENE THER, V16, P859, DOI 10.1089/hum.2005.16.859; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Ren JG, 2001, FEBS LETT, V488, P133, DOI 10.1016/S0014-5793(00)02397-8; Riou JF, 2002, P NATL ACAD SCI USA, V99, P2672, DOI 10.1073/pnas.052698099; Rubio MA, 2004, EXP CELL RES, V298, P17, DOI 10.1016/j.yexcr.2004.04.004; Rubio MA, 2002, J BIOL CHEM, V277, P28609, DOI 10.1074/jbc.M203747200; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Sedelnikova OA, 2004, INT J RADIAT BIOL, V80, P927, DOI 10.1080/09553000400017648; SHAW JP, 1986, J CELL PHYSIOL, V129, P193, DOI 10.1002/jcp.1041290210; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tamulevicius P, 2007, RADIAT RES, V167, P1, DOI 10.1667/RR0751.1; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; van Houten VMM, 2000, RECENT RESULTS CANC, V157, P90; Venkatachalam P, 2008, ONCOGENE, V27, P20, DOI 10.1038/sj.onc.1210634; Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769; Ward RJ, 2005, MOL PHARMACOL, V68, P779, DOI 10.1124/mol.105.011494; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388	68	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10812	10.1371/journal.pone.0010812	http://dx.doi.org/10.1371/journal.pone.0010812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520826	gold, Green Submitted, Green Published			2022-12-25	WOS:000278034800010
J	Brizuela, L; Dayon, A; Doumerc, N; Ader, I; Golzio, M; Izard, JC; Hara, Y; Malavaud, B; Cuvillier, O				Brizuela, Leyre; Dayon, Audrey; Doumerc, Nicolas; Ader, Isabelle; Golzio, Muriel; Izard, Jean-Claude; Hara, Yukihiko; Malavaud, Bernard; Cuvillier, Olivier			The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer	FASEB JOURNAL			English	Article						resveratrol; EGCg; phospholipase D; ERK1/2	MYELOID-LEUKEMIA CELLS; NF-KAPPA-B; GREEN TEA; PHOSPHOLIPASE-D; INDUCED APOPTOSIS; VEGF EXPRESSION; HEPATOMA-CELLS; POOR SURVIVAL; CYCLE ARREST; RESVERATROL	The sphingosine kinase-1/sphingosine 1-phosphate (SphK1/S1P) pathway has been associated with cancer promotion and progression and resistance to treatments in a number of cancers, including prostate adenocarcinoma. Here we provide the first evidence that dietary agents, namely, epigallocatechin gallate (EGCg, IC50 approximate to 75 mu M), resveratrol (IC50 approximate to 40 mu M), or a mixture of polyphenols from green tea [polyphenon E (PPE), IC50 approximate to 70 mu M] or grapevine extract (vineatrol, IC50 approximate to 30 mu M), impede prostate cancer cell growth in vitro and in vivo by inhibiting the SphK1/S1P pathway. We establish that SphK1 is a downstream effector of the ERK/phospholipase D (PLD) pathway, which is inhibited by green tea and wine polyphenols. Enforced expression of SphK1 impaired the ability of green tea and wine polyphenols, as well as pharmacological inhibitors of PLD and ERK activities, to induce apoptosis in PC-3 and C4-2B cells. The therapeutic efficacy of these polyphenols on tumor growth and the SphK1/S1P pathway were confirmed in animals using a heterotopic PC-3 tumor in place model. PC-3/SphK1 cells implanted in animals developed larger tumors and resistance to treatment with polyphenols. Furthermore, using an orthotopic PC-3/GFP model, the chemopreventive effect of an EGCg or PPE diet was associated with SphK1 inhibition, a decrease in primary tumor volume, and occurrence and number of metastases. These results provide the first demonstration that the prosurvival, antiapoptotic SphK1/S1P pathway represents a target of dietary green tea and wine polyphenols in cancer.-Brizuela, L., Dayon, A., Doumerc, N., Ader, I., Golzio, M., Izard, J.-C., Hara, Y., Malavaud, B., Cuvillier, O. The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer. FASEB J. 24, 3882-3894 (2010). www.fasebj.org	[Cuvillier, Olivier] CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France; [Brizuela, Leyre; Dayon, Audrey; Doumerc, Nicolas; Ader, Isabelle; Golzio, Muriel; Malavaud, Bernard; Cuvillier, Olivier] Univ Toulouse 3, Inst Pharmacol & Biol Struct, Univ Toulouse, F-31062 Toulouse, France; [Doumerc, Nicolas; Malavaud, Bernard; Cuvillier, Olivier] Hop Rangueil, Serv Urol & Transplantat Renale, Toulouse, France; [Izard, Jean-Claude] Actichem SA, Montauban, France; [Hara, Yukihiko] Mitsui Norin Ltd, Tokyo, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Mitsui Norin Co. Ltd.	Cuvillier, O (corresponding author), CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France.	olivier.cuvillier@ipbs.fr	CUVILLIER, Olivier/S-1631-2019; Ader-Perarnau, Isabelle/F-7160-2017; Golzio, Muriel/F-4715-2019; Brizuela, Leyre/B-1175-2010; CUVILLIER, Olivier/B-2567-2009	CUVILLIER, Olivier/0000-0003-3346-375X; Golzio, Muriel/0000-0002-7470-3708; CUVILLIER, Olivier/0000-0003-3346-375X; ADER, isabelle/0000-0001-5103-8509	Region Midi-Pyrenees	Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur)	This work was supported by the Region Midi-Pyrenees (to O.C.).	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; Adhami VM, 2004, CANCER RES, V64, P8715, DOI 10.1158/0008-5472.CAN-04-2840; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Aziz MH, 2005, FASEB J, V19, P1193, DOI 10.1096/fj.04-3582fje; Benitez DA, 2007, J ANDROL, V28, P282, DOI 10.2164/jandrol.106.000968; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Colin D, 2009, INT J CANCER, V124, P2780, DOI 10.1002/ijc.24264; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 2001, BLOOD, V98, P2828, DOI 10.1182/blood.V98.9.2828; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; Cuvillier Olivier, 2010, Curr Mol Pharmacol, V3, P53; Dayon A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008048; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Fitzpatrick JM, 2009, BJU INT, V103, pI, DOI 10.1111/j.1464-410X.2008.08369.x; Fulda S, 2006, CANCER DETECT PREV, V30, P217, DOI 10.1016/j.cdp.2006.03.007; Gioeli D, 1999, CANCER RES, V59, P279; Gupta S, 2001, P NATL ACAD SCI USA, V98, P10350, DOI 10.1073/pnas.171326098; Harper CE, 2007, CARCINOGENESIS, V28, P1946, DOI 10.1093/carcin/bgm144; Hastak K, 2003, ONCOGENE, V22, P4851, DOI 10.1038/sj.onc.1206708; Issuree PDA, 2009, FASEB J, V23, P2412, DOI 10.1096/fj.09-130542; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Johnson JJ, 2010, PHYTOMEDICINE, V17, P3, DOI 10.1016/j.phymed.2009.09.011; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Ju J, 2005, CANCER RES, V65, P10623, DOI 10.1158/0008-5472.CAN-05-1949; Kang DW, 2008, J BIOL CHEM, V283, P4094, DOI 10.1074/jbc.M707416200; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Lee MH, 2009, CANCER RES, V69, P7449, DOI 10.1158/0008-5472.CAN-09-1266; Li W, 2009, CLIN CANCER RES, V15, P1393, DOI 10.1158/1078-0432.CCR-08-1158; MARTIN A, 1993, J BIOL CHEM, V268, P23924; Nava VE, 2000, CANCER RES, V60, P4468; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Paruch S, 2005, FASEB J, V19, P142, DOI 10.1096/fj.05-3881fje; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Sauer L, 2009, INT J CANCER, V125, P2728, DOI 10.1002/ijc.24640; Seeni A, 2008, ASIAN PAC J CANCER P, V9, P7; Shankar S, 2007, MOL CELL BIOCHEM, V304, P273, DOI 10.1007/s11010-007-9510-x; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; Siddiqui IA, 2006, CARCINOGENESIS, V27, P833, DOI 10.1093/carcin/bgi323; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stewart JR, 2004, INVEST NEW DRUG, V22, P107, DOI 10.1023/B:DRUG.0000011787.75522.ec; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Vayalil PK, 2004, PROSTATE, V59, P33, DOI 10.1002/pros.10352; Xiao H, 2008, CARCINOGENESIS, V29, P113, DOI 10.1093/carcin/bgm204; Zhang QZ, 2006, MOL CANCER THER, V5, P1227, DOI 10.1158/1535-7163.MCT-05-0490; Zhang QZ, 2005, MOL CANCER THER, V4, P1465, DOI 10.1158/1535-7163.MCT-05-0198	57	53	54	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3882	3894		10.1096/fj.10-160838	http://dx.doi.org/10.1096/fj.10-160838			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20522783				2022-12-25	WOS:000285005900026
J	Ishimaru, Y; Katano, Y; Yamamoto, K; Akiba, M; Misaka, T; Roberts, RW; Asakura, T; Matsunami, H; Abe, K				Ishimaru, Yoshiro; Katano, Yuka; Yamamoto, Kurumi; Akiba, Masato; Misaka, Takumi; Roberts, Richard W.; Asakura, Tomiko; Matsunami, Hiroaki; Abe, Keiko			Interaction between PKD1L3 and PKD2L1 through their transmembrane domains is required for localization of PKD2L1 at taste pores in taste cells of circumvallate and foliate papillae	FASEB JOURNAL			English	Article						association; trafficking; sour taste receptor; polycystic kidney disease	TRANSIENT RECEPTOR; TRPP3 CHANNEL; POLYCYSTIN-L; KIDNEY; IDENTIFICATION; MEMBERS; FAMILY; MOUSE; ACID; MECHANOSENSATION	The polycystic kidney disease 1-like 3 (PKD1L3) and polycystic kidney disease 2-like 1 (PKD2L1) proteins have been proposed to form heteromers that function as sour taste receptors in mammals. Here, we show that PKD1L3 and PKD2L1 interact through their transmembrane domains, and not through the coiled-coil domain, by coimmunoprecipitation experiments using a series of deletion mutants. Deletion mutants lacking the critical interaction region were not transported to the cell surface and remained in the cytoplasm, whereas PKD1L3 and PKD2L1 proteins were expressed at the cell surface when both are transfected. Calcium imaging analysis revealed that neither the coiled-coil domain nor the EF-hand domain located in the C-terminal cytoplasmic tail of PKD2L1 was required for response on stimulation with an acidic solution. Finally, PKD2L1 did not localize to the taste pore but was distributed throughout the cytoplasm in taste cells of circumvallate and foliate papillae in PKD1L3(-/-) mice, whereas it localized to the taste pore in wild-type mice. Collectively, these results suggest that the interaction between PKD1L3 and PKD2L1 through their transmembrane domains is essential for proper trafficking of the channels to the cell surface in taste cells of circumvallate and foliate papillae and in cultured cells.-Ishimaru, Y., Katano, Y., Yamamoto, K., Akiba, M., Misaka, T., Roberts, R. W., Asakura, T., Matsunami, H., Abe, K. Interaction between PKD1L3 and PKD2L1 through their transmembrane domains is required for localization of PKD2L1 at taste pores in taste cells of circumvallate and foliate papillae. FASEB J. 24, 4058-4067 (2010). www.fasebj.org	[Ishimaru, Yoshiro; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Ishimaru, Yoshiro; Roberts, Richard W.; Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	University of Tokyo; Duke University	Ishimaru, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ayishi@mail.ecc.u-tokyo.ac.jp; aka7308@mail.ecc.u-tokyo.ac.jp	Ishimaru, Yoshiro/AAI-3049-2020	Misaka, Takumi/0000-0002-9547-5767	Japan Ministry of Education, Culture, Sports, Science, and Technology [20780089, 16108004, 20380183]; Kao Foundation for Arts and Sciences; Nestle Nutrition Council; Salt Science Research Foundation [0915]; U.S. National Institutes of Health [R21 DC008967]; Research and Development Program for New Bioindustry Initiatives; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008967, R01DC005782] Funding Source: NIH RePORTER	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kao Foundation for Arts and Sciences; Nestle Nutrition Council(Nestle SA); Salt Science Research Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research and Development Program for New Bioindustry Initiatives; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors are grateful to Cheryl Bock and Mei Lang Flowers (Duke Transgenic Mouse Facility) for microinjection of the DNA construct into embryonic stem cells and to Frederick W. Alt (Harvard Medical School, Boston, MA, USA) for the EF1 embryonic stem cell line. The authors also thank Qiuyi Chi and Taeko Fukuda for expert technical assistance and members of the Taste Science and Abe laboratories for critical readings of the manuscript. This work was supported in part by Japan Ministry of Education, Culture, Sports, Science, and Technology Grant-in-Aid for Young Scientists (B) 20780089 to Y.I. and Grants-in-Aid for Scientific Research 16108004 and 20380183 to K.A.; a Kao Foundation for Arts and Sciences grant to Y.I.; a Nestle Nutrition Council grant to Y.I.; a Salt Science Research Foundation grant (0915) to Y.I; a U.S. National Institutes of Health grant (R21 DC008967) to H.M.; and a Research and Development Program for New Bioindustry Initiatives grant to K.A.	Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Casuscelli J, 2009, AM J PHYSIOL-RENAL, V297, pF1310, DOI 10.1152/ajprenal.00412.2009; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Dai XQ, 2007, MOL PHARMACOL, V72, P1576, DOI 10.1124/mol.107.037150; Dai XQ, 2006, BBA-BIOMEMBRANES, V1758, P197, DOI 10.1016/j.bbamem.2006.01.020; Delmas P, 2004, BIOCHEM BIOPH RES CO, V322, P1374, DOI 10.1016/j.bbrc.2004.08.044; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Gao N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-20; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Hughes J, 1999, HUM MOL GENET, V8, P543, DOI 10.1093/hmg/8.3.543; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishii S, 2009, BIOCHEM BIOPH RES CO, V385, P346, DOI 10.1016/j.bbrc.2009.05.069; Ishimaru Y, 2009, J DENT RES, V88, P212, DOI 10.1177/0022034508330212; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2009, ODONTOLOGY, V97, P1, DOI 10.1007/s10266-008-0095-y; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kawaguchi H, 2010, J BIOL CHEM, V285, P17277, DOI 10.1074/jbc.C110.132944; Li AR, 2003, GENOMICS, V81, P596, DOI 10.1016/S0888-7543(03)00048-X; Li Q, 2002, FEBS LETT, V516, P270, DOI 10.1016/S0014-5793(02)02513-9; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Murakami M, 2005, J BIOL CHEM, V280, P5626, DOI 10.1074/jbc.M411496200; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	41	29	32	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					4058	4067		10.1096/fj.10-162925	http://dx.doi.org/10.1096/fj.10-162925			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20538909	Green Published			2022-12-25	WOS:000285005900041
J	Da Paula, AC; Sousa, M; Xu, Z; Dawson, ES; Boyd, AC; Sheppard, DN; Amaral, MD				Da Paula, Ana Carina; Sousa, Marisa; Xu, Zhe; Dawson, Elizabeth S.; Boyd, A. Christopher; Sheppard, David N.; Amaral, Margarida D.			Folding and Rescue of a Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Mutant Identified Using Human-Murine Chimeric Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN-1; CFTR CHLORIDE CHANNELS; DELTA-F508 MUTATION; GATING BEHAVIOR; MEMBRANE; STABILITY; DEFECTS; CELLS; DEGRADATION; MATURATION	Impairment of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel causes cystic fibrosis, a fatal genetic disease. Here, to gain insight into CFTR structure and function, we exploited interspecies differences between CFTR homologues using human (h)-murine (m) CFTR chimeras containing murine nucleotide-binding domains (NBDs) or regulatory domain on an hCFTR backbone. Among 15 hmCFTR chimeras analyzed, all but two were correctly processed, one containing part of mNBD1 and another containing part of mNBD2. Based on physicochemical distance analysis of divergent residues between human and murine CFTR in the two misprocessed hmCFTR chimeras, we generated point mutations for analysis of respective CFTR processing and functional properties. We identified one amino acid substitution (K584E-CFTR) that disrupts CFTR processing in NBD1. No single mutation was identified in NBD2 that disrupts protein processing. However, a number of NBD2 mutants altered channel function. Analysis of structural models of CFTR identified that although Lys(584) interacts with residue Leu(581) in human CFTR Glu(584) interacts with Phe(581) in mouse CFTR. Introduction of the murine residue (Phe(581)) in cis with K584E in human CFTR rescued the processing and trafficking defects of K584E-CFTR. Our data demonstrate that human-murine CFTR chimeras may be used to validate structural models of full-length CFTR. We also conclude that hmCFTR chimeras are a valuable tool to elucidate interactions between different domains of CFTR.	[Da Paula, Ana Carina; Sousa, Marisa; Amaral, Margarida D.] Univ Lisbon, Fac Sci, BioFIG Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Da Paula, Ana Carina; Sousa, Marisa; Amaral, Margarida D.] Natl Inst Hlth, Dept Genet, P-1649016 Lisbon, Portugal; [Xu, Zhe; Sheppard, David N.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Dawson, Elizabeth S.; Boyd, A. Christopher] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Genet Sect,Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	Universidade de Lisboa; University of Bristol; University of Edinburgh	Amaral, MD (corresponding author), Univ Lisbon, Fac Sci, BioFIG Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal.	mdamaral@fc.ul.pt	Sheppard, David N/AAV-4187-2021; Amaral, Margarida D/E-5748-2012	Sheppard, David N/0000-0001-5533-9130; Amaral, Margarida D/0000-0002-0828-8630; SOUSA, MARISA/0000-0003-2305-4813	Fundacao para a Ciencia ea Tecnologia (FCT), Portugal [PIC/IC/83103/2007, POCTI/MGI/47382/2002, SFRH/BD/17475/2004, SFRH/BD/35936/2007]; BioFIG from FCT, Portugal (Fonds Europeen de Developpement Regional-European Union); Biotechnology and Biological Sciences Research Council [BB/C517517/1]; CF Trust	Fundacao para a Ciencia ea Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); BioFIG from FCT, Portugal (Fonds Europeen de Developpement Regional-European Union); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CF Trust	This work was supported in part by Fundacao para a Ciencia ea Tecnologia (FCT), Portugal Grants PIC/IC/83103/2007; and POCTI/MGI/47382/2002 and pluriannual funding of BioFIG from FCT, Portugal (Fonds Europeen de Developpement Regional-European Union) (to M. D. A.) and by Biotechnology and Biological Sciences Research Council Grant BB/C517517/1 and the CF Trust (to D. N. S. and A. C. B.).; Recipient of FCT, Portugal Doctoral Fellowship SFRH/BD/17475/2004.; Recipient of FCT, Portugal Doctoral Fellowship SFRH/BD/35936/2007.	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; AMARAL MD, 2010, CURR DRUG T IN PRESS; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Chen JM, 2001, MOL BIOL EVOL, V18, P1771, DOI 10.1093/oxfordjournals.molbev.a003965; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; de Jonge H., 2009, PEDIATR PULM, V32, P291; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Farinha Carlos M, 2004, J Cyst Fibros, V3 Suppl 2, P73, DOI 10.1016/j.jcf.2004.05.017; Farinha CM, 2004, MOL CELL PROBE, V18, P235, DOI 10.1016/j.mcp.2004.03.005; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Haws CM, 1996, AM J PHYSIOL-CELL PH, V270, pC1544, DOI 10.1152/ajpcell.1996.270.5.C1544; HELLIWELL PS, 1994, ANN RHEUM DIS, V53, P726, DOI 10.1136/ard.53.11.726; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Kleinbaum DG, 2008, APPL REGRESSION ANAL, P114; Lansdell KA, 1998, J PHYSIOL-LONDON, V508, P379, DOI 10.1111/j.1469-7793.1998.379bq.x; Lansdell KA, 1998, J PHYSIOL-LONDON, V512, P751, DOI 10.1111/j.1469-7793.1998.751bd.x; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mendes F, 2005, CELL PHYSIOL BIOCHEM, V16, P281, DOI 10.1159/000089857; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Pollet JF, 2000, BBA-MOL BASIS DIS, V1500, P59, DOI 10.1016/S0925-4439(99)00088-5; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; RICH DP, 1993, RECEPTOR CHANNEL, V1, P221; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; SHEPPARD DN, 1995, EMBO J, V14, P876, DOI 10.1002/j.1460-2075.1995.tb07069.x; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; WARD CL, 1994, J BIOL CHEM, V269, P25710; Welsh MJ, 2001, METABOLIC MOL BASES, P5121	48	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27033	27044		10.1074/jbc.M110.120352	http://dx.doi.org/10.1074/jbc.M110.120352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551307	Green Published, hybrid			2022-12-25	WOS:000281172700035
J	Drury, JE; Mindnich, R; Penning, TM				Drury, Jason E.; Mindnich, Rebekka; Penning, Trevor M.			Characterization of Disease-related 5 beta-Reductase (AKR1D1) Mutations Reveals Their Potential to Cause Bile Acid Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDO-KETO REDUCTASE; HUMAN DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; CRYSTAL-STRUCTURE; GENE ANALYSIS; SRD5B1 AKR1D1; SUPERFAMILY; METABOLISM; RECEPTOR; BINDING	Bile acid deficiency is a serious syndrome in newborns that can result in death if untreated. 5 beta-Reductase deficiency is one form of bile acid deficiency and is characterized by dramatically decreased levels of physiologically active 5 beta-reduced bile acids. AKR1D1 (aldo-keto reductase 1D1) is the only known human enzyme that stereo-specifically reduces the Delta(4) double bond in 3-keto steroids and sterols to yield the 5 beta-hydrogenated product. Analysis of the AKR1D1 gene in five patients with 5 beta-reductase deficiency revealed five different mutations resulting in an amino acid substitution in the protein. To investigate a causal role for these observed point mutations in AKR1D1 in 5 beta-reductase deficiency, we characterized their effect on enzymatic properties. Attempts to purify mutant enzymes by overexpression in Escherichia coli only yielded sufficient amounts of the P133R mutant for further characterization. This enzyme displayed a highly reduced K-m and V-max reminiscent of uncompetitive kinetics with 4-cholesten-7 alpha-ol-3-one as substrate. In addition, this mutant displayed no change in cofactor affinity but was more thermolabile in the absence of NADPH as judged by CD spectroscopy. All mutants were compared following expression in HEK 293 cells. Although these enzymes were equally expressed based on mRNA levels, protein expression and functional activity were dramatically reduced. Cycloheximide treatment also revealed that several of the expressed mutants were less stable. Our findings show that the reported mutations in AKR1D1 in patients with 5 beta-reductase lead to significantly decreased levels of active enzyme and could be causal in the development of bile acid deficiency syndrome.	[Drury, Jason E.; Mindnich, Rebekka; Penning, Trevor M.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Penning, Trevor M.] Univ Penn, Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Penning, TM (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@upenn.edu			National Institutes of Health [R01-DK47015, P30 ES013508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK47015 and P30 ES013508 (to T. M. P.).	Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; CLAYTON PT, 1988, LANCET, V1, P1283; DESLYPERE JP, 1992, MOL CELL ENDOCRINOL, V88, P15, DOI 10.1016/0303-7207(92)90004-P; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Faucher F, 2008, BIOCHEMISTRY-US, V47, P8261, DOI 10.1021/bi800572s; Gonzales E, 2004, J HEPATOL, V40, P716, DOI 10.1016/j.jhep.2003.12.024; ICHIMIYA H, 1991, J LIPID RES, V32, P829; Inoue T, 1997, ARCH DIS CHILD-FETAL, V77, pF52, DOI 10.1136/fn.77.1.F52; Jez JM, 1998, BIOCHEMISTRY-US, V37, P9695, DOI 10.1021/bi980294p; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r; Kimura A, 1998, EUR J PEDIATR, V157, P386, DOI 10.1007/s004310050835; Komoto J, 2004, BIOCHEMISTRY-US, V43, P2188, DOI 10.1021/bi036046x; KONDO KH, 1994, EUR J BIOCHEM, V219, P357, DOI 10.1111/j.1432-1033.1994.tb19947.x; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Palermo M, 2008, STEROIDS, V73, P417, DOI 10.1016/j.steroids.2007.12.001; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Ratnam K, 1999, BIOCHEMISTRY-US, V38, P7856, DOI 10.1021/bi982838t; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SETCHELL KDR, 1988, J CLIN INVEST, V82, P2148, DOI 10.1172/JCI113837; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Sumazaki R, 1997, LANCET, V349, P329, DOI 10.1016/S0140-6736(05)62828-0; Ueki I, 2009, J GASTROEN HEPATOL, V24, P776, DOI 10.1111/j.1440-1746.2008.05669.x; Wright AS, 1996, J CLIN INVEST, V98, P2558, DOI 10.1172/JCI119074	29	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24529	24537		10.1074/jbc.M110.127779	http://dx.doi.org/10.1074/jbc.M110.127779			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522910	Green Published, hybrid			2022-12-25	WOS:000280542100025
J	Kiefel, H; Bondong, S; Erbe-Hoffmann, N; Hazin, J; Riedle, S; Wolf, J; Pfeifer, M; Arlt, A; Schafer, H; Muerkoster, SS; Altevogt, P				Kiefel, H.; Bondong, S.; Erbe-Hoffmann, N.; Hazin, J.; Riedle, S.; Wolf, J.; Pfeifer, M.; Arlt, A.; Schaefer, H.; Mueerkoester, S. Sebens; Altevogt, P.			L1CAM-integrin interaction induces constitutive NF-kappa B activation in pancreatic adenocarcinoma cells by enhancing IL-1 beta expression	ONCOGENE			English	Article						pancreatic tumour; L1CAM signalling; integrins	ADHESION MOLECULE L1; INTEGRIN-LINKED KINASE; CARCINOMA-CELLS; PRESENILIN/GAMMA-SECRETASE; THERAPEUTIC ANTIBODIES; MALIGNANT-MELANOMA; OVARIAN CARCINOMAS; COLORECTAL-CANCER; GENE-EXPRESSION; MIGRATION	L1 cell adhesion molecule (L1CAM) overexpression is often associated with bad prognosis in various human carcinomas. Recent studies also suggest a role of L1CAM in pancreatic ductal adenocarcinomas (PDAC). To further address its contribution, we expressed functional domains of L1CAM in PT45-P1 PDAC cells. We found that L1CAM that is full length (L1-FL), but neither the soluble ectodomain (L1ecto) nor the cytoplasmic part (L1cyt), could enhance cell proliferation or tumour growth in mice. Expression of L1-FL resulted in constitutive activation of NF-kappa B, which was abolished by L1CAM knockdown. We showed that the expression of IL-1 beta was selectively upregulated by L1-FL, and increased IL-1 beta levels were instrumental for sustained NF-kappa B activation. IL-1 beta production and NF-kappa B activation were abolished by knockdown of alpha 5-integrin and integrin-linked kinase, but insensitive to depletion of L1CAM cleavage proteinases. Supporting these data, PT45-P1 cells transduced with an L1CAM mutant deficient in integrin binding (L1-RGE) did not support the described L1-FL functions. Our results suggest that membranous L1CAM interacts with RGD-binding integrins, leading to sustained NF-kappa B activation by IL-1 beta production and autocrine/paracrine signalling. The unravelling of this novel mechanism sheds new light on the important role of L1CAM expression in PDAC cells. Oncogene (2010) 29, 4766-4778; doi:10.1038/onc.2010.230; published online 14 June 2010	[Kiefel, H.; Bondong, S.; Erbe-Hoffmann, N.; Hazin, J.; Riedle, S.; Wolf, J.; Pfeifer, M.; Altevogt, P.] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Arlt, A.; Schaefer, H.; Mueerkoester, S. Sebens] Univ Kiel, Clin Internal Med, Lab Mol Gastroenterol & Hepatol, Kiel, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Kiel	Altevogt, P (corresponding author), German Canc Res Ctr, D015,Neuenheimer Feld 280, D-69120 Baden Wurtemberg, Germany.	P.Altevogt@dkfz.de	Schäfer, Heiner/C-1055-2011; Arlt, Alexander/G-7308-2019; Sebens, Susanne/C-1222-2010	Arlt, Alexander/0000-0002-6160-1059; 	Deutsche Krebshilfe (Schwerpunktprogramm: Invasion and Migration); Deutsche Forschungsgemeinschaft [SE-1831/2-1]; EU [PE-14034]; Medigene Inc. (Munich)	Deutsche Krebshilfe (Schwerpunktprogramm: Invasion and Migration)(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); Medigene Inc. (Munich)	We acknowledge the competent help of Dr Alex Stoeck (University of Michigan, Ann Arbor) in retroviral expression in the early phase of the study. We also thank Ramona Straub and Dagmar Leisner for excellent technical assistance. This study was supported by grants from Deutsche Krebshilfe (Schwerpunktprogramm: Invasion and Migration), the Deutsche Forschungsgemeinschaft project nr. SE-1831/2-1 to S.S. and the EU-FP6 framework program OVCAD project nr. PE-14034 to PA. Further financial support was received from a collaborative research grant from Medigene Inc. (Munich) to PA.	Arlt A, 2002, CANCER RES, V62, P910; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Boo YJ, 2007, ANN SURG ONCOL, V14, P1703, DOI 10.1245/s10434-006-9281-8; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Fogel M, 2003, LANCET, V362, P869, DOI 10.1016/S0140-6736(03)14342-5; Fogel M, 2003, CANCER LETT, V189, P237, DOI 10.1016/S0304-3835(02)00513-X; Gast D, 2008, ONCOGENE, V27, P1281, DOI 10.1038/sj.onc.1210747; Gast D, 2005, INT J CANCER, V115, P658, DOI 10.1002/ijc.20869; Gast D, 2008, EXP CELL RES, V314, P2411, DOI 10.1016/j.yexcr.2008.04.004; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; Gouveia RM, 2008, J BIOL CHEM, V283, P28038, DOI 10.1074/jbc.M804991200; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Issa Y, 2009, J MOL MED, V87, P99, DOI 10.1007/s00109-008-0410-7; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kaifi JT, 2007, MODERN PATHOL, V20, P1183, DOI 10.1038/modpathol.3800955; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Maddaluno L, 2009, J EXP MED, V206, P623, DOI 10.1084/jem.20081211; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Meier F, 2006, INT J CANCER, V119, P549, DOI 10.1002/ijc.21880; Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Muerkoester SS, 2009, INT J ONCOL, V34, P243, DOI 10.3892/ijo_00000146; Muerkoster S, 2005, CANCER RES, V65, P1316, DOI 10.1158/0008-5472.CAN-04-1626; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Novak-Hofer I, 2008, CANCER LETT, V261, P193, DOI 10.1016/j.canlet.2007.11.012; Oleszewski M, 1999, J BIOL CHEM, V274, P24602, DOI 10.1074/jbc.274.35.24602; Primiano T, 2003, CANCER CELL, V4, P41, DOI 10.1016/S1535-6108(03)00169-7; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Reidy M, 2006, J BIOMED MATER RES A, V77A, P542, DOI 10.1002/jbm.a.30590; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Ruppert M, 1995, J CELL BIOL, V131, P1881, DOI 10.1083/jcb.131.6.1881; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Schniewind B, 2007, ONCOGENE, V26, P4850, DOI 10.1038/sj.onc.1210272; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Stoeck A, 2006, CANCER LETT, V239, P212, DOI 10.1016/j.canlet.2005.08.005; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Thies A, 2002, EUR J CANCER, V38, P1708, DOI 10.1016/S0959-8049(02)00105-3; Wolterink S, 2010, CANCER RES, V70, P2504, DOI 10.1158/0008-5472.CAN-09-3730	47	49	53	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	34					4766	4778		10.1038/onc.2010.230	http://dx.doi.org/10.1038/onc.2010.230			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	643VB	20543863				2022-12-25	WOS:000281326400003
J	Talotta, F; Mega, T; Bossis, G; Casalino, L; Basbous, J; Jariel-Encontre, I; Piechaczyk, M; Verde, P				Talotta, F.; Mega, T.; Bossis, G.; Casalino, L.; Basbous, J.; Jariel-Encontre, I.; Piechaczyk, M.; Verde, P.			Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein	ONCOGENE			English	Article						c-Jun stability; FRA-1; heterodimerization; RAS transformation	TRANSCRIPTIONAL ACTIVATION; PROTEASOMAL DEGRADATION; THYROID-CELLS; AP-1; FOS; PHOSPHORYLATION; JNK; UBIQUITINATION; TRANSFORMATION; INVASIVENESS	Multiple tumorigenic pathways converge on the activating protein-1 (AP-1) family of dimeric transcription complexes by affecting transcription, mRNA decay, posttranslational modifications, as well as stability of its JUN and FOS components. Several mechanisms have been implicated in the phosphorylation-and ubiquitylation-dependent control of c-Jun protein stability. Although its dimer composition has a major role in the regulation of AP-1, little is known about the influence of heterodimerization partners on the half-life of c-Jun. The FOS family member Fra-1 is overexpressed in various tumors and cancer cell lines wherein it controls motility, invasiveness, cell survival and cell division. Oncogene-induced accumulation of Fra-1 results from both increased transcription and phosphorylation-dependent stabilization of the protein. In this report, we describe a novel role of Fra-1 as a posttranslational regulator of c-Jun. By using both constitutively and inducible transformed rat thyroid cell lines, we found that c-Jun is stabilized in response to RAS oncoprotein expression. This stabilization requires the activity of the extracellular signal-related kinase (ERK) pathway, along with c-Jun heterodimerization with Fra-1. In particular, heterodimerization with Fra-1 inhibits c-Jun breakdown by a mechanism dependent on the phosphorylation of the Fra-1 C-terminal domain that positively controls the stability of the protein in response to ERK signaling. Therefore, Fra-1 modulates AP-1 dimer composition by promoting the accumulation of c-Jun in response to oncogenic RAS signaling. Oncogene (2010) 29, 4732-4740; doi:10.1038/onc.2010.211; published online 14 June 2010	[Talotta, F.; Mega, T.; Casalino, L.; Verde, P.] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80131 Naples, Italy; [Bossis, G.; Basbous, J.; Jariel-Encontre, I.; Piechaczyk, M.] Univ Montpellier I & II, Inst Genet Mol Montpellier, CNRS, UMR 5535, Montpellier, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Verde, P (corresponding author), CNR, Inst Genet & Biophys A Buzzati Traverso, I-80131 Naples, Italy.	verde@igb.cnr.it	Basbous, Jihane/AAQ-2040-2021; Casalino, Laura/C-1506-2015; PIECHACZYK, Marc/E-7896-2013; Bossis, Guillaume/C-7172-2012	Basbous, Jihane/0000-0002-3943-627X; Casalino, Laura/0000-0002-2557-0443; PIECHACZYK, Marc/0000-0003-1367-2597; bossis, guillaume/0000-0002-3349-8250	AIRC (Associazione Italiana per la Ricerca sul Cancro); AICR (Association for International Cancer Research, UK); MIUR (Ministero dell'Istruzione, Universita e Ricerca); INCA; PAI 'Galileo'	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); AICR (Association for International Cancer Research, UK); MIUR (Ministero dell'Istruzione, Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR)); INCA(Institut National du Cancer (INCA) France); PAI 'Galileo'	We thank Roberto Di Lauro for the FRTL-5<SUP>ER-RAS</SUP> cell line, and Dirk Bohmann, Claus Nerlov and Latifa Bakiri for expression vectors encoding various c-Jun derivatives. We also thank Ingram Iaccarino for critical reading of this paper. This work was supported by grants to Pasquale Verde from AIRC (Associazione Italiana per la Ricerca sul Cancro), AICR (Association for International Cancer Research, UK) and PRIN-MIUR (Ministero dell'Istruzione, Universita e Ricerca). Marc Piechaczyk's group is an 'Equipe Labellisee' of the French 'Ligue Nationale contre le Cancer'. Jihane Basbous was supported by an INCA contract. Exchanges between the two laboratories received support of the PAI 'Galileo'.	Adiseshaiah P, 2008, BIOCHEM BIOPH RES CO, V371, P304, DOI 10.1016/j.bbrc.2008.04.063; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Casalino L, 2007, EMBO J, V26, P1878, DOI 10.1038/sj.emboj.7601617; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Debinski W, 2005, MOL CANCER RES, V3, P237; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; ELBAHASSI M, 2004, CLIN EXP METASTAS, V21, P293; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; Fuchs SY, 1999, MOL CELL BIOL, V19, P3289; Fuchs SY, 1996, ONCOGENE, V13, P1531; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; OLIVIERO S, 1992, GENE DEV, V6, P1799, DOI 10.1101/gad.6.9.1799; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; PAPAVASSILIOU AG, 1992, SCIENCE, V258, P1941, DOI 10.1126/science.1470918; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vallone D, 1997, EMBO J, V16, P5310, DOI 10.1093/emboj/16.17.5310; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005	37	24	24	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	33					4732	4740		10.1038/onc.2010.211	http://dx.doi.org/10.1038/onc.2010.211			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20543861				2022-12-25	WOS:000281127400012
J	Perez, LH; Butler, M; Creasey, T; Dzink-Fox, J; Gounarides, J; Petit, S; Ropenga, A; Ryder, N; Smith, K; Smith, P; Parkinson, SJ				Perez, Laurent-Herve; Butler, Matt; Creasey, Tammy; Dzink-Fox, JoAnn; Gounarides, John; Petit, Stephanie; Ropenga, Anna; Ryder, Neil; Smith, Kathryn; Smith, Philip; Parkinson, Scott J.			Direct Bacterial Killing In Vitro by Recombinant Nod2 Is Compromised by Crohn's Disease-Associated Mutations	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CARD15 MUTATIONS; SUSCEPTIBILITY; RECEPTORS; LAMPREY; INNATE	Background: A homeostatic relationship with the intestinal microflora is increasingly appreciated as essential for human health and wellbeing. Mutations in the leucine-rich repeat (LRR) domain of Nod2, a bacterial recognition protein, are associated with development of the inflammatory bowel disorder, Crohn's disease. We investigated the molecular mechanisms underlying disruption of intestinal symbiosis in patients carrying Nod2 mutations. Methodology/Principal Findings: In this study, using purified recombinant LRR domains, we demonstrate that Nod2 is a direct antimicrobial agent and this activity is generally deficient in proteins carrying Crohn's-associated mutations. Wildtype, but not Crohn's-associated, Nod2 LRR domains directly interacted with bacteria in vitro, altered their metabolism and disrupted the integrity of the plasma membrane. Antibiotic activity was also expressed by the LRR domains of Nod1 and other pattern recognition receptors suggesting that the LRR domain is a conserved anti-microbial motif supporting innate cellular immunity. Conclusions/Significance: The lack of anti-bacterial activity demonstrated with Crohn's-associated Nod2 mutations in vitro, supports the hypothesis that a deficiency in direct bacterial killing contributes to the association of Nod2 polymorphisms with the disease.	[Perez, Laurent-Herve; Butler, Matt; Creasey, Tammy; Petit, Stephanie; Ropenga, Anna; Smith, Kathryn; Smith, Philip; Parkinson, Scott J.] Novartis Inst Biomed Res, Gastrointestinal Dis Area, Horsham, W Sussex, England; [Dzink-Fox, JoAnn; Ryder, Neil] Novartis Inst Biomed Res, Infect Dis Area, Cambridge, MA USA	Novartis; Novartis	Perez, LH (corresponding author), Novartis Inst Biomed Res, Gastrointestinal Dis Area, Horsham, W Sussex, England.	Scott.Parkinson@novartis.com	Petit, Stephane/A-6578-2017; Perez, Laurent/ABA-4145-2021	Petit, Stephane/0000-0003-0573-8592; Perez, Laurent/0000-0002-8860-7928	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	Funding: The study was funded by the Novartis Institutes for Biomedical Research which employs all of the authors and supports their research activities. Outside of this influence, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Austin CM, 2008, J INFECT DIS, V197, P1713, DOI 10.1086/588384; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Cameron HL, 2005, J PHARMACOL EXP THER, V314, P214, DOI 10.1124/jpet.105.085373; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Ferguson GP, 1998, J BACTERIOL, V180, P4314, DOI 10.1128/JB.180.16.4314-4318.1998; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lees Charlie W, 2009, Expert Rev Gastroenterol Hepatol, V3, P513, DOI 10.1586/egh.09.45; Lin CY, 2007, METABOLOMICS, V3, P55, DOI 10.1007/s11306-006-0043-1; Meinzer U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002769; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Naser SA, 2005, GASTROENTEROLOGY, V129, P1359, DOI 10.1053/j.gastro.2005.08.042; *NAT COMM CLIN LAB, M7A6 NCCLS; Nuding S, 2006, J MICROBIOL METH, V65, P335, DOI 10.1016/j.mimet.2005.08.004; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pierce ES, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000234; Schafer J, 1996, J PHYS I, V6, P5, DOI 10.1051/jp1:1996129; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	39	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10915	10.1371/journal.pone.0010915	http://dx.doi.org/10.1371/journal.pone.0010915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20531959	Green Submitted, Green Published, gold			2022-12-25	WOS:000278222400010
J	Goven, D; Boutten, A; Lecon-Malas, V; Marchal-Somme, J; Soler, P; Boczkowski, J; Bonay, M				Goven, Delphine; Boutten, Anne; Lecon-Malas, Veronique; Marchal-Somme, Joelle; Soler, Paul; Boczkowski, Jorge; Bonay, Marcel			Induction of Heme Oxygenase-1, Biliverdin Reductase and H-Ferritin in Lung Macrophage in Smokers with Primary Spontaneous Pneumothorax: Role of HIF-1 alpha	PLOS ONE			English	Article							HYPOXIA; EXPRESSION; CELLS; GENE; INFLAMMATION; SMOKING; RISK	Background: Few data concern the pathophysiology of primary spontaneous pneumothorax (PSP), which is associated with alveolar hypoxia/reoxygenation. This study tested the hypothesis that PSP is associated with oxidative stress in lung macrophages. We analysed expression of the oxidative stress marker 4-HNE; the antioxidant and anti-inflammatory proteins heme oxygenase-1 (HO-1), biliverdin reductase (BVR) and heavy chain of ferritin (H-ferritin); and the transcription factors controlling their expression Nrf2 and HIF-1 alpha, in lung samples from smoker and nonsmoker patients with PSP (PSP-S and PSP-NS), cigarette smoke being a risk factor of recurrence of the disease. Methodology/Principal Findings: mRNA was assessed by RT-PCR and proteins by western blot, immunohistochemistry and confocal laser analysis. 4-HNE, HO-1, BVR and H-ferritin were increased in macrophages from PSP-S as compared to PSP-NS and controls (C). HO-1 increase was associated with increased expression of HIF-1 alpha mRNA and protein in alveolar macrophages in PSP-S patients, whereas Nrf2 was not modified. To understand the regulation of HO-1, BVR and H-ferritin, THP-1 macrophages were exposed to conditions mimicking conditions in C, PSP-S and PSP-NS patients: cigarette smoke condensate (CS) or air exposure followed or not by hypoxia/reoxygenation. Silencing RNA experiments confirmed that HIF-1 alpha nuclear translocation was responsible for HO-1, BVR and H-ferritin induction mediated by CS and hypoxia/reoxygenation. Conclusions/Significance: PSP in smokers is associated with lung macrophage oxidative stress. The response to this condition involves HIF-1 alpha-mediated induction of HO-1, BVR and H-ferritin.	[Goven, Delphine; Boutten, Anne; Marchal-Somme, Joelle; Soler, Paul; Bonay, Marcel] Univ Denis Diderot Paris 7, INSERM, U700, Fac Med Site Bichat, Paris, France; [Boutten, Anne; Lecon-Malas, Veronique] Hop Bichat Claude Bernard, AP HP, Serv Biochim, F-75877 Paris, France; [Boczkowski, Jorge] Ctr Invest Clin 007, Paris, France; [Boczkowski, Jorge] Grp Hosp Univ Albert Chenevier Henri Mondor, Fac Med, INSERM, U955, Creteil, France; [Boczkowski, Jorge] Univ Paris 12, Fac Med, Creteil, France; [Bonay, Marcel] Hop Bichat Claude Bernard, AP HP, Serv Physiol Explorat Fonct, F-75877 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Goven, D (corresponding author), Univ Denis Diderot Paris 7, INSERM, U700, Fac Med Site Bichat, Paris, France.	marcel.bonay@bch.aphp.fr	Boczkowski, Jorge/S-7474-2018; Bonay, Marcel/ABG-2039-2020	Boczkowski, Jorge/0000-0001-6619-5785; Bonay, Marcel/0000-0003-1446-7456	Subvention de Recherche en Pneumologie, Appel d'Offre Automne, Societe de Pneumologie de Langue Francaise (SPLF); Societe de Pneumologie de Langue Francaise (SPLF)	Subvention de Recherche en Pneumologie, Appel d'Offre Automne, Societe de Pneumologie de Langue Francaise (SPLF); Societe de Pneumologie de Langue Francaise (SPLF)	Funding was provided by Subvention de Recherche en Pneumologie, Appel d'Offre Automne 2008, Societe de Pneumologie de Langue Francaise (SPLF), http://www.splf.org/s/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2007, AM J PHYSIOL-LUNG C, V293, pL170, DOI 10.1152/ajplung.00445.2006; Atzori L, 2004, RESP MED, V98, P530, DOI 10.1016/j.rmed.2003.11.007; BENSE L, 1987, CHEST, V92, P1009, DOI 10.1378/chest.92.6.1009; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Bonay Marcel, 2005, BMC Pulm Med, V5, P13, DOI 10.1186/1471-2466-5-13; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; Bouvry D, 2006, AM J RESP CELL MOL, V35, P519, DOI 10.1165/rcmb.2005-0478OC; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Cottin V, 1998, EUR RESPIR J, V12, P702, DOI 10.1183/09031936.98.12030702; De Smedt A, 2004, EUR RESPIR J, V23, P896, DOI 10.1183/09031936.04.00079304; Fields WR, 2005, TOXICOL SCI, V86, P84, DOI 10.1093/toxsci/kfi179; Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010; Hashiba T, 2001, GENE THER, V8, P1499, DOI 10.1038/sj.gt.3301540; Hisada T, 2000, EUR J PHARMACOL, V399, P229, DOI 10.1016/S0014-2999(00)00369-1; Jia YX, 1999, INT ARCH ALLERGY IMM, V120, P141, DOI 10.1159/000024232; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Knowles HJ, 2006, CANCER RES, V66, P2600, DOI 10.1158/0008-5472.CAN-05-2351; Lee DW, 2006, CURR MOL MED, V6, P883, DOI 10.2174/156652406779010849; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Li B, 2008, J BIOCHEM, V144, P643, DOI 10.1093/jb/mvn115; LIPPERT HL, 1991, EUR RESPIR J, V4, P324; Maestrelli P, 2001, AM J RESP CRIT CARE, V164, P1508, DOI 10.1164/ajrccm.164.8.2011083; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; MOLLIEX S, 1994, ANESTHESIOLOGY, V81, P668, DOI 10.1097/00000542-199409000-00021; Ning XH, 2007, AM J PHYSIOL-HEART C, V292, pH333, DOI 10.1152/ajpheart.00078.2006; Otterbein LE, 1999, J CLIN INVEST, V103, P1047, DOI 10.1172/JCI5342; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Sahn SA, 2000, NEW ENGL J MED, V342, P868, DOI 10.1056/NEJM200003233421207; Schramel FMNH, 1997, EUR RESPIR J, V10, P1372, DOI 10.1183/09031936.97.10061372; Smit HJM, 1999, RESP MED, V93, P262, DOI 10.1016/S0954-6111(99)90022-7; Subotic D, 2005, MED HYPOTHESES, V64, P1144, DOI 10.1016/j.mehy.2004.12.012; Tabakoglu E, 2004, MEDIAT INFLAMM, V13, P209, DOI 10.1080/09511920410001713475; Walmsley SR, 2008, AM J RESP CELL MOL, V38, P251, DOI 10.1165/rcmb.2007-0331TR; Zeng R, 2008, J AM SOC NEPHROL, V19, P380, DOI 10.1681/ASN.2006111194	39	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10886	10.1371/journal.pone.0010886	http://dx.doi.org/10.1371/journal.pone.0010886			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526373	Green Published, gold			2022-12-25	WOS:000278222100015
J	Shang, H; Zhong, P; Liu, J; Han, XX; Dai, D; Zhang, M; Zhao, K; Xu, RZ; Yu, XF				Shang, Hong; Zhong, Ping; Liu, Jing; Han, Xiaoxu; Dai, Di; Zhang, Min; Zhao, Ke; Xu, Rongzhen; Yu, Xiao-Fang			High Prevalence and Genetic Diversity of HCV among HIV-1 Infected People from Various High-Risk Groups in China	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; CIRCULATING RECOMBINANT; ANTIRETROVIRAL THERAPY; TYPE-1 GENOME; HEROIN USERS; BLOOD-DONORS; NON-A; HIV	Background: Co-infection with HIV-1 and HCV is a significant global public health problem and a major consideration for anti-HIV-1 treatment. HCV infection among HIV-1 positive people who are eligible for the newly launched nationwide anti-HIV-1 treatment program in China has not been well characterized. Methodology: A nationwide survey of HIV-1 positive injection drug uses (IDU), former paid blood donors (FBD), and sexually transmitted cases from multiple provinces including the four most affected provinces in China was conducted. HCV prevalence and genetic diversity were determined. We found that IDU and FBD have extremely high rates of HCV infection (97% and 93%, respectively). Surprisingly, people who acquired HIV-1 through sexual contact also had a higher rate of HCV infection (20%) than the general population. HIV-1 subtype and HCV genotypes were amazingly similar among FBD from multiple provinces stretching from Central to Northeast China. However, although patterns of overland trafficking of heroin and distinct HIV-1 subtypes could be detected among IDU, HCV genotypes of IDU were more diverse and exhibited significant regional differences. Conclusion: Emerging HIV-1 and HCV co-infection and possible sexual transmission of HCV in China require urgent prevention measures and should be taken into consideration in the nationwide antiretroviral treatment program.	[Shang, Hong; Liu, Jing; Han, Xiaoxu; Dai, Di; Zhang, Min] China Med Univ, Hosp 1, Minist Hlth, Key Lab AIDS Immunol, Shenyang, Liaoning, Peoples R China; [Zhong, Ping] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Zhao, Ke; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Ctr Virus & AIDS Res, Changchun, Jilin, Peoples R China; [Zhao, Ke; Yu, Xiao-Fang] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Xu, Rongzhen] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	China Medical University; Shanghai Center for Disease Control & Prevention; Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Zhejiang University	Shang, H (corresponding author), China Med Univ, Hosp 1, Minist Hlth, Key Lab AIDS Immunol, Shenyang, Liaoning, Peoples R China.	hongshang100@hotmail.com; xfyu@jhsph.edu			11th Five-Year Plan [2008ZX10001-001]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016540] Funding Source: NIH RePORTER	11th Five-Year Plan(National Key Technology R&D Program); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the 11th Five-Year Plan (2008ZX10001-001), mega-projects of national science research for the tenth five-years-project on tackling key problems of national science and technology (2004BA719A12), application research program of prevention and control of AIDS by the Ministry of Health (WA2006-02), and Program of the innovative group of institution of higher education by the Education Department of Liaoning Province (2008T202). This work was also supported in part by NIH grant DA016540 (X.F. Yu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Bonacini M, 1999, J VIRAL HEPATITIS, V6, P203, DOI 10.1046/j.1365-2893.1999.00153.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Garten RJ, 2008, WORLD J GASTROENTERO, V14, P1878, DOI 10.3748/wjg.14.1878; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Noppornpath S, 2008, J GEN VIROL, V89, P1276, DOI 10.1099/vir.0.83593-0; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Ragni MV, 2001, J INFECT DIS, V183, P1112, DOI 10.1086/319273; Sabin CA, 1997, J INFECT DIS, V175, P164, DOI 10.1093/infdis/175.1.164; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sulkowski MS, 2007, J VIRAL HEPATITIS, V14, P371, DOI 10.1111/j.1365-2893.2006.00816.x; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; SUN XH, 1994, AIDS, V8, pS55; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Thomas DL, 2008, ANNU REV MED, V59, P473, DOI 10.1146/annurev.med.59.081906.081110; WANG Y, 1994, J HEPATOL, V21, P634, DOI 10.1016/S0168-8278(94)80112-6; Wang YZ, 2009, J CLIN VIROL, V44, P195, DOI 10.1016/j.jcv.2008.12.009; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xia XS, 2008, J MED VIROL, V80, P1740, DOI 10.1002/jmv.21287; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhao Shu-Ming, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P676; 马现君, 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P733	36	30	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10631	10.1371/journal.pone.0010631	http://dx.doi.org/10.1371/journal.pone.0010631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523729	gold, Green Published, Green Submitted			2022-12-25	WOS:000278221900002
J	Fisher, Y; Nemirovsky, A; Baron, R; Monsonego, A				Fisher, Yair; Nemirovsky, Anna; Baron, Rona; Monsonego, Alon			T Cells Specifically Targeted to Amyloid Plaques Enhance Plaque Clearance in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INTERFERON-GAMMA; A-BETA; IFN-GAMMA; CEREBRAL-HEMORRHAGE; NASAL VACCINATION; IMMUNE INVASION; TRANSGENIC MICE; ANIMAL-MODEL; IMMUNIZATION	Patients with Alzheimer's disease (AD) exhibit substantial accumulation of amyloid-beta (A beta) plaques in the brain. Here, we examine whether A beta vaccination can facilitate the migration of T lymphocytes to specifically target A beta plaques and consequently enhance their removal. Using a new mouse model of AD, we show that immunization with A beta, but not with the encephalitogenic proteolipid protein (PLP), results in the accumulation of T cells at A beta plaques in the brain. Although both A beta-reactive and PLP-reactive T cells have a similar phenotype of Th1 cells secreting primarily IFN-gamma, the encephalitogenic T cells penetrated the spinal cord and caused experimental autoimmune encephalomyelitis (EAE), whereas A beta T cells accumulated primarily at A beta plaques in the brain but not the spinal cord and induced almost complete clearance of A beta. Furthermore, while a single vaccination with A beta resulted in upregulation of the phagocytic markers triggering receptors expressed on myeloid cells-2 (TREM2) and signal regulatory protein-beta 1 (SIRP beta 1) in the brain, it caused downregulation of the proinflammatory cytokines TNF-alpha and IL-6. We thus suggest that A beta deposits in the hippocampus area prioritize the targeting of A beta-reactive but not PLP-reactive T cells upon vaccination. The stimulation of A beta-reactive T cells at sites of A beta plaques resulted in IFN-gamma-induced chemotaxis of leukocytes and therapeutic clearance of A beta.	[Fisher, Yair] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Fisher, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel.	alonmon@bgu.ac.il			Israel Science Foundation (ISF) [846/05]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by the Israel Science Foundation (ISF 846/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, J NEUROSCI, V25, P8217, DOI 10.1523/JNEUROSCI.1859-05.2005; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; BOCHE D, 2008, BRAIN; Buckwalter MS, 2006, J NEUROSCI, V26, P11437, DOI 10.1523/JNEUROSCI.2436-06.2006; Burbach GJ, 2006, NEUROBIOL AGING; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; BUTOVSKY O, 2005, MOL CELL NEUROSCI; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; de Rosbo NK, 1998, J AUTOIMMUN, V11, P287, DOI 10.1006/jaut.1998.0202; Doak C, 2008, FASEB J, V22; Ercolini AM, 2006, J IMMUNOL, V176, P3293, DOI 10.4049/jimmunol.176.6.3293; FRANK MG, 2005, NEUROBIOL AGING; Frenkel D, 2005, J NEUROL SCI, V233, P125, DOI 10.1016/j.jns.2005.03.022; Frenkel D, 2005, J CLIN INVEST, V115, P2423, DOI 10.1172/JCI23241; Frenkel D, 2003, J IMMUNOL, V171, P6549, DOI 10.4049/jimmunol.171.12.6549; Frenkel D, 2000, P NATL ACAD SCI USA, V97, P11455, DOI 10.1073/pnas.97.21.11455; Gaikwad S, 2009, AM J PATHOL, V175, P2528, DOI 10.2353/ajpath.2009.090147; Gao X, 2000, MOL CELL NEUROSCI, V16, P338, DOI 10.1006/mcne.2000.0883; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hohlfeld R, 2006, NEUROL SCI, V27, pS1, DOI 10.1007/s10072-006-0537-7; Hohlfeld R, 2001, CURR OPIN NEUROL, V14, P299, DOI 10.1097/00019052-200106000-00006; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holmoy T, 2008, EUR J NEUROL, V15, P360, DOI 10.1111/j.1468-1331.2008.02065.x; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; Lee J, 2006, J NEUROSCI RES, V83, P1552, DOI 10.1002/jnr.20831; Maier M, 2006, J NEUROSCI, V26, P4717, DOI 10.1523/JNEUROSCI.0381-06.2006; Mastrangelo MA, 2009, AM J PATHOL, V175, P2076, DOI 10.2353/ajpath.2009.090059; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monsonego A, 2006, P NATL ACAD SCI USA, V103, P5048, DOI 10.1073/pnas.0506209103; Monsonego A, 2003, J CLIN INVEST, V112, P415, DOI 10.1172/JCI200318104; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Renno T, 1998, MOL CELL NEUROSCI, V12, P376, DOI 10.1006/mcne.1998.0725; Rosenmann H, 2008, EXP NEUROL, V212, P71, DOI 10.1016/j.expneurol.2008.03.007; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Shankar GM, 2008, NAT MED; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Wheeler RD, 2006, IMMUNOLOGY, V118, P527, DOI 10.1111/j.1365-2567.2006.02395.x; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zota V, 2009, J IMMUNOL, V183, P3522, DOI 10.4049/jimmunol.0900620	63	60	64	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10830	10.1371/journal.pone.0010830	http://dx.doi.org/10.1371/journal.pone.0010830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520819	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221500016
J	Kovacs, E; Harmat, V; Toth, J; Vertessy, BG; Modos, K; Kardos, J; Liliom, K				Kovacs, Erika; Harmat, Veronika; Toth, Judit; Vertessy, Beata G.; Modos, Karoly; Kardos, Jozsef; Liliom, Karoly			Structure and mechanism of calmodulin binding to a signaling sphingolipid reveal new aspects of lipid-protein interactions	FASEB JOURNAL			English	Article						X-ray crystallography; isothermal titration calorimetry; stopped flow; lipid binding; calcium signaling	IN-VITRO; SPHINGOSYLPHOSPHORYLCHOLINE; RELEASE; RECOGNITION; MODULATION; BRAIN	Lipid-protein interactions are rarely characterized at a structural molecular level due to technical difficulties; however, the biological significance of understanding the mechanism of these interactions is outstanding. In this report, we provide mechanistic insight into the inhibitory complex formation of the lipid mediator sphingosylphosphorylcholine with calmodulin, the most central and ubiquitous regulator protein in calcium signaling. We applied crystallographic, thermodynamic, kinetic, and spectroscopic approaches using purified bovine calmodulin and bovine cerebral microsomal fraction to arrive at our conclusions. Here we present 1) a 1.6-angstrom resolution crystal structure of their complex, in which the sphingolipid occupies the conventional hydrophobic binding site on calmodulin; 2) a peculiar stoichiometry-dependent binding process: at low or high protein-to-lipid ratio calmodulin binds lipid micelles or a few lipid molecules in a compact globular conformation, respectively, and 3) evidence that the sphingolipid displaces calmodulin from its targets on cerebral microsomes. We have ascertained the specificity of the interaction using structurally related lipids as controls. Our observations reveal the structural basis of selective calmodulin inhibition by the sphingolipid. On the basis of the crystallographic and biophysical characterization of the calmodulin-sphingosylphosphorylcholine interaction, we propose a novel lipid-protein binding model, which might be applicable to other interactions as well.-Kovacs, E., Harmat, V., Toth, J., Vertessy, B. G., Modos, K., Kardos, J., Liliom, K. Structure and mechanism of calmodulin binding to a signaling sphingolipid reveal new aspects of lipid-protein interactions. FASEB J. 24, 3829-3839 (2010). www.fasebj.org	[Kovacs, Erika; Toth, Judit; Vertessy, Beata G.; Liliom, Karoly] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1113 Budapest, Hungary; [Harmat, Veronika] Eotvos Lorand Univ, Lab Struct Chem & Biol, Inst Chem, Budapest, Hungary; [Kardos, Jozsef] Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary; [Harmat, Veronika] Eotvos Lorand Univ, Prot Modelling Res Grp, Hungarian Acad Sci, Budapest, Hungary; [Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol, H-1117 Budapest, Hungary; [Modos, Karoly] Semmelweis Univ, Inst Biophys & Radiat Biol, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Budapest University of Technology & Economics; Semmelweis University	Kovacs, E (corresponding author), Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Karolina Ut 29, H-1113 Budapest, Hungary.	kovacs@enzim.hu; liliom@enzim.hu	Liliom, Karoly/A-6563-2011; Kardos, József/J-1035-2017; Vertessy, Beata G/H-6202-2012; Harmat, Veronika/B-8033-2016	Liliom, Karoly/0000-0002-7177-6872; Kardos, József/0000-0002-2135-2932; Harmat, Veronika/0000-0002-1866-9904; Vertessy, Beata G./0000-0002-1288-2982	Hungarian Scientific Research Fund OTKA [61501, 67800, 67937, 72973, 68464, 81950, 72008, 68229, 78646]; U.S. National Institutes of Health [1R01TW008130-01]; Howard Hughes Medical Institutes [55000342]; EU [LSHG-CT-2006-031220]; Bolyai Fellowship; FOGARTY INTERNATIONAL CENTER [R01TW008130] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institutes(Howard Hughes Medical Institute); EU(European Commission); Bolyai Fellowship(Hungarian Academy of Sciences); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors thank the European Synchrotron Radiation Facility for provision of synchrotron radiation facilities, and Juan Sanchez Weatherby for assistance in using beamline ID23-1. The authors thank Dr. Ferenc Tolgyesi and the Institute of Biophysics and Radiation Biology, Semmelweis University, for providing the instrumentation for calorimetry experiments. This work was supported by the Hungarian Scientific Research Fund OTKA (grants 61501 to K.L.; 67800, 67937, and 72973 to V.H.; 68464 and 81950 to J.K.; 72008 to J.T.; and 68229 and 78646 to B.G.V.), the U.S. National Institutes of Health (grant 1R01TW008130-01 to J.T.), the Howard Hughes Medical Institutes (grant 55000342 to B.G.V.), and the EU (FP6 SPINE2c LSHG-CT-2006-031220 to B.G.V.). J.T. is a recipient of the Bolyai Fellowship.	Abuin EB, 1997, J COLLOID INTERF SCI, V186, P332, DOI 10.1006/jcis.1996.4648; Andersen KK, 2009, J MOL BIOL, V391, P207, DOI 10.1016/j.jmb.2009.06.019; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balshaw DM, 2002, J MEMBRANE BIOL, V185, P1, DOI 10.1007/s00232-001-0111-4; Betto R, 1997, BIOCHEM J, V322, P327, DOI 10.1042/bj3220327; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; BRYAN RK, 1990, FUND THEOR, V39, P221; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Harmat V, 2000, J MOL BIOL, V297, P747, DOI 10.1006/jmbi.2000.3607; Heringdorf DMZ, 2002, BBA-MOL CELL BIOL L, V1582, P178, DOI 10.1016/S1388-1981(02)00154-3; Kovacs E, 2008, BIOCHEM J, V410, P427, DOI 10.1042/BJ20071019; Kovacs E, 2010, J BIOL CHEM, V285, P1799, DOI 10.1074/jbc.M109.053116; LAPORTE DC, 1980, BIOCHEMISTRY-US, V19, P3814, DOI 10.1021/bi00557a025; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, PROTEIN CRYSTALLOGR, V26, P27; Liliom K, 2001, BIOCHEM J, V355, P189, DOI 10.1042/0264-6021:3550189; Lucas JL, 2006, PHARM RES-DORDR, V23, P647, DOI 10.1007/s11095-006-9784-9; Martinez-Luis S, 2007, PHYTOCHEMISTRY, V68, P1882, DOI 10.1016/j.phytochem.2007.02.025; MASSOM L, 1990, BIOCHEMISTRY-US, V29, P671, DOI 10.1021/bi00455a012; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MOLNAR A, 1995, EUR J PHARM-MOLEC PH, V291, P73; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nixon GF, 2008, PROG LIPID RES, V47, P62, DOI 10.1016/j.plipres.2007.11.001; Okamoto R, 2003, J LIPID RES, V44, P93, DOI 10.1194/jlr.M200225-JLR200; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Pal-Gabor H, 2009, BIOCHEMISTRY-US, V48, P5689, DOI 10.1021/bi900356r; Papish AL, 2002, BIOPHYS J, V83, P1455, DOI 10.1016/S0006-3495(02)73916-7; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rodriguez-Lafrasse C, 1999, NEUROCHEM RES, V24, P199, DOI 10.1023/A:1022501702403; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; VOLPE P, 1990, AM J PHYSIOL, V258, pC1077, DOI 10.1152/ajpcell.1990.258.6.C1077; Yoshii N, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2179074	39	7	7	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3829	3839		10.1096/fj.10-155614	http://dx.doi.org/10.1096/fj.10-155614			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20522785	Bronze, Green Published, Green Accepted			2022-12-25	WOS:000285005900021
J	Sha, L; Farrugia, G; Linden, DR; Szurszewski, JH				Sha, L.; Farrugia, G.; Linden, D. R.; Szurszewski, J. H.			The transwall gradient across the mouse colonic circular muscle layer is carbon monoxide dependent	FASEB JOURNAL			English	Article						heme oxygenase-2; interstitial cells of Cajal; smooth muscle; submucosal ganglion neurons	MEMBRANE-POTENTIAL GRADIENT; CANINE PROXIMAL COLON; ELECTRICAL SLOW WAVES; K-CA CHANNELS; SMOOTH-MUSCLE; NITRIC-OXIDE; MYOELECTRIC COMPLEXES; INTERSTITIAL-CELLS; HEME OXYGENASE-2; SMALL-INTESTINE	Gastric and small intestinal circular smooth muscle layers have a transwall resting membrane potential (RMP) gradient that is dependent on release of carbon monoxide (CO) from interstitial cells of Cajal (ICCs). Our aim was to determine whether a RMP gradient exists in the mouse colon and whether the gradient is CO dependent. Microelectrodes were used to record RMPs from muscle cells at different depths of the circular muscle layer from wild-type and heme oxygenase-2-knockout (HO-2-KO) mice. A transwall RMP gradient was present in wild-type mice. The CO scavenger oxyhemoglobin (20 mu M) and the heme oxygenase inhibitor chromium mesoporphyrin IX (CrMP, 5 mu M) abolished the transwall gradient. The gradient was absent in HO-2-KO mice. Tetrodotoxin (1 mu M) caused a significant depolarization in circular smooth muscle cells throughout the circular muscle layer and abolished the transwall gradient. Removal of the submucosal neurons abolished the gradient. The majority of submucosal neurons contained HO-2 immunoreactivity (HO-2-IR), while ICCs did not. These data show for the first time that a transwall gradient exists across the circular smooth muscle layer of the mouse colon, that the gradient is due to CO, and that the source of CO is the submucosal neurons.-Sha, L., Farrugia, G., Linden, D. R., Szurszewski, J. H. The transwall gradient across the mouse colonic circular muscle layer is carbon monoxide dependent. FASEB J. 24, 3840-3849 (2010). www.fasebj.org	[Sha, L.; Farrugia, G.; Linden, D. R.; Szurszewski, J. H.] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN 55905 USA; [Sha, L.; Farrugia, G.; Linden, D. R.; Szurszewski, J. H.] Mayo Clin, Enter NeuroSci Program, Coll Med, Rochester, MN 55905 USA; [Farrugia, G.; Szurszewski, J. H.] Mayo Clin, Div Gastroenterol & Hepatol, Coll Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Szurszewski, JH (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	gijoe@mayo.edu			U.S. National Institutes of Health [NIH DK17238]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017238, R37DK017238] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by U.S. National Institutes of Health grant NIH DK17238. The authors thank Dr. Solomon Snyder (Johns Hopkins University, Baltimore, MD, USA) for providing HO-2-KO mice and the antiserum used in this work. The authors thank Mr. William Harmsen for statistical analysis and Jan Applequist for her help in preparing this manuscript.	Appleton SD, 1999, DRUG METAB DISPOS, V27, P1214; BAUER AJ, 1985, J PHYSIOL-LONDON, V369, P283, DOI 10.1113/jphysiol.1985.sp015901; BAUER AJ, 1985, J PHYSIOL-LONDON, V366, P221, DOI 10.1113/jphysiol.1985.sp015793; BURKE EP, 1991, P NATL ACAD SCI USA, V88, P2370, DOI 10.1073/pnas.88.6.2370; BURKE EP, 1988, AM J PHYSIOL, V254, pC475, DOI 10.1152/ajpcell.1988.254.4.C475; BYWATER RAR, 1989, J PHYSIOL-LONDON, V413, P505, DOI 10.1113/jphysiol.1989.sp017666; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Farrugia G, 2003, P NATL ACAD SCI USA, V100, P8567, DOI 10.1073/pnas.1431233100; FARRUGIA G, 1993, AM J PHYSIOL, V264, pG1184; Flynn ERM, 1999, J PHYSIOL-LONDON, V518, P247, DOI 10.1111/j.1469-7793.1999.0247r.x; HARA Y, 1986, J PHYSIOL-LONDON, V372, P501, DOI 10.1113/jphysiol.1986.sp016022; Ingi T, 1996, NEURON, V16, P835, DOI 10.1016/S0896-6273(00)80103-8; KHARITONOV VG, 1995, P NATL ACAD SCI USA, V92, P2568, DOI 10.1073/pnas.92.7.2568; Liu HJ, 1999, J CLIN INVEST, V103, P963, DOI 10.1172/JCI5206; LIU LWC, 1993, J PHYSIOL-LONDON, V470, P445, DOI 10.1113/jphysiol.1993.sp019868; LYSTER DJK, 1995, GASTROENTEROLOGY, V108, P1371, DOI 10.1016/0016-5085(95)90684-3; NATHANSON JA, 1995, NEURON, V14, P781, DOI 10.1016/0896-6273(95)90222-8; Pasricha PJ, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-21; Piantadosi CA, 2002, NEW ENGL J MED, V347, P1054, DOI 10.1056/NEJMp020104; Piotrowska AP, 2003, J PEDIATR SURG, V38, P73, DOI 10.1053/jpsu.2003.50014; POSS KD, 1995, NEURON, V15, P867, DOI 10.1016/0896-6273(95)90177-9; SERIO R, 1991, AM J PHYSIOL, V260, pG636, DOI 10.1152/ajpgi.1991.260.4.G636; Sha L, 2005, GASTROENTEROLOGY, V128, pA629; Sha L, 2007, AM J PHYSIOL-GASTR L, V293, pG438, DOI 10.1152/ajpgi.00037.2007; Shah V, 2004, GASTROENTEROLOGY, V126, P903, DOI 10.1053/j.gastro.2003.11.046; SMITH TK, 1988, AM J PHYSIOL, V255, pC828, DOI 10.1152/ajpcell.1988.255.6.C828; SMITH TK, 1987, AM J PHYSIOL, V252, pC290, DOI 10.1152/ajpcell.1987.252.3.C290; Spencer NJ, 1998, J AUTONOM NERV SYST, V71, P37, DOI 10.1016/S0165-1838(98)00063-0; Spencer NJ, 1998, NEUROSCI LETT, V250, P153, DOI 10.1016/S0304-3940(98)00461-3; SUZUKI N, 1986, AM J PHYSIOL, V250, pG287; Szurszewski JH, 1987, PHYSL GASTROINTESTIN, P383; Tang XD, 2004, ANNU REV PHYSIOL, V66, P131, DOI 10.1146/annurev.physiol.66.041002.142720; Wang R, 1997, PFLUG ARCH EUR J PHY, V434, P285, DOI 10.1007/s004240050398; Xi Q, 2004, AM J PHYSIOL-HEART C, V286, pH610, DOI 10.1152/ajpheart.00782.2003; Xue L, 2000, P NATL ACAD SCI USA, V97, P1851, DOI 10.1073/pnas.97.4.1851; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848	37	14	14	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2010	24	10					3840	3849		10.1096/fj.10-156232	http://dx.doi.org/10.1096/fj.10-156232			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20543114	Green Published			2022-12-25	WOS:000285005900022
J	Tejero, J; Haque, MM; Durra, D; Stuehr, DJ				Tejero, Jesus; Haque, Mohammad Mahfuzul; Durra, Deborah; Stuehr, Dennis J.			A Bridging Interaction Allows Calmodulin to Activate NO Synthase through a Bi-modal Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; INTRAPROTEIN ELECTRON-TRANSFER; LASER FLASH-PHOTOLYSIS; REDUCTASE DOMAIN; CONFORMATIONAL EQUILIBRIUM; 2-DOMAIN CONSTRUCT; CONTROL ELEMENT; SURFACE-CHARGE; FLOW-THROUGH; CATALYSIS	Calmodulin (CaM) activates the nitric-oxide synthases (NOS) by a mechanism that is not completely understood. A recent crystal structure showed that bound CaM engages in a bridging interaction with the NOS FMN subdomain. We investigated its importance in neuronal NOS (nNOS) by mutating the two residues that primarily create the bridging interaction (Arg(752) in the FMN subdomain and Glu(47) in CaM). Mutations designed to completely destroy the bridging interaction prevented bound CaM from increasing electron flux through the FMN subdomain and diminished the FMN-to-heme electron transfer by 90%, whereas mutations that partly preserve the interaction had intermediate effects. The bridging interaction appeared to control FMN subdomain interactions with both its electron donor (NADPH-FAD subdomain) and electron acceptor (heme domain) partner subdomains in nNOS. We conclude that the Arg(752)-Glu(47) bridging interaction is the main feature that enables CaM to activate nNOS. The mechanism is bi-modal and links a single structural aspect of CaM binding to specific changes in nNOS protein conformational and electron transfer properties that are essential for catalysis.	[Tejero, Jesus; Haque, Mohammad Mahfuzul; Durra, Deborah; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [CA53914, GM51491, HL76491]; American Heart Association [0625632B]; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53914, GM51491, and HL76491 (to D. J. S.) and American Heart Association Postdoctoral Fellowship 0625632B (to J. T.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Feng CJ, 2007, J AM CHEM SOC, V129, P5621, DOI 10.1021/ja068685b; Feng CJ, 2006, BIOCHEMISTRY-US, V45, P6354, DOI 10.1021/bi060223n; Feng CJ, 2009, DALTON T, P6692, DOI 10.1039/b902884f; Feng CJ, 2009, J BIOL INORG CHEM, V14, P133, DOI 10.1007/s00775-008-0431-2; Feng CJ, 2006, J AM CHEM SOC, V128, P3808, DOI 10.1021/ja0578606; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; Guan ZW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.000810; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Jones RJ, 2004, J BIOL CHEM, V279, P36876, DOI 10.1074/jbc.M402808200; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; Newman E, 2004, J BIOL CHEM, V279, P33547, DOI 10.1074/jbc.M403892200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pfeiffer S, 1999, ANGEW CHEM INT EDIT, V38, P1715, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1714::AID-ANIE1714>3.0.CO;2-3; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2000, J BIOL CHEM, V275, P21914, DOI 10.1074/jbc.M002449200; Salerno JC, 2009, FEBS J, V276, P6677, DOI 10.1111/j.1742-4658.2009.07382.x; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Spratt DE, 2006, FEBS J, V273, P1759, DOI 10.1111/j.1742-4658.2006.05193.x; Spratt DE, 2007, BIOCHEMISTRY-US, V46, P8288, DOI 10.1021/bi062130b; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2000, HANDB EXP PHARMACOL, V143, P33; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P6696, DOI 10.1021/bi700339v; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682	53	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25941	25949		10.1074/jbc.M110.126797	http://dx.doi.org/10.1074/jbc.M110.126797			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20529840	Green Published, hybrid			2022-12-25	WOS:000280921000008
J	Haldar, S; Mitra, S; Chattopadhyay, K				Haldar, Shubhasis; Mitra, Samaresh; Chattopadhyay, Krishnananda			Role of Protein Stabilizers on the Conformation of the Unfolded State of Cytochrome c and Its Early Folding Kinetics INVESTIGATION AT SINGLE MOLECULAR RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ACID-BINDING PROTEIN; MAGNETIC CIRCULAR-DICHROISM; X-RAY-SCATTERING; DENATURED STATE; ELECTRON-TRANSFER; EARLY EVENTS; AGGREGATION; ARGININE; MECHANISM	An insight into the conformation and dynamics of unfolded and early intermediate states of a protein is essential to understand the mechanism of its aggregation and to design potent inhibitor molecules. Fluorescence correlation spectroscopy has been used to study the effects of several model protein stabilizers on the conformation of the unfolded state and early folding dynamics of tetramethyl rhodamine-labeled cytochrome c from Saccharomyces cerevisiae at single molecular resolution. Special attention has been given to arginine, which is a widely used stabilizer for improving refolding yield of different proteins. The value of the hydrodynamic radius (r(H)) obtained by analyzing the intensity fluctuations of the diffusing molecules has been found to increase in a two-state manner as the protein is unfolded by urea. The results further show that the presence of arginine and other protein stabilizers favors a relatively structured conformation of the unfolded states (r(H) of 29 angstrom) over an extended one (r(H) of 40 angstrom), which forms in their absence. Also, the time constant of a kinetic component (tau(R)) of about 30 mu s has been observed by analyzing the correlation functions, which represents formation of a collapsed state. This time constant varies with urea concentration representing an inverted Chevron plot that shows a roll-over behavior in the absence of arginine. To the best of our knowledge, this is one of the first applications of fluorescence correlation spectroscopy to study direct folding kinetics of a protein.	[Haldar, Shubhasis; Mitra, Samaresh; Chattopadhyay, Krishnananda] Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chattopadhyay, K (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	krish@iicb.res.in		Haldar, Shubhasis/0000-0002-4304-5570; Chattopadhyay, Krishnananda/0000-0002-1449-8909	Council of Scientific and Industrial Research Network [NWP005]; Indian National Science Academy	Council of Scientific and Industrial Research Network; Indian National Science Academy	The work was supported by Council of Scientific and Industrial Research Network Project Grant NWP005 and by a grant from the acknowledges Indian National Science Academy (to S.M.).	Andya JD, 2003, AAPS PHARMSCI, V5; Andya JD, 1999, PHARMACEUT RES, V16, P350, DOI 10.1023/A:1018805232453; ARAKAWA T, 1990, BIOCHEMISTRY-US, V29, P1924, DOI 10.1021/bi00459a037; Arakawa T, 2007, PROTEIN EXPRES PURIF, V52, P410, DOI 10.1016/j.pep.2006.10.005; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arakawa T, 2006, PROTEIN PEPTIDE LETT, V13, P921, DOI 10.2174/092986606778256171; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Bee JS, 2010, BIOTECHNOL BIOENG, V105, P121, DOI 10.1002/bit.22525; BOWLER BE, 1993, BIOCHEMISTRY-US, V32, P183, DOI 10.1021/bi00052a024; CARPENTER JF, 2002, CURRENT PROTOCOLS PR; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; Chattopadhyay K, 2003, BIOCHEMISTRY-US, V42, P14606, DOI 10.1021/bi0351662; Chattopadhyay K, 2002, BIOCHEMISTRY-US, V41, P4040, DOI 10.1021/bi012042l; Chattopadhyay K, 2002, P NATL ACAD SCI USA, V99, P14171, DOI 10.1073/pnas.172524899; Chen E, 2009, CURR PROTEIN PEPT SC, V10, P464, DOI 10.2174/138920309789352001; Chen HM, 2007, P NATL ACAD SCI USA, V104, P10459, DOI 10.1073/pnas.0704073104; CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307; Colon W, 1997, BIOCHEMISTRY-US, V36, P12535, DOI 10.1021/bi971697c; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; Eaton WA, 1996, STRUCTURE, V4, P1133, DOI 10.1016/S0969-2126(96)00121-9; ELOVE GA, 1994, BIOCHEMISTRY-US, V33, P6925, DOI 10.1021/bi00188a023; Frieden C, 2002, ADV PROTEIN CHEM, V62, P91; Ghosh R, 2009, BIOCHEMISTRY-US, V48, P1135, DOI 10.1021/bi802065j; Godbole S, 2000, J MOL BIOL, V296, P217, DOI 10.1006/jmbi.1999.3454; Goldbeck RA, 2009, INT J MOL SCI, V10, P1476, DOI 10.3390/ijms10041476; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hammack BN, 2001, J MOL BIOL, V311, P1091, DOI 10.1006/jmbi.2001.4909; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hess ST, 2002, BIOPHYS J, V83, P2300, DOI 10.1016/S0006-3495(02)73990-8; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Kim KY, 1998, PROTEIN SCI, V7, P1821, DOI 10.1002/pro.5560070818; Krishna MMG, 2006, J MOL BIOL, V359, P1410, DOI 10.1016/j.jmb.2006.04.035; Kurchan E, 2005, J MOL BIOL, V353, P730, DOI 10.1016/j.jmb.2005.08.034; Latypov RF, 2006, J MOL BIOL, V357, P1009, DOI 10.1016/j.jmb.2006.01.055; Lee JC, 2002, J MOL BIOL, V320, P159, DOI 10.1016/S0022-2836(02)00466-7; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Neuweiler H, 2009, P NATL ACAD SCI USA, V106, P18569, DOI 10.1073/pnas.0910860106; Pascher T, 1996, SCIENCE, V271, P1558, DOI 10.1126/science.271.5255.1558; Perroud TD, 2005, P NATL ACAD SCI USA, V102, P17570, DOI 10.1073/pnas.0508975102; Pletneva EV, 2005, J MOL BIOL, V345, P855, DOI 10.1016/j.jmb.2004.10.085; Pollack L, 1999, P NATL ACAD SCI USA, V96, P10115, DOI 10.1073/pnas.96.18.10115; Pradeep L, 2004, J BIOL CHEM, V279, P40303, DOI 10.1074/jbc.M406323200; Qiu LL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.168103; Qu YX, 1998, P NATL ACAD SCI USA, V95, P9268, DOI 10.1073/pnas.95.16.9268; Segel DJ, 1998, BIOCHEMISTRY-US, V37, P12443, DOI 10.1021/bi980535t; SHASTRY MC, 1996, PROTEINS, V24, P413; Sosnick TR, 1997, P NATL ACAD SCI USA, V94, P8545, DOI 10.1073/pnas.94.16.8545; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Thomas YG, 2000, BIOPOLYMERS, V57, P29, DOI 10.1002/(SICI)1097-0282(2000)57:1<29::AID-BIP5>3.0.CO;2-V; Werner JH, 2006, P NATL ACAD SCI USA, V103, P11130, DOI 10.1073/pnas.0604712103; Wilkins DK, 2000, EUR J BIOCHEM, V267, P2609, DOI 10.1046/j.1432-1327.2000.01270.x; Xia Y, 2007, INT J BIOL MACROMOL, V40, P437, DOI 10.1016/j.ijbiomac.2006.10.004	58	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25314	25323		10.1074/jbc.M110.116673	http://dx.doi.org/10.1074/jbc.M110.116673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538585	Green Published, hybrid			2022-12-25	WOS:000280682400024
J	Kudryashov, DS; Grintsevich, EE; Rubenstein, PA; Reisler, E				Kudryashov, Dmitri S.; Grintsevich, Elena E.; Rubenstein, Peter A.; Reisler, Emil			A Nucleotide State-sensing Region on Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; D-BINDING PROTEIN; MONOMERIC ACTIN; ATP HYDROLYSIS; ADP-ACTIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; YEAST ACTIN; BETA-ACTIN; F-ACTIN	The nucleotide state of actin (ATP, ADP-Pi, or ADP) is known to impact its interactions with other actin molecules upon polymerization as well as with multiple actin binding proteins both in the monomeric and filamentous states of actin. Recently, molecular dynamics simulations predicted that a sequence located at the interface of subdomains 1 and 3 (W-loop; residues 165-172) changes from an unstructured loop to a beta-turn conformation upon ATP hydrolysis (Zheng, X., Diraviyam, K., and Sept, D. (2007) Biophys. J. 93, 1277-1283). This region participates directly in the binding to other subunits in F-actin as well as to cofilin, profilin, and WH2 domain proteins and, therefore, could contribute to the nucleotide sensitivity of these interactions. The present study demonstrates a reciprocal communication between the W-loop region and the nucleotide binding cleft on actin. Point mutagenesis of residues 167, 169, and 170 and their site-specific labeling significantly affect the nucleotide release from the cleft region, whereas the ATP/ADP switch alters the fluorescence of probes located in the W-loop. In the ADP-Pi state, the W-loop adopts a conformation similar to that in the ATP state but different from the ADP state. Binding of latrunculin A to the nucleotide cleft favors the ATP-like conformation of the W-loop, whereas ADP-ribosylation of Arg-177 forces the W-loop into a conformation distinct from those in the ADP and ATP-states. Overall, our experimental data suggest that the W-loop of actin is a nucleotide sensor, which may contribute to the nucleotide state-dependent changes in F-actin and nucleotide state-modulated interactions of both G-and F-actin with actin-binding proteins.	[Kudryashov, Dmitri S.; Grintsevich, Elena E.; Reisler, Emil] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Reisler, Emil] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Iowa	Kudryashov, DS (corresponding author), 405 Hilgard Ave,MBI Boyer Hall,Rm 405, Los Angeles, CA 90095 USA.	dkudryas@ucla.edu	Kudryashov, Dmitri/P-9004-2014	Rubenstein, Peter/0000-0003-1225-4414; Kudryashov, Dmitri/0000-0003-1782-3305	National Institutes of Health [GM077190, GM33689]; National Science Foundation [MCB0316269]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190, R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077190 (to E. R.) and GM33689 (to P. A. R.). This work was also supported by National Science Foundation Grant MCB0316269 (to E. R.).	Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Bugyi B, 2008, FEBS LETT, V582, P2086, DOI 10.1016/j.febslet.2008.02.065; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; CARLIER MF, 1988, J BIOL CHEM, V263, P817; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Chu JW, 2005, P NATL ACAD SCI USA, V102, P13111, DOI 10.1073/pnas.0503732102; Cong Y, 2008, J MOL BIOL, V375, P331, DOI 10.1016/j.jmb.2007.10.027; COOKE R, 1975, BIOCHEMISTRY-US, V14, P3250, DOI 10.1021/bi00685a035; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; Dalhaimer P, 2008, J MOL BIOL, V376, P166, DOI 10.1016/j.jmb.2007.11.068; DE LA CRUZ EM, 1995, BIOCHEMISTRY-US, V34, P5452, DOI 10.1021/bi00016a016; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; GEIPEL U, 1989, EUR J BIOCHEM, V179, P229, DOI 10.1111/j.1432-1033.1989.tb14545.x; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Head JF, 2002, BIOCHEMISTRY-US, V41, P9015, DOI 10.1021/bi026054y; HERTZOG M, 2005, CURR PROTOC CELL BIO, pCH13; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kardos R, 2009, BIOPHYS J, V96, P2335, DOI 10.1016/j.bpj.2008.12.3906; Kim E, 2000, BIOPHYS CHEM, V86, P191, DOI 10.1016/S0301-4622(00)00143-5; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAHAM LE, 1995, EUR J BIOCHEM, V234, P1, DOI 10.1111/j.1432-1033.1995.001_c.x; LAL AA, 1984, J BIOL CHEM, V259, P3061; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Otterbein LR, 2002, P NATL ACAD SCI USA, V99, P8003, DOI 10.1073/pnas.122126299; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pfaendtner J, 2009, P NATL ACAD SCI USA, V106, P12723, DOI 10.1073/pnas.0902092106; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Schuler H, 2000, EUR J BIOCHEM, V267, P4054, DOI 10.1046/j.1432-1033.2000.01466.x; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SIKORSKI RS, 1989, GENETICS, V122, P19; Splettstoesser T, 2009, PROTEINS, V76, P353, DOI 10.1002/prot.22350; Stokasimov E, 2008, J BIOL CHEM, V283, P34844, DOI 10.1074/jbc.M804419200; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Verboven C, 2003, ACTA CRYSTALLOGR D, V59, P263, DOI 10.1107/S0907444902021455; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	62	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25591	25601		10.1074/jbc.M110.123869	http://dx.doi.org/10.1074/jbc.M110.123869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530485	hybrid, Green Published			2022-12-25	WOS:000280682400053
J	Vigetti, D; Genasetti, A; Karousou, E; Viola, M; Moretto, P; Clerici, M; Deleonibus, S; De Luca, G; Hascall, VC; Passi, A				Vigetti, Davide; Genasetti, Anna; Karousou, Evgenia; Viola, Manuela; Moretto, Paola; Clerici, Moira; Deleonibus, Sara; De Luca, Giancarlo; Hascall, Vincent C.; Passi, Alberto			Proinflammatory Cytokines Induce Hyaluronan Synthesis and Monocyte Adhesion in Human Endothelial Cells through Hyaluronan Synthase 2 (HAS2) and the Nuclear Factor-kappa B (NF-kappa B) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; INFLAMMATORY DISEASES; IN-VITRO; CD44; ACID; EXTRAVASATION; TRANSCRIPTION; INHIBITORS; EXPRESSION; RECEPTORS	Chronic inflammation is now accepted to have a critical role in the onset of several diseases as well as in vascular pathology, where macrophage transformation into foam cells contributes in atherosclerotic plaque formation. Endothelial cells (EC) have a critical function in recruitment of immune cells, and proinflammatory cytokines drive the specific expression of several adhesion proteins. During inflammatory responses several cells produce hyaluronan matrices that promote monocyte/macrophage adhesion through interactions with the hyaluronan receptor CD44 present on inflammatory cell surfaces. In this study, we used human umbilical chord vein endothelial cells (HUVECs) as a model to study the mechanism that regulates hyaluronan synthesis after treatment with proinflammatory cytokines. We found that interleukin 1 beta and tumor necrosis factors alpha and beta, but not transforming growth factors alpha and beta, strongly induced HA synthesis by NF-kappa B pathway. This signaling pathway mediated hyaluronan synthase 2 (HAS2) mRNA expression without altering other glycosaminoglycan metabolism. Moreover, we verified that U937 monocyte adhesion on stimulated HUVECs depends strongly on hyaluronan, and transfection with short interference RNA of HAS2 abrogates hyaluronan synthesis revealing the critical role of HAS2 in this process.	[Vigetti, Davide; Genasetti, Anna; Karousou, Evgenia; Viola, Manuela; Moretto, Paola; Clerici, Moira; Deleonibus, Sara; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University of Insubria; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	passi, alberto g/A-1752-2018; Vigetti, Davide/C-9861-2010; Viola, Manuela/B-7120-2011	passi, alberto g/0000-0003-3328-3089; Vigetti, Davide/0000-0002-6339-8453; Viola, Manuela/0000-0002-0634-6390	Fondazione Comunitaria del Varesotto-ONLUS; Centro Insubre di Biotecnologie per la Salute Umana	Fondazione Comunitaria del Varesotto-ONLUS; Centro Insubre di Biotecnologie per la Salute Umana	This work was supported by Fondazione Comunitaria del Varesotto-ONLUS, PRIN 2007 (to G. D. L.) and a young researcher award from the Centro Insubre di Biotecnologie per la Salute Umana (to D. V.).	Alam C. A. S., 2005, Inflammopharmacology, V12, P535; Anderson P, 2009, NAT IMMUNOL, V10, P233, DOI 10.1038/ni0309-233; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Estess P, 1999, J EXP MED, V190, P9, DOI 10.1084/jem.190.1.9; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; IALENTI A, 1994, AGENTS ACTIONS, V43, P44, DOI 10.1007/BF02005763; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Kao JJ, 2006, EXP GERONTOL, V41, P641, DOI 10.1016/j.exger.2006.04.003; Kaplan D, 1996, IMMUNOL TODAY, V17, P303, DOI 10.1016/0167-5699(96)30017-0; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Miltner O, 2002, OSTEOARTHR CARTILAGE, V10, P680, DOI 10.1053/joca.2002.0815; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; RUFFELL B, 2009, SCI HYALURONAN TODAY; Savani RC, 1995, INT J TISSUE REACT, V17, P141; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vigetti D, 2008, THESCIENTIFICWORLDJO, V8, P1116, DOI 10.1100/tsw.2008.145; Viola M, 2006, J PHARMACEUT BIOMED, V41, P36, DOI 10.1016/j.jpba.2005.10.010	41	99	102	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24639	24645		10.1074/jbc.M110.134536	http://dx.doi.org/10.1074/jbc.M110.134536			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522558	Green Published, hybrid			2022-12-25	WOS:000280542100036
J	Lyngaa, R; Norregaard, K; Kristensen, M; Kubale, V; Rosenkilde, MM; Kledal, TN				Lyngaa, R.; Norregaard, K.; Kristensen, M.; Kubale, V.; Rosenkilde, M. M.; Kledal, T. N.			Cell transformation mediated by the Epstein-Barr virus G protein-coupled receptor BILF1 is dependent on constitutive signaling	ONCOGENE			English	Article						Epstein-Barr virus; cell transformation; G protein-coupled receptor; constitutive activity; signaling; VEGF	SARCOMA-ASSOCIATED HERPESVIRUS; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; KAPOSIS-SARCOMA; 7-TRANSMEMBRANE RECEPTOR; LYTIC INFECTION; CHEMOKINE; EXPRESSION; GENE; US28	Epstein-Barr virus (EBV) open reading frame BILF1 encodes a seven trans-membrane (TM) G protein-coupled receptor that signals with high constitutive activity through G alpha(i) (Beisser et al., 2005; Paulsen et al., 2005). In this paper, the transforming potential of BILF1 is investigated in vitro in a foci formation assay using retrovirally transduced NIH3T3 cells, as well as in vivo by using nude mice. BILF1 revealed a substantial transforming potential that was dependent on constitutive signaling, as a signaling-deficient mutant completely lost its ability to transform cells in vitro, and an intermediately active triple-mutated receptor possessed an intermediate transforming potential. Furthermore, BILF1 expression induced vascular endothelial growth factor secretion in a constitutively active manner. In nude mice, BILF1 promoted tumor formation in 90% of cases, ORF74 (from Kaposi's sarcoma-associated herpes virus) in 100% of cases, whereas the signaling-deficient receptor resulted in tumor establishment in 40% of cases. These data suggest that BILF1, when expressed during EBV infection, could indeed be involved in the pathogenesis of EBV-associated diseases and malignancies. Furthermore, the correlation between receptor activity and the ability to mediate cell transformation in vitro and tumor formation in vivo supports the idea that inverse agonists for BILF1 could inhibit cell transformation and be relevant therapeutic candidates. Oncogene (2010) 29, 4388-4398; doi: 10.1038/onc.2010.173; published online 14 June 2010	[Lyngaa, R.; Kristensen, M.; Kledal, T. N.] Danish Tech Univ, Lab Cell Biol & Virol, DTU Nanotech, Dept Micro & Nanotechnol, DK-4000 Roskilde, Denmark; [Norregaard, K.; Kubale, V.; Rosenkilde, M. M.] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth Sci, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Kledal, TN (corresponding author), Danish Tech Univ, Virol Dept Micro & Nanotechnol, DTU Nanotech, Frederiksborgvej 399,Build 330, DK-4000 Roskilde, Denmark.	tnkl@risoe.dtu.dk		Rosenkilde, Mette Marie/0000-0001-9600-3254				Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Beisser PS, 2005, J VIROL, V79, P441, DOI 10.1128/JVI.79.1.441-449.2005; Beisser PS, 1999, J VIROL, V73, P7218, DOI 10.1128/JVI.73.9.7218-7230.1999; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Burger M, 1999, J IMMUNOL, V163, P2017; Cesarman E, 2000, J EXP MED, V191, P417, DOI 10.1084/jem.191.3.417; DavisPoynter NJ, 1997, J VIROL, V71, P1521, DOI 10.1128/JVI.71.2.1521-1529.1997; Geras-Raaka E, 1998, J EXP MED, V188, P405, DOI 10.1084/jem.188.2.405; Geras-Raaka E, 1998, BIOCHEM BIOPH RES CO, V253, P725, DOI 10.1006/bbrc.1998.9557; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Ho HH, 2001, J BIOL CHEM, V276, P1376, DOI 10.1074/jbc.M007885200; Hong GK, 2005, J VIROL, V79, P13984, DOI 10.1128/JVI.79.22.13984-13992.2005; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Krishna SM, 2006, VIRUS RES, V115, P85, DOI 10.1016/j.virusres.2005.07.010; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; McLean KA, 2004, VIROLOGY, V325, P241, DOI 10.1016/j.virol.2004.04.027; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Montone KT, 1996, MODERN PATHOL, V9, P621; Murono S, 2001, P NATL ACAD SCI USA, V98, P6905, DOI 10.1073/pnas.121016998; O'Neil JD, 2008, J GEN VIROL, V89, P2833, DOI 10.1099/vir.0.2008/003392-0; PALLESEN G, 1991, LANCET, V337, P320, DOI 10.1016/0140-6736(91)90943-J; Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001; Paulsen SJ, 2005, J VIROL, V79, P536, DOI 10.1128/JVI.79.1.536-546.2005; Paydas S, 2008, LEUKEMIA RES, V32, P1424, DOI 10.1016/j.leukres.2008.01.008; Pleskoff O, 2005, FEBS J, V272, P4163, DOI 10.1111/j.1742-4658.2005.04829.x; Rajagopal K, 2005, J CLIN INVEST, V115, P2971, DOI 10.1172/JCI26950; Rosenkilde MM, 2008, BRIT J PHARMACOL, V153, pS154, DOI 10.1038/sj.bjp.0707660; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Rosenkilde MM, 2006, CURR DRUG TARGETS, V7, P103, DOI 10.2174/138945006775270259; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Rosenkilde MM, 2005, MOL PHARMACOL, V68, P11, DOI 10.1124/mol.105.011239; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; Sheng W, 2003, J VIROL, V77, P3859, DOI 10.1128/JVI.77.6.3859-3865.2003; Smit MJ, 2002, J VIROL, V76, P1744, DOI 10.1128/JVI.76.4.1744-1752.2002; Sodhi A, 2000, CANCER RES, V60, P4873; Streblow DN, 2003, J BIOL CHEM, V278, P50456, DOI 10.1074/jbc.M307936200; Vieira J, 1998, J VIROL, V72, P8158, DOI 10.1128/JVI.72.10.8158-8165.1998; Vischer HF, 2008, BIOCHEM BIOPH RES CO, V377, P93, DOI 10.1016/j.bbrc.2008.09.082; Waldhoer M, 2002, J VIROL, V76, P8161, DOI 10.1128/JVI.76.16.8161-8168.2002; Walling DM, 2003, J INFECT DIS, V188, P883, DOI 10.1086/378072; Xue SA, 2002, INT J CANCER, V99, P635, DOI 10.1002/ijc.10372; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	47	38	40	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2010	29	31					4388	4398		10.1038/onc.2010.173	http://dx.doi.org/10.1038/onc.2010.173			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	634DG	20543866				2022-12-25	WOS:000280559100003
J	Lepoittevin, C; Frigerio, JM; Garnier-Gere, P; Salin, F; Cervera, MT; Vornam, B; Harvengt, L; Plomion, C				Lepoittevin, Camille; Frigerio, Jean-Marc; Garnier-Gere, Pauline; Salin, Franck; Cervera, Maria-Teresa; Vornam, Barbara; Harvengt, Luc; Plomion, Christophe			In Vitro vs In Silico Detected SNPs for the Development of a Genotyping Array: What Can We Learn from a Non-Model Species?	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; EXPRESSED SEQUENCE TAGS; LINKAGE-DISEQUILIBRIUM; ERRORS; GENOME; IDENTIFICATION; DNA; PERFORMANCE; TECHNOLOGY; IMPACT	Background: There is considerable interest in the high-throughput discovery and genotyping of single nucleotide polymorphisms (SNPs) to accelerate genetic mapping and enable association studies. This study provides an assessment of EST-derived and resequencing-derived SNP quality in maritime pine (Pinus pinaster Ait.), a conifer characterized by a huge genome size (similar to 23.8 Gb/C). Methodology/Principal Findings: A 384-SNPs GoldenGate genotyping array was built from i/ 184 SNPs originally detected in a set of 40 re-sequenced candidate genes (in vitro SNPs), chosen on the basis of functionality scores, presence of neighboring polymorphisms, minor allele frequencies and linkage disequilibrium and ii/ 200 SNPs screened from ESTs (in silico SNPs) selected based on the number of ESTs used for SNP detection, the SNP minor allele frequency and the quality of SNP flanking sequences. The global success rate of the assay was 66.9%, and a conversion rate (considering only polymorphic SNPs) of 51% was achieved. In vitro SNPs showed significantly higher genotyping-success and conversion rates than in silico SNPs (+11.5% and +18.5%, respectively). The reproducibility was 100%, and the genotyping error rate very low (0.54%, dropping down to 0.06% when removing four SNPs showing elevated error rates). Conclusions/Significance: This study demonstrates that ESTs provide a resource for SNP identification in non-model species, which do not require any additional bench work and little bio-informatics analysis. However, the time and cost benefits of in silico SNPs are counterbalanced by a lower conversion rate than in vitro SNPs. This drawback is acceptable for population-based experiments, but could be dramatic in experiments involving samples from narrow genetic backgrounds. In addition, we showed that both the visual inspection of genotyping clusters and the estimation of a per SNP error rate should help identify markers that are not suitable to the GoldenGate technology in species characterized by a large and complex genome.	[Lepoittevin, Camille; Frigerio, Jean-Marc; Garnier-Gere, Pauline; Salin, Franck; Plomion, Christophe] INRA, BIOGECO UMR1202, Cestas, France; [Lepoittevin, Camille; Frigerio, Jean-Marc; Garnier-Gere, Pauline; Salin, Franck; Plomion, Christophe] Univ Bordeaux, BIOGECO UMR1202, Talence, France; [Lepoittevin, Camille; Harvengt, Luc] FCBA, Biotechnol Lab, Nangis, France; [Cervera, Maria-Teresa] INIA, Dept Ecol & Genet Forestal, Madrid, Spain; [Vornam, Barbara] Univ Gottingen, Gottingen, Germany	INRAE; UDICE-French Research Universities; Universite de Bordeaux; University of Gottingen	Lepoittevin, C (corresponding author), INRA, BIOGECO UMR1202, Cestas, France.	camille.lepoittevin@pierroton.inra.fr	Harvengt, Luc/G-4569-2011; Cervera, M. Teresa/G-9181-2012; plomion, christophe/F-7578-2013	Harvengt, Luc/0000-0003-1524-5273; Cervera, M. Teresa/0000-0001-6797-2347; Lepoittevin, Camille/0000-0002-1270-9629; plomion, christophe/0000-0002-3176-2767	Agence Nationale de la Recherche Genoplante [GNP05013C]; Agence Nationale de la Recherche Plates-Formes Technologiques du Vivant [07PFTV002]; Aquitaine Region [20061201004PFM]; European Union [FP7-211868]	Agence Nationale de la Recherche Genoplante(French National Research Agency (ANR)); Agence Nationale de la Recherche Plates-Formes Technologiques du Vivant(French National Research Agency (ANR)); Aquitaine Region(Region Nouvelle-Aquitaine); European Union(European Commission)	This research was supported by grants from Agence Nationale de la Recherche Genoplante (GenoQB project, GNP05013C) and Agence Nationale de la Recherche Plates-Formes Technologiques du Vivant (BOOST-SNP project, 07PFTV002), the Aquitaine Region (20061201004PFM) and the European Union (NOVELTREE project, FP7-211868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Batley J, 2003, PLANT PHYSIOL, V132, P84, DOI 10.1104/pp.102.019422; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Chagne D., 2007, Association mapping in plants, P77, DOI 10.1007/978-0-387-36011-9_5; Cunningham JM, 2008, CANCER EPIDEM BIOMAR, V17, P1781, DOI 10.1158/1055-9965.EPI-07-2849; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Edwards D., 2007, Association mapping in plants, P53, DOI 10.1007/978-0-387-36011-9_4; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Gibbs JR, 2006, PLOS GENET, V2, P1511, DOI 10.1371/journal.pgen.0020150; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Gupta PK, 2001, CURR SCI INDIA, V80, P524; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Hao K, 2004, GENOMICS, V84, P623, DOI 10.1016/j.ygeno.2004.05.003; Henikoff S, 2003, ANNU REV PLANT BIOL, V54, P375, DOI 10.1146/annurev.arplant.54.031902.135009; HENRY RJ, 2008, PLANT GENOTYPING, V2; Hyten DL, 2008, THEOR APPL GENET, V116, P945, DOI 10.1007/s00122-008-0726-2; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; Labate JA, 2005, MOL BREEDING, V16, P343, DOI 10.1007/s11032-005-1911-5; Le Dantec L, 2004, PLANT MOL BIOL, V54, P461, DOI 10.1023/B:PLAN.0000036376.11710.6f; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oliphant A, 2002, BIOTECHNIQUES, P56; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; Pavy N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-174; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pot D, 2005, NEW PHYTOL, V167, P101, DOI 10.1111/j.1469-8137.2005.01417.x; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rafalski JA, 2002, PLANT SCI, V162, P329, DOI 10.1016/S0168-9452(01)00587-8; Rice KM, 2003, ANN HUM GENET, V67, P165, DOI 10.1046/j.1469-1809.2003.00020.x; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Saunders IW, 2007, GENOMICS, V90, P291, DOI 10.1016/j.ygeno.2007.05.011; Schmid KJ, 2003, GENOME RES, V13, P1250, DOI 10.1101/gr.728603; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Slate J, 2009, GENETICA, V136, P97, DOI 10.1007/s10709-008-9317-z; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Sobrino B, 2005, FORENSIC SCI INT, V154, P181, DOI 10.1016/j.forsciint.2004.10.020; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450	53	45	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11034	10.1371/journal.pone.0011034	http://dx.doi.org/10.1371/journal.pone.0011034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543950	Green Published, Green Submitted, gold			2022-12-25	WOS:000278557600012
J	de Mello, JCM; de Araujo, ESS; Stabellini, R; Fraga, AM; de Souza, JES; Sumita, DR; Camargo, AA; Pereira, LV				Moreira de Mello, Joana Carvalho; Souza de Araujo, Erica Sara; Stabellini, Raquel; Fraga, Ana Maria; Santana de Souza, Jorge Estefano; Sumita, Denilce R.; Camargo, Anamaria A.; Pereira, Lygia V.			Random X Inactivation and Extensive Mosaicism in Human Placenta Revealed by Analysis of Allele-Specific Gene Expression along the X Chromosome	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN CHORIONIC VILLI; EARLY MOUSE EMBRYOS; TROPHOBLASTIC CELLS; DNA-REPLICATION; YOLK-SAC; MAMMALS; REACTIVATION; MEMBRANES; PATTERNS	Imprinted inactivation of the paternal X chromosome in marsupials is the primordial mechanism of dosage compensation for X-linked genes between females and males in Therians. In Eutherian mammals, X chromosome inactivation (XCI) evolved into a random process in cells from the embryo proper, where either the maternal or paternal X can be inactivated. However, species like mouse and bovine maintained imprinted XCI exclusively in extraembryonic tissues. The existence of imprinted XCI in humans remains controversial, with studies based on the analyses of only one or two X-linked genes in different extraembryonic tissues. Here we readdress this issue in human term placenta by performing a robust analysis of allele-specific expression of 22 X-linked genes, including XIST, using 27 SNPs in transcribed regions. We show that XCI is random in human placenta, and that this organ is arranged in relatively large patches of cells with either maternal or paternal inactive X. In addition, this analysis indicated heterogeneous maintenance of gene silencing along the inactive X, which combined with the extensive mosaicism found in placenta, can explain the lack of agreement among previous studies. Our results illustrate the differences of XCI mechanism between humans and mice, and highlight the importance of addressing the issue of imprinted XCI in other species in order to understand the evolution of dosage compensation in placental mammals.	[Moreira de Mello, Joana Carvalho; Souza de Araujo, Erica Sara; Stabellini, Raquel; Fraga, Ana Maria; Pereira, Lygia V.] Univ Sao Paulo, Dept Genet & Biol Evolut, Genet Mol Lab, Sao Paulo, Brazil; [Santana de Souza, Jorge Estefano; Camargo, Anamaria A.] Ludwig Inst Canc Res, Sao Paulo Branch, Sao Paulo, Brazil	Universidade de Sao Paulo; Ludwig Institute for Cancer Research	de Mello, JCM (corresponding author), Univ Sao Paulo, Dept Genet & Biol Evolut, Genet Mol Lab, Sao Paulo, Brazil.	lpereira@usp.br	Camargo, Anamaria A/E-9388-2012; Pereira, Lygia V/C-1049-2012	Camargo, Anamaria A/0000-0002-6076-9597; Pereira, Lygia V/0000-0002-0002-725X	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: This work was funded by Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP: www.fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: www.cnpq.br). JCMM, ESSA, RS, AMF receive fellowships from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Anderson CL, 1999, AM J HUM GENET, V65, P699, DOI 10.1086/302556; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brown CJ, 1997, AM J HUM GENET, V60, P1333, DOI 10.1086/515488; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; COOPER DW, 1971, NATURE-NEW BIOL, V230, P155, DOI 10.1038/newbio230155a0; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Goto T, 1997, MOL HUM REPROD, V3, P77, DOI 10.1093/molehr/3.1.77; HARRISON KB, 1986, CYTOGENET CELL GENET, V41, P163, DOI 10.1159/000132221; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Looijenga LHJ, 1999, AM J HUM GENET, V64, P1445, DOI 10.1086/302382; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Migeon B R, 1978, Basic Life Sci, V12, P379; Migeon BR, 2005, AM J HUM GENET, V77, P355, DOI 10.1086/432815; MIGEON BR, 1986, P NATL ACAD SCI USA, V83, P2182, DOI 10.1073/pnas.83.7.2182; MIGEON BR, 1979, AM J HUM GENET, V31, P581; MOHANDAS TK, 1989, SOMAT CELL MOLEC GEN, V15, P131, DOI 10.1007/BF01535073; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROPERS HH, 1978, HUM GENET, V43, P265, DOI 10.1007/BF00278833; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stabellini Raquel, 2009, Epigenetics, V4, P388; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Uehara S, 2000, J HUM GENET, V45, P119, DOI 10.1007/s100380050197; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; Vasques LR, 2002, CYTOGENET GENOME RES, V99, P30, DOI 10.1159/000071570; Vasques LR, 2001, DNA RES, V8, P173, DOI 10.1093/dnares/8.4.173; Wagschal A, 2006, CYTOGENET GENOME RES, V113, P90, DOI 10.1159/000090819; WAKE N, 1976, NATURE, V262, P580, DOI 10.1038/262580a0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Willemsen R, 2002, HUM GENET, V110, P601, DOI 10.1007/s00439-002-0723-5; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Zeng SM, 2003, PLACENTA, V24, P270, DOI 10.1053/plac.2002.0889	44	88	91	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10947	10.1371/journal.pone.0010947	http://dx.doi.org/10.1371/journal.pone.0010947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532033	gold, Green Published, Green Submitted			2022-12-25	WOS:000278380500001
J	Ir, P; Men, C; Lucas, H; Meessen, B; Decoster, K; Bloom, G; Van Damme, W				Ir, Por; Men, Chean; Lucas, Henry; Meessen, Bruno; Decoster, Kristof; Bloom, Gerald; Van Damme, Wim			Self-Reported Serious Illnesses in Rural Cambodia: A Cross-Sectional Survey	PLOS ONE			English	Article							CATASTROPHIC HEALTH EXPENDITURE; DEVELOPING-COUNTRIES; INTERVIEW SURVEYS; LOW-INCOME; USER FEES; CARE; POVERTY; EQUITY; ACCESS; HOUSEHOLDS	Background: There is substantial evidence that ill-health is a major cause of impoverishment in developing countries. Major illnesses can have a serious economic impact on poor households through treatment costs and income loss. However, available methods for measuring the impact of ill-health on household welfare display several shortcomings and new methods are thus needed. To understand the potential complex impact of major illnesses on household livelihoods, a study on poverty and illness was conducted in rural Cambodia, as part of an international comparative research project. A cross-sectional survey was performed to identify households affected by major illness for further in-depth interviews. Methodology and Principal Findings: 5,975 households in three rural health districts were randomly selected through a two-stage cluster sampling and interviewed. 27% of the households reported at least one member with a serious illness in the year preceding the survey and 15% of the household members reported suffering from at least one serious illness. The most reported conditions include common tropical infectious diseases, chronic diseases (notably hypertension and heart diseases) and road traffic accidents. Such conditions were particularly concentrated among the poor, children under five, women, and the elderly. Poor women often reported complications related to pregnancy and delivery as serious illnesses. Conclusions and Significance: Despite some methodological limitations, this study provides new information on the frequency of self-reported serious illnesses among the rural Cambodia's population, which serves as a basis for further in-depth investigation on 'major illnesses' and their economic consequences on poor households. This can in turn help policy makers to formulate appropriate interventions to protect the poor from the financial burden associated with ill-health. Our findings suggest that every year a considerable proportion of rural population in Cambodia, especially the poor and vulnerable, are affected by serious illnesses, both communicable and non-communicable diseases.	[Ir, Por] Minist Hlth, Prov Hlth Dept, Siem Reap, Cambodia; [Ir, Por; Meessen, Bruno; Decoster, Kristof; Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Men, Chean] Ctr Adv Studies, Phnom Penh, Cambodia; [Lucas, Henry; Bloom, Gerald] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England	Institute of Tropical Medicine (ITM); University of Sussex	Ir, P (corresponding author), Minist Hlth, Prov Hlth Dept, Siem Reap, Cambodia.	irpor@yahoo.com	Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007; Bloom, Gerald/0000-0002-7047-2412; Meessen, Bruno/0000-0002-0359-8621	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the Sixth Framework Programme of the European Commission (http://www.povill.com/en_index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigdeli M, 2009, B WORLD HEALTH ORGAN, V87, P560, DOI 10.2471/BLT.08.053058; BOERMA JT, 1991, INT J EPIDEMIOL, V20, P1073, DOI 10.1093/ije/20.4.1073; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; *DEP PLANN HLTH IN, 2006, HLTH COV PLAN 2004 2; *DEP PLANN HLTH IN, 2008, NAT HLTH STAT 2007; FABRICANT SJ, 1993, B WORLD HEALTH ORGAN, V71, P341; FASSIN D, 1991, REV EPIDEMIOL SANTE, V39, P89; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hardeman W, 2004, HEALTH POLICY PLANN, V19, P22, DOI 10.1093/heapol/czh003; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Kenjiro Y, 2005, DEV CHANGE, V36, P759, DOI 10.1111/j.0012-155X.2005.00433.x; Khun S, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-10; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Leonard L, 2005, SOC SCI MED, V61, P229, DOI 10.1016/j.socscimed.2004.11.050; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; LUCAS H, 2008, STUDIES HLTH SERVICE, V23, P29; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Meessen B, 2003, TROP MED INT HEALTH, V8, P581, DOI 10.1046/j.1365-3156.2003.01081.x; *NAT I PUBL HLTH O, 2006, CAMB DEM HLTH SURV 2; National Center for HIV/AIDS Dermatology and STD (NCHADS), 2008, HIV SENT SURV 2006; National Institute of Statistics, 2009, GEN POP CENS CAMB 20; *OXF, 2000, HLTH LANDL; Paxton S, 2007, ASIA-PAC J PUBLIC HE, V19, P8, DOI 10.1177/10105395070190010301; Pilsczek FH, 2001, CAN MED ASSOC J, V165, P37; RODGERS Y, 2009, GENDER DEV IN PRESS; ROSS DA, 1986, STUD FAMILY PLANN, V17, P78, DOI 10.2307/1967068; Russell S, 2005, HEALTH POLICY PLANN, V20, P277, DOI 10.1093/heapol/czi035; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; *UNFPA CAMB, OBST DEL TRAIN HLTH; Van Damme W, 2003, LANCET, V362, P996, DOI 10.1016/S0140-6736(03)14375-9; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; *WHO, 2009, PREV CHRON DIS VIT I; World Health Organization, WHO FACT SHEET CARD; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; CAMBODIA COUNTRY PRO	42	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10930	10.1371/journal.pone.0010930	http://dx.doi.org/10.1371/journal.pone.0010930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	605AD	20532180	Green Submitted, Green Published, gold			2022-12-25	WOS:000278318700004
J	Huang, X; van den Berg, A; Gao, ZF; Visser, L; Nolte, I; Vos, H; Hepkema, B; Kooistra, W; Poppema, S; Diepstra, A				Huang, Xin; van den Berg, Anke; Gao, Zifen; Visser, Lydia; Nolte, Ilja; Vos, Hans; Hepkema, Bouke; Kooistra, Wierd; Poppema, Sibrand; Diepstra, Arjan			Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients	PLOS ONE			English	Article							REED-STERNBERG CELLS; COMPLEX CLASS-I; CD4(+) T-CELLS; DISEASE; EPITOPE; HLA-A-ASTERISK-02; IDENTIFICATION; PROTEIN	Background: In Caucasian populations, the tumor cells of Epstein Barr virus (EBV)-positive classical Hodgkin Lymphomas (cHL) patients more frequently express HLA class I and HLA class II molecules compared to EBV-negative cHL patients. HLA expression (in relation to EBV) in Asian cHL patients has not been previously investigated. Methodology/Principal Findings: We randomly selected 145 cHL patients with formalin-fixed, paraffin embedded tissue blocks available from 5 hospitals from the Northern part of China. Hematoxylin & Eosin-stained slides were used to reclassify the histological subtypes according to the WHO classification. EBV status was determined by visualization of EBERs in tumor cells using in situ hybridization. Membranous expression of HLA molecules was detected by immunohistochemistry using antibodies HC-10 (class I heavy chain) and anti-beta 2-microglobulin for HLA class I, and CR3/43 for HLA class II. EBV+ tumor cells were observed in 40% (58/145) of the cHL patients. As expected, the percentage of EBV+ cases was much higher in the mixed cellularity subtype (71%) than in the nodular sclerosis subtype (16%) (p<0.001). Expression of HLA class I was observed in 79% of the EBV+ cHL cases and in 30% of the EBV- cases (p<0.001). For HLA class II, 52% of EBV+ cHL cases were positive, compared to 43% in EBV- cases (p = 0.28). Conclusions: The results in the Northern China population were similar to those in the Caucasian population for HLA class I, but not for HLA class II.	[Huang, Xin; van den Berg, Anke; Visser, Lydia; Vos, Hans; Kooistra, Wierd; Poppema, Sibrand; Diepstra, Arjan] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Huang, Xin; Gao, Zifen] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Nolte, Ilja] Univ Groningen, Unit Genet Epidemiol & Bioinformat, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hepkema, Bouke] Univ Groningen, Dept Lab Med, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; Peking University; University of Groningen; University of Groningen	Huang, X (corresponding author), Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands.	a.diepstra@path.umcg.nl	Visser, Lydia/D-7675-2012; Poppema, Sibrand/D-1204-2012; van den Berg, Anke/H-1718-2011	van den Berg, Anke/0000-0002-8894-2638; Diepstra, Arjan/0000-0001-9239-1050	Bernoulli Bursary	Bernoulli Bursary	This work was supported by Bernoulli Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro T, 2008, CLIN CANCER RES, V14, P685, DOI 10.1158/1078-0432.CCR-07-1246; Bryden H, 1997, INT J CANCER, V72, P614, DOI 10.1002/(SICI)1097-0215(19970807)72:4<614::AID-IJC11>3.0.CO;2-B; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; DE JD, 2008, J INTERN MED, V264, P528; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2007, J CLIN ONCOL, V25, P3101, DOI 10.1200/JCO.2006.10.0917; Gandhi MK, 2004, BRIT J HAEMATOL, V125, P267, DOI 10.1111/j.1365-2141.2004.04902.x; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Lee SP, 1998, BLOOD, V92, P1020, DOI 10.1182/blood.V92.3.1020.415a20_1020_1030; Murray PG, 1998, BLOOD, V92, P2477, DOI 10.1182/blood.V92.7.2477.2477_2477_2483; Nakatsuka S, 2006, INT J HEMATOL, V83, P391, DOI 10.1532/IJH97.05184; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Omiya R, 2002, J IMMUNOL, V169, P2172, DOI 10.4049/jimmunol.169.4.2172; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; STAM NJ, 1986, J IMMUNOL, V137, P2299; Swerdlow E., 2008, WHO CLASSIFICATION T; Voo KS, 2002, CANCER RES, V62, P7195; Wang RF, 2003, METHODS, V29, P227, DOI 10.1016/S1046-2023(02)00345-6	19	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10865	10.1371/journal.pone.0010865	http://dx.doi.org/10.1371/journal.pone.0010865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526359	gold, Green Published, Green Submitted			2022-12-25	WOS:000278222100003
J	Frank, DM; Sarkar, S				Frank, David M.; Sarkar, Sahotra			Group Decisions in Biodiversity Conservation: Implications from Game Theory	PLOS ONE			English	Article							EXTRINSIC REWARDS; MULTIPLE CRITERIA; HOMO-ECONOMICUS; CORAL-REEFS; RED GROUSE; WILD DOGS; AREA; FOOD	Background: Decision analysis and game theory [1,2] have proved useful tools in various biodiversity conservation planning and modeling contexts [3-5]. This paper shows how game theory may be used to inform group decisions in biodiversity conservation scenarios by modeling conflicts between stakeholders to identify Pareto-inefficient Nash equilibria. These are cases in which each agent pursuing individual self-interest leads to a worse outcome for all, relative to other feasible outcomes. Three case studies from biodiversity conservation contexts showing this feature are modeled to demonstrate how game-theoretical representation can inform group decision-making. Methodology and Principal Findings: The mathematical theory of games is used to model three biodiversity conservation scenarios with Pareto-inefficient Nash equilibria: (i) a two-agent case involving wild dogs in South Africa; (ii) a three-agent raptor and grouse conservation scenario from the United Kingdom; and (iii) an n-agent fish and coral conservation scenario from the Philippines. In each case there is reason to believe that traditional mechanism-design solutions that appeal to material incentives may be inadequate, and the game-theoretical analysis recommends a resumption of further deliberation between agents and the initiation of trust-and confidence-building measures. Conclusions and Significance: Game theory can and should be used as a normative tool in biodiversity conservation contexts: identifying scenarios with Pareto-inefficient Nash equilibria enables constructive action in order to achieve (closer to) optimal conservation outcomes, whether by policy solutions based on mechanism design or otherwise. However, there is mounting evidence [6] that formal mechanism-design solutions may backfire in certain cases. Such scenarios demand a return to group deliberation and the creation of reciprocal relationships of trust.	[Frank, David M.; Sarkar, Sahotra] Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA; [Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Frank, DM (corresponding author), Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA.	sarkar@mail.utexas.edu	Dao, Rock/E-5736-2014		National Science Foundation (NSF) [SES-0645884, DEB-0553768]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) Grant No. SES-0645884. It also benefited from discussions of the National Center for Ecological Analysis and Synthesis Working Group on Complex Environmental Decisions (funded by NSF Grant DEB-0553768). NSF website: http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson E, 2006, SOCIAL PSYCHOL; Arrow KJ, 1986, SOCIAL CHOICE MULTIC; Bhat MG, 1999, ECOL ECON, V29, P391, DOI 10.1016/S0921-8009(98)00066-4; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Brown A.F., 1995, HEATHS MOORLAND CULT, P51; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Creel S., 2002, AFRICAN WILD DOG BEH; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Dodds WK, 2005, ENVIRON VALUE, V14, P411, DOI 10.3197/096327105774462683; Faith D. P, 1995, BIODIVERSITY REGIONA; Falkinger J, 2000, AM ECON REV, V90, P247, DOI 10.1257/aer.90.1.247; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; GIBSON CC, 1995, WORLD DEV, V23, P941, DOI 10.1016/0305-750X(95)00025-8; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; Gintis H, 2000, ECOL ECON, V35, P311, DOI 10.1016/S0921-8009(00)00216-0; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; GORDON H. SCOTT, 1953, JOUR FISH RES BD CANADA, V10, P442; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Gusset M, 2008, BIODIVERS CONSERV, V17, P83, DOI 10.1007/s10531-007-9232-0; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; HUDSON P, 2001, HEATHS MOORLANDS CUL, P282; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Lindsey PA, 2005, BIOL CONSERV, V123, P339, DOI 10.1016/j.biocon.2004.12.002; Lindsey PA, 2004, S AFR J WILDL RES, V34, P77; Maddock A, 1999, CONSERV BIOL, V13, P412, DOI 10.1046/j.1523-1739.1999.013002412.x; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Maynard Smith J., 1982, pi; Mcmanus JW, 1997, ENVIRON MANAGE, V21, P69, DOI 10.1007/s002679900006; McManus JW, 1997, CORAL REEFS, V16, pS121, DOI 10.1007/s003380050248; Moffett A, 2006, DIVERS DISTRIB, V12, P125, DOI 10.1111/j.1366-9516.2005.00202.x; Moffett A, 2006, BIOL CONSERV, V129, P181, DOI 10.1016/j.biocon.2005.10.033; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Newton I., 1979, POPULATION ECOLOGY R; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; *ORG EC COOP DEV, 1997, SUST FISH EC ASP MAN; Osborne M.J., 1994, COURSE GAME THEORY; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Pinkerton Evelyn, 1989, COOPERATIVE MANAGEME; REDFORD KH, 2001, CONSERVATION EXPLOIT, P00370; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Sarkar S, 2002, J BIOSCIENCES, V27, P299, DOI 10.1007/BF02704961; Sarkar S., 2005, BIODIVERSITY ENV PHI, DOI DOI 10.1017/CBO9780511498558; Sarkar S, 2004, CONSERV SOC, V2, P433; Sarkar S, 2008, BIOL PHILOS, V23, P217, DOI 10.1007/s10539-007-9092-8; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Sarkar S, 2008, RESONANCE, V13, P627, DOI 10.1007/s12045-008-0069-y; Sumaila UR, 1999, MAR POLICY, V23, P1, DOI 10.1016/S0308-597X(97)00045-6; Thirgood S, 2000, CONSERV BIOL, V14, P95, DOI 10.1046/j.1523-1739.2000.99013.x; Thirgood S, 1997, NATURE, V390, P547, DOI 10.1038/37450; THOMPSON DBA, 1995, BIOL CONSERV, V71, P163, DOI 10.1016/0006-3207(94)00043-P; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Ward JM, 1996, AUK, V113, P200; WATSON A, 1989, IBIS, V131, P336, DOI 10.1111/j.1474-919X.1989.tb02783.x; WATSON J, 1997, GOLDEN EAGLE; White AT, 2000, MAR POLLUT BULL, V40, P598, DOI 10.1016/S0025-326X(00)00022-9; WIERSMA UJ, 1992, J OCCUP ORGAN PSYCH, V65, P101, DOI 10.1111/j.2044-8325.1992.tb00488.x; [No title captured]	59	14	14	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10688	10.1371/journal.pone.0010688	http://dx.doi.org/10.1371/journal.pone.0010688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	603QA	20523732	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221900003
J	Wikelski, M; Moxley, J; Eaton-Mordas, A; Lopez-Uribe, MM; Holland, R; Moskowitz, D; Roubik, DW; Kays, R				Wikelski, Martin; Moxley, Jerry; Eaton-Mordas, Alexander; Lopez-Uribe, Margarita M.; Holland, Richard; Moskowitz, David; Roubik, David W.; Kays, Roland			Large-Range Movements of Neotropical Orchid Bees Observed via Radio Telemetry	PLOS ONE			English	Article							EULAEMA-MERIANA HYMENOPTERA; EUGLOSSINE BEES; HARMONIC RADAR; POLLEN DISPERSAL; FORAGING RANGE; INSECT PESTS; FLIGHT; APIDAE; POLLINATORS; LANDSCAPE	Neotropical orchid bees (Euglossini) are often cited as classic examples of trapline-foragers with potentially extensive foraging ranges. If long-distance movements are habitual, rare plants in widely scattered locations may benefit from euglossine pollination services. Here we report the first successful use of micro radio telemetry to track the movement of an insect pollinator in a complex and forested environment. Our results indicate that individual male orchid bees (Exaerete frontalis) habitually use large rainforest areas (at least 42-115 ha) on a daily basis. Aerial telemetry located individuals up to 5 km away from their core areas, and bees were often stationary, for variable periods, between flights to successive localities. These data suggest a higher degree of site fidelity than what may be expected in a free living male bee, and has implications for our understanding of biological activity patterns and the evolution of forest pollinators.	[Wikelski, Martin; Holland, Richard] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Wikelski, Martin; Moxley, Jerry] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Eaton-Mordas, Alexander] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Lopez-Uribe, Margarita M.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Moskowitz, David] EcolSciences Inc, Rockaway, NJ USA; [Wikelski, Martin; Roubik, David W.; Kays, Roland] Smithsonian Trop Res Inst, Balboa, Panama; [Kays, Roland] New York State Museum & Sci Serv, Albany, NY USA	Max Planck Society; Princeton University; University of Arizona; Cornell University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wikelski, M (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	rkays@mail.nysed.gov	Holland, Richard A/A-6107-2010	Holland, Richard A/0000-0003-4495-8061; Kays, Roland/0000-0002-2947-6665	US Environmental Protection Agency; New York State Museum; EcolSciences, Inc.; Smithsonian Tropical Research Institute; National Geographic Society	US Environmental Protection Agency(United States Environmental Protection Agency); New York State Museum; EcolSciences, Inc.; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); National Geographic Society(National Geographic Society)	The study was supported by the US Environmental Protection Agency, New York State Museum, EcolSciences, Inc., Smithsonian Tropical Research Institute and the National Geographic Society. EcolSciences, as the only commercial company among the funding organizations, had a role in the analysis, decision to publish, and preparation of the manuscript through the involvment of David Moskowitz.	ACKERMAN JD, 1982, BIOTROPICA, V14, P241, DOI 10.2307/2388080; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P299; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Boiteau G, 2009, ENVIRON ENTOMOL, V38, P168, DOI 10.1603/022.038.0121; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Borrell BJ, 2007, AM NAT, V169, P569, DOI 10.1086/512689; Brosi BJ, 2007, ECOL APPL, V17, P418, DOI 10.1890/06-0029; Cameron SA, 2004, ANNU REV ENTOMOL, V49, P377, DOI 10.1146/annurev.ento.49.072103.115855; Cameron SA, 2001, J KANSAS ENTOMOL SOC, V74, P142; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Combes SA, 2005, INTEGR COMP BIOL, V45, P980; Darveau CA, 2005, J EXP BIOL, V208, P3593, DOI 10.1242/jeb.01777; Darwin C, 1862, FERTILIZATION ORCHID; Degen B, 2004, BIOTROPICA, V36, P165; Dillon ME, 2004, J EXP BIOL, V207, P417, DOI 10.1242/jeb.00777; DODSON CH, 1969, SCIENCE, V164, P1243, DOI 10.1126/science.164.3885.1243; DODSON CH, 1970, BIOCH COEVOLUTION RO; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; DUDLEY R, 1995, J EXP BIOL, V198, P1065; Eltz T, 1999, J CHEM ECOL, V25, P157, DOI 10.1023/A:1020897302355; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hedin J, 2002, COMPUT ELECTRON AGR, V35, P171, DOI 10.1016/S0168-1699(02)00017-0; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; JANZEN DH, 1982, ECOLOGY, V63, P66, DOI 10.2307/1937032; Jarau S, 2009, CONTEMP TOP ENTOMOL, P1, DOI 10.1201/9781420075618; Keller L, 2007, AM NAT, V169, P1, DOI 10.1086/509938; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2004, J ANIM ECOL, V73, P517, DOI 10.1111/j.0021-8790.2004.00826.x; KROODSMA D E, 1975, Biotropica, V7, P71, DOI 10.2307/2989803; MacLeod A, 2002, CROP PROT, V21, P635, DOI 10.1016/S0261-2194(02)00016-9; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; PEDGLEY DE, 1993, INT J PEST MANAGE, V39, P3, DOI 10.1080/09670879309371751; Pemberton RW, 2006, ECOLOGY, V87, P1995, DOI 10.1890/0012-9658(2006)87[1995:OBDNOE]2.0.CO;2; RAW A, 1989, Revista Brasileira de Entomologia, V33, P103; Roubik D.W., 1989, ECOLOGY NATURAL HIST, DOI DOI 10.1126/SCIENCE.248.4958.1026; Roubik D. W., 2004, ORCHID BEES TROPICAL; Roubik DW, 1999, J KANSAS ENTOMOL SOC, V72, P394; ROUBIK DW, 1995, APIDOLOGIE, V26, P197, DOI 10.1051/apido:19950303; ROUBIK DW, 1983, J KANSAS ENTOMOL SOC, V56, P217; ROUBIK DW, 1993, J INSECT BEHAV, V6, P659, DOI 10.1007/BF01201668; Simpkin JL, 2000, WEST N AM NATURALIST, V60, P320; STERN DL, 1991, J KANSAS ENTOMOL SOC, V64, P421; Sword GA, 2005, NATURE, V433, P703, DOI 10.1038/433703a; Tonhasca A, 2002, BIOTROPICA, V34, P416, DOI 10.1111/j.1744-7429.2002.tb00555.x; von Frisch K, 1942, NATURWISSENSCHAFTEN, V30, P269; White G.C., 1990, ANAL WILDLIFE RADIO; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Willmer PG, 2004, ADV STUD BEHAV, V34, P347, DOI 10.1016/S0065-3454(04)34009-X	53	109	114	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10738	10.1371/journal.pone.0010738	http://dx.doi.org/10.1371/journal.pone.0010738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520813	Green Published, gold, Green Submitted			2022-12-25	WOS:000278221500005
J	Fiorillo, E; Orru, V; Stanford, SM; Liu, YG; Salek, M; Rapini, N; Schenone, AD; Saccucci, P; Delogu, LG; Angelini, F; Bitti, MLM; Schmedt, C; Chan, AC; Acuto, O; Bottini, N				Fiorillo, Edoardo; Orru, Valeria; Stanford, Stephanie M.; Liu, Yingge; Salek, Mogjiborahman; Rapini, Novella; Schenone, Aaron D.; Saccucci, Patrizia; Delogu, Lucia G.; Angelini, Federica; Bitti, Maria Luisa Manca; Schmedt, Christian; Chan, Andrew C.; Acuto, Oreste; Bottini, Nunzio			Autoimmune-associated PTPN22 R620W Variation Reduces Phosphorylation of Lymphoid Phosphatase on an Inhibitory Tyrosine Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; TERMINAL SRC KINASE; T-CELLS; PROTEIN; PHOSPHOTYROSINE; ACTIVATION; PEPTIDE; VARIANT; DOMAIN; PEP	A missense C1858T single nucleotide polymorphism in the PTPN22 gene recently emerged as a major risk factor for human autoimmunity. PTPN22 encodes the lymphoid tyrosine phosphatase (LYP), which forms a complex with the kinase Csk and is a critical negative regulator of signaling through the T cell receptor. The C1858T single nucleotide polymorphism results in the LYP-R620W variation within the LYP-Csk interaction motif. LYP-W620 exhibits a greatly reduced interaction with Csk and is a gain-of-function inhibitor of signaling. Here we show that LYP constitutively interacts with its substrate Lck in a Csk-dependent manner. T cell receptor-induced phosphorylation of LYP by Lck on an inhibitory tyrosine residue releases tonic inhibition of signaling by LYP. The R620W variation disrupts the interaction between Lck and LYP, leading to reduced phosphorylation of LYP, which ultimately contributes to gain-of-function inhibition of T cell signaling.	[Stanford, Stephanie M.; Schenone, Aaron D.; Bottini, Nunzio] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Fiorillo, Edoardo; Orru, Valeria; Stanford, Stephanie M.; Liu, Yingge; Delogu, Lucia G.; Bottini, Nunzio] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Salek, Mogjiborahman; Acuto, Oreste] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Rapini, Novella; Angelini, Federica; Bitti, Maria Luisa Manca] Tor Vergata Univ, Dept Pediat, I-00133 Rome, Italy; [Saccucci, Patrizia] Tor Vergata Univ, Dept Biopathol, I-00133 Rome, Italy; [Schmedt, Christian] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Chan, Andrew C.] Genentech Inc, Div Immunol, San Francisco, CA 94080 USA	La Jolla Institute for Immunology; University of Southern California; University of Oxford; University of Rome Tor Vergata; University of Rome Tor Vergata; Novartis; Roche Holding; Genentech	Bottini, N (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	nunzio@liai.org	Fiorillo, Edoardo/AAY-3804-2020; Valeria, Orru/AAY-3805-2020; Delogu, Lucia Gemma/AAM-9078-2020; novella, rapini/AAA-7970-2020; Ingegnoli, Francesca/B-6226-2017	Delogu, Lucia Gemma/0000-0002-2329-7260; novella, rapini/0000-0002-3104-5776; Ingegnoli, Francesca/0000-0002-6727-1273; Salek, Mogjiborahman/0000-0002-6664-4752; Orru, Valeria/0000-0002-6047-4625	National Institutes of Health [R01AI070544]; Juvenile Diabetes Research Foundation [1-2005-342]; Sardinian Regional Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Sardinian Regional Government(Regione Sardegna); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI070544 (to N. B.). This work was also supported by Juvenile Diabetes Research Foundation Grant 1-2005-342. This is manuscript 1298 from the La Jolla Institute for Allergy and Immunology.; Supported by Master and Back Fellowships from the Sardinian Regional Government.; Supported by the National Institutes of Health Training Grant in Cellular, Biochemical, and Molecular Biology at the University of Southern California.	Aarnisalo J, 2008, J AUTOIMMUN, V31, P13, DOI 10.1016/j.jaut.2008.01.001; Aoki N, 2004, J BIOL CHEM, V279, P10765, DOI 10.1074/jbc.M310401200; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hill RJ, 2002, EXP HEMATOL, V30, P237, DOI 10.1016/S0301-472X(01)00794-9; KIM JS, 1993, PROTEIN SCI, V2, P348; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; Liu YG, 2009, BIOCHEMISTRY-US, V48, P7525, DOI 10.1021/bi900332f; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Methi T, 2005, J IMMUNOL, V175, P7398, DOI 10.4049/jimmunol.175.11.7398; Mitra S, 2005, BIOORG MED CHEM LETT, V15, P5142, DOI 10.1016/j.bmcl.2005.08.054; Mitra S, 2007, ANAL BIOCHEM, V370, P249, DOI 10.1016/j.ab.2007.06.012; Nielsen C, 2007, GENES IMMUN, V8, P131, DOI 10.1038/sj.gene.6364369; Rahmouni S, 2005, MOL CELL BIOL, V25, P2227, DOI 10.1128/MCB.25.6.2227-2241.2005; Read RD, 2004, MOL CELL BIOL, V24, P6676, DOI 10.1128/mcb.24.15.6676-6689.2004; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Saito K, 2007, J BIOL CHEM, V282, P15170, DOI 10.1074/jbc.M608682200; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Taylor PJ, 1997, WOOL TECH SHEEP BREE, V45, P92; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200	41	74	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26506	26518		10.1074/jbc.M110.111104	http://dx.doi.org/10.1074/jbc.M110.111104			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538612	Green Published, hybrid			2022-12-25	WOS:000280921000068
J	McMichael, BK; Meyer, SM; Lee, BS				McMichael, Brooke K.; Meyer, Stephanie M.; Lee, Beth S.			c-Src-mediated Phosphorylation of Thyroid Hormone Receptor-interacting Protein 6 (TRIP6) Promotes Osteoclast Sealing Zone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIM DOMAIN PROTEINS; VACUOLAR H+-ATPASE; LYSOPHOSPHATIDIC ACID; BONE; PODOSOMES; EXPRESSION; OSTEOPETROSIS; LOCALIZATION; ORGANIZATION; P130(CAS)	Osteoclasts resorb bone through the formation of a unique attachment structure called the sealing zone. In this study, a role for thyroid hormone receptor-interacting protein 6 (TRIP6) in sealing zone formation and osteoclast activity was examined. TRIP6 was shown to reside in the sealing zone through its association with tropomyosin 4, an actin-binding protein that regulates sealing dimensions and bone resorptive capacity. Suppression of TRIP6 in mature osteoclasts by RNA interference altered sealing zone dimensions and inhibited bone resorption, whereas overexpression of TRIP6 increased the sealing zone perimeter and enhanced bone resorption. Treatment of osteoclasts with lysophosphatidic acid (LPA), which phosphorylates TRIP6 at tyrosine 55 through a c-Src-dependent mechanism, caused increased association of TRIP6 with the sealing zone, as did overexpression of a TRIP6 cDNA bearing a phosphomimetic mutation at tyrosine 55. Further, LPA treatment caused increases in osteoclast fusion, sealing zone perimeter, and bone resorptive capacity. In contrast, overexpression of TRIP6 containing a nonphosphorylatable amino acid residue at position 55 severely diminished sealing zone formation and bone resorption and suppressed the effects of LPA on the cytoskeleton. LPA effects were mediated through its receptor isoform LPA(2), as indicated by treatments with receptor-specific agonists and antagonists. Thus, these studies suggest that TRIP6 is a critical downstream regulator of c-Src signaling and that its phosphorylation is permissive for its presence in the sealing zone where it plays a positive role in osteoclast bone resorptive capacity.	[McMichael, Brooke K.; Meyer, Stephanie M.; Lee, Beth S.] Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Lee, BS (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387	Campus Microscopy and Imaging Facility at the Ohio State University	Campus Microscopy and Imaging Facility at the Ohio State University	We thank the Campus Microscopy and Imaging Facility at the Ohio State University for continued technical advice and support.	Bai CY, 2007, J CELL SCI, V120, P2828, DOI 10.1242/jcs.03477; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Chastre E, 2009, FASEB J, V23, P916, DOI 10.1096/fj.08-106344; Chellaiah MA, 2006, EUR J CELL BIOL, V85, P311, DOI 10.1016/j.ejcb.2006.01.008; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; E SY, 2009, J BIOL CHEM, V284, P14558, DOI 10.1074/jbc.M900185200; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Hurst-Kennedy J, 2009, BBA-MOL CELL RES, V1793, P836, DOI 10.1016/j.bbamcr.2009.01.020; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Karagiosis SA, 2007, BIOCHEM BIOPH RES CO, V357, P194, DOI 10.1016/j.bbrc.2007.03.121; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; Krits I, 2002, CALCIFIED TISSUE INT, V71, P530, DOI 10.1007/s00223-001-1112-0; Lai YJ, 2005, MOL CELL BIOL, V25, P5859, DOI 10.1128/MCB.25.14.5859-5868.2005; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee BS, 1999, J BONE MINER RES, V14, P2127, DOI 10.1359/jbmr.1999.14.12.2127; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Masiello LM, 2006, BONE, V39, P72, DOI 10.1016/j.bone.2005.12.013; McMichael BK, 2008, EXP CELL RES, V314, P564, DOI 10.1016/j.yexcr.2007.10.018; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; McMichael BK, 2010, J BIOL CHEM, V285, P9506, DOI 10.1074/jbc.M109.017269; McMichael BK, 2009, J BIOL CHEM, V284, P12266, DOI 10.1074/jbc.M808621200; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nakamura I, 1998, J BIOL CHEM, V273, P11144, DOI 10.1074/jbc.273.18.11144; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang Y, 2001, BBA-MOL CELL RES, V1538, P260, DOI 10.1016/S0167-4889(01)00077-5; Wang Y, 2003, BBA-MOL CELL RES, V1593, P115, DOI 10.1016/S0167-4889(02)00349-X; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Yi JS, 2002, J BIOL CHEM, V277, P9580, DOI 10.1074/jbc.M106922200; Zhao MK, 1999, GENE EXPRESSION, V8, P207; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	41	19	21	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26641	26651		10.1074/jbc.M110.119909	http://dx.doi.org/10.1074/jbc.M110.119909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547766	Green Published, hybrid			2022-12-25	WOS:000280921000079
J	Wetzelberger, K; Baba, SP; Thirunavukkarasu, M; Ho, YS; Maulik, N; Barski, OA; Conklin, DJ; Bhatnagar, A				Wetzelberger, Karin; Baba, Shahid P.; Thirunavukkarasu, Mahesh; Ho, Ye-Shih; Maulik, Nilanjana; Barski, Oleg A.; Conklin, Daniel J.; Bhatnagar, Aruni			Postischemic Deactivation of Cardiac Aldose Reductase ROLE OF GLUTATHIONE S-TRANSFERASE P AND GLUTAREDOXIN IN REGENERATION OF REDUCED THIOLS FROM SULFENIC ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-RADICAL GENERATION; MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA-REPERFUSION INJURY; TYROSINE-PHOSPHATASE 1B; CYSTEINE-SULFINIC ACID; REDOX REGULATION; SULFENIC ACID; STUNNED MYOCARDIUM; LIPID-PEROXIDATION; NITRIC-OXIDE	Aldose reductase (AR) is a multifunctional enzyme that catalyzes the reduction of glucose and lipid peroxidation-derived aldehydes. During myocardial ischemia, the activity of AR is increased due to the oxidation of its cysteine residues to sulfenic acids. It is not known, however, whether the activated, sulfenic form of the protein (AR-SOH) is converted back to its reduced, unactivated state (AR-SH). We report here that in perfused mouse hearts activation of AR during 15 min of global ischemia is completely reversed by 30 min of reperfusion. During reperfusion, AR-SOH was converted to a mixed disulfide (AR-SSG). Deactivation of AR and the appearance of AR-SSG during reperfusion were delayed in hearts of mice lacking glutathione S-transferase P (GSTP). In vitro, GSTP accelerated glutathiolation and inactivation of AR-SOH. Reduction of AR-SSG to AR-SH was facilitated by glutaredoxin (GRX). Ischemic activation of AR was increased in GRX-null hearts but was attenuated in the hearts of cardiospecific GRX transgenic mice. Incubation of AR-SSG with GRX led to the regeneration of the reduced form of the enzyme. In ischemic cardiospecific AR transgenic hearts, AR was co-immunoprecipitated with GSTP, whereas in reperfused hearts, the association of AR with GRX was increased. These findings suggest that upon reperfusion of the ischemic heart AR-SOH is converted to AR-SSG via GSTP-assisted glutathiolation. AR-SSG is then reduced by GRX to AR-SH. Sequential catalysis by GSTP and GRX may be a general redox switching mechanism that regulates the reduction of protein sulfenic acids to cysteines.	[Conklin, Daniel J.; Bhatnagar, Aruni] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA; [Thirunavukkarasu, Mahesh; Maulik, Nilanjana] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT 06030 USA; [Ho, Ye-Shih] Wayne State Univ, Coll Pharm & Hlth Sci, Detroit, MI 48201 USA	University of Louisville; University of Connecticut; Wayne State University	Bhatnagar, A (corresponding author), Univ Louisville, Diabet & Obes Ctr, 580 S Preston St,Delia Baxter Bldg,Rm 421, Louisville, KY 40202 USA.	aruni@lousiville.edu			National Institutes of Health [HL55477, HL59378, HL78825, HL89380, HL893802S1, RR024489]; America Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078825, R01HL089380, R01HL055477, R01HL059378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); America Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL55477, HL59378, HL78825, HL89380, HL893802S1, and RR024489. This work was also supported by a postdoctoral fellowship from the America Heart Association (to K.W.).	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Ananthakrishnan R, 2009, AM J PHYSIOL-HEART C, V296, pH333, DOI 10.1152/ajpheart.01012.2008; Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; Awasthi Y. C., 2007, TOXICOLOGY GLUTATHIO; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; BHATNAGAR A, 1990, BIOCHEM PHARMACOL, V39, P1115, DOI 10.1016/0006-2952(90)90292-S; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; BOLLI R, 1995, J CLIN INVEST, V96, P1066, DOI 10.1172/JCI118093; BOLLI R, 1989, CIRC RES, V65, P607, DOI 10.1161/01.RES.65.3.607; Bolli R, 1998, PROG CARDIOVASC DIS, V40, P477, DOI 10.1016/S0033-0620(98)80001-7; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513; Conklin DJ, 2009, AM J PHYSIOL-HEART C, V296, pH1586, DOI 10.1152/ajpheart.00867.2008; Conklin DJ, 2008, CIRCULATION, V118, pS546; Fernandez-Irigoyen J, 2008, BIOCHEM J, V411, P457, DOI 10.1042/BJ20071569; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Guo Y, 1999, P NATL ACAD SCI USA, V96, P11507, DOI 10.1073/pnas.96.20.11507; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Hill BG, 2007, IUBMB LIFE, V59, P21, DOI 10.1080/15216540701196944; Hill BG, 2009, BIOCHEM J, V417, P513, DOI 10.1042/BJ20081615; Hwang YC, 2001, FASEB J, V15, P243, DOI 10.1096/fj.01-0368fje; Hwang YYC, 2005, FASEB J, V19, P795, DOI 10.1096/fj.04-2780fje; Kaiserova K, 2008, J BIOL CHEM, V283, P9101, DOI 10.1074/jbc.M709671200; Kaiserova K, 2006, J BIOL CHEM, V281, P15110, DOI 10.1074/jbc.M600837200; Keith RJ, 2009, CHEM-BIOL INTERACT, V178, P242, DOI 10.1016/j.cbi.2008.10.055; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; LI XY, 1993, J CLIN INVEST, V92, P1025, DOI 10.1172/JCI116608; Malik G, 2008, J MOL CELL CARDIOL, V44, P261, DOI 10.1016/j.yjmcc.2007.08.022; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Spite M, 2007, BIOCHEM J, V405, P95, DOI 10.1042/BJ20061743; Srivastava S, 1999, BIOCHEMISTRY-US, V38, P42, DOI 10.1021/bi981794l; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; TORTOLANI AJ, 1993, FREE RADICAL BIO MED, V14, P421, DOI 10.1016/0891-5849(93)90091-8; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; West MB, 2008, CIRCULATION, V118, P1970, DOI 10.1161/CIRCULATIONAHA.108.791533; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; XIA Y, 1995, J BIOL CHEM, V270, P18797, DOI 10.1074/jbc.270.32.18797	52	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26135	26148		10.1074/jbc.M110.146423	http://dx.doi.org/10.1074/jbc.M110.146423			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538586	Green Published, hybrid			2022-12-25	WOS:000280921000031
J	Heise, CJ; Xu, BE; Deaton, SL; Cha, SK; Cheng, CJ; Earnest, S; Sengupta, S; Juang, YC; Stippec, S; Xu, YD; Zhao, YM; Huang, CL; Cobb, MH				Heise, Charles J.; Xu, Bing-e; Deaton, Staci L.; Cha, Seung-Kuy; Cheng, Chih-Jen; Earnest, Svetlana; Sengupta, Samarpita; Juang, Yu-Chi; Stippec, Steve; Xu, Yingda; Zhao, Yingming; Huang, Chou-Long; Cobb, Melanie H.			Serum and Glucocorticoid-induced Kinase (SGK) 1 and the Epithelial Sodium Channel Are Regulated by Multiple with No Lysine (WNK) Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-CL COTRANSPORTER; BLOOD-PRESSURE; ACTIVATES SGK1; IN-VITRO; HYPERTENSION; GENE; K+; PHOSPHORYLATION; HYPERKALEMIA; PATHOGENESIS	The four WNK (with no lysine (K)) protein kinases affect ion balance and contain an unusual protein kinase domain due to the unique placement of the active site lysine. Mutations in two WNKs cause a heritable form of ion imbalance culminating in hypertension. WNK1 activates the serum- and glucocorticoid-induced protein kinase SGK1; the mechanism is noncatalytic. SGK1 increases membrane expression of the epithelial sodium channel (ENaC) and sodium reabsorption via phosphorylation and sequestering of the E3 ubiquitin ligase neural precursor cell expressed, developmentally down-regulated 4-2 (Nedd4-2), which otherwise promotes ENaC endocytosis. Questions remain about the intrinsic abilities of WNK family members to regulate this pathway. We find that expression of the N termini of all four WNKs results in modest to strong activation of SGK1. In reconstitution experiments in the same cell line all four WNKs also increase sodium current blocked by the ENaC inhibitor amiloride. The N termini of the WNKs also have the capacity to interact with SGK1. More detailed analysis of activation by WNK4 suggests mechanisms in common with WNK1. Further evidence for the importance of WNK1 in this process comes from the ability of Nedd4-2 to bind to WNK1 and the finding that endogenous SGK1 has reduced activity if WNK1 is knocked down by small interfering RNA.	[Heise, Charles J.; Xu, Bing-e; Deaton, Staci L.; Earnest, Svetlana; Sengupta, Samarpita; Juang, Yu-Chi; Stippec, Steve; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Cha, Seung-Kuy; Cheng, Chih-Jen; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Xu, Yingda; Zhao, Yingming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	melanie.Cobb@utsouthwestern.edu	Cheng, Chih-Jen/AAM-3305-2021	Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [GM53032, DK59530]; University of Texas Southwestern O'Brien Center [DK79328, CA126832]; Robert A. Welch Foundation [I1243]; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059530, P30DK079328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern O'Brien Center; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM53032 (to M.H.C.) and DK59530 (to C.-L.H.), University of Texas Southwestern O'Brien Center Grant DK79328, Grant CA126832 (to Y.Z.), and Robert A. Welch Foundation Grant I1243 (to M.H.C.).	Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kahle KT, 2004, CURR OPIN NEPHROL HY, V13, P557, DOI 10.1097/00041552-200409000-00012; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Leng Q, 2006, J PHYSIOL-LONDON, V571, P275, DOI 10.1113/jphysiol.2005.102202; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Newhouse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005003; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4020, DOI 10.1073/pnas.0611727104; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Subramanya AR, 2006, KIDNEY INT, V70, P630, DOI 10.1038/sj.ki.5001634; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xie J, 2006, PEDIATR NEPHROL, V21, P1231, DOI 10.1007/s00467-006-0106-6; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yang CL, 2007, BIOCHEM BIOPH RES CO, V353, P535, DOI 10.1016/j.bbrc.2006.11.151; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	41	58	68	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25161	25167		10.1074/jbc.M110.103432	http://dx.doi.org/10.1074/jbc.M110.103432			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20525693	Green Published, hybrid			2022-12-25	WOS:000280682400008
J	Lapierre, DM; Tanabe, N; Pereverzev, A; Spencer, M; Shugg, RPP; Dixon, SJ; Sims, SM				Lapierre, Danielle M.; Tanabe, Natsuko; Pereverzev, Alexey; Spencer, Martha; Shugg, Ryan P. P.; Dixon, S. Jeffrey; Sims, Stephen M.			Lysophosphatidic Acid Signals through Multiple Receptors in Osteoclasts to Elevate Cytosolic Calcium Concentration, Evoke Retraction, and Promote Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; NF-KAPPA-B; PROTEIN-KINASE-C; EXPRESSION; RHO; CALCITONIN; INFLAMMATION; PATHOGENESIS; REQUIREMENT; OSTEOBLASTS	Lysophosphatidic acid (LPA) is a bioactive phospholipid whose functions are mediated by multiple G protein-coupled receptors. We have shown that osteoblasts produce LPA, raising the possibility that it mediates intercellular signaling among osteoblasts and osteoclasts. Here we investigated the expression, signaling and function of LPA receptors in osteoclasts. Focal application of LPA elicited transient increases in cytosolic calcium concentration ([Ca2+](i)), with 50% of osteoclasts responding at similar to 400 nM LPA. LPA-induced elevation of [Ca2+](i) was blocked by pertussis toxin or the LPA(1/3) receptor antagonist VPC-32183. LPA caused sustained retraction of osteoclast lamellipodia and disrupted peripheral actin belts. Retraction was insensitive to VPC-32183 or pertussis toxin, indicating involvement of a distinct signaling pathway. In this regard, inhibition of Rho-associated kinase stimulated respreading after LPA-induced retraction. Real-time reverse transcription-PCR revealed transcripts encoding LPA(1) and to a lesser extent LPA(2), LPA(4), and LPA(5) receptor subtypes. LPA induced nuclear translocation of NFATc1 and enhanced osteoclast survival, effects that were blocked by VPC-32183 or by a specific peptide inhibitor of NFAT activation. LPA slightly reduced the resorptive activity of osteoclasts in vitro. Thus, LPA binds to at least two receptor subtypes on osteoclasts: LPA(1), which couples through G(i/o) to elevate [Ca2+](i), activate NFATc1, and promote survival, and a second receptor that likely couples through G(12/13) and Rho to evoke and maintain retraction through reorganization of the actin cytoskeleton. These findings reveal a signaling axis in bone through which LPA, produced by osteoblasts, acts on multiple receptor subtypes to induce pleiotropic effects on osteoclast activity and function.	[Lapierre, Danielle M.; Tanabe, Natsuko; Pereverzev, Alexey; Spencer, Martha; Shugg, Ryan P. P.; Dixon, S. Jeffrey; Sims, Stephen M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Tanabe, Natsuko] Nihon Univ, Sch Dent, Tokyo 1018310, Japan	Western University (University of Western Ontario); Nihon University	Sims, SM (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	stephen.sims@schulich.uwo.ca	Sims, Stephen/G-4510-2013; Dixon, S. Jeffrey/G-3657-2013	Dixon, S. Jeffrey/0000-0001-9162-1686	Canadian Institutes of Health Research; Nihon University School of Dentistry, Tokyo, Japan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nihon University School of Dentistry, Tokyo, Japan	This study was supported by the Canadian Institutes of Health Research.; Supported by the Sato Fund, Nihon University School of Dentistry, Tokyo, Japan.	Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Boyce BF, 1999, LAB INVEST, V79, P83; Boyce BF, 2005, J BONE MINER METAB, V23, P11, DOI 10.1007/BF03026317; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; CHAMBERS TJ, 1982, J PATHOL, V136, P27, DOI 10.1002/path.1711360104; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Graler MH, 2002, BBA-MOL CELL BIOL L, V1582, P168, DOI 10.1016/S1388-1981(02)00152-X; GRAVEL MR, 1994, J BONE MINER RES, V9, P1769; Grey A, 2001, ENDOCRINOLOGY, V142, P1098, DOI 10.1210/en.142.3.1098; Heasley BH, 2004, BIOORG MED CHEM LETT, V14, P2735, DOI 10.1016/j.bmcl.2004.03.076; Hikiji H, 2004, J CLIN INVEST, V114, P85, DOI 10.1172/JC1200420504; Hosogaya S, 2008, ANN CLIN BIOCHEM, V45, P364, DOI 10.1258/acb.2008.007242; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Komarova SV, 2003, CALCIFIED TISSUE INT, V73, P265, DOI 10.1007/s00223-002-1051-4; Korcok J, 2005, J BIOL CHEM, V280, P16909, DOI 10.1074/jbc.M410764200; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Masiello LM, 2006, BONE, V39, P72, DOI 10.1016/j.bone.2005.12.013; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Naemsch LN, 2001, J BIOL CHEM, V276, P39107, DOI 10.1074/jbc.M105881200; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Ory S, 2000, J CELL SCI, V113, P1177; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Panupinthu N, 2007, J BIOL CHEM, V282, P3403, DOI 10.1074/jbc.M605620200; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Sugimoto N, 2006, EXP CELL RES, V312, P1899, DOI 10.1016/j.yexcr.2006.02.020; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Weidema AF, 1997, J PHYSIOL-LONDON, V503, P303, DOI 10.1111/j.1469-7793.1997.303bh.x; Weidema AF, 2001, AM J PHYSIOL-CELL PH, V280, pC1531, DOI 10.1152/ajpcell.2001.280.6.C1531; WOOD DA, 1991, J BIOL CHEM, V266, P15369; Zhao CQ, 2008, MOL PHARMACOL, V73, P587, DOI 10.1124/mol.107.038216; ZHENG ZG, 1993, AM J PHYSIOL, V264, pE74, DOI 10.1152/ajpendo.1993.264.1.E74; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	48	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25792	25801		10.1074/jbc.M110.109322	http://dx.doi.org/10.1074/jbc.M110.109322			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551326	Green Published, hybrid			2022-12-25	WOS:000280682400071
J	Opacic, M; Vos, EPP; Hesp, BH; Broos, J				Opacic, Milena; Vos, Erwin P. P.; Hesp, Ben H.; Broos, Jaap			Localization of the Substrate-binding Site in the Homodimeric Mannitol Transporter, EIImtl, of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PHOSPHOTRANSFERASE SYSTEM; TRYPTOPHAN PHOSPHORESCENCE SPECTROSCOPY; TRANSIENT STATE KINETICS; 2ND-ORDER RATE CONSTANTS; CYTOPLASMIC B-DOMAIN; ENZYME-IIMTL; FLUORESCENCE DECAY; MEMBRANE TOPOLOGY; NMR-SPECTROSCOPY; ACTIVE-SITE	The mannitol transporter from Escherichia coli, EIImtl, belongs to a class of membrane proteins coupling the transport of substrates with their chemical modification. EIImtl is functional as a homodimer, and it harbors one high affinity mannitol-binding site in the membrane-embedded C domain (IICmtl). To localize this binding site, 19 single Trp-containing mutants of EIImtl were biosynthetically labeled with 5-fluorotryptophan (5-FTrp) and mixed with azi-mannitol, a substrate analog acting as a Forster resonance energy transfer (FRET) acceptor. Typically, for mutants showing FRET, only one 5-FTrp was involved, whereas the 5-FTrp from the other monomer was too distant. This proves that the mannitol-binding site is asymmetrically positioned in dimeric IICmtl. Combined with the available two-dimensional projection maps of IICmtl, it is concluded that a second resting binding site is present in this transporter. Active transport of mannitol only takes place when EIImtl becomes phosphorylated at Cys(384) in the cytoplasmic B domain. Stably phosphorylated EIImtl mutants were constructed, and FRET experiments showed that the position of mannitol in IICmtl remains the same. We conclude that during the transport cycle, the phosphorylated B domain has to move to the mannitol-binding site, located in the middle of the membrane, to phosphorylate mannitol.	[Opacic, Milena; Vos, Erwin P. P.; Broos, Jaap] Univ Groningen, Biophys Chem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Hesp, Ben H.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Broos, J (corresponding author), Univ Groningen, Biophys Chem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands.	j.broos@rug.nl	Institute, Zernike/W-7033-2019		Netherlands Foundation for Chemical Research; Netherlands Organization for the Advancement of Scientific Research	Netherlands Foundation for Chemical Research; Netherlands Organization for the Advancement of Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Foundation for Chemical Research with financial aid from the Netherlands Organization for the Advancement of Scientific Research.	Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; BOER H, 1995, BIOCHEMISTRY-US, V34, P3239, DOI 10.1021/bi00010a013; Boer H, 1996, BIOCHEMISTRY-US, V35, P12901, DOI 10.1021/bi9611016; Broos J, 2003, PROTEIN SCI, V12, P1991, DOI 10.1110/ps.03142003; Broos J, 2002, J AM CHEM SOC, V124, P6812, DOI 10.1021/ja017812v; Broos J, 2004, J AM CHEM SOC, V126, P22, DOI 10.1021/ja0385585; Broos J, 2000, BIOCHEMISTRY-US, V39, P10877, DOI 10.1021/bi000803z; Dijkstra DS, 1996, BIOCHEMISTRY-US, V35, P6628; Dijkstra DS, 1996, ANAL BIOCHEM, V240, P142, DOI 10.1006/abio.1996.0341; ELFERINK MGL, 1990, J BACTERIOL, V172, P7119, DOI 10.1128/jb.172.12.7119-7125.1990; ERNI B, 1992, INT REV CYTOL, V137A, P127; Erni B, 2006, J BACTERIOL, V188, P7036, DOI 10.1128/JB.01074-06; HAAS E, 1978, BIOCHEMISTRY-US, V17, P5064, DOI 10.1021/bi00616a032; Koning RI, 1999, J MOL BIOL, V287, P845, DOI 10.1006/jmbi.1999.2650; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Legler PM, 2004, J BIOL CHEM, V279, P39115, DOI 10.1074/jbc.M406764200; LEHMANN J, 1993, CARBOHYD RES, V239, P133, DOI 10.1016/0008-6215(93)84209-O; LENGELER JW, 1994, BBA-BIOENERGETICS, V1188, P1, DOI 10.1016/0005-2728(94)90017-5; Liu TQ, 2005, J AM CHEM SOC, V127, P4104, DOI 10.1021/ja043154d; LOLKEMA JS, 1990, BIOCHEMISTRY-US, V29, P10120, DOI 10.1021/bi00495a016; LOLKEMA JS, 1992, BIOCHEMISTRY-US, V31, P5514, DOI 10.1021/bi00139a013; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P6716, DOI 10.1021/bi00241a012; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Meadow ND, 2005, J BIOL CHEM, V280, P41872, DOI 10.1074/jbc.M501440200; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Meadow ND, 2005, BIOCHEMISTRY-US, V44, P12790, DOI 10.1021/bi0502846; Meijberg W, 1998, J BIOL CHEM, V273, P7949, DOI 10.1074/jbc.273.14.7949; Nguyen TX, 2006, J MOL MICROB BIOTECH, V11, P345, DOI 10.1159/000095636; NIKAIDO H, 1992, SCIENCE, V258, P936, DOI 10.1126/science.1279804; Otte S, 2003, J BACTERIOL, V185, P2267, DOI 10.1128/JB.185.7.2267-2276.2003; Otten R, 2004, J BIOMOL NMR, V30, P461, DOI 10.1007/s10858-004-3498-2; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; REMAUT E, 1981, GENE, V15, P81, DOI 10.1016/0378-1119(81)90106-2; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; ROBILLARD GT, 1987, BIOCHEMISTRY-US, V26, P5796, DOI 10.1021/bi00392a032; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; ROOSSIEN FF, 1984, BIOCHEMISTRY-US, V23, P211, DOI 10.1021/bi00297a006; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; SaraceniRichards CA, 1997, J BACTERIOL, V179, P1135, DOI 10.1128/jb.179.4.1135-1142.1997; SaraceniRichards CA, 1997, J BACTERIOL, V179, P5171, DOI 10.1128/jb.179.16.5171-5177.1997; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; SUGIYAMA JE, 1991, P NATL ACAD SCI USA, V88, P9603, DOI 10.1073/pnas.88.21.9603; Suh JY, 2005, J MOL BIOL, V353, P1129, DOI 10.1016/j.jmb.2005.09.033; Toptygin D, 2002, J PHYS CHEM B, V106, P3724, DOI 10.1021/jp0133889; van Montfort BA, 2002, J BIOL CHEM, V277, P14717, DOI 10.1074/jbc.M201533200; van Montfort RLM, 1998, STRUCTURE, V6, P377, DOI 10.1016/S0969-2126(98)00039-2; Veldhuis G, 2005, J BIOL CHEM, V280, P35148, DOI 10.1074/jbc.M507061200; Veldhuis G, 2005, BIOPHYS J, V89, P201, DOI 10.1529/biophysj.105.062877; Veldhuis G, 2004, BIOPHYS J, V86, P1959, DOI 10.1016/S0006-3495(04)74259-9; Vervoort EB, 2005, J MOL BIOL, V346, P733, DOI 10.1016/j.jmb.2004.12.011; Visser NV, 2009, FEBS LETT, V583, P2785, DOI 10.1016/j.febslet.2009.07.022; Vos EPP, 2009, BIOCHEMISTRY-US, V48, P5284, DOI 10.1021/bi8020668; Vos EPP, 2009, BBA-BIOMEMBRANES, V1788, P581, DOI 10.1016/j.bbamem.2008.10.008; Winkler GR, 2006, J PHYS CHEM B, V110, P7058, DOI 10.1021/jp060043n; Yagur-Kroll S, 2005, J BIOL CHEM, V280, P19306, DOI 10.1074/jbc.M410896200	56	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25324	25331		10.1074/jbc.M110.122523	http://dx.doi.org/10.1074/jbc.M110.122523			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20522557	hybrid, Green Published			2022-12-25	WOS:000280682400025
J	Alzamora, R; Thali, RF; Gong, F; Smolak, C; Li, H; Baty, CJ; Bertrand, CA; Auchli, Y; Brunisholz, RA; Neumann, D; Hallows, KR; Pastor-Soler, NM				Alzamora, Rodrigo; Thali, Ramon F.; Gong, Fan; Smolak, Christy; Li, Hui; Baty, Catherine J.; Bertrand, Carol A.; Auchli, Yolanda; Brunisholz, Rene A.; Neumann, Dietbert; Hallows, Kenneth R.; Pastor-Soler, Nuria M.			PKA Regulates Vacuolar H+-ATPase Localization and Activity via Direct Phosphorylation of the A Subunit in Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; ACTIVATED PROTEIN-KINASE; RENAL EPITHELIAL-CELLS; MALE REPRODUCTIVE-TRACT; TRANSLOCATING ADENOSINE-TRIPHOSPHATASE; INTRACELLULAR PH REGULATION; EPIDIDYMAL CLEAR CELLS; YEAST V-ATPASE; INTERCALATED CELLS; URINARY ACIDIFICATION	The vacuolar H+-ATPase (V-ATPase) is a major contributor to luminal acidification in epithelia of Wolffian duct origin. In both kidney-intercalated cells and epididymal clear cells, cAMP induces V-ATPase apical membrane accumulation, which is linked to proton secretion. We have shown previously that the A subunit in the cytoplasmic V-1 sector of the V-ATPase is phosphorylated by protein kinase A (PKA). Here we have identified by mass spectrometry and mutagenesis that Ser-175 is the major PKA phosphorylation site in the A subunit. Overexpression in HEK-293T cells of either a wild-type (WT) or phosphomimic Ser-175 to Asp (S175D) A subunit mutant caused increased acidification of HCO3--containing culture medium compared with cells expressing vector alone or a PKA phosphorylation-deficient Ser-175 to Ala (S175A) mutant. Moreover, localization of the S175A A subunit mutant expressed in HEK-293T cells was more diffusely cytosolic than that of WT or S175D A subunit. Acute V-ATPase-mediated, bafilomycin-sensitive H+ secretion was up-regulated by a specific PKA activator in HEK-293T cells expressing WTA subunit in HCO3--free buffer. In cells expressing the S175D mutant, V-ATPase activity at the membrane was constitutively up-regulated and unresponsive to PKA activators, whereas cells expressing the S175A mutant had decreased V-ATPase activity that was unresponsive to PKA activation. Finally, Ser-175 was necessary for PKA-stimulated apical accumulation of the V-ATPase in a polarized rabbit cell line of collecting duct A-type intercalated cell characteristics (Clone C). In summary, these results indicate a novel mechanism for the regulation of V-ATPase localization and activity in kidney cells via direct PKA-dependent phosphorylation of the A subunit at Ser-175.	[Hallows, Kenneth R.; Pastor-Soler, Nuria M.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15263 USA; [Baty, Catherine J.; Bertrand, Carol A.; Hallows, Kenneth R.; Pastor-Soler, Nuria M.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Cell Biol & Physiol, Pittsburgh, PA 15263 USA; [Thali, Ramon F.; Neumann, Dietbert] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Auchli, Yolanda; Brunisholz, Rene A.] Univ Zurich, FGCZ, CH-8057 Zurich, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Hallows, KR (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, S976-1 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15263 USA.	hallows@pitt.edu	gong, fan/K-6004-2013; Hallows, Kenneth/A-8477-2013; gong, fan/F-2376-2010; Li, Hui/J-9884-2013	Hallows, Kenneth/0000-0002-2964-2440; Neumann, Dietbert/0000-0002-4316-684X	National Institutes of Health [P30 DK079307, R01 DK-075048, R01 DK-084184]; American Society of Nephrology Carl W. Gottschalk Research Scholar Award; American Heart Association [09GRNT2060539]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048, P30DK079307, R01DK084184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology Carl W. Gottschalk Research Scholar Award; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 DK079307 (to the Pittsburgh Kidney Research Center), R01 DK-075048 (to K. R. H.), and R01 DK-084184 (to N. M. P. -S.), the American Society of Nephrology Carl W. Gottschalk Research Scholar Award (to N. M. P. -S.), American Heart Association Grants AHA 09GRNT2060539 (to N. M. P. -S.) and 0825540D (to R. A.), Cystic Fibrosis Foundation Grant CFF R883-CR02 (to C. A. B.), Swiss National Science Foundation Grant 3100A0-11437/1, European Union FP6 contract LSHM-CT-2004-005272 (EXGENESIS), and a graduate training fellowship ETHIIRA from ETH Zurich (to R. F. T.).	Ahlin G, 2009, DRUG METAB DISPOS, V37, P2275, DOI 10.1124/dmd.109.028654; AlAwqati Q, 1996, AM J PHYSIOL-CELL PH, V270, pC1571, DOI 10.1152/ajpcell.1996.270.6.C1571; BASTANI B, 1991, J CLIN INVEST, V88, P126, DOI 10.1172/JCI115268; Beaulieu V, 2005, J BIOL CHEM, V280, P8452, DOI 10.1074/jbc.M412750200; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; BORON WF, 1986, ANNU REV PHYSIOL, V48, P377; Bouley R, 2005, AM J PHYSIOL-RENAL, V288, pF1103, DOI 10.1152/ajprenal.00337.2004; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; BROWN D, 1988, J CLIN INVEST, V82, P2114, DOI 10.1172/JCI113833; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Dames P, 2006, P NATL ACAD SCI USA, V103, P3926, DOI 10.1073/pnas.0600011103; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; DOBYAN DC, 1982, ANAT REC, V204, P185, DOI 10.1002/ar.1092040303; EDWARDS JC, 1992, AM J PHYSIOL, V263, pC521, DOI 10.1152/ajpcell.1992.263.2.C521; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gao ZH, 2003, J PHARMACOL EXP THER, V307, P870, DOI 10.1124/jpet.103.055525; GLUCK S, 1988, AM J PHYSIOL, V254, pF71, DOI 10.1152/ajprenal.1988.254.1.F71; GLUCK S, 1982, P NATL ACAD SCI-BIOL, V79, P4327, DOI 10.1073/pnas.79.14.4327; GLUCK S, 1992, J EXP BIOL, V172, P205; GLUCK S, 1984, J CLIN INVEST, V73, P1704, DOI 10.1172/JCI111378; Gong F, 2010, AM J PHYSIOL-RENAL, V298, pF1162, DOI 10.1152/ajprenal.00645.2009; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; HALLOWS KR, 1994, AM J PHYSIOL-CELL PH, V267, pC1057, DOI 10.1152/ajpcell.1994.267.4.C1057; Hamm L.L, 2008, BRENNER RECTORS KIDN, P248; HAMM LL, 1993, SEMIN NEPHROL, V13, P246; HAYS S, 1986, J CLIN INVEST, V78, P1279, DOI 10.1172/JCI112712; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; Marshansky V, 2002, CURR OPIN NEPHROL HY, V11, P527, DOI 10.1097/00041552-200209000-00009; MYERS M, 1993, J BIOL CHEM, V268, P9184; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Pastor-Soler NM, 2009, FASEB J, V23; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Rothenberger F, 2007, J AM SOC NEPHROL, V18, P2085, DOI 10.1681/ASN.2006070753; Sabolic I, 1997, KIDNEY INT, V51, P125, DOI 10.1038/ki.1997.16; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; SCHWARTZ GJ, 1985, J CLIN INVEST, V75, P1638, DOI 10.1172/JCI111871; SCHWARTZ JH, 1994, AM J PHYSIOL, V266, pF94, DOI 10.1152/ajprenal.1994.266.1.F94; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; STEINMETZ PR, 1986, AM J PHYSIOL, V251, pF173, DOI 10.1152/ajprenal.1986.251.2.F173; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Tuerk RD, 2007, J PROTEOME RES, V6, P3266, DOI 10.1021/pr070160a; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; VANADELSBERG J, 1986, J CELL BIOL, V102, P1638, DOI 10.1083/jcb.102.5.1638; VANADELSBERG J, 1994, CELL, V76, P1053, DOI 10.1016/0092-8674(94)90382-4; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; ZEIDEL ML, 1986, J CLIN INVEST, V77, P113, DOI 10.1172/JCI112264; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	62	75	75	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24676	24685		10.1074/jbc.M110.106278	http://dx.doi.org/10.1074/jbc.M110.106278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20525692	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000280542100040
J	Bansal, S; Liu, CP; Sepuri, NBV; Anandatheerthavarada, HK; Selvaraj, V; Hoek, J; Milne, GL; Guengerich, FP; Avadhani, NG				Bansal, Seema; Liu, Chuan-Peng; Sepuri, Naresh B. V.; Anandatheerthavarada, Hindupur K.; Selvaraj, Venkatesh; Hoek, Jan; Milne, Ginger L.; Guengerich, F. Peter; Avadhani, Narayan G.			Mitochondria-targeted Cytochrome P450 2E1 Induces Oxidative Damage and Augments Alcohol-mediated Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; RAT-LIVER; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; LIPID-PEROXIDATION; NADPH OXIDASE; ETHANOL; CYP2E1; ACTIVATION; PHOSPHORYLATION	The ethanol-inducible cytochrome P450 2E1 (CYP2E1) is also induced under different pathological and physiological conditions. Studies including ours have shown that CYP2E1 is bimodally targeted to both the endoplasmic reticulum (microsomes) (mc CYP2E1) and mitochondria (mt CYP2E1). In this study we investigated the role of mtCYP2E1 in ethanol-mediated oxidative stress in stable cell lines expressing predominantly mt CYP2E1 or mc CYP2E1. The ER+ mutation (A2L, A9L), which increases the affinity of the nascent protein for binding to the signal recognition particle, preferentially targets CYP2E1 to the endoplasmic reticulum. The Mt+ (L17G) and Mt++ (I8R, L11R, L17R) mutant proteins, showing progressively lower affinity for signal recognition particle binding, were targeted to mitochondria at correspondingly higher levels. The rate of GSH depletion, used as a measure of oxidative stress, was higher in cells expressing Mt++ and Mt+ proteins as compared with cells expressing ER+ protein. In addition, the cellular level of F-2-isoprostanes, a direct indicator of oxidative stress, was increased markedly in Mt++ cells after ethanol treatment. Notably, expression of Mt++ CYP2E1 protein in yeast cells caused more severe mitochondrial DNA damage and respiratory deficiency than the wild type or ER+ proteins as tested by the inability of cells to grow on glycerol or ethanol. Additionally, liver mitochondria from ethanol-fed rats containing high mt CYP2E1 showed higher levels of F-2-isoprostane production. These results strongly suggest that mt CYP2E1 induces oxidative stress and augments alcohol-mediated cell/tissue injury.	[Selvaraj, Venkatesh; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Selvaraj, Venkatesh; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Hoek, Jan] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Milne, Ginger L.] Vanderbilt Univ, Div Clin Pharmacol, Dept Med, Sch Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	University of Pennsylvania; University of Pennsylvania; Jefferson University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Avadhani, NG (corresponding author), 3800 Spruce St, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Sepuri, Naresh/AAF-2704-2020; Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X; Hoek, Jan/0000-0001-7127-4218	National Institutes of Health [R01 GM034883, R01 AA017749, R37 CA090426]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM034883 and R01 AA017749 (to N. G. A.) and R37 CA090426 (to F. P. G.).	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Albano E, 1996, HEPATOLOGY, V23, P155, DOI 10.1002/hep.510230121; Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496; Anandatheerthavarada HK, 1999, J BIOL CHEM, V274, P6617, DOI 10.1074/jbc.274.10.6617; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Bai JX, 2006, J BIOL CHEM, V281, P5128, DOI 10.1074/jbc.M510484200; Bhagwat SV, 1999, TOXICOL APPL PHARM, V156, P231, DOI 10.1006/taap.1999.8646; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bondoc FY, 1999, BIOCHEM PHARMACOL, V58, P461, DOI 10.1016/S0006-2952(99)00111-2; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008; Bradford BU, 2005, HEPATOLOGY, V41, P336, DOI 10.1002/hep.20532; Butura A, 2009, J HEPATOL, V50, P572, DOI 10.1016/j.jhep.2008.10.020; Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704; Dasari VR, 2006, J BIOL CHEM, V281, P30834, DOI 10.1074/jbc.M510725200; Dong HB, 2009, MOL PHARMACOL, V75, P555, DOI 10.1124/mol.108.051888; Dostalek M, 2008, J BIOL CHEM, V283, P17147, DOI 10.1074/jbc.M802447200; Dostalek M, 2007, MOL PHARMACOL, V72, P1419, DOI 10.1124/mol.107.040238; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9; Eliasson E, 1996, MOL PHARMACOL, V50, P573; ELIASSON E, 1992, J BIOL CHEM, V267, P15765; Gonzalez FJ, 2007, DRUG METAB DISPOS, V35, P1, DOI 10.1124/dmd.106.012492; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hegde RS, 1998, MOL CELL, V2, P85, DOI 10.1016/S1097-2765(00)80116-1; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P711, DOI 10.1016/j.freeradbiomed.2004.10.024; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; LIEBER CS, 1973, RES COMMUN CHEM PATH, V6, P983; LIEBER CS, 1970, BIOCHEM BIOPH RES CO, V40, P858, DOI 10.1016/0006-291X(70)90982-4; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Morgan K, 2002, HEPATOLOGY, V36, P122, DOI 10.1053/jhep.2002.33720; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; Neve EPA, 1999, FEBS LETT, V460, P309, DOI 10.1016/S0014-5793(99)01361-7; Neve EPA, 2000, J BIOL CHEM, V275, P17130, DOI 10.1074/jbc.M000957200; Neve EPA, 1996, ARCH BIOCHEM BIOPHYS, V333, P459, DOI 10.1006/abbi.1996.0415; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pahan K, 1997, FREE RADICAL BIO MED, V23, P963, DOI 10.1016/S0891-5849(97)00017-8; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Raza H, 2004, DIABETES, V53, P185, DOI 10.2337/diabetes.53.1.185; Robin MA, 2005, FEBS LETT, V579, P6895, DOI 10.1016/j.febslet.2005.11.029; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; RONIS MJ, 1996, CYTOCHROMES P450 PHA; RONIS MJJ, 1991, EUR J BIOCHEM, V198, P383, DOI 10.1111/j.1432-1033.1991.tb16026.x; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Sohn OS, 2001, CANCER RES, V61, P8435; Sumner SCJ, 1999, CHEM RES TOXICOL, V12, P1110, DOI 10.1021/tx990040k; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Wang Y, 2009, HEPATOLOGY, V50, P453, DOI 10.1002/hep.22978; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501	56	75	77	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24609	24619		10.1074/jbc.M110.121822	http://dx.doi.org/10.1074/jbc.M110.121822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529841	hybrid, Green Published			2022-12-25	WOS:000280542100033
J	Wentz, AE; d'Avignon, DA; Weber, ML; Cotter, DG; Doherty, JM; Kerns, R; Nagarajan, R; Reddy, N; Sambandam, N; Crawford, PA				Wentz, Anna E.; d'Avignon, D. Andre; Weber, Mary L.; Cotter, David G.; Doherty, Jason M.; Kerns, Robnet; Nagarajan, Rakesh; Reddy, Naveen; Sambandam, Nandakumar; Crawford, Peter A.			Adaptation of Myocardial Substrate Metabolism to a Ketogenic Nutrient Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETONE-BODY METABOLISM; FATTY-ACID OXIDATION; MITOCHONDRIAL 3-HYDROXY-3-METHYLGLUTARYL COENZYME; SUCCINYL-COA-3-OXOACID COA-TRANSFERASE; HEARTS OXIDIZING ACETOACETATE; PPAR-ALPHA; RAT HEARTS; PYRUVATE CARBOXYLATION; CONTRACTILE FUNCTION; FASTING RESPONSE	Heart muscle is metabolically versatile, converting energy stored in fatty acids, glucose, lactate, amino acids, and ketone bodies. Here, we use mouse models in ketotic nutritional states (24 h of fasting and a very low carbohydrate ketogenic diet) to demonstrate that heart muscle engages a metabolic response that limits ketone body utilization. Pathway reconstruction from microarray data sets, gene expression analysis, protein immunoblotting, and immunohistochemical analysis of myocardial tissue from nutritionally modified mouse models reveal that ketotic states promote transcriptional suppression of the key ketolytic enzyme, succinyl-CoA:3-oxoacid CoA transferase (SCOT; encoded by Oxct1), as well as peroxisome proliferator-activated receptor alpha-dependent induction of the key ketogenic enzyme HMGCS2. Consistent with reduction of SCOT, NMR profiling demonstrates that maintenance on a ketogenic diet causes a 25% reduction of myocardial C-13 enrichment of glutamate when C-13-labeled ketone bodies are delivered in vivo or ex vivo, indicating reduced procession of ketones through oxidative metabolism. Accordingly, unmetabolized substrate concentrations are higher within the hearts of ketogenic diet-fed mice challenged with ketones compared with those of chow-fed controls. Furthermore, reduced ketone body oxidation correlates with failure of ketone bodies to inhibit fatty acid oxidation. These results indicate that ketotic nutrient environments engage mechanisms that curtail ketolytic capacity, controlling the utilization of ketone bodies in ketotic states.	[Sambandam, Nandakumar; Crawford, Peter A.] Washington Univ, Dept Med, St Louis, MO 63108 USA; [d'Avignon, D. Andre] Washington Univ, Dept Chem, St Louis, MO 63108 USA; [Kerns, Robnet; Nagarajan, Rakesh] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Crawford, PA (corresponding author), 660 S Euclid Ave,Box 8086, St Louis, MO 63108 USA.	pcrawford@wustl.edu		Crawford, Peter/0000-0001-8597-4426; Wentz, Anna/0000-0002-3585-8379	National Institutes of Health [DK073282, DK020579]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK073282, P30DK020579, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073282 and DK020579.	Abel ED, 2004, FRONT BIOSCI-LANDMRK, V9, P201, DOI 10.2741/1216; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; AVOGARO A, 1990, AM J PHYSIOL, V258, pE606, DOI 10.1152/ajpendo.1990.258.4.E606; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009; Bergman BC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1103, DOI 10.1152/ajpendo.00613.2006; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; Comte B, 1997, J BIOL CHEM, V272, P26125, DOI 10.1074/jbc.272.42.26125; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; FINK G, 1988, J BIOL CHEM, V263, P18036; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; GE Y, 2003, SOCIEDAD ESTADISTICA, V12, P1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRINBLAT L, 1986, BIOCHEM J, V240, P49, DOI 10.1042/bj2400049; Hasselbaink DM, 2003, BIOCHEM J, V371, P753, DOI 10.1042/BJ20021617; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; JEFFREY FMH, 1995, BASIC RES CARDIOL, V90, P388, DOI 10.1007/BF00788500; Jones JG, 1997, ANAL BIOCHEM, V249, P201, DOI 10.1006/abio.1997.2172; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Leong HS, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp310; Lopaschuk GD, 2006, SEMIN CARDIOTHORAC V, V10, P228, DOI 10.1177/1089253206291150; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Marcondes S, 2001, P NATL ACAD SCI USA, V98, P7146, DOI 10.1073/pnas.141222598; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Oakes ND, 2006, AM J PHYSIOL-ENDOC M, V290, pE870, DOI 10.1152/ajpendo.00233.2005; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; QUANT PA, 1989, BIOCHEM SOC T, V17, P1089, DOI 10.1042/bst0171089; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; RUSSELL RR, 1991, J CLIN INVEST, V87, P384, DOI 10.1172/JCI115008; RUSSELL RR, 1991, AM J PHYSIOL, V261, pH1756, DOI 10.1152/ajpheart.1991.261.6.H1756; RUSSELL RR, 1992, J CLIN INVEST, V89, P968, DOI 10.1172/JCI115679; RUSSELL RR, 1995, AM J PHYSIOL-HEART C, V268, pH441, DOI 10.1152/ajpheart.1995.268.1.H441; Schneider JG, 2005, CELL METAB, V2, P341, DOI 10.1016/j.cmet.2005.11.006; Serra D, 1996, J BIOL CHEM, V271, P7529, DOI 10.1074/jbc.271.13.7529; Soeters MR, 2009, OBESITY, V17, P1326, DOI 10.1038/oby.2008.678; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stanley WC, 2003, AM J PHYSIOL-HEART C, V285, pH1626, DOI 10.1152/ajpheart.00332.2003; Stowe KA, 2006, FEBS LETT, V580, P4282, DOI 10.1016/j.febslet.2006.06.068; SULTAN AMN, 1992, MOL CELL BIOCHEM, V110, P17, DOI 10.1007/BF02385001; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; TORAASON M, 1989, TOXICOLOGY, V56, P107, DOI 10.1016/0300-483X(89)90216-3; Turko IV, 2001, AM J PHYSIOL-HEART C, V281, pH2289, DOI 10.1152/ajpheart.2001.281.6.H2289; van der Laan MJ, 2006, STAT APPL GENET MOL, V5; VANOVERSCHELDE JLJ, 1993, AM J PHYSIOL, V264, pH701, DOI 10.1152/ajpheart.1993.264.3.H701; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Vice E, 2005, METABOLISM, V54, P1542, DOI 10.1016/j.metabol.2005.05.023; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; WILLIAMS.DH, 1968, BIOCHEM J, V108, P353, DOI 10.1042/bj1080353; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yan J, 2009, CIRCULATION, V119, P2818, DOI 10.1161/CIRCULATIONAHA.108.832915; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87; Ziegler A, 2002, NMR BIOMED, V15, P222, DOI 10.1002/nbm.764	66	84	85	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24447	24456		10.1074/jbc.M110.100651	http://dx.doi.org/10.1074/jbc.M110.100651			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529848	Green Published, hybrid			2022-12-25	WOS:000280542100017
J	Dash, R; Su, ZZ; Lee, SG; Azab, B; Boukerche, H; Sarkar, D; Fisher, PB				Dash, R.; Su, Z-Z; Lee, S-G; Azab, B.; Boukerche, H.; Sarkar, D.; Fisher, P. B.			Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1	ONCOGENE			English	Article						CCN1; SARI; transcriptional regulation; AP-1; c-Jun	HUMAN BREAST-CANCER; DIFFERENTIATION-ASSOCIATED GENE-7; TISSUE GROWTH-FACTOR; ACTIVATOR PROTEIN-1; CELL-PROLIFERATION; NUDE-MICE; C-JUN; CYR61; EXPRESSION; TRANSCRIPTION	Enhanced expression of the CCN family of secretory integrin-binding proteins correlates with many essential components of the cancerous state, including tumor cell adhesion, proliferation, invasion and migration. Consequently, CCN1 expression is elevated in various cancers, including breast cancer, and its expression directly correlates with poor patient prognosis. Using subtraction-hybridization, combined with induction of cancer cell terminal differentiation, we cloned SARI (suppressor of activator protein (AP)-1, regulated by interferon (IFN)), an IFN-beta-inducible, potent tumor suppressor gene that exerts cancer-selective growth inhibitory effects. Forced expression of SARI using an adenovirus (Ad. SARI) inhibits AP-1 function and downregulates CCN1 expression in multiple cancer lineages, resulting in a profound inhibition in anchorage-independent cell growth and tumor cell invasion. Overexpression of SARI reduces CCN1-promoter activity through inhibition of AP-1 binding. Accordingly, SARI selectively blocks expression of the transformed state in rat embryo fibroblast cells that stably overexpress c-Jun. These results illustrate that SARI inhibits AP-1 transactivating factor binding to the cis-element of the CCN1 promoter, possibly through its interaction with c-Jun. Overall, SARI can directly inhibit CCN1-induced transformation by inhibiting the transcription of CCN1, as well as indirectly by inhibiting the expression of c-Jun (and hence blocking AP-1 activity). In these contexts, transformed cells 'addicted' to AP-1 activity are rendered susceptible to SARI-mediated inhibition of expression of the transformed phenotype. Oncogene (2010) 29, 4412-4423; doi: 10.1038/onc.2010.194; published online 7 June 2010	[Sarkar, D.; Fisher, P. B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, VCU Inst Mol Med, Richmond, VA 23298 USA; [Sarkar, D.; Fisher, P. B.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA; [Lee, S-G] Kyung Hee Univ, Canc Prevent Mat Dev Res Ctr, Coll Oriental Med, Seoul, South Korea; [Boukerche, H.] Univ Lyon 1, INSERM, F-69365 Lyon, France	Virginia Commonwealth University; Virginia Commonwealth University; Kyung Hee University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Fisher, PB (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, VCU Inst Mol Med, 1101 E Marshall St,Sanger Hall Bldg,Room 11-015, Richmond, VA 23298 USA.	pbfisher@vcu.edu	Azab, Belal/AAJ-5652-2021; Lee, Seok-Geun/B-3408-2011	Azab, Belal/0000-0003-0293-6489; Lee, Seok-Geun/0000-0002-0060-5777; dash, rupesh/0000-0001-5740-7053	National Institutes of Health [R01 CA097318, P01 CA104177]; National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P01CA104177, R01CA097318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Institutes of Health Grants R01 CA097318 and P01 CA104177; and by the National Foundation for Cancer Research. DS is a Harrison Endowed Scholar in Cancer Research. PBF holds the Thelma Newmeyer Corman Chair in Cancer Research.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; DASH R, 2010, CANC GENE THER; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Gery S, 2005, CLIN CANCER RES, V11, P7243, DOI 10.1158/1078-0432.CCR-05-0231; Grotendorst GR, 2000, ENDOCRINOLOGY, V141, P2254, DOI 10.1210/en.141.6.2254; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang Hongping, 1993, Molecular and Cellular Differentiation, V1, P285; Jiang WG, 2004, ENDOCR-RELAT CANCER, V11, P781, DOI 10.1677/erc.1.00825; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; Lebedeva IV, 2002, ONCOGENE, V21, P708, DOI 10.1038/sj.onc.1205116; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Leu SJ, 2004, J BIOL CHEM, V279, P44177, DOI 10.1074/jbc.M407850200; Ludes-Meyers JH, 2001, ONCOGENE, V20, P2771, DOI 10.1038/sj.onc.1204377; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MATTHEW GF, 1907, T ROYAL SOC CANADA, V1, P7; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; O'Kelly J, 2008, INT J ONCOL, V33, P59; OKELLY KH, 2005, CCN PROTEINS; Roskelley CD, 2002, SEMIN CANCER BIOL, V12, P97, DOI 10.1006/scbi.2001.0417; RYSECK RP, 1991, ONCOGENE, V6, P533; Sarkar D, 2005, P NATL ACAD SCI USA, V102, P14034, DOI 10.1073/pnas.0506837102; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shimizu T, 2005, ONCOL REP, V14, P441; Su Z, 2001, NUCLEIC ACIDS RES, V29, P1661, DOI 10.1093/nar/29.8.1661; Su ZZ, 2008, P NATL ACAD SCI USA, V105, P20906, DOI 10.1073/pnas.0807975106; Su ZZ, 2003, ONCOGENE, V22, P1164, DOI 10.1038/sj.onc.1206062; Su ZZ, 1998, P NATL ACAD SCI USA, V95, P14400, DOI 10.1073/pnas.95.24.14400; Taddei I, 2003, J MAMMARY GLAND BIOL, V8, P383, DOI 10.1023/B:JOMG.0000017426.74915.b9; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Tsai MS, 2002, ONCOGENE, V21, P964, DOI 10.1038/sj/onc/1205131; Vandel L, 1996, MOL CELL BIOL, V16, P1881; Vellon L, 2005, ONCOGENE, V24, P3759, DOI 10.1038/sj.onc.1208452; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xie D, 2001, J BIOL CHEM, V276, P14187, DOI 10.1074/jbc.M009755200; Zullo AJ, 2007, J IMMUNOL, V178, P58, DOI 10.4049/jimmunol.178.1.58	44	39	52	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 5	2010	29	31					4412	4423		10.1038/onc.2010.194	http://dx.doi.org/10.1038/onc.2010.194			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	634DG	20531301				2022-12-25	WOS:000280559100005
J	Das, M; Chu, PL; Santos, GM; Scheer, S; Vittinghoff, E; McFarland, W; Colfax, GN				Das, Moupali; Chu, Priscilla Lee; Santos, Glenn-Milo; Scheer, Susan; Vittinghoff, Eric; McFarland, Willi; Colfax, Grant N.			Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; PERINATAL TRANSMISSION; UNITED-STATES; PUBLIC-HEALTH; PARTNER NOTIFICATION; SEXUAL TRANSMISSION; SIMPLIFYING CONSENT; SURVEILLANCE DATA; COITAL ACT	Background: At the individual level, higher HIV viral load predicts sexual transmission risk. We evaluated San Francisco's community viral load (CVL) as a population level marker of HIV transmission risk. We hypothesized that the decrease in CVL in San Francisco from 2004-2008, corresponding with increased rates of HIV testing, antiretroviral therapy (ART) coverage and effectiveness, and population-level virologic suppression, would be associated with a reduction in new HIV infections. Methodology/Principal Findings: We used San Francisco's HIV/AIDS surveillance system to examine the trends in CVL. Mean CVL was calculated as the mean of the most recent viral load of all reported HIV-positive individuals in a particular community. Total CVL was defined as the sum of the most recent viral loads of all HIV-positive individuals in a particular community. We used Poisson models with robust standard errors to assess the relationships between the mean and total CVL and the primary outcome: annual numbers of newly diagnosed HIV cases. Both mean and total CVL decreased from 2004-2008 and were accompanied by decreases in new HIV diagnoses from 798 (2004) to 434 (2008). The mean (p = 0.003) and total CVL (p = 0.002) were significantly associated with new HIV cases from 2004-2008. Conclusions/Significance: Reductions in CVL are associated with decreased HIV infections. Results suggest that wide-scale ART could reduce HIV transmission at the population level. Because CVL is temporally upstream of new HIV infections, jurisdictions should consider adding CVL to routine HIV surveillance to track the epidemic, allocate resources, and to evaluate the effectiveness of HIV prevention and treatment efforts.	[Das, Moupali; Chu, Priscilla Lee; Santos, Glenn-Milo; Scheer, Susan; McFarland, Willi; Colfax, Grant N.] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Das, Moupali; Vittinghoff, Eric; McFarland, Willi; Colfax, Grant N.] Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco Department of Public Health; University of California System; University of California San Francisco	Das, M (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA USA.	moupali.das-douglas@ucsf.edu		Santos, Glenn-Milo/0000-0003-1009-5317	California HIV/AIDS [ID08-PHFE-018]	California HIV/AIDS	California HIV/AIDS Research Program Innovative Developmental Exploratory Award (ID08-PHFE-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2007, JAIDS-J ACQ IMM DEF, V46, P479, DOI 10.1097/QAI.0b013e3181594c61; [Anonymous], 2009, GUID US ANT AG HIV 1; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P597; Arnold M, 2009, SOC SCI MED, V69, P121, DOI 10.1016/j.socscimed.2009.04.019; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; Chen KT, 2009, AIDS PATIENT CARE ST, V23, P195, DOI 10.1089/apc.2008.0047; CHU PL, 2008, 17 INT AIDS C MEX CI; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Das-Douglas M, 2008, AM J PUBLIC HEALTH, V98, P1544, DOI 10.2105/AJPH.2008.142596; De Cock KM, 2008, LANCET, V371, P2068, DOI 10.1016/S0140-6736(08)60732-1; Dickover RE, 1996, JAMA-J AM MED ASSOC, V275, P599, DOI 10.1001/jama.275.8.599; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Frieden TR, 2009, ARCH INTERN MED, V169, P1650, DOI 10.1001/archinternmed.2009.309; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Harries AD, 2009, JAIDS-J ACQ IMM DEF, V52, pS14, DOI 10.1097/QAI.0b013e3181bbc99e; *HIV AIDS STAT EP, 2009, HIV AIDS EP ANN REP; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Kellogg TA, 2001, J ACQ IMMUN DEF SYND, V28, P380, DOI 10.1097/00126334-200112010-00012; Kim JY, 2006, NEW ENGL J MED, V355, P645, DOI 10.1056/NEJMp068166; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Krieger N, 2006, J URBAN HEALTH, V83, P355, DOI 10.1007/s11524-006-9040-y; Krieger N, 2003, EPIDEMIOLOGY, V14, P384, DOI 10.1097/01.ede.0000071473.69307.8a; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; LINGAPPA J, 2009, HIV 1 PLASMA RNA RIS; Mackenzie J, 1907, Q J MED, V1, P39; Marcus JL, 2009, AIDS, V23, P1024, DOI 10.1097/QAD.0b013e32832921a7; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; Nakhaee F, 2009, SEX HEALTH, V6, P129, DOI 10.1071/SH08007; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; REYNOLDS S, 2009, ART REDUCED RATE SEX; Salomon JA, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000327636.82542.87; *SAN FRANC AIDS OF, 2003, HIV AIDS EP ANN REP; *SAN FRANC AIDS OF, 2006, HIV AIDS EP ANN REP; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Scheer S, 2009, AIDS, V23, P533, DOI 10.1097/QAD.0b013e328322432b; SULLIVAN P, 2009, REDUCTION HIV TRANSM; Truong HHA, 2006, AIDS, V20, P2193, DOI 10.1097/01.aids.0000252059.85236.af; Truong HHM, 2009, JAIDS-J ACQ IMM DEF, V51, P502, DOI 10.1097/QAI.0b013e3181a25383; Wand H, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-19; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Zetola NM, 2008, PUBLIC HEALTH REP, V123, P41, DOI 10.1177/00333549081230S306; Zetola NM, 2007, J CLIN VIROL, V40, P68, DOI 10.1016/j.jcv.2007.06.004; Zetola NM, 2009, AM J PUBLIC HEALTH, V99, P1924, DOI 10.2105/AJPH.2009.173591; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17; Zetola NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002591; 2008, PEDIATRICS, V122, P1127	64	560	566	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11068	10.1371/journal.pone.0011068	http://dx.doi.org/10.1371/journal.pone.0011068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608QA	20548786	Green Published, Green Submitted, gold			2022-12-25	WOS:000278599600024
J	Kapoor, K; Rehan, M; Lynn, AM; Prasad, R				Kapoor, Khyati; Rehan, Mohd; Lynn, Andrew M.; Prasad, Rajendra			Employing Information Theoretic Measures and Mutagenesis to Identify Residues Critical for Drug-Proton Antiport Function in Mdr1p of Candida albicans	PLOS ONE			English	Article							MAJOR FACILITATOR SUPERFAMILY; HUMAN PATHOGENIC YEAST; ANTIFUNGAL EFFLUX; PROTEIN; ALIGNMENT; IDENTIFICATION; STRATEGY; CDR1P; PUMP	By employing information theoretic measures, this study presents a structure and functional analysis of a multidrug-proton antiporter Mdr1p of Candida albicans. Since CaMdr1p belongs to drug-proton antiporter (DHA1) family of Major Facilitator Superfamily (MFS) of transporters, we contrasted DHA1 (antiporters) with Sugar Porter family (symporters). Cumulative Relative Entropy (CRE) calculated for these two sets of alignments enabled us to selectively identify conserved residues of not only CaMdr1p but for the entire DHA1 family. Based on CRE, the highest scoring thirty positions were selected and predicted to impart functional specificity to CaMdr1p as well as to other drug-proton antiporters. Nineteen positions wherein the CaMdr1p residue matched with the most frequent amino acid at a particular alignment position of DHA1 members were subjected to site-directed mutagenesis and were replaced with either alanine or leucine. All these mutant variants, except one, displayed either complete or selective sensitivity to the tested drugs. The enhanced susceptibility of these mutant variants was corroborated with the simultaneously abrogated efflux of substrates. Taken together, based on scaled CRE between two MFS sub-families, we could accurately predict the functionally relevant residues of CaMdr1p. An extrapolation of these predictions to the entire DHA1 family members as validated from previously published data shows that these residues are functionally critical in other members of the DHA1 family also.	[Kapoor, Khyati; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Rehan, Mohd; Lynn, Andrew M.] Jawaharlal Nehru Univ, Sch Informat Technol, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Kapoor, K (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	andrew@mail.jnu.ac.in; rp47jnu@gmail.com	Rehan, Mohd/H-9835-2012	Rehan, Mohd/0000-0003-4898-6043	Department of Science and Technology, Indo-Swiss [INT/SWISS/P-31/2009]; Department of Biotechnology [BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008]; Council of Scientific and Industrial Research, India	Department of Science and Technology, Indo-Swiss(Department of Science & Technology (India)); Department of Biotechnology; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The work presented in this paper has been supported in parts by grants to one of us (RP) from Department of Science and Technology, Indo-Swiss, (INT/SWISS/P-31/2009), Department of Biotechnology (BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008). KK acknowledges Council of Scientific and Industrial Research, India, for the award of senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Chakrabarti S, 2007, J MOL BIOL, V373, P801, DOI 10.1016/j.jmb.2007.08.036; Chandrasekaran A, 2006, J NEUROCHEM, V98, P1551, DOI 10.1111/J.1471-4159.2006.03975.X; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Durbin R., 1998, BIOL SEQUENCE ANAL P; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gaur M, 2005, J MOL MICROB BIOTECH, V9, P3, DOI 10.1159/000088141; Gaur M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-579; Ginn SL, 2000, J BACTERIOL, V182, P1492, DOI 10.1128/JB.182.6.1492-1498.2000; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Ivnitski-Steele I, 2009, ANAL BIOCHEM, V394, P87, DOI 10.1016/j.ab.2009.07.001; Jeon J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000522; Kapoor K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000624; KIMURA M, 1979, SCI AM, V241, P98, DOI 10.1038/scientificamerican1179-98; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lo LW, 2003, P NATL ACAD SCI USA, V100, P4463, DOI 10.1073/pnas.0737647100; Nakamura K, 2001, ANTIMICROB AGENTS CH, V45, P3366, DOI 10.1128/AAC.45.12.3366-3374.2001; Ohno S., 1970, EVOLUTION GENE DUPLI; Pasrija R, 2007, EUKARYOT CELL, V6, P443, DOI 10.1128/EC.00315-06; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636; Prasad R, 2005, INT REV CYTOL, V242, P215; Saini P, 2005, J ANTIMICROB CHEMOTH, V56, P77, DOI 10.1093/jac/dki183; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; Srivastava PK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-104; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11041	10.1371/journal.pone.0011041	http://dx.doi.org/10.1371/journal.pone.0011041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548793	gold, Green Submitted, Green Published			2022-12-25	WOS:000278599600004
J	Kirkpatrick, CL; Marchetti, P; Purrello, F; Piro, S; Bugliani, M; Bosco, D; de Koning, EJP; Engelse, MA; Kerr-Conte, J; Pattou, F; Wollheim, CB				Kirkpatrick, Clare L.; Marchetti, Piero; Purrello, Francesco; Piro, Salvatore; Bugliani, Marco; Bosco, Domenico; de Koning, Eelco J. P.; Engelse, Marten A.; Kerr-Conte, Julie; Pattou, Francois; Wollheim, Claes B.			Type 2 Diabetes Susceptibility Gene Expression in Normal or Diabetic Sorted Human Alpha and Beta Cells: Correlations with Age or BMI of Islet Donors	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; GENOME-WIDE ASSOCIATION; ACTIVATED-RECEPTOR-GAMMA; MORBIDLY OBESE-PATIENTS; HUMAN PANCREATIC-ISLETS; TCF7L2 GENE; FTO GENE; IN-VIVO; VARIANTS; HETEROGENEITY	Background: Genome-wide association studies have identified susceptibility genes for development of type 2 diabetes. We aimed to examine whether a subset of these (comprising FTO, IDE, KCNJ11, PPARG and TCF7L2) were transcriptionally restricted to or enriched in human beta cells by sorting islet cells into alpha and beta-specific fractions. We also aimed to correlate expression of these transcripts in both alpha and beta cell types with phenotypic traits of the islet donors and to compare diabetic and non-diabetic cells. Methodology/Principal Findings: Islet cells were sorted using a previously published method and RNA was extracted, reverse transcribed and used as the template for quantitative PCR. Sorted cells were also analysed for insulin and glucagon immunostaining and insulin secretion from the beta cells as well as insulin, glucagon and GLP-1 content. All five genes were expressed in both alpha and beta cells, with significant enrichment of KCNJ11 in the beta cells and of TCF7L2 in the alpha cells. The ratio of KCNJ11 in beta to alpha cells was negatively correlated with BMI, while KCNJ11 expression in alpha cells was negatively correlated with age but not associated with BMI. Beta cell expression of glucagon, TCF7L2 and IDE was increased in cells from islets that had spent more time in culture prior to cell sorting. In beta cells, KCNJ11, FTO and insulin were positively correlated with each other. Diabetic alpha and beta cells had decreased expression of insulin, glucagon and FTO. Conclusions/Significance: This study has identified novel patterns of expression of type 2 diabetes susceptibility genes within sorted islet cells and suggested interactions of gene expression with age or BMI of the islet donors. However, expression of these genes in islets is less associated with BMI than has been found for other tissues.	[Kirkpatrick, Clare L.; Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Marchetti, Piero; Bugliani, Marco] Cisanello Hosp, Metab Unit, Dept Endocrinol & Metab, Pisa, Italy; [Purrello, Francesco; Piro, Salvatore] Univ Catania, Dept Internal Med, Garibaldi Nesima Hosp, Catania, Italy; [Bosco, Domenico] Univ Hosp, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [de Koning, Eelco J. P.; Engelse, Marten A.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Kerr-Conte, Julie; Pattou, Francois] Univ Lille Nord France, Univ Hosp Lille, INSERM, U859, Lille, France	University of Geneva; Presidio Ospedaliero Garibaldi-Nesima; University of Catania; University of Geneva; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Kirkpatrick, CL (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland.	claes.wollheim@unige.ch	Piro, Salvatore/P-7585-2019; Marchetti, Piero/J-7439-2013; Bugliani, Marco/I-3168-2019; Kirkpatrick, Clare L/M-1890-2018; Piro, Salvatore/H-9353-2012; Purrello, Francesco/K-9721-2016; Pattou, Francois/O-6151-2017; de Koning, Eelco JP/H-6030-2011	Piro, Salvatore/0000-0002-1781-0902; Marchetti, Piero/0000-0003-4907-0635; Bugliani, Marco/0000-0002-1744-1561; Kirkpatrick, Clare L/0000-0001-8564-8559; Piro, Salvatore/0000-0002-1781-0902; Purrello, Francesco/0000-0003-3313-8543; Pattou, Francois/0000-0001-8388-3766; de Koning, Eelco JP/0000-0002-1232-7022; Bosco, Domenico/0000-0003-3453-9613	Swiss National Science Foundation [310000-116750/1]; Eurodia 6th Framework Programme [LSHM-CT-2006-518153]; EFSD-Lilly [2008]; Juvenile Diabetes Research Foundation [31-2008-416]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Eurodia 6th Framework Programme; EFSD-Lilly(Eli Lilly); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was funded by the Swiss National Science Foundation (310000-116750/1), the Eurodia 6th Framework Programme (LSHM-CT-2006-518153) and an EFSD-Lilly grant (2008). Human islets were obtained thanks to a grant from the Juvenile Diabetes Research Foundation (31-2008-416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Brody F, 2007, SURG ENDOSC, V21, P941, DOI 10.1007/s00464-006-9098-3; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Du J, 2009, BIOCHEM BIOPH RES CO, V383, P485, DOI 10.1016/j.bbrc.2009.04.047; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fujita Y, 2010, GASTROENTEROLOGY, V138, P1966, DOI 10.1053/j.gastro.2010.01.049; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hattersley AT, 1998, DIABETIC MED, V15, P15, DOI 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M; Hindle AK, 2009, SURG ENDOSC, V23, P700, DOI 10.1007/s00464-008-0001-2; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Karaca M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005555; Katsuta H, 2010, DIABETOLOGIA, V53, P128, DOI 10.1007/s00125-009-1570-x; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Osmark P, 2009, DIABETOLOGIA, V52, P850, DOI 10.1007/s00125-009-1293-z; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Redonnet A, 2002, INT J OBESITY, V26, P920, DOI 10.1038/sj.ijo.0802025; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Ugleholdt R, 2004, ENDOCRINOLOGY, V145, P1349, DOI 10.1210/en.2003-0801; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	43	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11053	10.1371/journal.pone.0011053	http://dx.doi.org/10.1371/journal.pone.0011053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548773	gold, Green Published, Green Submitted			2022-12-25	WOS:000278599600014
J	Fridley, BL; Jenkins, G; Deyo-Svendsen, ME; Hebbring, S; Freimuth, R				Fridley, Brooke L.; Jenkins, Gregory; Deyo-Svendsen, Matthew E.; Hebbring, Scott; Freimuth, Robert			Utilizing Genotype Imputation for the Augmentation of Sequence Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFERRING MISSING GENOTYPES; INFERENCE; ACCURACY	Background: In recent years, capabilities for genotyping large sets of single nucleotide polymorphisms (SNPs) has increased considerably with the ability to genotype over 1 million SNP markers across the genome. This advancement in technology has led to an increase in the number of genome-wide association studies (GWAS) for various complex traits. These GWAS have resulted in the implication of over 1500 SNPs associated with disease traits. However, the SNPs identified from these GWAS are not necessarily the functional variants. Therefore, the next phase in GWAS will involve the refining of these putative loci. Methodology: A next step for GWAS would be to catalog all variants, especially rarer variants, within the detected loci, followed by the association analysis of the detected variants with the disease trait. However, sequencing a locus in a large number of subjects is still relatively expensive. A more cost effective approach would be to sequence a portion of the individuals, followed by the application of genotype imputation methods for imputing markers in the remaining individuals. A potentially attractive alternative option would be to impute based on the 1000 Genomes Project; however, this has the drawbacks of using a reference population that does not necessarily match the disease status and LD pattern of the study population. We explored a variety of approaches for carrying out the imputation using a reference panel consisting of sequence data for a fraction of the study participants using data from both a candidate gene sequencing study and the 1000 Genomes Project. Conclusions: Imputation of genetic variation based on a proportion of sequenced samples is feasible. Our results indicate the following sequencing study design guidelines which take advantage of the recent advances in genotype imputation methodology: Select the largest and most diverse reference panel for sequencing and genotype as many "anchor" markers as possible.	[Fridley, Brooke L.; Jenkins, Gregory; Deyo-Svendsen, Matthew E.; Freimuth, Robert] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Hebbring, Scott] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Fridley, BL (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	fridley.brooke@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956; Freimuth, Robert/0000-0002-9673-5612	National Institutes of Health [U01 GM61388, R01 GM28157]; Minnesota Partnership for Biotechnology and Medical Genomics [H9046000431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028157, U01GM061388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The research was supported by the National Institutes of Health U01 GM61388, R01 GM28157 and Minnesota Partnership for Biotechnology and Medical Genomics grant H9046000431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIERNACKA JM, 2008, ASSESSMENT GENOTYPE; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Dai JY, 2006, GENET EPIDEMIOL, V30, P690, DOI 10.1002/gepi.20180; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FOULKES AS, 2007, STAT MED; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; *GENOMEWEB, 2009, 1000 GEN PROJ SEQ NE; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2715, DOI 10.1001/jama.2008.823; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; NOTHNAGEL M, 2008, HUM GENET; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Roberts A, 2007, BIOINFORMATICS, V23, pI401, DOI 10.1093/bioinformatics/btm220; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sun YV, 2008, EUR J HUM GENET, V16, P487, DOI 10.1038/sj.ejhg.5201988; Yu ZX, 2007, HUM GENET, V122, P495, DOI 10.1007/s00439-007-0427-y; [No title captured]	25	17	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11018	10.1371/journal.pone.0011018	http://dx.doi.org/10.1371/journal.pone.0011018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543988	Green Published, gold, Green Submitted			2022-12-25	WOS:000278494900028
J	Ohad, I; Raanan, H; Keren, N; Tchernov, D; Kaplan, A				Ohad, Itzhak; Raanan, Hagai; Keren, Nir; Tchernov, Dan; Kaplan, Aaron			Light-Induced Changes within Photosystem II Protects Microcoleus sp in Biological Desert Sand Crusts against Excess Light	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; CHARGE RECOMBINATION; STATE TRANSITIONS; PHOTOINHIBITION; ACCLIMATION; OXYGEN; THERMOLUMINESCENCE; PHOTOSYNTHESIS; FLUORESCENCE; CYANOBACTERIUM	The filamentous cyanobacterium Microcoleus vaginatus, a major primary producer in desert biological sand crusts, is exposed to frequent hydration (by early morning dew) followed by desiccation during potentially damaging excess light conditions. Nevertheless, its photosynthetic machinery is hardly affected by high light, unlike "model'' organisms whereby light-induced oxidative stress leads to photoinactivation of the oxygen-evolving photosystem II (PSII). Field experiments showed a dramatic decline in the fluorescence yield with rising light intensity in both drying and artificially maintained wet plots. Laboratory experiments showed that, contrary to "model'' organisms, photosynthesis persists in Microcoleus sp. even at light intensities 2-3 times higher than required to saturate oxygen evolution. This is despite an extensive loss (85-90%) of variable fluorescence and thermoluminescence, representing radiative PSII charge recombination that promotes the generation of damaging singlet oxygen. Light induced loss of variable fluorescence is not inhibited by the electron transfer inhibitors 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU), 2,5-dibromo-3-methyl-6-isopropylbenzoquinone (DBMIB), nor the uncoupler carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), thus indicating that reduction of plastoquinone or O-2, or lumen acidification essential for non-photochemical quenching (NPQ) are not involved. The rate of Q(A)(-) re-oxidation in the presence of DCMU is enhanced with time and intensity of illumination. The difference in temperatures required for maximal thermoluminescence emissions from S-2/Q(A)(-) (Q band, 22 degrees C) and S-2,S-3/Q(B)(-) (B band, 25 degrees C) charge recombinations is considerably smaller in Microcoleus as compared to "model'' photosynthetic organisms, thus indicating a significant alteration of the S-2/Q(A)(-) redox potential. We propose that enhancement of non-radiative charge recombination with rising light intensity may reduce harmful radiative recombination events thereby lowering O-1(2) generation and oxidative photodamage under excess illumination. This effective photo-protective mechanism was apparently lost during the evolution from the ancestor cyanobacteria to the higher plant chloroplast.	[Ohad, Itzhak] Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel; [Raanan, Hagai; Keren, Nir; Kaplan, Aaron] Hebrew Univ Jerusalem, Dept Plant & Environm Sci, Jerusalem, Israel; [Tchernov, Dan] Hebrew Univ Jerusalem, Interuniv Inst Marine Sci Eilat, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ohad, I (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel.	aaronka@vms.huji.ac.il	Tchernov, Dan/AAE-2545-2021; Kaplan, Aaron/GLN-5655-2022; Keren, Nir/GON-9181-2022	Tchernov, Dan/0000-0003-1135-8270; Kaplan, Aaron/0000-0002-0815-5731; Keren, Nir/0000-0002-7356-8831	German DFG; BMBF-MOST; Bogan Foundation; Israeli Science Foundation (ISF); German-Israeli Science Foundation (GIF)	German DFG(German Research Foundation (DFG)); BMBF-MOST(Federal Ministry of Education & Research (BMBF)); Bogan Foundation; Israeli Science Foundation (ISF)(Israel Science Foundation); German-Israeli Science Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	Support for this study was obtained from the German DFG, the BMBF-MOST, and the Bogan Foundation to AK, the Israeli Science Foundation (ISF) and the German-Israeli Science Foundation (GIF) to AK and NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; Allakhverdiev SI, 1997, BIOCHEMISTRY-US, V36, P4149, DOI 10.1021/bi962170n; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; BONDARAVA N, 2009, PHYSIOL PLANTARUM, V138, P463; Campbell D, 1996, PLANT PHYSIOL, V111, P1293, DOI 10.1104/pp.111.4.1293; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Cser K, 2007, BBA-BIOENERGETICS, V1767, P233, DOI 10.1016/j.bbabio.2007.01.022; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Eisenstadt D, 2008, ENVIRON MICROBIOL, V10, P1997, DOI 10.1111/j.1462-2920.2008.01616.x; Eisenstadt D, 2010, PHOTOSYNTH RES, V103, P97, DOI 10.1007/s11120-009-9518-z; Fufezan C, 2007, J BIOL CHEM, V282, P12492, DOI 10.1074/jbc.M610951200; GLEITER HM, 1990, Z NATURFORSCH C, V45, P353; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Harel Y, 2004, PLANT PHYSIOL, V136, P3070, DOI 10.1104/pp.104.047712; Hassidim M, 1997, J PHYCOL, V33, P811, DOI 10.1111/j.0022-3646.1997.00811.x; Heber U, 2007, J EXP BOT, V58, P2745, DOI 10.1093/jxb/erm139; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; Hwang HJ, 2008, BIOCHEMISTRY-US, V47, P9747, DOI 10.1021/bi800568p; Ivanov AG, 2006, FEBS LETT, V580, P2797, DOI 10.1016/j.febslet.2006.04.018; Jacobs AFG, 2000, INT J BIOMETEOROL, V43, P184, DOI 10.1007/s004840050007; Kaminskaya O, 2007, BIOCHEMISTRY-US, V46, P1091, DOI 10.1021/bi0613022; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V313, P349; Krieger-Liszkay A, 1998, BIOCHEMISTRY-US, V37, P17339, DOI 10.1021/bi9822628; Krieger-Liszkay A, 2006, J EXP BOT, V57, P1677, DOI 10.1093/jxb/erl002; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; LITTMANN T, 2008, ECOL STUD, P49; MAENPAA P, 1995, PLANT PHYSIOL, V107, P187, DOI 10.1104/pp.107.1.187; Miyake C, 2002, PLANT CELL PHYSIOL, V43, P951, DOI 10.1093/pcp/pcf113; Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064; Ohad I, 2005, PHOTOCH PHOTOBIO SCI, V4, P977, DOI 10.1039/b506300k; OHAD I, 1990, J BIOL CHEM, V265, P1972; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; Rappaport F, 2005, BIOPHYS J, V88, P1948, DOI 10.1529/biophysj.104.050237; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Szczepaniak M, 2009, BIOPHYS J, V96, P621, DOI 10.1016/j.bpj.2008.09.036; Tandori J, 2001, PHOTOSYNTH RES, V70, P175, DOI 10.1023/A:1017907404325; Tang D, 2007, J ARID ENVIRON, V71, P312, DOI 10.1016/j.jaridenv.2007.05.004; Umate P, 2007, J BIOL CHEM, V282, P9758, DOI 10.1074/jbc.M608117200; Vasil'ev S, 2003, FEBS LETT, V543, P159, DOI 10.1016/S0014-5793(03)00442-3; Vass I, 2007, ANN NY ACAD SCI, V1113, P114, DOI 10.1196/annals.1391.017; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159; ZER H, 1994, J BIOL CHEM, V269, P17670	45	50	50	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11000	10.1371/journal.pone.0011000	http://dx.doi.org/10.1371/journal.pone.0011000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544016	gold, Green Published, Green Submitted			2022-12-25	WOS:000278494900012
J	Rowe, JS; Shah, SS; Motlhagodi, S; Bafana, M; Tawanana, E; Truong, HT; Wood, SM; Zetola, NM; Steenhoff, AP				Rowe, Jack S.; Shah, Samir S.; Motlhagodi, Stephen; Bafana, Margaret; Tawanana, Ephraim; Truong, Hong T.; Wood, Sarah M.; Zetola, Nicola M.; Steenhoff, Andrew P.			An Epidemiologic Review of Enteropathogens in Gaborone, Botswana: Shifting Patterns of Resistance in an HIV Endemic Region	PLOS ONE			English	Article							ENTERIC INFECTIONS; SOUTH-AFRICA; DIARRHEA; CHILDREN; PARASITES; ZIMBABWE; COHORT; ADULTS; ZAMBIA	Background: The epidemiology of diarrheal disease in Botswana, an HIV endemic region, is largely unknown. Our primary objective was to characterize the prevalent bacterial and parasitic enteropathogens in Gaborone, Botswana. Secondary objectives included determining corresponding antimicrobial resistance patterns and the value of stool white and red blood cells for predicting bacterial and parasitic enteropathogens. Methodology/Principal Findings: A retrospective cross-sectional study examined laboratory records of stool specimens analyzed by the Botswana National Health Laboratory in Gaborone, Botswana from February 2003 through July 2008. In 4485 specimens the median subject age was 23 [interquartile range 1.6-34] years. Overall, 14.4% (644 of 4485) of samples yielded a pathogen. Bacteria alone were isolated in 8.2% (367 of 4485), parasites alone in 5.6% (253 of 4485) and both in 0.5% (24 of 4485) of samples. The most common bacterial pathogens were Shigella spp. and Salmonella spp., isolated from 4.0% (180 of 4485) and 3.9% (175 of 4485) of specimens, respectively. Escherichia coli (22 of 4485) and Campylobacter spp. (22 of 4485) each accounted for 0.5% of pathogens. Comparing antimicrobial resistance among Shigella spp. and Salmonella spp. between two periods, February 2003 to February 2004 and July 2006 to July 2008, revealed an increase in ampicillin resistance among Shigella spp. from 43% to 83% (p<0.001). Among Salmonella spp., resistance to chloramphenicol decreased from 56% to 6% (p<0.001). The absence of stool white and red blood cells correlated with a high specificity and negative predictive value. Conclusions/Significance: Most gastroenteritis stools were culture and microscopy negative suggesting that viral pathogens were the majority etiologic agents in this Botswana cohort. Shigella spp. and Salmonella spp. were the most common bacteria; Isospora spp. and Cryptosporidium spp. were the most common parasites. Resistance to commonly used antimicrobials is high and should be closely monitored.	[Rowe, Jack S.; Truong, Hong T.; Zetola, Nicola M.; Steenhoff, Andrew P.] Botswana UPenn Partnership, Gaborone, Botswana; [Rowe, Jack S.; Shah, Samir S.; Steenhoff, Andrew P.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Motlhagodi, Stephen; Bafana, Margaret; Tawanana, Ephraim] Botswana Natl Hlth Lab, Gaborone, Botswana; [Motlhagodi, Stephen; Bafana, Margaret; Tawanana, Ephraim; Zetola, Nicola M.; Steenhoff, Andrew P.] Princess Marina Hosp, Gaborone, Botswana; [Shah, Samir S.; Wood, Sarah M.; Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Rowe, JS (corresponding author), Botswana UPenn Partnership, Gaborone, Botswana.	steenhoff@email.chop.edu	wood, sarah/GRR-3687-2022; Shah, Samir/B-2661-2015	Shah, Samir/0000-0001-7902-7000	University of Pennsylvania Center for AIDS Research [IP30AI45008-01]; Infectious Diseases Society; UPenn Center; Robert Wood Johnson Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	University of Pennsylvania Center for AIDS Research; Infectious Diseases Society; UPenn Center; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by the University of Pennsylvania Center for AIDS Research IP30AI45008-01 to APS (http://www.uphs.upenn.edu/aids/), Infectious Diseases Society of America Medical Student Award & UPenn Center for Clinical Epidemiology and Biostatistics Medical Student Award to JSR (http://www.idsociety.org/Content.aspx?id=1852). SSS was supported by the Robert Wood Johnson Foundation through its Physician Faculty Scholar Program (http://rwjfpfsp.stanford.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachou H, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-27; Brink AK, 2002, J INFECTION, V45, P99, DOI 10.1053/jinf.2002.1002; Brooks JT, 2006, CLIN INFECT DIS, V43, P393, DOI 10.1086/505866; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Clinical and Laboratory Standards Institute (CLSI), 2009, PERF STAND ANT DISK, V10th; Cranendonk R J, 2003, East Afr Med J, V80, P398; Gumbo T, 1999, AIDS, V13, P819, DOI 10.1097/00002030-199905070-00011; Huicho L, 1996, PEDIATR INFECT DIS J, V15, P486, DOI 10.1097/00006454-199606000-00004; Karanja Robert M, 2007, Afr Health Sci, V7, P62; KHUMALONGWENYA B, 1994, E AFR MED J, V71, P379; Lin J, 2002, J TROP PEDIATRICS, V48, P252, DOI 10.1093/tropej/48.4.252; Luo NP, 1996, E AFR MED J, V73, P395; Mandomando IM, 2007, AM J TROP MED HYG, V76, P522, DOI 10.4269/ajtmh.2007.76.522; Morse TD, 2007, EPIDEMIOL INFECT, V135, P1307, DOI 10.1017/S0950268806007758; Mwansa J, 2002, EMERG INFECT DIS, V8, P92, DOI 10.3201/eid0801.010018; Nakano T, 1998, ACTA PAEDIATR JAPON, V40, P259; Obimbo EM, 2004, PEDIATR INFECT DIS J, V23, P536, DOI 10.1097/01.inf.0000129692.42964.30; Reither K, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-104; Samie A, 2007, J INFECTION, V54, P558, DOI 10.1016/j.jinf.2006.10.047; Simango C, 2000, TROP MED INT HEALTH, V5, P503, DOI 10.1046/j.1365-3156.2000.00587.x; Simango C., 1997, Central African Journal of Medicine, V43, P172; Temu M M, 2007, Tanzan Health Res Bull, V9, P186; Urio EM, 2001, TROP MED INT HEALTH, V6, P55, DOI 10.1046/j.1365-3156.2001.00668.x; *WHO, 2008, BOTSW EP FACT SHEET; World Health Organization, 2003, MANUAL LAB IDENTIFIC	25	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10924	10.1371/journal.pone.0010924	http://dx.doi.org/10.1371/journal.pone.0010924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20543877	Green Published, gold, Green Submitted			2022-12-25	WOS:000278284700007
J	Liu, ZZ; Li, A; Schulz, V; Chen, M; Tuck, D				Liu, Zongzhi; Li, Ao; Schulz, Vincent; Chen, Min; Tuck, David			MixHMM: Inferring Copy Number Variation and Allelic Imbalance Using SNP Arrays and Tumor Samples Mixed with Stromal Cells	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; HIDDEN-MARKOV MODEL; CANCER-CELLS; ASSOCIATION; DETECT; TOOL	Background: Genotyping platforms such as single nucleotide polymorphism (SNP) arrays are powerful tools to study genomic aberrations in cancer samples. Allele specific information from SNP arrays provides valuable information for interpreting copy number variation (CNV) and allelic imbalance including loss-of-heterozygosity (LOH) beyond that obtained from the total DNA signal available from array comparative genomic hybridization (aCGH) platforms. Several algorithms based on hidden Markov models (HMMs) have been designed to detect copy number changes and copy-neutral LOH making use of the allele information on SNP arrays. However heterogeneity in clinical samples, due to stromal contamination and somatic alterations, complicates analysis and interpretation of these data. Methods: We have developed MixHMM, a novel hidden Markov model using hidden states based on chromosomal structural aberrations. MixHMM allows CNV detection for copy numbers up to 7 and allows more complete and accurate description of other forms of allelic imbalance, such as increased copy number LOH or imbalanced amplifications. MixHMM also incorporates a novel sample mixing model that allows detection of tumor CNV events in heterogeneous tumor samples, where cancer cells are mixed with a proportion of stromal cells. Conclusions: We validate MixHMM and demonstrate its advantages with simulated samples, clinical tumor samples and a dilution series of mixed samples. We have shown that the CNVs of cancer cells in a tumor sample contaminated with up to 80% of stromal cells can be detected accurately using Illumina BeadChip and MixHMM.	[Liu, Zongzhi; Li, Ao; Tuck, David] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Schulz, Vincent] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Chen, Min] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Liu, ZZ (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	david.tuck@yale.edu		Chen, Min/0000-0002-0676-3143; Schulz, Vincent/0000-0001-6333-4284	Yale Center of Excellence in Molecular Hematology (NIDDK) [DK072442]; Yale Comprehensive Cancer Center; Targeted Area of Research Excellence Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072442] Funding Source: NIH RePORTER	Yale Center of Excellence in Molecular Hematology (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Yale Comprehensive Cancer Center; Targeted Area of Research Excellence Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: Yale Center of Excellence in Molecular Hematology (NIDDK DK072442), Yale Comprehensive Cancer Center, Targeted Area of Research Excellence Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fenton LF., 1960, IRE T COMMUN SYST, V8, P57, DOI [DOI 10.1109/TCOM.1960.1097606, 10.1109/TCOM.1960.1097606]; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Lai W, 2008, BIOINFORMATICS, V24, P1014, DOI 10.1093/bioinformatics/btn067; Li C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-204; McCarroll SA, 2008, HUM MOL GENET, V17, pR135, DOI 10.1093/hmg/ddn282; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; NAVIN N, 2009, GENOME RES; Ohashi J, 2009, J HUM GENET, V54, P169, DOI 10.1038/jhg.2009.8; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Speleman F, 2008, CYTOGENET GENOME RES, V123, P176, DOI 10.1159/000184706; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; SUN W, 2009, NUCLEIC ACIDS RES; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang P, 2009, METHODS MOL BIOL, V556, P99, DOI 10.1007/978-1-60327-192-9_8; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	25	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10909	10.1371/journal.pone.0010909	http://dx.doi.org/10.1371/journal.pone.0010909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532221	gold, Green Submitted, Green Published			2022-12-25	WOS:000278222400006
J	Pisciotta, JM; Zou, Y; Baskakov, IV				Pisciotta, John M.; Zou, Yongjin; Baskakov, Ilia V.			Light-Dependent Electrogenic Activity of Cyanobacteria	PLOS ONE			English	Article							MARINE; ENERGY; CELLS; PHOTOTAXIS; DIVERSITY; SYSTEMS; SITE; CO2	Background: Cyanobacteria account for 20-30% of Earth's primary photosynthetic productivity and convert solar energy into biomass-stored chemical energy at the rate of similar to 450 TW [1]. These single-cell microorganisms are resilient predecessors of all higher oxygenic phototrophs and can be found in self-sustaining, nitrogen-fixing communities the world over, from Antarctic glaciers to the Sahara desert [2]. Methodology/Principal Findings: Here we show that diverse genera of cyanobacteria including biofilm-forming and pelagic strains have a conserved light-dependent electrogenic activity, i.e. the ability to transfer electrons to their surroundings in response to illumination. Naturally-growing biofilm-forming photosynthetic consortia also displayed light-dependent electrogenic activity, demonstrating that this phenomenon is not limited to individual cultures. Treatment with site-specific inhibitors revealed the electrons originate at the photosynthetic electron transfer chain (P-ETC). Moreover, electrogenic activity was observed upon illumination only with blue or red but not green light confirming that P-ETC is the source of electrons. The yield of electrons harvested by extracellular electron acceptor to photons available for photosynthesis ranged from 0.05% to 0.3%, although the efficiency of electron harvesting likely varies depending on terminal electron acceptor. Conclusions/Significance: The current study illustrates that cyanobacterial electrogenic activity is an important microbiological conduit of solar energy into the biosphere. The mechanism responsible for electrogenic activity in cyanobacteria appears to be fundamentally different from the one exploited in previously discovered electrogenic bacteria, such as Geobacter, where electrons are derived from oxidation of organic compounds and transported via a respiratory electron transfer chain (R-ETC) [3,4]. The electrogenic pathway of cyanobacteria might be exploited to develop light-sensitive devices or future technologies that convert solar energy into limited amounts of electricity in a self-sustainable, CO2-free manner.	[Pisciotta, John M.; Zou, Yongjin; Baskakov, Ilia V.] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Pisciotta, JM (corresponding author), Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	baskakov@umaryland.edu	Zou, Yongjin/B-2830-2015	Zou, Yongjin/0000-0002-9012-2639	Elkins Professorship Award	Elkins Professorship Award	This research was supported by Elkins Professorship Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WW, 2006, ADV PHOTO RESPIRAT, V21, P49; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; BENNETTO HP, 1983, BIOTECHNOL BIOENG, V25, P559, DOI 10.1002/bit.260250219; Berry S, 2002, BIOCHEMISTRY-US, V41, P3422, DOI 10.1021/bi011683d; BUDKOV NG, 2003, BIOCHIM BIOPHYS ACTA, V1604, P115; CHAIN RK, 2006, ARCH BIOCHEM BIOPHYS, V197, P52; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P11912, DOI 10.1021/bi010852r; Gomez-Alvarez V, 2007, FEMS MICROBIOL ECOL, V60, P60, DOI 10.1111/j.1574-6941.2006.00253.x; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; HIYAMA T, 1970, PLANT PHYSIOL, V46, P163, DOI 10.1104/pp.46.1.163; HONEYCUTT RC, 1972, PLANT PHYSIOL, V49, P376, DOI 10.1104/pp.49.3.376; Huner N. P. A., 2008, PHOTOPROTECTION PHOT, P155; Joshua S, 2005, PLANT PHYSIOL, V138, P1577, DOI 10.1104/pp.105.061168; Kruse O, 2005, PHOTOCH PHOTOBIO SCI, V4, P957, DOI 10.1039/b506923h; LAVERGNE J, 1982, BIOCHIM BIOPHYS ACTA, V682, P345, DOI 10.1016/0005-2728(82)90048-2; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Lovley DR, 2008, GEOBIOLOGY, V6, P225, DOI 10.1111/j.1472-4669.2008.00148.x; Lovley DR, 2008, CURR OPIN BIOTECH, V19, P564, DOI 10.1016/j.copbio.2008.10.005; Ng WO, 2003, J BACTERIOL, V185, P1599, DOI 10.1128/JB.185.5.1599-1607.2003; NULTSCH W, 1983, ARCH MICROBIOL, V134, P33, DOI 10.1007/BF00429403; Paumann M, 2005, BBA-BIOENERGETICS, V1707, P231, DOI 10.1016/j.bbabio.2004.12.007; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; PROTEAU PJ, 1993, EXPERIENTIA, V49, P825, DOI 10.1007/BF01923559; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Roberts AG, 2004, BIOCHEMISTRY-US, V43, P7707, DOI 10.1021/bi049521f; Stal L.J., 2000, ECOLOGY CYANOBACTERI, P61; TANAKA K, 1988, J CHEM TECHNOL BIOT, V42, P235; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Whitton B.A., 2000, ECOLOGY CYANOBACTERI; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; YAGISHITA T, 1993, J CHEM TECHNOL BIOT, V56, P393; YAMAGISHI A, 1987, ARCH BIOCHEM BIOPHYS, V259, P124, DOI 10.1016/0003-9861(87)90477-2; ZOU Y, 2009, BIOELECTROC IN PRESS; Zou YJ, 2009, BIOTECHNOL BIOENG, V104, P939, DOI 10.1002/bit.22466	37	139	142	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10821	10.1371/journal.pone.0010821	http://dx.doi.org/10.1371/journal.pone.0010821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520829	Green Published, gold, Green Submitted			2022-12-25	WOS:000278034800016
J	Headey, SJ; MacAskill, UK; Wright, MA; Claridge, JK; Edwards, PJB; Farley, PC; Christeller, JT; Laing, WA; Pascal, SM				Headey, Stephen J.; MacAskill, Ursula K.; Wright, Michele A.; Claridge, Jolyon K.; Edwards, Patrick J. B.; Farley, Peter C.; Christeller, John T.; Laing, William A.; Pascal, Steven M.			Solution Structure of the Squash Aspartic Acid Proteinase Inhibitor (SQAPI) and Mutational Analysis of Pepsin Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROGLOBULIN TYPE-1 DOMAINS; NMR STRUCTURE DETERMINATION; NEMATODE ASCARIS-SUUM; PORCINE PEPSIN; CYSTEINE PROTEINASES; CHEMICAL-SHIFT; CATHEPSIN-D; BINDING; SPECTROSCOPY; EQUISTATIN	The squash aspartic acid proteinase inhibitor (SQAPI), a proteinaceous proteinase inhibitor from squash, is an effective inhibitor of a range of aspartic proteinases. Proteinaceous aspartic proteinase inhibitors are rare in nature. The only other example in plants probably evolved from a precursor serine proteinase inhibitor. Earlier work based on sequence homology modeling suggested SQAPI evolved from an ancestral cystatin. In this work, we determined the solution structure of SQAPI using NMR and show that SQAPI shares the same fold as a plant cystatin. The structure is characterized by a four-strand anti-parallel beta-sheet gripping an alpha-helix in an analogous manner to fingers of a hand gripping a tennis racquet. Truncation and site-specific mutagenesis revealed that the unstructured N terminus and the loop connecting beta-strands 1 and 2 are important for pepsin inhibition, but the loop connecting strands 3 and 4 is not. Using ambiguous restraints based on the mutagenesis results, SQAPI was then docked computationally to pepsin. The resulting model places the N-terminal strand of SQAPI in the S' side of the substrate binding cleft, whereas the first SQAPI loop binds on the S side of the cleft. The backbone of SQAPI does not interact with the pepsin catalytic Asp(32)-Asp(215) diad, thus avoiding cleavage. The data show that SQAPI does share homologous structural elements with cystatin and appears to retain a similar protease inhibitory mechanism despite its different target. This strongly supports our hypothesis that SQAPI evolved from an ancestral cystatin.	[Wright, Michele A.; Laing, William A.] New Zealand Inst Plant & Food Res Ltd, Auckland 1142, New Zealand; [Headey, Stephen J.; Claridge, Jolyon K.; Edwards, Patrick J. B.; Pascal, Steven M.] Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand; [MacAskill, Ursula K.; Farley, Peter C.] Massey Univ, Inst Mol Biosci, Palmerston North 4442, New Zealand; [Christeller, John T.] New Zealand Inst Plant & Food Res Ltd, Palmerston North 4442, New Zealand	New Zealand Institute for Plant & Food Research Ltd; Massey University; Massey University; New Zealand Institute for Plant & Food Research Ltd	Laing, WA (corresponding author), New Zealand Inst Plant & Food Res Ltd, Auckland 1142, New Zealand.	william.laing@plantandfood.co.nz; s.pascal@massey.ac.nz	Pascal, Steven/AAP-5684-2021; Laing, William A/E-3636-2010; Edwards, P/E-2804-2018; Laing, William A/B-2800-2015; Christeller, John T/E-6904-2010	Laing, William A/0000-0003-0458-6590; Edwards, P/0000-0003-3776-7582; Laing, William A/0000-0003-0458-6590; Headey, Stephen/0000-0001-8015-7064				BARTELS THX, 1995, J BIOMOL NMR, V6, P1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Christeller J, 2005, PROTEIN PEPTIDE LETT, V12, P439, DOI 10.2174/0929866054395329; Christeller JT, 2006, J MOL EVOL, V63, P747, DOI 10.1007/s00239-005-0304-z; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; Christeller JT, 1998, EUR J BIOCHEM, V254, P160, DOI 10.1046/j.1432-1327.1998.2540160.x; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dash C, 2001, BIOCHEMISTRY-US, V40, P11525, DOI 10.1021/bi010594y; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Farley PC, 2002, J MOL RECOGNIT, V15, P135, DOI 10.1002/jmr.568; Galesa K, 2003, FEBS LETT, V539, P120, DOI 10.1016/S0014-5793(03)00215-1; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; LAING W, 2002, PROTEIN PROTEIN INTE, P77; Laing WA, 2004, P NATL ACAD SCI USA, V101, P16976, DOI 10.1073/pnas.0407453101; Lenarcic B, 1999, J BIOL CHEM, V274, P563, DOI 10.1074/jbc.274.2.563; Li M, 2000, NAT STRUCT BIOL, V7, P113, DOI 10.1038/72378; MARES M, 1989, FEBS LETT, V251, P94, DOI 10.1016/0014-5793(89)81435-8; Margis R, 1998, ARCH BIOCHEM BIOPHYS, V359, P24, DOI 10.1006/abbi.1998.0875; Marin A, 2004, J BIOMOL NMR, V30, P47, DOI 10.1023/B:JNMR.0000042948.12381.88; MARTZEN MR, 1990, BIOCHEMISTRY-US, V29, P7366, DOI 10.1021/bi00484a003; Mathialagan N, 1996, P NATL ACAD SCI USA, V93, P13653, DOI 10.1073/pnas.93.24.13653; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Nagata K, 2000, BIOCHEMISTRY-US, V39, P14753, DOI 10.1021/bi0006971; Ng KKS, 2000, NAT STRUCT BIOL, V7, P653, DOI 10.1038/77950; Petersen JFW, 1998, ADV EXP MED BIOL, V436, P391; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pol E, 1999, BIOCHEMISTRY-US, V38, P10519, DOI 10.1021/bi990488k; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; SCHU P, 1991, EUR J BIOCHEM, V197, P1, DOI 10.1111/j.1432-1033.1991.tb15874.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yao SG, 2004, BIOCHEMISTRY-US, V43, P11187, DOI 10.1021/bi049456+	36	11	12	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27019	27025		10.1074/jbc.M110.137018	http://dx.doi.org/10.1074/jbc.M110.137018			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20538608	Green Published, hybrid			2022-12-25	WOS:000281172700033
J	Lee, J; Moon, HJ; Lee, JM; Joo, CK				Lee, Jungeun; Moon, Hyun-Jeong; Lee, Jong-Min; Joo, Choun-Ki			Smad3 Regulates Rho Signaling via NET1 in the Transforming Growth Factor-beta-induced Epithelial-Mesenchymal Transition of Human Retinal Pigment Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING SMAD3; TGF-BETA; GENE-EXPRESSION; POTENTIAL ROLE; TRANSDIFFERENTIATION; DIFFERENTIATION; REORGANIZATION; PLASTICITY; INDUCTION; PATHWAYS	We previously demonstrated that RhoA-dependent signaling regulates transforming growth factor-beta 1 (TGF-beta 1)-induced cytoskeletal reorganization in the human retinal pigment epithelial cell line ARPE-19. Smad pathways have also been shown to mediate TGF-beta 1 activity. Here, we examined what regulates Rho GTPase activity and tested whether Smad signaling cross-talks with Rho pathways during TGF-beta 1-induced actin rearrangement. Using small interfering RNAs, we found that NET1, the guanine nucleotide exchange factor of RhoA, is critical for TGF-beta 1-induced cytoskeletal reorganization, N-cadherin expression, and RhoA activation. In ARPE-19 cells lacking NET1, TGF-beta 1-induced stress fibers and N-cadherin expression were not observed. Interestingly, in dominant-negative Smad3-expressing or constitutively active Smad7 cells, TGF-beta 1 failed to induce NET1 mRNA and protein expression. Consistent with these results, both dominant-negative Smad3 and constitutively active Smad7 blocked the cytoplasmic localization of NET1 and inhibited interactions between NET1 and RhoA. Finally, we found that NET1 is a direct gene target of TGF-beta 1 via Smad3. Taken together, our results demonstrate that Smad3 regulates RhoA activation and cytoskeletal reorganization by controlling NET1 in TGF-beta 1-induced ARPE-19 cells. These data define a new role for Smad3 as a modulator of RhoA activation in the regulation of TGF-beta 1-induced epithelial-mesenchymal transitions.	[Lee, Jungeun; Moon, Hyun-Jeong; Lee, Jong-Min; Joo, Choun-Ki] Catholic Univ Korea, Lab Ophthalmol & Visual Sci, Catholic Res Inst Med Sci, Coll Med, Seoul 137040, South Korea	Catholic University of Korea	Joo, CK (corresponding author), Catholic Univ Korea, Lab Ophthalmol & Visual Sci, Catholic Res Inst Med Sci, Coll Med, 505 Banpo Dong, Seoul 137040, South Korea.	leeje@catholic.ac.kr			Ministry of Education, Science, and Technology [CBM34-B3003-01-00-00]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Center for Biological Modulators of the 21C Frontier R&D Program, Ministry of Education, Science, and Technology Grant CBM34-B3003-01-00-00.	Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Broders-Bondon F, 2007, DEV DYNAM, V236, P2555, DOI 10.1002/dvdy.21273; Carrington L, 2000, INVEST OPHTH VIS SCI, V41, P1210; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Casellas R, 1998, DEV BIOL, V198, P1; Cassidy L, 1998, BRIT J OPHTHALMOL, V82, P181, DOI 10.1136/bjo.82.2.181; Chan AML, 1996, ONCOGENE, V12, P1259; Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hay ED, 1995, ACTA ANAT, V154, P8; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Ka SM, 2007, J AM SOC NEPHROL, V18, P1777, DOI 10.1681/ASN.2006080901; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Lee J, 2008, J CELL PHYSIOL, V216, P520, DOI 10.1002/jcp.21424; Lee KM, 1999, CELL BIOL INT, V23, P507, DOI 10.1006/cbir.1998.0401; Lee SC, 2001, OPHTHALMIC RES, V33, P80, DOI 10.1159/000055648; Lei HT, 2007, INVEST OPHTH VIS SCI, V48, P2335, DOI 10.1167/iovs.06-0965; Lu J, 2005, DEVELOPMENT, V132, P3231, DOI 10.1242/dev.01893; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Moustakas A, 1999, J CELL SCI, V112, P1169; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Taylor LM, 2000, J BIOL CHEM, V275, P16709, DOI 10.1074/jbc.275.22.16709; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Yang Y, 2006, ONCOGENE, V25, P7235, DOI 10.1038/sj.onc.1209712; Yingling JM, 1996, P NATL ACAD SCI USA, V93, P8940, DOI 10.1073/pnas.93.17.8940; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	59	40	45	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26618	26627		10.1074/jbc.M109.073155	http://dx.doi.org/10.1074/jbc.M109.073155			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547485	Green Published, hybrid			2022-12-25	WOS:000280921000077
J	Bartsch, M; Bednarek, P; Vivancos, PD; Schneider, B; von Roepenack-Lahaye, E; Foyer, CH; Kombrink, E; Scheel, D; Parker, JE				Bartsch, Michael; Bednarek, Pawel; Vivancos, Pedro D.; Schneider, Bernd; von Roepenack-Lahaye, Edda; Foyer, Christine H.; Kombrink, Erich; Scheel, Dierk; Parker, Jane E.			Accumulation of Isochorismate-derived 2,3-Dihydroxybenzoic 3-O-beta-D-Xyloside in Arabidopsis Resistance to Pathogens and Ageing of Leaves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; BENZOIC-ACID DERIVATIVES; SALICYLIC-ACID; CELL-DEATH; DEFENSE RESPONSES; BRUCELLA-ABORTUS; GENTISIC ACID; DISEASE RESISTANCE; MONOOXYGENASE FMO1; METHYL SALICYLATE	An intricate network of hormone signals regulates plant development and responses to biotic and abiotic stress. Salicylic acid (SA), derived from the shikimate/isochorismate pathway, is a key hormone in resistance to biotrophic pathogens. Several SA derivatives and associated modifying enzymes have been identified and implicated in the storage and channeling of benzoic acid intermediates or as bioactive molecules. However, the range and modes of action of SA-related metabolites remain elusive. In Arabidopsis, Enhanced Disease Susceptibility 1 (EDS1) promotes SA-dependent and SA-independent responses in resistance against pathogens. Here, we used metabolite profiling of Arabidopsis wild type and eds1 mutant leaf extracts to identify molecules, other than SA, whose accumulation requires EDS1 signaling. Nuclear magnetic resonance and mass spectrometry of isolated and purified compounds revealed 2,3-dihydroxybenzoic acid (2,3-DHBA) as an isochorismate-derived secondary metabolite whose accumulation depends on EDS1 in resistance responses and during ageing of plants. 2,3-DHBA exists predominantly as a xylose-conjugated form (2-hydroxy-3-beta-O-D-xylopyranosyloxy benzoic acid) that is structurally distinct from known SA-glucose conjugates. Analysis of DHBA accumulation profiles in various Arabidopsis mutants suggests an enzymatic route to 2,3-DHBA synthesis that is under the control of EDS1. We propose that components of the EDS1 pathway direct the generation or stabilization of 2,3-DHBA, which as a potentially bioactive molecule is sequestered as a xylose conjugate.	[Bartsch, Michael; Bednarek, Pawel; Kombrink, Erich; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Vivancos, Pedro D.; Foyer, Christine H.] Univ Leeds, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; [Schneider, Bernd] Max Planck Inst Chem Ecol, D-07745 Jena, Germany; [von Roepenack-Lahaye, Edda; Scheel, Dierk] Leibniz Inst Pflanzenbiochem, Abt Stress & Entwicklungsbiol, D-06120 Halle, Saale, Germany	Max Planck Society; University of Leeds; Max Planck Society; Leibniz Institut fur Pflanzenbiochemie	Parker, JE (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	parker@mpiz-koeln.mpg.de	Foyer, Christine/K-2143-2012; Díaz-Vivancos, Pedro/G-5301-2011; Bednarek, Pawel/D-2561-2009; Schneider, Bernd/A-3287-2014	Díaz-Vivancos, Pedro/0000-0001-6041-2128; Bednarek, Pawel/0000-0002-3064-7775; Schneider, Bernd/0000-0003-4788-1565; Foyer, Christine/0000-0001-5989-6989	Max Planck Society; Bundesministerium fur Bildung und Forschung GABI DILEMA; Deutsche Forschungsgemeinschaft [1212]; Fundacion Seneca	Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fur Bildung und Forschung GABI DILEMA(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacion Seneca(Fundacion Seneca)	This work was supported by the Max Planck Society, Bundesministerium fur Bildung und Forschung GABI DILEMA, and Deutsche Forschungsgemeinschaft Schwerpunkt programm 1212 (Plant-Microbe) grants (to J. E. P. and M. B.).; Recipient of a Fundacion Seneca post-doctoral research fellowship.	ABAD P, 1988, ANTIVIR RES, V9, P315, DOI 10.1016/0166-3542(88)90026-5; Amborabe BE, 2002, PLANT PHYSIOL BIOCH, V40, P1051, DOI 10.1016/S0981-9428(02)01470-5; Attaran E, 2009, PLANT CELL, V21, P954, DOI 10.1105/tpc.108.063164; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bednarek P, 2005, PLANT PHYSIOL, V138, P1058, DOI 10.1104/pp.104.057794; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bellaire BH, 2003, INFECT IMMUN, V71, P2927, DOI 10.1128/IAI.71.5.2927-2932.2003; Belles JM, 1999, MOL PLANT MICROBE IN, V12, P227, DOI 10.1094/MPMI.1999.12.3.227; Brazier-Hicks M, 2005, PLANT J, V42, P556, DOI 10.1111/j.1365-313X.2005.02398.x; Carviel JL, 2009, MOL PLANT PATHOL, V10, P621, DOI [10.1111/j.1364-3703.2009.00557.x, 10.1111/J.1364-3703.2009.00557.X]; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Dean JV, 2008, PHYSIOL PLANTARUM, V132, P417, DOI 10.1111/j.1399-3054.2007.01041.X; Dean JV, 2005, PLANTA, V221, P287, DOI 10.1007/s00425-004-1430-3; Fayos J, 2006, PHYTOCHEMISTRY, V67, P142, DOI 10.1016/j.phytochem.2005.10.014; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; FLOYD RA, 1984, J BIOCHEM BIOPH METH, V10, P221, DOI 10.1016/0165-022X(84)90042-3; Fobert PR, 2005, CURR OPIN PLANT BIOL, V8, P378, DOI 10.1016/j.pbi.2005.05.003; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Ge XC, 2007, PLANT PHYSIOL, V145, P204, DOI 10.1104/pp.107.103374; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GROOTVELD M, 1986, BIOCHEM J, V237, P499, DOI 10.1042/bj2370499; He YH, 2002, PLANT CELL, V14, P805, DOI 10.1105/tpc.010422; HENNIG J, 1993, PLANT J, V4, P593, DOI 10.1046/j.1365-313X.1993.04040593.x; IBRAHIM RK, 1959, NATURE, V184, P1803, DOI 10.1038/1841803a0; Ishikawa K, 2009, PLANT PHYSIOL, V151, P741, DOI 10.1104/pp.109.140442; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Karegoudar TB, 2000, J MICROBIOL, V38, P53; Kienow L, 2008, J EXP BOT, V59, P403, DOI 10.1093/jxb/erm325; Kim JH, 2008, FEMS MICROBIOL LETT, V281, P64, DOI 10.1111/j.1574-6968.2008.01072.x; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Lee HI, 1998, PHYTOPATHOLOGY, V88, P692, DOI 10.1094/PHYTO.1998.88.7.692; Leonard BA, 1997, VET RES, V28, P87; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; MORENO PRH, 1994, PLANT CELL REP, V14, P188, DOI 10.1007/BF00233788; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Muljono RAB, 2002, PLANT PHYSIOL BIOCH, V40, P231, DOI 10.1016/S0981-9428(02)01369-4; Mustafa NR, 2009, PHYTOCHEMISTRY, V70, P532, DOI 10.1016/j.phytochem.2009.01.009; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Parent MA, 2002, MICROB PATHOGENESIS, V32, P239, DOI 10.1006/mpat.2002.0500; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Shah J, 2009, CURR OPIN PLANT BIOL, V12, P459, DOI 10.1016/j.pbi.2009.05.011; Shapiro AD, 2001, PLANT PHYSIOL, V127, P1089, DOI 10.1104/pp.010096; Straus MR, 2010, PLANT J, V62, P628, DOI 10.1111/j.1365-313X.2010.04178.x; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; Wagstaff C, 2009, PLANT J, V57, P690, DOI 10.1111/j.1365-313X.2008.03722.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wildermuth MC, 2006, CURR OPIN PLANT BIOL, V9, P288, DOI 10.1016/j.pbi.2006.03.006; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yang YN, 2004, PLANT J, V40, P909, DOI 10.1111/j.1365-313X.2004.02267.x; YOUNG IG, 1968, BIOCHIM BIOPHYS ACTA, V165, P567, DOI 10.1016/0304-4165(68)90245-6; Zhou N, 1998, PLANT CELL, V10, P1021, DOI 10.1105/tpc.10.6.1021; Zimmermann P, 2005, CELL MOL BIOL LETT, V10, P515	73	60	61	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25654	25665		10.1074/jbc.M109.092569	http://dx.doi.org/10.1074/jbc.M109.092569			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538606	hybrid, Green Published			2022-12-25	WOS:000280682400059
J	DePaoli-Roach, AA; Tagliabracci, VS; Segvich, DM; Meyer, CM; Irimia, JM; Roach, PJ				DePaoli-Roach, Anna A.; Tagliabracci, Vincent S.; Segvich, Dyann M.; Meyer, Catalina M.; Irimia, Jose M.; Roach, Peter J.			Genetic Depletion of the Malin E3 Ubiquitin Ligase in Mice Leads to Lafora Bodies and the Accumulation of Insoluble Laforin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCLONUS EPILEPSY; GLYCOGEN-METABOLISM; PHOSPHATASE; DEGRADATION; MUTATIONS; COMPLEX; PHOSPHORYLATION; POLYGLUCOSANS; PROTEINS; DISEASE	Approximately 90% of cases of Lafora disease, a fatal teen-age-onset progressive myoclonus epilepsy, are caused by mutations in either the EPM2A or the EPM2B genes that encode, respectively, a glycogen phosphatase called laforin and an E3 ubiquitin ligase called malin. Lafora disease is characterized by the formation of Lafora bodies, insoluble deposits containing poorly branched glycogen or polyglucosan, in many tissues including skeletal muscle, liver, and brain. Disruption of the Epm2b gene in mice resulted in viable animals that, by 3 months of age, accumulated Lafora bodies in the brain and to a lesser extent in heart and skeletal muscle. Analysis of muscle and brain of the Epm2b(-/-) mice by Western blotting indicated no effect on the levels of glycogen synthase, PTG (type 1 phosphatase-targeting subunit), or debranching enzyme, making it unlikely that these proteins are targeted for destruction by malin, as has been proposed. Total laforin protein was increased in the brain of Epm2b(-/-) mice and, most notably, was redistributed from the soluble, low speed supernatant to the insoluble low speed pellet, which now contained 90% of the total laforin. This result correlated with elevated insolubility of glycogen and glycogen synthase. Because up-regulation of laforin cannot explain Lafora body formation, we conclude that malin functions to maintain laforin associated with soluble glycogen and that its absence causes sequestration of laforin to an insoluble polysaccharide fraction where it is functionally inert.	[DePaoli-Roach, Anna A.; Tagliabracci, Vincent S.; Segvich, Dyann M.; Meyer, Catalina M.; Irimia, Jose M.; Roach, Peter J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	DePaoli-Roach, AA (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	adepaoli@iupui.edu; proach@iupui.edu			National Institutes of Health [NS05645, DK27221]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027221, R56DK027221, R01DK027221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NS05645 and DK27221 (to P. J. R.).	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; BERGMEYER H, 1974, METHOD ENZYMAT AN, P1128; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Graham TE, 2009, APPL PHYSIOL NUTR ME, V34, P488, DOI 10.1139/H09-048; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Moses Shimon W., 2002, Current Molecular Medicine (Hilversum), V2, P177, DOI 10.2174/1566524024605815; Nakajima Hiromu, 2002, Current Molecular Medicine (Hilversum), V2, P197, DOI 10.2174/1566524024605734; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramachandran N, 2009, EPILEPSIA, V50, P29, DOI 10.1111/j.1528-1167.2009.02117.x; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; ROACH PJ, 1977, MOL CELL BIOCHEM, V15, P179, DOI 10.1007/BF01734108; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Savage David B, 2008, PLoS Med, V5, pe27, DOI 10.1371/journal.pmed.0050027; Singh S, 2009, HUM MUTAT, V30, P715, DOI 10.1002/humu.20954; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200	38	89	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25372	25381		10.1074/jbc.M110.148668	http://dx.doi.org/10.1074/jbc.M110.148668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538597	Green Published, hybrid			2022-12-25	WOS:000280682400030
J	Mueller, GA; Gosavi, RA; Krahn, JM; Edwards, LL; Cuneo, MJ; Glesner, J; Pomes, A; Chapman, MD; London, RE; Pedersen, LC				Mueller, Geoffrey A.; Gosavi, Rajendrakumar A.; Krahn, Joseph M.; Edwards, Lori L.; Cuneo, Matthew J.; Glesner, Jill; Pomes, Anna; Chapman, Martin D.; London, Robert E.; Pedersen, Lars C.			Der p 5 Crystal Structure Provides Insight into the Group 5 Dust Mite Allergens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOMIA-TROPICALIS; X-RAY; CROSS-REACTIVITY; T-CELL; RECOMBINANT; SENSITIZATION; PROTEIN; EXPOSURE; SUBUNIT; BIOLOGY	Group 5 allergens from house dust mites elicit strong IgE antibody binding in mite-allergic patients. The structure of Der p 5 was determined by x-ray crystallography to better understand the IgE epitopes, to investigate the biologic function in mites, and to compare with the conflicting published Blo t 5 structures, designated 2JMH and 2JRK in the Protein Data Bank. Der p 5 is a three-helical bundle similar to Blo t 5, but the interactions of the helices are more similar to 2JMH than 2JRK. The crystallo-graphic asymmetric unit contains three dimers of Der p 5 that are not exactly alike. Solution scattering techniques were used to assess the multimeric state of Der p 5 in vitro and showed that the predominant state was monomeric, similar to Blo t 5, but larger multimeric species are also present. In the crystal, the formation of the Der p 5 dimer creates a large hydrophobic cavity of similar to 3000 angstrom(3) that could be a ligand-binding site. Many allergens are known to bind hydrophobic ligands, which are thought to stimulate the innate immune system and have adjuvant-like effects on IgE-mediated inflammatory responses.	[London, Robert E.; Pedersen, Lars C.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Edwards, Lori L.] NIEHS, Prot Express Core Facil, NIH, Res Triangle Pk, NC 27709 USA; [Glesner, Jill; Pomes, Anna; Chapman, Martin D.] INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); INDOOR Biotechnologies	Mueller, GA (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	mueller3@niehs.nih.gov	London, Robert E/F-7990-2019; Pomés, Anna/H-7010-2019; Mueller, Geoffrey A/I-2909-2017; Pedersen, Lars/C-6173-2019	London, Robert E/0000-0001-9108-8463; Pomés, Anna/0000-0002-8729-1829; Mueller, Geoffrey A/0000-0001-8361-5323; Pedersen, Lars/0000-0002-4488-4077; Cuneo, Matthew/0000-0002-1475-6656; Chapman, Martin/0000-0002-0845-3632	NIAID [R01AI077653]; Intramural Research Program; NIEHS; National Institutes of Health, NIEHS [HHSN273200700046U]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102645, ZIAES102906] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI077653 from NIAID (to A. P. and M. D. C.), by the Intramural Research Program, and by NIEHS.; Supported by National Institutes of Health, NIEHS, under Delivery Order HHSN273200700046U to SRA International, Inc.	ARRUDA LK, 1991, CLIN EXP ALLERGY, V21, P433, DOI 10.1111/j.1365-2222.1991.tb01683.x; Arruda LK, 1997, AM J RESP CRIT CARE, V155, P343, DOI 10.1164/ajrccm.155.1.9001334; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caraballo L, 1998, J INVEST ALLERG CLIN, V8, P281; Caraballo L, 1998, INT ARCH ALLERGY IMM, V117, P38, DOI 10.1159/000023988; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Chew FT, 1999, CLIN EXP ALLERGY, V29, P982, DOI 10.1046/j.1365-2222.1999.00543.x; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; DeRose EF, 2004, STRUCTURE, V12, P2221, DOI 10.1016/j.str.2004.09.019; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; HEWITT CRA, 1995, J EXP MED, V182, P1537, DOI 10.1084/jem.182.5.1537; Ichikawa S, 2009, GENES CELLS, V14, P1055, DOI 10.1111/j.1365-2443.2009.01334.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kaiser L, 2003, J BIOL CHEM, V278, P37730, DOI 10.1074/jbc.M304740200; King C, 1998, J IMMUNOL, V161, P3645; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuo IC, 2003, J ALLERGY CLIN IMMUN, V111, P603, DOI 10.1067/mai.2003.167; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liaw SH, 2001, BIOCHEM BIOPH RES CO, V285, P308, DOI 10.1006/bbrc.2001.5184; Liaw SH, 1998, J STRUCT BIOL, V123, P265, DOI 10.1006/jsbi.1998.4031; LIN KL, 1994, J ALLERGY CLIN IMMUN, V94, P989, DOI 10.1016/0091-6749(94)90117-1; Mueller GA, 2005, J BACTERIOL, V187, P7081, DOI 10.1128/JB.187.20.7081-7089.2005; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Naik MT, 2008, STRUCTURE, V16, P125, DOI 10.1016/j.str.2007.10.022; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Simpson A, 2003, ALLERGY, V58, P53, DOI 10.1034/j.1398-9995.2003.23354.x; SPORIK R, 1992, CLIN EXP ALLERGY, V22, P897, DOI 10.1111/j.1365-2222.1992.tb02062.x; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thomas WR, 2007, IMMUNOL RES, V37, P187, DOI 10.1007/BF02697369; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Tomee JFC, 1998, J ALLERGY CLIN IMMUN, V102, P75, DOI 10.1016/S0091-6749(98)70057-0; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Weghofer M, 2008, ALLERGY, V63, P758, DOI 10.1111/j.1398-9995.2008.01647.x; Weghofer M, 2008, INT ARCH ALLERGY IMM, V147, P101, DOI 10.1159/000135696; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	44	45	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25394	25401		10.1074/jbc.M110.128306	http://dx.doi.org/10.1074/jbc.M110.128306			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534590	Green Published, hybrid			2022-12-25	WOS:000280682400032
J	Stamnaes, J; Pinkas, DM; Fleckenstein, B; Khosla, C; Sollid, LM				Stamnaes, Jorunn; Pinkas, Daniel M.; Fleckenstein, Burkhard; Khosla, Chaitan; Sollid, Ludvig M.			Redox Regulation of Transglutaminase 2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG LIVER TRANSGLUTAMINASE; TISSUE TRANSGLUTAMINASE; CELIAC-DISEASE; GLIADIN PEPTIDES; STRUCTURAL BASIS; CALCIUM-IONS; INACTIVATION; MECHANISM; ENZYME; TRANSAMIDATION	Transglutaminase 2 (TG2) in the extracellular matrix is largely inactive but is transiently activated upon certain types of inflammation and cell injury. The enzymatic activity of extracellular TG2 thus appears to be tightly regulated. As TG2 is known to be sensitive to changes in the redox environment, inactivation through oxidation presents a plausible mechanism. Using mass spectrometry, we have identified a redox-sensitive cysteine triad consisting of Cys(230), Cys(370), and Cys(371) that is involved in oxidative inactivation of TG2. Within this triad, Cys(370) was found to participate in disulfide bonds with both Cys(230) and its neighbor, Cys(371). Notably, Ca2+ was found to protect against formation of these disulfide bonds. To investigate the role of each cysteine residue, we created alanine mutants and found that Cys230 appears to promote oxidation and inactivation of TG2 by facilitating formation of Cys(370)-Cys(371) through formation of the Cys(230)-Cys(370) disulfide bond. Although vicinal disulfide pairs are found in several transglutaminase isoforms, Cys(230) is unique for TG2, suggesting that this residue acts as an isoform-specific redox sensor. Our findings suggest that oxidation is likely to influence the amount of active TG2 present in the extracellular environment.	[Stamnaes, Jorunn; Fleckenstein, Burkhard; Sollid, Ludvig M.] Univ Oslo, Inst Immunol, Ctr Immune Regulat, N-0027 Oslo, Norway; [Sollid, Ludvig M.] Oslo Univ Hosp, N-0027 Oslo, Norway; [Pinkas, Daniel M.; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	University of Oslo; University of Oslo; Stanford University; Stanford University; Stanford University	Stamnaes, J (corresponding author), Univ Oslo, Rikshosp, Inst Immunol, N-0027 Oslo, Norway.	jorunn.stamnas@rr-research.no	Pinkas, Daniel/AAE-3210-2020; Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; Stamnaes, Jorunn/0000-0002-0257-2112; Khosla, Chaitan/0000-0001-6529-495X; Pinkas, Daniel/0000-0002-4740-6695	National Institutes of Health [DK 063158]; Research Council of Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 063158 (to C. K.). This work was also supported by a grant from the Research Council of Norway (to L. M. S.).	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; BOOTHE RL, 1969, J BIOL CHEM, V244, P399; Casadio R, 1999, EUR J BIOCHEM, V262, P672, DOI 10.1046/j.1432-1327.1999.00437.x; CHUNG SI, 1970, J BIOL CHEM, V245, P681; CONNELLAN JM, 1969, J BIOL CHEM, V244, P3173; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; FOLK JE, 1967, J BIOL CHEM, V242, P1838; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Kiraly R, 2009, FEBS J, V276, P7083, DOI 10.1111/j.1742-4658.2009.07420.x; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mariani P, 2000, BIOPHYS J, V78, P3240, DOI 10.1016/S0006-3495(00)76860-3; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; ROTH WJ, 1986, J LEUKOCYTE BIOL, V39, P629, DOI 10.1002/jlb.39.6.629; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028	26	131	133	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25402	25409		10.1074/jbc.M109.097162	http://dx.doi.org/10.1074/jbc.M109.097162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547769	Green Published, hybrid			2022-12-25	WOS:000280682400033
J	Gkika, D; Flourakis, M; Lemonnier, L; Prevarskaya, N				Gkika, D.; Flourakis, M.; Lemonnier, L.; Prevarskaya, N.			PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression	ONCOGENE			English	Article						prostate cancer; ion channel regulation; kallikrein; cell migration	BRADYKININ B-2 RECEPTOR; BINDING PROTEIN-3; EPITHELIAL-CELLS; SEMINAL PLASMA; CHANNEL; ANTIGEN; GROWTH; IDENTIFICATION; KALLIKREINS; ACTIVATION	Although the transient receptor potential melastatin 8 (TRPM8) cold receptor is highly expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic indicator, the natural agonists of this channel in the prostate, as well as its physiological and pathological functions, remain unknown. In this study, we identified the well-known PCa marker, prostate-specific antigen (PSA), as a physiological TRPM8 agonist. Electrophysiological and Ca(2+) imaging studies demonstrated that PSA activated TRPM8-mediated current by the bradykinin 2 receptor signaling pathway. Further investigation of this mechanism by cell-surface biotinylation revealed that the increase in TRPM8 current induced by PSA was due to an increase in the number of functional TRPM8 channels on the plasma membrane. Importantly, wound-healing and migration assays revealed that TRPM8 activation by PSA reduced motility of the PC3 PCa cell line, suggesting that plasma membrane TRPM8 has a protective role in PCa progression. Consequently, PSA was identified as a natural TRPM8 agonist in the prostate and we propose a putative physiological role for both of these proteins in carcinogenesis, making this pathway a potentially important target for anticancer agent development. Oncogene (2010) 29, 4611-4616; doi: 10.1038/onc.2010.210; published online 7 June 2010	[Prevarskaya, N.] USTL, INSERM, Lab Physiol Cellulaire, Equipe Labellisee Ligue Natl Canc,U1003, F-59655 Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Prevarskaya, N (corresponding author), USTL, INSERM, Lab Physiol Cellulaire, Equipe Labellisee Ligue Natl Canc,U1003, Batiment SN3, F-59655 Villeneuve Dascq, France.	natacha.prevarskaya@univ-lille1.fr	Lemonnier, Loic/L-7289-2018; Gkika, Dimitra/S-3054-2019	Lemonnier, Loic/0000-0001-6200-5382; Gkika, Dimitra/0000-0001-8612-0836; Prevarskaya, natacha/0000-0003-0316-197X; Flourakis, Matthieu/0000-0002-5366-9125	Institut national de la Sante et de la Recherche Medicale (INSERM); Ministere de l'education nationale and the Ligue Nationale contre le cancer; Institut National du Cancer (INCa) [07/3d1616/pdoc-110-18/ng-nc]	Institut national de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'education nationale and the Ligue Nationale contre le cancer; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	This study was supported by grants from the Institut national de la Sante et de la Recherche Medicale (INSERM), Ministere de l'education nationale and the Ligue Nationale contre le cancer. Dr D Gkika was supported by a grant from the Institut National du Cancer (INCa) (Grant No: 07/3d1616/pdoc-110-18/ng-nc).	BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bindukumar B, 2005, NEOPLASIA, V7, P241, DOI 10.1593/neo.04529; Blaukat A, 2003, ANDROLOGIA, V35, P17, DOI 10.1046/j.1439-0272.2003.00533.x; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; COHEN P, 1992, J CLIN ENDOCR METAB, V75, P1046, DOI 10.1210/jc.75.4.1046; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Gkika D, 2009, BBA-MOL CELL RES, V1793, P953, DOI 10.1016/j.bbamcr.2008.11.010; Hecquet C, 2000, MOL PHARMACOL, V58, P828, DOI 10.1124/mol.58.4.828; Heidtmann HH, 1999, BRIT J CANCER, V81, P1269, DOI 10.1038/sj.bjc.6692167; Henshall SM, 2003, CANCER RES, V63, P4196; Kramarenko II, 2009, BIOCHEM PHARMACOL, V77, P269, DOI 10.1016/j.bcp.2008.09.027; Lilja H, 2003, UROLOGY, V62, P27, DOI 10.1016/S0090-4295(03)00775-1; LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; Platz EA, 2005, CANCER CAUSE CONTROL, V16, P255, DOI 10.1007/s10552-004-3484-8; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Srinivasan D, 2004, EUR J PHARMACOL, V504, P155, DOI 10.1016/j.ejphar.2004.10.004; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsavaler L, 2001, CANCER RES, V61, P3760; Yang ZH, 2009, ASIAN J ANDROL, V11, P157, DOI 10.1038/aja.2009.1; Zhang L, 2006, ENDOCR-RELAT CANCER, V13, P27, DOI 10.1677/erc.1.01093	28	74	77	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 12	2010	29	32					4611	4616		10.1038/onc.2010.210	http://dx.doi.org/10.1038/onc.2010.210			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	638AQ	20531306				2022-12-25	WOS:000280862300011
J	Leviatan, S; Sawada, K; Moriyama, Y; Nelson, N				Leviatan, Shani; Sawada, Keisuke; Moriyama, Yoshinori; Nelson, Nathan			Combinatorial Method for Overexpression of Membrane Proteins in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE-BINDING-PROTEIN; HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; FUSION; TRANSPORTER; PURIFICATION; CRYSTALLIZATION; STRATEGIES; CHANNEL	Membrane proteins constitute 20-30% of all proteins encoded by the genome of various organisms. Large amounts of purified proteins are required for activity and crystallization attempts. Thus, there is an unmet need for a heterologous membrane protein overexpression system for purification, crystallization, and activity determination. We developed a combinatorial method for overexpressing and purifying membrane proteins using Escherichia coli. This method utilizes short hydrophilic bacterial proteins, YaiN and YbeL, fused to the ends of the membrane proteins to serve as facilitating factors for expression and purification. Fourteen prokaryotic and mammalian membrane proteins were expressed using this system. Moderate to high expression was obtained for most proteins, and detergent solubilization combined with a short purification process produced stable, monodispersed membrane proteins. Five of the mammalian membrane proteins, overexpressed using our system, were reconstituted into liposomes and exhibited transport activity comparable with the native transporters.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Sawada, Keisuke; Moriyama, Yoshinori] Okayama Univ, Dept Membrane Biochem, Okayama 7008530, Japan	Tel Aviv University; Okayama University		nelson@post.tau.ac.il			Japan-Israel Scientific Research cooperation [3-6790]	Japan-Israel Scientific Research cooperation	This work was supported in part by Grant 3-6790 from the Japan-Israel Scientific Research cooperation.	Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beckwith J, 2000, METHOD ENZYMOL, V326, P3; Begum RR, 2000, J CHROMATOGR B, V737, P119, DOI 10.1016/S0378-4347(99)00480-6; Caffrey M, 2003, J STRUCT BIOL, V142, P108, DOI 10.1016/S1047-8477(03)00043-1; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Laage R, 2001, TRAFFIC, V2, P99, DOI 10.1034/j.1600-0854.2001.020204.x; LaVallie ER, 2000, METHOD ENZYMOL, V326, P322; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; MICHEL H, 1983, TRENDS BIOCHEM SCI, V8, P56, DOI 10.1016/0968-0004(83)90390-0; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Quick M, 2002, P NATL ACAD SCI USA, V99, P8597, DOI 10.1073/pnas.132266599; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Rudnick G, 2008, P NATL ACAD SCI USA, V105, P5949, DOI 10.1073/pnas.0802774105; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; White JF, 2004, FEBS LETT, V564, P289, DOI 10.1016/S0014-5793(04)00195-4; Zhan Y, 2001, GENE, V281, P1, DOI 10.1016/S0378-1119(01)00797-1; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020	28	44	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23548	23556		10.1074/jbc.M110.125492	http://dx.doi.org/10.1074/jbc.M110.125492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525689	hybrid, Green Published			2022-12-25	WOS:000280291400004
J	Schonrock, N; Ke, YD; Humphreys, D; Staufenbiel, M; Ittner, LM; Preiss, T; Gotz, J				Schonrock, Nicole; Ke, Yazi D.; Humphreys, David; Staufenbiel, Matthias; Ittner, Lars M.; Preiss, Thomas; Goetz, Juergen			Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-beta	PLOS ONE			English	Article							PRECURSOR-PROTEIN; POSTTRANSCRIPTIONAL REGULATION; MEDIATOR PROTEIN-2; TRANSGENIC MOUSE; EXPRESSION; BRAIN; HIPPOCAMPAL; TISSUE; MODEL; NEUROGENESIS	Normal brain development and function depends on microRNA (miRNA) networks to fine tune the balance between the transcriptome and proteome of the cell. These small non-coding RNA regulators are highly enriched in brain where they play key roles in neuronal development, plasticity and disease. In neurodegenerative disorders such as Alzheimer's disease (AD), brain miRNA profiles are altered; thus miRNA dysfunction could be both a cause and a consequence of disease. Our study dissects the complexity of human AD pathology, and addresses the hypothesis that amyloid-beta (A beta) itself, a known causative factor of AD, causes neuronal miRNA deregulation, which could contribute to the pathomechanisms of AD. We used sensitive TaqMan low density miRNA arrays (TLDA) on murine primary hippocampal cultures to show that about half of all miRNAs tested were down-regulated in response to A beta peptides. Time-course assays of neuronal A beta treatments show that A beta is in fact a powerful regulator of miRNA levels as the response of certain mature miRNAs is extremely rapid. Bioinformatic analysis predicts that the deregulated miRNAs are likely to affect target genes present in prominent neuronal pathways known to be disrupted in AD. Remarkably, we also found that the miRNA deregulation in hippocampal cultures was paralleled in vivo by a deregulation in the hippocampus of A beta 42-depositing APP23 mice, at the onset of Ab plaque formation. In addition, the miRNA deregulation in hippocampal cultures and APP23 hippocampus overlaps with those obtained in human AD studies. Taken together, our findings suggest that neuronal miRNA deregulation in response to an insult by A beta may be an important factor contributing to the cascade of events leading to AD.	[Schonrock, Nicole; Ke, Yazi D.; Ittner, Lars M.; Goetz, Juergen] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW, Australia; [Humphreys, David; Preiss, Thomas] VCCRI, Div Mol Genet, Sydney, NSW, Australia; [Staufenbiel, Matthias] Novartis Inst BioMed Res, Basel, Switzerland; [Preiss, Thomas] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Preiss, Thomas] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia	University of Sydney; Victor Chang Cardiac Research Institute; Novartis; University of New South Wales Sydney; University of New South Wales Sydney	Schonrock, N (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW, Australia.	nschonrock@med.usyd.edu.au; jgoetz@med.usyd.edu.au	Götz, Jürgen/C-2448-2014; Ke, Yazi/ABC-3052-2020; Preiss, Thomas/F-7355-2010	Götz, Jürgen/0000-0001-8501-7896; Ke, Yazi/0000-0002-1423-0451; Preiss, Thomas/0000-0001-6273-784X; Humphreys, David/0000-0003-4140-0089; Ittner, Lars/0000-0001-6738-3825	Human Frontier Science Program; National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); University of Sydney; J.O. & J.R. Wicking Trust; Wenkart Foundation; GlaxoSmithKline; Alzheimer's Australia	Human Frontier Science Program(Human Frontier Science Program); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); University of Sydney(University of Sydney); J.O. & J.R. Wicking Trust; Wenkart Foundation; GlaxoSmithKline(GlaxoSmithKline); Alzheimer's Australia	N.S. is supported by the Human Frontier Science Program. L. I. is supported by the National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC), and J.G. is supported by grants from the University of Sydney, the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), and the J.O. & J.R. Wicking Trust. Postgraduate scholarship support has been provided by the Wenkart Foundation, GlaxoSmithKline and Alzheimer's Australia. Novartis (via Matthias Staufenbiel) provided the APP23 mouse strain. All experiments were performed in Sydney, and Novartis did not fund any aspect of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; David DC, 2006, PROTEOMICS, V6, P6566, DOI 10.1002/pmic.200600634; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gotz J, 2008, J ALZHEIMERS DIS, V14, P423; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Gotz J, 2009, J ALZHEIMERS DIS, V18, P243, DOI 10.3233/JAD-2009-1143; Gotz J, 2004, INT J DEV NEUROSCI, V22, P453, DOI 10.1016/j.ijdevneu.2004.07.013; Gotz Jurgen, 2008, Neuropsychiatr Dis Treat, V4, P1033; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Guerreiro N, 2008, J ALZHEIMERS DIS, V13, P17; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; LAU P, 2010, SEMIN CELL DEV BIOL; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lubec G, 1999, J NEURAL TRANSM-SUPP, P161; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Nelson PT, 2009, NEUROSCI LETT, V466, P69, DOI 10.1016/j.neulet.2009.04.044; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; PODLISNY MB, 1987, SCIENCE, V238, P669, DOI 10.1126/science.2960019; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Sizova D, 2007, NEUROBIOL AGING, V28, P357, DOI 10.1016/j.neurobiolaging.2006.01.011; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; Van Dam D, 2005, CNS SPECTRUMS, V10, P207, DOI 10.1017/S1092852900010051; Vercauteren FGG, 2004, MOL BRAIN RES, V132, P241, DOI 10.1016/j.molbrainres.2004.10.012; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; Young KF, 2009, NEUROCHEM INT, V55, P796, DOI 10.1016/j.neuint.2009.08.002; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	70	149	159	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11070	10.1371/journal.pone.0011070	http://dx.doi.org/10.1371/journal.pone.0011070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552018	Green Published, gold, Green Submitted			2022-12-25	WOS:000278662900010
J	Choong, LY; Lim, S; Chong, PK; Wong, CY; Shah, N; Lim, YP				Choong, Lee Yee; Lim, Simin; Chong, Poh Kuan; Wong, Chow Yin; Shah, Nilesh; Lim, Yoon Pin			Proteome-Wide Profiling of the MCF10AT Breast Cancer Progression Model	PLOS ONE			English	Article							CELL LINEAGE MODEL; DIFFERENTIAL EXPRESSION; FUNCTIONAL-ANALYSIS; PHOSPHOPROTEOMICS; TRANSFORMATION; SIGNATURES; CALCIUM; SURFACE; FAMILY; TARGET	Background: Mapping the expression changes during breast cancer development should facilitate basic and translational research that will eventually improve our understanding and clinical management of cancer. However, most studies in this area are challenged by genetic and environmental heterogeneities associated with cancer. Methodology/Principal Findings: We conducted proteomics of the MCF10AT breast cancer model, which comprises of 4 isogenic xenograft-derived human cell lines that mimic different stages of breast cancer progression, using iTRAQ-based tandem mass spectrometry. Of more than 1200 proteins detected, 98 proteins representing at least 20 molecular function groups including kinases, proteases, adhesion, calcium binding and cytoskeletal proteins were found to display significant expression changes across the MCF10AT model. The number of proteins that showed different expression levels increased as disease progressed from AT1k pre-neoplastic cells to low grade CA1h cancer cells and high grade cancer cells. Bioinformatics revealed that MCF10AT model of breast cancer progression is associated with a major re-programming in metabolism, one of the first identified biochemical hallmarks of tumor cells (the "Warburg effect"). Aberrant expression of 3 novel breast cancer-associated proteins namely AK1, ATOX1 and HIST1H2BM were subsequently validated via immunoblotting of the MCF10AT model and immunohistochemistry of progressive clinical breast cancer lesions. Conclusion/Significance: The information generated by this study should serve as a useful reference for future basic and translational cancer research. Dysregulation of ATOX1, AK1 and HIST1HB2M could be detected as early as the pre-neoplastic stage. The findings have implications on early detection and stratification of patients for adjuvant therapy.	[Choong, Lee Yee; Lim, Simin; Chong, Poh Kuan; Shah, Nilesh; Lim, Yoon Pin] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Wong, Chow Yin] Singapore Gen Hosp, Dept Gen Surg, Singapore 169608, Singapore; [Lim, Yoon Pin] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore; [Lim, Yoon Pin] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore	National University of Singapore; Singapore General Hospital; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Choong, LY (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	csilyp@nus.edu.sg			Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR)	Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This research was supported by funding from the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chong PK, 2008, PROTEOMICS, V8, P4370, DOI 10.1002/pmic.200800051; Dawson PJ, 1996, AM J PATHOL, V148, P313; Dressman MA, 2003, CANCER RES, V63, P2194; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FINNEY L, 2008, CLIN EXP PHARM PHYSL; GODFROID E, 1991, J CELL SCI, V99, P595; Goodman VL, 2005, CURR CANCER DRUG TAR, V5, P543, DOI 10.2174/156800905774574066; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Heppner GH, 2000, BREAST CANCER RES, V2, P331; *ING, ING PATHW AN; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Ji JF, 2004, J CANCER RES CLIN, V130, P480, DOI 10.1007/s00432-004-0555-x; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lim S, 2009, J PROTEOME RES, V8, P4062, DOI 10.1021/pr900430n; Lim YP, 2003, MOL CANCER THER, V2, P1369; Lim YP, 1999, J BIOL CHEM, V274, P19025, DOI 10.1074/jbc.274.27.19025; Liu F, 2008, NEOPLASIA, V10, P1275, DOI 10.1593/neo.08810; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Miller FR, 2000, J MAMMARY GLAND BIOL, V5, P379, DOI 10.1023/A:1009577811584; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Olopade OI, 2008, CLIN CANCER RES, V14, P7988, DOI 10.1158/1078-0432.CCR-08-1211; Rhee DK, 2008, GENOMICS, V92, P419, DOI 10.1016/j.ygeno.2008.08.005; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; Silverstein MJ, 2003, BREAST, V12, P457, DOI 10.1016/S0960-9776(03)00153-X; Starcevic SL, 2003, TOXICOL SCI, V75, P74, DOI 10.1093/toxsci/kfg154; Starcevic SL, 2001, J NATL CANCER I, V93, P776, DOI 10.1093/jnci/93.10.776; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yamamoto S, 2005, ANN SURG ONCOL, V12, P925, DOI 10.1245/ASO.2005.07.002; Yao R, 2007, ANTICANCER RES, V27, P3051; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852	47	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11030	10.1371/journal.pone.0011030	http://dx.doi.org/10.1371/journal.pone.0011030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543960	Green Published, Green Submitted, gold			2022-12-25	WOS:000278557600009
J	Hansen, TB; Bramsen, JB; Kjems, J				Hansen, Thomas Birkballe; Bramsen, Jesper Bertram; Kjems, Jorgen			Re-Inspection of Small RNA Sequence Datasets Reveals Several Novel Human miRNA Genes	PLOS ONE			English	Article							MICRORNA PRECURSORS; IDENTIFICATION; CLASSIFICATION; TRANSCRIPTION; PREDICTION; BIOGENESIS; SUBSET; DROSHA		[Hansen, Thomas Birkballe; Bramsen, Jesper Bertram; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark	Aarhus University	Hansen, TB (corresponding author), Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark.	tbh@mb.au.dk	Kjems, Jorgen/I-3490-2016	Kjems, Jorgen/0000-0003-4128-9317; Hansen, Thomas/0000-0002-7573-9657	EU [LSHG-CT-2006-037900]; Danish Council for Independent Research	EU(European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by the SIROCCO EU consortium (LSHG-CT-2006-037900) and The Danish Council for Independent Research vertical bar Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Andronescu M, 2005, J MOL BIOL, V345, P987, DOI 10.1016/j.jmb.2004.10.082; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Guarnieri DJ, 2008, ANN MED, V40, P197, DOI 10.1080/07853890701771823; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Maroney PA, 2008, NAT PROTOC, V3, P279, DOI 10.1038/nprot.2007.530; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08	32	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10961	10.1371/journal.pone.0010961	http://dx.doi.org/10.1371/journal.pone.0010961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532037	Green Submitted, Green Published, gold			2022-12-25	WOS:000278380500007
J	Zhu, JF; Zhang, YT; Alber, MS; Newman, SA				Zhu, Jianfeng; Zhang, Yong-Tao; Alber, Mark S.; Newman, Stuart A.			Bare Bones Pattern Formation: A Core Regulatory Network in Varying Geometries Reproduces Major Features of Vertebrate Limb Development and Evolution	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; EMBRYONIC CHICK LIMB; DISCONTINUOUS GALERKIN METHODS; REACTION-DIFFUSION MODEL; FINITE-ELEMENT-METHOD; GENE-EXPRESSION; MICROMASS CULTURE; MOUSE LIMB; HOX GENES; MESENCHYMAL CONDENSATION	Background: Major unresolved questions regarding vertebrate limb development concern how the numbers of skeletal elements along the proximodistal (P-D) and anteroposterior (A-P) axes are determined and how the shape of a growing limb affects skeletal element formation. There is currently no generally accepted model for these patterning processes, but recent work on cartilage development (chondrogenesis) indicates that precartilage tissue self-organizes into nodular patterns by cell-molecular circuitry with local auto-activating and lateral inhibitory (LALI) properties. This process is played out in the developing limb in the context of a gradient of fibroblast growth factor (FGF) emanating from the apical ectodermal ridge (AER). Results: We have simulated the behavior of the core chondrogenic mechanism of the developing limb in the presence of an FGF gradient using a novel computational environment that permits simulation of LALI systems in domains of varying shape and size. The model predicts the normal proximodistal pattern of skeletogenesis as well as distal truncations resulting from AER removal. Modifications of the model's parameters corresponding to plausible effects of Hox proteins and formins, and of the reshaping of the model limb, bud yielded simulated phenotypes resembling mutational and experimental variants of the limb. Hypothetical developmental scenarios reproduce skeletal morphologies with features of fossil limbs. Conclusions: The limb chondrogenic regulatory system operating in the presence of a gradient has an inherent, robust propensity to form limb-like skeletal structures. The bare bones framework can accommodate ancillary gene regulatory networks controlling limb bud shaping and establishment of Hox expression domains. This mechanism accounts for major features of the normal limb pattern and, under variant geometries and different parameter values, those of experimentally manipulated, genetically aberrant and evolutionary early forms, with no requirement for an independent system of positional information.	[Zhu, Jianfeng; Zhang, Yong-Tao; Alber, Mark S.] Univ Notre Dame, Dept Math, Notre Dame, IN 46556 USA; [Alber, Mark S.] Univ Notre Dame, Ctr Study Biocomplex, Notre Dame, IN 46556 USA; [Newman, Stuart A.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	University of Notre Dame; University of Notre Dame; New York Medical College	Zhu, JF (corresponding author), Univ Notre Dame, Dept Math, Notre Dame, IN 46556 USA.	newman@nymc.edu	Newman, Stuart/W-1617-2019; Alber, Mark/AAR-1280-2020		National Science Foundation (NSF) [EF-0526854, DMS-0810413, DMS-0800612]; Oak Ridge Associated Universities (ORAU)	National Science Foundation (NSF)(National Science Foundation (NSF)); Oak Ridge Associated Universities (ORAU)	S. A. Newman acknowledges support from the National Science Foundation (NSF) Frontiers in Integrative Biological Research program (grant EF-0526854). Y.-T. Zhang's research is partially supported by NSF grant DMS-0810413 and the Oak Ridge Associated Universities (ORAU) Ralph E. Powe Junior Faculty Enhancement Award. This research of M. S. Alber is partially supported by NSF grant DMS-0800612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2005, NONLINEARITY, V18, P125, DOI 10.1088/0951-7715/18/1/007; Alber M, 2008, B MATH BIOL, V70, P460, DOI 10.1007/s11538-007-9264-3; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Chaturvedi R, 2005, J R SOC INTERFACE, V2, P237, DOI 10.1098/rsif.2005.0033; Cheng Y, 2008, MATH COMPUT, V77, P699, DOI 10.1090/S0025-5718-07-02045-5; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Christley S, 2007, PLOS COMPUT BIOL, V3, P743, DOI 10.1371/journal.pcbi.0030076.eor; Damon BJ, 2008, DEV BIOL, V321, P319, DOI 10.1016/j.ydbio.2008.06.018; Darwin C., 1859, ORIGIN SPECIES MEANS; De Boor C., 2001, PRACTICAL GUIDE SPLI; Deschamps J, 2004, SCIENCE, V304, P1610, DOI 10.1126/science.1099162; Dillon R, 1999, J THEOR BIOL, V197, P295, DOI 10.1006/jtbi.1998.0876; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Franssen RA, 2005, J MORPHOL, V265, P87, DOI 10.1002/jmor.10339; FRENZ DA, 1989, DEV BIOL, V136, P97, DOI 10.1016/0012-1606(89)90133-4; Fujimaki R, 2006, J BONE MINER METAB, V24, P191, DOI 10.1007/s00774-005-0671-y; GOETINCK PF, 1964, J EXP ZOOL, V155, P161, DOI 10.1002/jez.1401550204; GREGG BC, 1989, DEVELOPMENT, V105, P769; Hentschel HGE, 2004, P ROY SOC B-BIOL SCI, V271, P1713, DOI 10.1098/rspb.2004.2772; Johnson  C., 1987, NUMERICAL SOLUTION P, P278; KOSHER RA, 1979, J EMBRYOL EXP MORPH, V50, P75; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; LEFEVER R, 1967, J CHEM PHYS, V47, P1045, DOI 10.1063/1.1711987; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Li SG, 1996, J EXP ZOOL, V274, P234, DOI 10.1002/(SICI)1097-010X(19960301)274:4<234::AID-JEZ4>3.0.CO;2-Q; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Mackem S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.271pe33; Madzvamuse A, 2005, J SCI COMPUT, V24, P247, DOI 10.1007/s10915-004-4617-7; Maini PK, 2006, SCIENCE, V314, P1397, DOI 10.1126/science.1136396; MATSUTANI E, 1982, DEV BIOL, V92, P544, DOI 10.1016/0012-1606(82)90199-3; Meinhardt H., 2009, ALGORITHMIC BEAUTY S; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Miura T, 2000, DEV DYNAM, V217, P241, DOI 10.1002/(SICI)1097-0177(200003)217:3<241::AID-DVDY2>3.0.CO;2-K; Miura T, 2000, ANAT RECORD, V258, P100; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; Moftah MZ, 2002, DEV BIOL, V249, P270, DOI 10.1006/dbio.2002.0766; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Morishita Y, 2009, DEV DYNAM, V238, P415, DOI 10.1002/dvdy.21840; Morishita Y, 2008, B MATH BIOL, V70, P1957, DOI 10.1007/s11538-008-9334-1; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Newman SA, 2005, J EXP ZOOL PART B, V304B, P593, DOI 10.1002/jez.b.21066; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; Newman SA, 1996, BIOESSAYS, V18, P171, DOI 10.1002/bies.950180302; NEWMAN SA, 1980, J EMBRYOL EXP MORPH, V56, P191; NEWMAN SA, 1977, VERTEBRATE LIMB SOMI, P181; Newman Stuart A., 2007, Birth Defects Research, V81, P305, DOI 10.1002/bdrc.20112; Newman SA, 2008, CURR TOP DEV BIOL, V81, P311, DOI 10.1016/S0070-2153(07)81011-8; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nikbakht N, 1997, CELL MOL LIFE SCI, V53, P447, DOI 10.1007/s000180050054; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Pan YH, 2005, DEV BIOL, V286, P472, DOI 10.1016/j.ydbio.2005.08.037; Pavel E, 2007, INT J DEV BIOL, V51, P273, DOI 10.1387/ijdb.062249ep; Pearse RV, 2007, DEV BIOL, V310, P388, DOI 10.1016/j.ydbio.2007.08.002; Perez WD, 2010, DEV DYNAM, V239, P446, DOI 10.1002/dvdy.22183; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; ROS MA, 1994, DEV BIOL, V166, P59, DOI 10.1006/dbio.1994.1296; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; Salazar-Ciudad I, 2003, DEVELOPMENT, V130, P2027, DOI 10.1242/dev.00425; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SCHNELL S, MULTISCALE MODELS DE; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SUMMERBELL D, 1976, J EMBRYOL EXP MORPH, V35, P241; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vargesson N, 2001, DEV DYNAM, V220, P87; Yang YZ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.253pe3; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509; Yonei-Tamura S, 2008, EVOL DEV, V10, P737, DOI 10.1111/j.1525-142X.2008.00288.x; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhou F, 2009, HUM MOL GENET, V18, P2472, DOI 10.1093/hmg/ddp185; Zhu J, 2009, MATH MODEL NAT PHENO, V4, P131, DOI 10.1051/mmnp/20094405; Zhu JF, 2009, J SCI COMPUT, V40, P391, DOI 10.1007/s10915-008-9218-4	83	67	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10892	10.1371/journal.pone.0010892	http://dx.doi.org/10.1371/journal.pone.0010892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531940	Green Submitted, Green Published, gold			2022-12-25	WOS:000278222100021
J	Rui, DL; Muraro, D				Rui Dilao; Muraro, Daniele			A Software Tool to Model Genetic Regulatory Networks. Applications to the Modeling of Threshold Phenomena and of Spatial Patterning in Drosophila	PLOS ONE			English	Article							POSITIONAL INFORMATION; MELANOGASTER; EXPRESSION; BIOLOGY; EMBRYO	We present a general methodology in order to build mathematical models of genetic regulatory networks. This approach is based on the mass action law and on the Jacob and Monod operon model. The mathematical models are built symbolically by the Mathematica software package GeneticNetworks. This package accepts as input the interaction graphs of the transcriptional activators and repressors of a biological process and, as output, gives the mathematical model in the form of a system of ordinary differential equations. All the relevant biological parameters are chosen automatically by the software. Within this framework, we show that concentration dependent threshold effects in biology emerge from the catalytic properties of genes and its associated conservation laws. We apply this methodology to the segment patterning in Drosophila early development and we calibrate the genetic transcriptional network responsible for the patterning of the gap gene proteins Hunchback and Knirps, along the antero-posterior axis of the Drosophila embryo. In this approach, the zygotically produced proteins Hunchback and Knirps do not diffuse along the antero-posterior axis of the embryo of Drosophila, developing a spatial pattern due to concentration dependent thresholds. This shows that patterning at the gap genes stage can be explained by the concentration gradients along the embryo of the transcriptional regulators.	[Rui Dilao; Muraro, Daniele] Univ Tecn Lisboa, Nonlinear Dynam Grp, Inst Super Tecn, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico	Rui, DL (corresponding author), Univ Tecn Lisboa, Nonlinear Dynam Grp, Inst Super Tecn, Lisbon, Portugal.	rui@sd.ist.utl.pt	Dilão, Rui M A/L-5958-2013	Dilão, Rui M A/0000-0003-0190-4565	European project GENNETEC [FP6 STREP IST 034952]	European project GENNETEC	This work has been supported by European project GENNETEC, FP6 STREP IST 034952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves F, 2005, CR BIOL, V328, P429, DOI 10.1016/j.crvi.2005.01.009; Alves F, 2006, J THEOR BIOL, V241, P342, DOI 10.1016/j.jtbi.2005.11.034; Coppey M, 2007, DEV BIOL, V312, P623, DOI 10.1016/j.ydbio.2007.09.058; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; DILAO R, 2010, ARXIV09124391V1; Dilao R, 2010, J THEOR BIOL, V264, P847, DOI 10.1016/j.jtbi.2010.03.012; Dilao R, 2009, LECT NOTES COMPUT SC, V5483, P176, DOI 10.1007/978-3-642-01184-9_16; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; ELLNER SP, 2006, DYNAMIC MODELS BIOL, P8; Fomekong-Nanfack Y, 2007, BIOINFORMATICS, V23, P3356, DOI 10.1093/bioinformatics/btm433; GILBERT SF, 1997, DEV BIOL, P547; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Horn F, 1972, ARCH RATIONAL MECH A, V47, P187, DOI DOI 10.1007/BF00251225); JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2007, MECH DEVELOP, V124, P108, DOI 10.1016/j.mod.2006.11.001; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; KLIPP E, 2005, SYSTEMS BIOL PRACTIC, P282; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; NICOLIS G, 1977, SELF ORG NONEQUILIBR, P395; NussleinVolhard C, 1996, SCI AM, V275, P54; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Poustelnikova E, 2004, BIOINFORMATICS, V20, P2212, DOI 10.1093/bioinformatics/bth222; Reinitz J, 2007, NATURE, V448, P420, DOI 10.1038/448420a; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; Tyson JJ, 2007, NATURE, V445, P823, DOI 10.1038/445823a; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P166; VOLPERT AI, 1994, TRAVELING WAVE SOLUT, P299	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10743	10.1371/journal.pone.0010743	http://dx.doi.org/10.1371/journal.pone.0010743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523731	Green Submitted, Green Published, gold			2022-12-25	WOS:000278221900004
J	Fletcher, MA; Zeng, XR; Maher, K; Levis, S; Hurwitz, B; Antoni, M; Broderick, G; Klimas, NG				Fletcher, Mary A.; Zeng, Xiao R.; Maher, Kevin; Levis, Silvina; Hurwitz, Barry; Antoni, Michael; Broderick, Gordon; Klimas, Nancy G.			Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IMMUNOLOGICAL ABNORMALITIES; T-CELLS; CD26; EXPRESSION; DYSFUNCTION; RETROVIRUS; BLOOD; PREVALENCE; DEFICIENCY	Background: Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS. Methods/Results: Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and Cr-51 release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC. Conclusions: By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.	[Fletcher, Mary A.; Zeng, Xiao R.; Maher, Kevin; Levis, Silvina; Klimas, Nancy G.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Fletcher, Mary A.; Zeng, Xiao R.; Levis, Silvina; Klimas, Nancy G.] Miami Vet Hlth Care Ctr, Miami, FL USA; [Fletcher, Mary A.; Hurwitz, Barry; Antoni, Michael; Klimas, Nancy G.] Univ Miami, Dept Psychol, Coral Gables, FL 33124 USA; [Broderick, Gordon] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Miami; University of Miami; University of Alberta	Fletcher, MA (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	mfletche@med.miami.edu		Antoni, Michael/0000-0002-3971-0873	NIAAA [R21AA016635]; NIAID [R01AI065723, UO1 AI459940]; CFIDS Assoc. of America; NHLBI [RO1 HL65668]; NIAMD [R01 AR48932-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048932] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CFIDS Assoc. of America; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the NIAAA: R21AA016635 (PI MA Fletcher); NIAID: R01AI065723 (PI MA Fletcher); CFIDS Assoc. of America: (PI N Klimas); NIAID: UO1 AI459940 (PI N Klimas), NHLBI: RO1 HL65668 (PI B Hurwitz); NIAMD: R01 AR48932-01A1 (PI S Levis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; BARKER E, 1994, CLIN INFECT DIS, V18, pS136, DOI 10.1093/clinids/18.Supplement_1.S136; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; CALIGIURI M, 1987, J IMMUNOL, V139, P3306; Chandler HK, 2008, DISABIL REHABIL, V30, P1185, DOI 10.1080/09638280701500109; DEFREITAS E, 1991, P NATL ACAD SCI USA, V88, P2922, DOI 10.1073/pnas.88.7.2922; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Evengard B, 2003, PSYCHIAT CLIN NEUROS, V57, P361, DOI 10.1046/j.1440-1819.2003.01132.x; Evengard B, 2002, DRUGS, V62, P2433, DOI 10.2165/00003495-200262170-00003; FLETCHER MA, 1987, DIAGN CLIN IMMUNOL, V5, P69; Fuite J, 2008, GENOMICS, V92, P393, DOI 10.1016/j.ygeno.2008.08.008; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gerrity TR, 2002, NEUROIMMUNOMODULAT, V10, P134, DOI 10.1159/000067176; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P91, DOI 10.1016/j.bbi.2004.09.001; Holmes MJ, 1997, J PSYCHIATR RES, V31, P115, DOI 10.1016/S0022-3956(96)00048-9; Hurwitz BE, 2010, CLIN SCI, V118, P125, DOI 10.1042/CS20090055; Ibegbu CC, 2009, IMMUNOLOGY, V126, P346, DOI 10.1111/j.1365-2567.2008.02899.x; Jason LA, 2003, J HEALTH PSYCHOL, V8, P459, DOI 10.1177/13591053030084005; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jason Leonard A, 2006, Health Care Women Int, V27, P615, DOI 10.1080/07399330600803766; Jason Leonard A, 2008, Dyn Med, V7, P6, DOI 10.1186/1476-5918-7-6; KHAN AS, 1993, ANN INTERN MED, V118, P241, DOI 10.7326/0003-4819-118-4-199302150-00001; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Kogelnik AM, 2006, J CLIN VIROL, V37, pS33, DOI 10.1016/S1386-6532(06)70009-9; LANDAY AL, 1991, LANCET, V338, P707, DOI 10.1016/0140-6736(91)91440-6; Ledina D, 2007, MED SCI MONITOR, V13, pCS88; LEVINE PH, 1992, CANCER RES, V52, pS5516; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyall M, 2003, J PSYCHOSOM RES, V55, P79, DOI 10.1016/S0022-3999(02)00515-9; MAHER K, 2006, APPL IMMUNOL REV, V5, P353; Maher K, 2003, HDB CHRONIC FATIGUE, P124; Maher KJ, 2005, CLIN EXP IMMUNOL, V142, P505, DOI 10.1111/j.1365-2249.2005.02935.x; MUSCAT C, 1994, CLIN EXP IMMUNOL, V98, P252; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Richter B, 2008, VASC HEALTH RISK MAN, V4, P753, DOI 10.2147/VHRM.S1707; Siegel SD, 2006, J PSYCHOSOM RES, V60, P559, DOI 10.1016/j.jpsychores.2006.03.001; Straburzynska-Lupa A, 2010, CLIN EXP RHEUMATOL, V28, P19; Thornberry NA, 2009, BEST PRACT RES CL EN, V23, P479, DOI 10.1016/j.beem.2009.03.004; Yan SL, 2003, EUR J IMMUNOL, V33, P1519, DOI 10.1002/eji.200323469; Yang SS, 2006, J GASTROEN HEPATOL, V21, P1789, DOI 10.1111/j.1440-1746.2006.04677.x; ZWEIG MH, 1993, CLIN CHEM, V39, P561	46	82	85	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10817	10.1371/journal.pone.0010817	http://dx.doi.org/10.1371/journal.pone.0010817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520837	Green Published, gold			2022-12-25	WOS:000278034800013
J	Pitala, N; Siitari, H; Gustafsson, L; Brommer, JE				Pitala, Natalia; Siitari, Heli; Gustafsson, Lars; Brommer, Jon E.			Costs and Benefits of Experimentally Induced Changes in the Allocation of Growth versus Immune Function under Differential Exposure to Ectoparasites	PLOS ONE			English	Article							CELL-MEDIATED-IMMUNITY; NESTLING GREAT TITS; TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; GLUTATHIONE DEPLETION; LOCAL RECRUITMENT; RESPONSES; PARASITE; BIRD; IMMUNOCOMPETENCE	Background: Ecological immunology has focused on the costs of investment in immunocompetence. However, understanding optimal resource allocation to immune defence requires also identification of its benefits, which are likely to occur only when parasites are abundant. Methodology: We manipulated the abundance of parasitic hen fleas in blue tit (Cyanistes caeruleus) nests, and supplemented their hosts, the nestlings, with methionine (a sulphur amino acid enhancing cell-mediated immunity) during day 3-6. We found a significant interaction between these two experimental factors on the development of immune defences and growth rates. Only in parasitized nests did methionine supplementation boost immune (PHA) response, and did nestling with experimentally increased immunocompetence show a relatively faster growth rate than control nestlings between days 6-9. Hence, the allocation of resources into immune defence and its growth-benefits are apparent only in presence of parasites. The main cost of methionine-induced increased allocation to the immune system was an increase in mortality, independently of ectoparasites. Nestlings in all treatments compensated initial growth reduction and all reached equal body size at day 16 (just prior to fledging), indicating a lack of long-term benefits. In addition, methionine treatment tended (P = 0.09) to lower circulating plasma immunoglobulin levels, possibly indicating a trade-off between the cell-mediated and humoral components of the immune system. Conclusions: We found no strong benefits of an increased investment in immunocompetence in a parasite-rich environment. Any deviation from the growth trajectory (due to changes in allocation induced by methionine) is largely detrimental for survival. Hence, while costs are apparent identifying the benefits of investment in immunocompetence during ontogeny is challenging.	[Pitala, Natalia; Brommer, Jon E.] Univ Helsinki, Bird Ecol Unit, Dept Biol & Environm Sci, Helsinki, Finland; [Siitari, Heli] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Pitala, Natalia; Gustafsson, Lars] Uppsala Univ, Dept Anim Ecol Ecol & Evolut, Evolutionary Biol Ctr, Uppsala, Sweden	University of Helsinki; University of Jyvaskyla; Uppsala University	Pitala, N (corresponding author), Univ Helsinki, Bird Ecol Unit, Dept Biol & Environm Sci, Helsinki, Finland.	jon.brommer@helsinki.fi	Gustafsson, Lars/A-7634-2012; Gustafsson, Lars/O-8056-2019; Brommer, Jon E/C-3613-2008	Gustafsson, Lars/0000-0001-6566-2863; Gustafsson, Lars/0000-0001-6566-2863; Brommer, Jon E/0000-0002-2435-2612	Academy of Finland [1106104, 1118484, 1131390]	Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland (www.aka.fi) grant numbers 1106104, 1118484 and 1131390 (to J.E.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APANIUS V, 1998, AVIAN GROWTH DEV EVO; Baker DH, 2006, J NUTR, V136, p1670S, DOI 10.1093/jn/136.6.1670S; Berthouly A, 2007, FUNCT ECOL, V21, P335, DOI 10.1111/j.1365-2435.2006.01236.x; Bize P, 2008, AM NAT, V171, P107, DOI 10.1086/523943; Bjorklund M, 1997, J EVOLUTION BIOL, V10, P139, DOI 10.1046/j.1420-9101.1997.10020139.x; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Brommer JE, 2004, P ROY SOC B-BIOL SCI, V271, pS110, DOI 10.1098/rsbl.2003.0103; Buechler K, 2002, J ANIM ECOL, V71, P247, DOI 10.1046/j.1365-2656.2002.00591.x; Christe P, 2001, OECOLOGIA, V126, P333, DOI 10.1007/s004420000527; Christe P, 2000, HEREDITY, V85, P75, DOI 10.1046/j.1365-2540.2000.00732.x; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Deng K, 2007, ANIM FEED SCI TECH, V134, P66, DOI 10.1016/j.anifeedsci.2006.05.008; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; GMUNDER H, 1991, CELL IMMUNOL, V138, P229, DOI 10.1016/0008-8749(91)90147-4; Grimble RF, 1998, NUTRITION, V14, P605, DOI 10.1016/S0899-9007(98)80041-5; Grimble RF, 2006, J NUTR, V136, p1660S, DOI 10.1093/jn/136.6.1660S; GROSS RL, 1980, PHYSIOL REV, V60, P188, DOI 10.1152/physrev.1980.60.1.188; HARPER GH, 1992, J ANIM ECOL, V61, P317, DOI 10.2307/5324; JEANNIN P, 1995, J EXP MED, V182, P1785, DOI 10.1084/jem.182.6.1785; Kilpimaa J, 2005, EVOLUTION, V59, P2483, DOI 10.1554/04-678.1; KINSCHERF R, 1994, FASEB J, V8, P448, DOI 10.1096/fasebj.8.6.7909525; LIANG CM, 1989, J BIOL CHEM, V264, P13519; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Martinez MC, 2006, EDUC POLICY, V20, P299, DOI 10.1177/0895904805285017; Merino S, 2001, INT J PARASITOL, V31, P1187, DOI 10.1016/S0020-7519(01)00243-0; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; Moreno J, 2005, J AVIAN BIOL, V36, P251, DOI 10.1111/j.0908-8857.2005.03413.x; Muller W, 2004, FUNCT ECOL, V18, P719, DOI 10.1111/j.0269-8463.2004.00902.x; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; NUR N, 1984, J ANIM ECOL, V53, P497, DOI 10.2307/4530; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; Pitala N, 2009, EVOL ECOL RES, V11, P79; Potti J, 1999, OECOLOGIA, V120, P1, DOI 10.1007/s004420050826; RICHNER H, 1993, J ANIM ECOL, V62, P703, DOI 10.2307/5390; Rubin LL, 2007, BRAZ J POULT SCI, V9, P241, DOI 10.1590/S1516-635X2007000400006; Saino N, 1998, OIKOS, V81, P217, DOI 10.2307/3547043; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Schoeler GB, 2001, ANN TROP MED PARASIT, V95, P755, DOI 10.1080/0003498012011118; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Tripet F, 1999, ECOLOGY, V80, P1267, DOI 10.1890/0012-9658(1999)080[1267:DDPITP]2.0.CO;2; Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x; Tschirren B, 2007, FUNCT ECOL, V21, P372, DOI 10.1111/j.1365-2435.2007.01235.x; Tschirren B, 2006, P ROY SOC B-BIOL SCI, V273, P1773, DOI 10.1098/rspb.2006.3524; TSIAGBE VK, 1987, POULTRY SCI, V66, P1147, DOI 10.3382/ps.0661147	53	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10814	10.1371/journal.pone.0010814	http://dx.doi.org/10.1371/journal.pone.0010814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520832	Green Published, Green Submitted, gold			2022-12-25	WOS:000278034800011
J	Bi, LK; Gojestani, S; Wu, WH; Hsu, YMS; Zhu, JY; Ariizumi, K; Lin, X				Bi, Liangkuan; Gojestani, Sara; Wu, Weihui; Hsu, Yen-Michael S.; Zhu, Jiayuan; Ariizumi, Kiyoshi; Lin, Xin			CARD9 Mediates Dectin-2-induced I kappa B alpha Kinase Ubiquitination Leading to Activation of NF-kappa B in Response to Stimulation by the Hyphal Form of Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTOR; C-TYPE LECTIN; INNATE IMMUNE-RESPONSES; ADAPTER PROTEIN CARD9; ANTIFUNGAL IMMUNITY; FUNGAL-INFECTIONS; HOST-DEFENSE; DECTIN-1; INDUCTION; CELLS	The scaffold protein CARD9 plays an essential role in anti-fungus immunity and is implicated in mediating Dectin-1/Syk-induced NF-kappa B activation in response to Candida albicans infection. However, the molecular mechanism by which CARD9 mediates C. albicans-induced NF-kappa B activation is not fully characterized. Here we demonstrate that CARD9 is involved in mediating NF-kappa B activation induced by the hyphal form of C. albicans hyphae (Hyphae) but not by its heat-inactivated unicellular form. Our data show that inhibiting Dectin-2 expression selectively blocked Hyphae-induced NF-kappa B, whereas inhibiting Dectin-1 mainly suppressed zymosan-induced NF-kappa B, indicating that Hyphae-induced NF-kappa B activation is mainly through Dectin-2 and not Dectin-1. Consistently, we find that the hyphae stimulation induces CARD9 association with Bcl10, an adaptor protein that functions downstream of CARD9 and is also involved in C. albicans-induced NF-kappa B activation. This association is dependent on Dectin-2 but not Dectin-1 following the hyphae stimulation. Finally, we find that although both CARD9 and Syk are required for Hyphae-induced NF-kappa B activation, they regulate different signaling events in which CARD9 mediates I kappa B alpha kinase ubiquitination, whereas Syk regulates I kappa B alpha kinase phosphorylation. Together, our data demonstrated that CARD9 is selectively involved in Dectin-2-induced NF-kappa B activation in response to C. albicans hyphae challenging.	[Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Unit 108, Houston, TX 77030 USA; [Bi, Liangkuan; Zhu, Jiayuan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Burns, Guangzhou 510080, Guangdong, Peoples R China; [Gojestani, Sara; Lin, Xin] Univ Texas Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA; [Hsu, Yen-Michael S.; Lin, Xin] Univ Texas Houston, Grad Sch Biomed Sci, Program Immunol, Houston, TX 77030 USA; [Ariizumi, Kiyoshi] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lin, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Unit 108, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xllin@mdanderson.org			National Institutes of Health [RO1AI050848, RO1GM079451, R01GM065899]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079451, R01GM065899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI050848, RO1GM079451, and R01GM065899 (to X. L.). This work was also supported in part by a Graduate Student Fellowship from the China Scholarship Council (to L. B.).	Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mora-Montes HM, 2004, GLYCOBIOLOGY, V14, P593, DOI 10.1093/glycob/cwh091; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963	35	85	88	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25969	25977		10.1074/jbc.M110.131300	http://dx.doi.org/10.1074/jbc.M110.131300			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538615	Green Published, hybrid			2022-12-25	WOS:000280921000011
J	Fuentealba, RA; Udan, M; Bell, S; Wegorzewska, I; Shao, J; Diamond, MI; Weihl, CC; Baloh, RH				Fuentealba, Rodrigo A.; Udan, Maria; Bell, Shaughn; Wegorzewska, Iga; Shao, Jieya; Diamond, Marc I.; Weihl, Conrad C.; Baloh, Robert H.			Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; MOTOR-NEURON DISEASE; MUTANT HUNTINGTIN; CELLULAR TOXICITY; IN-VITRO; FUNCTIONAL IMPLICATIONS; TRANSCRIPTION FACTOR; BINDING-PROPERTIES	The identification of pathologic TDP-43 aggregates in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, followed by the discovery of dominantly inherited point mutations in TDP-43 in familial ALS, have been critical insights into the mechanism of these untreatable neurodegenerative diseases. However, the biochemical basis of TDP-43 aggregation and the mechanism of how mutations in TDP-43 lead to disease remain enigmatic. In efforts to understand how TDP-43 alters its cellular localization in response to proteotoxic stress, we found that TDP-43 is sequestered into polyglutamine aggregates. Furthermore, we found that binding to polyglutamine aggregates requires a previously uncharacterized glutamine/asparagine (Q/N)-rich region in the C-terminal domain of TDP-43. Sequestration into polyglutamine aggregates causes TDP-43 to be cleared from the nucleus and become detergent-insoluble. Finally, we observed that sequestration into polyglutamine aggregates led to loss of TDP-43-mediated splicing in the nucleus and that polyglutamine toxicity could be partially rescued by increasing expression of TDP-43. These data indicate pathologic sequestration into polyglutamine aggregates, and loss of nuclear TDP-43 function may play an unexpected role in polyglutamine disease pathogenesis. Furthermore, as Q/N domains have a strong tendency to self-aggregate and in some cases can function as prions, the identification of a Q/N domain in TDP-43 has important implications for the mechanism of pathologic aggregation of TDP-43 in ALS and other neurodegenerative diseases.	[Weihl, Conrad C.; Baloh, Robert H.] Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA; [Diamond, Marc I.; Weihl, Conrad C.; Baloh, Robert H.] Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Baloh, RH (corresponding author), Washington Univ, Dept Neurol, Sch Med, Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	rbaloh@wustl.edu		Fuentealba, Rodrigo/0000-0001-8724-091X	National Institutes of Health [NS055980, R01NS069669, R01AG031867, K08AG026271]; Neuroscience Blueprint Core [NS057105]; Hope Center for Neurological Disorders; McDonnell Center for Cellular and Molecular Neurobiology; Muscular Dystrophy Association [135428]; Children's Discovery Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069669, P30NS057105, K08NS055980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG026271, R01AG031867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Blueprint Core; Hope Center for Neurological Disorders; McDonnell Center for Cellular and Molecular Neurobiology; Muscular Dystrophy Association(Muscular Dystrophy Association); Children's Discovery Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055980 and R01NS069669 (to R. H. B.). This work was also supported by the Neuroscience Blueprint Core Grant NS057105 (to Washington University), the Hope Center for Neurological Disorders, the McDonnell Center for Cellular and Molecular Neurobiology, the Muscular Dystrophy Association Grant 135428, and Children's Discovery Institute.; Supported by National Institutes of Health Grants R01AG031867 and K08AG026271.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Galbiati F, 2000, J BIOL CHEM, V275, P37702, DOI 10.1074/jbc.M006657200; Garee JP, 2010, J CELL BIOCHEM, V109, P312, DOI 10.1002/jcb.22420; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; KING A, NEUROPATHOL IN PRESS; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Mitsui K, 2002, J NEUROSCI, V22, P9267; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Salazar AM, 2010, J NEUROSCI, V30, P515, DOI 10.1523/JNEUROSCI.2523-09.2010; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	77	119	122	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26304	26314		10.1074/jbc.M110.125039	http://dx.doi.org/10.1074/jbc.M110.125039			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554523	hybrid, Green Published			2022-12-25	WOS:000280921000048
J	Kawano, S; Miyaji, M; Ichiyasu, S; Tsutsui, KM; Tsutsui, K				Kawano, Shinji; Miyaji, Mary; Ichiyasu, Shoko; Tsutsui, Kimiko M.; Tsutsui, Ken			Regulation of DNA Topoisomerase II beta through RNA-dependent Association with Heterogeneous Nuclear Ribonucleoprotein U (hnRNP U)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATTACHMENT REGION DNA; BINDING-PROTEIN; SAF-A; EXPRESSION; TRANSCRIPTION; GENES; IDENTIFICATION; ISOFORMS; ELEMENTS; BRAIN	Recent studies suggest that DNA topoisomerase II beta (topo II beta) is involved in transcriptional activation of certain genes, which assumes accurate targeting of the enzyme to its action site. The target selection may be achieved by cooperation with unknown regulatory factors. To seek out such factors, we looked for proteins associated with the enzyme in differentiating cerebellar neurons. Antibody against topo II beta co-precipitated RNA-binding proteins including PSF, NonO/p54nrb, as well as hnRNP U/SAF-A/SP120. Reconstitution experiments with tag-purified proteins showed that topo II beta associates stoichiometrically with SP120 in the presence of RNA that was co-purified with SP120. The most effective RNA species for the complex formation was a subset of cellular polyadenylated RNAs. The C-terminal 187-residue domain of SP120 was necessary and sufficient for the association with both topo II beta and the endogenous RNA. The RNA isolated from the tag-purified SP120 inhibited the relaxation of supercoiled DNA by topo II beta. When the enzyme associates with SP120, however, the inhibition was abolished and the catalytic property was modulated to more processive mode, which may prolong its residence time at the genomic target site. Furthermore, the presence of SP120 was required for the stable expression of topo II beta in vivo. Thus, SP120 regulates the enzyme in dual ways.	[Tsutsui, Ken] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Genome Dynam, Okayama 7008558, Japan; [Kawano, Shinji; Miyaji, Mary; Ichiyasu, Shoko; Tsutsui, Kimiko M.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurogenom, Okayama 7008558, Japan	Okayama University; Okayama University	Tsutsui, K (corresponding author), 2-5-1 Shikata Cho, Okayama 7008558, Japan.	tsukken@cc.okayama-u.ac.jp	Tsutsui, Ken/B-1863-2011; TSUTSUI, Kimiko M/B-1955-2011; MIYAJI, Mary/B-2294-2011		MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant-in-aid for scientific research funding (to K. T.) from the MEXT, Japan.	Ameyar-Zazoua M, 2009, J BIOL CHEM, V284, P27974, DOI 10.1074/jbc.M109.037929; CHUNG TDY, 1989, P NATL ACAD SCI USA, V86, P9431, DOI 10.1073/pnas.86.23.9431; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Eggert H, 2001, J STEROID BIOCHEM, V78, P59, DOI 10.1016/S0960-0760(01)00074-7; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Martens JHA, 2002, MOL CELL BIOL, V22, P2598, DOI 10.1128/MCB.22.8.2598-2606.2002; Onishi Y, 2008, MOL CELL BIOL, V28, P3477, DOI 10.1128/MCB.02227-07; Park SW, 2008, NUCLEIC ACIDS RES, V36, P6080, DOI 10.1093/nar/gkn614; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Roshon MJ, 2005, TRANSGENIC RES, V14, P179, DOI 10.1007/s11248-004-8147-8; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; TSUTSUI K, 1993, J BIOL CHEM, V268, P12886; TSUTSUI K, 1993, J BIOL CHEM, V268, P19076; Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Yugami M, 2007, FEBS LETT, V581, P1, DOI 10.1016/j.febslet.2006.11.062; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250	28	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26451	26460		10.1074/jbc.M110.112979	http://dx.doi.org/10.1074/jbc.M110.112979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554522	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000280921000063
J	Basu, A; Datta, D; Zurakowski, D; Pal, S				Basu, Aninda; Datta, Dipak; Zurakowski, David; Pal, Soumitro			Altered VEGF mRNA Stability following Treatments with Immunosuppressive Agents IMPLICATIONS FOR CANCER DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYCLOSPORINE-A; BINDING PROTEIN; ACTIVATION; HUR; OVEREXPRESSION; CALCINEURIN; CELLS; TRANSPLANTATION; STABILIZATION	The high incidence of cancer and its aggressive progression is a common and major problem in patients receiving immunosuppressive therapy. The calcineurin inhibitors (CNIs) may have protumorigenic effects and can promote the overexpression of several molecules inducing tumor growth. We have recently demonstrated that CNIs can mediate the transcriptional activation of the angiogenic cytokine vascular endothelial growth factor (VEGF) and promote a rapid progression of human renal cancer. Here, we investigated whether the CNI cyclosporine (CsA) and the mTOR inhibitor rapamycin (RAPA) could alter the mRNA stability of VEGF in 786-0 and Caki-1 renal cancer cells. Following actinomycin D treatment, we observed that CsA increased, whereas RAPA decreased the VEGF mRNA stability as observed by real time PCR. It is established that the mRNA-binding protein HuR may play a critical role in VEGF mRNA stability. By using HuR-siRNA, we found that the knockdown of HuR significantly decreased the CNI-induced VEGF mRNA stability. By Western blot analysis, it has been observed that CNI treatment induced the translocation of HuR from the nucleus to the cytoplasm; CNIs also induced the association between HuR and PKC-delta and promoted the phosphorylation of HuR. Finally, we found that the inhibition of PKC-delta using a dominant negative plasmid significantly decreased the CsA-induced cytoplasmic translocation of HuR and VEGF mRNA stability. Together, targeting the pathways that promote CNI-induced transcription as well as the mRNA stability of VEGF might serve as novel therapeutics for the prevention and treatment of cancer in immunosuppressed patients.	[Basu, Aninda; Datta, Dipak; Pal, Soumitro] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Basu, Aninda; Datta, Dipak; Pal, Soumitro] Childrens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; [Zurakowski, David] Childrens Hosp, Dept Anesthesia, Boston, MA 02115 USA; [Basu, Aninda; Datta, Dipak; Zurakowski, David; Pal, Soumitro] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu			National Institutes of Health [R01 CA131145]; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA131145 and John-Merrill Grant ASN-AST (to S.P.).	Basu A, 2008, CANCER RES, V68, P5689, DOI 10.1158/0008-5472.CAN-07-6603; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bustami RT, 2004, AM J TRANSPLANT, V4, P87, DOI 10.1046/j.1600-6135.2003.00274.x; Chen CG, 2009, J SURG RES, V153, P156, DOI 10.1016/j.jss.2008.03.017; Cho CS, 2003, INT IMMUNOL, V15, P1369, DOI 10.1093/intimm/dxg138; Cho CS, 2003, CELL SIGNAL, V15, P85, DOI 10.1016/S0898-6568(02)00046-3; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Datta D, 2009, CANCER RES, V69, P8902, DOI 10.1158/0008-5472.CAN-09-1404; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Flaxenburg JA, 2004, J IMMUNOL, V172, P7503, DOI 10.4049/jimmunol.172.12.7503; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guba M, 2004, TRANSPLANTATION, V77, P1777, DOI 10.1097/01.tp.0000120181.89206.54; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Jamil B, 1999, TRANSPLANTATION, V68, P1597, DOI 10.1097/00007890-199911270-00027; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Koehl GE, 2004, TRANSPLANTATION, V77, P1319, DOI 10.1097/00007890-200405150-00002; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Murakami R, 2003, ARTERIOSCL THROM VAS, V23, P2034, DOI 10.1161/01.ATV.0000094234.60166.78; Nabors LB, 2001, CANCER RES, V61, P2154; Pal S, 1998, J BIOL CHEM, V273, P26277, DOI 10.1074/jbc.273.41.26277; Sindermann JR, 2002, BASIC RES CARDIOL, V97, P125, DOI 10.1007/s003950200002; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wimmer CD, 2007, KIDNEY INT, V71, P1271, DOI 10.1038/sj.ki.5002154	32	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25196	25202		10.1074/jbc.M110.119446	http://dx.doi.org/10.1074/jbc.M110.119446			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554520	Green Published, hybrid			2022-12-25	WOS:000280682400012
J	Plaza-Menacho, I; Morandi, A; Robertson, D; Pancholi, S; Drury, S; Dowsett, M; Martin, LA; Isacke, CM				Plaza-Menacho, I.; Morandi, A.; Robertson, D.; Pancholi, S.; Drury, S.; Dowsett, M.; Martin, L-A; Isacke, C. M.			Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance	ONCOGENE			English	Article						RET; breast cancer; endocrine therapy; tamoxifen; estrogen receptor; endocrine resistance	GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; ESTROGEN-RECEPTOR; MCF-7 CELLS; MEDIATED TRANSCRIPTION; THERAPY RESISTANCE; GENE-EXPRESSION; CROSS-TALK; SERINE 118; S6 KINASE	Endocrine therapy is the main therapeutic option for patients with estrogen receptor (ER alpha)-positive breast cancer. Resistance to this treatment is often associated with estrogen-independent activation of ER alpha. In this study, we show that in ER alpha-positive breast cancer cells, activation of the receptor tyrosine kinase RET (REarranged during Transfection) by its ligand GDNF results in increased ER alpha phosphorylation on Ser118 and Ser167 and estrogen-independent activation of ER alpha transcriptional activity. Further, we identify mTOR as a key component in this downstream signaling pathway. In tamoxifen response experiments, RET downregulation resulted in 6.2-fold increase in sensitivity of MCF7 cells to antiproliferative effects of tamoxifen, whereas GDNF stimulation had a protective effect against the drug. In tamoxifen-resistant (TAM(R)-1) MCF7 cells, targeting RET restored tamoxifen sensitivity. Finally, examination of two independent tissue microarrays of primary human breast cancers revealed that expression of RET protein was significantly associated with ER alpha-positive tumors and that in primary tumors from patients who subsequently developed invasive recurrence after adjuvant tamoxifen treatment, there was a twofold increase in the number of wRET-positive tumors. Together these findings identify RET as a potentially important therapeutic target in ER alpha-positive breast cancers and in particular in tamoxifen-resistant tumors. Oncogene (2010) 29, 4648-4657; doi:10.1038/onc.2010.209; published online 7 June 2010	[Plaza-Menacho, I.; Morandi, A.; Robertson, D.; Pancholi, S.; Drury, S.; Dowsett, M.; Martin, L-A; Isacke, C. M.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Drury, S.; Dowsett, M.] Royal Marsden Hosp Trust, Acad Dept Biochem, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Isacke, CM (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	clare.isacke@icr.ac.uk	Piris, Alejandro/D-3830-2014; Martin, Lesley-Ann/AAA-1841-2020; Plaza-Menacho, Ivan/K-8517-2017	Pancholi, Sunil/0000-0002-0880-1588; Morandi, Andrea/0000-0002-9222-5332; Plaza-Menacho, Ivan/0000-0003-4666-9431; Isacke, Clare/0000-0002-9222-3345	Breakthrough Breast Cancer; Association of International Cancer Research [09-0533]; Mary-Jean Mitchell Green Foundation; Ministerio de Educacion y Ciencia (MEC) of Spain [EX2006-1341]; NHS; Worldwide Cancer Research [09-0533] Funding Source: researchfish	Breakthrough Breast Cancer; Association of International Cancer Research; Mary-Jean Mitchell Green Foundation; Ministerio de Educacion y Ciencia (MEC) of Spain(Spanish Government); NHS; Worldwide Cancer Research	This work was supported by Breakthrough Breast Cancer (CMI, L-AM and MD), the Association of International Cancer Research (grant 09-0533; CMI, AM and IP-M), the Mary-Jean Mitchell Green Foundation (L-AM and MD) and the Ministerio de Educacion y Ciencia (MEC) of Spain (grant EX2006-1341; IP-M). We acknowledge NHS funding to the NIHR Biomedical Research Centre. We thank Anne E Lykkesfeldt for the TAM<SUP>R</SUP>-1 cells, Jorge Reis-Filho, Suzanne Parry, Kay Savage, Margaret Hills and Janine Salter for their help with the TMA staining and analysis, and to Ana Maria Pereira for her advice on the tamoxifen response experiments.	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Arpino G, 2007, JNCI-J NATL CANCER I, V99, P694, DOI 10.1093/jnci/djk151; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Berry NB, 2008, MOL ENDOCRINOL, V22, P1535, DOI 10.1210/me.2007-0449; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chang SB, 2007, J SURG RES, V138, P37, DOI 10.1016/j.jss.2006.07.003; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; Ghayad SE, 2008, CANCER SCI, V99, P1992, DOI 10.1111/j.1349-7006.2008.00955.x; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Howell A, 2004, BREAST CANCER RES, V6, P269, DOI 10.1186/bcr945; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; Johnston SRD, 2009, CLIN BREAST CANCER, V9, pS28, DOI 10.3816/CBC.2009.s.003; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kok M, 2009, JNCI-J NATL CANCER I, V101, P1725, DOI 10.1093/jnci/djp412; Kurokawa H, 2000, CANCER RES, V60, P5887; Leary AF, 2010, CLIN CANCER RES, V16, P1486, DOI 10.1158/1078-0432.CCR-09-1764; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; Macedo LF, 2008, CANCER RES, V68, P3516, DOI 10.1158/0008-5472.CAN-07-6807; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Massarweh S, 2006, ENDOCR-RELAT CANCER, V13, pS15, DOI 10.1677/erc.1.01273; Menacho IP, 2005, CANCER RES, V65, P1729, DOI 10.1158/0008-5472.CAN-04-2363; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nicholson RI, 1999, ENDOCR-RELAT CANCER, V6, P373, DOI 10.1677/erc.0.0060373; Nicholson RI, 2001, ENDOCR-RELAT CANCER, V8, P175, DOI 10.1677/erc.0.0080175; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Pancholi S, 2008, ENDOCR-RELAT CANCER, V15, P985, DOI 10.1677/ERC-07-0240; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P29230, DOI 10.1074/jbc.M703461200; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P6415, DOI 10.1074/jbc.M608952200; Reis JS, 2006, MODERN PATHOL, V19, P307, DOI 10.1038/modpathol.3800542; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shim WS, 2000, ENDOCRINOLOGY, V141, P396, DOI 10.1210/en.141.1.396; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Yamashita H, 2008, ENDOCR-RELAT CANCER, V15, P755, DOI 10.1677/ERC-08-0078; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Yue W, 2002, ENDOCRINOLOGY, V143, P3221, DOI 10.1210/en.2002-220186	54	103	111	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	33					4648	4657		10.1038/onc.2010.209	http://dx.doi.org/10.1038/onc.2010.209			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20531297				2022-12-25	WOS:000281127400004
J	Kamilar, JM; Muldoon, KM				Kamilar, Jason M.; Muldoon, Kathleen M.			The Climatic Niche Diversity of Malagasy Primates: A Phylogenetic Perspective	PLOS ONE			English	Article							ANCESTRAL STATES; COMMUNITY; EVOLUTIONARY; MADAGASCAR; ECOLOGY; LEMURS; SIGNAL; CONSERVATISM; SEPARATION; GRADIENT	Background: Numerous researchers have posited that there should be a strong negative relationship between the evolutionary distance among species and their ecological similarity. Alternative evidence suggests that members of adaptive radiations should display no relationship between divergence time and ecological similarity because rapid evolution results in near-simultaneous speciation early in the clade's history. In this paper, we performed the first investigation of ecological diversity in a phylogenetic context using a mammalian adaptive radiation, the Malagasy primates. Methodology/Principal Findings: We collected data for 43 extant species including: 1) 1064 species by locality samples, 2) GIS climate data for each sampling locality, and 3) the phylogenetic relationships of the species. We calculated the niche space of each species by summarizing the climatic variation at localities of known occurrence. Climate data from all species occurrences at all sites were entered into a principal components analysis. We calculated the mean value of the first two PCA axes, representing rainfall and temperature diversity, for each species. We calculated the K statistic using the Physig program for Matlab to examine how well the climatic niche space of species was correlated with phylogeny. Conclusions/Significance: We found that there was little relationship between the phylogenetic distance of Malagasy primates and their rainfall and temperature niche space, i.e., closely related species tend to occupy different climatic niches. Furthermore, several species from different genera converged on a similar climatic niche. These results have important implications for the evolution of ecological diversity, and the long-term survival of these endangered species.	[Kamilar, Jason M.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Kamilar, Jason M.] Yale Univ, Yale Mol Anthropol Lab, New Haven, CT 06520 USA; [Muldoon, Kathleen M.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Anat, Hanover, NH 03756 USA; [Muldoon, Kathleen M.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA	Yale University; Yale University; Dartmouth College; Dartmouth College	Kamilar, JM (corresponding author), Yale Univ, Dept Anthropol, New Haven, CT 06520 USA.	jason.kamilar@yale.edu	Kamilar, Jason/E-1990-2011	Kamilar, Jason/0000-0001-6082-9396				Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; Anderson TM, 2004, AM NAT, V164, P709, DOI 10.1086/425372; Andreasson U, 2007, BIOMARK MED, V1, P59, DOI 10.2217/17520363.1.1.59; Andriaholinirina N., 2006, Primate Report, V74, P25; [Anonymous], NATURAL HIST MADAGAS; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Chapman CA, 1999, J TROP ECOL, V15, P189, DOI 10.1017/S0266467499000759; Chazdon RL, 2003, ECOL MONOGR, V73, P331, DOI 10.1890/02-4037; Dammhahn M, 2008, OECOLOGIA, V157, P473, DOI 10.1007/s00442-008-1079-x; Edwards EJ, 2006, AM NAT, V167, P777, DOI 10.1086/504605; Fleagle JG, 1996, J HUM EVOL, V30, P489, DOI 10.1006/jhev.1996.0039; Fleagle John G., 1999, P92, DOI 10.1017/CBO9780511542381.007; GANZHORN JU, 1989, OECOLOGIA, V79, P279, DOI 10.1007/BF00388489; Ganzhorn JU, 1997, J ZOOL, V241, P533, DOI 10.1111/j.1469-7998.1997.tb04845.x; Godfrey Laurie G., 2004, Lemur News, V9, P9; GODFREY LR, 1997, NATURAL CHANGE HUMAN, P218; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hladik C.M., 1980, P41; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Jernvall J, 1998, P NATL ACAD SCI USA, V95, P11279, DOI 10.1073/pnas.95.19.11279; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Jury MR., 2003, NATURAL HIST MADAGAS, P75; Kamilar JM, 2010, J BIOGEOGR, V37, P801, DOI 10.1111/j.1365-2699.2009.02267.x; Kamilar JM, 2009, AM J PHYS ANTHROPOL, V139, P382, DOI 10.1002/ajpa.20993; Knouft JH, 2006, ECOLOGY, V87, pS29, DOI 10.1890/0012-9658(2006)87[29:PAOTEO]2.0.CO;2; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Louis Edward E. Jr, 2008, Primate Conservation, V23, P19, DOI 10.1896/052.023.0103; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Martins EP, 1999, SYST BIOL, V48, P642, DOI 10.1080/106351599260210; Mayor MI, 2004, INT J PRIMATOL, V25, P875, DOI 10.1023/B:IJOP.0000029127.31190.e9; McGarigal K., 2000, MULTIVARIATE STAT WI; MITTERMEIER RA, 2006, LEMURS MADAGASCAR; Muldoon KM, 2010, J BIOGEOGR, V37, P1144, DOI 10.1111/j.1365-2699.2010.02276.x; Muldoon KM, 2009, J MAMMAL, V90, P1111, DOI 10.1644/08-MAMM-A-242.1; MULDOON KM, 2009, AMERCAN J PHYS ANTHR, V44, P270; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Orlando L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-121; Ossi K, 2006, BEHAV ECOL SOCIOBIOL, V61, P53, DOI 10.1007/s00265-006-0236-7; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Rice NH, 2003, BIOL J LINN SOC, V80, P369, DOI 10.1046/j.1095-8312.2003.00242.x; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schreier BM, 2009, BIOTROPICA, V41, P283, DOI 10.1111/j.1744-7429.2008.00486.x; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Tattersall I, 2007, EVOL ANTHROPOL, V16, P12, DOI 10.1002/evan.20126; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webster AJ, 2002, P ROY SOC B-BIOL SCI, V269, P143, DOI 10.1098/rspb.2001.1873; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder AD, 2006, DEV PRIMATOL, P255, DOI 10.1007/0-387-31710-4_9	63	62	63	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11073	10.1371/journal.pone.0011073	http://dx.doi.org/10.1371/journal.pone.0011073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552016	Green Submitted, Green Published, gold			2022-12-25	WOS:000278662900013
J	Aslam, A; Chan, H; Warrell, DA; Misbah, S; Ogg, GS				Aslam, Aamir; Chan, Hsien; Warrell, David A.; Misbah, Siraj; Ogg, Graham S.			Tracking Antigen-Specific T-Cells during Clinical Tolerance Induction in Humans	PLOS ONE			English	Article							GRASS-POLLEN IMMUNOTHERAPY; BEE VENOM IMMUNOTHERAPY; BLOOD MONONUCLEAR-CELLS; VARICELLA-ZOSTER-VIRUS; ALTERED PEPTIDE LIGAND; CAT-ALLERGIC SUBJECTS; HOUSE-DUST MITE; INTERFERON-GAMMA; REGULATORY CELLS; MULTIPLE-SCLEROSIS	Allergen immunotherapy presents an opportunity to define mechanisms of induction of clinical tolerance in humans. Significant progress has been made in our understanding of changes in T cell responses during immunotherapy, but existing work has largely been based on functional T cell assays. HLA-peptide-tetrameric complexes allow the tracking of antigen-specific T-cell populations based on the presence of specific T-cell receptors and when combined with functional assays allow a closer assessment of the potential roles of T-cell anergy and clonotype evolution. We sought to develop tools to facilitate tracking of antigen-specific T-cell populations during wasp-venom immunotherapy in people with wasp-venom allergy. We first defined dominant immunogenic regions within Ves v 5, a constituent of wasp venom that is known to represent a target antigen for T-cells. We next identified HLA-DRB1*1501 restricted epitopes and used HLA class II tetrameric complexes alongside cytokine responses to Ves v 5 to track T-cell responses during immunotherapy. In contrast to previous reports, we show that there was a significant initial induction of IL-4 producing antigen-specific T-cells within the first 3-5 weeks of immunotherapy which was followed by reduction of circulating effector antigen-specific T-cells despite escalation of wasp-venom dosage. However, there was sustained induction of IL-10-producing and FOXP3 positive antigen-specific T cells. We observed that these IL-10 producing cells could share a common precursor with IL-4-producing T cells specific for the same epitope. Clinical tolerance induction in humans is associated with dynamic changes in frequencies of antigen-specific T-cells, with a marked loss of IL-4-producing T-cells and the acquisition of IL-10-producing and FOXP3-positive antigen-specific CD4+ T-cells that can derive from a common shared precursor to pre-treatment effector T-cells. The development of new approaches to track antigen specific T-cell responses during immunotherapy can provide novel insights into mechanisms of tolerance induction in humans and identify new potential treatment targets.	[Aslam, Aamir; Chan, Hsien; Ogg, Graham S.] Univ Oxford, MRC, Human Immunol Unit,Weatherall Inst Mol Med, Natl Inst Hlth Res,Biomed Res Ctr, Oxford, England; [Warrell, David A.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Misbah, Siraj] John Radcliffe Hosp, Dept Clin Immunol, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford	Aslam, A (corresponding author), Univ Oxford, MRC, Human Immunol Unit,Weatherall Inst Mol Med, Natl Inst Hlth Res,Biomed Res Ctr, Oxford, England.	graham.ogg@ndm.ox.ac.uk		Ogg, Graham/0000-0002-3097-045X	Medical Research Council; National Institute of Health Research Biomedical Research Centre; Medical Research Council [G84/6616, G1000800h] Funding Source: researchfish; MRC [G84/6616] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by the Medical Research Council and National Institute of Health Research Biomedical Research Centre Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 1999, FASEB J, V13, P603, DOI 10.1096/fasebj.13.6.603; Akdis CA, 1996, J CLIN INVEST, V98, P1676, DOI 10.1172/JCI118963; Akdis CA, 1997, J ALLERGY CLIN IMMUN, V99, P345, DOI 10.1016/S0091-6749(97)70052-6; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Alexander C, 2005, ALLERGY, V60, P1269, DOI 10.1111/j.1398-9995.2005.00885.x; Alexander C, 2005, CLIN EXP ALLERGY, V35, P52, DOI 10.1111/j.1365-2222.2005.02143.x; Ali FR, 2004, AM J RESP CRIT CARE, V169, P20, DOI 10.1164/rccm.200305-690OC; Ardern-Jones MR, 2007, P NATL ACAD SCI USA, V104, P5557, DOI 10.1073/pnas.0700733104; Aslam A, 2006, CLIN EXP ALLERGY, V36, P1274, DOI 10.1111/j.1365-2222.2006.02569.x; Bateman EAL, 2006, J ALLERGY CLIN IMMUN, V118, P1350, DOI 10.1016/j.jaci.2006.07.040; Bellinghausen I, 1997, EUR J IMMUNOL, V27, P1131, DOI 10.1002/eji.1830270513; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bohle B, 2005, CLIN EXP ALLERGY, V35, P367, DOI 10.1111/j.1365-2222.2005.02180.x; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; BOUSQUET J, 1987, J ALLERGY CLIN IMMUN, V79, P947, DOI 10.1016/0091-6749(87)90245-4; BOUSQUET J, 1987, ALLERGY, V42, P401, DOI 10.1111/j.1398-9995.1987.tb00355.x; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; Ebner C, 1997, CLIN EXP ALLERGY, V27, P1007, DOI 10.1111/j.1365-2222.1997.tb01252.x; Eusebius NP, 2002, INT ARCH ALLERGY IMM, V127, P234, DOI 10.1159/000053868; Ewbank PA, 2003, J ALLERGY CLIN IMMUN, V111, P155, DOI 10.1067/mai.2003.41; Francis JN, 2003, J ALLERGY CLIN IMMUN, V111, P1255, DOI 10.1067/mai.2003.1570; Gabrielsson S, 2001, ALLERGY, V56, P293, DOI 10.1034/j.1398-9995.2001.00472.x; Gafvelin G, 2005, INT ARCH ALLERGY IMM, V138, P59, DOI 10.1159/000087358; Gardner LM, 2004, CLIN EXP ALLERGY, V34, P1209, DOI 10.1111/j.1365-2222.2004.02009.x; GILLMAN SA, 1980, ANN ALLERGY, V45, P351; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Hall G, 2003, VACCINE, V21, P549, DOI 10.1016/S0264-410X(02)00394-8; Haselden BM, 2001, J ALLERGY CLIN IMMUN, V108, P349, DOI 10.1067/mai.2001.117461; Jeal H, 2006, AM J RESP CRIT CARE, V174, P21, DOI 10.1164/rccm.200506-964OC; Jones L, 2007, EUR J IMMUNOL, V37, P3393, DOI 10.1002/eji.200737648; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; JUTEL M, 1995, J IMMUNOL, V154, P4187; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Larche M, 2007, J ALLERGY CLIN IMMUN, V119, P906, DOI 10.1016/j.jaci.2007.02.015; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Macaubas C, 2006, J IMMUNOL, V176, P5069, DOI 10.4049/jimmunol.176.8.5069; Major T, 2002, VACCINE, V20, P1532, DOI 10.1016/S0264-410X(01)00496-0; Majori M, 1998, EUR RESPIR J, V11, P1263, DOI 10.1183/09031936.98.11061263; Majori M, 2000, CLIN EXP ALLERGY, V30, P341, DOI 10.1046/j.1365-2222.2000.00701.x; Malavige GN, 2008, CLIN EXP IMMUNOL, V152, P522, DOI 10.1111/j.1365-2249.2008.03633.x; Marcotte GV, 1998, J ALLERGY CLIN IMMUN, V101, P506, DOI 10.1016/S0091-6749(98)70358-6; MCHUGH SM, 1995, CLIN EXP ALLERGY, V25, P828, DOI 10.1111/j.1365-2222.1995.tb00025.x; MCMENAMIN C, 1993, J EXP MED, V178, P889, DOI 10.1084/jem.178.3.889; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; MULLER U, 1979, ALLERGY, V34, P369, DOI 10.1111/j.1398-9995.1979.tb02006.x; Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; O'Brien RM, 2000, CLIN EXP ALLERGY, V30, P333; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; Oldfield WLG, 2001, J IMMUNOL, V167, P1734, DOI 10.4049/jimmunol.167.3.1734; Pereira-Santos MC, 2008, CLIN EXP ALLERGY, V38, P291, DOI 10.1111/j.1365-2222.2007.02887.x; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; RENZ H, 1994, J IMMUNOL, V152, P351; Richards DF, 2000, EUR J IMMUNOL, V30, P2344, DOI 10.1002/1521-4141(2000)30:8<2344::AID-IMMU2344>3.0.CO;2-7; ROCKLIN RE, 1980, NEW ENGL J MED, V302, P1213, DOI 10.1056/NEJM198005293022201; Sade K, 2003, ALLERGY, V58, P430, DOI 10.1034/j.1398-9995.2003.00055.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schuerwegh AJ, 2001, CLIN EXP ALLERGY, V31, P740, DOI 10.1046/j.1365-2222.2001.01066.x; SECRIST H, 1993, J EXP MED, V178, P2123, DOI 10.1084/jem.178.6.2123; Smith TRF, 2004, ALLERGY, V59, P1097, DOI 10.1111/j.1398-9995.2004.00601.x; TAMIR R, 1987, J ALLERGY CLIN IMMUN, V79, P591, DOI 10.1016/S0091-6749(87)80154-9; Tarzi M, 2006, CLIN EXP ALLERGY, V36, P465, DOI 10.1111/j.1365-2222.2006.02469.x; VARNEY VA, 1993, J CLIN INVEST, V92, P644, DOI 10.1172/JCI116633; Verhoef A, 2005, PLOS MED, V2, P253, DOI 10.1371/journal.pmed.0020078; Wachholz PA, 2002, IMMUNOLOGY, V105, P56, DOI 10.1046/j.1365-2567.2002.01338.x; Wachholz PA, 2004, CURR OPIN ALLERGY CL, V4, P313, DOI 10.1097/01.all.0000136753.35948.c0; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	76	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11028	10.1371/journal.pone.0011028	http://dx.doi.org/10.1371/journal.pone.0011028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543955	Green Submitted, gold, Green Published			2022-12-25	WOS:000278557600007
J	Palma, C; Vendetti, S; Cassone, A				Palma, Carla; Vendetti, Silvia; Cassone, Antonio			Role of 4-1BB Receptor in the Control Played by CD8(+) T Cells on IFN-gamma Production by Mycobacterium tuberculosis Antigen-Specific CD4(+) T Cells	PLOS ONE			English	Article							PROTECTIVE IMMUNE-RESPONSE; INTERFERON-GAMMA; PULMONARY TUBERCULOSIS; MONOCLONAL-ANTIBODIES; BCG VACCINATION; IN-VIVO; INFECTION; MICE; CD137; BETA	Background: Antigen-specific IFN-gamma producing CD4(+) T cells are the main mediators of protection against Mycobacterium tuberculosis infection both under natural conditions and following vaccination. However these cells are responsible for lung damage and poor vaccine efficacy when not tightly controlled. Discovering new tools to control nonprotective antigenspecific IFN-gamma production without affecting protective IFN-gamma is a challenge in tuberculosis research. Methods and Findings: Immunization with DNA encoding Ag85B, a candidate vaccine antigen of Mycobacterium tuberculosis, elicited in mice a low but protective CD4(+) T cell-mediated IFN-gamma response, while in mice primed with DNA and boosted with Ag85B protein a massive increase in IFN-gamma response was associated with loss of protection. Both protective and non-protective Ag85B-immunization generated antigen-specific CD8(+) T cells which suppressed IFN-gamma-secreting CD4(+) T cells. However, ex vivo ligation of 4-1BB, a member of TNF-receptor super-family, reduced the massive, non-protective IFN-gamma responses by CD4(+) T cells in protein-boosted mice without affecting the low protective IFN-gamma-secretion in mice immunized with DNA. This selective inhibition was due to the induction of 4-1BB exclusively on CD8(+) T cells of DNA-primed and protein-boosted mice following Ag85B protein stimulation. The 4-1BB-mediated IFN-gamma inhibition did not require soluble IL10, TGF-beta, XCL-1 and MIP-1 beta. In vivo Ag85B stimulation induced 4-1BB expression on CD8(+) T cells and in vivo 4-1BB ligation reduced the activation, IFN-gamma production and expansion of Ag85B-specific CD4(+) T cells of DNA-primed and protein-boosted mice. Conclusion/Significance: Antigen-specific suppressor CD8(+) T cells are elicited through immunization with the mycobacterial antigen Ag85B. Ligation of 4-1BB receptor further enhanced their suppressive activity on IFN-gamma-secreting CD4(+) T cells. The selective expression of 4-1BB only on CD8(+) T cells in mice developing a massive, non-protective IFN-gamma response opens novel strategies for intervention in tuberculosis pathology and vaccination through T-cell co-stimulatorybased molecular targeting.	[Palma, Carla; Vendetti, Silvia; Cassone, Antonio] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Palma, C (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	c.palma@iss.it	PALMA, CARLA/C-8821-2016; Cassone, Antonio/J-4666-2019; VENDETTI, SILVIA/M-4369-2015	PALMA, CARLA/0000-0003-2583-5306; VENDETTI, SILVIA/0000-0002-8443-496X	Ministero della Salute (Italy) [H51]; European Commission [LSHP-CT-2003-503240]	Ministero della Salute (Italy)(Ministry of Health, Italy); European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding: This work was supported by the Ministero della Salute (Italy) grant H51 and European Commission grant LSHP-CT-2003-503240, MUVAPRED Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Barker LF, 2009, CURR OPIN IMMUNOL, V21, P331, DOI 10.1016/j.coi.2009.05.017; Bean AGD, 1999, J IMMUNOL, V162, P3504; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; BOESEN H, 1995, INFECT IMMUN, V63, P1491, DOI 10.1128/IAI.63.4.1491-1497.1995; Boussaud V, 1998, EUR RESPIR J, V12, P926, DOI 10.1183/09031936.98.12040926; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Cannons JL, 2001, J IMMUNOL, V167, P1313, DOI 10.4049/jimmunol.167.3.1313; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Choi BK, 2006, CYTOKINE, V34, P233, DOI 10.1016/j.cyto.2006.04.008; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dannenberg AM, 2001, TUBERCULOSIS, V81, P229, DOI 10.1054/tube.2001.0287; Delgado JC, 2002, P NATL ACAD SCI USA, V99, P7576, DOI 10.1073/pnas.062056099; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Doherty TM, 2004, J INFECT DIS, V190, P2146, DOI 10.1086/425931; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Giscombe R, 2006, J INTERN MED, V260, P224, DOI 10.1111/j.1365-2796.2006.01688.x; Gonzalez-Juarrero M, 2002, CELL IMMUNOL, V220, P13, DOI 10.1016/S0008-8749(03)00010-8; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Haynes LM, 2000, J NEUROIMMUNOL, V106, P43, DOI 10.1016/S0165-5728(00)00212-5; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1994, EUR J IMMUNOL, V24, P3216, DOI 10.1002/eji.1830241246; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Jones HP, 2002, J IMMUNOL, V168, P3493, DOI 10.4049/jimmunol.168.7.3493; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim YH, 2009, J LEUKOCYTE BIOL, V85, P817, DOI 10.1189/jlb.0408246; Koch R., 1890, DEUT MED WOCHENSCHR, V16, P1029, DOI [10.1055/s-0029-1207546, DOI 10.1055/S-0029-1207546]; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Leal IS, 2001, IMMUNOLOGY, V104, P157, DOI 10.1046/j.1365-2567.2001.01305.x; Li L, 2007, TUBERCULOSIS, V87, P526, DOI 10.1016/j.tube.2007.07.004; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mittler RS, 1999, J EXP MED, V190, P1535, DOI 10.1084/jem.190.10.1535; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Ordway D, 2007, J LEUKOCYTE BIOL, V82, P1221, DOI 10.1189/jlb.0607426; ORMER FM, 2003, J IMMUNOL, V171, P5430; Palma C, 2008, VACCINE, V26, P4237, DOI 10.1016/j.vaccine.2008.05.050; Palma C, 2007, CELL MICROBIOL, V9, P1455, DOI 10.1111/j.1462-5822.2007.00884.x; POLLOK KE, 1993, J IMMUNOL, V150, P771; Quinn KM, 2008, EUR J IMMUNOL, V38, P695, DOI 10.1002/eji.200737888; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Schwander SK, 1998, J INFECT DIS, V178, P1434, DOI 10.1086/314454; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; *WHO, 2008, 2008393 WHOHTMTB; Wilcox RA, 2002, J CLIN INVEST, V109, P651, DOI 10.1172/JCI200214184; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Zhang LJ, 2006, AUTOIMMUNITY, V39, P269, DOI 10.1080/08916930600753903	63	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11019	10.1371/journal.pone.0011019	http://dx.doi.org/10.1371/journal.pone.0011019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544034	Green Published, Green Submitted, gold			2022-12-25	WOS:000278494900029
J	Normand-Lauziere, F; Frisch, F; Labbe, SM; Bherer, P; Gagnon, R; Cunnane, SC; Carpentier, AC				Normand-Lauziere, Francois; Frisch, Frederique; Labbe, Sebastien M.; Bherer, Patrick; Gagnon, Rene; Cunnane, Stephen C.; Carpentier, Andre C.			Increased Postprandial Nonesterified Fatty Acid Appearance and Oxidation in Type 2 Diabetes Is Not Fully Established in Offspring of Diabetic Subjects	PLOS ONE			English	Article							SKELETAL-MUSCLE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SUBSTRATE OXIDATION; VLDL-TRIACYLGLYCEROL; WHOLE-BODY; PLASMA; LIPOLYSIS; METABOLISM; KINETICS	Background: It has been proposed that abnormal postprandial plasma nonesterified fatty acid (NEFA) metabolism may participate in the development of tissue lipotoxicity and type 2 diabetes (T2D). We previously found that non-diabetic offspring of two parents with T2D display increased plasma NEFA appearance and oxidation rates during intravenous administration of a fat emulsion. However, it is currently unknown whether plasma NEFA appearance and oxidation are abnormal during the postprandial state in these subjects at high-risk of developing T2D. Methodology: Palmitate appearance and oxidation rates and glycerol appearance rate were determined in eleven healthy offspring of two parents with T2D (positive family history, FH+), 13 healthy subjects without first-degree relatives with T2D (FH-) and 12 subjects with T2D at fasting, during normoglycemic hyperinsulinemic clamp and during continuous oral intake of a standard liquid meal to achieve steady postprandial NEFA and triacylglycerols (TG) without and with insulin infusion to maintain similar glycemia in all three groups. Principal Findings: Plasma palmitate appearance and oxidation were higher at fasting and during the clamp conditions in the T2D group (all P < 0.05). In the postprandial state, palmitate appearance, oxidative and non oxidative rates were all elevated in T2D (all P < 0.05) but not in FH+. Both T2D and FH+ displayed elevated postprandial TG vs. FH-(P < 0.001). Acute correction of hyperglycemia during the postprandial state did not affect these group differences. Increased waist circumference and BMI were positively associated with elevated postprandial plasma palmitate appearance and oxidation. Conclusions/Significance: Postprandial plasma NEFA intolerance observed in subjects with T2D is not fully established in non-diabetic offspring of both parents with T2D, despite the presence of increased postprandial plasma TG in the later. Elevated postprandial plasma NEFA appearance and oxidation in T2D is observed despite acute correction of the exaggerated glycemic excursion in this group.	[Normand-Lauziere, Francois; Frisch, Frederique; Labbe, Sebastien M.; Bherer, Patrick; Carpentier, Andre C.] Univ Sherbrooke, Div Endocrinol, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Bherer, Patrick; Gagnon, Rene] Univ Sherbrooke, Dept Pediat, Div Genet, Sherbrooke, PQ J1K 2R1, Canada; [Cunnane, Stephen C.] Res Ctr Aging, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke	Normand-Lauziere, F (corresponding author), Univ Sherbrooke, Div Endocrinol, Dept Med, Sherbrooke, PQ J1K 2R1, Canada.	andre.carpentier@usherbrooke.ca			Canadian Institutes of Health Research [CIHR MOP 53094]; Fonds de la recherche en sante du Quebec (FRSQ); Canadian Diabetes Association; NSERC	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Diabetes Association; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: This work was supported by a grant from the Canadian Institutes of Health Research (CIHR MOP 53094) and was performed at the Centre de recherche clinique Etienne-Le Bel, a research center funded by the Fonds de la recherche en sante du Quebec (FRSQ). ACC is currently the recipient of a FRSQ Senior Scholarship Award. FNL is the recipient of a FRSQ Research Studentship Award. SML is the recipient of a Canadian Diabetes Association Doctoral Studentship Award. SCC is a Canada Research Chair and his component of this project was supported by NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Axelsen M, 1999, ANN INTERN MED, V131, P27, DOI 10.7326/0003-4819-131-1-199907060-00006; Barrows BR, 2005, DIABETES, V54, P2668, DOI 10.2337/diabetes.54.9.2668; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Bergouignan A, 2008, AM J PHYSIOL-ENDOC M, V294, pE645, DOI 10.1152/ajpendo.00720.2007; BEYLOT M, 1987, J LIPID RES, V28, P414; Bickerton AST, 2008, DIABETOLOGIA, V51, P1466, DOI 10.1007/s00125-008-1040-x; Bickerton AST, 2007, DIABETES, V56, P168, DOI 10.2337/db06-0822; Blaak EE, 2000, AM J PHYSIOL-ENDOC M, V279, pE146, DOI 10.1152/ajpendo.2000.279.1.E146; Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598; Blaak EE, 2004, DIABETOLOGIA, V47, P1462, DOI 10.1007/s00125-004-1471-y; Blaak EE, 2002, DIABETES, V51, P784, DOI 10.2337/diabetes.51.3.784; Blaak EE, 2000, DIABETES, V49, P2102, DOI 10.2337/diabetes.49.12.2102; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Brassard P, 2008, J CLIN ENDOCR METAB, V93, P837, DOI 10.1210/jc.2007-1670; Carpentier A, 2001, DIABETES, V50, P1402, DOI 10.2337/diabetes.50.6.1402; Carpentier AC, 2005, AM J PHYSIOL-ENDOC M, V289, pE849, DOI 10.1152/ajpendo.00073.2005; Carpentier AC, 2007, AM J PHYSIOL-ENDOC M, V292, pE693, DOI 10.1152/ajpendo.00423.2006; Carpentier AC, 2010, J CLIN ENDOCR METAB, V95, P1256, DOI 10.1210/jc.2009-1932; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gastaldelli A, 2009, HEPATOLOGY, V50, P1087, DOI 10.1002/hep.23116; Guo ZK, 1999, DIABETES, V48, P1586, DOI 10.2337/diabetes.48.8.1586; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Heath RB, 2007, AM J PHYSIOL-ENDOC M, V292, pE732, DOI 10.1152/ajpendo.00409.2006; Heilbronn LK, 2007, DIABETES, V56, P2046, DOI 10.2337/db06-1687; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Jocken JWE, 2008, DIABETOLOGIA, V51, P320, DOI 10.1007/s00125-007-0866-y; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lavoie F, 2009, J CLIN ENDOCR METAB, V94, P998, DOI 10.1210/jc.2008-1021; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Mensink M, 2001, DIABETES, V50, P2548, DOI 10.2337/diabetes.50.11.2548; Miles JM, 2004, DIABETES, V53, P521, DOI 10.2337/diabetes.53.3.521; Miles JM, 2003, DIABETES, V52, P675, DOI 10.2337/diabetes.52.3.675; Mittendorfer B, 2003, DIABETES, V52, P1641, DOI 10.2337/diabetes.52.7.1641; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Park Y, 2000, AM J PHYSIOL-ENDOC M, V279, pE1258, DOI 10.1152/ajpendo.2000.279.6.E1258; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Ravikumar B, 2005, AM J PHYSIOL-ENDOC M, V288, pE789, DOI 10.1152/ajpendo.00557.2004; ROUST LR, 1993, DIABETES, V42, P1567, DOI 10.2337/diabetes.42.11.1567; Schiffelers SLH, 2001, INT J OBESITY, V25, P33, DOI 10.1038/sj.ijo.0801528; Sidossis LS, 1998, AM J PHYSIOL-ENDOC M, V275, pE798, DOI 10.1152/ajpendo.1998.275.5.E798; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; WOLFE RR, 1992, RADIOACTIVE STABLE I, P235	46	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10956	10.1371/journal.pone.0010956	http://dx.doi.org/10.1371/journal.pone.0010956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532041	Green Published, Green Submitted, gold			2022-12-25	WOS:000278380500002
J	Cork, DJ; Lembark, S; Tovanabutra, S; Robb, ML; Kim, JH				Cork, Douglas J.; Lembark, Steven; Tovanabutra, Sodsai; Robb, Merlin L.; Kim, Jerome H.			W-Curve Alignments for HIV-1 Genomic Comparisons	PLOS ONE			English	Article							CHAOS GAME REPRESENTATION; IMMUNODEFICIENCY-VIRUS TYPE-1; GRAPHICAL REPRESENTATION; NEUTRALIZING ANTIBODIES; DNA-SEQUENCES	Background: The W-curve was originally developed as a graphical visualization technique for viewing DNA and RNA sequences. Its ability to render features of DNA also makes it suitable for computational studies. Its main advantage in this area is utilizing a single-pass algorithm for comparing the sequences. Avoiding recursion during sequence alignments offers advantages for speed and in-process resources. The graphical technique also allows for multiple models of comparison to be used depending on the nucleotide patterns embedded in similar whole genomic sequences. The W-curve approach allows us to compare large numbers of samples quickly. Method: We are currently tuning the algorithm to accommodate quirks specific to HIV-1 genomic sequences so that it can be used to aid in diagnostic and vaccine efforts. Tracking the molecular evolution of the virus has been greatly hampered by gap associated problems predominantly embedded within the envelope gene of the virus. Gaps and hypermutation of the virus slow conventional string based alignments of the whole genome. This paper describes the W-curve algorithm itself, and how we have adapted it for comparison of similar HIV-1 genomes. A treebuilding method is developed with the W-curve that utilizes a novel Cylindrical Coordinate distance method and gap analysis method. HIV-1 C2-V5 env sequence regions from a Mother/Infant cohort study are used in the comparison. Findings: The output distance matrix and neighbor results produced by the W-curve are functionally equivalent to those from Clustal for C2-V5 sequences in the mother/infant pairs infected with CRF01_AE. Conclusions: Significant potential exists for utilizing this method in place of conventional string based alignment of HIV-1 genomes, such as Clustal X. With W-curve heuristic alignment, it may be possible to obtain clinically useful results in a short time-short enough to affect clinical choices for acute treatment. A description of the W-curve generation process, including a comparison technique of aligning extremes of the curves to effectively phase-shift them past the HIV-1 gap problem, is presented. Besides yielding similar neighbor-joining phenogram topologies, most Mother and Infant C2-V5 sequences in the cohort pairs geometrically map closest to each other, indicating that W-curve heuristics overcame any gap problem.	[Cork, Douglas J.; Tovanabutra, Sodsai; Robb, Merlin L.; Kim, Jerome H.] US Mil HIV Res Program, Rockville, MD USA; [Cork, Douglas J.; Tovanabutra, Sodsai] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA; [Cork, Douglas J.] IIT, Chicago, IL 60616 USA; [Lembark, Steven] Workhorse Comp, Woodhaven, NY USA; [Robb, Merlin L.; Kim, Jerome H.] Walter Reed Army Inst Res, Div Retrovirol, Rockville, MD USA	Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Illinois Institute of Technology; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Cork, DJ (corresponding author), US Mil HIV Res Program, Rockville, MD USA.	dcork@hivresearch.org			HIV-1 Research Project (MHRP) [W81XWH-07-2-0067-P00001]; Henry Jackson Foundation (HJF); Workhorse Computing; Military Medicine, Inc.; U.S. Department of Defense (DOD); NICHD [R01 HD34343-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034343] Funding Source: NIH RePORTER	HIV-1 Research Project (MHRP); Henry Jackson Foundation (HJF); Workhorse Computing; Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: Military HIV-1 Research Project (MHRP)/Henry Jackson Foundation (HJF) and Workhorse Computing. This work was funded by MHRP (Military HIV-1 Research Project) cooperative agreement (W81XWH-07-2-0067-P00001) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The cohort work was supported through NICHD by R01 HD34343-03 and partly by a cooperative agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Dept. of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JS, 2001, BIOINFORMATICS, V17, P429, DOI 10.1093/bioinformatics/17.5.429; Barnsley M, 1993, FRACTALS EVERYWHERE; BASU S, 1992, J MOL BIOL, V228, P715; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; Cork Douglas J., 2008, International Journal of Medical Engineering and Informatics, V1, P227, DOI 10.1504/IJMEI.2008.020752; Cork DJ, 2002, ANN NY ACAD SCI, V980, P32, DOI 10.1111/j.1749-6632.2002.tb04887.x; CORK DJ, 2003, DIMACS SERIES DISCRE, V61, P123; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Felsenstein J., 1992, PHYLIP PHYLOGENY INF; Feng J, 2008, CHEM PHYS LETT, V454, P355, DOI 10.1016/j.cplett.2008.01.041; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; HILL KA, 1992, J MOL EVOL, V35, P261; Huang GH, 2009, BIOPHYS CHEM, V143, P55, DOI 10.1016/j.bpc.2009.03.013; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Joseph J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-243; Mandelbrot BB, 2004, FRACTAL GEOMETRY NAT; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Nyambi PN, 1996, J VIROL, V70, P6235, DOI 10.1128/JVI.70.9.6235-6243.1996; OLIVER JL, 1993, J THEOR BIOL, V160, P457, DOI 10.1006/jtbi.1993.1030; Peitgen H.O., 1992, CHAOS FRACTALS NEW F; Polonis VR, 2001, AIDS RES HUM RETROV, V17, P69, DOI 10.1089/088922201750056807; SCARLATTI G, 1993, J INFECT DIS, V168, P207, DOI 10.1093/infdis/168.1.207; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tovanabutra S, 2007, AIDS, V21, P1050, DOI 10.1097/QAD.0b013e32810c8cf3; Wang YW, 2005, GENE, V346, P173, DOI 10.1016/j.gene.2004.10.021; WU D, 1993, VISUALIZATION 199 CP, V33, P308; Yu ZG, 2004, J THEOR BIOL, V226, P341, DOI 10.1016/j.jtbi.2003.09.009	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10829	10.1371/journal.pone.0010829	http://dx.doi.org/10.1371/journal.pone.0010829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532248	Green Published, Green Submitted, gold			2022-12-25	WOS:000278222400003
J	Sharma, R; Tsuchiya, M; Skobe, Z; Tannous, BA; Bartlett, JD				Sharma, Ramaswamy; Tsuchiya, Masahiro; Skobe, Ziedonis; Tannous, Bakhos A.; Bartlett, John D.			The Acid Test of Fluoride: How pH Modulates Toxicity	PLOS ONE			English	Article							RAT INCISOR ENAMEL; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; SODIUM-FLUORIDE; SECRETORY PATHWAY; DEPENDENT EVENT; MESSENGER-RNAS; ULTRASTRUCTURAL-CHANGES; DENTAL FLUOROSIS; RENAL CLEARANCE	Background: It is not known why the ameloblasts responsible for dental enamel formation are uniquely sensitive to fluoride (F-). Herein, we present a novel theory with supporting data to show that the low pH environment of maturating stage ameloblasts enhances their sensitivity to a given dose of F-. Enamel formation is initiated in a neutral pH environment (secretory stage); however, the pH can fall to below 6.0 as most of the mineral precipitates (maturation stage). Low pH can facilitate entry of F- into cells. Here, we asked if F- was more toxic at low pH, as measured by increased cell stress and decreased cell function. Methodology/Principal Findings: Treatment of ameloblast-derived LS8 cells with F- at low pH reduced the threshold dose of F- required to phosphorylate stress-related proteins, PERK, eIF2 alpha, JNK and c-jun. To assess protein secretion, LS8 cells were stably transduced with a secreted reporter, Gaussia luciferase, and secretion was quantified as a function of F- dose and pH. Luciferase secretion significantly decreased within 2 hr of F- treatment at low pH versus neutral pH, indicating increased functional toxicity. Rats given 100 ppm F- in their drinking water exhibited increased stress-mediated phosphorylation of eIF2 alpha in maturation stage ameloblasts (pH<6.0) as compared to secretory stage ameloblasts (pH similar to 7.2). Intriguingly, F--treated rats demonstrated a striking decrease in transcripts expressed during the maturation stage of enamel development (Klk4 and Amtn). In contrast, the expression of secretory stage genes, AmelX, Ambn, Enam and Mmp20, was unaffected. Conclusions: The low pH environment of maturation stage ameloblasts facilitates the uptake of F 2, causing increased cell stress that compromises ameloblast function, resulting in dental fluorosis.	[Sharma, Ramaswamy; Skobe, Ziedonis; Bartlett, John D.] Harvard Univ, Sch Dent Med, Forsyth Inst, Dept Cytokine Biol, Boston, MA 02115 USA; [Sharma, Ramaswamy; Skobe, Ziedonis; Bartlett, John D.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Tsuchiya, Masahiro] Tohoku Univ, Div Aging & Geriatr Dent, Sendai, Miyagi 980, Japan; [Tannous, Bakhos A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA USA; [Tannous, Bakhos A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA USA; [Tannous, Bakhos A.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; Tohoku University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sharma, R (corresponding author), Harvard Univ, Sch Dent Med, Forsyth Inst, Dept Cytokine Biol, 188 Longwood Ave, Boston, MA 02115 USA.	jbartlett@forsyth.org	Bartlett, John/L-9832-2017; Sharma, Ramaswamy/F-8401-2012; Tsuchiya, Masahiro/C-5553-2018	Tsuchiya, Masahiro/0000-0002-7000-4547; Bartlett, John/0000-0003-2052-6299	National Institute of Dental and Craniofacial Research [DE018106]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018106] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant DE018106 from the National Institute of Dental and Craniofacial Research (www.nidcr.nih.gov) to JDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGMARMANSSON B, 1984, CARIES RES, V18, P25, DOI 10.1159/000260743; Aoba T, 2002, CRIT REV ORAL BIOL M, V13, P155, DOI 10.1177/154411130201300206; AZAR HA, 1961, ANN INTERN MED, V55, P193, DOI 10.7326/0003-4819-55-2-193; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; BAWDEN JW, 1995, J DENT RES, V74, P1349, DOI 10.1177/00220345950740070501; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Bronckers ALJJ, 2009, J DENT RES, V88, P877, DOI 10.1177/0022034509343280; BRUSSOCK SM, 1987, J DENT RES, V66, P1594, DOI 10.1177/00220345870660101701; CDC, 1995, MMWR-MORBID MORTAL W, V44, P1; CHRISTENSEN R, 1990, J DENT RES, V69, P185; CONCONI FM, 1966, J MOL BIOL, V19, P525, DOI 10.1016/S0022-2836(66)80020-7; Dean HT, 1936, AM J PUBLIC HEALTH N, V26, P567, DOI 10.2105/AJPH.26.6.567; DenBesten P K, 1989, Adv Dent Res, V3, P199; DENBESTEN PK, 1992, J DENT RES, V71, P1238, DOI 10.1177/00220345920710051701; DenBesten PK, 2002, ARCH ORAL BIOL, V47, P763, DOI 10.1016/S0003-9969(02)00117-6; DENBESTEN PK, 1986, J DENT RES, V65, P1272, DOI 10.1177/00220345860650101401; EKSTRAND J, 1980, EUR J CLIN PHARMACOL, V18, P189, DOI 10.1007/BF00561589; EKSTRAND J, 1982, ACTA PHARMACOL TOX, V50, P321; Fawell J., 2006, FLUORIDE DRINKING WA; Fejerskov O, 1990, J Dent Res, V69 Spec No, P692; GARANT PR, 1972, J ULTRA MOL STRUCT R, V40, P333, DOI 10.1016/S0022-5320(72)90105-0; GARANT PR, 1984, TISSUE CELL, V16, P635, DOI 10.1016/0040-8166(84)90037-5; Garcia-Montalvo EA, 2009, TOXICOLOGY, V263, P75, DOI 10.1016/j.tox.2009.06.008; GODCHAUX W, 1976, J BIOL CHEM, V251, P292; Gow A, 2003, NEUROMOL MED, V4, P73, DOI 10.1385/NMM:4:1-2:73; Gstraunthaler G, 2000, AM J PHYSIOL-RENAL, V278, pF227, DOI 10.1152/ajprenal.2000.278.2.F227; GSTRAUNTHALER G, 1992, AM J PHYSIOL, V263, pC47, DOI 10.1152/ajpcell.1992.263.1.C47; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; He H, 1998, BBA-BIOMEMBRANES, V1372, P244, DOI 10.1016/S0005-2736(98)00064-9; HELGELAND K, 1976, SCAND J DENT RES, V84, P276; Hirano S, 1997, ARCH TOXICOL, V72, P52, DOI 10.1007/s002040050468; HOLLAND RI, 1979, CELL BIOL INT REP, V3, P701, DOI 10.1016/0309-1651(79)90074-2; HOLLAND RI, 1979, ACTA PHARMACOL TOX, V45, P96; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Holzer P, 2000, CURR OPIN GASTROEN, V16, P469, DOI 10.1097/00001574-200011000-00003; JARNBERG PO, 1981, ANESTHESIOLOGY, V54, P48; KALLENBA.E, 1967, ANAT REC, V157, P683, DOI 10.1002/ar.1091570413; KAWASE T, 1989, ARCH ORAL BIOL, V34, P103, DOI 10.1016/0003-9969(89)90133-7; KRUGER BJ, 1968, ARCH ORAL BIOL, V13, P969, DOI 10.1016/0003-9969(68)90012-5; Kubota K, 2005, J BIOL CHEM, V280, P23194, DOI 10.1074/jbc.M503288200; LIN SY, 1966, J MOL BIOL, V21, P51, DOI 10.1016/0022-2836(66)90079-9; Matsuo S, 2000, ARCH TOXICOL, V73, P611, DOI 10.1007/s002040050015; Matsuo S, 1996, ARCH TOXICOL, V70, P420, DOI 10.1007/s002040050294; Menoyo I, 2005, ARZNEIMITTELFORSCH, V55, P455; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; OGILVIE AL, 1953, J DENT RES, V32, P386, DOI 10.1177/00220345530320031301; RIGALLI A, 1990, CALCIFIED TISSUE INT, V46, P333, DOI 10.1007/BF02563825; Robinson C, 2004, CARIES RES, V38, P268, DOI 10.1159/000077766; ROUCH AJ, 1992, KIDNEY INT, V41, P342, DOI 10.1038/ki.1992.47; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SCHUSTER GS, 1981, CARIES RES, V15, P32, DOI 10.1159/000260497; Sharma R, 2008, ENVIRON HEALTH PERSP, V116, P1142, DOI 10.1289/ehp.11375; SHINODA H, 1975, CALC TISS RES, V18, P91, DOI 10.1007/BF02546229; SHINODA H, 1978, CALC TISS RES, V25, P75, DOI 10.1007/BF02010754; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith C E, 1996, Adv Dent Res, V10, P159; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 2006, EUR J ORAL SCI, V114, P147, DOI 10.1111/j.1600-0722.2006.00273.x; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Toyosawa S, 1996, CELL TISSUE RES, V285, P217, DOI 10.1007/s004410050639; TRILLER M, 1979, J DENT RES, V58, P1028, DOI 10.1177/002203457905800216011; Tsuchiya M, 2009, EUR J ORAL SCI, V117, P105, DOI 10.1111/j.1600-0722.2009.00612.x; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; VESCO C, 1970, Journal of Molecular Biology, V47, P335, DOI 10.1016/0022-2836(70)90306-2; Whitford GM, 1982, J APPL TOXICOL, V2, P303, DOI 10.1002/jat.2550020608; WHITFORD GM, 1979, AM J PHYSIOL, V236, pF141, DOI 10.1152/ajprenal.1979.236.2.F141; WHITFORD GM, 1984, CALCIFIED TISSUE INT, V36, P302, DOI 10.1007/BF02405334; WHITFORD GM, 1977, INFECT IMMUN, V18, P680, DOI 10.1128/IAI.18.3.680-687.1977; WHITFORD GM, 1991, P SOC EXP BIOL MED, V196, P178, DOI 10.3181/00379727-196-43176; WHITFORD GM, 1977, AM J PHYSIOL, V232, pF10, DOI 10.1152/ajprenal.1977.232.1.F10; WHITFORD GM, 1995, CARIES RES, V29, P20, DOI 10.1159/000262035; WHITFORD GM, 1976, AM J PHYSIOL, V230, P527, DOI 10.1152/ajplegacy.1976.230.2.527; Wright JT, 1996, J DENT RES, V75, P1936, DOI 10.1177/00220345960750120401; Zhang C, 2001, BIOCHEM BIOPH RES CO, V289, P718, DOI 10.1006/bbrc.2001.6044; Zhou R, 1996, ARCH ORAL BIOL, V41, P739, DOI 10.1016/S0003-9969(96)00078-7	78	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10895	10.1371/journal.pone.0010895	http://dx.doi.org/10.1371/journal.pone.0010895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531944	Green Published, Green Submitted, gold			2022-12-25	WOS:000278222100024
J	Shiozawa, Y; Jung, YH; Ziegler, AM; Pedersen, EA; Wang, JH; Wang, Z; Song, JH; Wang, JC; Lee, CH; Sud, S; Pienta, KJ; Krebsbach, PH; Taichman, RS				Shiozawa, Yusuke; Jung, Younghun; Ziegler, Anne M.; Pedersen, Elisabeth A.; Wang, Jianhua; Wang, Zhuo; Song, Junhui; Wang, Jingcheng; Lee, Clara H.; Sud, Sudha; Pienta, Kenneth J.; Krebsbach, Paul H.; Taichman, Russell S.			Erythropoietin Couples Hematopoiesis with Bone Formation	PLOS ONE			English	Article							STEM-CELL NICHE; OSTEOGENIC GROWTH PEPTIDE; PARATHYROID-HORMONE; IN-VIVO; MARROW; STIMULATION; DERIVATIVES; MECHANISM; TISSUE; BLOOD	Background: It is well established that bleeding activates the hematopoietic system to regenerate the loss of mature blood elements. We have shown that hematopoietic stem cells (HSCs) isolated from animals challenged with an acute bleed regulate osteoblast differentiation from marrow stromal cells. This suggests that HSCs participate in bone formation where the molecular basis for this activity is the production of BMP2 and BMP6 by HSCs. Yet, what stimulates HSCs to produce BMPs is unclear. Methodology/Principal Findings: In this study, we demonstrate that erythropoietin (Epo) activates Jak-Stat signaling pathways in HSCs which leads to the production of BMPs. Critically, Epo also directly activates mesenchymal cells to form osteoblasts in vitro, which in vivo leads to bone formation. Importantly, Epo first activates osteoclastogenesis which is later followed by osteoblastogenesis that is induced by either Epo directly or the expression of BMPs by HSCs to form bone. Conclusions/Significance: These data for the first time demonstrate that Epo regulates the formation of bone by both direct and indirect pathways, and further demonstrates the exquisite coupling between hematopoesis and osteopoiesis in the marrow.	[Shiozawa, Yusuke; Jung, Younghun; Ziegler, Anne M.; Pedersen, Elisabeth A.; Wang, Jianhua; Wang, Jingcheng; Lee, Clara H.; Taichman, Russell S.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Wang, Zhuo; Song, Junhui; Krebsbach, Paul H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Wang, Jianhua] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200030, Peoples R China; [Sud, Sudha; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Sud, Sudha; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Shanghai Jiao Tong University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shiozawa, Y (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	rtaich@umich.edu	Krebsbach, Paul H./AAC-4765-2021; Pienta, Kenneth/E-7679-2015	Taichman, Russell S./0000-0002-7890-0020; Pienta, Kenneth/0000-0002-4138-2186	Pediatric Oncology Research Fellowship; University of Michigan Dental School's Student Research Program; American Association of Dental Researcher's Student Fellowship Award; Department of Defense [PC073952]; National Institutes of Health [DK082481, DE020721, 1RC1DE020721]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082481] Funding Source: NIH RePORTER	Pediatric Oncology Research Fellowship; University of Michigan Dental School's Student Research Program; American Association of Dental Researcher's Student Fellowship Award; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was directly supported by a Pediatric Oncology Research Fellowship (Y.S.), the University of Michigan Dental School's Student Research Program (A.M.Z), and an American Association of Dental Researcher's Student Fellowship Award (A.M.Z.). This study was supported by grants from the Department of Defense (PC073952) and National Institutes of Health (DK082481, DE020721, 1RC1DE020721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; BAB I, 1992, EMBO J, V11, P1867, DOI 10.1002/j.1460-2075.1992.tb05238.x; Bab Itai A., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P31; BRYAN L S Jr, 1964, Bull Hist Med, V38, P516; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; DOMRACHEVA EV, 1985, TERAPEVT ARKH, V57, P40; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; FOLDES J, 1989, J BONE MINER RES, V4, P643; GAZIT D, 1990, ENDOCRINOLOGY, V126, P2607, DOI 10.1210/endo-126-5-2607; Goddard JC, 2004, J ROY SOC MED, V97, P191, DOI 10.1258/jrsm.97.4.191; Goltzman D, 2008, ARCH BIOCHEM BIOPHYS, V473, P218, DOI 10.1016/j.abb.2008.03.003; GREENBERG Z, 1995, J CLIN ENDOCR METAB, V80, P2330, DOI 10.1210/jc.80.8.2330; Gurevitch O, 1999, TRANSPLANTATION, V68, P1362, DOI 10.1097/00007890-199911150-00024; Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; Ihle J N, 1993, Semin Immunol, V5, P375, DOI 10.1006/smim.1993.1043; ILIZAROV G A, 1986, Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya, P54; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LEE MY, 1991, BLOOD, V77, P2135; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lucas TS, 1997, CLIN ORTHOP RELAT R, P267; Mennini T, 2006, MOL MED, V12, P153, DOI 10.2119/2006-00045.Mennini; Mizutani K, 2009, J CELL BIOCHEM, V106, P563, DOI 10.1002/jcb.22021; STEPANOVA NV, 1991, FIZIOL ZH SSSR, V37, P19; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Takenaka Tsuneo, 2003, International Urology and Nephrology, V35, P407, DOI 10.1023/B:UROL.0000022950.00626.e4; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yamaza T, 2009, BLOOD, V113, P2595, DOI 10.1182/blood-2008-10-182246; Yazigi A., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P463; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	33	123	134	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10853	10.1371/journal.pone.0010853	http://dx.doi.org/10.1371/journal.pone.0010853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523730	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221900008
J	Adams, SJ; DeTure, MA; McBride, M; Dickson, DW; Petrucelli, L				Adams, Stephanie J.; DeTure, Michael A.; McBride, Melinda; Dickson, Dennis W.; Petrucelli, Leonard			Three Repeat Isoforms of Tau Inhibit Assembly of Four Repeat Tau Filaments	PLOS ONE			English	Article							PROTEIN-TAU; EXPRESSION; AGGREGATION; CONSISTS; MUTATION; GENE	Tauopathies are defined by assembly of the microtubule associated protein tau into filamentous tangles and classified by the predominant tau isoform within these aggregates. The major isoforms are determined by alternative mRNA splicing of exon 10 generating tau with three (3R) or four (4R) similar to 32 amino acid imperfect repeats in the microtubule binding domain. In normal adult brains there is an approximately equimolar ratio of 3R and 4R tau which is altered by several disease-causing mutations in the tau gene. We hypothesized that when 4R and 3R tau isoforms are not at equimolar ratios aggregation is favored. Here we provide evidence for the first time that the combination of 3R and 4R tau isoforms results in less in vitro heparin induced polymerization than with 4R preparations alone. This effect was independent of reducing conditions and the presence of alternatively spliced exons 2 and 3 N-terminal inserts. The addition of even small amounts of 3R to 4R tau assembly reactions significantly decreased 4R assembly. Together these findings suggest that co-expression of 3R and 4R tau isoforms reduce tau filament assembly and that 3R tau isoforms inhibit 4R tau assembly. Expression of equimolar amounts of 3R and 4R tau in adult humans may be necessary to maintain proper neuronal microtubule dynamics and to prevent abnormal tau filament assembly. Importantly, these findings indicate that disruption of the normal equimolar 3R to 4R ratio may be sufficient to drive tau aggregation and that restoration of the tau isoform balance may have important therapeutic implications in tauopathies.	[Adams, Stephanie J.; DeTure, Michael A.; McBride, Melinda; Dickson, Dennis W.; Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA	Mayo Clinic	Adams, SJ (corresponding author), Mayo Clin, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA.	deture.michael@mayo.edu; petrucelli.leonard@mayo.edu		Dickson, Dennis W/0000-0001-7189-7917	NIA/NIH [AG027638, P01AG017216]; Robert and Clarice Smith Fellowship; NIH/NINDS [R21NS059363]; Mayo Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017216, F32AG027638] Funding Source: NIH RePORTER	NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert and Clarice Smith Fellowship; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a National Research Service Award postdoctoral fellowship AG027638 from NIA/NIH (S.J.A.), Robert and Clarice Smith Fellowship (S.J.A.). Alzheimer's Association (L. P.), NIH/NIA P01AG017216 (L. P. and D. W. D.), NIH/NINDS R21NS059363 (L. P.) and Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; DeTure M, 2006, BIOCHEM BIOPH RES CO, V339, P858, DOI 10.1016/j.bbrc.2005.11.087; DeTure MA, 2002, J BIOL CHEM, V277, P34755, DOI 10.1074/jbc.M201201200; Donahue CP, 2006, J BIOL CHEM, V281, P23302, DOI 10.1074/jbc.C600143200; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; KOSIK KS, 1989, ANN MED, V21, P109, DOI 10.3109/07853898909149195; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCOTT CW, 1991, J NEUROSCI RES, V30, P154, DOI 10.1002/jnr.490300116; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Sugino E, 2009, BIOCHEM BIOPH RES CO, V385, P236, DOI 10.1016/j.bbrc.2009.05.047; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	33	71	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10810	10.1371/journal.pone.0010810	http://dx.doi.org/10.1371/journal.pone.0010810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520830	Green Published, Green Submitted, gold			2022-12-25	WOS:000278034800008
J	Kawasaki, T; Ueyama, T; Lange, I; Feske, S; Saito, N				Kawasaki, Takumi; Ueyama, Takehiko; Lange, Ingo; Feske, Stefan; Saito, Naoaki			Protein Kinase C-induced Phosphorylation of Orai1 Regulates the Intracellular Ca2+ Level via the Store-operated Ca2+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; CALCIUM-ENTRY; STIM1; ACTIVATION; DOMAIN; CELLS; DEFICIENCY; INHIBITION; COMPLEX; BINDING	Ca2+ signals through store-operated Ca2+ (SOC) channels, activated by the depletion of Ca2+ from the endoplasmic reticulum, regulate various physiological events. Orai1 is the pore-forming subunit of the Ca2+ release-activated Ca2+ (CRAC) channel, the best characterized SOC channel. Orai1 is activated by stromal interaction molecule (STIM) 1, a Ca2+ sensor located in the endoplasmic reticulum. Orai1 and STIM1 are crucial for SOC channel activation, but the molecular mechanisms regulating Orai1 function are not fully understood. In this study, we demonstrate that protein kinase C (PKC) suppresses store-operated Ca2+ entry (SOCE) by phosphorylation of Orai1. PKC inhibitors and knockdown of PKC beta both resulted in increased Ca2+ influx. Orai1 is strongly phosphorylated by PKC in vitro and in vivo at N-terminal Ser-27 and Ser-30 residues. Consistent with these results, substitution of endogenous Orai1 with an Orai1 S27A/S30A mutant resulted in increased SOCE and CRAC channel currents. We propose that PKC suppresses SOCE and CRAC channel function by phosphorylation of Orai1 at N-terminal serine residues Ser-27 and Ser-30.	[Kawasaki, Takumi; Lange, Ingo; Feske, Stefan] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Kawasaki, Takumi; Ueyama, Takehiko; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan	New York University; NYU Langone Medical Center; Kobe University	Feske, S (corresponding author), NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	feskes01@nyumc.org; naosaito@kobe-u.ac.jp	Feske, stefan/ABB-3554-2021	Feske, stefan/0000-0001-5431-8178; Lange, Ingo/0000-0002-6703-0015	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Hyogo Science and Technology Association; Takeda Science Foundation; Uehara Foundation; National Institutes of Health [AI066128]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066128] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Foundation(Uehara Memorial Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant-in-aid for scientific research from the Global Center of Excellence (COE) Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. S.), grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. S.), the Hyogo Science and Technology Association (to N. S.), the Takeda Science Foundation (to N. S.), and an Uehara Foundation postdoctoral fellowship (to T. K.). This work was also supported in part by National Institutes of Health Grant AI066128 (to S. F.).	Albert AP, 2003, CELL CALCIUM, V33, P345, DOI 10.1016/S0143-4160(03)00048-4; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cejas PJ, 2005, MOL CELL BIOL, V25, P7900, DOI 10.1128/MCB.25.17.7900-7916.2005; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Haverstick DM, 1997, J BIOL CHEM, V272, P15426, DOI 10.1074/jbc.272.24.15426; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Keranen LM, 1997, J BIOL CHEM, V272, P25959, DOI 10.1074/jbc.272.41.25959; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Lee H, 1997, J BIOL CHEM, V272, P21831, DOI 10.1074/jbc.272.35.21831; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Lin X, 2006, CARCINOGENESIS, V27, P1538, DOI 10.1093/carcin/bgl002; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PAREKH AB, 1995, P NATL ACAD SCI USA, V92, P7907, DOI 10.1073/pnas.92.17.7907; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; PETERSEN CCH, 1994, J BIOL CHEM, V269, P32246; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Uchino M, 2004, J BIOL CHEM, V279, P2254, DOI 10.1074/jbc.M309894200; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	46	104	105	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25720	25730		10.1074/jbc.M109.022996	http://dx.doi.org/10.1074/jbc.M109.022996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534587	Green Published, hybrid			2022-12-25	WOS:000280682400065
J	Moreno, R; Fonseca, P; Rojo, F				Moreno, Renata; Fonseca, Pilar; Rojo, Fernando			The Crc Global Regulator Inhibits the Pseudomonas putida pWW0 Toluene/Xylene Assimilation Pathway by Repressing the Translation of Regulatory and Structural Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; TOL PLASMID PWW0; META-CLEAVAGE PATHWAY; ESCHERICHIA-COLI; DEGRADATION PATHWAY; TRANSCRIPTIONAL REGULATOR; NUTRIENT LIMITATION; CHEMOSTAT CULTURES; AROMATIC-COMPOUNDS; ARVILLA MT-2	In Pseudomonas putida, the expression of the pWW0 plasmid genes for the toluene/xylene assimilation pathway (the TOL pathway) is subject to complex regulation in response to environmental and physiological signals. This includes strong inhibition via catabolite repression, elicited by the carbon sources that the cells prefer to hydrocarbons. The Crc protein, a global regulator that controls carbon flow in pseudomonads, has an important role in this inhibition. Crc is a translational repressor that regulates the TOL genes, but how it does this has remained unknown. This study reports that Crc binds to sites located at the translation initiation regions of the mRNAs coding for XylR and XylS, two specific transcription activators of the TOL genes. Unexpectedly, eight additional Crc binding sites were found overlapping the translation initiation sites of genes coding for several enzymes of the pathway, all encoded within two polycistronic mRNAs. Evidence is provided supporting the idea that these sites are functional. This implies that Crc can differentially modulate the expression of particular genes within polycistronic mRNAs. It is proposed that Crc controls TOL genes in two ways. First, Crc inhibits the translation of the XylR and XylS regulators, thereby reducing the transcription of all TOL pathway genes. Second, Crc inhibits the translation of specific structural genes of the pathway, acting mainly on proteins involved in the first steps of toluene assimilation. This ensures a rapid inhibitory response that reduces the expression of the toluene/xylene degradation proteins when preferred carbon sources become available.	[Moreno, Renata; Fonseca, Pilar; Rojo, Fernando] CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rojo, F (corresponding author), CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Campus Univ Autonoma Madrid, Madrid 28049, Spain.	frojo@cnb.csic.es	Moreno, Renata/D-6139-2014; Rojo, Fernando/A-7038-2008	Moreno, Renata/0000-0001-5125-6995; Rojo, Fernando/0000-0003-1848-7745	Spanish Ministry of Science and Innovation [BFU2009-07009/BMC, CSD2007-00005]; Instituto de Salud Carlos III (Spanish Network for Research into Infectious Diseases) [REIPI RD06/0008]; European Development Regional Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (Spanish Network for Research into Infectious Diseases)(Instituto de Salud Carlos III); European Development Regional Fund(European Commission)	This work was supported by grants from the Spanish Ministry of Science and Innovation (Grants BFU2009-07009/BMC and CSD2007-00005) and from the Instituto de Salud Carlos III (Spanish Network for Research into Infectious Diseases; Grant REIPI RD06/0008), co-financed by the European Development Regional Fund.	Aranda-Olmedo I, 2005, APPL ENVIRON MICROB, V71, P4191, DOI 10.1128/AEM.71.8.4191-4198.2005; Aranda-Olmedo I, 2006, APPL ENVIRON MICROB, V72, P7418, DOI 10.1128/AEM.01067-06; Cases I, 1996, MOL MICROBIOL, V19, P7, DOI 10.1046/j.1365-2958.1996.345873.x; CERRETTI DP, 1988, J MOL BIOL, V204, P309, DOI 10.1016/0022-2836(88)90578-5; Cowles CE, 2000, J BACTERIOL, V182, P6339, DOI 10.1128/JB.182.22.6339-6346.2000; DEAN D, 1980, P NATL ACAD SCI-BIOL, V77, P3590, DOI 10.1073/pnas.77.6.3590; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Dominguez-Cuevas P, 2006, J BIOL CHEM, V281, P11981, DOI 10.1074/jbc.M509848200; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Duetz WA, 1996, APPL ENVIRON MICROB, V62, P601, DOI 10.1128/AEM.62.2.601-606.1996; Duetz WA, 1997, MICROBIOL-SGM, V143, P2331, DOI 10.1099/00221287-143-7-2331; DUETZ WA, 1994, J BACTERIOL, V176, P2354, DOI 10.1128/JB.176.8.2354-2361.1994; Fraile S, 2001, J BACTERIOL, V183, P5571, DOI 10.1128/JB.183.19.5571-5579.2001; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; Gallegos MT, 1996, J BACTERIOL, V178, P2356, DOI 10.1128/jb.178.8.2356-2361.1996; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gonzalez-Perez MM, 2004, J BACTERIOL, V186, P1898, DOI 10.1128/JB.186.6.1898-1901.2003; Greated A, 2002, ENVIRON MICROBIOL, V4, P856, DOI 10.1046/j.1462-2920.2002.00305.x; Hester KL, 2000, J BACTERIOL, V182, P1144, DOI 10.1128/JB.182.4.1144-1149.2000; Hester KL, 2000, J BACTERIOL, V182, P1150, DOI 10.1128/JB.182.4.1150-1153.2000; HOLTEL A, 1994, J BACTERIOL, V176, P1773, DOI 10.1128/jb.176.6.1773-1776.1994; INOUYE S, 1985, J BACTERIOL, V163, P863, DOI 10.1128/JB.163.3.863-869.1985; INOUYE S, 1987, P NATL ACAD SCI USA, V84, P5182, DOI 10.1073/pnas.84.15.5182; Kasai Y, 2001, J BACTERIOL, V183, P6662, DOI 10.1128/JB.183.22.6662-6666.2001; MACGREGOR CH, 1991, J BACTERIOL, V173, P7204, DOI 10.1128/jb.173.22.7204-7212.1991; MARQUES S, 1994, J BACTERIOL, V176, P2517; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Morales G, 2004, J BACTERIOL, V186, P1337, DOI 10.1128/JB.186.5.1337-1344.2004; Morales G, 2006, ENVIRON MICROBIOL, V8, P1764, DOI 10.1111/j.1462-2920.2006.01061.x; Moreno R, 2008, J BACTERIOL, V190, P1539, DOI 10.1128/JB.01604-07; Moreno R, 2007, MOL MICROBIOL, V64, P665, DOI 10.1111/j.1365-2958.2007.05685.x; Moreno R, 2009, NUCLEIC ACIDS RES, V37, P7678, DOI 10.1093/nar/gkp825; Moreno R, 2009, PROTEOMICS, V9, P2910, DOI 10.1002/pmic.200800918; RAMOS JL, 1987, MOL MICROBIOL, V1, P293, DOI 10.1111/j.1365-2958.1987.tb01935.x; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Romby P, 2003, TRENDS GENET, V19, P155, DOI 10.1016/S0168-9525(03)00020-9; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SALATREP.JM, 1971, EUR J BIOCHEM, V20, P400, DOI 10.1111/j.1432-1033.1971.tb01406.x; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; WILLIAMS PA, 1974, J BACTERIOL, V120, P416, DOI 10.1128/JB.120.1.416-423.1974; WORSEY MJ, 1975, J BACTERIOL, V124, P7, DOI 10.1128/JB.124.1.7-13.1975; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x; Yuste L, 2001, J BACTERIOL, V183, P6197, DOI 10.1128/JB.183.21.6197-6206.2001	48	46	47	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24412	24419		10.1074/jbc.M110.126615	http://dx.doi.org/10.1074/jbc.M110.126615			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529863	Green Published, hybrid			2022-12-25	WOS:000280542100013
J	Barbachano, A; Ordonez-Moran, P; Garcia, JM; Sanchez, A; Pereira, F; Larriba, MJ; Martinez, N; Hernandez, J; Landolfi, S; Bonilla, F; Palmer, HG; Rojas, JM; Munoz, A				Barbachano, A.; Ordonez-Moran, P.; Garcia, J. M.; Sanchez, A.; Pereira, F.; Larriba, M. J.; Martinez, N.; Hernandez, J.; Landolfi, S.; Bonilla, F.; Palmer, H. G.; Rojas, J. M.; Munoz, A.			SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity	ONCOGENE			English	Article						colon cancer; E-cadherin; SPROUTY-2; vitamin D; ZEB1	TRANSCRIPTION FACTOR SNAIL; VITAMIN-D-RECEPTOR; ACTIVATED PROTEIN-KINASE; EPITHELIAL TUMOR-CELLS; CARCINOMA-CELLS; GENE-EXPRESSION; DOWN-REGULATION; BETA-CATENIN; EPIGENETIC INACTIVATION; GROWTH	SPROUTY-2 (SPRY2) regulates receptor tyrosine kinase signalling and therefore cell growth and differentiation. In this study, we show that SPRY2 expression in colon cancer cells is inhibited by the active vitamin D metabolite 1 alpha,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) through E-cadherin-dependent and -independent mechanisms. In turn, SPRY2 represses both basal and 1,25(OH)(2)D(3)-induced E-cadherin expression. In line with this, SPRY2 induces ZEB1 RNA and protein, but not that of other epithelial-to-mesenchymal transition inducers that repress the CDH1/E-cadherin promoter. Consistently, SPRY2 and E-cadherin protein levels inversely correlate in colon cancer cell lines and xenografted tumours. Moreover, SPRY2 knockdown by small hairpin RNA increases CDH1/E-cadherin expression and, reciprocally, CDH1/E-cadherin knockdown increases that of SPRY2. In colon cancer patients, SPRY2 is upregulated in undifferentiated high-grade tumours and at the invasive front of low-grade carcinomas. Quantification of protein expression in 34 tumours confirmed an inverse correlation between SPRY2 and E-cadherin. Our data demonstrate a tumourigenic action of SPRY2 that is based on the repression of E-cadherin, probably by the induction of ZEB1, and a reciprocal regulation of SPRY2 and E-cadherin that dictates cell phenotype. We propose SPRY2 as a candidate novel marker for high-grade tumours and a target of therapeutic intervention in colon cancer. Oncogene (2010) 29, 4800-4813; doi:10.1038/onc.2010.225; published online 14 June 2010	[Barbachano, A.; Ordonez-Moran, P.; Pereira, F.; Larriba, M. J.; Munoz, A.] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Dept Canc Biol, Consejo Super Invest Cient, E-28049 Madrid, Spain; [Garcia, J. M.; Bonilla, F.] Hosp Univ Puerta Hierro, Madrid, Spain; [Sanchez, A.; Martinez, N.; Rojas, J. M.] Inst Salud Carlos III, Unidad Biol Celular, Area Biol Celular & Desarrollo, Ctr Nacl Microbiol, Madrid, Spain; [Hernandez, J.; Landolfi, S.] Hosp Univ Vall dHebron, Serv Anat Patol, Barcelona, Spain; [Palmer, H. G.] Vall dHebron Inst Oncol, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Puerta de Hierro-Majadahonda; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO)	Munoz, A (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Dept Canc Biol, Consejo Super Invest Cient, Arturo Duperier 4, E-28049 Madrid, Spain.	amunoz@iib.uam.es	Munoz, Alberto/O-6393-2014; Barbachano, Antonio/O-7731-2015; Palmer, Héctor G./AAG-8332-2019; Rojas, José M/D-3718-2018; LARRIBA, MARIA JESUS/O-4652-2014; Rojas, José M./AAA-3354-2021; Seoane, Joan/AAG-9173-2019; Ordonez-Moran, Paloma/B-6371-2016	Munoz, Alberto/0000-0003-3890-4251; Barbachano, Antonio/0000-0002-1248-5143; Rojas, José M/0000-0002-5383-3482; LARRIBA, MARIA JESUS/0000-0001-9035-7414; Rojas, José M./0000-0002-7547-2825; Seoane, Joan/0000-0002-6541-5974; Landolfi, Stefania/0000-0002-1059-635X; Palmer, Hector/0000-0002-9823-5638; Ordonez-Moran, Paloma/0000-0001-7688-1252; Pires Pereira, Fabio/0000-0002-9991-2805	Ministerio de Ciencia e Innovacion of Spain; Fondo Europeo de Desarrollo Regional [SAF2007-60341, RD06/0020/0009, RD06/0020/0020, SAF2006-04247, RD06/0020/0003, PS09/00562]; Comunidad de Madrid [S-GEN-0266/2006]; Spanish Association Against Cancer; European Union [MRTN-CT-2005-019496]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Europeo de Desarrollo Regional(European Commission); Comunidad de Madrid(Comunidad de Madrid); Spanish Association Against Cancer; European Union(European Commission)	We thank Drs R Bouillon, A Verstuyf, JP van de Velde, A Fabra, H Clevers, C Carlberg, E Batlle, L Sastre and A Garcia de Herreros for kindly providing us reagents, Dr M Pollan for help with statistical analysis, T Martinez for technical assistance, and R Rycroft for help with the English language editing of the paper. This study was supported by the Ministerio de Ciencia e Innovacion of Spain and Fondo Europeo de Desarrollo Regional (SAF2007-60341 and RD06/0020/0009 to AM, RD06/0020/0020 to FB, and SAF2006-04247, RD06/0020/0003 and FIS-Intrasalud (PS09/00562) to JMR), Comunidad de Madrid (S-GEN-0266/2006 to AM and FB), Spanish Association Against Cancer (to JMR), and European Union (MRTN-CT-2005-019496, NucSys, to AM).	Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Campbell MJ, 2006, EXPERT OPIN THER TAR, V10, P735, DOI 10.1517/14728222.10.5.735; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Ding W, 2007, J CELL PHYSIOL, V212, P796, DOI 10.1002/jcp.21078; Eelen G, 2007, CURR MED CHEM, V14, P1893; Efstathiou JA, 1999, P NATL ACAD SCI USA, V96, P2316, DOI 10.1073/pnas.96.5.2316; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; *IARC, 2008, INT AGENCY RES CANC, V5, P305; *IARC, 2008, INT AGENCY RES CANC, V5, P186; IARC, 2008, IARC WORK GROUP REP, V5, P1; *IARC, 2008, INT AGENCY RES CANC, V5, P216; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Martinez N, 2007, CELL SIGNAL, V19, P2277, DOI 10.1016/j.cellsig.2007.07.008; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Miyaki M, 1995, ONCOGENE, V11, P2547; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ordonez-Moran P, 2008, J CELL BIOL, V183, P697, DOI 10.1083/jcb.200803020; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Palmer HG, 2003, CANCER RES, V63, P7799; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sanchez A, 2008, ONCOGENE, V27, P4969, DOI 10.1038/onc.2008.129; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; TOMITA N, 1992, CANCER RES, V52, P6840; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; WIESE RJ, 1992, J BIOL CHEM, V267, P20082; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493	51	58	59	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2010	29	34					4800	4813		10.1038/onc.2010.225	http://dx.doi.org/10.1038/onc.2010.225			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	643VB	20543868	Green Submitted			2022-12-25	WOS:000281326400006
J	Kizilyaprak, C; Spehner, D; Devys, D; Schultz, P				Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick			In Vivo Chromatin Organization of Mouse Rod Photoreceptors Correlates with Histone Modifications	PLOS ONE			English	Article							CRYOELECTRON MICROSCOPY; NUCLEAR ARCHITECTURE; H4-K16 ACETYLATION; GENE-EXPRESSION; ACTIVE GENES; GENOME; FIBERS; TRANSCRIPTION; CHROMOSOMES; CODE	Background: The folding of genetic information into chromatin plays important regulatory roles in many nuclear processes and particularly in gene transcription. Post translational histone modifications are associated with specific chromatin condensation states and with distinct transcriptional activities. The peculiar chromatin organization of rod photoreceptor nuclei, with a large central domain of condensed chromatin surrounded by a thin border of extended chromatin was used as a model to correlate in vivo chromatin structure, histone modifications and transcriptional activity. Methodology: We investigated the functional relationships between chromatin compaction, distribution of histone modifications and location of RNA polymerase II in intact murine rod photoreceptors using cryo-preparation methods, electron tomography and immunogold labeling. Our results show that the characteristic central heterochromatin of rod nuclei is organized into concentric domains characterized by a progressive loosening of the chromatin architecture from inside towards outside and by specific combinations of silencing histone marks. The peripheral heterochromatin is formed by closely packed 30nm fibers as revealed by a characteristic optical diffraction signal. Unexpectedly, the still highly condensed most external heterochromatin domain contains acetylated histones, which are usually associated with active transcription and decondensed chromatin. Histone acetylation is thus not sufficient in vivo for complete chromatin decondensation. The euchromatin domain contains several degrees of chromatin compaction and the histone tails are hyperacetylated, enriched in H3K4 monomethylation and hypo trimethylated on H3K9, H3K27 and H4K20. The transcriptionally active RNA polymerases II molecules are confined in the euchromatin domain and are preferentially located at the vicinity of the interface with heterochromatin. Conclusions: Our results show that transcription is located in the most decondensed and highly acetylated chromatin regions, but since acetylation is found associated with compact chromatin it is not sufficient to decondense chromatin in vivo. We also show that a combination of histone marks defines distinct concentric heterochromatin domains.	[Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick] IGBMC, Illkirch Graffenstaden, France; [Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick] INSERM, U964, Illkirch Graffenstaden, France; [Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick] CNRS, UMR7104, Illkirch Graffenstaden, France; [Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick] Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kizilyaprak, C (corresponding author), IGBMC, Illkirch Graffenstaden, France.	patrick.schultz@igbmc.u-strasbg.fr		Devys, Didier/0000-0001-9655-3512; schultz, patrick/0000-0002-7310-6186	Fondation pour la Recherche Medicale; Ligue Contre le Cancer; Institut National de la Sante et de la Recherche Medicale; Center National pour la Recherche Scientifique; Strasbourg University; Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche; European Community Commission SPINE2 complexes [LSHG-CT-2006-031220]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Contre le Cancer(Ligue nationale contre le cancer); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Center National pour la Recherche Scientifique; Strasbourg University; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Community Commission SPINE2 complexes	Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Fondation pour la Recherche Medicale, the Ligue Contre le Cancer, the Institut National de la Sante et de la Recherche Medicale, the Center National pour la Recherche Scientifique, the Strasbourg University, the Association pour la Recherche sur le Cancer, the Agence Nationale pour la Recherche and the European Community Commission SPINE2 complexes (Contract No. LSHG-CT-2006-031220) under the Integrated Programme "Quality of Life and Management of Living Resources".	Abou-Sleymane G, 2006, HUM MOL GENET, V15, P691, DOI 10.1093/hmg/ddi483; ALLFREY VG, 1964, SCIENCE, V144, P559, DOI 10.1126/science.144.3618.559; Bassett A, 2009, CURR OPIN GENET DEV, V19, P159, DOI 10.1016/j.gde.2009.02.010; BELLARD M, 1977, COLD SPRING HARB SYM, V42, P779, DOI 10.1101/SQB.1978.042.01.078; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Bouchet-Marquis C, 2006, HISTOCHEM CELL BIOL, V125, P43, DOI 10.1007/s00418-005-0093-x; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Griffiths G, 1993, FINE STRUCTURE IMMUN, P371, DOI [10.1007/978-3-642-77095-1_11, DOI 10.1007/978-3-642-77095-1_11]; Hamiche A, 1996, J MOL BIOL, V257, P30, DOI 10.1006/jmbi.1996.0144; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Heitz E, 1928, JAHRB WISS BOT, V69, P762; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Horowitz-Scherer RA, 2006, CHROMOSOMA, V115, P1, DOI 10.1007/s00412-005-0035-3; HUMBEL B, 2007, HDB CRYOPREPARATION, P321; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; MCDOWALL AW, 1986, EMBO J, V5, P1395, DOI 10.1002/j.1460-2075.1986.tb04373.x; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; PAULSON JR, 1983, J CELL BIOL, V96, P1132, DOI 10.1083/jcb.96.4.1132; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; ROSE SM, 1984, J BIOL CHEM, V259, P8534; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SMITH RD, 1983, P NATL ACAD SCI-BIOL, V80, P5505, DOI 10.1073/pnas.80.18.5505; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; THOMA F, 1977, CELL, V12, P101, DOI 10.1016/0092-8674(77)90188-X; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Wilson MT, 1998, J MICROSC-OXFORD, V189, P219, DOI 10.1046/j.1365-2818.1998.00315.x; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; Wu JJ, 2006, CANCER RES, V66, P6899, DOI 10.1158/0008-5472.CAN-06-0276; YANIV M, 1986, CRIT REV BIOCHEM MOL, V21, P1, DOI 10.3109/10409238609113607; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	47	47	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11039	10.1371/journal.pone.0011039	http://dx.doi.org/10.1371/journal.pone.0011039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543957	Green Submitted, Green Published, gold			2022-12-25	WOS:000278557600016
J	Dalvai, M; Bystricky, K				Dalvai, Mathieu; Bystricky, Kerstin			Cell Cycle and Anti-Estrogen Effects Synergize to Regulate Cell Proliferation and ER Target Gene Expression	PLOS ONE			English	Article							BREAST-CANCER-CELLS; ESTROGEN-RECEPTOR; C-MYC; MCF7 CELLS; IN-VIVO; TAMOXIFEN; PROGRESSION; APOPTOSIS; ACTIVATION; GROWTH	Antiestrogens are designed to antagonize hormone induced proliferation and ER alpha target gene expression in mammary tumor cells. Commonly used drugs such as OH-Tamoxifen and ICI 182780 (Fulvestrant) block cell cycle progression in G0/G1. Inversely, the effect of cell cycle stage on ER regulated gene expression has not been tested directly. We show that in ER alpha-positive breast cancer cells (MCF-7) the estrogen receptor gene and downstream target genes are cell cycle regulated with expression levels varying as much as three-fold between phases of the cell cycle. Steroid free culture conditions commonly used to assess the effect of hormones or antiestrogens on gene expression also block MCF-7 cells in G1-phase when several ER alpha target genes are overexpressed. Thus, cell cycle effects have to be taken into account when analyzing the impact of hormonal treatments on gene transcription. We found that antiestrogens repress transcription of several ER alpha target genes specifically in S phase. This observation corroborates the more rapid and strong impact of antiestrogen treatments on cell proliferation in thymidine, hydroxyurea or aphidicolin arrested cells and correlates with an increase of apoptosis compared to similar treatments in lovastatin or nocodazol treated cells. Hence, cell cycle effects synergize with the action of antiestrogens. An interesting therapeutic perspective could be to enhance the action of anti-estrogens by associating hormone-therapy with specific cell cycle drugs.	[Dalvai, Mathieu; Bystricky, Kerstin] Univ Toulouse, UPS, Lab Biol Mol Eucaryote, Toulouse, France; [Dalvai, Mathieu; Bystricky, Kerstin] CNRS, Lab Biol Mol Eucaryote, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Dalvai, M (corresponding author), Univ Toulouse, UPS, Lab Biol Mol Eucaryote, Toulouse, France.	kerstin@biotoul.fr	Bystricky, Kerstin/AAA-3003-2020; BYSTRICKY, Kerstin/B-8670-2009	Bystricky, Kerstin/0000-0001-6717-3721; BYSTRICKY, Kerstin/0000-0001-6717-3721	CNRS (Centre National de la recherche scientifique); INCA (Institut national du Cancer); La Ligue Nationale Contre le Cancer	CNRS (Centre National de la recherche scientifique)(Centre National de la Recherche Scientifique (CNRS)); INCA (Institut national du Cancer)(Institut National du Cancer (INCA) France); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	MD was a recipient of a post-doctoral fellowship from the CNRS (Centre National de la recherche scientifique). This project was supported by grants from INCA (Institut national du Cancer) and La Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Beatson G., 1896, LANCET, V2, P104, DOI DOI 10.1016/S0140-6736(01)72307-0; Beatson GW, 1896, LANCET, V2, P162, DOI DOI 10.1016/S0140-6736(01)72384-7; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; COEZY E, 1982, CANCER RES, V42, P317; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; DUBIK D, 1992, ONCOGENE, V7, P1587; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HENDERSON BE, 1988, CANCER RES, V48, P246; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Jamerson MH, 2004, J MAMMARY GLAND BIOL, V9, P27, DOI 10.1023/B:JOMG.0000023586.69263.0b; JORDAN VC, 1984, PHARMACOL REV, V36, P245; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Kim BJ, 2008, BIOL CELL, V100, P675, DOI 10.1042/BC20070158; Mandlekar S, 2000, CANCER RES, V60, P6601; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Marino M, 2002, MOL BIOL CELL, V13, P3720, DOI 10.1091/mbc.E02-03-0153; Martin G, 1996, CANCER LETT, V100, P227, DOI 10.1016/0304-3835(95)04091-9; Maynadier M, 2008, FASEB J, V22, P671, DOI 10.1096/fj.07-9322com; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; MUSGROVE EA, 1993, MOL CELL BIOL, V13, P3577, DOI 10.1128/MCB.13.6.3577; Narayanan R, 2005, MOL CELL BIOL, V25, P2885, DOI 10.1128/MCB.25.8.2885-2898.2005; OSBORNE CK, 1983, CANCER RES, V43, P3583; PERRY RR, 1995, ANN SURG ONCOL, V2, P238, DOI 10.1007/BF02307030; PHAM TA, 1991, P NATL ACAD SCI USA, V88, P3125, DOI 10.1073/pnas.88.8.3125; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; REDDEL RR, 1983, CANCER RES, V43, P4618; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Said TK, 1997, ENDOCRINOLOGY, V138, P3933, DOI 10.1210/en.138.9.3933; Seshadri R, 1996, CLIN CANCER RES, V2, P1177; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Soria G, 2008, J CELL SCI, V121, P3271, DOI 10.1242/jcs.027730; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; Stendahl M, 2004, BRIT J CANCER, V90, P1942, DOI 10.1038/sj.bjc.6601831; SUTHERLAND RL, 1983, EUR J CANCER CLIN ON, V19, P615, DOI 10.1016/0277-5379(83)90177-3; Wang C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003523; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WATTS CKW, 1995, MOL ENDOCRINOL, V9, P1804, DOI 10.1210/me.9.12.1804; Webb P, 2003, J BIOL CHEM, V278, P6912, DOI 10.1074/jbc.M208501200; Xue LY, 2003, EXP CELL RES, V283, P135, DOI 10.1016/S0014-4827(02)00032-0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	47	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11011	10.1371/journal.pone.0011011	http://dx.doi.org/10.1371/journal.pone.0011011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543978	Green Submitted, Green Published, gold			2022-12-25	WOS:000278494900023
J	den Hertog, AL; Visser, DW; Ingham, CJ; Fey, FHAG; Klatser, PR; Anthony, RM				den Hertog, Alice L.; Visser, Dennis W.; Ingham, Colin J.; Fey, Frank H. A. G.; Klatser, Paul R.; Anthony, Richard M.			Simplified Automated Image Analysis for Detection and Phenotyping of Mycobacterium tuberculosis on Porous Supports by Monitoring Growing Microcolonies	PLOS ONE			English	Article							MGIT 960 SYSTEM; MICROSCOPIC-OBSERVATION; GROWTH	Background: Even with the advent of nucleic acid (NA) amplification technologies the culture of mycobacteria for diagnostic and other applications remains of critical importance. Notably microscopic observed drug susceptibility testing (MODS), as opposed to traditional culture on solid media or automated liquid culture, has shown potential to both speed up and increase the provision of mycobacterial culture in high burden settings. Methods: Here we explore the growth of Mycobacterial tuberculosis microcolonies, imaged by automated digital microscopy, cultured on a porous aluminium oxide (PAO) supports. Repeated imaging during colony growth greatly simplifies "computer vision'' and presumptive identification of microcolonies was achieved here using existing publically available algorithms. Our system thus allows the growth of individual microcolonies to be monitored and critically, also to change the media during the growth phase without disrupting the microcolonies. Transfer of identified microcolonies onto selective media allowed us, within 1-2 bacterial generations, to rapidly detect the drug susceptibility of individual microcolonies, eliminating the need for time consuming subculturing or the inoculation of multiple parallel cultures. Significance: Monitoring the phenotype of individual microcolonies as they grow has immense potential for research, screening, and ultimately M. tuberculosis diagnostic applications. The method described is particularly appealing with respect to speed and automation.	[den Hertog, Alice L.; Klatser, Paul R.; Anthony, Richard M.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Ingham, Colin J.] Microdish BV, Houten, Netherlands; [Fey, Frank H. A. G.] CCM Ctr Concepts Mechatron, Nuenen, Netherlands		den Hertog, AL (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	a.d.hertog@kit.nl	Anthony, Richard/AAP-3406-2020; Anthony, Richard M/G-5654-2010	Anthony, Richard/0000-0002-0550-5273; Anthony, Richard M/0000-0002-0550-5273; Klatser, Paul/0000-0003-3868-2409; Klatser, Paul/0000-0003-2127-9138	Microned [AP9-1]	Microned	Microned (Project AP9-1) provided financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2009, INT J TUBERC LUNG D, V13, P1051; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Ejigu GS, 2008, INT J TUBERC LUNG D, V12, P332; Guillier L, 2006, J MICROBIOL METH, V65, P324, DOI 10.1016/j.mimet.2005.08.007; Hanna BA, 1999, J CLIN MICROBIOL, V37, P748, DOI 10.1128/JCM.37.3.748-752.1999; Ingham CJ, 2005, APPL ENVIRON MICROB, V71, P8978, DOI 10.1128/AEM.71.12.8978-8981.2005; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; LEDERBERG J, 1952, J BACTERIOL, V63, P399, DOI 10.1128/JB.63.3.399-406.1952; Mejia GI, 1999, INT J TUBERC LUNG D, V3, P138; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Somoskovi A, 2000, J CLIN MICROBIOL, V38, P2395; *WHO STAG TB, 2007, 7 M REP; Zimic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009577	14	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11008	10.1371/journal.pone.0011008	http://dx.doi.org/10.1371/journal.pone.0011008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544033	Green Published, Green Submitted, gold			2022-12-25	WOS:000278494900020
J	Hoare, A; Kerr, SJ; Ruxrungtham, K; Ananworanich, J; Law, MG; Cooper, DA; Phanuphak, P; Wilson, DP				Hoare, Alexander; Kerr, Stephen J.; Ruxrungtham, Kiat; Ananworanich, Jintanat; Law, Matthew G.; Cooper, David A.; Phanuphak, Praphan; Wilson, David P.			Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY; VIRAL LOAD; VIROLOGICAL FAILURE; MUTATION PATTERNS; NAIVE INDIVIDUALS; BASE-LINE; ADHERENCE; TRANSMISSION	Background: Universal access to first-line antiretroviral therapy (ART) for HIV infection is becoming more of a reality in most low and middle income countries in Asia. However, second-line therapies are relatively scarce. Methods and Findings: We developed a mathematical model of an HIV epidemic in a Southeast Asian setting and used it to forecast the impact of treatment plans, without second-line options, on the potential degree of acquisition and transmission of drug resistant HIV strains. We show that after 10 years of universal treatment access, up to 20% of treatment-naive individuals with HIV may have drug-resistant strains but it depends on the relative fitness of viral strains. Conclusions: If viral load testing of people on ART is carried out on a yearly basis and virological failure leads to effective second-line therapy, then transmitted drug resistance could be reduced by 80%. Greater efforts are required for minimizing first-line failure, to detect virological failure earlier, and to procure access to second-line therapies.	[Hoare, Alexander; Kerr, Stephen J.; Ananworanich, Jintanat; Law, Matthew G.; Cooper, David A.; Wilson, David P.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Kerr, Stephen J.; Ruxrungtham, Kiat; Ananworanich, Jintanat; Phanuphak, Praphan] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Ruxrungtham, Kiat; Ananworanich, Jintanat; Phanuphak, Praphan] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand	University of New South Wales Sydney; Kirby Institute; Thai Red Cross Society; Chulalongkorn University	Hoare, A (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia.	Dwilson@nchecr.unsw.edu.au	Kerr, Stephen/J-6126-2012; Ananworanich, Jintanat/AAC-6348-2021; Wilson, David P/G-4614-2013	Kerr, Stephen/0000-0002-1919-4525; Ananworanich, Jintanat/0000-0003-1369-3224; Law, Matthew/0000-0002-3540-8837	Australian Research Council [DP0771620, FT0991990]; National Health and Medical Research Council [CDA568705]; National Institutes of Health [U01-AI069907]; Australian Government Department of Health and Ageing; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge funding from the Australian Research Council (DP0771620, FT0991990), National Health and Medical Research Council (CDA568705), and National Institutes of Health (U01-AI069907). The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Apisarnthanarak A, 2008, HIV MED, V9, P322, DOI 10.1111/j.1468-1293.2008.00562.x; Apisarnthanarak A, 2008, CLIN INFECT DIS, V46, P1630, DOI 10.1086/587753; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; Blower Sally, 2003, Current Drug Targets - Infectious Disorders, V3, P345, DOI 10.2174/1568005033480999; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; BUNJUMNONG O, 2002, THAILAND ACCESS ANTI; Chang SY, 2008, J ANTIMICROB CHEMOTH, V61, P689, DOI 10.1093/jac/dkn002; Chasombat Sanchai, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P704; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Chetchotisakd Ploenchan, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P152, DOI 10.1177/1545109706294288; Choi JY, 2008, JAIDS-J ACQ IMM DEF, V49, P237, DOI 10.1097/QAI.0b013e318188a919; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Dorrucci M, 2005, AIDS, V19, P331; Gatanaga H, 2007, ANTIVIR RES, V75, P75, DOI 10.1016/j.antiviral.2006.11.012; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Jittamala P, 2009, PEDIATR INFECT DIS J, V28, P826, DOI 10.1097/INF.0b013e3181a458f9; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; King MS, 2005, J INFECT DIS, V191, P2046, DOI 10.1086/430387; Kumarasamy N, 2009, CLIN INFECT DIS, V49, P306, DOI 10.1086/600044; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Maneesriwongul WL, 2006, JAIDS-J ACQ IMM DEF, V43, pS119, DOI 10.1097/01.qai.0000248346.79888.78; *NCHADS, 2009, ANN REP 2008 NCHADS; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Phillips AN, 2007, LANCET, V370, P1923, DOI 10.1016/S0140-6736(07)61815-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rojanapithayalkorn W, 2006, REPROD HEALTH MATTER, V14, P41, DOI 10.1016/S0968-8080(06)28270-3; Ruxrungtham K, 2008, HIV MED, V9, P883, DOI 10.1111/j.1468-1293.2008.00644.x; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Sanchez MS, 2005, B MATH BIOL, V67, P761, DOI 10.1016/j.bulm.2004.10.001; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Sirivichoyaku S, 2008, ANTIVIR THER, V13, P109; Srasuebkul Preeyaporn, 2007, AIDS Res Ther, V4, P18, DOI 10.1186/1742-6405-4-18; SUNGKANUPARPH S, 2010, ASIAN BIOME IN PRESS; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Tam LWY, 2008, JAIDS-J ACQ IMM DEF, V49, P266, DOI 10.1097/QAI.0b013e318189a753; Tang JW, 2004, J CLIN VIROL, V30, P1, DOI 10.1016/j.jcv.2003.12.002; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Van Laethem K, 2007, J CLIN VIROL, V39, P43, DOI 10.1016/j.jcv.2007.02.003; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; *WHO, 2009, M REP REV WHO ART GU; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson DP, 2006, P NATL ACAD SCI USA, V103, P14228, DOI 10.1073/pnas.0509689103; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; World Health Organization, 2008, UN ACC SCAL PRIOR HI; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization, 2009, RAP ADV ANT THER HIV; Yam WC, 2006, J CLIN VIROL, V35, P454, DOI 10.1016/j.jcv.2005.10.012; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	58	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10981	10.1371/journal.pone.0010981	http://dx.doi.org/10.1371/journal.pone.0010981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544022	Green Published, gold, Green Submitted			2022-12-25	WOS:000278494900007
J	Ayyadurai, S; Lepidi, H; Nappez, C; Raoult, D; Drancourt, M				Ayyadurai, Saravanan; Lepidi, Hubert; Nappez, Claude; Raoult, Didier; Drancourt, Michel			Lovastatin Protects against Experimental Plague in Mice	PLOS ONE			English	Article							YERSINIA-PESTIS; GENOME SEQUENCE; RESISTANCE; STATINS; SUSCEPTIBILITIES; STREPTOMYCIN; DOXYCYCLINE; INFECTION; SELECTION	Background: Plague is an ectoparasite-borne deadly infection caused by Yersinia pestis, a bacterium classified among the group A bioterrorism agents. Thousands of deaths are reported every year in some African countries. Tetracyclines and cotrimoxazole are used in the secondary prophylaxis of plague in the case of potential exposure to Y. pestis, but cotrimoxazole-resistant isolates have been reported. There is a need for additional prophylactic measures. We aimed to study the effectiveness of lovastatin, a cholesterol-lowering drug known to alleviate the symptoms of sepsis, for plague prophylaxis in an experimental model. Methodology: Lovastatin dissolved in Endolipide was intraperitoneally administered to mice (20 mg/kg) every day for 6 days prior to a Y. pestis Orientalis biotype challenge. Non-challenged, lovastatin-treated and challenged, untreated mice were also used as control groups in the study. Body weight, physical behavior and death were recorded both prior to infection and for 10 days post-infection. Samples of the blood, lungs and spleen were collected from dead mice for direct microbiological examination, histopathology and culture. The potential antibiotic effect of lovastatin was tested on blood agar plates. Conclusions/Significance: Lovastatin had no in-vitro antibiotic effect against Y. pestis. The difference in the mortality between control mice (11/15; 73.5%) and lovastatin-treated mice (3/15; 20%) was significant (P<0.004; Mantel-Haenszel test). Dead mice exhibited Y. pestis septicemia and inflammatory destruction of lung and spleen tissues not seen in lovastatin-treated surviving mice. These data suggest that lovastatin may help prevent the deadly effects of plague. Field observations are warranted to assess the role of lovastatin in the prophylaxis of human plague.	[Ayyadurai, Saravanan; Lepidi, Hubert; Nappez, Claude; Raoult, Didier; Drancourt, Michel] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, Fac Med, CNRS,UMR 6236,IRD 198,IFR48, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Ayyadurai, S (corresponding author), Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, Fac Med, CNRS,UMR 6236,IRD 198,IFR48, Marseille, France.	Michel.Drancourt@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974	URMITE	URMITE	The study is financed by the authors' laboratory URMITE, 27, bd Jean Moulin 13005 Marseille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIBEK K, BIOHAZARD CHILLING T, P336; Auerbach RK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000770; Botelho-Nevers E, 2008, INT J ANTIMICROB AG, V32, P344, DOI 10.1016/j.ijantimicag.2008.04.027; Botelho-Nevers E, 2008, J ANTIMICROB CHEMOTH, V62, P845, DOI 10.1093/jac/dkn282; Brouillard JE, 2006, PHARMACOTHERAPY, V26, P3, DOI 10.1592/phco.2006.26.1.3; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; CHAPIN KC, 2007, MANUAL CLIN MICROBIO, P257; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Eppinger M, 2009, J BACTERIOL, V191, P7628, DOI 10.1128/JB.01227-09; Frean J, 2003, J ANTIMICROB CHEMOTH, V52, P294, DOI 10.1093/jac/dkg363; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Galimand M, 2006, ANTIMICROB AGENTS CH, V50, P3233, DOI 10.1128/AAC.00306-06; Guiyoule A, 2001, EMERG INFECT DIS, V7, P43, DOI 10.3201/eid0701.010106; Hernandez E, 2003, J ANTIMICROB CHEMOTH, V52, P1029, DOI 10.1093/jac/dkg484; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Hurtle W, 2003, J CLIN MICROBIOL, V41, P3273, DOI 10.1128/JCM.41.7.3273-3283.2003; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Louie A, 2007, ANTIMICROB AGENTS CH, V51, P2661, DOI 10.1128/AAC.00073-07; MANTEL N, 1959, J NATL CANCER I, V22, P719; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Nduka OO, 2009, CRIT CARE CLIN, V25, P677, DOI 10.1016/j.ccc.2009.08.002; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Pouillot F, 2005, MICROBIOL-SGM, V151, P3759, DOI 10.1099/mic.0.28274-0; Russell P, 1996, J ANTIMICROB CHEMOTH, V37, P769, DOI 10.1093/jac/37.4.769; Song JL, 2003, MED MYCOL, V41, P417, DOI 10.1080/1369378031000137233; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wong JD, 2000, ANTIMICROB AGENTS CH, V44, P1995, DOI 10.1128/AAC.44.7.1995-1996.2000	32	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10928	10.1371/journal.pone.0010928	http://dx.doi.org/10.1371/journal.pone.0010928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532198	Green Published, gold, Green Submitted			2022-12-25	WOS:000278284700011
J	Feng, L; Sun, H; Zhang, Y; Li, DF; Wang, DC				Feng, Lei; Sun, Hui; Zhang, Ying; Li, De-Feng; Wang, Da-Cheng			Structural insights into the recognition mechanism between an antitumor galectin AAL and the Thomsen-Friedenreich antigen	FASEB JOURNAL			English	Article						glycan target for tumor on cell surface; complex structure between tumor-related protein and glycan; protein-glycan interaction mode	TF ANTIGEN; CANCER; BINDING; LECTIN; MUC1	Thomsen-Friedenreich (TF) antigen, which plays an important role in the regulation of cancer cell proliferation, occurs in similar to 90% of all human cancers and precancerous conditions. Although TF antigen has been known for almost 80 yr as a pancarcinoma antigen, the recognition mechanism between TF antigen and target protein has not been structurally characterized. A number of studies indicated that TF disaccharide is a potential ligand of the galactoside-binding galectins. In this work, we identified the TF antigen as a potential ligand of the antitumor galectin AAL (Agrocybe aegerita lectin) through glycan array analysis and reported the crystal structure of AAL complexed with the TF antigen. The structure provides a first look at the recognition mode between AAL and TF antigen, which is unique in a conservative (Glu-water-Arg-water) structural motif-based hydrogen bond network. Structure-based mutagenesis analysis further revealed the residues responsible for recognition specificity and binding affinity. Crystal structures of AAL complexed with two other TF-containing glycans showed that the unique TF recognition mode is kept intact, which may be commonly adopted in some cancer-related galectins. The finding provided the new target and approach for the antitumor drug design and relative strategy based on the AAL-TF recognition mode as a prototype model.-Feng, L., Sun, H., Zhang, Y., Li, D.-F., Wang, D.-C. Structural insights into the recognition mechanism between an antitumor galectin AAL and the Thomsen-Friedenreich antigen. FASEB J. 24, 3861-3868 (2010). www.fasebj.org	[Feng, Lei; Zhang, Ying; Li, De-Feng; Wang, Da-Cheng] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Feng, Lei] Chinese Acad Sci, Grad Sch, Beijing 100101, Peoples R China; [Sun, Hui] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University	Li, DF (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	dcwang@ibp.ac.cn			"973" and "863" Research Programs of China [2006CB806502, 2006CB910901, 2006AA02E135]; Ministry of Health, China [2009ZX09103676]; National Institute of General Medical Sciences [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	"973" and "863" Research Programs of China(Ministry of Science and Technology, China); Ministry of Health, China; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the "973" and "863" Research Programs of China (2006CB806502, 2006CB910901, 2006AA02E135) and the Ministry of Health, China (2009ZX09103676). The glycan array analysis was conducted by the Protein-Carbohydrate Interaction Core, and the TF antigen and GM1 pentasaccharide were provided by the Carbohydrate Synthesis/Protein Expression Core of the Consortium for Functional Glycomics (CFG), funded by the National Institute of General Medical Sciences grant GM62116. The authors thank David F. Smith and Jamie Heimburg-Molinaro (Consortium for Functional Glycomics) for screening the glycan array, and Yi Han, Yanxia Jia, and Chunchun Liu (Institute of Biophysics, Chinese Academy of Sciences) for their help with in-house X-ray data collection, ITC assay, and flow cytometric assay, respectively. The authors are also grateful to the Photo Factory (08G007; KEK, Tsukuba, Japan), and the Beijing and Shanghai Synchrotron Radiation Facility for providing access to the synchrotron radiation facilities for the X-ray diffraction experiment. The authors also thank Dr. Yonglin Hu for carefully checking and editing the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldus SE, 2004, CRIT REV CL LAB SCI, V41, P189, DOI 10.1080/10408360490452040; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano WL, 2005, PYMOL V 0 98; Gauto DF, 2009, J PHYS CHEM B, V113, P8717, DOI 10.1021/jp901196n; Hanisch FG, 1997, HISTOL HISTOPATHOL, V12, P263; Jeschke U, 2006, HISTOCHEM CELL BIOL, V126, P437, DOI 10.1007/s00418-006-0178-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Natchiar SK, 2006, ACTA CRYSTALLOGR D, V62, P1413, DOI 10.1107/S0907444906035712; Rossmann MG, 1999, ACTA CRYSTALLOGR D, V55, P1631, DOI 10.1107/S0907444999008379; Slovin SF, 2005, CANCER IMMUNOL IMMUN, V54, P694, DOI 10.1007/s00262-004-0598-5; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yang N, 2005, J BIOCHEM, V138, P145, DOI 10.1093/jb/mvi109; Yang N, 2005, BBA-PROTEINS PROTEOM, V1751, P209, DOI 10.1016/j.bbapap.2005.06.003; Yang N, 2009, J MOL BIOL, V387, P694, DOI 10.1016/j.jmb.2009.02.002; YU BJL, 1998, INT J CANCER, V73, P424; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao CG, 2003, BIOCHEM J, V374, P321, DOI 10.1042/BJ20030300	27	31	32	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3861	3868		10.1096/fj.10-159111	http://dx.doi.org/10.1096/fj.10-159111			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20530247	Green Published			2022-12-25	WOS:000285005900024
J	Sharir, H; Zinger, A; Nevo, A; Sekler, I; Hershfinkel, M				Sharir, Haleli; Zinger, Anna; Nevo, Andrey; Sekler, Israel; Hershfinkel, Michal			Zinc Released from Injured Cells Is Acting via the Zn2+-sensing Receptor, ZnR, to Trigger Signaling Leading to Epithelial Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NA+/H+ EXCHANGER NHE1; PROSTATE-CANCER CELLS; GROWTH-FACTOR-I; SENSING RECEPTOR; EXTRACELLULAR ZINC; INTERCELLULAR COMMUNICATION; EPIDERMAL-KERATINOCYTES; BIOLOGICAL APPLICATIONS; DEPENDENT ACTIVATION	A role for Zn2+ in accelerating wound healing is established, yet, the signaling pathways linking Zn2+ to tissue repair are not well known. We show that in the human HaCaT keratinocytes extracellular Zn2+ induces a metabotropic Ca2+ response that is abolished by silencing the expression of the G-protein-coupled receptor GPR39, suggesting that this Zn2+-sensing receptor, ZnR, is mediating the response. Keratinocytic-ZnR signaling is highly selective for Zn2+ and can be triggered by nanomolar concentrations of this ion. Interestingly, Zn2+ was also released following cellular injury, as monitored by a specific non-permeable fluorescent Zn2+ probe, ZnAF-2. Chelation of Zn2+ and scavenging of ATP from conditioned medium, collected from injured epithelial cultures, was sufficient to eliminate the metabotropic Ca2+ signaling. The signaling triggered by Zn2+, via ZnR, or by ATP further activated MAP kinase and induced up-regulation of the sodium/proton exchanger NHE1 activity. Finally, activation of ZnR/GPR39 signaling or application of ATP enhanced keratinocytes scratch closure in an in vitro model. Thus our results indicate that extracellular Zn2+, which is either applied or released following injury, activates ZnR/GPR39 to promote signaling leading to epithelial repair.	[Sharir, Haleli; Zinger, Anna; Nevo, Andrey; Hershfinkel, Michal] Ben Gurion Univ Negev, Dept Morphol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Sekler, Israel] Ben Gurion Univ Negev, Dept Physiol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Hershfinkel, M (corresponding author), Ben Gurion Univ Negev, Dept Morphol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.	hmichal@bgu.ac.il	Hershfinkel, Michal/F-1548-2012	Hershfinkel, Michal/0000-0003-1652-1989	Israel Science Foundation [585/05]; German Israeli Foundation [912-90.11/2006]	Israel Science Foundation(Israel Science Foundation); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Israel Science Foundation (Grant 585/05, to M.H.) and by the German Israeli Foundation (Grant 912-90.11/2006, to M.H.).	Andrews GK, 2008, BIOCHEM SOC T, V36, P1242, DOI 10.1042/BST0361242; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P279, DOI 10.1081/CLT-100102426; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Campbell M, 2005, CIRC RES, V96, P197, DOI 10.1161/01.RES.0000152966.88353.9d; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; Crivat G, 2006, ANAL CHEM, V78, P5799, DOI 10.1021/ac060764i; Darlenski R, 2009, EUR J PHARM BIOPHARM, V72, P295, DOI 10.1016/j.ejpb.2008.11.013; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dubi N, 2008, CARCINOGENESIS, V29, P1692, DOI 10.1093/carcin/bgn027; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Gazel A, 2008, J CELL PHYSIOL, V215, P292, DOI 10.1002/jcp.21394; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P104, DOI 10.1167/iovs.04-0846; Greco S, 2006, J ENDOCRINOL, V188, P79, DOI 10.1677/joe.1.06433; Hachem JR, 2005, J INVEST DERMATOL, V125, P790, DOI 10.1111/j.0022-202X.2005.23836.x; Han WN, 2009, PHOTOCHEM PHOTOBIOL, V85, P997, DOI 10.1111/j.1751-1097.2008.00531.x; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Hershfinkel M, 2007, MOL MED, V13, P331, DOI 10.2119/2006-00038.Hershfinkel; HERSHLINKEL M, 2006, MOL BIOL METAL HOMEO; Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p; Hirano T, 2000, ANGEW CHEM INT EDIT, V39, P1052, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1052::AID-ANIE1052>3.0.CO;2-5; Ho Y, 2008, MOL PHARMACOL, V74, P1141, DOI 10.1124/mol.108.049064; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang JS, 1999, EUR J BIOCHEM, V266, P943, DOI 10.1046/j.1432-1327.1999.00932.x; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jensen SL, 2008, J CUTAN PATHOL, V35, P1, DOI 10.1111/j.1600-0560.2008.00981.x; Kaisman-Elbaz T, 2009, J CELL PHYSIOL, V220, P222, DOI 10.1002/jcp.21754; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kay Alan R, 2004, BMC Physiol, V4, P4, DOI 10.1186/1472-6793-4-4; Kiss Z, 1997, FEBS LETT, V415, P71, DOI 10.1016/S0014-5793(97)01095-8; Knoell DL, 2009, CRIT CARE MED, V37, P1380, DOI 10.1097/CCM.0b013e31819cefe4; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Lansdown ABG, 1996, LANCET, V347, P706, DOI 10.1016/S0140-6736(96)90072-0; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; MacDonald RS, 1998, J NUTR, V128, P1600, DOI 10.1093/jn/128.10.1600; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Pirila E, 2007, WOUND REPAIR REGEN, V15, P47, DOI 10.1111/j.1524-475X.2006.00184.x; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Ravanti L, 2000, INT J MOL MED, V6, P391; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sammak PJ, 1997, J CELL SCI, V110, P465; Sarangarajan R, 2001, BBA-BIOMEMBRANES, V1511, P181, DOI 10.1016/S0005-2736(01)00273-5; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; Schneider L, 2009, J CELL BIOL, V185, P163, DOI 10.1083/jcb.200806019; Schwartz JR, 2005, DERMATOL SURG, V31, P837; Sharir H, 2005, BIOCHEM BIOPH RES CO, V332, P845, DOI 10.1016/j.bbrc.2005.05.036; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Takahashi H, 2008, J DERMATOL SCI, V50, P31, DOI 10.1016/j.jdermsci.2007.11.002; Taniguchi M, 2004, BIOORGAN MED CHEM, V12, P3125, DOI 10.1016/j.bmc.2004.04.006; Taylor KM, 2008, BIOCHEM SOC T, V36, P1247, DOI 10.1042/BST0361247; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Tenaud I, 2000, EXP DERMATOL, V9, P407, DOI 10.1034/j.1600-0625.2000.009006407.x; Tenaud I, 2009, J DERMATOL TREAT, V20, P91, DOI 10.1080/09546630802509089; Thuraisingam T, 2010, J INVEST DERMATOL, V130, P278, DOI 10.1038/jid.2009.209; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Yasuda SI, 2007, J RECEPT SIG TRANSD, V27, P235, DOI 10.1080/10799890701506147; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Zhao L, 2007, BIOCHEM BIOPH RES CO, V363, P82, DOI 10.1016/j.bbrc.2007.08.127	78	80	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26097	26106		10.1074/jbc.M110.107490	http://dx.doi.org/10.1074/jbc.M110.107490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20522546	Green Published, hybrid			2022-12-25	WOS:000280921000026
J	Lee, SH; Shen, GN; Jung, YS; Lee, SJ; Chung, JY; Kim, HS; Xu, Y; Choi, Y; Lee, JW; Ha, NC; Song, GY; Park, BJ				Lee, S-H; Shen, G-N; Jung, Y. S.; Lee, S-J; Chung, J-Y; Kim, H-S; Xu, Y.; Choi, Y.; Lee, J-W; Ha, N-C; Song, G. Y.; Park, B-J			Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells	ONCOGENE			English	Article						anticancer drug; p53; K-Ras; Snail; pancreatic cancer	PANCREATIC-CANCER; IN-VIVO; P53; EXPRESSION; BREAST; RESTORATION; SENESCENCE; MUTATIONS; PATHWAY; CATENIN	p53 is frequently mutated by genetic alternation or suppressed by various kinds of cellular signaling pathways in human cancers. Recently, we have revealed that p53 is suppressed and eliminated from cells by direct binding with oncogenic K-Ras-induced Snail. On the basis of the fact, we generated specific inhibitors against p53-Snail binding (GN25 and GN29). These chemicals can induce p53 expression and functions in K-Ras-mutated cells. However, it does not show cytotoxic effect on normal cells or K-Raswild- type cells. Moreover, GN25 can selectively activate wild-type p53 in p53(WT/MT) cancer cells. But single allelic mt p53 containing cell line, Panc-1, does not respond to our chemical. In vivo xenograft test also supports the antitumor effect of GN25 in K-Ras-mutated cell lines. These results suggest that our compounds are strong candidate for anticancer drug against K-Ras-initiated human cancers including pancreatic and lung cancers. Oncogene (2010) 29, 4576-4587; doi: 10.1038/onc.2010.208; published online 7 June 2010	[Lee, S-H; Jung, Y. S.; Lee, S-J; Chung, J-Y; Park, B-J] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea; [Lee, S-H; Shen, G-N; Choi, Y.] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Shen, G-N; Song, G. Y.] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea; [Kim, H-S; Xu, Y.; Lee, J-W; Ha, N-C] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea	Pusan National University; Korea University; Chungnam National University; Pusan National University	Park, BJ (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea.	gysong@cnu.ac.kr; bjpark1219@pusan.ac.kr	Kim, Heui-Soo/ABF-3773-2021; Choi, Yongseok/F-8375-2012; Lee, Jaewon/N-9064-2013; Lee, Sang Joon/AAG-2448-2019	Kim, Heui-Soo/0000-0002-5226-6594; Choi, Yongseok/0000-0002-3622-3439; Lee, Jaewon/0000-0003-3203-2130; Song, Gyu Yong/0000-0001-6058-5790	national cancer center of Korea [0920250]; Pusan National University [PNU-2008-101-20080596000]; Ministry of Education, Science and Technology [2009-0093815]	national cancer center of Korea; Pusan National University(Pusan National University); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by national cancer center of Korea (0920250; BJP), by the Bio-Scientific Research Grant funded by the Pusan National University (PNU-2008-101-20080596000; BJP) and by the Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093815; GYS).	Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Butz J, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-11; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Deramaudt T, 2005, BBA-REV CANCER, V1756, P97, DOI 10.1016/j.bbcan.2005.08.003; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kumaravel TS, 2005, BREAST CANCER RES TR, V91, P89, DOI 10.1007/s10549-004-5780-0; Lee SH, 2009, ONCOGENE, V28, P2005, DOI 10.1038/onc.2009.67; Lee SJ, 2009, INT J ONCOL, V34, P1637, DOI 10.3892/ijo_00000294; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Leslie A, 2003, CANCER RES, V63, P4656; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; WEINBERG RA, 2001, BIOL CANC, P311; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	25	33	33	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 12	2010	29	32					4576	4587		10.1038/onc.2010.208	http://dx.doi.org/10.1038/onc.2010.208			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	638AQ	20531295				2022-12-25	WOS:000280862300008
J	Gu, XG; Glushka, J; Lee, SG; Bar-Peled, M				Gu, Xiaogang; Glushka, John; Lee, Sung G.; Bar-Peled, Maor			Biosynthesis of a New UDP-sugar, UDP-2-acetamido-2-deoxyxylose, in the Human Pathogen Bacillus cereus Subspecies cytotoxis NVH 391-98.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCURONIC ACID DECARBOXYLASE; BETA-D-XYLOSYLTRANSFERASE; CRYPTOCOCCUS-NEOFORMANS; GLUCOSE 4,6-DEHYDRATASE; D-XYLOSE; CLONING; POLYSACCHARIDES; ANTIBIOTICS; PATHWAY; CAPSULE	We have identified an operon and characterized the functions of two genes from the severe food-poisoning bacterium, Bacillus cereus subsp. cytotoxis NVH 391-98, that are involved in the synthesis of a unique UDP-sugar, UDP-2-acetamido-2-deoxyxylose (UDP-N-acetyl-xylosamine, UDP-XylNAc). UGlcNAcDH encodes a UDP-N-acetyl-glucosamine 6-dehydrogenase, converting UDPN-acetylglucosamine (UDP-GlcNAc) to UDP-N-acetyl-glucosaminuronic acid (UDP-GlcNAcA). The second gene in the operon, UXNAcS, encodes a distinct decarboxylase not previously described in the literature, which catalyzes the formation of UDP-XylNAc from UDP-GlcNAcA in the presence of exogenous NAD(+). UXNAcS is specific and cannot utilize UDP-glucuronic acid and UDP-galacturonic acid as substrates. UXNAcS is active as a dimer with catalytic efficiency of 7 mM(-1) s(-1). The activity of UXNAcS is completely abolished by NADH but unaffected by UDP-xylose. A real-time NMR-based assay showed unambiguously the dual enzymatic conversions of UDP-GlcNAc to UDP-GlcNAcA and subsequently to UDP-XylNAc. From the analyses of all publicly available sequenced genomes, it appears that UXNAcS is restricted to pathogenic Bacillus species, including Bacillus anthracis and Bacillus thuringiensis. The identification of UXNAcS provides insight into the formation of UDP-XylNAc. Understanding the metabolic pathways involved in the utilization of this amino-sugar may allow the development of drugs to combat and eradicate the disease.	[Gu, Xiaogang; Glushka, John; Lee, Sung G.; Bar-Peled, Maor] Univ Georgia, CCRC, Athens, GA 30602 USA; [Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, CCRC, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu	gu, xiaogang/F-7440-2015		National Science Foundation [IOB-0453664]; BESC; Office of Biological and Environmental Research in the Department of Energy Office of Science; NIGMS, National Institutes of Health [GM66340]; Georgia Research Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066340, P41GM103390] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); BESC; Office of Biological and Environmental Research in the Department of Energy Office of Science; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Georgia Research Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant IOB-0453664 (to M.B.-P.). This work was also supported in part by BESC, the BioEnergy Science Center, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. This research also benefited from activities at the SE Collaboratory for High-Field Biomolecular NMR, a research resource at the University of Georgia, funded by NIGMS, National Institutes of Health, Grant GM66340 and the Georgia Research Alliance.	Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BALLARDIE FW, 1977, BIOORG CHEM, V6, P483, DOI 10.1016/0045-2068(77)90047-5; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Breazeale SD, 2002, J BIOL CHEM, V277, P2886, DOI 10.1074/jbc.M109377200; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; Fox A, 2003, J MICROBIOL METH, V54, P143, DOI 10.1016/S0167-7012(03)00095-2; Gerratana B, 2001, BIOCHEMISTRY-US, V40, P9187, DOI 10.1021/bi0108249; GLASER L, 1973, ANNU REV BIOCHEM, V42, P91, DOI 10.1146/annurev.bi.42.070173.000515; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Gu XG, 2009, J BIOCHEM, V146, P527, DOI 10.1093/jb/mvp099; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Kudo F, 2009, J ANTIBIOT, V62, P471, DOI 10.1038/ja.2009.76; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Lapidus A, 2008, CHEM-BIOL INTERACT, V171, P236, DOI 10.1016/j.cbi.2007.03.003; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; MARTIN JH, 1978, J ANTIBIOT, V31, P398, DOI 10.7164/antibiotics.31.398; Miller WL, 2004, J BIOL CHEM, V279, P37551, DOI 10.1074/jbc.M404749200; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Takaishi M, 2008, TETRAHEDRON, V64, P6651, DOI 10.1016/j.tet.2008.05.024; TEMEYER KB, 1987, J GEN MICROBIOL, V133, P503; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; WEIRENGA RK, 1986, J MOL BIOL, V187, P101	36	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24825	24833		10.1074/jbc.M110.125872	http://dx.doi.org/10.1074/jbc.M110.125872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529859	Green Published, hybrid			2022-12-25	WOS:000280542100055
J	Zern, BJ; Chu, HH; Wang, YD				Zern, Blaine J.; Chu, Hunghao; Wang, Yadong			Control Growth Factor Release Using a Self-Assembled [polycation:heparin] Complex	PLOS ONE			English	Article							FACTOR DELIVERY; SUSTAINED-RELEASE; HEPARIN; HYDROGELS; BINDING; MATRICES; SCAFFOLDS; PEPTIDES; AFFINITY; GELS	The importance of growth factors has been recognized for over five decades; however their utilization in medicine has yet to be fully realized. This is because free growth factors have short half-lives in plasma, making direct injection inefficient. Many growth factors are anchored and protected by sulfated glycosaminoglycans in the body. We set out to explore the use of heparin, a well-characterized sulfated glycosaminoglycan, for the controlled release of fibroblast growth factor-2 (FGF-2). Heparin binds a multitude of growth factors and maintains their bioactivity for an extended period of time. We used a biocompatible polycation to precipitate out the [heparin: FGF-2] complex from neutral buffer to form a release matrix. We can control the release rate of FGF-2 from the resultant matrix by altering the molecular weight of the polycation. The FGF-2 released from the delivery complex maintained its bioactivity and initiated cellular responses that were at least as potent as fresh bolus FGF-2 and fresh heparin stabilized FGF-2. This new delivery platform is not limited to FGF-2 but applicable to the large family of heparin-binding growth factors.	Georgia Inst Technol, Sch Chem & Biochem, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Zern, BJ (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	yaw20@pitt.edu		Wang, Yadong/0000-0003-2067-382X	NSF [DMR-1005766]	NSF(National Science Foundation (NSF))	Funding: This research is supported by an NSF Grant #DMR-1005766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002; Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034; Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Cleland JL, 2001, J CONTROL RELEASE, V72, P13, DOI 10.1016/S0168-3659(01)00258-9; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Henry TD, 2001, AM HEART J, V142, P872, DOI 10.1067/mhj.2001.118471; Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004; Hosaka A, 2004, CIRCULATION, V110, P3322, DOI 10.1161/01.CIR.0000147779.17602.18; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONAHA.106.639831; Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427; Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030; Lee KW, 2004, TRANSPLANT P, V36, P2464, DOI 10.1016/j.transproceed.2004.08.078; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lopez JJ, 1997, AM J PHYSIOL-HEART C, V273, pH1317, DOI 10.1152/ajpheart.1997.273.3.H1317; Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Sakiyama SE, 1999, FASEB J, V13, P2214, DOI 10.1096/fasebj.13.15.2214; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7; Seal BL, 2003, BIOMACROMOLECULES, V4, P1572, DOI 10.1021/bm0342032; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502; Takahashi Y, 2007, TISSUE ENG, V13, P293, DOI 10.1089/ten.2006.0088; Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.0.CO;2-N; WAKEFIELD LM, 1990, J CLIN INVEST, V86, P1976, DOI 10.1172/JCI114932; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098	36	39	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11017	10.1371/journal.pone.0011017	http://dx.doi.org/10.1371/journal.pone.0011017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543985	Green Published, Green Submitted, gold			2022-12-25	WOS:000278494900027
J	Goncalves, MAFV; Janssen, JM; Holkers, M; de Vries, AAF				Goncalves, Manuel A. F. V.; Janssen, Josephine M.; Holkers, Maarten; de Vries, Antoine A. F.			Rapid and Sensitive Lentivirus Vector-Based Conditional Gene Expression Assay to Monitor and Quantify Cell Fusion Activity	PLOS ONE			English	Article							HUMAN GENOME; ADENOVIRUS; COMPLEMENTATION; INTEGRATION; DYSTROPHIN	Cell-to-cell fusion is involved in multiple fundamental biological processes. Prominent examples include osteoclast and giant cell formation, fertilization and skeletal myogenesis which involve macrophage, sperm-egg and myoblast fusion, respectively. Indeed, the importance of cell fusion is underscored by the wide range of homeostatic as well as pathologic processes in which it plays a key role. Therefore, rapid and sensitive systems to trace and measure cell fusion events in various experimental systems are in demand. Here, we introduce a bipartite cell fusion monitoring system based on a genetic switch responsive to the site-specific recombinase FLP. To allow flexible deployment in both dividing as well as nondividing cell populations, inducer and reporter modules were incorporated in lentivirus vector particles. Moreover, the recombinase-inducible transcription units were designed in such a way as to minimize basal activity and chromosomal position effects in the "off'' and "on'' states, respectively. The lentivirus vector-based conditional gene expression assay was validated in primary human mesenchymal stem cells and in a differentiation model based on muscle progenitor cells from a Duchenne muscular dystrophy patient using reporter genes compatible with live-and single-cell imaging and with whole population measurements. Using the skeletal muscle cell differentiation model, we showed that the new assay displays low background activity, a 2-log dynamic range, high sensitivity and is amenable to the investigation of cell fusion kinetics. The utility of the bipartite cell fusion monitoring system was underscored by a study on the impact of drug-and RNAi-mediated p38 MAPK inhibition on human myocyte differentiation. Finally, building on the capacity of lentivirus vectors to readily generate transgenic animals the present FLP-inducible system should be adaptable, alone or together with Cre/loxP-based assays, to cell lineage tracing and conditional gene manipulation studies in vivo.	[Goncalves, Manuel A. F. V.; Janssen, Josephine M.; Holkers, Maarten; de Vries, Antoine A. F.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goncalves, MAFV (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands.	m.goncalves@lumc.nl	de Vries, Antoine/ABG-5787-2021; Goncalves, Manuel AFV/V-2248-2019	Goncalves, Manuel AFV/0000-0002-8111-1073; Janssen, Josephine Martine/0000-0002-3430-7014	Dutch Duchenne Parent Project (DPP); Association Francaise contre les Myopathies (AFM) [12259-SR-GROUPE E]	Dutch Duchenne Parent Project (DPP); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by research grants from the Dutch Duchenne Parent Project (DPP) and the Association Francaise contre les Myopathies (AFM; 12259-SR-GROUPE E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Carter A, 2008, J NATL CANCER I, V100, P1279, DOI 10.1093/jnci/djn336; Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; Goncalves MAFV, 2006, REV MED VIROL, V16, P167, DOI 10.1002/rmv.494; Goncalves MAFV, 2005, BIOESSAYS, V27, P506, DOI 10.1002/bies.20218; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Goncalves MAFV, 2008, MOL THER, V16, P741, DOI 10.1038/mt.2008.16; Goncalves MAFV, 2006, MOL THER, V13, P976, DOI 10.1016/j.ymthe.2005.11.018; Goncalves MAFV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003084; Hoffmann D, 2006, GENE THER, V13, P1534, DOI 10.1038/sj.gt.3302806; Holkers M, 2006, BIOTECHNIQUES, V41, P711, DOI 10.2144/000112307; Huang SMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006871; Klinghoffer RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006892; Li H, 2001, HUM GENE THER, V12, P2155, DOI 10.1089/10430340152710504; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Michiels F, 2003, NAT BIOTECHNOL, V21, P199, DOI 10.1038/nbt0203-199a; Michiels F, 2002, NAT BIOTECHNOL, V20, P1154, DOI 10.1038/nbt746; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Pfeifer Alexander, 2009, V530, P391, DOI 10.1007/978-1-59745-471-1_21; RENTIER B, 1978, J VIROL, V28, P567, DOI 10.1128/JVI.28.2.567-577.1978; Sambrook J, 2001, MOL CLONING LAB MANU; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shinn-Thomas Jessica H., 2008, V475, P347, DOI 10.1007/978-1-59745-250-2_20; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; van Nierop GP, 2009, NUCLEIC ACIDS RES, V37, P5725, DOI 10.1093/nar/gkp643; Vassilopoulos G, 2003, CURR OPIN GENET DEV, V13, P480, DOI 10.1016/S0959-437X(03)00110-2; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; Wu X, 2004, CELL MOL LIFE SCI, V61, P2588, DOI 10.1007/s00018-004-4206-9; YOFFE B, 1987, P NATL ACAD SCI USA, V84, P1429, DOI 10.1073/pnas.84.5.1429	35	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10954	10.1371/journal.pone.0010954	http://dx.doi.org/10.1371/journal.pone.0010954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532169	gold, Green Submitted, Green Published			2022-12-25	WOS:000278318700021
J	Taneja, NK; Dhingra, S; Mittal, A; Naresh, M; Tyagi, JS				Taneja, Neetu Kumra; Dhingra, Sakshi; Mittal, Aditya; Naresh, Mohit; Tyagi, Jaya Sivaswami			Mycobacterium tuberculosis Transcriptional Adaptation, Growth Arrest and Dormancy Phenotype Development Is Triggered by Vitamin C	PLOS ONE			English	Article							ASCORBIC-ACID; 2-COMPONENT SYSTEM; RESPONSE REGULATOR; HYPOXIC RESPONSE; CARBON-MONOXIDE; CROSS-TALK; SENSOR; DEVS; PROTEIN; EXPRESSION	Background: Tubercle bacilli are thought to persist in a dormant state during latent tuberculosis (TB) infection. Although little is known about the host factors that induce and maintain Mycobacterium tuberculosis (M. tb) within latent lesions, O-2 depletion, nutrient limitation and acidification are some of the stresses implicated in bacterial dormancy development/growth arrest. Adaptation to hypoxia and exposure to NO/CO is implemented through the DevRS/DosT two-component system which induces the dormancy regulon. Methodology/Principal Findings: Here we show that vitamin C (ascorbic acid/AA) can serve as an additional signal to induce the DevR regulon. Physiological levels of AA scavenge O-2 and rapidly induce the DevR regulon at an estimated O-2 saturation of <30%. The kinetics and magnitude of the response suggests an initial involvement of DosT and a sustained DevS-mediated response during bacterial adaptation to increasing hypoxia. In addition to inducing DevR regulon mechanisms, vitamin C induces the expression of selected genes previously shown to be responsive to low pH and oxidative stress, triggers bacterial growth arrest and promotes dormancy phenotype development in M. tb grown in axenic culture and intracellularly in THP-1 cells. Conclusions/Significance: Vitamin C mimics multiple intracellular stresses and has wide-ranging regulatory effects on gene expression and physiology of M. tb which leads to growth arrest and a 'dormant' drug-tolerant phenotype, but in a manner independent of the DevRS/DosT sytem. The 'AA-dormancy infection model' offers a potential alternative to other models of non-replicating persistence of M. tb and may be useful for investigating host-'dormant' M. tb interactions. Our findings offer a new perspective on the role of nutritional factors in TB and suggest a possible role for vitamin C in TB.	[Taneja, Neetu Kumra; Dhingra, Sakshi; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Mittal, Aditya] Indian Inst Technol Delhi, Sch Biol Sci, New Delhi, India; [Naresh, Mohit] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Taneja, NK (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	jstyagi@aiims.ac.in	Mittal, Aditya/E-3087-2010	Mittal, Aditya/0000-0002-4030-0951; TANEJA, NEETU/0000-0002-2390-7647	Department of Biotechnology (DBT); Department of Biotechnology, Government of India; Council for Scientific and Industrial Research (CSIR); DBT	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India)	JST and AM are thankful to the Department of Biotechnology (DBT) for research funding. JST is thankful to the Department of Biotechnology, Government of India, for a Tata Innovation Fellowship. NKT and SD are thankful to the Council for Scientific and Industrial Research (CSIR) and DBT for Senior and Junior Research Fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOSCA JB, 1948, DIS CHEST, V14, P107, DOI 10.1378/chest.14.1.107; BERGSTEN P, 1990, J BIOL CHEM, V265, P2584; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Bowie AG, 2000, J IMMUNOL, V165, P7180, DOI 10.4049/jimmunol.165.12.7180; Carcamo JM, 2002, BLOOD, V99, P3205, DOI 10.1182/blood.V99.9.3205; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Field CJ, 2002, J LEUKOCYTE BIOL, V71, P16; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; Gupta RK, 2009, J MED CHEM, V52, P6324, DOI 10.1021/jm900358q; Hemila H, 1999, AM J EPIDEMIOL, V150, P632, DOI 10.1093/oxfordjournals.aje.a010062; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Ioanoviciu A, 2009, BIOCHEMISTRY-US, V48, P5839, DOI 10.1021/bi802309y; Jariwalla R. J., 1996, ASCORBIC ACID BIOCH, P215; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Laggner H, 1999, EUR J BIOCHEM, V262, P659, DOI 10.1046/j.1432-1327.1999.00403.x; Lee JM, 2008, J BACTERIOL, V190, P6795, DOI 10.1128/JB.00401-08; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; May JM, 2005, FREE RADICAL BIO MED, V39, P1449, DOI 10.1016/j.freeradbiomed.2005.07.006; McConkey M, 1933, J EXP MED, V58, P503, DOI 10.1084/jem.58.4.503; Mowry S, 1999, J CHEM EDUC, V76, P970, DOI 10.1021/ed076p970; Mulder MA, 1999, MICROBIOL-SGM, V145, P2507, DOI 10.1099/00221287-145-9-2507; MUNETA P, 1985, AM POTATO J, V62, P531, DOI 10.1007/BF02854400; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rodrigue S, 2007, J BACTERIOL, V189, P1505, DOI 10.1128/JB.01371-06; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; SCARPA M, 1983, J BIOL CHEM, V258, P6695; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma D, 2006, FEMS IMMUNOL MED MIC, V48, P329, DOI 10.1111/j.1574-695X.2006.00160.x; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; SHULER ML, 1992, BIOPROCESS ENG BASIC, P163; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WASHKO PW, 1993, J BIOL CHEM, V268, P15531; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WELCH RW, 1995, J BIOL CHEM, V270, P12584, DOI 10.1074/jbc.270.21.12584; Wolucka BA, 2006, FEBS J, V273, P4435, DOI 10.1111/j.1742-4658.2006.05443.x; Yukl ET, 2007, BIOCHEMISTRY-US, V46, P9728, DOI 10.1021/bi7008695	58	94	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10860	10.1371/journal.pone.0010860	http://dx.doi.org/10.1371/journal.pone.0010860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523728	Green Published, Green Submitted, gold			2022-12-25	WOS:000278221900011
J	Masserdotti, G; Badaloni, A; Green, YS; Croci, L; Barili, V; Bergamini, G; Vetter, ML; Consalez, GG				Masserdotti, Giacomo; Badaloni, Aurora; Green, Yangsook Song; Croci, Laura; Barili, Valeria; Bergamini, Giorgio; Vetter, Monica L.; Consalez, G. Giacomo			ZFP423 Coordinates Notch and Bone Morphogenetic Protein Signaling, Selectively Up-regulating Hes5 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; TRANSCRIPTION FACTOR; XENOPUS-EMBRYOS; NEURONAL DIFFERENTIATION; CEREBELLAR DEVELOPMENT; PRIMARY NEUROGENESIS; LATERAL INHIBITION; FINGER PROTEIN; NERVOUS-SYSTEM; ACTIVATION	Zinc finger protein 423 encodes a 30 Zn-finger transcription factor involved in cerebellar and olfactory development. ZFP423 is a known interactor of SMAD1-SMAD4 and of Collier/Olf-1/EBF proteins, and acts as a modifier of retinoic acid-induced differentiation. In the present article, we show that ZFP423 interacts with the Notch1 intracellular domain in mammalian cell lines and in Xenopus neurula embryos, to activate the expression of the Notch1 target Hes5/ESR1. This effect is antagonized by EBF transcription factors, both in cultured cells and in Xenopus embryos, and amplified in vitro by BMP4, suggesting that ZFP423 acts to integrate BMP and Notch signaling, selectively promoting their convergence onto the Hes5 gene promoter.	[Bergamini, Giorgio; Consalez, G. Giacomo] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Masserdotti, Giacomo; Barili, Valeria; Bergamini, Giorgio; Consalez, G. Giacomo] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Green, Yangsook Song; Vetter, Monica L.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Utah System of Higher Education; University of Utah	Consalez, GG (corresponding author), Ist Sci San Raffaele, Div Neurosci, Via Olgettina 58, I-20132 Milan, Italy.	g.consalez@hsr.it	Barili, Valeria/J-4899-2016; Consalez, Giacomo/AAA-2146-2019; Croci, Laura/AAN-3841-2020	Barili, Valeria/0000-0001-7711-2156; Consalez, Giacomo/0000-0003-4594-6273; Croci, Laura/0000-0002-7826-428X; Green, Yangsook/0000-0003-3620-0971; Vetter, Monica/0000-0001-6262-8504	National Institutes of Health [EY012274]; EU; Italian Ministry of University and Research [MIUR-PRIN 2007]; San Raffaele Scientific Institute; NATIONAL EYE INSTITUTE [P30EY014800, R01EY012274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); San Raffaele Scientific Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012274 (to M. L. V.). This work was also supported by the EU consortium contract EuroSyStem (to G. G. C.) and the Fondazione CARIPLO (Network Operativo per la Biomedicina di Eccellenza in Lombardia), from the Italian Ministry of University and Research (MIUR-PRIN 2007).; Supported by a Ph.D. fellowship provided by the San Raffaele Scientific Institute.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; AUSUBEL FM, 1995, CURR PROT MOL BIOL; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Cheng LE, 2007, NEURON, V54, P547, DOI 10.1016/j.neuron.2007.04.029; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Chitnis A, 1996, DEVELOPMENT, V122, P2295; Chizhikov VV, 2006, DEVELOPMENT, V133, P2793, DOI 10.1242/dev.02441; Chung SH, 2008, NEUROSCIENCE, V153, P721, DOI 10.1016/j.neuroscience.2008.01.090; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Corradi A, 2003, DEVELOPMENT, V130, P401, DOI 10.1242/dev.00215; CROCI L, 2010, CELL DEATH IN PRESS; Croci L, 2006, DEVELOPMENT, V133, P2719, DOI 10.1242/dev.02437; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Davis JA, 1996, J NEUROSCI, V16, P5082; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; Dubois L, 1998, CURR BIOL, V8, P199, DOI 10.1016/S0960-9822(98)70084-3; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Garcia-Dominguez M, 2003, DEVELOPMENT, V130, P6013, DOI 10.1242/dev.00840; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; HARLAND RM, 1991, XENOPUS LAEVIS PRACT; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Henke RM, 2009, DEVELOPMENT, V136, P2945, DOI 10.1242/dev.035352; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Ku MC, 2006, J BIOL CHEM, V281, P5277, DOI 10.1074/jbc.M510004200; Lamar E, 2005, DEVELOPMENT, V132, P3619, DOI 10.1242/dev.01937; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Machold RP, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-5; Millen KJ, 2008, CURR OPIN NEUROBIOL, V18, P12, DOI 10.1016/j.conb.2008.05.010; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pozzoli O, 2001, DEV BIOL, V233, P495, DOI 10.1006/dbio.2001.0230; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Tsai RYL, 1997, J NEUROSCI, V17, P4159; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vincent VAM, 2002, J NEUROSCI RES, V69, P578, DOI 10.1002/jnr.10329; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 1997, J NEUROSCI, V17, P4149; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644	67	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30814	30824		10.1074/jbc.M110.142869	http://dx.doi.org/10.1074/jbc.M110.142869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20547764	Green Published, hybrid			2022-12-25	WOS:000282135500049
J	Chen, WM; Yu, B; Zhang, Q; Xu, PL				Chen, Wei-Min; Yu, Bo; Zhang, Qing; Xu, Peilin			Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION GENE NUDC; STIMULATING FACTOR-RECEPTOR; C-MPL; ERYTHROPOIETIN RECEPTOR; CELL-PROLIFERATION; MOVEMENT PROTEIN; IN-VITRO; HNUDC; MEGAKARYOCYTOPOIESIS; DIFFERENTIATION	Thrombopoietin (TPO) and its receptor (Mpl) have long been associated with megakaryocyte proliferation, differentiation, and platelet formation. However, studies have also shown that the extracellular domain of Mpl (Mpl-EC) interacts with human (h) NUDC, a protein previously characterized as a human homolog of a fungal nuclear migration protein. This study was undertaken to further delineate the putative binding domain on the Mpl receptor. Using the yeast two-hybrid system assay and co-immunoprecipitation, we identified that within the Mpl-EC domain 1 (Mpl-EC-D1), amino acids 102-251 were strongly involved in ligand binding. We subsequently expressed five sub-domains within this region with T7 phage display. Enzyme-linked immunosorbent binding assays identified a short stretch of peptide located between residues 206 and 251 as the minimum binding domain for both TPO and hNUDC. A series of sequential Ala replacement mutations in the region were subsequently used to identify the specific residues most involved in ligand binding. Our results point to two hydrophobic residues, Leu(228) and Leu(230), as having substantial effects on hNUDC binding. For TPO binding, mutations in residues Asp(235) and Leu(239) had the largest effect on binding efficacy. In addition, deletion of the conservative motif WGSWS reduced binding capacity for hNUDC but not for TPO. These separate binding sites on the Mpl receptor for TPO and hNUDC raise interesting implications for the cytokine-receptor interactions.	[Chen, Wei-Min; Yu, Bo; Zhang, Qing; Xu, Peilin] Zhongshan Univ, Key Lab Gene Engn, Educ Minist, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, PL (corresponding author), Zhongshan Univ, Key Lab Gene Engn, Educ Minist, Guangzhou 510275, Guangdong, Peoples R China.	xupeilin@hotmail.com		ZHANG, QING/0000-0003-3522-1471	National Natural Science Foundation of China [30971069]; National High-Tech Research and Development Program of China [2007AA21009]; Guang Dong National High-Tech Research and Development Program [2007B030702002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Guang Dong National High-Tech Research and Development Program	This work was supported by National Natural Science Foundation of China Grant 30971069, National High-Tech Research and Development Program of China Grant 2007AA21009, and Guang Dong National High-Tech Research and Development Program 2007B030702002.	Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; ALEXANDER WS, 1995, EMBO J, V14, P5569, DOI 10.1002/j.1460-2075.1995.tb00244.x; Alexander WS, 1998, CYTOKINES CELL MOL T, V4, P25; ALEXANDER WS, 1995, ONCOGENE, V10, P795; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; BAUMGARTNER JW, 1994, J BIOL CHEM, V269, P29094; Bunting S, 1997, BLOOD, V90, P3423, DOI 10.1182/blood.V90.9.3423; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; Deane CM, 1997, J MOL GRAPH MODEL, V15, P170, DOI 10.1016/S1093-3263(97)00102-2; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; Feese MD, 2004, P NATL ACAD SCI USA, V101, P1816, DOI 10.1073/pnas.0308530100; Gocke CD, 2000, LEUKEMIA LYMPHOMA, V39, P447, DOI 10.3109/10428190009113375; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Jagerschmidt A, 1998, BIOCHEM J, V333, P729, DOI 10.1042/bj3330729; Kaushansky K, 2003, ANN NY ACAD SCI, V996, P39, DOI 10.1111/j.1749-6632.2003.tb03230.x; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; Layton JE, 1997, J BIOL CHEM, V272, P29735, DOI 10.1074/jbc.272.47.29735; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Luoh SM, 2000, MOL CELL BIOL, V20, P507, DOI 10.1128/MCB.20.2.507-515.2000; Middleton SA, 1999, J BIOL CHEM, V274, P14163, DOI 10.1074/jbc.274.20.14163; Middleton SA, 1996, J BIOL CHEM, V271, P14045, DOI 10.1074/jbc.271.24.14045; Miller BA, 1999, EXP HEMATOL, V27, P742, DOI 10.1016/S0301-472X(98)00074-5; Morris SM, 1997, MOL ENDOCRINOL, V11, P229, DOI 10.1210/me.11.2.229; Murone MM, 1998, STEM CELLS, V16, P1, DOI 10.1002/stem.160001; Otto KG, 2001, BLOOD, V98, P2077, DOI 10.1182/blood.V98.7.2077; Pan RM, 2005, J CELL BIOCHEM, V96, P741, DOI 10.1002/jcb.20573; Pang SF, 2009, EXP CELL RES, V315, P3563, DOI 10.1016/j.yexcr.2009.06.020; Pearce KH, 1997, J BIOL CHEM, V272, P20595, DOI 10.1074/jbc.272.33.20595; Rajotte D, 1997, J EXP MED, V185, P1939, DOI 10.1084/jem.185.11.1939; Sabath DF, 1999, BLOOD, V94, P365, DOI 10.1182/blood.V94.1.365.413a46_365_367; Sabath DF, 2002, BBA-GENE STRUCT EXPR, V1574, P383, DOI 10.1016/S0167-4781(01)00357-8; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Tang YS, 2008, LEUKEMIA, V22, P1018, DOI 10.1038/leu.2008.20; VAINCHENKER W, 1995, THROMB HAEMOSTASIS, V74, P526; Wei MX, 2006, J CELL BIOCHEM, V98, P429, DOI 10.1002/jcb.20803; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x; Zhang MY, 2002, EXP CELL RES, V273, P73, DOI 10.1006/excr.2001.5414; Zhang YP, 2007, EXP CELL RES, V313, P3210, DOI 10.1016/j.yexcr.2007.06.021	41	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26697	26709		10.1074/jbc.M110.120956	http://dx.doi.org/10.1074/jbc.M110.120956			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20529857	hybrid, Green Published			2022-12-25	WOS:000280921000084
J	Liao, WQ; Elfrink, K; Bahler, M				Liao, Wanqin; Elfrink, Kerstin; Baehler, Martin			Head of Myosin IX Binds Calmodulin and Moves Processively toward the Plus-end of Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND-OVER-HAND; STEP-SIZE; LIGHT-CHAIN; CHLAMYDOMONAS-REINHARDTII; DIRECTED MOTOR; UNIQUE INSERT; NECK LENGTH; LEVER ARM; VI MOTOR; MECHANISM	Mammalian myosin IXb (Myo9b) has been shown to exhibit unique motor properties in that it is a single-headed processive motor and the rate-limiting step in its chemical cycle is ATP hydrolysis. Furthermore, it has been reported to move toward the minus-and the plus-end of actin filaments. To analyze the contribution of the light chain-binding domain to the movement, processivity, and directionality of a single-headed processive myosin, we expressed constructs of Caenorhabditis elegans myosin IX (Myo9) containing either the head (Myo9-head) or the head and the light chain-binding domain (Myo9-head-4IQ). Both constructs supported actin filament gliding and moved toward the plus-end of actin filaments. We identified in the head of class IX myosins a calmodulin-binding site at the N terminus of loop 2 that is unique among the myosin superfamily members. Ca2+/calmodulin negatively regulated ATPase and motility of the Myo9-head. The Myo9-head demonstrated characteristics of a processive motor in that it supported actin filament gliding and pivoting at low motor densities. Quantum dot-labeled Myo9-head moved along actin filaments with a considerable run length and frequently paused without dissociating even in the presence of obstacles. We conclude that class IX myosins are plus-end-directed motors and that even a single head exhibits characteristics of a processive motor.	[Liao, Wanqin; Elfrink, Kerstin; Baehler, Martin] Univ Munster, Inst Mol Cell Biol, D-48149 Munster, Germany	University of Munster	Bahler, M (corresponding author), Univ Munster, Inst Mol Cell Biol, Schlosspl 5, D-48149 Munster, Germany.	baehler@uni-muenster.de			Deutsche Forschungsgemeinschaft [DFG BA 1354/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant DFG BA 1354/9-1.	Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Bahler M, 2000, BBA-MOL CELL RES, V1496, P52, DOI 10.1016/S0167-4889(00)00008-2; Bahloul A, 2004, P NATL ACAD SCI USA, V101, P4787, DOI 10.1073/pnas.0306892101; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hippler M, 2001, PLANT J, V28, P595, DOI 10.1046/j.1365-313X.2001.01175.x; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; Kambara T, 2006, J BIOL CHEM, V281, P4949, DOI 10.1074/jbc.M509141200; Kohler D, 2003, J CELL BIOL, V161, P237, DOI 10.1083/jcb.200212039; Liao JC, 2009, J MOL BIOL, V392, P862, DOI 10.1016/j.jmb.2009.07.046; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; O'Connell CB, 2003, NAT CELL BIOL, V5, P171, DOI 10.1038/ncb924; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Okten Z, 2004, NAT STRUCT MOL BIOL, V11, P884, DOI 10.1038/nsmb815; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Post PL, 1998, J CELL SCI, V111, P941; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; Struchholz S, 2009, J BIOL CHEM, V284, P3663, DOI 10.1074/jbc.M808338200; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; TOYOSHIMA YY, 1990, P NATL ACAD SCI USA, V87, P7130, DOI 10.1073/pnas.87.18.7130; van den Boom F, 2007, MOL BIOL CELL, V18, P1507, DOI 10.1091/mbc.E06-08-0771; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; Xie P, 2006, BIOPHYS CHEM, V122, P90, DOI 10.1016/j.bpc.2006.02.010; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	45	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24933	24942		10.1074/jbc.M110.101105	http://dx.doi.org/10.1074/jbc.M110.101105			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538589	Green Published, hybrid			2022-12-25	WOS:000280542100066
J	Xu, YX; Liu, L; Caffaro, CE; Hirschberg, CB				Xu, Yu-Xin; Liu, Li; Caffaro, Carolina E.; Hirschberg, Carlos B.			Inhibition of Golgi Apparatus Glycosylation Causes Endoplasmic Reticulum Stress and Decreased Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SUGAR TRANSPORTERS; CAENORHABDITIS-ELEGANS; UDP-GALACTOSE; GENE; DEFICIENT; RESISTANT; VIRULENCE; DISEASES; MUTANTS; SULFATE	Nucleotide sugar transporters of the Golgi apparatus play an essential role in the glycosylation of proteins, lipids, and proteoglycans. Down-regulation of expression of the transporters for CMP-sialic acid, GDP-fucose, or both unexpectedly resulted in accumulation of glycoconjugates in the Golgi apparatus rather than in the plasma membrane. Pulse-chase experiments with radiolabeled sugars and amino acids showed decreased synthesis and secretion of both nonglycoproteins and glycoproteins. Further studies revealed that the above silencing induced endoplasmic reticulum stress and inhibited protein translation initiation. Together these results suggest that global inhibition of Golgi apparatus glycosylation may lead to important secondary metabolic changes, unrelated to glycosylation.	[Xu, Yu-Xin; Liu, Li; Caffaro, Carolina E.; Hirschberg, Carlos B.] Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, Boston, MA 02118 USA	Boston University	Hirschberg, CB (corresponding author), Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, Evans E438,72 E Concord St, Boston, MA 02118 USA.	caffaro@stanford.edu; chirschb@bu.edu	Xu, Yu-Xin/G-4041-2010	Hirschberg, Carlos/0000-0003-2299-7721; Xu, Yu-Xin/0000-0002-0200-4633; Liu, Li/0000-0002-3733-6961	National Institutes of Health [GM 30365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030365, R37GM030365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Grant GM 30365 (to C.B.H.).	Caffaro CE, 2007, J BIOL CHEM, V282, P27970, DOI 10.1074/jbc.M704485200; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Chen C, 2000, GLYCOBIOLOGY, V10, P531, DOI 10.1093/glycob/10.5.531; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; DALESSIO C, 2010, SEMIN CELL IN PRESS; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Dejima K, 2009, FASEB J, V23, P2215, DOI 10.1096/fj.08-123737; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Furuichi T, 2009, J MED GENET, V46, P562, DOI 10.1136/jmg.2008.065201; Gaur U, 2009, EXP PARASITOL, V122, P182, DOI 10.1016/j.exppara.2009.03.014; GUAN JL, 1985, CELL, V42, P489, DOI 10.1016/0092-8674(85)90106-0; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; LIU L, 2010, SEMIN CELL IN PRESS; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Smith TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007532; STANLEY P, 1977, SOMAT CELL GENET, V3, P391, DOI 10.1007/BF01542968; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Toma L, 1996, J BIOL CHEM, V271, P3897; Uccelletti D, 2004, J BIOL CHEM, V279, P27390, DOI 10.1074/jbc.M402624200; Xu YX, 2007, MOL CELL, V26, P287, DOI 10.1016/j.molcel.2007.03.020; ZHAO W, 2008, NUCLEOTIDE SUGAR TRA, P190	27	36	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24600	24608		10.1074/jbc.M110.134544	http://dx.doi.org/10.1074/jbc.M110.134544			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529871	hybrid, Green Published			2022-12-25	WOS:000280542100032
J	Feng, HJ; Macdonald, RL				Feng, Hua-Jun; Macdonald, Robert L.			Barbiturates Require the N Terminus and First Transmembrane Domain of the delta Subunit for Enhancement of alpha 1 beta 3 delta GABA(A) Receptor Currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; ACETYLCHOLINE-RECEPTOR; A RECEPTORS; NEUROACTIVE STEROIDS; ALPHA-SUBUNIT; L929 CELLS; M2 DOMAIN; CHANNEL; MODULATION; ACTIVATION	GABA(A) receptors are composed predominantly of alpha beta gamma receptors, which mediate primarily synaptic inhibition, and alpha beta delta receptors, which mediate primarily extrasynaptic inhibition. At saturating GABA concentrations, the barbiturate pentobarbital substantially increased the amplitude and desensitization of the alpha 1 beta 3 delta receptor but not the alpha 1 beta 3 gamma 2L receptor currents. To explore the structural domains of the delta subunit that are involved in pentobarbital potentiation and increased desensitization of alpha 1 beta 3 delta currents, chimeric cDNAs were constructed by progressive replacement of gamma 2L subunit sequence with a delta subunit sequence or a delta subunit sequence with a gamma 2L subunit sequence, and HEK293T cells were co-transfected with alpha 1 and beta 3 subunits or alpha 1 and beta 3 subunits and a gamma 2L, delta, or chimeric subunit. Currents evoked by a saturating concentration of GABA or by co-application of GABA and pentobarbital were recorded using the patch clamp technique. By comparing the extent of enhancement and changes in kinetic properties produced by pentobarbital among chimeric and wild type receptors, we concluded that although potentiation of alpha 1 beta 3 delta currents by pentobarbital required the delta subunit sequence from the N terminus to proline 241 in the first transmembrane domain (M1), increasing desensitization of alpha 1 beta 3 delta currents required a delta subunit sequence from the N terminus to isoleucine 235 in M1. These findings suggest that the delta subunit N terminus and N-terminal portion of the M1 domain are, at least in part, involved in transduction of the allosteric effect of pentobarbital to enhance alpha 1 beta 3 delta currents and that this effect involves a distinct but overlapping structural domain from that involved in altering desensitization.	[Feng, Hua-Jun; Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Feng, HJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, 6140 MRB 3,465 21st Ave S, Nashville, TN 37232 USA.	huajun.feng@vanderbilt.edu		Feng, Huajun/0000-0003-1544-4248	National Institutes of Health [NSR0I 33300]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NSR0I 33300 (to R. L. M.).	Adkins CE, 2001, J BIOL CHEM, V276, P38934, DOI 10.1074/jbc.M104318200; AKABAS MH, 1995, BIOCHEMISTRY-US, V34, P12496, DOI 10.1021/bi00039a002; Akk G, 2004, J PHYSIOL-LONDON, V556, P387, DOI 10.1113/jphysiol.2003.058230; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bianchi MT, 2007, J PHYSIOL-LONDON, V584, P769, DOI 10.1113/jphysiol.2007.142364; Bianchi MT, 2003, J NEUROSCI, V23, P10934; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Campagna-Slater V, 2007, NEUROSCI LETT, V418, P28, DOI 10.1016/j.neulet.2007.02.091; Carlson BX, 2000, MOL PHARMACOL, V57, P474, DOI 10.1124/mol.57.3.474; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2004, J NEUROPHYSIOL, V92, P1577, DOI 10.1152/jn.00285.2004; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; Feng HJ, 2004, MOL PHARMACOL, V66, P1517, DOI 10.1124/mol.104.003426; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Greenfield LJ, 1997, NEUROPHARMACOLOGY, V36, P63, DOI 10.1016/S0028-3908(96)00150-5; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Haas KF, 1999, J PHYSIOL-LONDON, V514, P27, DOI 10.1111/j.1469-7793.1999.027af.x; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lees G, 1998, ANESTHESIOLOGY, V88, P206, DOI 10.1097/00000542-199801000-00029; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li XS, 2000, J NEUROSCI, V20, P899, DOI 10.1523/JNEUROSCI.20-03-00899.2000; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Meera P, 2009, NEUROPHARMACOLOGY, V56, P155, DOI 10.1016/j.neuropharm.2008.08.011; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nishikawa K, 2003, ANESTHESIOLOGY, V99, P678, DOI 10.1097/00000542-200309000-00024; Olsen R. W., 2002, GLUTAMATE GABA RECEP, P202; Richardson JE, 2007, ANESTHESIOLOGY, V107, P412, DOI 10.1097/01.anes.0000278875.36639.2c; SAXENA NC, 1994, J NEUROSCI, V14, P7077; SCHULZ DW, 1981, BRAIN RES, V209, P177, DOI 10.1016/0006-8993(81)91179-3; Steinbach JH, 2001, J PHYSIOL-LONDON, V537, P715; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Thompson SA, 2002, MOL PHARMACOL, V61, P861, DOI 10.1124/mol.61.4.861; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m	46	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23614	23621		10.1074/jbc.M110.122564	http://dx.doi.org/10.1074/jbc.M110.122564			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525684	Green Published, hybrid			2022-12-25	WOS:000280291400011
J	Jin, G; Kawsar, HI; Hirsch, SA; Zeng, C; Jia, X; Feng, ZM; Ghosh, SK; Zheng, QY; Zhou, AM; McIntyre, TM; Weinberg, A				Jin, Ge; Kawsar, Hameem I.; Hirsch, Stanley A.; Zeng, Chun; Jia, Xun; Feng, Zhimin; Ghosh, Santosh K.; Zheng, Qing Yin; Zhou, Aimin; McIntyre, Thomas M.; Weinberg, Aaron			An Antimicrobial Peptide Regulates Tumor-Associated Macrophage Trafficking via the Chemokine Receptor CCR2, a Model for Tumorigenesis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MESSENGER-RNA QUANTIFICATION; ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; HUMAN BETA-DEFENSIN-3; GENE-EXPRESSION; MAST-CELLS; MAMMARY-TUMORS; BETA-DEFENSINS; IMMUNE-SYSTEM	Background: Tumor-associated macrophages (TAMs) constitute a significant part of infiltrating inflammatory cells that are frequently correlated with progression and poor prognosis of a variety of cancers. Tumor cell-produced human beta-defensin-3 (hBD-3) has been associated with TAM trafficking in oral cancer; however, its involvement in tumor-related inflammatory processes remains largely unknown. Methodology: The relationship between hBD-3, monocyte chemoattractant protein-1 (MCP-1), TAMs, and CCR2 was examined using immunofluorescence microscopy in normal and oral carcinoma in situ biopsy specimens. The ability of hBD-3 to chemoattract host macrophages in vivo using a nude mouse model and analysis of hBD-3 on monocytic cell migration in vitro, applying a cross-desensitization strategy of CCR2 and its pharmacological inhibitor (RS102895), respectively, was also carried out. Conclusions/Findings: MCP-1, the most frequently expressed tumor cell-associated chemokine, was not produced by tumor cells nor correlated with the recruitment of macrophages in oral carcinoma in situ lesions. However, hBD-3 was associated with macrophage recruitment in these lesions and hBD-3-expressing tumorigenic cells induced massive tumor infiltration of host macrophages in nude mice. HBD-3 stimulated the expression of tumor-promoting cytokines, including interleukin-1 alpha (IL-1 alpha), IL-6, IL-8, CCL18, and tumor necrosis factor-alpha (TNF-alpha) in macrophages derived from human peripheral blood monocytes. Monocytic cell migration in response to hBD-3 was inhibited by cross-desensitization with MCP-1 and the specific CCR2 inhibitor, RS102895, suggesting that CCR2 mediates monocyte/macrophage migration in response to hBD-3. Collectively, these results indicate that hBD-3 utilizes CCR2 to regulate monocyte/macrophage trafficking and may act as a tumor cell-produced chemoattractant to recruit TAMs. This novel mechanism is the first evidence of an hBD molecule orchestrating an in vivo outcome and demonstrates the importance of the innate immune system in the development of tumors.	[Jin, Ge; Kawsar, Hameem I.; Jia, Xun; Feng, Zhimin; Ghosh, Santosh K.; Weinberg, Aaron] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA; [Hirsch, Stanley A.] Case Western Reserve Univ, Sch Dent Med, Dept Oral Pathol, Cleveland, OH 44106 USA; [Zeng, Chun; Zhou, Aimin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Zheng, Qing Yin] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Jin, Ge; Zheng, Qing Yin] Case Comprehens Canc Ctr, Cleveland, OH USA; [McIntyre, Thomas M.] Case Western Reserve Univ, Cleveland Clin Coll Med, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University System of Ohio; Cleveland State University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Jin, G (corresponding author), Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA.	ge.jin@case.edu	Zheng, Qing/C-1731-2012; Ghosh, Santosh K/I-5461-2019	Ghosh, Santosh K/0000-0001-5669-7853; Weinberg, Aaron/0000-0002-9960-7181	American Heart Association [0535088N]; American Cancer Society [IRG-91-022-15]; NIH/NIDCR [P01DE019089, P01DE019759]; National Institutes of Health [NIH/R01DC007392, NIH/NIDCD R01DC009246]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE019089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009246, R01DC007392] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a Scientist Development Grant # 0535088N from the American Heart Association (http:www.americanheart.org) (GJ) and Grant # IRG-91-022-15 from the American Cancer Society (wwww.cancer.org) (GJ), NIH/NIDCR P01DE019089 and P01DE019759 (AW), and NIH/R01DC007392 and NIH/NIDCD R01DC009246 (QZ) from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Behbahani H, 2007, JAIDS-J ACQ IMM DEF, V45, P9, DOI 10.1097/QAI.0b013e3180415da7; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; BOTTAZZI B, 1990, J IMMUNOL, V144, P2409; Buettner M, 2007, INT J CANCER, V121, P2703, DOI 10.1002/ijc.23018; Burnett GT, 2008, ANTICANCER RES, V28, P2093; BYRNE PV, 1981, J CELL BIOL, V91, P848, DOI 10.1083/jcb.91.3.848; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Chao C, 2007, ONCOGENE, V26, P1013, DOI 10.1038/sj.onc.1209862; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dougherty ST, 1997, CANCER IMMUNOL IMMUN, V44, P165, DOI 10.1007/s002620050369; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Erreni M, 2009, METHOD ENZYMOL, V460, P105, DOI 10.1016/S0076-6879(09)05205-7; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Ferrara G, 2008, SCAND J IMMUNOL, V68, P668, DOI 10.1111/j.1365-3083.2008.02182.x; FU YX, 1990, CANCER RES, V50, P227; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Fujimoto J, 2000, CANCER RES, V60, P2632; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Ghosh SK, 2007, CLIN CHEM, V53, P757, DOI 10.1373/clinchem.2006.081430; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hacker G, 2002, IMMUNOLOGY, V105, P245; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HIMES RH, 1976, P NATL ACAD SCI USA, V73, P4397, DOI 10.1073/pnas.73.12.4397; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Imada A, 2000, EUR RESPIR J, V15, P1087, DOI 10.1034/j.1399-3003.2000.01517.x; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kawsar HI, 2010, PEPTIDES, V31, P195, DOI 10.1016/j.peptides.2009.12.008; Kawsar HI, 2009, ORAL ONCOL, V45, P696, DOI 10.1016/j.oraloncology.2008.10.016; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kesting MR, 2009, CANCER INVEST, V27, P575, DOI 10.1080/07357900802620851; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kurago ZB, 2008, HEAD NECK PATHOL, V2, P1, DOI 10.1007/s12105-007-0038-x; Leek RD, 1996, CANCER RES, V56, P4625; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Lentzsch S, 2003, BLOOD, V101, P3568, DOI 10.1182/blood-2002-08-2383; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Li CN, 2002, ONCOL REP, V9, P1219; Li JZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-241; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Liu SY, 2008, ORAL ONCOL, V44, P277, DOI 10.1016/j.oraloncology.2007.02.007; Malik MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-61; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Marcus B, 2004, CANCER-AM CANCER SOC, V101, P2779, DOI 10.1002/cncr.20701; Markiewski MM, 2009, CANCER RES, V69, P6367, DOI 10.1158/0008-5472.CAN-09-1918; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Mellado M, 1998, J IMMUNOL, V161, P805; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Overbergh L, 2005, CYTOKINE, V31, P454, DOI 10.1016/j.cyto.2005.07.002; Papageorgiou A, 2004, CANCER RES, V64, P8973, DOI 10.1158/0008-5472.CAN-04-1909; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Peller S, 2009, BLOOD CELL MOL DIS, V43, P74, DOI 10.1016/j.bcmd.2009.01.020; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Ribatti D, 2003, EUR J CLIN INVEST, V33, P420, DOI 10.1046/j.1365-2362.2003.01152.x; Salvesen HB, 1999, INT J CANCER, V84, P539; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Satoh J, 2004, CELL MOL NEUROBIOL, V24, P793, DOI 10.1007/s10571-004-6920-0; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Sciubba J J, 2001, Am J Clin Dermatol, V2, P239, DOI 10.2165/00128071-200102040-00005; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; SHAFER WG, 1975, ORAL SURG ORAL MED O, V39, P227, DOI 10.1016/0030-4220(75)90224-8; Shashkin PN, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-13; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; SICA A, 2008, CANC LETT; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Steube KG, 1997, LEUKEMIA RES, V21, P327, DOI 10.1016/S0145-2126(96)00129-4; Taylor K, 2008, J BIOL CHEM, V283, P6631, DOI 10.1074/jbc.M709238200; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Voronov E, 2007, ADV EXP MED BIOL, V601, P265; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Wu Y, 2008, J IMMUNOL, V181, P6384, DOI 10.4049/jimmunol.181.9.6384; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zheng XH, 2003, TOXICOLOGY, V187, P39, DOI 10.1016/S0300-483X(03)00025-8; Zhou YH, 1999, J LEUKOCYTE BIOL, V65, P265, DOI 10.1002/jlb.65.2.265; Zucchetto A, 2009, CANCER RES, V69, P4001, DOI 10.1158/0008-5472.CAN-08-4173	101	111	120	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10993	10.1371/journal.pone.0010993	http://dx.doi.org/10.1371/journal.pone.0010993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544025	Green Submitted, gold, Green Published			2022-12-25	WOS:000278494900010
J	Stander, S; Siepmann, D; Herrgott, I; Sunderkotter, C; Luger, TA				Staender, Sonja; Siepmann, Dorothee; Herrgott, Ilka; Sunderkoetter, Cord; Luger, Thomas A.			Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy	PLOS ONE			English	Article							SUBSTANCE-P INDUCTION; QUALITY-OF-LIFE; ATOPIC-DERMATITIS; TACHYKININ RECEPTORS; DOUBLE-BLIND; ITCH; NEUROPEPTIDES; SKIN; HISTAMINE; PRURITUS	Background: Chronic pruritus is a global clinical problem with a high impact on the quality of life and lack of specific therapies. It is an excruciating and frequent symptom of e. g. uncurable renal, liver and skin diseases which often does not respond to conventional treatment with e. g. antihistamines. Therefore antipruritic therapies which target physiological mechanisms of pruritus need to be developed. Substance P (SP) is a major mediator of pruritus. As it binds to the neurokinin receptor 1 (NKR1), we evaluated if the application of a NKR1 antagonist would significantly decrease chronic pruritus. Methods and Findings: Twenty hitherto untreatable patients with chronic pruritus (12 female, 8 male; mean age, 66.7 years) were treated with the NKR1 antagonist aprepitant 80 mg for one week. 16 of 20 patients (80%) experienced a considerable reduction of itch intensity, as assessed by the visual analog scale (VAS, range 0 to 10). Considering all patients, the mean value of pruritus intensity was significantly reduced from 8.4 VAS points (SD +/- 1.7) before treatment to 4.9 VAS points (SD +/- 3.2) (p < 0.001, CI 1.913-5.187). Patients with dermatological diseases (e. g. atopic diathesis, prurigo nodularis) had the best profit from the treatment. Side-effects were mild (nausea, vertigo, and drowsiness) and only occurred in three patients. Conclusions: The high response rate in patients with therapy refractory pruritus suggests that the NKR1 antagonist aprepitant may indeed exhibit antipruritic effects and may present a novel, effective treatment strategy based on pathophysiology of chronic pruritus. The results are promising enough to warrant confirming the efficacy of NKR1 antagonists in a randomized, controlled clinical trial.	[Staender, Sonja; Siepmann, Dorothee; Herrgott, Ilka; Sunderkoetter, Cord; Luger, Thomas A.] Univ Munster, Dept Dermatol, Neurodermatol & Competence Ctr Pruritus, D-4400 Munster, Germany	University of Munster	Stander, S (corresponding author), Univ Munster, Dept Dermatol, Neurodermatol & Competence Ctr Pruritus, Von Esmarch Str 56, D-4400 Munster, Germany.	sonja.staender@uni-muenster.de		Stander, Sonja/0000-0003-3612-7786; Sunderkotter, Cord/0000-0002-2929-145X				Almeida TA, 2004, CURR MED CHEM, V11, P2045, DOI 10.2174/0929867043364748; Andoh T, 1998, J PHARMACOL EXP THER, V286, P1140; Chizh BA, 2007, BRIT J ANAESTH, V98, P246, DOI 10.1093/bja/ael344; Dalgard F, 2007, J EUR ACAD DERMATOL, V21, P1215, DOI 10.1111/j.1468-3083.2007.02234.x; Dando TM, 2004, DRUGS, V64, P777, DOI 10.2165/00003495-200464070-00013; DeVane CL, 2001, PHARMACOTHERAPY, V21, P1061, DOI 10.1592/phco.21.13.1061.34612; Duval A, 2009, NEW ENGL J MED, V361, P1415, DOI 10.1056/NEJMc0906670; Furutani K, 1999, ARCH DERMATOL RES, V291, P466, DOI 10.1007/s004030050439; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Jarvikallio A, 2003, ARCH DERMATOL RES, V295, P2, DOI 10.1007/s00403-002-0378-z; Katsuno M, 2003, J DERMATOL SCI, V33, P55, DOI 10.1016/S0923-1811(03)00155-5; Keller M, 2006, BIOL PSYCHIAT, V59, P216, DOI 10.1016/j.biopsych.2005.07.013; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Kumagai H, 2010, NEPHROL DIAL TRANSPL, V25, P1251, DOI 10.1093/ndt/gfp588; Lofgren O, 1999, BURNS, V25, P125, DOI 10.1016/S0305-4179(98)00125-9; Matterne U, 2009, ACTA DERM-VENEREOL, V89, P250, DOI 10.2340/00015555-0641; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; MOLINA FA, 1992, BRIT J DERMATOL, V127, P344, DOI 10.1111/j.1365-2133.1992.tb00452.x; Palframan RT, 1996, BRIT J PHARMACOL, V118, P295, DOI 10.1111/j.1476-5381.1996.tb15402.x; PIERCEY MF, 1981, BRAIN RES, V210, P407, DOI 10.1016/0006-8993(81)90918-5; Pogatzki-Zahn E, 2008, DRUG NEWS PERSPECT, V21, P541, DOI 10.1358/dnp.2008.21.10.1314057; Salomon J, 2008, J EUR ACAD DERMATOL, V22, P223, DOI 10.1111/j.1468-3083.2007.02399.x; Schneider G, 2008, EUR J PAIN, V12, P834, DOI 10.1016/j.ejpain.2007.12.003; Song IS, 2000, EXP DERMATOL, V9, P42, DOI 10.1034/j.1600-0625.2000.009001042.x; Stander S, 2008, EXP DERMATOL, V17, P161, DOI 10.1111/j.1600-0625.2007.00664.x; Stander S, 2007, ACTA DERM-VENEREOL, V87, P291, DOI 10.2340/00015555-0305; Tessari G, 2009, J NEPHROL, V22, P241; Thomsen JS, 2002, BRIT J DERMATOL, V146, P792, DOI 10.1046/j.1365-2133.2002.04722.x; Weisshaar E, 2008, ACTA DERM-VENEREOL, V88, P234, DOI 10.2340/00015555-0432; Weisshaar E, 2009, ACTA DERM-VENEREOL, V89, P339, DOI 10.2340/00015555-0662	31	198	211	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10968	10.1371/journal.pone.0010968	http://dx.doi.org/10.1371/journal.pone.0010968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532044	Green Published, gold, Green Submitted			2022-12-25	WOS:000278380500013
J	Caesar, S; Karlsson, M; Forsman, A				Caesar, Sofia; Karlsson, Magnus; Forsman, Anders			Diversity and Relatedness Enhance Survival in Colour Polymorphic Grasshoppers	PLOS ONE			English	Article							PYGMY GRASSHOPPERS; GENETIC DIVERSITY; SOCIAL HETEROSIS; FITNESS BENEFITS; KIN RECOGNITION; EVOLUTION; SELECTION; POLYANDRY; PATTERN; CONSEQUENCES	Evolutionary theory predicts that different resource utilization and behaviour by alternative phenotypes may reduce competition and enhance productivity and individual performance in polymorphic, as compared with monomorphic, groups of individuals. However, firm evidence that members of more heterogeneous groups benefit from enhanced survival has been scarce or lacking. Furthermore, benefits associated with phenotypic diversity may be counterbalanced by costs mediated by reduced relatedness, since closely related individuals typically are more similar. Pygmy grasshoppers (Tetrix subulata) are characterized by extensive polymorphism in colour pattern, morphology, behaviour and physiology. We studied experimental groups founded by different numbers of mothers and found that survival was higher in low than in high density, that survival peaked at intermediate colour morph diversity in high density, and that survival was independent of diversity in low density where competition was less intense. We further demonstrate that survival was enhanced by relatedness, as expected if antagonistic and competitive interactions are discriminately directed towards non-siblings. We therefore also performed behavioural observations and staged encounters which confirmed that individuals recognized and responded differently to siblings than to non-siblings. We conclude that negative effects associated with competition are less manifest in diverse groups, that there is conflicting selection for and against genetic diversity occurring simultaneously, and that diversity and relatedness may facilitate the productivity and ecological success of groups of interacting individuals.	[Caesar, Sofia; Karlsson, Magnus; Forsman, Anders] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Linnaeus University	Caesar, S (corresponding author), Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden.	Anders.Forsman@lnu.se	Forsman, Anders/G-8778-2012	Forsman, Anders/0000-0001-9598-7618	Swedish Research Council [621-2007-5337, 217-2007-364]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding: The Swedish Research Council - Grant number 621-2007-5337 http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html. The Swedish Research Council Formas - Grant number 217-2007-364 http://www.formas.se. University of Kalmar; http://www.hik.se.LinnaeusUniversity; http://lnu.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesjo J, 2006, EVOL ECOL, V20, P235, DOI 10.1007/s10682-006-6178-8; Ahnesjo J, 2003, J EVOLUTION BIOL, V16, P1308, DOI 10.1046/j.1420-9101.2003.00610.x; [Anonymous], 2006, SAS MIXED MODELS; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BELL G, 1991, EVOLUTION, V45, P1036, DOI 10.1111/j.1558-5646.1991.tb04368.x; Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Caesar S, 2009, BEHAV ECOL, V20, P354, DOI 10.1093/beheco/arn153; Collett D., 1991, MODELLING BINARY DAT; Collett M, 1998, P NATL ACAD SCI USA, V95, P13052, DOI 10.1073/pnas.95.22.13052; DOBLER R, 2009, BEHAV ECOLOGY; Endler J.A., 1977, Monographs in Population Biology, pi; Ford E.B., 1965, GENETIC POLYMORPHISM; Forsman A, 1999, J EVOLUTION BIOL, V12, P391; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; Forsman A, 2001, OECOLOGIA, V129, P357, DOI 10.1007/s004420100743; Forsman A, 2008, ECOLOGY, V89, P1201, DOI 10.1890/07-1670.1; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; Forsman A, 2007, EVOL ECOL RES, V9, P1305; Forsman A, 2009, CONSERV BIOL, V23, P1535, DOI 10.1111/j.1523-1739.2009.01244.x; Griffiths SW, 2001, P ROY SOC B-BIOL SCI, V268, P1293, DOI 10.1098/rspb.2001.1660; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Karlsson M, 2008, OECOLOGIA, V154, P715, DOI 10.1007/s00442-007-0876-y; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Nabours R. K., 1929, Bibliographia Genetica 's-Gravenhage, V5, P27; Nonacs P, 2008, J EVOLUTION BIOL, V21, P631, DOI 10.1111/j.1420-9101.2007.01489.x; Nonacs P, 2007, J EVOLUTION BIOL, V20, P2253, DOI 10.1111/j.1420-9101.2007.01418.x; Pfennig DW, 1999, BEHAV ECOL, V10, P436, DOI 10.1093/beheco/10.4.436; PFENNIG DW, 1990, EVOLUTION, V44, P785, DOI 10.1111/j.1558-5646.1990.tb03805.x; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Santos M, 2008, J EVOLUTION BIOL, V21, P625, DOI 10.1111/j.1420-9101.2007.01484.x; Santos M, 1997, HEREDITY, V78, P302, DOI 10.1038/hdy.1997.45; SAS Institute, 2004, SAS 9 1 3 HELP DOC; Sherman PW, 1997, BEHAV ECOLOGY EVOLUT; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	44	41	42	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10880	10.1371/journal.pone.0010880	http://dx.doi.org/10.1371/journal.pone.0010880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526364	gold, Green Submitted, Green Published			2022-12-25	WOS:000278222100010
J	Farias, MEM; LaPointe, DA; Atkinson, CT; Czerwonka, C; Shrestha, R; Jarvi, SI				Farias, Margaret E. M.; LaPointe, Dennis A.; Atkinson, Carter T.; Czerwonka, Christopher; Shrestha, Rajesh; Jarvi, Susan I.			Taqman Real-Time PCR Detects Avipoxvirus DNA in Blood of Hawai'i 'Amakihi (Hemignathus virens)	PLOS ONE			English	Article							POX-LIKE LESIONS; RETICULOENDOTHELIOSIS VIRUS; VACCINIA-VIRUS; FOWL POXVIRUS; AVIAN POX; DIAGNOSIS; ASSAY; DIFFERENTIATION; EPIZOOTIOLOGY; INFECTIONS	Background: Avipoxvirus sp. is a significant threat to endemic bird populations on several groups of islands worldwide, including Hawai'i, the Galapagos Islands, and the Canary Islands. Accurate identification and genotyping of Avipoxvirus is critical to the study of this disease and how it interacts with other pathogens, but currently available methods rely on invasive sampling of pox-like lesions and may be especially harmful in smaller birds. Methodology/Principal Findings: Here, we present a nested TaqMan Real-Time PCR for the detection of the Avipoxvirus 4b core protein gene in archived blood samples from Hawaiian birds. The method was successful in amplifying Avipoxvirus DNA from packed blood cells of one of seven Hawaiian honeycreepers with confirmed Avipoxvirus infections and 13 of 28 Hawai'i 'amakihi (Hemignathus virens) with suspected Avipoxvirus infections based on the presence of pox-like lesions. Mixed genotype infections have not previously been documented in Hawai'i but were observed in two individuals in this study. Conclusions/Significance: We anticipate that this method will be applicable to other closely related strains of Avipoxvirus and will become an important and useful tool in global studies of the epidemiology of Avipoxvirus.	[Farias, Margaret E. M.; Czerwonka, Christopher; Shrestha, Rajesh; Jarvi, Susan I.] Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA	University of Hawaii System; University Hawaii Hilo	Farias, MEM (corresponding author), Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA.	jarvi@hawaii.edu			U.S. Geological Survey; Pacific Island Ecosystems Research Center; U.S. Geological Survey Wildlife; Invasive Species; National Science Foundation [DEB0083944]; NIH/NCRR IDeA Networks of Biomedical Research Excellence (INBRE) [P20RR016467]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER	U.S. Geological Survey(United States Geological Survey); Pacific Island Ecosystems Research Center; U.S. Geological Survey Wildlife; Invasive Species; National Science Foundation(National Science Foundation (NSF)); NIH/NCRR IDeA Networks of Biomedical Research Excellence (INBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this study was provided by: U.S. Geological Survey, Pacific Island Ecosystems Research Center (biology.usgs.gov/pierc/); U.S. Geological Survey Wildlife (biology.usgs.gov/wter/) and Invasive Species (biology.usgs.gov/invasive/) Programs; National Science Foundation (DEB0083944, www.nsf.gov); NIH/NCRR IDeA Networks of Biomedical Research Excellence (INBRE), P20RR016467 (http://www.ncrr.nih.gov/research_infrastructure/institutional_development_award/idea_networks_of_biomedical_research_excellence/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CT, 2005, CONDOR, V107, P537, DOI 10.1650/0010-5422(2005)107[0537:POPLAM]2.0.CO;2; Balinsky CA, 2007, J VIROL, V81, P11392, DOI 10.1128/JVI.01093-07; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044; Gonzalez A, 2008, INT MICROBIOL, V11, P203, DOI 10.2436/20.1501.01.61; Hauck R, 2009, AVIAN DIS, V53, P205, DOI 10.1637/8451-081908-Reg.1; Jarvi SI, 2008, CONSERV GENET, V9, P339, DOI 10.1007/s10592-007-9346-7; Kleindorfer S, 2006, J AVIAN BIOL, V37, P69, DOI 10.1111/j.0908-8857.2006.03503.x; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Lee LH, 1997, J VIROL METHODS, V63, P113, DOI 10.1016/S0166-0934(96)02119-2; Marshall R, 2007, J CLIN MICROBIOL, V45, P747, DOI 10.1128/JCM.01956-06; MINBAY A, 1973, AVIAN DIS, V17, P532, DOI 10.2307/1589151; Saijo M, 2008, JPN J INFECT DIS, V61, P140; Savona MR, 2006, JAMA-J AM MED ASSOC, V295, P1898, DOI 10.1001/jama.295.16.1898; Scaramozzino N, 2007, CLIN CHEM, V53, P606, DOI 10.1373/clinchem.2006.068635; Smith SA, 2002, CRIT REV MICROBIOL, V28, P149, DOI 10.1080/1040-840291046722; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Tadese T, 2008, VET MICROBIOL, V127, P39, DOI 10.1016/j.vetmic.2007.08.012; Thiel T, 2005, J WILDLIFE DIS, V41, P342, DOI 10.7589/0090-3558-41.2.342; Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; van Riper Charles III, 2007, P131, DOI 10.1002/9780470344668.ch6; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; VARGAS H, 1987, J FIELD ORNITHOL, V58, P101; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Watzinger F., 2006, Molecular Aspects of Medicine, V27, P254, DOI 10.1016/j.mam.2005.12.001; Woodworth BL, 2005, P NATL ACAD SCI USA, V102, P1531, DOI 10.1073/pnas.0409454102	27	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10745	10.1371/journal.pone.0010745	http://dx.doi.org/10.1371/journal.pone.0010745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523726	Green Submitted, Green Published, gold			2022-12-25	WOS:000278221900005
J	Steen, C; Wilczak, N; Hoogduin, JM; Koch, M; De Keyser, J				Steen, Christel; Wilczak, Nadine; Hoogduin, Johannes M.; Koch, Marcus; De Keyser, Jacques			Reduced Creatine Kinase B Activity in Multiple Sclerosis Normal Appearing White Matter	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; SPINAL-CORD; IMMUNOHISTOCHEMICAL LOCALIZATION; GLUTAMATE RECEPTORS; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; HUMAN-BRAIN; ASTROCYTES; CELLS; AXONS	Background: Two studies using P-31-magnetic resonance spectroscopy (MRS) reported enhanced phosphocreatine (PCr) levels in normal appearing white matter (NAWM) of subjects with multiple sclerosis (MS), but this finding could not be properly explained. Methodology/Principal Findings: We performed P-31-MRS and H-1-MRS in the NAWM in 36 subjects, including 17 with progressive MS, 9 with benign MS, and 10 healthy controls. Compared to controls, PCr/beta-ATP and PCr/total P-31 ratios were significantly increased in subjects with progressive MS, but not with benign MS. There was no correlation between PCr ratios and the N-acetylaspartate/creatine ratio, suggesting that elevated PCr levels in NAWM were not secondary to axonal loss. In the central nervous system, PCr is degraded by creatine kinase B (CK-B), which in the white matter is confined to astrocytes. In homogenates of NAWM from 10 subjects with progressive MS and 10 controls without central nervous system disease, we measured CK-B levels with an ELISA, and measured its activity with an enzymatic assay kit. Compared to controls, both CK-B levels and activity were decreased in subjects with MS (22.41 versus 46.28 mu g/ml; p = 0.0007, and 2.89 versus 7.76 U/l; p<0.0001). Conclusions/Significance: Our results suggest that PCr metabolism in the NAWM in MS is impaired due to decreased CK-B levels. Our findings raise the possibility that a defective PCr metabolism in astrocytes might contribute to the degeneration of oligodendrocytes and axons in MS.	[Steen, Christel; Wilczak, Nadine; Koch, Marcus; De Keyser, Jacques] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands; [Hoogduin, Johannes M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Hoogduin, Johannes M.] Univ Groningen, BCN Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [De Keyser, Jacques] Vrije Univ Brussel, Dept Neurol, UZ Brussel, Brussels, Belgium	University of Groningen; Utrecht University; Utrecht University Medical Center; University of Groningen; Vrije Universiteit Brussel	Steen, C (corresponding author), Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands.	Jacques.DeKeyser@uzbrussel.be	De Keyser, Jacques/AAA-8721-2021; Wilczak, Nadine/G-4422-2011; Koch, Marcus/L-9346-2019; De Keyser, Jacques/D-3725-2013	De Keyser, Jacques/0000-0002-3394-7757; Koch, Marcus/0000-0001-9972-5092; De Keyser, Jacques/0000-0002-3394-7757				Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Anderson CM, 2000, GLIA, V32, P1; [Anonymous], [No title captured]; Barnett FH, 2004, NEUROSURGERY, V55, P468, DOI 10.1227/00006123-200408000-00083; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Keyser J, 1999, NEUROLOGY, V53, P1628, DOI 10.1212/WNL.53.8.1628; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Domercq M, 2005, GLIA, V52, P36, DOI 10.1002/glia.20221; Fonseca LL, 2005, GLIA, V51, P286, DOI 10.1002/glia.20209; Greco A, 1999, NEUROLOGY, V53, P1876, DOI 10.1212/WNL.53.8.1876; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; HUSTED CA, 1994, ANN NEUROL, V36, P157, DOI 10.1002/ana.410360207; Koch M, 2006, J NEUROL, V253, P483, DOI 10.1007/s00415-005-0037-3; Koch M, 2007, J NEUROL SCI, V255, P35, DOI 10.1016/j.jns.2007.01.067; KUZHIKANDATHIL EV, 1994, J NEUROSCI RES, V39, P70, DOI 10.1002/jnr.490390110; Kuzhikandathil EV, 1999, J NEUROSCI RES, V56, P371, DOI 10.1002/(SICI)1097-4547(19990515)56:4<371::AID-JNR5>3.0.CO;2-W; LANGEMANN H, 1992, EUR NEUROL, V32, P248, DOI 10.1159/000116835; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Metz I, 2007, BRAIN, V130, P1254, DOI 10.1093/brain/awl370; MINDERHOUD JM, 1992, ARCH NEUROL-CHICAGO, V49, P161, DOI 10.1001/archneur.1992.00530260063021; Ouardouz M, 2009, ANN NEUROL, V65, P151, DOI 10.1002/ana.21533; Ouardouz M, 2009, ANN NEUROL, V65, P160, DOI 10.1002/ana.21539; PETROFF OAC, 1988, J NEUROCHEM, V51, P163, DOI 10.1111/j.1471-4159.1988.tb04850.x; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; RAINE CS, 1984, J NEUROCYTOL, V13, P21, DOI 10.1007/BF01148316; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Sarchielli P, 2003, ARCH NEUROL-CHICAGO, V60, P1082, DOI 10.1001/archneur.60.8.1082; Sonnewald U, 1997, GLIA, V21, P56, DOI 10.1002/(SICI)1098-1136(199709)21:1<56::AID-GLIA6>3.0.CO;2-#; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; THOMPSON RJ, 1980, BRAIN RES, V201, P423, DOI 10.1016/0006-8993(80)91046-X; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Vallejo-Illarramendi A, 2006, NEUROBIOL DIS, V21, P154, DOI 10.1016/j.nbd.2005.06.017; Werner P, 2000, ADV RES NEURODEGENER, V8, P375; Xu GY, 2008, NEUROSCIENCE, V153, P1034, DOI 10.1016/j.neuroscience.2008.02.065; YOSHIMINE T, 1983, BRAIN RES, V265, P101, DOI 10.1016/0006-8993(83)91338-0; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	39	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10811	10.1371/journal.pone.0010811	http://dx.doi.org/10.1371/journal.pone.0010811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520825	gold, Green Published, Green Submitted			2022-12-25	WOS:000278034800009
J	Mattoscio, D; Evangelista, V; De Cristofaro, R; Recchiuti, A; Pandolfi, A; Di Silvestre, S; Manarini, S; Martelli, N; Rocca, B; Petrucci, G; Angelini, DF; Battistini, L; Robuffo, I; Pensabene, T; Pieroni, L; Furnari, ML; Pardo, F; Quattrucci, S; Lancellotti, S; Davi, G; Romano, M				Mattoscio, Domenico; Evangelista, Virgilio; De Cristofaro, Raimondo; Recchiuti, Antonio; Pandolfi, Assunta; Di Silvestre, Sara; Manarini, Stefano; Martelli, Nicola; Rocca, Bianca; Petrucci, Giovanna; Angelini, Daniela F.; Battistini, Luca; Robuffo, Iole; Pensabene, Tiziana; Pieroni, Luisa; Furnari, Maria Lucia; Pardo, Francesca; Quattrucci, Serena; Lancellotti, Stefano; Davi, Giovanni; Romano, Mario			Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response	FASEB JOURNAL			English	Article						inflammation resolution; lipoxin; nitric oxide; platelet-leukocyte interaction	NITRIC-OXIDE PRODUCTION; P-SELECTIN; CELLS; NEUTROPHILS; ACTIVATION; 12-LIPOXYGENASE; MACROPHAGES; INHIBITION; SECRETION; AIRWAY	Inflammatory lung disease is a primary cause of morbidity and mortality in cystic fibrosis (CF). Mechanisms of unresolved acute inflammation in CF are not completely known, although the involvement of cystic fibrosis transmembrane conductance regulator (CFTR) in nonrespiratory cells is emerging. Here we examined CFTR expression and function in human platelets (PLTs) and found that they express a biologically active CFTR. CFTR blockade gave an similar to 50% reduction in lipoxin A(4) (LXA(4)) formation during PLT/polymorphonuclear leukocytes (PMN) coincubations by inhibiting the lipoxin synthase activity of PLT 12-lipoxygenase. PLTs from CF patients generated similar to 40% less LXA(4) compared to healthy subject PLTs. CFTR inhibition increased PLT-dependent PMN viability (33.0 +/- 5.7 vs. 61.2 +/- 8.2%; P=0.033), suppressed nitric oxide generation (0.23 +/- 0.04 vs. 0.11 +/- 0.002 pmol/10(8) PLTs; P=0.004), while reducing AKT (1.02 +/- 0.12 vs. 0.71 +/- 0.007 U; P=0.04), and increasing p38 MAPK phosphorylation (0.650 +/- 0.09 vs. 1.04 +/- 0.24 U; P=0.03). Taken together, these findings indicate that PLTs from CF patients are affected by the molecular defect of CFTR. Moreover, this CF PLT abnormality may explain the failure of resolution in CF.-Mattoscio, D., Evangelista, V., De Cristofaro, R., Recchiuti, A., Pandolfi, A., Di Silvestre, S., Manarini, S., Martelli, N., Rocca, B., Petrucci, B., Angelini, D. F., Battistini, L., Robuffo, I., Pensabene, T., Pieroni, L., Furnari, M. L., Pardo, F., Quattrucci, S., Lancellotti, S., Davi, G., Romano, M. Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J. 24, 3970-3980 (2010). www.fasebj.org	[Mattoscio, Domenico; Recchiuti, Antonio; Pandolfi, Assunta; Di Silvestre, Sara; Pieroni, Luisa; Romano, Mario] Gabriele DAnnunzio Univ Fdn, Dept Biomed Sci, Aging Res Ctr, CeSI, I-66013 Chieti, Italy; [Davi, Giovanni] Gabriele DAnnunzio Univ Fdn, Dept Med & Aging, Aging Res Ctr, CeSI, I-66013 Chieti, Italy; [Evangelista, Virgilio; Manarini, Stefano; Martelli, Nicola] Consorzio Mario Negri Sud, Lab Vasc Biol & Pharmacol, Chieti, Italy; [De Cristofaro, Raimondo; Lancellotti, Stefano] Catholic Univ, Sch Med, Inst Internal Med, Rome, Italy; [De Cristofaro, Raimondo; Lancellotti, Stefano] Catholic Univ, Sch Med, Geriatr & Haemostasis Res Ctr, Rome, Italy; [Rocca, Bianca; Petrucci, Giovanna] Catholic Univ, Sch Med, Inst Pharmacol, Rome, Italy; [Angelini, Daniela F.; Battistini, Luca] Inst Sci, Santa Lucia Fdn, Neuroimmunol Unit, Rome, Italy; [Robuffo, Iole] CNR, Inst Mol Genet, Chieti, Italy; [Quattrucci, Serena] Univ Roma La Sapienza, Cyst Fibrosis Res Ctr, Rome, Italy; [Pieroni, Luisa] IRCCS Fdn S Lucia, Lab Prote & Metabon, Rome, Italy; [Pensabene, Tiziana; Furnari, Maria Lucia; Pardo, Francesca] ARNAS, Children Hosp Di Cristina, Palermo, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consorzio Mario Negri Sud; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Sapienza University Rome; IRCCS Santa Lucia	Romano, M (corresponding author), Gabriele DAnnunzio Univ Fdn, Dept Biomed Sci, Aging Res Ctr, CeSI, Via Colle Ara, I-66013 Chieti, Italy.	mromano@unich.it	Lancellotti, Stefano/K-3939-2018; Battistini, Luca/D-6920-2014; LANCELLOTTI, Stefano/AAA-2950-2022; Angelini, Daniela F/J-8001-2018; Battistini, luca/ABE-1882-2021; Robuffo, Iole/O-2918-2015; rocca, bianca/K-3922-2018; Recchiuti, Antonio/K-7670-2016; Romano, Mario/I-7986-2012; pandolfi, assunta/K-4595-2016; Pieroni, Luisa/Q-6315-2019; De Cristofaro, Raimondo/K-3942-2018; Mattoscio, Domenico/K-1411-2018; Pieroni, Luisa/J-8651-2018; Petrucci, Giovanna/AAB-9192-2022; Davi, Giovanni/K-7659-2016	Battistini, Luca/0000-0002-6488-4891; LANCELLOTTI, Stefano/0000-0002-8090-9040; Angelini, Daniela F/0000-0003-4552-9226; Robuffo, Iole/0000-0001-5883-4225; Recchiuti, Antonio/0000-0002-1409-5261; Romano, Mario/0000-0001-8512-1458; pandolfi, assunta/0000-0003-4135-7631; Pieroni, Luisa/0000-0001-7141-1817; De Cristofaro, Raimondo/0000-0002-8066-8849; Mattoscio, Domenico/0000-0002-2149-2855; Pieroni, Luisa/0000-0001-7141-1817; Petrucci, Giovanna/0000-0002-9280-3673; Davi, Giovanni/0000-0002-3044-0870	Italian Foundation for Cystic Fibrosis Research [FFC 12/2005, FFC 15/2007]; Italian Ministry of University and Research [CEPR D.D. 484/Ric 2008]	Italian Foundation for Cystic Fibrosis Research; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Foundation for Cystic Fibrosis Research (grants FFC 12/2005 and FFC 15/2007 to M. R.) and by the Italian Ministry of University and Research (CEPR D.D. 484/Ric 2008 to V.E.). The authors thank Stefano Lattanzio, Irene Recchia, Elisabetta Ferrante, and Eleonora Cianci for technical assistance; Andrea Urbani for helpful discussion; and Mirella Collura for patient referral. The authors declare no conflicts of interest in connection with this manuscript.	ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; BalfourLynn IM, 1996, ARCH DIS CHILD, V75, P319, DOI 10.1136/adc.75.4.319; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bozza FA, 2009, AM J RESP CELL MOL, V40, P123, DOI 10.1165/rcmb.2008-0241TR; Brunetti M, 2000, THROMB HAEMOSTASIS, V84, P478; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Carrabino S, 2006, J CYST FIBROS, V5, P113, DOI 10.1016/j.jcf.2005.12.003; Ciabattoni G, 2000, AM J RESP CRIT CARE, V162, P1195, DOI 10.1164/ajrccm.162.4.9911071; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gangemi S, 2003, J APPL PHYSIOL, V94, P2237, DOI 10.1152/japplphysiol.01004.2002; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; HILL TD, 1989, PROSTAGLANDINS, V38, P21, DOI 10.1016/0090-6980(89)90013-0; Hopkins N, 2006, J PATHOL, V209, P198, DOI 10.1002/path.1963; Jean D, 2002, CRIT CARE MED, V30, P442, DOI 10.1097/00003246-200202000-00029; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kato H, 2008, ARCH BIOCHEM BIOPHYS, V475, P80, DOI 10.1016/j.abb.2008.04.023; Li GL, 2007, ENDOCRINOLOGY, V148, P3356, DOI 10.1210/en.2006-1441; McKeon DJ, 2008, THORAX, V63, P660, DOI 10.1136/thx.2008.096834; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Piccardoni P, 2001, BLOOD, V98, P108, DOI 10.1182/blood.V98.1.108; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robroeks CMHHT, 2008, PEDIAT ALLERG IMM-UK, V19, P652, DOI 10.1111/j.1399-3038.2007.00693.x; ROMANO M, 1992, BIOCHEMISTRY-US, V31, P8269, DOI 10.1021/bi00150a021; ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; Spalding A, 1998, HYPERTENSION, V31, P603, DOI 10.1161/01.HYP.31.2.603; von Hundelshausen P, 2007, CIRC RES, V100, P27, DOI 10.1161/01.RES.0000252802.25497.b7; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Weissmuller T, 2008, J CLIN INVEST, V118, P3682, DOI 10.1172/JCI35874; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003	36	61	63	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3970	3980		10.1096/fj.10-159921	http://dx.doi.org/10.1096/fj.10-159921			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20530751				2022-12-25	WOS:000285005900034
J	Riera, L; Lasorsa, E; Ambrogio, C; Surrenti, N; Voena, C; Chiarle, R				Riera, Ludovica; Lasorsa, Elena; Ambrogio, Chiara; Surrenti, Nadia; Voena, Claudia; Chiarle, Roberto			Involvement of Grb2 Adaptor Protein in Nucleophosmin-Anaplastic Lymphoma Kinase (NPM-ALK)-mediated Signaling and Anaplastic Large Cell Lymphoma Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; NPM-ALK; BINDING PROTEIN-2; FUSION PROTEIN; SH3 DOMAIN; TRANSFORMATION; PHOSPHORYLATION; DOWNSTREAM; PROLIFERATION; INTERFERENCE	Most anaplastic large cell lymphomas (ALCL) express oncogenic fusion proteins derived from chromosomal translocations or inversions of the anaplastic lymphoma kinase (ALK) gene. Frequently ALCL carry the t(2;5) translocation, which fuses the ALK gene to the nucleophosmin (NPM1) gene. The transforming activity mediated by NPM-ALK fusion induces different pathways that control proliferation and survival of lymphoma cells. Grb2 is an adaptor protein thought to play an important role in ALK-mediated transformation, but its interaction with NPM-ALK, as well as its function in regulating ALCL signaling pathways and cell growth, has never been elucidated. Here we show that active NPM-ALK, but not a kinase-dead mutant, bound and induced Grb2 phosphorylation in tyrosine 160. An intact SH3 domain at the C terminus of Grb2 was required for Tyr(160) phosphorylation. Furthermore, Grb2 did not bind to a single region but rather to different regions of NPM-ALK, mainly Tyr(152-156), Tyr(567), and a proline-rich region, Pro(415-417). Finally, shRNA knockdown experiments showed that Grb2 regulates primarily the NPM-ALK-mediated phosphorylation of SHP2 and plays a key role in ALCL cell growth.	[Riera, Ludovica; Lasorsa, Elena; Ambrogio, Chiara; Voena, Claudia; Chiarle, Roberto] Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy; [Riera, Ludovica; Lasorsa, Elena; Ambrogio, Chiara; Surrenti, Nadia; Voena, Claudia; Chiarle, Roberto] Univ Turin, Ctr Expt Res & Med Studies, I-10126 Turin, Italy	University of Turin; University of Turin	Chiarle, R (corresponding author), Univ Turin, Dept Biomed Sci & Human Oncol, Via Santena 7, I-10126 Turin, Italy.	roberto.chiarle@unito.it	VOENA, Claudia/ADJ-6244-2022	Ambrogio, Chiara/0000-0003-4122-701X; Voena, Claudia/0000-0002-1324-1431; RIERA, LUDOVICA/0000-0002-7695-6565; CHIARLE, Roberto/0000-0003-1564-8531	Associazione Italiana per la Ricerca sul Cancro (AIRC); Compagnia di San Paolo, Torino (Progetto Oncologia) [ERC-2009-StG]; Regione Piemonte (Ricerca Sanitaria Finalizzata and Ricerca Scientifica)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo, Torino (Progetto Oncologia)(Compagnia di San Paolo); Regione Piemonte (Ricerca Sanitaria Finalizzata and Ricerca Scientifica)(Regione Piemonte)	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC), the Compagnia di San Paolo, Torino (Progetto Oncologia), FP7 ERC-2009-StG (Proposal 242965-"LUNELY") (to R. C.) and the Regione Piemonte (Ricerca Sanitaria Finalizzata and Ricerca Scientifica).	Ambrogio C, 2005, BLOOD, V106, P3907, DOI 10.1182/blood-2005-03-1204; Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Boccalatte FE, 2009, BLOOD, V113, P2776, DOI 10.1182/blood-2008-06-161018; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Crockett DK, 2004, ONCOGENE, V23, P2617, DOI 10.1038/sj.onc.1207398; Dharmawardana PG, 2006, ANTI-CANCER DRUG, V17, P13, DOI 10.1097/01.cad.0000185180.72604.ac; Fixman ED, 1996, J BIOL CHEM, V271, P13116, DOI 10.1074/jbc.271.22.13116; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Garbay C, 2000, BIOCHEM PHARMACOL, V60, P1165, DOI 10.1016/S0006-2952(00)00428-7; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; GISHIZKY ML, 1995, P NATL ACAD SCI USA, V92, P10889, DOI 10.1073/pnas.92.24.10889; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Ho JMY, 2002, BLOOD, V100, P1438; Jones DA, 1997, ARCH BIOCHEM BIOPHYS, V337, P143, DOI 10.1006/abbi.1996.9789; Kuefer MU, 1997, BLOOD, V90, P2901, DOI 10.1182/blood.V90.8.2901; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Matsumura I, 2008, CANCER SCI, V99, P479, DOI 10.1111/j.1349-7006.2007.00717.x; Minoo P, 2003, CELL SIGNAL, V15, P319, DOI 10.1016/S0898-6568(02)00122-5; MORRIS SW, 1995, SCIENCE, V267, P316, DOI 10.1126/science.267.5196.316-b; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Piva R, 2002, MOL CELL BIOL, V22, P8375, DOI 10.1128/MCB.22.23.8375-8387.2002; Polgar D, 2005, MUTAT RES-FUND MOL M, V570, P9, DOI 10.1016/j.mrfmmm.2004.09.011; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Taulli R, 2005, CANCER GENE THER, V12, P456, DOI 10.1038/sj.cgt.7700815; Trinei M, 2000, CANCER RES, V60, P793; Vihinen M, 1996, CRIT REV IMMUNOL, V16, P251, DOI 10.1615/CritRevImmunol.v16.i3.20; Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350; Wan WH, 2006, BLOOD, V107, P1617, DOI 10.1182/blood-2005-08-3254; Wasik MA, 2009, SEMIN ONCOL, V36, pS27, DOI 10.1053/j.seminoncol.2009.02.007; Wellmann A, 1997, FASEB J, V11, P965, DOI 10.1096/fasebj.11.12.9337149; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yuzawa S, 2001, J MOL BIOL, V306, P527, DOI 10.1006/jmbi.2000.4396	44	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26441	26450		10.1074/jbc.M110.116327	http://dx.doi.org/10.1074/jbc.M110.116327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554525	Green Published, hybrid			2022-12-25	WOS:000280921000062
J	Staples, CJ; Owens, DM; Maier, JV; Cato, ACB; Keyse, SM				Staples, Christopher J.; Owens, David M.; Maier, Jana V.; Cato, Andrew C. B.; Keyse, Stephen M.			Cross-talk between the p38 alpha and JNK MAPK Pathways Mediated by MAP Kinase Phosphatase-1 Determines Cellular Sensitivity to UV Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; INNATE IMMUNE-RESPONSES; C-FOS; TRANSCRIPTIONAL ACTIVATION; DIFFERENTIAL REGULATION; CISPLATIN RESISTANCE; FEEDBACK-REGULATION; INDUCED APOPTOSIS; GENOTOXIC STRESS; GENE-EXPRESSION	MAPK phosphatase-1 (DUSP1/MKP-1) is a mitogen and stress-inducible dual specificity protein phosphatase, which can inactivate all three major classes of MAPK in mammalian cells. DUSP1/MKP-1 is implicated in cellular protection against a variety of genotoxic insults including hydrogen peroxide, ionizing radiation, and cisplatin, but its role in the interplay between different MAPK pathways in determining cell death and survival is not fully understood. We have used pharmacological and genetic tools to demonstrate that DUSP1/MKP-1 is an essential non-redundant regulator of UV-induced cell death in mouse embryo fibroblasts (MEFs). The induction of DUSP1/MKP-1 mRNA and protein in response to UV radiation is mediated by activation of the p38 alpha but not the JNK1 or JNK2 MAPK pathways. Furthermore, we identify MSK1 and -2 and their downstream effectors cAMP-response element-binding protein/ATF1 as mediators of UV-induced p38 alpha-dependent DUSP1/MKP-1 transcription. Dusp1/Mkp-1 null MEFs display increased signaling through both the p38 alpha and JNK MAPK pathways and are acutely sensitive to UV-induced apoptosis. This lethality is rescued by the reintroduction of wild-type DUSP1/MKP-1 and by a mutant of DUSP1/MKP-1, which is unable to bind to either p38 alpha or ERK1/2, but retains full activity toward JNK. Importantly, whereas small interfering RNA-mediated knockdown of DUSP1/MKP-1 sensitizes wild-type MEFs to UV radiation, DUSP1/MKP-1 knockdown in MEFS lacking JNK1 and -2 does not result in increased cell death. Our results demonstrate that cross-talk between the p38 alpha and JNK pathways mediated by induction of DUSP1/MKP-1 regulates the cellular response to UV radiation.	[Staples, Christopher J.; Owens, David M.; Keyse, Stephen M.] Univ Dundee, CR UK Stress Response Lab, Biomed Res Inst, Ninewells Hosp, Dundee DD1 9SY, Scotland; [Staples, Christopher J.; Owens, David M.; Keyse, Stephen M.] Univ Dundee, Sch Med, Dundee DD1 9SY, Scotland; [Maier, Jana V.; Cato, Andrew C. B.] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany	University of Dundee; University of Dundee; Helmholtz Association; Karlsruhe Institute of Technology	Keyse, SM (corresponding author), Univ Dundee, CR UK Stress Response Lab, Biomed Res Inst, Ninewells Hosp, Level 5, Dundee DD1 9SY, Scotland.	s.m.keyse@dundee.ac.uk	Cato, Andrew C. B./H-2071-2013; Keyse, Stephen M./B-9575-2009	Cato, Andrew C. B./0000-0001-8508-3834; Keyse, Stephen M./0000-0002-5150-8221; Staples, Christopher/0000-0002-0482-9954	Cancer Research UK; MRC; Cancer Research UK [12053] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	This work was supported a grant from Cancer Research UK (to S. M. K.) and a MRC Ph.D studentship (to C. J. S.).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burgun C, 2000, FEBS LETT, V484, P189, DOI 10.1016/S0014-5793(00)02153-0; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Christmann M, 2007, CARCINOGENESIS, V28, P183, DOI 10.1093/carcin/bgl119; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Dorfman K, 1996, ONCOGENE, V13, P925; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Iordanov MS, 1998, J BIOL CHEM, V273, P15794, DOI 10.1074/jbc.273.25.15794; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kinney CM, 2009, AM J PHYSIOL-CELL PH, V296, pC242, DOI 10.1152/ajpcell.00492.2008; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rojo F, 2009, CLIN CANCER RES, V15, P3530, DOI 10.1158/1078-0432.CCR-08-2070; Ryser S, 2004, BIOCHEM J, V378, P473, DOI 10.1042/BJ20031022; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Sanchez-Tillo E, 2007, J BIOL CHEM, V282, P12566, DOI 10.1074/jbc.M609662200; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shimada M, 2010, J BIOL CHEM, V285, P9390, DOI 10.1074/jbc.M109.057745; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Sommer A, 2000, FEBS LETT, V474, P146, DOI 10.1016/S0014-5793(00)01566-0; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vicent S, 2004, CLIN CANCER RES, V10, P3639, DOI 10.1158/1078-0432.CCR-03-0771; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang XX, 2007, CELL SIGNAL, V19, P1372, DOI 10.1016/j.cellsig.2007.03.013; Wang ZQ, 2008, J BIOL CHEM, V283, P21011, DOI 10.1074/jbc.M802229200; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xu QH, 2004, FREE RADICAL BIO MED, V36, P985, DOI 10.1016/j.freeradbiomed.2004.01.009; Yang HJ, 2004, CANCER BIOL THER, V3, P1277, DOI 10.4161/cbt.3.12.1370; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou JY, 2006, CANCER RES, V66, P4888, DOI 10.1158/0008-5472.CAN-05-4229; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	62	57	57	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25928	25940		10.1074/jbc.M110.117911	http://dx.doi.org/10.1074/jbc.M110.117911			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547488	Green Published, hybrid			2022-12-25	WOS:000280921000007
J	Jutooru, I; Chadalapaka, G; Lei, P; Safe, S				Jutooru, Indira; Chadalapaka, Gayathri; Lei, Ping; Safe, Stephen			Inhibition of NF kappa B and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-II TRIAL; TRANSCRIPTION FACTORS; ONCOGENIC MICRORNA-27A; FACTOR RECEPTOR; EXPRESSION; ANGIOGENESIS; PROLIFERATION; APOPTOSIS; SP1; ADENOCARCINOMA	Curcumin activates diverse anticancer activities that lead to inhibition of cancer cell and tumor growth, induction of apoptosis, and antiangiogenic responses. In this study, we observed that curcumin inhibits Panc28 and L3.6pL pancreatic cancer cell and tumor growth in nude mice bearing L3.6pL cells as xenografts. In addition, curcumin decreased expression of p50 and p65 proteins and NF kappa B-dependent transactivation and also decreased Sp1, Sp3, and Sp4 transcription factors that are over-expressed in pancreatic cancer cells. Because both Sp transcription factors and NF kappa B regulate several common genes such as cyclin D1, survivin, and vascular endothelial growth factor that contribute to the cancer phenotype, we also investigated interactions between Sp and NF kappa B transcription factors. Results of Sp1, Sp3, and Sp4 knockdown by RNA interference demonstrate that both p50 and p65 are Sp-regulated genes and that inhibition of constitutive or tumor necrosis factor-induced NF kappa B by curcumin is dependent on down-regulation of Sp1, Sp3, and Sp4 proteins by this compound. Curcumin also decreased mitochondrial membrane potential and induced reactive oxygen species in pancreatic cancer cells, and this pathway is required for down-regulation of Sp proteins in these cells, demonstrating that the mitochondriotoxic effects of curcumin are important for its anticancer activities.	[Jutooru, Indira; Chadalapaka, Gayathri; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Lei, Ping] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, 4466 TAMU,Vet Res Bldg,410, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu			National Institutes of Health [R01CA108718, R01CA136571]; Texas A&M AgriLife Research; NATIONAL CANCER INSTITUTE [R01CA136571, R01CA108718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M AgriLife Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA108718 and R01CA136571 and a grant from Texas A&M AgriLife Research.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Arbiser JL, 1998, MOL MED, V4, P376, DOI 10.1007/BF03401744; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bhaumik S, 1999, FEBS LETT, V456, P311, DOI 10.1016/S0014-5793(99)00969-2; Bramhall SR, 2001, J CLIN ONCOL, V19, P3447, DOI 10.1200/JCO.2001.19.15.3447; Chadalapaka G, 2008, CANCER RES, V68, P5345, DOI 10.1158/0008-5472.CAN-07-6805; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Evans DB, 1997, CANC PRINCIPLES PRAC, V1, P1126; Gold E B, 1998, Surg Oncol Clin N Am, V7, P67; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Haller DG, 2003, INT J RADIAT ONCOL, V56, P16, DOI 10.1016/S0360-3016(03)00448-6; Higgins KJ, 2006, BIOCHEM BIOPH RES CO, V345, P292, DOI 10.1016/j.bbrc.2006.04.111; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; Hotz HG, 2001, J GASTROINTEST SURG, V5, P131, DOI 10.1016/S1091-255X(01)80024-X; Hruban RH, 2001, J GASTROINTEST SURG, V5, P583, DOI 10.1016/S1091-255X(01)80099-8; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; JUTOORU I, 2010, MOL PHARM IN PRESS; Jutooru I, 2010, EXP CELL RES, V316, P2174, DOI 10.1016/j.yexcr.2010.04.027; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Khan S, 2007, J MOL ENDOCRINOL, V39, P289, DOI 10.1677/JME-07-0043; Klein AP, 2001, CANCER J, V7, P266; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Li DH, 2001, CANCER J, V7, P259; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; McKenna S, 2003, ONCOLOGIST, V8, P149, DOI 10.1634/theoncologist.8-2-149; McNally SJ, 2007, INT J MOL MED, V19, P165; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Moore MJ, 2003, J CLIN ONCOL, V21, P3296, DOI 10.1200/JCO.2003.02.098; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shi Q, 2001, CANCER RES, V61, P4143; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Thangapazham RL, 2006, AAPS J, V8, pE443, DOI 10.1208/aapsj080352; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Xiong HQ, 2004, J CLIN ONCOL, V22, P2610, DOI 10.1200/JCO.2004.12.040; Yang CH, 1999, BRIT J CANCER, V81, P796, DOI 10.1038/sj.bjc.6690766; YUROCHKO AD, 1995, J VIROL, V69, P5391, DOI 10.1128/JVI.69.9.5391-5400.1995; Yurochko AD, 1997, J VIROL, V71, P4638, DOI 10.1128/JVI.71.6.4638-4648.1997	48	156	162	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25332	25344		10.1074/jbc.M109.095240	http://dx.doi.org/10.1074/jbc.M109.095240			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538607	Green Published, hybrid			2022-12-25	WOS:000280682400026
J	Liang, GY; Taranova, O; Xia, K; Zhang, Y				Liang, Gaoyang; Taranova, Olena; Xia, Kai; Zhang, Yi			Butyrate Promotes Induced Pluripotent Stem Cell Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE COMPOUNDS; FIBROBLASTS; INDUCTION; MOUSE; EXPRESSION; PATHWAY; STATE; OCT4	Recent studies have demonstrated that embryonic stem cell-like induced pluripotent stem (iPS) cells can be generated by enforced expression of defined transcription factors. The fact that cell fate change is accompanied by changes in epigenetic modifications prompted us to investigate whether chemicals known to modulate epigenetic regulators are capable of enhancing the efficiency of iPS cell generation. Here, we report that butyrate, a natural small fatty acid and histone deacetylase inhibitor, significantly increases the efficiency of mouse iPS cell generation using the transcription factors Oct4, Sox2, Klf4, and c-Myc. We show that butyrate not only changes the reprogramming dynamics, but also increases the ratio of iPS cell colonies to total colonies by reducing the frequency of partially reprogrammed cells and transformed cells. Detailed analysis reveals that the effect of butyrate on reprogramming appears to be mediated by c-Myc and occurs during an early stage of reprogramming. Genome-wide gene expression analysis reveals up-regulation of ES cell-enriched genes when mouse embryonic fibroblasts are treated with butyrate during reprogramming. Thus, our study identifies butyrate as a chemical factor capable of promoting iPS cell generation.	[Liang, Gaoyang; Taranova, Olena; Xia, Kai; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Howard Hughes Med Inst, 450 West Dr, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Xia, Kai/B-7214-2014; Liang, Gaoyang/L-2087-2013; liang, gaoyang/A-8059-2010	Liang, Gaoyang/0000-0002-2157-974X; Xia, Kai/0000-0003-1326-0891; Zhang, Yi/0000-0002-2789-0811	National Institutes of Health through the NIDDK	National Institutes of Health through the NIDDK	This work was supported, in whole or in part, by a National Institutes of Health Beta Cell Biology Consortium project through the NIDDK.	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; NEWMARK HL, 1994, CANCER LETT, V78, P1, DOI 10.1016/0304-3835(94)90023-X; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	22	109	115	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25516	25521		10.1074/jbc.M110.142059	http://dx.doi.org/10.1074/jbc.M110.142059			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554530	hybrid, Green Published			2022-12-25	WOS:000280682400045
J	Furuya, F; Shimura, H; Yamashita, S; Endo, T; Kobayashi, T				Furuya, Fumihiko; Shimura, Hiroki; Yamashita, Sayaka; Endo, Toyoshi; Kobayashi, Tetsuro			Liganded Thyroid Hormone Receptor-alpha Enhances Proliferation of Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; CYCLE PROGRESSION; CANCER CELLS; MICE; REGENERATION; ACTIVATION; INDUCTION; APOPTOSIS; ISLETS; THYROGLOBULIN	Failure of the functional pancreatic beta-cell mass to expand in response to increased metabolic demand is a hallmark of type 2 diabetes. Lineage tracing studies indicate that replication of existing beta-cells is important for beta-cell proliferation in adult animals. In rat pancreatic beta-cell lines (RIN5F), treatment with 100 nM thyroid hormone (triiodothyronine, T-3) enhances cell proliferation. This result suggests that T-3 is required for beta-cell proliferation or replication. To identify the role of thyroid hormone receptor alpha (TR alpha) in the processes of beta-cell growth and cell cycle regulation, we constructed a recombinant adenovirus vector, AdTR alpha. Infection with AdTR alpha to RIN5F cells increased the expression of cyclin D1 mRNA and protein. Overexpression of the cyclin D1 protein in AdTR alpha-infected cells led to activation of the cyclin D1/cyclin- dependent kinase/retinoblastoma protein/E2F pathway, along with cell cycle progression and cell proliferation following treatment with 100 nM T-3. Conversely, lowering cellular cyclin D1 by small interfering RNA knockdown in AdTR alpha-infected cells led to down-regulation of the cyclin D1/CDK/Rb/E2F pathway and inhibited cell proliferation. Furthermore, in immunodeficient mice with streptozotocin-induced diabetes, intrapancreatic injection of AdTR alpha led to the restoration of islet function and to an increase in the beta-cell mass. These results support the hypothesis that liganded TR alpha plays a critical role in beta-cell replication and in expansion of the beta-cell mass during postnatal development. Thus, liganded TR alpha may be a target for therapeutic strategies that can induce the expansion and regeneration of beta-cells.	[Furuya, Fumihiko; Shimura, Hiroki; Yamashita, Sayaka; Endo, Toyoshi; Kobayashi, Tetsuro] Univ Yamanashi, Dept Internal Med 3, Interdisciplinary Grad Sch Med & Engn, Chuo, Yamanashi 4093898, Japan	University of Yamanashi	Kobayashi, T (corresponding author), 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	tetsurou@yamanashi.ac.jp						Barrera-Hernandez G, 1999, ENDOCRINOLOGY, V140, P5267, DOI 10.1210/en.140.11.5267; Cheng S Y, 2000, Rev Endocr Metab Disord, V1, P9, DOI 10.1023/A:1010052101214; CHIN WW, 1994, THYROID, V4, P389, DOI 10.1089/thy.1994.4.389; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Cozar-Castellano I, 2004, DIABETES, V53, P149, DOI 10.2337/diabetes.53.1.149; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FALZACAPPA CV, 2006, J CELL PHYSIOL, V206, P309, DOI [10.1002/jcp.20460, DOI 10.1002/jcp.20460, DOI 10.1002/JCP.20460]; Fazio EN, 2007, BIOCHEM BIOPH RES CO, V353, P823, DOI 10.1016/j.bbrc.2006.12.110; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2004, ENDOCRINOLOGY, V145, P2865, DOI 10.1210/en.2003-1258; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; Hassani Z, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm152; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Ledda-Columbano GM, 2005, J ENDOCRINOL, V185, P393, DOI 10.1677/joe.1.06110; LENZEN S, 1978, ENDOCRINOLOGY, V103, P1546, DOI 10.1210/endo-103-5-1546; LENZEN S, 1984, ENDOCR REV, V5, P411, DOI 10.1210/edrv-5-3-411; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; O'Shea PJ, 2005, MOL ENDOCRINOL, V19, P3045, DOI 10.1210/me.2005-0224; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P79, DOI 10.1210/jc.76.1.79; Rood PPM, 2006, PHARM RES-DORDR, V23, P227, DOI 10.1007/s11095-005-9095-6; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Shifrin AL, 2001, GENE THER, V8, P1480, DOI 10.1038/sj.gt.3301544; Shimura H, 2001, CANCER RES, V61, P3640; Sugden MC, 2008, BIOCHEM SOC T, V36, P891, DOI 10.1042/BST0360891; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Verga Falzacappa C, 2007, J MOL ENDOCRINOL, V38, P221, DOI DOI 10.1677/JME.1.02166; Verga Falzacappa C, 2009, J CELL BIOCHEM, V106, P835, DOI 10.1002/jcb.22045; Ximenes HM, 2007, LIFE SCI, V80, P2045, DOI 10.1016/j.lfs.2007.03.001; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06; Yu QS, 2008, MOL CELL BIOCHEM, V315, P17, DOI 10.1007/s11010-008-9783-8	39	45	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24477	24486		10.1074/jbc.M109.100222	http://dx.doi.org/10.1074/jbc.M109.100222			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529852	hybrid, Green Published			2022-12-25	WOS:000280542100020
J	Suzuki-Inoue, K; Inoue, O; Ding, G; Nishimura, S; Hokamura, K; Eto, K; Kashiwagi, H; Tomiyama, Y; Yatomi, Y; Umemura, K; Shin, Y; Hirashima, M; Ozaki, Y				Suzuki-Inoue, Katsue; Inoue, Osamu; Ding, Guo; Nishimura, Satoshi; Hokamura, Kazuya; Eto, Koji; Kashiwagi, Hirokazu; Tomiyama, Yoshiaki; Yatomi, Yutaka; Umemura, Kazuo; Shin, Yonchol; Hirashima, Masanori; Ozaki, Yukio			Essential in Vivo Roles of the C-type Lectin Receptor CLEC-2 EMBRYONIC/NEONATAL LETHALITY OF CLEC-2-DEFICIENT MICE BY BLOOD/LYMPHATIC MISCONNECTIONS AND IMPAIRED THROMBUS FORMATION OF CLEC-2-DEFICIENT PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-AGGREGATION; LYMPHATIC VASCULATURE; GLYCOPROTEIN-VI; PODOPLANIN; ACTIVATION; COLLAGEN; BLOOD; MICE; GPVI; SYK	CLEC-2 has been described recently as playing crucial roles in thrombosis/hemostasis, tumor metastasis, and lymphangiogenesis. The snake venom rhodocytin is known as a strong platelet activator, and we have shown that this effect is mediated by CLEC-2 (Suzuki-Inoue, K., Fuller, G. L., Garc a, A., Eble, J. A., Pohlmann, S., Inoue, O., Gartner, T. K., Hughan, S. C., Pearce, A. C., Laing, G. D., Theakston, R. D., Schweighoffer, E., Zitzmann, N., Morita, T., Tybulewicz, V. L., Ozaki, Y., and Watson, S. P. (2006) Blood 107, 542-549). Podoplanin, which is expressed on the surface of tumor cells, is an endogenous ligand for CLEC-2 and facilitates tumor metastasis by inducing platelet aggregation. Mice deficient in podoplanin, which is also expressed on the surface of lymphatic endothelial cells, show abnormal patterns of lymphatic vessel formation. In this study, we report on the generation and phenotype of CLEC-2-deficient mice. These mice are lethal at the embryonic/neonatal stages associated with disorganized and blood-filled lymphatic vessels and severe edema. Moreover, by transplantation of fetal liver cells from Clec-2(-/-) or Clec-2(+/+) embryos, we were able to demonstrate that CLEC-2 is involved in thrombus stabilization in vitro and in vivo, possibly through homophilic interactions without apparent increase in bleeding tendency. We propose that CLEC-2 could be an ideal novel target protein for an anti-platelet drug, which inhibits pathological thrombus formation but not physiological hemostasis.	[Suzuki-Inoue, Katsue; Inoue, Osamu; Ozaki, Yukio] Univ Yamanashi, Clin & Lab Med Dept, Fac Med, Yamanashi 4093898, Japan; [Ding, Guo; Hirashima, Masanori] Kobe Univ, Div Vasc Biol, Dept Physiol & Cell Biol, Sch Med, Kobe, Hyogo 6500017, Japan; [Nishimura, Satoshi] Univ Tokyo, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Nishimura, Satoshi] Univ Tokyo, Dept Lab Med, Grad Sch Med, Tokyo 1138655, Japan; [Nishimura, Satoshi] Univ Tokyo, Dept Translat Syst Biol & Med Initiat, Tokyo 1138655, Japan; [Nishimura, Satoshi] PREST, Japan Sci & Technol Agcy, Bunkyo Ku, Tokyo 1138655, Japan; [Hokamura, Kazuya; Umemura, Kazuo] Hamamatsu Univ Sch Med, Dept Pharmacol, Hamamatsu, Shizuoka 4313192, Japan; [Eto, Koji] Univ Tokyo, Stem Cell Bank, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Kashiwagi, Hirokazu] Osaka Univ, Dept Haematol & Oncol, Grad Sch Med C9, Suita, Osaka 5650871, Japan; [Yatomi, Yutaka] Osaka Univ Hosp, Dept Blood Transfus, Osaka 5650879, Japan; [Shin, Yonchol] Kogakuin Univ, Dept Appl Chem, Fac Engn, Tokyo 1920015, Japan	University of Yamanashi; Kobe University; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Hamamatsu University School of Medicine; University of Tokyo; Osaka University; Osaka University; Kogakuin University	Suzuki-Inoue, K (corresponding author), Univ Yamanashi, Clin & Lab Med Dept, Fac Med, 1110 Shimokato, Yamanashi 4093898, Japan.	katsuei@yamanashi.ac.jp; oinoue@yamanashi.ac.jp	Hirashima, Masanori/ABC-9204-2021	Hirashima, Masanori/0000-0002-0190-4381; Yatomi, Yutaka/0000-0003-1719-4297; Tomiyama, Yoshiaki/0000-0001-7645-0989	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Ministry of Health, Labor, and Welfare of Japan.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambien B, 2003, J CLIN INVEST, V112, P1589, DOI 10.1172/JCI200319284; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Hirashima M, 2008, DEV BIOL, V316, P149, DOI 10.1016/j.ydbio.2008.01.023; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Inoue O, 2006, BLOOD, V107, P1405, DOI 10.1182/blood-2005-06-2406; Inoue O, 2009, FEBS LETT, V583, P81, DOI 10.1016/j.febslet.2008.11.026; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Marshall ASJ, 2004, EUR J IMMUNOL, V34, P18, DOI 10.1002/eji.200324641; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Shin Y, 1998, BIOCHEM BIOPH RES CO, V245, P741, DOI 10.1006/bbrc.1998.8516; SUGIYAMA T, 1987, BLOOD, V69, P1712; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2001, BLOOD, V98, P3708, DOI 10.1182/blood.V98.13.3708; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Takizawa H, 2010, J CLIN INVEST, V120, P179, DOI 10.1172/JCI39503; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d	34	179	182	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24494	24507		10.1074/jbc.M110.130575	http://dx.doi.org/10.1074/jbc.M110.130575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20525685	hybrid, Green Published			2022-12-25	WOS:000280542100022
J	Snyder, M; Huang, XY; Zhang, JJ				Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian			Stat3 Directly Controls the Expression of Tbx5, Nkx2.5, and GATA4 and Is Essential for Cardiomyocyte Differentiation of P19CL6 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; SIGNAL TRANSDUCERS; DNA-BINDING; GENE; HEART; GROWTH; ACTIVATION; ROLES; INHIBITION	The transcription factor Stat3 (signal transducer and activator of transcription 3) mediates many physiological processes, including embryogenesis, stem cell self-renewal, and postnatal survival. In response to gp130 receptor activation, Stat3 becomes phosphorylated by the receptor-associated Janus kinase, forms dimers, and enters the nucleus where it binds to Stat3 target genes and regulates their expression. In this report, we demonstrate that Stat3 binds directly to the promoters and regulates the expression of three genes that are essential for cardiac differentiation: Tbx5, Nkx2.5, and GATA4. We further demonstrate that Tbx5, Nkx2.5, and GATA4 expression is dependent on Stat3 in response to ligand treatment and during ligand-independent differentiation of P19CL6 cells into cardiomyocytes. Finally, we show that Stat3 is necessary for the differentiation of P19CL6 cells into beating cardiomyocytes. All together, these results demonstrate that Stat3 is required for the differentiation of cardiomyocytes through direct transcriptional regulation of Tbx5, Nkx2.5, and GATA4.	[Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10065 USA	Cornell University	Zhang, JJ (corresponding author), Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, 1300 York Ave, New York, NY 10065 USA.	jjz2002@med.cornell.edu			National Institutes of Health [HL091525]; American Heart Association [0455896T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL091525 (to X.-Y.H.). This work was also supported by American Heart Association Grant 0455896T (to J.J.Z.).	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Aparicio OM, 2005, CURR PROTOC MOL BIOL; Becker S, 1998, FEBS LETT, V441, P141, DOI 10.1016/S0014-5793(98)01543-9; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Foshay K, 2005, STEM CELLS, V23, P530, DOI 10.1634/stemcells.2004-0293; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Grepin C, 1997, DEVELOPMENT, V124, P2387; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101, DOI 10.1247/csf.21.101; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Hatcher CJ, 2004, PHYSIOL GENOMICS, V18, P129, DOI 10.1152/physiolgenomics.00060.2004; Hatcher CJ, 2003, TRENDS MOL MED, V9, P512, DOI 10.1016/j.molmed.2003.10.004; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Horb ME, 1999, DEVELOPMENT, V126, P1739; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kataoka Y, 2003, J BIOL CHEM, V278, P44178, DOI 10.1074/jbc.M304884200; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Liu TH, 2005, CURR APPL PHYS, V5, P218, DOI 10.1016/j.cap.2003.11.089; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Snyder M, 2009, J BIOL CHEM, V284, P13466, DOI 10.1074/jbc.M809471200; Sun W, 2006, FEBS LETT, V580, P5880, DOI 10.1016/j.febslet.2006.09.054; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	54	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23639	23646		10.1074/jbc.M110.101063	http://dx.doi.org/10.1074/jbc.M110.101063			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20522556	Green Published, hybrid			2022-12-25	WOS:000280291400014
J	Zamborlini, A; Renault, N; Saib, A; Delelis, O				Zamborlini, Alessia; Renault, Noemie; Saib, Ali; Delelis, Olivier			Early Reverse Transcription Is Essential for Productive Foamy Virus Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY; HUMAN MACROPHAGES; HIV-1 INTEGRASE; GAG PROTEIN; TYPE-1 DNA; REPLICATION; EXPRESSION; CLEAVAGE; CIRCLES; GENOME	Background: Although viral RNA constitutes the majority of nucleic acids packaged in virions, a late occurring step of reverse transcription leads to the presence of infectious viral cDNA in foamy virus particles. This peculiarity distinguishes them from the rest of the retroviral family. Principal Findings: To evaluate the respective contribution of these viral nucleic acids in the replication of foamy viruses, their fate was studied by real-time PCR and RT-PCR early after infection, in the presence or in the absence of AZT. We found that an early reverse transcription step, which occurs during the first hours post-entry, is absolutely required for productive infection. Remarkably, sensitivity to AZT can be counteracted by increasing the multiplicity of infection (moi). We also show that 2-LTR circular viral DNA, which appears as soon as four hours post-infection, is transcriptionally competent. Conclusion: Taken together, our data demonstrate that an early reverse transcription process, which takes place soon after viral entry, is indispensable for infectivity of FVs at low moi, when the amount of DNA-containing particles is not sufficient to lead to a productive infection. This study demonstrates a key role of the packaged viral RNA in the foamy virus infection, suggesting that the replication of this virus can be achieved by involving either viral DNA or RNA genome, depending on the condition of infection.	[Zamborlini, Alessia; Renault, Noemie; Saib, Ali] Univ Paris Diderot, CNRS, INSERM, Inst Univ Hematol,UMR7212,U944, Paris, France; [Saib, Ali] Conservatoire Natl Arts & Metiers, Chaire Biol, Paris, France; [Delelis, Olivier] ENS Cachan, CNRS, LBPA, Cachan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Zamborlini, A (corresponding author), Univ Paris Diderot, CNRS, INSERM, Inst Univ Hematol,UMR7212,U944, Paris, France.	delelis@lbpa.ens-cachan.fr	Zamborlini, Alessia/ABE-2256-2021	Zamborlini, Alessia/0000-0002-8902-1996	Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS); F. Lacoste	Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); F. Lacoste	This work is supported by the Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) and by F. Lacoste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banda M, 2008, MUTAT RES-GEN TOX EN, V649, P126, DOI 10.1016/j.mrgentox.2007.08.005; Brussel A, 2004, J VIROL, V78, P11263, DOI 10.1128/JVI.78.20.11263-11271.2004; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; Delelis O, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-31; Delelis O, 2004, CURR OPIN MICROBIOL, V7, P400, DOI 10.1016/j.mib.2004.06.009; Delelis O, 2003, J VIROL, V77, P8141, DOI 10.1128/JVI.77.14.8141-8146.2003; Delelis Olivier, 2005, Methods Mol Biol, V304, P155; Delelis O, 2008, J BIOL CHEM, V283, P27838, DOI 10.1074/jbc.M803257200; Delelis O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000608; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Flugel RM, 2003, CURR TOP MICROBIOL, V277, P63; Gillim-Ross L, 2005, VIRAL IMMUNOL, V18, P190, DOI 10.1089/vim.2005.18.190; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; KLOTMAN ME, 1992, P NATL ACAD SCI USA, V89, P1148, DOI 10.1073/pnas.89.3.1148b; Lehmann-Che J, 2005, J VIROL, V79, P9244, DOI 10.1128/JVI.79.14.9244-9253.2005; Lo YT, 2010, J VIROL, V84, P2832, DOI 10.1128/JVI.02435-09; Merkulov GV, 1996, J VIROL, V70, P5548, DOI 10.1128/JVI.70.8.5548-5556.1996; Moebes A, 1997, J VIROL, V71, P7305, DOI 10.1128/JVI.71.10.7305-7311.1997; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Poon B, 2007, J VIROL, V81, P10515, DOI 10.1128/JVI.00947-07; Rinke CS, 2002, J VIROL, V76, P7560, DOI 10.1128/JVI.76.15.7560-7570.2002; Roy J, 2003, J VIROL, V77, P11324, DOI 10.1128/JVI.77.21.11324-11331.2003; Tobaly-Tapiero J, 2001, J VIROL, V75, P4367, DOI 10.1128/JVI.75.9.4367-4375.2001; Tobaly-Tapiero J, 2008, TRAFFIC, V9, P1717, DOI 10.1111/j.1600-0854.2008.00792.x; Trobridge GD, 1998, HUM GENE THER, V9, P2517, DOI 10.1089/10430349850019355; TRONO D, 1992, J VIROL, V66, P4893, DOI 10.1128/JVI.66.8.4893-4900.1992; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Wu YT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-61; Yu SF, 1996, SCIENCE, V271, P1579, DOI 10.1126/science.271.5255.1579; Yu SF, 1999, J VIROL, V73, P1565, DOI 10.1128/JVI.73.2.1565-1572.1999; YU SF, 1993, J VIROL, V67, P6618, DOI 10.1128/JVI.67.11.6618-6624.1993	32	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11023	10.1371/journal.pone.0011023	http://dx.doi.org/10.1371/journal.pone.0011023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552014	Green Published, gold, Green Submitted			2022-12-25	WOS:000278662900006
J	Li, AH; Waddell, SJ; Hinds, J; Malloff, CA; Bains, M; Hancock, RE; Lam, WL; Butcher, PD; Stokes, RW				Li, Alice H.; Waddell, Simon J.; Hinds, Jason; Malloff, Chad A.; Bains, Manjeet; Hancock, Robert E.; Lam, Wan L.; Butcher, Philip D.; Stokes, Richard W.			Contrasting Transcriptional Responses of a Virulent and an Attenuated Strain of Mycobacterium tuberculosis Infecting Macrophages	PLOS ONE			English	Article							GENOMIC ANALYSIS; GENE-EXPRESSION; BOVIS BCG; 2-COMPONENT SYSTEM; MURINE MACROPHAGES; ESCHERICHIA-COLI; HYPOXIC RESPONSE; TUBERCLE-BACILLI; INTERFERON-GAMMA; REGULATOR PHOP	Background: H37Rv and H37Ra are well-described laboratory strains of Mycobacterium tuberculosis derived from the same parental strain, H37, that show dramatically different pathogenic phenotypes. Methodology/Principal Findings: In this study, the transcriptomes of the two strains during axenic growth in broth and during intracellular growth within murine bone-marrow macrophages were compared by whole genome expression profiling. We identified and compared adaptations of either strain upon encountering an intracellular environment, and also contrasted the transcriptomes of the two strains while inside macrophages. In the former comparison, both strains induced genes that would facilitate intracellular survival including those involved in mycobactin synthesis and fatty acid metabolism. However, this response was stronger and more extensive for H37Rv than for H37Ra. This was manifested as the differential expression of a greater number of genes and an increased magnitude of expression for these genes in H37Rv. In comparing intracellular transcriptional signatures, fifty genes were found to be differentially expressed between the strains. Of these fifty, twelve were under control of the PhoPR regulon. Further differences between strains included genes whose products were members of the ESAT-6 family of proteins, or were associated with their secretion. Conclusions/Significance: Along with the recent identification of single nucleotide polymorphisms in H37Ra when compared to H37Rv, our demonstration of differential expression of PhoP-regulated and ESX-1 region-related genes during macrophage infection further highlights the significance of these genes in the attenuation of H37Ra.	[Li, Alice H.; Malloff, Chad A.; Lam, Wan L.; Stokes, Richard W.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Stokes, Richard W.] Univ British Columbia, Dept Paediat, Vancouver, BC, Canada; [Bains, Manjeet; Hancock, Robert E.; Stokes, Richard W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Stokes, Richard W.] British Columbia Childrens Hosp, Div Infect Dis, Vancouver, BC, Canada; [Waddell, Simon J.; Hinds, Jason; Butcher, Philip D.] St Georges Univ London, Div Cellular & Mol Med, Dept Med Microbiol, Ctr Infect, London, England	University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; St Georges University London	Li, AH (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.	rstokes@interchange.ubc.ca	Waddell, Simon J/A-9170-2013; Hancock, Robert E. W./E-1145-2013	Waddell, Simon J/0000-0002-3684-9116; Hancock, Robert E. W./0000-0001-5989-8503; Butcher, Philip/0000-0003-1223-9097; Hinds, Jason/0000-0002-2739-1908	Canadian Bacterial Diseases Network, Networks of Centres of Excellence; British Columbia Lung Association; British Columbia TB Vets Foundation; Child and Family Research Institute; Department of Pathology, University of British Columbia; MRC [G0802079] Funding Source: UKRI; Medical Research Council [G0802079] Funding Source: researchfish	Canadian Bacterial Diseases Network, Networks of Centres of Excellence; British Columbia Lung Association; British Columbia TB Vets Foundation; Child and Family Research Institute; Department of Pathology, University of British Columbia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Canadian Bacterial Diseases Network, Networks of Centres of Excellence, the British Columbia Lung Association, and the British Columbia TB Vets Foundation. R. W. S. is the recipient of a Child and Family Research Institute Investigatorship Award. A. L. was supported by a Hardwick Fellowship from the Department of Pathology, University of British Columbia and a graduate fellowship from the Child and Family Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Belisle JT, 1998, METH MOL B, V101, P31, DOI 10.1385/0-89603-471-2:31; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bolhuis A, 1999, J BIOL CHEM, V274, P24585, DOI 10.1074/jbc.274.35.24585; Brandt L, 1996, J IMMUNOL, V157, P3527; Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS FM, 1969, AM REV RESPIR DIS, V100, P631; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Dullaghan EM, 2002, MICROBIOL-SGM, V148, P3111, DOI 10.1099/00221287-148-10-3111; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Elhay MJ, 1998, INFECT IMMUN, V66, P3454, DOI 10.1128/IAI.66.7.3454-3456.1998; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gao Q, 2004, TUBERCULOSIS, V84, P188, DOI 10.1016/j.tube.2003.12.013; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; GOREN MB, 1974, INFECT IMMUN, V9, P142, DOI 10.1128/IAI.9.1.142-149.1974; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; IMAEDA T, 1985, INT J SYST BACTERIOL, V35, P147, DOI 10.1099/00207713-35-2-147; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Junqueira-Kipnis AP, 2006, IMMUNOLOGY, V119, P224, DOI 10.1111/j.1365-2567.2006.02427.x; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Lari N, 2001, J MED MICROBIOL, V50, P805, DOI 10.1099/0022-1317-50-9-805; LARSON CL, 1964, AM REV RESPIR DIS, V90, P742; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Li AH, 2008, MICROBIOL-SGM, V154, P2291, DOI 10.1099/mic.0.2008/019661-0; Li AH, 2008, J MICROBIOL METH, V75, P416, DOI 10.1016/j.mimet.2008.07.008; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; MADIGAN MT, 1997, BROCK BIOL MICROORGA, P136; Madigan MT, 1997, BROCK BIOL MICROORGA, P473; MANGAN JA, 2002, GENE EXPRESSION HOST, P137; Marrakchi H, 2002, MICROBIOL-SGM, V148, P951, DOI 10.1099/00221287-148-4-951; Menendez MD, 2005, J BACTERIOL, V187, P534, DOI 10.1128/JB.187.2.534-543.2005; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Mostowy S, 2004, TUBERCULOSIS, V84, P197, DOI 10.1016/j.tube.2004.02.002; Mustafa AS, 2006, INFECT IMMUN, V74, P4566, DOI 10.1128/IAI.01660-05; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Pollock JM, 1997, INFECT IMMUN, V65, P2587, DOI 10.1128/IAI.65.7.2587-2592.1997; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rivera-Marrero CA, 1998, MICROB PATHOGENESIS, V25, P307, DOI 10.1006/mpat.1998.0235; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rooyakkers AWJ, 2005, MICROB PATHOGENESIS, V39, P57, DOI 10.1016/j.micpath.2005.05.001; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 1999, BIOFACTORS, V10, P211, DOI 10.1002/biof.5520100219; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Soto CY, 2002, J CLIN MICROBIOL, V40, P3021, DOI 10.1128/JCM.40.8.3021-3024.2002; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STEENKEN W, 1946, AM REV TUBERC PULM, V54, P62; STEENKEN W, 1961, AM REV RESPIR DIS, V83, P550; Stokes RW, 2009, FUTURE MICROBIOL, V4, P1317, DOI [10.2217/fmb.09.94, 10.2217/FMB.09.94]; STOKES RW, 1993, J IMMUNOL, V151, P7067; Stokes RW, 1998, J IMMUNOL, V160, P5514; Stokes RW, 1999, CELL IMMUNOL, V197, P1, DOI 10.1006/cimm.1999.1554; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Teng F, 2002, INFECT IMMUN, V70, P1991, DOI 10.1128/IAI.70.4.1991-1996.2002; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Waddell S. J., 2008, V465, P83, DOI 10.1007/978-1-59745-207-6_6; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	88	36	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11066	10.1371/journal.pone.0011066	http://dx.doi.org/10.1371/journal.pone.0011066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548782	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000278599600022
J	Moore, AZ; Biggs, ML; Matteini, A; O'Connor, A; McGuire, S; Beamer, BA; Fallin, MD; Fried, LP; Walston, J; Chakravarti, A; Arking, DE				Moore, Ann Z.; Biggs, Mary L.; Matteini, Amy; O'Connor, Ashley; McGuire, Sarah; Beamer, Brock A.; Fallin, M. Danielle; Fried, Linda P.; Walston, Jeremy; Chakravarti, Aravinda; Arking, Dan E.			Polymorphisms in the Mitochondrial DNA Control Region and Frailty in Older Adults	PLOS ONE			English	Article							METABOLIC-RATE; FREE-RADICALS; DISEASES; REPLICATION; PHENOTYPE; LONGEVITY; PARADIGM; VARIANT; CANCER; RISK	Background: Mitochondria contribute to the dynamics of cellular metabolism, the production of reactive oxygen species, and apoptotic pathways. Consequently, mitochondrial function has been hypothesized to influence functional decline and vulnerability to disease in later life. Mitochondrial genetic variation may contribute to altered susceptibility to the frailty syndrome in older adults. Methodology/Principal Findings: To assess potential mitochondrial genetic contributions to the likelihood of frailty, mitochondrial DNA (mtDNA) variation was compared in frail and non-frail older adults. Associations of selected SNPs with a muscle strength phenotype were also explored. Participants were selected from the Cardiovascular Health Study (CHS), a population-based observational study (1989-1990, 1992-1993). At baseline, frailty was identified as the presence of three or more of five indicators (weakness, slowness, shrinking, low physical activity, and exhaustion). mtDNA variation was assessed in a pilot study, including 315 individuals selected as extremes of the frailty phenotype, using an oligonucleotide sequencing microarray based on the Revised Cambridge Reference Sequence. Three mtDNA SNPs were statistically significantly associated with frailty across all pilot participants or in sex-stratified comparisons: mt146, mt204, and mt228. In addition to pilot participants, 4,459 additional men and women with frailty classifications, and an overlapping subset of 4,453 individuals with grip strength measurements, were included in the study population genotyped at mt204 and mt228. In the study population, the mt204 C allele was associated with greater likelihood of frailty (adjusted odds ratio = 2.04, 95% CI = 1.07-3.60, p = 0.020) and lower grip strength (adjusted coefficient = 22.04, 95% CI = 23.33-20.74, p = 0.002). Conclusions: This study supports a role for mitochondrial genetic variation in the frailty syndrome and later life muscle strength, demonstrating the importance of the mitochondrial genome in complex geriatric phenotypes.	[Moore, Ann Z.; Matteini, Amy; Fallin, M. Danielle] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Biggs, Mary L.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [O'Connor, Ashley; McGuire, Sarah; Chakravarti, Aravinda; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Beamer, Brock A.] Univ Maryland, Sch Med, Div Gerontol, Baltimore, MD 21201 USA; [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Walston, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Columbia University; Johns Hopkins University	Moore, AZ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	arking@jhmi.edu			National Institute on Aging, Claude D. Pepper Older Americans Independence Centers [P30 AG021334]; National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; National Institute of Neurological Disorders and Stroke; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045133, N01HC075150, N01HC055222, N01HC085079, N01HC015103, N01HC035129, N01HC085086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021334] Funding Source: NIH RePORTER	National Institute on Aging, Claude D. Pepper Older Americans Independence Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging, Claude D. Pepper Older Americans Independence Centers, Grant P30 AG021334 and by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant number U01 HL080295 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MITOMAP HUM MIT GEN; BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Liu VWS, 2003, HUM MUTAT, V22, P173, DOI 10.1002/humu.10244; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ruggiero C, 2006, J GERONTOL A-BIOL, V61, P466, DOI 10.1093/gerona/61.5.466; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; TAPPER DP, 1981, J BIOL CHEM, V256, P5109; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008	26	33	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11069	10.1371/journal.pone.0011069	http://dx.doi.org/10.1371/journal.pone.0011069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548781	Green Submitted, gold, Green Published			2022-12-25	WOS:000278599600025
J	Cuamba, N; Morgan, JC; Irving, H; Steven, A; Wondji, CS				Cuamba, Nelson; Morgan, John C.; Irving, Helen; Steven, Andrew; Wondji, Charles S.			High Level of Pyrethroid Resistance in an Anopheles funestus Population of the Chokwe District in Mozambique	PLOS ONE			English	Article							AFRICAN MALARIA VECTOR; INSECTICIDE RESISTANCE; CULICIDAE; MOSQUITO; DIPTERA	Background: Although Anopheles funestus is difficult to rear, it is crucial to analyse field populations of this malaria vector in order to successfully characterise mechanisms of insecticide resistance observed in this species in Africa. In this study we carried out a large-scale field collection and rearing of An. funestus from Mozambique in order to analyse its susceptibility status to insecticides and to broadly characterise the main resistance mechanisms involved in natural populations. Methodology/Principal Findings: 3,000 F(1) adults were obtained through larval rearing. WHO susceptibility assays indicated a very high resistance to pyrethroids with no mortality recorded after 1h30min exposure and less than 50% mortality at 3h30min. Resistance to the carbamate, bendiocarb was also noted, with 70% mortality after 1h exposure. In contrast, no DDT resistance was observed, indicating that no kdr-type resistance was involved. The sequencing of the acetylcholinesterase gene indicated the absence of the G119S and F455W mutations associated with carbamate and organophosphate resistance. This could explain the absence of malathion resistance in this population. Both biochemical assays and quantitative PCR implicated up-regulated P450 genes in pyrethroid resistance, with GSTs playing a secondary role. The carbamate resistance observed in this population is probably conferred by the observed altered AChE with esterases also involved. Conclusion/Significance: The high level of pyrethroid resistance in this population despite the cessation of pyrethroid use for IRS in 1999 is a serious concern for resistance management strategies such as rotational use of insecticides. As DDT has now been re-introduced for IRS, susceptibility to DDT needs to be closely monitored to prevent the appearance and spread of resistance to this insecticide.	[Cuamba, Nelson] Natl Inst Hlth, Maputo, Mozambique; [Morgan, John C.; Irving, Helen; Steven, Andrew; Wondji, Charles S.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Cuamba, N (corresponding author), Natl Inst Hlth, Maputo, Mozambique.	c.s.wondji@liverpool.ac.uk	Wondji, Charles/AAG-1510-2020	Wondji, Charles S./0000-0003-0791-3673	Wellcome Trust; WHO/Gates Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); WHO/Gates Foundation(World Health OrganizationBill & Melinda Gates Foundation)	This work was supported by a Wellcome Trust Research Career Development Fellowship to CSW. NC was supported by a WHO/Gates Foundation Vector Biology and Control project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; [Anonymous], 1968, ANOPHELINAE AFR S SA; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Casimiro S, 2006, J MED ENTOMOL, V43, P267, DOI 10.1603/0022-2585(2006)043[0267:IRIAFD]2.0.CO;2; Casimiro SLR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-142; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Nabeshima T, 2004, BIOCHEM BIOPH RES CO, V313, P794, DOI 10.1016/j.bbrc.2003.11.141; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; *WHO, 1998, WHOCDSCPCMAL9812D; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	17	95	96	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11010	10.1371/journal.pone.0011010	http://dx.doi.org/10.1371/journal.pone.0011010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544036	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000278494900022
J	Hayakawa, I; Kawasaki, H				Hayakawa, Itaru; Kawasaki, Hiroshi			Rearrangement of Retinogeniculate Projection Patterns after Eye-Specific Segregation in Mice	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; VESICULAR GLUTAMATE TRANSPORTERS; EXPERIENCE-DEPENDENT PLASTICITY; RETINAL GANGLION-CELLS; PRIMARY VISUAL-CORTEX; SUPERIOR COLLICULUS; NEUROTROPHIC FACTOR; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; PRENATAL DEVELOPMENT	It has been of interest whether and when the rearrangement of neuronal circuits can be induced after projection patterns are formed during development. Earlier studies using cats reported that the rearrangement of retinogeniculate projections could be induced even after eye-specific segregation has occurred, but detailed and quantitative characterization of this rearrangement has been lacking. Here we delineate the structural changes of retinogeniculate projections in the C57BL/6 mouse in response to monocular enucleation (ME) after eye-specific segregation. When ME was performed after eye-specific segregation, rearrangement of retinogeniculate axons in the dorsal lateral geniculate nucleus (dLGN) was observed within 5 days. Although this rearrangement was observed both along the dorsomedial-ventrolateral and outer-inner axes in the dLGN, it occurred more rapidly along the outer-inner axis. We also examined the critical period for this rearrangement and found that the rearrangement became almost absent by the beginning of the critical period for ocular dominance plasticity in the primary visual cortex. Taken together, our findings serve as a framework for the assessment of phenotypes of genetically altered mouse strains as well as provide insights into the mechanisms underlying the rearrangement of retinogeniculate projections.	[Hayakawa, Itaru; Kawasaki, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Mol & Syst Neurobiol, Tokyo, Japan; [Hayakawa, Itaru; Kawasaki, Hiroshi] Univ Tokyo, Global COE Program, Comprehens Ctr Educ & Res Chem Biol Dis, Tokyo, Japan; [Hayakawa, Itaru; Kawasaki, Hiroshi] Univ Tokyo, 21st Century COE Program, Ctr Integrated Brain Med Sci, Tokyo, Japan; [Kawasaki, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Hayakawa, I (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol & Syst Neurobiol, Tokyo, Japan.	kawasaki@m.u-tokyo.ac.jp	Kawasaki, Hiroshi/C-4404-2015; KAWASAKI, Hiroshi/L-3736-2015	Kawasaki, Hiroshi/0000-0002-2514-1497; Hayakawa, Itaru/0000-0002-6384-0205	MEXT; Japan Science and Technology Agency (JST); Human Frontier Science Program (HFSP)	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Human Frontier Science Program (HFSP)(Human Frontier Science Program)	This work was supported by the global COE program "Comprehensive Center of Education and Research for Chemical Biology of the Diseases'' from MEXT, the 21st Century COE program "Center for Integrated Brain Medical Sciences'' from MEXT, Grant-in-Aid for Scientific Research on Priority Areas-Elucidation of neural network function in the brain from MEXT, PRESTO from Japan Science and Technology Agency (JST), and Human Frontier Science Program (HFSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Albright TD, 2000, CELL, V100, pS1; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Caleo M, 2000, CURR BIOL, V10, P1155, DOI 10.1016/S0960-9822(00)00713-2; Coleman JE, 2009, NEUROSCIENCE, V161, P561, DOI 10.1016/j.neuroscience.2009.03.045; Conner JM, 1997, J NEUROSCI, V17, P2295; Cramer Karina S., 1995, Current Opinion in Neurobiology, V5, P106, DOI 10.1016/0959-4388(95)80094-8; Cramer KS, 1999, DEV BRAIN RES, V116, P79, DOI 10.1016/S0165-3806(99)00077-2; Cramer KS, 1997, DEV BRAIN RES, V98, P287, DOI 10.1016/S0165-3806(96)00188-5; Demas J, 2003, J NEUROSCI, V23, P2851; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fujiyama F, 2003, J COMP NEUROL, V465, P234, DOI 10.1002/cne.10848; FUKUDA Y, 1983, J NEUROPHYSIOL, V50, P46, DOI 10.1152/jn.1983.50.1.46; GODEMENT P, 1980, J COMP NEUROL, V190, P611, DOI 10.1002/cne.901900402; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guido W., 2006, DEV PLASTICITY SENSO, P208; GUILLERY RW, 1972, J COMP NEUROL, V146, P407, DOI 10.1002/cne.901460306; Hahm JO, 1999, J COMP NEUROL, V411, P327, DOI 10.1002/(SICI)1096-9861(19990823)411:2<327::AID-CNE12>3.0.CO;2-#; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HICKEY TL, 1975, J COMP NEUROL, V161, P359, DOI 10.1002/cne.901610307; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Iwai L, 2009, NEUROSCIENCE, V159, P1326, DOI 10.1016/j.neuroscience.2009.02.010; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; JEFFERY G, 1984, DEV BRAIN RES, V13, P81, DOI 10.1016/0165-3806(84)90079-8; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawasaki H, 2004, J NEUROSCI, V24, P9962, DOI 10.1523/JNEUROSCI.2165-04.2004; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; LACHICA EA, 1990, J COMP NEUROL, V296, P303, DOI 10.1002/cne.902960210; Land PW, 2004, BRAIN RES, V996, P251, DOI 10.1016/j.brainres.2003.10.032; Leamey CA, 2003, J NEUROBIOL, V56, P153, DOI 10.1002/neu.10226; Leamey CA, 2001, J NEUROSCI, V21, P3871, DOI 10.1523/JNEUROSCI.21-11-03871.2001; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; LUND RD, 1973, BRAIN BEHAV EVOLUT, V8, P51, DOI 10.1159/000124347; LUND RD, 1971, SCIENCE, V171, P804, DOI 10.1126/science.171.3973.804; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Mimura Y, 2002, NEUROREPORT, V13, P1925, DOI 10.1097/00001756-200210280-00019; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; OGAWAMEGURO R, 1992, EXP BRAIN RES, V89, P59; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; REESE BE, 1988, BRAIN RES REV, V13, P119, DOI 10.1016/0165-0173(88)90017-3; ROBSON JA, 1978, SCIENCE, V201, P635, DOI 10.1126/science.675248; ROBSON JA, 1981, J COMP NEUROL, V195, P453, DOI 10.1002/cne.901950306; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; STRYKER MP, 1983, J NEUROSCI, V3, P1943; SUR M, 1982, NATURE, V300, P183, DOI 10.1038/300183a0; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Toda T, 2008, MOL CELL NEUROSCI, V39, P40, DOI 10.1016/j.mcn.2008.05.014; Toldi J, 1996, PROG NEUROBIOL, V48, P191, DOI 10.1016/0301-0082(95)00038-0; Upton AL, 1999, J NEUROSCI, V19, P7007, DOI 10.1523/JNEUROSCI.19-16-07007.1999; Williams AL, 2001, J COMP NEUROL, V430, P332; Yoshida M, 2009, NEUROSCI RES, V64, P118, DOI 10.1016/j.neures.2009.02.002	64	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11001	10.1371/journal.pone.0011001	http://dx.doi.org/10.1371/journal.pone.0011001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544023	Green Published, gold, Green Submitted			2022-12-25	WOS:000278494900013
J	Lin, GHY; Liu, YQ; Ambagala, T; Kwon, BS; Ohashi, PS; Watts, TH				Lin, Gloria H. Y.; Liu, Yuanqing; Ambagala, Thanuja; Kwon, Byoung S.; Ohashi, Pamela S.; Watts, Tania H.			Evaluating the Cellular Targets of Anti-4-1BB Agonist Antibody during Immunotherapy of a Pre-Established Tumor in Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; SUPERIOR ANTITUMOR IMMUNITY; 4-1BB LIGAND; IN-VIVO; DENDRITIC CELLS; CUTTING EDGE; MONOCLONAL-ANTIBODIES; CANCER-IMMUNOTHERAPY; ENHANCED SURVIVAL; MEMORY CELLS	Background: Manipulation of the immune system represents a promising avenue for cancer therapy. Rational advances in immunotherapy of cancer will require an understanding of the precise correlates of protection. Agonistic antibodies against the tumor necrosis factor receptor family member 4-1BB are emerging as a promising tool in cancer therapy, with evidence that these antibodies expand both T cells as well as innate immune cells. Depletion studies have suggested that several cell types can play a role in these immunotherapeutic regimens, but do not reveal which cells must directly receive the 4-1BB signals for effective therapy. Methodology/Principal Findings: We show that re-activated memory T cells are superior to resting memory T cells in control of an 8-day pre-established E.G7 tumor in mice. We find that ex vivo activation of the memory T cells allows the activated effectors to continue to divide and enter the tumor, regardless of antigen-specificity; however, only antigen-specific reactivated memory T cells show any efficacy in tumor control. When agonistic anti-4-1BB antibody is combined with this optimized adoptive T cell therapy, 80% of mice survive and are fully protected from tumor rechallenge. Using 4-1BB-deficient mice and mixed bone marrow chimeras, we find that it is sufficient to have 4-1BB only on the endogenous host alpha beta T cells or only on the transferred T cells for the effects of anti-4-1BB to be realized. Conversely, although multiple immune cell types express 4-1BB and both T cells and APC expand during anti-4-1BB therapy, 4-1BB on cells other than alpha beta T cells is neither necessary nor sufficient for the effect of anti-4-1BB in this adoptive immunotherapy model. Conclusions/Significance: This study establishes alpha beta T cells rather than innate immune cells as the critical target in anti-4-1BB therapy of a pre-established tumor. The study also demonstrates that ex vivo activation of memory T cells prior to infusion allows antigen-specific tumor control without the need for reactivation of the memory T cells in the tumor.	[Lin, Gloria H. Y.; Liu, Yuanqing; Ambagala, Thanuja; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Kwon, Byoung S.] Natl Canc Ctr, Cell & Immunobiol & R&D Ctr Canc Therapeut, Ilsan, South Korea; [Ohashi, Pamela S.] Princess Margaret Hosp, Campbell Family Canc Res Inst, Toronto, ON M4X 1K9, Canada; [Kwon, Byoung S.] Tulane Univ, Dept Med, New Orleans, LA 70118 USA	University of Toronto; National Cancer Center - Korea (NCC); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Tulane University	Lin, GHY (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tania.watts@utoronto.ca		Ohashi, Pamela S./0000-0003-2915-9317	Canadian Cancer Society [018119]; National Cancer Center [NCC-0890830-3]; Korean Research Foundation [KRF-2005-084-E00001]; Ontario Graduate scholarship; Canadian Institutes of Health	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Cancer Center; Korean Research Foundation(National Research Foundation of Korea); Ontario Graduate scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This research was supported by grant # 018119 from the Canadian Cancer Society http://www.ncic.cancer.ca (to T. H. W). B.S.K.'s lab is supported by grants from the National Cancer Center, NCC-0890830-3 and Korean Research Foundation, KRF-2005-084-E00001. G.H.Y.L. was supported by an Ontario Graduate scholarship and a Canadian Institutes of Health research studentship. T. H. W. holds the Sanofi Pasteur chair in Human Immunology at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; BUDHU S, J EXP MED, V207, P223; BUDHU S, J EXP MED, V207, pS221; Bukczynski J, 2004, P NATL ACAD SCI USA, V101, P1291, DOI 10.1073/pnas.0306567101; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Cheuk ATC, 2004, CANCER GENE THER, V11, P215, DOI 10.1038/sj.cgt.7700670; Choi BK, 2009, J IMMUNOL, V182, P4107, DOI 10.4049/jimmunol.0800459; DUBROT J, CANC IMMUNOL IMMUNOT; Ehrenstein MR, 2007, J EXP MED, V204, P2249, DOI 10.1084/jem.20071737; Futagawa T, 2002, INT IMMUNOL, V14, P275, DOI 10.1093/intimm/14.3.275; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gorak-Stolinska P, 2001, J LEUKOCYTE BIOL, V70, P756; Hermans IF, 1998, CANCER RES, V58, P3909; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houot R, 2009, BLOOD, V114, P3431, DOI 10.1182/blood-2009-05-223958; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Ito F, 2004, CANCER RES, V64, P8411, DOI 10.1158/0008-5472.CAN-04-0590; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Klebanoff CA, 2009, BLOOD, V114, P1776, DOI 10.1182/blood-2008-12-192419; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Li Q, 2007, INT J BIOL SCI, V3, P455; Lin GHY, 2009, J IMMUNOL, V182, P934, DOI 10.4049/jimmunol.182.2.934; Lynch DH, 2008, IMMUNOL REV, V222, P277, DOI 10.1111/j.1600-065X.2008.00621.x; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Martinet O, 2000, J NATL CANCER I, V92, P931, DOI 10.1093/jnci/92.11.931; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 1998, CELL IMMUNOL, V190, P167, DOI 10.1006/cimm.1998.1396; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Miller RE, 2002, J IMMUNOL, V169, P1792, DOI 10.4049/jimmunol.169.4.1792; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Murillo O, 2009, EUR J IMMUNOL, V39, P2424, DOI 10.1002/eji.200838958; Myers L, 2006, INT IMMUNOL, V18, P325, DOI 10.1093/intimm/dxh371; NARAZAKI H, 1941, BLOOD, P115; Niu LG, 2007, J IMMUNOL, V178, P4194, DOI 10.4049/jimmunol.178.7.4194; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Pan PY, 2004, J IMMUNOL, V172, P4779, DOI 10.4049/jimmunol.172.8.4779; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pulle G, 2006, J IMMUNOL, V176, P2739, DOI 10.4049/jimmunol.176.5.2739; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Rolle CE, 2008, CANCER RES, V68, P2984, DOI 10.1158/0008-5472.CAN-07-3040; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Spaner D, 1998, J IMMUNOL, V160, P2655; Stephan MT, 2007, NAT MED, V13, P1440, DOI 10.1038/nm1676; Takahashi C, 1999, J IMMUNOL, V162, P5037; TAMMANA S, 2009, HUM GENE THER; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Xu DP, 2004, INT J CANCER, V109, P499, DOI 10.1002/ijc.11696; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zhu YW, 2007, BLOOD, V109, P4882, DOI 10.1182/blood-2006-10-043463	64	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11003	10.1371/journal.pone.0011003	http://dx.doi.org/10.1371/journal.pone.0011003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543982	Green Published, Green Submitted, gold			2022-12-25	WOS:000278494900015
J	Miklavc, P; Frick, M; Wittekindt, OH; Haller, T; Dietl, P				Miklavc, Pika; Frick, Manfred; Wittekindt, Oliver H.; Haller, Thomas; Dietl, Paul			Fusion-Activated Ca2+ Entry: An "Active Zone'' of Elevated Ca2+ during the Postfusion Stage of Lamellar Body Exocytosis in Rat Type II Pneumocytes	PLOS ONE			English	Article							MEMBRANE-FUSION; COMPENSATORY ENDOCYTOSIS; NEUROENDOCRINE CELLS; REGULATED EXOCYTOSIS; SURFACTANT RELEASE; PORE EXPANSION; VESICLE FUSION; CALCIUM; MECHANISMS; SECRETION	Background: Ca2+ is essential for vesicle fusion with the plasma membrane in virtually all types of regulated exocytoses. However, in contrast to the well-known effects of a high cytoplasmic Ca2+ concentration ([Ca2+](c)) in the prefusion phase, the occurrence and significance of Ca2+ signals in the postfusion phase have not been described before. Methodology/Principal Findings: We studied isolated rat alveolar type II cells using previously developed imaging techniques. These cells release pulmonary surfactant, a complex of lipids and proteins, from secretory vesicles (lamellar bodies) in an exceptionally slow, Ca2+- and actin-dependent process. Measurements of fusion pore formation by darkfield scattered light intensity decrease or FM 1-43 fluorescence intensity increase were combined with analysis of [Ca2+](c) by ratiometric Fura-2 or Fluo-4 fluorescence measurements. We found that the majority of single lamellar body fusion events were followed by a transient (t(1/2) of decay - 3.2 s) rise of localized [Ca2+](c) originating at the site of lamellar body fusion. [Ca2+](c) increase followed with a delay of similar to 0.2-0.5 s (method-dependent) and in the majority of cases this signal propagated throughout the cell (at similar to 10 mm/s). Removal of Ca2+ from, or addition of Ni2+ to the extracellular solution, strongly inhibited these [Ca2+](c) transients, whereas Ca2+ store depletion with thapsigargin had no effect. Actin-GFP fluorescence around fused LBs increased several seconds after the rise of [Ca2+](c). Both effects were reduced by the non-specific Ca2+ channel blocker SKF96365. Conclusions/Significance: Fusion-activated Ca2+ entry (FACE) is a new mechanism that leads to [Ca2+](c) transients at the site of vesicle fusion. Substantial evidence from this and previous studies indicates that fusion-activated Ca2+ entry enhances localized surfactant release from type II cells, but it may also play a role for compensatory endocytosis and other cellular functions.	[Miklavc, Pika; Frick, Manfred; Wittekindt, Oliver H.; Dietl, Paul] Univ Ulm, Inst Gen Physiol, Ulm, Germany; [Frick, Manfred; Haller, Thomas] Med Univ Innsbruck, Dept Physiol & Med Phys, Innsbruck, Austria	Ulm University; Medical University of Innsbruck	Miklavc, P (corresponding author), Univ Ulm, Inst Gen Physiol, Ulm, Germany.	paul.dietl@uni-ulm.de	Haller, Thomas/H-9036-2015; Frick, Manfred/E-1374-2012	Haller, Thomas/0000-0001-9147-4081; Frick, Manfred/0000-0002-4763-1104	Austrian Science Fund (FWF) [P15742, P15743, P20472]; Deutsche Forschungsgemeinschaft (DFG) [D1402]; Austrian Science Fund (FWF) [P 20472] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work was supported by the Austrian Science Fund (FWF) grants P15742, P15743, and P20472, and Deutsche Forschungsgemeinschaft (DFG) grant D1402. Pika Miklavc was a research fellow of PulmoNet, a Marie Curie Research Training Network of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Chintagari NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009228; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Clapham DE, 2007, CELL, V129, P220, DOI 10.1016/j.cell.2007.03.034; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553; Dietl P, 2010, CELL PHYSIOL BIOCHEM, V25, P1, DOI 10.1159/000272046; ECKENHOFF RG, 1988, AM J PHYSIOL, V254, pC614, DOI 10.1152/ajpcell.1988.254.5.C614; FINKELSTEIN A, 1986, ANNU REV PHYSIOL, V48, P163, DOI 10.1146/annurev.ph.48.030186.001115; Frick M, 2001, AM J RESP CELL MOL, V25, P306, DOI 10.1165/ajrcmb.25.3.4493; Frick M, 2001, BIOCHEM PHARMACOL, V61, P1161, DOI 10.1016/S0006-2952(01)00582-2; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Haller T, 2001, J CELL BIOL, V155, P279, DOI 10.1083/jcb.200102106; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Ju YK, 2007, CIRC RES, V100, P1605, DOI 10.1161/CIRCRESAHA.107.152181; Juvin V, 2007, MOL PHARMACOL, V72, P1258, DOI 10.1124/mol.107.037044; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Mair N, 1999, AM J PHYSIOL-LUNG C, V276, pL376, DOI 10.1152/ajplung.1999.276.2.L376; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Miklavc P, 2009, BIOCHEM J, V424, P7, DOI 10.1042/BJ20091094; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ochs M, 2010, CELL PHYSIOL BIOCHEM, V25, P27, DOI 10.1159/000272061; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Singer W, 2003, BIOPHYS J, V84, P1344, DOI 10.1016/S0006-3495(03)74950-9; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Smith RM, 2000, J CELL BIOL, V148, P755, DOI 10.1083/jcb.148.4.755; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Thorn Peter, 2009, Commun Integr Biol, V2, P315; Wadsworth SJ, 2000, J MEMBRANE BIOL, V174, P41, DOI 10.1007/s002320001030; Wang JP, 2005, TOXICOL APPL PHARM, V209, P134, DOI 10.1016/j.taap.2005.04.002; Yu HYE, 2007, NAT CELL BIOL, V9, P149, DOI 10.1038/ncb1527; Zimmerberg J, 1999, ADV DRUG DELIVER REV, V38, P197, DOI 10.1016/S0169-409X(99)00029-0	43	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10982	10.1371/journal.pone.0010982	http://dx.doi.org/10.1371/journal.pone.0010982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544027	Green Published, gold, Green Submitted			2022-12-25	WOS:000278494900008
J	Rodriguez, E; Daly, M				Rodriguez, Estefania; Daly, Marymegan			Phylogenetic Relationships among Deep-Sea and Chemosynthetic Sea Anemones: Actinoscyphiidae and Actinostolidae (Actiniaria: Mesomyaria)	PLOS ONE			English	Article							ANTHOZOA-ACTINIARIA; HYDROTHERMAL VENTS; CNIDARIA; EVOLUTION; GENE; BIOGEOGRAPHY; BIOLOGY; MODEL	Sea anemones (Cnidaria, Actiniaria) are present in all marine ecosystems, including chemosynthetic environments. The high level of endemicity of sea anemones in chemosynthetic environments and the taxonomic confusion in many of the groups to which these animals belong makes their systematic relationships obscure. We use five molecular markers to explore the phylogenetic relationships of the superfamily Mesomyaria, which includes most of the species that live in chemosynthetic, deep-sea, and polar sea habitats and to test the monophyly of the recently defined clades Actinostolina and Chemosynthina. We found that sea anemones of chemosynthetic environments derive from at least two different lineages: one lineage including acontiate deep-sea taxa and the other primarily encompassing shallow-water taxa.	[Rodriguez, Estefania] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Daly, Marymegan] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	American Museum of Natural History (AMNH); University System of Ohio; Ohio State University	Rodriguez, E (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	erodriguez@amnh.org	Rodríguez, Estefanía/AAK-4634-2021; Daly, Marymegan/F-9178-2011	Rodríguez, Estefanía/0000-0002-5590-6606; 	National Science Foundation (NSF) [EF-0531763]; Training Award for New Investigators (TAWNI); American Museum of Natural History	National Science Foundation (NSF)(National Science Foundation (NSF)); Training Award for New Investigators (TAWNI); American Museum of Natural History	This work was supported mainly by National Science Foundation (NSF) EF-0531763 to M. Daly. Through the project, NSF EF-0531763 funds have been available for fieldwork, lab work and salary for E. Rodriguez. Several of the key samples of this study were collected thanks to Kevin Zelnio, who was supported through a Training Award for New Investigators (TAWNI) from the ChEss (Biogeography of Chemosynthetic Ecosystems) project of the Census Marine Life (CoML). Additional support to E. R. was provided by the Lerner Gray Fund for Marine Research from the American Museum of Natural History for fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Cairns S.D., 1982, Antarctic Research Series, V34, P1; CARLGREN OSKAR, 1949, K SVENSKA VETENSKAPSAKAD HANDL, V1, P1; Chen CA, 2000, MAR BIOTECHNOL, V2, P146; Chen CA, 2002, MOL PHYLOGENET EVOL, V23, P137, DOI 10.1016/S1055-7903(02)00008-8; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Daly M, 2008, MOL PHYLOGENET EVOL, V48, P292, DOI 10.1016/j.ympev.2008.02.022; Daly M, 2006, MAR BIOL, V148, P1241, DOI 10.1007/s00227-005-0170-7; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Daly M, 2002, EVOLUTION, V56, P502; Daly M, 2007, J NAT HIST, V41, P1, DOI 10.1080/00222930601121775; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; *FAUT, 2009, HEX WORLD; Fautin Daphne Gail, 2009, Bulletin of Zoological Nomenclature, V66, P312; Fisher CR, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.75; Geller JB, 2001, EVOLUTION, V55, P1781; Goloboff P, 2008, CLADISTICS, V24, P91; GUSMAO L, MOL PHYL EV IN PRESS; HURTADO LA, 2002, THESIS RUTGERS U NEW; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Kiel S, 2006, SCIENCE, V313, P1429, DOI 10.1126/science.1126286; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; MANUEL RL, 1981, SYNOPSIS BRIT FAUNA, V18; McArthur AG, 1998, GEOL SOC SPEC PUBL, V148, P271, DOI 10.1144/GSL.SP.1998.148.01.15; NEWMAN WA, 1985, B BIOL SOC WASH, V6, P231; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rodriguez E, 2005, HELGOLAND MAR RES, V59, P301, DOI 10.1007/s10152-005-0005-4; Rodriguez E., 2007, ZOOTAXA, V1668, P131; Rodriguez E, 2008, INVERTEBR SYST, V22, P439, DOI 10.1071/IS07053; SANAMYAN NP, 2007, INVERTEBRATE ZOOLOGY, V4, P83, DOI DOI 10.15298/INVERTZ00L.04.1.07; Sebastian S, 2007, DEEP-SEA RES PT II, V54, P1727, DOI 10.1016/j.dsr2.2007.07.004; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Song JG, 2003, ACTA PHYS-CHIM SIN, V19, P283, DOI 10.3866/PKU.WHXB20030322; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; WHEELER WC, 1993, CLADISTICS, V9, P1, DOI 10.1111/j.1096-0031.1993.tb00207.x; Yamaguchi T, 2004, J MAR BIOL ASSOC UK, V84, P111, DOI 10.1017/S0025315404008975h; Zelnio KA, 2009, MAR BIOL RES, V5, P547, DOI 10.1080/17451000902729662; [No title captured]	49	26	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10958	10.1371/journal.pone.0010958	http://dx.doi.org/10.1371/journal.pone.0010958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532040	Green Published, gold, Green Submitted			2022-12-25	WOS:000278380500004
J	Zeng, M; Kikuchi, H; Pino, MS; Chung, DC				Zeng, Min; Kikuchi, Hirotoshi; Pino, Maria S.; Chung, Daniel C.			Hypoxia Activates the K-Ras Proto-Oncogene to Stimulate Angiogenesis and Inhibit Apoptosis in Colon Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SIGNALING PATHWAYS; UP-REGULATION; EXPRESSION; ERK1/2; AKT; PROLIFERATION; INTERLEUKIN-8; METABOLISM; INDUCTION	The KRAS proto-oncogene plays a key role in the development of many human tumors and is commonly activated by somatic mutation or signaling through specific growth factor receptors. However, the interaction between the micro-environment and K-ras activity has not been defined. Hypoxia invariably develops as tumors outgrow their supply of oxygen. A series of well-orchestrated cellular adaptations occur that stimulate angiogenesis and enhance survival of the tumor in hypoxic conditions. Our previous studies demonstrated that mutant KRAS alleles can interact with hypoxia to induce vascular endothelial growth factor (VEGF) in colon cancer. We sought to determine whether similar hypoxic responses are also present in tumors without a KRAS mutation. Hypoxia consistently increased the levels of activated, GTP-bound K-ras in colon cancer cell lines with a wild-type KRAS gene, and this depended upon the activation of c-Src. Inhibition of c-Src by PP2 treatment or siRNA knockdown blocked the hypoxic activation of K-ras. This activation of K-ras did not depend upon EGFR and resulted in the phosphorylation of Akt and induction of VEGF expression. In addition, activation of K-ras significantly blocked apoptosis in hypoxic conditions. These studies reveal a unique adaptive mechanism in hypoxia that activates K-ras signaling in the absence of a mutant KRAS oncogene.	[Zeng, Min; Kikuchi, Hirotoshi; Pino, Maria S.; Chung, Daniel C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Zeng, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02115 USA.	dchung@partners.org		Kikuchi, Hirotoshi/0000-0002-1776-1020	National Institutes of Health [CA92594]; Kate J. and Dorothy L. Clapp Fund; NATIONAL CANCER INSTITUTE [R01CA092594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kate J. and Dorothy L. Clapp Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health grant CA92594; Kate J. and Dorothy L. Clapp Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Blancher C, 2001, CANCER RES, V61, P7349; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Jiang ZJ, 2002, BIOCHEM BIOPH RES CO, V294, P726, DOI 10.1016/S0006-291X(02)00540-5; Lee SM, 2006, CANCER LETT, V242, P231, DOI 10.1016/j.canlet.2005.11.001; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Mizukami Y, 2004, CANCER RES, V64, P1765, DOI 10.1158/0008-5472.CAN-03-3017; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Pham NA, 2009, INT J CANCER, V124, P280, DOI 10.1002/ijc.23912; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Singh A, 2005, FASEB J, V19, P161, DOI 10.1096/fj.04-2584hyp; Sodhi A, 2001, BIOCHEM BIOPH RES CO, V287, P292, DOI 10.1006/bbrc.2001.5532; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Xu L, 2004, CLIN CANCER RES, V10, P701, DOI 10.1158/1078-0432.CCR-0953-03; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Zhang XB, 2001, CANCER RES, V61, P6050; Zhu YH, 2005, ONCOGENE, V24, P6555, DOI 10.1038/sj.onc.1208800	26	46	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10966	10.1371/journal.pone.0010966	http://dx.doi.org/10.1371/journal.pone.0010966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532039	gold, Green Submitted, Green Published			2022-12-25	WOS:000278380500011
J	Alkaitis, MS; Solorzano, C; Landry, RP; Piomelli, D; Deleo, JA; Romero-Sandoval, EA				Alkaitis, Matthew S.; Solorzano, Carlos; Landry, Russell P.; Piomelli, Daniele; Deleo, Joyce A.; Romero-Sandoval, E. Alfonso			Evidence for a Role of Endocannabinoids, Astrocytes and p38 Phosphorylation in the Resolution of Postoperative Pain	PLOS ONE			English	Article							CB2 CANNABINOID RECEPTORS; ACTIVATED PROTEIN-KINASE; NEUROPATHIC PAIN; RAT MODEL; MECHANICAL HYPERSENSITIVITY; INFLAMMATORY PAIN; MAP KINASE; CONTRIBUTES; ANANDAMIDE; BRAIN	Background: An alarming portion of patients develop persistent or chronic pain following surgical procedures, but the mechanisms underlying the transition from acute to chronic pain states are not fully understood. In general, endocannabinoids (ECBs) inhibit nociceptive processing by stimulating cannabinoid receptors type 1 (CB(1)) and type 2 (CB(2)). We have previously shown that intrathecal administration of a CB(2) receptor agonist reverses both surgical incision-induced behavioral hypersensitivity and associated over-expression of spinal glial markers. We therefore hypothesized that endocannabinoid signaling promotes the resolution of acute postoperative pain bymodulating pro-inflammatory signaling in spinal cord glial cells. Methodology/Principal Findings: To test this hypothesis, rats receiving paw incision surgery were used as a model of acute postoperative pain that spontaneously resolves. We first characterized the concentration of ECBs and localization of CB(1) and CB(2) receptors in the spinal cord following paw incision. We then administered concomitant CB(1) and CB(2) receptor antagonists/inverse agonists (AM281 and AM630, 1 mg.kg(-1) each, i.p.) during the acute phase of paw incision-induced mechanical allodynia and evaluated the expression of glial cell markers and phosphorylated p38 (a MAPK associated with inflammation) in the lumbar dorsal horn. Dual blockade of CB(1) and CB(2) receptor signaling prevented the resolution of postoperative allodynia and resulted in persistent over-expression of spinal Glial Fibrillary Acidic Protein (GFAP, an astrocytic marker) and phospho-p38 in astrocytes. We provide evidence for the functional significance of these astrocytic changes by demonstrating that intrathecal administration of propentofylline (50 mu g, i.t.) attenuated both persistent behavioral hypersensitivity and over-expression of GFAP and phospho-p38 in antagonist-treated animals. Conclusions/Significance: Our results demonstrate that endocannabinoid signaling via CB(1) and CB(2) receptors is necessary for the resolution of paw incision-induced behavioral hypersensitivity and for the limitation of pro-inflammatory signaling in astrocytes following surgical insult. Our findings suggest that therapeutic strategies designed to enhance endocannabinoid signaling may prevent patients from developing persistent or chronic pain states following surgery.	[Alkaitis, Matthew S.; Landry, Russell P.; Deleo, Joyce A.; Romero-Sandoval, E. Alfonso] Dartmouth Med Sch, Neurosci Ctr Dartmouth, Lebanon, NH USA; [Alkaitis, Matthew S.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Solorzano, Carlos; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Solorzano, Carlos; Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Landry, Russell P.; Deleo, Joyce A.; Romero-Sandoval, E. Alfonso] Dartmouth Med Sch, Dept Anesthesiol, Lebanon, NH USA; [Deleo, Joyce A.; Romero-Sandoval, E. Alfonso] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Lebanon, NH USA	Dartmouth College; University of Oxford; University of California System; University of California Irvine; University of California System; University of California Irvine; Dartmouth College; Dartmouth College	Alkaitis, MS (corresponding author), Dartmouth Med Sch, Neurosci Ctr Dartmouth, Lebanon, NH USA.	Edgar.A.Romero-Sandoval@dartmouth.edu			Kaminsky Family Fund; National Institute of Drug Abuse [DA025211, DA11276]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011276, R01DA025211] Funding Source: NIH RePORTER	Kaminsky Family Fund; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to acknowledge the Kaminsky Family Fund (MA) (http://www.dartmouth.edu/ugar/undergrad/grants/index.html), the Office of Residential Life Class of 1989 Senior Scholars Program (MA) (http://www.dartmouth.edu/orl/life-in-res/spec-pgms/senior.html), American Pain Society 2008 Future Leaders in Pain Research Small Grants (AR-S) (http://www.ampainsoc.org/) and the National Institute of Drug Abuse DA025211 (AR-S) and DA11276 (JAD) (http:// www.nida.nih.gov/) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Astarita G, 2008, J LIPID RES, V49, P48, DOI 10.1194/jlr.M700354-JLR200; Boyle DL, 2006, PLOS MED, V3, P1616, DOI 10.1371/journal.pmed.0030338; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Butler RK, 2008, PAIN, V140, P491, DOI 10.1016/j.pain.2008.10.002; Cadas H, 1997, J NEUROSCI, V17, P1226; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cosenza M, 2000, SYNAPSE, V38, P477, DOI 10.1002/1098-2396(20001215)38:4<477::AID-SYN13>3.0.CO;2-Y; Costa B, 2006, BRIT J PHARMACOL, V148, P1022, DOI 10.1038/sj.bjp.0706798; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Garry EM, 2005, MOL CELL NEUROSCI, V30, P523, DOI 10.1016/j.mcn.2005.08.016; GRECO R, 2009, CEPHALALGIA; Guasti L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-35; Guindon J, 2007, BRIT J PHARMACOL, V150, P693, DOI 10.1038/sj.bjp.0706990; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Gwak YS, 2009, EXP NEUROL, V220, P154, DOI 10.1016/j.expneurol.2009.08.012; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Hosohata Y, 1997, EUR J PHARMACOL, V321, pR1, DOI 10.1016/S0014-2999(97)00047-2; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Ito N, 2009, ANESTHESIOLOGY, V111, P640, DOI 10.1097/ALN.0b013e3181b05f42; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Jin SX, 2003, J NEUROSCI, V23, P4017; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Khasabova IA, 2008, J NEUROSCI, V28, P11141, DOI 10.1523/JNEUROSCI.2847-08.2008; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Lan R, 1999, AAPS PharmSci, V1, pE4; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; REGGIO PH, 1995, LIFE SCI, V56, P2025, DOI 10.1016/0024-3205(95)00185-9; Roche M, 2008, IMMUNOLOGY, V125, P263, DOI 10.1111/j.1365-2567.2008.02838.x; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Romero-Sandoval A, 2008, ANESTHESIOLOGY, V108, P722, DOI 10.1097/ALN.0b013e318167af74; Romero-Sandoval A, 2007, ANESTHESIOLOGY, V106, P787, DOI 10.1097/01.anes.0000264765.33673.6c; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; SAEZCASSANELLI JL, 2007, J NEUROCHEM; Scott DA, 2004, PAIN, V109, P124, DOI 10.1016/j.pain.2004.01.020; Sheng WS, 2009, J NEUROIMMUNE PHARM, V4, P244, DOI 10.1007/s11481-009-9147-5; Sorkin LS, 2009, NEUROSCIENCE, V162, P462, DOI 10.1016/j.neuroscience.2009.05.008; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Svensson CI, 2010, MOL INTERV, V10, P25, DOI 10.1124/mi.10.1.6; Sweitzer SM, 2001, J PHARMACOL EXP THER, V297, P1210; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tawfik VL, 2008, NEUROSCIENCE, V152, P1086, DOI 10.1016/j.neuroscience.2008.01.065; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Tawfik VL, 2006, GLIA, V54, P193, DOI 10.1002/glia.20365; Vignali M, 2009, GLIA, V57, P791, DOI 10.1002/glia.20807; Wen YR, 2009, ANESTHESIOLOGY, V110, P155, DOI 10.1097/ALN.0b013e318190bc16; Wu CR, 2008, ANESTHESIOLOGY, V108, P1100, DOI 10.1097/ALN.0b013e31817302b3; Zhu XY, 2006, PAIN, V125, P43, DOI 10.1016/j.pain.2006.04.027	58	54	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10891	10.1371/journal.pone.0010891	http://dx.doi.org/10.1371/journal.pone.0010891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531936	gold, Green Published			2022-12-25	WOS:000278222100020
J	Isa, A; Nehlin, JO; Sabir, HJ; Andersen, TE; Gaster, M; Kassem, M; Barington, T				Isa, Adiba; Nehlin, Jan O.; Sabir, Hardee J.; Andersen, Tom E.; Gaster, Michael; Kassem, Moustapha; Barington, Torben			Impaired Cell Surface Expression of HLA-B Antigens on Mesenchymal Stem Cells and Muscle Cell Progenitors	PLOS ONE			English	Article								HLA class-I expression is weak in embryonic stem cells but increases rapidly during lineage progression. It is unknown whether all three classical HLA class-I antigens follow the same developmental program. In the present study, we investigated allele-specific expression of HLA-A, -B, and -C at the mRNA and protein levels on human mesenchymal stem cells from bone marrow and adipose tissue as well as striated muscle satellite cells and lymphocytes. Using multicolour flow cytometry, we found high cell surface expression of HLA-A on all stem cells and PBMC examined. Surprisingly, HLA-B was either undetectable or very weakly expressed on all stem cells protecting them from complement-dependent cytotoxicity (CDC) using relevant human anti-B and anti-Cw sera. IFN gamma stimulation for 48-72 h was required to induce full HLA-B protein expression. Quantitative real-time RT-PCR showed that IFN gamma induced a 9-42 fold increase of all six HLA-A,-B,-C gene transcripts. Interestingly, prior to stimulation, gene transcripts for all but two alleles were present in similar amounts suggesting that post-transcriptional mechanisms regulate the constitutive expression of HLA-A,-B, and -C. Locus-restricted expression of HLA-A, -B and -C challenges our current understanding of the function of these molecules as regulators of CD8(+) T-cell and NK-cell function and should lead to further inquiries into their expression on other cell types.	[Isa, Adiba; Nehlin, Jan O.; Sabir, Hardee J.; Barington, Torben] Univ So Denmark, Odense Univ Hosp, Dept Clin Immunol, Ctr Stem Cell Treatment, Odense, Denmark; [Andersen, Tom E.; Gaster, Michael; Kassem, Moustapha] Univ So Denmark, Odense Univ Hosp, Dept Endocrinol, Clin Mol Endocrinol KMEB, Odense, Denmark; [Andersen, Tom E.; Gaster, Michael; Kassem, Moustapha] Univ So Denmark, Ctr Med Biotechnol, Odense, Denmark; [Kassem, Moustapha] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; King Saud University	Isa, A (corresponding author), Univ So Denmark, Odense Univ Hosp, Dept Clin Immunol, Ctr Stem Cell Treatment, Odense, Denmark.	aisa@health.sdu.dk	Kassem, Moustapha/J-7688-2013; Barington, Torben/R-6841-2019; Barington, Torben/C-3922-2009; Kassem, Moustapha/O-3819-2019; Nehlin, Jan O./AAR-8721-2020	Kassem, Moustapha/0000-0003-1557-0869; Barington, Torben/0000-0001-6968-148X; Kassem, Moustapha/0000-0003-1557-0869; Nehlin, Jan O./0000-0001-6038-5027	Lundbeck Foundation; Odense University Hospital	Lundbeck Foundation(Lundbeckfonden); Odense University Hospital	This study was supported by the Lundbeck Foundation and by Odense University Hospital. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Boulet S, 2008, AIDS, V22, P1487, DOI 10.1097/QAD.0b013e3282ffde7e; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Boyton RJ, 2007, CLIN EXP IMMUNOL, V149, P1, DOI 10.1111/j.1365-2249.2007.03424.x; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; Brouwer RE, 2002, HUM IMMUNOL, V63, P200, DOI 10.1016/S0198-8859(01)00381-0; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Browne SK, 2006, J IMMUNOL, V177, P8612, DOI 10.4049/jimmunol.177.12.8612; BUHRING HJ, 2009, ANN NY ACAD SCI, V1176, P134; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; BURNS JS, 2005, CANCER RES, V65, P3135; Cabrera CM, 2007, CELL BIOL INT, V31, P1072, DOI 10.1016/j.cellbi.2007.03.015; Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028; CHEN E, 1986, MOL CELL BIOL, V6, P1698, DOI 10.1128/MCB.6.5.1698; CIFUENTESDIAZ C, 1992, MUSCLE NERVE, V15, P295, DOI 10.1002/mus.880150307; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; DECOOPY P, 2006, DIABETOLOGIA, V49, P1973; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; FLEMING KA, 1981, J CLIN PATHOL, V34, P779, DOI 10.1136/jcp.34.7.779; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; GASTER M, 2001, APMIS, V109, P744; HAKEM R, 1991, J IMMUNOL, V147, P2384; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Hiraki A, 2004, ANTICANCER RES, V24, P1525; Johnson DR, 2003, J IMMUNOL, V170, P1894, DOI 10.4049/jimmunol.170.4.1894; Jonjic S, 2008, CURR OPIN IMMUNOL, V20, P30, DOI 10.1016/j.coi.2007.11.002; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Maeurer MJ, 1996, J CLIN INVEST, V98, P1633, DOI 10.1172/JCI118958; Maeurer MJ, 1996, CLIN CANCER RES, V2, P641; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Nielsen C, 2004, LUPUS, V13, P510, DOI 10.1191/0961203303lu1052oa; ORTENBLAD N, 2005, BIOCHIM BIOPHYS ACTA, V1741, P214; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Reinders J, 2005, HUM IMMUNOL, V66, P912, DOI 10.1016/j.humimm.2005.06.010; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Shereck E, 2007, PEDIATR BLOOD CANCER, V49, P615, DOI 10.1002/pbc.21158; Synnergren J, 2007, STEM CELLS, V25, P473, DOI 10.1634/stemcells.2006-0247; UCCELLI A, 2008, NAT REV IMMUNOL; Uchanska-Ziegler B, 2007, RHEUMATOLOGY, V46, P555, DOI 10.1093/rheumatology/kel390; van den Elsen PJ, 1998, IMMUNOGENETICS, V48, P208, DOI 10.1007/s002510050425; WARING JF, 1995, J BIOL CHEM, V270, P12276, DOI 10.1074/jbc.270.20.12276; YAHATA G, 1990, CELL GROWTH DIFFER, V1, P73; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661	53	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10900	10.1371/journal.pone.0010900	http://dx.doi.org/10.1371/journal.pone.0010900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531935	Green Submitted, gold, Green Published			2022-12-25	WOS:000278222100029
J	Martin, MD; Seth, S; Koutsonanos, DG; Jacob, J; Compans, RW; Skountzou, I				Martin, Maria del P.; Seth, Shaguna; Koutsonanos, Dimitrios G.; Jacob, Joshy; Compans, Richard W.; Skountzou, Ioanna			Adjuvanted Influenza Vaccine Administered Intradermally Elicits Robust Long-Term Immune Responses that Confer Protection from Lethal Challenge	PLOS ONE			English	Article							IMMUNIZATION INDUCES MUCOSAL; ADP-RIBOSYLATING EXOTOXINS; TRANSCUTANEOUS IMMUNIZATION; DENDRITIC CELLS; RETINOIC ACID; ANTIBODY-RESPONSES; CHOLERA-TOXIN; T-CELLS; SKIN; ANTIGEN	Background: The respiratory illnesses caused by influenza virus can be dramatically reduced by vaccination. The current trivalent inactivated influenza vaccine is effective in eliciting systemic virus-specific antibodies sufficient to control viral replication. However, influenza protection generated after parenteral immunization could be improved by the induction of mucosal immune responses. Methodology/Principal Findings: Transcutaneous immunization, a non-invasive vaccine delivery method, was used to investigate the quality, duration and effectiveness of the immune responses induced in the presence of inactivated influenza virus co-administered with retinoic acid or oleic acid. We observed an increased migration of dendritic cells to the draining lymph nodes after dermal vaccination. Here we demonstrate that this route of vaccine delivery in combination with certain immunomodulators can induce potent immune responses that result in long-term protective immunity. Additionally, mice vaccinated with inactivated virus in combination with retinoic acid show an enhanced sIgA antibody response, increased number of antibody secreting cells in the mucosal tissues, and protection from a higher influenza lethal dose. Conclusions/Significance: The present study demonstrates that transdermal administration of inactivated virus in combination with immunomodulators stimulates dendritic cell migration, results in long-lived systemic and mucosal responses that confer effective protective immunity.	[Martin, Maria del P.; Koutsonanos, Dimitrios G.; Jacob, Joshy; Compans, Richard W.; Skountzou, Ioanna] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Seth, Shaguna] MDRNA Inc, Bothell, WA USA	Emory University	Martin, MD (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu; iskount@emory.edu	Compans, Richard W/I-4087-2013; Skountzou, Ioanna/A-4454-2010	Compans, Richard W/0000-0003-2360-335X; Skountzou, Ioanna/0000-0002-6429-244X	National Institutes of Health [A1074579]; NIH/NIAID [HHSN266200700006C]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants A1074579 and by contract HHSN266200700006C from NIH/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maria del P. Martin is a trainee supported by contract HHSN266200700006C from NIH/NIAID.	Amorij JP, 2007, VACCINE, V25, P6447, DOI 10.1016/j.vaccine.2007.06.054; Anjuere F, 2003, J IMMUNOL, V170, P1586, DOI 10.4049/jimmunol.170.3.1586; Asahi Y, 2002, J IMMUNOL, V168, P2930, DOI 10.4049/jimmunol.168.6.2930; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Chen DX, 2001, VACCINE, V19, P2908, DOI 10.1016/S0264-410X(00)00544-2; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; Deng YP, 1997, J IMMUNOL, V158, P1507; Eksteen B, 2009, GASTROENTEROLOGY, V137, P320, DOI 10.1053/j.gastro.2009.02.046; El-Ghorr AA, 2000, FEMS IMMUNOL MED MIC, V29, P255, DOI 10.1111/j.1574-695X.2000.tb01531.x; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Enioutina EY, 2000, VACCINE, V18, P2381, DOI 10.1016/S0264-410X(00)00008-6; Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962; GERHARD W, 1991, J VIROL, V65, P364, DOI 10.1128/JVI.65.1.364-372.1991; Glenn GM, 1999, INFECT IMMUN, V67, P1100, DOI 10.1128/IAI.67.3.1100-1106.1999; Gockel CM, 2000, MOL IMMUNOL, V37, P537, DOI 10.1016/S0161-5890(00)00074-2; Guebre-Xabier M, 2003, J VIROL, V77, P5218, DOI 10.1128/JVI.77.9.5218-5225.2003; Guerena-Burgueno F, 2002, INFECT IMMUN, V70, P1874, DOI 10.1128/IAI.70.4.1874-1880.2002; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; HENRI S, 2010, DISENTANGLING COMPLE; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kang SM, 2004, J VIROL, V78, P9624, DOI 10.1128/JVI.78.18.9624-9632.2004; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; Li ZX, 2008, J IMMUNOL, V180, P2504, DOI 10.4049/jimmunol.180.4.2504; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Moulds JM, 2009, TRANSFUS APHER SCI, V40, P185, DOI 10.1016/j.transci.2009.03.010; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; NOVAK M, 1993, VACCINE, V11, P55, DOI 10.1016/0264-410X(93)90339-Y; Oran AE, 2003, J IMMUNOL, V171, P1999, DOI 10.4049/jimmunol.171.4.1999; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187; ROMANI N, 1985, J EXP MED, V161, P1368, DOI 10.1084/jem.161.6.1368; Ronnelid J, 2008, ADV EXP MED BIOL, V632, P187, DOI 10.1007/978-0-387-78952-1_14; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Scharton-Kersten T, 2000, INFECT IMMUN, V68, P5306, DOI 10.1128/IAI.68.9.5306-5313.2000; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Sha ZY, 2005, VIROLOGY, V331, P387, DOI 10.1016/j.virol.2004.10.014; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Skountzou I, 2006, VACCINE, V24, P6110, DOI 10.1016/j.vaccine.2006.05.014; Stingl G, 1989, Curr Probl Dermatol, V18, P22; STREILEIN JW, 1983, J INVEST DERMATOL, V80, pS12, DOI 10.1111/1523-1747.ep12536743; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	50	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10897	10.1371/journal.pone.0010897	http://dx.doi.org/10.1371/journal.pone.0010897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531947	gold, Green Published, Green Submitted			2022-12-25	WOS:000278222100026
J	Shemesh, H; Arbiv, A; Gersani, M; Ovadia, O; Novoplansky, A				Shemesh, Hagai; Arbiv, Adi; Gersani, Mordechai; Ovadia, Ofer; Novoplansky, Ariel			The Effects of Nutrient Dynamics on Root Patch Choice	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; PLANT BEHAVIOR; HETEROGENEITY; RESPONSES; GROWTH; EXPLOITATION; ENVIRONMENTS; COMPETITION; INHIBITION; ALLOCATION	Plants have been recognized to be capable of allocating more roots to rich patches in the soil. We tested the hypothesis that in addition to their sensitivity to absolute differences in nutrient availability, plants are also responsive to temporal changes in nutrient availability. Different roots of the same Pisum sativum plants were subjected to variable homogeneous and heterogeneous temporally - dynamic and static nutrient regimes. When given a choice, plants not only developed greater root biomasses in richer patches; they discriminately allocated more resources to roots that developed in patches with increasing nutrient levels, even when their other roots developed in richer patches. These results suggest that plants are able to perceive and respond to dynamic environmental changes. This ability might enable plants to increase their performance by responding to both current and anticipated resource availabilities in their immediate proximity.	[Shemesh, Hagai; Arbiv, Adi; Gersani, Mordechai; Ovadia, Ofer] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Shemesh, Hagai; Arbiv, Adi; Novoplansky, Ariel] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Miterani Dept Desert Ecol, IL-84993 Sede Boqer, Israel	Ben Gurion University; Ben Gurion University	Shemesh, H (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	hagaig@bgu.ac.il	Ovadia, Ofer OO/C-8292-2012	Novoplansky, Ariel/0000-0003-0988-786X; Ovadia, Ofer/0000-0002-4941-4947	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	The study was supported in part by a research grant from the Israel Science Foundation to A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; APHALO PJ, 1995, FUNCT ECOL, V9, P5, DOI 10.2307/2390084; Bilbrough CJ, 1997, ECOLOGY, V78, P231; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Darwin C, 1880, POWER MOVEMENT PLANT; DESBIEZ MO, 1984, PLANTA, V160, P392, DOI 10.1007/BF00429754; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DREW MC, 1978, J EXP BOT, V29, P435, DOI 10.1093/jxb/29.2.435; Dyer AR, 2001, FUNCT ECOL, V15, P85, DOI 10.1046/j.1365-2435.2001.00487.x; Eisenbach M, 2007, J CELL PHYSIOL, V213, P574, DOI 10.1002/jcp.21238; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; GERSANI M, 1992, PLANT CELL ENVIRON, V15, P463, DOI 10.1111/j.1365-3040.1992.tb00997.x; Gilroy S, 2008, PLANT TROPISMS, P1; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hodge A, 2009, PLANT CELL ENVIRON, V32, P628, DOI 10.1111/j.1365-3040.2008.01891.x; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; INGESTAD T, 1988, PHYSIOL PLANTARUM, V72, P450, DOI 10.1111/j.1399-3054.1988.tb09150.x; JACKSON RB, 1993, ECOLOGY, V74, P612, DOI 10.2307/1939320; JONES M, 1987, PROC R SOC SER B-BIO, V232, P1, DOI 10.1098/rspb.1987.0058; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Kembel SW, 2005, AM NAT, V166, P216, DOI 10.1086/431287; Larsen KS, 2002, APPL SOIL ECOL, V21, P187, DOI 10.1016/S0929-1393(02)00093-8; LEVINS RICHARD, 1968; Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735; Masi E, 2009, P NATL ACAD SCI USA, V106, P4048, DOI 10.1073/pnas.0804640106; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; NOVOPLANSKY A, 1989, PHYSIOL PLANTARUM, V77, P136, DOI 10.1111/j.1399-3054.1989.tb05989.x; Novoplansky A, 1996, VEGETATIO, V127, P31, DOI 10.1007/BF00054845; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Nyanumba SM, 2007, DEV STRATEGIES PLANT; Owen JP, 2005, PHYSIOL ENTOMOL, V30, P293, DOI 10.1111/j.1365-3032.2005.00461.x; Quilchano C, 2008, ECOL RES, V23, P127, DOI 10.1007/s11284-007-0343-6; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Shimansky YP, 2009, BIOL CYBERN, V101, P379, DOI 10.1007/s00422-009-0341-6; Snow R, 1931, P R SOC LOND B-CONTA, V108, P305, DOI 10.1098/rspb.1931.0041; Spieler M, 1997, OECOLOGIA, V109, P184, DOI 10.1007/s004420050073; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Trewavas A, 2009, PLANT CELL ENVIRON, V32, P606, DOI 10.1111/j.1365-3040.2009.01929.x; van Wijk MT, 2003, J ECOL, V91, P664, DOI 10.1046/j.1365-2745.2003.00788.x; vanVuuren MMI, 1996, PLANT SOIL, V178, P185, DOI 10.1007/BF00011582; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Weijschede J, 2006, NEW PHYTOL, V172, P655, DOI 10.1111/j.1469-8137.2006.01885.x; Zar JH, 1999, BIOSTATISTICAL ANAL	48	43	46	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10824	10.1371/journal.pone.0010824	http://dx.doi.org/10.1371/journal.pone.0010824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520811	gold, Green Published			2022-12-25	WOS:000278221500013
J	Kananen, L; Surakka, I; Pirkola, S; Suvisaari, J; Lonnqvist, J; Peltonen, L; Ripatti, S; Hovatta, I				Kananen, Laura; Surakka, Ida; Pirkola, Sami; Suvisaari, Jaana; Lonnqvist, Jouko; Peltonen, Leena; Ripatti, Samuli; Hovatta, Iiris			Childhood Adversities Are Associated with Shorter Telomere Length at Adult Age both in Individuals with an Anxiety Disorder and Controls	PLOS ONE			English	Article							WHITE BLOOD-CELLS; OXIDATIVE STRESS; PSYCHIATRIC-DISORDERS; INSULIN-RESISTANCE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; DNA-DAMAGE; LIFE; HEALTH	Accelerated leukocyte telomere shortening has been previously associated to self-perceived stress and psychiatric disorders, including schizophrenia and mood disorders. We set out to investigate whether telomere length is affected in patients with anxiety disorders in which stress is a known risk factor. We also studied the effects of childhood and recent psychological distress on telomere length. We utilized samples from the nationally representative population-based Health 2000 Survey that was carried out between 2000-2001 in Finland to assess major public health problems and their determinants. We measured the relative telomere length of the peripheral blood cells by quantitative real-time PCR from 321 individuals with DSM-IV anxiety disorder or subthreshold diagnosis and 653 matched controls aged 30-87 years, who all had undergone the Composite International Diagnostic Interview. While telomere length did not differ significantly between cases and controls in the entire cohort, the older half of the anxiety disorder patients (48-87 years) exhibited significantly shorter telomeres than healthy controls of the same age (P = 0.013). Interestingly, shorter telomere length was also associated with a greater number of reported childhood adverse life events, among both the anxiety disorder cases and controls (P = 0.005). Childhood chronic or serious illness was the most significantly associated single event affecting telomere length at the adult age (P = 0.004). Self-reported current psychological distress did not affect telomere length. Our results suggest that childhood stress might lead to accelerated telomere shortening seen at the adult age. This finding has potentially important implications supporting the view that childhood adversities might have a considerable impact on well being later in life.	[Kananen, Laura; Hovatta, Iiris] Univ Helsinki, Res Program Mol Neurol, Fac Med, Helsinki, Finland; [Kananen, Laura; Peltonen, Leena; Hovatta, Iiris] Univ Helsinki, Dept Med Genet, Fac Med, Helsinki, Finland; [Surakka, Ida; Peltonen, Leena; Ripatti, Samuli] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Surakka, Ida; Peltonen, Leena; Ripatti, Samuli] Univ Helsinki, FIMM, Inst Mol Med Finland, Helsinki, Finland; [Pirkola, Sami; Suvisaari, Jaana; Lonnqvist, Jouko; Hovatta, Iiris] Natl Inst Hlth & Welf, Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Pirkola, Sami; Lonnqvist, Jouko] Helsinki Univ Cent Hosp, Dept Psychiat, Helsinki, Finland; [Peltonen, Leena] Broad Inst MIT & Harvard, Cambridge, MA USA; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton, Cambs, England	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute	Kananen, L (corresponding author), Univ Helsinki, Res Program Mol Neurol, Fac Med, Helsinki, Finland.	iiris.hovatta@helsinki.fi	Hovatta, Iiris/D-6871-2012; Ripatti, Samuli/H-9446-2014	Hovatta, Iiris/0000-0002-5990-7892; Ripatti, Samuli/0000-0002-0504-1202; Kananen, Laura/0000-0003-3742-8927; Surakka, Ida/0000-0002-6669-5541; Suvisaari, Jaana/0000-0001-7167-0990; Pirkola, Sami/0000-0003-0138-3130	Academy of Finland NEURO; Academy Research Fellowship; Biocentrum Helsinki; Sigrid Juselius Foundation; Yrjo and Tuulikki Ilvonen Foundation; LOreal; UNESCO	Academy of Finland NEURO(Academy of Finland); Academy Research Fellowship(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo and Tuulikki Ilvonen Foundation; LOreal; UNESCO	This work was supported by the Academy of Finland NEURO research program and Academy Research Fellowship (http://www.aka.fi), Biocentrum Helsinki (http://www.helsinki.fi/biocentrum), Sigrid Juselius Foundation (http://www.sigridjuselius.fi), Yrjo and Tuulikki Ilvonen Foundation, and LOreal and UNESCO Women in Science Fellowship ( to IH). The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013; Aromaa A., 2004, HLTH FUNCTIONAL CAPA; Aviv A, 2006, J CLIN ENDOCR METAB, V91, P635, DOI 10.1210/jc.2005-1814; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bandelow B, 2004, EUR ARCH PSY CLIN N, V254, P397, DOI 10.1007/s00406-004-0521-2; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bischoff C, 2005, TWIN RES HUM GENET, V8, P433, DOI 10.1375/twin.8.5.433; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Carter RM, 2001, DEPRESS ANXIETY, V13, P78, DOI 10.1002/da.1020; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; de Oliveira MR, 2007, NEUROTOXICOLOGY, V28, P1191, DOI 10.1016/j.neuro.2007.07.008; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Donner J, 2008, BIOL PSYCHIAT, V64, P672, DOI 10.1016/j.biopsych.2008.06.002; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Goodwin RD, 2005, PSYCHOL MED, V35, P881, DOI 10.1017/S0033291704003265; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Heistaro S., 2008, METHODOLOGY REPORT H; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Heun R, 2000, EUR PSYCHIAT, V15, P173, DOI 10.1016/S0924-9338(00)00228-5; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hovatta I, 2008, ANN MED, V40, P92, DOI 10.1080/07853890701747096; Huzen J, 2010, AGE AGEING, V39, P223, DOI 10.1093/ageing/afp256; Jeanclos E, 1998, DIABETES, V47, P482, DOI 10.2337/diabetes.47.3.482; Kao HT, 2008, MOL PSYCHIATR, V13, P118, DOI 10.1038/sj.mp.4002105; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Masood A, 2008, J PHARMACOL EXP THER, V326, P369, DOI 10.1124/jpet.108.137208; McLaughlin KA, 2010, ARCH GEN PSYCHIAT, V67, P124, DOI 10.1001/archgenpsychiatry.2009.187; Moffitt TE, 2007, PSYCHOL MED, V37, P441, DOI 10.1017/S0033291706009640; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Nakashima H, 2004, HYPERTENS RES, V27, P319, DOI 10.1291/hypres.27.319; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; Obana N, 2003, INTERNAL MED, V42, P150, DOI 10.2169/internalmedicine.42.150; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Pirkola S, 2005, SOC PSYCH PSYCH EPID, V40, P769, DOI 10.1007/s00127-005-0950-x; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; Rammal H, 2008, BRAIN BEHAV IMMUN, V22, P1156, DOI 10.1016/j.bbi.2008.06.005; Richards JB, 2008, ATHEROSCLEROSIS, V200, P271, DOI 10.1016/j.atherosclerosis.2007.12.035; Saarni SI, 2007, BRIT J PSYCHIAT, V190, P326, DOI 10.1192/bjp.bp.106.025106; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Souza CG, 2007, LIFE SCI, V81, P198, DOI 10.1016/j.lfs.2007.05.001; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wood SJ, 2009, ANN ACAD MED SINGAP, V38, P396; Yang ZW, 2009, HYPERTENSION, V53, P639, DOI 10.1161/HYPERTENSIONAHA.108.123752; Yu WY, 2008, J PSYCHIATR NEUROSCI, V33, P244	68	207	207	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10826	10.1371/journal.pone.0010826	http://dx.doi.org/10.1371/journal.pone.0010826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601CE	20520834	gold, Green Submitted, Green Published			2022-12-25	WOS:000278034800019
J	Pylkkanen, L; Okano, K				Pylkkaenen, Liina; Okano, Kana			The Nature of Abstract Orthographic Codes: Evidence from Masked Priming and Magnetoencephalography	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; EVENT-RELATED POTENTIALS; LETTER-STRING PERCEPTION; BRAIN POTENTIALS; LEXICAL ACCESS; FORM AREA; TIME-COURSE; FREQUENCY; MASKING; LENGTH	What kind of mental objects are letters? Research on letter perception has mainly focussed on the visual properties of letters, showing that orthographic representations are abstract and size/shape invariant. But given that letters are, by definition, mappings between symbols and sounds, what is the role of sound in orthographic representation? We present two experiments suggesting that letters are fundamentally sound-based representations. To examine the role of sound in orthographic representation, we took advantage of the multiple scripts of Japanese. We show two types of evidence that if a Japanese word is presented in a script it never appears in, this presentation immediately activated the ("actual") visual word form of that lexical item. First, equal amounts of masked repetition priming are observed for full repetition and when the prime appears in an atypical script. Second, visual word form frequency affects neuromagnetic measures already at 100-130 ms whether the word is presented in its conventional script or in a script it never otherwise appears in. This suggests that Japanese orthographic codes are not only shape-invariant, but also script invariant. The finding that two characters belonging to different writing systems can activate the same form representation suggests that sound identity is what determines orthographic identity: as long as two symbols express the same sound, our minds represent them as part of the same character/letter.	[Pylkkaenen, Liina] NYU, Dept Linguist, New York, NY 10003 USA; [Pylkkaenen, Liina] NYU, Dept Psychol, New York, NY 10003 USA; Tufts Univ, Dept Psychol, Medford, MA 02155 USA	New York University; New York University; Tufts University	Pylkkanen, L (corresponding author), NYU, Dept Linguist, Washington Sq, New York, NY 10003 USA.	liina.pylkkanen@nyu.edu			NSF [BCS-0545186]	NSF(National Science Foundation (NSF))	NSF BCS-0545186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S., 2003, NIHONGO NO GOI TOKUS, V7; Assadollahi R, 2003, NEUROREPORT, V14, P1183, DOI 10.1097/00001756-200306110-00016; Bowers JS, 1998, J EXP PSYCHOL HUMAN, V24, P1705, DOI 10.1037/0096-1523.24.6.1705; Chauncey K, 2008, LANG COGNITIVE PROC, V23, P183, DOI 10.1080/01690960701579839; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; DEHAENE S, TRENDS COGNITIVE SCI, V9, P335; Embick D, 2001, COGNITIVE BRAIN RES, V10, P345, DOI 10.1016/S0926-6410(00)00053-7; FERRAND L, 1994, Q J EXP PSYCHOL-A, V47, P365, DOI 10.1080/14640749408401116; Grainger J, 2003, MENTAL LEXICON: SOME WORDS TO TALK ABOUT WORDS, P1; Grainger J, 2008, TRENDS COGN SCI, V12, P381, DOI 10.1016/j.tics.2008.06.006; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, CLIN NEUROPHYSIOL, V115, P1090, DOI 10.1016/j.clinph.2003.12.020; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Longtin CM, 2003, LANG COGNITIVE PROC, V18, P313, DOI 10.1080/01690960244000036; LUKATELA G, 1994, J EXP PSYCHOL GEN, V123, P331, DOI 10.1037/0096-3445.123.4.331; Maurer U., 2008, SINGLE WORD READING, P43; Maurer U, 2008, J COGNITIVE NEUROSCI, V20, P1878, DOI 10.1162/jocn.2008.20125; Monahan PJ, 2008, BRAIN LANG, V106, P65, DOI 10.1016/j.bandl.2008.02.002; PAAP KR, 1984, J EXP PSYCHOL HUMAN, V10, P413, DOI 10.1037/0096-1523.10.3.413; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; PERFETTI CA, 1991, J MEM LANG, V30, P473, DOI 10.1016/0749-596X(91)90017-E; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Rastle K, 2004, PSYCHON B REV, V11, P1090, DOI 10.3758/BF03196742; Rastle K, 2000, LANG COGNITIVE PROC, V15, P507, DOI 10.1080/01690960050119689; RUGG MD, 1990, MEM COGNITION, V18, P367, DOI 10.3758/BF03197126; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Solomyak O, 2010, J COGNITIVE NEUROSCI, V22, P2042, DOI 10.1162/jocn.2009.21296; Solomyak O, 2009, BRAIN LANG, V108, P191, DOI 10.1016/j.bandl.2008.09.004; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; VANPETTEN C, 1990, MEM COGNITION, V18, P380, DOI 10.3758/BF03197127; Zweig E, 2009, LANG COGNITIVE PROC, V24, P412, DOI 10.1080/01690960802180420	35	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10793	10.1371/journal.pone.0010793	http://dx.doi.org/10.1371/journal.pone.0010793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520833	gold, Green Published, Green Submitted			2022-12-25	WOS:000278034800003
J	Eriksen, J; Bjorn-Yoshimoto, WE; Jorgensen, TN; Newman, AH; Gether, U				Eriksen, Jacob; Bjorn-Yoshimoto, Walden Emil; Jorgensen, Trine Nygaard; Newman, Amy Hauck; Gether, Ulrik			Postendocytic Sorting of Constitutively Internalized Dopamine Transporter in Cell Lines and Dopaminergic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MONOAMINE TRANSPORTERS; STRIATAL SYNAPTOSOMES; MEMBRANE TRAFFICKING; RECYCLING PATHWAY; UBIQUITINATION; ENDOCYTOSIS; IDENTIFICATION; GLUTAMATE; MECHANISM	The dopamine transporter (DAT) mediates reuptake of released dopamine and is the target for psychostimulants, such as cocaine and amphetamine. DAT undergoes marked constitutive endocytosis, but little is known about the fate and sorting of the endocytosed transporter. To study DAT sorting in cells lines, we fused the one-transmembrane segment protein Tac to DAT, thereby generating a transporter (TacDAT) with an extracellular antibody epitope suited for trafficking studies. TacDAT was functional and endocytosed constitutively in HEK293 cells. According to an ELISA-based assay, TacDAT intracellular accumulation was increased by the lysosomal protease inhibitor leupeptin and by monensin, an inhibitor of lysosomal degradation and recycling. Monensin also reduced TacDAT surface expression consistent with partial recycling. In both HEK293 cells and in the dopaminergic cell line 1Rb3An27, constitutively internalized TacDAT displayed primary co-localization with the late endosomal marker Rab7, less co-localization with the "short loop" recycling marker Rab4, and little co-localization with the marker of "long loop" recycling endosomes, Rab11. Removal by mutation of N-terminal ubiquitination sites did not affect this sorting pattern. The sorting pattern was distinct from a bona fide recycling membrane protein, the beta 2-adrenergic receptor, that co-localized primarily with Rab11 and Rab4. Constitutively internalized wild type DAT probed with the fluorescently tagged cocaine analogue JHC 1-64, exhibited the same co-localization pattern as TacDAT in 1Rb3An27 cells and in cultured midbrain dopaminergic neurons. We conclude that DAT is constitutively internalized and sorted in a ubiquitination-independent manner to late endosomes/lysosomes and in part to a Rab4 positive short loop recycling pathway.	[Eriksen, Jacob; Bjorn-Yoshimoto, Walden Emil; Jorgensen, Trine Nygaard; Gether, Ulrik] Panum Inst, Dept Neurosci & Pharmacol, Mol Neuropharmacol Grp, DK-2200 Copenhagen N, Denmark; [Eriksen, Jacob; Bjorn-Yoshimoto, Walden Emil; Jorgensen, Trine Nygaard; Gether, Ulrik] Panum Inst, Dept Neurosci & Pharmacol, Ctr Pharmacogen, DK-2200 Copenhagen N, Denmark; [Newman, Amy Hauck] Natl Inst Drug Abuse, Med Chem Sect, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Gether, U (corresponding author), Panum Inst, Dept Neurosci & Pharmacol, Mol Neuropharmacol Grp, 18-6 Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	gether@sund.ku.dk	Bjørn-Yoshimoto, Walden/ABH-3709-2020	Eriksen, Jacob/0000-0003-0726-9769; Bjorn-Yoshimoto, Walden Emil/0000-0003-1019-9239; Gether, Ulrik/0000-0002-0020-3807	National Institutes of Health [P01 DA 12408]; National Institute on Drug Abuse; Lundbeck Foundation; Danish Medical Research Councils; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Councils(Danish Medical Research Council); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G.) and by the National Institute on Drug Abuse Intramural Research Program (to A. H. N.). This work was also supported by the Lundbeck Foundation (to U. G.), the Danish Medical Research Councils (to U. G.), and "Fabrikant Vilhelm Pedersen og Hustrus Mindelegat" (to U. G.).	Adams FS, 1996, NEUROCHEM RES, V21, P619, DOI 10.1007/BF02527762; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; Chmelar RS, 2006, J BIOL CHEM, V281, P35381, DOI 10.1074/jbc.M605954200; Colgan L, 2007, TRAFFIC, V8, P512, DOI 10.1111/j.1600-0854.2007.00555.x; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Copeland BJ, 1996, J PHARMACOL EXP THER, V277, P1527; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; DIPORZIO U, 1980, NATURE, V288, P370, DOI 10.1038/288370a0; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Furman CA, 2009, NEUROSCI LETT, V463, P78, DOI 10.1016/j.neulet.2009.07.049; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kahlig KM, 2006, MOL PHARMACOL, V70, P542, DOI 10.1124/mol.106.023952; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2007, NEUROPHARMACOLOGY, V52, P100, DOI 10.1016/j.neuropharm.2006.07.011; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Moron JA, 2003, J NEUROSCI, V23, P8480; Mortensen OV, 2008, MOL BIOL CELL, V19, P2818, DOI 10.1091/mbc.E07-09-0980; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Tsao PI, 2001, PHARMACOL THERAPEUT, V89, P139, DOI 10.1016/S0163-7258(00)00107-8; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zahniser NR, 2009, SEMIN CELL DEV BIOL, V20, P411, DOI 10.1016/j.semcdb.2009.01.004; Zhu SJ, 1997, J PHARMACOL EXP THER, V282, P1358	61	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27289	27301		10.1074/jbc.M110.131003	http://dx.doi.org/10.1074/jbc.M110.131003			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551317	hybrid, Green Published			2022-12-25	WOS:000281172700059
J	Monzon, ME; Fregien, N; Schmid, N; Falcon, NS; Campos, M; Casalino-Matsuda, SM; Forteza, RM				Monzon, Maria E.; Fregien, Nevis; Schmid, Nathalie; Falcon, Nieves S.; Campos, Michael; Casalino-Matsuda, S. Marina; Forteza, Rosanna Malbran			Reactive Oxygen Species and Hyaluronidase 2 Regulate Airway Epithelial Hyaluronan Fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAAGSIEKTE SHEEP RETROVIRUS; FACTOR RECEPTOR ACTIVATION; PHOSPHOLIPASE-D; PROTEIN-KINASE; IN-VITRO; EXPRESSION; CELLS; INFLAMMATION; DEGRADATION; SYNTHESIZE	Hyaluronidase 2 (Hyal2) is a hyaluronan (HA)-degrading enzyme found intracellularly or/and anchored to the plasma membrane through glycosylphosphatidylinositol (GPI). Normal human bronchial epithelial cells (NHBE) grown at the air-liquid interphase (ALI), treated with PI-specific phospholipase C (PIPLC), exhibited increased Hyal activity in secretions and decreased protein and activity on the apical membrane, confirming that GPI-anchored Hyal2 is expressed in NHBE cells and it remains active in its soluble form. We have reported that HA degradation was mediated by reactive oxygen species (ROS) in human airways. Here we show that ROS increase Hyal2 expression and activity in NHBE cells and that the p38MAPK signaling pathway is involved in this effect. Hyal2 induction was confirmed by using small interfering RNA (siRNA) expressing lentivirus. These in vitro findings correlated in vivo with smokers, where increased Hyal2 immunoreactivity in the epithelium was associated with augmented levels of HA and the appearance of low molecular mass HA species in bronchial secretions. In summary, this work provides evidence that ROS induce Hyal2, suggesting that Hyal2 is likely responsible for the sustained HA fragmentation in the airway lumen observed in inflammatory conditions associated with oxidative stress.	[Casalino-Matsuda, S. Marina; Forteza, Rosanna Malbran] Univ Miami, Miller Sch Med, Div Pulm Crit Care Sleep Med, Miami, FL 33136 USA; [Fregien, Nevis] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA	University of Miami; University of Miami	Monzon, ME (corresponding author), Univ Miami, Div Pulm & Crit Care, Miller Sch Med, 1600 NW 10th Ave, Miami, FL 33136 USA.	mmonzonmedina@med.miami.edu; RForteza@med.miami.edu	Matsuda, Marina/AAH-2959-2019; Campos, Michael/X-2025-2019	Matsuda, Marina/0000-0002-7566-4560; Campos, Michael/0000-0001-5485-9062	National Institutes of Health [HL-073156]; Flight Attendant Medical Research Institute (FAMRI); James and Esther King Foundation [JEK12292]; AHA; JEK [12324]; American Lung Association of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI); James and Esther King Foundation; AHA(American Heart Association); JEK; American Lung Association of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-073156. This work was also supported by a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute (FAMRI) (to M. E. M.), a Bridge Award from the James and Esther King Foundation (JEK12292), and a Clinical Innovator Award from FAMRI (to R.M.F.); a Scientist Development Grant from AHA and JEK (12324) (to S. M. C.-M.), a Career Development Award from the American Lung Association of Florida, and a Clinical Innovator Award from FAMRI (to N.S.F.).	Al-Assaf S, 2006, FREE RADICAL BIO MED, V40, P2018, DOI 10.1016/j.freeradbiomed.2006.01.033; BASBAUM CB, 1988, HORM METAB RES, V20, P661, DOI 10.1055/s-2007-1010912; Bassa BV, 1999, AM J PHYSIOL-RENAL, V277, pF328, DOI 10.1152/ajprenal.1999.277.3.F328; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Blundell C.D., 2004, CHEM BIOL HYALURONAN; Borrill Zoe L, 2008, Int J Chron Obstruct Pulmon Dis, V3, P171; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; BREWIS IA, 1994, BIOCHEM J, V303, P633, DOI 10.1042/bj3030633; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Campos MA, 2004, AM J RESP CELL MOL, V30, P184, DOI 10.1165/rcmb.2003-0142OC; Casalino-Matsuda SM, 2009, AM J RESP CELL MOL, V40, P277, DOI 10.1165/rcmb.2008-0073OC; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Casalino-Matsuda SM, 2004, J BIOL CHEM, V279, P21606, DOI 10.1074/jbc.M309950200; Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P342; Chow G, 2006, OSTEOARTHR CARTILAGE, V14, P849, DOI 10.1016/j.joca.2006.02.009; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; DAY AJ, 2001, GLYCOFORUM; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; FORTEZA RM, 2002, GLYCOFORUM; Frati E, 1997, FREE RADICAL BIO MED, V22, P1139, DOI 10.1016/S0891-5849(96)00525-4; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; GUNTENHONER MW, 1992, MATRIX, V12, P388, DOI 10.1016/S0934-8832(11)80035-1; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; JEFFERY PK, 1992, RESPIRATION, V59, P13; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Khadaroo RG, 2003, SURGERY, V134, P242, DOI 10.1067/msy.2003.228; Kostikas K, 2002, AM J RESP CRIT CARE, V165, P1364, DOI 10.1164/rccm.200111-068OC; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lei ZB, 2002, CARDIOVASC RES, V53, P524, DOI 10.1016/S0008-6363(01)00491-6; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; LOW MG, 1988, P NATL ACAD SCI USA, V85, P980, DOI 10.1073/pnas.85.4.980; MAGUIRE GA, 1995, ANN CLIN BIOCHEM, V32, P74, DOI 10.1177/000456329503200107; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Mercer Becky A, 2006, Int J Chron Obstruct Pulmon Dis, V1, P137, DOI 10.2147/copd.2006.1.2.137; Miller AD, 2008, SEMIN CANCER BIOL, V18, P296, DOI 10.1016/j.semcancer.2008.03.010; Monzon ME, 2008, AM J RESP CELL MOL, V39, P289, DOI 10.1165/rcmb.2007-0361OC; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; O'Brien KD, 1999, CIRCULATION, V99, P2876, DOI 10.1161/01.CIR.99.22.2876; Pardue Erin L, 2008, Organogenesis, V4, P203; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Salustri A, 1999, HUM REPROD UPDATE, V5, P293, DOI 10.1093/humupd/5.4.293; Sinn PL, 2005, HUM GENE THER, V16, P479, DOI 10.1089/hum.2005.16.479; Skold CM, 1996, RESP MED, V90, P523, DOI 10.1016/S0954-6111(96)90144-4; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997	65	80	80	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26126	26134		10.1074/jbc.M110.135194	http://dx.doi.org/10.1074/jbc.M110.135194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554532	hybrid, Green Published			2022-12-25	WOS:000280921000030
J	Sun, XX; Wang, YG; Xirodimas, DP; Dai, MS				Sun, Xiao-Xin; Wang, Yue-Gang; Xirodimas, Dimitris P.; Dai, Mu-Shui			Perturbation of 60 S Ribosomal Biogenesis Results in Ribosomal Protein L5-and L11-dependent p53 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAMOND-BLACKFAN ANEMIA; CELL-CYCLE ARREST; ONCOPROTEIN MDM2; NUCLEOLAR DISRUPTION; C-MYC; L11; INHIBITION; PATHWAY; UBIQUITINATION; CANCER	Ribosomal proteins play an important role in p53 activation in response to nucleolar stress. Multiple ribosomal proteins, including L5, L11, L23, and S7, have been shown to bind to and inhibit MDM2, leading to p53 activation. However, it is not clear whether ribosomal protein regulation of MDM2 is specific to some, but not all ribosomal proteins. Here we show that L29 and L30, two ribosomal proteins from the 60 S ribosomal subunit, do not bind to MDM2 and do not inhibit MDM2-mediated p53 suppression, indicating that the ribosomal protein regulation of the MDM2-p53 feedback loop is specific. Interestingly, direct perturbation of the 60 S ribosomal biogenesis by knocking down either L29 or L30 drastically induced the level and activity of p53, leading to p53-depedent cell cycle arrest. This p53 activation was drastically inhibited by knockdown of L11 or L5. Consistently, knockdown of L29 or L30 enhanced the interaction of MDM2 with L11 and L5 and markedly inhibited MDM2-mediated p53 ubiquitination, suggesting that direct perturbation of 60 S ribosomal biogenesis activates p53 via L11- and L5-mediated MDM2 suppression. Mechanistically, knockdown of L30 or L29 significantly increased the NEDDylation and nuclear retention of L11. Knocking down endogenous NEDD8 suppressed p53 activation induced by knockdown of L30. These results demonstrate that NEDDylation of L11 plays a critical role in mediating p53 activation in response to perturbation of ribosomal biogenesis.	[Dai, Mu-Shui] Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Xirodimas, Dimitris P.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	Oregon Health & Science University; Oregon Health & Science University; University of Dundee	Dai, MS (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97239 USA.	daim@ohsu.edu		Xirodimas, Dimitris/0000-0001-9275-1140	NCI [R00 CA127134]; Medical Research Foundation of Oregon; Oregon Health & Science University; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE [R00CA127134] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Foundation of Oregon; Oregon Health & Science University; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 CA127134 from the NCI. This work was also supported by a grant from Medical Research Foundation of Oregon and a startup fund from Oregon Health & Science University (to M.-S. D.).; A recipient of a Cancer Research Development Award from the OHSU Knight Cancer Institute.	Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; DEOCALUNA R, 1995, NATURE, V0378; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Lai K, 2009, DEV DYNAM, V238, P76, DOI 10.1002/dvdy.21815; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Liu JJ, 2006, J CELL PHYSIOL, V207, P287, DOI 10.1002/jcp.20589; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Mekhail K, 2005, J CELL BIOL, V170, P733, DOI 10.1083/jcb.200506030; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	46	61	65	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25812	25821		10.1074/jbc.M109.098442	http://dx.doi.org/10.1074/jbc.M109.098442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554519	Green Published, hybrid			2022-12-25	WOS:000280682400073
J	Ahmed, IS; Rohe, HJ; Twist, KE; Craven, RJ				Ahmed, Ikhlas S.; Rohe, Hannah J.; Twist, Katherine E.; Craven, Rolf J.			Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROFILES; HEME-1 DOMAIN PROTEIN; BREAST-CANCER CELLS; LUNG-CANCER; TYROSINE KINASE; BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISMS; ANTIAPOPTOTIC ACTION; ESTROGEN-RECEPTOR	Tumorigenesis requires the concerted action of multiple pathways, including pathways that stimulate proliferation and metabolism. Epidermal growth factor receptor (EGFR) is a transmembrane receptor-tyrosine kinase that is associated with cancer progression, and the EGFR inhibitors erlotinib/tarceva and tyrphostin/AG-1478 are potent anti-cancer therapeutics. Pgrmc1 (progesterone receptor membrane component 1) is a cytochrome b(5)-related protein that is up-regulated in tumors and promotes cancer growth. Pgrmc1 and its homologues have been implicated in cell signaling, and we show here that Pgrmc1 increases susceptibility to AG-1478 and erlotinib, increases plasma membrane EGFR levels, and co-precipitates with EGFR. Pgrmc1 co-localizes with EGFR in cytoplasmic vesicles and co-fractionates with EGFR in high density microsomes. The findings have therapeutic potential because a Pgrmc1 small molecule ligand, which inhibits growth in a variety of cancer cell types, de-stabilized EGFR in multiple tumor cell lines. EGFR is one of the most potent receptor-tyrosine kinases driving tumorigenesis, and our data support a role for Pgrmc1 in promoting several cancer phenotypes at least in part by binding EGFR and stabilizing plasma membrane pools of the receptor.	[Ahmed, Ikhlas S.; Rohe, Hannah J.; Twist, Katherine E.; Craven, Rolf J.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky	Craven, RJ (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA.	rolf.craven@uky.edu			American Cancer Society [85-001-19-IRG]; Kentucky Lung Cancer Research Program	American Cancer Society(American Cancer Society); Kentucky Lung Cancer Research Program	This work was supported in part by American Cancer Society Grant 85-001-19-IRG and by the Kentucky Lung Cancer Research Program.	Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Bareschino MA, 2007, ANN ONCOL, V18, P35, DOI 10.1093/annonc/mdm222; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Craven RJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2191; Crudden G, 2006, J PHARMACOL EXP THER, V316, P448, DOI 10.1124/jpet.105.094631; Crudden G, 2005, TUMOR BIOL, V26, P142, DOI 10.1159/000086485; Difilippantonio S, 2003, EUR J CANCER, V39, P1936, DOI 10.1016/S0959-8049(03)00419-2; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Furukawa M, 2007, DNA CELL BIOL, V26, P178, DOI 10.1089/dna.2006.0573; Gerdes D, 1998, BIOL CHEM, V379, P907; Ghosh K, 2005, BIOCHEMISTRY-US, V44, P16729, DOI 10.1021/bi0511585; GOLDENBERG A, 1989, J NATL CANCER I, V81, P1616, DOI 10.1093/jnci/81.21.1616; Hand RA, 2003, J CELL BIOCHEM, V90, P534, DOI 10.1002/jcb.10648; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Irby RB, 2005, CANCER RES, V65, P1814, DOI 10.1158/0008-5472.CAN-04-3609; Jaramillo ML, 2008, CANCER BIOL THER, V7, P557, DOI 10.4161/cbt.7.4.5533; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Laurent-Puig P, 2009, CLIN CANCER RES, V15, P1133, DOI 10.1158/1078-0432.CCR-08-0905; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mallory JC, 2005, MOL PHARMACOL, V68, P1747, DOI 10.1124/mol.105.016519; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; Mifsud W, 2002, GENOME BIOL, V3; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Nagy P, 2003, EXP CELL RES, V285, P39, DOI 10.1016/S0014-4827(02)00050-2; Neubauer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2155; Nie AY, 2006, MOL CARCINOGEN, V45, P914, DOI 10.1002/mc.20205; Nolte I, 2000, BBA-PROTEIN STRUCT M, V1543, P123, DOI 10.1016/S0167-4838(00)00188-6; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Peluso JJ, 2005, BIOL REPROD, V73, P261, DOI 10.1095/biolreprod.105.041061; Peluso JJ, 2008, J CLIN ENDOCR METAB, V93, P1592, DOI 10.1210/jc.2007-2771; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Peluso JJ, 2009, ENDOCRINOLOGY, V150, P4846, DOI 10.1210/en.2009-0730; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Runko E, 2004, J NEUROSCI, V24, P9015, DOI 10.1523/JNEUROSCI.2385-04.2004; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; Sequist LV, 2008, ANNU REV MED, V59, P429, DOI 10.1146/annurev.med.59.090506.202405; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Thompson AM, 2007, BIOCHEMISTRY-US, V46, P14629, DOI 10.1021/bi7013739; Toulany M, 2007, MOL CANCER RES, V5, P863, DOI 10.1158/1541-7786.MCR-06-0297; Wang T, 2007, CANCER SCI, V98, P506, DOI 10.1111/j.1349-7006.2007.00428.x; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Zhang Min, 2005, Genet Vaccines Ther, V3, P5, DOI 10.1186/1479-0556-3-5	54	99	101	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24775	24782		10.1074/jbc.M110.134585	http://dx.doi.org/10.1074/jbc.M110.134585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538600	Green Published, hybrid			2022-12-25	WOS:000280542100050
J	Jones, MB; Nasirikenari, M; Feng, L; Migliore, MT; Choi, KS; Kazim, L; Lau, JTY				Jones, Mark B.; Nasirikenari, Mehrab; Feng, Li; Migliore, Marina T.; Choi, Kyoung-Soo; Kazim, Latif; Lau, Joseph T. Y.			Role for Hepatic and Circulatory ST6Gal-1 Sialyltransferase in Regulating Myelopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-PHASE RESPONSE; SERUM SIALYLTRANSFERASE; BETA-SECRETASE; P1 PROMOTER; RAT-LIVER; IN-VIVO; INFLAMMATION; SIALYLATION; EXPRESSION; MICE	Recent findings have established a role for the ST6Gal-1 sialyltransferase in modulating inflammatory cell production during Th1 and Th2 responses. ST6Gal-1 synthesizes the Sia(alpha 2,6) to Gal(beta 1,4) GlcNAc linkage on glycoproteins on cell surfaces and in systemic circulation. Engagement of P1, one of six promoter/regulatory regions driving murine ST6Gal-1 gene expression, generates the ST6Gal-1 for myelopoietic regulation. P1 utilization, however, is restricted to the liver and silent in hematopoietic cells. We considered the possibility that myelopoiesis is responsive to the sialylation of liver-derived circulatory glycoproteins, such that reduced alpha 2,6-sialylation results in elevated myelopoiesis. However, 2-dimensional differential in gel electrophoresis (2D-DIGE) analysis disclosed only minimal alterations in the sialylation of sera glycoproteins of ST6Gal-1deficient mice when compared with wild-type controls, either at baseline or during an acute phase response when the demand for sialylation is greatest. Furthermore, sera from ST6Gal-1-deficient animals did not enhance myelopoietic activity in ex vivo colony formation assays. Whereas there was only minimal consequence to the alpha 2,6-sialylation of circulatory glycoproteins, ablation of the P1 promoter did result in strikingly depressed levels of ST6Gal-1 released into systemic circulation. Therefore, we considered the alternative possibility that myelopoiesis may be regulated not by the hepatic sialyl glycoproteins, but by the ST6Gal-1 that was released directly into circulation. Supporting this, ex vivo colony formation was notably attenuated upon introduction of physiologic levels of ST6Gal-1 into the culture medium. Our data support the idea that circulatory ST6Gal-1, mostly of hepatic origin, limits myelopoiesis by a mechanism independent of hepatic sialylation of serum glycoproteins.	[Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, MRC330, Buffalo, NY 14263 USA; [Migliore, Marina T.; Choi, Kyoung-Soo; Kazim, Latif] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Lau, JTY (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, MRC330, Elm & Carlton St, Buffalo, NY 14263 USA.	joseph.lau@roswellpark.org			National Institutes of Health [AI056082, AI078429]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078429, R01AI056082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health the P1-mediated pool of ST6Gal-1 in the regulation of myeloGrant AI056082 (to J.T.Y.L.) and National Institutes of Health Grant AI078429 (to J.T.Y.L.).	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066; CHANDRASEKARAN EV, 1995, BIOCHEMISTRY-US, V34, P2925, DOI 10.1021/bi00009a024; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; EVANS IM, 1980, CANCER RES, V40, P3103; Ghosh S, 2006, INT IMMUNOL, V18, P603, DOI 10.1093/intimm/dxh402; Gracheva EV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1315; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hu YP, 1997, GLYCOCONJUGATE J, V14, P407, DOI 10.1023/A:1018535014976; IP C, 1978, CANCER RES, V38, P723; JAMIESON JC, 1987, COMP BIOCHEM PHYS B, V87, P11, DOI 10.1016/0305-0491(87)90463-9; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2004, GLYCOCONJUGATE J, V21, P25, DOI 10.1023/B:GLYC.0000043743.21735.ff; Kitazume S, 2003, GLYCOCONJUGATE J, V20, P59, DOI 10.1023/B:GLYC.0000016743.25495.45; Kitazume S, 2009, GLYCOBIOLOGY, V19, P479, DOI 10.1093/glycob/cwp003; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; LAMMERS G, 1986, COMP BIOCHEM PHYS B, V84, P181, DOI 10.1016/0305-0491(86)90203-8; Maguire TM, 1998, BBA-GEN SUBJECTS, V1379, P23, DOI 10.1016/S0304-4165(97)00077-9; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Shah MH, 2008, GLYCOCONJUGATE J, V25, P279, DOI 10.1007/s10719-007-9086-4; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Thorne-Tjomsland G, 2000, TRANSPLANTATION, V69, P806; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WOLOSKI BMRNJ, 1985, BIOCHEM BIOPH RES CO, V130, P30, DOI 10.1016/0006-291X(85)90377-8; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Wuensch SA, 2000, GLYCOBIOLOGY, V10, P67, DOI 10.1093/glycob/10.1.67; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068	36	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25009	25017		10.1074/jbc.M110.104406	http://dx.doi.org/10.1074/jbc.M110.104406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529847	hybrid, Green Published			2022-12-25	WOS:000280542100073
J	Zhao, M; Li, XD; Chen, ZJ				Zhao, Meng; Li, Xiao-Dong; Chen, Zhijian			CC2D1A, a DM14 and C2 Domain Protein, Activates NF-kappa B through the Canonical Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; GROWTH-FACTOR; UBIQUITIN; GENE; CYLD; IKK; IDENTIFICATION; TRAFFICKING; DROSOPHILA; KINASE	CC2D1A is an evolutionarily conserved protein that contains four DM14 domains at the N terminus and a C2 domain at the C terminus. Loss-of-function mutations in CC2D1A have been linked to mental retardation in human, but the biochemical function of this protein is largely unknown. Here, we show that CC2D1A is a potent activator of NF-kappa B. The activation of NF-kappa B by CC2D1A requires its C2 domain. CC2D1A activates NF-kappa B in a manner that depends on the ubiquitin-conjugating enzyme Ubc13, TNF receptor-associated factor TRAF2, the protein kinase TAK1, and the I kappa B kinase (IKK) complex. In addition, the deubiquitination enzyme Cylindromatosis (CYLD) negatively regulates the activity of CC2D1A. These results suggest that CC2D1A activates NF-kappa B through the canonical IKK pathway.	[Zhao, Meng; Li, Xiao-Dong; Chen, Zhijian] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Zhijian.Chen@UTSouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	National Institutes of Health [RO1AI060919]; Welch Foundation [I-1389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AI060919. This work was also supported by Welch Foundation Grant I-1389.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ou XM, 2003, J NEUROSCI, V23, P7415; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wilkinson KD, 2004, CELL, V119, P741, DOI 10.1016/S0092-8674(04)01154-7; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002	27	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24372	24380		10.1074/jbc.M109.100057	http://dx.doi.org/10.1074/jbc.M109.100057			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529849	Green Published, hybrid			2022-12-25	WOS:000280542100008
J	Wilson, K; Das, M; Wahl, KJ; Colton, RJ; Hickman, J				Wilson, Kerry; Das, Mainak; Wahl, Kathryn J.; Colton, Richard J.; Hickman, James			Measurement of Contractile Stress Generated by Cultured Rat Muscle on Silicon Cantilevers for Toxin Detection and Muscle Performance Enhancement	PLOS ONE			English	Article							SKELETAL-MUSCLE; DEFINED SYSTEM; IN-VITRO; FILMS; INTEGRATION; DEVICES; DIFFERENTIATION; MICROSTRUCTURES; FABRICATION; IMPROVEMENT	Background: To date, biological components have been incorporated into MEMS devices to create cell-based sensors and assays, motors and actuators, and pumps. Bio-MEMS technologies present a unique opportunity to study fundamental biological processes at a level unrealized with previous methods. The capability to miniaturize analytical systems enables researchers to perform multiple experiments in parallel and with a high degree of control over experimental variables for high-content screening applications. Methodology/Principal Findings: We have demonstrated a biological microelectromechanical system (BioMEMS) based on silicon cantilevers and an AFM detection system for studying the physiology and kinetics of myotubes derived from embryonic rat skeletal muscle. It was shown that it is possible to interrogate and observe muscle behavior in real time, as well as selectively stimulate the contraction of myotubes with the device. Stress generation of the tissue was estimated using a modification of Stoney's equation. Calculated stress values were in excellent agreement with previously published results for cultured myotubes, but not adult skeletal muscle. Other parameters such as time to peak tension (TPT), the time to half relaxation (KRT) were compared to the literature. It was observed that the myotubes grown on the BioMEMS device, while generating stress magnitudes comparable to those previously published, exhibited slower TPT and KRT values. However, growth in an enhanced media increased these values. From these data it was concluded that the myotubes cultured on the cantilevers were of an embryonic phenotype. The system was also shown to be responsive to the application of a toxin, veratridine. Conclusions/Significance: The device demonstrated here will provide a useful foundation for studying various aspects of muscle physiology and behavior in a controlled high-throughput manner as well as be useful for biosensor and drug discovery applications.	[Wilson, Kerry; Das, Mainak; Hickman, James] Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA; [Wahl, Kathryn J.] USN, Res Lab, Mol Interfaces & Tribol Sect, Washington, DC 20375 USA; [Colton, Richard J.] USN, Res Lab, Div Chem, Washington, DC 20375 USA	State University System of Florida; University of Central Florida; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Wilson, K (corresponding author), UCL, London Ctr Nanotechnol, London, England.	jhickman@mail.ucf.edu	Wahl, Kathryn J/A-6494-2012	Wahl, Kathryn/0000-0001-8163-6964	Office of Naval Research; NIH [5RO1-NS050452]; DARPA [F30602-02-2-0541]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050452] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to acknowledge the MEMS Exchange for fabrication of the cantilevers. Finally, the authors also acknowledge the support of the Office of Naval Research for this project.; The authors acknowledge funding support from NIH grant 5RO1-NS050452 and DARPA F30602-02-2-0541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER S, 1989, J APPL PHYS, V65, P164, DOI 10.1063/1.342563; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bousse L, 1996, SENSOR ACTUAT B-CHEM, V34, P270, DOI 10.1016/S0925-4005(96)01906-5; Brewer GJ, 2008, J NEUROSCI METH, V170, P181, DOI 10.1016/j.jneumeth.2008.01.009; Butt HJ, 1996, J COLLOID INTERF SCI, V180, P251, DOI 10.1006/jcis.1996.0297; CLOSE R, 1964, J PHYSIOL-LONDON, V173, P74, DOI 10.1113/jphysiol.1964.sp007444; Das M, 2007, NEUROSCIENCE, V146, P481, DOI 10.1016/j.neuroscience.2007.01.068; DAS M, 2010, BIOMATERIAL IN PRESS; Das M, 2007, NAT PROTOC, V2, P1795, DOI 10.1038/nprot.2007.229; Das M, 2006, BIOMATERIALS, V27, P4374, DOI 10.1016/j.biomaterials.2006.03.046; Das M, 2009, BIOMATERIALS, V30, P5392, DOI 10.1016/j.biomaterials.2009.05.081; Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Glass DJ, 2007, J CLIN INVEST, V117, P2388, DOI 10.1172/JCI33379; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Klein Claude A., 2000, J APPL PHYS, V88; LEE WE, 1995, CERAMIC FILMS COATIN; MEYER G, 1988, APPL PHYS LETT, V53, P1045, DOI 10.1063/1.100061; Mohan DK, 2006, BIOSENS BIOELECTRON, V21, P1804, DOI 10.1016/j.bios.2005.09.008; Moulard G, 1998, J VAC SCI TECHNOL A, V16, P736, DOI 10.1116/1.581053; Muller P, 2004, SURF SCI REP, V54, P157, DOI 10.1016/j.surfrep.2004.05.001; Pancrazio JJ, 1999, ANN BIOMED ENG, V27, P697, DOI 10.1114/1.225; Peterson CA, 1999, J VAC SCI TECHNOL A, V17, P2753, DOI 10.1116/1.581941; Ravenscroft MS, 1998, J AM CHEM SOC, V120, P12169, DOI 10.1021/ja973669n; SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439; SANDER D, 1995, REV SCI INSTRUM, V66, P4734, DOI 10.1063/1.1145316; Sin A, 2004, BIOTECHNOL PROGR, V20, P338, DOI 10.1021/bp034077d; Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632; Spetzler D, 2007, LAB CHIP, V7, P1633, DOI 10.1039/b711066a; Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021; Tanaka Y, 2007, LAB CHIP, V7, P207, DOI 10.1039/b612082b; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Wilson K, 2007, LAB CHIP, V7, P920, DOI 10.1039/b617939h; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308	34	58	70	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11042	10.1371/journal.pone.0011042	http://dx.doi.org/10.1371/journal.pone.0011042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548775	gold, Green Submitted, Green Published			2022-12-25	WOS:000278599600005
J	McElroy, SL; Byrne, JA; Chavez, SL; Behr, B; Hsueh, AJ; Westphal, LM; Pera, RAR				McElroy, Sohyun L.; Byrne, James A.; Chavez, Shawn L.; Behr, Barry; Hsueh, Aaron J.; Westphal, Lynn M.; Pera, Renee A. Reijo			Parthenogenic Blastocysts Derived from Cumulus-Free In Vitro Matured Human Oocytes	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MESSENGER-RNA; GROWTH-FACTOR; EMBRYO DEVELOPMENT; DEVELOPMENTAL COMPETENCE; MEIOTIC MATURATION; EXPRESSION; FERTILIZATION; PROMOTES; STIMULATION	Background: Approximately 20% of oocytes are classified as immature and discarded following intracytoplasmic sperm injection (ICSI) procedures. These oocytes are obtained from gonadotropin-stimulated patients, and are routinely removed from the cumulus cells which normally would mature the oocytes. Given the ready access to these human oocytes, they represent a potential resource for both clinical and basic science application. However culture conditions for the maturation of cumulus-free oocytes have not been optimized. We aimed to improve maturation conditions for cumulus-free oocytes via culture with ovarian paracrine/autocrine factors identified by single cell analysis. Methodology/Principal Finding: Immature human oocytes were matured in vitro via supplementation with ovarian paracrine/autocrine factors that were selected based on expression of ligands in the cumulus cells and their corresponding receptors in oocytes. Matured oocytes were artificially activated to assess developmental competence. Gene expression profiles of parthenotes were compared to IVF/ICSI embryos at morula and blastocyst stages. Following incubation in medium supplemented with ovarian factors (BDNF, IGF-I, estradiol, GDNF, FGF2 and leptin), a greater percentage of oocytes demonstrated nuclear maturation and subsequently, underwent parthenogenesis relative to control. Similarly, cytoplasmic maturation was also improved as indicated by development to blastocyst stage. Parthenogenic blastocysts exhibited mRNA expression profiles similar to those of blastocysts obtained after IVF/ICSI with the exception for MKLP2 and PEG1. Conclusions/Significance: Human cumulus-free oocytes from hormone-stimulated cycles are capable of developing to blastocysts when cultured with ovarian factor supplementation. Our improved IVM culture conditions may be used for obtaining mature oocytes for clinical purposes and/or for derivation of embryonic stem cells following parthenogenesis or nuclear transfer.	[McElroy, Sohyun L.; Byrne, James A.; Chavez, Shawn L.; Pera, Renee A. Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Ctr Human Embryon Stem Cell Res & Educ, Palo Alto, CA 94304 USA; [McElroy, Sohyun L.; Byrne, James A.; Chavez, Shawn L.; Behr, Barry; Hsueh, Aaron J.; Westphal, Lynn M.; Pera, Renee A. Reijo] Stanford Univ, Dept Obstet & Gynecol, Palo Alto, CA 94304 USA; [Behr, Barry; Westphal, Lynn M.] Stanford Hosp & Clin, Div Reprod Endocrinol & Infertil, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University	McElroy, SL (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Ctr Human Embryon Stem Cell Res & Educ, Palo Alto, CA 94304 USA.	reneer@stanford.edu	Chavez, Shawn L./ABF-6125-2021	Chavez, Shawn L./0000-0002-8285-0222; Byrne, James/0000-0002-2232-292X; Reijo Pera, Renee/0000-0002-6487-1329	California Institute for Regenerative Medicine [CIRM TG2-01159, CIRM RC1-00137]; Stanford University	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Stanford University(Stanford University)	This work was supported by a postdoctoral fellowship to SLM from the California Institute for Regenerative Medicine (CIRM TG2-01159), a comprehensive research grant to RARP (CIRM RC1-00137) and matching funds from Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2010, FERTIL STERIL, V93, P1394, DOI 10.1016/j.fertnstert.2009.04.007; BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; Ben-Haroush A, 2005, FERTIL STERIL, V84, P1257, DOI 10.1016/j.fertnstert.2005.05.018; Ben-Shlomo I, 2007, MOL ENDOCRINOL, V21, P2009, DOI 10.1210/me.2007-0087; Boelhauve M, 2005, BIOL REPROD, V73, P737, DOI 10.1095/biolreprod.105.041103; Brevini IAL, 2008, CELL PROLIFERAT, V41, P20, DOI 10.1111/j.1365-2184.2008.00485.x; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chian R C, 2002, Reprod Biomed Online, V5, P125; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Cibelli JB, 2006, METHOD ENZYMOL, V418, P117, DOI 10.1016/S0076-6879(06)18008-8; da Silva SJM, 2005, REPRODUCTION, V129, P423, DOI 10.1530/rep.1.00471; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; EDWARDS RG, 1969, NATURE, V221, P632, DOI 10.1038/221632a0; Fauser B, 1998, HUM REPROD, V13, P71; Friden B, 2005, HUM REPROD, V20, P2556, DOI 10.1093/humrep/dei109; Fuchimoto D, 2001, BIOL REPROD, V65, P986, DOI 10.1095/biolreprod65.4.986; GEBER S, 1995, HUM REPROD, V10, P1492, DOI 10.1093/HUMREP/10.6.1492; Geens M, 2009, HUM REPROD, V24, P2709, DOI 10.1093/humrep/dep262; Geuns E, 2007, EUR J HUM GENET, V15, P352, DOI 10.1038/sj.ejhg.5201759; Gomez E, 2009, REPRODUCTION, V137, P285, DOI 10.1530/REP-08-0220; Heindryckx B, 2007, HUM REPROD, V22, P1982, DOI 10.1093/humrep/dem106; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HILLIER SG, 1980, J CLIN ENDOCR METAB, V50, P640, DOI 10.1210/jcem-50-4-640; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Kawamura K, 2008, DEV BIOL, V315, P189, DOI 10.1016/j.ydbio.2007.12.029; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kimura N, 2007, Soc Reprod Fertil Suppl, V63, P327; Lee SH, 2004, BIOL REPROD, V71, P919, DOI 10.1095/biolreprod.103.026138; Leo CP, 2000, ENDOCRINOLOGY, V141, P3052, DOI 10.1210/en.141.9.3052; Linher KJ, 2007, ENDOCRINOLOGY, V148, P4292, DOI 10.1210/en.2007-0021; Liu JH, 2008, GENOMICS, V91, P121, DOI 10.1016/j.ygeno.2007.10.005; Liu JY, 2003, FERTIL STERIL, V80, P447, DOI 10.1016/S0015-0282(03)00665-4; Magnani L, 2008, REPROD FERT DEVELOP, V20, P818, DOI 10.1071/RD08072; McElroy SL, 2008, REPROD BIOMED ONLINE, V16, P684, DOI 10.1016/S1472-6483(10)60483-X; McNatty K P, 2007, Soc Reprod Fertil Suppl, V64, P55; Moncayo HE, 1998, HUM REPROD, V13, P3310, DOI 10.1093/humrep/13.12.3310; Patsoula E, 2001, REPRODUCTION, V121, P455, DOI 10.1530/rep.0.1210455; Reeka N, 1998, HUM REPROD, V13, P2199, DOI 10.1093/humrep/13.8.2199; Rougier N, 2001, MOL REPROD DEV, V59, P468, DOI 10.1002/mrd.1054; Shu YM, 2007, FERTIL STERIL, V87, P1022, DOI 10.1016/j.fertnstert.2006.08.110; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TESARIK J, 1995, J CLIN ENDOCR METAB, V80, P1438, DOI 10.1210/jc.80.4.1438; Trounson A, 1998, HUM REPROD, V13, P52, DOI 10.1093/humrep/13.suppl_3.52; Wasielak M, 2007, J REPROD DEVELOP, V53, P419, DOI 10.1262/jrd.18076; Wolgemuth DJ, 2002, RECENT PROG HORM RES, V57, P75, DOI 10.1210/rp.57.1.75; Zimmermann BG, 2008, PRENATAL DIAG, V28, P1087, DOI 10.1002/pd.2150	47	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10979	10.1371/journal.pone.0010979	http://dx.doi.org/10.1371/journal.pone.0010979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539753	Green Submitted, Green Published, gold			2022-12-25	WOS:000278465900004
J	Springer, DJ; Ren, P; Raina, R; Dong, YM; Behr, MJ; McEwen, BF; Bowser, SS; Samsonoff, WA; Chaturvedi, S; Chaturvedi, V				Springer, Deborah J.; Ren, Ping; Raina, Ramesh; Dong, Yimin; Behr, Melissa J.; McEwen, Bruce F.; Bowser, Samuel S.; Samsonoff, William A.; Chaturvedi, Sudha; Chaturvedi, Vishnu			Extracellular Fibrils of Pathogenic Yeast Cryptococcus gattii Are Important for Ecological Niche, Murine Virulence and Human Neutrophil Interactions	PLOS ONE			English	Article							DISEASE RESISTANCE; SALICYLIC-ACID; ACETYLSALICYLIC-ACID; DISTINCT ROLES; IN-VITRO; NEOFORMANS; ARABIDOPSIS; GENE; CAPSULE; PLANTS	Cryptococcus gattii, an emerging fungal pathogen of humans and animals, is found on a variety of trees in tropical and temperate regions. The ecological niche and virulence of this yeast remain poorly defined. We used Arabidopsis thaliana plants and plant-derived substrates to model C. gattii in its natural habitat. Yeast cells readily colonized scratch-wounded plant leaves and formed distinctive extracellular fibrils (40-100 nm diameter x500-3000 nm length). Extracellular fibrils were observed on live plants and plant-derived substrates by scanning electron microscopy (SEM) and by high voltage-EM (HVEM). Only encapsulated yeast cells formed extracellular fibrils as a capsule-deficient C. gattii mutant completely lacked fibrils. Cells deficient in environmental sensing only formed disorganized extracellular fibrils as apparent from experiments with a C. gattii STE12 alpha mutant. C. gattii cells with extracellular fibrils were more virulent in murine model of pulmonary and systemic cryptococcosis than cells lacking fibrils. C. gattii cells with extracellular fibrils were also significantly more resistant to killing by human polymorphonuclear neutrophils (PMN) in vitro even though these PMN produced elaborate neutrophil extracellular traps (NETs). These observations suggest that extracellular fibril formation could be a structural adaptation of C. gattii for cell-to-cell, cell-to-substrate and/or cell-to-phagocyte communications. Such ecological adaptation of C. gattii could play roles in enhanced virulence in mammalian hosts at least initially via inhibition of host PMN- mediated killing.	[Springer, Deborah J.; Ren, Ping; Dong, Yimin; Behr, Melissa J.; McEwen, Bruce F.; Bowser, Samuel S.; Samsonoff, William A.; Chaturvedi, Sudha; Chaturvedi, Vishnu] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Springer, Deborah J.; McEwen, Bruce F.; Chaturvedi, Sudha; Chaturvedi, Vishnu] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Raina, Ramesh] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Syracuse University	Springer, DJ (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	vishnu@wadsworth.org		Ren, Ping/0000-0002-4022-6667; Chaturvedi, Vishnu/0000-0002-3922-9676	National Institutes of Health (NIH) [AI-53732, AI-48462, P41-RR01219]; Wadsworth Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048462, R03AI053732] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wadsworth Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Partial financial support came from the National Institutes of Health (NIH) (AI-53732, AI-48462) and NIH biotechnology grant (P41-RR01219) and Clinical Laboratory Reference System funds from the Wadsworth Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nazhan S, 2004, ORAL SURG ORAL MED O, V97, P393, DOI 10.1016/j.tripleo.2003.08.004; Bohman S, 2004, PLANT J, V37, P9, DOI 10.1046/j.1365-313X.2003.01927.x; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Casadevall A, 2003, CURR OPIN MICROBIOL, V6, P332, DOI 10.1016/S1369-5274(03)00082-1; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chaturvedi S, 2005, MYCOPATHOLOGIA, V160, P207, DOI 10.1007/s11046-005-0162-7; Chaturvedi V, 1996, J IMMUNOL, V156, P3836; Chaturvedi V, 2002, INFECT IMMUN, V70, P5225, DOI 10.1128/IAI.70.9.5225-5235.2002; Chen XW, 2006, MOL PLANT PATHOL, V7, P391, DOI 10.1111/j.1364-3703.2006.00349.x; Clark ME, 2007, ENVIRON MICROBIOL, V9, P2844, DOI 10.1111/j.1462-2920.2007.01398.x; De Hoog GS, 2009, ATLAS CLIN FUNGI, V3rd, DOI DOI 10.4103/idoj.IDOJ_146_19; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; DONG ZM, 1995, INFECT IMMUN, V63, P2632, DOI 10.1128/IAI.63.7.2632-2644.1995; Dworkin M, 1999, BIOESSAYS, V21, P590, DOI 10.1002/(SICI)1521-1878(199907)21:7<590::AID-BIES7>3.0.CO;2-E; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Fonseca A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P263, DOI 10.1007/3-540-30985-3_13; Frases S, 2009, P NATL ACAD SCI USA, V106, P1228, DOI 10.1073/pnas.0808995106; Fullner KJ, 1998, J BACTERIOL, V180, P430, DOI 10.1128/JB.180.2.430-434.1998; Gao L, 2009, MOL BIOL CELL, V20, P2540, DOI 10.1091/mbc.E09-03-0194; Garcia-Rivera J, 2004, EUKARYOT CELL, V3, P385, DOI 10.1128/EC.3.2.385-392.2004; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hu GG, 2006, CURR GENET, V49, P341, DOI 10.1007/s00294-005-0054-x; Huerfano Sandra, 2001, Revista Iberoamericana de Micologia, V18, P131; Inacio J, 2005, FEMS YEAST RES, V5, P1167, DOI 10.1016/j.femsyr.2005.05.007; Jarrell KF, 2009, PILI AND FLAGELLA: CURRENT RESEARCH AND FUTURE TRENDS, P215; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; Machado CML, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-13; Machesky L, 2008, EMBO REP, V9, P139, DOI 10.1038/sj.embor.7401162; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; Narasipura SD, 2003, MOL MICROBIOL, V47, P1681, DOI 10.1046/j.1365-2958.2003.03393.x; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nicola AM, 2009, EUKARYOT CELL, V8, P1373, DOI 10.1128/EC.00044-09; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Okabayashi K, 2007, MYCOPATHOLOGIA, V163, P1, DOI 10.1007/s11046-006-0083-0; Panepinto J, 2009, MOL MICROBIOL, V71, P1165, DOI 10.1111/j.1365-2958.2008.06588.x; Polizzi G, 2006, PLANT DIS, V90, P114, DOI 10.1094/PD-90-0114B; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; RIEDER CL, 1985, J ELECTRON MICR TECH, V2, P11, DOI 10.1002/jemt.1060020103; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Roetschi A, 2001, PLANT J, V28, P293, DOI 10.1046/j.1365-313X.2001.01148.x; Rokusek D, 2005, J BIOMED MATER RES A, V75A, P588, DOI 10.1002/jbm.a.30459; Saarimaa C, 2006, J BACTERIOL, V188, P7016, DOI 10.1128/JB.00608-06; Sebolai OM, 2008, CAN J MICROBIOL, V54, P91, DOI [10.1139/W07-114, 10.1139/w07-114]; Sebolai OM, 2008, CAN J MICROBIOL, V54, P111, DOI 10.1139/w07-116; Sebolai OM, 2007, CAN J MICROBIOL, V53, P809, DOI 10.1139/W07-045; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Springer DJ, 2010, EMERG INFECT DIS, V16, P14, DOI 10.3201/eid1601.090369; STAIB F, 1981, ZBL BAKT-INT J MED M, V248, P575; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; van Baarlen P, 2007, DRUG DISCOV TODAY, V12, P167, DOI 10.1016/j.drudis.2006.12.007; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Varon M, 2000, J BACTERIOL, V182, P3877, DOI 10.1128/JB.182.13.3877-3880.2000; Walker JR, 2007, MOL MICROBIOL, V63, P629, DOI 10.1111/j.1365-2958.2006.05494.x; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Wright LC, 2002, FEMS MICROBIOL LETT, V209, P175, DOI 10.1111/j.1574-6968.2002.tb11128.x; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	68	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10978	10.1371/journal.pone.0010978	http://dx.doi.org/10.1371/journal.pone.0010978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539754	Green Published, Green Submitted, gold			2022-12-25	WOS:000278465900003
J	Fristedt, R; Granath, P; Vener, AV				Fristedt, Rikard; Granath, Pontus; Vener, Alexander V.			A Protein Phosphorylation Threshold for Functional Stacking of Plant Photosynthetic Membranes	PLOS ONE			English	Article							HARVESTING-COMPLEX-II; PHOTOSYSTEM-II; STATE TRANSITIONS; ISOLATED-CHLOROPLASTS; THYLAKOID MEMBRANES; ELECTRON-TRANSPORT; SUBSTRATE LEVEL; KINASE STT7; LIGHT; PHOSPHOPROTEIN	Phosphorylation of photosystem II (PSII) proteins affects macroscopic structure of thylakoid photosynthetic membranes in chloroplasts of the model plant Arabidopsis. In this study, light-scattering spectroscopy revealed that stacking of thylakoids isolated from wild type Arabidopsis and the mutant lacking STN7 protein kinase was highly influenced by cation (Mg++) concentrations. The stacking of thylakoids from the stn8 and stn7stn8 mutants, deficient in STN8 kinase and consequently in light-dependent phosphorylation of PSII, was increased even in the absence of Mg++. Additional PSII protein phosphorylation in wild type plants exposed to high light enhanced Mg++-dependence of thylakoid stacking. Protein phosphorylation in the plant leaves was analyzed during day, night and prolonged darkness using three independent techniques: immunoblotting with anti-phosphothreonine antibodies; Diamond ProQ phosphoprotein staining; and quantitative mass spectrometry of peptides released from the thylakoid membranes by trypsin. All assays revealed dark/night-induced increase in phosphorylation of the 43 kDa chlorophyll-binding protein CP43, which compensated for decrease in phosphorylation of the other PSII proteins in wild type and stn7, but not in the stn8 and stn7stn8 mutants. Quantitative mass spectrometry determined that every PSII in wild type and stn7 contained on average 2.5 +/- 0.1 or 1.4 +/- 0.1 phosphoryl groups during day or night, correspondingly, while less than every second PSII had a phosphoryl group in stn8 and stn7stn8. It is postulated that functional cation-dependent stacking of plant thylakoid membranes requires at least one phosphoryl group per PSII, and increased phosphorylation of PSII in plants exposed to high light enhances stacking dynamics of the photosynthetic membranes.	[Fristedt, Rikard; Granath, Pontus; Vener, Alexander V.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Fristedt, R (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	alexander.vener@liu.se			Swedish Research Council; Swedish Research Council for Environment, Agriculture and Spatial Planning	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agriculture and Spatial Planning(Swedish Research Council Formas)	This work was supported by grants from the Swedish Research Council and from the Swedish Research Council for Environment, Agriculture and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson PA, 2004, PHYSIOL PLANTARUM, V121, P334, DOI 10.1111/j.0031-9317.2004.00315.x; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2004, METH MOL B, V274, P271; Aro EM, 2003, ANTIOXID REDOX SIGN, V5, P55, DOI 10.1089/152308603321223540; Baena-Gonzalez E, 1999, PLANTA, V208, P196, DOI 10.1007/s004250050550; Barber J, 2006, BIOCHEM SOC T, V34, P619, DOI 10.1042/BST0340619; BARBER J, 1982, ANNU REV PLANT PHYS, V33, P261, DOI 10.1146/annurev.pp.33.060182.001401; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Chow WS, 2005, PHOTOCH PHOTOBIO SCI, V4, P1081, DOI 10.1039/b507310n; CHOW WS, 1980, ARCH BIOCHEM BIOPHYS, V201, P347, DOI 10.1016/0003-9861(80)90520-2; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Fristedt R, 2009, BIOCHEMISTRY-US, V48, P499, DOI 10.1021/bi8016334; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Hansson M, 2007, J BIOL CHEM, V282, P16214, DOI 10.1074/jbc.M605833200; IZAWA S, 1966, PLANT PHYSIOL, V41, P544, DOI 10.1104/pp.41.3.544; IZAWA S, 1966, PLANT PHYSIOL, V41, P533, DOI 10.1104/pp.41.3.533; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Khatoon M, 2009, J BIOL CHEM, V284, P25343, DOI 10.1074/jbc.M109.007740; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Koivuniemi A, 1995, BIOCHEMISTRY-US, V34, P16022, DOI 10.1021/bi00049a016; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; Noren H, 2004, PHYSIOL PLANTARUM, V121, P343, DOI 10.1111/j.0031-9317.2004.00350.x; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Shapiguzov A, 2010, P NATL ACAD SCI USA, V107, P4782, DOI 10.1073/pnas.0913810107; Spetea C, 1999, P NATL ACAD SCI USA, V96, P6547, DOI 10.1073/pnas.96.11.6547; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Tikkanen M, 2008, BBA-BIOENERGETICS, V1777, P1432, DOI 10.1016/j.bbabio.2008.08.004; Tikkanen M, 2006, PLANT MOL BIOL, V62, P779, DOI 10.1007/s11103-006-9044-8; Turkina MV, 2006, MOL CELL PROTEOMICS, V5, P1412, DOI 10.1074/mcp.M600066-MCP200; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; Vainonen JP, 2008, FEBS J, V275, P1767, DOI 10.1111/j.1742-4658.2008.06335.x; Vener AV, 2007, BBA-BIOENERGETICS, V1767, P449, DOI 10.1016/j.bbabio.2006.11.007; Vener AV, 2001, J BIOL CHEM, V276, P6959, DOI 10.1074/jbc.M009394200; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Vener AV, 2005, IUBMB LIFE, V57, P433, DOI 10.1080/15216540500138360; Vener AV, 1999, BIOCHEMISTRY-US, V38, P14955, DOI 10.1021/bi990971v; Vink M, 2000, PHOTOSYNTH RES, V64, P209, DOI 10.1023/A:1006455926748; Zer H, 1999, P NATL ACAD SCI USA, V96, P8277, DOI 10.1073/pnas.96.14.8277	45	59	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10963	10.1371/journal.pone.0010963	http://dx.doi.org/10.1371/journal.pone.0010963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532038	gold, Green Published, Green Submitted			2022-12-25	WOS:000278380500009
J	Chilov, D; Sinjushina, N; Saarimaki-Vire, J; Taketo, MM; Partanen, J				Chilov, Dmitri; Sinjushina, Natalia; Saarimaki-Vire, Jonna; Taketo, Makoto M.; Partanen, Juha			beta-Catenin Regulates Intercellular Signalling Networks and Cell-Type Specific Transcription in the Developing Mouse Midbrain-Rhombomere 1 Region	PLOS ONE			English	Article							INT-1 PROTOONCOGENE; ISTHMIC ORGANIZER; IN-VIVO; WNT; EXPRESSION; GENE; FGF8; HINDBRAIN; BRAIN; DIFFERENTIATION	beta-catenin is a multifunctional protein involved in both signalling by secreted factors of Wnt family and regulation of the cellular architecture. We show that beta-catenin stabilization in mouse midbrain-rhombomere1 region leads to robust up-regulation of several Wnt signalling target genes, including Fgf8. Suggestive of direct transcriptional regulation of the Fgf8 gene, beta-catenin stabilization resulted in Fgf8 up-regulation also in other tissues, specifically in the ventral limb ectoderm. Interestingly, stabilization of beta-catenin rapidly caused down-regulation of the expression of Wnt1 itself, suggesting a negative feedback loop. The changes in signal molecule expression were concomitant with deregulation of anterior-posterior and dorso-ventral patterning. The transcriptional regulatory functions of beta-catenin were confirmed by beta-catenin loss-of-function experiments. Temporally controlled inactivation of beta-catenin revealed a cell-autonomous role for beta-catenin in the maintenance of cell-type specific gene expression in the progenitors of midbrain dopaminergic neurons. These results highlight the role of beta-catenin in establishment of neuroectodermal signalling centers, promoting region-specific gene expression and regulation of cell fate determination.	[Chilov, Dmitri; Sinjushina, Natalia; Saarimaki-Vire, Jonna; Partanen, Juha] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Partanen, Juha] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan	University of Helsinki; University of Helsinki; Kyoto University	Chilov, D (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	Juha.M.Partanen@Helsinki.Fi		chilov, dmitri/0000-0002-2279-0854; Saarimaki-Vire, Jonna/0000-0002-8865-7060; Partanen, Juha/0000-0001-8850-4825	Academy of Finland; Biocentrum Helsinki; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by funding from the Academy of Finland, Biocentrum Helsinki, and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1997, DEVELOPMENT, V124, P3639; Alexandre P, 2006, DEVELOPMENT, V133, P2905, DOI 10.1242/dev.02460; Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Brault V, 2001, DEVELOPMENT, V128, P1253; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; CHILOV D, BETACATENIN MA UNPUB; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Jukkola T, 2006, DEV BIOL, V297, P141, DOI 10.1016/j.ydbio.2006.05.002; Kimmel RA, 2000, GENE DEV, V14, P1377; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Olander S, 2006, MECH DEVELOP, V123, P166, DOI 10.1016/j.mod.2005.11.001; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2004, CELL TISSUE RES, V318, P5, DOI 10.1007/s00441-004-0955-x; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	39	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10881	10.1371/journal.pone.0010881	http://dx.doi.org/10.1371/journal.pone.0010881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532162	Green Submitted, Green Published, gold			2022-12-25	WOS:000278318700002
J	Yan, XH; Lin, XM; Wang, QF; Zhang, YC; Chen, YM; Song, SJ; Jiang, TZ				Yan, Xiaohe; Lin, Xiaoming; Wang, Qifeng; Zhang, Yuanchao; Chen, Yingming; Song, Shaojie; Jiang, Tianzi			Dorsal Visual Pathway Changes in Patients with Comitant Extropia	PLOS ONE			English	Article							DISCORDANT BINOCULAR VISION; MAGNETIC-RESONANCE; HORIZONTAL CONNECTIONS; STRABISMIC CATS; WATER DIFFUSION; WHITE-MATTER; HUMAN BRAIN; CORTEX V1; NEURONS; MONKEY	Background: Strabismus is a disorder in which the eyes are misaligned. Persistent strabismus can lead to stereopsis impairment. The effect of strabismus on human brain is not unclear. The present study is to investigate whether the brain white structures of comitant exotropia patients are impaired using combined T1-weighted imaging and diffusion tensor imaging (DTI). Principal Findings: Thirteen patients with comitant strabismus and twelve controls underwent magnetic resonance imaging (MRI) with acquisition of T1-weighted and diffusion tensor images. T1-weighted images were used to analyze the change in volume of white matter using optimized voxel-based morphology (VBM) and diffusion tensor images were used to detect the change in white matter fibers using voxel-based analysis of DTI in comitant extropia patients. VBM analysis showed that in adult strabismus, white matter volumes were smaller in the right middle occipital gyrus, right occipital lobe/cuneus, right supramarginal gyrus, right cingulate gyrus, right frontal lobe/sub-gyral, right inferior temporal gyrus, left parahippocampa gyrus, left cingulate gyrus, left occipital lobe/cuneus, left middle frontal gyrus, left inferior parietal lobule, and left postcentral gyrus, while no brain region with greater white matter volume was found. Voxel-based analysis of DTI showed lower fractional anisotropy (FA) values in the right middle occipital gyrus and right supramarginal gyrus in strabismus patients, while brain region with increased FA value was found in the right inferior frontal gyrus. Conclusion: By combining VBM and voxel-based analysis of DTI results, the study suggests that the dorsal visual pathway was abnormal or impaired in patients with comitant exotropia.	[Yan, Xiaohe; Lin, Xiaoming; Song, Shaojie] Sun Yat Sen Univ, ZhongShan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Qifeng; Zhang, Yuanchao; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Chen, Yingming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Automation, CAS; Sun Yat Sen University	Yan, XH (corresponding author), Sun Yat Sen Univ, ZhongShan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	linxiaom@mail.sysu.edu.cn	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X; lin, xiao ming/0000-0001-7161-1085	Research Foundation of Science and Technology Plan Project, Guangdong, People's Republic of China [2007B031505002, 2008B060600031]	Research Foundation of Science and Technology Plan Project, Guangdong, People's Republic of China	These studies were supported by grants 2007B031505002 and 2008B060600031 from the Research Foundation of Science and Technology Plan Project, Guangdong, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Linera J, 2008, EUR J RADIOL, V67, P415, DOI 10.1016/j.ejrad.2008.02.045; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BAKER FH, 1974, BRAIN RES, V66, P185, DOI 10.1016/0006-8993(74)90140-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BLAKEMORE C, 1976, B SCHWEIZ AKAD MED, V32, P13; Busatto Geraldo F, 2008, Expert Rev Neurother, V8, P1691, DOI 10.1586/14737175.8.11.1691; Chan ST, 2004, NEUROIMAGE, V22, P986, DOI 10.1016/j.neuroimage.2004.02.021; Cheng H, 1995, J NEUROPHYSIOL, V74, P2558, DOI 10.1152/jn.1995.74.6.2558; CHEW E, 1994, ARCH OPHTHALMOL-CHIC, V112, P1349, DOI 10.1001/archopht.1994.01090220099030; CHINO YM, 1994, P NATL ACAD SCI USA, V91, P6938, DOI 10.1073/pnas.91.15.6938; CRAWFORD MLJ, 1979, INVEST OPHTH VIS SCI, V18, P496; CRAWFORD MLJ, 1983, INVEST OPHTH VIS SCI, V24, P491; CRAWFORD MLJ, 1984, INVEST OPHTH VIS SCI, V25, P779; Engelmann R, 2002, VISUAL NEUROSCI, V19, P39, DOI 10.1017/S0952523801191042; Fortin A, 2002, NEUROREPORT, V13, P895, DOI 10.1097/00001756-200205070-00032; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Govindan M, 2005, OPHTHALMOLOGY, V112, P104, DOI 10.1016/j.ophtha.2004.07.033; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kumagami T, 2000, INVEST OPHTH VIS SCI, V41, P948; Kwee IL, 1999, NEUROLOGY, V53, P1599, DOI 10.1212/WNL.53.7.1599; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mori T, 2002, INVEST OPHTH VIS SCI, V43, P1262; Nishida Y, 2001, NEUROREPORT, V12, P2259, DOI 10.1097/00001756-200107200-00043; Robaei D, 2006, OPHTHALMOLOGY, V113, P1146, DOI 10.1016/j.ophtha.2006.02.019; Scarabino T, 2003, EUR J RADIOL, V48, P154, DOI 10.1016/j.ejrad.2003.08.008; Schmidt KF, 2008, NEUROSCIENCE, V152, P128, DOI 10.1016/j.neuroscience.2007.08.038; Schmidt KE, 1997, J NEUROSCI, V17, P5480; SENGPIEL F, 1994, J NEUROSCI, V14, P6855; Sengpiel F, 2006, CEREB CORTEX, V16, P1750, DOI 10.1093/cercor/bhj110; Shu N, 2009, HUM BRAIN MAPP, V30, P220, DOI 10.1002/hbm.20507; SINGER W, 1980, EXP BRAIN RES, V40, P294, DOI 10.1007/BF00237794; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Zhang B, 2005, P NATL ACAD SCI USA, V102, P9026, DOI 10.1073/pnas.0500280102	38	43	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10931	10.1371/journal.pone.0010931	http://dx.doi.org/10.1371/journal.pone.0010931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532166	Green Published, gold, Green Submitted			2022-12-25	WOS:000278318700005
J	Bruining, H; de Sonneville, L; Swaab, H; de Jonge, M; Kas, M; van Engeland, H; Vorstman, J				Bruining, Hilgo; de Sonneville, Leo; Swaab, Hanna; de Jonge, Maretha; Kas, Martien; van Engeland, Herman; Vorstman, Jacob			Dissecting the Clinical Heterogeneity of Autism Spectrum Disorders through Defined Genotypes	PLOS ONE			English	Article							DIAGNOSTIC OBSERVATION SCHEDULE; KLINEFELTER-SYNDROME; RETT-SYNDROME; CHILDREN; INTERVIEW; ADOLESCENTS; MUTATIONS; GENETICS; SAMPLE; MECP2	Background: The etiology of autism spectrum disorders (ASD) is largely determined by different genetic factors of variable impact. This genetic heterogeneity could be a factor to explain the clinical heterogeneity of autism spectrum disorders. Here, a first attempt is made to assess whether genetically more homogeneous ASD groups are associated with decreased phenotypic heterogeneity with respect to their autistic symptom profile. Methodology: The autistic phenotypes of ASD subjects with 22q11 deletion syndrome (22q11DS) and ASD subjects with Klinefelter Syndrome (KS) were statistically compared to the symptom profile of a large (genetically) heterogeneous ASD sample. Autism diagnostic interview-revised (ADI-R) variables were entered in different statistical analyses to assess differences in symptom homogeneity and the feasibility of discrimination of group-specific ASD-symptom profiles. Principal Findings: The results showed substantially higher symptom homogeneity in both the genetic disorder ASD groups in comparison to the heterogeneous ASD sample. In addition, a robust discrimination between 22q11-ASD and KS-ASD and idiopathic ASD phenotypes was feasible on the basis of a reduced number of autistic scales and symptoms. The lack of overlap in discriminating subscales and symptoms between KS-ASD and 22q11DS-ASD suggests that their autistic symptom profiles cluster around different points in the total diagnostic space of profiles present in the general ASD population. Conclusion: The findings of the current study indicate that the clinical heterogeneity of ASDs may be reduced when subgroups based on a specific genotype are extracted from the idiopathic ASD population. The current strategy involving the widely used ADI-R offers a relatively straightforward possibility for assessing genotype-phenotype ASD relationships. Reverse phenotype strategies are becoming more feasible, given the accumulating evidence for the existence of genetic variants of large effect in a substantial proportion of the ASD population.	[Bruining, Hilgo; Swaab, Hanna; de Jonge, Maretha; van Engeland, Herman; Vorstman, Jacob] Univ Med Ctr Utrecht, Dept Children & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [de Sonneville, Leo; Swaab, Hanna] Leiden Univ, Dept Clin Child & Adolescent Studies, Leiden, Netherlands; [Kas, Martien] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Bruining, H (corresponding author), Univ Med Ctr Utrecht, Dept Children & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	h.bruining@Umcutrecht.nl	Kas, Martien J./G-8269-2018; Swaab, Hanna/AAD-2555-2019; De Jonge, Maretha V/F-4942-2013	Kas, Martien J./0000-0002-4471-8618; de Sonneville, Leo/0000-0003-0133-4953				Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abramsky L, 1997, PRENATAL DIAG, V17, P363, DOI 10.1002/(SICI)1097-0223(199704)17:4<363::AID-PD79>3.0.CO;2-O; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Beaudet AL, 2007, NAT MED, V13, P534, DOI 10.1038/nm0507-534; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bruining H, 2009, PEDIATRICS, V123, pE865, DOI 10.1542/peds.2008-1954; Brune CW, 2006, AM J PSYCHIAT, V163, P2148, DOI 10.1176/appi.ajp.163.12.2148; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; de Bildt A, 2004, J AUTISM DEV DISORD, V34, P129, DOI 10.1023/B:JADD.0000022604.22374.5f; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Ghidoni BB, 2007, CHILD ADOL PSYCH CL, V16, P723, DOI 10.1016/j.chc.2007.03.004; Kates WR, 2007, AM J MED GENET A, V143A, P2642, DOI 10.1002/ajmg.a.32012; Konstantareas MM, 1999, J AUTISM DEV DISORD, V29, P275, DOI 10.1023/A:1022155201662; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Mullen E. M, 1995, MULLEN SCALES EARLY; Nomura Y, 2005, J CHILD NEUROL, V20, P764, DOI 10.1177/08830738050200091201; Raven J. C., 1995, COLORED PROGR MATRIC; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SNIJDERS JT, 2009, SON R 2 5 7 NIET VER; Trappe R, 2001, AM J HUM GENET, V68, P1093, DOI 10.1086/320109; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Wassink TH, 2007, J AUTISM DEV DISORD, V37, P703, DOI 10.1007/s10803-006-0196-9; Wechsler D., 2014, WECHSLER PRESCHOOL P; WECHSLER D, 2002, WISC 3; Wechsler D., 1997, WECHSLER ADULT INTEL	33	71	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10887	10.1371/journal.pone.0010887	http://dx.doi.org/10.1371/journal.pone.0010887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526357	Green Published, gold, Green Submitted			2022-12-25	WOS:000278222100016
J	Chittenden, CM; Melnychuk, MC; Welch, DW; McKinley, RS				Chittenden, Cedar M.; Melnychuk, Michael C.; Welch, David W.; McKinley, R. Scott			An Investigation into the Poor Survival of an Endangered Coho Salmon Population	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; EN-ROUTE MORTALITY; SOCKEYE-SALMON; BRITISH-COLUMBIA; FRASER-RIVER; MARINE SURVIVAL; STOCK IDENTIFICATION; THOMPSON RIVER; CLIMATE-CHANGE; FRESH-WATER	To investigate reasons for the decline of an endangered population of coho salmon (O. kisutch), 190 smolts were acoustically tagged during three consecutive years and their movements and survival were estimated using the Pacific Ocean Shelf Tracking project (POST) array. Median travel times of the Thompson River coho salmon smolts to the lower Fraser River sub-array were 16, 12 and 10 days during 2004, 2005 and 2006, respectively. Few smolts were recorded on marine arrays. Freshwater survival rates of the tagged smolts during their downstream migration were 0.0-5.6% (0.0-9.0% s.e.) in 2004, 7.0% (6.2% s.e.) in 2005, and 50.9% (18.6% s.e.) in 2006. Overall smolt-to-adult return rates exhibited a similar pattern, which suggests that low freshwater survival rates of out-migrating smolts may be a primary reason for the poor conservation status of this endangered coho salmon population.	[Chittenden, Cedar M.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Chittenden, Cedar M.; McKinley, R. Scott] Univ British Columbia, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada; [Melnychuk, Michael C.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Melnychuk, Michael C.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Welch, David W.] Kintama Res Corp, Nanaimo, BC, Canada	UiT The Arctic University of Tromso; University of British Columbia; University of British Columbia; University of British Columbia	Chittenden, CM (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	Cedar.M.Chittenden@uit.no	Melnychuk, Michael/A-4680-2013	Melnychuk, Michael/0000-0002-6088-7657	Census of Marine Life; Gordon and Betty Moore Foundation; Pacific Salmon Foundation	Census of Marine Life; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Salmon Foundation	Funding for this work was provided by Census of Marine Life, the Gordon and Betty Moore Foundation, and the Pacific Salmon Foundation. The Pacific Ocean Shelf Tracking project (POST) acoustic receiver arrays were designed and deployed by Kintama Research Corp. None of these organizations were directly involved in the study design, analysis, or writing of the paper, nor the decision to submit the manuscript for publication. This work is a contribution to the Census of Marine Life.	Beacham TD, 2001, T AM FISH SOC, V130, P1116, DOI 10.1577/1548-8659(2001)130&lt;1116:EAAOMA&gt;2.0.CO;2; Beamish RJ, 2008, T AM FISH SOC, V137, P503, DOI 10.1577/T07-080.1; Beamish RJ, 1997, CAN J FISH AQUAT SCI, V54, P543, DOI 10.1139/cjfas-54-3-543; Beamish RJ, 2000, FISH OCEANOGR, V9, P114; Beamish RJ, 2004, PROG OCEANOGR, V60, P355, DOI 10.1016/j.pocean.2004.02.009; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P506, DOI 10.1139/cjfas-56-3-506; Bradford MJ, 1999, T AM FISH SOC, V128, P840, DOI 10.1577/1548-8659(1999)128<0840:TASTIT>2.0.CO;2; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P13, DOI 10.1139/cjfas-57-1-13; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 1987, AM FISHERIES SOC MON; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; Chittenden CM, 2009, T AM FISH SOC, V138, P1220, DOI 10.1577/T09-037.1; Chittenden C, 2009, ENVIRON BIOL FISH, V84, P129, DOI 10.1007/s10641-008-9396-9; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Coronado C, 1998, CAN J FISH AQUAT SCI, V55, P2067, DOI 10.1139/cjfas-55-9-2067; *COSEWIC, 2002, ASS STAT REP COH SAL; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Crossin GT, 2007, MAR BIOL, V152, P905, DOI 10.1007/s00227-007-0741-x; *DFO, 2006, 2006 MAR SURV FOR SO; *ENV CAN, 2001, STAT WAT QUAL S THOM; *ENV CAN, 2008, ARCH HYDR DAT; GISLASON G, 1996, EC VALUE SALMON CHIN; Groot C, 1991, PACIFIC SALMON LIFE; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hobday AJ, 2001, CAN J FISH AQUAT SCI, V58, P2021, DOI 10.1139/cjfas-58-10-2021; Hockersmith EE, 2003, N AM J FISH MANAGE, V23, P404, DOI 10.1577/1548-8675(2003)023<0404:COMRAS>2.0.CO;2; Irvine JR, 2005, FISHERIES, V30, P11, DOI 10.1577/1548-8446(2005)30[11:CSARA]2.0.CO;2; IRVINE JR, 2000, P C BIOL MAN SPEC HA, V2, P595; IRVINE JR, 1999, 9928 CSAS; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Koslow JA, 2002, FISH OCEANOGR, V11, P65, DOI 10.1046/j.1365-2419.2002.00187.x; Laake J., 2022, MARK, P109; Lacroix GL, 2008, CAN J FISH AQUAT SCI, V65, P2063, DOI 10.1139/F08-119; Lawson PW, 2004, CAN J FISH AQUAT SCI, V61, P360, DOI 10.1139/F04-003; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McPhail J.D., 1986, P615; MELNYCHUK M, 2009, MORTALITY MIGRATING; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Morrison J, 2002, J HYDROL, V263, P230, DOI 10.1016/S0022-1694(02)00065-3; Noakes Donald J., 2000, North Pacific Anadromous Fish Commission Bulletin, V2, P155; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; PERRY EA, 1995, AM FISH S S, V15, P152; PITRE KR, 1993, P 1992 COH WORKSH NA, P140; ROOD KM, 1995, CAN MAN REPT FISH AQ, V2297; ROUTLEDGE R, 1999, COAST WIDE COHO; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Shaklee JB, 1999, FISH RES, V43, P45, DOI 10.1016/S0165-7836(99)00066-1; Skalski JR, 2001, CAN J FISH AQUAT SCI, V58, P1987, DOI 10.1139/cjfas-58-10-1987; Small MP, 1998, MOL ECOL, V7, P141, DOI 10.1046/j.1365-294x.1998.00324.x; Small MP, 1998, FISH B-NOAA, V96, P843; SWAIN DP, 1991, CAN J FISH AQUAT SCI, V48, P1783, DOI 10.1139/f91-210; TAYLOR EB, 1986, PROG FISH CULT, V48, P171, DOI 10.1577/1548-8640(1986)48<171:DIMBWA>2.0.CO;2; Walters C, 1998, CAN J FISH AQUAT SCI, V55, P2533, DOI 10.1139/cjfas-55-12-2533; Ward BR, 2000, CAN J FISH AQUAT SCI, V57, P298, DOI 10.1139/cjfas-57-2-298; Welch DW, 2007, HYDROBIOLOGIA, V582, P289, DOI 10.1007/s10750-006-0553-x; Welch DW, 2008, PLOS BIOL, V6, P2101, DOI 10.1371/journal.pbio.0060265; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Welch DW, 2000, FISH OCEANOGR, V9, P17; Welch DW, 2004, DEEP-SEA RES PT II, V51, P897, DOI 10.1016/j.dsr2.2004.05.010; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Young JL, 2006, CAN J FISH AQUAT SCI, V63, P1067, DOI 10.1139/F06-014; Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719	64	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10869	10.1371/journal.pone.0010869	http://dx.doi.org/10.1371/journal.pone.0010869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526367	Green Published, gold			2022-12-25	WOS:000278222100005
J	McNulty, S; Bornmann, W; Schriewer, J; Werner, C; Smith, SK; Olson, VA; Damon, IK; Buller, M; Heuser, J; Kalman, D				McNulty, Shannon; Bornmann, William; Schriewer, Jill; Werner, Chas; Smith, Scott K.; Olson, Victoria A.; Damon, Inger K.; Buller, Mark; Heuser, John; Kalman, Daniel			Multiple Phosphatidylinositol 3-Kinases Regulate Vaccinia Virus Morphogenesis	PLOS ONE			English	Article							INTRACELLULAR MATURE VIRIONS; STRAIN L CELLS; ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT; ENVELOPE GLYCOPROTEIN; EXTRACELLULAR VIRUS; P85-ALPHA SUBUNIT; TYROSINE KINASES; PROGENY VACCINIA; RAB5 EFFECTORS	Poxvirus morphogenesis is a complex process that involves the successive wrapping of the virus in host cell membranes. We screened by plaque assay a focused library of kinase inhibitors for those that caused a reduction in viral growth and identified several compounds that selectively inhibit phosphatidylinositol 3-kinase (PI3K). Previous studies demonstrated that PI3Ks mediate poxviral entry. Using growth curves and electron microscopy in conjunction with inhibitors, we show that that PI3Ks additionally regulate morphogenesis at two distinct steps: immature to mature virion (IMV) transition, and IMV envelopment to form intracellular enveloped virions (IEV). Cells derived from animals lacking the p85 regulatory subunit of Type I PI3Ks (p85 alpha(-/-)beta(-/-)) presented phenotypes similar to those observed with PI3K inhibitors. In addition, VV appear to redundantly use PI3Ks, as PI3K inhibitors further reduce plaque size and number in p85 alpha(-/-)beta(-/-) cells. Together, these data provide evidence for a novel regulatory mechanism for virion morphogenesis involving phosphatidylinositol dynamics and may represent a new therapeutic target to contain poxviruses.	[McNulty, Shannon] Emory Univ, Sch Med, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA; [Bornmann, William] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Schriewer, Jill; Buller, Mark] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Smith, Scott K.; Olson, Victoria A.; Damon, Inger K.] Ctr Dis Control & Prevent, Poxvirus Team,Natl Ctr Zoonot Viral & Enter Dis, Poxvirus & Rabies Branch, Div Viral & Rickettsial Dis, Atlanta, GA USA; [Heuser, John] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; [Kalman, Daniel] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Saint Louis University; Centers for Disease Control & Prevention - USA; Washington University (WUSTL); Emory University	McNulty, S (corresponding author), Emory Univ, Sch Med, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA.	dkalman@emory.edu			National Institutes of Health [R56A105896101A2, R01A107246201A2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health R56A105896101A2 and R01A107246201A2 to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JA, 1973, J GEN VIROL, V21, P533, DOI 10.1099/0022-1317-21-3-533; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Betakova T, 1999, J VIROL, V73, P3534, DOI 10.1128/JVI.73.5.3534-3543.1999; BLASCO R, 1993, J VIROL, V67, P3319, DOI 10.1128/JVI.67.6.3319-3325.1993; BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991; Blouch RE, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-91; Bommarius B, 2007, MOL MICROBIOL, V63, P1748, DOI 10.1111/j.1365-2958.2007.05626.x; Brachmann SA, 2005, MOL CELL BIOL, V25, P2593, DOI 10.1128/MCB.25.7.2593-2606.2005; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Byrd CM, 2006, REV MED VIROL, V16, P187, DOI 10.1002/rmv.499; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; CHANG A, 1976, J GEN VIROL, V32, P275, DOI 10.1099/0022-1317-32-2-275; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Cheng KKF, 2009, J PAIN SYMPTOM MANAG, V37, P44, DOI 10.1016/j.jpainsymman.2007.12.019; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; Cluett EB, 1996, J CELL SCI, V109, P2121; Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; DALES S, 1965, AM J MED, V38, P699, DOI 10.1016/0002-9343(65)90191-9; DALES S, 1963, J CELL BIOL, V18, P51, DOI 10.1083/jcb.18.1.51; DALES S, 1968, VIROLOGY, V35, P564, DOI 10.1016/0042-6822(68)90286-9; Earley AK, 2008, J VIROL, V82, P2161, DOI 10.1128/JVI.01971-07; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; ERICSSON M, 1995, J VIROL, V69, P7072, DOI 10.1128/JVI.69.11.7072-7086.1995; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Gur I, 2008, INT J STD AIDS, V19, P503, DOI 10.1258/ijsa.2008.008186; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Herrera E, 1998, J VIROL, V72, P294, DOI 10.1128/JVI.72.1.294-302.1998; Heuser J, 2005, J CELL BIOL, V169, P269, DOI 10.1083/jcb.200412169; HILLER G, 1981, J VIROL, V39, P903, DOI 10.1128/JVI.39.3.903-913.1981; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Hollinshead M, 1999, J VIROL, V73, P1503, DOI 10.1128/JVI.73.2.1503-1517.1999; HOLOWCZAK JA, 1972, VIROLOGY, V50, P216, DOI 10.1016/0042-6822(72)90362-5; Hu NJ, 2009, VACCINE, V27, P2994, DOI 10.1016/j.vaccine.2009.02.103; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Husain M, 2002, J VIROL, V76, P7777, DOI 10.1128/JVI.76.15.7777-7789.2002; Husain M, 2001, J VIROL, V75, P7528, DOI 10.1128/JVI.75.16.7528-7542.2001; Ichihashi Y, 1996, VIROLOGY, V217, P478, DOI 10.1006/viro.1996.0142; Jezek Z, 1988, HUMAN MONKEYPOX; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; JOKLIK WK, 1964, J MOL BIOL, V8, P277, DOI 10.1016/S0022-2836(64)80137-6; KAJIOKA R, 1964, VIROLOGY, V24, P295, DOI 10.1016/0042-6822(64)90167-9; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KrijnseLocker J, 1996, J BIOL CHEM, V271, P14950, DOI 10.1074/jbc.271.25.14950; Law M, 2006, P NATL ACAD SCI USA, V103, P5989, DOI 10.1073/pnas.0601025103; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Mallardo M, 2002, J VIROL, V76, P5167, DOI 10.1128/JVI.76.10.5167-5183.2002; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; MOSS B, 1969, NATURE, V224, P1280, DOI 10.1038/2241280a0; PAYNE LG, 1979, J VIROL, V32, P614, DOI 10.1128/JVI.32.2.614-622.1979; Pedersen K, 2000, J VIROL, V74, P3525, DOI 10.1128/JVI.74.8.3525-3536.2000; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; POWIS G, 1994, CANCER RES, V54, P2419; Punjabi A, 2005, J VIROL, V79, P2171, DOI 10.1128/JVI.79.4.2171-2190.2005; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Risco C, 2002, J VIROL, V76, P1839, DOI 10.1128/JVI.76.4.1839-1855.2002; Rodriguez JR, 1997, J VIROL, V71, P1821; Roper RL, 1999, J VIROL, V73, P1108, DOI 10.1128/JVI.73.2.1108-1117.1999; RUECKLE TJ, 2005, AZOLIDINOLONEVINYL F; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Sanderson CM, 2000, J GEN VIROL, V81, P47, DOI 10.1099/0022-1317-81-1-47; SCHMELZ M, 1994, J VIROL, V68, P130, DOI 10.1128/JVI.68.1.130-147.1994; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Senkevich TG, 2000, P NATL ACAD SCI USA, V97, P12068, DOI 10.1073/pnas.210397997; Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799; Senkevich TG, 2002, VIROLOGY, V300, P296, DOI 10.1006/viro.2002.1608; Senkevich TG, 2000, VIROLOGY, V278, P244, DOI 10.1006/viro.2000.0656; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09; SODEIK B, 1993, J CELL BIOL, V121, P521, DOI 10.1083/jcb.121.3.521; Stein RC, 2000, MOL MED TODAY, V6, P347, DOI 10.1016/S1357-4310(00)01770-6; Stenmark H, 2001, SEMIN CELL DEV BIOL, V12, P193, DOI 10.1006/scdb.2000.0236; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Swimm A, 2004, MOL BIOL CELL, V15, P3520, DOI 10.1091/mbc.E04-02-0093; Szajner P, 2005, J CELL BIOL, V170, P971, DOI 10.1083/jcb.200504026; TOOZE J, 1993, EUR J CELL BIOL, V60, P163; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Unger B, 2004, J VIROL, V78, P8885, DOI 10.1128/JVI.78.16.8885-8901.2004; Vanderplasschen A, 1998, J GEN VIROL, V79, P877, DOI 10.1099/0022-1317-79-4-877; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Ward BM, 2005, J VIROL, V79, P4755, DOI 10.1128/JVI.79.8.4755-4763.2005; Ward BM, 2000, J VIROL, V74, P3771, DOI 10.1128/JVI.74.8.3771-3780.2000; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; White CL, 2000, J VIROL, V74, P9175, DOI 10.1128/JVI.74.19.9175-9183.2000; WOLFFE EJ, 1993, J VIROL, V67, P4732, DOI 10.1128/JVI.67.8.4732-4741.1993; WOSCHOLSKI R, 1994, FEBS LETT, V342, P109, DOI 10.1016/0014-5793(94)80482-6; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Yuan H, 2007, CHEM BIOL, V14, P321, DOI 10.1016/j.chembiol.2007.02.007; ZABOROWSKA I, 2009, J VIROL	108	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10884	10.1371/journal.pone.0010884	http://dx.doi.org/10.1371/journal.pone.0010884			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526370	Green Submitted, gold, Green Published			2022-12-25	WOS:000278222100013
J	Durr, ML; Mydlarz, WK; Shao, CB; Zahurak, ML; Chuang, AY; Hoque, MO; Westra, WH; Liegeois, NJ; Califano, JA; Sidransky, D; Ha, PK				Durr, Megan L.; Mydlarz, Wojciech K.; Shao, Chunbo; Zahurak, Marianna L.; Chuang, Alice Y.; Hoque, Mohammad O.; Westra, William H.; Liegeois, Nanette J.; Califano, Joseph A.; Sidransky, David; Ha, Patrick K.			Quantitative Methylation Profiles for Multiple Tumor Suppressor Gene Promoters in Salivary Gland Tumors	PLOS ONE			English	Article							ADENOID CYSTIC CARCINOMA; SQUAMOUS-CELL CARCINOMA; INDEPENDENT PROGNOSTIC-FACTOR; TISSUE INHIBITOR; PROSTATE-CANCER; BLADDER-CANCER; CLINICAL-SIGNIFICANCE; ABERRANT METHYLATION; LUNG-CANCER; E-CADHERIN	Background: Methylation profiling of tumor suppressor gene (TSGs) promoters is quickly becoming a powerful diagnostic tool for the early detection, prognosis, and even prediction of clinical response to treatment. Few studies address this in salivary gland tumors (SGTs); hence the promoter methylation profile of various TSGs was quantitatively assessed in primary SGT tissue to determine if tumor-specific alterations could be detected. Methodology: DNA isolated from 78 tumor and 17 normal parotid gland specimens was assayed for promoter methylation status of 19 TSGs by fluorescence-based, quantitative methylation-specific PCR (qMSP). The data were utilized in a binary fashion as well as quantitatively (using a methylation quotient) allowing for better profiling and interpretation of results. Principal Findings: The average number of methylation events across the studied genes was highest in salivary duct carcinoma (SDC), with a methylation value of 9.6, compared to the normal 4.5 (p<0.0003). There was a variable frequency and individual methylation quotient detected, depending on the TSG and the tumor type. When comparing normal, benign, and malignant SGTs, there was a statistically significant trend for increasing methylation in APC, Mint 1, PGP9.5, RAR-beta, and Timp3. Conclusions/Significance: Screening promoter methylation profiles in SGTs showed considerable heterogeneity. The methylation status of certain markers was surprisingly high in even normal salivary tissue, confirming the need for such controls. Several TSGs were found to be associated with malignant SGTs, especially SDC. Further study is needed to evaluate the potential use of these associations in the detection, prognosis, and therapeutic outcome of these rare tumors.	[Durr, Megan L.; Mydlarz, Wojciech K.; Shao, Chunbo; Chuang, Alice Y.; Hoque, Mohammad O.; Califano, Joseph A.; Sidransky, David; Ha, Patrick K.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Zahurak, Marianna L.] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Baltimore, MD 21205 USA; [Westra, William H.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Liegeois, Nanette J.] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Califano, Joseph A.; Ha, Patrick K.] Greater Baltimore Med Ctr, Milton J Dance Jr Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Durr, ML (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	pha1@jhmi.edu	Shao, Chunbo/C-5412-2011	Liegeois, Nanette/0000-0001-5002-1799; Hoque, Mohammad Obaidul/0000-0001-6701-9978	National Institute of Dental and Craniofacial Research [K08-DE018463]; Johns Hopkins Clinician Scientist Award; National Cancer Institute SPORE [5P50CA096784-05]; EDRN [U01CA084986]; National Institutes of Health (NIH) [T32DC000027]; NATIONAL CANCER INSTITUTE [U01CA084986, P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K08DE018463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000027] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Johns Hopkins Clinician Scientist Award; National Cancer Institute SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EDRN; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Dr. Ha is supported by the Johns Hopkins Clinician Scientist Award and the National Institute of Dental and Craniofacial Research (K08-DE018463). Dr. Sidransky is supported by the National Cancer Institute SPORE (5P50CA096784-05) and EDRN (U01CA084986). Dr. Califano is supported by the National Institute of Dental and Craniofacial Research, and the National Cancer Institute SPORE (5P50CA096784-05) and EDRN (U01CA084986). Dr. Mydlarz is supported, in part, by the National Institutes of Health (NIH) T32 training grant (T32DC000027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CH, 2005, CLIN CANCER RES, V11, P656; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Augello C, 2006, J CELL PHYSIOL, V207, P654, DOI 10.1002/jcp.20601; Bachman KE, 1999, CANCER RES, V59, P798; Cerilli LA, 1999, HUM PATHOL, V30, P1242, DOI 10.1016/S0046-8177(99)90044-8; Chan AOO, 2003, ONCOGENE, V22, P924, DOI 10.1038/sj.onc.1206123; Chen KM, 2007, ARCH OTOLARYNGOL, V133, P1131, DOI 10.1001/archotol.133.11.1131; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; *CYT SOFTW CORP, 1997, STATXACT 4 WIND VERS; Daa T, 2004, MODERN PATHOL, V17, P1475, DOI 10.1038/modpathol.3800209; Ellinger J, 2008, J UROLOGY, V179, P346, DOI 10.1016/j.juro.2007.08.091; ElNaggar AK, 1997, AM J SURG PATHOL, V21, P691, DOI 10.1097/00000478-199706000-00009; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2005, J PATHOL, V205, P172, DOI 10.1002/path.1707; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Esteller M, 2001, CANCER RES, V61, P3225; *FDN STAT COMP, 2004, R LANG ENV STAT COMP; Fukasawa M, 2006, J HUM GENET, V51, P368, DOI 10.1007/s10038-005-0355-4; Guo XL, 2007, INT J ORAL MAX SURG, V36, P350, DOI 10.1016/j.ijom.2006.11.004; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Harden SV, 2003, CLIN CANCER RES, V9, P1370; Henrique R, 2007, CLIN CANCER RES, V13, P6122, DOI 10.1158/1078-0432.CCR-07-1042; Hoque MO, 2008, J UROLOGY, V179, P743, DOI 10.1016/j.juro.2007.09.019; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Jeronimo C, 2004, CLIN CANCER RES, V10, P8472, DOI 10.1158/1078-0432.CCR-04-0894; Johns M E, 1989, Oncology (Williston Park), V3, P85; Johns M E, 1989, Oncology (Williston Park), V3, P47; Kishi M, 2005, ORAL ONCOL, V41, P161, DOI 10.1016/j.oraloncology.2004.08.004; Lalami Y, 2006, CURR OPIN ONCOL, V18, P258, DOI 10.1097/01.cco.0000219255.30220.90; Lee ES, 2008, CLIN CANCER RES, V14, P2664, DOI 10.1158/1078-0432.CCR-07-1232; Li J, 2005, CANCER-AM CANCER SOC, V104, P771, DOI 10.1002/cncr.21215; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Maruya S, 2004, MODERN PATHOL, V17, P637, DOI 10.1038/modpathol.3800104; Maruya S, 2004, J MOL DIAGN, V6, P180, DOI 10.1016/S1525-1578(10)60508-9; Maruya SI, 2003, ORL-J OTO-RHIN-LARYN, V65, P26, DOI 10.1159/000068658; Ninomiya I, 2008, ONCOL REP, V20, P1489, DOI 10.3892/or_00000170; Nishimine M, 2003, ONCOL REP, V10, P555; Ogi K, 2002, CLIN CANCER RES, V8, P3164; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Paz MF, 2004, CLIN CANCER RES, V10, P4933, DOI 10.1158/1078-0432.CCR-04-0392; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rosas SLB, 2001, CANCER LETT, V170, P73, DOI 10.1016/S0304-3835(01)00449-9; Rosenbaum E, 2005, CLIN CANCER RES, V11, P8321, DOI 10.1158/1078-0432.CCR-05-1183; Safar AM, 2005, CLIN CANCER RES, V11, P4400, DOI 10.1158/1078-0432.CCR-04-2378; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; *SAS I INC, 1985, SAS US GUID VERS; Sato N, 2003, CANCER RES, V63, P3735; SPIRO RH, 1974, AM J SURG, V128, P512, DOI 10.1016/0002-9610(74)90265-7; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Toyota M, 2001, BLOOD, V97, P2823, DOI 10.1182/blood.V97.9.2823; Uchida D, 2004, BRIT J CANCER, V91, P1131, DOI 10.1038/sj.bjc.6602004; Williams MD, 2006, CLIN CANCER RES, V12, P7353, DOI 10.1158/1078-0432.CCR-06-1272; Zhang CY, 2007, CANCER-AM CANCER SOC, V110, P87, DOI 10.1002/cncr.22758	53	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10828	10.1371/journal.pone.0010828	http://dx.doi.org/10.1371/journal.pone.0010828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520817	gold, Green Submitted, Green Published			2022-12-25	WOS:000278221500015
J	Fang, SY; Krahe, R; Lozano, G; Han, YH; Chen, W; Post, SM; Zhang, BL; Wilson, CD; Bachinski, LL; Strong, LC; Amos, CI				Fang, Shenying; Krahe, Ralf; Lozano, Guillermina; Han, Younghun; Chen, Wei; Post, Sean M.; Zhang, Baili; Wilson, Charmaine D.; Bachinski, Linda L.; Strong, Louise C.; Amos, Christopher I.			Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; ACCELERATES TUMOR-FORMATION; BREAST-CANCER; P53 MUTATIONS; FAMILIES; ONSET; VARIANTS; SARCOMA; SNP309; HUMANS	Background: Previous studies have shown that MDM2 SNP309 and p53 codon 72 have modifier effects on germline P53 mutations, but those studies relied on case-only studies with small sample sizes. The impact of MDM4 polymorphism on tumor onset in germline mutation carriers has not previously been studied. Methodology/Principal Findings: We analyzed 213 p53 germline mutation carriers including 168(78.9%) affected with cancer and 174 who had genotypic data. We analyzed time to first cancer using Kaplan-Meier and Cox proportional hazards methods, comparing risks according to polymorphism genotypes. For MDM2 SNP309, a significant difference of 9.0 years in the average age of cancer diagnosis was observed between GG/GT and TT carriers (18.6 versus 27.6 years, P = 0.0087). The hazards ratio was 1.58 (P = 0.03) comparing risks among individuals with GG/GT to risk among TT, but this effect was only significant in females (HR = 1.60, P = 0.02). Compared to other genotypes, P53 codon 72 PP homozygotes had a 2.24 times (P = 0.03) higher rate for time to develop cancer. We observed a multiplicative joint effect of MDM2 and p53 codon72 polymorphism on risk. The MDM4 polymorphism had no significant effects. Conclusions/Significance: Our results suggest that the MDM2 SNP309 G allele is associated with cancer risk in p53 germline mutation carriers and accelerates time to cancer onset with a pronounced effect in females. A multiplicative joint effect exists between the MDM2 SNP309 G allele and the p53 codon 72 G allele in the risk of cancer development. Our results further define cancer risk in carriers of germline p53 mutations.	[Fang, Shenying; Han, Younghun; Chen, Wei; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Krahe, Ralf; Lozano, Guillermina; Post, Sean M.; Zhang, Baili; Wilson, Charmaine D.; Bachinski, Linda L.; Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Fang, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	camos@mdanderson.org		Fang, Shenying/0000-0002-0604-793X	National Institutes of Health [P01-CA 34936-19A2]; NATIONAL CANCER INSTITUTE [P01CA034936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grant P01-CA 34936-19A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal GS, 2009, P NATL ACAD SCI USA, V106, P10236, DOI 10.1073/pnas.0901298106; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.037952; Chen XM, 2008, CARCINOGENESIS, V29, P2120, DOI 10.1093/carcin/bgn191; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; GARBER JE, 1991, CANCER RES, V51, P6094; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Jin SK, 2001, J CELL SCI, V114, P4139; Kleihues P, 1997, AM J PATHOL, V150, P1; Kulkarni DA, 2009, CARCINOGENESIS, V30, P1910, DOI 10.1093/carcin/bgp224; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LING DY, 1989, J AM STAT ASSOC, V84, P1074; LUSTBADER ED, 1992, AM J HUM GENET, V51, P344; MALKIN D, 1994, BBA-REV CANCER, V1198, P197, DOI 10.1016/0304-419X(94)90014-0; Marcel V, 2009, J MED GENET, V46, P766, DOI 10.1136/jmg.2009.066704; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Martin AM, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e34; Nichols KE, 2001, CANCER EPIDEM BIOMAR, V10, P83; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; STRONG LC, 1987, AM J PEDIAT HEMATOL, V9, P99; Xiong XJ, 2009, LEUKEMIA RES, V33, P1454, DOI 10.1016/j.leukres.2009.04.007	23	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10813	10.1371/journal.pone.0010813	http://dx.doi.org/10.1371/journal.pone.0010813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520810	Green Published, gold, Green Submitted			2022-12-25	WOS:000278221500010
J	Precht, WF; Aronson, RB; Moody, RM; Kaufman, L				Precht, William F.; Aronson, Richard B.; Moody, Ryan M.; Kaufman, Les			Changing Patterns of Microhabitat Utilization by the Threespot Damselfish, Stegastes planifrons, on Caribbean Reefs	PLOS ONE			English	Article							JAMAICAN CORAL REEFS; REGION-WIDE DECLINES; FLORIDA-KEYS; FISH COMMUNITIES; PROTECTED AREAS; AGE-STRUCTURE; POPULATION; ECOLOGY; SCALE; ZONATION	Background: The threespot damselfish, Stegastes planifrons (Cuvier), is important in mediating interactions among corals, algae, and herbivores on Caribbean coral reefs. The preferred microhabitat of S. planifrons is thickets of the branching staghorn coral Acropora cervicornis. Within the past few decades, mass mortality of A. cervicornis from white-band disease and other factors has rendered this coral a minor ecological component throughout most of its range. Methodology/Principal Findings: Survey data from Jamaica (heavily fished), Florida and the Bahamas (moderately fished), the Cayman Islands (lightly to moderately fished), and Belize (lightly fished) indicate that distributional patterns of S. planifrons are positively correlated with live coral cover and topographic complexity. Our results suggest that species-specific microhabitat preferences and the availability of topographically complex microhabitats are more important than the abundance of predatory fish as proximal controls on S. planifrons distribution and abundance. Conclusions/Significance: The loss of the primary microhabitat of S. planifrons-A. cervicornis-has forced a shift in the distribution and recruitment of these damselfish onto remaining high-structured corals, especially the Montastraea annularis species complex, affecting coral mortality and algal dynamics throughout the Caribbean.	[Precht, William F.] NOAA, Florida Keys Natl Marine Sanctuary, Key Largo, FL USA; [Aronson, Richard B.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Moody, Ryan M.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Kaufman, Les] Boston Univ, Dept Biol, Marine Program, Boston, MA 02215 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Florida Institute of Technology; Dauphin Island Sea Lab; Boston University	Precht, WF (corresponding author), NOAA, Florida Keys Natl Marine Sanctuary, Key Largo, FL USA.	raronson@fit.edu		Aronson, Richard/0000-0003-0383-3844	Northeastern University, Jamaica; Smithsonian Institution; National Geographic Society, Belize; National Geographic Society; Gordon and Betty Moore Foundation	Northeastern University, Jamaica; Smithsonian Institution(Smithsonian Institution); National Geographic Society, Belize(National Geographic Society); National Geographic Society(National Geographic Society); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	WFP and RBA thank Northeastern University's Three Seas Program for support in Jamaica, and the Smithsonian Institution's Caribbean Coral Reef Ecosystems (CCRE) Program and the National Geographic Society for support in Belize. LK received support from the National Geographic Society and the Marine Management Area Science Program of Conservation International (funded by the Gordon and Betty Moore Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrey CA, 2005, ENVIRON BIOL FISH, V73, P163, DOI 10.1007/s10641-004-5561-y; Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Aronson RB, 2001, EVOLUTIONARY PALEOECOLOGY, P171; Aronson Richard B., 1994, Atoll Research Bulletin, V421, P1; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Ault JS, 1998, FISH B-NOAA, V96, P395; Baker B, 1999, BIOSCIENCE, V49, P173, DOI 10.2307/1313506; Beukers JS, 1997, OECOLOGIA, V111, P50, DOI DOI 10.1007/S004420050419); BOHNSACK JA, 1982, WASHINGTON SEAGRANT, P258; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Caldow C, 2003, MAR ECOL PROG SER, V265, P185, DOI 10.3354/meps265185; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Ceccarelli DM, 2006, MAR ECOL PROG SER, V309, P255, DOI 10.3354/meps309255; Ceccarelli DM, 2001, OCEANOGR MAR BIOL, V39, P355; Chiappone M, 2000, MAR ECOL PROG SER, V198, P261, DOI 10.3354/meps198261; CLARKE RD, 1977, MAR BIOL, V40, P277, DOI 10.1007/BF00390882; Eakin CM, 1989, P ASS ISL MAR LAB CA, V22, P35; EBERSOLE JP, 1985, ECOLOGY, V66, P14, DOI 10.2307/1941302; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Friedlander A.M., 2008, 70 NOAA NOS NCCOS; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLADFELTER EH, 1992, ECOLOGICAL STUDIES 2, P14; GLYNN PW, 1990, ECOSYSTEMS WORLD, V25, P365; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; GOREAU TF, 1973, B MAR SCI, V23, P399; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Gutierrez L, 1998, OECOLOGIA, V115, P268, DOI 10.1007/s004420050516; Hardt M.J., 2008, FISH FISH, V10, P1; HARRIS R, 2009, TINY DAMSELFISH MAY; HERNANDEZDELAGA.EA, 1999, THESIS U PUERTO RICO; ITZKOWITZ M, 1979, AM NAT, V114, P585, DOI 10.1086/283504; JACKSON JBC, 1992, AM ZOOL, V32, P719; Kaufman L., 1986, P1; KAUFMAN L, 1981, PALEOBIOLOGY, V7, P527, DOI 10.1017/S0094837300025562; Kaufman L, 1977, P 3 INT COR REEF S, V1, P559; Kaufman L.S., 1983, Coral Reefs, V2, P43, DOI 10.1007/BF00304731; KAUFMAN LS, 1979, THESIS J HOPKINS U B; Knowlton N, 1990, SMITHSON CONTR MAR S, V31, P1, DOI DOI 10.5479/SI.01960768.31.1; KOSLOW JA, 1994, FISH B-NOAA, V92, P737; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Levin PS, 2000, BEHAV ECOL, V11, P565, DOI 10.1093/beheco/11.5.565; Liddell W. D., 1984, SEDIMENTA; LIRMAN D, 1994, J EXP MAR BIOL ECOL, V180, P71, DOI 10.1016/0022-0981(94)90080-9; Lirman D, 1999, B MAR SCI, V65, P235; Lobel PS., 1980, B MAR SCI, V30, P273; Ludwig JA, 1988, STAT ECOLOGY; LUOMA JR, 1996, AUDUBON MAG      NOV, P24; McClanahan Tim R., 2005, P247; MUNRO JL, 1983, ICLARM STUDIES REV, V7, P276; NEELY KL, 2008, THESIS U PROGRAM ECO; OGDEN JC, 1995, PUBL SERV GEOL LUX, V29; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pattengill-Semmens Christy V., 2003, Atoll Research Bulletin, V496, P226; Precht WF, 2006, CONSERV BIOL SER, P40; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Roberts CM, 2003, ORYX, V37, P166, DOI 10.1017/S0030605303000358; ROBERTSON DR, 1981, ECOLOGY, V62, P1162, DOI 10.2307/1937280; Schmitt EF, 2002, CORAL REEFS, V21, P216, DOI 10.1007/s00338-002-0216-y; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Steneck Robert S., 2005, P110; THOMAS J D, 1991, Invertebrate Taxonomy, V5, P469, DOI 10.1071/IT9910469; Thresher RE, 1980, REEF FISH BEHAV ECOL; Tolimieri N, 1998, MAR ECOL PROG SER, V167, P227, DOI 10.3354/meps167227; TOLLER W, 2002, 3 USVI DEP PLANN NAT; Vicente Vance P., 1994, P227; WELLINGTON GM, 1982, ECOL MONOGR, V52, P223, DOI 10.2307/2937329; WELLINGTON GM, 1985, OECOLOGIA, V68, P15, DOI 10.1007/BF00379466; Wilkes AA, 2008, SOUTHEAST NAT, V7, P483, DOI 10.1656/1528-7092-7.3.483; WILLIAMS AH, 1978, J EXP MAR BIOL ECOL, V34, P197, DOI 10.1016/S0022-0981(78)80002-1; WILLIAMS AH, 1981, ECOLOGY, V62, P1107, DOI 10.2307/1937008; WILLIAMS AH, 1980, AM NAT, V116, P138, DOI 10.1086/283616; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; WOODLEY JD, 1989, ASSESSMENT EC IMPACT	78	39	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10835	10.1371/journal.pone.0010835	http://dx.doi.org/10.1371/journal.pone.0010835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	20520809	Green Published, gold, Green Submitted			2022-12-25	WOS:000278221500021
J	Lepp, D; Roxas, B; Parreira, VR; Marri, PR; Rosey, EL; Gong, J; Songer, JG; Vedantam, G; Prescott, JF				Lepp, Dion; Roxas, Bryan; Parreira, Valeria R.; Marri, Pradeep R.; Rosey, Everett L.; Gong, Joshua; Songer, J. Glenn; Vedantam, Gayatri; Prescott, John F.			Identification of Novel Pathogenicity Loci in Clostridium perfringens Strains That Cause Avian Necrotic Enteritis	PLOS ONE			English	Article							ENTEROTOXIN GENE CPE; BROILER-CHICKENS; GENOME SEQUENCE; ENCODING PLASMIDS; VIBRIO-CHOLERAE; ALPHA-TOXIN; BETA2 TOXIN; VIRULENCE; IMMUNIZATION; EXPRESSION	Type A Clostridium perfringens causes poultry necrotic enteritis (NE), an enteric disease of considerable economic importance, yet can also exist as a member of the normal intestinal microbiota. A recently discovered pore-forming toxin, NetB, is associated with pathogenesis in most, but not all, NE isolates. This finding suggested that NE-causing strains may possess other virulence gene(s) not present in commensal type A isolates. We used high-throughput sequencing (HTS) technologies to generate draft genome sequences of seven unrelated C. perfringens poultry NE isolates and one isolate from a healthy bird, and identified additional novel NE-associated genes by comparison with nine publicly available reference genomes. Thirty-one open reading frames (ORFs) were unique to all NE strains and formed the basis for three highly conserved NE-associated loci that we designated NELoc-1 (42 kb), NELoc-2 (11.2 kb) and NELoc-3 (5.6 kb). The largest locus, NELoc-1, consisted of netB and 36 additional genes, including those predicted to encode two leukocidins, an internalin-like protein and a ricin-domain protein. Pulsed-field gel electrophoresis (PFGE) and Southern blotting revealed that the NE strains each carried 2 to 5 large plasmids, and that NELoc-1 and -3 were localized on distinct plasmids of sizes similar to 85 and similar to 70 kb, respectively. Sequencing of the regions flanking these loci revealed similarity to previously characterized conjugative plasmids of C. perfringens. These results provide significant insight into the pathogenetic basis of poultry NE and are the first to demonstrate that netB resides in a large, plasmid-encoded locus. Our findings strongly suggest that poultry NE is caused by several novel virulence factors, whose genes are clustered on discrete pathogenicity loci, some of which are plasmid-borne.	[Lepp, Dion; Parreira, Valeria R.; Prescott, John F.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Lepp, Dion; Gong, Joshua] Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada; [Roxas, Bryan; Songer, J. Glenn; Vedantam, Gayatri] Univ Arizona, Dept Vet Sci & Microbiol, Tucson, AZ USA; [Marri, Pradeep R.] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Rosey, Everett L.] Pfizer Anim Hlth, Vet Med Res & Dev, Kalamazoo, MI USA; [Vedantam, Gayatri] So Arizona VA Healthcare Syst, Tucson, AZ USA	University of Guelph; Agriculture & Agri Food Canada; University of Arizona; University of Arizona; Pfizer; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System	Lepp, D (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	prescott@uoguelph.ca			Agriculture and Agri-Food Canada (AAFC) [F.1208.FC]; Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Poultry Industry Council (PIC); United States Department of Agriculture (USDA) [2007-35204-18362]; Pfizer Animal Health	Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Poultry Industry Council (PIC); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Pfizer Animal Health	Funding: This work was funded by Agriculture and Agri-Food Canada (AAFC) A-base Fund (WBSE# F.1208.FC) (JG and DL), the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) and the Poultry Industry Council (PIC) (JFP, VRP and DL), United States Department of Agriculture (USDA) grant no. 2007-35204-18362 and Pfizer Animal Health (JGS). Apart from the input provided by ELR in the conception of the research and review of the manuscript, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arndt JW, 2005, J MOL BIOL, V346, P1083, DOI 10.1016/j.jmb.2004.12.039; ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Barbara AJ, 2008, VET MICROBIOL, V126, P377, DOI 10.1016/j.vetmic.2007.07.019; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Brouillette E, 2005, ANTIMICROB AGENTS CH, V49, P3109, DOI 10.1128/AAC.49.8.3109-3113.2005; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Carpusca I, 2006, MOL MICROBIOL, V62, P621, DOI 10.1111/j.1365-2958.2006.05401.x; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; CHEUNG JK, 2009, 6 CLOSTPATH INT C RO; Cooper KK, 2009, VET MICROBIOL, V133, P92, DOI 10.1016/j.vetmic.2008.06.001; Cooper KK, 2009, ANAEROBE, V15, P55, DOI 10.1016/j.anaerobe.2009.01.006; COOPER KK, 2009, VET MICROBI IN PRESS; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Fisher DJ, 2005, MOL MICROBIOL, V56, P747, DOI 10.1111/j.1365-2958.2005.04573.x; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gibert M, 1997, GENE, V203, P65, DOI 10.1016/S0378-1119(97)00493-9; Gusils C, 2003, CAN J MICROBIOL, V49, P472, DOI [10.1139/w03-055, 10.1139/W03-055]; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Jiang YF, 2009, AVIAN DIS, V53, P409, DOI 10.1637/8656-021109-Reg.1; Jolles P., 1999, CHITIN CHITINASES; JONAS K, 2009, ENV MICROBIOLOGY, V9999; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Keyburn AL, 2006, INFECT IMMUN, V74, P6496, DOI 10.1128/IAI.00806-06; Keyburn AL, 2010, VET RES, V41, DOI 10.1051/vetres/2009069; Khambualai O, 2009, BRIT POULTRY SCI, V50, P592, DOI 10.1080/00071660903247182; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulkarni RR, 2008, VACCINE, V26, P4194, DOI 10.1016/j.vaccine.2008.05.079; Kulkarni RR, 2007, CLIN VACCINE IMMUNOL, V14, P1070, DOI 10.1128/CVI.00162-07; Kulkarni RR, 2006, CLIN VACCINE IMMUNOL, V13, P1358, DOI 10.1128/CVI.00292-06; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Manasherob R, 2006, MICROBIOL-SGM, V152, P2651, DOI 10.1099/mic.0.28981-0; Manich M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003764; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Miyamoto K, 2008, J BACTERIOL, V190, P7178, DOI 10.1128/JB.00939-08; Morimoto K, 1997, J BACTERIOL, V179, P7306, DOI 10.1128/jb.179.23.7306-7314.1997; Morimoto K, 1999, APPL MICROBIOL BIOT, V51, P340, DOI 10.1007/s002530051400; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nakamura T, 2008, J MOL BIOL, V376, P854, DOI 10.1016/j.jmb.2007.12.031; OHTANI K, ANAEROBE IN PRESS; Olkowski AA, 2008, RES VET SCI, V85, P543, DOI 10.1016/j.rvsc.2008.02.007; QUINLAN AR, 2010, BIOINFORMATICS; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt M, 2004, MICROBIOL-SGM, V150, P3253, DOI 10.1099/mic.0.27197-0; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Thompson DR, 2006, VET MICROBIOL, V113, P25, DOI 10.1016/j.vetmic.2005.10.015; Van Immerseel F, 2009, TRENDS MICROBIOL, V17, P32, DOI 10.1016/j.tim.2008.09.005; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; 2009, ALPHA TOXIN ACCUMULA	78	81	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10795	10.1371/journal.pone.0010795	http://dx.doi.org/10.1371/journal.pone.0010795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20532244	gold, Green Published, Green Submitted			2022-12-25	WOS:000278034600019
J	Nitta, M; Kozono, D; Kennedy, R; Stommel, J; Ng, K; Zinn, PO; Kushwaha, D; Kesari, S; Furnari, F; Hoadley, KA; Chin, L; DePinho, RA; Cavenne, WK; D'Andrea, A; Chen, CC				Nitta, Masayuki; Kozono, David; Kennedy, Richard; Stommel, Jayne; Ng, Kimberly; Zinn, Pascal O.; Kushwaha, Deepa; Kesari, Santosh; Furnari, Frank; Hoadley, Katherine A.; Chin, Lynda; DePinho, Ronald A.; Cavenee, Webster K.; D'Andrea, Alan; Chen, Clark C.			Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DNA-DAMAGE RESPONSE; INTEGRATED GENOMIC ANALYSIS; REACTIVE OXYGEN; HUMAN CANCERS; REPAIR; CELLS; INSTABILITY; MODULATION; ACTIVATION	Despite the critical role of Epidermal Growth Factor Receptor (EGFR) in glioblastoma pathogenesis [1,2], EGFR targeted therapies have achieved limited clinical efficacy [3]. Here we propose an alternate therapeutic strategy based on the conceptual framework of non-oncogene addiction [4,5]. A directed RNAi screen revealed that glioblastoma cells overexpressing EGFRvIII [6], an oncogenic variant of EGFR, become hyper-dependent on a variety of DNA repair genes. Among these, there was an enrichment of Base Excision Repair (BER) genes required for the repair of Reactive Oxygen Species (ROS)-induced DNA damage, including poly-ADP ribose polymerase 1 (PARP1). Subsequent studies revealed that EGFRvIII overexpression in glioblastoma cells caused increased levels of ROS, DNA strand break accumulation, and genome instability. In a panel of primary glioblastoma lines, sensitivity to PARP1 inhibition correlated with the levels of EGFR activation and oxidative stress. Gene expression analysis indicated that reduced expression of BER genes in glioblastomas with high EGFR expression correlated with improved patient survival. These observations suggest that oxidative stress secondary to EGFR hyperactivation necessitates increased cellular reliance on PARP1 mediated BER, and offer critical insights into clinical trial design.	[Nitta, Masayuki; Kozono, David; Ng, Kimberly; Zinn, Pascal O.; Kushwaha, Deepa; D'Andrea, Alan; Chen, Clark C.] Dana-Farber Canc Inst, Dept Radiat Oncol, Boston, MA USA; [Kozono, David] Harvard Radiat Oncol Program, Boston, MA USA; [Kennedy, Richard] Almac Diagnost, Craigavon, North Ireland; [Stommel, Jayne; Chin, Lynda; DePinho, Ronald A.] Dana-Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA USA; [Kesari, Santosh] Univ Calif San Diego, Dept Neurol, Moores UCSD Canc Ctr, La Jolla, CA USA; [Furnari, Frank; Cavenee, Webster K.] Ludwig Inst Canc Res, La Jolla, CA USA; [Hoadley, Katherine A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Chen, Clark C.] Beth Israel Deaconess Med Ctr, Div Neurosurg, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Beth Israel Deaconess Medical Center	Nitta, M (corresponding author), Dana-Farber Canc Inst, Dept Radiat Oncol, Boston, MA USA.	clark_chen@dfci.harvard.edu	Chen, Clark C/C-8714-2013; Stommel, Jayne M/M-3439-2017; Kesari, Santosh/E-8461-2013	Chen, Clark C/0000-0001-6258-9277; Furnari, Frank/0000-0003-1909-4361; Hoadley, Katherine/0000-0002-1216-477X; DePinho, Ronald/0000-0002-5625-577X	Burroughs Wellcome Fund [CAMS 1006775.01]; National Brain Tumor Foundation; ABC2 Foundation	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Brain Tumor Foundation; ABC2 Foundation	CCC was supported by an award from the Burroughs Wellcome Fund (CAMS 1006775.01), National Brain Tumor Foundation, and ABC2 Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chen CC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-24; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Haince JF, 2005, TRENDS MOL MED, V11, P456, DOI 10.1016/j.molmed.2005.08.003; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Helbock HJ, 1999, METHOD ENZYMOL, V300, P156; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kim HW, 2003, CARCINOGENESIS, V24, P235, DOI 10.1093/carcin/24.2.235; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rassool FV, 2007, CANCER RES, V67, P8762, DOI 10.1158/0008-5472.CAN-06-4807; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tudek B, 2007, MOL ASPECTS MED, V28, P258, DOI 10.1016/j.mam.2007.05.003; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yoon JH, 2003, NUCLEIC ACIDS RES, V31, P5399, DOI 10.1093/nar/gkg730	33	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10767	10.1371/journal.pone.0010767	http://dx.doi.org/10.1371/journal.pone.0010767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20532243	Green Published, gold, Green Submitted			2022-12-25	WOS:000278034600002
J	Elson, AET; Dotson, CD; Egan, JM; Munger, SD				Elson, Amanda E. T.; Dotson, Cedrick D.; Egan, Josephine M.; Munger, Steven D.			Glucagon signaling modulates sweet taste responsiveness	FASEB JOURNAL			English	Article						proglucagon; glucagon receptor; gustation; 7B2; behavior	VASOACTIVE-INTESTINAL-PEPTIDE; RECEPTOR-CELLS; GUSTATORY RESPONSIVENESS; PROHORMONE CONVERTASE-2; COEXPRESSION PATTERNS; BITTER TASTE; ALPHA-CELLS; NULL MICE; RAT; BUDS	The gustatory system provides critical information about the quality and nutritional value of food before it is ingested. Thus, physiological mechanisms that modulate taste function in the context of nutritional needs or metabolic status could optimize ingestive decisions. We report that glucagon, which plays important roles in the maintenance of glucose homeostasis, enhances sweet taste responsiveness through local actions in the mouse gustatory epithelium. Using immunohistochemistry and confocal microscopy, we found that glucagon and its receptor (GlucR) are coexpressed in a subset of mouse taste receptor cells. Most of these cells also express the T1R3 taste receptor implicated in sweet and/or umami taste. Genetic or pharmacological disruption of glucagon signaling in behaving mice indicated a critical role for glucagon in the modulation of taste responsiveness. Scg5(-/-) mice, which lack mature glucagon, had significantly reduced responsiveness to sucrose as compared to wild-type littermates in brief-access taste tests. No significant differences were seen in responses to prototypical salty, sour, or bitter stimuli. Taste responsiveness to sucrose was similarly reduced upon acute and local disruption of glucagon signaling by the GlucR antagonist L-168,049. Together, these data indicate a role for local glucagon signaling in the peripheral modulation of sweet taste responsiveness.-Elson, A.E.T., Dotson, C.D., Egan, J.M., Munger, S.D. Glucagon signaling modulates sweet taste responsiveness. FASEB J. 24, 3960-3969 (2010). www.fasebj.org	[Elson, Amanda E. T.; Dotson, Cedrick D.; Munger, Steven D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Egan, Josephine M.] NIA, NIH, Baltimore, MD 21224 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Munger, SD (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 S Penn St,Rm S251, Baltimore, MD 21201 USA.	smung001@umaryland.edu		Dotson, Cedrick/0000-0003-0992-1191; Elson, Amanda/0000-0002-5744-5954	National Institute on Deafness and Communication Disorders [DC010110, DC010113]; Ajinomoto Amino Acid Research Program; National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010110, F31DC010113] Funding Source: NIH RePORTER	National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Ajinomoto Amino Acid Research Program; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Iris Lindberg (University of Maryland School of Medicine) and the S.D.M. laboratory for helpful comments on the manuscript, and Iris Lindberg, Maureen Charron (Albert Einstein School of Medicine, New York, NY, USA), and Charles Zuker (Columbia University, New York, NY, USA) for generous gifts of reagents. This work was supported by the National Institute on Deafness and Communication Disorders (DC010110, S. D. M.; DC010113, A.E.T.E.), the Ajinomoto Amino Acid Research Program (S.D.M.) and the National Institute on Aging Intramural Program (J.M.E.).	Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Behrens M, 2009, RESULTS PROBL CELL D, V47, P203, DOI 10.1007/400_2008_5; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; Cascieri MA, 1999, J BIOL CHEM, V274, P8694, DOI 10.1074/jbc.274.13.8694; Dallas-Yang Q, 2002, ANAL BIOCHEM, V301, P156, DOI 10.1006/abio.2001.5483; de Laszlo SE, 1999, BIOORG MED CHEM LETT, V9, P641, DOI 10.1016/S0960-894X(99)00081-5; DEJONG A, 1977, AM J PHYSIOL, V233, pE380, DOI 10.1152/ajpendo.1977.233.5.E380; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Egan JM, 2008, MOL INTERV, V8, P78, DOI 10.1124/mi.8.2.5; Feng XH, 2008, ACTA HISTOCHEM, V110, P151, DOI 10.1016/j.acthis.2007.10.005; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; GEARY N, 1993, AM J PHYSIOL, V264, pR116, DOI 10.1152/ajpregu.1993.264.1.R116; GEARY N, 1990, NEUROSCI BIOBEHAV R, V14, P323, DOI 10.1016/S0149-7634(05)80042-9; Gelling RW, 2009, AM J PHYSIOL-ENDOC M, V297, pE695, DOI 10.1152/ajpendo.00082.2009; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; GIZA BK, 1993, AM J PHYSIOL, V265, pR1231, DOI 10.1152/ajpregu.1993.265.6.R1231; GIZA BK, 1992, BRAIN RES BULL, V28, P637, DOI 10.1016/0361-9230(92)90116-F; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Gonzalez-Munoz C, 2008, EUR J PHARMACOL, V587, P243, DOI 10.1016/j.ejphar.2008.04.001; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Heppner KM, 2010, PHYSIOL BEHAV, V100, P545, DOI 10.1016/j.physbeh.2010.03.019; Herness S, 2002, J NEUROSCI, V22, P10018; Herness S, 2009, PHYSIOL BEHAV, V97, P581, DOI 10.1016/j.physbeh.2009.02.043; Karasawa N, 1997, J NEURAL TRANSM, V104, P1267, DOI 10.1007/BF01294727; Katayama T, 2007, BIOCHEM BIOPH RES CO, V357, P865, DOI 10.1016/j.bbrc.2007.04.001; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Kieffer TJ, 1996, ENDOCRINOLOGY, V137, P5119, DOI 10.1210/en.137.11.5119; LANGHANS W, 1982, SCIENCE, V218, P894, DOI 10.1126/science.7134979; Laurent V, 2004, ENDOCRINOLOGY, V145, P519, DOI 10.1210/en.2003-0829; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Lu SG, 2003, NEUROSCI LETT, V351, P157, DOI 10.1016/j.neulet.2003.07.016; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Ma J, 2009, AM J PHYSIOL-GASTR L, V296, pG735, DOI 10.1152/ajpgi.90708.2008; Ma XS, 2005, MOL ENDOCRINOL, V19, P198, DOI 10.1210/me.2004-0059; Maeda T, 2003, NEUROSCI LETT, V343, P17, DOI 10.1016/S0304-3940(03)00295-7; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Meier JJ, 2006, GASTROENTEROLOGY, V130, P44, DOI 10.1053/j.gastro.2005.10.004; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nakamura Y, 2008, DIABETES, V57, P2661, DOI 10.2337/db07-1103; Nelson TM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-32; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Peinado JR, 2005, ENDOCRINOLOGY, V146, P3438, DOI 10.1210/en.2004-1289; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; Seta Y, 2006, ARCH HISTOL CYTOL, V69, P273, DOI 10.1679/aohc.69.273; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; Westphal CH, 1999, CELL, V96, P689, DOI 10.1016/S0092-8674(00)80579-6; Woods SC, 2006, PHILOS T R SOC B, V361, P1219, DOI 10.1098/rstb.2006.1858; Yang RB, 2000, J COMP NEUROL, V425, P139, DOI 10.1002/1096-9861(20000911)425:1<139::AID-CNE12>3.0.CO;2-#; Yang RB, 2007, J COMP NEUROL, V502, P883, DOI 10.1002/cne.21317; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	60	51	52	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3960	3969		10.1096/fj.10-158105	http://dx.doi.org/10.1096/fj.10-158105			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20547661	Green Published			2022-12-25	WOS:000285005900033
J	Apostolatos, H; Apostolatos, A; Vickers, T; Watson, JE; Song, SJ; Vale, F; Cooper, DR; Sanchez-Ramos, J; Patel, NA				Apostolatos, Hercules; Apostolatos, Andre; Vickers, Timothy; Watson, James E.; Song, Shijie; Vale, Fernando; Cooper, Denise R.; Sanchez-Ramos, Juan; Patel, Niketa A.			Vitamin A Metabolite, All-trans-retinoic Acid, Mediates Alternative Splicing of Protein Kinase C delta VIII (PKC delta VIII) Isoform via Splicing Factor SC35	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC ACTIVATION; INDUCED APOPTOSIS; BETA-II; EXON; EXPRESSION; CELLS; IDENTIFICATION; SIGNALS; VARIANT; ELEMENT	Vitamin A metabolite, all-trans-retinoic acid (RA), induces cell growth, differentiation, and apoptosis and has an emerging role in gene regulation and alternative splicing events. Protein kinase C delta (PKC delta), a serine/threonine kinase, has a role in cell proliferation, differentiation, and apoptosis. We reported an alternatively spliced variant of human PKC delta, PKC delta VIII that functions as a pro-survival protein (1). RA regulates the splicing and expression of PKC delta VIII via utilization of a downstream 5' splice site of exon 10 on PKC delta pre-mRNA. Here, we further elucidate the molecular mechanisms involved in RA regulation of alternative splicing of PKC delta VIII mRNA. Overexpression and knockdown of the splicing factor SC35 (i.e. SRp30b) indicated that it is involved in PKC delta VIII alternative splicing. To identify the cis-elements involved in 5' splice site selection we cloned a minigene, which included PKC delta exon 10 and its flanking introns in the pSPL3 splicing vector. Alternative 5' splice site utilization in the minigene was promoted by RA. Further, co-transfection of SC35 with PKC delta minigene promoted selection of 5 delta splice site II. Mutation of the SC35 binding site in the PKC delta minigene abolished RA-mediated utilization of 5' splice splice II. RNA binding assays demonstrated that the enhancer element downstream of PKC delta exon 10 is a SC35 cis-element. We conclude that SC35 is pivotal in RA-mediated PKC delta pre-mRNA alternative splicing. This study demonstrates how a nutrient, vitamin A, via its metabolite RA, regulates alternative splicing and thereby gene expression of the pro-survival protein PKC delta VIII.	[Patel, Niketa A.] James A Haley Vet Hosp, Res Serv VAR 151, Tampa, FL 33612 USA; [Apostolatos, Hercules; Apostolatos, Andre; Cooper, Denise R.; Patel, Niketa A.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Vale, Fernando] Univ S Florida, Dept Neurosurg, Tampa, FL 33612 USA; [Vickers, Timothy] ISIS Pharmaceut, Carlsbad, CA 92008 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Isis Pharmaceuticals Inc	Patel, NA (corresponding author), James A Haley Vet Hosp, Res Serv VAR 151, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	npatel@health.usf.edu	Sanchez-Ramos, Juan/O-7870-2014; Cooper, Denise R./A-4740-2012; Patel, Niketa/A-1392-2012; Sanchez-Ramos, Juan/A-1188-2009	Sanchez-Ramos, Juan/0000-0002-3391-7857; Apostolatos, Andre/0000-0002-4527-7084; Patel, Niketa A./0000-0003-4811-8596	NIDDK; National Institutes of Health [54393]; Veteran's Administration MREP; Veterans Affairs [I01BX003689] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration MREP; Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grant 54393 (to D. R. C.) and a Veteran's Administration MREP Grant (to N. A. P.).	Anantharam V, 2002, J NEUROSCI, V22, P1738, DOI 10.1523/JNEUROSCI.22-05-01738.2002; Bonnet E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003487; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Chand HS, 2006, INT J CANCER, V118, P1713, DOI 10.1002/ijc.21550; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Donai H, 2000, MOL BRAIN RES, V85, P189, DOI 10.1016/S0169-328X(00)00221-7; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Ise R, 2005, FEBS LETT, V579, P1732, DOI 10.1016/j.febslet.2005.02.033; Jiang K, 2008, BIOCHEMISTRY-US, V47, P787, DOI 10.1021/bi7019782; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Kawaguchi T, 2006, FEBS LETT, V580, P2458, DOI 10.1016/j.febslet.2006.03.084; Kawahigashi H, 1998, BBA-GENE STRUCT EXPR, V1397, P305, DOI 10.1016/S0167-4781(98)00021-9; Khoo B, 2003, TRENDS BIOTECHNOL, V21, P328, DOI 10.1016/S0167-7799(03)00168-9; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Ladd AN, 2002, GENOME BIOL, V3; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; McCracken MA, 2003, MOL CANCER THER, V2, P273; Meshorer E, 2005, MOL PSYCHIATR, V10, P985, DOI 10.1038/sj.mp.4001735; Misiuta IE, 2003, DEV BRAIN RES, V145, P107, DOI 10.1016/S0165-3806(03)00221-9; Muro AF, 1998, FEBS LETT, V437, P137, DOI 10.1016/S0014-5793(98)01201-0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Patel NA, 2003, J BIOL CHEM, V278, P1149, DOI 10.1074/jbc.M206797200; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Peluso JJ, 2001, ENDOCRINOLOGY, V142, P4203, DOI 10.1210/en.142.10.4203; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Sakurai Y, 2001, BIOL PHARM BULL, V24, P973, DOI 10.1248/bpb.24.973; SITAILO L, 2004, J INVEST DERMATOL, V123, P1; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Stamm S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/hmg/11.20.2409; Ueyama T, 2000, BIOCHEM BIOPH RES CO, V269, P557, DOI 10.1006/bbrc.2000.2331; Vickers TA, 2006, J IMMUNOL, V176, P3652, DOI 10.4049/jimmunol.176.6.3652; Walton HS, 2007, J NEUROSCI METH, V160, P294, DOI 10.1016/j.jneumeth.2006.09.022; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Yang ZQ, 2007, NUCLEIC ACIDS RES, V35, P1919, DOI 10.1093/nar/gkl1092; Zrachia A, 2002, J BIOL CHEM, V277, P23693, DOI 10.1074/jbc.M111658200	46	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25987	25995		10.1074/jbc.M110.100735	http://dx.doi.org/10.1074/jbc.M110.100735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547768	hybrid, Green Published			2022-12-25	WOS:000280921000013
J	Dailey, TA; Boynton, TO; Albetel, AN; Gerdes, S; Johnson, MK; Dailey, HA				Dailey, Tamara A.; Boynton, Tye O.; Albetel, Angela-Nadia; Gerdes, Svetlana; Johnson, Michael K.; Dailey, Harry A.			Discovery and Characterization of HemQ AN ESSENTIAL HEME BIOSYNTHETIC PATHWAY COMPONENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRINOGEN OXIDASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHLORITE DISMUTASE; PURIFICATION; EXPRESSION; IDENTIFICATION; FERROCHELATASE; ENZYME; GENOMICS	Here we identify a previously undescribed protein, HemQ, that is required for heme synthesis in Gram-positive bacteria. We have characterized HemQ from Bacillus subtilis and a number of Actinobacteria. HemQ is a multimeric heme-binding protein. Spectroscopic studies indicate that this heme is high spin ferric iron and is ligated by a conserved histidine with the sixth coordination site available for binding a small molecule. The presence of HemQ along with the terminal two pathway enzymes, protoporphyrinogen oxidase (HemY) and ferrochelatase, is required to synthesize heme in vivo and in vitro. Although the exact role played by HemQ remains to be characterized, to be fully functional in vitro it requires the presence of a bound heme. HemQ possesses minimal peroxidase activity, but as a catalase it has a turnover of over 10(4) min(-1). We propose that this activity may be required to eliminate hydrogen peroxide that is generated by each turnover of HemY. Given the essential nature of heme synthesis and the restricted distribution of HemQ, this protein is a potential antimicrobial target for pathogens such as Mycobacterium tuberculosis.	[Dailey, Harry A.] Univ Georgia, Biomed & Hlth Sci Inst, Paul D Coverdell Ctr, Athens, GA 30602 USA; [Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Boynton, Tye O.; Dailey, Harry A.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Albetel, Angela-Nadia; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Gerdes, Svetlana] Fellowship Interpretat Genomes, Bar Ridge, IL 60527 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dailey, HA (corresponding author), Univ Georgia, Biomed & Hlth Sci Inst, Paul D Coverdell Ctr, Athens, GA 30602 USA.	hdailey@uga.edu			National Institutes of Health [DK032303, GM62524]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032303, R56DK032303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062524, R37GM062524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK032303 (to H. A. D.) and GM62524 (to M. K. J.).	Al-Karadaghi S, 1997, STRUCTURE, V5, P1501, DOI 10.1016/S0969-2126(97)00299-2; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; BEERS RF, 1952, J BIOL CHEM, V195, P133; Boynton TO, 2009, BIOCHEMISTRY-US, V48, P6705, DOI 10.1021/bi900850y; Braz GRC, 1999, CURR BIOL, V9, P703, DOI 10.1016/S0960-9822(99)80312-1; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Che DS, 2006, NUCLEIC ACIDS RES, V34, P2418, DOI 10.1093/nar/gkl294; CHEESMAN MR, 1991, ADV INORG CHEM RAD, V36, P201; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Corrigall AV, 1998, ARCH BIOCHEM BIOPHYS, V358, P251, DOI 10.1006/abbi.1998.0834; Dailey H. A., 2003, PORPHYRIN HDB, V12, P93; Dailey HA, 1997, J BIOL INORG CHEM, V2, P411, DOI 10.1007/s007750050151; DAILEY HA, 1983, J BIOL CHEM, V258, P1453; Dailey HA, 1996, J BIOL CHEM, V271, P8714, DOI 10.1074/jbc.271.15.8714; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Dailey TA, 1996, PROTEIN SCI, V5, P98; Dailey TA, 2002, J BACTERIOL, V184, P2460, DOI 10.1128/JB.184.9.2460-2464.2002; Dailey TA, 1995, ARCH BIOCHEM BIOPHYS, V324, P379, DOI 10.1006/abbi.1995.0051; de Geus DC, 2009, J MOL BIOL, V387, P192, DOI 10.1016/j.jmb.2009.01.036; Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Finnegan MG, 1996, BBA-BIOENERGETICS, V1274, P9, DOI 10.1016/0005-2728(95)00155-7; Hagedoorn PL, 2002, EUR J BIOCHEM, V269, P4905, DOI 10.1046/j.1432-1033.2002.03208.x; HANSSON M, 1994, EUR J BIOCHEM, V220, P201, DOI 10.1111/j.1432-1033.1994.tb18615.x; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecerof D, 2000, J MOL BIOL, V297, P221, DOI 10.1006/jmbi.2000.3569; Loewen P, 1996, GENE, V179, P39, DOI 10.1016/S0378-1119(96)00321-6; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; MIYAMOTO K, 1991, J MOL BIOL, V219, P393, DOI 10.1016/0022-2836(91)90180-E; Najahi-Missaoui W, 2005, BLOOD, V106, P1098, DOI 10.1182/blood-2004-12-4661; NAKAHIGASHI K, 1991, P NATL ACAD SCI USA, V88, P10520, DOI 10.1073/pnas.88.23.10520; O'Brian MR, 2002, ADV MICROB PHYSIOL, V46, P257, DOI 10.1016/S0065-2911(02)46006-7; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; Qin XH, 2010, J STRUCT BIOL, V170, P76, DOI 10.1016/j.jsb.2009.11.012; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Roberts GP, 2005, J INORG BIOCHEM, V99, P280, DOI 10.1016/j.jinorgbio.2004.10.032; SASARMAN A, 1979, J GEN MICROBIOL, V113, P297, DOI 10.1099/00221287-113-2-297; Schlafli P, 2009, CELL MOL LIFE SCI, V66, P876, DOI 10.1007/s00018-009-8699-0; SHEMIN D, 1946, J BIOL CHEM, V166, P621; Shepherd M, 2005, ANAL BIOCHEM, V344, P115, DOI 10.1016/j.ab.2005.06.012; Spiro T, 2008, ACS CHEM BIOL, V3, P673, DOI 10.1021/cb800269h; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	52	54	56	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25978	25986		10.1074/jbc.M110.142604	http://dx.doi.org/10.1074/jbc.M110.142604			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20543190	Green Published, hybrid			2022-12-25	WOS:000280921000012
J	Kelly, SM; Leung, SW; Apponi, LH; Bramley, AM; Tran, EJ; Chekanova, JA; Wente, SR; Corbett, AH				Kelly, Seth M.; Leung, Sara W.; Apponi, Luciano H.; Bramley, Anna M.; Tran, Elizabeth J.; Chekanova, Julia A.; Wente, Susan R.; Corbett, Anita H.			Recognition of Polyadenosine RNA by the Zinc Finger Domain of Nuclear Poly(A) RNA-binding Protein 2 (Nab2) Is Required for Correct mRNA 3 '-End Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL LENGTH CONTROL; SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC FIBRILS; GENE-EXPRESSION; EXPORT; YEAST; BIOGENESIS; COMPLEX; DEFECTS; MEX67P	Proteins bound to the poly(A) tail of mRNA transcripts, called poly(A)-binding proteins (Pabs), play critical roles in regulating RNA stability, translation, and nuclear export. Like many mRNA-binding proteins that modulate post-transcriptional processing events, assigning specific functions to Pabs is challenging because these processing events are tightly coupled to one another. To investigate the role that a novel class of zinc finger-containing Pabs plays in these coupled processes, we defined the mode of polyadenosine RNA recognition for the conserved Saccharomyces cerevisiae Nab2 protein and assessed in vivo consequences caused by disruption of RNA binding. The polyadenosine RNA recognition domain of Nab2 consists of three tandem Cys-Cys-Cys-His (CCCH) zinc fingers. Cells expressing mutant Nab2 proteins with decreased binding to polyadenosine RNA show growth defects as well as defects in poly(A) tail length but do not accumulate poly(A) RNA in the nucleus. We also demonstrate genetic interactions between mutant nab2 alleles and mutant alleles of the mRNA 3'-end processing machinery. Together, these data provide strong evidence that Nab2 binding to RNA is critical for proper control of poly(A) tail length.	[Kelly, Seth M.; Leung, Sara W.; Bramley, Anna M.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Apponi, Luciano H.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Tran, Elizabeth J.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Chekanova, Julia A.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	Emory University; Emory University; Vanderbilt University; University of Missouri System; University of Missouri Kansas City	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Corbett, Anita/AAH-6106-2021; Apponi, Luciano H/A-4081-2013; Tran, Elizabeth/G-7818-2018	Corbett, Anita/0000-0002-0461-6895; Chekanova, Julia/0000-0002-2214-8896; Tran, Elizabeth/0000-0002-9541-004X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728, R01GM065442, R37GM051219] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058728, R01 GM065442, R37 GM051219] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams A, 1997, METHODS YEAST GENETI; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569; Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Buratowski S, 2005, NATURE, V435, P1174, DOI 10.1038/4351174b; Chekanova JA, 2003, RNA, V9, P1476, DOI 10.1261/rna.5128903; Dheur S, 2005, J BIOL CHEM, V280, P24532, DOI 10.1074/jbc.M504720200; Farny NG, 2008, GENE DEV, V22, P66, DOI 10.1101/gad.1616008; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; Fasken MB, 2009, RNA BIOL, V6, P237, DOI 10.4161/rna.6.3.8330; Grant RP, 2008, J MOL BIOL, V376, P1048, DOI 10.1016/j.jmb.2007.11.087; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Leung SW, 2009, GENE, V439, P71, DOI 10.1016/j.gene.2009.02.022; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; MINVIELLESEBASTIA L, 1991, MOL CELL BIOL, V11, P3075, DOI 10.1128/MCB.11.6.3075; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; PATEL D, 1992, MOL CELL BIOL, V12, P3297, DOI 10.1128/MCB.12.7.3297; Sambrook J., 2002, MOL CLONING LAB MANU; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; SIKORSKI RS, 1989, GENETICS, V122, P19; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Viphakone N, 2008, NUCLEIC ACIDS RES, V36, P2418, DOI 10.1093/nar/gkn080; WACH A, 1994, YEAST, V10, P1808; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Zanotti KJ, 2006, BIOCHEMISTRY-US, V45, P8319, DOI 10.1021/bi060209a	44	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26022	26032		10.1074/jbc.M110.141127	http://dx.doi.org/10.1074/jbc.M110.141127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554526	Green Published, hybrid			2022-12-25	WOS:000280921000017
J	Reed, T; Lushington, GH; Xia, Y; Hirakawa, H; Travis, DM; Mure, M; Scott, EE; Limburg, J				Reed, Timothy; Lushington, Gerald H.; Xia, Yan; Hirakawa, Hidehiko; Travis, DeAnna M.; Mure, Minae; Scott, Emily E.; Limburg, Julian			Crystal Structure of Histamine Dehydrogenase from Nocardioides simplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON TRANSFERRING FLAVOPROTEIN; TRIMETHYLAMINE DEHYDROGENASE; MOLECULAR-CLONING; WILD-TYPE; 3-DIMENSIONAL STRUCTURE; PROTEIN CRYSTALS; AMMONIUM LIGANDS; BINDING PROTEINS; RECEPTOR; FLAVIN	Histamine dehydrogenase (HADH) isolated from Nocardioides simplex catalyzes the oxidative deamination of histamine to imidazole acetaldehyde. HADH is highly specific for histamine, and we are interested in understanding the recognition mode of histamine in its active site. We describe the first crystal structure of a recombinant form of HADH (HADH) to 2.7-angstrom resolution. HADH is a homodimer, where each 76-kDa subunit contains an iron-sulfur cluster ([4Fe-4S](2+)) and a 6-S-cysteinyl flavin mononucleotide (6-S-Cys-FMN) as redox cofactors. The overall structure of HADH is very similar to that of trimethylamine dehydrogenase (TMADH) from Methylotrophus methylophilus (bacterium W3A1). However, some distinct differences between the structure of HADH and TMADH have been found. Tyr(60), Trp(264), and Trp(355) provide the framework for the "aromatic bowl" that serves as a trimethylamine-binding site in TMADH is comprised of Gln(65), Trp(267), and Asp(358), respectively, in HADH. The surface Tyr(442) that is essential in transferring electrons to electron-transfer flavoprotein (ETF) in TMADH is not conserved in HADH. We use this structure to propose the binding mode for histamine in the active site of HADH through molecular modeling and to compare the interactions to those observed for other histamine-binding proteins whose structures are known.	[Limburg, Julian] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Lushington, Gerald H.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Xia, Yan] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas		mmure@ku.edu; eescott@ku.edu	Lushington, Gerald/AAH-3205-2020; Lushington, Gerald/P-8421-2019; Hirakawa, Hidehiko/A-3089-2013	Lushington, Gerald/0000-0001-5821-4253; Hirakawa, Hidehiko/0000-0003-0623-8573	National Institutes of Health [5P20 RR17708, MCB-0747377, RR-017708 RPH]; National Science Foundation [MCB-0747377]; University of Kansas Center for Research; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; National Institute of General Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Kansas Center for Research; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20 RR17708 (to J. L., COBRE Center in Protein Structure and Function) and GM079446 (to J. L. and M. M.), National Science Foundation MCB-0747377 (to M. M.), and the University of Kansas Center for Research (to J. L. and M. M.).; We thank Scott Schreiber for assistance in protein purification. We thank reviewers for their constructive and valuable critiques to improve our manuscript. We also thank Masao Ikeda-Saito and Kunio Miki for critical reading and helpful discussion in revising the manuscript. Crystals were grown and initially screened using the facilities of the Protein Structure Laboratory core facility at The University of Kansas (supported by National Institutes of Health Grant RR-017708 RPH). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences.	Bao LL, 2002, ANAL CHEM, V74, P1144, DOI 10.1021/ac0106086; Basran J, 2000, BIOCHEMISTRY-US, V39, P9188, DOI 10.1021/bi0006868; Basran J, 1997, BIOCHEMISTRY-US, V36, P1989, DOI 10.1021/bi962623o; Basran J, 2001, J BIOL CHEM, V276, P42887, DOI 10.1074/jbc.M108296200; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BELLAMY HD, 1989, J BIOL CHEM, V264, P11887; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Burgess SG, 2008, BIOCHEMISTRY-US, V47, P5168, DOI 10.1021/bi800127d; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dietmann S, 2001, NAT STRUCT BIOL, V8, P953, DOI 10.1038/nsb1101-953; DIXON DA, 1979, BIOCHEMISTRY-US, V18, P5770, DOI 10.1021/bi00593a004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fournel A, 1998, J CHEM PHYS, V109, P10905, DOI 10.1063/1.477786; Fujieda N, 2004, BIOCHEMISTRY-US, V43, P10800, DOI 10.1021/bi049061q; FUKUI H, 1994, BIOCHEM BIOPH RES CO, V201, P894, DOI 10.1006/bbrc.1994.1786; GANTZ I, 1991, P NATL ACAD SCI USA, V88, P429, DOI 10.1073/pnas.88.2.429; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; HUANG LX, 1995, J BIOL CHEM, V270, P23958, DOI 10.1074/jbc.270.41.23958; Hubbard PA, 2003, J BIOL CHEM, V278, P37553, DOI 10.1074/jbc.M304642200; Iwaki S, 2002, ANAL BIOCHEM, V304, P236, DOI 10.1006/abio.2002.5598; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jang MH, 1999, J BIOL CHEM, V274, P13147, DOI 10.1074/jbc.274.19.13147; Jones M, 2002, J BIOL CHEM, V277, P8457, DOI 10.1074/jbc.M111105200; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; LIM LW, 1988, J BIOL CHEM, V263, P3075; LIM LW, 1986, J BIOL CHEM, V261, P5140; Limburg J, 2005, ARCH BIOCHEM BIOPHYS, V436, P8, DOI 10.1016/j.abb.2004.11.024; Loechel C, 2003, ANALYST, V128, P166, DOI 10.1039/b211895e; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mewies M, 1997, BIOCHEMISTRY-US, V36, P7162, DOI 10.1021/bi970621d; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2000, BIOCHEM BIOPH RES CO, V279, P615, DOI 10.1006/bbrc.2000.4008; PACE CP, 1991, ARCH BIOCHEM BIOPHYS, V287, P97, DOI 10.1016/0003-9861(91)90393-W; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; RAINE ARC, 1995, PROTEIN SCI, V4, P2625, DOI 10.1002/pro.5560041222; Rarey M, 1996, J COMPUT AID MOL DES, V10, P41, DOI 10.1007/BF00124464; Reed TM, 2008, ACTA CRYSTALLOGR F, V64, P785, DOI 10.1107/S1744309108023336; Roberts P, 1999, BIOCHEMISTRY-US, V38, P14927, DOI 10.1021/bi9914098; ROHLFS RJ, 1995, J BIOL CHEM, V270, P22196, DOI 10.1074/jbc.270.38.22196; Scrutton NS, 1996, BIOCHEM J, V319, P1; Shin N, 2002, MOL PHARMACOL, V62, P38, DOI 10.1124/mol.62.1.38; Siddiqui JA, 2000, FEMS MICROBIOL LETT, V189, P183, DOI 10.1016/S0378-1097(00)00277-9; STEENKAMP DJ, 1982, BIOCHEM J, V207, P241, DOI 10.1042/bj2070241; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Trickey P, 2000, BIOCHEMISTRY-US, V39, P7678, DOI 10.1021/bi9927181; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zheng YJ, 1996, J AM CHEM SOC, V118, P9402, DOI 10.1021/ja9608151	63	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25782	25791		10.1074/jbc.M109.084301	http://dx.doi.org/10.1074/jbc.M109.084301			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538584	Green Published, hybrid			2022-12-25	WOS:000280682400070
J	Imaizumi, N; Monnier, Y; Hegi, M; Mirimanoff, RO; Ruegg, C				Imaizumi, Natsuko; Monnier, Yan; Hegi, Monika; Mirimanoff, Rene-Olivier; Rueegg, Curzio			Radiotherapy Suppresses Angiogenesis in Mice through TGF-beta RI/ALK5-Dependent Inhibition of Endothelial Cell Sprouting	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; IONIZING-RADIATION; DEPENDENT KINASE; GENE-EXPRESSION; MAMMARY-GLAND; CYCLE ARREST; MOUSE SKIN; CANCER; METASTASIS	Background: Radiotherapy is widely used to treat cancer. While rapidly dividing cancer cells are naturally considered the main target of radiotherapy, emerging evidence indicates that radiotherapy also affects endothelial cell functions, and possibly also their angiogenic capacity. In spite of its clinical relevance, such putative anti-angiogenic effect of radiotherapy has not been thoroughly characterized. We have investigated the effect of ionizing radiation on angiogenesis using in vivo, ex vivo and in vitro experimental models in combination with genetic and pharmacological interventions. Principal Findings: Here we show that high doses ionizing radiation locally suppressed VEGF-and FGF-2-induced Matrigel plug angiogenesis in mice in vivo and prevented endothelial cell sprouting from mouse aortic rings following in vivo or ex vivo irradiation. Quiescent human endothelial cells exposed to ionizing radiation in vitro resisted apoptosis, demonstrated reduced sprouting, migration and proliferation capacities, showed enhanced adhesion to matrix proteins, and underwent premature senescence. Irradiation induced the expression of P53 and P21 proteins in endothelial cells, but p53 or p21 deficiency and P21 silencing did not prevent radiation-induced inhibition of sprouting or proliferation. Radiation induced Smad-2 phosphorylation in skin in vivo and in endothelial cells in vitro. Inhibition of the TGF-beta type I receptor ALK5 rescued deficient endothelial cell sprouting and migration but not proliferation in vitro and restored defective Matrigel plug angiogenesis in irradiated mice in vivo. ALK5 inhibition, however, did not rescue deficient proliferation. Notch signaling, known to hinder angiogenesis, was activated by radiation but its inhibition, alone or in combination with ALK5 inhibition, did not rescue suppressed proliferation. Conclusions: These results demonstrate that irradiation of quiescent endothelial cells suppresses subsequent angiogenesis and that ALK5 is a critical mediator of this suppression. These results extend our understanding of radiotherapy-induced endothelial dysfunctions, relevant to both therapeutic and unwanted effects of radiotherapy.	[Imaizumi, Natsuko; Monnier, Yan; Rueegg, Curzio] CHUV, CePO, Div Expt Oncol, Epalinges, Switzerland; [Imaizumi, Natsuko; Monnier, Yan; Hegi, Monika; Mirimanoff, Rene-Olivier; Rueegg, Curzio] Univ Lausanne, CH-1066 Epalinges, Switzerland; [Imaizumi, Natsuko; Monnier, Yan; Hegi, Monika; Rueegg, Curzio] ISREC EPFL, NCCR Mol Oncol, Epalinges, Switzerland; [Hegi, Monika] CHU Vaudois, Ctr Univ Romand Neurochirurg, Lab Brain Tumor Biol & Genet, Lausanne, Switzerland; [Mirimanoff, Rene-Olivier] CHU Vaudois, Dept Radiooncol, Lausanne, Switzerland; [Rueegg, Curzio] Univ Fribourg, Fac Sci, Dept Med, CH-1700 Fribourg, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Fribourg	Imaizumi, N (corresponding author), Diagnoplex SA, Lausanne, Switzerland.	curzio.ruegg@unifr.ch	Hegi, Monika/O-4796-2015	Hegi, Monika/0000-0003-0855-6495	National Center of Competence in Research (NCCR); Swiss National Science Foundation; Oncosuisse [CCRP-OCS-01812-12-2005]; MEDIC foundation	National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; MEDIC foundation	This work was funded by the Molecular Oncology Program of the National Center of Competence in Research (NCCR) of ISREC-EPFL, a research instrument of the Swiss National Science Foundation, a Collaborative Research Grant from Oncosuisse (CCRP-OCS-01812-12-2005), and the MEDIC foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Natsuko Imaizumi was not employed by Diagnoplex SA at the time the work was performed, and Diagnoplex did not contribute financially, scientifically or in any other way to this study.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Akhtar Nasim, 2002, Angiogenesis, V5, P75, DOI 10.1023/A:1021507031486; Allan DS, 2009, INT J RADIAT ONCOL, V75, P220, DOI 10.1016/j.ijrobp.2009.04.033; Arocho A, 2006, DIAGN MOL PATHOL, V15, P56, DOI 10.1097/00019606-200603000-00009; Balasubramaniam P, 1992, J Postgrad Med, V38, P8; Barcellos-Hoff MH, 2006, MUTAT RES-FUND MOL M, V597, P32, DOI 10.1016/j.mrfmmm.2005.09.008; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; BARCELLOSHOFF MH, 1993, CANCER RES, V53, P3880; BARTON M, 1995, INT J RADIAT ONCOL, V31, P371, DOI 10.1016/0360-3016(94)E0126-5; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Brown JM, 2008, INT J RADIAT ONCOL, V71, P324, DOI 10.1016/j.ijrobp.2008.02.003; Burdelya LG, 2006, CANCER RES, V66, P9356, DOI 10.1158/0008-5472.CAN-06-1223; Castanares C, 2007, J CELL SCI, V120, P1256, DOI 10.1242/jcs.03419; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Davis TA, 2008, INT J RADIAT BIOL, V84, P713, DOI 10.1080/09553000802317778; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; Dorresteijn LDA, 2005, EUR J CANCER, V41, P1026, DOI 10.1016/j.ejca.2005.01.020; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Fajardo LF, 2005, ACTA ONCOL, V44, P13, DOI 10.1080/02841860510007440; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Igrashi K, 2007, EXP CELL RES, V313, P3326, DOI 10.1016/j.yexcr.2007.06.001; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim IY, 2005, J BIOCHEM MOL BIOL, V38, P1; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Kuo LJ, 2008, IN VIVO, V22, P305; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Lyng FM, 2006, INT J RADIAT BIOL, V82, P393, DOI 10.1080/09553000600803904; Mallet C, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0494; Martin M, 1997, ONCOGENE, V15, P981, DOI 10.1038/sj.onc.1201433; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; NICOSIA RF, 1990, LAB INVEST, V63, P115; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Oh CW, 2001, RADIAT RES, V156, P232, DOI 10.1667/0033-7587(2001)156[0232:IOASLP]2.0.CO;2; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; PASSANITI A, 1992, LAB INVEST, V67, P519; Qu JF, 2004, J RADIAT RES, V45, P341, DOI 10.1269/jrr.45.341; RANDALL K, 1995, INT J RADIAT BIOL, V68, P301, DOI 10.1080/09553009514551231; Randall K, 1996, INT J RADIAT BIOL, V70, P351, DOI 10.1080/095530096145085; Rofstad EK, 2005, CANCER RES, V65, P2387, DOI 10.1158/0008-5472.CAN-04-3039; Rosen EM, 1999, CANCER INVEST, V17, P56; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Spyridopoulos I, 2002, BASIC RES CARDIOL, V97, P117, DOI 10.1007/s003950200001; SUIT HD, 1992, INT J RADIAT ONCOL, V23, P653, DOI 10.1016/0360-3016(92)90025-D; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Tetik O, 2008, VASCULAR, V16, P239, DOI 10.2310/6670.2008.00013; Vicini FA, 2003, CANCER, V97, P910, DOI 10.1002/cncr.11143; VIKRAM B, 1984, HEAD NECK SURG, V6, P730, DOI 10.1002/hed.2890060305; WORTHINGTON RE, 1987, EXP HEMATOL, V15, P85; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	70	55	56	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11084	10.1371/journal.pone.0011084	http://dx.doi.org/10.1371/journal.pone.0011084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552031	gold, Green Published, Green Submitted			2022-12-25	WOS:000278662900022
J	Ombetta, JE; Thelier, N; Dong, CZ; Plocki, S; Tsagris, L; Rannou, F; Massicot, F; Djimde, A; El-Hayek, E; Shi, YM; Heymans, F; Gresh, N; Chauvet, C				Ombetta, Jean-Edouard; Thelier, Natacha; Dong, Chang Zhi; Plocki, Stephanie; Tsagris, Lydia; Rannou, Francois; Massicot, France; Djimde, Atime; El-Hayek, Elissar; Shi, Yiming; Heymans, Francoise; Gresh, Nohad; Chauvet, Caroline			Design of Group IIA Secreted/Synovial Phospholipase A(2) Inhibitors: An Oxadiazolone Derivative Suppresses Chondrocyte Prostaglandin E-2 Secretion	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POLARIZABLE MOLECULAR-MECHANICS; RHEUMATOID-ARTHRITIS; SELECTIVE INHIBITOR; NITRIC-OXIDE; OSTEOARTHRITIS; 4,5-DIHYDRO-3-(4-TETRADECYLOXYBENZYL)-1,2,4-4H-OXADIAZOL-5-ONE; CYCLOOXYGENASE-2; QUANTITIES; EXPRESSION	Group IIA secreted/synovial phospholipase A(2) (GIIAPLA(2)) is an enzyme involved in the synthesis of eicosanoids such as prostaglandin E-2 (PGE(2)), the main eicosanoid contributing to pain and inflammation in rheumatic diseases. We designed, by molecular modeling, 7 novel analogs of 3-{4-[5(indol-1-yl)pentoxy]benzyl}-4H-1,2,4-oxadiazol-5-one, denoted C1, an inhibitor of the GIIAPLA(2) enzyme. We report the results of molecular dynamics studies of the complexes between these derivatives and GIIAPLA(2), along with their chemical synthesis and results from PLA(2) inhibition tests. Modeling predicted some derivatives to display greater GIIAPLA(2) affinities than did C1, and such predictions were confirmed by in vitro PLA(2) enzymatic tests. Compound C8, endowed with the most favorable energy balance, was shown experimentally to be the strongest GIIAPLA(2) inhibitor. Moreover, it displayed an anti-inflammatory activity on rabbit articular chondrocytes, as shown by its capacity to inhibit IL-1 beta-stimulated PGE(2) secretion in these cells. Interestingly, it did not modify the COX-1 to COX-2 ratio. C8 is therefore a potential candidate for anti-inflammatory therapy in joints.	[Ombetta, Jean-Edouard] Univ Tours, Fac Pharm, Chim Organ Lab, Tours, France; [Thelier, Natacha; Tsagris, Lydia; Rannou, Francois; El-Hayek, Elissar; Chauvet, Caroline] Univ Paris 05, UFR Biomed St Peres, INSERM,UMR S 747, Lab Pharmacol Toxicol & Signalisat Cellulaire, Paris, France; [Dong, Chang Zhi; Plocki, Stephanie; Djimde, Atime; Shi, Yiming; Heymans, Francoise] Univ Paris Diderot, CNRS, UMR7086, Equipe Pharmacochim,ITODYS, Paris, France; [Rannou, Francois] Hop Cochin, AP HP, Serv Reeducat, F-75674 Paris, France; [Massicot, France] Univ Paris 05, Fac Pharm, EA4463, Lab Chim Toxicol Analyt & Cellulaire, Paris, France; [Gresh, Nohad] Univ Paris 05, UFR Biomed St Peres, CNRS, Lab Chim & Biochim Pharmacol & Toxicol,UMR8601, Paris, France	Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Ombetta, JE (corresponding author), Univ Tours, Fac Pharm, Chim Organ Lab, Tours, France.	caroline.chauvet@parisdescartes.fr	Shi, Yi-Ming/S-2780-2019	Shi, Yi-Ming/0000-0001-6933-4971; Dong, Changzhi/0000-0001-7927-6306	INSERM; University Paris Descartes; Arthritis Foundation Courtin; Paris Centre University (Paris Descartes and Paris Diderot); Ligue Nationale Contre le Cancer; Assistance Publique-Hopitaux de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; Arthritis Foundation Courtin; Paris Centre University (Paris Descartes and Paris Diderot); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Assistance Publique-Hopitaux de Paris	Funding: This study was supported in part by INSERM, University Paris Descartes, Arthritis Foundation Courtin and a program of Paris Centre University (Paris Descartes and Paris Diderot). The authors thank the computer center CINES-Montpellier for computer time and technical support. The authors also thank the Ligue Nationale Contre le Cancer for support. NT was supported by Assistance Publique-Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Assogba L, 2005, EUR J MED CHEM, V40, P850, DOI 10.1016/j.ejmech.2005.03.027; BOMALASKI JS, 1991, J IMMUNOL, V146, P3904; Boukli L, 2008, BIOORGAN MED CHEM, V16, P1242, DOI 10.1016/j.bmc.2007.10.077; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley JD, 2005, J RHEUMATOL, V32, P417; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; DEHAEN W, 1991, J ORG CHEM, V56, P896, DOI 10.1021/jo00002a083; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dong CZ, 2005, BIOORGAN MED CHEM, V13, P1989, DOI 10.1016/j.bmc.2005.01.016; Dong CZ, 2002, BIOCHEM J, V365, P505, DOI 10.1042/BJ20011648; Evans CH, 1996, METHOD ENZYMOL, V269, P75; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Francois M, 2004, J BIOL CHEM, V279, P28411, DOI 10.1074/jbc.M312708200; FRASER H, 2009, VARESPLADIB A 002 SE; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; Gresh N, 2007, J CHEM THEORY COMPUT, V3, P1960, DOI 10.1021/ct700134r; HARA S, 1989, J BIOCHEM-TOKYO, V105, P395, DOI 10.1093/oxfordjournals.jbchem.a122675; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; LANGLET J, 1988, J PHYS CHEM-US, V92, P1617, DOI 10.1021/j100317a048; Lin MKS, 1996, J RHEUMATOL, V23, P1162; Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; MURAKAMI M, 1990, FEBS LETT, V268, P113, DOI 10.1016/0014-5793(90)80986-S; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; Plocki S, 2005, EUR J ORG CHEM, V2005, P2747, DOI 10.1002/ejoc.200400541; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; REKKER RF, 1979, EUR J MED CHEM, V14, P479; Roux C, 2007, J COMPUT CHEM, V28, P938, DOI 10.1002/jcc.20586; SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292; SEILHAMER JJ, 1989, J BIOCHEM, V106, P38, DOI 10.1093/oxfordjournals.jbchem.a122815; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P1378, DOI 10.1002/art.21887; Touaibia M, 2007, J MED CHEM, V50, P1618, DOI 10.1021/jm060082n; Zeiher BG, 2005, CRIT CARE MED, V33, P1741, DOI 10.1097/01.CCM.0000171540.54520.69	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10914	10.1371/journal.pone.0010914	http://dx.doi.org/10.1371/journal.pone.0010914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20531958	Green Published, gold, Green Submitted			2022-12-25	WOS:000278222400009
J	Bopp, SER; Ramachandran, V; Henson, K; Luzader, A; Lindstrom, M; Spooner, M; Steffy, BM; Suzuki, O; Janse, C; Waters, AP; Zhou, YY; Wiltshire, T; Winzeler, EA				Bopp, Selina E. R.; Ramachandran, Vandana; Henson, Kerstin; Luzader, Angelina; Lindstrom, Merle; Spooner, Muriel; Steffy, Brian M.; Suzuki, Oscar; Janse, Chris; Waters, Andrew P.; Zhou, Yingyao; Wiltshire, Tim; Winzeler, Elizabeth A.			Genome Wide Analysis of Inbred Mouse Lines Identifies a Locus Containing Ppar-gamma as Contributing to Enhanced Malaria Survival	PLOS ONE			English	Article							PYRUVATE-KINASE DEFICIENCY; CEREBRAL MALARIA; PLASMODIUM-BERGHEI; SUSCEPTIBILITY LOCUS; GENETIC-CONTROL; PARASITE SEQUESTRATION; POPULATION-STRUCTURE; NATURAL-SELECTION; MURINE MALARIA; MICE	The genetic background of a patient determines in part if a person develops a mild form of malaria and recovers, or develops a severe form and dies. We have used a mouse model to detect genes involved in the resistance or susceptibility to Plasmodium berghei malaria infection. To this end we first characterized 32 different mouse strains infected with P. berghei and identified survival as the best trait to discriminate between the strains. We found a locus on chromosome 6 by linking the survival phenotypes of the mouse strains to their genetic variations using genome wide analyses such as haplotype associated mapping and the efficient mixed-model for association. This new locus involved in malaria resistance contains only two genes and confirms the importance of Ppar-gamma in malaria infection.	[Bopp, Selina E. R.; Ramachandran, Vandana; Henson, Kerstin; Winzeler, Elizabeth A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Ramachandran, Vandana] Inst Med Biol, Singapore, Singapore; [Henson, Kerstin; Luzader, Angelina; Lindstrom, Merle; Spooner, Muriel; Zhou, Yingyao; Winzeler, Elizabeth A.] Novartis Fdn, Genom Inst, La Jolla, CA USA; [Steffy, Brian M.; Suzuki, Oscar; Wiltshire, Tim] Univ N Carolina, Sch Pharm, Dept Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Janse, Chris] Leiden Univ, Med Ctr, Leiden, Netherlands; [Waters, Andrew P.] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland	Scripps Research Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Novartis; University of North Carolina; University of North Carolina Chapel Hill; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow	Bopp, SER (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	selina@scripps.edu	Waters, Andy P/C-9377-2009; Winzeler, Elizabeth/AAP-6752-2020	Waters, Andy P/0000-0001-8900-2982; Winzeler, Elizabeth/0000-0002-4049-2113; Bopp, Selina/0000-0002-9412-9766; Janse, Chris J/0000-0002-6410-6205	W.M. Keck Foundation	W.M. Keck Foundation(W.M. Keck Foundation)	EAW was supported by the W.M. Keck Foundation (www.wmkeck.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Ayi K, 2008, NEW ENGL J MED, V358, P1805, DOI 10.1056/NEJMoa072464; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BERGHOUT J, 2009, GENES IMMUN; Boggild AK, 2009, CLIN INFECT DIS, V49, P841, DOI 10.1086/605431; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; Burt RA, 2002, INFECT IMMUN, V70, P4750, DOI 10.1128/IAI.70.8.4750-4753.2002; Burt RA, 1999, IMMUNOGENETICS, V50, P278, DOI 10.1007/s002510050603; Campino S, 2005, GENES IMMUN, V6, P416, DOI 10.1038/sj.gene.6364219; CORDEIRO RSB, 1983, ANN TROP MED PARASIT, V77, P455, DOI 10.1080/00034983.1983.11811739; CURFS JHAJ, 1989, CLIN EXP IMMUNOL, V75, P136; Elased KM, 2001, MOL GENET METAB, V73, P248, DOI 10.1006/mgme.2001.3186; ELING WMC, 1980, INFECT IMMUN, V30, P635; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Frodsham AJ, 2004, HUM MOL GENET, V13, pR187, DOI 10.1093/hmg/ddh225; Goncalves LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001874; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Hermsen C, 1997, PARASITOLOGY, V114, P7, DOI 10.1017/S0031182096008293; Hernandez-Valladares M, 2004, MAMM GENOME, V15, P390, DOI 10.1007/s00335-004-3042-4; Hernandez-Valladares M, 2004, IMMUNOGENETICS, V56, P115, DOI 10.1007/s00251-004-0667-0; JACOBS RL, 1967, T ROY SOC TROP MED H, V61, P273, DOI 10.1016/0035-9203(67)90170-8; Jeninga EH, 2009, TRENDS ENDOCRIN MET, V20, P380, DOI 10.1016/j.tem.2009.04.005; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; KAUL DK, 1994, AM J TROP MED HYG, V50, P512, DOI 10.4269/ajtmh.1994.50.512; Kort WJ, 1998, LAB ANIM-UK, V32, P260, DOI 10.1258/002367798780559329; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; McClelland S, 2009, PPAR RES, V2009, DOI 10.1155/2009/193413; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MILLER LH, 1969, AM J TROP MED HYG, V18, P860, DOI 10.4269/ajtmh.1969.18.860; MILLER LH, 1971, AM J TROP MED HYG, V20, P816, DOI 10.4269/ajtmh.1971.20.816; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Nagayasu E, 2002, INFECT IMMUN, V70, P512, DOI 10.1128/IAI.70.2.512-516.2002; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Ohno T, 2001, IMMUNOGENETICS, V53, P736, DOI 10.1007/s00251-001-0390-z; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Robert V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-81; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Serghides L, 2009, J INFECT DIS, V199, P1536, DOI 10.1086/598222; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STUNNENBERG HG, 1993, BIOESSAYS, V15, P309, DOI 10.1002/bies.950150504; Watanabe T, 2008, HEPATOL RES, V38, P441, DOI 10.1111/j.1872-034X.2007.00313.x; Wilairatana Polrat, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P203; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087	55	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10903	10.1371/journal.pone.0010903	http://dx.doi.org/10.1371/journal.pone.0010903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531941	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000278222100032
J	Buchy, P; Vong, S; Chu, S; Garcia, JM; Tran, TH; Vo, MH; Channa, M; Do, QH; Nguyen, VVC; Simmons, C; Farrar, JJ; Peiris, M; de Jong, MD				Buchy, Philippe; Vong, Sirenda; Chu, Simon; Garcia, Jean-Michel; Tran Tinh Hien; Vo Minh Hien; Channa, Mey; Do Quang Ha; Nguyen Van Vinh Chau; Simmons, Cameron; Farrar, Jeremy J.; Peiris, Malik; de Jong, Menno D.			Kinetics of Neutralizing Antibodies in Patients Naturally Infected by H5N1 Virus	PLOS ONE			English	Article							INFLUENZA-A H5N1; POULTRY WORKERS; LOW-FREQUENCY; TRANSMISSION; THAILAND	Background: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-infected patients with severe clinical illness or asymptomatic infection. Methods: Using H5N1 microneutralisation (MN) and H5-pseudotype particle-based microneutralisation assays (H5pp) we analyzed sera sequentially obtained from 11 severely ill patients diagnosed by RT-PCR (follow-up range 1-139 weeks of disease onset) and 31 asymptomatically infected individuals detected in a sero-epidemiological study after exposure to H5N1 virus (follow-up range: 1-2 month -11 months after exposure). Results: Of 44 sera from 11 patients with H5N1 disease, 70% tested positive by MN (antibody titre >= 80) after 2 weeks and 100% were positive by 3 weeks after disease onset. The geometric mean MN titers in severely ill patients were 540 at 1-2 months and 173 at 10-12 months and thus were higher than the titers from asymptomatic individuals (149 at 1-2 months, 62.2 at 10-12 months). Fractional polynomial regression analysis demonstrated that in all severely ill patients, positive titers persisted beyond 2 years of disease onset, while 10 of 23 sera collected 10-11 months after exposure in asymptomatically infected individuals tested negative. Conclusions: Our results indicate that people with asymptomatic H5N1 infection have lower H5N1 antibody titres compared to those with severe illness and that in many asymptomatically infected patients the antibody titer decreased to levels below the threshold of positivity within one year. These data are essential for the design and interpretation of sero-epidemiological studies.	[Buchy, Philippe; Vong, Sirenda; Chu, Simon; Channa, Mey] Inst Pasteur Cambodia, Phnom Penh, Cambodia; [Garcia, Jean-Michel; Peiris, Malik] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Tran Tinh Hien; Vo Minh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tran Tinh Hien; Vo Minh Hien; Do Quang Ha; Nguyen Van Vinh Chau; Simmons, Cameron; Farrar, Jeremy J.; de Jong, Menno D.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Peiris, Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; University of Hong Kong; University of Oxford; University of Hong Kong; University of Amsterdam; Academic Medical Center Amsterdam	Buchy, P (corresponding author), Inst Pasteur Cambodia, Phnom Penh, Cambodia.	pbuchy@pasteur-kh.org	Garcia, Jean-Michel/J-7166-2013; Simmons, Cameron P/ABA-3896-2021; Farrar, Jeremy J./HGA-7610-2022; Chu, Simon/AAJ-7802-2020	Garcia, Jean-Michel/0000-0002-6005-9982; Simmons, Cameron P/0000-0002-9039-7392; Chu, Simon/0000-0003-4658-215X; BUCHY, Philippe/0000-0003-1372-3008; Farrar, Jeremy/0000-0002-2700-623X	AFD; Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services; University Grants Committee, Hong Kong [AoE/M-12/06]; Wellcome Trust, UK	AFD; Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services; University Grants Committee, Hong Kong; Wellcome Trust, UK(Wellcome Trust)	This work was supported by a grant from the AFD (French Agency for Development, SISEA project, RESPARI program, http://www.pasteurinternational.org/ip/easysite/pasteur-international-en/scientific-activities/projects/all-our-projects/sisea), by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, by the Area of Excellence Scheme of the University Grants Committee, Hong Kong (Grant AoE/M-12/06), and by the Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Buchy P, 2009, EMERG INFECT DIS, V15, P1641, DOI 10.3201/eid1510.090115; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Garcia JM, 2010, J CLIN VIROL, V47, P29, DOI 10.1016/j.jcv.2009.10.009; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hinjoy S, 2008, EMERG INFECT DIS, V14, P499, DOI 10.3201/eid1403.070662; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; REED LJ, 1938, AM J HYG, V27; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Takano R, 2009, ARCH VIROL, V154, P677, DOI 10.1007/s00705-009-0353-5; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; *WHO, REC LAB PROC DET AV; World Health Organization, CUM NUMB CONF HUM CA	26	58	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10864	10.1371/journal.pone.0010864	http://dx.doi.org/10.1371/journal.pone.0010864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20532246	Green Published, gold			2022-12-25	WOS:000278221900014
J	Carlin, S; Khan, N; Ku, T; Longo, VA; Larson, SM; Smith-Jones, PM				Carlin, Sean; Khan, Nahida; Ku, Thomas; Longo, Valerie A.; Larson, Steve M.; Smith-Jones, Peter M.			Molecular Targeting of Carbonic Anhydrase IX in Mice with Hypoxic HT29 Colorectal Tumor Xenografts	PLOS ONE			English	Article							RADIOLABELED MONOCLONAL-ANTIBODIES; RENAL-CELL CARCINOMA; IN-VITRO; MODELING ANALYSIS; INTRINSIC MARKER; POOR-PROGNOSIS; SOLID TUMORS; LUNG-CANCER; NECK-CANCER; NUDE-MICE	Background: Carbonic anhydrase IX (CAIX) is a membrane spanning protein involved in the enzymatic regulation of tumor acid-base balance. CAIX has been shown to be elevated in a number of hypoxic tumor types. The purpose of this study was to determine the efficiency of intact and IgG fragments of cG250 to target CAIX in vivo in a hypoxic tumor model. Methodology/Principal Findings: Conventional biodistribution studies were performed with In-111-DO3A-cG250, In-111-DO3A-F(ab')(2)-cG250 and In-111-DO3A-Fab-cG250. Additional ex vivo analysis of the tumor was performed with markers for tumor hypoxia, blood perfusion and endogenous CAIX expression. All four data sets were digitally correlated to determine the optimal agent for determining hypoxia in a HT29 colon cancer xenograft. The HT29 human colorectal tumor xenografts show strong CAIX expression in hypoxic areas of poor blood perfusion. The intact IgG had an initial high focal uptake at the periphery of these hypoxic regions and penetration into the areas of highest CAIX expression over the 7-day study period. The lower molecular weight antibody fragments had a faster uptake into areas of high CAIX expression, but had a much lower absolute uptake at the optimal imaging times. Conclusions/Significance: For the clinical detection of hypoxia induced CAIX using cG250 antibody based agents, imaging with the intact IgG at 7 days post injection would allow for the most sensitive and accurate detection of CAIX.	[Carlin, Sean; Khan, Nahida; Ku, Thomas; Longo, Valerie A.; Larson, Steve M.; Smith-Jones, Peter M.] Mem Sloan Kettering Canc Serv, Dept Radiol, New York, NY 10021 USA; [Carlin, Sean] Mem Sloan Kettering Canc Serv, Dept Med Phys, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Carlin, S (corresponding author), Mem Sloan Kettering Canc Serv, Dept Radiol, New York, NY 10021 USA.	smithjop@mskcc.org		Carlin, Sean/0000-0002-5401-0648	National Institutes of Health [P01 CA033049, P01 CA115675, P50 CA086438]; Byrne Foundation; Geoffrey Beene Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P01CA033049, P01CA115675, P50CA086438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Byrne Foundation; Geoffrey Beene Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health grants P01 CA033049, P01 CA115675 and P50 CA086438. In addition Dr Carlin was funded in part by generous grants from the Byrne Foundation and the Geoffrey Beene Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCHEGGER F, 1983, J EXP MED, V158, P413, DOI 10.1084/jem.158.2.413; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Chrastina A, 2003, INT J CANCER, V105, P873, DOI 10.1002/ijc.11142; Colcher D, 1998, Q J NUCL MED, V42, P225; Divgi CR, 2007, LANCET ONCOL, V8, P304, DOI 10.1016/S1470-2045(07)70044-X; Driessen A, 2006, ANN SURG, V243, P334, DOI 10.1097/01.sla.0000201452.09591.f3; DVORAK HF, 1988, AM J PATHOL, V133, P95; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUJIMORI K, 1989, CANCER RES, V49, P5656; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; He FQ, 2008, CANCER RES, V68, P8597, DOI 10.1158/0008-5472.CAN-08-0677; Hussain SA, 2004, ONCOL REP, V11, P1005; Javela S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-1; JUWEID M, 1992, CANCER RES, V52, P5144; Kivela AJ, 2005, WORLD J GASTROENTERO, V11, P155, DOI 10.3748/wjg.v11.i2.155; Korkeila E, 2009, BRIT J CANCER, V100, P874, DOI 10.1038/sj.bjc.6604949; Koukourakis MI, 2001, CLIN CANCER RES, V7, P3399; Koukourakis MI, 2006, J CLIN ONCOL, V24, P727, DOI 10.1200/JCO.2005.02.7474; LAWRENTSCHUK N, 2009, UROL ONCOL; Li XF, 2007, CANCER RES, V67, P7646, DOI 10.1158/0008-5472.CAN-06-4353; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Loncaster JA, 2001, CANCER RES, V61, P6394; Pantuck AJ, 2003, CLIN CANCER RES, V9, P4641; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Potter C, 2004, CELL CYCLE, V3, P164; Saarnio J, 2001, J HEPATOL, V35, P643, DOI 10.1016/S0168-8278(01)00193-3; Said HM, 2007, RADIOTHER ONCOL, V83, P398, DOI 10.1016/j.radonc.2007.05.003; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Smith-Jones PM, 2000, CANCER RES, V60, P5237; Smith-Jones PM, 2004, METHOD ENZYMOL, V386, P262; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Wouters A, 2007, ONCOLOGIST, V12, P690, DOI 10.1634/theoncologist.12-6-690; Wykoff CC, 2000, CANCER RES, V60, P7075; YOKOTA T, 1992, CANCER RES, V52, P3402	37	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10857	10.1371/journal.pone.0010857	http://dx.doi.org/10.1371/journal.pone.0010857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523727	Green Submitted, Green Published, gold			2022-12-25	WOS:000278221900009
J	Lepesheva, GI; Hargrove, TY; Anderson, S; Kleshchenko, Y; Furtak, V; Wawrzak, Z; Villalta, F; Waterman, MR				Lepesheva, Galina I.; Hargrove, Tatiana Y.; Anderson, Spencer; Kleshchenko, Yuliya; Furtak, Vyacheslav; Wawrzak, Zdzislaw; Villalta, Fernando; Waterman, Michael R.			Structural Insights into Inhibition of Sterol 14 alpha-Demethylase in the Human Pathogen Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAGAS-DISEASE; CRYSTAL-STRUCTURES; POSACONAZOLE; KETOCONAZOLE; CYP51; KINETOPLASTIDA; EPIMASTIGOTES; BIOSYNTHESIS; EPIDEMIOLOGY; CHEMOTHERAPY	Trypanosoma cruzi causes Chagas disease (American trypanosomiasis), which threatens the lives of millions of people and remains incurable in its chronic stage. The antifungal drug posaconazole that blocks sterol biosynthesis in the parasite is the only compound entering clinical trials for the chronic form of this infection. Crystal structures of the drug target enzyme, Trypanosoma cruzi sterol 14 alpha-demethylase (CYP51), complexed with posaconazole, another antifungal agent fluconazole and an experimental inhibitor, (R)-4'-chloro-N-(1-(2,4-dichlorophenyl)-2-(1H-imid-azol-1-yl)ethyl)biphenyl-4-carboxamide (VNF), allow prediction of important chemical features that enhance the drug potencies. Combined with comparative analysis of inhibitor binding parameters, influence on the catalytic activity of the trypanosomal enzyme and its human counterpart, and their cellular effects at different stages of the Trypanosoma cruzi life cycle, the structural data provide a molecular background to CYP51 inhibition and azole resistance and enlighten the path for directed design of new, more potent and selective drugs to develop an efficient treatment for Chagas disease.	[Lepesheva, Galina I.; Waterman, Michael R.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Anderson, Spencer; Wawrzak, Zdzislaw] Northwestern Univ, Ctr Synchrotron Res, Life Sci Collaborat Access Team, Dept Biochem Mol Biol & Cell Biol, Argonne, IL 60439 USA; [Kleshchenko, Yuliya; Furtak, Vyacheslav; Villalta, Fernando] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Vanderbilt University; Northwestern University; Meharry Medical College	Lepesheva, GI (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 622 RRB,23rd Pierce, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu		Villalta, Fernando/0000-0002-6232-0574	National Institutes of Health [GM 067871, AI 080580]; American Heart Association [0535121N];  [DE-AC02-06CH11357];  [085P1000817]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI080580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health Grants GM 067871 (to M. R. W. and G. I. L.) and AI 080580 (to F. V.). This work was also supported by American Heart Association Grant 0535121N (to G. I. L.), and use of the Advanced Photon Source and Life Sciences Collaborative Access Team Sector 21 was supported by Grants DE-AC02-06CH11357 and 085P1000817.	Apt W, 1998, AM J TROP MED HYG, V59, P133, DOI 10.4269/ajtmh.1998.59.133; Araujo MSS, 2000, J ANTIMICROB CHEMOTH, V45, P819, DOI 10.1093/jac/45.6.819; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEACH DH, 1986, BIOCHEM BIOPH RES CO, V136, P851, DOI 10.1016/0006-291X(86)90410-9; Buckner FS, 1998, ANTIMICROB AGENTS CH, V42, P3245, DOI 10.1128/AAC.42.12.3245; de Souza Wanderley, 2009, Interdiscip Perspect Infect Dis, V2009, P642502, DOI 10.1155/2009/642502; DOCAMPO R, 1981, MOL BIOCHEM PARASIT, V3, P169, DOI 10.1016/0166-6851(81)90047-5; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueiredo RCBQ, 2004, PARASITOLOGY, V129, P431, DOI 10.1017/S0031182004005797; GHOMARI MJ, 1997, J PHYS ORG CHEM, V10, P669; Guevara P, 2005, J MED ENTOMOL, V42, P48, DOI 10.1603/0022-2585(2005)042[0048:EOFGIT]2.0.CO;2; Gonzalez-Granado LI, 2009, LANCET, V373, P2025, DOI 10.1016/S0140-6736(09)61110-7; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Konkle ME, 2009, J MED CHEM, V52, P2846, DOI 10.1021/jm801643b; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; LIMA MF, 1989, MOL BIOCHEM PARASIT, V33, P159, DOI 10.1016/0166-6851(89)90030-3; Madison AN, 2007, INFECT IMMUN, V75, P4780, DOI 10.1128/IAI.00557-07; Moreira DRM, 2009, CURR DRUG TARGETS, V10, P212; Mann PA, 2003, ANTIMICROB AGENTS CH, V47, P577, DOI 10.1128/AAC.47.2.577-581.2003; Molina J, 2000, ANTIMICROB AGENTS CH, V44, P150, DOI 10.1128/AAC.44.1.150-155.2000; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Nagappan V, 2007, CLIN INFECT DIS, V45, P1610, DOI 10.1086/523576; NEVA FA, 2007, CECIL MED EXPERT CON, pCH368; OTNINOWSKI Z, 1995, HKL MANUAL; Paulino M, 2005, MINI-REV MED CHEM, V5, P499, DOI 10.2174/1389557053765565; Pena-Diaz J, 2004, MOL BIOL CELL, V15, P1356, DOI 10.1091/mbc.E03-10-0720; Soares MBP, 2009, MEM I OSWALDO CRUZ, V104, P325, DOI 10.1590/S0074-02762009000900043; Petrikkos G, 2007, INT J ANTIMICROB AG, V30, P108, DOI 10.1016/j.ijantimicag.2007.03.009; POULOS TL, 2005, CYTOCHROME P450 STRU; Quinones W, 2004, EXP PARASITOL, V106, P135, DOI 10.1016/j.exppara.2004.03.006; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Schiller DS, 2007, CLIN THER, V29, P1862, DOI 10.1016/j.clinthera.2007.09.015; Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Soeiro MNC, 2009, EXPERT OPIN THER TAR, V13, P105, DOI [10.1517/14728220802623881, 10.1517/14728220802623881 ]; Stramer S. L., 2007, Morbidity and Mortality Weekly Report, V56, P141; URBINA JA, 1988, ANTIMICROB AGENTS CH, V32, P1237, DOI 10.1128/AAC.32.8.1237; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; VILLALTA F, 1982, J PROTOZOOL, V29, P570, DOI 10.1111/j.1550-7408.1982.tb01338.x; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Zonios DI, 2008, SEMIN RESP CRIT CARE, V29, P198, DOI 10.1055/s-2008-1063858	46	115	117	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25582	25590		10.1074/jbc.M110.133215	http://dx.doi.org/10.1074/jbc.M110.133215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530488	Green Published, hybrid			2022-12-25	WOS:000280682400052
J	Guo, YJ; Golebiewska, U; D'Amico, S; Scarlata, S				Guo, Yuanjian; Golebiewska, Urszula; D'Amico, Stephen; Scarlata, Suzanne			The Small G Protein Rac1 Activates Phospholipase C delta 1 through Phospholipase C beta 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; GTP-BINDING PROTEIN; C-BETA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEMBRANE INTERACTIONS; COUPLED-RECEPTOR; ASSOCIATION; STIMULATION; DELTA; PURIFICATION	Rac1, which is associated with cytoskeletal pathways, can activate phospholipase C beta 2 (PLC beta 2) to increase intracellular Ca2+ levels. This increased Ca2+ can in turn activate the very robust PLC delta 1 to synergize Ca2+ signals. Wehave previously found that PLC beta 2 will bind to and inhibit PLC delta 1 in solution by an unknown mechanism and that PLC beta 2 center dot PLC delta 1 complexes can be disrupted by G beta gamma subunits. However, because the major populations of PLC beta 2 and PLC delta 1 are cytosolic, their regulation by G beta gamma subunits is not clear. Here, we have found that the pleckstrin homology (PH) domains of PLC beta 2 and PLC beta 3 are the regions that result in PLC delta 1 binding and inhibition. In cells, PLC beta 2 center dot PLC delta 1 form complexes as seen by Forster resonance energy transfer and co-immunoprecipitation, and microinjection of PH beta 2 dissociates the complex. Using PH beta 2 as a tool to assess the contribution of PLC delta inhibition of PLC delta 1 to Ca2+ release, we found that, although PH beta 2 only results in a 25% inhibition of PLC delta 1 in solution, in cells the presence of PH beta 2 appears to eliminates Ca2+ release suggesting a large threshold effect. Wefound that the small plasma membrane population of PLC beta 2 center dot PLC delta 1 is disrupted by activation of heterotrimeric G proteins, and that the major cytosolic population of the complexes are disrupted by Rac1 activation. Thus, the activity of PLC delta 1 is controlled by the amount of bound PLC beta 2 that changes with displacement of the enzyme by heterotrimeric or smallGproteins. Through PLC beta 2, PLC delta 1 activation is linked to surface receptors as well as signals that mediate cytoskeletal pathways.	SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Golebiewska, Urszula] Queensboro Community Coll, Dept Biol Sci & Geol, Bayside, NY 11364 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook		Suzanne.Scarlata@stonybrook.edu			National Institutes of Health [GM053132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053132.	Allen WE, 1997, J CELL SCI, V110, P707; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Ghosh Mousumi, 2003, V237, P55; Golebiewska U, 2008, BIOPHYS J, V95, P2575, DOI 10.1529/biophysj.108.129353; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Guo YJ, 2003, J BIOL CHEM, V278, P29995, DOI 10.1074/jbc.M301438200; Hardoy MC, 2006, J CLIN PSYCHOPHARM, V26, P379, DOI 10.1097/01.jcp.0000229483.52955.ec; Hodson EAM, 1998, BBA-MOL CELL RES, V1403, P97, DOI 10.1016/S0167-4889(98)00028-7; HOMMA Y, 1995, EMBO J, V14, P286, DOI 10.1002/j.1460-2075.1995.tb07002.x; HOMMA Y, 1989, BIOCHEM BIOPH RES CO, V164, P406, DOI 10.1016/0006-291X(89)91734-8; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; JHON DY, 1993, J BIOL CHEM, V268, P6654; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Lee SB, 1996, BLOOD, V88, P1684; Nagano K, 1999, J BIOL CHEM, V274, P2872, DOI 10.1074/jbc.274.5.2872; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Scarlata S, 2002, METHOD ENZYMOL, V345, P306; Schmidt M, 2000, J BIOL CHEM, V275, P32603, DOI 10.1074/jbc.M004784200; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tall EG, 2000, CURR BIOL, V10, P743, DOI 10.1016/S0960-9822(00)00541-8; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; Wang TL, 1999, BIOCHEMISTRY-US, V38, P1517, DOI 10.1021/bi982008f	39	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24999	25008		10.1074/jbc.M110.132654	http://dx.doi.org/10.1074/jbc.M110.132654			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530480	Green Published, hybrid			2022-12-25	WOS:000280542100072
J	Yousef, AF; Fonseca, GJ; Pelka, P; Ablack, JNG; Walsh, C; Dick, FA; Bazett-Jones, DP; Shaw, GS; Mymryk, JS				Yousef, A. F.; Fonseca, G. J.; Pelka, P.; Ablack, J. N. G.; Walsh, C.; Dick, F. A.; Bazett-Jones, D. P.; Shaw, G. S.; Mymryk, J. S.			Identification of a molecular recognition feature in the E1A oncoprotein that binds the SUMO conjugase UBC9 and likely interferes with polySUMOylation	ONCOGENE			English	Article						E1A; UBC9; SUMO; adenovirus	PML NUCLEAR-BODIES; UBIQUITIN LIGASE; SEQUENCE-ANALYSIS; ADENOVIRUS E1A; PROTEIN; YEAST; MOTIF; RNF4; TRANSFORMATION; SUMOYLATION	Hub proteins have central roles in regulating cellular processes. By targeting a single cellular hub, a viral oncogene may gain control over an entire module in the cellular interaction network that is potentially comprised of hundreds of proteins. The adenovirus E1A oncoprotein is a viral hub that interacts with many cellular hub proteins by short linear motifs/molecular recognition features (MoRFs). These interactions transform the architecture of the cellular protein interaction network and virtually reprogram the cell. To identify additional MoRFs within E1A, we screened portions of E1A for their ability to activate yeast pseudohyphal growth or differentiation. This identified a novel functional region within E1A conserved region 2 comprised of the sequence EVIDLT. This MoRF is necessary and sufficient to bind the N-terminal region of the SUMO conjugase UBC9, which also interacts with SUMO noncovalently and is involved in polySUMOylation. Our results suggest that E1A interferes with polySUMOylation, but not with monoSUMOylation. These data provide the first insight into the consequences of the interaction of E1A with UBC9, which was initially described in 1996. We further demonstrate that polySUMOylation regulates pseudohyphal growth and promyelocytic leukemia body reorganization by E1A. In conclusion, the interaction of the E1A oncogene with UBC9 mimics the normal binding between SUMO and UBC9 and represents a novel mechanism to modulate polySUMOylation. Oncogene (2010) 29, 4693-4704; doi:10.1038/onc.2010.226; published online 14 June 2010	[Yousef, A. F.; Fonseca, G. J.; Ablack, J. N. G.; Walsh, C.; Mymryk, J. S.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 4L6, Canada; [Pelka, P.; Dick, F. A.; Mymryk, J. S.] Univ Western Ontario, Dept Oncol, London Reg Canc Program, London, ON N6A 4L6, Canada; [Dick, F. A.; Shaw, G. S.] Univ Western Ontario, Dept Biochem, London, ON N6A 4L6, Canada; [Bazett-Jones, D. P.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Mymryk, JS (corresponding author), Univ Western Ontario, Dept Microbiol, London Reg Canc Program, 790 Commissioners Rd E, London, ON N6A 4L6, Canada.	jmymryk@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625; Yousef, Ahmed F./0000-0001-5734-489X	Canadian Institutes of Health Research [MOP-75647]; OGS award; OGSST award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); OGS award; OGSST award	This work was supported by a grant from the Canadian Institutes of Health Research to JSM (MOP-75647). AFY and PP were supported by CIHR Strategic Training Program in Cancer Research and Technology Transfer awards. GJF and JNA held OGS and OGSST awards. We thank Drs C Brandl, R Hay, J Taylor, K Uzunova, J Dohmen, A Strunnikov, G Fink, E Yeh and O Janne for generously providing reagents essential for this study.	Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Avvakumov N, 2004, VIROLOGY, V329, P477, DOI 10.1016/j.virol.2004.08.007; Avvakumov N, 2002, J VIROL, V76, P7968, DOI 10.1128/JVI.76.16.7968-7975.2002; BAYLEY ST, 1994, INT J ONCOL, V5, P425; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dunnebier T, 2009, INT J CANCER, V125, P596, DOI 10.1002/ijc.24286; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hateboer G, 1996, J BIOL CHEM, V271, P25906, DOI 10.1074/jbc.271.42.25906; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Mullen JR, 2008, J BIOL CHEM, V283, P19912, DOI 10.1074/jbc.M802690200; Mymryk JS, 1997, BIOCHEM CELL BIOL, V75, P95, DOI 10.1139/bcb-75-2-95; O'Connor MJ, 1999, J VIROL, V73, P3574; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; Sekiyama N, 2010, PROTEINS, V78, P1491, DOI 10.1002/prot.22667; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; TRENTIN JJ, 1962, SCIENCE, V137, P835, DOI 10.1126/science.137.3533.835; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yousef AF, 2008, INT J CANCER, V122, P942, DOI 10.1002/ijc.23174; Zhang ZY, 2001, MOL BIOL CELL, V12, P699, DOI 10.1091/mbc.12.3.699; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459	58	24	26	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	33					4693	4704		10.1038/onc.2010.226	http://dx.doi.org/10.1038/onc.2010.226			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20543865				2022-12-25	WOS:000281127400008
J	Kravets, A; Qin, H; Ahmad, A; Bethlendy, G; Gao, QS; Rustchenko, E				Kravets, Anatoliy; Qin, Hong; Ahmad, Ausaf; Bethlendy, Gabor; Gao, Qinshan; Rustchenko, Elena			Widespread Occurrence of Dosage Compensation in Candida albicans	PLOS ONE			English	Article							ANEUPLOIDY; MECHANISM; MUTANTS; STRAINS	The important human pathogen Candida albicans possesses an unusual form of gene regulation, in which the copy number of an entire specific chromosome or a large portion of a specific chromosome changes in response to a specific adverse environment, thus, insuring survival. In the absence of the adverse environment, the altered portion of the genome can be restored to its normal condition. One major question is how C. albicans copes with gene imbalance arising by transitory aneuploid states. Here, we compared transcriptomes from cells with either two copies or one copy of chromosome 5 (Ch5) in, respectively, a diploid strain 3153A and its representative derivative Sor55. Statistical analyses revealed that at least 40% of transcripts from the monosomic Ch5 are fully compensated to a disomic level, thus, indicating the existence of a genome-wide mechanism maintaining cellular homeostasis. Only approximately 15% of transcripts were diminished twofold in accordance with what would be expected for Ch5 monosomy. Another minor portion of approximately 6% of transcripts, unexpectedly, increased up to twofold and higher than the disomic level, demonstrating indirect control by monosomy. Array comparative genome hybridization revealed that only few out of approximately 500 genes on the monosomic Ch5b were duplicated, thus, not causing a global up regulation. Dosage compensation was confirmed with several representative genes from another monosomic Ch5a in the mutant Sor60. We suggest that C. albicans's unusual regulation of gene expression by the loss and gain of entire chromosomes is coupled with widespread compensation of gene dosage at the transcriptional level.	[Kravets, Anatoliy; Ahmad, Ausaf; Rustchenko, Elena] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Qin, Hong] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA; [Bethlendy, Gabor] Roche Diagnost Corp, Indianapolis, IN USA; [Gao, Qinshan] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA	University of Rochester; Spelman College; Roche Holding; Icahn School of Medicine at Mount Sinai	Kravets, A (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	elena_bulgac@urmc.rochester.edu	Ahmad, Ausaf/T-3014-2019; Ahmad, Ausaf/AAR-6733-2020	Ahmad, Ausaf/0000-0002-5029-9536	National Institutes of Health [AI29433]; Pfizer Global Pharmaceuticals, Pfizer Inc.; University of Rochester;  [P30 AG18254]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG018254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Global Pharmaceuticals, Pfizer Inc.(Pfizer); University of Rochester; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant AI29433 and Pfizer Global Pharmaceuticals, Pfizer Inc. to Fred Sherman, as well as partially supported by P30 AG18254 to Hong Qin. The authors are grateful to the University of Rochester funds that enabled this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, YEAST, V25, P433, DOI 10.1002/yea.1597; Arnold AP, 2008, ANNU REV GENOM HUM G, V9, P109, DOI 10.1146/annurev.genom.9.081307.164220; Bell O, 2008, MOL CELL BIOL, V28, P3401, DOI 10.1128/MCB.00006-08; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; Dementyeva EV, 2009, BIOESSAYS, V31, P21, DOI 10.1002/bies.080149; Ding Yongzeng, 2007, J Biomol Tech, V18, P321; Epstein C.J, 1986, CONSEQUENCES CHROMOS; Graves Jennifer A Marshall, 2007, J Biol, V6, P1; Greenberg JR, 2005, YEAST, V22, P957, DOI 10.1002/yea.1282; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Kabir MA, 2005, GENE, V345, P279, DOI 10.1016/j.gene.2004.11.029; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; LIM WK, 2007, BIOINFORMATICS; Makarevitch I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-7; Melamed E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r202; Patalano S, 2009, DEVELOPMENT, V136, P689, DOI 10.1242/dev.027656; Perepnikhatka V, 1999, J BACTERIOL, V181, P4041, DOI 10.1128/JB.181.13.4041-4049.1999; Phillips JL, 2001, CANCER RES, V61, P8143; Platzer P, 2002, CANCER RES, V62, P1134; RUSTCHENKO E, 2003, RECENT RES DEV BACTE, P91; Rustchenko E, 2007, FEMS YEAST RES, V7, P2, DOI 10.1111/j.1567-1364.2006.00150.x; RUSTCHENKO EP, 1993, J BACTERIOL, V175, P7189, DOI 10.1128/JB.175.22.7189-7199.1993; Rustchfnko Elena, 2008, P197; Serazin-Leroy V, 1998, MOL CELL PROBE, V12, P283, DOI 10.1006/mcpr.1998.0182; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210	29	13	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e10856	10.1371/journal.pone.0010856	http://dx.doi.org/10.1371/journal.pone.0010856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552010	Green Published, gold, Green Submitted			2022-12-25	WOS:000278662900001
J	Savy, M; Hennig, BJ; Doherty, CP; Fulford, AJ; Bailey, R; Holland, MJ; Sirugo, G; Rockett, KA; Kwiatkowski, DP; Prentice, AM; Cox, SE				Savy, Mathilde; Hennig, Branwen J.; Doherty, Conor P.; Fulford, Anthony J.; Bailey, Robin; Holland, Martin J.; Sirugo, Giorgio; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Prentice, Andrew M.; Cox, Sharon E.			Haptoglobin and Sickle Cell Polymorphisms and Risk of Active Trachoma in Gambian Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; HEMOGLOBIN SCAVENGER RECEPTOR; GENETIC SUSCEPTIBILITY; CHLAMYDIA-PNEUMONIAE; INFECTIOUS-DISEASES; ENDEMIC POPULATION; SCARRING TRACHOMA; IRON RESTRICTION; SEX-DIFFERENCES; 2-2 PHENOTYPE	Background: Susceptibility and resistance to trachoma, the leading infectious cause of blindness, have been associated with a range of host genetic factors. In vitro studies of the causative organism, Chlamydia trachomatis, demonstrate that iron availability regulates its growth, suggesting that host genes involved in regulating iron status and/or availability may modulate the risk of trachoma. The objective was to investigate whether haptoglobin (Hp) haplotypes constructed from the functional polymorphism (Hp1/Hp2) plus the functional promoter SNPs-61A-C (rs5471) and-101C-G (rs5470), or sickle cell trait (HbAS, rs334) were associated with risk of active trachoma when stratified by age and sex, in rural Gambian children. Methodology and Principal Findings: In two cross sectional surveys of children aged 6-78 months (n = 836), the prevalence of the clinical signs of active trachoma was 21.4%. Within boys, haplotype E (-101G, -61A, Hp1), containing the variant allele of the -101C-G promoter SNP, was associated with a two-fold increased risk of active trachoma (OR = 2.0 [1.17-3.44]). Within girls, an opposite association was non-significant (OR = 0.58 [0.32-1.04]; P = 0.07) and the interaction by sex was statistically significant (P = 0.001). There was no association between trachoma and HbAS. Conclusions: These data indicate that genetic variation in Hp may affect susceptibility to active trachoma differentially by sex in The Gambia.	[Savy, Mathilde; Hennig, Branwen J.; Fulford, Anthony J.; Prentice, Andrew M.; Cox, Sharon E.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1, England; [Doherty, Conor P.; Bailey, Robin; Holland, Martin J.; Sirugo, Giorgio] MRC Labs, Fajara, Gambia; [Bailey, Robin; Holland, Martin J.] London Sch Hyg & Trop Med, Dept Infect Trop Dis, London WC1, England; [Sirugo, Giorgio] San Pietro Hosp, Dept Med Genet, Rome, Italy; [Rockett, Kirk A.; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Malaria Programme, Hinxton, England	University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute	Savy, M (corresponding author), London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1, England.	Sharon.Cox@lshtm.ac.uk	Hennig, Branwen/M-6444-2014; Prentice, Andrew/AAG-1961-2019; Cox, Sharon E/ABA-7986-2020; Sirugo, Giorgio/N-9056-2019; Holland, Martin J/K-6502-2012; Sirugo, Giorgio/L-1628-2016	Cox, Sharon E/0000-0002-9908-2936; Holland, Martin J/0000-0002-5828-6318; Kwiatkowski, Dominic/0000-0002-5023-0176; Savy, Mathilde/0000-0003-0562-9601; Hennig, Branwen J./0000-0003-4127-8386	Medical Research Council, UK; MRC [MC_U123292699, G19/9, MC_U123292700] Funding Source: UKRI; Medical Research Council [G19/9, G0600718B, MC_U123292699, MC_U123292700] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou A, 2007, BRIT J OPHTHALMOL, V91, P13, DOI 10.1136/bjo.2006.099507; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Al-Younes HM, 2001, CELL MICROBIOL, V3, P427, DOI 10.1046/j.1462-5822.2001.00125.x; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Arredouani M, 2003, IMMUNOLOGY, V108, P144, DOI 10.1046/j.1365-2567.2003.01569.x; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; Atik B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003600; Atkinson SH, 2006, PLOS MED, V3, P652, DOI 10.1371/journal.pmed.0030172; Atkinson SH, 2007, CLIN INFECT DIS, V44, P802, DOI 10.1086/511868; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; CLAYTON D, SNPHAP PROGRAM ESTIM; Clementi M, 2006, REPROD TOXICOL, V21, P345, DOI 10.1016/j.reprotox.2005.08.006; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; Conway DJ, 1996, J INFECT DIS, V174, P643, DOI 10.1093/infdis/174.3.643; Courtright P, 2004, EMERG INFECT DIS, V10, P2012, DOI 10.3201/eid1011.040353; COX SE, 2008, TROP MED INT HLTH; Cox SE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000362; Delanghe JR, 2007, CLIN CHEM, V53, P1397, DOI 10.1373/clinchem.2007.088658; Delanghe JR, 1998, AIDS, V12, P1027, DOI 10.1097/00002030-199809000-00009; Elagib AA, 1998, T ROY SOC TROP MED H, V92, P309, DOI 10.1016/S0035-9203(98)91025-2; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Freidank HM, 2001, J MED MICROBIOL, V50, P223, DOI 10.1099/0022-1317-50-3-223; Friis T, 2003, JAIDS-J ACQ IMM DEF, V33, P74, DOI 10.1097/00126334-200305010-00011; Gambhir M, 2007, LANCET INFECT DIS, V7, P420, DOI 10.1016/S1473-3099(07)70137-8; GRANT DJ, 1993, AM J HUM GENET, V52, P974; GUETTA J, 2006, ATHEROSCLEROSIS; Harding-Esch EM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000573; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; *INT TRACH IN, 2006, ANN REP 2006; Jallow M, 2009, NAT GENET; Kasvosve I, 2002, CLIN CHEM LAB MED, V40, P810, DOI 10.1515/CCLM.2002.140; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Koch W, 2003, CLIN CHEM, V49, P1937, DOI 10.1373/clinchem.2003.022442; Koch W, 2002, CLIN CHEM, V48, P1377; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Langlois M, 1997, EUR J CLIN CHEM CLIN, V35, P199; Langlois MR, 2000, CLIN CHEM, V46, P1619; Larue RW, 2007, INFECT IMMUN, V75, P2374, DOI 10.1128/IAI.01465-06; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Minang JT, 2004, ACTA TROP, V90, P107, DOI 10.1016/j.actatropica.2003.10.016; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Mozzato-Chamay N, 2000, J INFECT DIS, V182, P1545, DOI 10.1086/315891; Mustafa S, 2004, DIABETES CARE, V27, P2103, DOI 10.2337/diacare.27.9.2103; Natividad A, 2007, GENES IMMUN, V8, P288, DOI 10.1038/sj.gene.6364384; Natividad A, 2005, GENES IMMUN, V6, P332, DOI 10.1038/sj.gene.6364182; Natividad A, 2008, HUM MOL GENET, V17, P323, DOI 10.1093/hmg/ddm310; Natividad A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-138; Okazaki T, 1997, CLIN CHEM, V43, P2012; Quaye IK, 2006, J ATHEROSCLER THROMB, V13, P90, DOI 10.5551/jat.13.90; Quaye IKE, 2000, HUM HERED, V50, P382, DOI 10.1159/000022944; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Raulston JE, 1997, INFECT IMMUN, V65, P4539, DOI 10.1128/IAI.65.11.4539-4547.1997; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SINGH IP, 1986, HUM HERED, V36, P31, DOI 10.1159/000153596; Sirugo G, 2004, NAT GENET, V36, P785, DOI 10.1038/ng0804-785; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Teye K, 2003, CLIN GENET, V64, P439, DOI 10.1034/j.1399-0004.2003.00149.x; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; vanOoij C, 1997, INFECT IMMUN, V65, P758, DOI 10.1128/IAI.65.2.758-766.1997; WARD M, 1990, SCAND J INFECT DIS, P137; West S K, 2001, Ophthalmic Epidemiol, V8, P137, DOI 10.1076/opep.8.2.137.4158; Wieringa FT, 2007, BRIT J NUTR, V98, P1070, DOI 10.1017/S0007114507756945; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	67	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11075	10.1371/journal.pone.0011075	http://dx.doi.org/10.1371/journal.pone.0011075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552021	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000278662900015
J	Zhang, SF; Wei, JN; Guo, XJ; Liu, TX; Kang, L				Zhang, Sufang; Wei, Jianing; Guo, Xiaojiao; Liu, Tong-Xian; Kang, Le			Functional Synchronization of Biological Rhythms in a Tritrophic System	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; PLANT VOLATILES; SOCIAL SYNCHRONIZATION; EMERGENCE RHYTHM; PARASITIC WASP; BEAN-PLANTS; LIGHT; CLOCK; HOST; EMISSIONS	In a tritrophic system formed by a plant, an herbivore and a natural enemy, each component has its own biological rhythm. However, the rhythm correlations among the three levels and the underlying mechanisms in any tritrophic system are largely unknown. Here, we report that the rhythms exhibited bidirectional correlations in a model tritrophic system involving a lima bean, a pea leafminer and a parasitoid. From the bottom-up perspective, the rhythm was initiated from herbivore feeding, which triggered the rhythms of volatile emissions; then the rhythmic pattern of parasitoid activities was affected, and these rhythms were synchronized by a light switch signal. Increased volatile concentration can enhance the intensity of parasitoid locomotion and oviposition only under light. From the top-down perspective, naive and oviposition-experienced parasitoids were able to utilize the different volatile rhythm information from the damaged plant to locate host leafminers respectively. Our results indicated that the three interacting organisms in this system can achieve rhythmic functional synchronization under a natural light-dark photoperiod, but not under constant light or darkness. These findings provide new insight into the rhythm synchronization of three key players that contribute to the utilization of light and chemical signals, and our results may be used as potential approaches for manipulating natural enemies.	[Zhang, Sufang; Wei, Jianing; Guo, Xiaojiao; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Zhang, Sufang] Univ Sci & Technol China, Coll Life Sci, Hefei 230026, Peoples R China; [Liu, Tong-Xian] NW A&F Univ, Key Lab Appl Entomol, Yangling, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Northwest A&F University - China	Zhang, SF (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	lkang@ioz.ac.cn	Wei, Jianing/L-7575-2019; Kang, Le/ABD-1116-2022	Wei, Jianing/0000-0002-8517-2164; Kang, Le/0000-0003-4262-2329	National Basic Research Program of China (973 Program) [2006CB102006, 2006CB102002X]; Chinese Academy of Sciences [KSCX2-YW-N-006]; National Nature Science Foundation of China [30670356, 30621003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Basic Research Program of China (973 Program) (No. 2006CB102006 and 2006CB102002X), the Chinese Academy of Sciences (Project No: KSCX2-YW-N-006), and the National Nature Science Foundation of China (30670356 and 30621003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEMAND R, 1994, PHYSIOL ENTOMOL, V19, P1, DOI 10.1111/j.1365-3032.1994.tb01067.x; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Arimura GI, 2008, PLANT PHYSIOL, V146, P965, DOI 10.1104/pp.107.111088; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; CROWLEY M, 1980, BEHAV ECOL SOCIOBIOL, V7, P99, DOI 10.1007/BF00299514; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; EDMONDS SC, 1977, PHYSIOL BEHAV, V18, P915, DOI 10.1016/0031-9384(77)90201-3; ENGELMAN.W, 1966, EXPERIENTIA, V22, P606, DOI 10.1007/BF01895281; Fantinou AA, 1998, BIOCONTROL, V43, P141, DOI 10.1023/A:1009984318289; Goldbeter A, 2008, CURR BIOL, V18, pR751, DOI 10.1016/j.cub.2008.06.044; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Halle S, 1995, J BIOL RHYTHM, V10, P211, DOI 10.1177/074873049501000304; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; LEWIS WJ, 1988, NATURE, V331, P257, DOI 10.1038/331257a0; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Maeda T, 2000, EXP APPL ACAROL, V24, P415, DOI 10.1023/A:1006449108245; MARTINHEIL, 2008, NEW PHYTOL, V178, P41; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Pyza E, 2001, J INSECT PHYSIOL, V47, P897, DOI 10.1016/S0022-1910(01)00062-2; Shiojiri K, 2006, PLOS BIOL, V4, P1044, DOI 10.1371/journal.pbio.0040164; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; Wei JN, 2006, CHEM SENSES, V31, P467, DOI 10.1093/chemse/bjj051; Wei JN, 2006, PLANTA, V224, P279, DOI 10.1007/s00425-005-0212-x; Wei JN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000852	32	12	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11064	10.1371/journal.pone.0011064	http://dx.doi.org/10.1371/journal.pone.0011064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20552008	Green Published, gold, Green Submitted			2022-12-25	WOS:000278599600020
J	McNulty, SN; Foster, JM; Mitreva, M; Hotopp, JCD; Martin, J; Fischer, K; Wu, B; Davis, PJ; Kumar, S; Brattig, NW; Slatko, BE; Weil, GJ; Fischer, PU				McNulty, Samantha N.; Foster, Jeremy M.; Mitreva, Makedonka; Hotopp, Julie C. Dunning; Martin, John; Fischer, Kerstin; Wu, Bo; Davis, Paul J.; Kumar, Sanjay; Brattig, Norbert W.; Slatko, Barton E.; Weil, Gary J.; Fischer, Peter U.			Endosymbiont DNA in Endobacteria-Free Filarial Nematodes Indicates Ancient Horizontal Genetic Transfer	PLOS ONE			English	Article							INTRACELLULAR BACTERIA; INTERFERING RNAS; BRUGIA-MALAYI; MOUSE OOCYTES; WOLBACHIA; EVOLUTION; TRANSCRIPTION; PSEUDOGENES; EUKARYOTES; EXPRESSION	Background: Wolbachia are among the most abundant symbiotic microbes on earth; they are present in about 66% of all insect species, some spiders, mites and crustaceans, and most filarial nematode species. Infected filarial nematodes, including many pathogens of medical and veterinary importance, depend on Wolbachia for proper development and survival. The mechanisms behind this interdependence are not understood. Interestingly, a minority of filarial species examined to date are naturally Wolbachia-free. Methodology/Principal Findings: We used 454 pyrosequencing to survey the genomes of two distantly related Wolbachia-free filarial species, Acanthocheilonema viteae and Onchocerca flexuosa. This screen identified 49 Wolbachia-like DNA sequences in A. viteae and 114 in O. flexuosa. qRT-PCR reactions detected expression of 30 Wolbachia-like sequences in A. viteae and 56 in O. flexuosa. Approximately half of these appear to be transcribed from pseudogenes. In situ hybridization showed that two of these pseudogene transcripts were specifically expressed in developing embryos and testes of both species. Conclusions/Significance: These results strongly suggest that the last common ancestor of extant filarial nematodes was infected with Wolbachia and that this former endosymbiont contributed to their genome evolution. Horizontally transferred Wolbachia DNA may explain the ability of some filarial species to live and reproduce without the endosymbiont while other species cannot.	[McNulty, Samantha N.; Fischer, Kerstin; Weil, Gary J.; Fischer, Peter U.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; [Foster, Jeremy M.; Wu, Bo; Davis, Paul J.; Kumar, Sanjay; Slatko, Barton E.] New England Biolabs Inc, Ipswich, MA USA; [Mitreva, Makedonka; Martin, John] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA; [Hotopp, Julie C. Dunning] Univ Maryland, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA; [Brattig, Norbert W.] Bernhard Nocht Inst Trop Med, Hamburg, Germany	Washington University (WUSTL); New England Biolabs; Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; Bernhard Nocht Institut fur Tropenmedizin	McNulty, SN (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA.	snpiper@artsci.wustl.edu	Fischer, Peter/A-2746-2008; Dunning Hotopp, Julie/E-7762-2010; Kumar, Sanjay/AAO-2593-2021	Dunning Hotopp, Julie/0000-0003-3862-986X; Fischer, Peter/0000-0003-4558-3417; Mitreva, Makedonka/0000-0001-9572-3436	University of Maryland School of Medicine; Barnes Jewish Hospital Foundation; New England Biolabs; NSF [EF-0826732]; NIH [T32-AI007172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172] Funding Source: NIH RePORTER; Emerging Frontiers [0826732] Funding Source: National Science Foundation	University of Maryland School of Medicine; Barnes Jewish Hospital Foundation; New England Biolabs; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Sequencing studies were funded by the University of Maryland School of Medicine internal funds, The Barnes Jewish Hospital Foundation, New England Biolabs, NSF Grant EF-0826732 to JCDH and NIH T32-AI007172 for SNM. JF, BW, PJD, SK and BS are employees of New England Biolabs; this funder is therefore considered by PLoS ONE to have played a role in study design, data collection and analysis; however the authors confirm that the funder did not play a direct role in the study.	ASH LR, 1970, J PARASITOL, V56, P969, DOI 10.2307/3277515; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Baranov PV, 2001, NUCLEIC ACIDS RES, V29, P264, DOI 10.1093/nar/29.1.264; Bird DM, 2003, INT J PARASITOL, V33, P1269, DOI 10.1016/S0020-7519(03)00160-7; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Casiraghi M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/j.ijpara.2003.10.004; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Hoerauf A, 2003, MED MICROBIOL IMMUN, V192, P211, DOI 10.1007/s00430-002-0174-6; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; KOZEK WJ, 1977, J PARASITOL, V63, P992, DOI 10.2307/3279832; Lucius R., 1995, Applied Parasitology, V36, P22; McGarry Helen F., 2003, Filaria Journal, V2, pUnpaginated, DOI 10.1186/1475-2883-2-9; Mitreva Makedonka, 2009, V532, P517, DOI [10.1007/978-1-60327-853-9_30, 10.1007/978-1-60327-853-9-30]; NIKOH N, 2007, GENOME RES; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; PLENGEBONIG A, 1995, PARASITOL RES, V81, P66, DOI 10.1007/BF00932419; PODLAHA O, 2009, TRENDS GENET; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Scott AL, 2009, PARASITOL INT, V58, P6, DOI 10.1016/j.parint.2008.09.003; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Whitaker JW, 2009, BIOCHEM SOC T, V37, P792, DOI 10.1042/BST0370792; Williams DL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-397; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	35	84	86	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11029	10.1371/journal.pone.0011029	http://dx.doi.org/10.1371/journal.pone.0011029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543958	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000278557600008
J	Chambers, R; Takimoto, T				Chambers, Raychel; Takimoto, Toru			Trafficking of Sendai Virus Nucleocapsids Is Mediated by Intracellular Vesicles	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PLASMA-MEMBRANE TRANSPORT; CANINE KIDNEY-CELLS; DYNEIN LIGHT-CHAIN; MATRIX PROTEIN; MARBURG-VIRUS; RAB PROTEINS; LIVING CELLS; P-PROTEIN; BASOLATERAL TRANSPORT	Background: Paramyxoviruses are assembled at the plasma membrane budding sites after synthesis of all the structural components in the cytoplasm. Although viral ribonuclocapsid (vRNP) is an essential component of infectious virions, the process of vRNP translocation to assembly sites is poorly understood. Methodology/Principal Findings: To analyze real-time trafficking of vRNPs in live infected cells, we created a recombinant Sendai virus (SeV), rSeVLeGFP, which expresses L protein fused to enhanced green fluorescent protein (eGFP). The rSeVLeGFP showed similar growth kinetics compared to wt SeV, and newly synthesized LeGFP could be detected as early as 8 h postinfection. The majority of LeGFP co-localized with other components of vRNPs, NP and P proteins, suggesting the fluorescent signals of LeGFP represent the locations of vRNPs. Analysis of LeGFP movement using time-lapse digital video microscopy revealed directional and saltatory movement of LeGFP along microtubules. Treatment of the cells with nocodazole restricted vRNP movement and reduced progeny virion production without affecting viral protein synthesis, suggesting the role of microtubules in vRNP trafficking and virus assembly. Further study with an electron microscope showed close association of vRNPs with intracellular vesicles present in infected cells. In addition, the vRNPs co-localized with Rab11a protein, which is known to regulate the recycling endocytosis pathway and Golgi-to-plasma membrane trafficking. Simultaneous movement between LeGFP and Rab11a was also observed in infected cells, which constitutively express mRFP-tagged Rab11a. Involvement of recycling endosomes in vRNP translocation was also suggested by the fact that vRNPs move concomitantly with recycling transferrin labeled with Alexa 594. Conclusions/Significance: Collectively, our results strongly suggest a previously unrecognized involvement of the intracellular vesicular trafficking pathway in vRNP translocation and provide new insights into the transport of viral structural components to the assembly sites of enveloped viruses.	[Chambers, Raychel; Takimoto, Toru] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Chambers, R (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	toru_takimoto@urmc.rochester.edu		Tripp, Ralph/0000-0002-2924-9956	National Institute of Allergy and Infectious Disease [AI055940]; NIH [T32 AI007362]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055940, T32AI007362, R01AI081779] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI055940 from the National Institute of Allergy and Infectious Disease. RC was supported by NIH training grant T32 AI007362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Bousse T, 2002, J VIROL, V76, P8244, DOI 10.1128/JVI.76.16.8244-8251.2002; Brignati MJ, 2003, J VIROL, V77, P4888, DOI 10.1128/JVI.77.8.4888-4898.2003; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Coronel EC, 2001, J VIROL, V75, P1117, DOI 10.1128/JVI.75.3.1117-1123.2001; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hammer JA, 2002, CURR OPIN CELL BIOL, V14, P69, DOI 10.1016/S0955-0674(01)00296-4; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; HOMANN HE, 1991, J VIROL, V65, P1304, DOI 10.1128/JVI.65.3.1304-1309.1991; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; IKONEN E, 1995, CELL, V81, P571, DOI 10.1016/0092-8674(95)90078-0; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kato A, 2002, J VIROL, V76, P7114, DOI 10.1128/JVI.76.14.7114-7124.2002; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; Kolesnikova L, 2004, J VIROL, V78, P12277, DOI 10.1128/JVI.78.22.12277-12287.2004; Kolesnikova L, 2004, J VIROL, V78, P2382, DOI 10.1128/JVI.78.5.2382-2393.2004; Kolesnikova L, 2002, J VIROL, V76, P1825, DOI 10.1128/JVI.76.4.1825-1838.2002; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lamb R.A., 2006, FIELDS VIROLOGY, P1449; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Meyers JM, 2002, J BIOL CHEM, V277, P49003, DOI 10.1074/jbc.M205728200; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Poisson N, 2001, J GEN VIROL, V82, P2691, DOI 10.1099/0022-1317-82-11-2691; Prekeris R, 2001, J BIOL CHEM, V276, P38966, DOI 10.1074/jbc.M106133200; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021; SANDERSON CM, 1993, J VIROL, V67, P651, DOI 10.1128/JVI.67.2.651-663.1993; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schonteich E, 2008, J CELL SCI, V121, P3824, DOI 10.1242/jcs.032441; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Suikkanen S, 2003, J VIROL, V77, P10270, DOI 10.1128/JVI.77.19.10270-10279.2003; TAKAHASHI T, 1992, GENET ANAL-BIOMOL E, V9, P91, DOI 10.1016/1050-3862(92)90004-O; Takimoto T, 2004, J VIROL, V78, P6043, DOI 10.1128/JVI.78.11.6043-6047.2004; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Tang Y, 1999, J VIROL, V73, P10508, DOI 10.1128/JVI.73.12.10508-10513.1999; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Utley TJ, 2008, P NATL ACAD SCI USA, V105, P10209, DOI 10.1073/pnas.0712144105; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhan X, 2008, VACCINE, V26, P3480, DOI 10.1016/j.vaccine.2008.04.022	61	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10994	10.1371/journal.pone.0010994	http://dx.doi.org/10.1371/journal.pone.0010994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20543880	Green Published, gold, Green Submitted			2022-12-25	WOS:000278465900011
J	Concepcion, F; Chen, J				Concepcion, Francis; Chen, Jeannie			Q344ter Mutation Causes Mislocalization of Rhodopsin Molecules That Are Catalytically Active: A Mouse Model of Q344ter-Induced Retinal Degeneration	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; LIGHT-INDUCED DAMAGE; 2 APOPTOTIC PATHWAYS; PHOTORECEPTOR APOPTOSIS; MONOCLONAL-ANTIBODIES; BOVINE RHODOPSIN; TRANSGENIC MICE; CELL-DEATH; PROTEIN; TRANSPORT	Q344ter is a naturally occurring rhodopsin mutation in humans that causes autosomal dominant retinal degeneration through mechanisms that are not fully understood, but are thought to involve an early termination that removed the trafficking signal, QVAPA, leading to its mislocalization in the rod photoreceptor cell. To better understand the disease mechanism(s), transgenic mice that express Q344ter were generated and crossed with rhodopsin knockout mice. Dark-reared Q344ter(rho+/-) mice exhibited retinal degeneration, demonstrating that rhodopsin mislocalization caused photoreceptor cell death. This degeneration is exacerbated by light-exposure and is correlated with the activation of transducin as well as other G-protein signaling pathways. We observed numerous sub-micrometer sized vesicles in the interphotoreceptor space of Q344ter(rho+/-) and Q344ter(rho-/-) retinas, similar to that seen in another rhodopsin mutant, P347S. Whereas light microscopy failed to reveal outer segment structures in Q344ter(rho-/-) rods, shortened and disorganized rod outer segment structures were visible using electron microscopy. Thus, some Q344ter molecules trafficked to the outer segment and formed disc structures, albeit inefficiently, in the absence of full length wildtype rhodopsin. These findings helped to establish the in vivo role of the QVAPA domain as well as the pathways leading to Q344ter-induced retinal degeneration.	[Concepcion, Francis] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Concepcion, F (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA.	jeannie@usc.edu			National Institutes of Health [EY12155]; Vision Core Grant; NATIONAL EYE INSTITUTE [R01EY012155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported the National Institutes of Health (EY12155) to JC and by a Vision Core Grant to Doheny Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Berson EL, 2002, INVEST OPHTH VIS SCI, V43, P3027; BLANKS JC, 1992, EXP EYE RES, V54, P637, DOI 10.1016/0014-4835(92)90019-O; Brill E, 2007, INVEST OPHTH VIS SCI, V48, P5445, DOI 10.1167/iovs.06-1402; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Chen JY, 2006, J NEUROSCI, V26, P11929, DOI 10.1523/JNEUROSCI.3212-06.2006; Concepcion F, 2002, VISION RES, V42, P417, DOI 10.1016/S0042-6989(01)00195-X; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Deretic D, 1996, J BIOL CHEM, V271, P2279, DOI 10.1074/jbc.271.4.2279; Gregory-Evans K, 1998, TRENDS GENET, V14, P103, DOI 10.1016/S0168-9525(98)01402-4; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Hagstrom SA, 2001, INVEST OPHTH VIS SCI, V42, P1955; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; HECKENLIVELY JR, 1995, P NATL ACAD SCI USA, V92, P11100, DOI 10.1073/pnas.92.24.11100; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jozwick C, 2006, EXP EYE RES, V83, P1074, DOI 10.1016/j.exer.2006.05.012; KANAHO Y, 1984, J BIOL CHEM, V259, P7378; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; LAIRD DW, 1988, INVEST OPHTH VIS SCI, V29, P419; Lee ES, 2007, INVEST OPHTH VIS SCI, V48, P2868, DOI 10.1167/iovs.06-0035; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2000, METHOD ENZYMOL, V316, P167; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Naash MI, 1996, J NEUROSCI, V16, P7853; Noell W K, 1966, Invest Ophthalmol, V5, P450; NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3; Oguni N, 1996, HISTOCHEM CELL BIOL, V106, P235; Oh KT, 2003, AM J OPHTHALMOL, V136, P306, DOI 10.1016/S0002-9394(03)00206-X; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Organisciak DT, 2003, INVEST OPHTH VIS SCI, V44, P486, DOI 10.1167/iovs.02-0708; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Roca A, 2004, NEUROSCIENCE, V129, P779, DOI 10.1016/j.neuroscience.2004.08.021; Shi G, 2004, REC ADV HUM BIOL, V10, P93; Sim-Selley LJ, 2002, METHOD ENZYMOL, V344, P42; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tam BM, 2006, J NEUROSCI, V26, P203, DOI 10.1523/JNEUROSCI.3849-05.2006; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Taylor MR, 2000, METHOD ENZYMOL, V316, P536; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Vaughan DK, 2003, INVEST OPHTH VIS SCI, V44, P848, DOI 10.1167/iovs.02-0709; Wang DY, 2005, CLIN CHIM ACTA, V351, P5, DOI 10.1016/j.cccn.2004.08.004; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; White DA, 2007, INVEST OPHTH VIS SCI, V48, P1942, DOI 10.1167/iovs.06-1131; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	69	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10904	10.1371/journal.pone.0010904	http://dx.doi.org/10.1371/journal.pone.0010904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532191	Green Submitted, Green Published, gold			2022-12-25	WOS:000278284700003
J	Tonge, PD; Olariu, V; Coca, D; Kadirkamanathan, V; Burrell, KE; Billings, SA; Andrews, PW				Tonge, Peter D.; Olariu, Victor; Coca, Daniel; Kadirkamanathan, Visakan; Burrell, Kelly E.; Billings, Stephen A.; Andrews, Peter W.			Prepatterning in the Stem Cell Compartment	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; TERATOCARCINOMA CELLS; INFORMATION CRITERION; LINEAGE-COMMITMENT; NEURAL PRECURSORS; PROGENITOR CELLS; MODEL SELECTION; GLOBO-SERIES; IN-VITRO; PLURIPOTENCY	The mechanism by which an apparently uniform population of cells can generate a heterogeneous population of differentiated derivatives is a fundamental aspect of pluripotent and multipotent stem cell behaviour. One possibility is that the environment and the differentiation cues to which the cells are exposed are not uniform. An alternative, but not mutually exclusive possibility is that the observed heterogeneity arises from the stem cells themselves through the existence of different interconvertible substates that pre-exist before the cells commit to differentiate. We have tested this hypothesis in the case of apparently homogeneous pluripotent human embryonal carcinoma (EC) stem cells, which do not follow a uniform pattern of differentiation when exposed to retinoic acid. Instead, they produce differentiated progeny that include both neuronal and non-neural phenotypes. Our results suggest that pluripotent NTERA2 stem cells oscillate between functionally distinct substates that are primed to select distinct lineages when differentiation is induced.	[Tonge, Peter D.; Burrell, Kelly E.; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Olariu, Victor; Coca, Daniel; Kadirkamanathan, Visakan; Billings, Stephen A.] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Tonge, PD (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	p.w.andrews@sheffield.ac.uk		Andrews, Peter/0000-0001-7215-4410; Kadirkamanathan, Visakan/0000-0002-4243-2501	Medical Research Council; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council; European Research Council; European Union [LSHG-CT-2006-018739]; EPSRC [EP/G042209/1, EP/H00453X/1] Funding Source: UKRI; MRC [G0802627, G0700785] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H00453X/1, EP/G042209/1] Funding Source: researchfish; Medical Research Council [G0802627, G0700785] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge that this work was supported by funding from the Medical Research Council (www.mrc.ac.uk), the Engineering and Physical Sciences Research Council (www.epsrc.ac.uk), Biotechnology and Biological Sciences Research Council (www.bbscr.ac.uk), European Research Council (erc.europa.eu) and the ESTOOLS consortium (www.estools.eu), under the Sixth Research Framework Programme of the European Union contract LSHG-CT-2006-018739. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H, 1973, INT S INF THEOR, P267, DOI DOI 10.2307/2334537; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Bozdogan H, 2000, J MATH PSYCHOL, V44, P62, DOI 10.1006/jmps.1999.1277; BURNHAM KP, 1999, MODEL SELECTION MULT; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Crawford TQ, 2007, DEV DYNAM, V236, P886, DOI 10.1002/dvdy.21083; Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; GOKHALE DV, 1978, COMMUNICATIONS STAT, V10, P987; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; HUEBNER K, 1981, P NATL ACAD SCI-BIOL, V78, P5071, DOI 10.1073/pnas.78.8.5071; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KOHLER G, 1975, NATURE, V256, P497; KULLBACK DVG, 1978, INFORM CONTINGENCY T; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; WAN JKS, 2008, NUCL ACIDS RES, V6; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	45	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10901	10.1371/journal.pone.0010901	http://dx.doi.org/10.1371/journal.pone.0010901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531938	Green Accepted, gold, Green Published			2022-12-25	WOS:000278222100030
J	Zhang, Q; Yang, RY; Tang, JJ; Yang, HS; Hu, SJ; Chen, X				Zhang, Qian; Yang, Ruyi; Tang, Jianjun; Yang, Haishui; Hu, Shuijin; Chen, Xin			Positive Feedback between Mycorrhizal Fungi and Plants Influences Plant Invasion Success and Resistance to Invasion	PLOS ONE			English	Article							SOLIDAGO-CANADENSIS L.; SOIL BIOTA; COMMUNITY STRUCTURE; GROWTH; GRASS; NITROGEN; COLONIZATION; COEXISTENCE; SERPENTINE; DIVERSITY	Negative or positive feedback between arbuscular mycorrhizal fungi (AMF) and host plants can contribute to plant species interactions, but how this feedback affects plant invasion or resistance to invasion is not well known. Here we tested how alterations in AMF community induced by an invasive plant species generate feedback to the invasive plant itself and affect subsequent interactions between the invasive species and its native neighbors. We first examined the effects of the invasive forb Solidago canadensis L. on AMF communities comprising five different AMF species. We then examined the effects of the altered AMF community on mutualisms formed with the native legume forb species Kummerowia striata (Thunb.) Schindl. and on the interaction between the invasive and native plants. The host preferences of the five AMF were also assessed to test whether the AMF form preferred mutualistic relations with the invasive and/or the native species. We found that S. canadensis altered AMF spore composition by increasing one AMF species (Glomus geosporum) while reducing Glomus mosseae, which is the dominant species in the field. The host preference test showed that S. canadensis had promoted the abundance of AMF species (G. geosporum) that most promoted its own growth. As a consequence, the altered AMF community enhanced the competitiveness of invasive S. canadensis at the expense of K. striata. Our results demonstrate that the invasive S. canadensis alters soil AMF community composition because of fungal-host preference. This change in the composition of the AMF community generates positive feedback to the invasive S. canadensis itself and decreases AM associations with native K. striata, thereby making the native K. striata less dominant.	[Zhang, Qian; Yang, Ruyi; Tang, Jianjun; Yang, Haishui; Chen, Xin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Ruyi] Anhui Normal Univ, Coll Environm Sci, Wuhu, Peoples R China; [Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	Zhejiang University; Anhui Normal University; University of North Carolina; North Carolina State University	Chen, X (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chen-tang@zju.edu.cn	Schlyter, Fredrik/F-8567-2015	Schlyter, Fredrik/0000-0002-1244-0308; Hu, Shuijin/0000-0002-3225-5126; Yang, Haishui/0000-0001-7255-9653	Zhejiang Provincial Natural Science Foundation of China [Z5090089]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20070335079]; Natural Science Foundation of China (NSFC) [3073020, 30870405]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Zhejiang Provincial Natural Science Foundation of China (No. Z5090089), the Research Fund for the Doctoral Program of Higher Education of China (RFDP, No. 20070335079), and the Natural Science Foundation of China (NSFC, No. 3073020 and 30870405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 1996, J ECOL, V84, P71, DOI 10.2307/2261701; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; Bray SR, 2003, ECOL APPL, V13, P565, DOI 10.1890/1051-0761(2003)013[0565:MDAGPA]2.0.CO;2; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Carey EV, 2004, PLANT ECOL, V172, P133, DOI 10.1023/B:VEGE.0000026031.14086.f1; Chen X, 2005, APPL SOIL ECOL, V28, P259, DOI 10.1016/j.apsoil.2004.07.009; Chen X, 2004, AGR ECOSYST ENVIRON, V102, P377, DOI 10.1016/j.agee.2003.08.006; Cornejo P, 2004, FEMS MICROBIOL LETT, V241, P265, DOI 10.1016/j.femsle.2004.10.030; Eom AH, 2000, OECOLOGIA, V122, P435, DOI 10.1007/s004420050050; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Kiers ET, 2006, ECOLOGY, V87, P1627, DOI 10.1890/0012-9658(2006)87[1627:MSITAM]2.0.CO;2; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kowalchuk GA, 2002, MOL ECOL, V11, P571, DOI 10.1046/j.0962-1083.2001.01457.x; Liang ZB, 2008, SOIL BIOL BIOCHEM, V40, P956, DOI 10.1016/j.soilbio.2007.11.016; Lu JZ, 2007, ACTA PHYTOTAXON SIN, V45, P670, DOI 10.1360/aps06200; Marler MJ, 1999, ECOLOGY, V80, P1180, DOI 10.1890/0012-9658(1999)080[1180:MIECEO]2.0.CO;2; Moora M, 2004, FUNCT ECOL, V18, P554, DOI 10.1111/j.0269-8463.2004.00876.x; Mummey DL, 2006, PLANT SOIL, V288, P81, DOI 10.1007/s11104-006-9091-6; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; SCHEUBLIN TR, 2007, J ECOL, V85, P2682; Seifert EK, 2009, ECOLOGY, V90, P1055, DOI 10.1890/08-0419.1; SEMPLE JC, 2006, FLORA N AM MAGNOLI 2; SEMPLE JC, 2006, FLORA N AM MAGNOLI 7; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Stampe ED, 2003, OIKOS, V100, P362, DOI 10.1034/j.1600-0706.2003.12006.x; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Sykorova Z, 2007, APPL ENVIRON MICROB, V73, P5426, DOI 10.1128/AEM.00987-07; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; Tang J.J., 2009, B SCI TECHNOLOGY, V25, P233; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 2003, NEW PHYTOL, V157, P569, DOI 10.1046/j.1469-8137.2003.00688.x; van der Putten WH, 2007, ECOLOGY, V88, P978, DOI 10.1890/06-1051; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vogelsang KM, 2009, ECOLOGY, V90, P399, DOI 10.1890/07-2144.1; Weber E, 2001, CONSERV BIOL, V15, P122, DOI 10.1046/j.1523-1739.2001.99424.x; Yang RY, 2007, ALLELOPATHY J, V19, P241; ZANBINKI CA, 2002, FUNCT ECOL, V16, P758; Zhang Q, 2007, ALLELOPATHY J, V20, P71; Zhang SS, 2009, APPL SOIL ECOL, V41, P215, DOI 10.1016/j.apsoil.2008.11.002	60	126	144	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12380	10.1371/journal.pone.0012380	http://dx.doi.org/10.1371/journal.pone.0012380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20548795	Green Submitted, gold, Green Published			2022-12-25	WOS:000281154300014
J	Jensen, MA; Fukushima, M; Davis, RW				Jensen, Michael A.; Fukushima, Marilyn; Davis, Ronald W.			DMSO and Betaine Greatly Improve Amplification of GC-Rich Constructs in De Novo Synthesis	PLOS ONE			English	Article							FACTOR-II RECEPTOR; ESCHERICHIA-COLI; PCR-AMPLIFICATION; DNA AMPLIFICATION; REPEAT SEQUENCES; GENE SYNTHESIS; GENOME; CANCER; EXPRESSION; GROWTH	In Synthetic Biology, de novo synthesis of GC-rich constructs poses a major challenge because of secondary structure formation and mispriming. While there are many web-based tools for codon optimizing difficult regions, no method currently exists that allows for potentially phenotypically important sequence conservation. Therefore, to overcome these limitations in researching GC-rich genes and their non-coding elements, we explored the use of DMSO and betaine in two conventional methods of assembly and amplification. For this study, we compared the polymerase (PCA) and ligase-based (LCR) methods for construction of two GC-rich gene fragments implicated in tumorigenesis, IGF2R and BRAF. Though we found no benefit in employing either DMSO or betaine during the assembly steps, both additives greatly improved target product specificity and yield during PCR amplification. Of the methods tested, LCR assembly proved far superior to PCA, generating a much more stable template to amplify from. We further report that DMSO and betaine are highly compatible with all other reaction components of gene synthesis and do not require any additional protocol modifications. Furthermore, we believe either additive will allow for the production of a wide variety of GC-rich gene constructs without the need for expensive and time-consuming sample extraction and purification prior to downstream application.	[Jensen, Michael A.; Fukushima, Marilyn; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Stanford University	Jensen, MA (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	m.a.jensen@stanford.edu	; Kjaer, Andreas/E-8932-2015	Bjorkling, Fredrik/0000-0001-7018-8334; Kjaer, Andreas/0000-0002-2706-5547; Erichsen, Kamille Dumong/0000-0002-8814-7220	National Institutes of Health [P01-HG000205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health [P01-HG000205]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au LC, 1998, BIOCHEM BIOPH RES CO, V248, P200, DOI 10.1006/bbrc.1998.8929; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; BRODY RS, 1986, J BIOL CHEM, V261, P7136; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P4371, DOI 10.1093/nar/20.16.4371; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; D'Souza GGM, 2007, PHARM RES-DORDR, V24, P228, DOI 10.1007/s11095-006-9150-y; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Drouin R, 2005, BIOCHEM CELL BIOL, V83, P147, DOI 10.1139/O04-134; FRACKMAN S, 1998, BETAINE DMSO ENHANCI; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601; Hapgood JP, 2001, CELL BIOL INT, V25, P17, DOI 10.1006/cbir.2000.0674; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jayaraj S, 2005, NUCLEIC ACIDS RES, V33, P3011, DOI 10.1093/nar/gki614; KHORANA HG, 1979, SCIENCE, V203, P614, DOI 10.1126/science.366749; Kotsinas A, 2008, CANCER LETT, V259, P177, DOI 10.1016/j.canlet.2007.10.013; Marcuello E, 2004, INT J CANCER, V112, P733, DOI 10.1002/ijc.20487; MCCONLOGUE L, 1988, NUCLEIC ACIDS RES, V16, P9869, DOI 10.1093/nar/16.20.9869; McDowell DG, 1998, NUCLEIC ACIDS RES, V26, P3340, DOI 10.1093/nar/26.14.3340; Meyer Peter, 2003, J Carcinog, V2, P7, DOI 10.1186/1477-3163-2-7; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; PANZER S, 1995, STEM CELLS, V13, P146, DOI 10.1002/stem.5530130206; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Sahdev S, 2007, MOL CELL PROBE, V21, P303, DOI 10.1016/j.mcp.2007.03.004; Sanli G, 2001, J MOL MICROB BIOTECH, V3, P123; SARKAR G, 1990, NUCLEIC ACIDS RES, V18, P7465, DOI 10.1093/nar/18.24.7465; Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Spiess AN, 2004, CLIN CHEM, V50, P1256, DOI 10.1373/clinchem.2004.031336; Stahler P, 2006, J BIOTECHNOL, V124, P206, DOI 10.1016/j.jbiotec.2005.12.011; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; WEISSMAN SM, 2000, Patent No. 6114150; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; Zavras AI, 2003, CANCER RES, V63, P296; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	107	120	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11024	10.1371/journal.pone.0011024	http://dx.doi.org/10.1371/journal.pone.0011024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20885974	Green Published, Green Submitted, gold			2022-12-25	WOS:000278662900007
J	Barott, K; Smith, J; Dinsdale, E; Hatay, M; Sandin, S; Rohwer, F				Barott, Katie; Smith, Jennifer; Dinsdale, Elizabeth; Hatay, Mark; Sandin, Stuart; Rohwer, Forest			Hyperspectral and Physiological Analyses of Coral-Algal Interactions	PLOS ONE			English	Article							CLIMATE-CHANGE; REEF COMMUNITY; MASS MORTALITY; ORGANIC-CARBON; PHASE-SHIFTS; COMPETITION; FLUORESCENCE; REFLECTANCE; DEGRADATION; MACROALGAE	Space limitation leads to competition between benthic, sessile organisms on coral reefs. As a primary example, reef-building corals are in direct contact with each other and many different species and functional groups of algae. Here we characterize interactions between three coral genera and three algal functional groups using a combination of hyperspectral imaging and oxygen microprofiling. We also performed in situ interaction transects to quantify the relative occurrence of these interaction on coral reefs. These studies were conducted in the Southern Line Islands, home to some of the most remote and near-pristine reefs in the world. Our goal was to determine if different types of coral-coral and coral-algal interactions were characterized by unique fine-scale physiological signatures. This is the first report using hyperspectral imaging for characterization of marine benthic organisms at the micron scale and proved to be a valuable tool for discriminating among different photosynthetic organisms. Consistent patterns emerged in physiology across different types of competitive interactions. In cases where corals were in direct contact with turf or macroalgae, there was a zone of hypoxia and altered pigmentation on the coral. In contrast, interaction zones between corals and crustose coralline algae (CCA) were not hypoxic and the coral tissue was consistent across the colony. Our results suggest that at least two main characteristic coral interaction phenotypes exist: 1) hypoxia and coral tissue disruption, seen with interactions between corals and fleshy turf and/or some species of macroalgae, and 2) no hypoxia or tissue disruption, seen with interactions between corals and some species of CCA. Hyperspectral imaging in combination with oxygen profiling provided useful information on competitive interactions between benthic reef organisms, and demonstrated that some turf and fleshy macroalgae can be a constant source of stress for corals, while CCA are not.	[Barott, Katie; Dinsdale, Elizabeth; Hatay, Mark; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Smith, Jennifer; Sandin, Stuart] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Barott, K (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	katiebarott@gmail.com	Rohwer, Forest/AAC-5315-2019	dinsdale, elizabeth/0000-0002-2177-203X; Obura, David/0000-0003-2256-6649; Barott, Katie/0000-0001-7371-4870; Rohwer, Forest/0000-0003-1548-5429	San Diego State University; Gordon and Betty Moore Foundation; Canadian Institute for Advanced Research; National Geographic Society; National Science Foundation	San Diego State University; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by San Diego State University, the Gordon and Betty Moore Foundation, and the Canadian Institute for Advanced Research. The Southern Line Islands expedition was organized and sponsored by the National Geographic Society. KB was supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; BENAYAHU Y, 1981, B MAR SCI, V31, P514; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; CARPENTER RC, 1988, P NATL ACAD SCI USA, V85, P511, DOI 10.1073/pnas.85.2.511; CHORNESKY EA, 1983, BIOL BULL, V165, P569, DOI 10.2307/1541466; CHORNESKY EA, 1989, ECOLOGY, V70, P843, DOI 10.2307/1941353; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hattery D, 2002, 31ST APPLIED IMAGERY PATTERN RECOGNITION WORKSHOP, PROCEEDINGS, P124; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hochberg EJ, 2004, CORAL REEFS, V23, P84, DOI 10.1007/s00338-003-0350-1; Hochberg EJ, 2000, CORAL REEFS, V19, P164, DOI 10.1007/s003380000087; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; KAWAGUTI S, 1944, PHYSL REEF CORALS, V6; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; LOGAN A, 1984, CORAL REEFS, V3, P131, DOI 10.1007/BF00301957; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Mazel CH, 1997, OPT ENG, V36, P2612, DOI 10.1117/1.601486; Mazel CH, 1997, P SOC PHOTO-OPT INS, V2963, P240, DOI 10.1117/12.266450; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Miller MW, 1998, OCEANOGR MAR BIOL<D>, V36, P65; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Ostrander GK, 2000, P NATL ACAD SCI USA, V97, P5297, DOI 10.1073/pnas.090104897; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pinter PJ, 2003, PHOTOGRAMM ENG REM S, V69, P647, DOI 10.14358/PERS.69.6.647; Rouse Jr. J.W., 1974, MONITORING VERNAL AD; Sabins FF, 1999, ORE GEOL REV, V14, P157, DOI 10.1016/S0169-1368(99)00007-4; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SALIH A, 1997, P AUSTR COR REEF SOC, P217; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SCHLICHTER D, 1994, OECOLOGIA, V99, P124, DOI 10.1007/BF00317092; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tanner JE, 1997, J EXP MAR BIOL ECOL, V214, P19, DOI 10.1016/S0022-0981(97)00024-5; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; VOGEL A, 2007, J BIOMED OPT, V12; WELLINGTON GM, 1980, OECOLOGIA, V47, P340, DOI 10.1007/BF00398527; Wilkinson C., 2004, STATUS CORAL REEFS W; Zawada DG, 2003, LIMNOL OCEANOGR, V48, P412, DOI 10.4319/lo.2003.48.1_part_2.0412	57	103	106	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8043	10.1371/journal.pone.0008043	http://dx.doi.org/10.1371/journal.pone.0008043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956632	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828100006
J	Li, YH; Lu, WY; King, TD; Liu, CC; Bijur, GN; Bu, GJ				Li, Yonghe; Lu, Wenyan; King, Taj D.; Liu, Chia-Chen; Bijur, Gautam N.; Bu, Guojun			Dkk1 Stabilizes Wnt Co-Receptor LRP6: Implication for Wnt Ligand-Induced LRP6 Down-Regulation	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-6; KREMEN PROTEINS; WINGLESS; INTERNALIZATION; DICKKOPF-1; MECHANISM; ENDOCYTOSIS; ACTIVATION; INDUCTION; PATHWAYS	Background: The low density lipoprotein receptor-related protein-6 (LRP6) is an essential co-receptor for canonical Wnt signaling. Dickkopf 1 (Dkk1), a major secreted Wnt signaling antagonist, binds to LRP6 with high affinity and prevents the Frizzled-Wnt-LRP6 complex formation in response to Wnts. Previous studies have demonstrated that Dkk1 promotes LRP6 internalization and degradation when it forms a ternary complex with the cell surface receptor Kremen. Methodology/Principal Findings: In the present study, we found that transfected Dkk1 induces LRP6 accumulation while inhibiting Wnt/LRP6 signaling. Treatment with Dkk1-conditioned medium or recombinant Dkk1 protein stabilized LRP6 with a prolonged half-life and induces LRP6 accumulation both at the cell surface and in endosomes. We also demonstrated that Kremen2 co-expression abrogated the effect of Dkk1 on LRP6 accumulation, indicating that the effect of Kremen2 is dominant over Dkk1 regulation of LRP6. Furthermore, we found that Wnt3A treatment induces LRP6 down-regulation, an effect paralleled with a Wnt/LRP6 signaling decay, and that Dkk1 treatment blocked Wnt3A-induced LRP6 down-regulation. Finally, we found that LRP6 turnover was blocked by an inhibitor of caveolae-mediated endocytosis. Conclusions/Significance: Our results reveal a novel role for Dkk1 in preventing Wnt ligand-induced LRP6 down-regulation and contribute significantly to our understanding of Dkk1 function in Wnt/LRP6 signaling.	[Li, Yonghe; Lu, Wenyan; King, Taj D.] So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA; [Li, Yonghe; Liu, Chia-Chen; Bu, Guojun] Washington Univ, St Louis Childrens Hosp, Dept Pediat, Sch Med, St Louis, MO 63110 USA; [Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bijur, Gautam N.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Li, YH (corresponding author), So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA.	y.li@sri.org; bu@wustl.edu		Du, Hanjian/0000-0002-2353-8802	National Institutes of Health [CA124531, AG031784, AG027924]; NATIONAL CANCER INSTITUTE [R01CA124531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG027924, R01AG027924, R01AG031784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported in part by grants from the National Institutes of Health CA124531 (to Y.L.), and AG031784 and AG027924 (to G. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Davidson G, 2002, DEVELOPMENT, V129, P5587, DOI 10.1242/dev.00154; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Sakane H, 2010, J CELL SCI, V123, P360, DOI 10.1242/jcs.058008; Schulze J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010309; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	40	93	97	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11014	10.1371/journal.pone.0011014	http://dx.doi.org/10.1371/journal.pone.0011014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543981	Green Published, gold, Green Submitted			2022-12-25	WOS:000278494900026
